PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Traboulsee, AL; Knox, KB; Machan, L; Zhao, YS; Yee, I; Rauscher, A; Klass, D; Szkup, P; Otani, R; Kopriva, D; Lala, S; Li, DK; Sadovnick, D				Traboulsee, Anthony L.; Knox, Katherine B.; Machan, Lindsay; Zhao, Yinshan; Yee, Irene; Rauscher, Alexander; Klass, Darren; Szkup, Peter; Otani, Robert; Kopriva, David; Lala, Shanti; Li, David K.; Sadovnick, Dessa			Prevalence of extracranial venous narrowing on catheter venography in people with multiple sclerosis, their siblings, and unrelated healthy controls: a blinded, case-control study	LANCET			English	Article							ENDOVASCULAR TREATMENT; INSUFFICIENCY; ASSOCIATION; DRAINAGE; FLOW	Background Chronic cerebrospinal venous insufficiency has been proposed as a unique combination of extracranial venous blockages and haemodynamic flow abnormalities that occurs only in patients with multiple sclerosis and not in healthy people. Initial reports indicated that all patients with multiple sclerosis had chronic cerebrospinal venous insufficiency. We aimed to establish the prevalence of venous narrowing in people with multiple sclerosis, unaffected full siblings, and unrelated healthy volunteers. Methods We did an assessor-blinded, case-control, multicentre study of people with multiple sclerosis, unaffected siblings, and unrelated healthy volunteers. We enrolled the study participants between January, 2011 and March, 2012, and they comprised 177 adults: 79 with multiple sclerosis, 55 siblings, and 43 unrelated controls, from three centres in Canada. We assessed narrowing of the internal jugular and azygous veins with catheter venography and ultrasound criteria for chronic cerebrospinal venous insufficiency proposed by Zamboni and colleagues. Catheter venography data were available for 149 participants and ultrasound data for 171 participants. Findings Catheter venography criteria for chronic cerebrospinal venous insufficiency were positive for one of 65 (2%) people with multiple sclerosis, one of 46 (2%) siblings, and one of 32 (3%) unrelated controls (p=1.0 for all comparisons). Greater than 50% narrowing of any major vein was present in 48 of 65 (74%) people with multiple sclerosis, 31 of 47 (66%) siblings (p=0.41 for comparison with patients with multiple sclerosis), and 26 of 37 (70%) unrelated controls (p=0.82). The ultrasound criteria for chronic cerebrospinal venous insufficiency were fulfilled in 35 of 79 (44%) participants with multiple sclerosis, 17 of 54 (31%) siblings (p=0.15 for comparison with patients with multiple sclerosis) and 17 of 38 (45%) unrelated controls (p=0.98). The sensitivity of the ultrasound criteria for detection of greater than 50% narrowing on catheter venography was 0.406 (95% CI 0.311-0.508), and specificity was 0.643 (0.480-0.780). Interpretation This study shows that chronic cerebrospinal venous insufficiency occurs rarely in both patients with multiple sclerosis and in healthy people. Extracranial venous narrowing of greater than 50% is a frequent finding in patients with multiple sclerosis, unaffected siblings, and unrelated controls. The ultrasound criteria are neither sensitive nor specific for narrowing on catheter venography. The significance of venous narrowing to multiple sclerosis symptomatology remains unknown.	[Traboulsee, Anthony L.; Zhao, Yinshan; Sadovnick, Dessa] Univ British Columbia, Dept Med, Vancouver, BC V6T 2B5, Canada; [Machan, Lindsay; Rauscher, Alexander; Klass, Darren; Li, David K.] Univ British Columbia, Dept Radiol, Vancouver, BC V6T 2B5, Canada; [Yee, Irene; Sadovnick, Dessa] Univ British Columbia, Dept Med Genet, Vancouver, BC V6T 2B5, Canada; [Knox, Katherine B.] Univ Saskatchewan, Coll Med, Dept Phys Med & Rehabil, Saskatoon, SK S7N 0W0, Canada; [Szkup, Peter; Otani, Robert] Univ Saskatchewan, Coll Med, Dept Med Imaging, Saskatoon, SK S7N 0W0, Canada; [Kopriva, David; Lala, Shanti] Univ Saskatchewan, Dept Surg, Regina, SK, Canada	University of British Columbia; University of British Columbia; University of British Columbia; University of Saskatchewan; University of Saskatchewan; University of Saskatchewan	Traboulsee, AL (corresponding author), Univ British Columbia, Univ British Columbia Hosp, 2211 Wesbrook Mall,Room S199, Vancouver, BC V6T 2B5, Canada.	t.traboulsee@ubc.ca	Traboulsee, Anthony L/AAB-2051-2020; Zhao, Yinshan/K-4789-2014	Zhao, Yinshan/0000-0001-5433-4637; Rauscher, Alexander/0000-0002-1961-8252; Traboulsee, Anthony/0000-0002-0351-9639; klass, darren/0000-0001-7937-1143	MS Society of Canada; Saskatoon City Hospital Foundation; Lotte and John Hecht Memorial Foundation; Vancouver Coastal Health Foundation; Wolridge Foundation	MS Society of Canada; Saskatoon City Hospital Foundation; Lotte and John Hecht Memorial Foundation; Vancouver Coastal Health Foundation; Wolridge Foundation	MS Society of Canada, Saskatoon City Hospital Foundation, Lotte and John Hecht Memorial Foundation, Vancouver Coastal Health Foundation, and the Wolridge Foundation.	Brod SA, 2013, MULT SCLER J, V19, P1499, DOI 10.1177/1352458513494493; Centonze D, 2011, ANN NEUROL, V70, P51, DOI 10.1002/ana.22436; DeLuca GC, 2007, P NATL ACAD SCI USA, V104, P20896, DOI 10.1073/pnas.0707731105; Doepp F, 2011, NEUROLOGY, V77, P1745, DOI 10.1212/WNL.0b013e318236f0ea; Doepp F, 2010, ANN NEUROL, V68, P173, DOI 10.1002/ana.22085; Dyment DA, 2006, J NEUROL NEUROSUR PS, V77, P258, DOI 10.1136/jnnp.2005.063008; Dyment DA, 2004, LANCET NEUROL, V3, P104, DOI 10.1016/S1474-4422(03)00663-X; Ebers GC, 2004, LANCET, V363, P1773, DOI 10.1016/S0140-6736(04)16304-6; EBERS GC, 1995, NATURE, V377, P150, DOI 10.1038/377150a0; FOG T, 1963, ACTA NEUROL SCAND, V39, P258; Ghezzi A, 2013, MULT SCLER J, V19, P961, DOI 10.1177/1352458513475491; Gisolf J, 2004, J PHYSIOL-LONDON, V560, P317, DOI 10.1113/jphysiol.2004.070409; Juurlink BHJ, 1998, MED HYPOTHESES, V51, P299, DOI 10.1016/S0306-9877(98)90052-4; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Laupacis A, 2011, CAN MED ASSOC J, V183, pE1203, DOI 10.1503/cmaj.111074; Mayer CA, 2011, J NEUROL NEUROSUR PS, V82, P436, DOI 10.1136/jnnp.2010.231613; Multiple Sclerosis International Federation, WHAT IS MS; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Sadovnick AD, 2009, AM J EPIDEMIOL, V170, P289, DOI 10.1093/aje/kwp143; Scalise F, 2013, PHLEBOLOGY, V28, P409, DOI 10.1258/phleb.2012.012079; Simka M, 2013, PHLEBOLOGY, V28, P285, DOI 10.1258/phleb.2012.011125; Sundstrom P, 2010, ANN NEUROL, V68, P255, DOI 10.1002/ana.22132; Tsivgoulis G, 2011, NEUROLOGY, V77, P1241, DOI 10.1212/WNL.0b013e318230a149; Valdueza JM, WHAT WENT WRONG; Valdueza JM, 2013, J CEREBR BLOOD F MET, V33, P657, DOI 10.1038/jcbfm.2013.31; Vedantham S, 2010, J VASC INTERV RADIOL, V21, P1335, DOI 10.1016/j.jvir.2010.07.004; Wattjes MP, 2011, J NEUROL NEUROSUR PS, V82, P429, DOI 10.1136/jnnp.2010.223479; Willer CJ, 2003, P NATL ACAD SCI USA, V100, P12877, DOI 10.1073/pnas.1932604100; Zamboni P, 2009, J NEUROL NEUROSUR PS, V80, P392, DOI 10.1136/jnnp.2008.157164; Zamboni P, 2009, J VASC SURG, V50, P1348, DOI 10.1016/j.jvs.2009.07.096; Zivadinov R, 2011, AM J NEURORADIOL, V32, P938, DOI 10.3174/ajnr.A2386	31	66	68	0	20	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 11	2014	383	9912					138	145		10.1016/S0140-6736(13)61747-X	http://dx.doi.org/10.1016/S0140-6736(13)61747-X			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	287YX	24119384				2022-12-28	WOS:000329579600029
J	Murakami, K; Elmlund, H; Kalisman, N; Bushnell, DA; Adams, CM; Azubel, M; Elmlund, D; Levi-Kalisman, Y; Liu, X; Gibbons, BJ; Levitt, M; Kornberg, RD				Murakami, Kenji; Elmlund, Hans; Kalisman, Nir; Bushnell, David A.; Adams, Christopher M.; Azubel, Maia; Elmlund, Dominika; Levi-Kalisman, Yael; Liu, Xin; Gibbons, Brian J.; Levitt, Michael; Kornberg, Roger D.			Architecture of an RNA Polymerase II Transcription Pre-Initiation Complex	SCIENCE			English	Article							ELONGATION-FACTOR TFIIS; PREINITIATION COMPLEX; STRUCTURAL BASIS; CRYSTAL-STRUCTURE; CROSS-LINKING; ANGSTROM RESOLUTION; MASS-SPECTROMETRY; DNA; MECHANISM; SUBUNIT	The protein density and arrangement of subunits of a complete, 32-protein, RNA polymerase II (pol II) transcription pre-initiation complex (PIC) were determined by means of cryogenic electron microscopy and a combination of chemical cross-linking and mass spectrometry. The PIC showed a marked division in two parts, one containing all the general transcription factors (GTFs) and the other pol II. Promoter DNA was associated only with the GTFs, suspended above the pol II cleft and not in contact with pol II. This structural principle of the PIC underlies its conversion to a transcriptionally active state; the PIC is poised for the formation of a transcription bubble and descent of the DNA into the pol II cleft.	[Murakami, Kenji; Elmlund, Hans; Kalisman, Nir; Bushnell, David A.; Azubel, Maia; Elmlund, Dominika; Levi-Kalisman, Yael; Liu, Xin; Gibbons, Brian J.; Levitt, Michael; Kornberg, Roger D.] Stanford Univ, Dept Biol Struct, Stanford, CA 94305 USA; [Adams, Christopher M.] Stanford Univ, Stanford Univ Mass Spectrometry, Stanford, CA 94305 USA	Stanford University; Stanford University	Kornberg, RD (corresponding author), Stanford Univ, Dept Biol Struct, Stanford, CA 94305 USA.	kornberg@stanford.edu	ELMLUND, HANS/AAA-6625-2021	Elmlund, Dominika/0000-0002-1910-8017; Kalisman, Nir/0000-0003-1615-7136; Elmlund, Hans/0000-0002-6992-0601	NIH [GM49885, AI21144, GM063817]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR028096] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI021144] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063817, R01GM036659] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by NIH grants GM49885 and AI21144 to R.D.K. and GM063817 to M.L. The EM map has been deposited in the EMDataBank under accession code EMD-2394.	BURATOWSKI S, 1989, CELL, V56, P549, DOI 10.1016/0092-8674(89)90578-3; Burley SK, 1996, ANNU REV BIOCHEM, V65, P769, DOI 10.1146/annurev.bi.65.070196.004005; Bushnell DA, 2004, SCIENCE, V303, P983, DOI 10.1126/science.1090838; Bushnell DA, 2003, P NATL ACAD SCI USA, V100, P6969, DOI 10.1073/pnas.1130601100; Chang WH, 2000, CELL, V102, P609, DOI 10.1016/S0092-8674(00)00083-0; Chen ZA, 2010, EMBO J, V29, P717, DOI 10.1038/emboj.2009.401; Chung WH, 2003, MOL CELL, V12, P1003, DOI 10.1016/S1097-2765(03)00387-3; CONAWAY RC, 1993, ANNU REV BIOCHEM, V62, P161; Cramer P, 2000, SCIENCE, V288, P640, DOI 10.1126/science.288.5466.640; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; Elmlund D, 2012, J STRUCT BIOL, V180, P420, DOI 10.1016/j.jsb.2012.07.010; Elmlund D, 2010, STRUCTURE, V18, P777, DOI 10.1016/j.str.2010.06.001; FEAVER WJ, 1991, CELL, V67, P1223, DOI 10.1016/0092-8674(91)90298-D; Forget D, 2004, MOL CELL BIOL, V24, P1122, DOI 10.1128/MCB.24.3.1122-1131.2004; Gaiser F, 2000, J MOL BIOL, V302, P1119, DOI 10.1006/jmbi.2000.4110; Gibbons BJ, 2012, P NATL ACAD SCI USA, V109, P1949, DOI 10.1073/pnas.1105266109; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; GUZDER SN, 1994, NATURE, V369, P578, DOI 10.1038/369578a0; He Y, 2013, NATURE, V495, P481, DOI 10.1038/nature11991; Holstege FCP, 1997, EMBO J, V16, P7468, DOI 10.1093/emboj/16.24.7468; Jawhari A, 2006, EMBO REP, V7, P500, DOI 10.1038/sj.embor.7400663; Kainov DE, 2008, NAT STRUCT MOL BIOL, V15, P980, DOI 10.1038/nsmb.1478; Kalisman N, 2012, P NATL ACAD SCI USA, V109, P2884, DOI 10.1073/pnas.1119472109; Kastner B, 2008, NAT METHODS, V5, P53, DOI 10.1038/NMETH1139; Kettenberger H, 2004, MOL CELL, V16, P955, DOI 10.1016/j.molcel.2004.11.040; Kim B, 2007, P NATL ACAD SCI USA, V104, P16068, DOI 10.1073/pnas.0704573104; Kim TK, 2000, SCIENCE, V288, P1418, DOI 10.1126/science.288.5470.1418; Kim TK, 1997, P NATL ACAD SCI USA, V94, P12268, DOI 10.1073/pnas.94.23.12268; KIM YJ, 1994, CELL, V77, P599, DOI 10.1016/0092-8674(94)90221-6; Kornberg RD, 2005, TRENDS BIOCHEM SCI, V30, P235, DOI 10.1016/j.tibs.2005.03.011; Kornberg RD, 2007, P NATL ACAD SCI USA, V104, P12955, DOI 10.1073/pnas.0704138104; Kostrewa D, 2009, NATURE, V462, P323, DOI 10.1038/nature08548; Lasker K, 2012, P NATL ACAD SCI USA, V109, P1380, DOI 10.1073/pnas.1120559109; Liu X, 2010, SCIENCE, V327, P206, DOI 10.1126/science.1182015; Mekler V, 2002, CELL, V108, P599, DOI 10.1016/S0092-8674(02)00667-0; Miller G, 2006, NAT STRUCT MOL BIOL, V13, P603, DOI 10.1038/nsmb1117; Murakami K, 2013, J BIOL CHEM, V288, P6325, DOI 10.1074/jbc.M112.433623; Murakami K, 2012, P NATL ACAD SCI USA, V109, P4816, DOI 10.1073/pnas.1201448109; NIKOLOV DB, 1995, NATURE, V377, P119, DOI 10.1038/377119a0; Okuda M, 2000, EMBO J, V19, P1346, DOI 10.1093/emboj/19.6.1346; Okuda M, 2008, EMBO J, V27, P1161, DOI 10.1038/emboj.2008.47; Pal M, 2005, MOL CELL, V19, P101, DOI 10.1016/j.molcel.2005.05.024; Prather DA, 2005, MOL CELL BIOL, V25, P2650, DOI 10.1128/MCB.25.7.2650-2659.2005; Schultz P, 2000, CELL, V102, P599, DOI 10.1016/S0092-8674(00)00082-9; Tan S, 1996, NATURE, V381, P127, DOI 10.1038/381127a0	45	120	120	2	76	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 8	2013	342	6159					709	+		10.1126/science.1238724	http://dx.doi.org/10.1126/science.1238724			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247UK	24072820	Green Accepted			2022-12-28	WOS:000326647600034
J	Richter, C; Boschker, H; Dietsche, W; Fillis-Tsirakis, E; Jany, R; Loder, F; Kourkoutis, LF; Muller, DA; Kirtley, JR; Schneider, CW; Mannhart, J				Richter, C.; Boschker, H.; Dietsche, W.; Fillis-Tsirakis, E.; Jany, R.; Loder, F.; Kourkoutis, L. F.; Muller, D. A.; Kirtley, J. R.; Schneider, C. W.; Mannhart, J.			Interface superconductor with gap behaviour like a high-temperature superconductor	NATURE			English	Article							PSEUDOGAP; PHYSICS; FLUCTUATIONS; PRECURSOR; DENSITY; ORIGIN; STATE; TC	The physics of the superconducting state in two-dimensional (2D) electron systems is relevant to understanding the high-transition-temperature copper oxide superconductors and for the development of future superconductors based on interface electron systems(1). But it is not yet understood how fundamental superconducting parameters, such as the spectral density of states, change when these superconducting electron systems are depleted of charge carriers. Here we use tunnel spectroscopy with planar junctions to measure the behaviour of the electronic spectral density of states as a function of carrier density, clarifying this issue experimentally. We chose the conducting LaAlO3-SrTiO3 interface(2) as the 2D superconductor, because this electron system can be tuned continuously with an electric gate field(3). We observed an energy gap of the order of 40 micro-electronvolts in the density of states, whose shape is well described by the Bardeen-Cooper-Schrieffer superconducting gap function. In contrast to the dome-shaped dependence of the critical temperature, the gap increases with charge carrier depletion in both the underdoped region and the overdoped region. These results are analogous to the pseudogap behaviour of the high-transition-temperature copper oxide superconductors and imply that the smooth continuation of the superconducting gap into pseudogap-like behaviour could be a general property of 2D superconductivity.	[Richter, C.; Boschker, H.; Dietsche, W.; Fillis-Tsirakis, E.; Mannhart, J.] Max Planck Inst Solid State Res, D-70569 Stuttgart, Germany; [Richter, C.; Jany, R.; Loder, F.] Univ Augsburg, Ctr Elect Correlat & Magnetism, D-86135 Augsburg, Germany; [Kourkoutis, L. F.; Muller, D. A.] Cornell Univ, Sch Appl & Engn Phys, Ithaca, NY 14853 USA; [Kourkoutis, L. F.; Muller, D. A.] Kavli Inst Cornell Nanoscale Sci, Ithaca, NY 14853 USA; [Kirtley, J. R.] Stanford Univ, Ctr Probing Nanoscale, Stanford, CA 94305 USA; [Schneider, C. W.] Paul Scherrer Inst, CH-5232 Villigen, Switzerland	Max Planck Society; University of Augsburg; Cornell University; Stanford University; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute	Mannhart, J (corresponding author), Max Planck Inst Solid State Res, D-70569 Stuttgart, Germany.	j.mannhart@fkf.mpg.de	Richter, Christoph/A-6172-2013; Boschker, Hans/N-1834-2015; Muller, David/A-7745-2010; Schneider, Christof W/I-5857-2014; Schneider, Christof/AAC-9106-2020; Kourkoutis, Lena/B-4229-2010	Richter, Christoph/0000-0002-6591-1118; Boschker, Hans/0000-0003-3533-9867; Muller, David/0000-0003-4129-0473; Schneider, Christof W/0000-0002-4292-8574; Schneider, Christof/0000-0002-4292-8574; Kourkoutis, Lena/0000-0002-1303-1362	German Science Foundation [TRR 80]; NSF [DMR-1120296]	German Science Foundation(German Research Foundation (DFG)); NSF(National Science Foundation (NSF))	We acknowledge discussions with M. Beasley, A. P. Kampf and T. Kopp, technical support from M. Hagel, I. Hagel, M. Schmid and D. Zhang, and financial support from the German Science Foundation (TRR 80). Electron microscopy and spectroscopy was performed at the Cornell Center for Materials Research (CCMR), which is an NSF MRSEC supported by NSF grant DMR-1120296.	Berner G, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.247601; Bert JA, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.060503; BINNIG G, 1980, PHYS REV LETT, V45, P1352, DOI 10.1103/PhysRevLett.45.1352; Caviglia AD, 2008, NATURE, V456, P624, DOI 10.1038/nature07576; Damascelli A, 2003, REV MOD PHYS, V75, P473, DOI 10.1103/RevModPhys.75.473; Ding H, 1996, NATURE, V382, P51, DOI 10.1038/382051a0; DYNES RC, 1978, PHYS REV LETT, V41, P1509, DOI 10.1103/PhysRevLett.41.1509; Feld M, 2011, NATURE, V480, P75, DOI 10.1038/nature10627; Fischer O, 2007, REV MOD PHYS, V79, P353, DOI 10.1103/RevModPhys.79.353; Ghiringhelli G, 2012, SCIENCE, V337, P821, DOI 10.1126/science.1223532; GIAEVER I, 1960, PHYS REV LETT, V5, P147, DOI 10.1103/PhysRevLett.5.147; Hinkov V, 2008, SCIENCE, V319, P597, DOI 10.1126/science.1152309; Joshua A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2116; Kalisky B., NATURE MATER IN THE; Kivelson SA, 1998, NATURE, V393, P550, DOI 10.1038/31177; Lee PA, 2006, REV MOD PHYS, V78, P17, DOI 10.1103/RevModPhys.78.17; Miyakawa N, 1999, PHYS REV LETT, V83, P1018, DOI 10.1103/PhysRevLett.83.1018; Norman MR, 2005, ADV PHYS, V54, P715, DOI [10.1080/00018730500459906, 10.1080/00018730500489906]; Ohtomo A, 2004, NATURE, V427, P423, DOI 10.1038/nature02308; Orenstein J, 2000, SCIENCE, V288, P468, DOI 10.1126/science.288.5465.468; Pereiro J., 2011, PHYS EXPRESS, V1, P208; Renner C, 1998, PHYS REV LETT, V80, P149, DOI 10.1103/PhysRevLett.80.149; Sacepe B, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1140; Schneider CW, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3515849; SERVOIN JL, 1980, PHYS REV B, V22, P5501, DOI 10.1103/PhysRevB.22.5501; TRANQUADA JM, 1995, NATURE, V375, P561, DOI 10.1038/375561a0; UEMURA YJ, 1989, PHYS REV LETT, V62, P2317, DOI 10.1103/PhysRevLett.62.2317; WARREN WW, 1989, PHYS REV LETT, V62, P1193, DOI 10.1103/PhysRevLett.62.1193	30	194	193	5	284	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 24	2013	502	7472					528	+		10.1038/nature12494	http://dx.doi.org/10.1038/nature12494			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	238YN	24097347				2022-12-28	WOS:000325988400049
J	Qu, S; Kolodziej, EP; Long, SA; Gloer, JB; Patterson, EV; Baltrusaitis, J; Jones, GD; Benchetler, PV; Cole, EA; Kimbrough, KC; Tarnoff, MD; Cwiertny, DM				Qu, Shen; Kolodziej, Edward P.; Long, Sarah A.; Gloer, James B.; Patterson, Eric V.; Baltrusaitis, Jonas; Jones, Gerrad D.; Benchetler, Peter V.; Cole, Emily A.; Kimbrough, Kaitlin C.; Tarnoff, Matthew D.; Cwiertny, David M.			Product-to-Parent Reversion of Trenbolone: Unrecognized Risks for Endocrine Disruption	SCIENCE			English	Article							REPRODUCTIVE ENDOCRINOLOGY; GROWTH PROMOTERS; AQUEOUS-SOLUTION; FATHEAD MINNOW; ACETATE; IDENTIFICATION; POPULATIONS; METABOLITES; FEEDLOT; SYSTEMS	Trenbolone acetate (TBA) is a high-value steroidal growth promoter often administered to beef cattle, whose metabolites are potent endocrine-disrupting compounds. We performed laboratory and field phototransformation experiments to assess the fate of TBA metabolites and their photoproducts. Unexpectedly, we observed that the rapid photohydration of TBA metabolites is reversible under conditions representative of those in surface waters (pH 7, 25 degrees C). This product-to-parent reversion mechanism results in diurnal cycling and substantial regeneration of TBA metabolites at rates that are strongly temperature-and pH-dependent. Photoproducts can also react to produce structural analogs of TBA metabolites. These reactions also occur in structurally similar steroids, including human pharmaceuticals, which suggests that predictive fate models and regulatory risk assessment paradigms must account for transformation products of high-risk environmental contaminants such as endocrine-disrupting steroids.	[Qu, Shen; Tarnoff, Matthew D.; Cwiertny, David M.] Univ Iowa, Dept Civil & Environm Engn, Seamans Ctr Engn Arts & Sci 4105, Iowa City, IA 52242 USA; [Kolodziej, Edward P.; Jones, Gerrad D.; Benchetler, Peter V.; Cole, Emily A.; Kimbrough, Kaitlin C.] Univ Nevada, Dept Civil & Environm Engn, Reno, NV 89557 USA; [Long, Sarah A.; Gloer, James B.] Univ Iowa, Dept Chem, Iowa City, IA 52242 USA; [Patterson, Eric V.] Truman State Univ, Dept Chem, Kirksville, MO 63501 USA; [Baltrusaitis, Jonas] Univ Twente, Fac Sci & Technol, MESA Inst Nanotechnol, PhotoCatalyt Synth Grp, NL-7500 AE Enschede, Netherlands; [Baltrusaitis, Jonas] Univ Iowa, Coll Publ Hlth, Dept Occupat & Environm Hlth, Iowa City, IA 52242 USA; [Cwiertny, David M.] Univ Iowa, Seamans Ctr Engn Arts & Sci 4133, Dept Chem & Biochem Engn, Iowa City, IA 52242 USA	University of Iowa; Nevada System of Higher Education (NSHE); University of Nevada Reno; University of Iowa; University of Twente; University of Iowa; University of Iowa	Kolodziej, EP (corresponding author), Univ Nevada, Dept Civil & Environm Engn, Mail Stop 258, Reno, NV 89557 USA.	koloj@unr.edu; david-cwiertny@uiowa.edu	Baltrusaitis, Jonas/AAW-6072-2021; Baltrusaitis, Jonas/AAT-3166-2020; Qu, Shen/B-3405-2014; Kolodziej, Edward/I-8416-2017	Baltrusaitis, Jonas/0000-0001-5634-955X; Kolodziej, Edward/0000-0002-7968-4198; Patterson, Eric/0000-0002-0310-7626	U.S. Department of Agriculture [2010-65102-20425, 2010-65102-20407]; NIH [S10-RR025500]; National Center for Research Resources, NIH [UL1RR024979]; National Institute of General Medical Sciences, NIH [8 P20 GM103440-11]; NSF [CHE-074096, CHE-1039925, CHE-1044356]; Direct For Mathematical & Physical Scien [1229354] Funding Source: National Science Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024979, S10RR025500] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005605] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103440] Funding Source: NIH RePORTER	U.S. Department of Agriculture(United States Department of Agriculture (USDA)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NSF(National Science Foundation (NSF)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by U.S. Department of Agriculture grants 2010-65102-20425 and 2010-65102-20407. NMR instrumentation was supported in part by NIH grant S10-RR025500, with additional support from National Center for Research Resources, NIH, grant UL1RR024979. LC/MS/MS instrumentation was supported by National Institute of General Medical Sciences, NIH, grant 8 P20 GM103440-11. Computational resources were provided in part by NSF grants CHE-074096, CHE-1039925, and CHE-1044356. Any opinions, findings, conclusions, or recommendations expressed here are those of the authors and do not necessarily represent the official views of sponsoring agencies. The authors acknowledge D. Latch, Y. P. Chin, D. Quilici, J. Bristow, the Sierra Foothill Research and Extension Center and its personnel, and the suggestions of two anonymous reviewers. All data are available in the supplementary materials. The authors declare no conflict of interest.	Ankley GT, 2003, ENVIRON TOXICOL CHEM, V22, P1350, DOI [10.1897/1551-5028(2003)022&lt;1350:EOTAGP&gt;2.0.CO;2, 10.1002/etc.5620220623]; Blazer VS, 2012, ENVIRON MONIT ASSESS, V184, P4309, DOI 10.1007/s10661-011-2266-5; De Marco R, 2011, CHEM BIOL DRUG DES, V78, P269, DOI 10.1111/j.1747-0285.2011.01147.x; Durhan EJ, 2006, ENVIRON HEALTH PERSP, V114, P65, DOI 10.1289/ehp.8055; Fenner K, 2013, SCIENCE, V341, P752, DOI 10.1126/science.1236281; Gall HE, 2011, ENVIRON SCI TECHNOL, V45, P8755, DOI 10.1021/es2011435; Guillette LJ, 2001, REPRODUCTION, V122, P857, DOI 10.1530/reprod/122.6.857; Ibarburu M.A., 2007, P NCCC 134 M APPL CO; Jensen KM, 2006, ENVIRON SCI TECHNOL, V40, P3112, DOI 10.1021/es052174s; Kidd KA, 2007, P NATL ACAD SCI USA, V104, P8897, DOI 10.1073/pnas.0609568104; Kolodziej EP, 2013, ENVIRON SCI TECHNOL, V47, P5031, DOI 10.1021/es3052069; Latch DE, 2003, J PHOTOCH PHOTOBIO A, V158, P63, DOI 10.1016/S1010-6030(03)00103-5; Leet JK, 2012, ENVIRON SCI TECHNOL, V46, P13440, DOI 10.1021/es302599t; LONG ER, 1995, ENVIRON MANAGE, V19, P81, DOI 10.1007/BF02472006; OETTEL M, 1980, CONTRACEPTION, V21, P61, DOI 10.1016/0010-7824(80)90140-7; Qu S, 2012, ENVIRON SCI TECHNOL, V46, P13202, DOI 10.1021/es303091c; Schiffer B, 2001, ENVIRON HEALTH PERSP, V109, P1145, DOI 10.2307/3454862; Stackhouse KR, 2012, J ANIM SCI, V90, P4656, DOI 10.2527/jas.2011-4654; Stavreva DA, 2012, SCI REP-UK, V2, DOI 10.1038/srep00937; Syntex Animal Health, 1995, SYN PLUS TRENB AC ES	21	64	66	6	186	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 18	2013	342	6156					347	351		10.1126/science.1243192	http://dx.doi.org/10.1126/science.1243192			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235XG	24072818	Green Accepted			2022-12-28	WOS:000325755100041
J	Steppenbeck, D; Takeuchi, S; Aoi, N; Doornenbal, P; Matsushita, M; Wang, H; Baba, H; Fukuda, N; Go, S; Honma, M; Lee, J; Matsui, K; Michimasa, S; Motobayashi, T; Nishimura, D; Otsuka, T; Sakurai, H; Shiga, Y; Soderstrom, PA; Sumikama, T; Suzuki, H; Taniuchi, R; Utsuno, Y; Valiente-Dobon, JJ; Yoneda, K				Steppenbeck, D.; Takeuchi, S.; Aoi, N.; Doornenbal, P.; Matsushita, M.; Wang, H.; Baba, H.; Fukuda, N.; Go, S.; Honma, M.; Lee, J.; Matsui, K.; Michimasa, S.; Motobayashi, T.; Nishimura, D.; Otsuka, T.; Sakurai, H.; Shiga, Y.; Soederstroem, P. -A.; Sumikama, T.; Suzuki, H.; Taniuchi, R.; Utsuno, Y.; Valiente-Dobon, J. J.; Yoneda, K.			Evidence for a new nuclear 'magic number' from the level structure of Ca-54	NATURE			English	Article							PHYSICS; N=32	Atomic nuclei are finite quantum systems composed of two distinct types of fermion-protons and neutrons. In a manner similar to that of electrons orbiting in an atom, protons and neutrons in a nucleus form shell structures. In the case of stable, naturally occurring nuclei, large energy gaps exist between shells that fill completely when the proton or neutron number is equal to 2, 8, 20, 28, 50, 82 or 126 (ref. 1). Away from stability, however, these so-called 'magic numbers' are known to evolve in systems with a large imbalance of protons and neutrons. Although some of the standard shell closures can disappear, new ones are known to appear(2,3). Studies aiming to identify and understand such behaviour are of major importance in the field of experimental and theoretical nuclear physics. Here we report a spectroscopic study of the neutron-rich nucleus Ca-54 (a bound system composed of 20 protons and 34 neutrons) using proton knockout reactions involving fast radioactive projectiles. The results highlight the doubly magic nature of Ca-54 and provide direct experimental evidence for the onset of a sizable subshell closure at neutron number 34 in isotopes far from stability.	[Steppenbeck, D.; Matsushita, M.; Go, S.; Michimasa, S.; Otsuka, T.] Univ Tokyo, Ctr Nucl Study, Bunkyo Ku, Tokyo 1130033, Japan; [Takeuchi, S.; Doornenbal, P.; Wang, H.; Baba, H.; Fukuda, N.; Lee, J.; Motobayashi, T.; Sakurai, H.; Soederstroem, P. -A.; Suzuki, H.; Yoneda, K.] RIKEN Nishina Ctr, Wako, Saitama 3510198, Japan; [Aoi, N.] Osaka Univ, Res Ctr Nucl Phys, Osaka 5670047, Japan; [Honma, M.] Aizu Univ, Ctr Math Sci, Aizu Wakamatsu, Fukushima 9658580, Japan; [Matsui, K.; Otsuka, T.; Sakurai, H.; Taniuchi, R.] Univ Tokyo, Dept Phys, Bunkyo Ku, Tokyo 1130033, Japan; [Nishimura, D.] Tokyo Univ Sci, Dept Phys, Noda, Chiba 2788510, Japan; [Shiga, Y.] Rikkyo Univ, Dept Phys, Toshima Ku, Tokyo 1718501, Japan; [Sumikama, T.] Tohoku Univ, Dept Phys, Sendai, Miyagi 9808578, Japan; [Utsuno, Y.] Japan Atom Energy Agcy, Tokai, Ibaraki 3191195, Japan; [Valiente-Dobon, J. J.] Ist Nazl Fis Nucl, Lab Nazl Legnaro, I-35020 Legnaro, Italy	University of Tokyo; RIKEN; Osaka University; University of Aizu; University of Tokyo; Tokyo University of Science; Rikkyo University; Tohoku University; Japan Atomic Energy Agency; Istituto Nazionale di Fisica Nucleare (INFN)	Steppenbeck, D (corresponding author), Univ Tokyo, Ctr Nucl Study, Bunkyo Ku, Tokyo 1130033, Japan.	steppenbeck@cns.s.u-tokyo.ac.jp	考, 青井/ABD-1691-2020; Takeuchi, Satoshi/O-1529-2016; OTSUKA, TAKAHARU/G-5072-2014; wang, he/AAF-7277-2019; SAKURAI, HIROYOSHI/G-5085-2014; Sumikama, Toshiyuki/P-6499-2017; Soderstrom, Par-Anders/E-2983-2017	考, 青井/0000-0003-3303-8542; wang, he/0000-0002-0161-8879; SAKURAI, HIROYOSHI/0000-0002-6215-4254; Soderstrom, Par-Anders/0000-0002-9504-2814; Taniuchi, Ryo/0000-0002-8057-7074; Utsuno, Yutaka/0000-0001-5404-7320; Doornenbal, Pieter/0000-0001-7530-4066; Michimasa, Shin'ichiro/0000-0002-5667-9636	Grants-in-Aid for Scientific Research [23244049] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Agostinelli S, 2003, NUCL INSTRUM METH A, V506, P250, DOI 10.1016/S0168-9002(03)01368-8; Bastin B, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.022503; Burger A, 2005, PHYS LETT B, V622, P29, DOI 10.1016/j.physletb.2005.07.004; CHAPMAN R, 1968, NUCL PHYS A, VA119, P305, DOI 10.1016/0375-9474(68)90302-3; Coraggio L, 2009, PHYS REV C, V80, DOI 10.1103/PhysRevC.80.044311; Crawford HL, 2010, PHYS REV C, V82, DOI 10.1103/PhysRevC.82.014311; Dinca DC, 2005, PHYS REV C, V71, DOI 10.1103/PhysRevC.71.041302; Gade A, 2006, PHYS REV C, V74, DOI 10.1103/PhysRevC.74.021302; Hagen G, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.032502; Holt JD, 2012, J PHYS G NUCL PARTIC, V39, DOI 10.1088/0954-3899/39/8/085111; Honma M., 2008, RIKEN ACCEL PROG REP, V41, P32; HUCK A, 1985, PHYS REV C, V31, P2226, DOI 10.1103/PhysRevC.31.2226; Janssens RVF, 2009, NATURE, V459, P1069, DOI 10.1038/4591069a; Janssens RVF, 2005, NATURE, V435, P897, DOI 10.1038/435897a; Janssens RVF, 2002, PHYS LETT B, V546, P55, DOI 10.1016/S0370-2693(02)02682-5; Kaneko K, 2011, PHYS REV C, V83, DOI 10.1103/PhysRevC.83.014320; Kubo T, 2012, PROG THEOR EXP PHYS, V2012, DOI 10.1093/ptep/pts064; Liddick SN, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.072502; MAYER MG, 1949, PHYS REV, V75, P1969, DOI 10.1103/PhysRev.75.1969; Ohnishi T, 2008, J PHYS SOC JPN, V77, DOI 10.1143/JPSJ.77.083201; Otsuka T, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.232502; Otsuka T, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.082502; Otsuka T, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.032501; Perrot F, 2006, PHYS REV C, V74, DOI 10.1103/PhysRevC.74.014313; Prisciandaro JI, 2001, PHYS LETT B, V510, P17, DOI 10.1016/S0370-2693(01)00565-2; Rejmund M, 2007, PHYS REV C, V76, DOI 10.1103/PhysRevC.76.021304; Rodriguez TR, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.062501; Utsuno Y, 2012, PROG THEOR PHYS SUPP, P304; Warner D, 2004, NATURE, V430, P517, DOI 10.1038/430517a; Wienholtz F, 2013, NATURE, V498, P346, DOI 10.1038/nature12226	30	260	273	0	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 10	2013	502	7470					207	210		10.1038/nature12522	http://dx.doi.org/10.1038/nature12522			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RU	24108051				2022-12-28	WOS:000325436100044
J	Nyblom, M; Poulsen, H; Gourdon, P; Reinhard, L; Andersson, M; Lindahl, E; Fedosova, N; Nissen, P				Nyblom, Maria; Poulsen, Hanne; Gourdon, Pontus; Reinhard, Linda; Andersson, Magnus; Lindahl, Erik; Fedosova, Natalya; Nissen, Poul			Crystal Structure of Na+, K+-ATPase in the Na+-Bound State	SCIENCE			English	Article							ONSET DYSTONIA-PARKINSONISM; SODIUM-POTASSIUM PUMP; DE-NOVO MUTATIONS; CALCIUM-PUMP; ALTERNATING HEMIPLEGIA; TERMINAL TYROSINES; ATP1A3; AFFINITY; BINDING; NA,K-ATPASE	The Na+, K+-adenosine triphosphatase (ATPase) maintains the electrochemical gradients of Na+ and K+ across the plasma membrane-a prerequisite for electrical excitability and secondary transport. Hitherto, structural information has been limited to K+-bound or ouabain-blocked forms. We present the crystal structure of a Na+-bound Na+, K+-ATPase as determined at 4.3 angstrom resolution. Compared with the K+-bound form, large conformational changes are observed in the a subunit whereas the beta and gamma subunit structures are maintained. The locations of the three Na+ sites are indicated with the unique site III at the recently suggested IIIb, as further supported by electrophysiological studies on leak currents. Extracellular release of the third Na+ from IIIb through IIIa, followed by exchange of Na+ for K+ at sites I and II, is suggested.	[Nyblom, Maria; Poulsen, Hanne; Gourdon, Pontus; Reinhard, Linda; Fedosova, Natalya; Nissen, Poul] Danish Natl Res Fdn, Ctr Membrane Pumps Cells & Dis PUMPkin, DK-8000 Aarhus, Denmark; [Nyblom, Maria; Poulsen, Hanne; Gourdon, Pontus; Reinhard, Linda; Nissen, Poul] Aarhus Univ, Dept Mol Biol & Genet, DK-8000 Aarhus, Denmark; [Poulsen, Hanne; Gourdon, Pontus; Nissen, Poul] Nord EMBL Partnership Mol Med, Danish Res Inst Translat Neurosci DANDRITE, Aarhus, Denmark; [Andersson, Magnus; Lindahl, Erik] KTH Royal Inst Technol, Swedish E Sci Res Ctr, Dept Theoret Phys, Sci Life Lab, SE-17121 Solna, Sweden; [Lindahl, Erik] Stockholm Univ, Dept Biochem & Biophys, Sci Life Lab, SE-10691 Stockholm, Sweden; [Fedosova, Natalya] Aarhus Univ, Dept Biomed, DK-8000 Aarhus, Denmark	Danmarks Grundforskningsfond; Aarhus University; Royal Institute of Technology; Stockholm University; Aarhus University	Poulsen, H (corresponding author), Danish Natl Res Fdn, Ctr Membrane Pumps Cells & Dis PUMPkin, DK-8000 Aarhus, Denmark.	hp@mb.au.dk; pn@mb.au.dk	Gourdon, Pontus/HCI-8898-2022; Gourdon, Pontus/E-1076-2014	Gourdon, Pontus/0000-0002-8631-3539; Gourdon, Maria/0000-0001-8801-1756; Andersson, Magnus/0000-0002-3364-6647; Fedosova, Natalya U./0000-0002-1706-6108; Nissen, Poul/0000-0003-0948-6628	Danscatt program of the Danish Natural Science Research Council; Swedish Research Council; Danish Council for Independent Research in Medical Sciences; European Research Council [209825, 250322]; Lundbeck Foundation; Carlsberg Foundation; L'Oreal/United Nations Educational, Scientific, and Cultural Organization; Lundbeck Foundation [R139-2012-12689] Funding Source: researchfish	Danscatt program of the Danish Natural Science Research Council; Swedish Research Council(Swedish Research CouncilEuropean Commission); Danish Council for Independent Research in Medical Sciences; European Research Council(European Research Council (ERC)European Commission); Lundbeck Foundation(Lundbeckfonden); Carlsberg Foundation(Carlsberg Foundation); L'Oreal/United Nations Educational, Scientific, and Cultural Organization; Lundbeck Foundation(Lundbeckfonden)	B. Vilsen and J. Petersen, Department of Biomedicine, Aarhus University, Denmark, are thanked for preparing enzyme for crystallization. We thank C. Schulze-Briese, T. Tomizaki, and V. Olieric (Swiss Light Source) for assistance with synchrotron data collection; B. Bjerring Jensen, A. M. Nielsen, and J. L. Karlsen for technical assistance; and J. P. Morth, L. Yatime, M. Laursen, H. Khandelia, and M. J. Clausen for valuable discussions. Support was provided by the Danscatt program of the Danish Natural Science Research Council. M.N. was supported by the Swedish Research Council, L. R. by the Danish Council for Independent Research in Medical Sciences, E. L. by a European Research Council starting grant (contract 209825), and P.N. by a European Research Council advanced grant (contract 250322). H. P. was supported by the Lundbeck Foundation, the Carlsberg Foundation, and L'Oreal/United Nations Educational, Scientific, and Cultural Organization. The authors made the following contributions: H. P. and P.N. performed study design. M.N. crystallized the protein, collected and processed x-ray data, and determined and refined the structure, assisted by L. R. and P. G. The structural analysis was carried out by M. N., L. R., and P. G., assisted by P.N., whereas M. A. and E. L. performed the MD simulations, assisted by P. G. H. P. designed and performed the electrophysiological studies. N. F. designed and performed the deocclusion experiments. M. N., L. R., P. G., H. P., and P.N. wrote the paper. All authors discussed the results and commented on the manuscript. Coordinates and structure factors have been deposited in the Protein Data Bank (PDB) with accession no. 4hqj.	Aguiar PD, 2004, NEURON, V43, P169, DOI 10.1016/j.neuron.2004.06.028; Anselm IA, 2009, NEUROLOGY, V73, P400, DOI 10.1212/WNL.0b013e3181b04acd; Azizan EAB, 2013, NAT GENET, V45, P1055, DOI 10.1038/ng.2716; Blanco G, 1998, AM J PHYSIOL-RENAL, V275, pF633, DOI 10.1152/ajprenal.1998.275.5.F633; Blanco-Arias P, 2009, HUM MOL GENET, V18, P2370, DOI 10.1093/hmg/ddp170; De Fusco M, 2003, NAT GENET, V33, P192, DOI 10.1038/ng1081; Dempski RE, 2006, J BIOL CHEM, V281, P36338, DOI 10.1074/jbc.M604788200; Einholm AP, 2010, J BIOL CHEM, V285, P26245, DOI 10.1074/jbc.M110.123976; ESMANN M, 1985, BIOCHEM BIOPH RES CO, V127, P857, DOI 10.1016/S0006-291X(85)80022-X; Heinzen EL, 2012, NAT GENET, V44, P1030, DOI 10.1038/ng.2358; Holmgren M, 2000, NATURE, V403, P898, DOI 10.1038/35002599; Imagawa T, 2005, J BIOL CHEM, V280, P18736, DOI 10.1074/jbc.M500137200; JEWELLMOTZ EA, 1993, BIOCHEMISTRY-US, V32, P13523, DOI 10.1021/bi00212a018; Laursen M, 2013, P NATL ACAD SCI USA, V110, P10958, DOI 10.1073/pnas.1222308110; Li CM, 2006, J MEMBRANE BIOL, V213, P1, DOI 10.1007/s00232-006-0035-0; Meier S, 2010, J GEN PHYSIOL, V135, P115, DOI 10.1085/jgp.200910301; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; Ogawa H, 2002, P NATL ACAD SCI USA, V99, P15977, DOI 10.1073/pnas.202622299; Ogawa H, 2009, P NATL ACAD SCI USA, V106, P13742, DOI 10.1073/pnas.0907054106; Olesen C, 2007, NATURE, V450, P1036, DOI 10.1038/nature06418; Poulsen H, 2010, NATURE, V467, P99, DOI 10.1038/nature09309; Rosewich H, 2012, LANCET NEUROL, V11, P764, DOI 10.1016/S1474-4422(12)70182-5; Shinoda T, 2009, NATURE, V459, P446, DOI 10.1038/nature07939; Sorensen TLM, 2004, SCIENCE, V304, P1672, DOI 10.1126/science.1099366; Toustrup-Jensen MS, 2009, J BIOL CHEM, V284, P18715, DOI 10.1074/jbc.M109.015099; Toyoshima C, 2004, NATURE, V430, P529, DOI 10.1038/nature02680; Toyoshima C, 2013, NATURE, V495, P260, DOI 10.1038/nature11899; Vasilyev A, 2004, J MEMBRANE BIOL, V198, P65, DOI 10.1007/s00232-004-0660-4; Vedovato N, 2010, J GEN PHYSIOL, V136, P63, DOI 10.1085/jgp.201010407; Winther AML, 2013, NATURE, V495, P265, DOI 10.1038/nature11900; Yatime L, 2011, J STRUCT BIOL, V174, P296, DOI 10.1016/j.jsb.2010.12.004; Zanotti-Fregonara P, 2008, J NEUROL SCI, V273, P148, DOI 10.1016/j.jns.2008.06.033	32	139	140	3	84	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 4	2013	342	6154					123	127		10.1126/science.1243352	http://dx.doi.org/10.1126/science.1243352			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	227PP	24051246				2022-12-28	WOS:000325126100060
J	Rao, R; Euhus, D; Mayo, HG; Balch, C				Rao, Roshni; Euhus, David; Mayo, Helen G.; Balch, Charles			Axillary Node Interventions in Breast Cancer A Systematic Review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							SENTINEL-LYMPH-NODE; EXTENDED RADICAL-MASTECTOMY; FINE-NEEDLE-ASPIRATION; 25-YEAR FOLLOW-UP; RANDOMIZED-TRIAL; CONSERVATIVE SURGERY; CONSERVING THERAPY; TECHNICAL OUTCOMES; CLINICAL-PRACTICE; RECURRENCE RATE	IMPORTANCE Recent data from clinical trials have challenged traditional thinking about axillary surgery in patients with breast cancer. OBJECTIVES To summarize evidence regarding the role of axillary interventions (surgical and nonsurgical) in breast cancer treatment and to review the association of these axillary interventions with recurrence of axillary node metastases, mortality, and morbidity outcomes in patients with breast cancer. EVIDENCE REVIEW Ovid MEDLINE (1946-July 2013), Cochrane Database of Systematic Reviews (2005-July 2013), Cochrane Database of Abstracts of Reviews of Effects (1994-July 2013), and Cochrane Central Register of Controlled Trials (1989-July 2013) were searched for publications on axillary interventions in breast cancer. Clinical trials, observational studies, and meta-analyses with at least 2-year follow-up were included. A total of 1070 publications were reviewed, 17 of which met final inclusion criteria. FINDINGS Partial mastectomy followed by whole breast radiation is breast-conserving therapy. For women with no suspicious, palpable axillary nodes who undergo breast-conserving therapy, there is little evidence of benefit from surgical complete axillary node dissection compared with sentinel node biopsy alone. Complete axillary node dissection in patients with no palpable lymph nodes, compared with sentinel node biopsy, provides no survival benefit and is associated with a 1% to 3% reduction in recurrence of axillary lymph node metastases, but is associated with a 14% risk of lymphedema. Surgical axillary staging via sentinel node biopsy in patients with benign axillary nodes on radiological and clinical examination helps to inform decisions regarding adjuvant systemic and radiation therapy. Patients and physicians should tailor axillary lymph node interventions to maximize regional disease control and minimize morbidity. Complete axillary lymph node dissection is indicated in patients who present with palpable or needle biopsy-proven axillary metastases, patients with positive sentinel nodes undergoing mastectomy (who do not, as a standard, receive adjuvant radiation), patients with more than 3 positive sentinel nodes undergoing breast-conserving therapy, and patients not meeting eligibility criteria for recent trials establishing the safety of sentinel node biopsy alone in patients with breast cancer and metastases in their sentinel nodes. CONCLUSION AND RELEVANCE Available evidence suggests that axillary node dissection is associated with more harm than benefit in women undergoing breast-conserving therapy who do not have palpable, suspicious lymph nodes, who have tumors 3.0 cm or smaller, and who have 3 or fewer positive nodes on sentinel node biopsy.	[Rao, Roshni; Euhus, David; Balch, Charles] Univ Texas SW Med Ctr Dallas, Dept Surg, Div Surg Oncol, Dallas, TX 75390 USA; [Mayo, Helen G.] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Rao, R (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Surg, Div Surg Oncol, 5323 Harry Hines Blvd,E6-222, Dallas, TX 75390 USA.	roshni.rao@utsouthwestern.edu	Mayo, Helen/F-9734-2011	Mayo, Helen/0000-0003-1238-370X	PER Group; Merck	PER Group; Merck(Merck & Company)	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Euhus reports payment from PER Group for speaking at CME conferences. Dr Balch reports consultancy for Amgen and payment for lectures/speakers bureaus from Merck. No other disclosures were reported.	Albain KS, 2009, BREAST, V18, pS141, DOI 10.1016/S0960-9776(09)70290-5; Albain KS, 2010, LANCET ONCOL, V11, P55, DOI 10.1016/S1470-2045(09)70314-6; Alran S, 2007, ANN SURG ONCOL, V14, P2195, DOI 10.1245/s10434-006-9331-2; Andersson Y, 2012, BRIT J SURG, V99, P226, DOI 10.1002/bjs.7820; Barth A, 1997, CANCER-AM CANCER SOC, V79, P1918, DOI 10.1002/(SICI)1097-0142(19970515)79:10<1918::AID-CNCR12>3.0.CO;2-Y; Barthelmes L, 2010, EJSO-EUR J SURG ONC, V36, P399, DOI 10.1016/j.ejso.2009.10.007; Bevers TB, 2009, J NATL COMPR CANC NE, V7, P1060, DOI 10.6004/jnccn.2009.0070; Canavese G, 2009, ANN ONCOL, V20, P1001, DOI 10.1093/annonc/mdn746; Carlson RW, 2009, J NATL COMPR CANC NE, V7, P122, DOI 10.6004/jnccn.2009.0012; Carlson RW, 1999, ONCOLOGY-NY, V13, P41; Carlson RW, 2000, ONCOLOGY-NY, V14, P33; Cotlar Alvin M, 2003, Curr Surg, V60, P329, DOI 10.1016/S0149-7944(02)00777-8; Cox CE, 2001, J AM COLL SURGEONS, V193, P593, DOI 10.1016/S1072-7515(01)01086-9; Del Bianco P, 2008, EJSO-EUR J SURG ONC, V34, P508, DOI 10.1016/j.ejso.2007.05.017; Elkin EB, 2005, CANCER-AM CANCER SOC, V104, P1149, DOI 10.1002/cncr.21285; Fenton JJ, 2011, J NATL CANCER I, V103, P1152, DOI 10.1093/jnci/djr206; Fisher B, 2002, NEW ENGL J MED, V347, P1233, DOI 10.1056/NEJMoa022152; Fleissig A, 2006, BREAST CANCER RES TR, V95, P279, DOI 10.1007/s10549-005-9025-7; Fredriksson I, 2002, BRIT J SURG, V89, P902, DOI 10.1046/j.1365-2168.2002.02117.x; Gainer SM, 2012, ANN SURG ONCOL, V19, P3152, DOI 10.1245/s10434-012-2523-z; Galimberti V, 2013, LANCET ONCOL, V14, P297, DOI 10.1016/S1470-2045(13)70035-4; Galper S, 1999, INT J RADIAT ONCOL, V45, P1157, DOI 10.1016/S0360-3016(99)00334-X; Gill G, 2009, ANN SURG ONCOL, V16, P266, DOI 10.1245/s10434-008-0229-z; Gill PG, 2004, ANN SURG ONCOL, V11, p216S, DOI 10.1245/ASO.2004.12.912; GIULIANO AE, 1994, ANN SURG, V220, P391, DOI 10.1097/00000658-199409000-00015; Giuliano AE, 2010, ANN SURG, V252, P426, DOI 10.1097/SLA.0b013e3181f08f32; Giuliano AE, 2011, JAMA-J AM MED ASSOC, V305, P569, DOI 10.1001/jama.2011.90; Goodman MD, 2005, J SURG ONCOL, V92, P134, DOI 10.1002/jso.20337; Greco M, 2000, ANN SURG, V232, P1, DOI 10.1097/00000658-200007000-00001; Grills IS, 2003, INT J RADIAT ONCOL, V56, P658, DOI 10.1016/S0360-3016(03)00017-8; Gur AS, 2009, J AM COLL SURGEONS, V208, P229, DOI 10.1016/j.jamcollsurg.2008.10.029; Halsted W S, 1894, Ann Surg, V20, P497, DOI 10.1097/00000658-189407000-00075; HALVERSON KJ, 1993, INT J RADIAT ONCOL, V26, P593, DOI 10.1016/0360-3016(93)90274-Y; HARRIS JR, 1985, BREAST CANCER RES TR, V5, P17, DOI 10.1007/BF01807645; Harvell DME, 2008, BREAST CANCER RES TR, V112, P475, DOI 10.1007/s10549-008-9897-4; Helyer LK, 2010, BREAST J, V16, P48, DOI 10.1111/j.1524-4741.2009.00855.x; Hoebers FJP, 2000, CANCER, V88, P1633, DOI 10.1002/(SICI)1097-0142(20000401)88:7<1633::AID-CNCR18>3.0.CO;2-S; Hughes KS, 2004, NEW ENGL J MED, V351, P971, DOI 10.1056/NEJMoa040587; Jacobs AK, 2013, J AM COLL CARDIOL, V61, P213, DOI 10.1016/j.jacc.2012.09.025; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; JOHANSEN H, 1990, ACTA ONCOL, V29, P709, DOI 10.3109/02841869009092988; Johansen H, 2008, ACTA ONCOL, V47, P633, DOI 10.1080/02841860801989753; Kim C, 2010, NAT REV CLIN ONCOL, V7, P340, DOI 10.1038/nrclinonc.2010.61; Kohrt HE, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-66; Korkola JE, 2003, CANCER RES, V63, P7167; Krag DN, 2007, LANCET ONCOL, V8, P881, DOI 10.1016/S1470-2045(07)70278-4; Krag DN, 2010, LANCET ONCOL, V11, P927, DOI 10.1016/S1470-2045(10)70207-2; Krag DN, 2009, JNCI-J NATL CANCER I, V101, P1356, DOI 10.1093/jnci/djp281; Krishnamurthy S, 2009, CANCER CYTOPATHOL, V117, P451, DOI 10.1002/cncy.20055; Langer I, 2005, ANN SURG, V241, P152, DOI 10.1097/01.sla.0000149305.23322.3c; Louis-Sylvestre C, 2004, J CLIN ONCOL, V22, P97, DOI 10.1200/JCO.2004.12.108; Lucci A, 2007, J CLIN ONCOL, V25, P3657, DOI 10.1200/JCO.2006.07.4062; Mamounas EP, 2010, J CLIN ONCOL, V28, P1677, DOI 10.1200/JCO.2009.23.7610; Mansel RE, 2006, J NATL CANCER I, V98, P599, DOI 10.1093/jnci/djj158; Martelli G, 2005, ANN SURG, V242, P1, DOI 10.1097/01.sla.0000167759.15670.14; Martelli G, 2008, CANCER-AM CANCER SOC, V112, P481, DOI 10.1002/cncr.23213; Memorial Sloan-Kettering Cancer Center, 2012, BREAST CANC PRED TOO; Mittendorf EA, 2012, ANN SURG, V255, P109, DOI 10.1097/SLA.0b013e318238f461; Rao R, 2009, ANN SURG ONCOL, V16, P1170, DOI 10.1245/s10434-009-0421-9; Rivadeneira DE, 2000, J AM COLL SURGEONS, V191, P1, DOI 10.1016/S1072-7515(00)00310-0; Rudenstam CM, 2006, J CLIN ONCOL, V24, P337, DOI 10.1200/JCO.2005.01.5784; Shah C, 2012, INT J RADIAT ONCOL, V83, P1095, DOI 10.1016/j.ijrobp.2011.09.058; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Straver ME, 2010, ANN SURG ONCOL, V17, P1854, DOI 10.1245/s10434-010-0945-z; van la Parra RFD, 2009, ANN SURG ONCOL, V16, P1128, DOI 10.1245/s10434-009-0359-y; Van Zee KJ, 2003, ANN SURG ONCOL, V10, P1140, DOI 10.1245/ASO.2003.03.015; VERONESI U, 1990, ANN SURG, V211, P250; Veronesi U, 2005, ANN ONCOL, V16, P383, DOI 10.1093/annonc/mdi089; Veronesi U, 2003, NEW ENGL J MED, V349, P546, DOI 10.1056/NEJMoa012782; Veronesi U, 2010, ANN SURG, V251, P595, DOI 10.1097/SLA.0b013e3181c0e92a; Wang Z, 2011, BREAST CANCER RES TR, V129, P675, DOI 10.1007/s10549-011-1665-1; Yates L, 2012, INT J RADIAT ONCOL, V82, P2093, DOI 10.1016/j.ijrobp.2011.01.066; Zavagno G, 2008, ANN SURG, V247, P207, DOI 10.1097/SLA.0b013e31812e6a73	73	106	109	2	31	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 2	2013	310	13					1385	1394		10.1001/jama.2013.277804	http://dx.doi.org/10.1001/jama.2013.277804			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	227GB	24084924				2022-12-28	WOS:000325098100024
J	Tsujinaka, T; Yamamoto, K; Fujita, J; Endo, S; Kawada, J; Nakahira, S; Shimokawa, T; Kobayashi, S; Yamasaki, M; Akamaru, Y; Miyamoto, A; Mizushima, T; Shimizu, J; Umeshita, K; Ito, T; Doki, Y; Mori, M				Tsujinaka, Toshimasa; Yamamoto, Kazuyoshi; Fujita, Junya; Endo, Shunji; Kawada, Junji; Nakahira, Shin; Shimokawa, Toshio; Kobayashi, Shogo; Yamasaki, Makoto; Akamaru, Yusuke; Miyamoto, Atsushi; Mizushima, Tsunekazu; Shimizu, Junzo; Umeshita, Koji; Ito, Toshinori; Doki, Yuichiro; Mori, Masaki		Osaka Univ	Subcuticular sutures versus staples for skin closure after open gastrointestinal surgery: a phase 3, multicentre, open-label, randomised controlled trial	LANCET			English	Article							SURGICAL SITE INFECTION; ANTIMICROBIAL PROPHYLAXIS; WOUND-INFECTION; PREVENTION; LAPAROTOMY; IMPACT	Background Staples have been widely used for skin closure after open gastrointestinal surgery. The potential advantages of subcuticular sutures compared with staples have not been assessed. We assessed the differences in the frequency of wound complications, including superficial incisional surgical site infection and hypertrophic scar formation, depending on whether subcuticular sutures or staples are used. Methods We did a multicentre, open-label, randomised controlled trial at 24 institutions between June 1, 2009, and Feb 28, 2012. Eligible patients aged 20 years or older, with adequate organ function and undergoing elective open upper or lower gastrointestinal surgery, were randomly assigned preoperatively to either staples or subcuticular sutures for skin closure. Randomisation was done via a computer-generated permuted-block sequence, and was stratified by institution, sex, and type of surgery (ie, upper or lower gastrointestinal surgery). Our primary endpoint was the incidence of wound complications within 30 days of surgery. Analysis was done by intention to treat. This study is registered with UMIN-CTR, UMIN000002480. Findings 1080 patients were enrolled and randomly assigned in a one to one ratio: 562 to subcuticular sutures and 518 to staples. 1072 were eligible for the primary endpoint and 1058 for the secondary endpoint. Of the 558 patients who received subcuticular sutures, 382 underwent upper gastrointestinal surgery and 176 underwent lower gastrointestinal surgery. Wound complications occurred in 47 of 558 patients (8.4%, 95% CI 6.3-11.0). Of the 514 who received staples, 413 underwent upper gastrointestinal surgery and 101 underwent lower gastrointestinal surgery. Wound complications occurred in 59 of 514 (11.5%, 95% CI 8.9-14.6). Overall, the rate of wound complications did not differ significantly between the subcuticular sutures and staples groups (odds ratio 0.709, 95% CI 0.474-1.062; p=0.12). Interpretation The efficacy of subcuticular sutures was not validated as an improvement over a standard procedure for skin closure to reduce the incidence of wound complications after open gastrointestinal surgery.	[Tsujinaka, Toshimasa] Kaizuka City Hosp, Dept Surg, Kaizuka, Osaka 5970015, Japan; [Yamamoto, Kazuyoshi; Miyamoto, Atsushi] Osaka Natl Hosp, Natl Hosp Org, Dept Surg, Osaka, Japan; [Fujita, Junya] NTT West Osaka Hosp, Dept Surg, Osaka, Japan; [Endo, Shunji] Higashiosaka City Gen Hosp, Dept Surg, Osaka, Japan; [Kawada, Junji] Osaka Gen Med Ctr, Dept Surg, Osaka, Japan; [Nakahira, Shin] Kansai Rosai Hosp, Dept Surg, Amagasaki, Hyogo, Japan; [Shimokawa, Toshio] Univ Yamanashi, Grad Sch Med & Engn, Yamanashi, Japan; [Kobayashi, Shogo; Yamasaki, Makoto; Mizushima, Tsunekazu; Umeshita, Koji; Ito, Toshinori; Doki, Yuichiro; Mori, Masaki] Osaka Univ, Grad Sch Med, Dept Surg Gastroenterol, Osaka, Japan; [Ito, Toshinori] Osaka Univ, Grad Sch Med, Dept Complementary & Alternat Med, Osaka, Japan; [Akamaru, Yusuke] Osaka Koseinenkin Hosp, Dept Surg, Osaka, Japan; [Shimizu, Junzo] Osaka Rosai Hosp, Dept Surg, Osaka, Japan	Osaka National Hospital; Kansai Rosai Hospital; University of Yamanashi; Osaka University; Osaka University; Osaka Rosai Hospital	Tsujinaka, T (corresponding author), Kaizuka City Hosp, Dept Surg, 3-10-20 Hori, Kaizuka, Osaka 5970015, Japan.	tsujinaka@hosp.kaizuka.osaka.jp			Johnson Johnson	Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA)	Johnson & Johnson.	Alderdice F, 2003, COCHRANE DB SYST REV, V2; ANGELINI GD, 1984, THORAX, V39, P942, DOI 10.1136/thx.39.12.942; Basha SL, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.07.011; Bratzler DW, 2004, CLIN INFECT DIS, V38, P1706, DOI 10.1086/421095; Bratzler DW, 2005, ARCH SURG-CHICAGO, V140, P174, DOI 10.1001/archsurg.140.2.174; Cervantes-Sanchez CR, 2000, WORLD J SURG, V24, P38, DOI 10.1007/s002689910008; CHU CC, 1984, AM J SURG, V147, P197, DOI 10.1016/0002-9610(84)90088-6; Clay FSH, 2011, AM J OBSTET GYNECOL, V204, P378, DOI 10.1016/j.ajog.2010.11.018; Clughtai T, 2000, CAN J CARDIOL, V16, P1403; Cromi A, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.02.001; Elola-Olaso AM, 2012, HPB, V14, P136, DOI 10.1111/j.1477-2574.2011.00417.x; Fisher G T, 1980, Ann Plast Surg, V4, P144, DOI 10.1097/00000637-198002000-00012; Frishman GN, 1997, J REPROD MED, V42, P627; Hawn MT, 2011, ANN SURG, V254, P494, DOI 10.1097/SLA.0b013e31822c6929; Heyland DK, 2001, JAMA-J AM MED ASSOC, V286, P944, DOI 10.1001/jama.286.8.944; Inotsume-Kojima Y, 2011, J HOSP INFECT, V77, P162, DOI 10.1016/j.jhin.2010.07.016; Johnson A, 2006, J HOSP INFECT, V64, P30, DOI 10.1016/j.jhin.2006.03.020; Johnson RG, 1997, ANN SURG, V226, P606, DOI 10.1097/00000658-199711000-00005; Khan RJK, 2006, J BONE JOINT SURG BR, V88B, P238, DOI 10.1302/0301-620X.88B2.16923; Kirkland KB, 1999, INFECT CONT HOSP EP, V20, P725, DOI 10.1086/501572; Leaper D, 2008, BMJ-BRIT MED J, V337, pa1924; Mackeen AD, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003577.pub3; Mangram AJ, 1999, INFECT CONT HOSP EP, V20, P250, DOI 10.1086/501620; Mullen JC, 1999, CAN J CARDIOL, V15, P65; Naotake F, 2010, HEPATO-GASTROENTEROL, V57, P1024; Nikfarjam M, 2009, AM J SURG, V198, P381, DOI 10.1016/j.amjsurg.2008.12.021; Obermair A, 2007, ANZ J SURG, V77, P460, DOI 10.1111/j.1445-2197.2007.04095.x; Ortega G, 2012, J SURG RES, V174, P33, DOI 10.1016/j.jss.2011.05.056; Perencevich EN, 2003, EMERG INFECT DIS, V9, P196; RANABOLDO CJ, 1992, BRIT J SURG, V79, P1172, DOI 10.1002/bjs.1800791122; Reid K, 2010, DIS COLON RECTUM, V53, P1374, DOI 10.1007/DCR.0b013e3181ed3f7e; Rousseau JA, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2009.01.019; Sanni Aliu, 2007, Interact Cardiovasc Thorac Surg, V6, P243; Shetty A A, 2004, J Orthop Surg (Hong Kong), V12, P191; SHNIDER SM, 1963, ANESTHESIOLOGY, V24, P11, DOI 10.1097/00000542-196301000-00002; Smith RL, 2004, ANN SURG, V239, P599, DOI 10.1097/01.sla.0000124292.21605.99; Smyth STM, 2000, J HOSP INFECT, V45, P173, DOI 10.1053/jhin.2000.0736; Sugiura T, 2012, WORLD J SURG, V36, P2888, DOI 10.1007/s00268-012-1742-6; Talbot TR, 2005, AM J INFECT CONTROL, V33, P353, DOI 10.1016/j.ajic.2004.10.008; TAUBE M, 1983, ANN ROY COLL SURG, V65, P164; Togo S, 2008, J GASTROINTEST SURG, V12, P1041, DOI 10.1007/s11605-007-0297-6; Tuuli MG, 2011, OBSTET GYNECOL, V117, P682, DOI 10.1097/AOG.0b013e31820ad61e; Wang ZX, 2013, BRIT J SURG, V100, P465, DOI 10.1002/bjs.9062; Watanabe A, 2008, SURG TODAY, V38, P404, DOI 10.1007/s00595-007-3637-y	44	41	41	0	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 28	2013	382	9898					1105	1112		10.1016/S0140-6736(13)61780-8	http://dx.doi.org/10.1016/S0140-6736(13)61780-8			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	228SG	24075050				2022-12-28	WOS:000325208100026
J	Vallance, P; Chalmers, I				Vallance, Patrick; Chalmers, Iain			Secure use of individual patient data from clinical trials	LANCET			English	Editorial Material									[Vallance, Patrick] GlaxoSmithKline, Brentford TW8 9GS, Middx, England; [Chalmers, Iain] James Lind Initiat, Oxford, England	GlaxoSmithKline	Vallance, P (corresponding author), GlaxoSmithKline, Brentford TW8 9GS, Middx, England.	patrick.5.vallance@gsk.com						Agar J., 2005, HIST POLICY; AllTrials, 2013, ALL TRIALS REG ALL R; [Anonymous], 1988, BRIT MED J, V296, P320; [Anonymous], 1988, NEW ENGL J MED, V319, P1681; [Anonymous], 1970, LANCET, V1, P203; [Anonymous], BMJ; Chalmers I, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f105; Gymrek M, 2013, SCIENCE, V339, P321, DOI 10.1126/science.1229566; The Royal Society, 2012, SCI OPEN ENTERPRISE	9	14	14	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 28	2013	382	9898					1073	1074		10.1016/S0140-6736(13)62001-2	http://dx.doi.org/10.1016/S0140-6736(13)62001-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	228SG	24075034				2022-12-28	WOS:000325208100005
J	Blake, DF; Morris, RV; Kocurek, G; Morrison, SM; Downs, RT; Bish, D; Ming, DW; Edgett, KS; Rubin, D; Goetz, W; Madsen, MB; Sullivan, R; Gellert, R; Campbell, I; Treiman, AH; McLennan, SM; Yen, AS; Grotzinger, J; Vaniman, DT; Chipera, SJ; Achilles, CN; Rampe, EB; Sumner, D; Meslin, PY; Maurice, S; Forni, O; Gasnault, O; Fisk, M; Schmidt, M; Mahaffy, P; Leshin, LA; Glavin, D; Steele, A; Freissinet, C; Navarro-Gonzalez, R; Yingst, RA; Kah, LC; Bridges, N; Lewis, KW; Bristow, TF; Farmer, JD; Crisp, JA; Stolper, EM; Marais, DJD; Sarrazin, P				Blake, D. F.; Morris, R. V.; Kocurek, G.; Morrison, S. M.; Downs, R. T.; Bish, D.; Ming, D. W.; Edgett, K. S.; Rubin, D.; Goetz, W.; Madsen, M. B.; Sullivan, R.; Gellert, R.; Campbell, I.; Treiman, A. H.; McLennan, S. M.; Yen, A. S.; Grotzinger, J.; Vaniman, D. T.; Chipera, S. J.; Achilles, C. N.; Rampe, E. B.; Sumner, D.; Meslin, P-Y.; Maurice, S.; Forni, O.; Gasnault, O.; Fisk, M.; Schmidt, M.; Mahaffy, P.; Leshin, L. A.; Glavin, D.; Steele, A.; Freissinet, C.; Navarro-Gonzalez, R.; Yingst, R. A.; Kah, L. C.; Bridges, N.; Lewis, K. W.; Bristow, T. F.; Farmer, J. D.; Crisp, J. A.; Stolper, E. M.; Marais, D. J. Des; Sarrazin, P.		MSL Sci Team	Curiosity at Gale Crater, Mars: Characterization and Analysis of the Rocknest Sand Shadow	SCIENCE			English	Article							MERIDIANI-PLANUM; GUSEV CRATER; CALIBRATION; MINERALOGY; SALTATION; DEPOSITS; DUST; SOIL	The Rocknest aeolian deposit is similar to aeolian features analyzed by the Mars Exploration Rovers (MERs) Spirit and Opportunity. The fraction of sand <150 micrometers in size contains similar to 55% crystalline material consistent with a basaltic heritage and similar to 45% x-ray amorphous material. The amorphous component of Rocknest is iron-rich and silicon-poor and is the host of the volatiles (water, oxygen, sulfur dioxide, carbon dioxide, and chlorine) detected by the Sample Analysis at Mars instrument and of the fine-grained nanophase oxide component first described from basaltic soils analyzed by MERs. The similarity between soils and aeolian materials analyzed at Gusev Crater, Meridiani Planum, and Gale Crater implies locally sourced, globally similar basaltic materials or globally and regionally sourced basaltic components deposited locally at all three locations.	[Blake, D. F.; Bristow, T. F.; Marais, D. J. Des] NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; [Morris, R. V.; Ming, D. W.; Achilles, C. N.; Rampe, E. B.] NASA, Lyndon B Johnson Space Ctr, Houston, TX 77058 USA; [Kocurek, G.] Univ Texas Austin, Dept Geol Sci, Austin, TX 78712 USA; [Morrison, S. M.; Downs, R. T.] Univ Arizona, Dept Geol, Tucson, AZ 85721 USA; [Bish, D.] Indiana Univ, Dept Geol Sci, Bloomington, IN 47405 USA; [Edgett, K. S.] Malin Space Sci Syst, San Diego, CA 92191 USA; [Rubin, D.] US Geol Survey, Santa Cruz, CA 95060 USA; [Goetz, W.] Max Planck Inst Sonnensyst Forsch, D-37191 Katlenburg Lindau, Germany; [Madsen, M. B.] Univ Copenhagen, Niels Bohr Inst, DK-2100 Copenhagen, Denmark; [Sullivan, R.] Cornell Univ, Ctr Radiophys & Space Res, Ithaca, NY 14850 USA; [Gellert, R.; Campbell, I.] Univ Guelph, Guelph, ON N1G 2W1, Canada; [Treiman, A. H.] Lunar & Planetary Inst, Houston, TX 77058 USA; [McLennan, S. M.] SUNY Stony Brook, Stony Brook, NY 11790 USA; [Yen, A. S.; Crisp, J. A.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Grotzinger, J.; Stolper, E. M.] CALTECH, Pasadena, CA 91125 USA; [Vaniman, D. T.; Yingst, R. A.] Planetary Sci Inst, Tucson, AZ 85719 USA; [Chipera, S. J.] Chesapeake Energy, Oklahoma City, OK 73102 USA; [Sumner, D.] Univ Calif Davis, Davis, CA 95616 USA; [Meslin, P-Y.; Maurice, S.; Forni, O.; Gasnault, O.] UPS OMP CNRS, IRAP, F-31028 Toulouse, France; [Fisk, M.] Oregon State Univ, Corvallis, OR 97331 USA; [Schmidt, M.] Finnish Meteorol Inst, FI-00101 Helsinki, Finland; [Mahaffy, P.; Glavin, D.; Freissinet, C.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Leshin, L. A.] Rensselaer Polytech Inst, Troy, NY 12180 USA; [Steele, A.] Carnegie Inst Sci, Geophys Lab, Washington, DC 20015 USA; [Navarro-Gonzalez, R.] Univ Nacl Autonoma Mexico, Mexico City 04510, DF, Mexico; [Kah, L. C.] Univ Tennessee, Dept Earth & Planetary Sci, Knoxville, TN 37996 USA; [Bridges, N.] Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA; [Lewis, K. W.] Princeton Univ, Princeton, NJ 08544 USA; [Farmer, J. D.] Arizona State Univ, Phoenix, AZ 85004 USA; [Sarrazin, P.] SETI Inst, Mountain View, CA 94043 USA	National Aeronautics & Space Administration (NASA); NASA Ames Research Center; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; University of Texas System; University of Texas Austin; University of Arizona; Indiana University System; Indiana University Bloomington; United States Department of the Interior; United States Geological Survey; Max Planck Society; University of Copenhagen; Niels Bohr Institute; Cornell University; University of Guelph; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); California Institute of Technology; University of California System; University of California Davis; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Oregon State University; Finnish Meteorological Institute; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Rensselaer Polytechnic Institute; Carnegie Institution for Science; Universidad Nacional Autonoma de Mexico; University of Tennessee System; University of Tennessee Knoxville; Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; Princeton University; Arizona State University; Arizona State University-Downtown Phoenix	Blake, DF (corresponding author), NASA, Ames Res Ctr, Moffett Field, CA 94035 USA.	david.blake@nasa.gov	Zorzano, María-Paz/F-2184-2015; Muller, Jan-Peter/Q-8886-2019; Harri, Ari-Matti/C-7142-2012; Gómez, Felipe/L-7315-2014; Benna, Mehdi/F-3489-2012; Navarro-González, Rafael/D-1748-2009; Floyd, Melissa/D-4626-2012; Lemmon, Mark T/E-9983-2010; Hayes, Alexander G/P-2024-2014; Madsen, Morten Bo/D-2082-2011; Malakhov, Alexey Vladimirovich/F-7953-2017; FABRE, Cécile/B-5827-2012; Franz, Heather B/F-3508-2012; Sumner, Dawn Y/E-8744-2011; Martin-Torres, Javier/G-6329-2015; Blanco, Juan Jose/E-3627-2014; GEFFROY, Claude/AAB-9152-2019; Stipp, Susan L.S./B-8494-2019; Balic-Zunic, Tonci/A-6362-2013; De Pablo, Miguel Ángel/J-6442-2014; Glavin, Daniel P/D-6194-2012; Bish, David/AAY-7618-2020; Farmer, Jack D/B-9343-2019; Gomez-Elvira, Javier/K-5829-2014; Avalos, Juan Jose Blanco/AAB-9447-2021; Ramos, Miguel/K-2230-2014; Rodriguez-Manfredi, Jose/L-8001-2014; Sullivan, Robert/AAR-8193-2020; Rodriguez-Manfredi, Jose/AAG-9826-2021; Prats, Benito/F-9467-2019; Gasnault, Olivier/F-4327-2010; Dworkin, Jason P./C-9417-2012; szopa, cyril/C-6865-2015; Kah, Linda C/J-3754-2019; Steele, Andrew/A-3573-2013; Crisp, Joy/H-8287-2016; Vicenzi, Edward/T-9430-2017	Zorzano, María-Paz/0000-0002-4492-9650; Muller, Jan-Peter/0000-0002-5077-3736; Harri, Ari-Matti/0000-0001-8541-2802; Gómez, Felipe/0000-0001-9977-7060; Navarro-González, Rafael/0000-0002-6078-7621; Lemmon, Mark T/0000-0002-4504-5136; Hayes, Alexander G/0000-0001-6397-2630; Madsen, Morten Bo/0000-0001-8909-5111; Malakhov, Alexey Vladimirovich/0000-0003-4292-7077; FABRE, Cécile/0000-0001-8627-4050; Sumner, Dawn Y/0000-0002-7343-2061; Martin-Torres, Javier/0000-0001-6479-2236; Blanco, Juan Jose/0000-0002-8666-0696; GEFFROY, Claude/0000-0002-2731-9658; Stipp, Susan L.S./0000-0001-7009-643X; Balic-Zunic, Tonci/0000-0003-1687-1233; De Pablo, Miguel Ángel/0000-0002-4496-2741; Glavin, Daniel P/0000-0001-7779-7765; Gomez-Elvira, Javier/0000-0002-9068-9846; Avalos, Juan Jose Blanco/0000-0002-8666-0696; Ramos, Miguel/0000-0003-3648-6818; Rodriguez-Manfredi, Jose/0000-0003-0461-9815; Rodriguez-Manfredi, Jose/0000-0003-0461-9815; Prats, Benito/0000-0003-3869-3351; Gasnault, Olivier/0000-0002-6979-9012; Dworkin, Jason P./0000-0002-3961-8997; szopa, cyril/0000-0002-0090-4056; Kah, Linda C/0000-0001-7172-2033; Steele, Andrew/0000-0001-9643-2841; Crisp, Joy/0000-0002-3202-4416; Vicenzi, Edward/0000-0003-2085-6546; McLennan, Scott/0000-0003-4259-7178; Edgett, Kenneth/0000-0001-7197-5751; Morrison, Shaunna/0000-0002-1712-8057; Forni, Olivier/0000-0001-6772-9689; Johnson, Jeffrey/0000-0002-5586-4901; Rubin, David/0000-0003-1169-1452	NASA Mars Science Laboratory Mission; Danish Council for Independent Research/Natural Sciences (Det Frie Forskningsrad Natur og Univers FNU) [12-127126, 11-107019]; Deutsche Forschungsgemeinschaft (DFG) [GO 2288/1-1]; NASA; Science and Technology Facilities Council [ST/J005193/1] Funding Source: researchfish; UK Space Agency [ST/J005339/1, ST/I003118/1] Funding Source: researchfish	NASA Mars Science Laboratory Mission; Danish Council for Independent Research/Natural Sciences (Det Frie Forskningsrad Natur og Univers FNU); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); NASA(National Aeronautics & Space Administration (NASA)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); UK Space Agency	Support from the NASA Mars Science Laboratory Mission is gratefully acknowledged. The chemical and mineralogical data presented here are derived from the archived data sets in the NASA Planetary Data System (PDS) http://pds-geosciences.wustl.edu/missions/msl, specifically MSL-M-CHEMIN-2-EDR-V1.0 and MSL-M-APXS-2-EDR-V1.0. M. B. M. was funded by the Danish Council for Independent Research/Natural Sciences (Det Frie Forskningsrad Natur og Univers FNU grants 12-127126 and 11-107019). W. G. acknowledges partial funding by the Deutsche Forschungsgemeinschaft (DFG grant GO 2288/1-1). Some of this research was carried out at the Jet Propulsion Laboratory, California Institute of Technology, under a contract with NASA.	Almeida MP, 2008, P NATL ACAD SCI USA, V105, P6222, DOI 10.1073/pnas.0800202105; Anderson MS, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.4757861; Anderson RC, 2012, SPACE SCI REV, V170, P57, DOI 10.1007/s11214-012-9898-9; ARVIDSON RE, 1983, SCIENCE, V222, P463, DOI 10.1126/science.222.4623.463; Bagnold R., 1941, PHYS BLOWN SAND DESE; Berger J. A., 2013, 45 LUN PLAN SCI C MA; Bish DL, 2013, SCIENCE, V341, DOI 10.1126/science.1238932; Blake D, 2012, SPACE SCI REV, V170, P341, DOI 10.1007/s11214-012-9905-1; Claudin P, 2006, EARTH PLANET SC LETT, V252, P30, DOI 10.1016/j.epsl.2006.09.004; Edgett KS, 2012, SPACE SCI REV, V170, P259, DOI 10.1007/s11214-012-9910-4; ELLWOOD JM, 1975, J SEDIMENT PETROL, V45, P554; FRYBERGER SG, 1992, SEDIMENTOLOGY, V39, P319, DOI 10.1111/j.1365-3091.1992.tb01041.x; Gellert R, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002555; Gellert R., 2013, 45 LUN PLAN SCI C MA; Goetz W, 2010, J GEOPHYS RES-PLANET, V115, DOI 10.1029/2009JE003437; Golombek M, 2010, J GEOPHYS RES-PLANET, V115, DOI 10.1029/2010JE003628; Herkenhoff K. E., 2008, MARTIAN SURFACE COMP, P451, DOI DOI 10.1017/CB09780511536076.021; HESP PA, 1981, J SEDIMENT PETROL, V51, P101; Jerolmack DJ, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002544; Kok JF, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.074502; Leshin LA, 2013, SCIENCE, V341, DOI 10.1126/science.1238937; LINDSLEY DH, 1983, AM MINERAL, V68, P477; Mahaffy PR, 2012, SPACE SCI REV, V170, P401, DOI 10.1007/s11214-012-9879-z; McSween HY, 2009, SCIENCE, V324, P736, DOI 10.1126/science.1165871; Meslin PY, 2013, SCIENCE, V341, DOI 10.1126/science.1238670; Milliken RE, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL041870; Ming DW, 2008, J GEOPHYS RES-PLANET, V113, DOI 10.1029/2008JE003195; Morris RV, 2008, J GEOPHYS RES-PLANET, V113, DOI 10.1029/2008JE003201; Morris RV, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002584; Newman CE, 2005, ICARUS, V174, P135, DOI 10.1016/j.icarus.2004.10.023; OWEN PR, 1964, J FLUID MECH, V20, P225, DOI 10.1017/S0022112064001173; Phillips RJ, 2011, SCIENCE, V332, P838, DOI 10.1126/science.1203091; Shao YP, 2000, J GEOPHYS RES-ATMOS, V105, P22437, DOI 10.1029/2000JD900304; Soderblom LA, 2004, SCIENCE, V306, P1723, DOI 10.1126/science.1105127; Sullivan R, 2005, NATURE, V436, P58, DOI 10.1038/nature03641; Sullivan R, 2008, J GEOPHYS RES-PLANET, V113, DOI 10.1029/2008JE003101; Taylor SR, 2009, PLANETARY CRUSTS: THEIR COMPOSITION, ORIGIN AND EVOLUTION, P1; Warren P. H., 1979, P LUNAR PLANET SCI C, P583; Yen A.S., 2013, LUNAR PLANETARY SCI, V44; Yen AS, 2005, NATURE, V436, P49, DOI 10.1038/nature03637	40	193	196	4	163	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 27	2013	341	6153							1239505	10.1126/science.1239505	http://dx.doi.org/10.1126/science.1239505			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	224NS	24072928				2022-12-28	WOS:000324894600005
J	Omori, T; Kusama, T; Kawata, S; Ohnuma, I; Sutou, Y; Araki, Y; Ishida, K; Kainuma, R				Omori, Toshihiro; Kusama, Tomoe; Kawata, Shingo; Ohnuma, Ikuo; Sutou, Yuji; Araki, Yoshikazu; Ishida, Kiyohito; Kainuma, Ryosuke			Abnormal Grain Growth Induced by Cyclic Heat Treatment	SCIENCE			English	Article							TRANSFORMATION-MISMATCH PLASTICITY; INTERNAL-STRESS SUPERPLASTICITY; SINGLE-CRYSTALS; PSEUDOELASTICITY; COHERENCY; ALUMINUM; ALLOYS; SIZE	In polycrystalline materials, grain growth occurs at elevated temperatures to reduce the total area of grain boundaries with high energy. The grain growth rate usually slows down with annealing time, making it hard to obtain grains larger than a millimeter in size. We report a crystal growth method that employs only a cyclic heat treatment to obtain a single crystal of more than several centimeters in a copper-based shape-memory alloy. This abnormal grain growth phenomenon results from the formation of a subgrain structure introduced through phase transformation. These findings provide a method of fabricating a single-crystal or large-grain structure important for shape-memory properties, magnetic properties, and creep properties, among others.	[Omori, Toshihiro; Kusama, Tomoe; Kawata, Shingo; Ohnuma, Ikuo; Sutou, Yuji; Ishida, Kiyohito; Kainuma, Ryosuke] Tohoku Univ, Grad Sch Engn, Dept Mat Sci, Sendai, Miyagi 9808579, Japan; [Araki, Yoshikazu] Kyoto Univ, Grad Sch Engn, Dept Architecture & Architectural Engn, Nishikyo Ku, Kyoto 6158540, Japan	Tohoku University; Kyoto University	Omori, T (corresponding author), Tohoku Univ, Grad Sch Engn, Dept Mat Sci, 6-6-02 Aoba Yama, Sendai, Miyagi 9808579, Japan.	omori@material.tohoku.ac.jp	Sutou, Yuji/GNM-7287-2022; Omori, Toshihiro/A-4478-2017; OHNUMA, Ikuo/J-4253-2015; Araki, Yoshikazu/F-1894-2013	Omori, Toshihiro/0000-0001-9174-0239; Araki, Yoshikazu/0000-0001-9569-1753; Sutou, Yuji/0000-0002-3067-2727	Japan Science and Technology Agency; Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology, Japan; Grants-in-Aid for Scientific Research [22226011] Funding Source: KAKEN	Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Japan Science and Technology Agency and by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science and a Grant for Excellent Graduate Schools from the Ministry of Education, Culture, Sports, Science and Technology, Japan. We thank K. R. A. Ziebeck, Cavendish Laboratory, University of Cambridge, for his help in critical reading of the manuscript. T.O., T.K., R.K., K.I., T. Tanaka, S. Kise, K. Nakamizo, K. Ishikawa, M. Nakano, and S. Teshigawara are inventors on Japanese patent application number 2013-099996, applied for by Tohoku University, Furukawa Techno Material Co., and Furukawa Electric Co.	Araki Y, 2011, EARTHQ ENG STRUCT D, V40, P107, DOI 10.1002/eqe.1029; BROWN LM, 1970, PHILOS MAG, V21, P329, DOI 10.1080/14786437008238420; Carpenter HCH, 1921, P R SOC LOND A-CONTA, V100, P329, DOI 10.1098/rspa.1921.0089; Ciulik J, 2009, SCRIPTA MATER, V61, P895, DOI 10.1016/j.scriptamat.2009.07.021; Fujiwara T., 1941, J SCI HIROSHIMA U, V11, P89; Fujiwara T., 1939, J SCI HIROSHIMA U, V9, P227; Fujiwara T., 1938, J SCI HIROSHIMA U  A, V8, P293; GonzalezDoncel G, 1996, METALL MATER TRANS A, V27, P2837, DOI 10.1007/BF02652375; Goss N.P., 1935, T AM SOC MET, V23, P511; Holm EA, 2010, SCIENCE, V328, P1138, DOI 10.1126/science.1187833; Humphreys FJ, 2004, RECRYSTALLIZATION RE, V2nd, P368; Kainuma R, 1996, METALL MATER TRANS A, V27, P2187, DOI 10.1007/BF02651873; Li Q., 1998, METALL MATER TRANS A, V38A, P44; Martin J.W., 1997, STABILITY MICROSTRUC, P28; MULLINS WW, 1958, ACTA METALL MATER, V6, P414, DOI 10.1016/0001-6160(58)90020-8; Schuh C, 2000, ACTA MATER, V48, P1639, DOI 10.1016/S1359-6454(00)00018-5; Schuh C, 2001, ACTA MATER, V49, P3387, DOI 10.1016/S1359-6454(01)00272-5; Schuh C, 2001, ACTA MATER, V49, P199, DOI 10.1016/S1359-6454(00)00318-9; SHERBY OD, 1989, PROG MATER SCI, V33, P169, DOI 10.1016/0079-6425(89)90004-2; SMITH CS, 1948, T AM I MIN MET ENG, V175, P15; Sutou Y, 2008, MATER SCI TECH-LOND, V24, P896, DOI 10.1179/174328408X302567; Sutou Y, 2005, ACTA MATER, V53, P4121, DOI 10.1016/j.actamat.2005.05.013; Sutou Y, 2013, ACTA MATER, V61, P3842, DOI 10.1016/j.actamat.2013.03.022; WEATHERLY GC, 1968, PHILOS MAG, V17, P791, DOI 10.1080/14786436808223030; WU MY, 1987, METALL TRANS A, V18, P451, DOI 10.1007/BF02648806; Ye B, 2010, ACTA MATER, V58, P3851, DOI 10.1016/j.actamat.2010.03.047; Zwigl P, 1997, ACTA MATER, V45, P5285, DOI 10.1016/S1359-6454(97)00186-9; Zwigl P, 1998, METALL MATER TRANS A, V29, P2571, DOI 10.1007/s11661-998-0229-4	28	165	172	17	333	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 27	2013	341	6153					1500	1502		10.1126/science.1238017	http://dx.doi.org/10.1126/science.1238017			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	224NS	24072918				2022-12-28	WOS:000324894600046
J	Eyre, DW; Cule, ML; Wilson, DJ; Griffiths, D; Vaughan, A; O'Connor, L; Ip, CLC; Golubchik, T; Batty, EM; Finney, JM; Wyllie, DH; Didelot, X; Piazza, P; Bowden, R; Dingle, KE; Harding, RM; Crook, DW; Wilcox, MH; Peto, TEA; Walker, AS				Eyre, David W.; Cule, Madeleine L.; Wilson, Daniel J.; Griffiths, David; Vaughan, Alison; O'Connor, Lily; Ip, Camilla L. C.; Golubchik, Tanya; Batty, Elizabeth M.; Finney, John M.; Wyllie, David H.; Didelot, Xavier; Piazza, Paolo; Bowden, Rory; Dingle, Kate E.; Harding, Rosalind M.; Crook, Derrick W.; Wilcox, Mark H.; Peto, Tim E. A.; Walker, A. Sarah			Diverse Sources of C. difficile Infection Identified on Whole-Genome Sequencing	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACQUIRED CLOSTRIDIUM-DIFFICILE; CARE FACILITY RESIDENTS; COLONIZATION; DISEASE; EPIDEMIOLOGY; TRANSMISSION; ACQUISITION; RISK; GUIDELINES; ADMISSIONS	BackgroundIt has been thought that Clostridium difficile infection is transmitted predominantly within health care settings. However, endemic spread has hampered identification of precise sources of infection and the assessment of the efficacy of interventions. MethodsFrom September 2007 through March 2011, we performed whole-genome sequencing on isolates obtained from all symptomatic patients with C. difficile infection identified in health care settings or in the community in Oxfordshire, United Kingdom. We compared single-nucleotide variants (SNVs) between the isolates, using C. difficile evolution rates estimated on the basis of the first and last samples obtained from each of 145 patients, with 0 to 2 SNVs expected between transmitted isolates obtained less than 124 days apart, on the basis of a 95% prediction interval. We then identified plausible epidemiologic links among genetically related cases from data on hospital admissions and community location. ResultsOf 1250 C. difficile cases that were evaluated, 1223 (98%) were successfully sequenced. In a comparison of 957 samples obtained from April 2008 through March 2011 with those obtained from September 2007 onward, a total of 333 isolates (35%) had no more than 2 SNVs from at least 1 earlier case, and 428 isolates (45%) had more than 10 SNVs from all previous cases. Reductions in incidence over time were similar in the two groups, a finding that suggests an effect of interventions targeting the transition from exposure to disease. Of the 333 patients with no more than 2 SNVs (consistent with transmission), 126 patients (38%) had close hospital contact with another patient, and 120 patients (36%) had no hospital or community contact with another patient. Distinct subtypes of infection continued to be identified throughout the study, which suggests a considerable reservoir of C. difficile. ConclusionsOver a 3-year period, 45% of C. difficile cases in Oxfordshire were genetically distinct from all previous cases. Genetically diverse sources, in addition to symptomatic patients, play a major part in C. difficile transmission. (Funded by the U.K. Clinical Research Collaboration Translational Infection Research Initiative and others.) Where does Clostridium difficile come from? In this report from the United Kingdom, of 1223 C. difficile isolates that were evaluated on whole-genome sequencing over a 3-year period, more than 45% were genetically distinct from all previous isolates. Most episodes of Clostridium difficile infection are believed to result from recent acquisition within a health care setting. Prevention efforts have therefore focused on symptomatic patients, their immediate environment, and judicious use of antimicrobial drugs.(1),(2) Person-to-person transmission of C. difficile infection and surrounding contamination have been well documented.(2)-(5) However, there are multiple other potential sources, including patients with asymptomatic colonization(6),(7) and sources in the wider environment, such as water, farm animals or pets, and food.(8) The contribution of cases acquired from these sources to the overall burden of disease is unclear, particularly with increasing reports of community-associated ...	[Eyre, David W.; Wilson, Daniel J.; Griffiths, David; Vaughan, Alison; O'Connor, Lily; Finney, John M.; Wyllie, David H.; Dingle, Kate E.; Crook, Derrick W.; Peto, Tim E. A.; Walker, A. Sarah] Univ Oxford, Nuffield Dept Clin Med, Oxford, England; [Cule, Madeleine L.; Ip, Camilla L. C.; Golubchik, Tanya; Didelot, Xavier; Bowden, Rory] Univ Oxford, Dept Stat, Oxford OX1 3TG, England; [Harding, Rosalind M.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Eyre, David W.; Cule, Madeleine L.; Griffiths, David; Vaughan, Alison; Ip, Camilla L. C.; Golubchik, Tanya; Batty, Elizabeth M.; Finney, John M.; Wyllie, David H.; Didelot, Xavier; Bowden, Rory; Dingle, Kate E.; Harding, Rosalind M.; Crook, Derrick W.; Peto, Tim E. A.; Walker, A. Sarah] John Radcliffe Hosp, NIHR Oxford Biomed Res Ctr, Oxford OX3 9DU, England; [Wilson, Daniel J.; Batty, Elizabeth M.; Piazza, Paolo; Bowden, Rory] Wellcome Trust Ctr Human Genet, Oxford, England; [O'Connor, Lily; Crook, Derrick W.; Peto, Tim E. A.] Oxford Univ Hosp Natl Hlth Serv Trust, Oxford, England; [Wilcox, Mark H.] Leeds Teaching Hosp, Leeds, W Yorkshire, England; [Wilcox, Mark H.] Univ Leeds, Dept Microbiol, Leeds Gen Infirm, Leeds LS2 9JT, W Yorkshire, England; [Walker, A. Sarah] MRC, Clin Trials Unit, London, England	University of Oxford; University of Oxford; University of Oxford; University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; Oxford University Hospitals NHS Foundation Trust; University of Leeds; Leeds General Infirmary; University of Leeds; Medical Research Council Clinical Trials Unit	Eyre, DW (corresponding author), John Radcliffe Hosp, NIHR Oxford Biomed Res Ctr, Oxford OX3 9DU, England.	david.eyre@ndm.ox.ac.uk	Wilson, Daniel J/AAE-8975-2019; Didelot, Xavier/P-4282-2019; Walker, Sarah/HDM-8717-2022; Eyre, David W/P-6887-2016; Golubchik, Tanya/B-4226-2018	Wilson, Daniel J/0000-0002-0940-3311; Didelot, Xavier/0000-0003-1885-500X; Eyre, David W/0000-0001-5095-6367; Golubchik, Tanya/0000-0003-2765-9828; peto, tim/0000-0003-3477-8307; Dingle, Kate/0000-0002-2303-5957; Batty, Liz/0000-0001-8559-452X; Piazza, Paolo/0000-0002-3736-1841	NIHR under its Oxford Biomedical Research Centre Infection Theme; United Kingdom Clinical Research Collaboration (UKCRC) Modernising Medical Microbiology Consortium; Medical Research Council under the UKCRC Translational Infection Research Initiative; Biotechnology and Biological Sciences Research Council under the UKCRC Translational Infection Research Initiative; NIHR on behalf of the Department of Health [G0800778]; Wellcome Trust [087646/Z/08/Z]; MRC [G0600719, G0800778, MR/K010174/1] Funding Source: UKRI; Medical Research Council [G0800778, MR/K010174/1B, G0600719, G0600719B, MR/K010174/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10047, NF-SI-0508-10279, DRF-2010-03-40] Funding Source: researchfish	NIHR under its Oxford Biomedical Research Centre Infection Theme; United Kingdom Clinical Research Collaboration (UKCRC) Modernising Medical Microbiology Consortium; Medical Research Council under the UKCRC Translational Infection Research Initiative(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council under the UKCRC Translational Infection Research Initiative(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NIHR on behalf of the Department of Health; Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	Supported by the NIHR under its Oxford Biomedical Research Centre Infection Theme and the United Kingdom Clinical Research Collaboration (UKCRC) Modernising Medical Microbiology Consortium, the latter funded under the UKCRC Translational Infection Research Initiative through grants from the Medical Research Council, the Biotechnology and Biological Sciences Research Council, and the NIHR on behalf of the Department of Health (G0800778) and the Wellcome Trust (087646/Z/08/Z). Profs. Crook and Peto are NIHR Senior Investigators. Dr. Eyre is an NIHR Doctoral Research Fellow.	[Anonymous], 2011, ANN REP CHIEF MED OF; Bartsch SM, 2012, EUR J CLIN MICROBIOL, V31, P3163, DOI 10.1007/s10096-012-1681-z; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; CLABOTS CR, 1992, J INFECT DIS, V166, P561, DOI 10.1093/infdis/166.3.561; Cohen SH, 2010, INFECT CONT HOSP EP, V31, P431, DOI 10.1086/651706; Dancer SJ, 2013, INT J ANTIMICROB AG, V41, P137, DOI 10.1016/j.ijantimicag.2012.10.013; Department of Health, 2012, UPD GUID DIAGN REP C; Didelot X, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-12-r118; Dubberke ER, 2007, ARCH INTERN MED, V167, P1092, DOI 10.1001/archinte.167.10.1092; Enoch DA, 2011, J INFECTION, V63, P105, DOI 10.1016/j.jinf.2011.05.016; Eyre DW, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003059; Eyre DW, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001124; Eyre DW, 2012, J CLIN MICROBIOL, V50, P142, DOI 10.1128/JCM.05177-11; Griffiths D, 2010, J CLIN MICROBIOL, V48, P770, DOI 10.1128/JCM.01796-09; Harbarth S, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001171; He M, 2013, NAT GENET, V45, P109, DOI 10.1038/ng.2478; He M, 2010, P NATL ACAD SCI USA, V107, P7527, DOI 10.1073/pnas.0914322107; Health Protection Agency, 2012, RES MAND CLOSTR DIFF; Health Protection Agency, Q EP COMM MAND MRSA; Hensgens MPM, 2012, CLIN MICROBIOL INFEC, V18, P635, DOI 10.1111/j.1469-0691.2012.03853.x; Jinno S, 2012, INFECT CONT HOSP EP, V33, P638, DOI 10.1086/665712; JOHNSON S, 1990, LANCET, V336, P97, DOI 10.1016/0140-6736(90)91605-A; Loo VG, 2011, NEW ENGL J MED, V365, P1693, DOI 10.1056/NEJMoa1012413; MCFARLAND LV, 1989, NEW ENGL J MED, V320, P204, DOI 10.1056/NEJM198901263200402; Miyajima F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022804; Muto CA, 2007, CLIN INFECT DIS, V45, P999, DOI 10.1086/521855; Noren T, 2004, J CLIN MICROBIOL, V42, P3635, DOI [10.1128/JCM.42.8.3635-3643.2004, 10.1128/jcm.42.8.3635-3643.2004]; Ozaki E, 2004, J MED MICROBIOL, V53, P167, DOI 10.1099/jmm.0.05376-0; Riggs MM, 2007, CLIN INFECT DIS, V45, P992, DOI 10.1086/521854; Rodrigo AG, 1999, EVOLUTION OF HIV, P233; SAMORE MH, 1994, CLIN INFECT DIS, V18, P181, DOI 10.1093/clinids/18.2.181; Sethi AK, 2010, INFECT CONT HOSP EP, V31, P21, DOI 10.1086/649016; Shim JK, 1998, LANCET, V351, P633, DOI 10.1016/S0140-6736(97)08062-8; Stabler RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031559; Stabler RA, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r102; Starr JM, 2009, J HOSP INFECT, V71, P49, DOI 10.1016/j.jhin.2008.09.013; Stoesser NE, 2013, CLIN INFECT DIS, V56, P1680, DOI 10.1093/cid/cit089; Surawicz CM, 2013, AM J GASTROENTEROL, V108, P478, DOI 10.1038/ajg.2013.4; Vonberg RP, 2008, CLIN MICROBIOL INFEC, V14, P2, DOI 10.1111/j.1469-0691.2008.01992.x; Walker AS, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001172; Wilcox MH, 2012, CLIN INFECT DIS, V55, P1056, DOI 10.1093/cid/cis614; Wilcox MH, 2011, SUMMARY RES UNDERPIN; Wyllie DH, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000160	43	442	460	0	54	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 26	2013	369	13					1195	1205		10.1056/NEJMoa1216064	http://dx.doi.org/10.1056/NEJMoa1216064			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	224LT	24066741	Green Accepted, Green Published			2022-12-28	WOS:000324888200006
J	Sachs, JD				Sachs, Jeffrey D.			High stakes at the UN on the Sustainable Development Goals	LANCET			English	Editorial Material									Columbia Univ, Earth Inst, New York, NY 10027 USA	Columbia University	Sachs, JD (corresponding author), Columbia Univ, Earth Inst, New York, NY 10027 USA.	sachs@ei.columbia.edu						High-Level Panel of Eminent Persons on the Post-2015 Development Agenda, 2013, HIGH LEV PAN EM PERS; *LEAD COUNC SUST D, 2013, ACT AG SUST DEV REP; Sachs J. D., 2013, GLOBAL DEV WINNING G; Sachs JD, 2012, LANCET, V379, P2206, DOI 10.1016/S0140-6736(12)60685-0; UN, 2013, 68 SESS GEN ASS NEW	5	9	10	0	16	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 21	2013	382	9897					1001	1002		10.1016/S0140-6736(13)61956-X	http://dx.doi.org/10.1016/S0140-6736(13)61956-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	222PB	24054524				2022-12-28	WOS:000324742200004
J	Good, MF				Good, Michael F.			Pasteur Approach to a Malaria Vaccine May Take the Lead	SCIENCE			English	Editorial Material							CD8+ T-CELLS; PLASMODIUM-FALCIPARUM; PROTECTIVE IMMUNITY; ESCHERICHIA-COLI; SPOROZOITES; ANTIBODIES; EXPRESSION; BERGHEI; MICE		Griffith Univ, Inst Glycom, Gold Coast 4222, Australia	Griffith University	Good, MF (corresponding author), Griffith Univ, Inst Glycom, Gold Coast 4222, Australia.	michael.good@griffith.edu.au						Casares S, 2010, VACCINE, V28, P4880, DOI 10.1016/j.vaccine.2010.05.033; CLYDE DF, 1973, AM J MED SCI, V266, P169, DOI 10.1097/00000441-197309000-00002; ELLIS J, 1983, NATURE, V302, P536, DOI 10.1038/302536a0; Epstein JE, 2011, SCIENCE, V334, P475, DOI 10.1126/science.1211548; FREUND J, 1948, AM J TROP MED, V28, P1; KEMP DJ, 1983, P NATL ACAD SCI-BIOL, V80, P3787, DOI 10.1073/pnas.80.12.3787; Luke TC, 2003, J EXP BIOL, V206, P3803, DOI 10.1242/jeb.00644; Mian-McCarthy S, 2012, NEW ENGL J MED, V367, P2284, DOI 10.1056/NEJMoa1208394; Mueller AK, 2005, NATURE, V433, P164, DOI 10.1038/nature03188; NUSSENZWEIG RS, 1967, NATURE, V216, P160, DOI 10.1038/216160a0; Purcell LA, 2008, INFECT IMMUN, V76, P1193, DOI 10.1128/IAI.01399-07; RIECKMANN KH, 1974, T ROY SOC TROP MED H, V68, P258, DOI 10.1016/0035-9203(74)90129-1; SCHOFIELD L, 1987, NATURE, V330, P664, DOI 10.1038/330664a0; Seder RA, 2013, SCIENCE, V341, P1359, DOI 10.1126/science.1241800; van Dijk MR, 2005, P NATL ACAD SCI USA, V102, P12194, DOI 10.1073/pnas.0500925102; WEISS WR, 1988, P NATL ACAD SCI USA, V85, P573, DOI 10.1073/pnas.85.2.573	16	4	4	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 20	2013	341	6152					1352	1353		10.1126/science.1244157	http://dx.doi.org/10.1126/science.1244157			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	220PK	24052298				2022-12-28	WOS:000324597200032
J	Sarkar, CA				Sarkar, Casim A.			Concentrating (on) Native Proteins to Control Cell Fate	SCIENCE			English	Editorial Material							SYNTHETIC BIOLOGY; MODULES		Univ Minnesota, Dept Biomed Engn, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Sarkar, CA (corresponding author), Univ Minnesota, Dept Biomed Engn, Minneapolis, MN 55455 USA.	csarkar@umn.edu						Aldridge BB, 2006, NAT CELL BIOL, V8, P1195, DOI 10.1038/ncb1497; Avruch J, 2007, BBA-MOL CELL RES, V1773, P1150, DOI 10.1016/j.bbamcr.2006.11.006; Bashor CJ, 2008, SCIENCE, V319, P1539, DOI 10.1126/science.1151153; Ferrell JE, 1996, TRENDS BIOCHEM SCI, V21, P460, DOI 10.1016/S0968-0004(96)20026-X; Galloway KE, 2013, SCIENCE, V341, P1358, DOI 10.1126/science.1235005; Khalil AS, 2010, NAT REV GENET, V11, P367, DOI 10.1038/nrg2775; O'Shaughnessy EC, 2012, CURR OPIN BIOTECH, V23, P785, DOI 10.1016/j.copbio.2012.01.004; O'Shaughnessy EC, 2011, CELL, V144, P119, DOI 10.1016/j.cell.2010.12.014; Purnick PEM, 2009, NAT REV MOL CELL BIO, V10, P410, DOI 10.1038/nrm2698; Win MN, 2007, P NATL ACAD SCI USA, V104, P14283, DOI 10.1073/pnas.0703961104; Yokobayashi Y, 2002, P NATL ACAD SCI USA, V99, P16587, DOI 10.1073/pnas.252535999	11	1	1	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 20	2013	341	6152					1349	1351		10.1126/science.1243994	http://dx.doi.org/10.1126/science.1243994			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	220PK	24052296				2022-12-28	WOS:000324597200030
J	Moon, KA; Guallar, E; Umans, JG; Devereux, RB; Best, LG; Francesconi, KA; Goessler, W; Pollak, J; Silbergeld, EK; Howard, BV; Navas-Acien, A				Moon, Katherine A.; Guallar, Eliseo; Umans, Jason G.; Devereux, Richard B.; Best, Lyle G.; Francesconi, Kevin A.; Goessler, Walter; Pollak, Jonathan; Silbergeld, Ellen K.; Howard, Barbara V.; Navas-Acien, Ana			Association Between Exposure to Low to Moderate Arsenic Levels and Incident Cardiovascular Disease	ANNALS OF INTERNAL MEDICINE			English	Article							DRINKING-WATER; WELL-WATER; CAROTID ATHEROSCLEROSIS; METHYLATION CAPABILITY; HYPERENDEMIC AREAS; BLACKFOOT DISEASE; VASCULAR-DISEASE; HEART-DISEASE; MORTALITY; POPULATION	Background: Long-term exposure to high levels of arsenic is associated with increased risk for cardiovascular disease, whereas risk from long-term exposure to low to moderate arsenic levels (< 100 mu g/L in drinking water) is unclear. Objective: To evaluate the association between long-term exposure to low to moderate arsenic levels and incident cardiovascular disease. Design: Prospective cohort study. Setting: The Strong Heart Study baseline visit between 1989 and 1991, with follow-up through 2008. Patients: 3575 American Indian men and women aged 45 to 74 years living in Arizona, Oklahoma, and North and South Dakota. Measurements: The sum of inorganic and methylated arsenic species in urine at baseline was used as a biomarker of long-term arsenic exposure. Outcomes were incident fatal and nonfatal cardiovascular disease. Results: A total of 1184 participants developed fatal and nonfatal cardiovascular disease. When the highest and lowest quartiles of arsenic concentrations (> 15.7 vs. < 5.8 mu g/g creatinine) were compared, the hazard ratios for cardiovascular disease, coronary heart disease, and stroke mortality after adjustment for sociodemographic factors, smoking, body mass index, and lipid levels were 1.65 (95% CI, 1.20 to 2.27; P for trend < 0.001), 1.71 (CI, 1.19 to 2.44; P for trend < 0.001), and 3.03 (CI, 1.08 to 8.50; P for trend = 0.061), respectively. The corresponding hazard ratios for incident cardiovascular disease, coronary heart disease, and stroke were 1.32 (CI, 1.09 to 1.59; P for trend = 0.002), 1.30 (CI, 1.04 to 1.62; P for trend = 0.006), and 1.47 (CI, 0.97 to 2.21; P for trend = 0.032). These associations varied by study region and were attenuated after further adjustment for diabetes, hypertension, and kidney disease measures. Limitation: Direct measurement of individual arsenic levels in drinking water was unavailable. Conclusion: Long-term exposure to low to moderate arsenic levels was associated with cardiovascular disease incidence and mortality.	Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; Johns Hopkins Med Inst, Baltimore, MD 21205 USA; Natl Ctr Cardiovasc Res, Madrid, Spain; MedStar Hlth Res Inst, Hyattsville, MD USA; Georgetown Univ, Washington, DC USA; Georgetown Howard Univ Ctr Clin & Translat Sci, Washington, DC USA; Cornell Med Ctr, Weill Med Coll, New York Presbyterian Hosp, New York, NY USA; Missouri Breaks Ind Res, Timber Lake, SD USA; Karl Franzens Univ Graz, Graz, Austria	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Medicine; Centro Nacional de Investigaciones Cardiovasculares (CNIC); MedStar Health Research Institute; Georgetown University; Cornell University; NewYork-Presbyterian Hospital; University of Graz	Navas-Acien, A (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Environm Hlth Sci, 615 North Wolfe St,Room W7513D, Baltimore, MD 21205 USA.	anavas@jhsph.edu	Guallar, Eliseo/D-3807-2014; Goessler, Walter/A-1084-2016	Guallar, Eliseo/0000-0002-4471-9565; Goessler, Walter/0000-0002-0142-9373	National Heart, Lung, and Blood Institute; National Institute of Environmental Health Sciences; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL041654, R01HL109319, U01HL041642, U01HL041652, U01HL065521, R01HL090863, R01HL109284, T32HL007024] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES021367, P30ES003819] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	National Heart, Lung, and Blood Institute and National Institute of Environmental Health Sciences.	Abhyankar LN, 2012, ENVIRON HEALTH PERSP, V120, P494, DOI 10.1289/ehp.1103988; Afridi HI, 2011, BIOL TRACE ELEM RES, V141, P26, DOI 10.1007/s12011-010-8713-2; Afridi HI, 2010, BIOL TRACE ELEM RES, V134, P1, DOI 10.1007/s12011-009-8450-6; Alaerts G., 2001, ARSENIC DRINKING WAT; Balakumar P, 2009, CARDIOVASC TOXICOL, V9, P169, DOI 10.1007/s12012-009-9050-6; Bunderson M, 2004, TOXICOL APPL PHARM, V201, P32, DOI 10.1016/j.taap.2004.04.008; Center for American Indian Health Research, 2001, STRONG HEART STUD OP, VII; Chen CJ, 1996, ARTERIOSCL THROM VAS, V16, P504, DOI 10.1161/01.ATV.16.4.504; Chen Y, 2011, INT J EPIDEMIOL, V40, P828, DOI 10.1093/ije/dyr022; Chen Y, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2431; Cheng TJ, 2010, WATER RES, V44, P5770, DOI 10.1016/j.watres.2010.05.040; CULLEN WR, 1989, CHEM REV, V89, P713, DOI 10.1021/cr00094a002; ENGEL RR, 1994, ARCH ENVIRON HEALTH, V49, P418, DOI 10.1080/00039896.1994.9954996; Focazio M.J., 2000, RETROSPECTIVE ANAL O; Gong G, 2012, ENVIRON RES, V113, P52, DOI 10.1016/j.envres.2012.01.003; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Gribble MO, 2012, AM J EPIDEMIOL, V176, P865, DOI 10.1093/aje/kws153; Howard BV, 1999, CIRCULATION, V99, P2389, DOI 10.1161/01.CIR.99.18.2389; HOWARD BV, 1992, DIABETES, V41, P4, DOI 10.2337/diab.41.2.S4; Hsieh YC, 2011, ENVIRON RES, V111, P804, DOI 10.1016/j.envres.2011.05.003; Huang YL, 2009, SCI TOTAL ENVIRON, V407, P2608, DOI 10.1016/j.scitotenv.2008.12.061; Huang YK, 2007, TOXICOL APPL PHARM, V218, P135, DOI 10.1016/j.taap.2006.10.022; Hughes MF, 2006, ENVIRON HEALTH PERSP, V114, P1790, DOI 10.1289/ehp.9058; James KA, 2013, ENVIRON RES, V123, P33, DOI 10.1016/j.envres.2013.02.005; James K, 2013, AM J KIDNEY DIS, V61, P364, DOI 10.1053/j.ajkd.2012.12.004; Medrano MJ, 2010, ENVIRON RES, V110, P448, DOI 10.1016/j.envres.2009.10.002; Karagas M R, 2001, Int J Occup Med Environ Health, V14, P171; Kim NH, 2013, AM J EPIDEMIOL, V177, P962, DOI 10.1093/aje/kws329; Kurzius-Spencer M, 2013, J EXPO SCI ENV EPID, V23, P442, DOI 10.1038/jes.2012.120; LEE ET, 1990, AM J EPIDEMIOL, V132, P1141, DOI 10.1093/oxfordjournals.aje.a115757; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Lewis DR, 1999, ENVIRON HEALTH PERSP, V107, P359, DOI 10.2307/3434539; Lisabeth LD, 2010, STROKE, V41, P2499, DOI 10.1161/STROKEAHA.110.585281; Marchiset-Ferlay N, 2012, ENVIRON INT, V39, P150, DOI 10.1016/j.envint.2011.07.015; Maull EA, 2012, ENVIRON HEALTH PERSP, V120, P1658, DOI 10.1289/ehp.1104579; Meliker JR, 2007, ENVIRON HEALTH-GLOB, V6, DOI 10.1186/1476-069X-6-4; Moon K, 2012, CURR ATHEROSCLER REP, V14, P542, DOI 10.1007/s11883-012-0280-x; National Research Council, 1999, ARS DRINK WAT; Navas-Acien A, 2005, AM J EPIDEMIOL, V162, P1037, DOI 10.1093/aje/kwi330; Navas-Acien Ana, 2013, JAMA Intern Med, V173, P1395, DOI 10.1001/jamainternmed.2013.6405; Navas-Acien A, 2009, ENVIRON HEALTH PERSP, V117, P1428, DOI 10.1289/ehp.0800509; Nermell B, 2008, ENVIRON RES, V106, P212, DOI 10.1016/j.envres.2007.08.005; Parvez F, 2006, ENVIRON HEALTH PERSP, V114, P355, DOI 10.1289/ehp.7903; POMROY C, 1980, TOXICOL APPL PHARM, V53, P550, DOI 10.1016/0041-008X(80)90368-3; Rapant S, 2009, ENVIRON GEOCHEM HLTH, V31, P11, DOI 10.1007/s10653-008-9152-2; Ruiz-Navarro ML, 1998, SCI TOTAL ENVIRON, V216, P55, DOI 10.1016/S0048-9697(98)00136-3; Ryan PB, 2000, ENVIRON HEALTH PERSP, V108, P731, DOI 10.2307/3434726; Scheer J, 2012, ANAL METHODS-UK, V4, P406, DOI 10.1039/c2ay05638k; Simeonova PP, 2003, ENVIRON HEALTH PERSP, V111, P1744, DOI 10.1289/ehp.6332; Sohel N, 2009, EPIDEMIOLOGY, V20, P824, DOI 10.1097/EDE.0b013e3181bb56ec; Srivastava S, 2009, TOXICOL APPL PHARM, V241, P90, DOI 10.1016/j.taap.2009.08.004; States JC, 2009, TOXICOL SCI, V107, P312, DOI 10.1093/toxsci/kfn236; Steinmaus CM, 2005, ENVIRON RES, V99, P164, DOI 10.1016/j.envres.2004.10.003; Stoddart M L, 2000, Am Indian Alsk Native Ment Health Res, V9, P20; Tellez-Plaza M, 2013, ENVIRON HEALTH PERSP, V121, P345, DOI 10.1289/ehp.1205305; Tseng CH, 2005, TOXICOL APPL PHARM, V206, P299, DOI 10.1016/j.taap.2004.11.022; Tseng CH, 2005, J ENVIRON SCI HEAL C, V23, P55, DOI 10.1081/GNC-200051860; USEPA, 2001, FED REGISTER, V66, P6976; Vahter M, 2007, ENVIRON RES, V104, P85, DOI 10.1016/j.envres.2006.08.003; VARSANYI I, 1991, ENVIRON GEOCHEM HLTH, V13, P14, DOI 10.1007/BF01783491; Voinescu GC, 2002, AM J MED SCI, V323, P39, DOI 10.1097/00000441-200201000-00007; Wade TJ, 2009, INT J ENV RES PUB HE, V6, P1107, DOI 10.3390/ijerph6031107; Wolf G, 2002, AM J KIDNEY DIS, V39, P1, DOI 10.1053/ajkd.2002.29865; Xia YJ, 2009, INT J ENV RES PUB HE, V6, P1010, DOI 10.3390/ijerph6031010; Yoshikawa Masaharu, 2008, Environmental Health and Preventive Medicine, V13, P207, DOI 10.1007/s12199-008-0032-2; Yuan Y, 2007, AM J EPIDEMIOL, V166, P1381, DOI 10.1093/aje/kwm238; ZALDIVAR R, 1980, ZBL BAKT MIK HYG B, V170, P44; Zheng LY, 2013, AM J KIDNEY DIS, V61, P385, DOI 10.1053/j.ajkd.2012.09.011; Zierold KM, 2004, AM J PUBLIC HEALTH, V94, P1936, DOI 10.2105/AJPH.94.11.1936	69	193	198	3	36	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 19	2013	159	10					649	+		10.7326/0003-4819-159-10-201311190-00719	http://dx.doi.org/10.7326/0003-4819-159-10-201311190-00719			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	276FB	24061511	Green Accepted			2022-12-28	WOS:000328732700013
J	Sun, YD; Li, L; Macho, AP; Han, ZF; Hu, ZH; Zipfel, C; Zhou, JM; Chai, JJ				Sun, Yadong; Li, Lei; Macho, Alberto P.; Han, Zhifu; Hu, Zehan; Zipfel, Cyril; Zhou, Jian-Min; Chai, Jijie			Structural Basis for flg22-Induced Activation of the Arabidopsis FLS2-BAK1 Immune Complex	SCIENCE			English	Article							BACTERIAL ELICITOR FLAGELLIN; INNATE IMMUNITY; MOLECULAR-PATTERNS; RECEPTOR; PERCEPTION; KINASE; FLS2; RECOGNITION; BAK1; BRI1	Flagellin perception in Arabidopsis is through recognition of its highly conserved N-terminal epitope (flg22) by flagellin-sensitive 2 (FLS2). Flg22 binding induces FLS2 heteromerization with BRASSINOSTEROID INSENSITIVE 1-associated kinase 1 (BAK1) and their reciprocal activation followed by plant immunity. Here, we report the crystal structure of FLS2 and BAK1 ectodomains complexed with flg22 at 3.06 angstroms. A conserved and a nonconserved site from the inner surface of the FLS2 solenoid recognize the C-and N-terminal segment of flg22, respectively, without oligomerization or conformational changes in the FLS2 ectodomain. Besides directly interacting with FLS2, BAK1 acts as a co-receptor by recognizing the C terminus of the FLS2-bound flg22. Our data reveal the molecular mechanisms underlying FLS2-BAK1 complex recognition of flg22 and provide insight into the immune receptor complex activation.	[Sun, Yadong; Han, Zhifu; Hu, Zehan; Chai, Jijie] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China; [Sun, Yadong; Han, Zhifu; Hu, Zehan; Chai, Jijie] Tsinghua Peking Ctr Life Sci, Beijing 100084, Peoples R China; [Li, Lei; Zhou, Jian-Min] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Plant Genom, Beijing 100101, Peoples R China; [Li, Lei; Zhou, Jian-Min] Chinese Acad Sci, Inst Genet & Dev Biol, Natl Ctr Plant Gene Res, Beijing 100101, Peoples R China; [Macho, Alberto P.; Zipfel, Cyril] Sainsbury Lab, Norwich NR4 7UH, Norfolk, England	Tsinghua University; Tsinghua University; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Han, ZF (corresponding author), Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China.	hanzhifu@mail.tsinghua.edu.cn; jmzhou@genetics.ac.cn; chaijj@mail.tsinghua.edu.cn	Hu, Zehan/AAU-4752-2021; ZIPFEL, CYRIL/ABD-5076-2021; Macho, Alberto/L-1393-2014; Zhou, Jian-Min/A-3140-2013; Hu, Zehan/AAH-7139-2020; poinssot, benoit/B-2569-2009; ZIPFEL, CYRIL B/D-7103-2011	Hu, Zehan/0000-0002-4648-5301; ZIPFEL, CYRIL/0000-0003-4935-8583; Zhou, Jian-Min/0000-0002-9943-2975; poinssot, benoit/0000-0001-5890-4318; ZIPFEL, CYRIL B/0000-0003-4935-8583; Sun, Yadong/0000-0003-4470-6630; Li, LEI/0000-0001-5376-6462; Chai, Jijie/0000-0001-7591-3873; Macho, Alberto P/0000-0001-9935-8026	State Key Program of National Natural Science of China [31130063]; National Outstanding Young Scholar Science Foundation of China [31025008]; Chinese Natural Science Foundation [31230007]; Chinese Ministry of Science and Technology [2011CB100700]; Gatsby Charitable Foundation; European Research Council; Federation of European Biochemical Societies	State Key Program of National Natural Science of China(National Natural Science Foundation of China (NSFC)); National Outstanding Young Scholar Science Foundation of China; Chinese Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); Gatsby Charitable Foundation; European Research Council(European Research Council (ERC)European Commission); Federation of European Biochemical Societies	We thank S. Huang and J. He at Shanghai Synchrotron Radiation Facility (SSRF) for assistance with data collection. This research was funded by State Key Program of National Natural Science of China (31130063) and the National Outstanding Young Scholar Science Foundation of China (31025008) to J. C.; Chinese Natural Science Foundation (31230007) and Chinese Ministry of Science and Technology (2011CB100700) to J.-M.Z.; and the Gatsby Charitable Foundation and the European Research Council to C.Z. A. P. M. is supported by a postdoctoral fellowship from the Federation of European Biochemical Societies. The coordinates and structural factors for FLS2LRR-flg22-BAK1LRR and FLS2 Delta LRR2-6 have been deposited in Protein Data Bank with accession codes 4MN8 and 4MNA, respectively.	Bauer Z, 2001, J BIOL CHEM, V276, P45669, DOI 10.1074/jbc.M102390200; Boller T, 2009, ANNU REV PLANT BIOL, V60, P379, DOI 10.1146/annurev.arplant.57.032905.105346; Chinchilla D, 2006, PLANT CELL, V18, P465, DOI 10.1105/tpc.105.036574; Chinchilla D, 2007, NATURE, V448, P497, DOI 10.1038/nature05999; Dunning FM, 2007, PLANT CELL, V19, P3297, DOI 10.1105/tpc.106.048801; Felix G, 1999, PLANT J, V18, P265, DOI 10.1046/j.1365-313X.1999.00265.x; Feng F, 2012, NATURE, V485, P114, DOI 10.1038/nature10962; Gomez-Gomez L, 2000, MOL CELL, V5, P1003, DOI 10.1016/S1097-2765(00)80265-8; Hecht V, 2001, PLANT PHYSIOL, V127, P803, DOI 10.1104/pp.010324; Heese A, 2007, P NATL ACAD SCI USA, V104, P12217, DOI 10.1073/pnas.0705306104; Hothorn M, 2011, NATURE, V474, P467, DOI 10.1038/nature10153; Li J, 2002, CELL, V110, P213, DOI 10.1016/S0092-8674(02)00812-7; Liu TT, 2012, SCIENCE, V336, P1160, DOI 10.1126/science.1218867; Lu DP, 2010, P NATL ACAD SCI USA, V107, P496, DOI 10.1073/pnas.0909705107; Meindl T, 2000, PLANT CELL, V12, P1783, DOI 10.1105/tpc.12.9.1783; Mueller K, 2012, PLANT CELL, V24, P2213, DOI 10.1105/tpc.112.096073; Mythreye K, 2009, CELL SIGNAL, V21, P1548, DOI 10.1016/j.cellsig.2009.05.001; Nam KH, 2002, CELL, V110, P203, DOI 10.1016/S0092-8674(02)00814-0; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Roux M, 2011, PLANT CELL, V23, P2440, DOI 10.1105/tpc.111.084301; Santiago J, 2013, SCIENCE, V341, P889, DOI 10.1126/science.1242468; Schulze B, 2010, J BIOL CHEM, V285, P9444, DOI 10.1074/jbc.M109.096842; Schwessinger B, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002046; She J, 2011, NATURE, V474, P472, DOI 10.1038/nature10178; Song DH, 2012, IMMUNOL REV, V250, P216, DOI 10.1111/j.1600-065X.2012.01167.x; Sun WX, 2012, PLANT CELL, V24, P1096, DOI 10.1105/tpc.112.095919; Tan X, 2007, NATURE, V446, P640, DOI 10.1038/nature05731; Yoon SI, 2012, SCIENCE, V335, P859, DOI 10.1126/science.1215584; Zhang J, 2010, CELL HOST MICROBE, V7, P290, DOI 10.1016/j.chom.2010.03.007; Zipfel C, 2004, NATURE, V428, P764, DOI 10.1038/nature02485	30	436	476	47	365	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 1	2013	342	6158					624	628		10.1126/science.1243825	http://dx.doi.org/10.1126/science.1243825			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RJ	24114786				2022-12-28	WOS:000326334300050
J	Bauer, DE; Kamran, SC; Lessard, S; Xu, J; Fujiwara, Y; Lin, C; Shao, Z; Canver, MC; Smith, EC; Pinello, L; Sabo, PJ; Vierstra, J; Voit, RA; Yuan, GC; Porteus, MH; Stamatoyannopoulos, JA; Lettre, G; Orkin, SH				Bauer, Daniel E.; Kamran, Sophia C.; Lessard, Samuel; Xu, Jian; Fujiwara, Yuko; Lin, Carrie; Shao, Zhen; Canver, Matthew C.; Smith, Elenoe C.; Pinello, Luca; Sabo, Peter J.; Vierstra, Jeff; Voit, Richard A.; Yuan, Guo-Cheng; Porteus, Matthew H.; Stamatoyannopoulos, John A.; Lettre, Guillaume; Orkin, Stuart H.			An Erythroid Enhancer of BCL11A Subject to Genetic Variation Determines Fetal Hemoglobin Level	SCIENCE			English	Article							GENOME-WIDE ASSOCIATION; SICKLE-CELL-DISEASE; HAPLOTYPE FUSION PCR; LYMPHOID DEVELOPMENT; COMMON DISEASE; GLOBIN; DNA; DISSECTION; EXPRESSION; DYNAMICS	Genome-wide association studies (GWASs) have ascertained numerous trait-associated common genetic variants, frequently localized to regulatory DNA. We found that common genetic variation at BCL11A associated with fetal hemoglobin (HbF) level lies in noncoding sequences decorated by an erythroid enhancer chromatin signature. Fine-mapping uncovers a motif-disrupting common variant associated with reduced transcription factor (TF) binding, modestly diminished BCL11A expression, and elevated HbF. The surrounding sequences function in vivo as a developmental stage-specific, lineage-restricted enhancer. Genome engineering reveals the enhancer is required in erythroid but not B-lymphoid cells for BCL11A expression. These findings illustrate how GWASs may expose functional variants of modest impact within causal elements essential for appropriate gene expression. We propose the GWAS-marked BCL11A enhancer represents an attractive target for therapeutic genome engineering for the beta-hemoglobinopathies.	[Bauer, Daniel E.; Xu, Jian; Fujiwara, Yuko; Lin, Carrie; Shao, Zhen; Smith, Elenoe C.; Orkin, Stuart H.] Boston Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA; [Bauer, Daniel E.; Orkin, Stuart H.] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Bauer, Daniel E.; Kamran, Sophia C.; Xu, Jian; Canver, Matthew C.; Orkin, Stuart H.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Kamran, Sophia C.; Orkin, Stuart H.] Howard Hughes Med Inst, Boston, MA 02115 USA; [Lessard, Samuel; Lettre, Guillaume] Montreal Heart Inst, Montreal, PQ H1T 1C8, Canada; [Lessard, Samuel; Lettre, Guillaume] Univ Montreal, Montreal, PQ H1T 1C8, Canada; [Pinello, Luca; Yuan, Guo-Cheng] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Sabo, Peter J.; Vierstra, Jeff; Stamatoyannopoulos, John A.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Sabo, Peter J.; Vierstra, Jeff; Stamatoyannopoulos, John A.] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Voit, Richard A.; Porteus, Matthew H.] Stanford Univ, Dept Pediat, Palo Alto, CA 94304 USA; [Yuan, Guo-Cheng] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Universite de Montreal; Universite de Montreal; Harvard University; Dana-Farber Cancer Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Stanford University; Harvard University; Harvard T.H. Chan School of Public Health	Orkin, SH (corresponding author), Boston Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA.	stuart_orkin@dfci.harvard.edu	Kamran, Sophia C./AAB-2976-2019	Kamran, Sophia C./0000-0001-9283-6515; Canver, Matthew/0000-0002-8146-3992; Pinello, Luca/0000-0003-1109-3823; Vierstra, Jeff/0000-0001-6406-8563; Shao, Zhen/0000-0002-4934-4360	Doris Duke Charitable Foundation [2009089]; Canadian Institute of Health Research [123382]; Amon Carter Foundation; Hyundai Hope on Wheels; NIH [U54HG004594, U54HG007010, R01HL032259, P01HL032262, P30DK049216]; Lucille Packard Foundation; National Institute of Diabetes and Digestive and Kidney Diseases Career Development [K08DK093705]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL032259, P01HL032262] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005085, U54HG007010] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK049216, K08DK093705] Funding Source: NIH RePORTER	Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Amon Carter Foundation; Hyundai Hope on Wheels; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lucille Packard Foundation; National Institute of Diabetes and Digestive and Kidney Diseases Career Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank A. Woo, A. Cantor, M. Kowalczyk, S. Burns, J. Wright, J. Snow, J. Trowbridge, and members of the Orkin laboratory-particularly C. Peng, P. Das, G. Guo, M. Kerenyi, and E. Baena-for discussions. C. Guo and F. Alt provided the pre-B cell line; A. He and W. Pu provided the pWHERE lacZ reporter construct; C. Currie and M. Nguyen provided technical assistance; D. Bates and T. Kutyavin provided expertise with sequence analysis; R. Sandstrom provided help with data management; G. Losyev and J. Daley provided aid with flow cytometry; and J. Desimini provided graphical assistance. L. Yan at EpigenDx (Hopkinton, Massachusetts) conducted the custom pyrosequencing reactions. This work was funded by grants from the Doris Duke Charitable Foundation (2009089) and Canadian Institute of Health Research (123382) to G. L.; Amon Carter Foundation, Hyundai Hope on Wheels, NIH, Lucille Packard Foundation to M. H. P.; NIH grants U54HG004594 and U54HG007010 to J. A. S.; and NIH R01HL032259, P01HL032262, and P30DK049216 (Center of Excellence in Molecular Hematology) to S. H. O. D. E. B. is supported by National Institute of Diabetes and Digestive and Kidney Diseases Career Development Award K08DK093705. D. E. B., J. X., and S. H. O. are inventors on a patent application related to this work, filed by Boston Children's Hospital. The CSSCD samples with DNA and associated phenotype information are available from the National Heart, Lung, and Blood Institute to researchers that have appropriate institutional review board approval to use the materials.	Bauer DE, 2012, BLOOD, V120, P2945, DOI 10.1182/blood-2012-06-292078; Bhatnagar P, 2011, J HUM GENET, V56, P316, DOI 10.1038/jhg.2011.12; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Esteghamat F, 2013, BLOOD, V121, P2553, DOI 10.1182/blood-2012-06-434530; FARBER MD, 1985, J CHRON DIS, V38, P495, DOI 10.1016/0021-9681(85)90033-5; Frazer KA, 2009, NAT REV GENET, V10, P241, DOI 10.1038/nrg2554; Fugger L, 2012, NEW ENGL J MED, V367, P2370, DOI 10.1056/NEJMp1212285; John A, 2012, DEVELOPMENT, V139, P1831, DOI 10.1242/dev.072850; Joung JK, 2013, NAT REV MOL CELL BIO, V14, P49, DOI 10.1038/nrm3486; Kassouf MT, 2010, GENOME RES, V20, P1064, DOI 10.1101/gr.104935.110; Koehler AN, 2010, CURR OPIN CHEM BIOL, V14, P331, DOI 10.1016/j.cbpa.2010.03.022; Kowalczyk MS, 2012, MOL CELL, V45, P447, DOI 10.1016/j.molcel.2011.12.021; Lee HJ, 2010, GENOME RES, V20, P81, DOI 10.1101/gr.099747.109; Leid M, 2004, GENE EXPR PATTERNS, V4, P733, DOI 10.1016/j.modgep.2004.03.009; Lettre G, 2008, P NATL ACAD SCI USA, V105, P11869, DOI 10.1073/pnas.0804799105; Liu PT, 2003, NAT IMMUNOL, V4, P525, DOI 10.1038/ni925; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Melnikov A, 2012, NAT BIOTECHNOL, V30, P271, DOI 10.1038/nbt.2137; Menzel S, 2007, NAT GENET, V39, P1197, DOI 10.1038/ng2108; Nuinoon M, 2010, HUM GENET, V127, P303, DOI 10.1007/s00439-009-0770-2; Patwardhan RP, 2012, NAT BIOTECHNOL, V30, P265, DOI 10.1038/nbt.2136; Paul DS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002139; Sankaran VG, 2009, NATURE, V460, P1093, DOI 10.1038/nature08243; Sankaran VG, 2008, SCIENCE, V322, P1839, DOI 10.1126/science.1165409; Soler E, 2010, GENE DEV, V24, P277, DOI 10.1101/gad.551810; Solovieff N, 2010, BLOOD, V115, P1815, DOI 10.1182/blood-2009-08-239517; Turner DJ, 2009, NAT PROTOC, V4, P1771, DOI 10.1038/nprot.2009.184; Tyson J, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-693; Uda M, 2008, P NATL ACAD SCI USA, V105, P1620, DOI 10.1073/pnas.0711566105; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; van der Harst P, 2012, NATURE, V492, P369, DOI 10.1038/nature11677; van der Oost J, 2013, SCIENCE, V339, P768, DOI 10.1126/science.1234726; Xu J, 2013, P NATL ACAD SCI USA, V110, P6518, DOI 10.1073/pnas.1303976110; Xu J, 2011, SCIENCE, V334, P993, DOI 10.1126/science.1211053; Xu J, 2010, GENE DEV, V24, P783, DOI 10.1101/gad.1897310; Yu Y, 2012, J EXP MED, V209, P2467, DOI 10.1084/jem.20121846	37	395	440	0	70	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 11	2013	342	6155					253	257		10.1126/science.1242088	http://dx.doi.org/10.1126/science.1242088			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232EV	24115442	Green Accepted			2022-12-28	WOS:000325475200047
J	Wilcken, B				Wilcken, Bridget			Newborn Screening: Gaps in the Evidence	SCIENCE			English	Editorial Material							CYSTIC-FIBROSIS; OUTCOMES; DISEASE		[Wilcken, Bridget] Childrens Hosp Westmead, Westmead, NSW 2145, Australia; [Wilcken, Bridget] Univ Sydney, Sydney, NSW 2008, Australia	University of Sydney; University of Sydney	Wilcken, B (corresponding author), Childrens Hosp Westmead, Westmead, NSW 2145, Australia.	bridget.wilcken@health.nsw.gov.au						Bonham J. R., 2012, EXPANDED NEWBORN SCR; Chace DH, 2003, CLIN CHEM, V49, P1797, DOI 10.1373/clinchem.2003.022178; Comeau AM, 2002, SCIENCE, V295, P44; Dees RH, 2013, PUBLIC HEALTH ETH-UK, V6, P114, DOI 10.1093/phe/phs033; Duffner PK, 2009, GENET MED, V11, P450, DOI 10.1097/GIM.0b013e3181a16e04; DUSSAULT JH, 1975, J PEDIATR-US, V86, P670, DOI 10.1016/S0022-3476(75)80349-0; Farrell PM, 2005, J PEDIATR-US, V147, pS30, DOI 10.1016/j.jpeds.2005.08.012; Grosse Scott D., 2004, Morbidity and Mortality Weekly Report, V53, P1; GUTHRIE R, 1963, PEDIATRICS, V32, P338; Guthrie R., 1964, PUBLICATION US DEP H, V419; Heringer J, 2010, ANN NEUROL, V68, P743, DOI 10.1002/ana.22095; HHS, NOM COND; McKay KO, 2007, J INHERIT METAB DIS, V30, P544, DOI 10.1007/s10545-007-0620-0; Pollitt RJ, 2007, J INHERIT METAB DIS, V30, P423, DOI 10.1007/s10545-007-0647-2; Ross LF, 2012, J INHERIT METAB DIS, V35, P627, DOI 10.1007/s10545-011-9435-0; Watson M.S., 2006, PEDIATRICS, V117, pS296, DOI DOI 10.1542/PEDS.2005-26331; Wilcken B, 2012, PATHOLOGY, V44, P73, DOI 10.1097/PAT.0b013e32834e843f; Wilcken B, 2009, PEDIATRICS, V124, pE241, DOI 10.1542/peds.2008-0586; Wilson MM, 1968, PUBLIC HLTH PAPERS, V34	19	17	17	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 11	2013	342	6155					197	198		10.1126/science.1243944	http://dx.doi.org/10.1126/science.1243944			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	232EV	24115426				2022-12-28	WOS:000325475200028
J	Heller, HM; Wu, CC; Pierce, VM; Kradin, RL				Heller, Howard M.; Wu, Carol C.; Pierce, Virginia M.; Kradin, Richard L.			Case 31-2013: A 29-Year-Old Man with Abdominal Pain, Fever, and Weight Loss	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DISSEMINATED HISTOPLASMOSIS; GASTROINTESTINAL HISTOPLASMOSIS; AIDS; DIAGNOSIS	A 29-year-old man was seen in an outpatient clinic because of abdominal pain, fever, and weight loss. Testing for HIV antibodies was positive, and the CD4 T-lymphocyte count was 10 per cubic millimeter. Chest imaging revealed tiny nodules in both lungs. Presentation of CaseDr. Nosheen Reza (Medicine): A 29-year-old man was seen in an outpatient clinic affiliated with this hospital because of abdominal pain, fever, and weight loss. The patient was reportedly well until unintentional weight loss occurred approximately 6 weeks before presentation. Three weeks before presentation, upper abdominal pain developed that the patient rated at 8 on a scale of 0 to 10, with 10 indicating the most severe pain. The pain radiated to his throat, increased after eating and drinking, and did not diminish with ibuprofen. At the outpatient clinic, the patient reported nausea, occasional vomiting, decreased food ...	[Heller, Howard M.] MIT, Dept Med, Cambridge, MA 02139 USA; [Heller, Howard M.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Wu, Carol C.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Pierce, Virginia M.; Kradin, Richard L.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Heller, Howard M.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Wu, Carol C.] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Pierce, Virginia M.; Kradin, Richard L.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Heller, HM (corresponding author), MIT, Dept Med, 77 Massachusetts Ave, Cambridge, MA 02139 USA.			Pierce, Virginia/0000-0002-3723-1326				Agudelo CA, 2012, AM J TROP MED HYG, V87, P1094, DOI 10.4269/ajtmh.2012.12-0292; Allen CM, 2010, ANN THORAC MED, V5, P201, DOI 10.4103/1817-1737.69106; Assi M, 2006, DIAGN MICR INFEC DIS, V55, P195, DOI 10.1016/j.diagmicrobio.2006.01.015; Chalasani N, 1999, AIDS PATIENT CARE ST, V13, P343, DOI 10.1089/apc.1999.13.343; Gutierrez ME, 2005, CLIN INFECT DIS, V40, P1199, DOI 10.1086/428842; Hage CA, 2011, CLIN INFECT DIS, V53, P448, DOI 10.1093/cid/cir435; Kahi CJ, 2005, AM J GASTROENTEROL, V100, P220, DOI 10.1111/j.1572-0241.2005.40823.x; LAGUNA F, 1994, CLIN INFECT DIS, V19, P48, DOI 10.1093/clinids/19.1.48; Larone D.H., 2011, MED IMPORTANT FUNGI; SAROSI GA, 1992, CLIN INFECT DIS, V14, pS60, DOI 10.1093/clinids/14.Supplement_1.S60; Spinner MA, 2012, CASE REP GASTROINTES, V2012, DOI 10.1155/2012/515872; Suh KN, 2001, CLIN INFECT DIS, V32, P483, DOI 10.1086/318485; Thompson MA, 2012, JAMA-J AM MED ASSOC, V308, P387, DOI 10.1001/jama.2012.7961; WHEAT LJ, 1990, MEDICINE, V69, P361, DOI 10.1097/00005792-199011000-00004	14	2	2	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 10	2013	369	15					1453	1461		10.1056/NEJMcpc1304165	http://dx.doi.org/10.1056/NEJMcpc1304165			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	231QE	24106939				2022-12-28	WOS:000325431500014
J	Possner, AB				Possner, Adam B.			As If He Were Family	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									George Washington Univ, Washington, DC 20052 USA	George Washington University	Possner, AB (corresponding author), George Washington Univ, Washington, DC 20052 USA.	apossner@mfa.gwu.edu							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 9	2013	310	14					1447	1448		10.1001/jama.2013.277277	http://dx.doi.org/10.1001/jama.2013.277277			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	230PK	24104371				2022-12-28	WOS:000325354100017
J	Korones, DN				Korones, David N.			What Would You Do if It Were Your Kid?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								When patients or family members ask us what we'd do if the patient were our relative, how do we balance our professional judgment with personal judgments? And what if what we're recommending is different from what we would do for our own child or spouse? I know we're not supposed to have favorites, but Lizzy was one of mine. She was 8 years old. Her eyes still sparkled, even though her curly brown hair had long since fallen out because of radiation and chemotherapy for a malignant brain tumor. When the tumor recurred, her parents and I knew she would ultimately die of her disease. But she felt fine, and it was impossible not to give second-line therapy a try. Things did not go well. Within 2 months, Lizzy had a worn and vacant stare, and her normally animated face was expressionless. Then, during an	[Korones, David N.] Univ Rochester, Med Ctr, Dept Pediat, Rochester, NY 14642 USA; [Korones, David N.] Univ Rochester, Med Ctr, Div Palliat Care, Rochester, NY 14642 USA; [Korones, David N.] Lifetime Care, CompassionNet Program, Rochester, NY USA	University of Rochester; University of Rochester	Korones, DN (corresponding author), Univ Rochester, Med Ctr, Dept Pediat, Rochester, NY 14642 USA.								0	5	5	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 3	2013	369	14					1291	1293		10.1056/NEJMp1304941	http://dx.doi.org/10.1056/NEJMp1304941			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	227KI	24088090				2022-12-28	WOS:000325111200005
J	Rubin, JP; Marra, KG				Rubin, J. Peter; Marra, Kacey G.			Adipose stem cell therapy for soft tissue reconstruction	LANCET			English	Editorial Material							BREAST; AUGMENTATION; SOCIETY; VIVO		[Rubin, J. Peter; Marra, Kacey G.] Univ Pittsburgh, Dept Plast Surg, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Rubin, JP (corresponding author), Univ Pittsburgh, Dept Plast Surg, Pittsburgh, PA 15261 USA.	rubinjp@upmc.edu	Marra, Kacey/AAD-2799-2019	Marra, Kacey/0000-0002-8437-4864				BILLINGS E, 1989, PLAST RECONSTR SURG, V83, P368, DOI 10.1097/00006534-198902000-00033; Bourin P, 2013, CYTOTHERAPY, V15, P641, DOI 10.1016/j.jcyt.2013.02.006; Coleman SR, 2006, PLAST RECONSTR SURG, V118, p108S, DOI 10.1097/01.prs.0000234610.81672.e7; Cunningham B, 2009, AESTHET PLAST SURG, V33, P440, DOI 10.1007/s00266-009-9364-6; Fisher C, 2013, PLAST RECONSTR SURG, V132, P351, DOI 10.1097/PRS.0b013e3182958796; Khouri R, 2009, CLIN PLAST SURG, V36, P269, DOI 10.1016/j.cps.2008.11.009; Kling RE, 2013, PLAST RECONSTR SURG, V132, P35, DOI 10.1097/PRS.0b013e318290fad1; Kolle SFT, 2013, LANCET, V382, P1113, DOI 10.1016/S0140-6736(13)61410-5; Lepperdinger G, 2008, EXP GERONTOL, V43, P1018, DOI 10.1016/j.exger.2008.07.004; Li H, 2011, PLAST RECONSTR SURG, V128, P663, DOI 10.1097/PRS.0b013e318221db33; Patrikoski M, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt175; Planat-Benard V, 2004, CIRCULATION, V109, P656, DOI 10.1161/01.CIR.0000114522.38265.61; Rehman J, 2004, CIRCULATION, V109, P1292, DOI 10.1161/01.CIR.0000121425.42966.F1; Yoshimura K, 2008, AESTHET PLAST SURG, V32, P48, DOI 10.1007/s00266-007-9019-4; Zimmerlin L, 2011, TISSUE ENG PT A, V17, P93, DOI [10.1089/ten.tea.2010.0248, 10.1089/ten.TEA.2010.0248]; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	16	12	13	0	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 28	2013	382	9898					1077	1079		10.1016/S0140-6736(13)61744-4	http://dx.doi.org/10.1016/S0140-6736(13)61744-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	228SG	24075037				2022-12-28	WOS:000325208100008
J	Angelopoulos, V; Runov, A; Zhou, XZ; Turner, DL; Kiehas, SA; Li, SS; Shinohara, I				Angelopoulos, V.; Runov, A.; Zhou, X. -Z.; Turner, D. L.; Kiehas, S. A.; Li, S. -S.; Shinohara, I.			Electromagnetic Energy Conversion at Reconnection Fronts	SCIENCE			English	Article							GEOMAGNETIC TAIL; MAGNETOTAIL; SUBSTORMS; GEOTAIL; FLOW	Earth's magnetotail contains magnetic energy derived from the kinetic energy of the solar wind. Conversion of that energy back to particle energy ultimately powers Earth's auroras, heats the magnetospheric plasma, and energizes the Van Allen radiation belts. Where and how such electromagnetic energy conversion occurs has been unclear. Using a conjunction between eight spacecraft, we show that this conversion takes place within fronts of recently reconnected magnetic flux, predominantly at 1- to 10-electron inertial length scale, intense electrical current sheets (tens to hundreds of nanoamperes per square meter). Launched continually during intervals of geomagnetic activity, these reconnection outflow flux fronts convert similar to 10 to 100 gigawatts per square Earth radius of power, consistent with local magnetic flux transport, and a few times 10(15) joules of magnetic energy, consistent with global magnetotail flux reduction.	[Angelopoulos, V.; Runov, A.; Zhou, X. -Z.; Turner, D. L.; Li, S. -S.] Univ Calif Los Angeles, Dept Earth Planetary & Space Sci, Los Angeles, CA 90095 USA; [Angelopoulos, V.; Runov, A.; Zhou, X. -Z.; Turner, D. L.; Li, S. -S.] Univ Calif Los Angeles, Inst Geophys & Planetary Phys, Los Angeles, CA 90095 USA; [Kiehas, S. A.] Austrian Acad Sci, Space Res Inst, A-8042 Graz, Austria; [Shinohara, I.] JAXA, Inst Space & Astronaut Sci, Chuo Ku, Sagamihara, Kanagawa 2525210, Japan	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Austrian Academy of Sciences; Japan Aerospace Exploration Agency (JAXA); Institute of Space & Astronautical Science (ISAS)	Angelopoulos, V (corresponding author), Univ Calif Los Angeles, Dept Earth Planetary & Space Sci, 595 Charles Young Dr East, Los Angeles, CA 90095 USA.	vassilis@ucla.edu	Zhou, Xuzhi/D-1831-2011; Turner, Drew L/G-3224-2012	Zhou, Xuzhi/0000-0003-4953-1761; Turner, Drew L/0000-0002-2425-7818; Angelopoulos, Vassilis/0000-0001-7024-1561	NASA [NAS5-02099]; Austrian Science Fund (FWF) [J3041-N16]	NASA(National Aeronautics & Space Administration (NASA)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	Funded by NASA NAS5-02099 and Austrian Science Fund (FWF) J3041-N16. Data obtained from: http://themis.ssl.berkeley.edu. We thank J. Hohl and E. Masongsong for editorial help, the THEMIS and ancillary data providers (http://themis.igpp.ucla.edu/roadrules.shtml), National Oceanic and Atmospheric Administration for the GOES data, NASA/SPDF for the solar wind data (http://omniweb.gsfc.nasa.gov/ow_min.html), and WDD-C2 for the AL index.	Akasofu S.-I., 1977, PHYSICS OF MAGNETOSP; Angelopoulos V, 2011, SPACE SCI REV, V165, P3, DOI 10.1007/s11214-010-9687-2; ANGELOPOULOS V, 1993, GEOPHYS RES LETT, V20, P1711, DOI 10.1029/93GL00847; Angelopoulos V, 2008, SPACE SCI REV, V141, P5, DOI 10.1007/s11214-008-9336-1; Angelopoulos V, 1996, J GEOPHYS RES-SPACE, V101, P24599, DOI 10.1029/96JA01665; ANGELOPOULOS V, 1994, J GEOPHYS RES-SPACE, V99, P21257, DOI 10.1029/94JA01263; Angelopoulos V, 1997, J GEOPHYS RES-SPACE, V102, P211, DOI 10.1029/96JA03217; Axford WI, 1999, PHYS CHEM EARTH PT C, V24, P147, DOI 10.1016/S1464-1917(98)00022-1; Baker DN, 1996, J GEOPHYS RES-SPACE, V101, P12975, DOI 10.1029/95JA03753; Birn J, 2005, ANN GEOPHYS-GERMANY, V23, P3365, DOI 10.5194/angeo-23-3365-2005; Hamrin M, 2011, J GEOPHYS RES-SPACE, V116, DOI 10.1029/2010JA016383; Kamide Y, 1998, J GEOPHYS RES-SPACE, V103, P17705, DOI 10.1029/98JA01426; Li SS, 2011, J GEOPHYS RES-SPACE, V116, DOI 10.1029/2010JA015884; Li SS, 2013, J GEOPHYS RES-SPACE, V118, P2133, DOI 10.1002/jgra.50105; Liu J, 2013, J GEOPHYS RES-SPACE, V118, P2000, DOI 10.1002/jgra.50092; Liu J, 2011, J GEOPHYS RES-SPACE, V116, DOI 10.1029/2010JA015877; Marghitu O., 2010, THE CLUSTER ACTIVE A, P453, DOI [10.1007/978-90-481-3499-132, DOI 10.1007/978-90-481-3499-132]; MCPHERRON RL, 1979, REV GEOPHYS, V17, P657, DOI 10.1029/RG017i004p00657; Nakamura R, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019558; NISHIDA A, 1994, GEOPHYS RES LETT, V21, P2871, DOI 10.1029/94GL01223; Ohtani S, 2004, J GEOPHYS RES-SPACE, V109, DOI 10.1029/2003JA010002; RICHARDSON IG, 1985, J GEOPHYS RES-SPACE, V90, P2133, DOI 10.1029/JA090iA12p12133; Runov A, 2011, J GEOPHYS RES-SPACE, V116, DOI 10.1029/2010JA016316; Sarris ET, 1996, J GEOMAGN GEOELECTR, V48, P649, DOI 10.5636/jgg.48.649; Sergeev V, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL040658; Sergeev VA, 1996, SPACE SCI REV, V75, P551, DOI 10.1007/BF00833344; Shukhtina MA, 2009, ANN GEOPHYS-GERMANY, V27, P1583, DOI 10.5194/angeo-27-1583-2009; Sitnov MI, 2009, J GEOPHYS RES-SPACE, V114, DOI 10.1029/2008JA013980; TSYGANENKO NA, 1995, J GEOPHYS RES-SPACE, V100, P5599, DOI 10.1029/94JA03193; Ugai M, 2011, ANN GEOPHYS-GERMANY, V29, P1411, DOI 10.5194/angeo-29-1411-2011; Zhang XJ, 2011, J GEOPHYS RES-SPACE, V116, DOI 10.1029/2010JA015885	31	202	202	1	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 27	2013	341	6153					1478	1482		10.1126/science.1236992	http://dx.doi.org/10.1126/science.1236992			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	224NS	24072917				2022-12-28	WOS:000324894600041
J	Jennings, JH; Rizzi, G; Stamatakis, AM; Ung, RL; Stuber, GD				Jennings, Joshua H.; Rizzi, Giorgio; Stamatakis, Alice M.; Ung, Randall L.; Stuber, Garret D.			The Inhibitory Circuit Architecture of the Lateral Hypothalamus Orchestrates Feeding	SCIENCE			English	Article							MELANIN-CONCENTRATING HORMONE; EXTENDED AMYGDALA; SELF-STIMULATION; NEURONS; OREXIN; RATS; AREA; REINFORCEMENT; RECEPTORS; DISTINCT	The growing prevalence of overeating disorders is a key contributor to the worldwide obesity epidemic. Dysfunction of particular neural circuits may trigger deviations from adaptive feeding behaviors. The lateral hypothalamus (LH) is a crucial neural substrate for motivated behavior, including feeding, but the precise functional neurocircuitry that controls LH neuronal activity to engage feeding has not been defined. We observed that inhibitory synaptic inputs from the extended amygdala preferentially innervate and suppress the activity of LH glutamatergic neurons to control food intake. These findings help explain how dysregulated activity at a number of unique nodes can result in a cascading failure within a defined brain network to produce maladaptive feeding.	[Jennings, Joshua H.; Rizzi, Giorgio; Stamatakis, Alice M.; Ung, Randall L.; Stuber, Garret D.] Univ N Carolina, Dept Psychiat, Chapel Hill, NC 27599 USA; [Jennings, Joshua H.; Stamatakis, Alice M.; Stuber, Garret D.] Univ N Carolina, Neurobiol Curriculum, Chapel Hill, NC 27599 USA; [Rizzi, Giorgio] Univ Med Ctr Utrecht, Dept Neurosci & Pharmacol, Brain Ctr Rudolf Magnus, Master Program Neurosci & Cognit, NL-3584 CX Utrecht, Netherlands; [Stuber, Garret D.] Univ N Carolina, Bowles Ctr Alcohol Studies, Chapel Hill, NC 27599 USA; [Stuber, Garret D.] Univ N Carolina, Ctr Neurosci, Chapel Hill, NC 27599 USA; [Stuber, Garret D.] Univ N Carolina, Dept Cell Biol & Physiol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Utrecht University; Utrecht University Medical Center; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Stuber, GD (corresponding author), Univ N Carolina, Dept Psychiat, Chapel Hill, NC 27599 USA.	gstuber@med.unc.edu	, UNC Neuroscience Microscopy Core/AAE-8305-2022; Core, Vector/CAF-4832-2022; Stuber, Garret/E-1160-2011	Stuber, Garret/0000-0003-1730-4855; Ung, Randall/0000-0002-5303-3741	Klarman Family Foundation; Brain and Behavior Research Foundation; Foundation of Hope; National Institute on Drug Abuse [DA032750]; National Institute on Alcohol Abuse and Alcoholism [AA022234, AA011605];  [NS007431];  [DA034472]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS045892, T32NS007431] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P50AA011605, P60AA011605, R01AA022234] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R37DA032750, F31DA034472, R01DA032750] Funding Source: NIH RePORTER	Klarman Family Foundation; Brain and Behavior Research Foundation; Foundation of Hope; National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); ; ; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank the Stuber laboratory and C. Bulik for discussion. We thank K. Deisseroth and E. Boyden for viral constructs and the University of North Carolina (UNC) Vector Core for viral packaging, North Carolina (UNC) Vector Core for viral packaging, B. Lowell and L. Vong for mice, and the UNC Neuroscience Center Microscopy Core (P30 NS045892). This study was supported by the Klarman Family Foundation, the Brain and Behavior Research Foundation, the Foundation of Hope, and the National Institute on Drug Abuse (DA032750) and the National Institute on Alcohol Abuse and Alcoholism (AA022234 and AA011605). A. M. S. was supported by NS007431 and DA034472.	Angeles-Castellanos M, 2007, NEUROSCIENCE, V144, P344, DOI 10.1016/j.neuroscience.2006.08.064; Atasoy D, 2012, NATURE, V488, P172, DOI 10.1038/nature11270; Berthoud HR, 2011, PHYSIOL BEHAV, V104, P29, DOI 10.1016/j.physbeh.2011.04.051; Chow BY, 2010, NATURE, V463, P98, DOI 10.1038/nature08652; de Olmos JS, 1999, ANN NY ACAD SCI, V877, P1; DELGADO JMR, 1953, AM J PHYSIOL, V172, P162, DOI 10.1152/ajplegacy.1952.172.1.162; Hahn JD, 2012, J COMP NEUROL, V520, P1831, DOI 10.1002/cne.23064; HOEBEL BG, 1962, SCIENCE, V135, P375, DOI 10.1126/science.135.3501.375; Jennings JH, 2013, NATURE, V496, P224, DOI 10.1038/nature12041; Johnson PM, 2010, NAT NEUROSCI, V13, P635, DOI 10.1038/nn.2519; Karnani MM, 2013, J PHYSIOL-LONDON, V591, P933, DOI 10.1113/jphysiol.2012.243493; Kim SY, 2013, NATURE, V496, P219, DOI 10.1038/nature12018; Knight ZA, 2012, CELL, V151, P1126, DOI 10.1016/j.cell.2012.10.039; Kudo T, 2012, J NEUROSCI, V32, P18035, DOI 10.1523/JNEUROSCI.4057-12.2012; Leinninger GM, 2011, CELL METAB, V14, P313, DOI 10.1016/j.cmet.2011.06.016; Mattis J, 2012, NAT METHODS, V9, P159, DOI [10.1038/nmeth.1808, 10.1038/NMETH.1808]; OLDS J, 1954, J COMP PHYSIOL PSYCH, V47, P419, DOI 10.1037/h0058775; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; Sharf R, 2010, BIOL PSYCHIAT, V67, P753, DOI 10.1016/j.biopsych.2009.12.035; STANLEY BG, 1993, BRAIN RES, V613, P88; Swanson LW, 2005, NEUROSCI LETT, V387, P80, DOI 10.1016/j.neulet.2005.06.066; Turenius CI, 2009, BRAIN RES, V1262, P16, DOI 10.1016/j.brainres.2009.01.016; Watabe-Uchida M, 2012, NEURON, V74, P858, DOI 10.1016/j.neuron.2012.03.017; Wickersham IR, 2007, NAT METHODS, V4, P47, DOI 10.1038/NMETH999; WISE RA, 1968, SCIENCE, V162, P377, DOI 10.1126/science.162.3851.377	25	290	295	2	65	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 27	2013	341	6153					1517	1521		10.1126/science.1241812	http://dx.doi.org/10.1126/science.1241812			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	224NS	24072922	Green Submitted, Green Accepted			2022-12-28	WOS:000324894600052
J	Li, PP; Spann, NJ; Kaikkonen, MU; Lu, M; Oh, DY; Fox, JN; Bandyopadhyay, G; Talukdar, S; Xu, JF; Lagakos, WS; Patsouris, D; Armando, A; Quehenberger, O; Dennis, EA; Watkins, SM; Auwerx, J; Glass, CK; Olefsky, JM				Li, Pingping; Spann, Nathanael J.; Kaikkonen, Minna U.; Lu, Min; Oh, Da Young; Fox, Jesse N.; Bandyopadhyay, Gautam; Talukdar, Saswata; Xu, Jianfeng; Lagakos, William S.; Patsouris, David; Armando, Aaron; Quehenberger, Oswald; Dennis, Edward A.; Watkins, Steven M.; Auwerx, Johan; Glass, Christopher K.; Olefsky, Jerrold M.			NCoR Repression of LXRs Restricts Macrophage Biosynthesis of Insulin-Sensitizing Omega 3 Fatty Acids	CELL			English	Article							PPAR-GAMMA; ADIPOSE-TISSUE; INFLAMMATION; OBESITY; ACTIVATION; RESISTANCE; ROLES; TRANSREPRESSION; COREPRESSORS; STIMULATION	Macrophage-mediated inflammation is a major contributor to obesity-associated insulin resistance. The corepressor NCoR interacts with inflammatory pathway genes in macrophages, suggesting that its removal would result in increased activity of inflammatory responses. Surprisingly, we find that macrophage-specific deletion of NCoR instead results in an anti-inflammatory phenotype along with robust systemic insulin sensitization in obese mice. We present evidence that derepression of LXRs contributes to this paradoxical anti-inflammatory phenotype by causing increased expression of genes that direct biosynthesis of palmitoleic acid and omega 3 fatty acids. Remarkably, the increased omega 3 fatty acid levels primarily inhibit NF-kappa B-dependent inflammatory responses by uncoupling NF-kappa B binding and enhancer/promoter histone acetylation from subsequent steps required for proinflammatory gene activation. This provides a mechanism for the in vivo anti-inflammatory insulin-sensitive phenotype observed in mice with macrophage-specific deletion of NCoR. Therapeutic methods to harness this mechanism could lead to a new approach to insulin-sensitizing therapies.	[Li, Pingping; Lu, Min; Oh, Da Young; Bandyopadhyay, Gautam; Talukdar, Saswata; Xu, Jianfeng; Lagakos, William S.; Patsouris, David; Quehenberger, Oswald; Glass, Christopher K.; Olefsky, Jerrold M.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Spann, Nathanael J.; Kaikkonen, Minna U.; Fox, Jesse N.; Glass, Christopher K.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Armando, Aaron; Quehenberger, Oswald; Dennis, Edward A.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Dennis, Edward A.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Kaikkonen, Minna U.] Univ Eastern Finland, Dept Biotechnol & Mol Med, AI Virtanen Inst, Kuopio 70211, Finland; [Watkins, Steven M.] Lip Technol Inc, West Sacramento, CA 95691 USA; [Auwerx, Johan] Ecole Polytech Fed Lausanne, Lab Integrat & Syst Physiol, CH-1015 Lausanne, Switzerland	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Eastern Finland; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Glass, CK (corresponding author), Univ Calif San Diego, Dept Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.	cglass@ucsd.edu; jolefsky@ucsd.edu	Glass, Christopher/AAI-3933-2021; Kaikkonen, Minna U/AAK-3612-2020; Li, Pingping/F-1109-2019; Dennis, Edward A./M-5554-2019; Auwerx, Johan/ABE-9307-2021	Glass, Christopher/0000-0003-4344-3592; Kaikkonen, Minna U/0000-0001-6294-0979; Li, Pingping/0000-0003-0679-270X; Dennis, Edward A./0000-0003-3738-3140; Talukdar, Saswata/0000-0003-3042-0025; Auwerx, Johan/0000-0002-5065-5393	Ecole Polytechnique Federale de Lausanne; Swiss National Science Foundation; EU Ideas program [ERC-AdG-23118]; Eunice Kennedy Shriver NICHD/NIH through a Cooperative Centers Program in Reproduction and Infertility Research;  [DK033651];  [DK074868];  [DK-063491];  [DK-09062];  [GM069338];  [DK091183]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P50HD012303] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA023100] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK074868, R01DK033651, R37DK033651, F32DK009062, P30DK063491, R01DK091183] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM069338] Funding Source: NIH RePORTER	Ecole Polytechnique Federale de Lausanne; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); EU Ideas program; Eunice Kennedy Shriver NICHD/NIH through a Cooperative Centers Program in Reproduction and Infertility Research; ; ; ; ; ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Flow Cytometry Resource (Dennis Young) for FACS analysis at the Rebecca and John Moores Cancer Center and thank Jachelle M. Ofrecio for genotyping at UCSD. This study was funded in part by grants to J.M.O. (DK033651, DK074868, DK-063491, and DK-09062), C.K.G. (DK074868, GM069338, and DK091183), and J.A. (the Ecole Polytechnique Federale de Lausanne, the Swiss National Science Foundation, and the EU Ideas program [ERC-AdG-23118]). This study was also funded by the Eunice Kennedy Shriver NICHD/NIH through a Cooperative Centers Program in Reproduction and Infertility Research to J.M.O.	Barish GD, 2012, CELL METAB, V15, P554, DOI 10.1016/j.cmet.2012.02.012; Bouhlel MA, 2007, CELL METAB, V6, P137, DOI 10.1016/j.cmet.2007.06.010; Brown HA, 2007, METHOD ENZYMOL, V434, P49, DOI 10.1016/S0076-6879(07)34004-4; Cao HM, 2008, CELL, V134, P933, DOI 10.1016/j.cell.2008.07.048; CHEN JD, 1995, NATURE, V377, P454, DOI 10.1038/377454a0; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Codina A, 2005, P NATL ACAD SCI USA, V102, P6009, DOI 10.1073/pnas.0500299102; Escoubet-Lozach L, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002401; FOLCH J, 1957, J BIOL CHEM, V226, P497; Ghisletti S, 2009, GENE DEV, V23, P681, DOI 10.1101/gad.1773109; Glass CK, 2010, NAT REV IMMUNOL, V10, P365, DOI 10.1038/nri2748; Glass CK, 2006, NAT REV IMMUNOL, V6, P44, DOI 10.1038/nri1748; Haffner S, 2003, CIRCULATION, V108, P1541, DOI 10.1161/01.CIR.0000088845.17586.EC; Hargreaves DC, 2009, CELL, V138, P129, DOI 10.1016/j.cell.2009.05.047; He HSHS, 2010, NAT GENET, V42, P343, DOI 10.1038/ng.545; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hevener AL, 2007, J CLIN INVEST, V117, P1658, DOI 10.1172/JCI31561; HORLEIN AJ, 1995, NATURE, V377, P397, DOI 10.1038/377397a0; Hu X, 2003, MOL ENDOCRINOL, V17, P1019, DOI 10.1210/me.2002-0399; Jager J, 2007, ENDOCRINOLOGY, V148, P241, DOI 10.1210/en.2006-0692; Kintscher U, 2008, ARTERIOSCL THROM VAS, V28, P1304, DOI 10.1161/ATVBAHA.108.165100; Lai F, 2013, NATURE, V494, P497, DOI 10.1038/nature11884; Lanthier N, 2010, AM J PHYSIOL-GASTR L, V298, pG107, DOI 10.1152/ajpgi.00391.2009; Li PP, 2011, CELL, V147, P815, DOI 10.1016/j.cell.2011.09.050; Medzhitov R, 2009, NAT REV IMMUNOL, V9, P692, DOI 10.1038/nri2634; Mori Trevor A, 2004, Curr Atheroscler Rep, V6, P461, DOI 10.1007/s11883-004-0087-5; Mottis A, 2013, GENE DEV, V27, P819, DOI 10.1101/gad.214023.113; Mullican SE, 2011, GENE DEV, V25, P2480, DOI 10.1101/gad.175950.111; Ng HH, 2003, MOL CELL, V11, P709, DOI 10.1016/S1097-2765(03)00092-3; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Ostuni R, 2013, CELL, V152, P157, DOI 10.1016/j.cell.2012.12.018; Pascual G, 2005, NATURE, V437, P759, DOI 10.1038/nature03988; Reaven GM, 2005, ANNU REV NUTR, V25, P391, DOI 10.1146/annurev.nutr.24.012003.132155; Rosenfeld MG, 2006, GENE DEV, V20, P1405, DOI 10.1101/gad.1424806; Rotter V, 2003, J BIOL CHEM, V278, P45777, DOI 10.1074/jbc.M301977200; Shoelson SE, 2007, GASTROENTEROLOGY, V132, P2169, DOI 10.1053/j.gastro.2007.03.059; Spann NJ, 2012, CELL, V151, P138, DOI 10.1016/j.cell.2012.06.054; Wagner BL, 2003, MOL CELL BIOL, V23, P5780, DOI 10.1128/MCB.23.16.5780-5789.2003; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yamamoto H, 2011, CELL, V147, P827, DOI 10.1016/j.cell.2011.10.017; Yang HW, 2010, J IMMUNOL, V185, P1836, DOI 10.4049/jimmunol.1000021; Yang ZY, 2005, MOL CELL, V19, P535, DOI 10.1016/j.molcel.2005.06.029	44	113	116	0	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 26	2013	155	1					200	214		10.1016/j.cell.2013.08.054	http://dx.doi.org/10.1016/j.cell.2013.08.054			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	224UX	24074869	Bronze, Green Published, Green Accepted			2022-12-28	WOS:000324916700020
J	Moore, WB; Webb, AAG				Moore, William B.; Webb, A. Alexander G.			Heat-pipe Earth	NATURE			English	Article							BARBERTON GREENSTONE-BELT; SOUTHERN WEST GREENLAND; ITSAQ GNEISS COMPLEX; ISOTOPE EVIDENCE; PLATE-TECTONICS; JACK HILLS; CRUST; GA; ZIRCONS; ORIGIN	The heat transport and lithospheric dynamics of early Earth are currently explained by plate tectonic and vertical tectonic models, but these do not offer a global synthesis consistent with the geologic record. Here we use numerical simulations and comparison with the geologic record to explore a heat-pipe model in which volcanism dominates surface heat transport. These simulations indicate that a cold and thick lithosphere developed as a result of frequent volcanic eruptions that advected surface materials downwards. Declining heat sources over time led to an abrupt transition to plate tectonics. Consistent with model predictions, the geologic record shows rapid volcanic resurfacing, contractional deformation, a low geothermal gradient across the bulk of the lithosphere and a rapid decrease in heat-pipe volcanism after initiation of plate tectonics. The heat-pipe Earth model therefore offers a coherent geodynamic framework in which to explore the evolution of our planet before the onset of plate tectonics.	[Moore, William B.] Hampton Univ, Dept Atmospher & Planetary Sci, Hampton, VA 23668 USA; [Moore, William B.] Natl Inst Aerosp, Hampton, VA 23666 USA; [Webb, A. Alexander G.] Louisiana State Univ, Dept Geol & Geophys, Baton Rouge, LA 70803 USA	Hampton University; National Institute for Aerospace; Louisiana State University System; Louisiana State University	Moore, WB (corresponding author), Hampton Univ, Dept Atmospher & Planetary Sci, Hampton, VA 23668 USA.	william.moore@hamptonu.edu	Webb, A. Alexander G./B-4027-2013; Webb, Alexander/AAX-7001-2020	Webb, Alexander/0000-0001-8007-8489	NSF Geophysics; NASA PGG; NASA Astrobiology Institute; Louisiana State University; Directorate For Geosciences [1246983] Funding Source: National Science Foundation	NSF Geophysics(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); NASA PGG; NASA Astrobiology Institute; Louisiana State University; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This research has been supported by NSF Geophysics, NASA PG&G, the NASA Astrobiology Institute and a start-up fund from Louisiana State University, and has made use of the Astrophysics Data System. We thank M. Stiegler for discussions.	Bedard JH, 2013, PRECAMBRIAN RES, V229, P20, DOI 10.1016/j.precamres.2012.04.001; Blichert-Toft J, 2008, EARTH PLANET SC LETT, V265, P686, DOI 10.1016/j.epsl.2007.10.054; Bowring SA, 1999, CONTRIB MINERAL PETR, V134, P3, DOI 10.1007/s004100050465; Breuer D., 2007, TREATISE GEOPHYS, V10, DOI [10.1016/b978-044452748-6.00161-9, DOI 10.1016/B978-044452748-6.00161-9]; BUNDY FP, 1989, PHYSICA A, V156, P169, DOI 10.1016/0378-4371(89)90115-5; Davies GF, 2006, EARTH PLANET SC LETT, V243, P376, DOI 10.1016/j.epsl.2006.01.053; Dhuime B, 2012, SCIENCE, V335, P1334, DOI 10.1126/science.1216066; Franck S, 1998, TECTONOPHYSICS, V291, P9, DOI 10.1016/S0040-1951(98)00027-4; Friend CRL, 2005, J GEOL, V113, P375, DOI 10.1086/430239; Friend CRL, 2002, CONTRIB MINERAL PETR, V143, P71, DOI 10.1007/s00410-001-0332-7; Guitreau M, 2012, EARTH PLANET SC LETT, V337, P211, DOI 10.1016/j.epsl.2012.05.029; Harrison TM, 2009, ANNU REV EARTH PL SC, V37, P479, DOI 10.1146/annurev.earth.031208.100151; Hickman A.H., 2004, PRECAMBRIAN EARTH TE, P54; Hoffmann JE, 2011, GEOCHIM COSMOCHIM AC, V75, P4157, DOI 10.1016/j.gca.2011.04.027; Kamber BS, 2005, EARTH PLANET SC LETT, V240, P276, DOI 10.1016/j.epsl.2005.09.037; Korenaga J, 2011, J GEOPHYS RES-SOL EA, V116, DOI 10.1029/2011JB008410; Lowe DR, 2007, DEV PREC G, V15, P481, DOI 10.1016/S0166-2635(07)15053-2; McGovern PJ, 2004, J GEOPHYS RES-PLANET, V109, DOI 10.1029/2004JE002286; Menneken M, 2007, NATURE, V448, P917, DOI 10.1038/nature06083; Mojzsis SJ, 2001, NATURE, V409, P178, DOI 10.1038/35051557; Moyen JF, 2011, LITHOS, V123, P21, DOI 10.1016/j.lithos.2010.09.015; Moyen JF, 2007, DEV PREC G, V15, P607, DOI 10.1016/S0166-2635(07)15056-8; Nemchin AA, 2008, NATURE, V454, P92, DOI 10.1038/nature07102; Nutman AP, 2007, DEV PREC G, V15, P187, DOI 10.1016/S0166-2635(07)15033-7; O'Neill C, 2007, EARTH PLANET SC LETT, V262, P552, DOI 10.1016/j.epsl.2007.04.056; OREILLY TC, 1981, GEOPHYS RES LETT, V8, P313, DOI 10.1029/GL008i004p00313; Pease V., 2008, DID PLATE TECTONICS, P199; Schenk PM, 1998, SCIENCE, V279, P1514, DOI 10.1126/science.279.5356.1514; Shirey SB, 2011, SCIENCE, V333, P434, DOI 10.1126/science.1206275; Stern RJ, 2008, GEOL SOC AM SPEC PAP, V440, P265, DOI 10.1130/2008.2440(13); Stiegler MT, 2011, GEOL SOC AM BULL, V123, P1112, DOI 10.1130/B30191.1; Tackley PJ, 2008, PHYS EARTH PLANET IN, V171, P7, DOI 10.1016/j.pepi.2008.08.005; TAKAHASHI E, 1986, J GEOPHYS RES-SOLID, V91, P9367, DOI 10.1029/JB091iB09p09367; Turcotte D, 2002, GEODYNAMICS, P1; van Hunen J, 2008, LITHOS, V103, P217, DOI 10.1016/j.lithos.2007.09.016; van Hunen J, 2012, ANNU REV EARTH PL SC, V40, P195, DOI [10.1146/annurev-earth-842711-105255, 10.1146/annurev-earth-042711-105255]; Van Kranendonk MJ, 2007, DEV PREC G, V15, P307, DOI 10.1016/S0166-2635(07)15041-6; Van Kranendonk MJ, 2011, J AFR EARTH SCI, V60, P346, DOI 10.1016/j.jafrearsci.2011.03.012; Veeder GJ, 2004, ICARUS, V169, P264, DOI 10.1016/j.icarus.2003.11.016; WARREN PH, 1987, J GEOPHYS RES-SOLID, V92, P3453, DOI 10.1029/JB092iB05p03453; Wilde SA, 2001, NATURE, V409, P175, DOI 10.1038/35051550; Zegers TE, 1999, TECTONOPHYSICS, V311, P45, DOI 10.1016/S0040-1951(99)00157-2	42	182	191	10	110	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 26	2013	501	7468					501	505		10.1038/nature12473	http://dx.doi.org/10.1038/nature12473			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223RP	24067709				2022-12-28	WOS:000324826300048
J	Padmanabhan, N; Jia, DX; Geary-Joo, C; Wu, XC; Ferguson-Smith, AC; Fung, E; Bieda, MC; Snyder, FF; Gravel, RA; Cross, JC; Watson, ED				Padmanabhan, Nisha; Jia, Dongxin; Geary-Joo, Colleen; Wu, Xuchu; Ferguson-Smith, Anne C.; Fung, Ernest; Bieda, Mark C.; Snyder, Floyd F.; Gravel, Roy A.; Cross, James C.; Watson, Erica D.			Mutation in Folate Metabolism Causes Epigenetic Instability and Transgenerational Effects on Development	CELL			English	Article							TANDEM MASS-SPECTROMETRY; METHIONINE SYNTHASE REDUCTASE; METHYLENETETRAHYDROFOLATE REDUCTASE; IMPRINTED GENES; MICE DEFICIENT; DNA METHYLTRANSFERASES; METHYLATION; MOUSE; HOMOCYSTEINE; DEFECTS	The importance of maternal folate consumption for normal development is well established, yet the molecular mechanism linking folate metabolism to development remains poorly understood. The enzyme methionine synthase reductase (Mtrr) is necessary for utilization of methyl groups from the folate cycle. We found that a hypomorphic mutation of the mouse Mtrr gene results in intrauterine growth restriction, developmental delay, and congenital malformations, including neural tube, heart, and placental defects. Importantly, these defects were dependent upon the Mtrr genotypes of the maternal grandparents. Furthermore, we observed widespread epigenetic instability associated with altered gene expression in the placentas of wild-type grand-progeny of Mtrr-deficient maternal grandparents. Embryo transfer experiments revealed that Mtrr deficiency in mice lead to two distinct, separable phenotypes: adverse effects on their wild-type daughters' uterine environment, leading to growth defects in wild-type grandprogeny, and the appearance of congenital malformations independent of maternal environment that persist for five generations, likely through transgenerational epigenetic inheritance.	[Padmanabhan, Nisha; Ferguson-Smith, Anne C.; Watson, Erica D.] Univ Cambridge, Dept Physiol Dev & Neurosci, Ctr Trophoblast Res, Cambridge CB2 3EG, England; [Jia, Dongxin; Wu, Xuchu; Bieda, Mark C.; Snyder, Floyd F.; Gravel, Roy A.; Cross, James C.; Watson, Erica D.] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB T2N 4N1, Canada; [Geary-Joo, Colleen] Univ Calgary, Clara Christie Ctr Mouse Genom, Transgen Serv, Calgary, AB T2N 4N1, Canada; [Ferguson-Smith, Anne C.] Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England; [Fung, Ernest; Snyder, Floyd F.; Gravel, Roy A.; Cross, James C.] Univ Calgary, Dept Med Genet, Calgary, AB T2N 4N1, Canada; [Bieda, Mark C.; Snyder, Floyd F.; Gravel, Roy A.; Cross, James C.] Univ Calgary, Alberta Childrens Hosp Res Inst Child & Maternal, Calgary, AB T2N 4N1, Canada; [Cross, James C.; Watson, Erica D.] Univ Calgary, Dept Comparat Biol & Expt Med, Calgary, AB T2N 4N1, Canada	University of Cambridge; University of Calgary; University of Calgary; University of Cambridge; University of Calgary; University of Calgary; University of Calgary	Watson, ED (corresponding author), Univ Cambridge, Dept Physiol Dev & Neurosci, Ctr Trophoblast Res, Cambridge CB2 3EG, England.	edw23@cam.ac.uk	Padmanabhan, Nisha/ABE-4879-2020; Cross, James/AAU-2973-2020; Cross, James/F-4814-2011	Padmanabhan, Nisha/0000-0003-1253-2162; Cross, James/0000-0003-0956-9378; Cross, James/0000-0003-0956-9378; Watson, Erica/0000-0003-4496-2271; Ferguson-Smith, Anne/0000-0002-7608-5894	CIHR; NIH-NHLBI; Centre for Trophoblast Research (CTR); CTR graduate studentship; EpiHealth and Epigenesys; MRC; Wellcome Trust; CIHR Training Program in Genetics, Child Development and Health; NSERC; MRC [MR/J001597/1] Funding Source: UKRI; Medical Research Council [MR/J001597/1] Funding Source: researchfish; Wellcome Trust [095606/Z/11/Z] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058955] Funding Source: NIH RePORTER	CIHR(Canadian Institutes of Health Research (CIHR)); NIH-NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Centre for Trophoblast Research (CTR); CTR graduate studentship; EpiHealth and Epigenesys; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); CIHR Training Program in Genetics, Child Development and Health(Canadian Institutes of Health Research (CIHR)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank Cameron Fielding, Xiang Zhao, Frances Snider, and Nuala Daw for their technical assistance. This work was supported by grants from the CIHR (to R.A.G. and J.C.C.), NIH-NHLBI (to R.A.G.), and Centre for Trophoblast Research (CTR) (to E.D.W.). N.P. was funded by a CTR graduate studentship. A.C.F.-S. was supported by FP7 grants from EpiHealth and Epigenesys, MRC, and Wellcome Trust. E.D.W. was funded by the CIHR Training Program in Genetics, Child Development and Health and fellowships from the CTR, NSERC, and CIHR.	AGELL N, 1983, FEBS LETT, V155, P209, DOI 10.1016/0014-5793(82)80604-2; Anway MD, 2005, SCIENCE, V308, P1466, DOI 10.1126/science.1108190; Castro R, 2004, J MED GENET, V41, P454, DOI 10.1136/jmg.2003.017244; Chan D, 2010, ENDOCRINOLOGY, V151, P3363, DOI 10.1210/en.2009-1340; Chen ZT, 2001, HUM MOL GENET, V10, P433, DOI 10.1093/hmg/10.5.433; Coan PM, 2005, PLACENTA, V26, pS10, DOI 10.1016/j.placenta.2004.12.009; Deng L, 2008, MOL GENET METAB, V94, P336, DOI 10.1016/j.ymgme.2008.03.004; Elmore CL, 2007, MOL GENET METAB, V91, P85, DOI 10.1016/j.ymgme.2007.02.001; Friso S, 2002, P NATL ACAD SCI USA, V99, P5606, DOI 10.1073/pnas.062066299; Ghandour H, 2004, J NUTR, V134, P2975, DOI 10.1093/jn/134.11.2975; Ghandour H, 2002, J NUTR, V132, P1357, DOI 10.1093/jn/132.6.1357; Grishok A, 2000, SCIENCE, V287, P2494, DOI 10.1126/science.287.5462.2494; Hague WM, 2003, BEST PRACT RES CL OB, V17, P459, DOI 10.1016/S1521-6934(03)00009-9; Hart DJ, 2002, ANAL BIOCHEM, V305, P206, DOI 10.1006/abio.2002.5662; Hata K, 2002, DEVELOPMENT, V129, P1983; Hemberger M, 2010, EPIGENETICS-US, V5, P24, DOI 10.4161/epi.5.1.10589; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Magera MJ, 1999, CLIN CHEM, V45, P1517; Messerschmidt DM, 2012, SCIENCE, V335, P1499, DOI 10.1126/science.1216154; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Pickell L, 2009, BIRTH DEFECTS RES A, V85, P531, DOI 10.1002/bdra.20575; Piedrahita JA, 1999, NAT GENET, V23, P228, DOI 10.1038/13861; Rampersaud E, 2003, CLIN GENET, V63, P210, DOI 10.1034/j.1399-0004.2003.00043.x; Rassoulzadegan M, 2006, NATURE, V441, P469, DOI 10.1038/nature04674; Rozen S, 2000, Methods Mol Biol, V132, P365; Saitou M, 2012, DEVELOPMENT, V139, P15, DOI 10.1242/dev.050849; SHANE B, 1985, ANNU REV NUTR, V5, P115, DOI 10.1146/annurev.nu.05.070185.000555; Sinclair KD, 2007, P NATL ACAD SCI USA, V104, P19351, DOI 10.1073/pnas.0707258104; Smith DEC, 2006, CLIN CHEM LAB MED, V44, P450, DOI 10.1515/CCLM.2006.085; Stouder C, 2010, REPRODUCTION, V139, P373, DOI 10.1530/REP-09-0340; Swanson DA, 2001, MOL CELL BIOL, V21, P1058, DOI 10.1128/MCB.21.4.1058-1065.2001; Tunster SJ, 2013, REPRODUCTION, V145, pR117, DOI 10.1530/REP-12-0511; Ueda O, 2003, BIOL REPROD, V69, P1085, DOI 10.1095/biolreprod.103.017608; VANDERPUT NMJ, 1995, LANCET, V346, P1070, DOI 10.1016/S0140-6736(95)91743-8; Vastenhouw NL, 2006, NATURE, V442, P882, DOI 10.1038/442882a; Waes JGV, 2008, BIRTH DEFECTS RES A, V82, P494, DOI 10.1002/bdra.20453; WAINFAN E, 1975, CANCER RES, V35, P2830; Weaving G, 2006, ANN CLIN BIOCHEM, V43, P474, DOI 10.1258/000456306778904605; Yamada K, 2006, P NATL ACAD SCI USA, V103, P9476, DOI 10.1073/pnas.0603694103	39	180	181	0	57	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 26	2013	155	1					81	93		10.1016/j.cell.2013.09.002	http://dx.doi.org/10.1016/j.cell.2013.09.002			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	224UX	24074862	Bronze, Green Accepted			2022-12-28	WOS:000324916700011
J	Dagres, N; Triantafyllis, A; Anastasiou-Nana, M				Dagres, Nikolaos; Triantafyllis, Andreas; Anastasiou-Nana, Maria			A 70 year old woman with chest pain after a stressful event	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							APICAL BALLOONING SYNDROME; NORMAL CORONARY-ARTERIES; TAKOTSUBO CARDIOMYOPATHY; TAKO-TSUBO; MYOCARDIAL-INFARCTION		[Dagres, Nikolaos; Triantafyllis, Andreas; Anastasiou-Nana, Maria] Univ Athens, Attikon Univ Hosp, Cardiol Dept 2, Athens 12462, Greece	National & Kapodistrian University of Athens; University Hospital Attikon	Dagres, N (corresponding author), Univ Athens, Attikon Univ Hosp, Cardiol Dept 2, Athens 12462, Greece.	nikolaosdagres@yahoo.de						Agewall S, 2011, ATHEROSCLEROSIS, V219, P10, DOI 10.1016/j.atherosclerosis.2011.04.036; Angelini P, 2008, CATHETER CARDIO INTE, V71, P342, DOI 10.1002/ccd.21338; Bybee KA, 2004, ANN INTERN MED, V141, P858, DOI 10.7326/0003-4819-141-11-200412070-00010; Chopard R, 2011, ARCH CARDIOVASC DIS, V104, P509, DOI 10.1016/j.acvd.2011.05.004; Collste O, 2013, J INTERN MED, V273, P189, DOI 10.1111/j.1365-2796.2012.02567.x; Deshmukh A, 2012, AM HEART J, V164, P66, DOI 10.1016/j.ahj.2012.03.020; Dib C, 2009, AM HEART J, V157, P933, DOI 10.1016/j.ahj.2008.12.023; Eitel I, 2008, EUR HEART J, V29, P2651, DOI 10.1093/eurheartj/ehn433; Eitel I, 2011, JAMA-J AM MED ASSOC, V306, P277, DOI 10.1001/jama.2011.992; Fazio G, 2010, J CLIN MONIT COMPUT, V24, P101, DOI 10.1007/s10877-009-9217-5; Foo TKF, 2004, RADIOLOGY, V230, P845, DOI 10.1148/radiol.2303021411; Gianni M, 2006, EUR HEART J, V27, P1523, DOI 10.1093/eurheartj/ehl032; Haghi D, 2006, EUR HEART J, V27, P2433, DOI 10.1093/eurheartj/ehl274; Haghi D, 2010, CLIN CARDIOL, V33, P307, DOI 10.1002/clc.20747; Hamm CW, 2011, EUR HEART J, V32, P2999, DOI 10.1093/eurheartj/ehr236; Kosuge M, 2012, CIRC J, V76, P462, DOI 10.1253/circj.CJ-11-1036; Kosuge M, 2010, J AM COLL CARDIOL, V55, P2514, DOI 10.1016/j.jacc.2009.12.059; Mansencal N, 2013, INT J CARDIOL; Marra MP, 2013, HEART RHYTHM, V10, P70, DOI 10.1016/j.hrthm.2012.09.004; Migliore F, 2013, JACC-CARDIOVASC IMAG, V6, P32, DOI 10.1016/j.jcmg.2012.08.013; Prasad A, 2008, AM HEART J, V155, P408, DOI 10.1016/j.ahj.2007.11.008; Rossini R, 2013, AM J CARDIOL, V112, P150, DOI 10.1016/j.amjcard.2013.03.006; Sharkey SW, 2010, J AM COLL CARDIOL, V55, P333, DOI 10.1016/j.jacc.2009.08.057; Sharkey SW, 2005, CIRCULATION, V111, P472, DOI 10.1161/01.CIR.0000153801.51470.EB; Villareal RP, 2001, MAYO CLIN PROC, V76, P79, DOI 10.4065/76.1.79; Wittstein IS, 2005, NEW ENGL J MED, V352, P539, DOI 10.1056/NEJMoa043046	26	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 23	2013	347								f5583	10.1136/bmj.f5583	http://dx.doi.org/10.1136/bmj.f5583			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	227BZ	24062187				2022-12-28	WOS:000325084200002
J	Bedard, PL; Hansen, AR; Ratain, MJ; Siu, LL				Bedard, Philippe L.; Hansen, Aaron R.; Ratain, Mark J.; Siu, Lillian L.			Tumour heterogeneity in the clinic	NATURE			English	Review							FACTOR RECEPTOR 2; METASTATIC BREAST-CANCER; HER2 GENE AMPLIFICATION; ANTI-EGFR THERAPY; CELL LUNG CANCERS; ACQUIRED-RESISTANCE; COLORECTAL-CANCER; INTRATUMOR HETEROGENEITY; IN-SITU; MUTATIONAL EVOLUTION	Recent therapeutic advances in oncology have been driven by the identification of tumour genotype variations between patients, called interpatient heterogeneity, that predict the response of patients to targeted treatments. Subpopulations of cancer cells with unique genomes in the same patient may exist across different geographical regions of a tumour or evolve over time, called intratumour heterogeneity. Sequencing technologies can be used to characterize intratumour heterogeneity at diagnosis, monitor clonal dynamics during treatment and identify the emergence of clinical resistance during disease progression. Genetic interpatient and intratumour heterogeneity can pose challenges for the design of clinical trials that use these data.	[Bedard, Philippe L.; Hansen, Aaron R.; Siu, Lillian L.] Univ Hlth Network, Div Med Oncol & Hematol, Princess Margaret Canc Ctr, Toronto, ON, Canada; [Bedard, Philippe L.; Hansen, Aaron R.; Siu, Lillian L.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Ratain, Mark J.] Univ Chicago, Dept Med, Chicago, IL 60637 USA	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University of Chicago	Siu, LL (corresponding author), Univ Hlth Network, Div Med Oncol & Hematol, Princess Margaret Canc Ctr, Toronto, ON, Canada.	lillian.siu@uhn.ca	wang, edwin/G-5372-2010	Hansen, Aaron/0000-0002-2363-8707; Bedard, Philippe/0000-0002-6771-2999	Cancer Care Ontario Applied Cancer Research Units Grant; US National Institute of Health [U01 GM61393]; NATIONAL CANCER INSTITUTE [UM1CA186644] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM061393] Funding Source: NIH RePORTER	Cancer Care Ontario Applied Cancer Research Units Grant; US National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported in part by the Cancer Care Ontario Applied Cancer Research Units Grant (P. L. B, L. L. S) and by the US National Institute of Health Grant U01 GM61393 (M.J.R).	Albiges L., 2012, CANCER RES, V72, pS1746; Amir E, 2012, J CLIN ONCOL, V30, P587, DOI 10.1200/JCO.2010.33.5232; [Anonymous], 1992, Fed Regist, V57, P7002; Antonescu CR, 2005, CLIN CANCER RES, V11, P4182, DOI 10.1158/1078-0432.CCR-04-2245; Aparicio S, 2013, NEW ENGL J MED, V368, P842, DOI 10.1056/NEJMra1204892; Artale S, 2008, J CLIN ONCOL, V26, P4217, DOI 10.1200/JCO.2008.18.7286; Bai H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054170; Bang YJ, 2010, LANCET, V376, P1302; Barker AD, 2009, CLIN PHARMACOL THER, V86, P97, DOI 10.1038/clpt.2009.68; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Baselga J, 2012, NEW ENGL J MED, V366, P520, DOI 10.1056/NEJMoa1109653; Bedard P, 2013, J CLIN ONCOL, V31, P11002; Begley CG, 2012, NATURE, V483, P531, DOI 10.1038/483531a; Beltran H, 2013, EUR UROL, V63, P920, DOI 10.1016/j.eururo.2012.08.053; Berry DA, 2012, CLIN CANCER RES, V18, P638, DOI 10.1158/1078-0432.CCR-11-2018; Bozzetti C, 2011, BRIT J CANCER, V104, P1372, DOI 10.1038/bjc.2011.121; Buttitta F, 2013, CLIN CANCER RES, V19, P691, DOI 10.1158/1078-0432.CCR-12-1958; Callaway E., 2012, NATURE          0202; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Chan KCA, 2013, CLIN CHEM, V59, P211, DOI 10.1373/clinchem.2012.196014; Chang HJ, 2011, JPN J CLIN ONCOL, V41, P593, DOI 10.1093/jjco/hyr020; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Colombino M, 2012, J CLIN ONCOL, V30, P2522, DOI 10.1200/JCO.2011.41.2452; COONS SW, 1995, CANCER RES, V55, P1569; Cristofanilli M, 2004, NEW ENGL J MED, V351, P781, DOI 10.1056/NEJMoa040766; Dancey JE, 2012, CELL, V148, P409, DOI 10.1016/j.cell.2012.01.014; Davies C, 2011, LANCET, V378, P771, DOI 10.1016/S0140-6736(11)60993-8; Dawson SJ, 2013, NEW ENGL J MED, V368, P1199, DOI 10.1056/NEJMoa1213261; De Roock W, 2008, ANN ONCOL, V19, P508, DOI 10.1093/annonc/mdm496; Diaz LA, 2012, NATURE, V486, P537, DOI 10.1038/nature11219; Dienstmann R, 2012, MOL CANCER THER, V11, P2062, DOI 10.1158/1535-7163.MCT-12-0290; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Elisei R, 2008, J CLIN ENDOCR METAB, V93, P682, DOI 10.1210/jc.2007-1714; FIDLER IJ, 1982, SCIENCE, V217, P998, DOI 10.1126/science.7112116; Forshew T, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003726; Gabler NB, 2011, MED CARE, V49, P761, DOI 10.1097/MLR.0b013e318215d90d; Gargis AS, 2012, NAT BIOTECHNOL, V30, P1033, DOI 10.1038/nbt.2403; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Garraway L. A., 2013, GENOMICS DRIVEN CLIN; Gasch C, 2013, CLIN CHEM, V59, P252, DOI 10.1373/clinchem.2012.188557; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Getz M., 2012, BREAST CANC GENOME G; Gong Y, 2011, CANCER-AM CANCER SOC, V117, P705, DOI 10.1002/cncr.25506; Heinrich MC, 2006, J CLIN ONCOL, V24, P4764, DOI 10.1200/JCO.2006.06.2265; Heselmeyer-Haddad K, 2012, AM J PATHOL, V181, P1807, DOI 10.1016/j.ajpath.2012.07.012; Hollebecque A, 2013, ASCO M, V31, P2512; Hou Y, 2012, CELL, V148, P873, DOI 10.1016/j.cell.2012.02.028; Jang MH, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3239; Janjigian YY, 2012, ANN ONCOL, V23, P2656, DOI 10.1093/annonc/mds104; Johnson CE, 2012, BREAST CANCER RES TR, V133, P889, DOI 10.1007/s10549-011-1835-1; Kalikaki A, 2008, BRIT J CANCER, V99, P923, DOI 10.1038/sj.bjc.6604629; Kaplan R., 2013, MRC FOCUS 4 NEW TRIA; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Kim ES, 2011, CANCER DISCOV, V1, P44, DOI 10.1158/2159-8274.CD-10-0010; Kim H, 2013, HISTOPATHOLOGY, V62, P305, DOI 10.1111/j.1365-2559.2012.04356.x; Kim H, 2011, J THORAC ONCOL, V6, P1359, DOI 10.1097/JTO.0b013e31821cfc73; Kim MA, 2011, HISTOPATHOLOGY, V59, P822, DOI 10.1111/j.1365-2559.2011.04012.x; Kinde I, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004952; Knijn N, 2011, BRIT J CANCER, V104, P1020, DOI 10.1038/bjc.2011.26; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kopetz S, 2010, J CLIN ONCOL, V28, DOI 10.1200/jco.2010.28.15_suppl.3534; Kummar S., 2012, CHALLENGES INCORPORA; Kurzrock R., 2012, WINTHER WIN THERAPEU; Leary RJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004742; Liedtke C, 2009, ANN ONCOL, V20, P1953, DOI 10.1093/annonc/mdp263; Lillie EO, 2011, PERS MED, V8, P161, DOI 10.2217/PME.11.7; Lindstrom LS, 2012, J CLIN ONCOL, V30, P2601, DOI 10.1200/JCO.2011.37.2482; Lipson D, 2012, NAT MED, V18, P382, DOI 10.1038/nm.2673; Maheswaran S, 2008, NEW ENGL J MED, V359, P366, DOI 10.1056/NEJMoa0800668; MD Anderson Cancer Center, 2012, SHEIK KHAL BIN ZAYED; Melcher C., 2012, CANCER RES, V72; Mendelsohn J, 2013, J CLIN ONCOL, V31, P1904, DOI 10.1200/JCO.2012.45.3605; Mick R, 2000, CONTROL CLIN TRIALS, V21, P343, DOI 10.1016/S0197-2456(00)00058-1; Miller V.A., 2013, J CLIN ONCOL, V31, P11020, DOI [10.1200/jco.2013.31.15_suppl.11020, DOI 10.1200/JCO.2013.31.15_SUPPL.11020]; Misale S, 2012, NATURE, V486, P532, DOI 10.1038/nature11156; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Murtaza M, 2013, NATURE, V497, P108, DOI 10.1038/nature12065; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Newburger DE, 2013, GENOME RES, V23, P1097, DOI 10.1101/gr.151670.112; Niikura N, 2012, J CLIN ONCOL, V30, P593, DOI 10.1200/JCO.2010.33.8889; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Papillon-Cavanagh S, 2013, J AM MED INFORM ASSN, V20, P597, DOI 10.1136/amiajnl-2012-001442; Park S, 2009, J THORAC ONCOL, V4, P809, DOI 10.1097/JTO.0b013e3181a94af4; Perez K, 2013, EXP MOL PATHOL, V95, P74, DOI 10.1016/j.yexmp.2013.01.004; Rodon J, 2012, NAT REV CLIN ONCOL, V9, P359, DOI 10.1038/nrclinonc.2012.48; Rollins B., 2013, J CLIN ONCOL, V31, P1531; Rye IH, 2012, CANCER RES, V72, DOI 10.1158/0008-5472.SABCS12-P3-05-04; Sakurada A, 2008, J THORAC ONCOL, V3, P527, DOI 10.1097/JTO.0b013e318168be93; Schmid K, 2009, CLIN CANCER RES, V15, P4554, DOI 10.1158/1078-0432.CCR-09-0089; Schwarzenbach H, 2011, NAT REV CANCER, V11, P426, DOI 10.1038/nrc3066; Sequist LV, 2011, ANN ONCOL, V22, P2616, DOI 10.1093/annonc/mdr489; Shah SP, 2012, NATURE, V486, P395, DOI 10.1038/nature10933; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Sleijfer S, 2013, J CLIN ONCOL, V31, P1834, DOI 10.1200/JCO.2012.45.3639; Starczynski J, 2012, AM J CLIN PATHOL, V137, P595, DOI 10.1309/AJCPATBZ2JFN1QQC; Swanton C, 2012, CANCER RES, V72, P4875, DOI 10.1158/0008-5472.CAN-12-2217; Taniguchi K, 2008, CANCER SCI, V99, P929, DOI 10.1111/j.1349-7006.2008.00782.x; Tao Y, 2011, P NATL ACAD SCI USA, V108, P12042, DOI 10.1073/pnas.1108715108; Tapia C, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1676; Thompson AM, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2771; Tolmachev V, 2010, LANCET ONCOL, V11, P992, DOI 10.1016/S1470-2045(10)70088-7; Tougeron D, 2013, ANN ONCOL, V24, P1267, DOI 10.1093/annonc/mds620; Tran B, 2013, INT J CANCER, V132, P1547, DOI 10.1002/ijc.27817; Tran B, 2012, J CLIN ONCOL, V30, P647, DOI 10.1200/JCO.2011.39.2316; Tsimberidou AM, 2012, CLIN CANCER RES, V18, P6373, DOI 10.1158/1078-0432.CCR-12-1627; Turner NC, 2012, LANCET ONCOL, V13, pE178, DOI 10.1016/S1470-2045(11)70335-7; Vakiani E, 2012, J CLIN ONCOL, V30, P2956, DOI 10.1200/JCO.2011.38.2994; Vanderbilt-Ingram Cancer Center, 2011, PERS CANC THER VAND; Voest E., 2012, DELIVERING STRATIFIE; Wagle N, 2012, CANCER DISCOV, V2, P82, DOI 10.1158/2159-8290.CD-11-0184; Walker I, 2013, J CLIN ONCOL, V31; Walter MJ, 2012, NEW ENGL J MED, V366, P1090, DOI 10.1056/NEJMoa1106968; Weller M, 2010, NAT REV NEUROL, V6, P39, DOI 10.1038/nrneurol.2009.197; Williams P., 2013, REQUEST INFORM RFI E; Wilmott JS, 2012, MOL CANCER THER, V11, P2704, DOI 10.1158/1535-7163.MCT-12-0530; Wu X, 2012, NATURE, V482, P529, DOI 10.1038/nature10825; Xu X, 2012, CELL, V148, P886, DOI 10.1016/j.cell.2012.02.025; Xu XH, 2012, J CLIN ONCOL, V30; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515; Yancovitz M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029336; Yoon HH, 2012, J CLIN ONCOL, V30, P3932, DOI 10.1200/JCO.2012.43.1890	122	781	804	12	265	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 19	2013	501	7467					355	364		10.1038/nature12627	http://dx.doi.org/10.1038/nature12627			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219XT	24048068	Green Accepted			2022-12-28	WOS:000324545700034
J	Blackberry, ID; Furler, JS; Best, JD; Chondros, P; Vale, M; Walker, C; Dunning, T; Segal, L; Dunbar, J; Audehm, R; Liew, D; Young, D				Blackberry, Irene D.; Furler, John S.; Best, James D.; Chondros, Patty; Vale, Margarite; Walker, Christine; Dunning, Trisha; Segal, Leonie; Dunbar, James; Audehm, Ralph; Liew, Danny; Young, Doris			Effectiveness of general practice based, practice nurse led telephone coaching on glycaemic control of type 2 diabetes: the Patient Engagement And Coaching for Health (PEACH) pragmatic cluster randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CORONARY-HEART-DISEASE; SELF-MANAGEMENT; POSITION STATEMENT; CLINICAL-TRIAL; LIFE-STYLE; INTERVENTION; CARE; PEOPLE; HYPERTENSION; CHOLESTEROL	Objective To evaluate the effectiveness of goal focused telephone coaching by practice nurses in improving glycaemic control in patients with type 2 diabetes in Australia. Design Prospective, cluster randomised controlled trial, with general practices as the unit of randomisation. Setting General practices in Victoria, Australia. Participants 59 of 69 general practices that agreed to participate recruited sufficient patients and were randomised. Of 829 patients with type 2 diabetes (glycated haemoglobin (HbA(1c)) >7.5% in the past 12 months) who were assessed for eligibility, 473 (236 from 30 intervention practices and 237 from 29 control practices) agreed to participate. Intervention Practice nurses from intervention practices received two days of training in a telephone coaching programme, which aimed to deliver eight telephone and one face to face coaching episodes per patient. Main outcome measures The primary end point was mean absolute change in HbA(1c) between baseline and 18 months in the intervention group compared with the control group. Results The intervention and control patients were similar at baseline. None of the practices dropped out over the study period; however, patient attrition rates were 5% in each group (11/236 and 11/237 in the intervention and control group, respectively). The median number of coaching sessions received by the 236 intervention patients was 3 (interquartile range 1-5), of which 25% (58/236) did not receive any coaching sessions. At 18 months' follow-up the effect on glycaemic control did not differ significantly (mean difference 0.02, 95% confidence interval -0.20 to 0.24, P=0.84) between the intervention and control groups, adjusted for HbA(1c) measured at baseline and the clustering. Other biochemical and clinical outcomes were similar in both groups. Conclusions A practice nurse led telephone coaching intervention implemented in the real world primary care setting produced comparable outcomes to usual primary care in Australia. The addition of a goal focused coaching role onto the ongoing generalist role of a practice nurse without prescribing rights was found to be ineffective.	[Blackberry, Irene D.; Furler, John S.; Chondros, Patty; Young, Doris] Univ Melbourne, Gen Practice & Primary Hlth Care Acad Ctr, Melbourne, Vic 3053, Australia; [Best, James D.] Univ Melbourne, Melbourne Med Sch, Parkville, Vic 3052, Australia; [Vale, Margarite] Univ Melbourne, Dept Med, St Vincents Hosp, Fitzroy, Vic 3065, Australia; [Walker, Christine] Chron Illness Alliance, Surry Hills, Vic, Australia; [Dunning, Trisha] Deakin Univ, Sch Nursing & Midwifery, Geelong, Vic 3217, Australia; [Dunning, Trisha] Barwon Hlth, Geelong, Vic, Australia; [Segal, Leonie] Univ S Australia, Sch Populat Hlth Div Hlth Sci, North Terrace, SA, Australia; [Dunbar, James] Flinders Univ S Australia, Univ Dept Rural Hlth, Warrnambool, Vic, Australia; [Dunbar, James] Deakin Univ, Warrnambool, Vic, Australia; [Audehm, Ralph] Dianella Community Hlth, Broadmeadows, Vic, Australia; [Liew, Danny] Univ Melbourne, Royal Melbourne Hosp, Melbourne EpiCtr, Parkville, Vic, Australia	University of Melbourne; University of Melbourne; St Vincent's Hospital Melbourne; University of Melbourne; Deakin University; University of South Australia; Flinders University South Australia; Deakin University; Royal Melbourne Hospital; University of Melbourne	Blackberry, ID (corresponding author), Univ Melbourne, Gen Practice & Primary Hlth Care Acad Ctr, 200 Berkeley St, Melbourne, Vic 3053, Australia.	i.blackberry@unimelb.edu.au	Chondros, Patty/AAT-6426-2020; Audehm, Ralph/AAE-9543-2020; Segal, Leonie/B-2357-2009; Furler, John S/A-7858-2010	Audehm, Ralph/0000-0001-9136-8772; Segal, Leonie/0000-0002-6391-6791; Furler, John S/0000-0003-0339-5848; Blackberry, Irene/0000-0003-4482-4936; Best, James/0000-0002-5239-9274; Chondros, Patty/0000-0003-0393-8734; Liew, Danny/0000-0002-0131-623X	Australian National Health and Medical Research Council [359374, 566586]	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This study was supported by the Australian National Health and Medical Research Council (ID 359374 and 566586). The funder was not involved in the study design, data collection, analysis, and interpretation.	Aujoulat I, 2007, PATIENT EDUC COUNS, V66, P13, DOI 10.1016/j.pec.2006.09.008; Aylen T, 2006, EUR DIABETES NURSING, V3, P28; Bailey CJ, 2011, INT J CLIN PRACT, V65, P314, DOI 10.1111/j.1742-1241.2010.02544.x; Balkau B, 2012, DIABETES METAB, V38, pS29, DOI 10.1016/S1262-3636(12)71532-X; Barrera M, 2002, AM J COMMUN PSYCHOL, V30, P637, DOI 10.1023/A:1016369114780; Blackberry ID, 2009, MED J AUSTRALIA, V191, P492, DOI 10.5694/j.1326-5377.2009.tb02911.x; Campbell MK, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5661; Chatterjee R, 2011, CURR DIABETES REV, V7, P406, DOI 10.2174/157339911797579197; Crowley MJ, 2013, AM HEART J, V166, P179, DOI 10.1016/j.ahj.2013.04.004; DeGuzman PB, 2012, DIABETES VASC DIS RE, V9, P138, DOI 10.1177/1479164111431471; Dennis SM, 2013, AUST HEALTH REV, V37, P381, DOI 10.1071/AH13005; Department of Health and Ageing, 2007, PRACT NURS AUSTR NUR; Fischer HH, 2012, AM J MANAG CARE, V18, P77; Frosch DL, 2011, ARCH INTERN MED, V171, P2011, DOI 10.1001/archinternmed.2011.497; Funnell MM, 2012, DIABETES CARE, V35, pS101, DOI 10.2337/dc12-s101; Furler J, 2008, BMC HEALTH SERV RES, V8, P214; Gaede P, 2008, NEW ENGL J MED, V358, P580, DOI 10.1056/NEJMoa0706245; GOLDSTEIN DE, 1987, CLIN CHEM, V33, P2267; Gonzales R, 2011, ARCH INTERN MED, V171, P1999, DOI 10.1001/archinternmed.2011.496; Goode AD, 2011, AM J HEALTH PROMOT, V25, P257, DOI 10.4278/ajhp.090223-QUAN-75; Halcomb Elizabeth, 2004, Eur J Cardiovasc Nurs, V3, P135, DOI 10.1016/j.ejcnurse.2004.02.002; Halcomb EJ, 2008, J CLIN NURS, V17, P6, DOI 10.1111/j.1365-2702.2007.02141.x; Halcomb EJ, 2006, J ADV NURS, V55, P376, DOI 10.1111/j.1365-2648.2006.03908_1.x; Hodge A, 2000, AUST NZ J PUBL HEAL, V24, P576, DOI 10.1111/j.1467-842X.2000.tb00520.x; Hordacre A, 2007, MOVING AHEAD; Hu FB, 2011, DIABETES CARE, V34, P1249, DOI 10.2337/dc11-0442; Hutchison AJ, 2011, J TELEMED TELECARE, V17, P451, DOI 10.1258/jtt.2011.110513; Inzucchi SE, 2012, DIABETOLOGIA, V55, P1577, DOI 10.1007/s00125-012-2534-0; Jansink R, 2013, SCAND J PRIM HEALTH, V31, P119, DOI 10.3109/02813432.2013.797178; Johnson DW, 2012, MED J AUSTRALIA, V197, P224, DOI 10.5694/mja11.11468; Jordan RE, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-707; Keleher H, 2007, MED J AUSTRALIA, V187, P108, DOI 10.5694/j.1326-5377.2007.tb01153.x; Knight AW, 2012, BMJ QUAL SAF, V18, P18; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Naik AD, 2012, BMC GERIATR, V12, DOI 10.1186/1471-2318-12-37; Parker RM, 2009, BMC NURS, V8, DOI 10.1186/1472-6955-8-5; Quinn CC, 2011, DIABETES CARE, V34, P1934, DOI 10.2337/dc11-0366; Rapley Pat, 2003, Nurs Health Sci, V5, P289, DOI 10.1046/j.1442-2018.2003.00162.x; Richardson J, 2004, AUST ECON REV, V37, P62, DOI DOI 10.1111/j.1467-8462.2004.00308.x; Rudd C, 2005, GEN PRACTICE AUSTR 2, P358; Sacco WP, 2009, J BEHAV MED, V32, P349, DOI 10.1007/s10865-009-9209-4; Shojania KG, 2006, JAMA-J AM MED ASSOC, V296, P427, DOI 10.1001/jama.296.4.427; Spencer MS, 2011, AM J PUBLIC HEALTH, V101, P2253, DOI 10.2105/AJPH.2010.300106; Stone RA, 2010, DIABETES CARE, V33, P478, DOI 10.2337/dc09-1012; Thom DH, 2013, ANN FAM MED, V11, P137, DOI 10.1370/afm.1443; Vale MJ, 2003, ARCH INTERN MED, V163, P2775, DOI 10.1001/archinte.163.22.2775; Vale MJ, 2002, J CLIN EPIDEMIOL, V55, P245, DOI 10.1016/S0895-4356(01)00460-7; van der Wulp I, 2012, DIABETIC MED, V29, pe390, DOI 10.1111/j.1464-5491.2012.03629.x; Walker C, 2011, J NURS HEALTHC CHRON, V4, P419; Walker C, 2011, J NURS HEALTHCARE CH, V3, P419; Wertz Debra, 2012, Manag Care, V21, P44; Wolever RQ, 2010, DIABETES EDUCATOR, V36, P629, DOI 10.1177/0145721710371523; Young D, 2007, BMC FAM PRACT, V8, DOI 10.1186/1471-2296-8-20; Zafar A, 2010, PRIM CARE DIABETES, V4, P203, DOI 10.1016/j.pcd.2010.07.003; Zhang YR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042551; Zwarenstein M, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2390	56	67	67	0	23	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 18	2013	347								f5272	10.1136/bmj.f5272	http://dx.doi.org/10.1136/bmj.f5272			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	223SM	24048296	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000324829800004
J	Wang, C; Chang, WC; Guo, YS; Huang, H; Peck, SC; Pandelia, ME; Lin, GM; Liu, HW; Krebs, C; Bollinger, JM				Wang, Chen; Chang, Wei-chen; Guo, Yisong; Huang, Hui; Peck, Spencer C.; Pandelia, Maria E.; Lin, Geng-min; Liu, Hung-wen; Krebs, Carsten; Bollinger, J. Martin, Jr.			Evidence that the Fosfomycin-Producing Epoxidase, HppE, Is a Non-Heme-Iron Peroxidase	SCIENCE			English	Article							ISOPENICILLIN-N-SYNTHASE; KETOGLUTARATE DIOXYGENASE TAUD; SPIN FE(IV) COMPLEX; ANTIBIOTIC FOSFOMYCIN; OXYGEN-ACTIVATION; ESCHERICHIA-COLI; PSEUDOMONAS-SYRINGAE; ALIPHATIC HALOGENASE; ELECTRONIC-STRUCTURE; CATALYTIC MECHANISM	The iron-dependent epoxidase HppE converts (S)-2-hydroxypropyl-1-phosphonate (S-HPP) to the antibiotic fosfomycin [(1R,2S)-epoxypropylphosphonate] in an unusual 1,3-dehydrogenation of a secondary alcohol to an epoxide. HppE has been classified as an oxidase, with proposed mechanisms differing primarily in the identity of the O-2-derived iron complex that abstracts hydrogen (H center dot) from C1 of S-HPP to initiate epoxide ring closure. We show here that the preferred cosubstrate is actually H2O2 and that HppE therefore almost certainly uses an iron(IV)-oxo complex as the H center dot abstractor. Reaction with H2O2 is accelerated by bound substrate and produces fosfomycin catalytically with a stoichiometry of unity. The ability of catalase to suppress the HppE activity previously attributed to its direct utilization of O-2 implies that reduction of O-2 and utilization of the resultant H2O2 were actually operant.	[Wang, Chen; Krebs, Carsten; Bollinger, J. Martin, Jr.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Chang, Wei-chen; Guo, Yisong; Pandelia, Maria E.; Krebs, Carsten; Bollinger, J. Martin, Jr.] Penn State Univ, Dept Chem, University Pk, PA 16802 USA; [Huang, Hui; Lin, Geng-min; Liu, Hung-wen] Univ Texas Austin, Coll Pharm, Div Med Chem, Austin, TX 78712 USA; [Huang, Hui; Lin, Geng-min; Liu, Hung-wen] Univ Texas Austin, Dept Chem & Biochem, Austin, TX 78712 USA; [Peck, Spencer C.] Univ Illinois, Dept Chem, Urbana, IL USA; [Peck, Spencer C.] Univ Illinois, Howard Hughes Med Inst, Urbana, IL USA; [Peck, Spencer C.] Univ Illinois, Inst Genom Biol, Urbana, IL USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Illinois System; University of Illinois Urbana-Champaign; Howard Hughes Medical Institute; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Liu, HW (corresponding author), Univ Texas Austin, Coll Pharm, Div Med Chem, Austin, TX 78712 USA.	h.w.liu@mail.utexas.edu; ckrebs@psu.edu; jmb21@psu.edu	Bollinger, Joseph/C-1425-2016; Guo, Yisong/C-7785-2009; Krebs, Carsten/D-4773-2009	Guo, Yisong/0000-0002-4132-3565; Krebs, Carsten/0000-0002-3302-7053; Lin, Geng-Min/0000-0001-8123-0921; Peck, Spencer/0000-0002-1599-6635; CHANG, WEI-CHEN/0000-0002-2341-9846	NIH [GM 040541, GM 069657]; Welch Foundation [F-1511]; NSF [MCB-0642058]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069657, R01GM040541] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the NIH (GM 040541 to H.-w.L. and GM 069657 to C.K. and J.M.B.), the Welch Foundation (F-1511 to H.-w.L.), and the NSF (MCB-0642058 to C.K. and J.M.B.). We thank M. T. Green for helpful discussions.	Bollinger JM, 2006, J INORG BIOCHEM, V100, P586, DOI 10.1016/j.jinorgbio.2006.01.022; Borowski T, 2010, J AM CHEM SOC, V132, P12887, DOI 10.1021/ja101877a; Broadwater JA, 1999, BIOCHEMISTRY-US, V38, P12197, DOI 10.1021/bi9914199; Brown CD, 2007, J AM CHEM SOC, V129, P7427, DOI 10.1021/ja071364v; Chang WC, 2013, NATURE, V496, P114, DOI 10.1038/nature11998; Christian GJ, 2012, CHEM SCI, V3, P1600, DOI 10.1039/c2sc00754a; Cicchillo RM, 2009, NATURE, V459, P871, DOI 10.1038/nature07972; Dassama LMK, 2012, BIOCHEMISTRY-US, V51, P1607, DOI 10.1021/bi201906x; De Faveri G, 2011, CHEM SOC REV, V40, P1722, DOI 10.1039/c0cs00077a; Fujimori DG, 2007, J AM CHEM SOC, V129, P13408, DOI 10.1021/ja076454e; Galonic DP, 2007, NAT CHEM BIOL, V3, P113, DOI 10.1038/nchembio856; HAMMERSCHMIDT F, 1991, J CHEM SOC PERK T 1, P1993, DOI 10.1039/p19910001993; HANAUSKEABEL HM, 1982, J THEOR BIOL, V94, P421, DOI 10.1016/0022-5193(82)90320-4; HIDAKA T, 1995, MOL GEN GENET, V249, P274, DOI 10.1007/BF00290527; Higgins LJ, 2005, NATURE, V437, P838, DOI 10.1038/nature03924; Hirao H, 2011, INORG CHEM, V50, P6637, DOI 10.1021/ic200522r; Hoffart LM, 2006, P NATL ACAD SCI USA, V103, P14738, DOI 10.1073/pnas.0604005103; Kim DH, 1996, BIOCHEMISTRY-US, V35, P4923, DOI 10.1021/bi952937w; Kim SY, 2012, ANTIMICROB AGENTS CH, V56, P4175, DOI 10.1128/AAC.06478-11; Krebs C, 2007, ACCOUNTS CHEM RES, V40, P484, DOI 10.1021/ar700066p; Krebs C, 2013, COORDIN CHEM REV, V257, P234, DOI 10.1016/j.ccr.2012.06.020; Lehnert N, 2002, J AM CHEM SOC, V124, P10810, DOI 10.1021/ja012621d; Li FF, 2010, J AM CHEM SOC, V132, P2134, DOI 10.1021/ja9101908; Liu PH, 2001, J AM CHEM SOC, V123, P4619, DOI 10.1021/ja004153y; Lundberg M, 2008, BIOCHEMISTRY-US, V47, P1031, DOI 10.1021/bi701577q; MARQUARDT JL, 1994, BIOCHEMISTRY-US, V33, P10646, DOI 10.1021/bi00201a011; MASSEY V, 1994, J BIOL CHEM, V269, P22459; Matthews ML, 2009, P NATL ACAD SCI USA, V106, P17723, DOI 10.1073/pnas.0909649106; Matthews ML, 2009, BIOCHEMISTRY-US, V48, P4331, DOI 10.1021/bi900109z; Mbughuni MM, 2010, P NATL ACAD SCI USA, V107, P16788, DOI 10.1073/pnas.1010015107; Milaczewska A, 2013, CHEM-EUR J, V19, P770, DOI 10.1002/chem.201202825; Miller EW, 2007, NAT CHEM BIOL, V3, P263, DOI 10.1038/nchembio871; MILLER VP, 1993, BIOCHEMISTRY-US, V32, P11934, DOI 10.1021/bi00095a025; MORELLO JA, 1964, J APPL PHYSIOL, V19, P522, DOI 10.1152/jappl.1964.19.3.522; Munos JW, 2008, BIOCHEMISTRY-US, V47, P8726, DOI 10.1021/bi800877v; Price JC, 2003, BIOCHEMISTRY-US, V42, P7497, DOI 10.1021/bi030011f; Price JC, 2005, BIOCHEMISTRY-US, V44, P8138, DOI 10.1021/bi050227c; Roach PL, 1997, NATURE, V387, P827, DOI 10.1038/42990; Solomon EI, 2000, CHEM REV, V100, P235, DOI 10.1021/cr9900275; Switala J, 2002, ARCH BIOCHEM BIOPHYS, V401, P145, DOI 10.1016/S0003-9861(02)00049-8; Tarasev M, 2004, BIOCHEMISTRY-US, V43, P12799, DOI 10.1021/bi0490587; Thibodeaux CJ, 2012, CHEM REV, V112, P1681, DOI 10.1021/cr200073d; van der Donk WA, 2010, CURR OPIN STRUC BIOL, V20, P673, DOI 10.1016/j.sbi.2010.08.005; Veal EA, 2007, MOL CELL, V26, P1, DOI 10.1016/j.molcel.2007.03.016; Whitteck JT, 2009, J AM CHEM SOC, V131, P16225, DOI 10.1021/ja906238r; Yan F, 2006, BIOCHEMISTRY-US, V45, P11473, DOI 10.1021/bi060839c; Ye SF, 2012, CHEM-EUR J, V18, P6555, DOI 10.1002/chem.201102829; Yun D, 2011, J AM CHEM SOC, V133, P11262, DOI 10.1021/ja2025728; Zhao ZB, 2002, ANGEW CHEM INT EDIT, V41, P4529, DOI 10.1002/1521-3773(20021202)41:23<4529::AID-ANIE4529>3.0.CO;2-2	49	56	57	0	77	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 22	2013	342	6161					991	995		10.1126/science.1240373	http://dx.doi.org/10.1126/science.1240373			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EZ	24114783	Green Accepted			2022-12-28	WOS:000327223500046
J	Di Ruscio, A; Ebralidze, AK; Benoukraf, T; Amabile, G; Goff, LA; Terragni, J; Figueroa, ME; Pontes, LLD; Alberich-Jorda, M; Zhang, P; Wu, MC; D'Alo, F; Melnick, A; Leone, G; Ebralidze, KK; Pradhan, S; Rinn, JL; Tenen, DG				Di Ruscio, Annalisa; Ebralidze, Alexander K.; Benoukraf, Touati; Amabile, Giovanni; Goff, Loyal A.; Terragni, Jolyon; Figueroa, Maria Eugenia; Pontes, Lorena Lobo De Figueiredo; Alberich-Jorda, Meritxell; Zhang, Pu; Wu, Mengchu; D'Alo, Francesco; Melnick, Ari; Leone, Giuseppe; Ebralidze, Konstantin K.; Pradhan, Sriharsa; Rinn, John L.; Tenen, Daniel G.			DNMT1-interacting RNAs block gene-specific DNA methylation	NATURE			English	Article							GENOME-WIDE IDENTIFICATION; TRANSCRIPTION FACTORS; EXPRESSION; MAINTENANCE; POLYMERASE; METHYLTRANSFERASE; CHROMATIN; REVEALS; CANCER; SITES	DNA methylation was first described almost a century ago; however, the rules governing its establishment and maintenance remain elusive. Here we present data demonstrating that active transcription regulates levels of genomic methylation. We identify a novel RNA arising from the CEBPA gene locus that is critical in regulating the local DNA methylation profile. This RNA binds to DNMT1 and prevents CEBPA gene locus methylation. Deep sequencing of transcripts associated with DNMT1 combined with genome-scale methylation and expression profiling extend the generality of this finding to numerous gene loci. Collectively, these results delineate the nature of DNMT1-RNA interactions and suggest strategies for gene-selective demethylation of therapeutic targets in human diseases.	[Di Ruscio, Annalisa; Ebralidze, Alexander K.; Amabile, Giovanni; Pontes, Lorena Lobo De Figueiredo; Alberich-Jorda, Meritxell; Zhang, Pu; Rinn, John L.; Tenen, Daniel G.] Harvard Univ, Sch Med, Harvard Stem Cell Inst, Boston, MA 02115 USA; [Di Ruscio, Annalisa; Ebralidze, Alexander K.; Amabile, Giovanni; Pontes, Lorena Lobo De Figueiredo; Alberich-Jorda, Meritxell; Ebralidze, Konstantin K.; Rinn, John L.] Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA; [D'Alo, Francesco; Leone, Giuseppe] Univ Cattolica Sacro Cuore, Inst Hematol, I-00168 Rome, Italy; [Benoukraf, Touati; Wu, Mengchu; Tenen, Daniel G.] Natl Univ Singapore, Canc Sci Inst, Singapore 117599, Singapore; [Goff, Loyal A.; Rinn, John L.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Goff, Loyal A.; Rinn, John L.] Broad Inst MIT & Harvard, Cambridge Ctr 7, Cambridge, MA 02142 USA; [Goff, Loyal A.] MIT, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA; [Terragni, Jolyon; Pradhan, Sriharsa] New England Biolabs Inc, Ipswich, MA 01938 USA; [Figueroa, Maria Eugenia] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Alberich-Jorda, Meritxell] Acad Sci Czech Republ, Inst Mol Genet, CR-14220 Prague, Czech Republic; [Melnick, Ari] C620 Weill Cornell Med Coll, Dept Med, New York, NY 10021 USA	Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; National University of Singapore; Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); New England Biolabs; University of Michigan System; University of Michigan; Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences	Tenen, DG (corresponding author), Harvard Univ, Sch Med, Harvard Stem Cell Inst, Boston, MA 02115 USA.	daniel.tenen@nus.edu.sg	de Figueiredo Pontes, Lorena Lobo/GPC-6003-2022; Figueiredo-Pontes, Lorena L/K-6520-2013; Melnick, Ari/AAA-5763-2020; Figueroa, Maria/AAE-8662-2019; Benoukraf, Touati/K-9978-2019; Jorda, Meritxell Alberich/G-3137-2014; Giuseppe Leone, Full Professor/I-9166-2019	de Figueiredo Pontes, Lorena Lobo/0000-0002-2139-5756; Figueiredo-Pontes, Lorena L/0000-0002-2139-5756; Benoukraf, Touati/0000-0002-4789-8028; Jorda, Meritxell Alberich/0000-0002-8093-641X; Giuseppe Leone, Full Professor/0000-0002-7812-5300; Tenen, Daniel/0000-0002-6423-3888; Goff, Loyal/0000-0003-2875-451X; Di Ruscio, Annalisa/0000-0002-9705-4245; Figueroa, Maria Eugenia/0000-0003-4887-4981; Rinn, John/0000-0002-7231-7539	National Institutes of Health (NIH) [CA118316, CA66996, HL56745, T32 HL007917-11A1]; Italian Foundation for Cancer Research (FIRC); Societa Italiana di Ematologia Sperimentale (SIES); FAMRI CIA [103063]; Fondazione Roma; American Italian Cancer Foundation Fellowship (AICF); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2011/11822-6]; National Research Foundation; Singapore Ministry of Education under its Centres of Excellence initiative; MSMT Navrat grant [LK21307]; New England Biolabs; Singapore Ministry of Health's National Medical Research Council under its Singapore Translational Research (STaR) Investigator Award; NATIONAL CANCER INSTITUTE [P01CA066996, R01CA118316] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056745, R01HL112719, T32HL007917] Funding Source: NIH RePORTER; Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Italian Foundation for Cancer Research (FIRC)(Fondazione AIRC per la ricerca sul cancro); Societa Italiana di Ematologia Sperimentale (SIES); FAMRI CIA; Fondazione Roma(Fondazione RomaEuropean Commission); American Italian Cancer Foundation Fellowship (AICF); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Research Foundation; Singapore Ministry of Education under its Centres of Excellence initiative(Ministry of Education, Singapore); MSMT Navrat grant; New England Biolabs; Singapore Ministry of Health's National Medical Research Council under its Singapore Translational Research (STaR) Investigator Award(Ministry of Health-SingaporeNational Medical Research Council, Singapore); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)	This work was supported by grants CA118316, CA66996 and HL56745 from the National Institutes of Health (NIH) to D.G.T., the Italian Foundation for Cancer Research (FIRC) 'Leonino Fontana e Maria Lionello' fellowship, the NIH T32 HL007917-11A1 and the Societa Italiana di Ematologia Sperimentale (SIES) 'Dr. Tito Bastianello' fellowship to A.D.R.; FAMRI CIA (103063) grant to A.K.E.; Fondazione Roma 'Progetto cellule staminali' to G.L. and F.D'A.; the American Italian Cancer Foundation Fellowship (AICF) to G.A.; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)-grant no. 2011/11822-6-to L.L.D.F.P.; the National Research Foundation and the Singapore Ministry of Education under its Centres of Excellence initiative to M.W. and T.B.; the MSMT Navrat grant LK21307 to M.A.-J. S.P. and J.T. were supported by New England Biolabs. We thank R. White, D. Johnson, M. Frank-Kamenetskii, S. M. Mirkin, D. Gautheret, B. Tazon-Vega, C. Bonifer, C. Bock, M. T. Voso, J. J. Dunn (deceased) and R. A. M. Fouchier for helpful advice and reagents; I. Rigoutsos for providing the latest released pyknons database; all the members of the Tenen Laboratory; P. Tan and T. S. Ting from the Genome Institute of Singapore; R. Soong from the Cancer Science Institute Translational Interface; J. LaVecchio and G. Buruzula from the Harvard Stem Cell Institute/Joslin Diabetes Center flow cytometry facility; and F. Hyde from Epicentre-Illumina. This research is supported by the Singapore Ministry of Health's National Medical Research Council under its Singapore Translational Research (STaR) Investigator Award (D.G.T.).	Akalin A, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-10-R87, 10.1186/gb-2012-13-10-r87]; Benoukraf T, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1281; BLOBEL G, 1966, SCIENCE, V154, P1662, DOI 10.1126/science.154.3757.1662; Bock C, 2005, BIOINFORMATICS, V21, P4067, DOI 10.1093/bioinformatics/bti652; Bock C, 2010, NAT BIOTECHNOL, V28, P1106, DOI 10.1038/nbt.1681; BOLDEN A, 1984, J BIOL CHEM, V259, P2437; BOLDEN AH, 1986, MOL CELL BIOL, V6, P1135, DOI 10.1128/MCB.6.4.1135; Christman JK, 2002, ONCOGENE, V21, P5483, DOI 10.1038/sj.onc.1205699; Dieci G, 2007, TRENDS GENET, V23, P614, DOI 10.1016/j.tig.2007.09.001; DUNN JJ, 1988, GENE, V68, P259, DOI 10.1016/0378-1119(88)90028-5; Ebisuya M, 2008, NAT CELL BIOL, V10, P1106, DOI 10.1038/ncb1771; Ebralidze A, 2004, SCIENCE, V303, P383, DOI 10.1126/science.1088679; Ebralidze AK, 2008, GENE DEV, V22, P2085, DOI 10.1101/gad.1654808; Esteve PO, 2006, GENE DEV, V20, P3089, DOI 10.1101/gad.1463706; Figueroa ME, 2010, CANCER CELL, V17, P13, DOI 10.1016/j.ccr.2009.11.020; FRANKKAMENETSKII MD, 1995, ANNU REV BIOCHEM, V64, P65, DOI 10.1146/annurev.bi.64.070195.000433; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; FUERST TR, 1986, P NATL ACAD SCI USA, V83, P8122, DOI 10.1073/pnas.83.21.8122; GILL G, 1988, NATURE, V334, P721, DOI 10.1038/334721a0; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Guttman M, 2012, NATURE, V482, P339, DOI 10.1038/nature10887; Hackanson B, 2008, CANCER RES, V68, P3142, DOI 10.1158/0008-5472.CAN-08-0483; Harrow J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s4; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Huarte M, 2010, CELL, V142, P409, DOI 10.1016/j.cell.2010.06.040; Illingworth RS, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001134; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Jothi R, 2008, NUCLEIC ACIDS RES, V36, P5221, DOI 10.1093/nar/gkn488; Karreth FA, 2011, CELL, V147, P382, DOI 10.1016/j.cell.2011.09.032; Keene JD, 2007, NAT REV GENET, V8, P533, DOI 10.1038/nrg2111; LEONHARDT H, 1992, CELL, V71, P865, DOI 10.1016/0092-8674(92)90561-P; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Listerman I, 2007, PLOS GENET, V3, P2268, DOI 10.1371/journal.pgen.0030212; Maniatis T., 1982, MOL CLONING; Meissner A, 2005, NUCLEIC ACIDS RES, V33, P5868, DOI 10.1093/nar/gki901; Mitchell JA, 2008, GENE DEV, V22, P20, DOI 10.1101/gad.454008; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nagano T, 2008, SCIENCE, V322, P1717, DOI 10.1126/science.1163802; Oler AJ, 2010, NAT STRUCT MOL BIOL, V17, P620, DOI 10.1038/nsmb.1801; Pagano A, 2007, PLOS GENET, V3, P174, DOI 10.1371/journal.pgen.0030001; Poliseno L, 2010, NATURE, V465, P1033, DOI 10.1038/nature09144; Pradhan S, 2003, BIOCHEMISTRY-US, V42, P5321, DOI 10.1021/bi034160+; Preker P, 2008, SCIENCE, V322, P1851, DOI 10.1126/science.1164096; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Raha D, 2010, P NATL ACAD SCI USA, V107, P3639, DOI 10.1073/pnas.0911315106; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Robertson KD, 2001, ONCOGENE, V20, P3139, DOI 10.1038/sj.onc.1204341; Sambrook J., 2001, MOL CLONING LAB MANU; Saxonov S, 2006, P NATL ACAD SCI USA, V103, P1412, DOI 10.1073/pnas.0510310103; Shin HJ, 2009, BIOINFORMATICS, V25, P2605, DOI 10.1093/bioinformatics/btp479; Smith ZD, 2009, METHODS, V48, P226, DOI 10.1016/j.ymeth.2009.05.003; Song JK, 2011, SCIENCE, V331, P1036, DOI 10.1126/science.1195380; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Svedruzic ZM, 2008, CURR MED CHEM, V15, P92, DOI 10.2174/092986708783330700; Tada T, 2006, JNCI-J NATL CANCER I, V98, P396, DOI 10.1093/jnci/djj093; Tay Y, 2011, CELL, V147, P344, DOI 10.1016/j.cell.2011.09.029; Tenen DG, 2003, NAT REV CANCER, V3, P89, DOI 10.1038/nrc989; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tsirigos A, 2008, NUCLEIC ACIDS RES, V36, P3484, DOI 10.1093/nar/gkn155; Wouters BJ, 2007, BLOOD, V110, P3706, DOI 10.1182/blood-2007-02-073486; Xi YP, 2009, BMC BIOINFORMATICS, V10, DOI [10.1186/1471-2105-10-S1-S58, 10.1186/1471-2105-10-232]; Zhao J, 2010, MOL CELL, V40, P939, DOI 10.1016/j.molcel.2010.12.011	66	355	370	4	110	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 21	2013	503	7476					371	+		10.1038/nature12598	http://dx.doi.org/10.1038/nature12598			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KG	24107992	Green Accepted, Green Submitted			2022-12-28	WOS:000327163200035
J	Hnisz, D; Abraham, BJ; Lee, TI; Lau, A; Saint-Andre, V; Sigova, AA; Hoke, HA; Young, RA				Hnisz, Denes; Abraham, Brian J.; Lee, Tong Ihn; Lau, Ashley; Saint-Andre, Violaine; Sigova, Alla A.; Hoke, Heather A.; Young, Richard A.			Super-Enhancers in the Control of Cell Identity and Disease	CELL			English	Article							CHROMATIN REMODELING COMPLEX; MASTER TRANSCRIPTION FACTORS; GENE-EXPRESSION; GLOBIN GENE; PLURIPOTENCY; COMPONENT; MEDIATOR; CANCER; LOCI; RNAS	Super-enhancers are large clusters of transcriptional enhancers that drive expression of genes that define cell identity. Improved understanding of the roles that super-enhancers play in biology would be afforded by knowing the constellation of factors that constitute these domains and by identifying super-enhancers across the spectrum of human cell types. We describe here the population of transcription factors, cofactors, chromatin regulators, and transcription apparatus occupying super-enhancers in embryonic stem cells and evidence that super-enhancers are highly transcribed. We produce a catalog of super-enhancers in a broad range of human cell types and find that super-enhancers associate with genes that control and define the biology of these cells. Interestingly, disease-associated variation is especially enriched in the super-enhancers of disease-relevant cell types. Furthermore, we find that cancer cells generate super-enhancers at oncogenes and other genes important in tumor pathogenesis. Thus, super-enhancers play key roles in human cell identity in health and in disease.	[Hnisz, Denes; Abraham, Brian J.; Lee, Tong Ihn; Lau, Ashley; Saint-Andre, Violaine; Sigova, Alla A.; Hoke, Heather A.; Young, Richard A.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Lau, Ashley; Hoke, Heather A.; Young, Richard A.] MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	Young, RA (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	young@wi.mit.edu	Hnisz, Denes/AAE-9592-2019; Young, Richard A/F-6495-2012; Abraham, Brian/C-2230-2019; Saint-André, Violaine/AAQ-8488-2020	Hnisz, Denes/0000-0002-6256-1693; Young, Richard A/0000-0001-8855-8647; Abraham, Brian/0000-0001-8085-3027; 	National Institutes of Health [HG002668, CA109901, CA146445];  [P30AG10161];  [R01AG17917];  [R01AG36042];  [RC2AG36547]; NATIONAL CANCER INSTITUTE [R01CA146445, P01CA109901] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002668] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG010161, R01AG017917, R01AG036042, RC2AG036547] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank David Orlando and Charles Lin for bioinformatics support; Lee Lawton, Jamie Newman, Peter Rahl, and Warren Whyte for sharing data; Nancy Hannett for assistance with data acquisition; Tom Volkert, Jennifer Love, Sumeet Gupta, and Jeong-Ah Kwon at the Whitehead Genome Technologies Core for Solexa sequencing; and members of the Young lab for helpful discussions. We acknowledge the Genome Centers at the Broad Institute and the University of California and San Diego for ChIP-seq data sets produced in the framework of the ENCODE and NIH Roadmap Epigenome Projects and the Rush Alzheimer's Disease Center at Rush University Medical Center, Chicago (supported by P30AG10161, R01AG17917, R01AG36042, and RC2AG36547). This work was supported by the National Institutes of Health grants HG002668 (R.A.Y.), CA109901 (R.A.Y.) and CA146445 (R.A.Y. and T. I. L.). R.A.Y. is a founder of Syros Pharmaceuticals.	Ahmadiyeh N, 2010, P NATL ACAD SCI USA, V107, P9742, DOI 10.1073/pnas.0910668107; Bertram L, 2008, NAT REV NEUROSCI, V9, P768, DOI 10.1038/nrn2494; BISHOP JM, 1987, SCIENCE, V235, P305, DOI 10.1126/science.3541204; Bonifer C, 2000, TRENDS GENET, V16, P310, DOI 10.1016/S0168-9525(00)02029-1; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Bulger M, 2011, CELL, V144, P327, DOI 10.1016/j.cell.2011.01.024; Calo E, 2013, MOL CELL, V49, P825, DOI 10.1016/j.molcel.2013.01.038; Carey M, 1998, CELL, V92, P5, DOI 10.1016/S0092-8674(00)80893-4; Chapuis J, 2013, MOL PSYCHIATR, V18, P1225, DOI 10.1038/mp.2013.1; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Cherry ABC, 2012, CELL, V148, P1110, DOI 10.1016/j.cell.2012.02.031; Costa-Reis P, 2013, CURR RHEUMATOL REP, V15, DOI 10.1007/s11926-013-0369-4; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Deng Y, 2010, NAT REV RHEUMATOL, V6, P683, DOI 10.1038/nrrheum.2010.176; Denslow SA, 2007, ONCOGENE, V26, P5433, DOI 10.1038/sj.onc.1210611; Dowen JM, 2013, STEM CELL REP, V1, P371, DOI 10.1016/j.stemcr.2013.09.002; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Forbes SA, 2010, NUCLEIC ACIDS RES, V38, pD652, DOI 10.1093/nar/gkp995; FORRESTER WC, 1990, GENE DEV, V4, P1637, DOI 10.1101/gad.4.10.1637; Foster CT, 2010, MOL CELL BIOL, V30, P4851, DOI 10.1128/MCB.00521-10; Garraway LA, 2013, CELL, V153, P17, DOI 10.1016/j.cell.2013.03.002; Graf T, 2009, NATURE, V462, P587, DOI 10.1038/nature08533; Grossman SR, 2013, CELL, V152, P703, DOI 10.1016/j.cell.2013.01.035; GROSVELD F, 1987, CELL, V51, P975, DOI 10.1016/0092-8674(87)90584-8; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Ho L, 2009, P NATL ACAD SCI USA, V106, P5181, DOI 10.1073/pnas.0812889106; Ho LN, 2009, P NATL ACAD SCI USA, V106, P5187, DOI 10.1073/pnas.0812888106; Iwakawa R, 2013, GENE CHROMOSOME CANC, V52, P802, DOI 10.1002/gcc.22076; Jang MK, 2005, MOL CELL, V19, P523, DOI 10.1016/j.molcel.2005.06.027; Jiang YW, 1998, P NATL ACAD SCI USA, V95, P8538, DOI 10.1073/pnas.95.15.8538; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kaji K, 2006, NAT CELL BIOL, V8, P285, DOI 10.1038/ncb1372; Kaji K, 2007, DEVELOPMENT, V134, P1123, DOI 10.1242/dev.02802; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Lai F, 2013, NATURE, V494, P497, DOI 10.1038/nature11884; Lam MTY, 2013, NATURE, V498, P511, DOI 10.1038/nature12209; Lee TI, 2013, CELL, V152, P1237, DOI 10.1016/j.cell.2013.02.014; Lelli KM, 2012, ANNU REV GENET, V46, P43, DOI 10.1146/annurev-genet-110711-155437; Levine M, 2003, NATURE, V424, P147, DOI 10.1038/nature01763; Li WB, 2013, NATURE, V498, P516, DOI 10.1038/nature12210; Ling JH, 2004, J BIOL CHEM, V279, P51704, DOI 10.1074/jbc.M404039200; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Maston GA, 2006, ANNU REV GENOM HUM G, V7, P29, DOI 10.1146/annurev.genom.7.080505.115623; Merika M, 1998, MOL CELL, V1, P277, DOI 10.1016/S1097-2765(00)80028-3; Mousavi K, 2013, MOL CELL, V51, P606, DOI 10.1016/j.molcel.2013.07.022; Mullen AC, 2011, CELL, V147, P565, DOI 10.1016/j.cell.2011.08.050; Natoli G, 2012, ANNU REV GENET, V46, P1, DOI 10.1146/annurev-genet-110711-155459; Neph S, 2012, NATURE, V489, P83, DOI 10.1038/nature11212; Ng HH, 2011, NAT CELL BIOL, V13, P490, DOI 10.1038/ncb0511-490; Noble JA, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007732; Ong CT, 2011, NAT REV GENET, V12, P283, DOI 10.1038/nrg2957; Orom UA, 2010, CELL, V143, P46, DOI 10.1016/j.cell.2010.09.001; Panne D, 2008, CURR OPIN STRUC BIOL, V18, P236, DOI 10.1016/j.sbi.2007.12.002; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Reynolds N, 2012, CELL STEM CELL, V10, P583, DOI 10.1016/j.stem.2012.02.020; Reynolds N, 2012, EMBO J, V31, P593, DOI 10.1038/emboj.2011.431; Schnetz MP, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001023; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Sigova AA, 2013, P NATL ACAD SCI USA, V110, P2876, DOI 10.1073/pnas.1221904110; Spitz F, 2012, NAT REV GENET, V13, P613, DOI 10.1038/nrg3207; Tanzi Rudolph E, 2012, Cold Spring Harb Perspect Med, V2, DOI 10.1101/cshperspect.a006296; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; TUAN D, 1985, P NATL ACAD SCI USA, V82, P6384, DOI 10.1073/pnas.82.19.6384; Vernot B, 2012, GENOME RES, V22, P1689, DOI 10.1101/gr.134890.111; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Whyte WA, 2012, NATURE, V482, P221, DOI 10.1038/nature10805; Xie W, 2013, SCIENCE, V341, P245, DOI 10.1126/science.1236254; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	77	2021	2075	12	229	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 7	2013	155	4					934	947		10.1016/j.cell.2013.09.053	http://dx.doi.org/10.1016/j.cell.2013.09.053			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	251MW	24119843	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000326934300021
J	Zhao, SW; Kumar, R; Sakai, A; Vetting, MW; Wood, BM; Brown, S; Bonanno, JB; Hillerich, BS; Seidel, RD; Babbitt, PC; Almo, SC; Sweedler, JV; Gerlt, JA; Cronan, JE; Jacobson, MP				Zhao, Suwen; Kumar, Ritesh; Sakai, Ayano; Vetting, Matthew W.; Wood, B. McKay; Brown, Shoshana; Bonanno, Jeffery B.; Hillerich, Brandan S.; Seidel, Ronald D.; Babbitt, Patricia C.; Almo, Steven C.; Sweedler, Jonathan V.; Gerlt, John A.; Cronan, John E.; Jacobson, Matthew P.			Discovery of new enzymes and metabolic pathways by using structure and genome context	NATURE			English	Article							PROLINE BETAINE; ENOLASE SUPERFAMILY; GLYCINE BETAINE; PARACOCCUS-DENITRIFICANS; SINORHIZOBIUM-MELILOTI; DIVERGENT EVOLUTION; COMPATIBLE SOLUTES; PROTEIN-PRODUCTION; MASS-SPECTROMETRY; GENE-EXPRESSION	Assigning valid functions to proteins identified in genome projects is challenging: overprediction and database annotation errors are the principal concerns(1). We and others(2) are developing computation-guided strategies for functional discovery with 'metabolite docking' to experimentally derived(3) or homology-based(4) three-dimensional structures. Bacterial metabolic pathways often are encoded by 'genome neighbourhoods' (gene clusters and/or operons), which can provide important clues for functional assignment. We recently demonstrated the synergy of docking and pathway context by 'predicting' the intermediates in the glycolytic pathway in Escherichia coli(5). Metabolite docking to multiple binding proteins and enzymes in the same pathway increases the reliability of in silico predictions of substrate specificities because the pathway intermediates are structurally similar. Here we report that structure-guided approaches for predicting the substrate specificities of several enzymes encoded by a bacterial gene cluster allowed the correct prediction of the in vitro activity of a structurally characterized enzyme of unknown function (PDB 2PMQ), 2-epimerization of trans-4-hydroxy-L-proline betaine (tHyp-B) and cis-4-hydroxy-D-proline betaine (cHyp-B), and also the correct identification of the catabolic pathway in which Hyp-B 2-epimerase participates. The substrate-liganded pose predicted by virtual library screening (docking) was confirmed experimentally. The enzymatic activities in the predicted pathway were confirmed by in vitro assays and genetic analyses; the intermediates were identified by metabolomics; and repression of the genes encoding the pathway by high salt concentrations was established by transcriptomics, confirming the osmolyte role of tHyp-B. This study establishes the utility of structure-guided functional predictions to enable the discovery of new metabolic pathways.	[Zhao, Suwen; Jacobson, Matthew P.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA; [Kumar, Ritesh; Sakai, Ayano; Wood, B. McKay; Sweedler, Jonathan V.; Gerlt, John A.; Cronan, John E.] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; [Vetting, Matthew W.; Bonanno, Jeffery B.; Hillerich, Brandan S.; Seidel, Ronald D.; Almo, Steven C.] Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA; [Brown, Shoshana; Babbitt, Patricia C.] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA; [Sweedler, Jonathan V.; Gerlt, John A.] Univ Illinois, Dept Chem, Urbana, IL 61801 USA; [Gerlt, John A.; Cronan, John E.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA; [Cronan, John E.] Univ Illinois, Dept Microbiol, Urbana, IL 61801 USA	University of California System; University of California San Francisco; University of Illinois System; University of Illinois Urbana-Champaign; Yeshiva University; Albert Einstein College of Medicine; University of California System; University of California San Francisco; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Babbitt, PC (corresponding author), Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA.	babbitt@cgl.ucsf.edu; steve.almo@einstein.yu.edu; jsweedle@illinois.edu; j-gerlt@illinois.edu; j-cronan@life.uiuc.edu; matt.jacobson@ucsf.edu	KUMAR, RITESH/P-3347-2018; Jacobson, Matthew/Y-5161-2018; Cronan, John/V-6626-2019; Sweedler, Jonathan V/A-9405-2009; KUMAR, RITESH/P-1265-2019	KUMAR, RITESH/0000-0001-7170-8645; Jacobson, Matthew/0000-0001-6262-655X; Sweedler, Jonathan V/0000-0003-3107-9922; KUMAR, RITESH/0000-0001-7170-8645; Zhao, Suwen/0000-0001-5609-434X	US National Institutes of Health [U54GM093342, U54GM074945, U54GM094662]; National Institutes of Health [P41-GM103311]; US DOE [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM074945, U54GM093342, U54GM094662, P41GM103311] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US DOE(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by cooperative agreements from the US National Institutes of Health (U54GM093342, U54GM074945 and U54GM094662). Molecular graphics and analyses were performed with the University of California, San Francisco (UCSF) Chimera package. Chimera is developed by the Resource for Biocomputing, Visualization, and Informatics at UCSF (supported by National Institutes of Health P41-GM103311). Use of the Advanced Photon Source, an Office of Science User Facility operated for the US Department of Energy (DOE) Office of Science by Argonne National Laboratory, was supported by the US DOE under contract no. DE-AC02-06CH11357. Use of the Lilly Research Laboratories Collaborative Access Team (LRL-CAT) beamline at Sector 31 of the Advanced Photon Source was provided by Eli Lilly Company, which operates the facility.	Alloing G, 2006, J BACTERIOL, V188, P6308, DOI 10.1128/JB.00585-06; AMIN US, 1995, ARCH MICROBIOL, V163, P138, DOI 10.1007/s002030050183; Babbitt PC, 1996, BIOCHEMISTRY-US, V35, P16489, DOI 10.1021/bi9616413; Babbitt PC, 1997, J BIOL CHEM, V272, P30591, DOI 10.1074/jbc.272.49.30591; Bar-Even A, 2011, BIOCHEMISTRY-US, V50, P4402, DOI 10.1021/bi2002289; Barber AE, 2012, BIOINFORMATICS, V28, P2845, DOI 10.1093/bioinformatics/bts532; BERNARD T, 1986, ARCH MICROBIOL, V143, P359, DOI 10.1007/BF00412803; Burg MB, 1997, ANNU REV PHYSIOL, V59, P437, DOI 10.1146/annurev.physiol.59.1.437; Burnet MW, 2000, GENE, V244, P151, DOI 10.1016/S0378-1119(99)00554-5; CHAMBERS ST, 1987, J CLIN INVEST, V79, P731, DOI 10.1172/JCI112878; Daughtry KD, 2012, J AM CHEM SOC, V134, P2823, DOI 10.1021/ja2111898; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Erb TJ, 2012, NAT CHEM BIOL, V8, P926, DOI [10.1038/NCHEMBIO.1087, 10.1038/nchembio.1087]; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fox B. G., 2009, CURR PROTOCOLS PROTE; Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o; Gerlt JA, 2005, ARCH BIOCHEM BIOPHYS, V433, P59, DOI 10.1016/j.abb.2004.07.034; Gerlt JA, 2012, J BIOL CHEM, V287, P29, DOI 10.1074/jbc.R111.240945; Gerlt JA, 2011, BIOCHEMISTRY-US, V50, P9950, DOI 10.1021/bi201312u; GLOUX K, 1989, ARCH MICROBIOL, V151, P143, DOI 10.1007/BF00414429; GOLDMANN A, 1994, FEMS MICROBIOL LETT, V115, P305, DOI 10.1016/0378-1097(94)90031-0; HANSON AD, 1994, P NATL ACAD SCI USA, V91, P306, DOI 10.1073/pnas.91.1.306; Hermann JC, 2007, NATURE, V448, P775, DOI 10.1038/nature05981; Hermann JC, 2006, J AM CHEM SOC, V128, P15882, DOI 10.1021/ja065860f; Kalyanaraman C, 2005, BIOCHEMISTRY-US, V44, P2059, DOI 10.1021/bi0481186; Kalyanaraman C, 2010, BIOCHEMISTRY-US, V49, P4003, DOI 10.1021/bi100445g; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kempf B, 1998, ARCH MICROBIOL, V170, P319, DOI 10.1007/s002030050649; LARSEN PI, 1987, ARCH MICROBIOL, V147, P1, DOI 10.1007/BF00492896; Lenky CC, 2012, ANAL BIOCHEM, V420, P7, DOI 10.1016/j.ab.2011.09.013; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Li C, 2010, J CHROMATOGR B, V878, P1809, DOI 10.1016/j.jchromb.2010.05.014; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matsson M, 1998, ARCH MICROBIOL, V170, P27, DOI 10.1007/s002030050611; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Oufir M, 2009, J CHROMATOGR A, V1216, P1094, DOI 10.1016/j.chroma.2008.12.030; Sauder Michael J., 2008, V426, P561, DOI 10.1007/978-1-60327-058-8_37; Schiefner A, 2004, J BIOL CHEM, V279, P5588, DOI 10.1074/jbc.M309771200; Schnoes AM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000605; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Song L, 2007, NAT CHEM BIOL, V3, P486, DOI 10.1038/nchembio.2007.11; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Suite S, 2009, LIGPREP VERSION 2 3; Suite S., 2009, PROTEIN PREPARATION; Tanabe M., 2012, BIOINFORMATICS, V38; VANSPANNING RJM, 1991, J BACTERIOL, V173, P6962, DOI 10.1128/jb.173.21.6962-6970.1991; Wargo MJ, 2008, J BACTERIOL, V190, P2690, DOI 10.1128/JB.01393-07; Watanabe S, 2012, J BIOL CHEM, V287, P32674, DOI 10.1074/jbc.M112.374272; White CE, 2012, MOL MICROBIOL, V85, P1133, DOI 10.1111/j.1365-2958.2012.08164.x; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	51	99	102	1	175	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 31	2013	502	7473					698	+		10.1038/nature12576	http://dx.doi.org/10.1038/nature12576			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243CC	24056934	Green Submitted, Green Accepted			2022-12-28	WOS:000326293200051
J	Kain, P; Boyle, SM; Tharadra, SK; Guda, T; Pham, C; Dahanukar, A; Ray, A				Kain, Pinky; Boyle, Sean Michael; Tharadra, Sana Khalid; Guda, Tom; Christine Pham; Dahanukar, Anupama; Ray, Anandasankar			RETRACTED: Odour receptors and neurons for DEET and new insect repellents (Retracted article. See vol. 536, 2016)	NATURE			English	Article; Retracted Publication							VOLATILE ORGANIC-COMPOUNDS; ANOPHELES-GAMBIAE; AEDES-AEGYPTI; MALARIA MOSQUITO; CELLULAR BASIS; DROSOPHILA; IDENTIFICATION; ODORS; BEHAVIOR; MUTANT	There are major impediments to finding improved DEET alternatives because the receptors causing olfactory repellency are unknown, and new chemicals require exorbitant costs to determine safety for human use. Here we identify DEET-sensitive neurons in a pit-like structure in the Drosophila melanogaster antenna called the sacculus. They express a highly conserved receptor, Ir40a, and flies in which these neurons are silenced or Ir40a is knocked down lose avoidance to DEET. We used a computational structure-activity screen of >400,000 compounds that identified >100 natural compounds as candidate repellents. We tested several and found that most activate Ir40a(+) neurons and are repellents for Drosophila. These compounds are also strong repellents for mosquitoes. The candidates contain chemicals that do not dissolve plastic, are affordable and smell mildly like grapes, with three considered safe in human foods. Our findings pave the way to discover new generations of repellents that will help fight deadly insect-borne diseases worldwide.	[Kain, Pinky; Tharadra, Sana Khalid; Guda, Tom; Dahanukar, Anupama; Ray, Anandasankar] Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA; [Boyle, Sean Michael; Dahanukar, Anupama; Ray, Anandasankar] Univ Calif Riverside, Genet Genom & Bioinformat Program, Riverside, CA 92521 USA; [Christine Pham; Dahanukar, Anupama; Ray, Anandasankar] Univ Calif Riverside, Neurosci Program, Riverside, CA 92521 USA; [Dahanukar, Anupama; Ray, Anandasankar] Univ Calif Riverside, Inst Integrat Genome Biol, Riverside, CA 92521 USA	University of California System; University of California Riverside; University of California System; University of California Riverside; University of California System; University of California Riverside; University of California System; University of California Riverside	Ray, A (corresponding author), Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA.	anand.ray@ucr.edu	kain, pinky/A-9893-2014	Pham, Christine/0000-0002-5123-1381; Ray, Anandasankar/0000-0003-4133-2581	Whitehall Foundation; NINDS [R21NS074332, R56AI099778, R01AI087785]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI087785, R56AI099778] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS074332] Funding Source: NIH RePORTER	Whitehall Foundation; NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank A. Ganguly and D. Carter for help with calcium imaging; Z. Wisotsky for help with gustatory experiments; D. MacWilliam for help with olfactory experiments; J. Wang for sharing the NFAT transgenic fly line; and R. Benton for sharing the Ir40a-Gal4 fly line. This work was partly funded by a Whitehall Foundation grant to A. D., an R21NS074332 (NINDS) to A. D. and A. R., and an R56AI099778 (NIAID) and R01AI087785 (NIAID) to A. R. The granting agencies had no role in experimental design or analysis.	Abramson CI, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.12201; Abuin L, 2011, NEURON, V69, P44, DOI 10.1016/j.neuron.2010.11.042; Ai M, 2010, NATURE, V468, P691, DOI 10.1038/nature09537; [Anonymous], 2007, DRAGON SOFTWARE WIND; [Anonymous], 2007, FLAV FRAGR 2007 2008; Benton R, 2009, CELL, V136, P149, DOI 10.1016/j.cell.2008.12.001; Bohbot JD, 2012, NEUROPHARMACOLOGY, V62, P2086, DOI 10.1016/j.neuropharm.2012.01.004; Bostrom J, 2003, J MOL GRAPH MODEL, V21, P449, DOI 10.1016/S1093-3263(02)00204-8; Carey AF, 2010, NATURE, V464, P66, DOI 10.1038/nature08834; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Corbel V, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-47; Cork A, 1996, MED VET ENTOMOL, V10, P269, DOI 10.1111/j.1365-2915.1996.tb00742.x; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Curran AM, 2005, J CHEM ECOL, V31, P1607, DOI 10.1007/s10886-005-5801-4; de Bruyne M, 1999, J NEUROSCI, V19, P4520; DeGennaro M, 2013, NATURE, V498, P487, DOI 10.1038/nature12206; Ditzen M, 2008, SCIENCE, V319, P1838, DOI 10.1126/science.1153121; ELSAYED AM, 2009, PHEROBASE DATABASE I; Gallagher M, 2008, BRIT J DERMATOL, V159, P780, DOI 10.1111/j.1365-2133.2008.08748.x; Haddad R, 2008, NAT METHODS, V5, P425, DOI [10.1038/nmeth.1197, 10.1038/NMETH.1197]; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Hou XW, 2004, J STORED PROD RES, V40, P47, DOI 10.1016/S0022-474X(02)00063-2; Karatzoglou A, 2006, J STAT SOFTW, V15; Katritzky AR, 2008, P NATL ACAD SCI USA, V105, P7359, DOI 10.1073/pnas.0800571105; Kline DL, 2003, J MED ENTOMOL, V40, P463, DOI 10.1603/0022-2585-40.4.463; KLOCKE JA, 1987, J CHEM ECOL, V13, P2131, DOI 10.1007/BF01012562; Klun JA, 2004, J MED ENTOMOL, V41, P418, DOI 10.1603/0022-2585-41.3.418; Knudsen JT, 2006, BOT REV, V72, P1, DOI 10.1663/0006-8101(2006)72[1:DADOFS]2.0.CO;2; Krajick K, 2006, SCIENCE, V313, P36, DOI 10.1126/science.313.5783.36; Lee Y, 2010, NEURON, V67, P555, DOI 10.1016/j.neuron.2010.07.006; Liu C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000467; Logan JG, 2008, J CHEM ECOL, V34, P308, DOI 10.1007/s10886-008-9436-0; Masuyama K, 2012, J NEUROGENET, V26, P89, DOI 10.3109/01677063.2011.642910; Meijerink J, 2000, J CHEM ECOL, V26, P1367, DOI 10.1023/A:1005475422978; Mumcuoglu KY, 1996, ENTOMOL EXP APPL, V78, P309, DOI 10.1111/j.1570-7458.1996.tb00795.x; Pellegrino M, 2011, NATURE, V478, P511, DOI 10.1038/nature10438; Pelz D, 2006, J NEUROBIOL, V66, P1544, DOI 10.1002/neu.20333; Reeder NL, 2001, J ECON ENTOMOL, V94, P1584, DOI 10.1603/0022-0493-94.6.1584; Silbering AF, 2011, J NEUROSCI, V31, P13357, DOI 10.1523/JNEUROSCI.2360-11.2011; Stanczyk NM, 2010, P NATL ACAD SCI USA, V107, P8575, DOI 10.1073/pnas.1001313107; Strickman D., 2007, INSECT REPELLENTS PR, P195; SWEENEY ST, 1995, NEURON, V14, P341, DOI 10.1016/0896-6273(95)90290-2; Syed Z, 2008, P NATL ACAD SCI USA, V105, P13598, DOI 10.1073/pnas.0805312105; Syed Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017705; Tentschert J, 2000, NATURWISSENSCHAFTEN, V87, P377, DOI 10.1007/s001140050745; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Turner SL, 2011, NATURE, V474, P87, DOI 10.1038/nature10081; Turner SL, 2009, NATURE, V461, P277, DOI 10.1038/nature08295; Walker JD, 2003, ENVIRON TOXICOL CHEM, V22, P1870, DOI 10.1897/01-454; Weiss LA, 2011, NEURON, V69, P258, DOI 10.1016/j.neuron.2011.01.001; Xia YF, 2008, P NATL ACAD SCI USA, V105, P6433, DOI 10.1073/pnas.0801007105; ZENG XN, 1991, J CHEM ECOL, V17, P1469, DOI 10.1007/BF00983777; Zeng XN, 1996, J CHEM ECOL, V22, P237, DOI 10.1007/BF02055096	53	95	106	0	179	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 24	2013	502	7472					507	+		10.1038/nature12594	http://dx.doi.org/10.1038/nature12594			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	238YN	24089210	Green Accepted, Green Submitted			2022-12-28	WOS:000325988400045
J	Katz, SJ; Hawley, S				Katz, Steven J.; Hawley, Sarah			The Value of Sharing Treatment Decision Making With Patients Expecting Too Much?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							MASTECTOMY; RECEIPT; CARE		[Katz, Steven J.; Hawley, Sarah] Univ Michigan, Dept Med, Ann Arbor, MI 48109 USA; [Katz, Steven J.; Hawley, Sarah] Univ Michigan, Dept Hlth Management & Policy, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Katz, SJ (corresponding author), Univ Michigan, Dept Med, 2800 Plymouth Rd,North Campus Res Complex,Bldg 16, Ann Arbor, MI 48109 USA.	skatz@umich.edu	KATZ, STEVEN/ABH-8886-2020					Arterburn D, 2012, HEALTH AFFAIR, V31, P2094, DOI 10.1377/hlthaff.2011.0686; Hawley ST, 2009, JNCI-J NATL CANCER I, V101, P1337, DOI 10.1093/jnci/djp271; Lee EO, 2013, NEW ENGL J MED, V368, P6, DOI 10.1056/NEJMp1209500; Livaudais JC, 2013, J GEN INTERN MED, V28, P630, DOI 10.1007/s11606-012-2274-3; Morrow M, 2009, JAMA-J AM MED ASSOC, V302, P1551, DOI 10.1001/jama.2009.1450; O'Connor AM, 2009, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001431.pub2, 10.1002/14651858.CD001431.pub3, 10.1002/14651858.CD001431.pub4]; Rosenberg SM, 2013, ANN INTERN MED, V159, P373, DOI 10.7326/0003-4819-159-6-201309170-00003; Weeks JC, 2012, NEW ENGL J MED, V367, P1616, DOI 10.1056/NEJMoa1204410; Wennberg DE, 2010, NEW ENGL J MED, V363, P1245, DOI 10.1056/NEJMsa0902321; Wennberg JE, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1513	10	47	49	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 16	2013	310	15					1559	1560		10.1001/jama.2013.278944	http://dx.doi.org/10.1001/jama.2013.278944			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	234EP	24061082				2022-12-28	WOS:000325624800014
J	Guo, W; Wang, X				Guo, Wei; Wang, Xin			Gingival Melanoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								An otherwise healthy 45-year-old man presented with a 4-week history of nonpainful discoloration of the maxillary gingiva. He had no history of pigmented skin lesions. An otherwise healthy 45-year-old man presented with a 4-week history of nonpainful discoloration of the maxillary gingiva. He had no history of pigmented skin lesions. Intraoral examination showed areas of the gingiva that were black. The lesion was a pigmented macule, 1.5 cm by 4 cm in greatest dimension, with asymmetric and irregular borders and colors. Histopathological examination revealed an infiltrating lentiginous melanoma. Oral melanoma is a rare neoplasm. Exposure to the sun is clearly linked to cutaneous melanoma but is not clearly associated with oral melanoma. The patient underwent partial maxillectomy with 2-cm margins, but he declined adjuvant radiotherapy ...	[Guo, Wei] Shanghai Jiao Tong Univ, Peoples Hosp 9, Shanghai 200030, Peoples R China; Nanjing Med Univ, Affiliated Wuxi Peoples Hosp, Wuxi, Jiangsu, Peoples R China	Shanghai Jiao Tong University; Nanjing Medical University	Wang, X (corresponding author), Nanjing Med Univ, Affiliated Wuxi Peoples Hosp, Wuxi, Jiangsu, Peoples R China.	wangxin1975@gmail.com							0	2	2	0	17	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 10	2013	369	15					1452	1452		10.1056/NEJMicm1305723	http://dx.doi.org/10.1056/NEJMicm1305723			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	231QE	24106938				2022-12-28	WOS:000325431500013
J	Paulson, T				Paulson, Tom			A MORTAL FOE	NATURE			English	Editorial Material																			0	92	94	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 10	2013	502	7470					S2	S3		10.1038/502S2a	http://dx.doi.org/10.1038/502S2a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RU	24108078	Bronze			2022-12-28	WOS:000325436100002
J	Faber, KT				Faber, Katherine T.			Small Volumes Create Super(elastic) Effects	SCIENCE			English	Editorial Material							SHAPE-MEMORY; COMPOSITES; ZIRCONIA		Northwestern Univ, Robert R McCormick Sch Engn & Appl Sci, Dept Mat Sci & Engn, Evanston, IL 60208 USA	Northwestern University	Faber, KT (corresponding author), Northwestern Univ, Robert R McCormick Sch Engn & Appl Sci, Dept Mat Sci & Engn, Evanston, IL 60208 USA.	k-faber@northwestern.edu	Faber, Katherine/B-6741-2009	Faber, Katherine/0000-0001-6585-2536				Daum B, 2013, ACTA MATER, V61, P4996, DOI 10.1016/j.actamat.2013.04.046; EVANS AG, 1986, ACTA METALL MATER, V34, P761, DOI 10.1016/0001-6160(86)90052-0; GARVIE RC, 1975, NATURE, V258, P703, DOI 10.1038/258703a0; Karaca HE, 2013, ACTA MATER, V61, P5036, DOI 10.1016/j.actamat.2013.04.039; KRIVEN WM, 1988, J AM CERAM SOC, V71, P1021, DOI 10.1111/j.1151-2916.1988.tb05786.x; Lai A, 2013, SCIENCE, V341, P1505, DOI 10.1126/science.1239745; Li YW, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4795330; MAGLEY DJ, 1990, J AM CERAM SOC, V73, P1641, DOI 10.1111/j.1151-2916.1990.tb09808.x; Manuel M., 2009, SELF HEALING MAT FUN, P251; Radousky HB, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/50/502001; REYESMOREL PE, 1988, J AM CERAM SOC, V71, P648, DOI 10.1111/j.1151-2916.1988.tb06383.x; Shih CH, 2013, J MATER SCI, V48, P5219, DOI 10.1007/s10853-013-7311-z; Wei ZG, 1998, J MATER SCI, V33, P3743, DOI 10.1023/A:1004692329247	13	5	6	2	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 27	2013	341	6153					1464	1465		10.1126/science.1245097	http://dx.doi.org/10.1126/science.1245097			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	224NS	24072914				2022-12-28	WOS:000324894600037
J	Cogliati, S; Frezza, C; Soriano, ME; Varanita, T; Quintana-Cabrera, R; Corrado, M; Cipolat, S; Costa, V; Casarin, A; Gomes, LC; Perales-Clemente, E; Salviati, L; Fernandez-Silva, P; Enriquez, JA; Scorrano, L				Cogliati, Sara; Frezza, Christian; Soriano, Maria Eugenia; Varanita, Tatiana; Quintana-Cabrera, Ruben; Corrado, Mauro; Cipolat, Sara; Costa, Veronica; Casarin, Alberto; Gomes, Ligia C.; Perales-Clemente, Ester; Salviati, Leonardo; Fernandez-Silva, Patricio; Enriquez, Jose A.; Scorrano, Luca			Mitochondrial Cristae Shape Determines Respiratory Chain Supercomplexes Assembly and Respiratory Efficiency	CELL			English	Article							DOMINANT OPTIC ATROPHY; ATP SYNTHASE; CYTOCHROME-C; OXIDATIVE-PHOSPHORYLATION; ENDOPLASMIC-RETICULUM; MAMMALIAN-CELLS; INNER MEMBRANE; COMPLEX-I; APOPTOSIS; PROTEIN	Respiratory chain complexes assemble into functional quaternary structures called supercomplexes (RCS) within the folds of the inner mitochondrial membrane, or cristae. Here, we investigate the relationship between respiratory function and mitochondrial ultrastructure and provide evidence that cristae shape determines the assembly and stability of RCS and hence mitochondrial respiratory efficiency. Genetic and apoptotic manipulations of cristae structure affect assembly and activity of RCS in vitro and in vivo, independently of changes to mitochondrial protein synthesis or apoptotic outer mitochondrial membrane permeabilization. We demonstrate that, accordingly, the efficiency of mitochondria-dependent cell growth depends on cristae shape. Thus, RCS assembly emerges as a link between membrane morphology and function.	[Cogliati, Sara; Frezza, Christian; Soriano, Maria Eugenia; Varanita, Tatiana; Quintana-Cabrera, Ruben; Corrado, Mauro; Cipolat, Sara; Costa, Veronica; Gomes, Ligia C.; Scorrano, Luca] Venetian Inst Mol Med, Dulbecco Telethon Inst, I-35129 Padua, Italy; [Cogliati, Sara; Soriano, Maria Eugenia; Varanita, Tatiana; Quintana-Cabrera, Ruben; Scorrano, Luca] Univ Padua, Dept Biol, I-35121 Padua, Italy; [Corrado, Mauro; Scorrano, Luca] IRCCS Fdn Santa Lucia, I-00143 Rome, Italy; [Casarin, Alberto; Salviati, Leonardo] Univ Padua, Dept Woman & Child Hlth, Clin Genet Unit, I-35128 Padua, Italy; [Perales-Clemente, Ester; Enriquez, Jose A.] Ctr Nacl Invest Cardiovasc Carlos III, Madrid 28029, Spain; [Fernandez-Silva, Patricio] Univ Zaragoza, Fac Ciencias, Dept Bioquim & Biol Mol & Celular, E-50009 Zaragoza, Spain	Fondazione Telethon; Dulbecco Telethon Institute (DTI); Veneto Institute Molecular Medicine; University of Padua; IRCCS Santa Lucia; University of Padua; Centro Nacional de Investigaciones Cardiovasculares (CNIC); University of Zaragoza	Enriquez, JA (corresponding author), Ctr Nacl Invest Cardiovasc Carlos III, Melchor Fernandez Almagro 3, Madrid 28029, Spain.	jaenriquez@cnic.es; luca.scorrano@unipd.it	Cogliati, Sara/H-6156-2015; Frezza, Christian/G-2174-2010; Scorrano, Luca/A-6652-2008; Scorrano, Luca/K-3967-2019; Quintana-Cabrera, Ruben/A-4937-2019; Cogliati, Sara/GLR-0692-2022; Enríquez, J.A./M-8468-2016; Silva, Patricio Fernandez/U-2256-2017; Cogliati, Sara/ABC-2688-2020; Salviati, Leonardo/L-1007-2016	Cogliati, Sara/0000-0002-0374-3489; Frezza, Christian/0000-0002-3293-7397; Scorrano, Luca/0000-0002-8515-8928; Scorrano, Luca/0000-0002-8515-8928; Quintana-Cabrera, Ruben/0000-0002-0601-349X; Cogliati, Sara/0000-0002-0374-3489; Enríquez, J.A./0000-0002-3671-2961; Silva, Patricio Fernandez/0000-0001-8971-7355; Salviati, Leonardo/0000-0001-5642-9963; Soriano, Maria Eugenia/0000-0002-7971-2961; Perales-Clemente, Ester/0000-0002-6333-4070; Varanita, Tatiana/0000-0002-4952-6148	Telethon Italy [GGP12162, GPP10005B, TCR02016]; AIRC Italy, MOH Italy [GR 09.021]; Swiss National Foundation [31-118171]; MINECO [SAF2012-32776, CSD2007-00020]; DGA [B55, PIPAMER O905]; CAM [S2011/BMD-2402]; Journal of Cell Science Travelling Fellowship; AIRC Biennial Fellowship; Instituto de Salud Carlos III-MICINN; Pro-CNIC Foundation; MRC [MC_UU_12022/6] Funding Source: UKRI	Telethon Italy(Fondazione Telethon); AIRC Italy, MOH Italy(Fondazione AIRC per la ricerca sul cancro); Swiss National Foundation(Swiss National Science Foundation (SNSF)); MINECO(Spanish Government); DGA; CAM; Journal of Cell Science Travelling Fellowship; AIRC Biennial Fellowship(Fondazione AIRC per la ricerca sul cancro); Instituto de Salud Carlos III-MICINN(Instituto de Salud Carlos IIIMinistry of Science and Innovation, Spain (MICINN)Spanish Government); Pro-CNIC Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank A. Gross (Weizmann Institute) for anti-BID antibody, A. Latorre-Pellicer (CNIC) for mtDNA RT-PCR, and M. Albiero (VIMM) for tail vein injections. L.S. is a senior scientist of the Dulbecco-Telethon Institute. This work is supported by Telethon Italy (GGP12162, GPP10005B, and TCR02016), AIRC Italy, MOH Italy (GR 09.021), and Swiss National Foundation (31-118171). J.A.E. is supported by MINECO (SAF2012-32776 and CSD2007-00020), DGA (B55, PIPAMER O905), and CAM (S2011/BMD-2402). S. C. was supported by a Journal of Cell Science Travelling Fellowship. C. F. was supported by an AIRC Biennial Fellowship. The CNIC is funded by the Instituto de Salud Carlos III-MICINN and the Pro-CNIC Foundation.	Acin-Perez R, 2004, MOL CELL, V13, P805, DOI 10.1016/S1097-2765(04)00124-8; Acin-Perez R, 2008, MOL CELL, V32, P529, DOI 10.1016/j.molcel.2008.10.021; Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944; Campanella M, 2008, CELL METAB, V8, P13, DOI 10.1016/j.cmet.2008.06.001; Cereghetti GM, 2008, P NATL ACAD SCI USA, V105, P15803, DOI 10.1073/pnas.0808249105; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026; Chen YC, 2012, CELL METAB, V15, P348, DOI 10.1016/j.cmet.2012.02.006; Cheng EHYA, 2001, MOL CELL, V8, P705, DOI 10.1016/S1097-2765(01)00320-3; Cipolat S, 2004, P NATL ACAD SCI USA, V101, P15927, DOI 10.1073/pnas.0407043101; Cipolat S, 2006, CELL, V126, P163, DOI 10.1016/j.cell.2006.06.021; Costa V, 2010, EMBO MOL MED, V2, P490, DOI 10.1002/emmm.201000102; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Davies KM, 2011, P NATL ACAD SCI USA, V108, P14121, DOI 10.1073/pnas.1103621108; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; Dimmer KS, 2006, PHYSIOLOGY, V21, P233, DOI 10.1152/physiol.00010.2006; Duvezin-Caubet S, 2006, J BIOL CHEM, V281, P37972, DOI 10.1074/jbc.M606059200; Frey TG, 2000, TRENDS BIOCHEM SCI, V25, P319, DOI 10.1016/S0968-0004(00)01609-1; Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025; Germain M, 2005, EMBO J, V24, P1546, DOI 10.1038/sj.emboj.7600592; Gomes LC, 2011, NAT CELL BIOL, V13, P589, DOI 10.1038/ncb2220; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Griparic L, 2001, TRAFFIC, V2, P235, DOI 10.1034/j.1600-0854.2001.1r008.x; HACKENBROCK CR, 1966, J CELL BIOL, V30, P269, DOI 10.1083/jcb.30.2.269; Landes T, 2010, EMBO REP, V11, P459, DOI 10.1038/embor.2010.50; Lapuente-Brun E, 2013, SCIENCE, V340, P1567, DOI 10.1126/science.1230381; Legros F, 2002, MOL BIOL CELL, V13, P4343, DOI 10.1091/mbc.E02-06-0330; Lodi R, 2004, ANN NEUROL, V56, P719, DOI 10.1002/ana.20278; Merkwirth C, 2008, GENE DEV, V22, P476, DOI 10.1101/gad.460708; Minauro-Sanmiguel F, 2005, P NATL ACAD SCI USA, V102, P12356, DOI 10.1073/pnas.0503893102; Paumard P, 2002, EMBO J, V21, P221, DOI 10.1093/emboj/21.3.221; PFEIFFER DR, 1995, J BIOL CHEM, V270, P4923, DOI 10.1074/jbc.270.9.4923; Santel A, 2003, J CELL SCI, V116, P2763, DOI 10.1242/jcs.00479; Santel A, 2001, J CELL SCI, V114, P867; Schagger H, 1995, METHOD ENZYMOL, V260, P190, DOI 10.1016/0076-6879(95)60137-6; Scorrano L, 2002, DEV CELL, V2, P55, DOI 10.1016/S1534-5807(01)00116-2; Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245; Strauss M, 2008, EMBO J, V27, P1154, DOI 10.1038/emboj.2008.35; Strogolova V, 2012, MOL CELL BIOL, V32, P1363, DOI 10.1128/MCB.06369-11; Sun MG, 2007, NAT CELL BIOL, V9, P1057, DOI 10.1038/ncb1630; Vogel F, 2006, J CELL BIOL, V175, P237, DOI 10.1083/jcb.200605138; Vukotic M, 2012, CELL METAB, V15, P336, DOI 10.1016/j.cmet.2012.01.016; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wei MC, 2000, GENE DEV, V14, P2060; Yamaguchi R, 2008, MOL CELL, V31, P557, DOI 10.1016/j.molcel.2008.07.010; Yoon Y, 2001, MOL BIOL CELL, V12, P2894, DOI 10.1091/mbc.12.9.2894; Zanna C, 2008, BRAIN, V131, P352, DOI 10.1093/brain/awm335	47	696	716	15	100	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 26	2013	155	1					160	171		10.1016/j.cell.2013.08.032	http://dx.doi.org/10.1016/j.cell.2013.08.032			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	224UX	24055366	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000324916700017
J	Eisenstein, M				Eisenstein, Michael			PLANT BREEDING Discovery in a dry spell	NATURE			English	Editorial Material							MAIZE											BOYER JS, 1982, SCIENCE, V218, P443, DOI 10.1126/science.218.4571.443; Castiglioni P, 2008, PLANT PHYSIOL, V147, P446, DOI 10.1104/pp.108.118828; Lobell DB, 2013, NAT CLIM CHANGE, V3, P497, DOI [10.1038/nclimate1832, 10.1038/NCLIMATE1832]	3	31	31	0	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 26	2013	501	7468					S7	S9		10.1038/501S7a	http://dx.doi.org/10.1038/501S7a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223RP	24067764	Bronze			2022-12-28	WOS:000324826300004
J	Williams, SN				Williams, Simon Nicholas			Bring in universal mental health checks in schools	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ADOLESCENT DEPRESSION; COST-EFFECTIVENESS; FOLLOW-UP; INTERVENTION; CHILDREN; PREVENTION; DISORDERS; PREVALENCE; RISK		[Williams, Simon Nicholas] Univ Cambridge, Dept Publ Hlth & Primary Care, Inst Publ Hlth, Cambridge CB2 0SR, England	University of Cambridge	Williams, SN (corresponding author), Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA.	simonwilliams@northwestern.edu		Williams, Simon/0000-0003-2854-9946				Bupa, 2011, CANC DIAGN TREATM 20; Centre for Mental Health , 2010, EC SOC COSTS MENT HL; Cuijpers P, 2006, EUR CHILD ADOLES PSY, V15, P300, DOI 10.1007/s00787-006-0537-4; Dadds MR, 1999, J CONSULT CLIN PSYCH, V67, P145, DOI 10.1037/0022-006X.67.1.145; Department of Health, 2011, NO HLTH MENT HLTH CR; Domino ME, 2008, AM J PSYCHIAT, V165, P588, DOI 10.1176/appi.ajp.2008.07101610; Durlak JA, 1998, AM J COMMUN PSYCHOL, V26, P775, DOI 10.1023/A:1022162015815; Friedli L, 2007, MENTAL HLTH PROMOTIO; Gould MS, 2003, J AM ACAD CHILD PSY, V42, P386, DOI 10.1097/01.CHI.0000046821.95464.CF; Jolly J, 2001, BECK YOUTH INVENTORI; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kim-Cohen J, 2003, ARCH GEN PSYCHIAT, V60, P709, DOI 10.1001/archpsyc.60.7.709; Lynch FL, 2005, ARCH GEN PSYCHIAT, V62, P1241, DOI 10.1001/archpsyc.62.11.1241; McCrone P, 2005, EUR CHILD ADOLES PSY, V14, P407, DOI 10.1007/s00787-005-0491-6; Merikangas KR, 2010, PEDIATRICS, V125, P75, DOI 10.1542/peds.2008-2598; Scott S, 2001, BRIT MED J, V323, P191, DOI 10.1136/bmj.323.7306.191; Stallard P, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6058; Stein BD, 2003, JAMA-J AM MED ASSOC, V290, P603, DOI 10.1001/jama.290.5.603; Zechmeister I, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-20	19	4	4	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 24	2013	347								f5478	10.1136/bmj.f5478	http://dx.doi.org/10.1136/bmj.f5478			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	227CT	24065552				2022-12-28	WOS:000325086800002
J	Baytekin, HT; Baytekin, B; Hermans, TM; Kowalczyk, B; Grzybowski, BA				Baytekin, H. Tarik; Baytekin, Bilge; Hermans, Thomas M.; Kowalczyk, Bartlomiej; Grzybowski, Bartosz A.			Control of Surface Charges by Radicals as a Principle of Antistatic Polymers Protecting Electronic Circuitry	SCIENCE			English	Article								Even minute quantities of electric charge accumulating on polymer surfaces can cause shocks, explosions, and multibillion-dollar losses to electronic circuitry. This paper demonstrates that to remove static electricity, it is not at all necessary to "target" the charges themselves. Instead, the way to discharge a polymer is to remove radicals from its surface. These radicals colocalize with and stabilize the charges; when they are scavenged, the surfaces discharge rapidly. This radical-charge interplay allows for controlling static electricity by doping common polymers with small amounts of radical-scavenging molecules, including the familiar vitamin E. The effectiveness of this approach is demonstrated by rendering common polymers dust-mitigating and also by using them as coatings that prevent the failure of electronic circuitry.	[Grzybowski, Bartosz A.] Northwestern Univ, Dept Chem, Evanston, IL 60208 USA; Northwestern Univ, Dept Chem & Biol Engn, Evanston, IL 60208 USA	Northwestern University; Northwestern University	Grzybowski, BA (corresponding author), Northwestern Univ, Dept Chem, 2145 Sheridan Rd, Evanston, IL 60208 USA.	grzybor@northwestern.edu	Grzybowski, Bartosz A/H-5741-2017; Baytekin, Bilge/O-1823-2019; Baytekin, Bilge/K-4719-2014; Hermans, Thomas/D-5629-2012	Baytekin, Bilge/0000-0002-3867-3863; Baytekin, Bilge/0000-0002-3867-3863; Grzybowski, Bartosz/0000-0001-6613-4261; Hermans, Thomas/0000-0003-1121-1754	Non-Equilibrium Energy Research Center (NERC), an Energy Frontier Research Center; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-SC0000989]; Human Frontier Science Program	Non-Equilibrium Energy Research Center (NERC), an Energy Frontier Research Center(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Human Frontier Science Program(Human Frontier Science Program)	This work was supported by the Non-Equilibrium Energy Research Center (NERC), which is an Energy Frontier Research Center funded by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences under award DE-SC0000989. T.M.H. acknowledges a grant from the Human Frontier Science Program. We thank T. Aytun for help in measuring transistor characteristics.	Angelopoulos M, 2001, IBM J RES DEV, V45, P57, DOI 10.1147/rd.451.0057; Baytekin B, 2012, J AM CHEM SOC, V134, P7223, DOI 10.1021/ja300925h; Baytekin HT, 2011, SCIENCE, V333, P308, DOI 10.1126/science.1201512; Baytekin HT, 2012, ANGEW CHEM INT EDIT, V51, P4843, DOI 10.1002/anie.201200057; Burgo TAL, 2012, LANGMUIR, V28, P7407, DOI 10.1021/la301228j; Fergusson D. C., 2011, SPACECRAFT CHARGING, V237; Gibson N, 1997, J ELECTROSTAT, V40-1, P21, DOI 10.1016/S0304-3886(97)00010-7; GREASON WD, 1987, IEEE T IND APPL, V23, P205, DOI 10.1109/TIA.1987.4504895; KUZUYA M, 1993, MACROMOLECULES, V26, P1990, DOI 10.1021/ma00060a030; Lacks DJ, 2012, ANGEW CHEM INT EDIT, V51, P6822, DOI 10.1002/anie.201202896; Loeb L.B., 1965, ELECT CORONAS, V1st; LOWELL J, 1980, ADV PHYS, V29, P947, DOI 10.1080/00018738000101466; Miyasaka M, 2003, ADV FUNCT MATER, V13, P113, DOI 10.1002/adfm.200390016; Orlando JJ, 2012, CHEM SOC REV, V41, P6294, DOI 10.1039/c2cs35166h; SALANECK WR, 1976, J APPL PHYS, V47, P144, DOI 10.1063/1.322306; Shinbrot T, 2008, EPL-EUROPHYS LETT, V83, DOI 10.1209/0295-5075/83/24004; SOLOMON DH, 1965, J POLYM SCI PART A, V3, P3107, DOI 10.1002/pol.1965.100030906; Tolinski M, 2009, PDL HANDB SER, P79; Voldman S. H., 2009, ESD FAILURE MECH MOD; Volta Alessandro, 1800, PHILOS T ROYAL SOC L, V90, P403, DOI DOI 10.1098/RSTL.1800.0018; Waltman MJ, 2008, TALANTA, V77, P249, DOI 10.1016/j.talanta.2008.06.014; Williams MW, 2012, AIP ADV, V2, DOI 10.1063/1.3687233	22	102	106	6	206	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 20	2013	341	6152					1368	1371		10.1126/science.1241326	http://dx.doi.org/10.1126/science.1241326			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	220PK	24052302				2022-12-28	WOS:000324597200039
J	Mahmood, SS; Levy, D; Vasan, RS; Wang, TJ				Mahmood, Syed S.; Levy, Daniel; Vasan, Ramachandran S.; Wang, Thomas J.			The Framingham Heart Study and the epidemiology of cardiovascular disease: a historical perspective	LANCET			English	Review							RISK-FACTORS; FOLLOW-UP; SYSTOLIC HYPERTENSION; ATRIAL-FIBRILLATION; DIABETES-MELLITUS; NATURAL-HISTORY; BLOOD-PRESSURE; FAILURE; POPULATION; MORTALITY	On Sept 29, 2013, the Framingham Heart Study will celebrate 65 years since the examination of the first volunteer in 1948. During this period, the study has provided substantial insight into the epidemiology and risk factors of cardiovascular disease. The origins of the study are closely linked to the cardiovascular health of President Franklin D Roosevelt and his premature death from hypertensive heart disease and stroke in 1945. In this Review we describe the events leading to the foundation of the Framingham Heart Study, and provide a brief historical overview of selected contributions from the study.	[Mahmood, Syed S.] Harvard Univ, Sch Med, Dept Med, Massachusetts Gen Hosp, Boston, MA USA; [Levy, Daniel; Vasan, Ramachandran S.; Wang, Thomas J.] NHLBI, Framingham Heart Study, Framingham, MA USA; [Levy, Daniel] NHLBI, Populat Res Branch, Div Intramural Res, NIH, Bethesda, MD 20892 USA; [Vasan, Ramachandran S.] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; [Vasan, Ramachandran S.] Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Boston, MA 02118 USA; [Wang, Thomas J.] Vanderbilt Univ, Div Cardiovasc Med, Nashville, TN 37235 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Boston University; Boston University; Vanderbilt University	Wang, TJ (corresponding author), Vanderbilt Univ Sch Med, Div Cardiovasc Med, Nashville, TN 37232 USA.	thomas.j.wang@vanderbilt.edu	Ramachandran, Vasan/Y-2527-2019; Levy, Daniel/ABB-2752-2021; Levy, Daniel/ABF-6873-2021	Ramachandran, Vasan/0000-0001-7357-5970; Levy, Daniel/0000-0003-1843-8724; Wang, Thomas/0000-0003-4063-6508; Mahmood, Syed Saad/0000-0001-6938-1321	NIH [N01-HC-25195]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank Paul Sorlie (National Heart, Lung, and Blood Institute, Bethesda, MD, USA) for his assistance in granting access to the Framingham Archives. We thank Gerald Oppenheimer (Department of Sociomedical Sciences, Columbia University, New York, NY, USA) for comments on the history of the Framingham Heart Study. This work was supported by NIH contract N01-HC-25195.	ANITSCHKOW N, 1983, ARTERIOSCLEROSIS, V3, P178; [Anonymous], 1991, JAMA, V265, P3255; [Anonymous], 1977, JAMA, V237, P255; [Anonymous], 2012, EUR HLTH REP 2012 CH; [Anonymous], 1968, CRIT EV FRAM MON; [Anonymous], 2002, 3 EXP PAN DET EV TRE; Beeson PB, 1963, CECIL LOEB TXB MED; BENACK RT, 1969, ANN NY ACAD SCI, V156, P594, DOI 10.1111/j.1749-6632.1969.tb16754.x; BENJAMIN EJ, 1994, JAMA-J AM MED ASSOC, V271, P840, DOI [DOI 10.1001/JAMA.1994.03510350050036, DOI 10.1001/JAMA.271.11.840]; BERNSTEIN BJ, 1976, WESTERN POLIT QUART, V29, P202, DOI 10.2307/448105; BLACKBURN H, 1995, CIRCULATION, V91, P1253, DOI 10.1161/01.CIR.91.4.1253; BRUENN HG, 1970, ANN INTERN MED, V72, P579, DOI 10.7326/0003-4819-72-4-579; Bumgarner J, 1994, HLTH PRESIDENTS; CAIRD FI, 1963, POSTGRAD MED J, V39, P408, DOI 10.1136/pgmj.39.453.408; CASTELLI WP, 1977, CIRCULATION, V55, P767, DOI 10.1161/01.CIR.55.5.767; CHAPMAN J. M., 1957, AMER JOUR PUBL HEALTH, V47, P33, DOI 10.2105/AJPH.47.4_Pt_2.33; DAWBER T. R., 1957, AMER JOUR PUBL HEALTH, V47, P4, DOI 10.2105/AJPH.47.4_Pt_2.4; Dawber TR, 1951, AM J PUBLIC HEALTH N, V41, P279, DOI 10.2105/ajph.41.3.279; Dawber Thomas R., 1980, FRAMINGHAM HEART STU; Fineberg MH, 1927, AM J MED SCI, V173, P835; GARCIA MJ, 1974, DIABETES, V23, P105, DOI 10.2337/diab.23.2.105; GIBSON TC, 1966, J CHRON DIS, V19, P141, DOI 10.1016/0021-9681(66)90045-2; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Goldsmith H., 2007, CONSPIRACY SILENCE H; GORDON T, 1977, AM J MED, V62, P707, DOI 10.1016/0002-9343(77)90874-9; Gordon T, 1968, FRAMINGHAM STUDY; GUBNER RS, 1962, AM J CARDIOL, V9, P773, DOI 10.1016/0002-9149(62)90139-X; Harrison TR, 1966, PRINCIPLES INTERNAL; Herrick JB, 1912, J AMER MED ASSOC, V59, P2015; HUBERT HB, 1983, CIRCULATION, V67, P968, DOI 10.1161/01.CIR.67.5.968; Hunt SA, 2005, CIRCULATION, V112, pE154, DOI 10.1161/CIRCULATIONAHA.105.167586; Kannel W B, 1972, N Engl J Med, V287, P781, DOI 10.1056/NEJM197210192871601; KANNEL WB, 1970, J AMER MED ASSOC, V214, P301, DOI 10.1001/jama.214.2.301; KANNEL WB, 1976, AM J CARDIOL, V38, P46, DOI 10.1016/0002-9149(76)90061-8; KANNEL WB, 1990, J AM COLL CARDIOL, V15, P206, DOI 10.1016/0735-1097(90)90203-2; KANNEL WB, 1979, CIRCULATION, V59, P8, DOI 10.1161/01.CIR.59.1.8; KANNEL WB, 1974, AM J CARDIOL, V34, P29, DOI 10.1016/0002-9149(74)90089-7; KANNEL WB, 1971, AM J CARDIOL, V27, P335, DOI 10.1016/0002-9149(71)90428-0; KANNEL WB, 1961, ANN INTERN MED, V55, P33, DOI 10.7326/0003-4819-55-1-33; KANNEL WB, 1979, AM J EPIDEMIOL, V110, P281, DOI 10.1093/oxfordjournals.aje.a112813; KANNEL WB, 1965, AM J PUBLIC HEALTH N, V55, P1355, DOI 10.2105/AJPH.55.9.1355; Kannel WB, 2000, J HUM HYPERTENS, V14, P83, DOI 10.1038/sj.jhh.1000949; KEEN H, 1965, LANCET, V2, P505; Kenchaiah S, 2002, NEW ENGL J MED, V347, P305, DOI 10.1056/NEJMoa020245; KEYS A, 1989, ANN MED, V21, P163, DOI 10.3109/07853898909149927; KEYS A, 1960, CIRCULATION, V22, P1091, DOI 10.1161/01.CIR.22.6.1091; Klara R., 2010, FDRS FUNERAL TRAIN; Levy D, 1996, JAMA-J AM MED ASSOC, V275, P1557, DOI 10.1001/jama.275.20.1557; Levy D, 2002, NEW ENGL J MED, V347, P1397, DOI 10.1056/NEJMoa020265; Levy D., 2006, CHANGE HEART PEOPLE; LIEBOW IM, 1949, AM J MED, V7, P660, DOI 10.1016/0002-9343(49)90388-5; LIEBOW IM, 1955, AM J MED, V18, P438, DOI 10.1016/0002-9343(55)90224-2; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; MCKEE PA, 1971, NEW ENGL J MED, V285, P1441, DOI 10.1056/NEJM197112232852601; McNamara PM, 1967, COMMUNICATION   1117; Meadors GF, 1948, COMMUNICATION; Meadors GF, 1947, JUSTIFICATION BUDGET; MICKERSON JN, 1963, AM HEART J, V65, P267, DOI 10.1016/0002-8703(63)90161-3; Moran L., 1966, CHURCHILL TAKEN DIAR; National Heart Institute, 1949, HEART DIS EP STUD MA; Oppenheimer GM, 2006, INT J EPIDEMIOL, V35, P720, DOI 10.1093/ije/dyl014; Oransky I, 2006, LANCET, V367, P106, DOI 10.1016/S0140-6736(06)67950-6; Oransky I, 2004, LANCET, V364, P2174, DOI 10.1016/S0140-6736(04)17578-8; PARTAMIA.JO, 1965, NEW ENGL J MED, V273, P455, DOI 10.1056/NEJM196508262730901; PRICHARD BN, 1964, BMJ-BRIT MED J, V2, P725, DOI 10.1136/bmj.2.5411.725; Robbins LC, 1947, COMMUNICATION; Root HF, 1939, J AMER MED ASSOC, V113, P27, DOI 10.1001/jama.1939.02800260029008; Splansky GL, 2007, AM J EPIDEMIOL, V165, P1328, DOI 10.1093/aje/kwm021; Staessen JA, 1997, LANCET, V350, P757, DOI 10.1016/S0140-6736(97)05381-6; TRUETT J, 1967, J CHRON DIS, V20, P511, DOI 10.1016/0021-9681(67)90082-3; US Department of Health Education and Welfare, 1979, DHEW PUBL; US Public Health Service, 1947, AGR ADM REL FISC YEA; US Senate Committee on Labor and Public Welfare, 1948, 80 US C 2 SESS JUN 1; Vasan RS, 1997, NEW ENGL J MED, V336, P1350, DOI 10.1056/NEJM199705083361903; Vasan RS, 1999, J AM COLL CARDIOL, V33, P1948, DOI 10.1016/S0735-1097(99)00118-7; Wang TJ, 2004, JAMA-J AM MED ASSOC, V292, P2471, DOI 10.1001/jama.292.20.2471; Wang TJ, 2003, CIRCULATION, V108, P977, DOI 10.1161/01.CIR.0000085166.44904.79; Waterston D, 1939, Br Heart J, V1, P237; WERKO L, 1976, AM HEART J, V91, P87, DOI 10.1016/S0002-8703(76)80439-5; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; WOLF PA, 1978, NEUROLOGY, V28, P973, DOI 10.1212/WNL.28.10.973	81	644	699	10	91	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 15	2014	383	9921					999	1008		10.1016/S0140-6736(13)61752-3	http://dx.doi.org/10.1016/S0140-6736(13)61752-3			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD8MR	24084292	Green Accepted			2022-12-28	WOS:000333520700030
J	Kiritsi, D; Diaz-Cascajo, C; Mann, RH; Happle, R; Jakob, T; Kern, JS				Kiritsi, Dimitra; Diaz-Cascajo, Carlos; Mann, Rolf Hoff; Happle, Rudolf; Jakob, Thilo; Kern, Johannes S.			A band-like balding disorder	LANCET			English	Editorial Material									[Kiritsi, Dimitra; Happle, Rudolf; Jakob, Thilo; Kern, Johannes S.] Univ Med Ctr Freiburg, Dept Dermatol & Venereol, Freiburg, Germany; [Diaz-Cascajo, Carlos] Ctr Dermatopathol Freiburg, Freiburg, Germany	University of Freiburg	Kiritsi, D (corresponding author), Univ Freiburg, Med Ctr, Dept Dermatol, Hauptstr 7, D-79104 Freiburg, Germany.	dimitra.kiritsi@uniklinik-freiburg.de	Kiritsi, Dimitra/AAL-4762-2020	Kiritsi, Dimitra/0000-0002-2331-8981; Kern, Johannes S/0000-0001-6372-8048					0	2	2	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 15	2014	383	9917					E14	E14		10.1016/S0140-6736(13)60804-1	http://dx.doi.org/10.1016/S0140-6736(13)60804-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AA5KP	24119978				2022-12-28	WOS:000331137700002
J	Bogorad, IW; Lin, TS; Liao, JC				Bogorad, Igor W.; Lin, Tzu-Shyang; Liao, James C.			Synthetic non-oxidative glycolysis enables complete carbon conservation	NATURE			English	Article							ESCHERICHIA-COLI; PATHWAY; FLUX; ASSIMILATION; METABOLISM; CATABOLISM; EXPRESSION; CONVERSION; PRODUCTS; GLUCOSE	Glycolysis, or its variations, is a fundamental metabolic pathway in life that functions in almost all organisms to decompose external or intracellular sugars. The pathway involves the partial oxidation and splitting of sugars to pyruvate, which in turn is decarboxylated to produce acetyl-coenzyme A (CoA) for various biosynthetic purposes. The decarboxylation of pyruvate loses a carbon equivalent, and limits the theoretical carbon yield to only two moles of two-carbon (C2) metabolites per mole of hexose. This native route is a major source of carbon loss in biorefining and microbial carbon metabolism. Here we design and construct a non-oxidative, cyclic pathway that allows the production of stoichiometric amounts of C2 metabolites from hexose, pentose and triose phosphates without carbon loss. We tested this pathway, termed non-oxidative glycolysis (NOG), in vitro and in vivo in Escherichia coli. NOG enables complete carbon conservation in sugar catabolism to acetyl-CoA, and can be used in conjunction with CO2 fixation(1) and other one-carbon (C1) assimilation pathways(2) to achieve a 100% carbon yield to desirable fuels and chemicals.	[Bogorad, Igor W.; Lin, Tzu-Shyang; Liao, James C.] Univ Calif Los Angeles, Dept Chem & Biomol Engn, Los Angeles, CA 90095 USA; [Bogorad, Igor W.] Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA 90095 USA; [Liao, James C.] Univ Calif Los Angeles, Inst Genom & Prote, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Liao, JC (corresponding author), Univ Calif Los Angeles, Dept Chem & Biomol Engn, 420 Westwood Plaza, Los Angeles, CA 90095 USA.	liaoj@ucla.edu		Bogorad, Igor/0000-0002-7023-2494; Liao, James/0000-0002-4580-7276	National Science Foundation (NSF) [MCB-1139318]; Department of Energy (DOE) [DE0-SC0006698]; NSF Integrative Graduate Education and Research Traineeship (IGERT) [0903720]	National Science Foundation (NSF)(National Science Foundation (NSF)); Department of Energy (DOE)(United States Department of Energy (DOE)); NSF Integrative Graduate Education and Research Traineeship (IGERT)(National Science Foundation (NSF))	This work was partially supported by National Science Foundation (NSF) grant MCB-1139318 and Department of Energy (DOE) grant DE0-SC0006698. I. W. B. was supported by NSF Integrative Graduate Education and Research Traineeship (IGERT) grant no. 0903720.	ASLANIDIS C, 1990, NUCLEIC ACIDS RES, V18, P6069, DOI 10.1093/nar/18.20.6069; Atsumi S, 2008, METAB ENG, V10, P305, DOI 10.1016/j.ymben.2007.08.003; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; BASSHAM JA, 1954, J AM CHEM SOC, V76, P1760, DOI 10.1021/ja01636a012; Berg IA, 2007, SCIENCE, V318, P1782, DOI 10.1126/science.1149976; Causey TB, 2003, P NATL ACAD SCI USA, V100, P825, DOI 10.1073/pnas.0337684100; DALDAL F, 1983, J BACTERIOL, V153, P390, DOI 10.1128/JB.153.1.390-394.1983; Drake HL, 2004, RES MICROBIOL, V155, P868, DOI 10.1016/j.resmic.2004.10.001; Dugar D, 2011, NAT BIOTECHNOL, V29, P1074, DOI 10.1038/nbt.2055; Gonzalez R, 2002, BIOTECHNOL PROGR, V18, P6, DOI 10.1021/bp010121i; Gronenberg LS, 2013, CURR OPIN CHEM BIOL, V17, P462, DOI 10.1016/j.cbpa.2013.03.037; Guterl JK, 2012, CHEMSUSCHEM, V5, P2165, DOI 10.1002/cssc.201200365; Lan EI, 2012, P NATL ACAD SCI USA, V109, P6018, DOI 10.1073/pnas.1200074109; Li H, 2012, SCIENCE, V335, P1596, DOI 10.1126/science.1217643; Liao JC, 1996, BIOTECHNOL BIOENG, V52, P129, DOI 10.1002/(SICI)1097-0290(19961005)52:1<129::AID-BIT13>3.0.CO;2-J; Liu LX, 2012, J BACTERIOL, V194, P5413, DOI 10.1128/JB.00713-12; Liu XY, 2011, P NATL ACAD SCI USA, V108, P6899, DOI 10.1073/pnas.1103014108; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; MELENDEZHEVIA E, 1985, J THEOR BIOL, V117, P251, DOI 10.1016/S0022-5193(85)80220-4; Nelson D.L., 2005, LEHNINGER PRINCIPLES, DOI DOI 10.1002/BMB.2005.494033010419; PATNAIK R, 1992, J BACTERIOL, V174, P7527, DOI 10.1128/JB.174.23.7527-7532.1992; Peekhaus N, 1998, J BACTERIOL, V180, P3495, DOI 10.1128/JB.180.14.3495-3502.1998; Ragsdale SW, 2006, CHEM REV, V106, P3317, DOI 10.1021/cr0503153; Ragsdale SW, 2008, BBA-PROTEINS PROTEOM, V1784, P1873, DOI 10.1016/j.bbapap.2008.08.012; ROSEMAN S, 1990, J BIOL CHEM, V265, P2993; SCHUSTER R, 1993, COMPUT APPL BIOSCI, V9, P79; Tao H, 2001, J BACTERIOL, V183, P2979, DOI 10.1128/JB.183.10.2979-2988.2001; Tcherkez GGB, 2006, P NATL ACAD SCI USA, V103, P7246, DOI 10.1073/pnas.0600605103; Ye XT, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-120; Yin XH, 2005, FEMS MICROBIOL LETT, V246, P251, DOI 10.1016/j.femsle.2005.04.013; Yurimoto H, 2005, CHEM REC, V5, P367, DOI 10.1002/tcr.20056	31	220	243	15	211	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 31	2013	502	7473					693	+		10.1038/nature12575	http://dx.doi.org/10.1038/nature12575			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243CC	24077099				2022-12-28	WOS:000326293200050
J	Siponen, MI; Legrand, P; Widdrat, M; Jones, SR; Zhang, WJ; Chang, MCY; Faivre, D; Arnoux, P; Pignol, D				Siponen, Marina I.; Legrand, Pierre; Widdrat, Marc; Jones, Stephanie R.; Zhang, Wei-Jia; Chang, Michelle C. Y.; Faivre, Damien; Arnoux, Pascal; Pignol, David			Structural insight into magnetochrome-mediated magnetite biomineralization	NATURE			English	Article							C-TYPE CYTOCHROME; MAGNETOSPIRILLUM-GRYPHISWALDENSE; SMALL-ANGLE; PROTEIN; REFINEMENT; SCATTERING; REVEALS	Magnetotactic bacteria align along the Earth's magnetic field using an organelle called the magnetosome, a biomineralized magnetite (Fe(II)Fe(III)(2)O-4) or greigite (Fe(II)Fe(III)(2)S-4) crystal embedded in a lipid vesicle. Although the need for both iron(II) and iron(III) is clear, little is known about the biological mechanisms controlling their ratio(1). Here we present the structure of the magnetosome-associated protein MamP and find that it is built on a unique arrangement of a self-plugged PDZ domain fused to two magnetochrome domains, defining a new class of c-type cytochrome exclusively found in magnetotactic bacteria. Mutational analysis, enzyme kinetics, co-crystallization with iron(II) and an in vitro MamP-assisted magnetite production assay establish MamP as an iron oxidase that contributes to the formation of iron(III) ferrihydrite eventually required for magnetite crystal growth in vivo. These results demonstrate the molecular mechanisms of iron management taking place inside the magnetosome and highlight the role of magnetochrome in iron biomineralization.	[Siponen, Marina I.; Arnoux, Pascal; Pignol, David] Commissariat Energie Atom & Energies Alternat, Direct Sci Vivant, Inst Biol Environm & Biotechnol, Lab Bioenerget Cellulaire, F-13108 St Paul Les Durance, France; [Siponen, Marina I.; Arnoux, Pascal; Pignol, David] CNRS, Unite Mixte Rech Biol Vegetaleet Microbiol Enviro, F-13108 St Paul Les Durance, France; [Siponen, Marina I.; Arnoux, Pascal; Pignol, David] Aix Marseille Univ, F-13108 St Paul Les Durance, France; [Legrand, Pierre] Synchrotron SOLEIL, F-91192 Gif Sur Yvette, France; [Widdrat, Marc; Faivre, Damien] Max Planck Inst Colloids & Interfaces, Dept Biomat, D-14424 Potsdam, Germany; [Jones, Stephanie R.; Chang, Michelle C. Y.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Jones, Stephanie R.; Chang, Michelle C. Y.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Zhang, Wei-Jia] Aix Marseille Univ, Lab Chim Bacterienne, Inst Microbiol Mediterranee, UMR7283,CNRS, F-13402 Marseille 20, France; [Zhang, Wei-Jia; Arnoux, Pascal; Pignol, David] CNRS, Lab Int Assoc Biomineralisat & Nanostruct, F-13402 Marseille 20, France	CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; SOLEIL Synchrotron; Max Planck Society; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS)	Pignol, D (corresponding author), Commissariat Energie Atom & Energies Alternat, Direct Sci Vivant, Inst Biol Environm & Biotechnol, Lab Bioenerget Cellulaire, F-13108 St Paul Les Durance, France.	pascal.arnoux@cea.fr; david.pignol@cea.fr	LEGRAND, Pierre/G-7709-2011; faivre, damien/D-3713-2009	LEGRAND, Pierre/0000-0003-2431-2255; faivre, damien/0000-0001-6191-3389; PIGNOL, David/0000-0002-8070-0319; ARNOUX, Pascal/0000-0003-4609-4893	Eurotalent program; ToxNuc-E program; Max Planck Society; ERC [256915-MB2]; Defense Advanced Research Projects Agency [N66001-12-1-4230]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM066698] Funding Source: NIH RePORTER	Eurotalent program; ToxNuc-E program; Max Planck Society(Max Planck SocietyFoundation CELLEX); ERC(European Research Council (ERC)European Commission); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work received institutional support from the Commissariat a l'Energie Atomique et aux Energies Alternatives, the Centre National de la Recherche Scientifique, Aix-Marseille University and the Max Planck Society. We are grateful to BM-30 (ESRF, Grenoble, France) and X06SA (SLS, Villigen, Switzerland) staff for technical assistance in synchrotron data collection. We thank J. Perez (SOLEIL, GIF-sur-Yvette) for help in SAXS data collection, and A. Komeili for the gift of the wild-type and Delta mamP AMB-1 strains. We acknowledge S. Siegel and C. Li for their support at the mu Spot beamline of BESSY II, Helmholtz Zentrum Berlin. We thank the AFMB laboratory (Marseille) for circular dichroism measurements. M. I. S. was supported by a grant from the Eurotalent and ToxNuc-E programs. D. F. is supported by the Max Planck Society and a Starting Grant from the ERC (256915-MB2). S. R. J. and M.C.Y.C. thank the Defense Advanced Research Projects Agency (N66001-12-1-4230) for support.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Baumgartner J, 2013, P NATL ACAD SCI USA, V110, P14883, DOI 10.1073/pnas.1307119110; Baumgartner J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057070; Baumgartner J, 2013, NAT MATER, V12, P310, DOI [10.1038/NMAT3558, 10.1038/nmat3558]; BELL PE, 1987, APPL ENVIRON MICROB, V53, P2610, DOI 10.1128/AEM.53.11.2610-2616.1987; BLAKEMORE R, 1975, SCIENCE, V190, P377, DOI 10.1126/science.170679; Clausen T, 2011, NAT REV MOL CELL BIO, V12, P152, DOI 10.1038/nrm3065; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fischer A, 2011, J R SOC INTERFACE, V8, P1011, DOI 10.1098/rsif.2010.0576; Fischer H, 2010, J APPL CRYSTALLOGR, V43, P101, DOI 10.1107/S0021889809043076; FRANKEL RB, 1984, PHILOS T R SOC B, V304, P567, DOI 10.1098/rstb.1984.0047; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Jolivet JP, 2004, CHEM COMMUN, P481, DOI 10.1039/b304532n; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Komeili A, 2012, FEMS MICROBIOL REV, V36, P232, DOI 10.1111/j.1574-6976.2011.00315.x; Krojer T, 2002, NATURE, V416, P455, DOI 10.1038/416455a; Lee HJ, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-8; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Liu J, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00037; Lohse I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021486; Fdez-Gubieda ML, 2013, ACS NANO, V7, P3297, DOI 10.1021/nn3059983; Murat D, 2010, P NATL ACAD SCI USA, V107, P5593, DOI 10.1073/pnas.0914439107; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Paris O, 2007, J APPL CRYSTALLOGR, V40, pS466, DOI 10.1107/S0021889806045444; Quinlan A, 2011, MOL MICROBIOL, V80, P1075, DOI 10.1111/j.1365-2958.2011.07631.x; Schuler D, 2008, FEMS MICROBIOL REV, V32, P654, DOI 10.1111/j.1574-6976.2008.00116.x; Siponen MI, 2012, BIOCHEM SOC T, V40, P1319, DOI 10.1042/BST20120104; Smith LJ, 2010, PROTEINS, V78, P2349, DOI 10.1002/prot.22747; Uebe R, 2011, MOL MICROBIOL, V82, P818, DOI 10.1111/j.1365-2958.2011.07863.x; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Zhang C, 2013, J BACTERIOL, V195, P876, DOI 10.1128/JB.01750-12	32	95	104	6	237	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 31	2013	502	7473					681	+		10.1038/nature12573	http://dx.doi.org/10.1038/nature12573			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243CC	24097349				2022-12-28	WOS:000326293200047
J	Lewin, JC; Atkins, GL; McNeely, L				Lewin, John C.; Atkins, G. Lawrence; McNeely, Larry			The Elusive Path to Health Care Sustainability	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Lewin, John C.; McNeely, Larry] Natl Coalit Hlth Care, Washington, DC 20006 USA; [Atkins, G. Lawrence] Natl Acad Social Insurance, Washington, DC USA		Lewin, JC (corresponding author), Natl Coalit Hlth Care, 1825 K St,Ste 411, Washington, DC 20006 USA.	jlewinmd@gmail.com						[Anonymous], 2013, CONFR COSTS STAB US; Bipartisan Policy Center, 2013, BIP RX PAT CTR CAR S; Engelberg Center for Health Care Reform at Brookings, 2013, BEND CURV PERS CTR H; Kaiser Family Foundation, 2013, POL OPT SUST MED FUT; National Coalition on Health Care, 2012, CURB COSTS IMPR CAR; Robert Wood Johnson Foundation, 2013, PARTN SUST HLTH CAR; Urban Institute, 2013, CAN MED BE PRES WHIL	7	6	6	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 23	2013	310	16					1669	1670		10.1001/jama.2013.280147	http://dx.doi.org/10.1001/jama.2013.280147			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	238LR	24080945				2022-12-28	WOS:000325948500017
J	Poorey, K; Viswanathan, R; Carver, MN; Karpova, TS; Cirimotich, SM; McNally, JG; Bekiranov, S; Auble, DT				Poorey, Kunal; Viswanathan, Ramya; Carver, Melissa N.; Karpova, Tatiana S.; Cirimotich, Shana M.; McNally, James G.; Bekiranov, Stefan; Auble, David T.			Measuring Chromatin Interaction Dynamics on the Second Time Scale at Single-Copy Genes	SCIENCE			English	Article							TRANSCRIPTION ACTIVATION; GAL4 TURNOVER; GENOME; PROMOTER; LOCALIZATION; ORGANIZATION; KINETICS; MOT1	The chromatin immunoprecipitation (ChIP) assay is widely used to capture interactions between chromatin and regulatory proteins, but it is unknown how stable most native interactions are. Although live-cell imaging suggests short-lived interactions at tandem gene arrays, current methods cannot measure rapid binding dynamics at single-copy genes. We show, by using a modified ChIP assay with subsecond temporal resolution, that the time dependence of formaldehyde cross-linking can be used to extract in vivo on and off rates for site-specific chromatin interactions varying over a similar to 100-fold dynamic range. By using the method, we show that a regulatory process can shift weakly bound TATA-binding protein to stable promoter interactions, thereby facilitating transcription complex formation. This assay provides an approach for systematic, quantitative analyses of chromatin binding dynamics in vivo.	[Poorey, Kunal; Viswanathan, Ramya; Carver, Melissa N.; Cirimotich, Shana M.; Bekiranov, Stefan; Auble, David T.] Univ Virginia Hlth Syst, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA; [Karpova, Tatiana S.; McNally, James G.] NCI, Ctr Canc Res Core Fluorescence Imaging Facil, Lab Receptor Biol & Gene Express, NIH, Bethesda, MD 20892 USA	University of Virginia; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Bekiranov, S (corresponding author), Univ Virginia Hlth Syst, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA.	sb3de@virginia.edu; auble@virginia.edu	Viswanathan, Ramya/L-5935-2019	Karpova, Tatiana/0000-0001-6025-2128	NIH, National Cancer Institute, Center for Cancer Research; NIH [GM55763]; NATIONAL CANCER INSTITUTE [ZICBC011574] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055763] Funding Source: NIH RePORTER	NIH, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank K. Struhl, F. Pugh, S. Hahn, and P. deHaseth for discussion; R. Nakamoto and M. Galkin for discussions and help with the KinTek instrument; and J. Muldoon, J. Hopper, F. Pugh, and S. Hahn for strains and plasmids. J. G. M. and T. S. K. were supported by the intramural program of the NIH, National Cancer Institute, Center for Cancer Research. Supported by NIH grant GM55763 to D.T.A.	Collins GA, 2009, NATURE, V461, pE7, DOI 10.1038/nature08406; Deal RB, 2010, SCIENCE, V328, P1161, DOI 10.1126/science.1186777; Hager GL, 2009, MOL CELL, V35, P741, DOI 10.1016/j.molcel.2009.09.005; Karpova TS, 2008, SCIENCE, V319, P466, DOI 10.1126/science.1150559; Larson DR, 2011, SCIENCE, V332, P475, DOI 10.1126/science.1202142; Lickwar CR, 2012, NATURE, V484, P251, DOI 10.1038/nature10985; Nalley K, 2009, NATURE, V461, pE8, DOI 10.1038/nature08407; Rhee HS, 2011, CELL, V147, P1408, DOI 10.1016/j.cell.2011.11.013; Roberts DN, 2003, P NATL ACAD SCI USA, V100, P14695, DOI 10.1073/pnas.2435566100; Robinett CC, 1996, J CELL BIOL, V135, P1685, DOI 10.1083/jcb.135.6.1685; Sprouse RO, 2008, P NATL ACAD SCI USA, V105, P13304, DOI 10.1073/pnas.0801901105; Sprouse RO, 2008, J BIOL CHEM, V283, P24935, DOI 10.1074/jbc.M803749200; Suter DM, 2011, SCIENCE, V332, P472, DOI 10.1126/science.1198817; Traven A, 2006, EMBO REP, V7, P496, DOI 10.1038/sj.embor.7400679; van Royen ME, 2011, CHROMOSOME RES, V19, P83, DOI 10.1007/s10577-010-9172-5; van Werven FJ, 2009, NAT STRUCT MOL BIOL, V16, P1043, DOI 10.1038/nsmb.1674; Viswanathan R, 2011, BBA-GENE REGUL MECH, V1809, P488, DOI 10.1016/j.bbagrm.2011.05.012	17	65	65	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 18	2013	342	6156					369	372		10.1126/science.1242369	http://dx.doi.org/10.1126/science.1242369			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235XG	24091704	Green Accepted			2022-12-28	WOS:000325755100048
J	Milathianaki, D; Boutet, S; Williams, GJ; Higginbotham, A; Ratner, D; Gleason, AE; Messerschmidt, M; Seibert, MM; Swift, DC; Hering, P; Robinson, J; White, WE; Wark, JS				Milathianaki, D.; Boutet, S.; Williams, G. J.; Higginbotham, A.; Ratner, D.; Gleason, A. E.; Messerschmidt, M.; Seibert, M. M.; Swift, D. C.; Hering, P.; Robinson, J.; White, W. E.; Wark, J. S.			Femtosecond Visualization of Lattice Dynamics in Shock-Compressed Matter	SCIENCE			English	Article							METALLIZATION	The ultrafast evolution of microstructure is key to understanding high-pressure and strain-rate phenomena. However, the visualization of lattice dynamics at scales commensurate with those of atomistic simulations has been challenging. Here, we report femtosecond x-ray diffraction measurements unveiling the response of copper to laser shock-compression at peak normal elastic stresses of similar to 73 gigapascals (GPa) and strain rates of 10(9) per second. We capture the evolution of the lattice from a one-dimensional (1D) elastic to a 3D plastically relaxed state within a few tens of picoseconds, after reaching shear stresses of 18 GPa. Our in situ high-precision measurement of material strength at spatial (<1 micrometer) and temporal (<50 picoseconds) scales provides a direct comparison with multimillion-atom molecular dynamics simulations.	[Milathianaki, D.; Boutet, S.; Williams, G. J.; Ratner, D.; Messerschmidt, M.; Seibert, M. M.; Hering, P.; Robinson, J.; White, W. E.] SLAC Natl Accelerator Lab, Menlo Pk, CA 94025 USA; [Higginbotham, A.; Wark, J. S.] Univ Oxford, Dept Phys, Clarendon Lab, Oxford OX1 3PU, England; [Gleason, A. E.] Stanford Univ, Dept Geol & Environm Sci, Stanford, CA 94305 USA; [Seibert, M. M.] Uppsala Univ, Dept Cell & Mol Biol, S-75124 Uppsala, Sweden; [Swift, D. C.] Lawrence Livermore Natl Lab, Livermore, CA 94551 USA	Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; University of Oxford; Stanford University; Uppsala University; United States Department of Energy (DOE); Lawrence Livermore National Laboratory	Milathianaki, D (corresponding author), SLAC Natl Accelerator Lab, Menlo Pk, CA 94025 USA.	despina@slac.stanford.edu	Messerschmidt, Marc/F-3796-2010; Milathianaki, Despina/AAG-5381-2021; Messerschmidt, Marc/Y-8929-2019	Messerschmidt, Marc/0000-0002-8641-3302; Messerschmidt, Marc/0000-0002-8641-3302; Hering, Philippe/0000-0002-6837-3159; /0000-0001-5211-9933; Seibert, Mark Marvin/0000-0003-0251-0744	LCLS; UK Atomic Weapons Establishment; UK Engineering and Physical Sciences Research Council [EP/J017256/1]; Engineering and Physical Sciences Research Council [EP/J017256/1] Funding Source: researchfish; EPSRC [EP/J017256/1] Funding Source: UKRI	LCLS; UK Atomic Weapons Establishment; UK Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank M. Bionta, A. Fry, S. Edstrom, J. Koglin, S. Guillet, I. Ofte, and G. Stewart for assisting with our experimental requirements, data processing, and illustrations. Raw x-ray data are available upon request. This work was funded as part of the in-house research effort of LCLS, a National User Facility operated by Stanford University on behalf of the U. S. Department of Energy, Office of Basic Energy Sciences. A. H. acknowledges support from the UK Atomic Weapons Establishment and J. S. W. from the UK Engineering and Physical Sciences Research Council under grant EP/J017256/1.	Bolme CA, 2007, J APPL PHYS, V102, DOI 10.1063/1.2767376; Boutet S, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/3/035024; Bringa EM, 2005, SCIENCE, V309, P1838, DOI 10.1126/science.1116723; Bringa M, 2006, NAT MATER, V5, P805, DOI 10.1038/nmat1735; Celliers PM, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3310076; Chen MW, 2006, NAT MATER, V5, P614, DOI 10.1038/nmat1689; Chisholm MF, 2005, SCIENCE, V307, P701, DOI 10.1126/science.1105962; Crowhurst JC, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.144302; Cullity B.D., 2001, ELEMENTS XRAY DIFFRA, Vthird; Dubrovinsky L, 2007, SCIENCE, V316, P1880, DOI 10.1126/science.1142105; Dupont V, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.134111; Emma P, 2010, NAT PHOTONICS, V4, P641, DOI [10.1038/NPHOTON.2010.176, 10.1038/nphoton.2010.176]; Higginbotham A, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.024112; Jensen BJ, 2008, J APPL PHYS, V104, DOI 10.1063/1.2936899; Kadau K, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.135701; Kalantar DH, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.075502; Loveridge-Smith A, 2001, PHYS REV LETT, V86, P2349, DOI 10.1103/PhysRevLett.86.2349; McWilliams RS, 2012, SCIENCE, V338, P1330, DOI 10.1126/science.1229450; Milathianaki D, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.014101; Murphy WJ, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/6/065404; Nellis WJ, 2006, REP PROG PHYS, V69, P1479, DOI 10.1088/0034-4885/69/5/R05; Orowan E, 1942, NATURE, V149, P643, DOI 10.1038/149643a0; Philipp HT, 2011, NUCL INSTRUM METH A, V649, P67, DOI 10.1016/j.nima.2010.11.189; Shehadeh MA, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2364853; Suggit MJ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2225; Swift DC, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.066115; Swift DC, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.036406; Thoma K, 2004, ADV SPACE RES-SERIES, V34, P1063, DOI 10.1016/j.asr.2003.03.034; Winey JM, 2009, J APPL PHYS, V106, DOI 10.1063/1.3236654	29	142	147	8	131	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 11	2013	342	6155					220	223		10.1126/science.1239566	http://dx.doi.org/10.1126/science.1239566			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232EV	24115435				2022-12-28	WOS:000325475200038
J	Doubilet, PM; Benson, CB; Bourne, T; Blaivas, M				Doubilet, Peter M.; Benson, Carol B.; Bourne, Tom; Blaivas, Michael		Soc Radiologists Ultrasound Multis	Diagnostic Criteria for Nonviable Pregnancy Early in the First Trimester	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							HUMAN CHORIONIC-GONADOTROPIN; EARLY EMBRYONIC DEMISE; DOUBLE SAC SIGN; SERUM BETA-HCG; ECTOPIC PREGNANCY; VAGINAL SONOGRAPHY; EARLY INTRAUTERINE; GESTATIONAL SAC; INTRADECIDUAL SIGN; UNKNOWN LOCATION	Determining the viability of a pregnancy is a major challenge, especially with a pregnancy of unknown location. This review provides specific guidance, including stringent criteria for nonviability, that can reduce the risk of inadvertent harm to a potentially normal pregnancy. Over the past two to three decades, pelvic ultrasonography and measurement of the serum concentration of human chorionic gonadotropin (hCG) (Table 1) have become mainstays in the diagnosis and management of early-pregnancy problems. These tests, which allow earlier detection of pregnancy and more accurate diagnosis of its complications than were previously possible, have revolutionized the management of intrauterine pregnancies and markedly reduced the morbidity and mortality associated with ectopic pregnancy.(1),(2) Although these tests have indisputable benefits, their misuse and misinterpretation can lead to interventions that inadvertently damage pregnancies that might have had normal outcomes.(3),(4) There are well-documented instances ...	[Doubilet, Peter M.; Benson, Carol B.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Doubilet, Peter M.; Benson, Carol B.] Harvard Univ, Sch Med, Boston, MA USA; [Bourne, Tom] Imperial Coll, Queen Charlottes & Chelsea Hosp, London, England; [Blaivas, Michael] Univ S Carolina, Columbia, SC 29208 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Imperial College London; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Doubilet, PM (corresponding author), Brigham & Womens Hosp, Dept Radiol, 75 Francis St, Boston, MA 02115 USA.	pdoubilet@partners.org	Doubilet, Peter/AAY-7351-2021; Bourne, Tom/I-6478-2012	Bourne, Tom/0000-0003-1421-6059; Timor-Tritsch, Ilan/0000-0001-9774-3107	National Institute for Health Research Biomedical Research Centre based at Imperial College Healthcare National Health Service Trust and Imperial College London; World Class CME; International Institute for Continuing Medical Education; GE Healthcare; Institute for Advanced Medical Education; Cook OB/GYN; Pfizer; Shionogi; Bayer; Merck; Warner Chilcott; GE Medical Systems	National Institute for Health Research Biomedical Research Centre based at Imperial College Healthcare National Health Service Trust and Imperial College London; World Class CME; International Institute for Continuing Medical Education; GE Healthcare(General ElectricGE Healthcare); Institute for Advanced Medical Education; Cook OB/GYN; Pfizer(Pfizer); Shionogi; Bayer(Bayer AG); Merck(Merck & Company); Warner Chilcott; GE Medical Systems(General Electric)	Supported by funding from the National Institute for Health Research Biomedical Research Centre based at Imperial College Healthcare National Health Service Trust and Imperial College London (to Dr. Bourne).; Dr. Benacerraf reports receiving lecture fees from World Class CME and the International Institute for Continuing Medical Education and travel reimbursement from GE Healthcare. Dr. Benson reports receiving fees for expert testimony in medical malpractice cases regarding standard of care for interpretation of ultrasonographic examinations and lecture fees from the International Institute for Continuing Medical Education and the Institute for Advanced Medical Education. Dr. Doubilet reports receiving fees for expert testimony in medical malpractice cases regarding standard of care for interpretation of ultrasonographic examinations and lecture fees from the International Institute for Continuing Medical Education. Dr. Filly reports receiving fees for expert testimony in medical malpractice cases as an expert in diagnostic sonography and lecture fees from World Class CME. He also reports being co-holder of a patent for a needle-guide device used for venous access under ultrasonographic guidance. Dr. Goldstein reports receiving consulting fees from Cook OB/GYN, Pfizer, Shionogi, and Bayer and lecture fees from Merck and Warner Chilcott. Dr. Lyons reports receiving lecture fees from GE Medical Systems and holding stock in Zonare Medical Systems. No other potential conflict of interest relevant to this article was reported.	Abdallah Y, 2011, ULTRASOUND OBST GYN, V38, P497, DOI 10.1002/uog.10109; Abdallah Y, 2011, ULTRASOUND OBST GYN, V38, P503, DOI 10.1002/uog.10075; ACKERMAN TE, 1993, RADIOLOGY, V189, P727, DOI 10.1148/radiology.189.3.8234696; Adhikari S, 2007, AM J EMERG MED, V25, P591, DOI 10.1016/j.ajem.2006.11.020; American College of Obstetricians and Gynecologists, 2009, Obstet Gynecol, V113, P451, DOI 10.1097/AOG.0b013e31819930b0; American Institute of Ultrasound in Medicine, 2010, J Ultrasound Med, V29, P166; Barnhart K, 2011, FERTIL STERIL, V95, P857, DOI 10.1016/j.fertnstert.2010.09.006; Barnhart KT, 2012, FERTIL STERIL, V98, P1061, DOI 10.1016/j.fertnstert.2012.09.018; Barnhart KT, 2009, NEW ENGL J MED, V361, P379, DOI 10.1056/NEJMcp0810384; BATEMAN BG, 1990, OBSTET GYNECOL, V75, P421; Benson CB, 2013, J ULTRAS MED, V32, P389; BERNASCHEK G, 1988, AM J OBSTET GYNECOL, V158, P608, DOI 10.1016/0002-9378(88)90039-7; Bignardi T, 2008, HUM REPROD, V23, P1964, DOI 10.1093/humrep/den221; BRADLEY WG, 1982, RADIOLOGY, V143, P223, DOI 10.1148/radiology.143.1.7063730; BREE RL, 1989, AM J ROENTGENOL, V153, P75, DOI 10.2214/ajr.153.1.75; BROMLEY B, 1991, RADIOLOGY, V178, P375, DOI 10.1148/radiology.178.2.1987595; BROWN DL, 1990, J ULTRAS MED, V9, P631; Condous G, 2007, ULTRASOUND OBST GYN, V29, P680, DOI 10.1002/uog.4015; Condous G, 2005, ULTRASOUND OBST GYN, V26, P770, DOI 10.1002/uog.2636; Connolly A, 2013, OBSTET GYNECOL, V121, P65, DOI [10.1097/AOG.0b013e318278f421, http://10.1097/AOG.0b013e318278f421]; Creanga AA, 2011, OBSTET GYNECOL, V117, P837, DOI 10.1097/AOG.0b013e3182113c10; Deutchman M, 2009, AM FAM PHYSICIAN, V79, P985; DOUBILET P, 1983, MED DECIS MAKING, V3, P177, DOI 10.1177/0272989X8300300206; Doubilet PM, 2013, J ULTRAS MED, V32, P1207, DOI 10.7863/ultra.32.7.1207; Doubilet PM, 2011, J ULTRAS MED, V30, P1637, DOI 10.7863/jum.2011.30.12.1637; Doubilet PM, 2010, J ULTRAS MED, V29, P685, DOI 10.7863/jum.2010.29.5.685; Galstyan K, 2006, INT J FERTIL WOMEN M, V51, P14; GOLDSTEIN I, 1991, OBSTET GYNECOL, V77, P885; GOLDSTEIN SR, 1992, OBSTET GYNECOL, V80, P670; Hahn SA, 2012, ANN EMERG MED, V60, P381, DOI 10.1016/j.annemergmed.2012.04.021; Hamilton J, 2011, ULTRASOUND OBSTET S1, V38, P7; Jeve Y, 2011, ULTRASOUND OBST GYN, V38, P489, DOI 10.1002/uog.10108; KADAR N, 1981, OBSTET GYNECOL, V58, P156; Kirk E, 2007, HUM REPROD, V22, P1744, DOI 10.1093/humrep/dem073; LEVI CS, 1988, RADIOLOGY, V167, P383, DOI 10.1148/radiology.167.2.3282258; LEVI CS, 1990, RADIOLOGY, V176, P71, DOI 10.1148/radiology.176.1.2191372; Levi CS, 1998, DIAGNOSTIC ULTRASOUN, P127; LINDSAY DJ, 1992, RADIOLOGY, V183, P115, DOI 10.1148/radiology.183.1.1549656; Mehta TS, 1997, RADIOLOGY, V205, P569, DOI 10.1148/radiology.205.2.9356647; Moore C, 2004, EMERG MED CLIN N AM, V22, P697, DOI 10.1016/j.emc.2004.04.005; MUELLER CE, 1979, J CLIN ULTRASOUND, V7, P133, DOI 10.1002/jcu.1870070212; Nurmohamed L, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.07.002; PENNELL RG, 1991, J ULTRAS MED, V10, P63; Pexsters A, 2011, ULTRASOUND OBST GYN, V38, P510, DOI 10.1002/uog.8884; Rowling SE, 1997, RADIOLOGY, V203, P211, DOI 10.1148/radiology.203.1.9122395; Sagili H, 2008, OBSTET GYNAECOL, V10, P224, DOI 10.1576/toag.10.4.224.27438; Savitz DA, 2002, AM J OBSTET GYNECOL, V187, P1660, DOI 10.1067/mob.2002.127601; Shaunik A, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.11.021; Shwayder JM, 2010, OBSTET GYNECOL, V116, P8, DOI 10.1097/AOG.0b013e3181e5e2ec; Thilaganathan B, 2011, ULTRASOUND OBST GYN, V38, P487, DOI 10.1002/uog.10110; TONGSONG T, 1994, INT J GYNECOL OBSTET, V46, P297, DOI 10.1016/0020-7292(94)90409-X; Yegul NT, 2010, J CLIN ULTRASOUND, V38, P113, DOI 10.1002/jcu.20673; YEH HC, 1986, RADIOLOGY, V161, P463, DOI 10.1148/radiology.161.2.3532191	53	172	184	2	20	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 10	2013	369	15					1443	1451		10.1056/NEJMra1302417	http://dx.doi.org/10.1056/NEJMra1302417			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	231QE	24106937	Green Published			2022-12-28	WOS:000325431500012
J	Katz, IT; Bassett, IV; Wright, AA				Katz, Ingrid T.; Bassett, Ingrid V.; Wright, Alexi A.			PEPFAR in Transition - Implications for HIV Care in South Africa	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								With the U.S. government halving the budget for the President's Emergency Plan for AIDS Relief in South Africa by 2017, the country is transitioning to full ownership of its HIV program. Will the move jeopardize the health of 1.7 million South Africans being treated for HIV? This summer marked the 10th anniversary of the creation of the President's Emergency Plan for AIDS Relief (PEPFAR), widely considered the most ambitious and successful global public health program since smallpox eradication. Over the past decade, PEPFAR has funded HIV-AIDS treatment for more than 5 million people in resource-limited settings in sub-Saharan Africa. Now, the U.S. government has reached a turning point in its emergency response and has decided to reduce funding to many of these countries, including South Africa, recipient of the most PEPFAR dollars. In August 2012, the U.S. government announced it would cut South Africa's PEPFAR budget ...	[Katz, Ingrid T.] Massachusetts Gen Hosp, Div Womens Hlth, Brigham & Womens Hosp, Ctr Global Hlth, Boston, MA 02114 USA; [Katz, Ingrid T.; Bassett, Ingrid V.; Wright, Alexi A.] Harvard Univ, Sch Med, Boston, MA USA; [Bassett, Ingrid V.] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA; [Bassett, Ingrid V.] Massachusetts Gen Hosp, Div Gen Med, Boston, MA 02114 USA; [Bassett, Ingrid V.] Massachusetts Gen Hosp, Med Practice Evaluat Ctr, Boston, MA 02114 USA; [Wright, Alexi A.] Dana Farber Canc Ctr, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Dana-Farber Cancer Institute	Katz, IT (corresponding author), Massachusetts Gen Hosp, Div Womens Hlth, Brigham & Womens Hosp, Ctr Global Hlth, Boston, MA 02114 USA.		Bassett, Ingrid V./ABI-7674-2020; Wright, Alexi/T-5793-2019	Bassett, Ingrid V./0000-0001-6920-6080; Katz, Ingrid/0000-0002-3014-238X	NIMH NIH HHS [K23 MH097667, R01 MH090326] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [K23MH097667, R01MH090326] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Bassett Ingrid, 2013, 8 INT C HIV TREATM P; Bendavid E, 2012, JAMA-J AM MED ASSOC, V307, P2060, DOI 10.1001/jama.2012.2001; Bor J, 2013, SCIENCE, V339, P961, DOI 10.1126/science.1230413; Chigwedere P, 2008, JAIDS-J ACQ IMM DEF, V49, P410, DOI 10.1097/QAI.0b013e31818a6cd5; Katz IT, 2011, AIDS, V25, P2177, DOI 10.1097/QAD.0b013e32834b6464	5	39	39	0	23	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 10	2013	369	15					1385	1387		10.1056/NEJMp1310982	http://dx.doi.org/10.1056/NEJMp1310982			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	231QE	24106930	Green Accepted			2022-12-28	WOS:000325431500002
J	Dean, J				Dean, John			Mandatory moaning	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Royal Devon & Exeter Hosp, Exeter EX2 5DW, Devon, England	University of Exeter	Dean, J (corresponding author), Royal Devon & Exeter Hosp, Exeter EX2 5DW, Devon, England.	lub.dub@virgin.net							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 9	2013	347								f5968	10.1136/bmj.f5968	http://dx.doi.org/10.1136/bmj.f5968			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	235ON	24108161				2022-12-28	WOS:000325729100009
J	Baulcombe, D				Baulcombe, David			Small RNA-the Secret of Noble Rot	SCIENCE			English	Editorial Material									Univ Cambridge, Dept Plant Sci, Cambridge CB2 3EA, England	University of Cambridge	Baulcombe, D (corresponding author), Univ Cambridge, Dept Plant Sci, Cambridge CB2 3EA, England.	dcb40@cam.ac.uk		Baulcombe, David/0000-0003-0780-6878				Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Lisch D, 2013, NAT REV GENET, V14, P49, DOI 10.1038/nrg3374; Nowara D, 2010, PLANT CELL, V22, P3130, DOI 10.1105/tpc.110.077040; Sarkies P, 2013, SCIENCE, V341, P467, DOI 10.1126/science.1243175; Weiberg A, 2013, SCIENCE, V342, P118, DOI 10.1126/science.1239705	6	11	11	0	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 4	2013	342	6154					45	46		10.1126/science.1245010	http://dx.doi.org/10.1126/science.1245010			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	227PP	24092716				2022-12-28	WOS:000325126100034
J	Spence, D				Spence, Des			FROM THE FRONTLINE The art of deception	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk						BBC News, 2013, BBC NEWS; McClure RJ, 1996, ARCH DIS CHILD, V75, P57, DOI 10.1136/adc.75.1.57	2	0	0	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 2	2013	347								f5889	10.1136/bmj.f5889	http://dx.doi.org/10.1136/bmj.f5889			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	231OU	24089428				2022-12-28	WOS:000325427400016
J	Soreide, K; Alderson, D; Bergenfelz, A; Beynon, J; Connor, S; Deckelbaum, DL; Dejong, CH; Earnshaw, JJ; Kyamanywa, P; Perez, RO; Sakai, Y; Winter, DC				Soreide, Kjetil; Alderson, Derek; Bergenfelz, Anders; Beynon, John; Connor, Saxon; Deckelbaum, Dan L.; Dejong, Cornelis H.; Earnshaw, Jonathan J.; Kyamanywa, Patrick; Perez, Rodrigo O.; Sakai, Yoshiharu; Winter, Desmond C.		Int Res Collaboration Surg IRIS Ad	Strategies to improve clinical research in surgery through international collaboration	LANCET			English	Review							HEALTH TECHNOLOGY-ASSESSMENT; QUALITY-OF-LIFE; INTERVENTIONAL PROCEDURES; HUMANITARIAN CRISES; SURGICAL CONDITIONS; PANCREATIC SURGERY; MEDICAL DEVICES; PATIENT ACCESS; LOW-INCOME; TRIALS	More than 235 million patients undergo surgery every year worldwide, but less than 1% are enrolled in surgical clinical trials-few of which are international collaborations. Several levels of action are needed to improve this situation. International research collaborations in surgery between developed and developing countries could encourage capacity building and quality improvement, and mutually enhance care for patients with surgical disorders. Low-income and middle-income countries increasingly report much the same range of surgical diseases as do high-income countries (eg, cancer, cardiovascular disease, and the surgical sequelae of metabolic syndrome); collaboration is therefore of mutual interest. Large multinational trials that cross cultures and levels of socioeconomic development might have faster results and wider applicability than do single-country trials. Surgeons educated in research methods, and aided by research networks and trial centres, are needed to foster these international collaborations. Barriers to collaboration could be overcome by adoption of global strategies for regulation, health insurance, ethical approval, and indemnity coverage for doctors.	[Soreide, Kjetil] Stavanger Univ Hosp, Dept Gastrointestinal Surg, N-4068 Stavanger, Norway; [Soreide, Kjetil] Univ Bergen, Dept Clin Med, Bergen, Norway; [Alderson, Derek] Univ Birmingham, Queen Elizabeth Hosp, Univ Hosp Birmingham NHS Fdn Trust, Coll Med & Dent Sci,Sch Canc Sci,Acad Dept Surg, Birmingham B15 2TH, W Midlands, England; [Bergenfelz, Anders] Skane Univ Hosp, Dept Surg, Lund, Sweden; [Beynon, John] Abertawe Bro Morgannwg Univ Trust, Dept Colorectal Surg, Swansea, W Glam, Wales; [Connor, Saxon] Christchurch Hosp, Dept Surg, Christchurch, New Zealand; [Deckelbaum, Dan L.] McGill Univ, Ctr Hlth, Ctr Global Surg, Montreal, PQ, Canada; [Dejong, Cornelis H.] Univ Hosp Maastricht, Dept Surg, Maastricht, Netherlands; [Dejong, Cornelis H.] Maastricht Univ, Sch Nutr Toxicol & Metab, NUTRIM, Maastricht, Netherlands; [Earnshaw, Jonathan J.] Gloucestershire Royal Hosp, Dept Vasc Surg, Gloucester GL1 3NN, England; [Kyamanywa, Patrick] Natl Univ Rwanda, Fac Med, Dept Surg, Butare, Rwanda; [Perez, Rodrigo O.] Univ Sao Paulo, Sch Med, Dept Gastroenterol, Colorectal Surg Div, BR-05508 Sao Paulo, Brazil; [Sakai, Yoshiharu] Kyoto Univ, Dept Surg, Kyoto, Japan; [Winter, Desmond C.] St Vincents Univ Hosp, Dept Surg, Dublin 4, Ireland	Stavanger University Hospital; University of Bergen; University of Birmingham; Lund University; Skane University Hospital; Christchurch Hospital New Zealand; McGill University; Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Gloucestershire Royal Hospital; University of Rwanda; Universidade de Sao Paulo; Kyoto University; University College Dublin; Saint Vincent's University Hospital	Soreide, K (corresponding author), Stavanger Univ Hosp, Dept Gastrointestinal Surg, POB 8100, N-4068 Stavanger, Norway.	ksoreide@mac.com	Søreide, Kjetil/A-9797-2010; connor, saxon/N-7641-2013; Perez, Rodrigo Oliva/A-2163-2013; Sammour, Tarik/H-3467-2019	Søreide, Kjetil/0000-0001-7594-4354; connor, saxon/0000-0002-5788-2185; Perez, Rodrigo Oliva/0000-0003-1704-2277; Sammour, Tarik/0000-0002-4918-8871; Kim, Nam-Kyu/0000-0003-0639-5632				Adebamowo C A, 2009, Afr J Med Med Sci, V38 Suppl 2, P5; Al-Refaie Waddah B, 2012, Adv Surg, V46, P269; Albrecht TL, 2006, CANCER, V107, P171, DOI 10.1002/cncr.21966; Ashton CM, 2009, J MED ETHICS, V35, P579, DOI 10.1136/jme.2008.028175; Attieh R, 2012, INT J TECHNOL ASSESS, V28, P445, DOI 10.1017/S026646231200058X; Banks PA, 2013, GUT, V62, P102, DOI 10.1136/gutjnl-2012-302779; Basu S, 2012, NEW ENGL J MED, V367, P485, DOI 10.1056/NEJMp1204170; Belyansky I, 2011, ANN SURG, V254, P709, DOI 10.1097/SLA.0b013e3182359d07; Bergqvist D, 2012, SCAND J SURG, V101, P132, DOI 10.1177/145749691210100210; Bhutta ZA, 2010, LANCET, V375, P1137, DOI 10.1016/S0140-6736(10)60450-3; Bonjer HJ, 2005, LANCET ONCOL, V6, P477, DOI 10.1016/S1470-2045(05)70221-7; Bridoux V, 2012, J GASTROINTEST SURG, V16, P1758, DOI 10.1007/s11605-012-1952-0; Burkle FM, 2012, PREHOSP DISASTER MED, V27, P577, DOI 10.1017/S1049023X12001306; Califf RM, 2012, JAMA-J AM MED ASSOC, V307, P1838, DOI 10.1001/jama.2012.3424; Califf RM, 2009, JAMA-J AM MED ASSOC, V302, P2025, DOI 10.1001/jama.2009.1655; Cameron BH, 2010, CAN J SURG, V53, P11; Campbell B, 2012, BRIT J SURG, V99, P744, DOI 10.1002/bjs.8791; Canadian Network for International Surgery, AFR INJ DATABASE; Chimowitz MI, 2011, NEW ENGL J MED, V365, P993, DOI 10.1056/NEJMoa1105335; Chin R, 2011, GLOBAL CLINICAL TRIALS: EFFECTIVE IMPLEMENTATION AND MANAGEMENT, P3, DOI 10.1016/B978-0-12-381537-8.10001-9; Chirdan LB, 2012, LANCET, V380, P1040, DOI 10.1016/S0140-6736(12)61305-1; Colavita PD, 2012, ANN SURG, V256, P714, DOI 10.1097/SLA.0b013e3182734130; DeMets DL, 2011, JAMA-J AM MED ASSOC, V305, P713, DOI 10.1001/jama.2011.175; Demotes-Mainard J, 2005, LANCET, V365, P107, DOI 10.1016/S0140-6736(05)17720-4; Demyttenaere SV, 2009, CAN J SURG, V52, pE146; Dewan Y, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-87; Diener MK, 2012, CHIRURG, V83, P315, DOI 10.1007/s00104-011-2219-0; Diener MK, 2012, Z EVIDENZ FORTBILD Q, V106, P336, DOI 10.1016/j.zefq.2012.05.005; Diener MK, 2011, LANCET, V377, P1514, DOI 10.1016/S0140-6736(11)60237-7; Eckstein HH, 2008, LANCET NEUROL, V7, P893, DOI 10.1016/S1474-4422(08)70196-0; Gambadauro P, 2013, SURG TODAY, V43, P115, DOI 10.1007/s00595-012-0267-9; Garas G, 2012, WORLD J SURG, V36, P1723, DOI 10.1007/s00268-012-1597-x; Glickman SW, 2012, J EMPIR RES HUM RES, V7, P71, DOI 10.1525/jer.2012.7.1.71; Glickman SW, 2010, ACAD EMERG MED, V17, P1297, DOI 10.1111/j.1553-2712.2010.00930.x; Glickman SW, 2009, NEW ENGL J MED, V360, P816, DOI 10.1056/NEJMsb0803929; Gomes WJ, 2013, EUR J CARDIO-THORAC, V43, P238, DOI 10.1093/ejcts/ezs417; Groen RS, 2012, WORLD J SURG, V36, P771, DOI 10.1007/s00268-012-1448-9; Hailey D, 2009, INT J TECHNOL ASSESS, V25, P415, DOI 10.1017/S0266462309990067; Hannaford B, 2013, IEEE T BIO-MED ENG, V60, P954, DOI 10.1109/TBME.2012.2228858; Haynes AB, 2009, NEW ENGL J MED, V360, P491, DOI 10.1056/NEJMsa0810119; Jarman AF, 2012, AM J SURG, V204, P339, DOI 10.1016/j.amjsurg.2011.11.008; Kappetein AP, 2013, EUR J CARDIO-THORAC, V43, P211, DOI 10.1093/ejcts/ezs619; Knebel P, 2012, LANGENBECK ARCH SURG, V397, P611, DOI 10.1007/s00423-012-0922-z; Knies S, 2013, INT J TECHNOL ASSESS, V29, P71, DOI 10.1017/S0266462312000785; Knop C, 2006, EUR SPINE J, V15, P1687, DOI 10.1007/s00586-006-0135-7; Koch M, 2011, SURGERY, V149, P680, DOI 10.1016/j.surg.2010.12.002; Kushner AL, 2010, ARCH SURG-CHICAGO, V145, P154, DOI 10.1001/archsurg.2009.263; Lallas CD, 2004, J UROLOGY, V171, P1880, DOI 10.1097/01.ju.0000120221.39184.3c; Leow JJ, 2012, SURGERY, V151, P767, DOI 10.1016/j.surg.2011.12.024; Linden AF, 2012, WORLD J SURG, V36, P1056, DOI 10.1007/s00268-012-1482-7; Maddern GJ, 2006, SURG CLIN N AM, V86, P115, DOI 10.1016/j.suc.2005.10.010; Maddern G, 2008, ANZ J SURG, V78, P853, DOI 10.1111/j.1445-2197.2008.04679.x; Maletis Gregory B, 2011, J Bone Joint Surg Am, V93 Suppl 3, P31, DOI 10.2106/JBJS.K.00905; McCulloch P, 2009, LANCET, V374, P1105, DOI 10.1016/S0140-6736(09)61116-8; Miller FG, 2011, JAMA-J AM MED ASSOC, V306, P2024, DOI 10.1001/jama.2011.1631; Moreno-Serra R, 2012, LANCET, V380, P917, DOI 10.1016/S0140-6736(12)61039-3; Mukhopadhyay Baijayanta, 2009, Mcgill J Med, V12, P27; Muysoms F, 2012, HERNIA, V16, P239, DOI 10.1007/s10029-012-0912-7; Nickerson JW, 2012, PREHOSP DISASTER MED, V27, P184, DOI 10.1017/S1049023X12000556; Ozgediz D, 2008, B WORLD HEALTH ORGAN, V86, P646, DOI 10.2471/BLT.07.050435; Patel A, 2007, LANCET, V370, P829, DOI 10.1016/S0140-6736(07)61303-8; Patel Pratik B, 2012, Plast Surg Int, V2012, P892437, DOI 10.1155/2012/892437; Paxton Elizabeth W, 2011, J Bone Joint Surg Am, V93 Suppl 3, P20, DOI 10.2106/JBJS.K.01045; Perkovic Vlado, 2012, J Bone Joint Surg Am, V94 Suppl 1, P92, DOI 10.2106/JBJS.L.00274; Petroze RT, 2012, BRIT J SURG, V99, P436, DOI 10.1002/bjs.7816; Petroze RT, 2013, WORLD J SURG, V37, P1500, DOI 10.1007/s00268-012-1769-8; Petroze RT, 2013, SURGERY, V153, P457, DOI 10.1016/j.surg.2012.10.001; Pinkney TD, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-217; Plumb J, 2010, INT J TECHNOL ASSESS, V26, P102, DOI 10.1017/S0266462309990614; Plumb J, 2009, INT J TECHNOL ASSESS, V25, P124, DOI 10.1017/S0266462309090175; Qureshi JS, 2013, SURGERY, V153, P272, DOI 10.1016/j.surg.2012.08.004; Rahbari NN, 2011, HPB, V13, P528, DOI 10.1111/j.1477-2574.2011.00319.x; Rahbari NN, 2010, SURGERY, V147, P339, DOI 10.1016/j.surg.2009.10.012; Rangan Amar, 2012, J Bone Joint Surg Am, V94 Suppl 1, P97, DOI 10.2106/JBJS.L.00241; Rangel SJ, 2002, J PEDIATR SURG, V37, P990, DOI 10.1053/jpsu.2002.33826; Rice TW, 2009, DIS ESOPHAGUS, V22, P1, DOI 10.1111/j.1442-2050.2008.00901.x; Ringdal KG, 2008, SCAND J TRAUMA RESUS, V16, DOI 10.1186/1757-7241-16-7; Ringdal KG, 2011, CRIT CARE, V15, DOI 10.1186/cc10485; Schilsky RL, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001712; Scholefield JH, 2012, BRIT J SURG, V99, P1607, DOI 10.1002/bjs.8935; Sedrakyan Art, 2011, J Bone Joint Surg Am, V93 Suppl 3, P76, DOI 10.2106/JBJS.K.01141; Sedrakyan Art, 2011, J Bone Joint Surg Am, V93 Suppl 3, P1, DOI 10.2106/JBJS.K.01125; Seiler CM, 2009, BUNDESGESUNDHEITSBLA, V52, P433, DOI 10.1007/s00103-009-0827-3; Seiler CM, 2009, SURGERY, V145, P590, DOI 10.1016/j.surg.2009.03.001; Shakur H, 2010, LANCET, V376, P23, DOI 10.1016/S0140-6736(10)60835-5; Shukla PJ, 2010, SURGERY, V147, P144, DOI 10.1016/j.surg.2009.09.003; Sibai Tarek, 2012, J Bone Joint Surg Am, V94 Suppl 1, P49, DOI 10.2106/JBJS.L.00240; Stechemesser B, 2012, HERNIA, V16, P269, DOI 10.1007/s10029-012-0908-3; Stengel Dirk, 2012, J Bone Joint Surg Am, V94 Suppl 1, P85, DOI 10.2106/JBJS.L.00248; The CRASH-2 collaborators, 2011, LANCET, V377, P1096; Trindade IEK, 2006, CLEFT PALATE-CRAN J, V43, P722, DOI 10.1597/05-124; Tsimberidou Apostolia M, 2013, Am Soc Clin Oncol Educ Book, P118, DOI 10.1200/EdBook_AM.2013.33.118; Underwood Malcolm J, 2012, Asian Cardiovasc Thorac Ann, V20, P9, DOI 10.1177/0218492311432583; van der Pas MHGM, 2013, LANCET ONCOL, V14, P210, DOI 10.1016/S1470-2045(13)70016-0; Walker S, 2012, VALUE HEALTH, V15, P570, DOI 10.1016/j.jval.2011.12.013; Weiser TG, 2008, LANCET, V372, P139, DOI 10.1016/S0140-6736(08)60878-8; Weiser TG, 2009, LANCET, V374, P1113, DOI 10.1016/S0140-6736(09)61161-2; Wente MN, 2007, SURGERY, V142, P761, DOI 10.1016/j.surg.2007.05.005; Wild M, 2009, INFORM HEALTH SOC CA, V34, P81, DOI 10.1080/17538150902865078; Xylinas E, 2012, EUR UROL, V62, P943, DOI 10.1016/j.eururo.2012.08.022; Yeung M, 2012, ACTA ORTHOP, V83, P328, DOI 10.3109/17453674.2012.704562	101	53	55	0	23	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 28	2013	382	9898					1140	1151		10.1016/S0140-6736(13)61455-5	http://dx.doi.org/10.1016/S0140-6736(13)61455-5			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	228SG	24075054				2022-12-28	WOS:000325208100030
J	Leshin, LA; Mahaffy, PR; Webster, CR; Cabane, M; Coll, P; Conrad, PG; Archer, PD; Atreya, SK; Brunner, AE; Buch, A; Eigenbrode, JL; Flesch, GJ; Franz, HB; Freissinet, C; Glavin, DP; McAdam, AC; Miller, KE; Ming, DW; Morris, RV; Navarro-Gonzalez, R; Niles, PB; Owen, T; Pepin, RO; Squyres, S; Steele, A; Stern, JC; Summons, RE; Sumner, DY; Sutter, B; Szopa, C; Teinturier, S; Trainer, MG; Wray, JJ; Grotzinger, JP				Leshin, L. A.; Mahaffy, P. R.; Webster, C. R.; Cabane, M.; Coll, P.; Conrad, P. G.; Archer, P. D., Jr.; Atreya, S. K.; Brunner, A. E.; Buch, A.; Eigenbrode, J. L.; Flesch, G. J.; Franz, H. B.; Freissinet, C.; Glavin, D. P.; McAdam, A. C.; Miller, K. E.; Ming, D. W.; Morris, R. V.; Navarro-Gonzalez, R.; Niles, P. B.; Owen, T.; Pepin, R. O.; Squyres, S.; Steele, A.; Stern, J. C.; Summons, R. E.; Sumner, D. Y.; Sutter, B.; Szopa, C.; Teinturier, S.; Trainer, M. G.; Wray, J. J.; Grotzinger, J. P.		MSL Sci Team	Volatile, Isotope, and Organic Analysis of Martian Fines with the Mars Curiosity Rover	SCIENCE			English	Article							CHEMICAL-COMPOSITION; GALE CRATER; CARBONATE; PERCHLORATE; CHEMISTRY; ABUNDANCE; ROCKNEST; ALH84001; SULFUR; ORIGIN	Samples from the Rocknest aeolian deposit were heated to similar to 835 degrees C under helium flow and evolved gases analyzed by Curiosity's Sample Analysis at Mars instrument suite. H2O, SO2, CO2, and O-2 were the major gases released. Water abundance (1.5 to 3 weight percent) and release temperature suggest that H2O is bound within an amorphous component of the sample. Decomposition of fine-grained Fe or Mg carbonate is the likely source of much of the evolved CO2. Evolved O-2 is coincident with the release of Cl, suggesting that oxygen is produced from thermal decomposition of an oxychloride compound. Elevated delta D values are consistent with recent atmospheric exchange. Carbon isotopes indicate multiple carbon sources in the fines. Several simple organic compounds were detected, but they are not definitively martian in origin.	[Leshin, L. A.] Rensselaer Polytech Inst, Dept Earth & Environm Sci, Troy, NY 12180 USA; [Leshin, L. A.] Rensselaer Polytech Inst, Sch Sci, Troy, NY 12180 USA; [Mahaffy, P. R.; Conrad, P. G.; Brunner, A. E.; Eigenbrode, J. L.; Franz, H. B.; Freissinet, C.; Glavin, D. P.; McAdam, A. C.; Stern, J. C.; Trainer, M. G.] NASA, Goddard Space Flight Ctr, Planetary Environm Lab, Greenbelt, MD 20771 USA; [Webster, C. R.; Flesch, G. J.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Cabane, M.; Szopa, C.; Teinturier, S.] Univ Paris 06, LATMOS, Univ Versailles St Quentin, UMR 8970,CNRS, F-75005 Paris, France; [Coll, P.] Univ Paris Diderot, Univ Paris Est, LISA, F-94000 Creteil, France; [Coll, P.] CNRS, F-94000 Creteil, France; [Archer, P. D., Jr.; Ming, D. W.; Morris, R. V.; Niles, P. B.; Sutter, B.] NASA, Lyndon B Johnson Space Ctr, Astromat Res & Explorat Sci Directorate, Houston, TX 77058 USA; [Atreya, S. K.] Univ Michigan, Dept Atmospher Ocean & Space Sci, Ann Arbor, MI 48109 USA; [Brunner, A. E.] Univ Maryland, Dept Astron, College Pk, MD 20742 USA; [Buch, A.] Ecole Cent Paris, Lab Genie Procedes & Mat, F-92295 Chatenay Malabry, France; [Franz, H. B.] Univ Maryland Baltimore Cty, Ctr Res & Explorat Space Sci & Technol, Baltimore, MD 21250 USA; [Miller, K. E.; Summons, R. E.] MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA; [Navarro-Gonzalez, R.] Univ Nacl Autonoma Mexico, Inst Ciencias Nucl, Mexico City 04510, DF, Mexico; [Owen, T.] Univ Hawaii, Inst Astron, Honolulu, HI 96822 USA; [Pepin, R. O.] Univ Minnesota, Sch Phys & Astron, Minneapolis, MN 55455 USA; [Squyres, S.] Cornell Univ, Dept Astron, Ithaca, NY 14853 USA; [Steele, A.] Carnegie Inst Sci, Geophys Lab, Washington, DC 20015 USA; [Sumner, D. Y.] Univ Calif Davis, Dept Geol, Davis, CA 95616 USA; [Sutter, B.] Jacobs, Houston, TX 77058 USA; [Wray, J. J.] Georgia Inst Technol, Sch Earth & Atmospher Sci, Atlanta, GA 30332 USA; [Grotzinger, J. P.] CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA	Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Cite; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Centre National de la Recherche Scientifique (CNRS); Universite Gustave-Eiffel; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; University of Michigan System; University of Michigan; University System of Maryland; University of Maryland College Park; UDICE-French Research Universities; Universite Paris Saclay; University System of Maryland; University of Maryland Baltimore County; Massachusetts Institute of Technology (MIT); Universidad Nacional Autonoma de Mexico; University of Hawaii System; University of Minnesota System; University of Minnesota Twin Cities; Cornell University; Carnegie Institution for Science; University of California System; University of California Davis; University System of Georgia; Georgia Institute of Technology; California Institute of Technology	Leshin, LA (corresponding author), Rensselaer Polytech Inst, Dept Earth & Environm Sci, Troy, NY 12180 USA.	leshin@rpi.edu	Hayes, Alexander G/P-2024-2014; Balic-Zunic, Tonci/A-6362-2013; Webster, Chris/M-9315-2019; Harri, Ari-Matti/C-7142-2012; Prats, Benito/F-9467-2019; Eigenbrode, Jennifer L/D-4651-2012; Dworkin, Jason P./C-9417-2012; Floyd, Melissa/D-4626-2012; Teinturier, Samuel/AAS-8663-2020; Ramos, Miguel/K-2230-2014; Rodriguez-Manfredi, Jose/L-8001-2014; Sumner, Dawn Y/E-8744-2011; Summons, Roger Everett/AAL-3789-2020; Stern, Jennifer/E-3135-2012; Trainer, Melissa G/E-1477-2012; Gómez, Felipe/L-7315-2014; Glavin, Daniel P/D-6194-2012; Zorzano, María-Paz/F-2184-2015; Franz, Heather B/F-3508-2012; Blanco, Juan Jose/E-3627-2014; Martin-Torres, Javier/G-6329-2015; Stipp, Susan L.S./B-8494-2019; szopa, cyril/C-6865-2015; Wray, James J/B-8457-2008; Navarro-González, Rafael/D-1748-2009; Avalos, Juan Jose Blanco/AAB-9447-2021; Gomez-Elvira, Javier/K-5829-2014; Steele, Andrew/A-3573-2013; Benna, Mehdi/F-3489-2012; Muller, Jan-Peter/Q-8886-2019; De Pablo, Miguel Ángel/J-6442-2014; Lemmon, Mark T/E-9983-2010; Malakhov, Alexey Vladimirovich/F-7953-2017; GEFFROY, Claude/AAB-9152-2019; Rodriguez-Manfredi, Jose/AAG-9826-2021; Vicenzi, Edward/T-9430-2017; Gasnault, Olivier/F-4327-2010; McAdam, Amy/E-1556-2012	Hayes, Alexander G/0000-0001-6397-2630; Balic-Zunic, Tonci/0000-0003-1687-1233; Harri, Ari-Matti/0000-0001-8541-2802; Prats, Benito/0000-0003-3869-3351; Eigenbrode, Jennifer L/0000-0003-3089-1986; Dworkin, Jason P./0000-0002-3961-8997; Teinturier, Samuel/0000-0003-1755-9524; Ramos, Miguel/0000-0003-3648-6818; Rodriguez-Manfredi, Jose/0000-0003-0461-9815; Sumner, Dawn Y/0000-0002-7343-2061; Stern, Jennifer/0000-0002-0162-8807; Gómez, Felipe/0000-0001-9977-7060; Glavin, Daniel P/0000-0001-7779-7765; Zorzano, María-Paz/0000-0002-4492-9650; Blanco, Juan Jose/0000-0002-8666-0696; Martin-Torres, Javier/0000-0001-6479-2236; Stipp, Susan L.S./0000-0001-7009-643X; szopa, cyril/0000-0002-0090-4056; Wray, James J/0000-0001-5559-2179; Navarro-González, Rafael/0000-0002-6078-7621; Avalos, Juan Jose Blanco/0000-0002-8666-0696; Gomez-Elvira, Javier/0000-0002-9068-9846; Steele, Andrew/0000-0001-9643-2841; Muller, Jan-Peter/0000-0002-5077-3736; De Pablo, Miguel Ángel/0000-0002-4496-2741; Lemmon, Mark T/0000-0002-4504-5136; Malakhov, Alexey Vladimirovich/0000-0003-4292-7077; GEFFROY, Claude/0000-0002-2731-9658; Rodriguez-Manfredi, Jose/0000-0003-0461-9815; Vicenzi, Edward/0000-0003-2085-6546; Buch, Arnaud/0000-0002-2097-7252; Wilson, Sharon/0000-0001-8872-8546; Gasnault, Olivier/0000-0002-6979-9012; McAdam, Amy/0000-0001-9120-2991	UK Space Agency [ST/I003118/1] Funding Source: researchfish	UK Space Agency		Anderson RC, 2012, SPACE SCI REV, V170, P57, DOI 10.1007/s11214-012-9898-9; Bandfield JL, 2003, SCIENCE, V301, P1084, DOI 10.1126/science.1088054; Becker L, 1999, ADV SPACE RES-SERIES, V24, P477, DOI 10.1016/S0273-1177(99)00090-3; Biemann K., 1977, Journal of Geophysical Research, V82, P4641, DOI 10.1029/JS082i028p04641; Biemann K, 2011, J GEOPHYS RES-PLANET, V116, DOI 10.1029/2011JE003869; Bish DL, 2013, SCIENCE, V341, DOI 10.1126/science.1238932; Bish D. L., 1990, THERMAL ANAL CLAY SC, V3, P95, DOI [10.1029/2012GL051952, DOI 10.1029/2012GL051952]; Blake DF, 2013, SCIENCE, V341, DOI 10.1126/science.1239505; Bruckner J, 2003, J GEOPHYS RES-PLANET, V108, DOI [10.1029/2003JE002060, 10.1029/2003JE002150]; Cannon KM, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051952; Catling DC, 2010, J GEOPHYS RES-PLANET, V115, DOI 10.1029/2009JE003425; CLARK BC, 1982, J GEOPHYS RES, V87, P59, DOI 10.1029/JB087iB12p10059; CLARK BC, 1979, J GEOPHYS RES, V84, P8395, DOI 10.1029/JB084iB14p08395; Farquhar J, 2000, NATURE, V404, P50, DOI 10.1038/35003517; FURUICHI R, 1974, J THERM ANAL, V6, P305, DOI 10.1007/BF01950062; Gellert R, 2004, SCIENCE, V305, P829, DOI 10.1126/science.1099913; Glavin D. P., 2013, J GEOPHYS RES-PLANET, DOI [10.1002/jgre.20127, DOI 10.1002/JGRE.20127]; Grady MM., 2004, INT J ASTROBIOL, V3, P117, DOI DOI 10.1017/S1473550404002071; Greenwood JP, 1997, GEOCHIM COSMOCHIM AC, V61, P4449, DOI 10.1016/S0016-7037(97)00246-9; Hecht MH, 2009, SCIENCE, V325, P64, DOI 10.1126/science.1172466; Hoefs J., 1980, STABLE ISOTOPE GEOCH; Jull AJT, 1997, J GEOPHYS RES-PLANET, V102, P1663, DOI 10.1029/96JE03111; Keller JM, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2006JE002679; Kim YS, 2013, J AM CHEM SOC, V135, P4910, DOI 10.1021/ja3122922; Lauer Jr H. V., 2012, LUNAR PLANET SCI, V43; Leshin LA, 2000, GEOPHYS RES LETT, V27, P2017, DOI 10.1029/1999GL008455; Leshin LA, 1996, GEOCHIM COSMOCHIM AC, V60, P2635, DOI 10.1016/0016-7037(96)00122-6; Mahaffy PR, 2013, SCIENCE, V341, P263, DOI 10.1126/science.1237966; Mahaffy PR, 2012, SPACE SCI REV, V170, P401, DOI 10.1007/s11214-012-9879-z; MARKOWIT.MM, 1965, J PHYS CHEM-US, V69, P1114, DOI 10.1021/j100888a005; Moldoveanu S. C., 1998, ANAL PYROLYSIS NATUR, P496; Navarro-Gonzalez R, 2010, J GEOPHYS RES-PLANET, V115, DOI 10.1029/2010JE003599; Niles PB, 2010, SCIENCE, V329, P1334, DOI 10.1126/science.1192863; Niles PB, 2005, GEOCHIM COSMOCHIM AC, V69, P2931, DOI 10.1016/j.gca.2004.12.012; Novak RE, 2011, PLANET SPACE SCI, V59, P163, DOI 10.1016/j.pss.2010.06.017; Schuttlefield JD, 2011, J AM CHEM SOC, V133, P17521, DOI 10.1021/ja2064878; Sephton MA, 2002, PLANET SPACE SCI, V50, P711, DOI 10.1016/S0032-0633(02)00053-3; Sephton MA, 2002, NAT PROD REP, V19, P292, DOI 10.1039/b103775g; Steele A, 2007, METEORIT PLANET SCI, V42, P1549, DOI 10.1111/j.1945-5100.2007.tb00590.x; Steele A, 2012, SCIENCE, V337, P212, DOI 10.1126/science.1220715; Sutter B, 2012, ICARUS, V218, P290, DOI 10.1016/j.icarus.2011.12.002; Taylor S. R., 2009, EVOLUTION; Wanke H, 2001, SPACE SCI REV, V96, P317, DOI 10.1023/A:1011961725645; Webster CR, 2013, SCIENCE, V341, P260, DOI 10.1126/science.1237961; WRIGHT IP, 1992, GEOCHIM COSMOCHIM AC, V56, P817, DOI 10.1016/0016-7037(92)90100-W; WRIGHT IP, 1986, GEOCHIM COSMOCHIM AC, V50, P983, DOI 10.1016/0016-7037(86)90379-0; Yen AS, 2005, NATURE, V436, P49, DOI 10.1038/nature03637	48	314	318	7	236	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 27	2013	341	6153							1238937	10.1126/science.1238937	http://dx.doi.org/10.1126/science.1238937			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	224NS	24072926				2022-12-28	WOS:000324894600003
J	Heffernan, O				Heffernan, Olive			THE DRY FACTS	NATURE			English	Editorial Material																			0	18	18	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 26	2013	501	7468					S2	S3		10.1038/501S2a	http://dx.doi.org/10.1038/501S2a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223RP	24067762	Bronze			2022-12-28	WOS:000324826300002
J	Oram, RA; McDonald, TJ; Vaidya, B				Oram, Richard A.; McDonald, Timothy J.; Vaidya, Bijay			Investigating hypokalaemia	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CLINICAL-PRACTICE		[Oram, Richard A.] Royal Devon & Exeter Hosp, Dept Renal Med, Exeter EX2 5DW, Devon, England; [McDonald, Timothy J.] Royal Devon & Exeter Hosp, Dept Blood Sci, Exeter EX2 5DW, Devon, England; [Vaidya, Bijay] Royal Devon & Exeter Hosp, Dept Endocrinol, Exeter EX2 5DW, Devon, England; [Vaidya, Bijay] Univ Exeter, Sch Med, Exeter EX2 5DW, Devon, England; [Oram, Richard A.; McDonald, Timothy J.] Univ Exeter, Sch Med, NIHR Exeter Clin Res Facil, Exeter EX2 5DW, Devon, England	University of Exeter; University of Exeter; University of Exeter; University of Exeter; University of Exeter	Vaidya, B (corresponding author), Royal Devon & Exeter Hosp, Dept Endocrinol, Exeter EX2 5DW, Devon, England.	b.vaidya@exeter.ac.uk	Vaidya, Bijay/AAF-1947-2020	Oram, Richard/0000-0003-3581-8980; Vaidya, Bijay/0000-0002-2223-0494; McDonald, Timothy James/0000-0003-3559-6660	National Institute for Health Research [NF-SI-0611-10219, ACF-2007-23-001] Funding Source: researchfish; Diabetes UK [11/0004171] Funding Source: Medline; Department of Health [NF-SI-0611-10219] Funding Source: Medline	National Institute for Health Research(National Institute for Health Research (NIHR)); Diabetes UK(Diabetes UK); Department of Health		Cohn JN, 2000, ARCH INTERN MED, V160, P2429, DOI 10.1001/archinte.160.16.2429; Cowley NJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f16; Halperin ML, 1998, LANCET, V352, P135; Liamis G, 2013, AM J MED, V126, P256, DOI 10.1016/j.amjmed.2012.06.037; Lin SH, 2004, ARCH INTERN MED, V164, P1561, DOI 10.1001/archinte.164.14.1561; Nieman LK, 2008, J CLIN ENDOCR METAB, V93, P1526, DOI 10.1210/jc.2008-0125; Pathology-Harmony-Group, 2011, HARM REF INT; Reid Alasdair, 2012, JRSM Short Rep, V3, P80, DOI 10.1258/shorts.2012.011179; SIEGEL D, 1992, JAMA-J AM MED ASSOC, V267, P1083, DOI 10.1001/jama.267.8.1083; The Royal College of Pathologists (UK), 2010, OUT OF HOURS REP LAB; Tiu SC, 2005, J CLIN ENDOCR METAB, V90, P72, DOI 10.1210/jc.2004-1149; WHANG R, 1992, ARCH INTERN MED, V152, P40, DOI 10.1001/archinte.152.1.40	12	1	1	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 24	2013	347								f5137	10.1136/bmj.f5137	http://dx.doi.org/10.1136/bmj.f5137			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	227CT	24065427				2022-12-28	WOS:000325086800001
J	Spence, D				Spence, Des			Bad medicine: monitoring patients' drugs	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							METHOTREXATE					destwo@yahoo.co.uk						Chakravarty K, 2008, RHEUMATOLOGY, V47, P924, DOI 10.1093/rheumatology/kel216a; eGuidelines.co.uk, QOF CLIN IND 2013 14; Faculty of Family Planning & Reproductive Health Care, 2007, CLIN GUID 1 PRESCR C; Parker R, 2010, POSTGRAD MED J, V86, P208, DOI 10.1136/pgmj.2009.085787; Yazici Y, 2002, J RHEUMATOL, V29, P1586	5	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 24	2013	347								f5779	10.1136/bmj.f5779	http://dx.doi.org/10.1136/bmj.f5779			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	227CT	24065433				2022-12-28	WOS:000325086800012
J	Spiegelhalter, D				Spiegelhalter, David			Are you 45% more likely to die in a UK hospital rather than a US hospital?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							DEATHS		Univ Cambridge, Cambridge, England	University of Cambridge	Spiegelhalter, D (corresponding author), Univ Cambridge, Cambridge, England.	d.spiegelhalter@statslab.cam.ac.uk						AHRQ, 2013, CLIN CLASS SOFTW ICD; Berwick D, 2013, IMPROVING SAFETY PAT; Broad JB, 2013, INT J PUBLIC HEALTH, V58, P257, DOI 10.1007/s00038-012-0394-5; Jarman B., CALCULATION INT HSMR; Jarman B., 2013, CH4 NEWS DATA INT HS; Jarman Brian, 2004, BMJ, V328, P605, DOI 10.1136/bmj.328.7440.605; Risky Business, 2013, RISKY BUSINESS; Silverman E, 2004, J HEALTH ECON, V23, P369, DOI 10.1016/j.jhealeco.2003.09.007; Silverman R., 2013, TELEGRAPH; Spiegelhalter D, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4893	10	8	8	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 24	2013	347								f5775	10.1136/bmj.f5775	http://dx.doi.org/10.1136/bmj.f5775			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	227CT	24065613				2022-12-28	WOS:000325086800011
J	Spence, D				Spence, Des			Make children move	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk						Griffiths LJ, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002893; National Health Executive, 2013, YAWNING GAP BETWEEN; Public Health England, 2013, HOW HEALTHY BEHAVIOU; Waters E, 2010, COCHRANE REVIEW, V3	4	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 19	2013	347								f5618	10.1136/bmj.f5618	http://dx.doi.org/10.1136/bmj.f5618			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	223SY	24052586				2022-12-28	WOS:000324831500007
J	Lee, MT; Bonneau, AR; Takacs, CM; Bazzini, AA; DiVito, KR; Fleming, ES; Giraldez, AJ				Lee, Miler T.; Bonneau, Ashley R.; Takacs, Carter M.; Bazzini, Ariel A.; DiVito, Kate R.; Fleming, Elizabeth S.; Giraldez, Antonio J.			Nanog, Pou5f1 and SoxB1 activate zygotic gene expression during the maternal-to-zygotic transition	NATURE			English	Article							ENDODERM FORMATION; HUMAN FIBROBLASTS; PLURIPOTENCY; GENOME; OCT4; NETWORK; IDENTIFICATION; TRANSLATION; DYNAMICS; PROTEIN	After fertilization, maternal factors direct development and trigger zygotic genome activation (ZGA) at the maternal-to-zygotic transition (MZT). In zebrafish, ZGA is required for gastrulation and clearance of maternal messenger RNAs, which is in part regulated by the conserved microRNA miR-430. However, the factors that activate the zygotic program in vertebrates are unknown. Here we show that Nanog, Pou5f1 (also called Oct4) and SoxB1 regulate zygotic gene activation in zebrafish. We identified several hundred genes directly activated by maternal factors, constituting the first wave of zygotic transcription. Ribosome profiling revealed that nanog, sox19b and pou5f1 are the most highly translated transcription factors pre-MZT. Combined loss of these factors resulted in developmental arrest before gastrulation and a failure to activate >75% of zygotic genes, including miR-430. Our results demonstrate that maternal Nanog, Pou5f1 and SoxB1 are required to initiate the zygotic developmental program and induce clearance of the maternal program by activating miR-430 expression.	[Lee, Miler T.; Bonneau, Ashley R.; Takacs, Carter M.; Bazzini, Ariel A.; DiVito, Kate R.; Fleming, Elizabeth S.; Giraldez, Antonio J.] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; [Giraldez, Antonio J.] Yale Univ, Sch Med, Yale Stem Cell Ctr, New Haven, CT 06520 USA	Yale University; Yale University	Giraldez, AJ (corresponding author), Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA.	antonio.giraldez@yale.edu		Giraldez, Antonio/0000-0002-6823-137X	NIH [F32HD071697-02, T32GM007499, F32HD061194-03]; Pew Fellows Program in Biomedical Sciences; Pew Scholars Program in the Biomedical Sciences; Yale Scholars Program;  [R01GM081602-06];  [R01GM103789-01];  [R01HD074078-02]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [F32HD071697, R01HD074078, F32HD061194] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081602, R01GM103789, T32GM007499] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pew Fellows Program in Biomedical Sciences; Pew Scholars Program in the Biomedical Sciences; Yale Scholars Program; ; ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Y. Kamachi, W. Driever, A. F. Schier, N. Ivanova and I.-H. Park for reagents and fish lines; S. Mane and J. Overton for outstanding sequencing support; E. Zdobnov for hosting genomics data; A. Hubaud, N. Darricarrere and M. Koziol for contribution in the early stages of this project; and all the members of the Giraldez laboratory for discussions. This work was supported by NIH grants F32HD071697-02 (M.T.L.), T32GM007499 (A.R.B), F32HD061194-03 (C.M.T.), Pew Fellows Program in Biomedical Sciences (A.A.B), R01GM081602-06, R01GM103789-01, R01HD074078-02, the Pew Scholars Program in the Biomedical Sciences and the Yale Scholars Program (A.J.G.).	Aanes H, 2011, GENOME RES, V21, P1328, DOI 10.1101/gr.116012.110; Amsterdam A, 2004, P NATL ACAD SCI USA, V101, P12792, DOI 10.1073/pnas.0403929101; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Andersen IS, 2013, CURR TOP DEV BIOL, V104, P85, DOI 10.1016/B978-0-12-416027-9.00003-6; Bazzini AA, 2012, SCIENCE, V336, P233, DOI 10.1126/science.1215704; Belting HG, 2011, DEV BIOL, V356, P323, DOI 10.1016/j.ydbio.2011.05.660; Berg MG, 2012, CELL, V150, P53, DOI 10.1016/j.cell.2012.05.029; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chambers I, 2009, DEVELOPMENT, V136, P2311, DOI 10.1242/dev.024398; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Collins JE, 2012, GENOME RES, V22, P2067, DOI 10.1101/gr.137901.112; Foygel K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004109; Frum T, 2013, DEV CELL, V25, P610, DOI 10.1016/j.devcel.2013.05.004; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; Giraldez AJ, 2010, CURR OPIN GENET DEV, V20, P369, DOI 10.1016/j.gde.2010.04.003; Gurdon JB, 2008, SCIENCE, V322, P1811, DOI 10.1126/science.1160810; GURDON JB, 1958, NATURE, V182, P64, DOI 10.1038/182064a0; Hamatani T, 2004, DEV CELL, V6, P117, DOI 10.1016/S1534-5807(03)00373-3; Harvey SA, 2013, DEVELOPMENT, V140, P2703, DOI 10.1242/dev.095091; Hauptmann G, 2002, DEVELOPMENT, V129, P1645; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Iwafuchi-Doi M, 2011, DEV BIOL, V352, P354, DOI 10.1016/j.ydbio.2010.12.027; Jiang L, 2013, CELL, V153, P773, DOI 10.1016/j.cell.2013.04.041; Judson RL, 2009, NAT BIOTECHNOL, V27, P459, DOI 10.1038/nbt.1535; Kaida D, 2010, NATURE, V468, P664, DOI 10.1038/nature09479; KANE DA, 1993, DEVELOPMENT, V119, P447; Keramari M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013952; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Liang HL, 2008, NATURE, V456, P400, DOI 10.1038/nature07388; Lindeman LC, 2011, DEV CELL, V21, P993, DOI 10.1016/j.devcel.2011.10.008; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Lund E, 2009, RNA, V15, P2351, DOI 10.1261/rna.1882009; Lunde K, 2004, CURR BIOL, V14, P48, DOI 10.1016/j.cub.2003.11.022; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; Matter N, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni041; Messerschmidt DM, 2010, DEV BIOL, V344, P129, DOI 10.1016/j.ydbio.2010.04.020; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Okuda Y, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000936; Onichtchouk D, 2012, GENESIS, V50, P75, DOI 10.1002/dvg.20800; Onichtchouk D, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.9; Potok ME, 2013, CELL, V153, P759, DOI 10.1016/j.cell.2013.04.030; Rosel TD, 2011, EMBO J, V30, P1965, DOI 10.1038/emboj.2011.106; Soufi A, 2012, CELL, V151, P994, DOI 10.1016/j.cell.2012.09.045; Subramanyam D, 2011, NAT BIOTECHNOL, V29, P443, DOI 10.1038/nbt.1862; Tadros W, 2009, DEVELOPMENT, V136, P3033, DOI 10.1242/dev.033183; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tan MH, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2012.65; ten Bosch JR, 2006, DEVELOPMENT, V133, P1967, DOI 10.1242/dev.02373; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vastenhouw NL, 2010, NATURE, V464, P922, DOI 10.1038/nature08866; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Xu C, 2012, DEV CELL, V22, P625, DOI 10.1016/j.devcel.2012.01.003; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	59	273	285	2	80	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 21	2013	503	7476					360	+		10.1038/nature12632	http://dx.doi.org/10.1038/nature12632			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KG	24056933	Green Accepted			2022-12-28	WOS:000327163200033
J	Huang, PY; Kurasch, S; Alden, JS; Shekhawat, A; Alemi, AA; McEuen, PL; Sethna, JP; Kaiser, U; Muller, DA				Huang, Pinshane Y.; Kurasch, Simon; Alden, Jonathan S.; Shekhawat, Ashivni; Alemi, Alexander A.; McEuen, Paul L.; Sethna, James P.; Kaiser, Ute; Muller, David A.			Imaging Atomic Rearrangements in Two-Dimensional Silica Glass: Watching Silica's Dance	SCIENCE			English	Article							FLOW; DEFORMATION; MICROSCOPY; GRAPHENE	Structural rearrangements control a wide range of behavior in amorphous materials, and visualizing these atomic-scale rearrangements is critical for developing and refining models for how glasses bend, break, and melt. It is difficult, however, to directly image atomic motion in disordered solids. We demonstrate that using aberration-corrected transmission electron microscopy, we can excite and image atomic rearrangements in a two-dimensional silica glass-revealing a complex dance of elastic and plastic deformations, phase transitions, and their interplay. We identified the strain associated with individual ring rearrangements, observed the role of vacancies in shear deformation, and quantified fluctuations at a glass/liquid interface. These examples illustrate the wide-ranging and fundamental materials physics that can now be studied at atomic-resolution via transmission electron microscopy of two-dimensional glasses.	[Huang, Pinshane Y.; Alden, Jonathan S.; Muller, David A.] Cornell Univ, Sch Appl & Engn Phys, Ithaca, NY 14853 USA; [Kurasch, Simon; Kaiser, Ute] Univ Ulm, Electron Microscopy Grp Mat Sci, D-89081 Ulm, Germany; [Shekhawat, Ashivni; Alemi, Alexander A.; McEuen, Paul L.; Sethna, James P.] Cornell Univ, Atom & Solid State Phys Lab, Ithaca, NY 14853 USA; [McEuen, Paul L.; Muller, David A.] Cornell Univ, Kavli Inst Cornell Nanoscale Sci, Ithaca, NY 14853 USA	Cornell University; Ulm University; Cornell University; Cornell University	Muller, DA (corresponding author), Cornell Univ, Sch Appl & Engn Phys, Ithaca, NY 14853 USA.	dm24@cornell.edu	Muller, David/A-7745-2010	Muller, David/0000-0003-4129-0473; Huang, Pinshane/0000-0002-1095-1833; Alemi, Alexander/0000-0001-7147-9184	NSF through the Cornell Center for Materials Research [NSF DMR-1120296]; NSF Graduate Research Fellowship Program [DGE-0707428]; NSF [PHY-0941095]; Air Force Office of Scientific Research through the Graphene MURI [FA9550-09-1-0691, FA9550-10-1-0410]; Deutsche Forschungsgemeinschaft (German Research Foundation); Ministry of Science, Research and the Arts (MWK) of Baden-Wurttemberg through the Sub Angstrom Low-Voltage Electron Microscopy project; Division Of Physics [0941095] Funding Source: National Science Foundation	NSF through the Cornell Center for Materials Research(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); NSF Graduate Research Fellowship Program(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); Air Force Office of Scientific Research through the Graphene MURI; Deutsche Forschungsgemeinschaft (German Research Foundation)(German Research Foundation (DFG)); Ministry of Science, Research and the Arts (MWK) of Baden-Wurttemberg through the Sub Angstrom Low-Voltage Electron Microscopy project; Division Of Physics(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	The raw data presented in this work are available in the supplementary movies. S. K. acquired, aligned, and preprocessed the TEM data under the supervision of U. K. P.Y.H. and J.S.A. designed and conducted the atom tracking and strain and deformation analysis under the supervision of D. A. M. and P. L. M. A. S., A. A. A., and J.P.S. contributed theoretical understanding via continuum mechanics analysis and LAMMPS simulations. P.Y.H., J.S.A, and D. A. M. wrote the paper. All authors contributed to the discussion of results and commented on and edited the paper. This work was supported by the NSF through the Cornell Center for Materials Research (NSF DMR-1120296). Additional support for P.Y.H. was provided by the NSF Graduate Research Fellowship Program under grant DGE-0707428. A. A. A., A. S., and J.P.S. were supported by NSF grant PHY-0941095. J.S.A. and P. L. M were supported by the Air Force Office of Scientific Research through the Graphene MURI (FA9550-09-1-0691 and FA9550-10-1-0410). U. K. and S. K. acknowledge support from the Deutsche Forschungsgemeinschaft (German Research Foundation) and the Ministry of Science, Research and the Arts (MWK) of Baden-Wurttemberg through the Sub Angstrom Low-Voltage Electron Microscopy project. The authors acknowledge discussions with M. K. Blees, I. Cohen, S. J. Gerbode, R. Hovden, J. Kotakoski, A. V. Krasheninnikov, B. Leahy, Y.-C. Lin, M. L. Manning, E. R. Weeks, and A. M. van der Zande. We thank A. Srivastava, V. Skakalova, and J. Smet from the Max Planck Institute for Solid State Research in Stuttgart, Germany, for the sample. Microscopy support and maintenance were provided by J. Biskupek.	AJAYAN PM, 1992, PHIL MAG LETT, V65, P43, DOI 10.1080/09500839208215146; ARGON AS, 1979, MATER SCI ENG, V39, P101, DOI 10.1016/0025-5416(79)90174-5; Auld B, 1973, ACOUSTIC FIELDS WAVE, V1; Ben Romdhane F, 2013, ACS NANO, V7, P5175, DOI 10.1021/nn400905k; Crocker JC, 1996, J COLLOID INTERF SCI, V179, P298, DOI 10.1006/jcis.1996.0217; Donnelly SE, 2002, SCIENCE, V296, P507, DOI 10.1126/science.1068521; Falk ML, 2010, EUR PHYS J B, V75, P405, DOI 10.1140/epjb/e2010-00157-7; Falk ML, 1998, PHYS REV E, V57, P7192, DOI 10.1103/PhysRevE.57.7192; GRANNAN ER, 1990, PHYS REV B, V41, P7784, DOI 10.1103/PhysRevB.41.7784; Hashimoto A, 2004, NATURE, V430, P870, DOI 10.1038/nature02817; HE H, 1985, PHYS REV LETT, V54, P2107, DOI 10.1103/PhysRevLett.54.2107; Hernandez-Guzman J, 2009, P NATL ACAD SCI USA, V106, P15198, DOI 10.1073/pnas.0904682106; Hobbs L.W., 1980, J PHYSIQUE C, V41, DOI DOI 10.1051/JPHYSCOL:1980660; Howe JM, 2004, MRS BULL, V29, P951, DOI 10.1557/mrs2004.266; Huang PY, 2012, NANO LETT, V12, P1081, DOI 10.1021/nl204423x; Kegel WK, 2000, SCIENCE, V287, P290, DOI 10.1126/science.287.5451.290; Kotakoski J, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.245420; Kotakoski J, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.105505; Kurasch S, 2012, NANO LETT, V12, P3168, DOI 10.1021/nl301141g; Lee Z, 2009, NANO LETT, V9, P3365, DOI 10.1021/nl901664k; Lichtenstein L, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.106101; Lichtenstein L, 2012, ANGEW CHEM INT EDIT, V51, P404, DOI 10.1002/anie.201107097; Loffler D, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.146104; MAEDA K, 1978, PHYS STATUS SOLIDI A, V49, P685, DOI 10.1002/pssa.2210490233; Manning ML, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.056106; Mayr SG, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.055505; Meyer JC, 2008, NANO LETT, V8, P3582, DOI 10.1021/nl801386m; Nakamura E, 2013, ANGEW CHEM INT EDIT, V52, P236, DOI 10.1002/anie.201205693; Pantelic RS, 2012, SOLID STATE COMMUN, V152, P1375, DOI 10.1016/j.ssc.2012.04.038; PLIMPTON S, 1995, J COMPUT PHYS, V117, P1, DOI 10.1006/jcph.1995.1039; Schall P, 2007, SCIENCE, V318, P1895, DOI 10.1126/science.1149308; Warner JH, 2012, SCIENCE, V337, P209, DOI 10.1126/science.1217529; Weeks ER, 2000, SCIENCE, V287, P627, DOI 10.1126/science.287.5453.627; Wilson M, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.214108; Zachariasen WH, 1932, J AM CHEM SOC, V54, P3841, DOI 10.1021/ja01349a006; Zheng K, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1021	36	161	163	7	323	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 11	2013	342	6155					224	227		10.1126/science.1242248	http://dx.doi.org/10.1126/science.1242248			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232EV	24115436				2022-12-28	WOS:000325475200039
J	DeWeerdt, S				DeWeerdt, Sarah			An age-old problem	NATURE			English	Editorial Material							TUBERCULOSIS VACCINE											Day CL, 2013, AM J RESP CRIT CARE, V188, P492, DOI 10.1164/rccm.201208-1385OC; Ottenhoff THM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002607; Tameris M, 2013, TUBERCULOSIS, V93, P143, DOI 10.1016/j.tube.2013.01.003; Tameris MD, 2013, LANCET, V381, P1021, DOI 10.1016/S0140-6736(13)60177-4	4	4	4	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 10	2013	502	7470					S8	S9		10.1038/502S8a	http://dx.doi.org/10.1038/502S8a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RU	24108081	Bronze			2022-12-28	WOS:000325436100005
J	Humphries, C				Humphries, Courtney			A sleeping giant	NATURE			English	Editorial Material							TUBERCULOSIS											Esmail H, 2012, DRUG DISCOV TODAY, V17, P514, DOI 10.1016/j.drudis.2011.12.013; Pethe K, 2013, NAT MED, V19, P1157, DOI 10.1038/nm.3262; Ramakrishnan L, 2012, NAT REV IMMUNOL, V12, P352, DOI 10.1038/nri3211; Zumla A, 2013, NEW ENGL J MED, V368, P745, DOI 10.1056/NEJMra1200894	4	4	4	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 10	2013	502	7470					S14	S15		10.1038/502S14a	http://dx.doi.org/10.1038/502S14a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RU	24108076	Bronze			2022-12-28	WOS:000325436100008
J	Li, H; Song, ZN; Zhang, XJ; Huang, Y; Li, SG; Mao, YT; Ploehn, HJ; Bao, Y; Yu, M				Li, Hang; Song, Zhuonan; Zhang, Xiaojie; Huang, Yi; Li, Shiguang; Mao, Yating; Ploehn, Harry J.; Bao, Yu; Yu, Miao			Ultrathin, Molecular-Sieving Graphene Oxide Membranes for Selective Hydrogen Separation	SCIENCE			English	Article							ZEOLITE MEMBRANES; GAS SEPARATION; POROUS GRAPHENE; HIGH-FLUX; PERMEATION; PERMEABILITY	Ultrathin, molecular-sieving membranes have great potential to realize high-flux, high-selectivity mixture separation at low energy cost. Current microporous membranes [pore size < 1 nanometer (nm)], however, are usually relatively thick. With the use of current membrane materials and techniques, it is difficult to prepare microporous membranes thinner than 20 nm without introducing extra defects. Here, we report ultrathin graphene oxide (GO) membranes, with thickness approaching 1.8 nm, prepared by a facile filtration process. These membranes showed mixture separation selectivities as high as 3400 and 900 for H-2/CO2 and H-2/N-2 mixtures, respectively, through selective structural defects on GO.	[Li, Hang; Song, Zhuonan; Zhang, Xiaojie; Huang, Yi; Mao, Yating; Ploehn, Harry J.; Yu, Miao] Univ S Carolina, Dept Chem Engn, Columbia, SC 29208 USA; [Li, Hang; Song, Zhuonan; Zhang, Xiaojie; Huang, Yi; Yu, Miao] Univ S Carolina, Catalysis Renewable Fuels Ctr, Columbia, SC 29208 USA; [Li, Shiguang] Inst Gas Technol, Des Plaines, IL 60018 USA; [Bao, Yu] Rochester Inst Technol, Coll Appl Sci & Technol, Rochester, NY 14623 USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Rochester Institute of Technology	Yu, M (corresponding author), Univ S Carolina, Dept Chem Engn, Columbia, SC 29208 USA.	yumiao@cec.sc.edu	Song, Zhuonan/G-9815-2015; HUANG, Yi/G-3405-2011; Mao, Yating/AAU-8411-2021	Huang, Yi/0000-0003-0733-3513; , xiaojie/0000-0003-4924-8333	University of South Carolina	University of South Carolina	We thank the University of South Carolina for start-up funding, S. Ma for experimental assistance on XPS, C. T. Williams for assistance with Raman spectroscopy, and J. R. Regalbuto for suggestions on writing the manuscript. M.Y. and H. L. are inventors on U.S. patent application number 61/850,415 ("Ultrathin, Molecular-Sieving Graphene Oxide Membranes for Separations"), applied for by the University of South Carolina.	Bernardo P, 2009, IND ENG CHEM RES, V48, P4638, DOI 10.1021/ie8019032; Brunetti A, 2010, J MEMBRANE SCI, V359, P115, DOI 10.1016/j.memsci.2009.11.040; Bunch JS, 2008, NANO LETT, V8, P2458, DOI 10.1021/nl801457b; Chen SS, 2011, ACS NANO, V5, P1321, DOI 10.1021/nn103028d; de Vos RM, 1998, SCIENCE, V279, P1710, DOI 10.1126/science.279.5357.1710; Dikin DA, 2007, NATURE, V448, P457, DOI 10.1038/nature06016; Du HL, 2011, J PHYS CHEM C, V115, P23261, DOI 10.1021/jp206258u; Elyassi B, 2007, J MEMBRANE SCI, V288, P290, DOI 10.1016/j.memsci.2006.11.027; Gu YF, 2009, J MEMBRANE SCI, V345, P267, DOI 10.1016/j.memsci.2009.09.009; Guan GQ, 2003, J MEMBRANE SCI, V214, P191, DOI 10.1016/S0376-7388(02)00544-6; Guo HL, 2009, J AM CHEM SOC, V131, P1646, DOI 10.1021/ja8074874; Hong M, 2005, IND ENG CHEM RES, V44, P4035, DOI 10.1021/ie048739v; Hong M, 2008, J MEMBRANE SCI, V307, P277, DOI 10.1016/j.memsci.2007.09.031; Jiang DE, 2009, NANO LETT, V9, P4019, DOI 10.1021/nl9021946; Kanezashi M, 2008, AICHE J, V54, P1478, DOI 10.1002/aic.11457; Koenig SP, 2012, NAT NANOTECHNOL, V7, P728, DOI [10.1038/NNANO.2012.162, 10.1038/nnano.2012.162]; Lai ZP, 2003, SCIENCE, V300, P456, DOI 10.1126/science.1082169; Lee C, 2008, SCIENCE, V321, P385, DOI 10.1126/science.1157996; Leenaerts O, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.3021413; Li YS, 2010, J MEMBRANE SCI, V354, P48, DOI 10.1016/j.memsci.2010.02.074; Nair RR, 2012, SCIENCE, V335, P442, DOI 10.1126/science.1211694; Ockwig NW, 2007, CHEM REV, V107, P4078, DOI 10.1021/cr0501792; Oyama ST, 2004, J MEMBRANE SCI, V244, P45, DOI 10.1016/j.memsci.2004.06.046; Park HB, 2007, SCIENCE, V318, P254, DOI 10.1126/science.1146744; Qin X, 2013, SURF SCI, V607, P153, DOI 10.1016/j.susc.2012.08.024; Robeson LM, 2008, J MEMBRANE SCI, V320, P390, DOI 10.1016/j.memsci.2008.04.030; Scholes CA, 2010, INT J GREENH GAS CON, V4, P739, DOI 10.1016/j.ijggc.2010.04.001; Shiflett MB, 1999, SCIENCE, V285, P1902, DOI 10.1126/science.285.5435.1902; Tang Z, 2009, LANGMUIR, V25, P4848, DOI 10.1021/la900474y; Tomita T, 2004, MICROPOR MESOPOR MAT, V68, P71, DOI 10.1016/j.micromeso.2003.11.016; Yu M, 2011, ACCOUNTS CHEM RES, V44, P1196, DOI 10.1021/ar200083e; Yu MA, 2011, J AM CHEM SOC, V133, P1748, DOI 10.1021/ja108681n	32	985	1023	59	1743	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 4	2013	342	6154					95	98		10.1126/science.1236686	http://dx.doi.org/10.1126/science.1236686			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	227PP	24092739				2022-12-28	WOS:000325126100052
J	Song, YT; Chen, X; Dabade, V; Shield, TW; James, RD				Song, Yintao; Chen, Xian; Dabade, Vivekanand; Shield, Thomas W.; James, Richard D.			Enhanced reversibility and unusual microstructure of a phase-transforming material	NATURE			English	Article							SHAPE-MEMORY ALLOYS; X-RAY-DIFFRACTION; HYSTERESIS; ALCHEMI; DRIVEN; STRAIN	Materials undergoing reversible solid-to-solid martensitic phase transformations are desirable for applications in medical sensors and actuators(1), eco-friendly refrigerators(2,3) and energy conversion devices(4). The ability to pass back and forth through the phase transformation many times without degradation of properties (termed 'reversibility') is critical for these applications. Materials tuned to satisfy a certain geometric compatibility condition have been shown(2,5-14) to exhibit high reversibility, measured by low hysteresis and small migration of transformation temperature under cycling(6,9,12,15). Recently, stronger compatibility conditions called the 'cofactor conditions'(5,15) have been proposed theoretically to achieve even better reversibility. Here we report the enhanced reversibility and unusual microstructure of the first martensitic material, Zn45Au30Cu25, that closely satisfies the cofactor conditions. We observe four striking properties of thismaterial. (1) Despite a transformation strain of 8%, the transformation temperature shifts less than 0.5 degrees C after more than 16,000 thermal cycles. For comparison, the transformation temperature of the ubiquitous NiTi alloy shifts up to 20 degrees C in the first 20 cycles(9,16). (2) The hysteresis remains approximately 2 degrees C during this cycling. For comparison, the hysteresis of the NiTi alloy is up to 70 degrees C (refs 9, 12). (3) The alloy exhibits an unusual riverine microstructure of martensite not seen in other martensites. (4) Unlike that of typical polycrystal martensites, its microstructure changes drastically in consecutive transformation cycles, whereas macroscopic properties such as transformation temperature and latent heat are nearly reproducible. These results promise a concrete strategy for seeking ultra-reliable martensitic materials.	[Song, Yintao; Chen, Xian; Dabade, Vivekanand; Shield, Thomas W.; James, Richard D.] Univ Minnesota, Dept Aerosp Engn & Mech, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	James, RD (corresponding author), Univ Minnesota, Dept Aerosp Engn & Mech, Minneapolis, MN 55455 USA.	james@umn.edu		Shield, Thomas W/0000-0002-0662-7029; Song, Yintao/0000-0002-4052-2407; James, Richard/0000-0001-6019-6613	MURI [FA9550-12-1-0458, W911NF-07-1-0410]; NSF-PIRE [OISE-0967140]; Graduate School of the University of Minnesota	MURI(MURI); NSF-PIRE(National Science Foundation (NSF)NSF - Office of the Director (OD)); Graduate School of the University of Minnesota(University of Minnesota System)	We acknowledge the financial support of MURI projects FA9550-12-1-0458 (administered by AFOSR) and W911NF-07-1-0410 (administered by ARO). This research also benefited from the support of NSF-PIRE grant number OISE-0967140. Y.S. thanks the Graduate School of the University of Minnesota for support through a Doctoral Dissertation Fellowship.	AMENGUAL A, 1987, THERMOCHIM ACTA, V116, P195, DOI 10.1016/0040-6031(87)88179-0; BALL JM, 1987, ARCH RATION MECH AN, V100, P13, DOI 10.1007/BF00281246; Bechtold C, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4748307; Bhattacharya K, 1996, ACTA MATER, V44, P529, DOI 10.1016/1359-6454(95)00198-0; Bhattacharya K., 2003, MICROSTRUCTURE MARTE; BOWLES JS, 1954, ACTA METALL MATER, V2, P129, DOI 10.1016/0001-6160(54)90102-9; Chen X., 2013, J MECH PHYS SOLIDS; Cui J, 2006, NAT MATER, V5, P286, DOI 10.1038/nmat1593; Delville R, 2010, PHILOS MAG, V90, P177, DOI 10.1080/14786430903074755; Eggeler G, 2004, MAT SCI ENG A-STRUCT, V378, P24, DOI 10.1016/j.msea.2003.10.327; James RD, 2005, SPRINGER SERIES MATE, V79, P159; Liu J, 2012, NAT MATER, V11, P620, DOI [10.1038/NMAT3334, 10.1038/nmat3334]; Louie MW, 2010, SOLID STATE IONICS, V181, P173, DOI 10.1016/j.ssi.2008.11.014; Meethong N, 2007, ADV FUNCT MATER, V17, P1115, DOI 10.1002/adfm.200600938; Mott N. F., 1990, METAL INSULATOR TRAN; Moya X, 2013, ADV MATER, V25, P1360, DOI 10.1002/adma.201203823; Norfleet DM, 2009, ACTA MATER, V57, P3549, DOI 10.1016/j.actamat.2009.04.009; Pitteri M., 2010, CONTINUUM MODELS PHA; SETHNA JP, 1993, PHYS REV LETT, V70, P3347, DOI 10.1103/PhysRevLett.70.3347; Sethna JP, 2001, NATURE, V410, P242, DOI 10.1038/35065675; Srivastava V, 2011, ADV ENERGY MATER, V1, P97, DOI 10.1002/aenm.201000048; Srivastava V, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3456562; TADAKI T, 1987, T JPN I MET, V28, P883, DOI 10.2320/matertrans1960.28.883; TADAKI T, 1990, MATER T JIM, V31, P935, DOI 10.2320/matertrans1989.31.935; TADAKI T, 1990, MATER T JIM, V31, P941, DOI 10.2320/matertrans1989.31.941; Vives E, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.060101; WALIA H, 1988, J ENDODONT, V14, P346, DOI 10.1016/S0099-2399(88)80196-1; WECHSLER MS, 1953, T AM I MIN MET ENG, V197, P1503; Zarnetta R, 2010, ADV FUNCT MATER, V20, P1917, DOI 10.1002/adfm.200902336; Zhang ZY, 2009, ACTA MATER, V57, P4332, DOI 10.1016/j.actamat.2009.05.034	30	274	275	12	352	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 3	2013	502	7469					85	88		10.1038/nature12532	http://dx.doi.org/10.1038/nature12532			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	227IM	24091977				2022-12-28	WOS:000325106000035
J	Varughese, N; Duong, A; Emre, S; Xu, MN; Lee, AI				Varughese, Neal; Duong, Angie; Emre, Sukru; Xu, Mina; Lee, Alfred Ian			Venting the Spleen	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							FDG-PET/CT; SPLENOSIS; SPLENECTOMY; LYMPHOMA; TISSUE	A 19-year-old woman presented with a 4-day history of abdominal pain in the right upper quadrant and epigastrium, with occasional radiation to her back. She also noted profound fatigue and a 13.6-kg weight loss during the preceding months. ForewordIn this Journal feature, information about a real patient is presented in stages (boldface type) to an expert clinician, who responds to the information, sharing his or her reasoning with the reader (regular type). The authors' commentary follows.StageA 19-year-old woman presented to a community hospital with a 4-day history of abdominal pain, located in the right upper quadrant and epigastrium, with occasional radiation to her back. She described the pain as intermittent and variable in intensity, associated with nausea, and occurring independently of oral intake or body position. A review of systems was notable for profound fatigue and a 13.6-kg (30-lb) weight loss during the preceding months, which she attributed to stress in the wake of her parents' recent divorce. She reported no fever, sweats, jaundice, dyspnea, vomiting, diarrhea, constipation, urinary abnormalities, joint aches, or rash.	[Varughese, Neal] Yale Univ, Sch Med, Dept Med, New Haven, CT 06520 USA; [Duong, Angie; Xu, Mina] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06520 USA; [Emre, Sukru] Yale Univ, Sch Med, Dept Surg, New Haven, CT 06520 USA; [Lee, Alfred Ian] Yale Univ, Sch Med, Sect Hematol, New Haven, CT 06520 USA	Yale University; Yale University; Yale University; Yale University	Lee, AI (corresponding author), Yale Univ, Sch Med, 333 Cedar St, New Haven, CT 06520 USA.	alfred.lee@yale.edu						BASILE RM, 1989, ARCH SURG-CHICAGO, V124, P1087; CORAZZA GR, 1984, BRIT MED J, V289, P861, DOI 10.1136/bmj.289.6449.861; Fremont RD, 2007, SOUTH MED J, V100, P589, DOI 10.1097/SMJ.0b013e318038d1f8; Horger M, 2003, EUR J NUCL MED MOL I, V30, P316, DOI 10.1007/s00259-002-1043-7; Lin WC, 2003, AM J ROENTGENOL, V180, P493, DOI 10.2214/ajr.180.2.1800493; LIVINGSTON CD, 1983, ARCH SURG-CHICAGO, V118, P617; Lustberg MB, 2008, EUR J HAEMATOL, V81, P154, DOI 10.1111/j.1600-0609.2008.01088.x; MAZUR EM, 1978, AM J MED, V65, P843, DOI 10.1016/0002-9343(78)90804-5; NIELSEN JL, 1981, SCAND J HAEMATOL, V27, P51; PERRY MC, 1974, MAYO CLIN PROC, V49, P875; SIRINEK KR, 1984, SOUTHERN MED J, V77, P764, DOI 10.1097/00007611-198406000-00026; STOBIE GH, 1947, CAN MED ASSOC J, V56, P374; Thomas DL, 2009, CLIN NUCL MED, V34, P891, DOI 10.1097/RLU.0b013e3181bed135; Tomas, 2000, Clin Positron Imaging, V3, P176, DOI 10.1016/S1095-0397(00)00088-1	14	3	4	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 3	2013	369	14					1357	1363		10.1056/NEJMcps1210943	http://dx.doi.org/10.1056/NEJMcps1210943			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	227KI	24088096				2022-12-28	WOS:000325111200014
J	Ferrante, JM; Lee, JH; McCarthy, EP; Fisher, KJ; Chen, R; Gonzalez, EC; Love-Jackson, K; Roetzheim, RG				Ferrante, Jeanne M.; Lee, Ji-Hyun; McCarthy, Ellen P.; Fisher, Kate J.; Chen, Ren; Gonzalez, Eduardo C.; Love-Jackson, Kymia; Roetzheim, Richard G.			Primary Care Utilization and Colorectal Cancer Incidence and Mortality Among Medicare Beneficiaries	ANNALS OF INTERNAL MEDICINE			English	Article							STAGE; STATISTICS; DIAGNOSIS; SERVICES; QUALITY	Background: Utilization of primary care may decrease colorectal cancer (CRC) incidence and death through greater receipt of CRC screening tests. Objective: To examine the association of primary care utilization with CRC incidence, CRC deaths, and all-cause mortality. Design: Population-based, case-control study. Setting: Medicare program. Participants: Persons aged 67 to 85 years diagnosed with CRC between 1994 and 2005 in U. S. Surveillance, Epidemiology, and End Results (SEER) regions matched with control patients (n = 205 804 for CRC incidence, 54 160 for CRC mortality, and 121 070 for all-cause mortality). Measurements: Primary care visits in the 4- to 27-month period before CRC diagnosis, CRC incidence, CRC mortality, and all-cause mortality. Results: Compared with persons having 0 or 1 primary care visit, persons with 5 to 10 visits had lower CRC incidence (adjusted odds ratio [OR], 0.94 [95% CI, 0.91 to 0.96]) and mortality (adjusted OR, 0.78 [CI, 0.75 to 0.82]) and lower all-cause mortality (adjusted OR, 0.79 [CI, 0.76 to 0.82]). Associations were stronger in patients with late-stage CRC diagnosis, distal lesions, and diagnosis in more recent years when there was greater Medicare screening coverage. Ever receipt of CRC screening and polypectomy mediated the association of primary care utilization with CRC incidence. Limitation: This study used administrative data, which made it difficult to identify potential confounders and prevented examination of the content of primary care visits. Conclusion: Medicare beneficiaries with higher utilization of primary care have lower CRC incidence and mortality and lower overall mortality. Increasing and promoting access to primary care in the United States for Medicare beneficiaries may help decrease the national burden of CRC. Primary Funding Source: American Cancer Society.	Rutgers Robert Wood Johnson Med Sch, New Brunswick, NJ USA; Canc Inst New Jersey, New Brunswick, NJ USA; Univ S Florida, H Lee Moffitt Canc Ctr, Tampa, FL 33682 USA; Univ S Florida, Tampa, FL USA; Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Boston, MA 02215 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Ferrante, JM (corresponding author), Rutgers Robert Wood Johnson Med Sch, Dept Family Med & Community Hlth, 1 Worlds Fair Dr,Suite 1500, Somerset, NJ 08873 USA.	jeanne.ferrante@rutgers.edu	Gonzalez, Eduardo C/I-4975-2012; Roetzheim, Richard/J-4696-2012; Ferrante, Jeanne/C-7452-2014	Ferrante, Jeanne/0000-0003-0222-5396	American Cancer Society; NATIONAL CANCER INSTITUTE [P30CA076292] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	American Cancer Society.	[Anonymous], HCPCS GEN INF; [Anonymous], 2010, CANC TRENDS PROGR RE; Baldwin LM, 2002, MED CARE, V40, P82; Beebe M, 2004, CURR PROC TERM CPT 2; Brookhart MA, 2007, AM J EPIDEMIOL, V166, P348, DOI 10.1093/aje/kwm070; Calonge N, 2008, ANN INTERN MED, V149, P627, DOI 10.7326/0003-4819-149-9-200811040-00243; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Collwill JM, 2008, HEALTH AFFAIR, V27, pW232, DOI 10.1377/hlthaff.27.3.w232; Cormen T., 2009, INTRO ALGORITHMS; Edmonds Jack, 1971, MATH PROGRAM, V1, P127, DOI [10.1007/BF01584082, DOI 10.1007/BF01584082]; Ferrante JM, 2011, ARCH INTERN MED, V171, P1747, DOI 10.1001/archinternmed.2011.470; Ferrante JM, 2010, ANN FAM MED, V8, P108, DOI 10.1370/afm.1080; Friedberg MW, 2010, HEALTH AFFAIR, V29, P766, DOI 10.1377/hlthaff.2010.0025; Gonzalez EC, 2001, DIS COLON RECTUM, V44, P251, DOI 10.1007/BF02234301; Gornick ME, 2004, HEALTH SERV RES, V39, P1403, DOI 10.1111/j.1475-6773.2004.00296.x; Gross CP, 2006, JAMA-J AM MED ASSOC, V296, P2815, DOI 10.1001/jama.296.23.2815; Hao YP, 2009, CANCER CAUSE CONTROL, V20, P1855, DOI 10.1007/s10552-009-9379-y; Hughes Cindy, 2011, Fam Pract Manag, V18, P22; Iglehart John K, 2010, Health Aff (Millwood), V29, P758, DOI 10.1377/hlthaff.2010.0411; Kirschner CG, 1994, PHYS CURR PROC TERM; Klabunde CN, 2006, AM J PREV MED, V30, P313, DOI 10.1016/j.amepre.2005.11.006; Lang K, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-227; Lin DY, 1998, BIOMETRICS, V54, P948, DOI 10.2307/2533848; McCarthy EP, 1998, ANN INTERN MED, V128, P729, DOI 10.7326/0003-4819-128-9-199805010-00005; Neugut AI, 2010, JAMA-J AM MED ASSOC, V304, P461, DOI 10.1001/jama.2010.1001; Ogle KS, 2000, CANCER, V88, P653, DOI 10.1002/(SICI)1097-0142(20000201)88:3<653::AID-CNCR24>3.0.CO;2-1; Okie S, 2012, NEW ENGL J MED, V366, P1849, DOI 10.1056/NEJMp1201526; Roetzheim RG, 1999, J FAM PRACTICE, V48, P850; Schoen RE, 2012, NEW ENGL J MED, V366, P2345, DOI 10.1056/NEJMoa1114635; Schonberg MA, 2011, J CLIN ONCOL, V29, P1570, DOI 10.1200/JCO.2010.33.0472; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Starfield B, 2010, HEALTH AFFAIR, V29, P1030, DOI 10.1377/hlthaff.2010.0002; Starfield B, 2009, J AMBUL CARE MANAG, V32, P216, DOI 10.1097/JAC.0b013e3181ac9ca2; U.S. Department of Health and Human Services and Office of Disease Prevention and Health Promotion, 2010, HLTH PEOPL 2020; Valderas JM, 2009, ANN FAM MED, V7, P104, DOI 10.1370/afm.949; Warren JL, 2002, MED CARE, V40, P3; Wee CC, 2005, PREV MED, V41, P23, DOI 10.1016/j.ypmed.2004.11.004; Yabroff KR, 2008, JNCI-J NATL CANCER I, V100, P630, DOI 10.1093/jnci/djn103	39	35	36	0	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 1	2013	159	7					437	U136		10.7326/0003-4819-159-7-201310010-00003	http://dx.doi.org/10.7326/0003-4819-159-7-201310010-00003			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	234FQ	24081284	Green Accepted			2022-12-28	WOS:000325628000001
J	Druzd, D; Scheiermann, C				Druzd, David; Scheiermann, Christoph			Some Monocytes Got Rhythm	SCIENCE			English	Editorial Material							CIRCADIAN CLOCK; MACROPHAGES; INNATE		[Druzd, David; Scheiermann, Christoph] Univ Munich, Walter Brendel Ctr Expt Med, D-81377 Munich, Germany	University of Munich	Druzd, D (corresponding author), Univ Munich, Walter Brendel Ctr Expt Med, Marchioninistr 15, D-81377 Munich, Germany.	christoph.scheiermann@med.uni-muenchen.de	Scheiermann, Christoph/B-8261-2014	Scheiermann, Christoph/0000-0002-9212-0995				Casanova-Acebes M, 2013, CELL, V153, P1025, DOI 10.1016/j.cell.2013.04.040; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Gibbs JE, 2012, P NATL ACAD SCI USA, V109, P582, DOI 10.1073/pnas.1106750109; HALBERG F, 1960, P SOC EXP BIOL MED, V103, P142; Keller M, 2009, P NATL ACAD SCI USA, V106, P21407, DOI 10.1073/pnas.0906361106; Mendez-Ferrer S, 2008, NATURE, V452, P442, DOI 10.1038/nature06685; Nguyen KD, 2013, SCIENCE, V341, P1483, DOI 10.1126/science.1240636; Scheiermann C, 2013, NAT REV IMMUNOL, V13, P190, DOI 10.1038/nri3386; Silver AC, 2012, IMMUNITY, V36, P251, DOI 10.1016/j.immuni.2011.12.017; Wang W, 2011, NATURE, V470, P110, DOI 10.1038/nature09766	10	8	8	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 27	2013	341	6153					1462	1464		10.1126/science.1244445	http://dx.doi.org/10.1126/science.1244445			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	224NS	24072913				2022-12-28	WOS:000324894600036
J	Kyte, D; Draper, H; Calvert, M				Kyte, Derek; Draper, Heather; Calvert, Melanie			Patient-Reported Outcome Alerts Ethical and Logistical Considerations in Clinical Trials	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Kyte, Derek; Draper, Heather; Calvert, Melanie] Univ Birmingham, Birmingham B15 2TT, W Midlands, England; [Calvert, Melanie] Med Res Council Midland Hub Trials Methodol Res, Birmingham, W Midlands, England	University of Birmingham	Calvert, M (corresponding author), Univ Birmingham, Sch Hlth & Populat Sci, Birmingham B15 2TT, W Midlands, England.	m.calvert@bham.ac.uk	Calvert, Melanie/F-7055-2011	Calvert, Melanie/0000-0002-1856-837X; kyte, Derek/0000-0002-7679-6741; Draper, Heather/0000-0002-0020-4252	MRC [G0800808] Funding Source: UKRI; Medical Research Council [G0800808] Funding Source: Medline; National Institute for Health Research [SPCR-017] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research(National Institute for Health Research (NIHR))		Basch EM, 2011, VALUE HEALTH, V14, pA10, DOI 10.1016/j.jval.2011.02.060; Fayers PM, 1997, EUR J CANCER, V33, P20, DOI 10.1016/S0959-8049(96)00412-1; Keeley T, QUAL LIFE RES, DOI [10.1007/s11136-013-0480-2, DOI 10.1007/S11136-013-0480-2]; Kyte D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076625; Sackett DL, 2011, CLIN TRIALS, V8, P440, DOI 10.1177/1740774511410995; Snyder CF, 2009, QUAL LIFE RES, V18, P793, DOI 10.1007/s11136-009-9497-8	6	33	34	1	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 25	2013	310	12					1229	1230		10.1001/jama.2013.277222	http://dx.doi.org/10.1001/jama.2013.277222			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	222SO	24065005	Green Submitted			2022-12-28	WOS:000324751800015
J	Smith, JM				Smith, Jeanette M.			Apples Thomas Worthington Whittredge	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 25	2013	310	12					1210	1211		10.1001/jama.2013.5327	http://dx.doi.org/10.1001/jama.2013.5327			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	222SO	24064992				2022-12-28	WOS:000324751800001
J	Smith, R; Rabadan-Diehl, C; Wu, YF; Niessen, L; Prabhakaran, D; Xavier, D; Ghannem, H; Kimaiyo, S; Levitt, N; Denman, CA; Ramirez-Zea, M; Miranda, J; Rubenstein, A				Smith, Richard; Rabadan-Diehl, Christina; Wu, Yangfeng; Niessen, Louis; Prabhakaran, Dorajai; Xavier, Denis; Ghannem, Hassen; Kimaiyo, Sylvester; Levitt, Naomi; Denman, Catalina A.; Ramirez-Zea, Manuel; Miranda, Jaime; Rubenstein, Adolfo		UnitedHlth Grp Natl Heart Lung	A global research network for non-communicable diseases	LANCET			English	Editorial Material							FRAMINGHAM		[Smith, Richard; Rabadan-Diehl, Christina; Wu, Yangfeng; Niessen, Louis; Prabhakaran, Dorajai; Xavier, Denis; Ghannem, Hassen; Kimaiyo, Sylvester; Levitt, Naomi; Denman, Catalina A.; Ramirez-Zea, Manuel; Miranda, Jaime; Rubenstein, Adolfo; UnitedHlth Grp Natl Heart Lung] Inst Ctr Excellence, London SW4 0LD, England		Smith, R (corresponding author), Inst Ctr Excellence, London SW4 0LD, England.	richardswsmith@yahoo.co.uk	Prabhakaran, Dorairaj/B-4147-2011; Niessen, Louis/F-6254-2015	Prabhakaran, Dorairaj/0000-0002-3172-834X; Niessen, Louis/0000-0002-8639-5191				Greenberg H, 2010, PROG CARDIOVASC DIS, V53, P1, DOI 10.1016/j.pcad.2010.05.003; Institute of Medicine, 2010, PROMOTING CARDIOVASC; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Nabel EG, 2009, LANCET, V373, P2004, DOI 10.1016/S0140-6736(09)61074-6; Nugent RA, 2010, 228 CTR GLOB DEV; Puska P, 2010, PROG CARDIOVASC DIS, V53, P15, DOI 10.1016/j.pcad.2010.01.003; Quam L, 2006, LANCET, V368, P1221, DOI 10.1016/s0140-6736(06)69422-1; Stevens D, 2007, LANCET, V370, P1901, DOI 10.1016/S0140-6736(07)61802-9; United Nations, 2011, REPORT SPECIAL RAPPO; UnitedHealth National Heart Lung and Blood Centres of Excellence, 2011, BMJ-BRIT MED J, V342, P76; World Health Organization, 2013, GLOB ACT PLAN PREV C	11	16	16	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 26	2014	383	9927					1446	1447		10.1016/S0140-6736(13)61808-5	http://dx.doi.org/10.1016/S0140-6736(13)61808-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AG3NI	24094840				2022-12-28	WOS:000335325800008
J	Marlow, N				Marlow, Neil			Treatment of blood glucose concentrations in newborn babies	LANCET			English	Editorial Material							NEONATAL HYPOGLYCEMIA		UCL EGA Inst Womens Hlth, London WC1E 6AU, England	University of London; University College London	Marlow, N (corresponding author), UCL EGA Inst Womens Hlth, London WC1E 6AU, England.	n.marlow@ucl.ac.uk	Marlow, Neil/D-2918-2009	Marlow, Neil/0000-0001-5890-2953	National Institute for Health Research [NF-SI-0512-10034] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		Boardman JP, 2013, ARCH DIS CHILDHOOD-E, V98, P2, DOI 10.1136/archdischild-2012-302569; Boluyt N, 2006, PEDIATRICS, V117, P2231, DOI 10.1542/peds.2005-1919; BOURCHIER D, 1992, NEW ZEAL MED J, V105, P22; Harris DL, 2012, J PEDIATR-US, V161, P787, DOI 10.1016/j.jpeds.2012.05.022; Harris DL, 2013, LANCET; Rozance PJ, 2010, EARLY HUM DEV, V86, P275, DOI 10.1016/j.earlhumdev.2010.05.002; Tait RME., 2000, ARCH DIS CHILD S, V82, pA30; 1989, LANCET, V1, P882	8	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 21	2013	382	9910					2045	2046		10.1016/S0140-6736(13)61755-9	http://dx.doi.org/10.1016/S0140-6736(13)61755-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	275OX	24075363				2022-12-28	WOS:000328687800010
J	Cotten, M; Watson, SJ; Kellam, P; Al-Rabeeah, AA; Makhdoom, HQ; Assiri, A; Al-Tawfiq, JA; Alhakeem, RF; Madani, H; AlRabiah, FA; Al Hajjar, S; Al-Nassir, WN; Albarrak, A; Flemban, H; Balkhy, HH; Alsubaie, S; Palser, AL; Gall, A; Bashford-Rogers, R; Rambaut, A; Zumla, AI; Memish, ZA				Cotten, Matthew; Watson, Simon J.; Kellam, Paul; Al-Rabeeah, Abdullah A.; Makhdoom, Hatem Q.; Assiri, Abdullah; Al-Tawfiq, Jaffar A.; Alhakeem, Rafat F.; Madani, Hossam; AlRabiah, Fahad A.; Al Hajjar, Sami; Al-Nassir, Wafa N.; Albarrak, Ali; Flemban, Hesham; Balkhy, Hanan H.; Alsubaie, Sarah; Palser, Anne L.; Gall, Astrid; Bashford-Rogers, Rachael; Rambaut, Andrew; Zumla, Alimuddin I.; Memish, Ziad A.			Transmission and evolution of the Middle East respiratory syndrome coronavirus in Saudi Arabia: a descriptive genomic study	LANCET			English	Article							PHYLOGENETIC ANALYSIS; SPIKE PROTEIN; ACTIVATION; RECEPTOR; INFERENCE; CLEAVAGE	Background Since June, 2012, Middle East respiratory syndrome coronavirus (MERS-CoV) has, worldwide, caused 104 infections in people including 49 deaths, with 82 cases and 41 deaths reported from Saudi Arabia. In addition to confirming diagnosis, we generated the MERS-CoV genomic sequences obtained directly from patient samples to provide important information on MERS-CoV transmission, evolution, and origin. Methods Full genome deep sequencing was done on nucleic acid extracted directly from PCR-confirmed clinical samples. Viral genomes were obtained from 21 MERS cases of which 13 had 100%, four 85-95%, and four 30-50% genome coverage. Phylogenetic analysis of the 21 sequences, combined with nine published MERS-CoV genomes, was done. Findings Three distinct MERS-CoV genotypes were identified in Riyadh. Phylogeographic analyses suggest the MERS-CoV zoonotic reservoir is geographically disperse. Selection analysis of the MERS-CoV genomes reveals the expected accumulation of genetic diversity including changes in the S protein. The genetic diversity in the Al-Hasa cluster suggests that the hospital outbreak might have had more than one virus introduction. Interpretation We present the largest number of MERS-CoV genomes (21) described so far. MERS-CoV full genome sequences provide greater detail in tracking transmission. Multiple introductions of MERS-CoV are identified and suggest lower R 0 values. Transmission within Saudi Arabia is consistent with either movement of an animal reservoir, animal products, or movement of infected people. Further definition of the exposures responsible for the sporadic introductions of MERS-CoV into human populations is urgently needed.	[Al-Rabeeah, Abdullah A.; Assiri, Abdullah; Alhakeem, Rafat F.; Zumla, Alimuddin I.; Memish, Ziad A.] Minist Hlth, Global Ctr Mass Gatherings Med, Riyadh 11176, Saudi Arabia; [Cotten, Matthew; Watson, Simon J.; Kellam, Paul; Palser, Anne L.; Gall, Astrid; Bashford-Rogers, Rachael] Wellcome Trust Sanger Inst, Hinxton, England; [Makhdoom, Hatem Q.; Madani, Hossam] Minist Hlth, Jeddah Reg Lab, Jeddah, Saudi Arabia; [Al-Tawfiq, Jaffar A.] Saudi Aramco Med Serv Org, Dhahran, Saudi Arabia; [Rambaut, Andrew] Ashworth Labs, Inst Evolutionary Biol, Edinburgh, Midlothian, Scotland; [Rambaut, Andrew] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA; [AlRabiah, Fahad A.; Al Hajjar, Sami] King Faisal Specialist Hosp & Res Ctr, Riyadh, Saudi Arabia; [Al-Nassir, Wafa N.] Natl Guard Hlth Affairs Dammam, Imam Abdulrahman Bin Mohamed Hosp, Dammam, Saudi Arabia; [Albarrak, Ali] Prince Sultan Mil Med City, Riyadh, Saudi Arabia; [Flemban, Hesham] Alhada Mil Hosp, Riyadh, Saudi Arabia; [Balkhy, Hanan H.] King Abdul Aziz Med City, Riyadh, Saudi Arabia; [Alsubaie, Sarah] King Saud Univ, Riyadh 11451, Saudi Arabia; [Kellam, Paul; Zumla, Alimuddin I.] UCL, Div Infect & Immun, London, England; [Zumla, Alimuddin I.] UCL Hosp NHS Fdn Trust, London, England	Wellcome Trust Sanger Institute; Ministry of Health - Saudi Arabia; Saudi Aramco; University of Edinburgh; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); King Faisal Specialist Hospital & Research Center; Prince Sultan Military Medical City; King Saud University; University of London; University College London; University of London; University College London	Memish, ZA (corresponding author), Minist Hlth, Global Ctr Mass Gatherings Med, Riyadh 11176, Saudi Arabia.	zmemish@yahoo.com	Memish, Ziad Ahmed/AEJ-9424-2022; assiri, abdullah/AAF-5665-2021; Rambaut, Andrew/B-2481-2009; Assiri, Abdullah M./GQP-2239-2022; ZUMLA, Alimuddin/ABA-8208-2020	Memish, Ziad Ahmed/0000-0002-5099-0714; assiri, abdullah/0000-0002-5605-2876; Rambaut, Andrew/0000-0003-4337-3707; ZUMLA, Alimuddin/0000-0002-5111-5735; Rambaut FRSE, Professor Andrew/0000-0002-1278-598X; Cotten, Matthew/0000-0002-3361-3351; Kellam, Paul/0000-0003-3166-4734; Gall, Astrid/0000-0001-6452-5816; Bashford-Rogers, Rachael/0000-0002-6838-0711; Alsubaie, Sarah/0000-0002-3128-5921	Saudi Arabian Ministry of Health; Wellcome Trust; European Community; National Institute of Health Research University College London Hospitals Biomedical Research Centre	Saudi Arabian Ministry of Health; Wellcome Trust(Wellcome TrustEuropean Commission); European Community(European Commission); National Institute of Health Research University College London Hospitals Biomedical Research Centre	Funding Saudi Arabian Ministry of Health, Wellcome Trust, European Community, and National Institute of Health Research University College London Hospitals Biomedical Research Centre.	AlBarrak AM, 2012, SAUDI MED J, V33, P1265; [Anonymous], 2013, MIDDL E RESP SYNDR C; Assiri A, 2013, NEW ENGL J MED, V369, P407, DOI 10.1056/NEJMoa1306742; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Belouzard S, 2009, P NATL ACAD SCI USA, V106, P5871, DOI 10.1073/pnas.0809524106; Bottcher E, 2006, J VIROL, V80, P9896, DOI 10.1128/JVI.01118-06; Breban R, 2013, LANCET, V382, P694, DOI 10.1016/S0140-6736(13)61492-0; Corman VM, 2012, EUROSURVEILLANCE, V17, P2; Corman VM, 2012, EUROSURVEILLANCE, V17, P3; Cotten M, 2013, EMERG INFECT DIS, V19, P736, DOI 10.3201/eid1905.130057; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI 10.1093/molbev/mss075; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Duckert P, 2004, PROTEIN ENG DES SEL, V17, P107, DOI 10.1093/protein/gzh013; Guan Y, 2004, LANCET, V363, P99, DOI 10.1016/S0140-6736(03)15259-2; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Ithete NL, 2013, EMERG INFECT DIS, V19, P1697, DOI 10.3201/eid1910.130946; Li WH, 2005, EMBO J, V24, P1634, DOI 10.1038/sj.emboj.7600640; Lu GW, 2013, NATURE, V500, P227, DOI 10.1038/nature12328; Matsuyama S, 2010, J VIROL, V84, P12658, DOI 10.1128/JVI.01542-10; Memish ZA, 2013, EMERG INFECT DIS, V19, P1819, DOI 10.3201/eid1911.131172; Memish ZA, 2013, NEW ENGL J MED, V368, P2487, DOI 10.1056/NEJMoa1303729; Minin VN, 2008, MOL BIOL EVOL, V25, P1459, DOI 10.1093/molbev/msn090; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Raj VS, 2013, NATURE, V495, P251, DOI 10.1038/nature12005; Rambaut A., NOVEL HUMAN BETACORO; Reusken CBEM, 2013, LANCET INFECT DIS, V13, P859, DOI 10.1016/S1473-3099(13)70164-6; Sheahan T, 2008, J VIROL, V82, P2274, DOI 10.1128/JVI.02041-07; Song HD, 2005, P NATL ACAD SCI USA, V102, P2430, DOI 10.1073/pnas.0409608102; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; van Boheemen S, 2012, MBIO, V3, DOI 10.1128/mBio.00473-12; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721	32	220	243	1	61	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 14	2013	382	9909					1993	2002		10.1016/S0140-6736(13)61887-5	http://dx.doi.org/10.1016/S0140-6736(13)61887-5			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	269EI	24055451	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000328223700026
J	Ring, AM; Manglik, A; Kruse, AC; Enos, MD; Weis, WI; Garcia, KC; Kobilka, BK				Ring, Aaron M.; Manglik, Aashish; Kruse, Andrew C.; Enos, Michael D.; Weis, William I.; Garcia, K. Christopher; Kobilka, Brian K.			Adrenaline-activated structure of beta(2)-adrenoceptor stabilized by an engineered nanobody	NATURE			English	Article							PROTEIN-COUPLED RECEPTOR; ADRENERGIC-RECEPTOR; LIGAND-BINDING; AGONIST; ADRENOCEPTOR; RHODOPSIN; COMPLEX; DISPLAY; SERINE; STATE	G-protein-coupled receptors (GPCRs) are integral membrane proteins that have an essential role in human physiology, yet the molecular processes through which they bind to their endogenous agonists and activate effector proteins remain poorly understood. So far, it has not been possible to capture an active-state GPCR bound to its native neurotransmitter. Crystal structures of agonist-bound GPCRs have relied on the use of either exceptionally high-affinity agonists(1,2) or receptor stabilization by mutagenesis(3-5). Many natural agonists such as adrenaline, which activates the beta(2)-adrenoceptor (beta(2)AR), bind with relatively low affinity, and they are often chemically unstable. Using directed evolution, we engineered a high-affinity camelid antibody fragment that stabilizes the active state of the beta(2)AR, and used this to obtain crystal structures of the activated receptor bound to multiple ligands. Here we present structures of the active-state human beta(2)AR bound to three chemically distinct agonists: the ultrahigh-affinity agonist BI167107, the high-affinity catecholamine agonist hydroxybenzyl isoproterenol, and the low-affinity endogenous agonist adrenaline. The crystal structures reveal a highly conserved overall ligand recognition and activation mode despite diverse ligand chemical structures and affinities that range from 100 nM to similar to 80 pM. Overall, the adrenaline-bound receptor structure is similar to the others, but it has substantial rearrangements in extracellular loop three and the extracellular tip of transmembrane helix 6. These structures also reveal a water-mediated hydrogen bond between two conserved tyrosines, which appears to stabilize the active state of the beta(2)AR and related GPCRs.	[Ring, Aaron M.; Manglik, Aashish; Kruse, Andrew C.; Enos, Michael D.; Weis, William I.; Garcia, K. Christopher; Kobilka, Brian K.] Stanford Univ, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Ring, Aaron M.; Enos, Michael D.; Weis, William I.; Garcia, K. Christopher] Stanford Univ, Dept Biol Struct, Stanford, CA 94305 USA; [Garcia, K. Christopher] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA	Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University	Garcia, KC (corresponding author), Stanford Univ, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA.	kcgarcia@stanford.edu; kobilka@stanford.edu	Weis, William I/G-1437-2011	Weis, William I/0000-0002-5583-6150; Enos, Michael/0000-0003-3208-7043; Ring, Aaron/0000-0003-3699-2446; Kobilka, Brian/0000-0001-5958-3990	Stanford Medical Scientist Training Program; American Heart Association; National Science Foundation; Ruth L. Kirschstein National Research Service Award; National Institutes of Health [NS02847123, GM08311806]; Mathers Foundation; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083118, T32GM008294] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS028471, R01NS028471] Funding Source: NIH RePORTER	Stanford Medical Scientist Training Program; American Heart Association(American Heart Association); National Science Foundation(National Science Foundation (NSF)); Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mathers Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank D. Hilger for critical reading of the manuscript. We acknowledge support from the Stanford Medical Scientist Training Program (A.M. and A.M.R.), the American Heart Association (A.M.), the National Science Foundation (A.C.K.), the Ruth L. Kirschstein National Research Service Award (A.M.R.), National Institutes of Health grants NS02847123 and GM08311806 (B.K.K.), from the Mathers Foundation (B.K.K., W.I.W. and K.C.G.), and from the Howard Hughes Medical Institute (K.C.G.).	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Caffrey M, 2009, NAT PROTOC, V4, P706, DOI 10.1038/nprot.2009.31; Chao G, 2006, NAT PROTOC, V1, P755, DOI 10.1038/nprot.2006.94; Deupi X, 2012, P NATL ACAD SCI USA, V109, P119, DOI 10.1073/pnas.1114089108; Elgeti M, 2011, J AM CHEM SOC, V133, P7159, DOI 10.1021/ja200545n; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Goncalves JA, 2010, P NATL ACAD SCI USA, V107, P19861, DOI 10.1073/pnas.1009405107; KOBILKA BK, 1995, ANAL BIOCHEM, V231, P269, DOI 10.1006/abio.1995.1533; Lebon G, 2011, NATURE, V474, P521, DOI 10.1038/nature10136; Liapakis G, 2000, J BIOL CHEM, V275, P37779, DOI 10.1074/jbc.M002092200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nygaard R, 2013, CELL, V152, P532, DOI 10.1016/j.cell.2013.01.008; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Rosenbaum DM, 2011, NATURE, V469, P236, DOI 10.1038/nature09665; Schneider EH, 2010, J PHARMACOL EXP THER, V333, P382, DOI 10.1124/jpet.109.163220; Serrano-Vega MJ, 2008, P NATL ACAD SCI USA, V105, P877, DOI 10.1073/pnas.0711253105; STRADER CD, 1989, J BIOL CHEM, V264, P13572; Venkatakrishnan AJ, 2013, NATURE, V494, P185, DOI 10.1038/nature11896; Wang Z, 2005, PROTEIN ENG DES SEL, V18, P337, DOI 10.1093/protein/gzi036; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Warne T, 2011, NATURE, V469, P241, DOI 10.1038/nature09746; White JF, 2012, NATURE, V490, P508, DOI 10.1038/nature11558; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104; Xu F, 2011, SCIENCE, V332, P322, DOI 10.1126/science.1202793; Zou YZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046039	27	341	347	9	178	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 24	2013	502	7472					575	+		10.1038/nature12572	http://dx.doi.org/10.1038/nature12572			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	238YN	24056936	Green Submitted, Green Accepted			2022-12-28	WOS:000325988400060
J	Morelli, A; Ertmer, C; Westphal, M; Rehberg, S; Kampmeier, T; Ligges, S; Orecchioni, A; D'Egidio, A; D'Ippoliti, F; Raffone, C; Venditti, M; Guarracino, F; Girardis, M; Tritapepe, L; Pietropaoli, P; Mebazaa, A; Singer, M				Morelli, Andrea; Ertmer, Christian; Westphal, Martin; Rehberg, Sebastian; Kampmeier, Tim; Ligges, Sandra; Orecchioni, Alessandra; D'Egidio, Annalia; D'Ippoliti, Fiorella; Raffone, Cristina; Venditti, Mario; Guarracino, Fabio; Girardis, Massimo; Tritapepe, Luigi; Pietropaoli, Paolo; Mebazaa, Alexander; Singer, Mervyn			Effect of Heart Rate Control With Esmolol on Hemodynamic and Clinical Outcomes in Patients With Septic Shock A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CARDIAC EVENTS; SURVIVAL; THERAPY; SEPSIS	IMPORTANCE beta-Blocker therapy may control heart rate and attenuate the deleterious effects of beta-adrenergic receptor stimulation in septic shock. However, beta-Blockers are not traditionally used for this condition and may worsen cardiovascular decompensation related through negative inotropic and hypotensive effects. OBJECTIVE To investigate the effect of the short-acting beta-blocker esmolol in patients with severe septic shock. DESIGN, SETTING, AND PATIENTS Open-label, randomized phase 2 study, conducted in a university hospital intensive care unit (ICU) between November 2010 and July 2012, involving patients in septic shock with a heart rate of 95/min or higher requiring high-dose norepinephrine to maintain a mean arterial pressure of 65 mm Hg or higher. INTERVENTIONS We randomly assigned 77 patients to receive a continuous infusion of esmolol titrated to maintain heart rate between 80/min and 94/min for their ICU stay and 77 patients to standard treatment. MAIN OUTCOMES AND MEASURES Our primary outcomewas a reduction in heart rate below the predefined threshold of 95/min and to maintain heart rate between 80/min and 94/min by esmolol treatment over a 96-hour period. Secondary outcomes included hemodynamic and organ function measures; norepinephrine dosages at 24, 48, 72, and 96 hours; and adverse events and mortality occurring within 28 days after randomization. RESULTS Targeted heart rateswere achieved in all patients in the esmolol group compared with those in the control group. The median AUC for heart rate during the first 96 hours was -28/min (IQR, -37 to -21) for the esmolol group vs -6/min (95% CI, -14 to 0) for the control group with a mean reduction of 18/min (P < .001). For stroke volume index, the median AUC for esmolol was 4 mL/m(2) (IQR, -1 to 10) vs 1 mL/m2 for the control group (IQR, -3 to 5; P = .02), whereas the left ventricular stroke work index for esmolol was 3 mL/m(2) (IQR, 0 to 8) vs 1 mL/m(2) for the control group (IQR, -2 to 5; P = .03). For arterial lactatemia, median AUC for esmolol was -0.1 mmol/L (IQR, -0.6 to 0.2) vs 0.1 mmol/L for the control group (IQR, -0.3 for 0.6; P = .007); for norepinephrine, -0.11 beta g/kg/min (IQR, -0.46 to 0.02) for the esmolol group vs -0.01 beta g/kg/min (IQR, -0.2 to 0.44) for the control group (P =.003). Fluid requirements were reduced in the esmolol group: median AUC was 3975 mL/24 h (IQR, 3663 to 4200) vs 4425 mL/24 h (IQR, 4038 to 4775) for the control group (P <.001). We found no clinically relevant differences between groups in other cardiopulmonary variables nor in rescue therapy requirements. Twenty-eight day mortalitywas 49.4% in the esmolol group vs 80.5% in the control group (adjusted hazard ratio, 0.39; 95% CI, 0.26 to 0.59; P < .001). CONCLUSIONS AND RELEVANCE For patients in septic shock, open-label use of esmolol vs standard care was associated with reductions in heart rates to achieve target levels, without increased adverse events. The observed improvement in mortality and other secondary clinical outcomes warrants further investigation.	[Morelli, Andrea; Orecchioni, Alessandra; D'Egidio, Annalia; D'Ippoliti, Fiorella; Raffone, Cristina; Tritapepe, Luigi; Pietropaoli, Paolo] Univ Rome, Dept Anesthesiol & Intens Care, I-00161 Rome, Italy; [Ertmer, Christian; Westphal, Martin; Rehberg, Sebastian; Kampmeier, Tim] Univ Munster, Dept Anesthesiol Intens Care & Pain Med, D-48149 Munster, Germany; [Ligges, Sandra] Univ Munster, Inst Biostat & Clin Res, D-48149 Munster, Germany; [Venditti, Mario] Univ Roma La Sapienza, Policlin Umberto 1, Dept Publ Hlth & Infect Dis, I-00185 Rome, Italy; [Guarracino, Fabio] Univ Hosp, Dept Anesthesia & Intens Care, Pisa, Italy; [Girardis, Massimo] Univ Hosp Modena, Dept Anaesthesiol & Intens Care, Modena, Italy; [Mebazaa, Alexander] Lariboisiere Hosp, Dept Anesthesiol & Crit Care Med, Paris, France; [Singer, Mervyn] UCL, Bloomsbury Inst Intens Care Med, London WC1E 6BT, England	Sapienza University Rome; University of Munster; University of Munster; Sapienza University Rome; University Hospital Sapienza Rome; University of Pisa; Azienda Ospedaliero Universitaria Pisana; Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia Hospital; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; University of London; University College London	Morelli, A (corresponding author), Univ Rome, Dept Anesthesiol & Intens Care, Viale Policlin 155, I-00161 Rome, Italy.	andrea.morelli@uniroma1.it	Rehberg, Sebastian/AAD-5191-2019; Singer, Mervyn/Q-6142-2019; MORELLI, ANDREA/D-1515-2018; Ligges, Sandra/A-8095-2013; Rehberg, Sebastian/HCL-7369-2022; Girardis, Massimo/K-8974-2016; Singer, Mervyn/J-4425-2012; tritapepe, luigi/A-5505-2016	Singer, Mervyn/0000-0002-1042-6350; MORELLI, ANDREA/0000-0001-6065-1006; Girardis, Massimo/0000-0002-2453-0829; Singer, Mervyn/0000-0002-1042-6350; tritapepe, luigi/0000-0003-0480-1705; Guarracino, Fabio/0000-0002-2562-0199; Mebazaa, Alexandre/0000-0001-8715-7753; VENDITTI, Mario/0000-0003-2639-0281; Kampmeier, Tim/0000-0003-4329-7521	Department of Anesthesiology and Intensive Care of the University of Rome	Department of Anesthesiology and Intensive Care of the University of Rome	This study was funded by an independent research grant from the Department of Anesthesiology and Intensive Care of the University of Rome "La Sapienza."	Ackland GL, 2010, CRIT CARE MED, V38, P388, DOI 10.1097/CCM.0b013e3181c03dfa; Annane D, 2005, LANCET, V365, P63, DOI 10.1016/S0140-6736(04)17667-8; Benbenishty J, 2011, HEART LUNG, V40, P247, DOI 10.1016/j.hrtlng.2010.04.007; BENEDICT CR, 1992, CIRC SHOCK, V38, P165; de Montmollin E, 2009, CRIT CARE, V13, DOI 10.1186/cc8026; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; Dunser Martin W, 2009, J Intensive Care Med, V24, P293, DOI 10.1177/0885066609340519; FEINSTEIN AR, 1990, J CLIN EPIDEMIOL, V43, P339, DOI 10.1016/0895-4356(90)90120-E; KAUFMAN MP, 1982, CIRC RES, V50, P133, DOI 10.1161/01.RES.50.1.133; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; Luckner G, 2005, CRIT CARE MED, V33, P2659, DOI 10.1097/01.CCM.0000186749.34028.40; Magder SA, 2012, CRIT CARE MED, V40, P239, DOI 10.1097/CCM.0b013e318232e50c; MATTHEWS JNS, 1990, BRIT MED J, V300, P230, DOI 10.1136/bmj.300.6719.230; Mori K, 2011, INTENS CARE MED, V37, P1849, DOI 10.1007/s00134-011-2326-x; Nuding S, 2011, CLIN RES CARDIOL, V100, P915, DOI 10.1007/s00392-011-0323-2; Park JH, 2005, CHEST, V128, P296, DOI 10.1378/chest.128.1.296; PARKER MM, 1987, CRIT CARE MED, V15, P923, DOI 10.1097/00003246-198710000-00006; Pocock SJ, 2002, LANCET, V359, P1686, DOI 10.1016/S0140-6736(02)08594-X; Rudiger A, 2007, CRIT CARE MED, V35, P1599, DOI 10.1097/01.CCM.0000266683.64081.02; Sander O, 2005, CRIT CARE MED, V33, P81, DOI 10.1097/01.CCM.0000150028.64264.14; Schmittinger CA, 2013, SHOCK, V39, P329, DOI 10.1097/SHK.0b013e318289376b; Schmittinger CA, 2012, INTENS CARE MED, V38, P950, DOI 10.1007/s00134-012-2531-2; Schmittinger CA, 2008, CRIT CARE, V12, DOI 10.1186/cc6976; SENN S, 1994, STAT MED, V13, P1715, DOI 10.1002/sim.4780131703; Singer M, 2007, LANCET, V370, P636, DOI 10.1016/S0140-6736(07)61317-8; VOLZZANG C, 1994, EUR J CLIN PHARMACOL, V46, P399; [No title captured]	27	431	474	4	44	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 23	2013	310	16					1683	1691		10.1001/jama.2013.278477	http://dx.doi.org/10.1001/jama.2013.278477			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	238LR	24108526				2022-12-28	WOS:000325948500024
J	Erickson, JR; Pereira, L; Wang, LG; Han, GH; Ferguson, A; Dao, K; Copeland, RJ; Despa, F; Hart, GW; Ripplinger, CM; Bers, DM				Erickson, Jeffrey R.; Pereira, Laetitia; Wang, Lianguo; Han, Guanghui; Ferguson, Amanda; Dao, Khanha; Copeland, Ronald J.; Despa, Florin; Hart, Gerald W.; Ripplinger, Crystal M.; Bers, Donald M.			Diabetic hyperglycaemia activates CaMKII and arrhythmias by O-linked glycosylation	NATURE			English	Article							CA2+/CALMODULIN-DEPENDENT PROTEIN-KINASE; HEART-FAILURE; CARDIAC-HYPERTROPHY; N-ACETYLGLUCOSAMINE; CYTOSOLIC PROTEINS; CARDIOMYOCYTES; MYOCYTES; MELLITUS; RECEPTOR; INSIGHT	Ca2+/calmodulin-dependent protein kinase II (CaMKII) is an enzyme with important regulatory functions in the heart and brain, and its chronic activation can be pathological. CaMKII activation is seen in heart failure, and can directly induce pathological changes in ion channels, Ca2+ handling and gene transcription(1). Here, in human, rat and mouse, we identify a novel mechanism linking CaMKII and hyperglycaemic signalling in diabetes mellitus, which is a key risk factor for heart(2) and neurodegenerative diseases(3,4). Acute hyperglycaemia causes covalent modification of CaMKII by O-linked N-acetylglucosamine (O-GlcNAc). O-GlcNAc modification of CaMKII at Ser 279 activates CaMKII autonomously, creating molecular memory even after Ca2+ concentration declines. O-GlcNAc-modified CaMKII is increased in the heart and brain of diabetic humans and rats. In cardiomyocytes, increased glucose concentration significantly enhances CaMKII-dependent activation of spontaneous sarcoplasmic reticulum Ca2+ release events that can contribute to cardiac mechanical dysfunction and arrhythmias(1). These effects were prevented by pharmacological inhibition of O-GlcNAc signalling or genetic ablation of CaMKII delta. In intact perfused hearts, arrhythmias were aggravated by increased glucose concentration through O-GlcNAc- and CaMKII-dependent pathways. In diabetic animals, acute blockade of O-GlcNAc inhibited arrhythmogenesis. Thus, O-GlcNAc modification of CaMKII is a novel signalling event in pathways that may contribute critically to cardiac and neuronal pathophysiology in diabetes and other diseases.	[Erickson, Jeffrey R.; Pereira, Laetitia; Wang, Lianguo; Ferguson, Amanda; Dao, Khanha; Despa, Florin; Ripplinger, Crystal M.; Bers, Donald M.] Univ Calif Davis, Dept Pharmacol, Davis, CA 95616 USA; [Erickson, Jeffrey R.] Univ Otago, Dept Physiol, Dunedin 9054, New Zealand; [Han, Guanghui; Copeland, Ronald J.; Hart, Gerald W.] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA; [Despa, Florin] Univ Kentucky, Dept Mol & Biomed Pharmacol, Lexington, KY 40536 USA	University of California System; University of California Davis; University of Otago; Johns Hopkins University; University of Kentucky	Bers, DM (corresponding author), Univ Calif Davis, Dept Pharmacol, 451 Hlth Sci Dr, Davis, CA 95616 USA.	dmbers@ucdavis.edu	Wang, Lianguo/B-5644-2012; Han, Guanghui/N-8573-2013	Wang, Lianguo/0000-0002-4747-0419; Han, Guanghui/0000-0002-9893-9168; Ripplinger, Crystal/0000-0002-9908-4106; Bers, Donald/0000-0002-2237-9483; Pereira, Laetitia/0000-0002-0080-3546; Hart, Gerald/0000-0001-7812-4351	American Heart Association [13SDG14680072]; National Institutes of Health (NIH) [T32HL86350, 1R01HL118474-01A1, R01DK61671, P01HL107153, R01HL111600, P01HL080101, R37HL30077]; NSF CBET [1133339]; ADA [1-13-IN-70]; AHA [13GRNT16470034]; Fondation Leducq Transatlantic CaMKII Alliance; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL030077, R01HL118474, R01HL111600, P01HL107153, R37HL030077, R01HL105242, T32HL086350, P01HL080101] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079637, R01DK061671] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG010129] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF CBET(National Science Foundation (NSF)); ADA(American Diabetes Association); AHA(American Heart Association); Fondation Leducq Transatlantic CaMKII Alliance(Leducq Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Y. Hayashi for providing initial Camui samples, H. Schulman for helpful discussions, K. Margulies for human heart samples, L.-W. Jin, M. Melara and the University of California, Davis Alzheimer's Disease Center (NIH-P30AG010129) for human brain samples, and J. H. Brown for providing CaMKII delta-knockout mice. We thank Pfizer, Inc. for the gift of a breeding pair of HIP rats to F.D. This work was supported by American Heart Association 13SDG14680072 and National Institutes of Health (NIH) T32HL86350 (J.R.E.); NIH 1R01HL118474-01A1, NSF CBET 1133339, ADA 1-13-IN-70 and AHA 13GRNT16470034 (F.D.); NIH R01DK61671 and P01HL107153 (G.W.H.); NIH R01HL111600 (C.M.R.); NIH P01HL080101, R37HL30077 and Fondation Leducq Transatlantic CaMKII Alliance (D.M.B.). G.W.H. receives a share of royalty on sales of the CTD 110.6 antibody, which are managed by Johns Hopkins University.	Anderson ME, 2011, J MOL CELL CARDIOL, V51, P468, DOI 10.1016/j.yjmcc.2011.01.012; Ashpole NM, 2011, MOL CELL NEUROSCI, V46, P720, DOI 10.1016/j.mcn.2011.02.003; Biessels GJ, 2006, LANCET NEUROL, V5, P64, DOI 10.1016/S1474-4422(05)70284-2; Bimboese P, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.206482; Butler AE, 2004, DIABETES, V53, P1509, DOI 10.2337/diabetes.53.6.1509; Chatham JC, 2010, BBA-GEN SUBJECTS, V1800, P57, DOI 10.1016/j.bbagen.2009.07.004; CURTIS MJ, 1988, CARDIOVASC RES, V22, P656, DOI 10.1093/cvr/22.9.656; Del Gobbo LC, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-23; Despa S, 2012, CIRC RES, V110, P598, DOI [10.1161/CIRCRESAHA.111.258285, 10.1161/circresaha.111.258285]; Dias WB, 2009, J BIOL CHEM, V284, P21327, DOI 10.1074/jbc.M109.007310; Erickson JR, 2008, CELL, V133, P462, DOI 10.1016/j.cell.2008.02.048; Erickson JR, 2011, CIRC RES, V109, P729, DOI 10.1161/CIRCRESAHA.111.247148; Gao Y, 2001, J BIOL CHEM, V276, P9838, DOI 10.1074/jbc.M010420200; Guo T, 2006, CIRC RES, V99, P398, DOI 10.1161/01.RES.0000236756.06252.13; Haan MN, 2006, NAT CLIN PRACT NEURO, V2, P159, DOI 10.1038/ncpneuro0124; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Hoch B, 1999, CIRC RES, V84, P713, DOI 10.1161/01.RES.84.6.713; Hudmon A, 2002, BIOCHEM J, V364, P593, DOI 10.1042/BJ20020228; Kohlhaas M, 2006, CIRC RES, V98, P235, DOI 10.1161/01.RES.0000200739.90811.9f; Kreppel LK, 1997, J BIOL CHEM, V272, P9308; Ling HY, 2009, J CLIN INVEST, V119, P1230, DOI 10.1172/JCI38022; Luo M, 2013, J CLIN INVEST, V123, P1262, DOI 10.1172/JCI65268; Rengifo J, 2007, J NEUROSCI, V27, P13813, DOI 10.1523/JNEUROSCI.2069-07.2007; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Rosenberg OS, 2005, CELL, V123, P849, DOI 10.1016/j.cell.2005.10.029; Takao K, 2005, J NEUROSCI, V25, P3107, DOI 10.1523/JNEUROSCI.0085-05.2005; van Oort RJ, 2010, CIRCULATION, V122, P2669, DOI 10.1161/CIRCULATIONAHA.110.982298; Zhang T, 2003, CIRC RES, V92, P912, DOI 10.1161/01.RES.0000069686.31472.C5; Zhao ZH, 2011, J MOL CELL CARDIOL, V50, P128, DOI 10.1016/j.yjmcc.2010.11.001; Zhu-Mauldin X, 2012, J BIOL CHEM, V287, P39094, DOI 10.1074/jbc.M112.383778	30	387	400	6	144	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 17	2013	502	7471					372	+		10.1038/nature12537	http://dx.doi.org/10.1038/nature12537			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235GY	24077098	Green Accepted			2022-12-28	WOS:000325706300053
J	Maillard, PV; Ciaudo, C; Marchais, A; Li, Y; Jay, F; Ding, SW; Voinnet, O				Maillard, P. V.; Ciaudo, C.; Marchais, A.; Li, Y.; Jay, F.; Ding, S. W.; Voinnet, Olivier			Antiviral RNA Interference in Mammalian Cells	SCIENCE			English	Article							DOUBLE-STRANDED-RNA; GENE-EXPRESSION; SUPPRESSION; IMMUNITY; DICER; MICRORNAS; VIRUSES; ARABIDOPSIS; BIOGENESIS; MECHANISM	In antiviral RNA interference (RNAi), the DICER enzyme processes virus-derived double-stranded RNA (dsRNA) into small interfering RNAs (siRNAs) that guide ARGONAUTE proteins to silence complementary viral RNA. As a counterdefense, viruses deploy viral suppressors of RNAi (VSRs). Well-established in plants and invertebrates, the existence of antiviral RNAi remains unknown in mammals. Here, we show that undifferentiated mouse cells infected with encephalomyocarditis virus (EMCV) or Nodamura virus (NoV) accumulate similar to 22-nucleotide RNAs with all the signature features of siRNAs. These derive from viral dsRNA replication intermediates, incorporate into AGO2, are eliminated in Dicer knockout cells, and decrease in abundance upon cell differentiation. Furthermore, genetically ablating a NoV-encoded VSR that antagonizes DICER during authentic infections reduces NoV accumulation, which is rescued in RNAi-deficient mouse cells. We conclude that antiviral RNAi operates in mammalian cells.	[Maillard, P. V.; Ciaudo, C.; Marchais, A.; Jay, F.; Voinnet, Olivier] Swiss Fed Inst Technol ETH Z, Dept Biol, CH-8092 Zurich, Switzerland; [Li, Y.; Ding, S. W.] Univ Calif Riverside, Dept Plant Pathol & Microbiol, Riverside, CA 92521 USA	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of California System; University of California Riverside	Voinnet, O (corresponding author), Swiss Fed Inst Technol ETH Z, Dept Biol, CH-8092 Zurich, Switzerland.	voinneto@ethz.ch	Ciaudo, Constance/A-2014-2012; Marchais, Antonin/GLV-6267-2022; Ding, Shou Wei/AAC-2533-2020; Maillard, Pierre V/V-4305-2019; Li, Yang/GVT-7396-2022; Marchais, Antonin/G-2627-2013	Ciaudo, Constance/0000-0002-0857-4506; Marchais, Antonin/0000-0003-0954-8294; Maillard, Pierre V/0000-0003-4611-388X; Li, Yang/0000-0002-6065-4706; Marchais, Antonin/0000-0003-0954-8294; JAY, Florence/0000-0001-7353-8299; Voinnet, Olivier/0000-0001-6982-9544; Ding, SW/0000-0002-4697-8413	Swiss National Foundation; Federation of European Biochemical Societies; Bettencourt Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052447] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094396, RC1GM091896] Funding Source: NIH RePORTER	Swiss National Foundation(Swiss National Science Foundation (SNSF)); Federation of European Biochemical Societies; Bettencourt Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Voinnet laboratory for advice and discussions and L. Bakkali-Kassimi, G. Meister, E. Brocchi, and J.-C. Paillart for reagents. Supported by a Prospective Researchers Fellowship from the Swiss National Foundation to P. V. M., a fellowship from the Federation of European Biochemical Societies to C. C., and an award from the Bettencourt Foundation to O.V.	Aliyari R, 2008, CELL HOST MICROBE, V4, P387, DOI 10.1016/j.chom.2008.09.001; Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Babiarz JE, 2008, GENE DEV, V22, P2773, DOI 10.1101/gad.1705308; Billy E, 2001, P NATL ACAD SCI USA, V98, P14428, DOI 10.1073/pnas.261562698; Chalupnikova Katerina, 2013, Methods Mol Biol, V942, P291, DOI 10.1007/978-1-62703-119-6_16; Chao JA, 2005, NAT STRUCT MOL BIOL, V12, P952, DOI 10.1038/nsmb1005; Deleris A, 2006, SCIENCE, V313, P68, DOI 10.1126/science.1128214; Diaz-Pendon JA, 2007, PLANT CELL, V19, P2053, DOI 10.1105/tpc.106.047449; Ding SW, 2007, CELL, V130, P413, DOI 10.1016/j.cell.2007.07.039; Gan L, 2002, J NEUROSCI METH, V121, P151, DOI 10.1016/S0165-0270(02)00230-3; Goubau D, 2013, IMMUNITY, V38, P855, DOI 10.1016/j.immuni.2013.05.007; Haasnoot J, 2007, NAT BIOTECHNOL, V25, P1435, DOI 10.1038/nbt1369; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Li Y, 2013, SCIENCE, V342, P231, DOI 10.1126/science.1241911; Ma E, 2008, J MOL BIOL, V380, P237, DOI 10.1016/j.jmb.2008.05.005; Murchison EP, 2005, P NATL ACAD SCI USA, V102, P12135, DOI 10.1073/pnas.0505479102; Paddison PJ, 2002, P NATL ACAD SCI USA, V99, P1443, DOI 10.1073/pnas.032652399; Parameswaran P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000764; Pfeffer S, 2005, NAT METHODS, V2, P269, DOI 10.1038/NMETH746; Su H, 2009, GENE DEV, V23, P304, DOI 10.1101/gad.1749809; Sullivan CS, 2005, J VIROL, V79, P7371, DOI 10.1128/JVI.79.12.7371-7379.2005; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; Umbach JL, 2009, GENE DEV, V23, P1151, DOI 10.1101/gad.1793309; Wang XH, 2006, SCIENCE, V312, P452, DOI 10.1126/science.1125694; Wang XB, 2011, PLANT CELL, V23, P1625, DOI 10.1105/tpc.110.082305; Weber F, 2006, J VIROL, V80, P5059, DOI 10.1128/JVI.80.10.5059-5064.2006; Yi CE, 2003, J BIOL CHEM, V278, P934, DOI 10.1074/jbc.M205946200	27	280	292	1	101	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 11	2013	342	6155					235	238		10.1126/science.1241930	http://dx.doi.org/10.1126/science.1241930			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232EV	24115438	Green Accepted			2022-12-28	WOS:000325475200042
J	Mora, C; Frazier, AG; Longman, RJ; Dacks, RS; Walton, MM; Tong, EJ; Sanchez, JJ; Kaiser, LR; Stender, YO; Anderson, JM; Ambrosino, CM; Fernandez-Silva, I; Giuseffi, LM; Giambelluca, TW				Mora, Camilo; Frazier, Abby G.; Longman, Ryan J.; Dacks, Rachel S.; Walton, Maya M.; Tong, Eric J.; Sanchez, Joseph J.; Kaiser, Lauren R.; Stender, Yuko O.; Anderson, James M.; Ambrosino, Christine M.; Fernandez-Silva, Iria; Giuseffi, Louise M.; Giambelluca, Thomas W.			The projected timing of climate departure from recent variability	NATURE			English	Article							GLOBAL PATTERNS; CHANGE IMPACTS; SPECIES RICHNESS; RANGE SHIFTS; BIODIVERSITY; EXTINCTION; DISEASE; EVENTS; FUTURE; FACE	Ecological and societal disruptions by modern climate change are critically determined by the time frame over which climates shift beyond historical analogues. Here we present a new index of the year when the projected mean climate of a given location moves to a state continuously outside the bounds of historical variability under alternative greenhouse gas emissions scenarios. Using 1860 to 2005 as the historical period, this index has a global mean of 2069 (+/- 18 years s.d.) for near-surface air temperature under an emissions stabilization scenario and 2047 (+/- 14 years s.d.) under a 'business-as-usual' scenario. Unprecedented climates will occur earliest in the tropics and among low-income countries, highlighting the vulnerability of global biodiversity and the limited governmental capacity to respond to the impacts of climate change. Our findings shed light on the urgency of mitigating greenhouse gas emissions if climates potentially harmful to biodiversity and society are to be prevented.	[Mora, Camilo; Frazier, Abby G.; Longman, Ryan J.; Sanchez, Joseph J.; Kaiser, Lauren R.; Stender, Yuko O.; Giuseffi, Louise M.; Giambelluca, Thomas W.] Univ Hawaii Manoa, Dept Geog, Honolulu, HI 96822 USA; [Dacks, Rachel S.; Walton, Maya M.; Anderson, James M.; Ambrosino, Christine M.] Univ Hawaii Manoa, Dept Biol, Honolulu, HI 96822 USA; [Walton, Maya M.; Tong, Eric J.; Stender, Yuko O.; Anderson, James M.; Ambrosino, Christine M.; Fernandez-Silva, Iria] Univ Hawaii Manoa, Hawaii Inst Marine Biol, Kaneohe, HI 96744 USA; [Tong, Eric J.] Univ Hawaii Manoa, Dept Oceanog, Honolulu, HI 96822 USA; [Fernandez-Silva, Iria] Univ Ryukyus, TRO SIS, Nishihara, Okinawa 9030213, Japan	University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa; University of the Ryukyus	Mora, C (corresponding author), Univ Hawaii Manoa, Dept Geog, Honolulu, HI 96822 USA.	cmora@hawaii.edu	Fernandez-Silva, Iria/AAA-8996-2020; Frazier, Abby/P-5511-2017	Frazier, Abby/0000-0003-4076-4577; Anderson, James/0000-0002-4900-5916; Giambelluca, Thomas/0000-0002-6798-3780	Pacific Islands Climate Change Cooperative (PICCC) [F10AC00077]; National Science Foundation Hawai'i EPSCoR [EPS-0903833]; Pacific Islands Climate Science Center; PICCC [F10A00079]; National Science Foundation; Japanese Society for the Promotion of Science; EPSCoR [0903833] Funding Source: National Science Foundation	Pacific Islands Climate Change Cooperative (PICCC); National Science Foundation Hawai'i EPSCoR; Pacific Islands Climate Science Center; PICCC; National Science Foundation(National Science Foundation (NSF)); Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); EPSCoR(National Science Foundation (NSF)NSF - Office of the Director (OD))	We thank D. Beilman for commenting on the paper; E. Wingert for help on the figures; D. Olsen for technical support; H. Kreft and the International Union for Conservation of Nature, BirdLife International, the Food and Agriculture Organization of the United Nations, the World Bank Database, the National Centers for Environmental Prediction, the World Database of Protected Areas, and the Gridded Human Population of the World Database for making their data openly available. We acknowledge the World Climate Research Programme's Working Group on Coupled Modelling, which is responsible for CMIP5, and we thank the climate modelling groups (listed in Extended Data Table 1) for producing and making available their model outputs. This work was made possible by funding from the University of Hawai'i Sea Grant to C. M. The paper was developed as part of the graduate course on 'Methods for Large Scale Analyses' in the Department of Geography, University of Hawai'i at Manoa. A.G.F. and T.W.G were supported by Pacific Islands Climate Change Cooperative (PICCC) award F10AC00077 and National Science Foundation Hawai'i EPSCoR grant no. EPS-0903833. R.J.L. was supported by the Pacific Islands Climate Science Center and PICCC award F10A00079. R. S. D. and E.J.T. were supported by National Science Foundation Graduate Fellowships, and I.F.-S. by a postdoctoral fellowship from the Japanese Society for the Promotion of Science.	Allen CD, 2010, FOREST ECOL MANAG, V259, P660, DOI 10.1016/j.foreco.2009.09.001; Alley RB, 2003, SCIENCE, V299, P2005, DOI 10.1126/science.1081056; Angert AL, 2011, ECOL LETT, V14, P677, DOI 10.1111/j.1461-0248.2011.01620.x; [Anonymous], 2011, ECOLOGICAL NICHES GE; Baird A, 2008, SCIENCE, V320, P315, DOI 10.1126/science.320.5874.315; Baker AC, 2008, ESTUAR COAST SHELF S, V80, P435, DOI 10.1016/j.ecss.2008.09.003; Berg MP, 2010, GLOBAL CHANGE BIOL, V16, P587, DOI 10.1111/j.1365-2486.2009.02014.x; Berry HL, 2010, INT J PUBLIC HEALTH, V55, P123, DOI 10.1007/s00038-009-0112-0; Carey C, 2003, DIVERS DISTRIB, V9, P111, DOI 10.1046/j.1472-4642.2003.00011.x; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Chown SL, 1998, ECOGRAPHY, V21, P342, DOI 10.1111/j.1600-0587.1998.tb00399.x; Colwell RK, 2008, SCIENCE, V322, P258, DOI 10.1126/science.1162547; CROWLEY TJ, 1988, SCIENCE, V240, P996, DOI 10.1126/science.240.4855.996; Deutsch CA, 2008, P NATL ACAD SCI USA, V105, P6668, DOI 10.1073/pnas.0709472105; Devictor V, 2012, NAT CLIM CHANGE, V2, P121, DOI 10.1038/NCLIMATE1347; Diaz S, 2006, PLOS BIOL, V4, P1300, DOI 10.1371/journal.pbio.0040277; Doney SC, 2012, ANNU REV MAR SCI, V4, P11, DOI 10.1146/annurev-marine-041911-111611; Epstein PR, 2002, EPIDEMIOLOGY, V13, P373, DOI 10.1097/00001648-200207000-00001; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Khasnis AA, 2005, ARCH MED RES, V36, P689, DOI 10.1016/j.arcmed.2005.03.041; Kier G, 2009, P NATL ACAD SCI USA, V106, P9322, DOI 10.1073/pnas.0810306106; Kloor K., 2009, NATURE REP CLIM CHAN, V3, P145, DOI DOI 10.1038/CLIMATE.2009.120; La Sorte FA, 2012, J ANIM ECOL, V81, P914, DOI 10.1111/j.1365-2656.2012.01958.x; Lobell DB, 2012, PLANT PHYSIOL, V160, P1686, DOI 10.1104/pp.112.208298; McKechnie AE, 2010, BIOL LETTERS, V6, P253, DOI 10.1098/rsbl.2009.0702; Meinshausen M, 2011, CLIMATIC CHANGE, V109, P213, DOI 10.1007/s10584-011-0156-z; Mora Camilo, 2013, P239; Mora C, 2011, MAR ECOL PROG SER, V434, P251, DOI 10.3354/meps09214; Pandolfi JM, 2011, SCIENCE, V333, P418, DOI 10.1126/science.1204794; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Patz JA, 2006, ANN TROP MED PARASIT, V100, P535, DOI 10.1179/136485906X97426; Raven J, 2005, OCEAN ACIDIFICATION; Reilly J., 2000, IRREVERSIBILITY UNCE; Rockstrom J, 2009, NATURE, V461, P472, DOI 10.1038/461472a; Sherwood SC, 2010, P NATL ACAD SCI USA, V107, P9552, DOI 10.1073/pnas.0913352107; Solomon S., 2007, CLIMATE CHANGE PHYS; Sorte CJB, 2013, OIKOS, V122, P161, DOI 10.1111/j.1600-0706.2012.00066.x; Taylor KE, 2012, B AM METEOROL SOC, V93, P485, DOI 10.1175/BAMS-D-11-00094.1; Taylor RG, 2013, NAT CLIM CHANGE, V3, P322, DOI [10.1038/nclimate1744, 10.1038/NCLIMATE1744]; Thomas CD, 2006, TRENDS ECOL EVOL, V21, P415, DOI 10.1016/j.tree.2006.05.012; Tittensor DP, 2010, NATURE, V466, P1098, DOI 10.1038/nature09329; Tol RSJ, 2002, ENVIRON RESOUR ECON, V21, P47, DOI 10.1023/A:1014500930521; van Vliet J, 2009, ENERG ECON, V31, pS152, DOI 10.1016/j.eneco.2009.06.010; van Vuuren DP, 2011, CLIMATIC CHANGE, V109, P5, DOI [10.1007/s10584-011-0148-z, 10.1007/s10584-011-0157-y]; Williams JW, 2007, FRONT ECOL ENVIRON, V5, P475, DOI 10.1890/070037; Williams JW, 2007, P NATL ACAD SCI USA, V104, P5738, DOI 10.1073/pnas.0606292104; Zeebe RE, 2008, SCIENCE, V321, P51, DOI 10.1126/science.1159124; Zhang X, 2013, GEOPHYS RES LETT, V40, P1111, DOI 10.1002/grl.50279; Zhu K, 2012, GLOBAL CHANGE BIOL, V18, P1042, DOI 10.1111/j.1365-2486.2011.02571.x	51	421	430	8	259	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 10	2013	502	7470					183	+		10.1038/nature12540	http://dx.doi.org/10.1038/nature12540			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RU	24108050				2022-12-28	WOS:000325436100040
J	Murch, KW; Weber, SJ; Macklin, C; Siddiqi, I				Murch, K. W.; Weber, S. J.; Macklin, C.; Siddiqi, I.			Observing single quantum trajectories of a superconducting quantum bit	NATURE			English	Article							CURRENT SITUATION; NOISE; AMPLIFICATION; MECHANICS; FEEDBACK; COLLAPSE; QUBIT; SPIN	The length of time that a quantum system can exist in a superposition state is determined by how strongly it interacts with its environment. This interaction entangles the quantum state with the inherent fluctuations of the environment. If these fluctuations are not measured, the environment can be viewed as a source of noise, causing random evolution of the quantum system from an initially pure state into a statistical mixture-a process known as decoherence. However, by accurately measuring the environment in real time, the quantum system can be maintained in a pure state and its time evolution described by a 'quantum trajectory'(1,2) determined by the measurement outcome. Here we use weak measurements to monitor a microwave cavity containing a superconducting quantum bit (qubit), and track the individual quantum trajectories(3) of the system. In this setup, the environment is dominated by the fluctuations of a single electromagnetic mode of the cavity. Using a near-quantum-limited parametric amplifier(4,5), we selectively measure either the phase or the amplitude of the cavity field, and thereby confine trajectories to either the equator or a meridian of the Bloch sphere. We perform quantum state tomography at discrete times along the trajectory to verify that we have faithfully tracked the state of the quantum system as it diffuses on the surface of the Bloch sphere. Our results demonstrate that decoherence can be mitigated by environmental monitoring, and validate the foundation of quantum feedback approaches based on Bayesian statistics(6-8). Moreover, our experiments suggest a new means of implementing 'quantum steering'(9)-the harnessing of action at a distance to manipulate quantum states through measurement.	[Murch, K. W.; Weber, S. J.; Macklin, C.; Siddiqi, I.] Univ Calif Berkeley, Dept Phys, Quantum Nanoelect Lab, Berkeley, CA 94720 USA; [Murch, K. W.] Washington Univ, Dept Phys, St Louis, MO 63130 USA	University of California System; University of California Berkeley; Washington University (WUSTL)	Murch, KW (corresponding author), Univ Calif Berkeley, Dept Phys, Quantum Nanoelect Lab, Berkeley, CA 94720 USA.	katerm@berkeley.edu	Siddiqi, Irfan/E-5548-2015		Army Research Office, Office of Naval Research and the Office of the Director of National Intelligence (ODNI), Intelligence Advanced Research Projects Activity (IARPA) through the Army Research Office	Army Research Office, Office of Naval Research and the Office of the Director of National Intelligence (ODNI), Intelligence Advanced Research Projects Activity (IARPA) through the Army Research Office	We thank H. Wiseman, A. N. Korotkov, E. M. Levenson-Falk and N. Roch for discussions, and R. Vijay for contributions to preliminary experiments. This research was supported in part by the Army Research Office, Office of Naval Research and the Office of the Director of National Intelligence (ODNI), Intelligence Advanced Research Projects Activity (IARPA), through the Army Research Office. All statements of fact, opinion or conclusions contained herein are those of the authors and should not be construed as representing the official views or policies of IARPA, the ODNI or the US government.	Boissonneault M, 2009, PHYS REV A, V79, DOI 10.1103/PhysRevA.79.013819; Campagne-Ibarcq P, 2013, PHYS REV X, V3, DOI 10.1103/PhysRevX.3.021008; Carmichael H, 1993, OPEN SYSTEMS APPROAC; Carmichael H. J., 1994, P INT S COH STAT PRE, P75; Castellanos-Beltran MA, 2008, NAT PHYS, V4, P929, DOI 10.1038/nphys1090; CAVES CM, 1982, PHYS REV D, V26, P1817, DOI 10.1103/PhysRevD.26.1817; Clerk AA, 2010, REV MOD PHYS, V82, P1155, DOI 10.1103/RevModPhys.82.1155; Gambetta J, 2008, PHYS REV A, V77, DOI 10.1103/PhysRevA.77.012112; Groen JP, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.090506; Guerlin C, 2007, NATURE, V448, P889, DOI 10.1038/nature06057; Hatridge M, 2013, SCIENCE, V339, P178, DOI 10.1126/science.1226897; Hatridge M, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.134501; Katz N, 2006, SCIENCE, V312, P1498, DOI 10.1126/science.1126475; Katz N, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.200401; Kim YS, 2012, NAT PHYS, V8, P117, DOI [10.1038/nphys2178, 10.1038/NPHYS2178]; Koch J, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.042319; Korotkov A. N., 2011, QUANTUM BAYESIAN APP; Korotkov AN, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.166805; Kuzmich A, 1999, PHYS REV A, V60, P2346, DOI 10.1103/PhysRevA.60.2346; Kuzmich A, 2000, PHYS REV LETT, V85, P1594, DOI 10.1103/PhysRevLett.85.1594; Paik H, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.240501; Riste D, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.240502; Sayrin C, 2011, NATURE, V477, P73, DOI 10.1038/nature10376; Schleier-Smith MH, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.073604; Schrodinger E, 1935, NATURWISSENSCHAFTEN, V23, P844, DOI 10.1007/BF01491987; Schrodinger E, 1935, NATURWISSENSCHAFTEN, V23, P807, DOI 10.1007/BF01491891; Schroedinger E., 1935, NATURWISSENSCHAFTEN, V23, P823, DOI [DOI 10.1007/BF01491914, 10.1007/BF01491914]; Schuster DI, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.123602; Takano T, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.033601; Vijay R, 2012, NATURE, V490, P77, DOI 10.1038/nature11505; Vijay R, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.110502; Wiseman H. M., 2010, QUANTUM MEASUREMENT	32	241	246	4	96	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 10	2013	502	7470					211	214		10.1038/nature12539	http://dx.doi.org/10.1038/nature12539			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RU	24108052	Green Submitted			2022-12-28	WOS:000325436100045
J	Stange, DE; Koo, BK; Huch, M; Sibbel, G; Basak, O; Lyubimova, A; Kujala, P; Bartfeld, S; Koster, J; Geahlen, JH; Peters, PJ; van Es, JH; van de Wetering, M; Mills, JC; Clevers, H				Stange, Daniel E.; Koo, Bon-Kyoung; Huch, Meritxell; Sibbel, Greg; Basak, Onur; Lyubimova, Anna; Kujala, Pekka; Bartfeld, Sina; Koster, Jan; Geahlen, Jessica H.; Peters, Peter J.; van Es, Johan H.; van de Wetering, Marc; Mills, Jason C.; Clevers, Hans			Differentiated Troy(+) Chief Cells Act as Reserve Stem Cells to Generate All Lineages of the Stomach Epithelium	CELL			English	Article							RECEPTOR FAMILY-MEMBER; MOUSE STOMACH; ZYMOGENIC CELLS; LIVER-REGENERATION; PROGENITOR CELLS; SMALL-INTESTINE; PARIETAL-CELLS; ADULT STEM; IN-VITRO; METAPLASIA	Proliferation of the self-renewing epithelium of the gastric corpus occurs almost exclusively in the isthmus of the glands, from where cells migrate bidirectionally toward pit and base. The isthmus is therefore generally viewed as the stem cell zone. We find that the stem cell marker Troy is expressed at the gland base by a small subpopulation of fully differentiated chief cells. By lineage tracing with a Troy-eGFP-ires-CreERT2 allele, single marked chief cells are shown to generate entirely labeled gastric units over periods of months. This phenomenon accelerates upon tissue damage. Troy(+) chief cells can be cultured to generate long-lived gastric organoids. Troy marks a specific subset of chief cells that display plasticity in that they are capable of replenishing entire gastric units, essentially serving as quiescent "reserve" stem cells. These observations challenge the notion that stem cell hierarchies represent a "one-way street."	[Stange, Daniel E.; Koo, Bon-Kyoung; Huch, Meritxell; Basak, Onur; Lyubimova, Anna; Bartfeld, Sina; van Es, Johan H.; van de Wetering, Marc; Clevers, Hans] Hubrecht Inst Dev Biol & Stem Cell Res, NL-3584 CT Utrecht, Netherlands; [Stange, Daniel E.; Koo, Bon-Kyoung; Huch, Meritxell; Basak, Onur; Lyubimova, Anna; Bartfeld, Sina; van Es, Johan H.; van de Wetering, Marc; Clevers, Hans] Univ Med Ctr Utrecht, NL-3584 CT Utrecht, Netherlands; [Stange, Daniel E.] Univ Dresden, Univ Hosp Carl Gustav Carus, Dept Gen Thorac & Vasc Surg, D-01307 Dresden, Germany; [Koo, Bon-Kyoung] Univ Cambridge, Wellcome Trust Med Res Council Stem Cell Inst, Cambridge CB2 1QR, England; [Sibbel, Greg; Geahlen, Jessica H.; Mills, Jason C.] Washington Univ, Sch Med, Dept Med, Div Gastroenterol, St Louis, MO 63110 USA; [Lyubimova, Anna] MIT, Dept Phys & Biol, Cambridge, MA 02139 USA; [Kujala, Pekka; Peters, Peter J.] Antoni van Leeuwenhoek Hosp, Netherlands Canc Inst, Div Cell Biol 2, NL-1066 CX Amsterdam, Netherlands; [Koster, Jan] Univ Amsterdam, Acad Med Ctr, Dept Oncogen, NL-1100 DE Amsterdam, Netherlands	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Technische Universitat Dresden; Carl Gustav Carus University Hospital; University of Cambridge; Washington University (WUSTL); Massachusetts Institute of Technology (MIT); Netherlands Cancer Institute; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam	Clevers, H (corresponding author), Hubrecht Inst Dev Biol & Stem Cell Res, NL-3584 CT Utrecht, Netherlands.	h.clevers@hubrecht.eu	van+Es, Johan/ABD-5411-2021; Stange, Daniel E/O-1837-2015; Basak, Onur/GLV-6113-2022; Koo, Bon-Kyoung/V-5219-2017; Mills, Jason/AAA-6688-2021; Koster, Jan/C-5934-2008	Stange, Daniel E/0000-0003-4246-2230; Basak, Onur/0000-0002-6864-3403; Koo, Bon-Kyoung/0000-0002-4134-8033; Mills, Jason/0000-0002-0402-4662; Koster, Jan/0000-0002-0890-7585; Bartfeld, Sina/0000-0003-2493-8282	Centre for Biomedical Genetics (CBG); European Research Council [EU/232814-StemCellMark, EU/Health-F4-2007-200720]; National Research Foundation of Korea [NRF2011-357-C00093]; Wellcome Trust [097922/C/11/Z]; EU Marie Curie Fellowship [EU/236954-ICSC-Lgr5, EU/300686-InfO]; Cancer Genomics Center (CGCII); TI Pharma [T3-106, DK094989, 2P30 DK052574]; NATIONAL CANCER INSTITUTE [T32CA113275] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK052574, R01DK094989] Funding Source: NIH RePORTER	Centre for Biomedical Genetics (CBG); European Research Council(European Research Council (ERC)European Commission); National Research Foundation of Korea(National Research Foundation of Korea); Wellcome Trust(Wellcome TrustEuropean Commission); EU Marie Curie Fellowship(European Commission); Cancer Genomics Center (CGCII); TI Pharma; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the Centre for Biomedical Genetics (CBG) to D.E.S.; the European Research Council (EU/232814-StemCellMark), the National Research Foundation of Korea (NRF2011-357-C00093), and the Wellcome Trust (097922/C/11/Z) to B.-K.K.; an EU Marie Curie Fellowship (EU/236954-ICSC-Lgr5) to M.H.; the Cancer Genomics Center (CGCII) to O.B.; an EU Marie Curie Fellowship (EU/300686-InfO) to S.B.; a grant from TI Pharma (T3-106) to J.H.v.E.; the European Research Council (EU/Health-F4-2007-200720) to M.v.d.W.; and DK094989, 2P30 DK052574 to J.C.M. We would like to thank R. Siegmund for graphical abstract design, Mark J. Miller and the Washington University School of Medicine In vivo Imaging Core (IVIC) for help with two-photon imaging, the Washington University Digestive Disease Core Center (DDRCC) Advanced Imaging and Tissue Analysis Core and Shradha Khurana for help in figure preparation, James Goldenring for constructive discussion, and Frederic J. de Sauvage for Lgr5-DTR:eGFP mice.	Arnold K, 2011, CELL STEM CELL, V9, P317, DOI 10.1016/j.stem.2011.09.001; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2010, CELL STEM CELL, V6, P25, DOI 10.1016/j.stem.2009.11.013; Batlle E, 2002, CELL, V111, P251, DOI 10.1016/S0092-8674(02)01015-2; Bredemeyer AJ, 2009, DEV BIOL, V325, P211, DOI 10.1016/j.ydbio.2008.10.025; Capoccia BJ, 2013, J CLIN INVEST, V123, P1475, DOI 10.1172/JCI65703; CHEN KY, 1975, J ANAT, V120, P421; Fafilek B, 2013, GASTROENTEROLOGY, V144, P381, DOI 10.1053/j.gastro.2012.10.048; Fausto N, 2000, J HEPATOL, V32, P19, DOI 10.1016/S0168-8278(00)80412-2; Goldenring JR, 2011, EXP CELL RES, V317, P2759, DOI 10.1016/j.yexcr.2011.08.017; Hashimoto T, 2008, CELL CYCLE, V7, P106, DOI 10.4161/cc.7.1.5135; Huh WJ, 2012, GASTROENTEROLOGY, V142, P21, DOI 10.1053/j.gastro.2011.09.050; Huh WJ, 2010, GASTROENTEROLOGY, V139, P2038, DOI 10.1053/j.gastro.2010.08.050; Itzkovitz S, 2012, NAT CELL BIOL, V14, P106, DOI 10.1038/ncb2384; Jaks V, 2008, NAT GENET, V40, P1291, DOI 10.1038/ng.239; Kao JY, 2010, GASTROENTEROLOGY, V138, P1046, DOI 10.1053/j.gastro.2009.11.043; KARAM SM, 1993, ANAT REC, V236, P314, DOI 10.1002/ar.1092360205; KARAM SM, 1993, ANAT REC, V236, P297, DOI 10.1002/ar.1092360204; KARAM SM, 1993, ANAT REC, V236, P259, DOI 10.1002/ar.1092360202; Koo BK, 2012, NATURE, V488, P665, DOI 10.1038/nature11308; LERNER C, 1990, EXP HEMATOL, V18, P114; Li LH, 2010, SCIENCE, V327, P542, DOI 10.1126/science.1180794; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; Masaki T, 2013, CELL, V152, P51, DOI 10.1016/j.cell.2012.12.014; Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60; Mills JC, 2011, GASTROENTEROLOGY, V140, P412, DOI 10.1053/j.gastro.2010.12.001; Munoz J, 2012, EMBO J, V31, P3079, DOI 10.1038/emboj.2012.166; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Nam KT, 2010, GASTROENTEROLOGY, V139, P2028, DOI 10.1053/j.gastro.2010.09.005; Nomura S, 2004, GASTROENTEROLOGY, V127, P582, DOI 10.1053/j.gastro.2004.05.029; Peters PJ, 2006, CURR PROTOC CELL BIO, DOI [10.1002/0471143030.CB0407S30, DOI 10.1002/0471143030.CB0407S30]; Qiao XTT, 2011, J GASTROENTEROL, V46, P855, DOI 10.1007/s00535-011-0413-y; Quante M, 2010, GASTROENTEROLOGY, V139, P2018, DOI 10.1053/j.gastro.2010.08.003; Raj A, 2008, NAT METHODS, V5, P877, DOI 10.1038/NMETH.1253; Ramsey VG, 2007, DEVELOPMENT, V134, P211, DOI 10.1242/dev.02700; Shao ZH, 2005, NEURON, V45, P353, DOI 10.1016/j.neuron.2004.12.050; Shi GL, 2009, GASTROENTEROLOGY, V136, P1368, DOI 10.1053/j.gastro.2008.12.066; Tashima K, 2009, AM J PHYSIOL-GASTR L, V296, pG319, DOI 10.1152/ajpgi.90355.2008; Tian H, 2011, NATURE, V478, P255, DOI 10.1038/nature10408; Van Der Flier LG, 2007, GASTROENTEROLOGY, V132, P628, DOI 10.1053/j.gastro.2006.08.039; van der Flier LG, 2009, CELL, V136, P903, DOI 10.1016/j.cell.2009.01.031; WILLEMS G, 1972, Z ZELLFORSCH MIK ANA, V134, P505, DOI 10.1007/BF00307670; Wong VWY, 2012, NAT CELL BIOL, V14, P401, DOI 10.1038/ncb2464	43	343	353	1	28	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 10	2013	155	2					357	368		10.1016/j.cell.2013.09.008	http://dx.doi.org/10.1016/j.cell.2013.09.008			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	235LH	24120136	Green Accepted, Bronze			2022-12-28	WOS:000325719800013
J	Arie, S				Arie, Sophie			WORKING WITH THE DRUG INDUSTRY How a marriage with big pharma ended in divorce	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												sophiearie@fmail.co.uk						Dyer C, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e2489; Horton R, 2013, LANCET, V381, P358, DOI 10.1016/S0140-6736(13)60139-7; Spurling GK, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000352	3	2	2	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 8	2013	347								f6062	10.1136/bmj.f6062	http://dx.doi.org/10.1136/bmj.f6062			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	235OJ	24103763				2022-12-28	WOS:000325728600010
J	Davies, E				Davies, Edward			RECRUITMENT TO DRUG TRIALS Investigating the fallout of a suicide	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												edavies@bmj.com						[Anonymous], 2013, COMMUNICATION; [Anonymous], 2013, COMMUNICATION; Elliot C, 2012, COMMUNICATION; Howard M., 2013, GOVERNOR M DAYTON MI; Minnesota House of Representatives, 2009, PROH DRUG TRIAL PART; Perry S., 2010, DISTRUBING SUICIDE T; State of Minnesota Board of Social Science, 2012, AGR CORR ACT JM KENN; US Food and Drug Administration, 2005, EST INSP REP 2005	8	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 8	2013	347								f6039	10.1136/bmj.f6039	http://dx.doi.org/10.1136/bmj.f6039			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	235OJ	24103695				2022-12-28	WOS:000325728600008
J	Hastings, MH				Hastings, Michael H.			A Looser Clock to Cure Jet Lag	SCIENCE			English	Editorial Material							CIRCADIAN CLOCK; BRAIN; TIME		MRC, Mol Biol Lab, Div Neurobiol, Cambridge CB2 0QH, England	MRC Laboratory Molecular Biology	Hastings, MH (corresponding author), MRC, Mol Biol Lab, Div Neurobiol, Francis Crick Ave, Cambridge CB2 0QH, England.	mha@mrc-lmb.cam.ac.uk		Hastings, Michael Harvey/0000-0001-8576-6651	MRC [MC_U105170643] Funding Source: UKRI; Medical Research Council [MC_U105170643] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Bargmann CI, 2013, NAT METHODS, V10, P483, DOI 10.1038/NMETH.2451; Brancaccio M, 2013, NEURON, V78, P714, DOI 10.1016/j.neuron.2013.03.011; Edgar RS, 2012, NATURE, V485, P459, DOI 10.1038/nature11088; Hastings MH, 2003, NAT REV NEUROSCI, V4, P649, DOI 10.1038/nrn1177; Koike N, 2012, SCIENCE, V338, P349, DOI 10.1126/science.1226339; Liu AC, 2007, CELL, V129, P605, DOI 10.1016/j.cell.2007.02.047; Maywood ES, 2011, P NATL ACAD SCI USA, V108, P14306, DOI 10.1073/pnas.1101767108; Monsees GM, 2012, INT J CANCER, V131, P2547, DOI 10.1002/ijc.27564; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Schmidt TM, 2011, TRENDS NEUROSCI, V34, P572, DOI 10.1016/j.tins.2011.07.001; Yamaguchi Y, 2013, SCIENCE, V342, P85, DOI 10.1126/science.1238599; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101	12	6	6	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 4	2013	342	6154					52	53		10.1126/science.1245474	http://dx.doi.org/10.1126/science.1245474			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	227PP	24092721				2022-12-28	WOS:000325126100039
J	Kim, HW; Yoon, HW; Yoon, SM; Yoo, BM; Ahn, BK; Cho, YH; Shin, HJ; Yang, H; Paik, U; Kwon, S; Choi, JY; Park, HB				Kim, Hyo Won; Yoon, Hee Wook; Yoon, Seon-Mi; Yoo, Byung Min; Ahn, Byung Kook; Cho, Young Hoon; Shin, Hye Jin; Yang, Hoichang; Paik, Ungyu; Kwon, Soongeun; Choi, Jae-Young; Park, Ho Bum			Selective Gas Transport Through Few-Layered Graphene and Graphene Oxide Membranes	SCIENCE			English	Article							POROUS GRAPHENE; SEPARATION; PERMEATION; WATER	Graphene is a distinct two-dimensional material that offers a wide range of opportunities for membrane applications because of ultimate thinness, flexibility, chemical stability, and mechanical strength. We demonstrate that few-and several-layered graphene and graphene oxide (GO) sheets can be engineered to exhibit the desired gas separation characteristics. Selective gas diffusion can be achieved by controlling gas flow channels and pores via different stacking methods. For layered (3- to 10-nanometer) GO membranes, tunable gas transport behavior was strongly dependent on the degree of interlocking within the GO stacking structure. High carbon dioxide/nitrogen selectivity was achieved by well-interlocked GO membranes in high relative humidity, which is most suitable for postcombustion carbon dioxide capture processes, including a humidified feed stream.	[Kim, Hyo Won; Yoon, Hee Wook; Yoo, Byung Min; Ahn, Byung Kook; Cho, Young Hoon; Shin, Hye Jin; Paik, Ungyu; Park, Ho Bum] Hanyang Univ, Dept Energy Engn, Seoul 133791, South Korea; [Yoon, Seon-Mi; Choi, Jae-Young] Samsung Elect, SAIT, Suwon 446712, South Korea; [Yoon, Seon-Mi; Choi, Jae-Young] SAIT, Graphene Res Ctr, Suwon 446712, South Korea; [Yang, Hoichang] Inha Univ, Dept Adv Fiber Engn, Inchon 402751, South Korea; [Kwon, Soongeun] Samsung Corning Precis Mat, Ansan 336725, South Korea	Hanyang University; Samsung; Samsung Electronics; Inha University; Corning Inc	Choi, JY (corresponding author), Samsung Elect, SAIT, Suwon 446712, South Korea.	jaeyoung88.choi@samsung.com; badtzhb@hanyang.ac.kr	Park, Ho Bum/C-2941-2016	Park, Ho Bum/0000-0002-8003-9698; Cho, Young Hoon/0000-0002-8863-1979	Korea Carbon Capture and Sequestration Research and Development Center (KCRC) [2012-0008907]; Korea government (Ministry of Science, Information Communication Technology and Future Planning); National Synchrotron Light Source at Brookhaven National Laboratory [DE-AC02-98CH10886]; Hanyang University [200900000001052]	Korea Carbon Capture and Sequestration Research and Development Center (KCRC); Korea government (Ministry of Science, Information Communication Technology and Future Planning); National Synchrotron Light Source at Brookhaven National Laboratory; Hanyang University	This work was mainly supported by Korea Carbon Capture and Sequestration Research and Development Center (KCRC) (grant no. 2012-0008907) funded by the Korea government (Ministry of Science, Information Communication Technology and Future Planning). We thank the National Synchrotron Light Source at Brookhaven National Laboratory for providing the X9 beam line (grant no. DE-AC02-98CH10886) and B. D. McCloskey for thoughtful reading and commentary on our paper. H. B. P. also acknowledges support by the research fund of Hanyang University (grant no. 200900000001052).	Bhatia SK, 2011, PHYS CHEM CHEM PHYS, V13, P15350, DOI 10.1039/c1cp21166h; Blankenburg S, 2010, SMALL, V6, P2266, DOI 10.1002/smll.201001126; Bunch JS, 2008, NANO LETT, V8, P2458, DOI 10.1021/nl801457b; Cote LJ, 2009, J AM CHEM SOC, V131, P1043, DOI 10.1021/ja806262m; de Vos RM, 1998, SCIENCE, V279, P1710, DOI 10.1126/science.279.5357.1710; Dikin DA, 2007, NATURE, V448, P457, DOI 10.1038/nature06016; Duong DL, 2012, NATURE, V490, P235, DOI 10.1038/nature11562; Du NY, 2011, NAT MATER, V10, P372, DOI [10.1038/NMAT2989, 10.1038/nmat2989]; Eigler S, 2012, CHEM MATER, V24, P1276, DOI 10.1021/cm203223z; Huang PY, 2011, NATURE, V469, P389, DOI 10.1038/nature09718; Jiang DE, 2009, NANO LETT, V9, P4019, DOI 10.1021/nl9021946; Leenaerts O, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.3021413; Li XS, 2009, NANO LETT, V9, P4359, DOI 10.1021/nl902623y; Li XS, 2009, SCIENCE, V324, P1312, DOI 10.1126/science.1171245; Lui CH, 2009, NATURE, V462, P339, DOI 10.1038/nature08569; MASUDA T, 1983, J AM CHEM SOC, V105, P7473, DOI 10.1021/ja00363a061; Nair RR, 2012, SCIENCE, V335, P442, DOI 10.1126/science.1211694; Park HB, 2007, SCIENCE, V318, P254, DOI 10.1126/science.1146744; PINNAU I, 1991, IND ENG CHEM RES, V30, P1837, DOI 10.1021/ie00056a024; Poshusta JC, 2001, J MEMBRANE SCI, V186, P25, DOI 10.1016/S0376-7388(00)00666-9; RAO MB, 1993, J MEMBRANE SCI, V85, P253, DOI 10.1016/0376-7388(93)85279-6; Robeson LM, 2008, J MEMBRANE SCI, V320, P390, DOI 10.1016/j.memsci.2008.04.030; Schrier J, 2012, ACS APPL MATER INTER, V4, P3745, DOI 10.1021/am300867d; Shekhawata D., 2003, 20031200 DOENETL; Shiflett MB, 1999, SCIENCE, V285, P1902, DOI 10.1126/science.285.5435.1902; SPECTOR MS, 1994, PHYS REV LETT, V73, P2867, DOI 10.1103/PhysRevLett.73.2867; Strathmann H, 2011, INTRO MEMBRANE SCI T; Suda H, 1997, J PHYS CHEM B, V101, P3988, DOI 10.1021/jp963997u; Torrisi A, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3276105; Zhu YW, 2010, ADV MATER, V22, P3906, DOI 10.1002/adma.201001068	30	1037	1078	66	1654	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 4	2013	342	6154					91	95		10.1126/science.1236098	http://dx.doi.org/10.1126/science.1236098			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	227PP	24092738				2022-12-28	WOS:000325126100051
J	Bakshi, P; Partridge, J; Dhesi, J				Bakshi, Prabhat; Partridge, Judith; Dhesi, Jugdeep			Indications for and use of inferior vena cava filters in the preoperative phase	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							DEEP-VEIN THROMBOSIS; VENOUS THROMBOEMBOLISM; PULMONARY-EMBOLISM; PREVENTION; INTERRUPTION; TRIAL		[Bakshi, Prabhat; Partridge, Judith; Dhesi, Jugdeep] Guys & St Thomas NHS Fdn Trust, Dept Ageing & Hlth, London SE1 7EH, England	Guy's & St Thomas' NHS Foundation Trust	Bakshi, P (corresponding author), Guys & St Thomas NHS Fdn Trust, Dept Ageing & Hlth, London SE1 7EH, England.	pbakshi@doctors.org.uk	Dhesi, Jugdeep/K-5631-2019	Dhesi, Jugdeep/0000-0003-0815-0233; Partridge, Judith Stephanie Louise/0000-0003-0176-5307				Anderson RC, 2006, PHARMACOTHERAPY, V26, P1595, DOI 10.1592/phco.26.11.1595; Baglin TP, 2006, BRIT J HAEMATOL, V134, P590, DOI 10.1111/j.1365-2141.2006.06226.x; Crowther MA, 2007, AM J MED, V120, pS13, DOI 10.1016/j.amjmed.2007.07.015; Decousus H, 2005, CIRCULATION, V112, P416, DOI 10.1161/CIRCULATIONHA.104.512834; Decousus H, 1998, NEW ENGL J MED, V338, P409, DOI 10.1056/NEJM199802123380701; FDA. US Food and Drug Administration, 2010, REM RETR INF VEN CAV; Food and Drug Administration, 2010, INF VEN CAV IVC FILT; Geerts WH, 2004, CHEST, V126, p338S, DOI 10.1378/chest.126.3_suppl.338S; Geerts WH, 2008, CHEST, V133, p381S, DOI 10.1378/chest.08-0656; Godoy-Garcia F, 2011, ARCH INTERN MED, V171, P1953, DOI 10.1001/archinternmed.2011.526; Goei Anthony D, 2011, Semin Intervent Radiol, V28, P118, DOI 10.1055/s-0031-1273946; KAKKAR VV, 1972, LANCET, V2, P101; Kearon C, 2008, CHEST, V133, p454S, DOI 10.1378/chest.08-0658; Kearon C, 2012, CHEST, V141, pE419S, DOI 10.1378/chest.11-2301; Medicines and Healthcare Products Regulatory Agency, 2013, MED DEV AL RETR INF; Mobin-Uddin K, 1967, SURG FORUM, V18, P209; Moore PS, 2010, J VASC SURG, V52, P118, DOI 10.1016/j.jvs.2009.09.067; Nazzal M, 2010, ANN VASC SURG, V24, P480, DOI 10.1016/j.avsg.2009.07.015; Shang EK, 2011, VASC ENDOVASC SURG, V45, P290, DOI 10.1177/1538574410395038; Uberoi R, 2011, 1 UK INFERIOR VENA C; White RH, 2000, ARCH INTERN MED, V160, P2033, DOI 10.1001/archinte.160.13.2033; Young T, 2010, COCHRANE DB SYST REV, V2	22	0	1	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 30	2013	347								f5807	10.1136/bmj.f5807	http://dx.doi.org/10.1136/bmj.f5807			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	231NY	24081818	Green Published			2022-12-28	WOS:000325425000002
J	Diener, MK; Buchler, MW				Diener, Markus K.; Buechler, Markus W.			Sutures or staples for abdominal wound closure: case closed?	LANCET			English	Editorial Material							MULTICENTER; TRIAL		[Buechler, Markus W.] Heidelberg Univ, German Surg Soc, Study Ctr, D-69120 Heidelberg, Germany; Heidelberg Univ, Dept Gen Visceral & Transplantat Surg, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Buchler, MW (corresponding author), Heidelberg Univ, German Surg Soc, Study Ctr, D-69120 Heidelberg, Germany.	markus.buechler@med.uni-heidelberg.de						Diener MK, 2011, LANCET, V377, P1514, DOI 10.1016/S0140-6736(11)60237-7; Heger U, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-245; Horton R, 1996, LANCET, V347, P984, DOI 10.1016/S0140-6736(96)90137-3; Knebel P, 2012, LANGENBECK ARCH SURG, V397, P611, DOI 10.1007/s00423-012-0922-z; Rahbari NN, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-142; Seiler CM, 2009, ANN SURG, V249, P576, DOI 10.1097/SLA.0b013e31819ec6c8; Tsujinaka T, 2013, LANCET, V382, P1105, DOI 10.1016/S0140-6736(13)61780-8	7	0	0	1	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 28	2013	382	9898					1076	1077		10.1016/S0140-6736(13)61166-6	http://dx.doi.org/10.1016/S0140-6736(13)61166-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	228SG	24075036				2022-12-28	WOS:000325208100007
J	Stolper, EM; Baker, MB; Newcombe, ME; Schmidt, ME; Treiman, AH; Cousin, A; Dyar, MD; Fisk, MR; Gellert, R; King, PL; Leshin, L; Maurice, S; McLennan, SM; Minitti, ME; Perrett, G; Rowland, S; Sautter, V; Wiens, RC				Stolper, E. M.; Baker, M. B.; Newcombe, M. E.; Schmidt, M. E.; Treiman, A. H.; Cousin, A.; Dyar, M. D.; Fisk, M. R.; Gellert, R.; King, P. L.; Leshin, L.; Maurice, S.; McLennan, S. M.; Minitti, M. E.; Perrett, G.; Rowland, S.; Sautter, V.; Wiens, R. C.		MSL Sci Team	The Petrochemistry of Jake_M: A Martian Mugearite	SCIENCE			English	Article							X-RAY SPECTROMETER; GUSEV CRATER; CHEMICAL-COMPOSITION; MANTLE METASOMATISM; MELTING EXPERIMENTS; MAGMATIC SYSTEMS; WATER CONTENTS; MARS; METEORITE; BASALTS	"Jake_M," the first rock analyzed by the Alpha Particle X-ray Spectrometer instrument on the Curiosity rover, differs substantially in chemical composition from other known martian igneous rocks: It is alkaline (>15% normative nepheline) and relatively fractionated. Jake_M is compositionally similar to terrestrial mugearites, a rock type typically found at ocean islands and continental rifts. By analogy with these comparable terrestrial rocks, Jake_M could have been produced by extensive fractional crystallization of a primary alkaline or transitional magma at elevated pressure, with or without elevated water contents. The discovery of Jake_M suggests that alkaline magmas may be more abundant on Mars than on Earth and that Curiosity could encounter even more fractionated alkaline rocks (for example, phonolites and trachytes).	[Stolper, E. M.; Baker, M. B.; Newcombe, M. E.] CALTECH, Pasadena, CA 91125 USA; [Schmidt, M. E.] Brock Univ, St Catharines, ON L2T 3V8, Canada; [Treiman, A. H.] Lunar & Planetary Inst, Houston, TX 77058 USA; [Cousin, A.; Wiens, R. C.] Los Alamos Natl Lab, Los Alamos, NM 87545 USA; [Cousin, A.; Maurice, S.] Inst Rech Astrophys & Planetol, F-31028 Toulouse, France; [Dyar, M. D.] Mt Holyoke Coll, S Hadley, MA 01075 USA; [Fisk, M. R.] Oregon State Univ, Corvallis, OR 97331 USA; [Gellert, R.; Perrett, G.] Univ Guelph, Guelph, ON N1G 2W1, Canada; [King, P. L.] Australian Natl Univ, Res Sch Earth Sci, Acton, ACT 0200, Australia; [Leshin, L.] Rensselaer Polytech Inst, Troy, NY 12180 USA; [McLennan, S. M.] SUNY Stony Brook, Stony Brook, NY 11794 USA; [Minitti, M. E.] Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA; [Rowland, S.] Univ Hawaii, Honolulu, HI 96822 USA; [Sautter, V.] Lab Mineral & Cosmochim Museum, F-75005 Paris, France	California Institute of Technology; Brock University; United States Department of Energy (DOE); Los Alamos National Laboratory; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Mount Holyoke College; Oregon State University; University of Guelph; Australian National University; Rensselaer Polytechnic Institute; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; University of Hawaii System	Stolper, EM (corresponding author), CALTECH, Pasadena, CA 91125 USA.	ems@gps.caltech.edu	Ramos, Miguel/K-2230-2014; King, Penelope/A-1791-2011; Rodriguez-Manfredi, Jose/AAG-9826-2021; Malakhov, Alexey Vladimirovich/F-7953-2017; Martin-Torres, Javier/G-6329-2015; Navarro-González, Rafael/D-1748-2009; Blanco, Juan Jose/E-3627-2014; Avalos, Juan Jose Blanco/AAB-9447-2021; Steele, Andrew/A-3573-2013; szopa, cyril/C-6865-2015; Harri, Ari-Matti/C-7142-2012; FABRE, Cécile/B-5827-2012; Zorzano, María-Paz/F-2184-2015; Rodriguez-Manfredi, Jose/L-8001-2014; Stipp, Susan L.S./B-8494-2019; Hayes, Alexander G/P-2024-2014; De Pablo, Miguel Ángel/J-6442-2014; Floyd, Melissa/D-4626-2012; Gomez-Elvira, Javier/K-5829-2014; Gómez, Felipe/L-7315-2014; Balic-Zunic, Tonci/A-6362-2013; GEFFROY, Claude/AAB-9152-2019; Nikiforov, Sergei/ABI-1265-2020; Dworkin, Jason P./C-9417-2012; Romeral Planelló, Julio J./T-1788-2017; Prats, Benito/F-9467-2019; Muller, Jan-Peter/Q-8886-2019; IMPMC, ROCKS @/U-8478-2017; Franz, Heather B/F-3508-2012; Lemmon, Mark T/E-9983-2010; Teinturier, Samuel/AAS-8663-2020; Benna, Mehdi/F-3489-2012; Sirven, Jean-Baptiste/H-5782-2013; Vicenzi, Edward/T-9430-2017; Gasnault, Olivier/F-4327-2010	Ramos, Miguel/0000-0003-3648-6818; King, Penelope/0000-0002-8364-9168; Rodriguez-Manfredi, Jose/0000-0003-0461-9815; Malakhov, Alexey Vladimirovich/0000-0003-4292-7077; Martin-Torres, Javier/0000-0001-6479-2236; Navarro-González, Rafael/0000-0002-6078-7621; Blanco, Juan Jose/0000-0002-8666-0696; Avalos, Juan Jose Blanco/0000-0002-8666-0696; Steele, Andrew/0000-0001-9643-2841; szopa, cyril/0000-0002-0090-4056; Harri, Ari-Matti/0000-0001-8541-2802; FABRE, Cécile/0000-0001-8627-4050; Zorzano, María-Paz/0000-0002-4492-9650; Rodriguez-Manfredi, Jose/0000-0003-0461-9815; Stipp, Susan L.S./0000-0001-7009-643X; Hayes, Alexander G/0000-0001-6397-2630; De Pablo, Miguel Ángel/0000-0002-4496-2741; Gomez-Elvira, Javier/0000-0002-9068-9846; Gómez, Felipe/0000-0001-9977-7060; Balic-Zunic, Tonci/0000-0003-1687-1233; GEFFROY, Claude/0000-0002-2731-9658; Nikiforov, Sergei/0000-0002-7221-8602; Dworkin, Jason P./0000-0002-3961-8997; Romeral Planelló, Julio J./0000-0002-2205-067X; Prats, Benito/0000-0003-3869-3351; Muller, Jan-Peter/0000-0002-5077-3736; Lemmon, Mark T/0000-0002-4504-5136; Teinturier, Samuel/0000-0003-1755-9524; Sirven, Jean-Baptiste/0000-0002-5523-6809; Ewing, Ryan/0000-0001-6337-610X; BERGER, Gilles/0000-0003-4806-5594; Mitrofanov, Igor/0000-0001-7204-2101; Rice, Melissa/0000-0002-8370-4139; Wilson, Sharon/0000-0001-8872-8546; Martinez-Frias, Jesus/0000-0002-2609-4485; Richardson, Mark/0000-0001-9633-4141; McLennan, Scott/0000-0003-4259-7178; Buch, Arnaud/0000-0002-2097-7252; Vicenzi, Edward/0000-0003-2085-6546; Gasnault, Olivier/0000-0002-6979-9012; Newcombe, Megan Eve/0000-0002-8450-768X; Beegle, Luther/0000-0002-4944-4353; Pla-Garcia, Jorge/0000-0002-8047-3937	NSF; NASA; Canadian Space Agency; Centre National d'Etudes Spatiales; Science and Technology Facilities Council [ST/J005193/1] Funding Source: researchfish; UK Space Agency [ST/J005339/1, ST/I003118/1] Funding Source: researchfish	NSF(National Science Foundation (NSF)); NASA(National Aeronautics & Space Administration (NASA)); Canadian Space Agency(Canadian Space Agency); Centre National d'Etudes Spatiales(Centre National D'etudes Spatiales); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); UK Space Agency	P. Antoshechkin provided insight concerning several aspects of MELTS and S. Lambart ran early MELTS calculations and provided initial compilations of terrestrial alkaline lavas. We would also like to thank two anonymous referees for constructive reviews of the manuscript and the MSL Project engineering and management teams for their efforts in making the mission such a success. This work was supported by grants from the NSF, NASA, the Canadian Space Agency, and the Centre National d'Etudes Spatiales. Compositional data for Jake_M are reported in Table 1.	Ablay GJ, 1998, J PETROL, V39, P905, DOI 10.1093/petrology/39.5.905; ABLAY GJ, 1995, B VOLCANOL, V57, P337, DOI 10.1007/BF00301292; Agee CB, 2013, SCIENCE, V339, P780, DOI 10.1126/science.1228858; Andujar J, 2008, CHEM GEOL, V257, P173, DOI 10.1016/j.chemgeo.2008.08.012; Aoudjehane HC, 2012, SCIENCE, V338, P785, DOI 10.1126/science.1224514; Baker DR, 2012, EARTH-SCI REV, V114, P298, DOI 10.1016/j.earscirev.2012.06.005; Beier C, 2006, J PETROL, V47, P1375, DOI 10.1093/petrology/egl014; Carmichael ISE, 1974, IGNEOUS PETROLOGY; CARROLL MR, 1994, REV MINERAL, V30, P231; Cousin A., 2013, LUNAR PLANET SCI C, V44; Cross W., 1903, QUANTITATIVE CLASSIF; Danni JC, 2001, METEORIT PLANET SCI, V36, P793, DOI 10.1111/j.1945-5100.2001.tb01917.x; Dasgupta R, 2007, J PETROL, V48, P2093, DOI 10.1093/petrology/egm053; Day JMD, 2006, METEORIT PLANET SCI, V41, P581, DOI 10.1111/j.1945-5100.2006.tb00484.x; DREIBUS G, 1987, ICARUS, V71, P225, DOI 10.1016/0019-1035(87)90148-5; Edgar A. D., 1987, ALKALINE IGNEOUS ROC, P29; EGGLER DH, 1972, CONTRIB MINERAL PETR, V34, P261, DOI 10.1007/BF00373757; Filiberto J, 2008, ICARUS, V197, P52, DOI 10.1016/j.icarus.2008.04.016; Filiberto J, 2011, EARTH PLANET SC LETT, V304, P527, DOI 10.1016/j.epsl.2011.02.029; Filiberto J, 2009, GEOLOGY, V37, P1087, DOI 10.1130/G30488A.1; Foley CN, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE002018; Gellert R, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002555; Gellert R., 2013, LUNAR PLANET SCI C, V44; GHIORSO MS, 1995, CONTRIB MINERAL PETR, V119, P197, DOI 10.1007/BF00307281; GREEN DH, 1974, CONTRIB MINERAL PETR, V48, P33, DOI 10.1007/BF00399108; GREEN DH, 1987, MAGMATIC PROCESSES P, P139; Grotzinger J. P., 2013, LUNAR PLANET SCI C, V44; Harker A., 2018, SOCIAL DYSFUNCTION, P439; Hewins R. H., 2013, LUNAR PLANET SCI C; Humayun M., 2013, LUNAR PLANET SCI C; IRVINE TN, 1971, CAN J EARTH SCI, V8, P523, DOI 10.1139/e71-055; JOHNSON MC, 1991, GEOCHIM COSMOCHIM AC, V55, P349, DOI 10.1016/0016-7037(91)90423-3; Karner J, 2003, AM MINERAL, V88, P806; Karner J, 2006, AM MINERAL, V91, P1574, DOI 10.2138/am.2006.2103; Keshav S, 2004, EARTH PLANET SC LETT, V223, P365, DOI 10.1016/j.epsl.2004.04.029; Kogiso T, 2003, EARTH PLANET SC LETT, V216, P603, DOI 10.1016/S0012-821X(03)00538-7; Lacroix A, 1917, CR HEBD ACAD SCI, V164, P581; Le Maitre R.W., 2002, IGNEOUS ROCKS CLASSI, DOI DOI 10.1017/S0016756803388028; Lloyd F.E., 1975, PHYS CHEM EARTH, V9, P389, DOI DOI 10.1016/0079-1946(75)90030-0; Lodders K, 1997, ICARUS, V126, P373, DOI 10.1006/icar.1996.5653; Matzen AK, 2011, J PETROL, V52, P1243, DOI 10.1093/petrology/egq089; McCubbin FM, 2010, EARTH PLANET SC LETT, V292, P132, DOI 10.1016/j.epsl.2010.01.028; McLennan SM, 2003, METEORIT PLANET SCI, V38, P895, DOI 10.1111/j.1945-5100.2003.tb00286.x; McSween HY, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2006JE002698; McSween HY, 2009, SCIENCE, V324, P736, DOI 10.1126/science.1165871; MCSWEEN HY, 1994, METEORITICS, V29, P757, DOI 10.1111/j.1945-5100.1994.tb01092.x; MENZIES M, 1980, AM J SCI, V280, P622; Meyer C., 2012, MARTIAN METEORITE CO; Ming DW, 2008, J GEOPHYS RES-PLANET, V113, DOI 10.1029/2008JE003195; Minitti M. E., 2013, LUNAR PLANET SCI C, V44; Morris RV, 2008, J GEOPHYS RES-PLANET, V113, DOI 10.1029/2008JE003201; MUIR ID, 1961, J GEOL, V69, P186, DOI 10.1086/626727; Nekvasil H, 2007, METEORIT PLANET SCI, V42, P979, DOI 10.1111/j.1945-5100.2007.tb01145.x; Pilet S, 2008, SCIENCE, V320, P916, DOI 10.1126/science.1156563; PRESNALL DC, 1978, CONTRIB MINERAL PETR, V66, P203, DOI 10.1007/BF00372159; Rhodes JM, 1996, J GEOPHYS RES-SOL EA, V101, P11729, DOI 10.1029/95JB03704; Rieder R, 2004, SCIENCE, V306, P1746, DOI 10.1126/science.1104358; Ruzicka A, 2001, GEOCHIM COSMOCHIM AC, V65, P979, DOI 10.1016/S0016-7037(00)00599-8; Sautter V, 2006, EARTH PLANET SC LETT, V252, P45, DOI 10.1016/j.epsl.2006.09.024; Schmidt M. E., 2013, LUNAR PLANET SCI C; Schmidt ME, 2010, EARTH PLANET SC LETT, V296, P67, DOI 10.1016/j.epsl.2010.04.046; Smith PM, 2005, GEOCHEM GEOPHY GEOSY, V6, DOI 10.1029/2004GC000816; Squyres SW, 2007, SCIENCE, V316, P738, DOI 10.1126/science.1139045; STOLPER E, 1979, GEOCHIM COSMOCHIM AC, V43, P589, DOI 10.1016/0016-7037(79)90167-4; STOLZ AJ, 1984, MINERAL MAG, V48, P167, DOI 10.1180/minmag.1984.048.347.02; Taylor G. J., 2006, J GEOPHYS RES, V111; Treiman AH, 2003, METEORIT PLANET SCI, V38, P1849, DOI 10.1111/j.1945-5100.2003.tb00019.x; TREIMAN AH, 1993, GEOCHIM COSMOCHIM AC, V57, P4753, DOI 10.1016/0016-7037(93)90198-6; Tuff J, 2013, NATURE, V498, P342, DOI 10.1038/nature12225; Usui T, 2008, J GEOPHYS RES-PLANET, V113, DOI 10.1029/2008JE003225; Wadhwa M, 2008, REV MINERAL GEOCHEM, V68, P493, DOI 10.2138/rmg.2008.68.17; WANKE H, 1988, PHILOS T R SOC A, V325, P545, DOI 10.1098/rsta.1988.0067; Wanke H, 2001, SPACE SCI REV, V96, P317, DOI 10.1023/A:1011961725645; WILKINSON JF, 1969, NATURE, V222, P553, DOI 10.1038/222553a0; Wilson M., 1989, IGNEOUS PETROGENESIS, P342, DOI 10.1007/978-1-4020-6788-4; Winter J.D., 2010, INTRO IGNEOUS METAMO; WYLLIE PJ, 1964, AM J SCI, V262, P930, DOI 10.2475/ajs.262.7.930; WYLLIE PJ, 1979, AM MINERAL, V64, P469; Yen AS, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2006JE002797; YODER HS, 1962, J PETROL, V3, P342, DOI 10.1093/petrology/3.3.342	80	131	132	0	90	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 27	2013	341	6153							1239463	10.1126/science.1239463	http://dx.doi.org/10.1126/science.1239463			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	224NS	24072927	Green Accepted			2022-12-28	WOS:000324894600004
J	Chakravarti, A; Clark, AG; Mootha, VK				Chakravarti, Aravinda; Clark, Andrew G.; Mootha, Vamsi K.			Distilling Pathophysiology from Complex Disease Genetics	CELL			English	Article							ENVIRONMENT INTERACTION; MUTATIONS; TRAITS; COMMON	Technologies for genome-wide sequence interrogation have dramatically improved our ability to identify loci associated with complex human disease. However, a chasm remains between correlations and causality that stems, in part, from a limiting theoretical framework derived from Mendelian genetics and an incomplete understanding of disease physiology. Here we propose a set of criteria, akin to Koch's postulates for infectious disease, for assigning causality between genetic variants and human disease phenotypes.	[Chakravarti, Aravinda] Johns Hopkins Univ, Sch Med, Baltimore, MD 21205 USA; [Clark, Andrew G.] Cornell Univ, Ithaca, NY 14850 USA; [Mootha, Vamsi K.] Massachusetts Gen Hosp, Boston, MA 02114 USA	Johns Hopkins University; Cornell University; Harvard University; Massachusetts General Hospital	Chakravarti, A (corresponding author), Johns Hopkins Univ, Sch Med, Baltimore, MD 21205 USA.	aravinda@jhmi.edu		Clark, Andrew/0000-0001-7159-8511	NHLBI NIH HHS [R01 HL072904] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL072904] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Alberts B., 2010, MOL BIOL CELL; Altenburg E, 1920, GENETICS, V5, P1; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Brooke BS, 2008, NEW ENGL J MED, V358, P2787, DOI 10.1056/NEJMoa0706585; BROWN MS, 1992, CELL, V71, P187, DOI 10.1016/0092-8674(92)90346-E; Chakravarti A, 2001, NATURE, V409, P822, DOI 10.1038/35057281; Chin BL, 2012, GENETICS, V192, P1523, DOI 10.1534/genetics.112.145573; Dutkowski J, 2013, NAT BIOTECHNOL, V31, P38, DOI 10.1038/nbt.2463; Emison ES, 2010, AM J HUM GENET, V87, P60, DOI 10.1016/j.ajhg.2010.06.007; FALKOW S, 1988, REV INFECT DIS, V10, pS274; Falkow S, 2004, NAT REV MICROBIOL, V2, P67, DOI 10.1038/nrmicro799; Farago AF, 2012, CELL, V149, P246, DOI 10.1016/j.cell.2012.03.015; Graham DB, 2013, TRENDS IMMUNOL, V34, P371, DOI 10.1016/j.it.2013.04.001; Groop L, 2013, MOL CELL ENDOCRINOL; GUYTON AC, 1972, ANNU REV PHYSIOL, V34, P13, DOI 10.1146/annurev.ph.34.030172.000305; Hartman JL, 2001, SCIENCE, V291, P1001, DOI 10.1126/science.291.5506.1001; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Ilsley GR, 2013, ELIFE, V2, DOI 10.7554/eLife.00522; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kohane IS, 2006, JAMA-J AM MED ASSOC, V296, P212, DOI 10.1001/jama.296.2.212; Ludolph AC, 2012, CURR OPIN NEUROL, V25, P530, DOI 10.1097/WCO.0b013e328356d328; MacArthur DG, 2012, SCIENCE, V335, P823, DOI 10.1126/science.1215040; McCallion AS, 2003, COLD SPRING HARB SYM, V68, P373, DOI 10.1101/sqb.2003.68.373; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Musunuru K, 2010, NATURE, V466, P714, DOI 10.1038/nature09266; PLUMP AS, 1992, CELL, V71, P343, DOI 10.1016/0092-8674(92)90362-G; Provine, 1971, ORIGINS THEORETICAL; Raj A, 2010, NATURE, V463, P913, DOI 10.1038/nature08781; Sparrow DB, 2012, CELL, V149, P295, DOI 10.1016/j.cell.2012.02.054; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Watson JD, 2007, MOL BIOL GENE; Yang J, 2011, NAT GENET, V43, P519, DOI 10.1038/ng.823; Yosef N, 2013, NATURE, V496, P461, DOI 10.1038/nature11981; Zerba KE, 1996, GENETICS, V143, P463	35	58	60	1	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 26	2013	155	1					21	26		10.1016/j.cell.2013.09.001	http://dx.doi.org/10.1016/j.cell.2013.09.001			6	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	224UX	24074858	Green Accepted, Bronze			2022-12-28	WOS:000324916700006
J	Chanda, B; Ditadi, A; Iscove, NN; Keller, G				Chanda, Bhaskar; Ditadi, Andrea; Iscove, Norman N.; Keller, Gordon			Retinoic Acid Signaling Is Essential for Embryonic Hematopoietic Stem Cell Development	CELL			English	Article							ALDEHYDE DEHYDROGENASE; DEFINITIVE HEMATOPOIESIS; RECEPTOR-ALPHA; GENERATION; SPECIFICATION; PROGENITORS; ENDOTHELIUM; EXPRESSION; GAMMA; REQUIREMENT	Hematopoietic stem cells (HSCs) develop from a specialized subpopulation of endothelial cells known as hemogenic endothelium (HE). Although the HE origin of HSCs is now well established in different species, the signaling pathways that control this transition remain poorly understood. Here, we show that activation of retinoic acid (RA) signaling in aorta-gonad-mesonephros-derived HE ex vivo dramatically enhanced its HSC potential, whereas conditional inactivation of the RA metabolizing enzyme retinal dehydrogenase 2 in VE-cadherin expressing endothelial cells in vivo abrogated HSC development. Wnt signaling completely blocked the HSC inductive effects of RA modulators, whereas inhibition of the pathway promoted the development of HSCs in the absence of RA signaling. Collectively, these findings position RA and Wnt signaling as key regulators of HSC development and in doing so provide molecular insights that will aid in developing strategies for their generation from pluripotent stem cells.	[Chanda, Bhaskar; Ditadi, Andrea; Iscove, Norman N.; Keller, Gordon] Univ Toronto, McEwen Ctr Regenerat Med, Toronto, ON M5G 1L7, Canada; [Chanda, Bhaskar; Iscove, Norman N.; Keller, Gordon] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 1L7, Canada; [Iscove, Norman N.; Keller, Gordon] Univ Toronto, Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON M5G 1L7, Canada	University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre	Keller, G (corresponding author), Univ Toronto, McEwen Ctr Regenerat Med, Toronto, ON M5G 1L7, Canada.	gkeller@uhnresearch.ca	Ditadi, Andrea/K-3461-2016	Ditadi, Andrea/0000-0003-3283-8943; Keller, Gordon/0000-0001-9309-9297	Banting and Best Canada Graduate PhD Scholarship from CIHR [FRN-72038762, MOP-93569]; Magna-Golftown Postdoctoral Fellowship; NIH [UO1 HL100405]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL100405] Funding Source: NIH RePORTER	Banting and Best Canada Graduate PhD Scholarship from CIHR; Magna-Golftown Postdoctoral Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank Dr. Shanthini Socknathan at John Hopkins University, Dr. Nancy Speck at the University of Pennsylvania, and Dr. Kenneth Murphy at Washington University for providing Raldh2<SUP>f/f</SUP> mice, VEC-Cre mice, and TOP and FOP Flash A2lox mouse ESC lines, respectively. We also thank the following people for their assistance in different experiments: Arian Khandani and Tharsan Theruvillapurium for cell sorting, Robert Banh for western blot analyses, Alexander Mikryukov and David Tsui for immunohistochemistry, and Wilfred Ip for luciferase assay. In addition, we thank the Keller laboratory members for their feedback on the manuscript. B.C. is supported by a Banting and Best Canada Graduate PhD Scholarship from CIHR (FRN-72038762), and A.D. by Magna-Golftown Postdoctoral Fellowship. This research is funded by operating grants from CIHR (MOP-93569) and NIH (UO1 HL100405).	Antonchuk J, 2002, CELL, V109, P39, DOI 10.1016/S0092-8674(02)00697-9; APFEL C, 1992, P NATL ACAD SCI USA, V89, P7129, DOI 10.1073/pnas.89.15.7129; Armstrong L, 2004, STEM CELLS, V22, P1142, DOI 10.1634/stemcells.2004-0170; Balmer JE, 2005, J STEROID BIOCHEM, V96, P347, DOI 10.1016/j.jsbmb.2005.05.005; Balmer JE, 2002, J LIPID RES, V43, P1773, DOI 10.1194/jlr.R100015-JLR200; Bertrand JY, 2010, NATURE, V464, P108, DOI 10.1038/nature08738; Bertrand JY, 2005, P NATL ACAD SCI USA, V102, P134, DOI 10.1073/pnas.0402270102; Boisset JC, 2010, NATURE, V464, P116, DOI 10.1038/nature08764; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; Chen MJ, 2011, CELL STEM CELL, V9, P541, DOI 10.1016/j.stem.2011.10.003; Chen MJ, 2009, NATURE, V457, P887, DOI 10.1038/nature07619; Clarke RL, 2013, NAT CELL BIOL, V15, P502, DOI 10.1038/ncb2724; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; de Jong JLO, 2010, BLOOD, V116, P201, DOI 10.1182/blood-2009-10-249557; DELESCLUSE C, 1991, MOL PHARMACOL, V40, P556; Duester G, 1999, ADV EXP MED BIOL, V463, P311; Duester G, 2008, CELL, V134, P921, DOI 10.1016/j.cell.2008.09.002; Easwaran V, 1999, CURR BIOL, V9, P1415, DOI 10.1016/S0960-9822(00)80088-3; Eilken HM, 2009, NATURE, V457, P896, DOI 10.1038/nature07760; Fitch SR, 2012, CELL STEM CELL, V11, P554, DOI 10.1016/j.stem.2012.07.002; GIANNI M, 1993, BIOCHEM BIOPH RES CO, V196, P252, DOI 10.1006/bbrc.1993.2242; Goessling W, 2009, CELL, V136, P1136, DOI 10.1016/j.cell.2009.01.015; Goldie LC, 2008, BLOOD, V112, P3194, DOI 10.1182/blood-2008-02-139055; Gonsalves FC, 2011, P NATL ACAD SCI USA, V108, P5954, DOI 10.1073/pnas.1017496108; Hadland BK, 2004, BLOOD, V104, P3097, DOI 10.1182/blood-2004-03-1224; Hess DA, 2004, BLOOD, V104, P1648, DOI 10.1182/blood-2004-02-0448; Irion S, 2010, DEVELOPMENT, V137, P2829, DOI 10.1242/dev.042119; JONES RJ, 1995, BLOOD, V85, P2742, DOI 10.1182/blood.V85.10.2742.bloodjournal85102742; Kaimakis P, 2013, BBA-GEN SUBJECTS, V1830, P2395, DOI 10.1016/j.bbagen.2012.10.004; Kumano K, 2003, IMMUNITY, V18, P699, DOI 10.1016/S1074-7613(03)00117-1; Kumar S, 2012, BBA-MOL CELL BIOL L, V1821, P198, DOI 10.1016/j.bbalip.2011.04.004; Lancrin C, 2009, NATURE, V457, P892, DOI 10.1038/nature07679; Lindsley RC, 2006, DEVELOPMENT, V133, P3787, DOI 10.1242/dev.02551; Lund BW, 2005, J MED CHEM, V48, P7517, DOI 10.1021/jm050891r; Mark M., 2009, NUCL RECEPT SIGNAL, V7, pe002; Medvinsky A, 1996, CELL, V86, P897, DOI 10.1016/S0092-8674(00)80165-8; Mikkola HKA, 2003, NATURE, V421, P547, DOI 10.1038/nature01345; Mukouyama Y, 2000, DEV BIOL, V220, P27, DOI 10.1006/dbio.2000.9617; Niederreither K, 1999, NAT GENET, V21, P444, DOI 10.1038/7788; Purton LE, 2006, J EXP MED, V203, P1283, DOI 10.1084/jem.20052105; Ren X, 2010, BLOOD, V115, P5338, DOI 10.1182/blood-2009-09-244640; Rhinn M, 2012, DEVELOPMENT, V139, P843, DOI 10.1242/dev.065938; Ruiz-Herguido C, 2012, J EXP MED, V209, P1457, DOI 10.1084/jem.20120225; Rybtsov S, 2011, J EXP MED, V208, P1305, DOI 10.1084/jem.20102419; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Schlaeger TM, 2005, BLOOD, V105, P3871, DOI 10.1182/blood-2004-11-4467; Taoudi S, 2005, DEVELOPMENT, V132, P4179, DOI 10.1242/dev.01974; Taoudi S, 2008, CELL STEM CELL, V3, P99, DOI 10.1016/j.stem.2008.06.004; TSAI FY, 1994, NATURE, V371, P221, DOI 10.1038/371221a0; Walkley CR, 2007, CELL, V129, P1097, DOI 10.1016/j.cell.2007.05.014; Wang Q, 1996, CELL, V87, P697, DOI 10.1016/S0092-8674(00)81389-6; Xiao JH, 2003, J BIOL CHEM, V278, P29954, DOI 10.1074/jbc.M304761200; Yokomizo T, 2001, GENES CELLS, V6, P13, DOI 10.1046/j.1365-2443.2001.00393.x; Yoshimoto M, 2009, NATURE, V457, P801, DOI 10.1038/457801a; Yu C, 2010, BLOOD, V116, P4786, DOI 10.1182/blood-2010-01-263335; Zon LI, 2008, NATURE, V453, P306, DOI 10.1038/nature07038	56	127	137	2	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 26	2013	155	1					215	227		10.1016/j.cell.2013.08.055	http://dx.doi.org/10.1016/j.cell.2013.08.055			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	224UX	24074870	Bronze			2022-12-28	WOS:000324916700021
J	Cho, TA; Schmahmann, JD; Cunnane, ME				Cho, Tracey A.; Schmahmann, Jeremy D.; Cunnane, Mary E.			Case 30-2013: A 19-Year-Old Man with Otalgia, Slurred Speech, and Ataxia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							EPSTEIN-BARR-VIRUS; ACUTE CEREBELLAR-ATAXIA; BRAIN; ENCEPHALITIS		[Cho, Tracey A.; Schmahmann, Jeremy D.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Cunnane, Mary E.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Cho, Tracey A.; Schmahmann, Jeremy D.] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; [Cunnane, Mary E.] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Cho, TA (corresponding author), Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA.		Schmahmann, Jeremy/ABF-1215-2021; Cho, Tracey/O-8645-2018	Schmahmann, Jeremy/0000-0003-0706-5125; Cho, Tracey/0000-0002-6208-1489	WorldCare Clinical; Oncolytics Biotech	WorldCare Clinical; Oncolytics Biotech	Dr. Cunnane reports receiving payment from WorldCare Clinical for image interpretation for a drug trial sponsored by Oncolytics Biotech. No other potential conflict of interest relevant to this article was reported.	Abul-Kasim K, 2009, J CHILD NEUROL, V24, P720, DOI 10.1177/0883073808327842; AMBLER M, 1971, ANN INTERN MED, V75, P579, DOI 10.7326/0003-4819-75-4-579; [Anonymous], INFECT CENTRAL NERVO; Babinski F, 1899, REV NEUROLOGIQUE, V7, P806; BRAY PF, 1992, NEUROLOGY, V42, P278, DOI 10.1212/WNL.42.2.278; CONNOLLY AM, 1994, ANN NEUROL, V35, P673, DOI 10.1002/ana.410350607; Daaboul Y, 1998, NEUROL RES, V20, P85; Doja A, 2006, J CHILD NEUROL, V21, P384, DOI 10.1177/08830738060210051101; GIERONKORTHALS MA, 1994, J CHILD NEUROL, V9, P381, DOI 10.1177/088307389400900408; Go T, 2003, ACTA PAEDIATR, V92, P504; Hausler M, 2002, J MED VIROL, V68, P253, DOI 10.1002/jmv.10201; HEATH RG, 1977, J NERV MENT DIS, V165, P300; Holmes G, 1939, BRAIN, V62, P1, DOI 10.1093/brain/62.1.1; ITO H, 1994, NEUROLOGY, V44, P1506, DOI 10.1212/WNL.44.8.1506; KLOCKGETHER T, 1993, J NEUROL, V240, P17, DOI 10.1007/BF00838440; Krienen FM, 2009, CEREB CORTEX, V19, P2485, DOI 10.1093/cercor/bhp135; LEINER HC, 1986, BEHAV NEUROSCI, V100, P443, DOI 10.1037/0735-7044.100.4.443; Levisohn L, 2000, BRAIN, V123, P1041, DOI 10.1093/brain/123.5.1041; Martinez-Gonzalez MJ, 2006, REV NEUROLOGIA, V42, P321, DOI 10.33588/rn.4206.2006075; Mesulam M., 2000, PRINCIPLES BEHAV COG; MIDDLETON FA, 1994, SCIENCE, V266, P458, DOI 10.1126/science.7939688; Nussinovitch M, 2003, CLIN PEDIATR, V42, P581, DOI 10.1177/000992280304200702; PEDNEAULT L, 1992, ANN NEUROL, V32, P184, DOI 10.1002/ana.410320210; PETERSON K, 1992, NEUROLOGY, V42, P1931, DOI 10.1212/wnl.42.10.1931; Schmahmann JD, 2009, NEUROSCIENCE, V162, P852, DOI 10.1016/j.neuroscience.2009.06.023; Schmahmann JD, 1997, INT REV NEUROBIOL, V41, P31, DOI 10.1016/S0074-7742(08)60346-3; Schmahmann JD, 2004, NEUROLOGY, V62, P1443, DOI 10.1212/01.WNL.0000120752.24980.B3; Schmahmann JD, 1998, BRAIN, V121, P561, DOI 10.1093/brain/121.4.561; Schmahmann JD, 2000, J NEUROLINGUIST, V13, P189, DOI 10.1016/S0911-6044(00)00011-7; SCHMAHMANN JD, 1991, ARCH NEUROL-CHICAGO, V48, P1178, DOI 10.1001/archneur.1991.00530230086029; Schmahmann JD, 2007, CEREBELLUM, V6, P254, DOI 10.1080/14734220701490995; Schmahmann JD, 2010, NEUROPSYCHOL REV, V20, P236, DOI 10.1007/s11065-010-9142-x; Schoch B, 2006, NEUROIMAGE, V30, P36, DOI 10.1016/j.neuroimage.2005.09.018; Stoodley CJ, 2010, BEHAV NEUROL, V23, P65, DOI [10.3233/BEN-2010-0268, 10.1155/2010/840942]; Strick PL, 2009, ANNU REV NEUROSCI, V32, P413, DOI 10.1146/annurev.neuro.31.060407.125606; Tedesco AM, 2011, BRAIN, V134, P3669, DOI 10.1093/brain/awr266; Uchibori A, 2005, NEUROLOGY, V65, P1114, DOI 10.1212/01.wnl.0000178802.38268.1e; Van Lierde A, 2004, EUR J PEDIATR, V163, P689, DOI 10.1007/s00431-004-1529-3; WEISS S, 1959, NEUROLOGY, V9, P711, DOI 10.1212/WNL.9.11.711	39	7	7	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 26	2013	369	13					1253	1261		10.1056/NEJMcpc1214218	http://dx.doi.org/10.1056/NEJMcpc1214218			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	224LT	24066747				2022-12-28	WOS:000324888200013
J	Niu, DW; Willoughby, PH; Woods, BP; Baire, B; Hoye, TR				Niu, Dawen; Willoughby, Patrick H.; Woods, Brian P.; Baire, Beeraiah; Hoye, Thomas R.			Alkane desaturation by concerted double hydrogen atom transfer to benzyne	NATURE			English	Article							DIELS-ALDER REACTION; CYCLOAROMATIZATION; INTERMEDIATE; GENERATION; ARYNES	The removal of two vicinal hydrogen atoms from an alkane to produce an alkene is a challenge for synthetic chemists(1,2). In nature, desaturases and acetylenases are adept at achieving this essential oxidative functionalization reaction, for example during the biosynthesis of unsaturated fatty acids(3), eicosanoids, gibberellins(4) and carotenoids(5). Alkane-to-alkene conversion almost always involves one or more chemical intermediates in a multistep reaction pathway; these may be either isolable species (such as alcohols or alkyl halides) or reactive intermediates (such as carbocations, alkyl radicals, or sigma-alkyl-metal species). Here we report a desaturation reaction of simple, unactivated alkanes that is mechanistically unique. We show that benzynes are capable of the concerted removal of two vicinal hydrogen atoms from a hydrocarbon. The discovery of this exothermic, net redox process was enabled by the simple thermal generation of reactive benzyne intermediates through the hexadehydro-Diels-Alder cycloisomerization reaction of triyne substrates(6). We are not aware of any single-step, bimolecular reaction in which two hydrogen atoms are simultaneously transferred from a saturated alkane. Computational studies indicate a preferred geometry with eclipsed vicinal C-H bonds in the alkane donor.	[Niu, Dawen; Willoughby, Patrick H.; Woods, Brian P.; Baire, Beeraiah; Hoye, Thomas R.] Univ Minnesota, Dept Chem, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Hoye, TR (corresponding author), Univ Minnesota, Dept Chem, 207 Pleasant St SE, Minneapolis, MN 55455 USA.	hoye@umn.edu	Niu, Dawen/M-4910-2013; Baire, Beeraiah/Q-1284-2019	Baire, Beeraiah/0000-0001-8810-1620; Niu, Dawen/0000-0002-5114-4413; Willoughby, Patrick/0000-0001-5163-0502	University of Minnesota Graduate School Doctoral Dissertation Fellowship; National Science Foundation Graduate Research Fellowship program; National Institute of General Medical Sciences [GM65597]; National Cancer Institute of the US Department of Health and Human Services [CA76497]; NATIONAL CANCER INSTITUTE [R01CA076497] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065597] Funding Source: NIH RePORTER	University of Minnesota Graduate School Doctoral Dissertation Fellowship(University of Minnesota System); National Science Foundation Graduate Research Fellowship program(National Science Foundation (NSF)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Cancer Institute of the US Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. J. Cramer for helpful discussions about the computational studies. D.N. and P. H. W. thank the University of Minnesota Graduate School Doctoral Dissertation Fellowship and National Science Foundation Graduate Research Fellowship program, respectively. Financial support from the National Institute of General Medical Sciences (GM65597) and the National Cancer Institute (CA76497) of the US Department of Health and Human Services is acknowledged. Portions of this work were performed with hardware and software resources available through the University of Minnesota Supercomputing Institute (MSI).	Ajaz A, 2011, J ORG CHEM, V76, P9320, DOI 10.1021/jo201567d; Baire B, 2013, NAT PROTOC, V8, P501, DOI 10.1038/nprot.2013.017; Bhattacharya A, 2012, PLANT PHYSIOL, V160, P837, DOI 10.1104/pp.112.201756; BLOOMFIELD DK, 1960, J BIOL CHEM, V235, P337; Bradley AZ, 1997, J AM CHEM SOC, V119, P9917, DOI 10.1021/ja972141f; Buist PH, 2004, NAT PROD REP, V21, P249, DOI 10.1039/b302094k; COREY EJ, 1961, J AM CHEM SOC, V83, P2957, DOI 10.1021/ja01474a043; Davies HML, 2011, CHEM SOC REV, V40, P1855, DOI 10.1039/c1cs90010b; de Almeida G, 2013, ORG LETT, V15, P3038, DOI 10.1021/ol401225n; Fernandez I, 2007, J ORG CHEM, V72, P1488, DOI 10.1021/jo062310r; Fernandez I, 2009, CHEM REV, V109, P6687, DOI 10.1021/cr900209c; HIMESHIMA Y, 1983, CHEM LETT, P1211, DOI 10.1246/cl.1983.1211; Hoffmann R. W., 2013, ANGEW CHEM INT EDIT, V52, P2; Hoffmann R. W., 1967, ORGANIC CHEM, V11; Hoye TR, 2012, NATURE, V490, P208, DOI 10.1038/nature11518; Hoye TR, 2004, ORG LETT, V6, P953, DOI 10.1021/ol049979+; Hunig S., 1961, TETRAHEDRON LETT, V2, P353; LINSTEAD RP, 1952, NATURE, V169, P100, DOI 10.1038/169100a0; Ma ZX, 2012, ORG LETT, V14, P2742, DOI 10.1021/ol300967a; Miyawaki K, 1997, TETRAHEDRON LETT, V38, P3943, DOI 10.1016/S0040-4039(97)00785-5; Moran NA, 2010, SCIENCE, V328, P624, DOI 10.1126/science.1187113; Pauli GF, 2007, J NAT PROD, V70, P589, DOI 10.1021/np060535r; Sumida Y, 2013, ORG LETT, V15, P2806, DOI 10.1021/ol401140d; Tadross PM, 2012, CHEM REV, V112, P3550, DOI 10.1021/cr200478h; Tsui JA, 2009, ORGANOMETALLICS, V28, P4906, DOI 10.1021/om900578d; Voica AF, 2012, NAT CHEM, V4, P629, DOI [10.1038/NCHEM.1385, 10.1038/nchem.1385]; Yun SY, 2013, J AM CHEM SOC, V135, P4668, DOI 10.1021/ja400477r	27	114	114	3	177	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 26	2013	501	7468					531	534		10.1038/nature12492	http://dx.doi.org/10.1038/nature12492			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223RP	24067712	Green Accepted			2022-12-28	WOS:000324826300054
J	Oullier, O				Oullier, Olivier			Behavioural insights are vital to policy-making	NATURE			English	Editorial Material									[Oullier, Olivier] Aix Marseille Univ, Marseilles, France	UDICE-French Research Universities; Aix-Marseille Universite	Oullier, O (corresponding author), Aix Marseille Univ, Marseilles, France.	olivier@oullier.fr							0	15	15	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 26	2013	501	7468					463	463		10.1038/501463a	http://dx.doi.org/10.1038/501463a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	223RP	24067675	Bronze			2022-12-28	WOS:000324826300021
J	Stuart-Smith, RD; Bates, AE; Lefcheck, JS; Duffy, JE; Baker, SC; Thomson, RJ; Stuart-Smith, JF; Hill, NA; Kininmonth, SJ; Airoldi, L; Becerro, MA; Campbell, SJ; Dawson, TP; Navarrete, SA; Soler, GA; Strain, EMA; Willis, TJ; Edgar, GJ				Stuart-Smith, Rick D.; Bates, Amanda E.; Lefcheck, Jonathan S.; Duffy, J. Emmett; Baker, Susan C.; Thomson, Russell J.; Stuart-Smith, Jemina F.; Hill, Nicole A.; Kininmonth, Stuart J.; Airoldi, Laura; Becerro, Mikel A.; Campbell, Stuart J.; Dawson, Terence P.; Navarrete, Sergio A.; Soler, German A.; Strain, Elisabeth M. A.; Willis, Trevor J.; Edgar, Graham J.			Integrating abundance and functional traits reveals new global hotspots of fish diversity	NATURE			English	Article							MARINE BIODIVERSITY; PATTERNS; BIOGEOGRAPHY; COMMUNITIES; CONSUMERS; EVENNESS; GRADIENT; ENTROPY; FORESTS	Species richness has dominated our view of global biodiversity patterns for centuries(1,2). The dominance of this paradigm is reflected in the focus by ecologists and conservation managers on richness and associated occurrence-based measures for understanding drivers of broad-scale diversity patterns and as a biological basis for management(3,4). However, this is changing rapidly, as it is now recognized that not only the number of species but the species present, their phenotypes and the number of individuals of each species are critical in determining the nature and strength of the relationships between species diversity and a range of ecological functions (such as biomass production and nutrient cycling)(5). Integrating these measures should provide a more relevant representation of global biodiversity patterns in terms of ecological functions than that provided by simple species counts. Here we provide comparisons of a traditional global biodiversity distribution measure based on richness with metrics that incorporate species abundances and functional traits. We use data from standardized quantitative surveys of 2,473 marine reef fish species at 1,844 sites, spanning 133 degrees of latitude from all ocean basins, to identify new diversity hotspots in some temperate regions and the tropical eastern Pacific Ocean. These relate to high diversity of functional traits amongst individuals in the community (calculated using Rao's Q(6)), and differ from previously reported patterns in functional diversity and richness for terrestrial animals, which emphasize species-rich tropical regions only(7,8). There is a global trend for greater evenness in the number of individuals of each species, across the reef fish species observed at sites ('community evenness'), at higher latitudes. This contributes to the distribution of functional diversity hotspots and contrasts with well-known latitudinal gradients in richness(2,4). Our findings suggest that the contribution of species diversity to a range of ecosystem functions varies over large scales, and imply that in tropical regions, which have higher numbers of species, each species contributes proportionally less to community-level ecological processes on average than species in temperate regions. Metrics of ecological function usefully complement metrics of species diversity in conservation management, including when identifying planning priorities and when tracking changes to biodiversity values.	[Stuart-Smith, Rick D.; Bates, Amanda E.; Thomson, Russell J.; Stuart-Smith, Jemina F.; Hill, Nicole A.; Soler, German A.; Edgar, Graham J.] Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas 7001, Australia; [Lefcheck, Jonathan S.; Duffy, J. Emmett] Virginia Inst Marine Sci, Dept Biol Sci, Gloucester Point, VA 23062 USA; [Baker, Susan C.] Univ Tasmania, Sch Plant Sci, Hobart, Tas 7001, Australia; [Kininmonth, Stuart J.] Stockholm Univ, Stockholm Resilience Ctr, SE-11419 Stockholm, Sweden; [Airoldi, Laura; Strain, Elisabeth M. A.] Univ Bologna, Dipartimento Sci Biol Geol & Ambientali, I-48123 Ravenna, Italy; [Airoldi, Laura] Stanford Univ, Hopkins Marine Stn, Pacific Grove, CA 93950 USA; [Becerro, Mikel A.] IPNA CSIC, Nat Prod & Agrobiol Inst, Tenerife 38206, Spain; [Campbell, Stuart J.] Wildlife Conservat Soc, Indonesia Marine Program, Bogor 16151, Jawa Barat, Indonesia; [Dawson, Terence P.] Univ Dundee, Sch Environm, Dundee DD1 4HN, Scotland; [Navarrete, Sergio A.] Pontificia Univ Catolica Chile, Estn Costera Invest Marinas, Santiago, Chile; [Navarrete, Sergio A.] Pontificia Univ Catolica Chile, Ctr Marine Conservat, Santiago, Chile; [Willis, Trevor J.] Univ Portsmouth, Inst Marine Sci, Sch Biol Sci, Portsmouth PO4 9LY, Hants, England	University of Tasmania; William & Mary; Virginia Institute of Marine Science; University of Tasmania; Stockholm University; University of Bologna; Stanford University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Productos Naturales y Agrobiologia (IPNA); Wildlife Conservation Society - Indonesia; University of Dundee; Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile; University of Portsmouth	Stuart-Smith, RD (corresponding author), Univ Tasmania, Inst Marine & Antarctic Studies, Private Bag 49, Hobart, Tas 7001, Australia.	rstuarts@utas.edu.au	Becerro, Mikel/ABC-9478-2021; Stuart-Smith, Rick/I-5214-2019; Duffy, J. Emmett/ABF-9200-2020; Lefcheck, Jonathan/H-8768-2019; Baker, Susan/O-8482-2019; Willis, Trevor/F-5337-2012; Edgar, Graham/C-8341-2013; Hill, Nicole/AAI-7323-2021; Dawson, Terence Peter/E-4724-2011; Thomson, Russell J/H-5653-2012; Stuart-Smith, Rick D/M-1829-2013; Strain, Elisabeth/U-3520-2017; Bates, Amanda E./ABD-6874-2021; Airoldi, Laura/I-3553-2019; Baker, Susan C/F-9307-2011; Hill, Nicole A/J-7856-2014; Edgar, Graham/AAY-3797-2020; Kininmonth, Stuart/N-9299-2013	Becerro, Mikel/0000-0002-6047-350X; Stuart-Smith, Rick/0000-0002-8874-0083; Duffy, J. Emmett/0000-0001-8595-6391; Lefcheck, Jonathan/0000-0002-8787-1786; Baker, Susan/0000-0002-7593-0267; Willis, Trevor/0000-0002-0357-1189; Edgar, Graham/0000-0003-0833-9001; Hill, Nicole/0000-0001-9329-6717; Dawson, Terence Peter/0000-0002-4314-1378; Thomson, Russell J/0000-0003-4949-4120; Stuart-Smith, Rick D/0000-0002-8874-0083; Strain, Elisabeth/0000-0003-2165-9544; Bates, Amanda E./0000-0002-0198-4537; Airoldi, Laura/0000-0001-5046-0871; Baker, Susan C/0000-0002-7593-0267; Hill, Nicole A/0000-0001-9329-6717; Edgar, Graham/0000-0003-0833-9001; Kininmonth, Stuart/0000-0001-9198-3396; Campbell, Stuart/0000-0002-1158-3200	Australian Government's National Environmental Research Program; National Geographic Society; Conservation International; Wildlife Conservation Society Indonesia; Winston Churchill Memorial Trust; ASSEMBLE Marine	Australian Government's National Environmental Research Program(Australian Government); National Geographic Society(National Geographic Society); Conservation International; Wildlife Conservation Society Indonesia; Winston Churchill Memorial Trust; ASSEMBLE Marine	We thank the many Reef Life Survey (RLS) divers who participated in data collection and provide ongoing expertize and commitment to the program, University of Tasmania staff including T. Cooper, M. Davey, N. Barrett, J. Berkhout and E. Oh, and T. Bird for assistance running models and checking code. Development of the RLS data set was supported by the former Commonwealth Environment Research Facilities Program, and analyses were supported by the Australian Research Council, Institute for Marine and Antarctic Studies, and the Marine Biodiversity Hub, a collaborative partnership supported through the Australian Government's National Environmental Research Program. Additional funding and support for field surveys was provided by grants from the National Geographic Society, Conservation International, Wildlife Conservation Society Indonesia, The Winston Churchill Memorial Trust, and ASSEMBLE Marine.	Allen GR, 2008, AQUAT CONSERV, V18, P541, DOI 10.1002/aqc.880; Botta-Dukat Z, 2005, J VEG SCI, V16, P533, DOI 10.1111/j.1654-1103.2005.tb02393.x; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Cadotte MW, 2011, J APPL ECOL, V48, P1067, DOI 10.1111/j.1365-2664.2011.02056.x; Devictor V, 2010, ECOL LETT, V13, P1030, DOI 10.1111/j.1461-0248.2010.01493.x; Duffy JE, 2013, BIOSCIENCE, V63, P350, DOI 10.1525/bio.2013.63.5.8; Duffy JE, 2009, FRONT ECOL ENVIRON, V7, P437, DOI 10.1890/070195; Edgar GJ, 2004, J EXP MAR BIOL ECOL, V308, P269, DOI 10.1016/j.jembe.2004.03.004; Edgar GJ, 2004, J BIOGEOGR, V31, P1107, DOI 10.1111/j.1365-2699.2004.01055.x; Edgar GJ, 2009, ECOL APPL, V19, P1967, DOI 10.1890/09-0610.1; Edgar GJ, 2009, MAR ECOL PROG SER, V388, P51, DOI 10.3354/meps08149; Ellis N, 2012, ECOLOGY, V93, P156, DOI 10.1890/11-0252.1; Fonseca CR, 2001, J ECOL, V89, P118, DOI 10.1046/j.1365-2745.2001.00528.x; Gamfeldt L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2328; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; Grime JP, 1998, J ECOL, V86, P902, DOI 10.1046/j.1365-2745.1998.00306.x; Hillebrand H, 2004, AM NAT, V163, P192, DOI 10.1086/381004; Jones JPG, 2011, CONSERV BIOL, V25, P450, DOI 10.1111/j.1523-1739.2010.01605.x; Jost L, 2006, OIKOS, V113, P363, DOI 10.1111/j.2006.0030-1299.14714.x; Karpievitch YV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007087; Laliberte E., 2011, FD MEASURING FUNCTIO; Laliberte E, 2010, ECOLOGY, V91, P299, DOI 10.1890/08-2244.1; Luck GW, 2009, BIOSCIENCE, V59, P223, DOI 10.1525/bio.2009.59.3.7; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Mora C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000606; MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.1093/biomet/37.1-2.17; Mouillot D, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001569; Mouillot D, 2013, TRENDS ECOL EVOL, V28, P167, DOI 10.1016/j.tree.2012.10.004; Pala C, 2013, SCIENCE, V339, P640, DOI 10.1126/science.339.6120.640; Roberts CM, 2002, SCIENCE, V295, P1280, DOI 10.1126/science.1067728; Rodrigues ASL, 2004, NATURE, V428, P640, DOI 10.1038/nature02422; Safi K, 2011, PHILOS T R SOC B, V366, P2536, DOI 10.1098/rstb.2011.0024; Silverman B.W., 1986, DENSITY ESTIMATION S, DOI 10.1201/9781315140919; Spalding MD, 2007, BIOSCIENCE, V57, P573, DOI 10.1641/B570707; Stevens RD, 2003, ECOL LETT, V6, P1099, DOI 10.1046/j.1461-0248.2003.00541.x; Strobl C, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-307; Tittensor DP, 2010, NATURE, V466, P1098, DOI 10.1038/nature09329; Tuomisto H, 2012, OIKOS, V121, P1203, DOI 10.1111/j.1600-0706.2011.19897.x; Tyberghein L, 2012, GLOBAL ECOL BIOGEOGR, V21, P272, DOI 10.1111/j.1466-8238.2011.00656.x; Wiens JJ, 2004, TRENDS ECOL EVOL, V19, P639, DOI 10.1016/j.tree.2004.09.011; Wittebolle L, 2009, NATURE, V458, P623, DOI 10.1038/nature07840; Wood LJ, 2008, ORYX, V42, P340, DOI 10.1017/S003060530800046X	42	354	364	30	479	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 26	2013	501	7468					539	+		10.1038/nature12529	http://dx.doi.org/10.1038/nature12529			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223RP	24067714	Green Submitted			2022-12-28	WOS:000324826300056
J	Furstner, A				Fuerstner, Alois			Teaching Metathesis "Simple" Stereochemistry	SCIENCE			English	Review							RING-CLOSING METATHESIS; OLEFIN-METATHESIS; ALKYLIDENE COMPLEXES; ALKYNE METATHESIS; Z-ALKENES; CATALYSTS; EFFICIENT; MOLYBDENUM; SELECTIVITY; BEARING	Applications of metal-catalyzed olefin metathesis reactions manifested dramatic growth during the late 20th and early 21st centuries, culminating in the 2005 Nobel Prize awarded to three of the pioneers. The standard catalysts developed during that time frame and their descendants have profoundly changed the mindset of the synthetic community, even though they do not provide a handle to control selectivity issues as fundamental as the E/Z geometry of the newly formed double bond. With yet another generation of catalysts in the making that are far superior in this regard, a new wave seems to be building up that is expected to have enormous impact, too. The current state of the art is critically assessed, as are possible alternatives such as the metathesis of triple bonds followed by stereoselective semi-reduction.	Max Planck Inst Kohlenforsch, D-45470 Mulheim, Germany	Max Planck Society	Furstner, A (corresponding author), Max Planck Inst Kohlenforsch, Kaiser Wilhelm Pl 1, D-45470 Mulheim, Germany.	fuerstner@kofo.mpg.de			Max-Planck-Gesellschaft; Fonds der Chemischen Industrie; SusChemSys (Ziel 2 Programm, NRW)	Max-Planck-Gesellschaft(Max Planck Society); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); SusChemSys (Ziel 2 Programm, NRW)	I acknowledge support from the Max-Planck-Gesellschaft, Fonds der Chemischen Industrie, and SusChemSys (Ziel 2 Programm, NRW).	Benson S, 2011, ANGEW CHEM INT EDIT, V50, P8739, DOI 10.1002/anie.201103270; Connon SJ, 2003, ANGEW CHEM INT EDIT, V42, P1900, DOI 10.1002/anie.200200556; Furstner A, 2007, J AM CHEM SOC, V129, P9150, DOI 10.1021/ja072334v; Furstner A, 2013, ANGEW CHEM INT EDIT, V52, P2794, DOI 10.1002/anie.201204513; Furstner A, 2011, CHEM COMMUN, V47, P6505, DOI 10.1039/c1cc10464k; Furstner A, 2002, J AM CHEM SOC, V124, P7061, DOI 10.1021/ja020238i; Furstner A, 2000, ANGEW CHEM INT EDIT, V39, P3012; Gagnepain J, 2011, CHEM-EUR J, V17, P6964, DOI 10.1002/chem.201100178; Gallenkamp D, 2011, J AM CHEM SOC, V133, P9232, DOI 10.1021/ja2031085; Gatti M, 2010, J AM CHEM SOC, V132, P15179, DOI 10.1021/ja108253f; Grubbs R. H., 2003, HDB METATHESIS, V1-3; Grubbs RH, 2006, ANGEW CHEM INT EDIT, V45, P3760, DOI 10.1002/anie.200600680; Haberlag B, 2012, ANGEW CHEM INT EDIT, V51, P13019, DOI 10.1002/anie.201207772; Heppekausen J, 2012, CHEM-EUR J, V18, P10281, DOI 10.1002/chem.201200621; Heppekausen J, 2011, ANGEW CHEM INT EDIT, V50, P7829, DOI 10.1002/anie.201102012; Heppekausen J, 2010, J AM CHEM SOC, V132, P11045, DOI 10.1021/ja104800w; Hoveyda AH, 2007, NATURE, V450, P243, DOI 10.1038/nature06351; Jakubec P, 2009, J AM CHEM SOC, V131, P16632, DOI 10.1021/ja908399s; Jiang AJ, 2009, J AM CHEM SOC, V131, P16630, DOI 10.1021/ja908098t; Keitz BK, 2011, J AM CHEM SOC, V133, P9686, DOI 10.1021/ja203488e; Khan RKM, 2013, J AM CHEM SOC, V135, P10258, DOI 10.1021/ja404208a; Kiesewetter ET, 2013, J AM CHEM SOC, V135, P6026, DOI 10.1021/ja403188t; Lee CW, 2000, ORG LETT, V2, P2145, DOI 10.1021/ol006059s; Liu P, 2012, J AM CHEM SOC, V134, P1464, DOI 10.1021/ja2108728; Marinescu SC, 2011, J AM CHEM SOC, V133, P11512, DOI 10.1021/ja205002v; Martin HJ, 2010, ANGEW CHEM INT EDIT, V49, P5614, DOI 10.1002/anie.201000227; Marx VM, 2013, J AM CHEM SOC, V135, P94, DOI 10.1021/ja311241q; Meek SJ, 2011, NATURE, V471, P461, DOI 10.1038/nature09957; Micoine K, 2013, CHEM-EUR J, V19, P7370, DOI 10.1002/chem.201300393; Micoine K, 2010, J AM CHEM SOC, V132, P14064, DOI 10.1021/ja107141p; Nicolaou KC, 2005, ANGEW CHEM INT EDIT, V44, P4490, DOI 10.1002/anie.200500369; Occhipinti G, 2013, J AM CHEM SOC, V135, P3331, DOI 10.1021/ja311505v; Persich P, 2013, CHEM-EUR J, V19, P13047, DOI 10.1002/chem.201302320; Radkowski K, 2013, ANGEW CHEM INT EDIT, V52, P355, DOI 10.1002/anie.201205946; Rosebrugh LE, 2013, J AM CHEM SOC, V135, P1276, DOI 10.1021/ja311916m; Samojlowicz C, 2009, CHEM REV, V109, P3708, DOI 10.1021/cr800524f; Schrock RR, 2006, ANGEW CHEM INT EDIT, V45, P3748, DOI 10.1002/anie.200600085; Schrock RR, 2003, ANGEW CHEM INT EDIT, V42, P4592, DOI 10.1002/anie.200300576; Trost BM, 2001, J AM CHEM SOC, V123, P12726, DOI 10.1021/ja0121033; Valot G, 2013, ANGEW CHEM INT EDIT, V52, P9534, DOI 10.1002/anie.201301700; Vougioukalakis GC, 2010, CHEM REV, V110, P1746, DOI 10.1021/cr9002424; Wagner J, 2000, J ORG CHEM, V65, P9255, DOI 10.1021/jo001296u; Wang CB, 2013, CHEM-EUR J, V19, P2726, DOI 10.1002/chem.201204045; Wang CB, 2013, ANGEW CHEM INT EDIT, V52, P1939, DOI 10.1002/anie.201209180; Wang YK, 2013, ORG LETT, V15, P1218, DOI 10.1021/ol400134d; Wang YK, 2011, J AM CHEM SOC, V133, P9196, DOI 10.1021/ja202012s; Wei XD, 2013, ORG LETT, V15, P1016, DOI 10.1021/ol303498m; Willwacher J, 2012, ANGEW CHEM INT EDIT, V51, P12041, DOI 10.1002/anie.201206670; Yu M, 2011, NATURE, V479, P88, DOI 10.1038/nature10563	49	147	149	3	146	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 20	2013	341	6152					1357	+	1229713	10.1126/science.1229713	http://dx.doi.org/10.1126/science.1229713			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	220PK	24052310				2022-12-28	WOS:000324597200035
J	Ye, LL; Lay, T; Kanamori, H; Koper, KD				Ye, Lingling; Lay, Thorne; Kanamori, Hiroo; Koper, Keith D.			Energy Release of the 2013 M-w 8.3 Sea of Okhotsk Earthquake and Deep Slab Stress Heterogeneity	SCIENCE			English	Article							BOLIVIAN EARTHQUAKE; JUNE 9; MECHANISM; RUPTURE	Earth's deepest earthquakes occur in subducting oceanic lithosphere, where temperatures are lower than in ambient mantle. On 24 May 2013, a magnitude 8.3 earthquake ruptured a 180-kilometer-long fault within the subducting Pacific plate about 609 kilometers below the Sea of Okhotsk. Global seismic P wave recordings indicate a radiated seismic energy of similar to 1.5 x 10(17) joules. A rupture velocity of similar to 4.0 to 4.5 kilometers/second is determined by back-projection of short-period P waves, and the fault width is constrained to give static stress drop estimates (similar to 12 to 15 megapascals) compatible with theoretical radiation efficiency for crack models. A nearby aftershock had a stress drop one to two orders of magnitude higher, indicating large stress heterogeneity in the deep slab, and plausibly within the rupture process of the great event.	[Ye, Lingling; Lay, Thorne] Univ Calif Santa Cruz, Dept Earth & Planetary Sci, Santa Cruz, CA 95064 USA; [Kanamori, Hiroo] CALTECH, Seismol Lab, Pasadena, CA 91125 USA; [Koper, Keith D.] Univ Utah, Dept Geol & Geophys, Salt Lake City, UT 84112 USA	University of California System; University of California Santa Cruz; California Institute of Technology; Utah System of Higher Education; University of Utah	Lay, T (corresponding author), Univ Calif Santa Cruz, Dept Earth & Planetary Sci, Santa Cruz, CA 95064 USA.	tlay@ucsc.edu	Lay, Thorne/ABE-6272-2021		NSF [EAR-1245717]; Directorate For Geosciences [1245717] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank E. Brodsky for helpful discussions and three anonymous reviewers for their thoughtful comments. The Incorporated Research Institutions for Seismology (IRIS) data management center provided the seismic recordings. This work was supported in part by NSF under grant EAR-1245717 (T.L.). All data used are available from the IRIS data center at www.iris.edu.	Allmann BP, 2009, J GEOPHYS RES-SOL EA, V114, DOI 10.1029/2008JB005821; Antolik M, 1996, GEOPHYS RES LETT, V23, P1589, DOI 10.1029/96GL00968; BECK SL, 1995, GEOPHYS RES LETT, V22, P2257, DOI 10.1029/95GL01089; CHEN WP, 1995, GEOPHYS RES LETT, V22, P2261, DOI 10.1029/95GL01805; CHUNG WY, 1980, PHYS EARTH PLANET IN, V23, P134, DOI 10.1016/0031-9201(80)90008-4; Convers JA, 2011, J GEOPHYS RES-SOL EA, V116, DOI 10.1029/2010JB007928; FOSSUM AF, 1975, J GEOPHYS RES, V80, P3343, DOI 10.1029/JB080i023p03343; Freund L. B., 1972, Journal of Elasticity, V2, P341, DOI 10.1007/BF00045718; GREEN HW, 1989, NATURE, V341, P733, DOI 10.1038/341733a0; GREEN HW, 1995, ANNU REV EARTH PL SC, V23, P169, DOI 10.1146/annurev.ea.23.050195.001125; Houston H, 1998, J GEOPHYS RES-SOL EA, V103, P29895, DOI 10.1029/98JB02135; Ihmle PF, 1998, J GEOPHYS RES-SOL EA, V103, P17919, DOI 10.1029/98JB00603; Kanamori H, 2004, REP PROG PHYS, V67, P1429, DOI 10.1088/0034-4885/67/8/R03; Kanamori H, 1998, SCIENCE, V279, P839, DOI 10.1126/science.279.5352.839; Kanamori H, 2006, GEOPHYS MONOGR SER, V170, P3, DOI 10.1029/170GM03; KIKUCHI M, 1994, GEOPHYS RES LETT, V21, P2341, DOI 10.1029/94GL02483; KOSTROV BV, 1966, PMM-J APPL MATH MEC+, V30, P1241; Lay T, 2009, J GEOPHYS RES-SOL EA, V114, DOI 10.1029/2008JB006280; Mott NF, 1948, MEC ENG, V165, P16; Newman AV, 1998, J GEOPHYS RES-SOL EA, V103, P26885, DOI 10.1029/98JB02236; Noda H, 2013, GEOPHYS J INT, V193, P1691, DOI 10.1093/gji/ggt074; Rivera L, 2005, GEOPHYS J INT, V162, P148, DOI 10.1111/j.1365-246X.2005.02643.x; SILVER PG, 1995, SCIENCE, V268, P69, DOI 10.1126/science.268.5207.69; Tibi R, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2002JB001948; Venkataraman A, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2003JB002548; WIENS DA, 1995, GEOPHYS RES LETT, V22, P2245, DOI 10.1029/95GL01598; Winslow NW, 1999, PHYS EARTH PLANET IN, V115, P181, DOI 10.1016/S0031-9201(99)00077-1; Wu LR, 2001, B SEISMOL SOC AM, V91, P102, DOI 10.1785/0120000081	28	76	82	0	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 20	2013	341	6152					1380	1384		10.1126/science.1242032	http://dx.doi.org/10.1126/science.1242032			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	220PK	24052306				2022-12-28	WOS:000324597200043
J	Trochsler, M; Maddern, GJ				Trochsler, Markus; Maddern, Guy J.			Adhesion barriers for abdominal surgery: a sticky problem	LANCET			English	Editorial Material							PERITONEAL ADHESIONS; PATHOGENESIS; PREVENTION		[Trochsler, Markus; Maddern, Guy J.] Univ Adelaide, Queen Elizabeth Hosp, Discipline Surg, Woodville, SA 5011, Australia	University of Adelaide	Maddern, GJ (corresponding author), Univ Adelaide, Queen Elizabeth Hosp, Discipline Surg, Woodville, SA 5011, Australia.	guy.maddern@adelaide.edu.au		Maddern, Guy/0000-0003-2064-181X				Ahmed G, 2008, COCHRANE DB SYST REV, V2; BUCKMAN RF, 1976, J SURG RES, V20, P1, DOI 10.1016/0022-4804(76)90075-5; Keus F, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-90; KUBANYI A, 1947, BRIT MED J, V2, P55, DOI 10.1136/bmj.2.4514.55-a; Kumar S, 2009, COCHRANE DB SYST REV, V1; Lauder CIW, 2010, DIGEST SURG, V27, P347, DOI 10.1159/000314805; Metwally M, 2008, COCHRANE DB SYST REV, V2; Parker MC, 2005, COLORECTAL DIS, V7, P551, DOI 10.1111/j.1463-1318.2005.00857.x; SCHADE DS, 1968, ANN SURG, V167, P500, DOI 10.1097/00000658-196804000-00006; Ten Broek RP, 2013, LANCET; Thompson J, 1998, DIGEST SURG, V15, P153, DOI 10.1159/000018610; Trew G, 2009, GYNECOL SURG, V6, P25, DOI 10.1007/s10397-008-0409-7; WEIBEL MA, 1973, AM J SURG, V126, P345, DOI 10.1016/S0002-9610(73)80123-0	13	11	14	0	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 4	2014	383	9911					8	10		10.1016/S0140-6736(13)62002-4	http://dx.doi.org/10.1016/S0140-6736(13)62002-4			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	284SP	24075278				2022-12-28	WOS:000329341200009
J	Crowley, RA; Tape, TG				Crowley, Ryan A.; Tape, Thomas G.			Health Policy Basics: Health Insurance Marketplaces	ANNALS OF INTERNAL MEDICINE			English	Article								Starting on 1 October 2013, most individuals and small businesses will be able to shop for and enroll in health insurance coverage through their state's health insurance marketplace, also known as an exchange. The health insurance marketplaces will serve as a one-stop resource to help the uninsured and the underinsured find comprehensive health coverage that fits their needs and budget and determine whether they qualify for health insurance tax credits provided by the Patient Protection and Affordable Care Act. Physicians may benefit because insured patients are more likely to have a regular source of care, adhere to medical regimens, and access preventive care. However, implementation of the marketplaces may prove challenging if enrollment numbers are insufficient, technical problems arise, and patients are unable to access providers. Despite these potential issues, physicians are encouraged to educate themselves about how the marketplaces work so they can direct their patients to find the coverage that best meets their medical needs.	[Crowley, Ryan A.; Tape, Thomas G.] Amer Coll Physicians, Philadelphia, PA 19106 USA	American College of Physicians	Crowley, RA (corresponding author), Amer Coll Physicians, Customer Serv, 190 N Independence Mall West, Philadelphia, PA 19106 USA.	custserv@acponline.org			American College of Physicians	American College of Physicians	Financial support for the development of this article comes exclusively from the American College of Physicians operating budget.	[Anonymous], 2013, 2013 POV GUID; Government Accountability Office, 2013, PAT PROT AFF CAR ACT; Hewitt Maria, 2012, FACILITATING STATE H; Holahan J, 2013, CROSS CUTTING ISSUES; Institute of Medicine Committee on Health Insurance Status and Its Consequences, 2009, AM UN CRIS CONS HLTH; Kaiser Family Foundation, 2013, HLTH INS COV TOT POP; Kaiser Family Foundation, 2013, KAIS HLTH TRACK POLL; Kaiser Family Foundation, 2013, STAT DEC CREAT HLTH; Loewenstein G, 2013, J HEALTH ECON, V32, P850, DOI 10.1016/j.jhealeco.2013.04.004; Robertson Ruth, 2013, INSURING FUTURE CURR	10	1	1	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 3	2013	159	11					784	+		10.7326/0003-4819-159-10-201311190-00724	http://dx.doi.org/10.7326/0003-4819-159-10-201311190-00724			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	276EN	24061932				2022-12-28	WOS:000328731000010
J	Kwon, Y; Vinayagam, A; Sun, XY; Dephoure, N; Gygi, SP; Hong, PY; Perrimon, N				Kwon, Young; Vinayagam, Arunachalam; Sun, Xiaoyun; Dephoure, Noah; Gygi, Steven P.; Hong, Pengyu; Perrimon, Norbert			The Hippo Signaling Pathway Interactome	SCIENCE			English	Article							TUMOR-SUPPRESSOR PATHWAY; AFFINITY PURIFICATION; DROSOPHILA; COMPLEXES; GROWTH; CANCER	The Hippo pathway controls metazoan organ growth by regulating cell proliferation and apoptosis. Many components have been identified, but our knowledge of the composition and structure of this pathway is still incomplete. Using existing pathway components as baits, we generated by mass spectrometry a high-confidence Drosophila Hippo protein-protein interaction network (Hippo-PPIN) consisting of 153 proteins and 204 interactions. Depletion of 67% of the proteins by RNA interference regulated the transcriptional coactivator Yorkie (Yki) either positively or negatively. We selected for further characterization a new member of the alpha-arrestin family, Leash, and show that it promotes degradation of Yki through the lysosomal pathway. Given the importance of the Hippo pathway in tumor development, the Hippo-PPIN will contribute to our understanding of this network in both normal growth and cancer.	[Kwon, Young; Vinayagam, Arunachalam; Perrimon, Norbert] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Perrimon, Norbert] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; [Sun, Xiaoyun; Hong, Pengyu] Brandeis Univ, Dept Comp Sci, Volen Ctr Complex Syst, Waltham, MA 02454 USA; [Dephoure, Noah; Gygi, Steven P.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Brandeis University; Harvard University; Harvard Medical School	Perrimon, N (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	perrimon@receptor.med.harvard.edu	Dephoure, Noah/N-7818-2014; Kwon, Young/AHC-8026-2022; Hong, Pengyu/AAE-6736-2020	Dephoure, Noah/0000-0001-5802-2657; Hong, Pengyu/0000-0002-3177-2754; arunachalam, vinayagam/0000-0003-0091-4497; Perrimon, Norbert/0000-0001-7542-472X; Kwon, Young/0000-0002-8937-3182	Damon Runyon Cancer Research Foundation;  [R01-DK088718];  [P01-CA120964]; NATIONAL CANCER INSTITUTE [P01CA120964] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088718] Funding Source: NIH RePORTER	Damon Runyon Cancer Research Foundation; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank the Transgenic RNAi Project, Drosophila RNAi Screening Center, and Bloomington Stock Center for fly stocks and reagents; C. Villata, E. Heffern, and R. Binari for technical support; L. Sansores-Garcia and G. Halder for help with the Yki-reporter assay; S. Blair and K. Irvine for reagents; and P. Karpowicz and R. Sopko for comments. Y.K. was supported by the Damon Runyon Cancer Research Foundation. This work was supported by R01-DK088718 and P01-CA120964 to N.P. N.P. is an Investigator of the Howard Hughes Medical Institute. AP/MS data are presented in the supplementary materials. RNAi screen data are available at Drosophila RNAi Screening Center.	Cho E, 2006, NAT GENET, V38, P1142, DOI 10.1038/ng1887; Choi H, 2011, NAT METHODS, V8, P70, DOI 10.1038/NMETH.1541; Draheim KM, 2010, ONCOGENE, V29, P5032, DOI 10.1038/onc.2010.250; Friedman AA, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002029; Halder G, 2012, NAT REV MOL CELL BIO, V13, P591, DOI 10.1038/nrm3416; Halder G, 2011, DEVELOPMENT, V138, P9, DOI 10.1242/dev.045500; Karpowicz P, 2010, DEVELOPMENT, V137, P4135, DOI 10.1242/dev.060483; Kyriakakis P, 2008, FLY, V2, P229, DOI 10.4161/fly.6669; Mao YL, 2011, GENE DEV, V25, P131, DOI 10.1101/gad.610511; Oh H, 2013, CELL REP, V3, P309, DOI 10.1016/j.celrep.2013.01.008; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Ren FF, 2010, P NATL ACAD SCI USA, V107, P21064, DOI 10.1073/pnas.1012759107; Ribeiro PS, 2010, MOL CELL, V39, P521, DOI 10.1016/j.molcel.2010.08.002; Rock JM, 2013, SCIENCE, V340, P871, DOI 10.1126/science.1235822; Sansores-Garcia L, 2011, EMBO J, V30, P2325, DOI 10.1038/emboj.2011.157; Staley BK, 2012, DEV DYNAM, V241, P3, DOI 10.1002/dvdy.22723; Tofaris GK, 2011, P NATL ACAD SCI USA, V108, P17004, DOI 10.1073/pnas.1109356108; Vinayagam A, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003629; Wehr MC, 2013, NAT CELL BIOL, V15, P61, DOI 10.1038/ncb2658; Yu FX, 2013, GENE DEV, V27, P355, DOI 10.1101/gad.210773.112	20	124	126	2	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 8	2013	342	6159					737	740		10.1126/science.1243971	http://dx.doi.org/10.1126/science.1243971			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247UK	24114784	Green Accepted			2022-12-28	WOS:000326647600043
J	Ferrero, DM; Moeller, LM; Osakada, T; Horio, N; Li, Q; Roy, DS; Cichy, A; Spehr, M; Touhara, K; Liberles, SD				Ferrero, David M.; Moeller, Lisa M.; Osakada, Takuya; Horio, Nao; Li, Qian; Roy, Dheeraj S.; Cichy, Annika; Spehr, Marc; Touhara, Kazushige; Liberles, Stephen D.			A juvenile mouse pheromone inhibits sexual behaviour through the vomeronasal system	NATURE			English	Article							CHEMOSENSORY RECEPTORS; OLFACTORY EPITHELIUM; AGGRESSIVE-BEHAVIOR; PROTEIN PHEROMONES; MUTANT MICE; NEURONS; ORGAN; PEPTIDES; HYPOTHALAMUS; EXPRESSION	Animals display a repertoire of different social behaviours. Appropriate behavioural responses depend on sensory input received during social interactions. In mice, social behaviour is driven by pheromones, chemical signals that encode information related to age, sex and physiological state(1). However, although mice show different social behaviours towards adults, juveniles and neonates, sensory cues that enable specific recognition of juvenile mice are unknown. Here we describe a juvenile pheromone produced by young mice before puberty, termed exocrine-gland secreting peptide 22 (ESP22). ESP22 is secreted from the lacrimal gland and released into tears of 2- to 3-week-old mice. Upon detection, ESP22 activates high-affinity sensory neurons in the vomeronasal organ, and down-stream limbic neurons in the medial amygdala. Recombinant ESP22, painted on mice, exerts a powerful inhibitory effect on adult male mating behaviour, which is abolished in knockout mice lacking TRPC2, a key signalling component of the vomeronasal organ(2,3). Furthermore, knockout of TRPC2 or loss of ESP22 production results in increased sexual behaviour of adult males towards juveniles, and sexual responses towards ESP22-deficient juveniles are suppressed by ESP22 painting. Thus, we describe a pheromone of sexually immature mice that controls an innate social behaviour, a response pathway through the accessory olfactory system and a new role for vomeronasal organ signalling in inhibiting sexual behaviour towards young. These findings provide a molecular framework for understanding how a sensory system can regulate behaviour.	[Ferrero, David M.; Li, Qian; Roy, Dheeraj S.; Liberles, Stephen D.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Moeller, Lisa M.; Cichy, Annika; Spehr, Marc] Rhein Westfal TH Aachen, Dept Chemosensat, Inst Biol 2, Aachen, Germany; [Osakada, Takuya; Horio, Nao; Touhara, Kazushige] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Tokyo 1138657, Japan; [Touhara, Kazushige] Univ Tokyo, Japan Sci & Technol Agcy, ERATO Touhara Chemosensory Signal Project, Tokyo 1138657, Japan	Harvard University; Harvard Medical School; RWTH Aachen University; University of Tokyo; Japan Science & Technology Agency (JST); University of Tokyo	Liberles, SD (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.	Stephen_Liberles@hms.harvard.edu	Li, Qian/AAE-8688-2022; Spehr, Marc/AAK-3162-2021; Osakada, Takuya/GLV-1245-2022; Spehr, Marc/B-3140-2011; Li, Qian/P-4417-2015	Li, Qian/0000-0003-1300-3377; Spehr, Marc/0000-0001-6616-4196; Spehr, Marc/0000-0001-6616-4196; Li, Qian/0000-0003-1300-3377; Osakada, Takuya/0000-0003-3752-6594; Cichy, Annika/0000-0002-4620-7854; Liberles, Stephen/0000-0002-2177-9741	National Institutes of Health [R01 DC010155]; Japan Society for the Promotion of Science; ERATO Touhara Chemosensory Signal Project from the Japan Science and Technology Agency; Boehringer Ingelheim Fonds PhD Fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC010155] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); ERATO Touhara Chemosensory Signal Project from the Japan Science and Technology Agency; Boehringer Ingelheim Fonds PhD Fellowship(Boehringer Ingelheim); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank M. Albers and S. R. Datta for reading the manuscript, J. Yang, C. Mark Fletcher and Y. Tachie-Baffour for experimental assistance, and the Taplin Mass Spectrometry Facility for mass spectrometry analysis. This work was supported by a grant from the National Institutes of Health (to S.D.L., award number R01 DC010155) and in part by a Grant-in-Aid for Young Scientists (S) from the Japan Society for the Promotion of Science, and by ERATO Touhara Chemosensory Signal Project from the Japan Science and Technology Agency (to K.T.). N.H. is supported by a Grant-in-Aid for JSPS Fellows, M.S. is a Lichtenberg-Professor of the Volkswagen Foundation and D.M.F. is supported by a Boehringer Ingelheim Fonds PhD Fellowship.	Chamero P, 2007, NATURE, V450, P899, DOI 10.1038/nature05997; Chamero P, 2011, P NATL ACAD SCI USA, V108, P12898, DOI 10.1073/pnas.1107770108; Choi GB, 2005, NEURON, V46, P647, DOI 10.1016/j.neuron.2005.04.011; Dulac C, 2006, ANNU REV GENET, V40, P449, DOI 10.1146/annurev.genet.39.073003.093937; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Ferrero DM, 2010, WIRES SYST BIOL MED, V2, P23, DOI 10.1002/wsbm.39; Franklin K.B.J., 2008, MOUSE BRAIN STEREOTA; Haga S, 2010, NATURE, V466, P118, DOI 10.1038/nature09142; Hagendorf S, 2009, J NEUROSCI, V29, P206, DOI 10.1523/JNEUROSCI.3656-08.2009; He J, 2010, J NEUROSCI, V30, P7473, DOI 10.1523/JNEUROSCI.0825-10.2010; Karn RC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047697; Kimoto H, 2005, NATURE, V437, P898, DOI 10.1038/nature04033; Kimoto H, 2007, CURR BIOL, V17, P1879, DOI 10.1016/j.cub.2007.09.042; Leypold BG, 2002, P NATL ACAD SCI USA, V99, P6376, DOI 10.1073/pnas.082127599; Li Q, 2013, CURR BIOL, V23, P11, DOI 10.1016/j.cub.2012.10.047; Liberles SD, 2006, NATURE, V442, P645, DOI 10.1038/nature05066; Liberles SD, 2009, P NATL ACAD SCI USA, V106, P9842, DOI 10.1073/pnas.0904464106; Logan DW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003280; Mandiyan VS, 2005, NAT NEUROSCI, V8, P1660, DOI 10.1038/nn1589; Montmayeur JP, 2001, NAT NEUROSCI, V4, P492, DOI 10.1038/87440; Nodari F, 2008, J NEUROSCI, V28, P6407, DOI 10.1523/JNEUROSCI.1425-08.2008; NOVOTNY M, 1985, P NATL ACAD SCI USA, V82, P2059, DOI 10.1073/pnas.82.7.2059; Novotny MV, 2003, BIOCHEM SOC T, V31, P117, DOI 10.1042/BST0310117; Papes F, 2010, CELL, V141, P692, DOI 10.1016/j.cell.2010.03.037; Peng JM, 2001, J MASS SPECTROM, V36, P1083, DOI 10.1002/jms.229; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Spehr J, 2009, J NEUROSCI, V29, P2125, DOI 10.1523/JNEUROSCI.5416-08.2009; Stowers L, 2002, SCIENCE, V295, P1493, DOI 10.1126/science.1069259; Tirindelli R, 2009, PHYSIOL REV, V89, P921, DOI 10.1152/physrev.00037.2008; Touhara K, 2008, CURR OPIN PHARMACOL, V8, P759, DOI 10.1016/j.coph.2008.09.001; Wang ZS, 2006, J NEUROSCI, V26, P7375, DOI 10.1523/JNEUROSCI.1967-06.2006; Yang CF, 2013, CELL, V153, P896, DOI 10.1016/j.cell.2013.04.017	32	109	117	0	96	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 17	2013	502	7471					368	+		10.1038/nature12579	http://dx.doi.org/10.1038/nature12579			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235GY	24089208	Green Accepted, Green Submitted			2022-12-28	WOS:000325706300052
J	Marmot, M				Marmot, Michael			Universal health coverage and social determinants of health	LANCET			English	Editorial Material									[Marmot, Michael] UCL, UCL Inst Hlth Equ, London WC1E 7HB, England; [Marmot, Michael] UCL, Dept Epidemiol & Publ Hlth, London WC1E 7HB, England	University of London; University College London; University of London; University College London	Marmot, M (corresponding author), UCL, UCL Inst Hlth Equ, London WC1E 7HB, England.	m.marmot@ucl.ac.uk	Marmot, M G/Y-3920-2019	Marmot, M G/0000-0002-2431-6419	ESRC [ES/F02679X/1] Funding Source: UKRI; MRC [G0902037, G1000616, G0701830, G0601647] Funding Source: UKRI; Economic and Social Research Council [ES/F02679X/1] Funding Source: researchfish; British Heart Foundation [RG/07/008/23674] Funding Source: Medline; Medical Research Council [G19/35, G0601647, G0902037, G0701830, G0100222, G8802774, G1000616] Funding Source: Medline	ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Allen M, 2013, WORKING FOR HEALTH E; Bloomer E, 2013, THE IMPACT OF THE EC; Stuckler David, 2013, THE BODY ECONOMIC WH; United Nations General Assembly, 2012, GLOBAL HEALTH AND FO; WHO, 2013, WHO WORLD BANK CONVE; WHO, 2012, WHAT IS UNIVERSAL HE; World Health Organisation, 1978, INTERNATIONAL CONFER; World Health Organization, 2012, UNIVERSAL HEALTH COV; World Health Organization, 2008, FINAL REPORT OF THE	9	49	52	0	19	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 12	2013	382	9900					1227	1228		10.1016/S0140-6736(13)61791-2	http://dx.doi.org/10.1016/S0140-6736(13)61791-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	235XP	24120189				2022-12-28	WOS:000325756400006
J	Aubert, J; Finlay, CC; Fournier, A				Aubert, Julien; Finlay, Christopher C.; Fournier, Alexandre			Bottom-up control of geomagnetic secular variation by the Earth's inner core	NATURE			English	Article							MAGNETIC-FIELD; ROTATION; SURFACE; MODELS; STRATIFICATION; EVOLUTION; STEADY; GROWTH; FLOW	Temporal changes in the Earth's magnetic field, known as geomagnetic secular variation, occur most prominently at low latitudes in the Atlantic hemisphere(1,2) (that is, from 290 degrees east to 90 degrees east), whereas in the Pacific hemisphere there is comparatively little activity. This is a consequence of the geographical localization of intense, westward drifting, equatorial magnetic flux patches at the core surface(3). Despite successes in explaining the morphology of the geomagnetic field(4), numerical models of the geodynamo have so far failed to account systematically for this striking pattern of geomagnetic secular variation. Here we show that it can be reproduced provided that two mechanisms relying on the inner core are jointly considered. First, gravitational coupling(5) aligns the inner core with the mantle, forcing the flow of liquid metal in the outer core into a giant, westward drifting, sheet-like gyre(6). The resulting shear concentrates azimuthal magnetic flux at low latitudes close to the core-mantle boundary, where it is expelled by core convection and subsequently transported westward. Second, differential inner-core growth(7,8), fastest below Indonesia(6,9), causes an asymmetric buoyancy release in the outer core which in turn distorts the gyre, forcing it to become eccentric, in agreement with recent core flow inversions(6,10,11). This bottom-up heterogeneous driving of core convection dominates top-down driving from mantle thermal heterogeneities, and localizes magnetic variations in a longitudinal sector centred beneath the Atlantic, where the eccentric gyre reaches the core surface. To match the observed pattern of geomagnetic secular variation, the solid material forming the inner core must now be in a state of differential growth rather than one of growth and melting induced by convective translation(7,8).	[Aubert, Julien; Fournier, Alexandre] Univ Paris Diderot, Inst Phys Globe Paris, Sorbonne Paris Cite, UMR 7154,CNRS, F-75005 Paris, France; [Finlay, Christopher C.] Tech Univ Denmark, Natl Space Inst, Div Geomagnetism, DK-2800 Lyngby, Denmark	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universite Paris Cite; Technical University of Denmark	Aubert, J (corresponding author), Univ Paris Diderot, Inst Phys Globe Paris, Sorbonne Paris Cite, UMR 7154,CNRS, F-75005 Paris, France.	aubert@ipgp.fr	Aubert, Julien/A-5616-2011; Fournier, Alexandre/A-5774-2011; Finlay, Christopher C/B-5062-2014	Aubert, Julien/0000-0002-2756-0724; Fournier, Alexandre/0000-0003-3276-0496; Finlay, Christopher C/0000-0002-4592-2290	French Agence Nationale de la Recherche [ANR-2011-BS56-011]; GENCI-IDRIS [2012-042122, 2013-042122]	French Agence Nationale de la Recherche(French National Research Agency (ANR)); GENCI-IDRIS	This work was supported by the French Agence Nationale de la Recherche (grant ANR-2011-BS56-011). Numerical computations were performed at S-CAPAD, IPGP, France, and using HPC resources from GENCI-IDRIS (grants 2012-042122 and at 2013-042122). This is IPGP contribution 3419.	Ahrens T.J., 1995, GLOBAL EARTH PHYS HD, V1; Alboussiere T, 2010, NATURE, V466, P744, DOI 10.1038/nature09257; Aubert J, 2008, NATURE, V454, P758, DOI 10.1038/nature07109; Aubert J, 2013, GEOPHYS J INT, V192, P537, DOI 10.1093/gji/ggs051; Aubert J, 2011, GEOPHYS J INT, V184, P162, DOI 10.1111/j.1365-246X.2010.04842.x; Aubert J, 2009, GEOPHYS J INT, V179, P1414, DOI 10.1111/j.1365-246X.2009.04361.x; Buffett BA, 1996, GEOPHYS RES LETT, V23, P2279, DOI 10.1029/96GL02083; Buffett BA, 2000, GEOPHYS RES LETT, V27, P3125, DOI 10.1029/2000GL011705; Christensen UR, 2006, GEOPHYS J INT, V166, P97, DOI 10.1111/j.1365-246X.2006.03009.x; Christensen U. R., 2007, TREATISE GEOPHYS, V8; Christensen UR, 2010, EARTH PLANET SC LETT, V296, P487, DOI 10.1016/j.epsl.2010.06.009; Christensen UR, 2003, PHYS EARTH PLANET IN, V138, P39, DOI 10.1016/S0031-9201(03)00064-5; Davies CJ, 2013, PHYS EARTH PLANET IN, V214, P104, DOI 10.1016/j.pepi.2012.10.001; Dumberry M, 2007, GEOPHYS J INT, V170, P886, DOI 10.1111/j.1365-246X.2007.03484.x; Finlay CC, 2012, GEOPHYS J INT, V189, P761, DOI 10.1111/j.1365-246X.2012.05395.x; Finlay CC, 2003, SCIENCE, V300, P2084, DOI 10.1126/science.1083324; Fournier A, 2010, SPACE SCI REV, V155, P247, DOI 10.1007/s11214-010-9669-4; Gillet N, 2009, GEOCHEM GEOPHY GEOSY, V10, DOI 10.1029/2008GC002290; Glatzmaier GA, 1996, SCIENCE, V274, P1887, DOI 10.1126/science.274.5294.1887; Gubbins D, 2013, PHYS EARTH PLANET IN, V215, P21, DOI 10.1016/j.pepi.2012.11.001; Gubbins D, 2011, NATURE, V473, P361, DOI 10.1038/nature10068; Helffrich G, 2010, NATURE, V468, P807, DOI 10.1038/nature09636; Holme R, 2011, GEOPHYS J INT, V186, P521, DOI 10.1111/j.1365-246X.2011.05066.x; Jackson A, 2000, PHILOS T ROY SOC A, V358, P957, DOI 10.1098/rsta.2000.0569; Kuang WL, 1997, NATURE, V389, P371, DOI 10.1038/38712; Lesur V, 2010, EARTH PLANETS SPACE, V62, P765, DOI 10.5047/eps.2010.07.007; Lhuillier F, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047356; Masters G., 2000, EARTHS DEEP INTERIOR, V117, P63, DOI DOI 10.1029/GM117P0063; Miyagoshi T, 2010, NATURE, V463, P793, DOI 10.1038/nature08754; Monnereau M, 2010, SCIENCE, V328, P1014, DOI 10.1126/science.1186212; Olsen N, 2010, EARTH PLANETS SPACE, V62, P719, DOI 10.5047/eps.2010.07.003; Olson P, 2012, NAT GEOSCI, V5, P565, DOI [10.1038/NGEO1506, 10.1038/ngeo1506]; Pais MA, 2008, GEOPHYS J INT, V173, P421, DOI 10.1111/j.1365-246X.2008.03741.x; Sabaka TJ, 2004, GEOPHYS J INT, V159, P521, DOI 10.1111/j.1365-246X.2004.02421.x; Sakuraba A, 2009, NAT GEOSCI, V2, P802, DOI 10.1038/NGEO643	35	134	134	1	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 10	2013	502	7470					219	+		10.1038/nature12574	http://dx.doi.org/10.1038/nature12574			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RU	24108054	Green Submitted			2022-12-28	WOS:000325436100047
J	Delmas, P; Coste, B				Delmas, Patrick; Coste, Bertrand			Mechano-Gated Ion Channels in Sensory Systems	CELL			English	Review							TOUCH RECEPTOR NEURONS; OF-FUNCTION MUTATIONS; TRP CHANNELS; HAIR-CELLS; C. ELEGANS; MECHANOTRANSDUCTION CHANNEL; MECHANOSENSITIVE CURRENTS; MOLECULAR-MECHANISMS; INNER-EAR; DROSOPHILA	Living organisms sense their physical environment through cellular mechanotransduction, which converts mechanical forces into electrical and biochemical signals. In turn, signal transduction serves a wide variety of functions, from basic cellular processes as diverse as proliferation, differentiation, migration, and apoptosis up to some of the most sophisticated senses, including touch and hearing. Accordingly, defects in mechanosensing potentially lead to diverse diseases and disorders such as hearing loss, cardiomyopathies, muscular dystrophies, chronic pain, and cancer. Here, we review the status of mechanically activated ion channel discovery and discuss current challenges to define their properties and physiological functions.	[Delmas, Patrick; Coste, Bertrand] Aix Marseille Univ, CNRS, Ctr Rech Neurobiol & Neurophysiol Marseille, UMR 7286,CS80011, F-13344 Marseille 15, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Delmas, P (corresponding author), Aix Marseille Univ, CNRS, Ctr Rech Neurobiol & Neurophysiol Marseille, UMR 7286,CS80011, Bd Pierre Dramard, F-13344 Marseille 15, France.	patrick.delmas@univ-amu.fr		Coste, Bertrand/0000-0002-0163-2494	CNRS; Agence Nationale de la Recherche [ANR-08-MNPS-025-02, ANR-08-GENO-027-02, ANR-09-MNPS-037-01, ANR-12-PDOC-0005-01]; Fondation pour la Recherche Medicale [DEQ20130326482]	CNRS(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche(French National Research Agency (ANR)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	We apologize to authors whose work could not be cited due to space limitations. Work in our laboratory is supported by grants from the CNRS, Agence Nationale de la Recherche (ANR-08-MNPS-025-02, ANR-08-GENO-027-02, ANR-09-MNPS-037-01, and ANR-12-PDOC-0005-01), and the Fondation pour la Recherche Medicale (Equipes FRM 2013 DEQ20130326482).	Albuisson J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2899; Andolfo I, 2013, BLOOD, V121, P3925, DOI 10.1182/blood-2013-02-482489; Anishkin A, 2013, P NATL ACAD SCI USA, V110, P4886, DOI 10.1073/pnas.1302018110; Arnadottir J, 2011, J NEUROSCI, V31, P12695, DOI 10.1523/JNEUROSCI.4580-10.2011; Arnadottir J, 2010, ANNU REV BIOPHYS, V39, P111, DOI 10.1146/annurev.biophys.37.032807.125836; Bae C, 2013, P NATL ACAD SCI USA, V110, pE1162, DOI 10.1073/pnas.1219777110; Beurg M, 2009, NAT NEUROSCI, V12, P553, DOI 10.1038/nn.2295; Chatzigeorgiou M, 2013, NATURE, V494, P95, DOI 10.1038/nature11845; Chatzigeorgiou M, 2010, NAT NEUROSCI, V13, P861, DOI 10.1038/nn.2581; Cheng LE, 2010, NEURON, V67, P373, DOI 10.1016/j.neuron.2010.07.004; Christensen AP, 2007, NAT REV NEUROSCI, V8, P510, DOI 10.1038/nrn2149; COREY DP, 1979, NATURE, V281, P675, DOI 10.1038/281675a0; Coste B, 2013, P NATL ACAD SCI USA, V110, P4667, DOI 10.1073/pnas.1221400110; Coste B, 2010, SCIENCE, V330, P55, DOI 10.1126/science.1193270; Delmas P, 2011, NAT REV NEUROSCI, V12, P139, DOI 10.1038/nrn2993; Dubin AE, 2012, CELL REP, V2, P511, DOI 10.1016/j.celrep.2012.07.014; Effertz T, 2012, NAT NEUROSCI, V15, P1198, DOI 10.1038/nn.3175; Effertz T, 2011, CURR BIOL, V21, P592, DOI 10.1016/j.cub.2011.02.048; Eijkelkamp N, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2673; Geffeney SL, 2011, NEURON, V71, P845, DOI 10.1016/j.neuron.2011.06.038; Gopfert MC, 2006, NAT NEUROSCI, V9, P999, DOI 10.1038/nn1735; Hao JZ, 2013, NEURON, V77, P899, DOI 10.1016/j.neuron.2012.12.035; Hao JZ, 2010, J NEUROSCI, V30, P13384, DOI 10.1523/JNEUROSCI.2926-10.2010; Hu J, 2006, J PHYSIOL-LONDON, V577, P815, DOI 10.1113/jphysiol.2006.117648; Kamikouchi A, 2009, NATURE, V458, P165, DOI 10.1038/nature07810; Kang LJ, 2010, NEURON, V67, P381, DOI 10.1016/j.neuron.2010.06.032; Kawashima Y, 2011, J CLIN INVEST, V121, P4796, DOI 10.1172/JCI60405; Kazmierczak P, 2012, TRENDS NEUROSCI, V35, P220, DOI 10.1016/j.tins.2011.10.007; Kim KX, 2013, J GEN PHYSIOL, V141, P141, DOI 10.1085/jgp.201210913; Kim SE, 2012, NATURE, V483, P209, DOI 10.1038/nature10801; Kung C, 2005, NATURE, V436, P647, DOI 10.1038/nature03896; Labay V, 2010, BIOCHEMISTRY-US, V49, P8592, DOI 10.1021/bi1004377; Lehnert BP, 2013, NEURON, V77, P115, DOI 10.1016/j.neuron.2012.11.030; Liang X, 2013, CURR BIOL, V23, P755, DOI 10.1016/j.cub.2013.03.065; Matthews BD, 2010, INTEGR BIOL-UK, V2, P435, DOI 10.1039/c0ib00034e; McHugh BJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040346; McHugh BJ, 2010, J CELL SCI, V123, P51, DOI 10.1242/jcs.056424; Morris CE, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00025; O'Hagan R, 2005, NAT NEUROSCI, V8, P43, DOI 10.1038/nn1362; Pan BF, 2013, NEURON, V79, P504, DOI 10.1016/j.neuron.2013.06.019; Peng AW, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1533; Rugiero F, 2010, J PHYSIOL-LONDON, V588, P301, DOI 10.1113/jphysiol.2009.182360; Xiong W, 2012, CELL, V151, P1283, DOI 10.1016/j.cell.2012.10.041; Yan ZQ, 2013, NATURE, V493, P221, DOI 10.1038/nature11685; Zarychanski R, 2012, BLOOD, V120, P1908, DOI 10.1182/blood-2012-04-422253; Zhong LX, 2010, CURR BIOL, V20, P429, DOI 10.1016/j.cub.2009.12.057	46	104	105	2	106	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 10	2013	155	2					278	284		10.1016/j.cell.2013.09.026	http://dx.doi.org/10.1016/j.cell.2013.09.026			7	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	235LH	24120130	Bronze			2022-12-28	WOS:000325719800006
J	Frank, DA; de Cuba, SE; Sandel, M; Black, MM				Frank, Deborah A.; de Cuba, Stephanie Ettinger; Sandel, Megan; Black, Maureen M.			SNAP cuts will harm children in the USA	LANCET			English	Editorial Material							STAMP-PROGRAM PARTICIPATION; HEALTH OUTCOMES; FOOD		[Frank, Deborah A.] Boston Med Ctr, Dept Pediat, Div Growth & Dev, Boston, MA 02118 USA; [de Cuba, Stephanie Ettinger] Boston Univ, Sch Publ Hlth, Data Coordinating Ctr, Boston, MA USA; [Black, Maureen M.] Univ Maryland, Sch Med, Dept Pediat, Growth & Nutr Div, Baltimore, MD 21201 USA	Boston Medical Center; Boston University; University System of Maryland; University of Maryland Baltimore	Frank, DA (corresponding author), Boston Med Ctr, Dept Pediat, Div Growth & Dev, Boston, MA 02118 USA.	dafrank@bu.edu		Ettinger de Cuba, Stephanie/0000-0003-1789-1009; Black, Maureen/0000-0002-6427-4639				Almond D, 2011, REV ECON STAT, V93, P387, DOI 10.1162/REST_a_00089; Cook JT, 2013, ADV NUTR, V4, P51, DOI 10.3945/an.112.003228; Frongillo EA, 2006, J NUTR, V136, P1077, DOI 10.1093/jn/136.4.1077; Institute of Medicine and National Resource Council, 2013, SUPPL NUTR ASS PROGR; Jones SJ, 2003, ARCH PEDIAT ADOL MED, V157, P780, DOI 10.1001/archpedi.157.8.780; Keith-Jennings B., 2012, SNAP PLAYS CRITICAL; Kreider B, 2012, J AM STAT ASSOC, V107, P958, DOI 10.1080/01621459.2012.682828; Lee BJ, 2007, CHILD YOUTH SERV REV, V29, P501, DOI 10.1016/j.childyouth.2006.10.005; Leung CW, 2013, PEDIATRICS, V131, P463, DOI 10.1542/peds.2012-0889; Nord M, 2011, ERR116; Schanzenbach DW, 2012, 1766718535 NBER; Strayer M, 2012, CHARACTERISTICS SUPP	12	3	3	0	19	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 5	2013	382	9899					1155	1156		10.1016/S0140-6736(13)61805-X	http://dx.doi.org/10.1016/S0140-6736(13)61805-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	228SL	24095184				2022-12-28	WOS:000325209100005
J	Wang, DS; Song, CM; Barabasi, AL				Wang, Dashun; Song, Chaoming; Barabasi, Albert-Laszlo			Quantifying Long-Term Scientific Impact	SCIENCE			English	Article							CITATION; NETWORKS; JOURNALS; SCIENCE; INDEX	The lack of predictability of citation-based measures frequently used to gauge impact, from impact factors to short-term citations, raises a fundamental question: Is there long-term predictability in citation patterns? Here, we derive a mechanistic model for the citation dynamics of individual papers, allowing us to collapse the citation histories of papers from different journals and disciplines into a single curve, indicating that all papers tend to follow the same universal temporal pattern. The observed patterns not only help us uncover basic mechanisms that govern scientific impact but also offer reliable measures of influence that may have potential policy implications.	[Wang, Dashun; Song, Chaoming; Barabasi, Albert-Laszlo] Northeastern Univ, Dept Biol, Dept Phys, Ctr Complex Network Res, Boston, MA 02115 USA; [Wang, Dashun; Song, Chaoming; Barabasi, Albert-Laszlo] Northeastern Univ, Dept Comp Sci, Boston, MA 02115 USA; [Wang, Dashun] IBM Thomas J Watson Res Ctr, Yorktown Hts, NY 10598 USA; [Song, Chaoming] Univ Miami, Dept Phys, Coral Gables, FL 33124 USA; [Barabasi, Albert-Laszlo] Dana Farber Canc Inst, Ctr Canc Syst Biol, Boston, MA 02115 USA; [Barabasi, Albert-Laszlo] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med, Boston, MA 02115 USA; [Barabasi, Albert-Laszlo] Cent European Univ, Ctr Network Sci, Budapest, Hungary	Northeastern University; Northeastern University; International Business Machines (IBM); University of Miami; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Central European University	Barabasi, AL (corresponding author), Northeastern Univ, Dept Biol, Dept Phys, Ctr Complex Network Res, Boston, MA 02115 USA.	alb@neu.edu	Barabasi, Albert-Laszlo/S-6474-2017	Barabasi, Albert/0000-0002-4028-3522	Lockheed Martin Corporation [SRA 11.18.11]; Network Science Collaborative Technology Alliance; U.S. Army Research Laboratory [W911NF-09-2-0053]; Defense Advanced Research Projects Agency [11645021]; Future and Emerging Technologies Project [317 532]; European Commission	Lockheed Martin Corporation; Network Science Collaborative Technology Alliance; U.S. Army Research Laboratory(United States Department of DefenseUS Army Research Laboratory (ARL)); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Future and Emerging Technologies Project; European Commission(European CommissionEuropean Commission Joint Research Centre)	The authors thank P. Azoulay, C. Hidalgo, J. Loscalzo, D. Pedreschi, B. Uzzi, M. Vidal, and members of Center for Complex Network Research for insightful discussions and the anonymous referee for suggesting the lognormal model, which led to the analytical prediction of the citation threshold for preferential attachment. The PR data set is available upon request through American Physical Society. Supported by Lockheed Martin Corporation (SRA 11.18.11), the Network Science Collaborative Technology Alliance is sponsored by the U.S. Army Research Laboratory under agreement W911NF-09-2-0053, Defense Advanced Research Projects Agency under agreement 11645021, and the Future and Emerging Technologies Project 317 532 "Multiplex" financed by the European Commission.	Acuna DE, 2012, NATURE, V489, P201, DOI 10.1038/489201a; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barabasi AL, 2012, NATURE, V491, P40, DOI 10.1038/491040a; Bass F. M., 2004, Management Science, V50, P1833, DOI 10.1287/mnsc.1040.0300; Bianconi G, 2001, EUROPHYS LETT, V54, P436, DOI 10.1209/epl/i2001-00260-6; Caldarelli G, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.258702; Caldarelli G., 2007, SCALE FREE NETWORKS; Dorogovtsev SN, 2003, EVOLUTION NETWORKS B; Egghe L, 2006, SCIENTOMETRICS, V69, P131, DOI 10.1007/s11192-006-0144-7; Eom YH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024926; Evans JA, 2011, SCIENCE, V331, P721, DOI 10.1126/science.1201765; Evans JA, 2009, SCIENCE, V323, P1025, DOI 10.1126/science.1154562; Fersht A, 2009, P NATL ACAD SCI USA, V106, P6883, DOI 10.1073/pnas.0903307106; Fuyuno I, 2006, NATURE, V441, P792, DOI 10.1038/441792b; Garfield E, 2006, JAMA-J AM MED ASSOC, V295, P90, DOI 10.1001/jama.295.1.90; Gompertz B., 1825, PHILOS T R SOC LOND, V115, P513, DOI [10.1098/rstl.1825.0026, DOI 10.1098/RSTL.1825.0026]; Hirsch JE, 2005, P NATL ACAD SCI USA, V102, P16569, DOI 10.1073/pnas.0507655102; Jones BF, 2008, SCIENCE, V322, P1259, DOI 10.1126/science.1158357; Kuhn T.S., 1962, STRUCTURE SCI REVOLU, V1st ed; Lehmann S, 2006, NATURE, V444, P1003, DOI 10.1038/4441003a; MAHAJAN V, 1990, J MARKETING, V54, P1, DOI 10.2307/1252170; Medo M, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.238701; Peterson GJ, 2010, P NATL ACAD SCI USA, V107, P16023, DOI 10.1073/pnas.1010757107; PRICE DJD, 1965, SCIENCE, V149, P510; Radicchi F, 2008, P NATL ACAD SCI USA, V105, P17268, DOI 10.1073/pnas.0806977105; Radicchi F, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.056103; Redner S, 2005, PHYS TODAY, V58, P49, DOI 10.1063/1.1996475; Redner S, 1998, EUR PHYS J B, V4, P131, DOI 10.1007/s100510050359; Seglen PO, 1997, BRIT MED J, V314, P498; Stringer MJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001683	30	309	320	14	297	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 4	2013	342	6154					127	132		10.1126/science.1237825	http://dx.doi.org/10.1126/science.1237825			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	227PP	24092745	Green Submitted			2022-12-28	WOS:000325126100061
J	Barrett, JFR; Hannah, ME; Hutton, EK; Willan, AR; Allen, AC; Armson, BA; Gafni, A; Joseph, KS; Mason, D; Ohlsson, A; Ross, S; Sanchez, JJ; Asztalos, EV				Barrett, Jon F. R.; Hannah, Mary E.; Hutton, Eileen K.; Willan, Andrew R.; Allen, Alexander C.; Armson, B. Anthony; Gafni, Amiram; Joseph, K. S.; Mason, Dalah; Ohlsson, Arne; Ross, Susan; Sanchez, J. Johanna; Asztalos, Elizabeth V.		Twin Birth Study Collaborative Grp	A Randomized Trial of Planned Cesarean or Vaginal Delivery for Twin Pregnancy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							UNITED-STATES 1995-2008; PERINATAL-MORTALITY; RETROSPECTIVE COHORT; MULTIPLE BIRTHS; GESTATIONAL-AGE; SECTION; TERM; MORBIDITY; TRENDS; DEATH	BackgroundTwin birth is associated with a higher risk of adverse perinatal outcomes than singleton birth. It is unclear whether planned cesarean section results in a lower risk of adverse outcomes than planned vaginal delivery in twin pregnancy. MethodsWe randomly assigned women between 32 weeks 0 days and 38 weeks 6 days of gestation with twin pregnancy and with the first twin in the cephalic presentation to planned cesarean section or planned vaginal delivery with cesarean only if indicated. Elective delivery was planned between 37 weeks 5 days and 38 weeks 6 days of gestation. The primary outcome was a composite of fetal or neonatal death or serious neonatal morbidity, with the fetus or infant as the unit of analysis for the statistical comparison. ResultsA total of 1398 women (2795 fetuses) were randomly assigned to planned cesarean delivery and 1406 women (2812 fetuses) to planned vaginal delivery. The rate of cesarean delivery was 90.7% in the planned-cesarean-delivery group and 43.8% in the planned-vaginal-delivery group. Women in the planned-cesarean-delivery group delivered earlier than did those in the planned-vaginal-delivery group (mean number of days from randomization to delivery, 12.4 vs. 13.3; P=0.04). There was no significant difference in the composite primary outcome between the planned-cesarean-delivery group and the planned-vaginal-delivery group (2.2% and 1.9%, respectively; odds ratio with planned cesarean delivery, 1.16; 95% confidence interval, 0.77 to 1.74; P=0.49). ConclusionsIn twin pregnancy between 32 weeks 0 days and 38 weeks 6 days of gestation, with the first twin in the cephalic presentation, planned cesarean delivery did not significantly decrease or increase the risk of fetal or neonatal death or serious neonatal morbidity, as compared with planned vaginal delivery. (Funded by the Canadian Institutes of Health Research; ClinicalTrials.gov number, NCT00187369; Current Controlled Trials number, ISRCTN74420086.) In this randomized trial comparing delivery strategies in women with twin gestation, planned cesarean section did not significantly increase or decrease the risk of fetal or neonatal death or serious neonatal morbidity, as compared with planned vaginal delivery. Because of assisted reproductive technologies, twin pregnancy occurs more frequently now than in the past, and it complicates 2 to 3% of all births.(1),(2) Twins are at higher risk for an adverse perinatal outcome than singletons.(3),(4) Planned cesarean section, as compared with planned vaginal delivery, may reduce this risk.(5) Although a small, randomized, controlled trial did not show better perinatal outcomes with planned cesarean section than with planned vaginal delivery,(6) several cohort studies have shown a reduced risk of adverse perinatal outcomes for both twins, or for the second twin, when twins at or near term were delivered	[Barrett, Jon F. R.; Hannah, Mary E.] Univ Toronto, Dept Obstet & Gynaecol, Toronto, ON, Canada; [Mason, Dalah; Sanchez, J. Johanna] Univ Toronto, Ctr Mother Infant & Child Res, Sunnybrook Res Inst, Toronto, ON, Canada; [Asztalos, Elizabeth V.] Univ Toronto, Dept Newborn & Dev Paediat, Toronto, ON, Canada; [Willan, Andrew R.] Univ Toronto, Sunnybrook Hlth Sci Ctr, Program Child Hlth Evaluat Sci, SickKids Res Inst,Dalla Lana Sch Pub Hlth, Toronto, ON, Canada; [Ohlsson, Arne] McMaster Univ, Dept Paediat, Mt Sinai Hosp, Hamilton, ON, Canada; [Hutton, Eileen K.] McMaster Univ, Midwifery Educ Program, Mt Sinai Hosp, Hamilton, ON, Canada; [Gafni, Amiram] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Allen, Alexander C.] Dalhousie Univ, Dept Pediat, Halifax, NS, Canada; [Armson, B. Anthony] Dalhousie Univ, Dept Obstet & Gynaecol, Izaak Walton Killam Hlth Ctr, Halifax, NS, Canada; [Joseph, K. S.] Univ British Columbia, Izaak Walton Killam Hlth Ctr, Dept Obstet & Gynae cology, Vancouver, BC V5Z 1M9, Canada; [Joseph, K. S.] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V5Z 1M9, Canada; [Ross, Susan] Univ Alberta, Dept Obstet & Gynaecol, Edmonton, AB, Canada	University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Hospital for Sick Children (SickKids); Sunnybrook Health Science Center; McMaster University; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; McMaster University; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; McMaster University; Dalhousie University; Dalhousie University; University of British Columbia; University of British Columbia; University of Alberta	Barrett, JFR (corresponding author), Sunnybrook Hlth Sci Ctr, M4-172 2075 Bayview Ave, Toronto, ON M4N 3M5, Canada.	jon.barrett@sunnybrook.ca	Asztalos, Elizabeth/L-8834-2019; Duley, Lelia/E-8107-2015; RODO, CARLOTA/K-9179-2017; Calderon, Iracema/W-4336-2019; Gardener, Glenn/AAM-2241-2020; de Sa, Renato Augusto Moreira/B-4778-2014; Lawrence, Annemarie/I-4180-2013; Verhoeven, C.J.M./E-8128-2018; Cecatti, Jose Guilherme/M-5945-2013; Surita, Fernanda Garanhani/H-9575-2012; Carreras, Elena/N-7698-2016; Dodd, Jodie/Y-6849-2019	Asztalos, Elizabeth/0000-0002-9468-2860; Duley, Lelia/0000-0001-6721-5178; RODO, CARLOTA/0000-0001-8801-5677; Calderon, Iracema/0000-0003-4761-4336; Gardener, Glenn/0000-0002-8123-0718; Lawrence, Annemarie/0000-0002-8736-4741; Cecatti, Jose Guilherme/0000-0003-1285-8445; Surita, Fernanda Garanhani/0000-0003-4335-0337; Carreras, Elena/0000-0003-3471-7248; Dodd, Jodie/0000-0002-6363-4874; Sanchez, Johanna/0000-0003-2295-3251; Hutton, Eileen/0000-0003-0895-7395; Roumen, Frans JME/0000-0003-2319-4808; Verhoeven, Corine/0000-0002-0001-0888; Llurba Olive, Elisa/0000-0003-4048-6407; Hinshaw, Kim/0000-0003-0468-4326; Santana, Danielly/0000-0001-8912-2626; Joseph, K.S./0000-0003-2317-5607; Bricker, Leanne/0000-0001-7713-2771	Canadian Institutes of Health Research [63164]; Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	Funded by the Canadian Institutes of Health Research	Arabin B, 2012, OBSTET GYNECOL, V119, P657, DOI 10.1097/AOG.0b013e318248be0b; Armson BA, 2006, OBSTET GYNECOL, V108, P556, DOI 10.1097/01.AOG.0000227747.37184.0a; Bergh T, 1999, LANCET, V354, P1579, DOI 10.1016/S0140-6736(99)04345-7; Cheung YB, 2000, AM J EPIDEMIOL, V152, P1107, DOI 10.1093/aje/152.12.1107; GHAI V, 1988, CLIN PERINATOL, V15, P123, DOI 10.1016/S0095-5108(18)30730-9; Hannah ME, 2000, LANCET, V356, P1375, DOI 10.1016/S0140-6736(00)02840-3; Hoffmann E, 2012, ACTA OBSTET GYN SCAN, V91, P463, DOI 10.1111/j.1600-0412.2011.01356.x; Hogle Karen L, 2003, J Obstet Gynaecol Can, V25, P14; Imaizumi Y, 2001, PAEDIATR PERINAT EP, V15, P298, DOI 10.1046/j.1365-3016.2001.00361.x; KIELY JL, 1990, B NEW YORK ACAD MED, V66, P618; Klar N, 2001, STAT MED, V20, P3729, DOI 10.1002/sim.1115; Lee HC, 2011, OBSTET GYNECOL, V118, P1095, DOI 10.1097/AOG.0b013e3182318651; Pan W, 2001, CONTROL CLIN TRIALS, V22, P211, DOI 10.1016/S0197-2456(01)00131-3; Persad VL, 2001, OBSTET GYNECOL, V98, P1032, DOI 10.1016/S0029-7844(01)01597-6; PUISSANT F, 1982, ACTA GENET MED GEMEL, V31, P213, DOI 10.1017/S000156600000831X; RABINOVICI J, 1987, AM J OBSTET GYNECOL, V156, P52, DOI 10.1016/0002-9378(87)90201-8; Smith GCS, 2005, BJOG-INT J OBSTET GY, V112, P1139, DOI 10.1111/j.1471-0528.2005.00631.x; Smith GCS, 2002, BRIT MED J, V325, P1004, DOI 10.1136/bmj.325.7371.1004; Smith GCS, 2007, BMJ-BRIT MED J, V334, P576, DOI 10.1136/bmj.39118.483819.55; Su M, 2003, AM J OBSTET GYNECOL, V189, P740, DOI 10.1067/S0002-9378(03)00822-6; Wilcox LS, 1996, FERTIL STERIL, V65, P361, DOI 10.1016/S0015-0282(16)58100-X; World Health Organization, 2004, NEON PER MORT COUNTR	22	277	293	2	47	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 3	2013	369	14					1295	1305		10.1056/NEJMoa1214939	http://dx.doi.org/10.1056/NEJMoa1214939			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	227KI	24088091	Bronze, Green Accepted			2022-12-28	WOS:000325111200007
J	Bretschneider, T; Heim, JB; Heine, D; Winkler, R; Busch, B; Kusebauch, B; Stehle, T; Zocher, G; Hertweck, C				Bretschneider, Tom; Heim, Joel B.; Heine, Daniel; Winkler, Robert; Busch, Benjamin; Kusebauch, Bjoern; Stehle, Thilo; Zocher, Georg; Hertweck, Christian			Vinylogous chain branching catalysed by a dedicated polyketide synthase module	NATURE			English	Article							COMBINATORIAL BIOSYNTHESIS; BACTERIAL ENDOSYMBIONT; CRYSTAL-STRUCTURE; ENZYMOLOGY; EVOLUTION; LOGIC	Bacteria use modular polyketide synthases (PKSs) to assemble complex polyketides, many of which are leads for the development of clinical drugs, in particular anti-infectives and anti-tumoral agents(1). Because these multifarious compounds are notoriously difficult to synthesize, they are usually produced by microbial fermentation. During the past two decades, an impressive body of knowledge on modular PKSs(2,3) has been gathered that not only provides detailed insight into the biosynthetic pathways but also allows the rational engineering of enzymatic processing lines to yield structural analogues(4,5). Notably, a hallmark of all PKS modules studied so far is the head-to-tail fusion of acyl and malonyl building blocks, which leads to linear backbones. Yet, structural diversity is limited by this uniform assembly mode. Here we demonstrate a new type of PKS module from the endofungal bacterium Burkholderia rhizoxinica that catalyses a Michael-type acetyl addition to generate a branch in the carbon chain. In vitro reconstitution of the entire PKS module, X-ray structures of a ketosynthase-branching didomain and mutagenesis experiments revealed a crucial role of the ketosynthase domain in branching the carbon chain. We present a trapped intermediary state in which acyl carrier protein and ketosynthase are covalently linked by the branched polyketide and suggest a new mechanism for chain alkylation, which is functionally distinct from terpenoid-like beta-branching. For the rice seedling blight toxin rhizoxin, one of the strongest known anti-mitotic agents, the non-canonical polyketide modification is indispensable for phytotoxic and anti-tumoral activities. We propose that the formation of related pharmacophoric groups follows the same general scheme and infer a unifying vinylogous branching reaction for PKS modules with a ketosynthase-branching-acyl-carrier-protein architecture. This study unveils the structure and function of a new PKS module that broadens the biosynthetic scope of polyketide biosynthesis and sets the stage for rationally creating structural diversity.	[Bretschneider, Tom; Heine, Daniel; Winkler, Robert; Busch, Benjamin; Kusebauch, Bjoern; Hertweck, Christian] Leibniz Inst Nat Prod Res & Infect Biol HKI, Dept Biomol Chem, D-07745 Jena, Germany; [Heim, Joel B.; Stehle, Thilo; Zocher, Georg] Univ Tubingen, Interfac Inst Biochem, D-72076 Tubingen, Germany; [Stehle, Thilo] Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN 37232 USA; [Hertweck, Christian] Univ Jena, Chair Nat Prod Chem, D-07737 Jena, Germany	Hans Knoll Institute (HKI); Eberhard Karls University of Tubingen; Vanderbilt University; Friedrich Schiller University of Jena	Hertweck, C (corresponding author), Leibniz Inst Nat Prod Res & Infect Biol HKI, Dept Biomol Chem, D-07745 Jena, Germany.	georg.zocher@uni-tuebingen.de; christian.hertweck@hki-jena.de	Hertweck, Christian/AAZ-8452-2021; Heim, Joel Benjamin/K-3615-2016; Hertweck, Christian/G-1896-2014; Winkler, Robert/A-1500-2009	Hertweck, Christian/0000-0002-0367-337X; Heim, Joel Benjamin/0000-0001-9702-9480; Hertweck, Christian/0000-0002-0367-337X; Winkler, Robert/0000-0001-6732-1958; Kusebauch, Bjorn/0000-0003-0223-7987	DFG [SFB 766]; Studienstiftung des Deutschen Volkes	DFG(German Research Foundation (DFG)); Studienstiftung des Deutschen Volkes	We thank A. Perner for mass specrometry analyses, H. Heineke for NMR measurements, S. Schneider for preliminary studies on the PPTase, and U. Knupfer for help in protein production. We thank the DFG for financial support (SFB 766) and the Swiss Light Source beamline X06DA for offering beamtime. D. H. is financially supported by a stipend of the Studienstiftung des Deutschen Volkes.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bretschneider T, 2012, NAT CHEM BIOL, V8, P154, DOI 10.1038/nchembio.746; Calderone CT, 2008, NAT PROD REP, V25, P845, DOI 10.1039/b807243d; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Crawford JM, 2009, NATURE, V461, P1139, DOI 10.1038/nature08475; Dorrestein PC, 2006, BIOCHEMISTRY-US, V45, P12756, DOI 10.1021/bi061169d; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fischbach MA, 2006, CHEM REV, V106, P3468, DOI 10.1021/cr0503097; Fuchs SW, 2013, ANGEW CHEM INT EDIT, V52, P4108, DOI 10.1002/anie.201210116; Hertweck C, 2009, ANGEW CHEM INT EDIT, V48, P4688, DOI 10.1002/anie.200806121; Hong J, 2004, TETRAHEDRON, V60, P5653, DOI 10.1016/j.tet.2004.04.032; Horn U, 1996, APPL MICROBIOL BIOT, V46, P524, DOI 10.1007/s002530050855; Jez JM, 2000, BIOCHEMISTRY-US, V39, P890, DOI 10.1021/bi991489f; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Keatinge-Clay AT, 2012, NAT PROD REP, V29, P1050, DOI 10.1039/c2np20019h; Khosla C, 2009, J ORG CHEM, V74, P6416, DOI 10.1021/jo9012089; Khosla C, 2009, CURR OPIN CHEM BIOL, V13, P135, DOI 10.1016/j.cbpa.2008.12.018; Kusebauch B, 2011, CHEMMEDCHEM, V6, P1998, DOI 10.1002/cmdc.201100319; Kusebauch B, 2009, ANGEW CHEM INT EDIT, V48, P5001, DOI 10.1002/anie.200900277; Lackner G, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-210; Lackner G, 2011, J BACTERIOL, V193, P783, DOI 10.1128/JB.01318-10; Lim SK, 2009, J BIOL CHEM, V284, P29746, DOI 10.1074/jbc.M109.046805; Maier T, 2008, SCIENCE, V321, P1315, DOI 10.1126/science.1161269; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Partida-Martinez LP, 2007, CHEMBIOCHEM, V8, P41, DOI 10.1002/cbic.200600393; Partida-Martinez LP, 2005, NATURE, V437, P884, DOI 10.1038/nature03997; Piel J, 2010, NAT PROD REP, V27, P996, DOI 10.1039/b816430b; Rajski SR, 2010, CHEMBIOCHEM, V11, P1951, DOI 10.1002/cbic.201000370; Scherlach K, 2006, J AM CHEM SOC, V128, P11529, DOI 10.1021/ja062953o; Scherlach K, 2012, ANGEW CHEM INT EDIT, V51, P9615, DOI 10.1002/anie.201204540; Schmitt I, 2008, ISME J, V2, P632, DOI 10.1038/ismej.2008.19; Schrodinger L. L. C., 2010, PYMOL MOL GRAPH SYST; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Tang YY, 2006, P NATL ACAD SCI USA, V103, P11124, DOI 10.1073/pnas.0601924103; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Tsai SC, 2009, METHOD ENZYMOL, V459, P17, DOI 10.1016/S0076-6879(09)04602-3; Wang B, 2013, ORG LETT, V15, P1278, DOI 10.1021/ol400224n; Weissman KJ, 2005, NAT REV MICROBIOL, V3, P925, DOI 10.1038/nrmicro1287; Wilson MC, 2012, NAT PROD REP, V29, P72, DOI 10.1039/c1np00082a; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Wong FT, 2012, CURR OPIN CHEM BIOL, V16, P117, DOI 10.1016/j.cbpa.2012.01.018	43	83	84	6	122	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 3	2013	502	7469					124	+		10.1038/nature12588	http://dx.doi.org/10.1038/nature12588			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	227IM	24048471				2022-12-28	WOS:000325106000044
J	Kapoor, R; Johnson, RA				Kapoor, Roger; Johnson, Richard A.			Porphyria Cutanea Tarda and Hypertrichosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								A 54-year-old woman with hepatitis C infection presented with excess hair on her face, which she had had since the age of 25 years, and new erosions on her hands. Several ulcerations, milia, and thickened skin were noted on the dorsal aspect of her hands. A 54-year-old woman who had had hepatitis C infection for 12 years presented with excess hair on her face, which she had had since the age of 25 years, and new erosions on her hands. On physical examination, several ulcerations, milia, and thickened skin were noted on the dorsal aspect of both hands (Panel A). Excess hair growth (hypertrichosis) was noted in the temporal and malar facial areas (Panel B). Laboratory studies revealed an elevated level of 24-hour urinary porphyrin of 707 g (851 nmol; normal, <30 g [36 nmol]). Porphyria cutanea tarda refers to a group of anomalies in ...	[Kapoor, Roger] Beloit Hlth Syst, Beloit, WI USA; [Johnson, Richard A.] Massachusetts Gen Hosp, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital	Kapoor, R (corresponding author), Beloit Hlth Syst, Beloit, WI USA.	rogerkapoor@gmail.com							0	0	0	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 3	2013	369	14					1356	1356		10.1056/NEJMicm1010902	http://dx.doi.org/10.1056/NEJMicm1010902			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	227KI	24088095				2022-12-28	WOS:000325111200013
J	Manson, JE; Chlebowski, RT; Stefanick, ML; Aragaki, AK; Rossouw, JE; Prentice, RL; Anderson, G; Howard, BV; Thomson, CA; LaCroix, AZ; Wactawski-Wende, J; Jackson, RD; Limacher, M; Margolis, KL; Wassertheil-Smoller, S; Beresford, SA; Cauley, JA; Eaton, CB; Gass, M; Hsia, J; Johnson, KC; Kooperberg, C; Kuller, LH; Lewis, CE; Liu, SM; Martin, LW; Ockene, JK; O'Sullivan, MJ; Powell, LH; Simon, MS; Van Horn, L; Vitolins, MZ; Wallace, RB				Manson, JoAnn E.; Chlebowski, Rowan T.; Stefanick, Marcia L.; Aragaki, Aaron K.; Rossouw, Jacques E.; Prentice, Ross L.; Anderson, Garnet; Howard, Barbara V.; Thomson, Cynthia A.; LaCroix, Andrea Z.; Wactawski-Wende, Jean; Jackson, Rebecca D.; Limacher, Marian; Margolis, Karen L.; Wassertheil-Smoller, Sylvia; Beresford, Shirley A.; Cauley, Jane A.; Eaton, Charles B.; Gass, Margery; Hsia, Judith; Johnson, Karen C.; Kooperberg, Charles; Kuller, Lewis H.; Lewis, Cora E.; Liu, Simin; Martin, Lisa W.; Ockene, Judith K.; O'Sullivan, Mary Jo; Powell, Lynda H.; Simon, Michael S.; Van Horn, Linda; Vitolins, Mara Z.; Wallace, Robert B.			Menopausal Hormone Therapy and Health Outcomes During the Intervention and Extended Poststopping Phases of the Women's Health Initiative Randomized Trials	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ESTROGEN PLUS PROGESTIN; CONJUGATED EQUINE ESTROGEN; CORONARY-HEART-DISEASE; MILD COGNITIVE IMPAIRMENT; POSTMENOPAUSAL WOMEN; BREAST-CANCER; HYSTERECTOMY; RISK; MAMMOGRAPHY; DEMENTIA	IMPORTANCE Menopausal hormone therapy continues in clinical use but questions remain regarding its risks and benefits for chronic disease prevention. OBJECTIVE To report a comprehensive, integrated overview of findings from the 2 Women's Health Initiative (WHI) hormone therapy trials with extended postintervention follow-up. DESIGN, SETTING, AND PARTICIPANTS A total of 27 347 postmenopausal women aged 50 to 79 years were enrolled at 40 US centers. INTERVENTIONS Women with an intact uterus received conjugated equine estrogens (CEE; 0.625 mg/d) plus medroxyprogesterone acetate (MPA; 2.5 mg/d) (n = 8506) or placebo (n = 8102). Women with prior hysterectomy received CEE alone (0.625 mg/d) (n = 5310) or placebo (n = 5429). The intervention lasted a median of 5.6 years in CEE plus MPA trial and 7.2 years in CEE alone trial with 13 years of cumulative follow-up until September 30, 2010. MAIN OUTCOMES AND MEASURES Primary efficacy and safety outcomes were coronary heart disease (CHD) and invasive breast cancer, respectively. A global index also included stroke, pulmonary embolism, colorectal cancer, endometrial cancer, hip fracture, and death. RESULTS During the CEE plus MPA intervention phase, the numbers of CHD cases were 196 for CEE plus MPA vs 159 for placebo (hazard ratio [HR], 1.18; 95% CI, 0.95-1.45) and 206 vs 155, respectively, for invasive breast cancer (HR, 1.24; 95% CI, 1.01-1.53). Other risks included increased stroke, pulmonary embolism, dementia (in women aged >= 65 years), gallbladder disease, and urinary incontinence; benefits included decreased hip fractures, diabetes, and vasomotor symptoms. Most risks and benefits dissipated postintervention, although some elevation in breast cancer risk persisted during cumulative follow-up (434 cases for CEE plus MPA vs 323 for placebo; HR, 1.28 [95% CI, 1.11-1.48]). The risks and benefits were more balanced during the CEE alone intervention with 204 CHD cases for CEE alone vs 222 cases for placebo (HR, 0.94; 95% CI, 0.78-1.14) and 104 vs 135, respectively, for invasive breast cancer (HR, 0.79; 95% CI, 0.61-1.02); cumulatively, there were 168 vs 216, respectively, cases of breast cancer diagnosed (HR, 0.79; 95% CI, 0.65-0.97). Results for other outcomes were similar to CEE plus MPA. Neither regimen affected all-cause mortality. For CEE alone, younger women(aged 50-59 years) had more favorable results for all-cause mortality, myocardial infarction, and the global index (nominal P<.05 for trend by age). Absolute risks of adverse events (measured by the global index) per 10 000 women annually taking CEE plus MPA ranged from 12 excess cases for ages of 50-59 years to 38 for ages of 70-79 years; for women taking CEE alone, from 19 fewer cases for ages of 50-59 years to 51 excess cases for ages of 70-79 years. Quality-of-life outcomes had mixed results in both trials. CONCLUSIONS AND RELEVANCE Menopausal hormone therapy has a complex pattern of risks and benefits. Findings from the intervention and extended postintervention follow-up of the 2 WHI hormone therapy trials do not support use of this therapy for chronic disease prevention, although it is appropriate for symptom management in some women.	[Manson, JoAnn E.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Boston, MA 02215 USA; [Chlebowski, Rowan T.] Harbor UCLA Med Ctr, Los Angeles Biomed Res Inst, Torrance, CA 90509 USA; [Stefanick, Marcia L.] Stanford Prevent Res Ctr, Stanford, CA USA; [Aragaki, Aaron K.; Prentice, Ross L.; Anderson, Garnet; LaCroix, Andrea Z.; Beresford, Shirley A.; Kooperberg, Charles] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA; [Rossouw, Jacques E.] NHLBI, Bethesda, MD 20892 USA; [Howard, Barbara V.] MedStar Hlth Res Inst, Washington, DC USA; [Howard, Barbara V.] Georgetown Howard Univ Ctr Clin & Translat Sci, Washington, DC USA; [Thomson, Cynthia A.] Univ Arizona, Mel & Enid Zuckerman Coll Publ Hlth, Tucson, AZ USA; [Wactawski-Wende, Jean] SUNY Buffalo, Dept Social & Prevent Med, Buffalo, NY 14260 USA; [Jackson, Rebecca D.] Ohio State Univ, Div Endocrinol Diabet & Metab, Columbus, OH 43210 USA; [Limacher, Marian] Univ Florida, Gainesville, FL USA; [Margolis, Karen L.] HealthPartners Inst Educ & Res, Minneapolis, MN USA; [Wassertheil-Smoller, Sylvia] Albert Einstein Coll Med, New York, NY USA; [Cauley, Jane A.; Kuller, Lewis H.] Univ Pittsburgh, Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA 15260 USA; [Eaton, Charles B.] Brown Univ, Dept Family Med & Epidemiol, Alpert Med Sch, Providence, RI 02912 USA; [Gass, Margery] Cleveland Clin, North Amer Menopause Soc, Cleveland, OH 44106 USA; [Gass, Margery] Case Western Reserve Univ, Sch Med, Cleveland, OH USA; [Hsia, Judith] AstraZeneca, Clin Res, Wilmington, DE USA; [Johnson, Karen C.] Univ Tennessee, Hlth Sci Ctr, Dept Prevent Med, Memphis, TN USA; [Lewis, Cora E.] Univ Alabama, Dept Med, Tuscaloosa, AL 35487 USA; [Liu, Simin] Brown Univ, Dept Epidemiol, Providence, RI 02912 USA; [Liu, Simin] Brown Univ, Dept Med, Providence, RI 02912 USA; [Martin, Lisa W.] George Washington Univ, Div Cardiol, Sch Med & Hlth Sci, Washington, DC USA; [Ockene, Judith K.] Univ Massachusetts, Sch Med, Worcester, MA USA; [O'Sullivan, Mary Jo] Univ Miami, Dept Obstet & Gynecol, Div Res, Miami, FL USA; [Powell, Lynda H.] Rush Univ, Med Ctr, Dept Prevent Med, Chicago, IL 60612 USA; [Simon, Michael S.] Wayne State Univ, Karmanos Canc Inst, Detroit, MI USA; [Van Horn, Linda] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Vitolins, Mara Z.] Wake Forest Sch Med, Dept Epidemiol & Prevent, Winston Salem, NC USA; [Wallace, Robert B.] Univ Iowa, Dept Epidemiol, Coll Publ Hlth, Iowa City, IA USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; Stanford University; Fred Hutchinson Cancer Center; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); MedStar Health Research Institute; University of Arizona; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University System of Ohio; Ohio State University; State University System of Florida; University of Florida; Yeshiva University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Brown University; Cleveland Clinic Foundation; Case Western Reserve University; AstraZeneca; University of Tennessee System; University of Tennessee Health Science Center; University of Alabama System; University of Alabama Tuscaloosa; Brown University; Brown University; George Washington University; University of Massachusetts System; University of Massachusetts Worcester; University of Miami; Rush University; Barbara Ann Karmanos Cancer Institute; Wayne State University; Northwestern University; Feinberg School of Medicine; Wake Forest University; University of Iowa	Manson, JE (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, 900 Commonwealth Ave,3rd Floor, Boston, MA 02215 USA.	jmanson@rics.bwh.harvard.edu	Liu, Simin/I-3689-2014; Liu, Simin/GSN-4159-2022; Wactawski-Wende, Jean/AGH-5457-2022; LaCroix, Andrea/N-9880-2018	Liu, Simin/0000-0003-2098-3844; Wactawski-Wende, Jean/0000-0003-3096-9595; LaCroix, Andrea/0000-0002-9532-976X; Cauley, Jane A/0000-0003-0752-4408; Margolis, Karen/0000-0003-1862-7402; Eaton, Charles/0000-0002-7723-9461; Martin, Lisa Warsinger/0000-0003-4352-0914	National Heart, Lung, and Blood Institute, National Institutes of Health, US Department of Health and Human Services [N01WH22110, 24152, 32100-2, 32105-6, 32108-9, 32111-13, 321115, 32118-32119, 32122, 42107-26, 42129-32, 44221]; WOMEN&apos;S HEALTH INITIATIVE - OFFICE OF THE DIRECTOR NIH [N01WH032102, N01WH042119, N01WH042117, N01WH042118, N01WH042125, N01WH042107, N01WH032119, N01WH042116, N01WH032118, N01WH032108, N01WH042114, N01WH042108, N01WH032112, N01WH042109, N01WH042124, N01WH032101, N01WH042113, N01WH032111, N01WH042122, N01WH032106, N01WH042115, N01WH022110, N01WH042129, N01WH042123, N01WH042132, N01WH042120, N01WH042111, N01WH032113, N01WH042131, N01WH042126, N01WH042130, N01WH032109, N01WH042110, N01WH042112, N01WH032105, N01WH032122, N01WH032100, N01WH042121] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute, National Institutes of Health, US Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); WOMEN&apos;S HEALTH INITIATIVE - OFFICE OF THE DIRECTOR NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The Women's Health Initiative is funded by the National Heart, Lung, and Blood Institute, National Institutes of Health, US Department of Health and Human Services through contracts N01WH22110, 24152, 32100-2, 32105-6, 32108-9, 32111-13, 321115, 32118-32119, 32122, 42107-26, 42129-32, and 44221. Wyeth-Ayerst donated the study drugs.	Anderson G, 1998, CONTROL CLIN TRIALS, V19, P61; Anderson GL, 2012, LANCET ONCOL, V13, P476, DOI 10.1016/S1470-2045(12)70075-X; Anderson GL, 2003, JAMA-J AM MED ASSOC, V290, P1739, DOI 10.1001/jama.290.13.1739; Anderson GL, 2004, JAMA-J AM MED ASSOC, V291, P1701, DOI 10.1001/jama.291.14.1701; Archer DF, 2009, CLIMACTERIC, V12, P368, DOI 10.1080/13697130903195606; Banks E, 2003, LANCET, V362, P419, DOI 10.1016/S0140-6736(03)14065-2; Beral V, 1997, LANCET, V350, P1047, DOI 10.1016/S0140-6736(97)08233-0; Bonds DE, 2006, DIABETOLOGIA, V49, P459, DOI 10.1007/s00125-005-0096-0; Brunner RL, 2005, ARCH INTERN MED, V165, P1976, DOI 10.1001/archinte.165.17.1976; Chlebowski RT, 2008, ARCH INTERN MED, V168, P370, DOI 10.1001/archinternmed.2007.123; Chlebowski RT, 2012, JNCI-J NATL CANCER I, V104, P517, DOI 10.1093/jnci/djs014; Chlebowski RT, 2010, JNCI-J NATL CANCER I, V102, P1413, DOI 10.1093/jnci/djq285; Chlebowski RT, 2009, LANCET, V374, P1243, DOI 10.1016/S0140-6736(09)61526-9; Chlebowski RT, 2009, NEW ENGL J MED, V360, P573, DOI 10.1056/NEJMoa0807684; Chlebowski RT, 2004, NEW ENGL J MED, V350, P991, DOI 10.1056/NEJMoa032071; Chlebowski RT, 2003, JAMA-J AM MED ASSOC, V289, P3243, DOI 10.1001/jama.289.24.3243; Espeland MA, 2013, JAMA INTERN MED, V173, P1429, DOI 10.1001/jamainternmed.2013.7727; Gast GCM, 2011, MATURITAS, V70, P373, DOI 10.1016/j.maturitas.2011.09.005; Gast GCM, 2011, MENOPAUSE, V18, P146, DOI 10.1097/gme.0b013e3181f464fb; GRADY D, 1992, ANN INTERN MED, V117, P1016, DOI 10.7326/0003-4819-117-12-1016; GRADY D, 1992, ANN INTERN MED, V117, P1038; Hays J, 2003, NEW ENGL J MED, V348, P1839, DOI 10.1056/NEJMoa030311; Heiss G, 2008, JAMA-J AM MED ASSOC, V299, P1036, DOI 10.1001/jama.299.9.1036; Hendrix SL, 2005, JAMA-J AM MED ASSOC, V293, P935, DOI 10.1001/jama.293.8.935; Hendrix SL, 2006, CIRCULATION, V113, P2425, DOI 10.1161/CIRCULATIONAHA.105.594077; Hersh AL, 2004, JAMA-J AM MED ASSOC, V291, P47, DOI 10.1001/jama.291.1.47; Hsia J, 2006, ARCH INTERN MED, V166, P357, DOI 10.1001/archinte.166.3.357; Huang AJ, 2009, MENOPAUSE, V16, P639, DOI 10.1097/gme.0b013e31819c11e4; Jackson RD, 2006, J BONE MINER RES, V21, P817, DOI 10.1359/JBMR.060312; Jordan VC, 2011, CANCER PREV RES, V4, P633, DOI 10.1158/1940-6207.CAPR-11-0185; Kim JJ, 2013, ENDOCR REV, V34, P130, DOI 10.1210/er.2012-1043; LaCroix AZ, 2011, JAMA-J AM MED ASSOC, V305, P1305, DOI 10.1001/jama.2011.382; Lantto H, 2012, MENOPAUSE, V19, P82, DOI 10.1097/gme.0b013e318221bae8; Levine DW, 2005, PSYCHOSOM MED, V67, P98, DOI 10.1097/01.psy.0000151743.58067.f0; Levine DW, 2003, PSYCHOL ASSESSMENT, V15, P137, DOI 10.1037/1040-3590.15.2.137; Lewis-Wambi JS, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2255; Manson JE, 2003, NEW ENGL J MED, V349, P523, DOI 10.1056/NEJMoa030808; Margolis KL, 2004, DIABETOLOGIA, V47, P1175, DOI 10.1007/s00125-004-1448-x; Mendelsohn ME, 2005, SCIENCE, V308, P1583, DOI 10.1126/science.1112062; Mikkola TS, 2002, CARDIOVASC RES, V53, P605, DOI 10.1016/S0008-6363(01)00466-7; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Santen RJ, 2010, J CLIN ENDOCR METAB, V95, pS7, DOI 10.1210/jc.2009-2509; Shumaker SA, 2004, JAMA-J AM MED ASSOC, V291, P2947, DOI 10.1001/jama.291.24.2947; Shumaker SA, 2003, JAMA-J AM MED ASSOC, V289, P2651, DOI 10.1001/jama.289.20.2651; Stefanick ML, 2006, JAMA-J AM MED ASSOC, V295, P1647, DOI 10.1001/jama.295.14.1647; Utian WH, 2010, MENOPAUSE, V17, P242, DOI 10.1097/gme.0b013e3181d0f6b9; Walitt B, 2008, ARTHRIT RHEUM-ARTHR, V59, P302, DOI 10.1002/art.23325; Wassertheil-Smoller S, 2003, JAMA-J AM MED ASSOC, V289, P2673, DOI 10.1001/jama.289.20.2673	48	839	891	0	72	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 2	2013	310	13					1353	1368		10.1001/jama.2013.278040	http://dx.doi.org/10.1001/jama.2013.278040			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	227GB	24084921	Green Accepted, Bronze			2022-12-28	WOS:000325098100021
J	Meslin, PY; Gasnault, O; Forni, O; Schroder, S; Cousin, A; Berger, G; Clegg, SM; Lasue, J; Maurice, S; Sautter, V; Le Mouelic, S; Wiens, RC; Fabre, C; Goetz, W; Bish, D; Mangold, N; Ehlmann, B; Lanza, N; Harri, AM; Anderson, R; Rampe, E; McConnochie, TH; Pinet, P; Blaney, D; Leveille, R; Archer, D; Barraclough, B; Bender, S; Blake, D; Blank, JG; Bridges, N; Clark, BC; DeFlores, L; Delapp, D; Dromart, G; Dyar, MD; Fisk, M; Gondet, B; Grotzinger, J; Herkenhoff, K; Johnson, J; Lacour, JL; Langevin, Y; Leshin, L; Lewin, E; Madsen, MB; Melikechi, N; Mezzacappa, A; Mischna, MA; Moores, JE; Newsom, H; Ollila, A; Perez, R; Renno, N; Sirven, JB; Tokar, R; de la Torre, M; d'Uston, L; Vaniman, D; Yingst, A				Meslin, P-Y.; Gasnault, O.; Forni, O.; Schroeder, S.; Cousin, A.; Berger, G.; Clegg, S. M.; Lasue, J.; Maurice, S.; Sautter, V.; Le Mouelic, S.; Wiens, R. C.; Fabre, C.; Goetz, W.; Bish, D.; Mangold, N.; Ehlmann, B.; Lanza, N.; Harri, A-M.; Anderson, R.; Rampe, E.; McConnochie, T. H.; Pinet, P.; Blaney, D.; Leveille, R.; Archer, D.; Barraclough, B.; Bender, S.; Blake, D.; Blank, J. G.; Bridges, N.; Clark, B. C.; DeFlores, L.; Delapp, D.; Dromart, G.; Dyar, M. D.; Fisk, M.; Gondet, B.; Grotzinger, J.; Herkenhoff, K.; Johnson, J.; Lacour, J-L.; Langevin, Y.; Leshin, L.; Lewin, E.; Madsen, M. B.; Melikechi, N.; Mezzacappa, A.; Mischna, M. A.; Moores, J. E.; Newsom, H.; Ollila, A.; Perez, R.; Renno, N.; Sirven, J-B.; Tokar, R.; de la Torre, M.; d'Uston, L.; Vaniman, D.; Yingst, A.		MSL Sci Team	Soil Diversity and Hydration as Observed by ChemCam at Gale Crater, Mars	SCIENCE			English	Article							CHEMICAL-COMPOSITION; INSTRUMENT SUITE; HYDROUS MINERALS; MARTIAN SURFACE; WATER; CHEMISTRY; ALLOPHANE; ROCKS; CURIOSITY; ROCKNEST	The ChemCam instrument, which provides insight into martian soil chemistry at the submillimeter scale, identified two principal soil types along the Curiosity rover traverse: a fine-grained mafic type and a locally derived, coarse-grained felsic type. The mafic soil component is representative of widespread martian soils and is similar in composition to the martian dust. It possesses a ubiquitous hydrogen signature in ChemCam spectra, corresponding to the hydration of the amorphous phases found in the soil by the CheMin instrument. This hydration likely accounts for an important fraction of the global hydration of the surface seen by previous orbital measurements. ChemCam analyses did not reveal any significant exchange of water vapor between the regolith and the atmosphere. These observations provide constraints on the nature of the amorphous phases and their hydration.	[Meslin, P-Y.; Gasnault, O.; Forni, O.; Schroeder, S.; Berger, G.; Lasue, J.; Maurice, S.; Pinet, P.; d'Uston, L.] Univ Toulouse, UPS OMP, IRAP, F-31028 Toulouse, France; [Meslin, P-Y.; Gasnault, O.; Forni, O.; Schroeder, S.; Berger, G.; Lasue, J.; Maurice, S.; Pinet, P.; d'Uston, L.] IRAP, CNRS, F-31028 Toulouse 4, France; [Cousin, A.; Clegg, S. M.; Wiens, R. C.; Lanza, N.; Delapp, D.] Los Alamos Natl Lab, Los Alamos, NM 87545 USA; [Sautter, V.] Museum Natl Hist Nat, Lab Mineral & Cosmochim Museum, F-75005 Paris, France; [Le Mouelic, S.; Mangold, N.] Univ Nantes, LPGN, CNRS, UMR6112, F-44322 Nantes, France; [Fabre, C.] Univ Lorraine, GeoRessources, CNRS, UMR7356, F-54506 Vandoeuvre Les Nancy, France; [Goetz, W.] Max Planck Inst Sonnensyst Forsch, D-37191 Katlenburg Lindau, Germany; [Bish, D.] Indiana Univ, Bloomington, IN 47405 USA; [Ehlmann, B.; Grotzinger, J.; de la Torre, M.] CALTECH, Pasadena, CA 91125 USA; [Ehlmann, B.; Blaney, D.; DeFlores, L.; Mischna, M. A.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Harri, A-M.] Finnish Meteorol Inst, Earth Observat Res Div, FIN-00101 Helsinki, Finland; [Anderson, R.; Herkenhoff, K.] US Geol Survey, Astrogeol Sci Ctr, Flagstaff, AZ 86001 USA; [Rampe, E.; Archer, D.] NASA, Lyndon B Johnson Space Ctr, Houston, TX 77058 USA; [McConnochie, T. H.] Univ Maryland, College Pk, MD 20740 USA; [Leveille, R.] Canadian Space Agcy, St Hubert, PQ J3Y 8Y9, Canada; [Barraclough, B.; Bender, S.; Tokar, R.; Vaniman, D.; Yingst, A.] Planetary Sci Inst, Tucson, AZ 85719 USA; [Blake, D.; Blank, J. G.] NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; [Johnson, J.] Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA; [Clark, B. C.] Space Sci Inst, Boulder, CO 80301 USA; [Dromart, G.] ENS, F-69007 Lyon, France; [Dyar, M. D.] Mt Holyoke Coll, S Hadley, MA 01075 USA; [Fisk, M.] Oregon State Univ, Corvallis, OR 97331 USA; [Gondet, B.; Langevin, Y.] Inst Astrophys Spatiale, F-91405 Orsay, France; [Lacour, J-L.; Sirven, J-B.] Commissariat Energie Atom & Energies Alternat, Ctr Saclay, F-91400 Orsay, France; [Leshin, L.] Rensselaer Polytech Inst, Troy, NY 12180 USA; [Lewin, E.] ISTerre, F-38041 Grenoble, France; [Madsen, M. B.] Univ Copenhagen, Niels Bohr Inst, DK-2100 Copenhagen, Denmark; [Melikechi, N.; Mezzacappa, A.] Delaware State Univ, Opt Sci Ctr Appl Res, Dover, DE 19901 USA; [Moores, J. E.] York Univ, Ctr Res Earth & Space Sci, Toronto, ON M3J 1P3, Canada; [Newsom, H.; Ollila, A.] Univ New Mexico, Albuquerque, NM 87131 USA; [Perez, R.] Ctr Natl Etud Spatiales, F-31400 Toulouse, France; [Renno, N.] Univ Michigan, Dept Atmospher Ocean & Space Sci, Ann Arbor, MI 48109 USA	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); United States Department of Energy (DOE); Los Alamos National Laboratory; Museum National d'Histoire Naturelle (MNHN); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Le Mans Universite; Nantes Universite; Universite d'Angers; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Universite de Lorraine; Max Planck Society; Indiana University System; Indiana University Bloomington; California Institute of Technology; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Finnish Meteorological Institute; United States Department of the Interior; United States Geological Survey; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; University System of Maryland; University of Maryland College Park; Canadian Space Agency; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; Ecole Normale Superieure de Lyon (ENS de LYON); Mount Holyoke College; Oregon State University; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Saclay; CEA; Rensselaer Polytechnic Institute; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite Gustave-Eiffel; Universite de Savoie; University of Copenhagen; Niels Bohr Institute; Delaware State University; York University - Canada; University of New Mexico; University of Michigan System; University of Michigan	Meslin, PY (corresponding author), Univ Toulouse, UPS OMP, IRAP, F-31028 Toulouse, France.	pmeslin@irap.omp.eu	Balic-Zunic, Tonci/A-6362-2013; Bish, David/AAY-7618-2020; FABRE, Cécile/B-5827-2012; Martin-Torres, Javier/G-6329-2015; Floyd, Melissa/D-4626-2012; Prats, Benito/F-9467-2019; Harri, Ari-Matti/C-7142-2012; Madsen, Morten Bo/D-2082-2011; szopa, cyril/C-6865-2015; Stipp, Susan L.S./B-8494-2019; Ramos, Miguel/K-2230-2014; Teinturier, Samuel/AAS-8663-2020; Gómez, Felipe/L-7315-2014; BERGER, Gilles/F-7118-2016; pinet, patrick/ABF-6172-2021; Hayes, Alexander G/P-2024-2014; Lemmon, Mark T/E-9983-2010; IMPMC, ROCKS @/U-8478-2017; Mischna, Michael/AAF-3861-2020; Franz, Heather B/F-3508-2012; Gasnault, Olivier/F-4327-2010; Moores, John E./AAO-6622-2021; Benna, Mehdi/F-3489-2012; Blanco, Juan Jose/E-3627-2014; LEWIN, Éric/F-1451-2017; Muller, Jan-Peter/Q-8886-2019; GEFFROY, Claude/AAB-9152-2019; De La Torre Juarez, Manuel/G-8105-2017; Dworkin, Jason P./C-9417-2012; Zorzano, María-Paz/F-2184-2015; Rodriguez-Manfredi, Jose/L-8001-2014; Steele, Andrew/A-3573-2013; Sirven, Jean-Baptiste/H-5782-2013; De Pablo, Miguel Ángel/J-6442-2014; Blaney, Diana/M-1756-2019; Malakhov, Alexey Vladimirovich/F-7953-2017; Avalos, Juan Jose Blanco/AAB-9447-2021; Rodriguez-Manfredi, Jose/AAG-9826-2021; Gomez-Elvira, Javier/K-5829-2014; Navarro-González, Rafael/D-1748-2009; Vicenzi, Edward/T-9430-2017	Balic-Zunic, Tonci/0000-0003-1687-1233; FABRE, Cécile/0000-0001-8627-4050; Martin-Torres, Javier/0000-0001-6479-2236; Prats, Benito/0000-0003-3869-3351; Harri, Ari-Matti/0000-0001-8541-2802; Madsen, Morten Bo/0000-0001-8909-5111; szopa, cyril/0000-0002-0090-4056; Stipp, Susan L.S./0000-0001-7009-643X; Ramos, Miguel/0000-0003-3648-6818; Teinturier, Samuel/0000-0003-1755-9524; Gómez, Felipe/0000-0001-9977-7060; pinet, patrick/0000-0002-1933-5631; Hayes, Alexander G/0000-0001-6397-2630; Lemmon, Mark T/0000-0002-4504-5136; Mischna, Michael/0000-0002-8022-5319; Gasnault, Olivier/0000-0002-6979-9012; Moores, John E./0000-0001-9435-1095; Blanco, Juan Jose/0000-0002-8666-0696; Muller, Jan-Peter/0000-0002-5077-3736; GEFFROY, Claude/0000-0002-2731-9658; De La Torre Juarez, Manuel/0000-0003-1393-5297; Dworkin, Jason P./0000-0002-3961-8997; Zorzano, María-Paz/0000-0002-4492-9650; Rodriguez-Manfredi, Jose/0000-0003-0461-9815; Steele, Andrew/0000-0001-9643-2841; Sirven, Jean-Baptiste/0000-0002-5523-6809; De Pablo, Miguel Ángel/0000-0002-4496-2741; Blaney, Diana/0000-0002-4267-7939; Malakhov, Alexey Vladimirovich/0000-0003-4292-7077; Avalos, Juan Jose Blanco/0000-0002-8666-0696; Rodriguez-Manfredi, Jose/0000-0003-0461-9815; Gomez-Elvira, Javier/0000-0002-9068-9846; Navarro-González, Rafael/0000-0002-6078-7621; Le Mouelic, Stephane/0000-0001-5260-1367; Vicenzi, Edward/0000-0003-2085-6546; Clegg, Sam/0000-0002-0338-0948; Wilson, Sharon/0000-0001-8872-8546; Forni, Olivier/0000-0001-6772-9689; BERGER, Gilles/0000-0003-4806-5594	Centre National d'Etudes Spatiales (CNES); NASA's Mars Program Office; Deutsche Forschungsgemeinschaft [GO 2288/1-1]; Science and Technology Facilities Council [ST/J005193/1] Funding Source: researchfish; UK Space Agency [ST/I003118/1, ST/J005339/1] Funding Source: researchfish	Centre National d'Etudes Spatiales (CNES)(Centre National D'etudes Spatiales); NASA's Mars Program Office; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); UK Space Agency	This research was carried out with funding from the Centre National d'Etudes Spatiales (CNES). Work in the United States was carried out under contract from NASA's Mars Program Office. W. G. acknowledges partial funding from Deutsche Forschungsgemeinschaft grant GO 2288/1-1. This team gratefully acknowledges JPL for developing and leading this successful mission. The data reported in this paper are archived at the Planetary Data System, accessible at http://pds-geosciences.wustl.edu/missions/msl/index.htm.	Aharonson O, 2006, J GEOPHYS RES-PLANET, V111, DOI [10.1029/2005JE002636, 10.1029/2005JE002636.]; ANDERSON DM, 1979, J MOL EVOL, V14, P33, DOI 10.1007/BF01732365; BALLOU EV, 1978, NATURE, V271, P644, DOI 10.1038/271644a0; Bartoli F, 2007, EUR J SOIL SCI, V58, P450, DOI 10.1111/j.1365-2389.2007.00899.x; Beck P, 2010, J GEOPHYS RES-PLANET, V115, DOI 10.1029/2009JE003539; BIEMANN K, 1976, SCIENCE, V194, P72, DOI 10.1126/science.194.4260.72; Bish DL, 2013, SCIENCE, V341, DOI 10.1126/science.1238932; Blake DF, 2013, SCIENCE, V341, DOI 10.1126/science.1239505; Boynton WV, 2007, J GEOPHYS RES-PLANET, V112, DOI 10.1029/2007JE002887; Carr M. H, 2007, SURFACE MARS; Carter J, 2013, J GEOPHYS RES-PLANET, V118, P831, DOI 10.1029/2012JE004145; Carter J, 2010, SCIENCE, V328, P1682, DOI 10.1126/science.1189013; Christensen PR, 2000, J GEOPHYS RES-PLANET, V105, P9609, DOI 10.1029/1999JE001127; Clark B. C.  III, 1977, Journal of Geophysical Research, V82, P4577, DOI 10.1029/JS082i028p04577; CLARK BC, 1982, J GEOPHYS RES, V87, P59, DOI 10.1029/JB087iB12p10059; Clegg S., 2013, LUNAR PLANET SCI C, V44; Clegg SM, 2009, SPECTROCHIM ACTA B, V64, P79, DOI 10.1016/j.sab.2008.10.045; Eggleton RA, 1998, CLAY CLAY MINER, V46, P400, DOI 10.1346/CCMN.1998.0460404; Ehlmann BL, 2011, NATURE, V479, P53, DOI 10.1038/nature10582; Fialips CI, 2005, ICARUS, V178, P74, DOI 10.1016/j.icarus.2005.04.020; Fisk M., 2013, LUNAR PLANET SCI C, V44; Forni O, 2013, SPECTROCHIM ACTA B, V86, P31, DOI 10.1016/j.sab.2013.05.003; Gasnault O, 2010, ICARUS, V207, P226, DOI 10.1016/j.icarus.2009.11.010; Gellert R, 2004, SCIENCE, V305, P829, DOI 10.1126/science.1099913; Goetz W, 2005, NATURE, V436, P62, DOI 10.1038/nature03807; Janchen J, 2009, ICARUS, V200, P463, DOI 10.1016/j.icarus.2008.12.006; Jakosky B. M., 1992, MARS, P969; JAKOSKY BM, 1985, SPACE SCI REV, V41, P131, DOI 10.1007/BF00241348; Jouglet D, 2007, J GEOPHYS RES-PLANET, V112, DOI 10.1029/2006JE002846; Khan H, 2006, CLAY SCI, V12, P261; KITAGAWA Y, 1974, AM MINERAL, V59, P1094; Kocurek G., 2013, LUNAR PLANET SCI C, V44; Le Mouelic S., 2009, 1 WORKSH HYP IM SIGN, DOI [10.1109/WHISPERS.2009.5289003, DOI 10.1109/WHISPERS.2009.5289003]; Leshin LA, 2013, SCIENCE, V341, DOI 10.1126/science.1238937; Maltagliati L, 2011, ICARUS, V213, P480, DOI 10.1016/j.icarus.2011.03.030; Maurice S, 2012, SPACE SCI REV, V170, P95, DOI 10.1007/s11214-012-9912-2; Maurice S, 2011, J GEOPHYS RES-PLANET, V116, DOI 10.1029/2011JE003810; McGlynn IO, 2012, J GEOPHYS RES-PLANET, V117, DOI 10.1029/2011JE003861; McSween HY, 2010, J GEOPHYS RES-PLANET, V115, DOI 10.1029/2010JE003582; MCSWEEN HY, 1994, METEORITICS, V29, P757, DOI 10.1111/j.1945-5100.1994.tb01092.x; Milliken RE, 2007, J GEOPHYS RES-PLANET, V112, DOI 10.1029/2006JE002853; Morris RV, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2006JE002791; Mustard JF, 2008, NATURE, V454, P305, DOI 10.1038/nature07097; Newsom HE, 2007, J GEOPHYS RES-PLANET, V112, DOI 10.1029/2006JE002680; Pike WT, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL049896; Pommerol A, 2009, ICARUS, V204, P114, DOI 10.1016/j.icarus.2009.06.013; Poulet F, 2008, ASTRON ASTROPHYS, V487, pL41, DOI 10.1051/0004-6361:200810150; Poulet F, 2005, NATURE, V438, P623, DOI 10.1038/nature04274; Rampe EB, 2012, GEOLOGY, V40, P995, DOI 10.1130/G33215.1; Renno NO, 2009, J GEOPHYS RES-PLANET, V114, DOI 10.1029/2009JE003362; Rieder R, 2004, SCIENCE, V306, P1746, DOI 10.1126/science.1104358; Rogers AD, 2008, J GEOPHYS RES-PLANET, V113, DOI 10.1029/2007JE002995; Sautter V., 2013, GEOPH RES ABSTR, V15; Shoji S., 1993, VOLCANIC ASH SOILS G; Smith PH, 2009, SCIENCE, V325, P58, DOI 10.1126/science.1172339; SOIL SURVEY STAFF, 1999, SOIL TAX BAS SYST SO, V2nd; Taylor SR, 2009, PLANETARY CRUSTS: THEIR COMPOSITION, ORIGIN AND EVOLUTION, P1; Tokano T, 2005, J GEOPHYS RES-PLANET, V110, DOI 10.1029/2005JE002410; Wanke H, 2001, SPACE SCI REV, V96, P317, DOI 10.1023/A:1011961725645; Wiens RC, 2013, SPECTROCHIM ACTA B, V82, P1, DOI 10.1016/j.sab.2013.02.003; Wiens R. C., 2013, LUNAR PLANET SCI C, V44; Wiens RC, 2012, SPACE SCI REV, V170, P167, DOI 10.1007/s11214-012-9902-4; Williams RME, 2013, SCIENCE, V340, P1068, DOI 10.1126/science.1237317; Yen AS, 2005, NATURE, V436, P49, DOI 10.1038/nature03637	64	206	208	5	221	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 27	2013	341	6153							1238670	10.1126/science.1238670	http://dx.doi.org/10.1126/science.1238670			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	224NS	24072924				2022-12-28	WOS:000324894600001
J	Bourzac, K				Bourzac, Katherine			WATER The flow of technology	NATURE			English	Editorial Material							GROUNDWATER DEPLETION											Burney J, 2010, P NATL ACAD SCI USA, V107, P1848, DOI 10.1073/pnas.0909678107; Famiglietti JS, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046442; O'Shaughnessy SA, 2012, T ASABE, V55, P451; O'Shaughnessy SA, 2010, AGR WATER MANAGE, V97, P1310, DOI 10.1016/j.agwat.2010.03.012; Rodell M, 2009, NATURE, V460, P999, DOI 10.1038/nature08238; Segal E, 2006, PLANT SOIL, V282, P333, DOI 10.1007/s11104-006-0003-6; Voss KA, 2013, WATER RESOUR RES, V49, P904, DOI 10.1002/wrcr.20078	7	17	17	0	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 26	2013	501	7468					S4	S6		10.1038/501S4a	http://dx.doi.org/10.1038/501S4a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223RP	24067763	Bronze			2022-12-28	WOS:000324826300003
J	East, R				East, Roger			MICROBIOME Soil science comes to life	NATURE			English	Editorial Material																		Barrow Jerry R, 2008, Commun Integr Biol, V1, P69; Marasco R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048479; Redman RS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014823; Zolla G, 2013, APPL SOIL ECOL, V68, P1, DOI 10.1016/j.apsoil.2013.03.007	4	42	47	3	141	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 26	2013	501	7468					S18	S19		10.1038/501S18a	http://dx.doi.org/10.1038/501S18a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	223RP	24067761				2022-12-28	WOS:000324826300015
J	Loupy, A; Lefaucheur, C; Vernerey, D; Prugger, C; van Huyen, JPD; Mooney, N; Suberbielle, C; Fremeaux-Bacchi, V; Mejean, A; Desgrandchamps, F; Anglicheau, D; Nochy, D; Charron, D; Empana, JP; Delahousse, M; Legendre, C; Glotz, D; Hill, GS; Zeevi, A; Jouven, X				Loupy, Alexandre; Lefaucheur, Carmen; Vernerey, Dewi; Prugger, Christof; van Huyen, Jean-Paul Duong; Mooney, Nuala; Suberbielle, Caroline; Fremeaux-Bacchi, Veronique; Mejean, Arnaud; Desgrandchamps, Francois; Anglicheau, Dany; Nochy, Dominique; Charron, Dominique; Empana, Jean-Philippe; Delahousse, Michel; Legendre, Christophe; Glotz, Denis; Hill, Gary S.; Zeevi, Adriana; Jouven, Xavier			Complement-Binding Anti-HLA Antibodies and Kidney-Allograft Survival	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HUMAN-LEUKOCYTE ANTIGEN; MEDIATED REJECTION; C1Q ASSAY; CLASSIFICATION; DEPOSITION; DIAGNOSIS; FAILURE; MARKER	BackgroundAnti-HLA antibodies hamper successful transplantation, and activation of the complement cascade is involved in antibody-mediated rejection. We investigated whether the complement-binding capacity of anti-HLA antibodies plays a role in kidney-allograft failure. MethodsWe enrolled patients who received kidney allografts at two transplantation centers in Paris between January 1, 2005, and January 1, 2011, in a population-based study. Patients were screened for the presence of circulating donor-specific anti-HLA antibodies and their complement-binding capacity. Graft injury phenotype and the time to kidney-allograft loss were assessed. ResultsThe primary analysis included 1016 patients. Patients with complement-binding donor-specific anti-HLA antibodies after transplantation had the lowest 5-year rate of graft survival (54%), as compared with patients with non-complement-binding donor-specific anti-HLA antibodies (93%) and patients without donor-specific anti-HLA antibodies (94%) (P<0.001 for both comparisons). The presence of complement-binding donor-specific anti-HLA antibodies after transplantation was associated with a risk of graft loss that was more than quadrupled (hazard ratio, 4.78; 95% confidence interval [CI], 2.69 to 8.49) when adjusted for clinical, functional, histologic, and immunologic factors. These antibodies were also associated with an increased rate of antibody-mediated rejection, a more severe graft injury phenotype with more extensive microvascular inflammation, and increased deposition of complement fraction C4d within graft capillaries. Adding complement-binding donor-specific anti-HLA antibodies to a traditional risk model improved the stratification of patients at risk for graft failure (continuous net reclassification improvement, 0.75; 95% CI, 0.54 to 0.97). ConclusionsAssessment of the complement-binding capacity of donor-specific anti-HLA antibodies appears to be useful in identifying patients at high risk for kidney-allograft loss. This study showed that assessment of the complement-binding capacity of donor-specific anti-HLA antibodies may help identify patients at high risk for kidney-allograft loss and may improve risk stratification to guide treatment. Despite considerable advances in transplantation, the induced alloimmune response remains a major determinant of late kidney-allograft loss.(1)-(3) In the United States and Europe, thousands of kidney transplants fail each year, and kidney-allograft failure is a major cause of end-stage renal disease, leading to increased morbidity, mortality, and costs.(4),(5) One of the most important advances in transplantation medicine has been the recognition that anti-HLA antibodies are destructive.(6)-(10) Various studies over the past decade have indicated that the alloimmune response, mediated by anti-HLA antibodies, plays a key role in the failure of kidney allografts; this concept has been extended ...	[Loupy, Alexandre; Lefaucheur, Carmen; van Huyen, Jean-Paul Duong; Fremeaux-Bacchi, Veronique; Delahousse, Michel; Legendre, Christophe; Glotz, Denis; Jouven, Xavier] Paris Translat Res Ctr Organ Transplantat, Paris, France; [Loupy, Alexandre; Lefaucheur, Carmen; Vernerey, Dewi; Prugger, Christof; van Huyen, Jean-Paul Duong; Empana, Jean-Philippe; Jouven, Xavier] INSERM, U970, Paris, France; [Loupy, Alexandre; Anglicheau, Dany; Legendre, Christophe] Univ Paris 05, Hop Necker, Dept Kidney Transplantat, Paris, France; [Loupy, Alexandre; Anglicheau, Dany; Legendre, Christophe] AP HP, Paris, France; [Lefaucheur, Carmen; Glotz, Denis] Paris Diderot Univ, Hop St Louis, AP HP, Dept Nephrol & Kidney Transplantat, Paris, France; [Suberbielle, Caroline; Charron, Dominique] Paris Diderot Univ, Hop St Louis, AP HP, Dept Immunol & Histocompatibil, Paris, France; [Desgrandchamps, Francois] Paris Diderot Univ, Hop St Louis, AP HP, Dept Urol, Paris, France; [van Huyen, Jean-Paul Duong; Nochy, Dominique; Hill, Gary S.] Georges Pompidou European Hosp, Dept Pathol, Paris, France; [Fremeaux-Bacchi, Veronique] Georges Pompidou European Hosp, Dept Immunol, Paris, France; [Mejean, Arnaud] Georges Pompidou European Hosp, Dept Urol, Paris, France; [Mooney, Nuala; Glotz, Denis] INSERM, U940, Paris, France; [Delahousse, Michel] Foch Hosp, Dept Nephrol & Kidney Transplantat, Suresnes, France; [Zeevi, Adriana] Univ Pittsburgh, Med Ctr, Dept Transplantat Pathol, Pittsburgh, PA USA	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Hospital Foch; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Loupy, A (corresponding author), Paris Translat Res Ctr Organ Transplantat, Paris, France.	alexandreloupy@gmail.com	lefaucheur, carmen/AAS-7494-2020; Empana, Jean-Philippe/AAF-6923-2021; Loupy, Alexandre/K-8512-2019	Empana, Jean-Philippe/0000-0002-1469-7772; Glotz, Denis/0000-0001-5258-4237; Mooney, Nuala/0000-0002-3516-6882; Prugger, Christof/0000-0003-1845-0950				[Anonymous], 2012, AM J TRANSPLANT, V12, P1, DOI 10.1111/j.1600-6143.2011.03886.x; Bohmig GA, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V1341091; Chen G, 2011, HUM IMMUNOL, V72, P849, DOI 10.1016/j.humimm.2011.07.001; Chin C, 2011, J HEART LUNG TRANSPL, V30, P158, DOI 10.1016/j.healun.2010.08.020; Collins AB, 1999, J AM SOC NEPHROL, V10, P2208; Colvin RB, 2005, NAT REV IMMUNOL, V5, P807, DOI 10.1038/nri1702; Colvin RB, 2007, J AM SOC NEPHROL, V18, P1046, DOI 10.1681/ASN.2007010073; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; FEUCHT HE, 1991, CLIN EXP IMMUNOL, V86, P464; Freitas MCS, 2013, TRANSPLANTATION, V95, P1113, DOI 10.1097/TP.0b013e3182888db6; Gaston RS, 2010, TRANSPLANTATION, V90, P68, DOI 10.1097/TP.0b013e3181e065de; Hourmant M, 2005, J AM SOC NEPHROL, V16, P2804, DOI 10.1681/ASN.2004121130; Lachmann N, 2013, TRANSPLANTATION, V95, P694, DOI 10.1097/TP.0b013e31827b3dc3; Lachmann N, 2009, TRANSPLANTATION, V87, P1505, DOI 10.1097/TP.0b013e3181a44206; Lamb KE, 2011, AM J TRANSPLANT, V11, P450, DOI 10.1111/j.1600-6143.2010.03283.x; Lefaucheur C, 2009, AM J TRANSPLANT, V9, P1099, DOI 10.1111/j.1600-6143.2009.02591.x; Lefaucheur C, 2010, J AM SOC NEPHROL, V21, P1398, DOI 10.1681/ASN.2009101065; Loupy A, 2011, AM J TRANSPLANT, V11, P56, DOI 10.1111/j.1600-6143.2010.03364.x; Loupy A, 2010, TRANSPLANTATION, V89, P1403, DOI 10.1097/TP.0b013e3181da1cc3; Nankivell BJ, 2011, LANCET, V378, P1428, DOI 10.1016/S0140-6736(11)60699-5; Nankivell BJ, 2010, NEW ENGL J MED, V363, P1451, DOI 10.1056/NEJMra0902927; Otten HG, 2012, AM J TRANSPLANT, V12, P1618, DOI 10.1111/j.1600-6143.2011.03985.x; PATEL R, 1969, NEW ENGL J MED, V280, P735, DOI 10.1056/NEJM196904032801401; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pencina MJ, 2004, STAT MED, V23, P2109, DOI 10.1002/sim.1802; Racusen LC, 2003, AM J TRANSPLANT, V3, P708, DOI 10.1034/j.1600-6143.2003.00072.x; Racusen LC, 2006, CLIN J AM SOC NEPHRO, V1, P415, DOI 10.2215/CJN.01881105; Sellares J, 2012, AM J TRANSPLANT, V12, P388, DOI 10.1111/j.1600-6143.2011.03840.x; Sis B, 2009, AM J TRANSPLANT, V9, P2312, DOI 10.1111/j.1600-6143.2009.02761.x; Solez K, 2008, AM J TRANSPLANT, V8, P753, DOI 10.1111/j.1600-6143.2008.02159.x; Stegall MD, 2011, AM J TRANSPLANT, V11, P2405, DOI 10.1111/j.1600-6143.2011.03757.x; Sutherland SM, 2012, PEDIATR TRANSPLANT, V16, P12, DOI 10.1111/j.1399-3046.2011.01599.x; Terasaki PI, 2004, AM J TRANSPLANT, V4, P438, DOI 10.1111/j.1600-6143.2004.00360.x; Yabu JM, 2011, TRANSPLANTATION, V91, P342, DOI 10.1097/TP.0b013e318203fd26; Zeevi A, 2012, HUM IMMUNOL, V73, P48, DOI 10.1016/j.humimm.2011.10.011	35	604	622	0	36	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 26	2013	369	13					1215	1226		10.1056/NEJMoa1302506	http://dx.doi.org/10.1056/NEJMoa1302506			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	224LT	24066742				2022-12-28	WOS:000324888200008
J	Russell, TP				Russell, Thomas P.			Polymers Find Plenty of Wiggle Room at the Bottom	SCIENCE			English	Editorial Material									[Russell, Thomas P.] Univ Massachusetts, Dept Polymer Sci & Engn, Amherst, MA 01003 USA; [Russell, Thomas P.] Tohoku Univ, Adv Inst Mat Res, Aoba Ku, Sendai, Miyagi 9808577, Japan	University of Massachusetts System; University of Massachusetts Amherst; Tohoku University	Russell, TP (corresponding author), Univ Massachusetts, Dept Polymer Sci & Engn, Amherst, MA 01003 USA.	russell@mail.pse.umass.edu	Russell, Thomas Paul/ADL-3689-2022	Russell, Thomas Paul/0000-0001-6384-5826				BAHAR I, 1992, MACROMOLECULES, V25, P816, DOI 10.1021/ma00028a048; Feynman R.P., 1992, J MICROELECTROMECH S, V1, P60, DOI 10.1109/84.128057; Serghei A, 2013, NANO LETT, V13, P577, DOI 10.1021/nl304103y; Serghei A, 2010, SOFT MATTER, V6, P1111, DOI 10.1039/b921757f; Shin K, 2007, NAT MATER, V6, P961, DOI 10.1038/nmat2031; Tress M, 2013, SCIENCE, V341, P1371, DOI 10.1126/science.1238950	6	16	17	0	93	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 20	2013	341	6152					1351	1352		10.1126/science.1244110	http://dx.doi.org/10.1126/science.1244110			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	220PK	24052297				2022-12-28	WOS:000324597200031
J	Charles, R; Fadden, M; Brook, J				Charles, Robert; Fadden, Marc; Brook, Jacqueline			Acute epiglottitis	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MANAGEMENT		[Charles, Robert; Fadden, Marc; Brook, Jacqueline] Dewsbury Dist Hosp, Dept Anaesthet, Dewsbury WF13 4HS, England		Charles, R (corresponding author), Dewsbury Dist Hosp, Dept Anaesthet, Dewsbury WF13 4HS, England.	robertcharles@nhs.net						Ames WA, 2000, BRIT J ANAESTH, V85, P795, DOI 10.1093/bja/85.5.795; Caplan RA, 2003, ANESTHESIOLOGY, V98, P1269; Cook TM, 2011, MAJOR COMPLICATIONS, P204; Fink JB, 2006, RESPIR CARE, V51, P651; Henderson JJ, 2004, ANAESTHESIA, V59, P675, DOI 10.1111/j.1365-2044.2004.03831.x; Hess DR, 2006, RESPIR CARE, V51, P608; Mathoera RB, 2008, NETH J MED, V66, P373; McVernon J, 2004, BMJ-BRIT MED J, V329, P655, DOI 10.1136/bmj.329.7467.655; Park KW, 1998, ANESTHESIOLOGY, V88, P254, DOI 10.1097/00000542-199801000-00034; Reuben AD, 2004, EMERG MED J, V21, P131, DOI 10.1136/emj.2002.003483; Sack JL, 2002, POSTGRAD MED, V112, P81, DOI 10.3810/pgm.2002.07.1258; Smith SW, 1999, ACAD EMERG MED, V6, P953, DOI 10.1111/j.1553-2712.1999.tb01247.x	12	8	8	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 19	2013	347								f5235	10.1136/bmj.f5235	http://dx.doi.org/10.1136/bmj.f5235			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	223SY	24052580				2022-12-28	WOS:000324831500001
J	Forster, A; Dickerson, J; Young, J; Patel, A; Kalra, L; Nixon, J; Smithard, D; Knapp, M; Holloway, I; Anwar, S; Farrin, A				Forster, Anne; Dickerson, Josie; Young, John; Patel, Anita; Kalra, Lalit; Nixon, Jane; Smithard, David; Knapp, Martin; Holloway, Ivana; Anwar, Shamaila; Farrin, Amanda		TRACS Trial Collaboration	A structured training programme for caregivers of inpatients after stroke (TRACS): a cluster randomised controlled trial and cost-effectiveness analysis	LANCET			English	Article							ADMINISTERED VERSION; CARE GIVERS; SURVIVORS; BURDEN; IMPACT	Background Most patients who have had a stroke are dependent on informal caregivers for activities of daily living. The TRACS trial investigated a training programme for caregivers (the London Stroke Carers Training Course, LSCTC) on physical and psychological outcomes, including cost-effectiveness, for patients and caregivers after a disabling stroke. Methods We undertook a pragmatic, multicentre, cluster randomised controlled trial with a parallel cost-effectiveness analysis. Stroke units were eligible if four of five criteria used to define a stroke unit were met, a substantial number of patients on the unit had a diagnosis of stroke, staff were able to deliver the LSCTC, and most patients were discharged to a permanent place of residence. Stroke units were randomly assigned to either LSCTC or usual care (control group), stratified by geographical region and quality of care, and using blocks of size 2. Patients with a diagnosis of stroke, likely to return home with residual disability and with a caregiver providing support were eligible. The primary outcome for patients was self-reported extended activities of daily living at 6 months, measured with the Nottingham Extended Activities of Daily Living (NEADL) scale. The primary outcome for caregivers was self-reported burden at 6 months, measured with the caregivers burden scale (CBS). We combined patient and caregiver costs with primary outcomes and quality-adjusted life-years (QALYs) to assess cost-effectiveness. This trial is registered with controlled-trials.com, number ISRCTN 49208824. Findings We assessed 49 stroke units for eligibility, of which 36 were randomly assigned to either the intervention group or the control group. Between Feb 27, 2008, and Feb 9, 2010, 928 patient and caregiver dyads were registered, of which 450 were in the intervention group, and 478 in the control group. Patients' self-reported extended activities of daily living did not differ between groups at 6 months (adjusted mean NEADL score 27.4 in the intervention group versus 27.6 in the control group, difference -0.2 points [95% CI -3.0 to 2.5], p value=0.866, ICC=0.027). The caregiver burden scale did not differ between groups either (adjusted mean CBS 45.5 in the intervention group versus 45.0 in the control group, difference 0.5 points [95% CI -1.7 to 2.7], p value=0.660, ICC=0.013). Patient and caregiver costs were similar in both groups (length of the initial stroke admission and associated costs were 13 pound 127 for the intervention group and 12 pound 471 for the control group; adjusted mean difference 1243 pound [95% CI -1533 to 4019]; p value=0.380). Probabilities of cost-effectiveness based on QALYs were low. Interpretation In a large scale, robust evaluation, results from this study have shown no differences between the LSCTC and usual care on any of the assessed outcomes. The immediate period after stroke might not be the ideal time to deliver structured caregiver training.	[Forster, Anne; Dickerson, Josie; Young, John] Bradford Teaching Hosp NHS Fdn Trust, Acad Unit Elderly Care & Rehabil, Bradford, W Yorkshire, England; [Forster, Anne; Dickerson, Josie; Young, John] Univ Leeds, Bradford, W Yorkshire, England; [Patel, Anita; Knapp, Martin] Kings Coll London, Inst Psychiat, London WC2R 2LS, England; [Kalra, Lalit; Smithard, David] Kings Coll London, Dept Stroke Med, London WC2R 2LS, England; [Nixon, Jane; Holloway, Ivana; Anwar, Shamaila; Farrin, Amanda] Univ Leeds, Clin Trials Res Unit, Leeds, W Yorkshire, England; [Knapp, Martin] Univ London London Sch Econ & Polit Sci, Personal Social Serv Res Unit, London WC2A 2AE, England	University of Leeds; University of London; King's College London; University of London; King's College London; University of Leeds; University of London; London School Economics & Political Science	Forster, A (corresponding author), Bradford Royal Infirm, Acad Unit Elderly Care & Rehabil, Temple Bank House, Bradford BD9 6RJ, W Yorkshire, England.	a.forster@leeds.ac.uk	Patel, Anita/F-9832-2010	Farrin, Amanda/0000-0002-2876-0584; Knapp, Martin/0000-0003-1427-0215; Bowen, Audrey/0000-0003-4075-1215; Forster, Anne/0000-0001-7466-4414; Patel, Anita/0000-0003-0769-1732; young, john/0000-0003-4085-9306	Medical Research Council; MRC [G0501807] Funding Source: UKRI; Medical Research Council [G0501807] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Medical Research Council.	Brooke P, 1999, INT J GERIATR PSYCH, V14, P936, DOI 10.1002/(SICI)1099-1166(199911)14:11<936::AID-GPS39>3.3.CO;2-T; Brooks R, 1996, HEALTH POLICY, V37, P53, DOI 10.1016/0168-8510(96)00822-6; Carter J, 1997, CLIN REHABIL, V11, P131, DOI 10.1177/026921559701100206; Dennis M, 2003, STROKE, V34, P127, DOI 10.1161/01.STR.0000044165.41303.50; Dewey HM, 2002, STROKE, V33, P1028, DOI 10.1161/01.STR.0000013067.24300.B0; Duncan PW, 2002, CLIN REHABIL, V16, P493, DOI 10.1191/0269215502cr510oa; Elmstahl S, 1996, ARCH PHYS MED REHAB, V77, P177, DOI 10.1016/S0003-9993(96)90164-1; Forster A, 2012, INT J STROKE, V7, P94, DOI 10.1111/j.1747-4949.2011.00722.x; Gompertz P., 1994, CLIN REHABIL, V8, P233, DOI [DOI 10.1177/026921559400800308, 10.1177/026921559400800308]; Grant JS, 2013, TOP STROKE REHABIL, V20, P44, DOI 10.1310/tsr2001-44; Intercollegiate Stroke Working Party, 2006, NAT SENT STROK AUD 2; Intercollegiate Stroke Working Party, 2010, NAT SENT STROK AUD 2; Intercollegiate Stroke Working Party, 2008, NAT CLIN GUID STROK; Kalra L, 2004, BMJ-BRIT MED J, V328, P1099, DOI 10.1136/bmj.328.7448.1099; Larson J, 2005, J CLIN NURS, V14, P995, DOI 10.1111/j.1365-2702.2005.01206.x; Legg LA, 2011, COCHRANE DB SYST REV, V10; Lincoln N B, 1992, Disabil Rehabil, V14, P41; Mackenzie A, 2007, DISABIL REHABIL, V29, P111, DOI 10.1080/09638280600731599; Murray J, 2003, BRIT J GEN PRACT, V53, P803; National Audit Office, 2005, HC452 NAT AUD OFF; Nouri F., 1987, CLIN REHABIL, V1, P301, DOI [DOI 10.1177/026921558700100409, 10.1177/026921558700100409]; Parker CJ, 2001, CLIN REHABIL, V15, P42, DOI 10.1191/026921501666968247; Patel A, 2004, BMJ-BRIT MED J, V328, P1102, DOI 10.1136/bmj.328.7448.1102; Patel A, 2004, STROKE, V35, P196, DOI 10.1161/01.STR.0000105390.20430.9F; Rothwell PM, 2004, LANCET, V363, P1925, DOI 10.1016/S0140-6736(04)16405-2; Tooth L, 2005, BRAIN INJURY, V19, P963, DOI 10.1080/02699050500110785; Ukoumunne OC, 1999, HLTH TECHNOLOGY ASSE, V3, piii, DOI [DOI 10.3310/HTA3050, DOI 10.3310/hta3050]; Visser-Meily A, 2005, PATIENT EDUC COUNS, V56, P257, DOI 10.1016/j.pec.2004.02.013; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	29	85	88	0	39	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 21	2013	382	9910					2069	2076		10.1016/S0140-6736(13)61603-7	http://dx.doi.org/10.1016/S0140-6736(13)61603-7			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	275OX	24054816	Green Accepted			2022-12-28	WOS:000328687800027
J	ten Hoope-Bender, P				ten Hoope-Bender, Petra			Continuity of maternity carer for all women	LANCET			English	Editorial Material							HEALTH		ICS Integrare, CH-1202 Geneva, Switzerland		ten Hoope-Bender, P (corresponding author), ICS Integrare, CH-1202 Geneva, Switzerland.	petra.tenhoope@integrare.es						[Anonymous], 2016, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003519.PUB3; Hodnett ED, 2013, COCHRANE DB SYST REV, V5; International Confederation of Midwives, INTERNATIONAL DEFINI; Johanson R, 2002, BRIT MED J, V324, P892, DOI 10.1136/bmj.324.7342.892; Requejo J, 2012, COUNTDOWN TO 2015 MA; Sandall J, 2013, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD004667.pub3, 10.1002/14651858.CD004667.pub5]; Souza JP, 2013, LANCET, V381, P1747, DOI 10.1016/S0140-6736(13)60686-8; Tinajero AR, 2010, THE REVIEW OF CARE E; Tracy SK, 2013, LANCET, V382, P1723, DOI 10.1016/S0140-6736(13)61406-3; Villar J, 2006, LANCET, V367, P1819, DOI 10.1016/S0140-6736(06)68704-7	10	5	5	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 23	2013	382	9906					1685	1687		10.1016/S0140-6736(13)61793-6	http://dx.doi.org/10.1016/S0140-6736(13)61793-6			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	259PX	24050809				2022-12-28	WOS:000327539900008
J	Casalino, LP				Casalino, Lawrence P.			Professionalism and Caring for Medicaid Patients - The 5% Commitment?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PHYSICIANS; CARE	Refusing to care for poor, vulnerable patients seems incompatible with the core professional principle that physicians should put the patient's interest first. Could we ask all physicians to commit to including at least 5% Medicaid enrollees among their patients? Medicaid is an important federal-state partnership that provides health insurance for more than one fifth of the U.S. population 73 million low-income people in 2012. The Affordable Care Act will expand Medicaid coverage to millions more. But 30% of office-based physicians do not accept new Medicaid patients, and in some specialties, the rate of nonacceptance is much higher for example, 40% in orthopedics, 44% in general internal medicine, 45% in dermatology, and 56% in psychiatry.(1) Physicians practicing in higher-income areas are less likely to accept new Medicaid patients.(2) Physicians who do accept new Medicaid patients may use various ...	Weill Cornell Med Coll, Dept Publ Hlth, Div Outcomes & Effectiveness Res, New York, NY USA	Cornell University	Casalino, LP (corresponding author), Weill Cornell Med Coll, Dept Publ Hlth, Div Outcomes & Effectiveness Res, New York, NY USA.		Casalino, Lawrence/ABE-1245-2020	Casalino, Lawrence/0000-0002-7927-7859				Bisgaier J, 2011, NEW ENGL J MED, V364, P2324, DOI 10.1056/NEJMsa1013285; BURSTIN HR, 1993, JAMA-J AM MED ASSOC, V270, P1697, DOI 10.1001/jama.270.14.1697; Decker SL, 2013, HEALTH AFFAIR, V32, P1183, DOI 10.1377/hlthaff.2013.0361; Long SK, 2013, HEALTH AFFAIR, V32, P1560, DOI 10.1377/hlthaff.2012.1010; Sommers Anna S, 2011, Medicare Medicaid Res Rev, V1, DOI 10.5600/mmrr.001.02.a01	5	8	8	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 7	2013	369	19					1775	1777		10.1056/NEJMp1310974	http://dx.doi.org/10.1056/NEJMp1310974			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	247HF	24106910				2022-12-28	WOS:000326607800003
J	Caplan, A; Shah, NR				Caplan, Arthur; Shah, Nirav R.			Managing the Human Toll Caused by Seasonal Influenza New York State's Mandate to Vaccinate or Mask	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							HEALTH-CARE WORKERS		[Caplan, Arthur] NYU, Langone Med Ctr, Div Med Eth, New York, NY 10016 USA; [Shah, Nirav R.] New York State Dept Hlth, New York, NY USA	New York University; NYU Langone Medical Center	Caplan, A (corresponding author), NYU, Langone Med Ctr, Div Med Eth, 227 E 30th St,7th Floor, New York, NY 10016 USA.	arthur.caplan@nyumc.org	Shah, Nirav R./B-6622-2008	Shah, Nirav R./0000-0003-2044-7865				[Anonymous], VACCINE EFFECTIVENES; Bureau of Communicable Disease Control, STATEWIDE INFLUENZA; Caban-Martinez AJ, 2010, PREV MED, V50, P210, DOI 10.1016/j.ypmed.2010.01.001; Caplan A, 2011, LANCET, V378, P310, DOI 10.1016/S0140-6736(11)61156-2; CDC, WHAT YOU SHOULD KNOW; Lemaitre M, 2009, J AM GERIATR SOC, V57, P1580, DOI 10.1111/j.1532-5415.2009.02402.x; Rakita RM, 2010, INFECT CONT HOSP EP, V31, P881, DOI 10.1086/656210; Salgado CD, 2004, INFECT CONT HOSP EP, V25, P923, DOI 10.1086/502321	8	8	8	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 6	2013	310	17					1797	1798		10.1001/jama.2013.280633	http://dx.doi.org/10.1001/jama.2013.280633			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	246PH	24081030				2022-12-28	WOS:000326550900008
J	Vlastakis, B; Kirchmair, G; Leghtas, Z; Nigg, SE; Frunzio, L; Girvin, SM; Mirrahimi, M; Devoret, MH; Schoelkopf, RJ				Vlastakis, Brian; Kirchmair, Gerhard; Leghtas, Zaki; Nigg, Simon E.; Frunzio, Luigi; Girvin, S. M.; Mirrahimi, Mazyar; Devoret, M. H.; Schoelkopf, R. J.			Deterministically Encoding Quantum Information Using 100-Photon Schrodinger Cat States	SCIENCE			English	Article							SINGLE MICROWAVE PHOTONS; NUMBER STATES; CIRCUIT; DECOHERENCE; ELECTRODYNAMICS; FIELD	In contrast to a single quantum bit, an oscillator can store multiple excitations and coherences provided one has the ability to generate and manipulate complex multiphoton states. We demonstrate multiphoton control by using a superconducting transmon qubit coupled to a waveguide cavity resonator with a highly ideal off-resonant coupling. This dispersive interaction is much greater than decoherence rates and higher-order nonlinearities to allow simultaneous manipulation of hundreds of photons. With a tool set of conditional qubit-photon logic, we mapped an arbitrary qubit state to a superposition of coherent states, known as a "cat state." We created cat states as large as 111 photons and extended this protocol to create superpositions of up to four coherent states. This control creates a powerful interface between discrete and continuous variable quantum computation and could enable applications in metrology and quantum information processing.	[Vlastakis, Brian; Kirchmair, Gerhard; Leghtas, Zaki; Nigg, Simon E.; Frunzio, Luigi; Girvin, S. M.; Mirrahimi, Mazyar; Devoret, M. H.; Schoelkopf, R. J.] Yale Univ, Dept Phys, New Haven, CT 06511 USA; [Vlastakis, Brian; Kirchmair, Gerhard; Leghtas, Zaki; Nigg, Simon E.; Frunzio, Luigi; Girvin, S. M.; Mirrahimi, Mazyar; Devoret, M. H.; Schoelkopf, R. J.] Yale Univ, Dept Appl Phys, New Haven, CT 06511 USA; [Leghtas, Zaki; Mirrahimi, Mazyar] Inria Paris Rocquencourt, F-78153 Le Chesnay, France	Yale University; Yale University	Vlastakis, B (corresponding author), Yale Univ, Dept Phys, New Haven, CT 06511 USA.	brian.vlastakis@yale.edu	Frunzio, Luigi/O-1573-2019; Kirchmair, Gerhard/J-5218-2013; Schoelkopf, Robert J/J-8178-2012	Frunzio, Luigi/0000-0002-0272-5481; Kirchmair, Gerhard/0000-0003-4286-8839; Mirrahimi, Mazyar/0000-0001-9471-6031; Leghtas, Zaki/0000-0002-9172-1537	NSF [PHY-0969725, MRSECDMR 1119826, DMR-1004406]; Office of the Director of National Intelligence (ODNI); Intelligence Advanced Research Projects Activity (IARPA) through the Army Research Office [W911NF-09-1-0369]; U.S. Army Research Office [W911NF-09-1-0514]; Yale Institute for Nanoscience and Quantum Engineering (YINQE); French Agence Nationale de la Recherche under the project EPOQ2 [ANR-09-JCJC-0070]	NSF(National Science Foundation (NSF)); Office of the Director of National Intelligence (ODNI); Intelligence Advanced Research Projects Activity (IARPA) through the Army Research Office; U.S. Army Research Office; Yale Institute for Nanoscience and Quantum Engineering (YINQE); French Agence Nationale de la Recherche under the project EPOQ2(French National Research Agency (ANR))	We thank M. D. Reed, M. Hatridge, and T. L. Brecht for discussions. This research was supported by NSF (grant PHY-0969725), the Office of the Director of National Intelligence (ODNI), the Intelligence Advanced Research Projects Activity (IARPA) through the Army Research Office (W911NF-09-1-0369), and the U.S. Army Research Office (W911NF-09-1-0514). Facilities use was supported by the Yale Institute for Nanoscience and Quantum Engineering (YINQE) and NSF (MRSECDMR 1119826). S. M. G. and Z.L. acknowledge support from NSF (DMR-1004406). M. M. and Z.L. acknowledge support from French Agence Nationale de la Recherche under the project EPOQ2 (ANR-09-JCJC-0070).	Bertet P, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.200402; Boissonneault M, 2009, PHYS REV A, V79, DOI 10.1103/PhysRevA.79.013819; Braunstein SL, 2005, REV MOD PHYS, V77, P513, DOI 10.1103/RevModPhys.77.513; Brune M, 1996, PHYS REV LETT, V77, P4887, DOI 10.1103/PhysRevLett.77.4887; Caves CM, 2010, OPT COMMUN, V283, P695, DOI 10.1016/j.optcom.2009.10.065; Deleglise S, 2008, NATURE, V455, P510, DOI 10.1038/nature07288; DiCarlo L, 2009, NATURE, V460, P240, DOI 10.1038/nature08121; Eichler C, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.240501; Haroche S., 2006, EXPLORING QUANTUM; Hatridge M, 2013, SCIENCE, V339, P178, DOI 10.1126/science.1226897; Hofheinz M, 2009, NATURE, V459, P546, DOI 10.1038/nature08005; Houck AA, 2007, NATURE, V449, P328, DOI 10.1038/nature06126; Jeong H, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.042103; Johnson BR, 2010, NAT PHYS, V6, P663, DOI 10.1038/NPHYS1710; Kirchmair G, 2013, NATURE, V495, P205, DOI 10.1038/nature11902; Leek PJ, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.100504; Leghtas Z, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.120501; Leghtas Z, 2013, PHYS REV A, V87, DOI 10.1103/PhysRevA.87.042315; Lutterbach LG, 1997, PHYS REV LETT, V78, P2547, DOI 10.1103/PhysRevLett.78.2547; Mariantoni M, 2011, NAT PHYS, V7, P287, DOI [10.1038/nphys1885, 10.1038/NPHYS1885]; Miller R, 2005, J PHYS B-AT MOL OPT, V38, pS551, DOI 10.1088/0953-4075/38/9/007; Monroe C, 1996, SCIENCE, V272, P1131, DOI 10.1126/science.272.5265.1131; Nigg SE, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.243604; Ourjoumtsev A, 2007, NATURE, V448, P784, DOI 10.1038/nature06054; Paik H, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.240501; Raimond JM, 2005, J PHYS B-AT MOL OPT, V38, pS535, DOI 10.1088/0953-4075/38/9/006; Schuster DI, 2007, NATURE, V445, P515, DOI 10.1038/nature05461; Vijay R, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.110502; Wallraff A, 2004, NATURE, V431, P162, DOI 10.1038/nature02851; Zurek WH, 2001, NATURE, V412, P712, DOI 10.1038/35089017	31	379	387	1	89	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 1	2013	342	6158					607	610		10.1126/science.1243289	http://dx.doi.org/10.1126/science.1243289			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RJ	24072821				2022-12-28	WOS:000326334300045
J	Farihi, J; Gansicke, BT; Koester, D				Farihi, J.; Gaensicke, B. T.; Koester, D.			Evidence for Water in the Rocky Debris of a Disrupted Extrasolar Minor Planet	SCIENCE			English	Article							WHITE-DWARFS; ACCRETION; DUST; DIFFERENTIATION; DIFFUSION; METALS; DISKS	The existence of water in extrasolar planetary systems is of great interest because it constrains the potential for habitable planets and life. We have identified a circumstellar disk that resulted from the destruction of a water-rich and rocky extrasolar minor planet. The parent body formed and evolved around a star somewhat more massive than the Sun, and the debris now closely orbits the white dwarf remnant of the star. The stellar atmosphere is polluted with metals accreted from the disk, including oxygen in excess of that expected for oxide minerals, indicating that the parent body was originally composed of 26% water by mass. This finding demonstrates that water-bearing planetesimals exist around A- and F-type stars that end their lives as white dwarfs.	[Farihi, J.] Univ Cambridge, Inst Astron, Cambridge CB3 0HA, England; [Gaensicke, B. T.] Univ Warwick, Dept Phys, Coventry CV5 7AL, W Midlands, England; [Koester, D.] Univ Kiel, Inst Theoret Phys & Astrophys, D-24098 Kiel, Germany	University of Cambridge; University of Warwick; University of Kiel	Farihi, J (corresponding author), Univ Cambridge, Inst Astron, Madingley Rd, Cambridge CB3 0HA, England.	jfarihi@ast.cam.ac.uk	Gaensicke, Boris T/A-9421-2012	Gaensicke, Boris T/0000-0002-2761-3005; Farihi, Jay/0000-0003-1748-602X	NASA [NAS 5-26555]; W. M. Keck Foundation; UK Science and Technology Facilities Council [ST/J003344/1, ST/I001719/1]; European Research Council under the European Union [267697]; NOAO through the Telescope System Instrumentation Program [2011B-0554]; NSF;  [12169];  [12474]; STFC [ST/I001719/1, ST/K003453/1, ST/J003344/3, ST/J003344/2, ST/K003453/2, ST/J003344/1] Funding Source: UKRI; Science and Technology Facilities Council [ST/J003344/1, ST/J003344/3, ST/K003453/2, ST/K003453/1, ST/I001719/1, ST/J003344/2] Funding Source: researchfish	NASA(National Aeronautics & Space Administration (NASA)); W. M. Keck Foundation(W.M. Keck Foundation); UK Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); European Research Council under the European Union(European Research Council (ERC)); NOAO through the Telescope System Instrumentation Program; NSF(National Science Foundation (NSF)); ; ; STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	This work is based on observations made with the Hubble Space Telescope, which is operated by the Association of Universities for Research in Astronomy under NASA contract NAS 5-26555. These observations are associated with program programs 12169 and 12474. Some of the data presented herein were obtained at the W. M. Keck Observatory, which is operated as a scientific partnership among the California Institute of Technology, the University of California, and NASA. The Observatory was made possible by the generous financial support of the W. M. Keck Foundation. J.F. acknowledges support from the UK Science and Technology Facilities Council in the form of an Ernest Rutherford Fellowship (ST/J003344/1). The research leading to these results has received funding from the European Research Council under the European Union's Seventh Framework Programme (FP/2007-2013)/ERC Grant Agreement no. 267697 (WDTracer). B. T. G. was supported in part by the UK Science and Technology Facilities Council (ST/I001719/1). Keck telescope time for program 2011B-0554 was granted by NOAO through the Telescope System Instrumentation Program, funded by NSF.	Batalha NM, 2011, ASTROPHYS J, V729, DOI 10.1088/0004-637X/729/1/27; Debes JH, 2012, ASTROPHYS J, V747, DOI 10.1088/0004-637X/747/2/148; Desharnais S, 2008, ASTROPHYS J, V672, P540, DOI 10.1086/523699; Farihi J, 2008, ASTROPHYS J, V674, P431, DOI 10.1086/521715; Farihi J, 2012, MON NOT R ASTRON SOC, V421, P1635, DOI 10.1111/j.1365-2966.2012.20421.x; Farihi J, 2011, ASTROPHYS J LETT, V728, DOI 10.1088/2041-8205/728/1/L8; Farihi J, 2010, MON NOT R ASTRON SOC, V404, P2123, DOI 10.1111/j.1365-2966.2010.16426.x; Farihi J, 2010, ASTROPHYS J, V714, P1386, DOI 10.1088/0004-637X/714/2/1386; Farihi J, 2009, ASTROPHYS J, V694, P805, DOI 10.1088/0004-637X/694/2/805; Fressin F, 2012, NATURE, V482, P195, DOI 10.1038/nature10780; Gansicke BT, 2012, MON NOT R ASTRON SOC, V424, P333, DOI 10.1111/j.1365-2966.2012.21201.x; Gansicke BT, 2006, SCIENCE, V314, P1908, DOI 10.1126/science.1135033; Girven J, 2012, ASTROPHYS J, V749, DOI 10.1088/0004-637X/749/2/154; Jura M, 2008, ASTRON J, V135, P1785, DOI 10.1088/0004-6256/135/5/1785; Jura M, 2007, ASTROPHYS J, V663, P1285, DOI 10.1086/518767; Jura M, 2003, ASTROPHYS J, V584, pL91, DOI 10.1086/374036; Jura M, 2010, ASTRON J, V140, P1129, DOI 10.1088/0004-6256/140/5/1129; Jura M, 2009, ASTROPHYS J, V699, P1473, DOI 10.1088/0004-637X/699/2/1473; Jura M, 2009, ASTRON J, V137, P3191, DOI 10.1088/0004-6256/137/2/3191; Klein B, 2010, ASTROPHYS J, V709, P950, DOI 10.1088/0004-637X/709/2/950; Koester D, 2005, ASTRON ASTROPHYS, V439, P317, DOI 10.1051/0004-6361:20053058; Koester D, 2006, ASTRON ASTROPHYS, V453, P1051, DOI 10.1051/0004-6361:20064843; Koester D, 2009, ASTRON ASTROPHYS, V498, P517, DOI 10.1051/0004-6361/200811468; Lisse CM, 2012, ASTROPHYS J, V747, DOI 10.1088/0004-637X/747/2/93; Reach WT, 2005, ASTROPHYS J, V635, pL161, DOI 10.1086/499561; Rivkin A.S., 2002, ASTEROIDS, VIII, P235, DOI DOI 10.1038/NATURE09028; Russell CT, 2012, SCIENCE, V336, P684, DOI 10.1126/science.1219381; Sing DK, 2011, MON NOT R ASTRON SOC, V416, P1443, DOI 10.1111/j.1365-2966.2011.19142.x; Thomas PC, 2005, NATURE, V437, P224, DOI 10.1038/nature03938; Tremblay PE, 2008, ASTROPHYS J, V672, P1144, DOI 10.1086/524134; Visscher C, 2013, ASTROPHYS J LETT, V767, DOI 10.1088/2041-8205/767/1/L12; Xu S, 2012, ASTROPHYS J, V745, DOI 10.1088/0004-637X/745/1/88; Zuckerman B, 2007, ASTROPHYS J, V671, P872, DOI 10.1086/522223; Zuckerman B, 2003, ASTROPHYS J, V596, P477, DOI 10.1086/377492	34	114	114	3	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 11	2013	342	6155					218	220		10.1126/science.1239447	http://dx.doi.org/10.1126/science.1239447			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232EV	24115434	Green Submitted, Green Accepted			2022-12-28	WOS:000325475200037
J	Forster, S; Meinel, K; Hammer, R; Trautmann, M; Widdra, W				Foerster, Stefan; Meinel, Klaus; Hammer, Rene; Trautmann, Martin; Widdra, Wolf			Quasicrystalline structure formation in a classical crystalline thin-film system	NATURE			English	Article							TRANSLATIONAL SYMMETRY; BATIO3 FILMS; PT(111); ORDER	The discovery of quasicrystals(1)-crystalline structures that show order while lacking periodicity-forced a paradigm shift in crystallography. Initially limited to intermetallic systems(1-4), the observation of quasicrystalline structures has recently expanded to include 'soft' quasicrystals in the fields of colloidal and supermolecular chemistry(5-9). Here we report an aperiodic oxide that grows as a two-dimensional quasicrystal on a periodic single-element substrate. On a Pt(111) substrate with 3-fold symmetry, the perovskite barium titanate BaTiO3 forms a high-temperature interface-driven structure with 12-fold symmetry. The building blocks of this dodecagonal structure assemble with the theoretically predicted Stampfli-Gahler tiling(10,11) having a fundamental length-scale of 0.69 nm. This example of interface-driven formation of ultrathin quasicrystals from a typical periodic perovskite oxide potentially extends the quasicrystal concept to a broader range of materials. In addition, it demonstrates that frustration at the interface between two periodic materials can drive a thin film into an aperiodic quasicrystalline phase, as proposed previously(12). Such structures might also find use as ultrathin buffer layers for the accommodation of large lattice mismatches in conventional epitaxy(13).	[Foerster, Stefan; Meinel, Klaus; Hammer, Rene; Trautmann, Martin; Widdra, Wolf] Univ Halle Wittenberg, Inst Phys, D-06120 Halle, Germany; [Widdra, Wolf] Max Planck Inst Mikrostrukturphys, D-06120 Halle, Germany	Martin Luther University Halle Wittenberg; Max Planck Society	Widdra, W (corresponding author), Univ Halle Wittenberg, Inst Phys, D-06120 Halle, Germany.	wolf.widdra@physik.uni-halle.de	Widdra, Wolf/J-5225-2012	Widdra, Wolf/0000-0003-1884-8715	Deutsche Forschungsgemeinschaft [Sonderforschungsbereich 762]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank P. A. Thiel for discussions, R. Kulla for technical support, and E. M. Zollner for assisting in sample preparation. Financial support was provided by Deutsche Forschungsgemeinschaft Sonderforschungsbereich 762 'Functionality of Oxidic Interfaces'.	BENDERSKY L, 1985, PHYS REV LETT, V55, P1461, DOI 10.1103/PhysRevLett.55.1461; Dotera T, 2011, ISR J CHEM, V51, P1197, DOI 10.1002/ijch.201100146; Forster S, 2012, SURF INTERFACE ANAL, V44, P628, DOI 10.1002/sia.4812; Forster S, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3633703; Forster S, 2010, SURF SCI, V604, P2163, DOI 10.1016/j.susc.2010.09.009; Franke KJ, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.036103; Franke KJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett89.156104; Gahler F., 1988, QUASICRYSTALLINE MAT, P272; Hayashida K, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.195502; ISHIMASA T, 1985, PHYS REV LETT, V55, P511, DOI 10.1103/PhysRevLett.55.511; Li GH, 1997, APPL PHYS LETT, V71, P897, DOI 10.1063/1.119681; Mikhael J, 2008, NATURE, V454, P501, DOI 10.1038/nature07074; NIIZEKI N, 1987, J PHYS A-MATH GEN, V20, pL405, DOI 10.1088/0305-4470/20/6/012; Seah M. P., 1979, Surface and Interface Analysis, V1, P2, DOI 10.1002/sia.740010103; SHECHTMAN D, 1984, PHYS REV LETT, V53, P1951, DOI 10.1103/PhysRevLett.53.1951; Smith AR, 1996, SCIENCE, V273, P226, DOI 10.1126/science.273.5272.226; STAMPFLI P, 1986, HELV PHYS ACTA, V59, P1260; Talapin DV, 2009, NATURE, V461, P964, DOI 10.1038/nature08439; WANG N, 1987, PHYS REV LETT, V59, P1010, DOI 10.1103/PhysRevLett.59.1010; Zeng XB, 2004, NATURE, V428, P157, DOI 10.1038/nature02368	20	115	117	4	273	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 10	2013	502	7470					215	+		10.1038/nature12514	http://dx.doi.org/10.1038/nature12514			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RU	24108053				2022-12-28	WOS:000325436100046
J	Zeron-Medina, J; Wang, XT; Repapi, E; Campbell, MR; Su, D; Castro-Giner, F; Davies, B; Peterse, EFP; Sacilotto, N; Walker, GJ; Terzian, T; Tomlinson, IP; Box, NF; Meinshausen, N; De Val, S; Bell, DA; Bond, GL				Zeron-Medina, Jorge; Wang, Xuting; Repapi, Emmanouela; Campbell, Michelle R.; Su, Dan; Castro-Giner, Francesc; Davies, Benjamin; Peterse, Elisabeth F. P.; Sacilotto, Natalia; Walker, Graeme J.; Terzian, Tamara; Tomlinson, Ian P.; Box, Neil F.; Meinshausen, Nicolai; De Val, Sarah; Bell, Douglas A.; Bond, Gareth L.			A Polymorphic p53 Response Element in KIT Ligand Influences Cancer Risk and Has Undergone Natural Selection	CELL			English	Article							GERM-CELL CANCER; SINGLE-NUCLEOTIDE POLYMORPHISMS; TUMOR-SUPPRESSOR PATHWAY; FACTOR-BINDING-SITES; TESTICULAR CANCER; HUMAN GENOME; DNA-DAMAGE; TRANSCRIPTIONAL ACTIVATION; HAPLOTYPE STRUCTURE; GENETIC-VARIANTS	The ability of p53 to regulate transcription is crucial for tumor suppression and implies that inherited polymorphisms in functional p53-binding sites could influence cancer. Here, we identify a polymorphic p53 responsive element and demonstrate its influence on cancer risk using genome-wide data sets of cancer susceptibility loci, genetic variation, p53 occupancy, and p53-binding sites. We uncover a single-nucleotide polymorphism (SNP) in a functional p53-binding site and establish its influence on the ability of p53 to bind to and regulate transcription of the KITLG gene. The SNP resides in KITLG and associates with one of the largest risks identified among cancer genome-wide association studies. We establish that the SNP has undergone positive selection throughout evolution, signifying a selective benefit, but go on to show that similar SNPs are rare in the genome due to negative selection, indicating that polymorphisms in p53-binding sites are primarily detrimental to humans.	[Zeron-Medina, Jorge; Repapi, Emmanouela; Peterse, Elisabeth F. P.; Sacilotto, Natalia; De Val, Sarah; Bond, Gareth L.] Univ Oxford, Nuffield Dept Clin Med, Ludwig Inst Canc Res, Oxford OX3 7DQ, England; [Wang, Xuting; Campbell, Michelle R.; Su, Dan; Bell, Douglas A.] NIEHS, Environm Genom Grp, Mol Genet Lab, NIH, Res Triangle Pk, NC 27709 USA; [Castro-Giner, Francesc; Tomlinson, Ian P.] Univ Oxford, Wellcome Trust Ctr Human Genet, Mol & Populat Genet Lab, Oxford OX3 7BN, England; [Davies, Benjamin] Univ Oxford, Wellcome Trust Ctr Human Genet, Transgen Technol Res Grp, Oxford OX3 7BN, England; [Walker, Graeme J.] Queensland Inst Med Res, Skin Carcinogenesis Lab, Herston, Qld 4006, Australia; [Terzian, Tamara; Box, Neil F.] Univ Colorado Denver, Dept Dermatol, Aurora, CO 80045 USA; [Terzian, Tamara; Box, Neil F.] Univ Colorado Denver, Charles C Gates Ctr Regenerat Med & Stem Cell Bio, Aurora, CO 80045 USA; [Meinshausen, Nicolai] Univ Oxford, Dept Stat, Oxford OX1 3TG, England	Ludwig Institute for Cancer Research; University of Oxford; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; Wellcome Centre for Human Genetics; QIMR Berghofer Medical Research Institute; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Oxford	Bell, DA (corresponding author), NIEHS, Environm Genom Grp, Mol Genet Lab, NIH, POB 12233, Res Triangle Pk, NC 27709 USA.	bell1@niehs.nih.gov; gareth.bond@ndm.ox.ac.uk	Bell, Douglas A/C-7687-2019; su, dan/GYJ-1940-2022; Davies, Ben/GYD-9163-2022; Castro-Giner, Francesc/D-7992-2014; Box, Neil/F-3591-2010; Zeron-Medina, Jorge/E-2480-2013	Bell, Douglas A/0000-0001-7700-0840; Davies, Ben/0000-0003-3405-507X; Castro-Giner, Francesc/0000-0001-6111-0754; Box, Neil/0000-0002-3486-0346; Zeron-Medina, Jorge/0000-0001-5030-3219; Davies, Benjamin/0000-0003-3623-600X; /0000-0001-8085-0731; Wang, Xuting/0000-0001-6781-8008	Ludwig Institute for Cancer Research; Development Fund-Oxford Cancer Research Centre-University of Oxford; Nuffield Department of Medicine; Clarendon Fund; Wellcome Trust [090532/Z/09/Z]; Oxford NIHR Comprehensive Biomedical Research Centre; Intramural Research Program of the National Institute of Environmental Health Sciences-National Institutes of Health [Z01ES100475, Z01ES046008]; Australian NHMRC; NIAMS [1P30AR057212, 5K01AR063203]; Cancer Council of Queensland; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR057212, K01AR063203] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES046008, Z01ES100475, ZIAES100475, Z01ES065079, ZIAES046008] Funding Source: NIH RePORTER; British Heart Foundation [PG/10/83/28610] Funding Source: researchfish; Medical Research Council [MR/J007765/1] Funding Source: researchfish; MRC [MR/J007765/1] Funding Source: UKRI	Ludwig Institute for Cancer Research; Development Fund-Oxford Cancer Research Centre-University of Oxford; Nuffield Department of Medicine; Clarendon Fund; Wellcome Trust(Wellcome TrustEuropean Commission); Oxford NIHR Comprehensive Biomedical Research Centre; Intramural Research Program of the National Institute of Environmental Health Sciences-National Institutes of Health; Australian NHMRC(National Health and Medical Research Council (NHMRC) of Australia); NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Cancer Council of Queensland(Cancer Council Queensland); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded in part by the Ludwig Institute for Cancer Research, the Development Fund-Oxford Cancer Research Centre-University of Oxford, the Nuffield Department of Medicine, the Clarendon Fund, the Wellcome Trust (090532/Z/09/Z), the Oxford NIHR Comprehensive Biomedical Research Centre, the Intramural Research Program of the National Institute of Environmental Health Sciences-National Institutes of Health (projects: Z01ES100475 and Z01ES046008), the Australian NHMRC, Cancer Council of Queensland and the NIAMS (projects: 1P30AR057212 and 5K01AR063203). The authors would like to acknowledge Daniel Biggs and Nicole Hortin for assistance with ES cell culture; Shuangshuang Dai for Linux computing support; Colin Goding and Will Fairbrother for helpful discussions; and Suzanne Christen, Claire Beveridge, Elisabeth Bond, and Mark Shipman for help with the preparation of this manuscript.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Amigo J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-428; Atwal GS, 2007, P NATL ACAD SCI USA, V104, P4524, DOI 10.1073/pnas.0610998104; Atwal GS, 2009, P NATL ACAD SCI USA, V106, P10236, DOI 10.1073/pnas.0901298106; Bandele OJ, 2011, NUCLEIC ACIDS RES, V39, P178, DOI 10.1093/nar/gkq764; Beckerman R, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000935; BECKMAN G, 1994, HUM HERED, V44, P266, DOI 10.1159/000154228; Belyi VA, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001198; Bieging KT, 2012, TRENDS CELL BIOL, V22, P97, DOI 10.1016/j.tcb.2011.10.006; Bond GL, 2004, CELL, V119, P591, DOI 10.1016/j.cell.2004.11.022; Bosl GJ, 1997, NEW ENGL J MED, V337, P242, DOI 10.1056/NEJM199707243370406; Botcheva K, 2011, CELL CYCLE, V10, P4237, DOI 10.4161/cc.10.24.18383; Chanock S, 2009, NAT GENET, V41, P765, DOI 10.1038/ng0709-765; Chao C, 2000, EMBO J, V19, P4967, DOI 10.1093/emboj/19.18.4967; Chen CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023376; Chia VM, 2010, CANCER EPIDEM BIOMAR, V19, P1151, DOI 10.1158/1055-9965.EPI-10-0031; Chresta CM, 1996, CANCER RES, V56, P1834; CROOK T, 1994, CELL, V79, P817, DOI 10.1016/0092-8674(94)90071-X; Czene K, 2002, INT J CANCER, V99, P260, DOI 10.1002/ijc.10332; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Freed-Pastor WA, 2012, GENE DEV, V26, P1268, DOI 10.1101/gad.190678.112; Garner MJ, 2005, INT J CANCER, V116, P331, DOI 10.1002/ijc.21032; Gautier M, 2012, BIOINFORMATICS, V28, P1176, DOI 10.1093/bioinformatics/bts115; Gilbert D, 2011, NAT REV CANCER, V11, P278, DOI 10.1038/nrc3021; Gutekunst M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019198; Hitz C, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm475; Holmes L, 2008, PUBLIC HEALTH, V122, P862, DOI 10.1016/j.puhe.2007.10.010; Houldsworth J, 1998, ONCOGENE, V16, P2345, DOI 10.1038/sj.onc.1201770; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Jolma A, 2013, CELL, V152, P327, DOI 10.1016/j.cell.2012.12.009; Junttila MR, 2009, NAT REV CANCER, V9, P821, DOI 10.1038/nrc2728; Kanetsky PA, 2009, NAT GENET, V41, P811, DOI 10.1038/ng.393; KOTHARY R, 1988, NATURE, V335, P435, DOI 10.1038/335435a0; Lane D, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000893; Lao O, 2007, ANN HUM GENET, V71, P354, DOI 10.1111/j.1469-1809.2006.00341.x; Lennartsson J, 2012, PHYSIOL REV, V92, P1619, DOI 10.1152/physrev.00046.2011; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Lu WJ, 2009, NAT REV CANCER, V9, P758, DOI 10.1038/nrc2732; Lu X, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000984; Lutzker SG, 1998, APMIS, V106, P85, DOI 10.1111/j.1699-0463.1998.tb01323.x; Lutzker SG, 1996, NAT MED, V2, P804, DOI 10.1038/nm0796-804; MALKIN D, 1990, SCIENCE, V250, P1233, DOI 10.1126/science.1978757; Masters JRW, 2003, NAT REV CANCER, V3, P517, DOI 10.1038/nrc1120; McGowan KA, 2008, NAT GENET, V40, P963, DOI 10.1038/ng.188; MOUL JW, 1994, CANCER, V73, P388, DOI 10.1002/1097-0142(19940115)73:2<388::AID-CNCR2820730225>3.0.CO;2-Q; Murase D, 2009, J BIOL CHEM, V284, P4343, DOI 10.1074/jbc.M805570200; Nikulenkov F, 2012, CELL DEATH DIFFER, V19, P1992, DOI 10.1038/cdd.2012.89; Noureddine MA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000462; PENG HQ, 1993, CANCER RES, V53, P3574; PIETENPOL JA, 1994, P NATL ACAD SCI USA, V91, P1998, DOI 10.1073/pnas.91.6.1998; Post SM, 2010, CANCER CELL, V18, P220, DOI 10.1016/j.ccr.2010.07.010; Rapley EA, 2009, NAT GENET, V41, P807, DOI 10.1038/ng.394; ROSS RK, 1979, BRIT J CANCER, V39, P284, DOI 10.1038/bjc.1979.53; Schodel J, 2012, NAT GENET, V44, P420, DOI 10.1038/ng.2204; Shi H, 2009, AM J HUM GENET, V84, P534, DOI 10.1016/j.ajhg.2009.03.009; Smeenk L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017574; Sperka T, 2012, NAT REV MOL CELL BIO, V13, P579, DOI 10.1038/nrm3420; Sur IK, 2012, SCIENCE, V338, P1360, DOI 10.1126/science.1228606; Terzian T, 2010, PIGM CELL MELANOMA R, V23, P781, DOI 10.1111/j.1755-148X.2010.00773.x; Turnbull C, 2010, NAT GENET, V42, P604, DOI 10.1038/ng.607; Valouev A, 2008, NAT METHODS, V5, P829, DOI 10.1038/NMETH.1246; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Walker GJ, 2009, J INVEST DERMATOL, V129, P184, DOI 10.1038/jid.2008.210; Wang XT, 2007, HUM MOL GENET, V16, P1188, DOI 10.1093/hmg/ddm066; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043	65	97	99	0	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 10	2013	155	2					410	422		10.1016/j.cell.2013.09.017	http://dx.doi.org/10.1016/j.cell.2013.09.017			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	235LH	24120139	Bronze, Green Accepted			2022-12-28	WOS:000325719800017
J	Chisnall, B				Chisnall, Ben			Lister restaged: one sure step for science and safer surgery A re-enactment of Joseph Lister's inaugural lecture at King's College London demonstrated to a modern audience the magnitude of the aseptic surgery revolution	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Kings Coll London, London, England	University of London; King's College London	Chisnall, B (corresponding author), Kings Coll London, London, England.	ben.b.chisnall@kcl.ac.uk		Chisnall, Ben/0000-0002-2495-3186				Bonnin J G, 1967, J Bone Joint Surg Br, V49, P4; Lister J, 1877, Br Med J, V2, P465	2	1	1	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 9	2013	347								f6075	10.1136/bmj.f6075	http://dx.doi.org/10.1136/bmj.f6075			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	235ON	24108170				2022-12-28	WOS:000325729100019
J	Inzinger, M; Massone, C; Arzberger, E; Hofmann-Wellenhof, R				Inzinger, Martin; Massone, Cesare; Arzberger, Edith; Hofmann-Wellenhof, Rainer			Hair repigmentation in melanoma	LANCET			English	Editorial Material									[Inzinger, Martin; Massone, Cesare; Arzberger, Edith; Hofmann-Wellenhof, Rainer] Med Univ Graz, Dept Dermatol, A-8036 Graz, Austria	Medical University of Graz	Inzinger, M (corresponding author), Med Univ Graz, Dept Dermatol, Auenbrugger Pl 8, A-8036 Graz, Austria.	martin.inzinger@medunigraz.at		massone, cesare/0000-0002-0996-643X				Argenziano G, 2012, J AM ACAD DERMATOL, V67, P54, DOI 10.1016/j.jaad.2011.07.019; Blume-Peytavi U., 2008, HAIR GROWTH DISORDER; Dummer R, 2001, LANCET, V357, P598, DOI 10.1016/S0140-6736(00)04059-9; Garbe C, 2012, EUR J CANCER, V48, P2375, DOI 10.1016/j.ejca.2012.06.013; Gershenwald JE, 2011, NEW ENGL J MED, V364, P1738, DOI 10.1056/NEJMct1002967	5	8	8	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 5	2013	382	9899					1224	1224		10.1016/S0140-6736(13)61604-9	http://dx.doi.org/10.1016/S0140-6736(13)61604-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	228SL	24095196				2022-12-28	WOS:000325209100027
J	de Goeij, JM; van Oevelen, D; Vermeij, MJA; Osinga, R; Middelburg, JJ; de Goeij, AFPM; Admiraal, W				de Goeij, Jasper M.; van Oevelen, Dick; Vermeij, Mark J. A.; Osinga, Ronald; Middelburg, Jack J.; de Goeij, Anton F. P. M.; Admiraal, Wim			Surviving in a Marine Desert: The Sponge Loop Retains Resources Within Coral Reefs	SCIENCE			English	Article							ORGANIC-CARBON; HALISARCA-CAERULEA; POPULATIONS; COMMUNITY; REMOVAL; PRODUCTIVITY; MICROBES; BACTERIA; MATTER; DOC	Ever since Darwin's early descriptions of coral reefs, scientists have debated how one of the world's most productive and diverse ecosystems can thrive in the marine equivalent of a desert. It is an enigma how the flux of dissolved organic matter (DOM), the largest resource produced on reefs, is transferred to higher trophic levels. Here we show that sponges make DOM available to fauna by rapidly expelling filter cells as detritus that is subsequently consumed by reef fauna. This "sponge loop" was confirmed in aquarium and in situ food web experiments, using C-13- and N-15-enriched DOM. The DOM-sponge-fauna pathway explains why biological hot spots such as coral reefs persist in oligotrophic seas-the reef's paradox-and has implications for reef ecosystem functioning and conservation strategies.	[de Goeij, Jasper M.; Admiraal, Wim] Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Dept Aquat Ecol & Ecotoxicol, POB 94248, NL-1090 GE Amsterdam, Netherlands; [van Oevelen, Dick] NIOZ Royal Netherlands Inst Sea Res, Dept Ecosyst Studies, NL-4400 AC Yerseke, Netherlands; [Vermeij, Mark J. A.] Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Dept Aquat Microbiol, Willemstad, Curacao, Netherlands; [Osinga, Ronald] Wageningen Univ, Dept Aquaculture & Fisheries, NL-6700 AH Wageningen, Netherlands; [Middelburg, Jack J.] Univ Utrecht, Fac Geosci, NL-3584 CD Utrecht, Netherlands; [de Goeij, Anton F. P. M.] Maastricht Univ, Fac Hlth Med & Life Sci, NL-6200 MD Maastricht, Netherlands	University of Amsterdam; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); University of Amsterdam; Wageningen University & Research; Utrecht University; Maastricht University	de Goeij, JM (corresponding author), Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Dept Aquat Ecol & Ecotoxicol, POB 94248, NL-1090 GE Amsterdam, Netherlands.	j.m.degoeij@uva.nl	Middelburg, Jack/B-4951-2011; Vermeij, Mark/AAR-6757-2020; Vermeij, Mark/B-2752-2013; de Goeij, Jasper/L-6992-2017	Middelburg, Jack/0000-0003-3601-9072; Vermeij, Mark/0000-0001-9612-9527; Vermeij, Mark/0000-0001-9612-9527; de Goeij, Jasper/0000-0002-3411-3084	Innovational Research Incentives Scheme of the Netherlands Organization for Scientific Research (NWO-VENI) [863.10.009]; Schure-Beijerinck-Popping fund	Innovational Research Incentives Scheme of the Netherlands Organization for Scientific Research (NWO-VENI); Schure-Beijerinck-Popping fund	J.M.d.G. and D.v.O. contributed equally to this work. We thank D. M. de Bakker, C. G. W. Whalen, and B. E. Alexander for their technical assistance in the field and lab; C. E. Mueller, and P. van Rijswijk for preparation of the DOM substrate, lab assistance, and isotope analysis; and E. R. Hunting for discussion. This work was supported financially by the Innovational Research Incentives Scheme of the Netherlands Organization for Scientific Research (NWO-VENI; 863.10.009, granted to J.M.d.G.) and the Schure-Beijerinck-Popping fund. J.M.d.G. and R.O. are also affiliated with Porifarma BV Poelbos 3, 6718 HT Ede, Netherlands. The authors declare no conflicts of interest. A detailed description of all materials and methods and additional data are available as supplementary materials. All authors discussed the experimental data and jointly wrote the manuscript. The data are deposited in DRYAD, accession no. http://doi.org/10.5061/dryad.4gb17.	Atkinson M.J., 2003, BIOGEOCHEMISTRY MARI, P40; AZAM F, 1983, MAR ECOL PROG SER, V10, P257, DOI 10.3354/meps010257; Bowen BW, 2013, TRENDS ECOL EVOL, V28, P359, DOI 10.1016/j.tree.2013.01.018; CROSSLAND CJ, 1991, CORAL REEFS, V10, P55, DOI 10.1007/BF00571824; De Goeij JM, 2009, J EXP BIOL, V212, P3892, DOI 10.1242/jeb.034561; de Goeij JM, 2008, MAR ECOL PROG SER, V357, P139, DOI 10.3354/meps07403; de Goeij JM, 2008, LIMNOL OCEANOGR, V53, P1376, DOI 10.4319/lo.2008.53.4.1376; de Goeij JM, 2007, LIMNOL OCEANOGR, V52, P2608, DOI 10.4319/lo.2007.52.6.2608; Dubinsky Z, 2001, AQUAT SCI, V63, P4, DOI 10.1007/PL00001343; Gonzalez-Rivero M, 2011, ECOL MODEL, V222, P1847, DOI 10.1016/j.ecolmodel.2011.03.020; Haas AF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027973; Haas AF, 2010, J EXP MAR BIOL ECOL, V389, P53, DOI 10.1016/j.jembe.2010.03.018; HATCHER BG, 1990, TRENDS ECOL EVOL, V5, P149, DOI 10.1016/0169-5347(90)90221-X; Hughes TP, 2007, CURR BIOL, V17, P360, DOI 10.1016/j.cub.2006.12.049; McMurray SE, 2010, ECOLOGY, V91, P560, DOI 10.1890/08-2060.1; Nelson CE, 2011, ISME J, V5, P1374, DOI 10.1038/ismej.2011.12; Norstrom AV, 2009, MAR ECOL PROG SER, V376, P295, DOI 10.3354/meps07815; ODUM HT, 1955, ECOL MONOGR, V25, P291, DOI 10.2307/1943285; REISWIG HM, 1971, BIOL BULL, V141, P568, DOI 10.2307/1540270; Ribes M, 2012, ENVIRON MICROBIOL, V14, P1224, DOI 10.1111/j.1462-2920.2012.02701.x; Richter C, 2001, NATURE, V413, P726, DOI 10.1038/35099547; Sandin SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001548; Scheffers SR, 2004, CORAL REEFS, V23, P413, DOI 10.1007/s00338-004-0400-3; Slattery M, 2013, MAR ECOL PROG SER, V476, P71, DOI 10.3354/meps10139; Southwell MW, 2008, LIMNOL OCEANOGR, V53, P986, DOI 10.4319/lo.2008.53.3.0986; Tanaka Y, 2008, B MAR SCI, V82, P237; van Oevelen D, 2009, LIMNOL OCEANOGR, V54, P1829, DOI 10.4319/lo.2009.54.6.1829; Wild C, 2004, NATURE, V428, P66, DOI 10.1038/nature02344; Witte U, 1997, MAR ECOL PROG SER, V154, P241, DOI 10.3354/meps154241; Yahel G, 2003, LIMNOL OCEANOGR, V48, P141, DOI 10.4319/lo.2003.48.1.0141	30	411	415	16	287	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 4	2013	342	6154					108	110		10.1126/science.1241981	http://dx.doi.org/10.1126/science.1241981			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	227PP	24092742				2022-12-28	WOS:000325126100056
J	Thomas, CD				Thomas, Chris D.			The Anthropocene could raise biological diversity	NATURE			English	Editorial Material									Univ York, York YO10 5DD, N Yorkshire, England	University of York - UK	Thomas, CD (corresponding author), Univ York, York YO10 5DD, N Yorkshire, England.	chris.thomas@york.ac.uk	Thomas, Chris D/A-1894-2012; Thomas, Chris D/A-1460-2014	Thomas, Chris D/0000-0003-2822-1334; Thomas, Chris D/0000-0003-2822-1334					0	72	77	1	170	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 3	2013	502	7469					7	7		10.1038/502007a	http://dx.doi.org/10.1038/502007a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	227IM	24091946	Bronze			2022-12-28	WOS:000325106000004
J	Gibson, L; Lynam, AJ; Bradshaw, CJA; He, FL; Bickford, DP; Woodruff, DS; Bumrungsri, S; Laurance, WF				Gibson, Luke; Lynam, Antony J.; Bradshaw, Corey J. A.; He, Fangliang; Bickford, David P.; Woodruff, David S.; Bumrungsri, Sara; Laurance, William F.			Near-Complete Extinction of Native Small Mammal Fauna 25 Years After Forest Fragmentation	SCIENCE			English	Article							SPECIES LOSS; DEFORESTATION; BIODIVERSITY; RATES; AREA	Tropical forests continue to be felled and fragmented around the world. A key question is how rapidly species disappear from forest fragments and how quickly humans must restore forest connectivity to minimize extinctions. We surveyed small mammals on forest islands in Chiew Larn Reservoir in Thailand 5 to 7 and 25 to 26 years after isolation and observed the near-total loss of native small mammals within 5 years from <10-hectare (ha) fragments and within 25 years from 10- to 56-ha fragments. Based on our results, we developed an island biogeographic model and estimated mean extinction half-life (50% of resident species disappearing) to be 13.9 years. These catastrophic extinctions were probably partly driven by an invasive rat species; such biotic invasions are becoming increasingly common in human-modified landscapes. Our results are thus particularly relevant to other fragmented forest landscapes and suggest that small fragments are potentially even more vulnerable to biodiversity loss than previously thought.	[Gibson, Luke; Bickford, David P.] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore; [Lynam, Antony J.] Wildlife Conservat Soc, Global Conservat Programs, Bronx, NY 10460 USA; [Bradshaw, Corey J. A.] Univ Adelaide, Inst Environm, Adelaide, SA 5005, Australia; [Bradshaw, Corey J. A.] Univ Adelaide, Sch Earth & Environm Sci, Adelaide, SA 5005, Australia; [He, Fangliang] Sun Yat Sen Univ, State Key Lab Biocontrol, SYSU Alberta Joint Lab Biodivers Conservat, Guangzhou 510275, Guangdong, Peoples R China; [He, Fangliang] Sun Yat Sen Univ, Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China; [He, Fangliang] Univ Alberta, Dept Renewable Resources, Edmonton, AB T6G 2H1, Canada; [Woodruff, David S.] Univ Calif San Diego, Div Biol Sci, Ecol Behav & Evolut Sect, La Jolla, CA 92093 USA; [Bumrungsri, Sara] Prince Songkla Univ, Fac Sci, Dept Biol, Hat Yai, Songkhla, Thailand; [Laurance, William F.] James Cook Univ, Ctr Trop Environm & Sustainable Sci, Cairns, Qld 4878, Australia; [Laurance, William F.] James Cook Univ, Sch Marine & Trop Biol, Cairns, Qld 4878, Australia	National University of Singapore; Wildlife Conservation Society; University of Adelaide; University of Adelaide; Sun Yat Sen University; Sun Yat Sen University; University of Alberta; University of California System; University of California San Diego; Prince of Songkla University; James Cook University; James Cook University	Gibson, L (corresponding author), Natl Univ Singapore, Dept Biol Sci, 14 Sci Dr 4, Singapore 117543, Singapore.	lggibson@nus.edu.sg; fhe@mail.sysu.edu.cn; dbsbdp@nus.edu.sg	Bickford, David P/A-5306-2011; Laurance, William F/B-2709-2012; Bradshaw, Corey J.A./A-1311-2008; Lynam, Antony/H-3036-2015; /Y-6615-2018	Bickford, David P/0000-0003-1478-3387; Laurance, William F/0000-0003-4430-9408; Bradshaw, Corey J.A./0000-0002-5328-7741; Lynam, Antony/0000-0002-8395-7902; /0000-0002-7706-3355	NSF [BSR-9000486, BSR-9300182]; National University of Singapore [R-154-000-479-112]; Ah Meng Memorial Conservation Fund [R-154-000-521-720]; Singapore International Graduate Award; Australian Research Council (ARC); National Sciences and Engineering Research Council of Canada; Sun Yat-sen University; ARC Australian Laureate Fellowship	NSF(National Science Foundation (NSF)); National University of Singapore(National University of Singapore); Ah Meng Memorial Conservation Fund; Singapore International Graduate Award; Australian Research Council (ARC)(Australian Research Council); National Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Sun Yat-sen University; ARC Australian Laureate Fellowship(Australian Research Council)	We thank our Thai field assistants for their invaluable efforts; the National Research Council of Thailand and the Department of National Parks, Wildlife and Plant Conservation for granting access and collection permission; and the superintendents and staff of Khlong Saeng Wildlife Sanctuary and Khao Sok National Park for access to Chiew Larn reservoir. We thank J.-F. Cosson for genetically confirming the identity of Rattus tiomanicus. Finally, we are indebted to N. Sodhi for providing this research opportunity on extinction debt. Field research in 1992-1994 was funded by grants BSR-9000486 and BSR-9300182 from NSF to D.S.W. Field research in 2012-2013 was funded by grant R-154-000-479-112 from the National University of Singapore and grant R-154-000-521-720 from the Ah Meng Memorial Conservation Fund. L.G. was supported by a Singapore International Graduate Award, C.J.A.B. by an Australian Research Council (ARC) Future Fellowship, F.H. by the National Sciences and Engineering Research Council of Canada and Sun Yat-sen University, and W.F.L. by an ARC Australian Laureate Fellowship. This study was approved by the Institutional Animal Care and Use Committee of the National University of Singapore.	Achard F, 2002, SCIENCE, V297, P999, DOI 10.1126/science.1070656; Asner GP, 2009, CONSERV BIOL, V23, P1386, DOI 10.1111/j.1523-1739.2009.01333.x; Blackburn TM, 2004, SCIENCE, V305, P1955, DOI 10.1126/science.1101617; Broadbent EN, 2008, BIOL CONSERV, V141, P1745, DOI 10.1016/j.biocon.2008.04.024; Brooks TM, 1999, CONSERV BIOL, V13, P1140, DOI 10.1046/j.1523-1739.1999.98341.x; Canale GR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041671; Diamond J, 2001, SCIENCE, V294, P1847, DOI 10.1126/science.1067012; DIAMOND JM, 1972, P NATL ACAD SCI USA, V69, P3199, DOI 10.1073/pnas.69.11.3199; Dirzo R, 2003, ANNU REV ENV RESOUR, V28, P137, DOI 10.1146/annurev.energy.28.050302.105532; Ellis EC, 2010, GLOBAL ECOL BIOGEOGR, V19, P589, DOI 10.1111/j.1466-8238.2010.00540.x; European Commission, 2020, GUID GEOGR IND GIS S; Feeley KJ, 2008, ANIM CONSERV, V11, P366, DOI 10.1111/j.1469-1795.2008.00207.x; Ferraz G, 2003, P NATL ACAD SCI USA, V100, P14069, DOI 10.1073/pnas.2336195100; Gibson L, 2011, NATURE, V478, P378, DOI 10.1038/nature10425; Halley JM, 2011, P NATL ACAD SCI USA, V108, P2316, DOI 10.1073/pnas.1011217108; Hanski I, 2013, P NATL ACAD SCI USA, V110, P12715, DOI 10.1073/pnas.1311491110; Harris DB, 2007, ECOLOGY, V88, P2330, DOI 10.1890/06-1701.1; Harris DB, 2009, BIOL INVASIONS, V11, P1611, DOI 10.1007/s10530-008-9393-0; Jones H, 2008, POETRY WALES, V43, P22; Laurance WF, 2012, NATURE, V489, P290, DOI 10.1038/nature11318; Laurance WF, 2011, BIOL CONSERV, V144, P56, DOI 10.1016/j.biocon.2010.09.021; Laurance WF, 2009, TRENDS ECOL EVOL, V24, P659, DOI 10.1016/j.tree.2009.06.009; Lynam AJ, 1999, BIOL CONSERV, V91, P191, DOI 10.1016/S0006-3207(99)00082-8; NAKHASATHIEN S, 1989, Oryx, V23, P146; Prugh LR, 2008, P NATL ACAD SCI USA, V105, P20770, DOI 10.1073/pnas.0806080105; Terborgh J, 2001, SCIENCE, V294, P1923, DOI 10.1126/science.1064397; TILMAN D, 1994, NATURE, V371, P65, DOI 10.1038/371065a0; Turner IM, 1996, TRENDS ECOL EVOL, V11, P330, DOI 10.1016/0169-5347(96)10046-X	28	225	237	8	276	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 27	2013	341	6153					1508	1510		10.1126/science.1240495	http://dx.doi.org/10.1126/science.1240495			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	224NS	24072921				2022-12-28	WOS:000324894600049
J	Grotzinger, JP				Grotzinger, John P.			Analysis of Surface Materials by the Curiosity Mars Rover INTRODUCTION	SCIENCE			English	Editorial Material									CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA	California Institute of Technology	Grotzinger, JP (corresponding author), CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA.								0	36	37	2	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 27	2013	341	6153					1475	1475		10.1126/science.1244258	http://dx.doi.org/10.1126/science.1244258			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	224NS	24072916				2022-12-28	WOS:000324894600040
J	Banaszynski, LA; Wen, DC; Dewell, S; Whitcomb, SJ; Lin, MY; Diaz, N; Elsasser, SJ; Chapgier, A; Goldberg, AD; Canaani, E; Rafii, S; Zheng, DY; Allis, CD				Banaszynski, Laura A.; Wen, Duancheng; Dewell, Scott; Whitcomb, Sarah J.; Lin, Mingyan; Diaz, Nichole; Elsaesser, Simon J.; Chapgier, Ariane; Goldberg, Aaron D.; Canaani, Eli; Rafii, Shahin; Zheng, Deyou; Allis, C. David			Hira-Dependent Histone H3.3 Deposition Facilitates PRC2 Recruitment at Developmental Loci in ES Cells	CELL			English	Article							EMBRYONIC STEM-CELLS; REGULATING GENE-EXPRESSION; RNA-POLYMERASE-II; GENOME-WIDE; CHROMATIN; PLURIPOTENT; ACETYLATION; COMPLEX; TRANSCRIPTION; GASTRULATION	Polycomb repressive complex 2 (PRC2) regulates gene expression during lineage specification through trimethylation of lysine 27 on histone H3 (H3K27me3). In Drosophila, polycomb binding sites are dynamic chromatin regions enriched with the histone variant H3.3. Here, we show that, in mouse embryonic stem cells (ESCs), H3.3 is required for proper establishment of H3K27me3 at the promoters of developmentally regulated genes. Upon H3.3 depletion, these promoters show reduced nucleosome turnover measured by deposition of de novo synthesized histones and reduced PRC2 occupancy. Further, we show H3.3-dependent interaction of PRC2 with the histone chaperone, Hira, and that Hira localization to chromatin requires H3.3. Our data demonstrate the importance of H3.3 in maintaining a chromatin landscape in ESCs that is important for proper gene regulation during differentiation. Moreover, our findings support the emerging notion that H3.3 has multiple functions in distinct genomic locations that are not always correlated with an "active'' chromatin state.	[Banaszynski, Laura A.; Whitcomb, Sarah J.; Diaz, Nichole; Elsaesser, Simon J.; Goldberg, Aaron D.; Allis, C. David] Rockefeller Univ, Lab Chromatin Biol & Epigenet, New York, NY 10065 USA; [Wen, Duancheng; Rafii, Shahin] Weill Cornell Med Coll, Ansary Stem Cell Inst, Howard Hughes Med Inst, New York, NY 10065 USA; [Wen, Duancheng; Rafii, Shahin] Weill Cornell Med Coll, Dept Med Genet, New York, NY 10065 USA; [Dewell, Scott] Rockefeller Univ, Genom Resource Ctr, New York, NY 10065 USA; [Lin, Mingyan; Zheng, Deyou] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10461 USA; [Chapgier, Ariane] Inst Child Hlth, Mol Med Unit, London WC1N 1EH, England; [Canaani, Eli] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel; [Zheng, Deyou] Albert Einstein Coll Med, Dept Neurol, Bronx, NY 10461 USA; [Zheng, Deyou] Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10461 USA	Rockefeller University; Cornell University; Howard Hughes Medical Institute; Cornell University; Rockefeller University; Yeshiva University; Albert Einstein College of Medicine; University of London; University College London; Weizmann Institute of Science; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Allis, CD (corresponding author), Rockefeller Univ, Lab Chromatin Biol & Epigenet, New York, NY 10065 USA.	alliscd@rockefeller.edu	Elsässer, Simon/B-8911-2014; lin, mingyan/HDL-9420-2022; Elsässer, Simon/AAM-3986-2020	Elsässer, Simon/0000-0001-8724-4849; Elsässer, Simon/0000-0001-8724-4849; Goldberg, Aaron/0000-0002-2892-2643; Zheng, Deyou/0000-0003-4354-5337; Wen, Duancheng/0000-0002-3160-6289; Whitcomb, Sarah/0000-0002-1392-1496; Chapgier, Ariane/0000-0002-1734-0744	Rockefeller University Fund; Tri-Institutional Stem Cell Initiative; US National Institute of Mental Health [MH087840, MH073164]; Damon Runyon Cancer Research Foundation; Rockefeller University Women & Science Initiative; NICHD; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH087840, R01MH073164, R33MH087840] Funding Source: NIH RePORTER; British Heart Foundation [FS/10/31/28395] Funding Source: researchfish	Rockefeller University Fund; Tri-Institutional Stem Cell Initiative; US National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Damon Runyon Cancer Research Foundation; Rockefeller University Women & Science Initiative; NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); British Heart Foundation(British Heart Foundation)	This work was supported by The Rockefeller University Fund (to C. D. A.), Tri-Institutional Stem Cell Initiative (to C. D. A. and S. R.), US National Institute of Mental Health (MH087840 and MH073164 to D.Z.), Damon Runyon Cancer Research Foundation (L. A. B.), and The Rockefeller University Women & Science Initiative (L. A. B.). We thank I. Falciatori for help with the teratoma assay, Y. Zhang for purified recombinant PRC2 complex, and S. Chen and Y. Shi for the Jmjd3 antibody. The Troma-I hybridoma developed by P. Brulet and R. Kemler was obtained from the Developmental Studies Hybridoma Bank developed under the auspices of the NICHD and maintained by the Department of Biology at The University of Iowa. We thank L. Baker, E. Korb, E. Duncan, and C. Lu for critical reading of this manuscript and J. Wysocka and members of the Allis lab for helpful discussions.	Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Brookes E, 2012, CELL STEM CELL, V10, P157, DOI 10.1016/j.stem.2011.12.017; Brookes E, 2009, EMBO REP, V10, P1213, DOI 10.1038/embor.2009.221; Bush KM, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-7; Couldrey C, 1999, HUM MOL GENET, V8, P2489, DOI 10.1093/hmg/8.13.2489; Cox SG, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002938; Cui BW, 2006, MOL CELL BIOL, V26, P7719, DOI 10.1128/MCB.01139-06; Deal RB, 2010, SCIENCE, V328, P1161, DOI 10.1126/science.1186777; Dunleavy EM, 2011, NUCLEUS-PHILA, V2, P146, DOI 10.4161/nucl.2.2.15211; Filipescu D, 2013, TRENDS GENET, V29, P630, DOI 10.1016/j.tig.2013.06.002; Gaspar-Maia A, 2011, NAT REV MOL CELL BIO, V12, P36, DOI 10.1038/nrm3036; Goldberg AD, 2010, CELL, V140, P678, DOI 10.1016/j.cell.2010.01.003; Hodl M, 2009, CURR BIOL, V19, P1221, DOI 10.1016/j.cub.2009.05.048; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hudson QJ, 2010, HEREDITY, V105, P45, DOI 10.1038/hdy.2010.23; Koh KP, 2011, CELL STEM CELL, V8, P200, DOI 10.1016/j.stem.2011.01.008; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lau PNI, 2011, P NATL ACAD SCI USA, V108, P2801, DOI 10.1073/pnas.1012798108; Li G, 2010, GENE DEV, V24, P368, DOI 10.1101/gad.1886410; Loyola A, 2006, MOL CELL, V24, P309, DOI 10.1016/j.molcel.2006.08.019; Lu CW, 2008, NAT GENET, V40, P921, DOI 10.1038/ng.173; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Meshorer E, 2006, DEV CELL, V10, P105, DOI 10.1016/j.devcel.2005.10.017; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Mito Y, 2007, SCIENCE, V315, P1408, DOI 10.1126/science.1134004; Morasso MI, 1999, P NATL ACAD SCI USA, V96, P162, DOI 10.1073/pnas.96.1.162; Pasini D, 2010, NUCLEIC ACIDS RES, V38, P4958, DOI 10.1093/nar/gkq244; Pchelintsev NA, 2013, CELL REP, V3, P1012, DOI 10.1016/j.celrep.2013.03.026; Peng JC, 2009, CELL, V139, P1290, DOI 10.1016/j.cell.2009.12.002; Ray-Gallet D, 2011, MOL CELL, V44, P928, DOI 10.1016/j.molcel.2011.12.006; Reynolds N, 2012, EMBO J, V31, P593, DOI 10.1038/emboj.2011.431; Roberts C, 2002, MOL CELL BIOL, V22, P2318, DOI 10.1128/MCB.22.7.2318-2328.2002; Rossant J, 2008, CELL, V132, P527, DOI 10.1016/j.cell.2008.01.039; Sakai A, 2009, CURR BIOL, V19, P1816, DOI 10.1016/j.cub.2009.09.021; Schwartzentruber J, 2012, NATURE, V482, P226, DOI [10.1038/nature10833, 10.1007/s13311-012-0137-6]; Surface LE, 2010, CELL STEM CELL, V7, P288, DOI 10.1016/j.stem.2010.08.004; Szenker E, 2012, CELL REP, V1, P730, DOI 10.1016/j.celrep.2012.05.006; Tagami H, 2004, CELL, V116, P51, DOI 10.1016/S0092-8674(03)01064-X; Tie F, 2009, DEVELOPMENT, V136, P3131, DOI 10.1242/dev.037127; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Weake VM, 2010, NAT REV GENET, V11, P426, DOI 10.1038/nrg2781; WELLMAN SE, 1987, GENE, V59, P29, DOI 10.1016/0378-1119(87)90263-0; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	45	174	180	0	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 26	2013	155	1					107	120		10.1016/j.cell.2013.08.061	http://dx.doi.org/10.1016/j.cell.2013.08.061			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	224UX	24074864	Green Accepted, Bronze			2022-12-28	WOS:000324916700013
J	Esmail, A; Roberts, C				Esmail, Aneez; Roberts, Chris			Academic performance of ethnic minority candidates and discrimination in the MRCGP examinations between 2010 and 2012: analysis of data	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CERTIFICATION	Objective To determine the difference in failure rates in the postgraduate examination of the Royal College of General Practitioners (MRCGP) by ethnic or national background, and to identify factors associated with pass rates in the clinical skills assessment component of the examination. Design Analysis of data provided by the Royal College of General Practitioners and the General Medical Council. Participants Cohort of 5095 candidates sitting the applied knowledge test and clinical skills assessment components of the MRCGP examination between November 2010 and November 2012. A further analysis was carried out on 1175 candidates not trained in the United Kingdom, who sat an English language capability test (IELTS) and the Professional and Linguistic Assessment Board (PLAB) examination (as required for full medical registration), controlling for scores on these examinations and relating them to pass rates of the clinical skills assessment. Setting United Kingdom. Results After controlling for age, sex, and performance in the applied knowledge test, significant differences persisted between white UK graduates and other candidate groups. Black and minority ethnic graduates trained in the UK were more likely to fail the clinical skills assessment at their first attempt than their white UK colleagues (odds ratio 3.536 (95% confidence interval 2.701 to 4.629), P<0.001; failure rate 17% v 4.5%). Black and minority ethnic candidates who trained abroad were also more likely to fail the clinical skills assessment than white UK candidates (14.741 (11.397 to 19.065), P<0.001; 65% v 4.5%). For candidates not trained in the UK, black or minority ethnic candidates were more likely to fail than white candidates, but this difference was no longer significant after controlling for scores in the applied knowledge test, IELTS, and PLAB examinations (adjusted odds ratio 1.580 (95% confidence interval 0.878 to 2.845), P=0.127). Conclusions Subjective bias due to racial discrimination in the clinical skills assessment may be a cause of failure for UK trained candidates and international medical graduates. The difference between British black and minority ethnic candidates and British white candidates in the pass rates of the clinical skills assessment, despite controlling for prior attainment, suggests that subjective bias could also be a factor. Changes to the clinical skills assessment could improve the perception of the examination as being biased against black and minority ethnic candidates. The difference in training experience and other cultural factors between candidates trained in the UK and abroad could affect outcomes. Consideration should be given to strengthening postgraduate training for international medical graduates.	[Esmail, Aneez; Roberts, Chris] Univ Manchester, Fac Med & Human Sci, Manchester M13 9PL, Lancs, England	University of Manchester	Esmail, A (corresponding author), Univ Manchester, Fac Med & Human Sci, Manchester M13 9PL, Lancs, England.	aneez.esmail@manchester.ac.uk	Esmail, Aneez/I-6903-2013	Esmail, Aneez/0000-0001-7061-7434	General Medical Council	General Medical Council	All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure. pdf and declare: AE and CR were commissioned by the General Medical Council to carry out an independent review of the failure rates in the MRCGP examination, and declare that they received a fee from the General Medical Council for carrying out this work; no other relationships or activities that could appear to have influenced the submitted work.	Boulet JR, 2006, ACAD MED, V81, pS116, DOI 10.1097/00001888-200610001-00029; Dewhurst NG, 2007, BMC MED, V5, DOI 10.1186/1741-7015-5-8; Epstein RM, 2007, NEW ENGL J MED, V356, P387, DOI 10.1056/NEJMra054784; Esmail A, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d709; Esmail S, 2000, BRIT MED J, V320, P375; Health and Social Care Information Centre, 2013, GEN PERS MED SERV EN; Patterson F, 2011, BRIT J GEN PRACT, V61, P712, DOI 10.3399/bjgp11X612936; Skrondal A., 2004, GEN LATENT VARIABLE; Spike NA, 1999, MED EDUC, V33, P612, DOI 10.1046/j.1365-2923.1999.00307.x; Tyrer SP., 2002, PSYCHIATR BULL, V26, P257, DOI [DOI 10.1192/PB.26.7.257, 10.1192/pb.26.7.257]; Wakeford R, 2012, EDUC PRIM CARE, V23, P148, DOI 10.1080/14739879.2012.11494097; Woolf K, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d901	12	83	83	0	15	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 26	2013	347								f5662	10.1136/bmj.f5662	http://dx.doi.org/10.1136/bmj.f5662			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	227CY	24072882	hybrid, Green Published			2022-12-28	WOS:000325087400002
J	Khan, I; McCreery, C				Khan, Imran; McCreery, Charles			Uremic Pericarditis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								A 36-year-old man who was an active user of illicit intravenous drugs was admitted to the hospital with acute renal failure. He had been feeling generally unwell for the preceding 6 months. A 36-year-old man who was an active user of illicit intravenous drugs was admitted to the hospital with acute renal failure. He had been feeling generally unwell for the preceding 6 months. He was short of breath at rest, and his heart rate was 108 beats per minute and his blood pressure 140/80 mm Hg. He also had generalized edema and a pericardial rub. Laboratory assessment revealed a white-cell count of 25,400 cells per cubic millimeter, a blood urea nitrogen level of 102 mg per deciliter (37 mmol per liter), a creatinine level of 4.5 mg per deciliter (398 mol ...	[Khan, Imran; McCreery, Charles] St Vincents Univ Hosp, Dublin 4, Ireland	University College Dublin; Saint Vincent's University Hospital	Khan, I (corresponding author), St Vincents Univ Hosp, Dublin 4, Ireland.								0	0	0	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 26	2013	369	13					E17	E17		10.1056/NEJMicm1203491	http://dx.doi.org/10.1056/NEJMicm1203491			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	224LT	24066764				2022-12-28	WOS:000324888200001
J	Berry, SD; Samelson, EJ; Pencina, MJ; McLean, RR; Cupples, LA; Broe, KE; Kiel, DP				Berry, Sarah D.; Samelson, Elizabeth J.; Pencina, Michael J.; McLean, Robert R.; Cupples, L. Adrienne; Broe, Kerry E.; Kiel, Douglas P.			Repeat Bone Mineral Density Screening and Prediction of Hip and Major Osteoporotic Fracture	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							POSTMENOPAUSAL WOMEN; OLDER WOMEN; RISK; MEN; PERSPECTIVE; SERVICES; EFFICACY; SAFETY; BMD	IMPORTANCE Screening for osteoporosis with bone mineral density (BMD) is recommended for older adults. It is unclear whether repeating a BMD screening test improves fracture risk assessment. OBJECTIVES To determine whether changes in BMD after 4 years provide additional information on fracture risk beyond baseline BMD and to quantify the change in fracture risk classification after a second BMD measure. DESIGN, SETTING, AND PARTICIPANTS Population-based cohort study involving 310 men and 492 women from the Framingham Osteoporosis Study with 2 measures of femoral neck BMD taken from 1987 through 1999. MAIN OUTCOMES AND MEASURES Risk of hip or major osteoporotic fracture through 2009 or 12 years following the second BMD measure. RESULTS Mean age was 74.8 years. The mean (SD) BMD change was -0.6% per year (1.8%). Throughout a median follow-up of 9.6 years, 76 participants experienced an incident hip fracture and 113 participants experienced a major osteoporotic fracture. Annual percent BMD change per SD decrease was associated with risk of hip fracture (hazard ratio [HR], 1.43 [95% CI, 1.16 to 1.78]) and major osteoporotic fracture (HR, 1.21 [95% CI, 1.01 to 1.45]) after adjusting for baseline BMD. At 10 years' follow-up, 1 SD decrease in annual percent BMD change compared with the mean BMD change was associated with 3.9 excess hip fractures per 100 persons. In receiver operating characteristic (ROC) curve analyses, the addition of BMD change to a model with baseline BMD did not meaningfully improve performance. The area under the curve (AUC) was 0.71 (95% CI, 0.65 to 0.78) for the baseline BMD model compared with 0.68 (95% CI, 0.62 to 0.75) for the BMD percent change model. Moreover, the addition of BMD change to a model with baseline BMD did not meaningfully improve performance (AUC, 0.72 [95% CI, 0.66 to 0.79]). Using the net reclassification index, a second BMD measure increased the proportion of participants reclassified as high risk of hip fracture by 3.9% (95% CI, -2.2% to 9.9%), whereas it decreased the proportion classified as low risk by -2.2%(95% CI, -4.5% to 0.1%). CONCLUSIONS AND RELEVANCE In untreated men and women of mean age 75 years, a second BMD measure after 4 years did not meaningfully improve the prediction of hip or major osteoporotic fracture. Repeating a BMD measure within 4 years to improve fracture risk stratification may not be necessary in adults this age untreated for osteoporosis.	[Berry, Sarah D.; Samelson, Elizabeth J.; McLean, Robert R.; Broe, Kerry E.; Kiel, Douglas P.] Hebrew SeniorLife, Inst Aging Res, Boston, MA 02131 USA; [Berry, Sarah D.; Samelson, Elizabeth J.; McLean, Robert R.; Kiel, Douglas P.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Boston, MA 02215 USA; [Pencina, Michael J.; Cupples, L. Adrienne] Boston Univ, Sch Publ Hlth, Boston, MA USA; [Pencina, Michael J.] Duke Clin Res Inst, Durham, NC USA; [Pencina, Michael J.] Duke Dept Biostat & Bioinformat, Durham, NC USA; [Cupples, L. Adrienne] Framingham Heart Dis Epidemiol Study, Framingham, MA USA	Harvard University; Hebrew SeniorLife; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Boston University; Duke University; Framingham Heart Study	Berry, SD (corresponding author), Hebrew SeniorLife, Inst Aging Res, 1200 Ctr St, Boston, MA 02131 USA.	sarahberry@hsl.harvard.edu		Kiel, Douglas/0000-0001-8474-0310; Samelson, Elizabeth/0000-0003-1086-1560; Cupples, L. Adrienne/0000-0003-0273-7965	National Institutes of Health [R01-AR/AG 41398, NIA K23 AG033204]; National Heart, Lung, and Blood Institute's Framingham Heart Study [N01-HC-25195]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR041398] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K23AG033204] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung, and Blood Institute's Framingham Heart Study(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was funded in part through grants R01-AR/AG 41398 and NIA K23 AG033204 from the National Institutes of Health, N01-HC-25195 from the National Heart, Lung, and Blood Institute's Framingham Heart Study, and contributions from the Friends of Hebrew SeniorLife.	Austin PC, 2010, J CLIN EPIDEMIOL, V63, P46, DOI 10.1016/j.jclinepi.2009.03.012; Berger C, 2009, J BONE MINER RES, V24, P361, DOI [10.1359/jbmr.081004, 10.1359/JBMR.081004]; Black DM, 2012, J CLIN ENDOCR METAB, V97, P1176, DOI 10.1210/jc.2012-1528; Boonen S, 2011, J CLIN ENDOCR METAB, V96, P1727, DOI 10.1210/jc.2010-2784; Boonen S, 2006, J AM GERIATR SOC, V54, P782, DOI 10.1111/j.1532-5415.2006.00695.x; Boonen S, 2010, J AM GERIATR SOC, V58, P292, DOI 10.1111/j.1532-5415.2009.02673.x; Boonen S, 2010, J AM GERIATR SOC, V58, P658, DOI 10.1111/j.1532-5415.2010.02763.x; Calonge N, 2011, ANN INTERN MED, V154, P356, DOI 10.7326/0003-4819-154-5-201103010-00307; Cawthon PM, 2012, J BONE MINER RES, V27, P2179, DOI 10.1002/jbmr.1671; DAWBER TR, 1951, AM J PUBLIC HLTH NAT, V41, P279; Gourlay ML, 2012, NEW ENGL J MED, V366, P225, DOI 10.1056/NEJMoa1107142; Hillier TA, 2007, ARCH INTERN MED, V167, P155, DOI 10.1001/archinte.167.2.155; Kanis JA, 2008, OSTEOPOROSIS INT, V19, P385, DOI 10.1007/s00198-007-0543-5; KIEL DP, 1995, J BONE MINER RES, V10, P1130; KIEL DP, 1987, NEW ENGL J MED, V317, P1169, DOI 10.1056/NEJM198711053171901; Leslie WD, 2012, J CLIN ENDOCR METAB, V97, P1211, DOI 10.1210/jc.2011-2871; Lewiecki EM, 2012, J BONE MINER RES, V27, P739, DOI 10.1002/jbmr.1580; McAdam-Marx C, 2012, J AM GERIATR SOC, V60, P511, DOI 10.1111/j.1532-5415.2011.03837.x; National Osteoporosis Foundation, 2013, CLIN GUID PREV TREAT; Nguyen TV, 2005, J BONE MINER RES, V20, P1195, DOI 10.1359/JBMR.050215; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Riis BJ, 1996, BONE, V19, P9, DOI 10.1016/8756-3282(96)00102-0; Tosteson ANA, 2008, AM J MANAG CARE, V14, P605; Yu EW, 2012, JAMA-J AM MED ASSOC, V307, P2591, DOI 10.1001/jama.2012.6977; Zhang J, 2012, J BONE MINER RES, V27, P858, DOI 10.1002/jbmr.1534	25	53	54	0	8	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 25	2013	310	12					1256	1262		10.1001/jama.2013.277817	http://dx.doi.org/10.1001/jama.2013.277817			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	222SO	24065012	Green Accepted, Bronze			2022-12-28	WOS:000324751800022
J	Klein, CA				Klein, Christoph A.			Selection and adaptation during metastatic cancer progression	NATURE			English	Article							DISSEMINATED TUMOR-CELLS; PRIMARY COLORECTAL CANCERS; BREAST-CANCER; BONE-MARROW; CLONAL EVOLUTION; IN-SITU; ADHESION MOLECULE; GENOMIC ANALYSIS; GENETIC-ANALYSIS; DIVERSITY	Cancer is often regarded as a process of asexual evolution driven by genomic and genetic instability. Mutation, selection and adaptation are by convention thought to occur primarily within, and to a lesser degree outside, the primary tumour. However, disseminated cancer cells that remain after 'curative' surgery exhibit extreme genomic heterogeneity before the manifestation of metastasis. This heterogeneity is later reduced by selected clonal expansion, suggesting that the disseminated cells had yet to acquire key traits of fully malignant cells. Abrogation of the cells' progression outside the primary tumour implies new challenges and opportunities for diagnosis and adjuvant therapies.	[Klein, Christoph A.] Univ Regensburg, D-93053 Regensburg, Germany; [Klein, Christoph A.] Fraunhofer Inst Toxicol & Expt Med, Personalized Tumor Therapy Project Grp, Regensburg, Germany	University of Regensburg; Fraunhofer Gesellschaft	Klein, CA (corresponding author), Univ Regensburg, D-93053 Regensburg, Germany.	christoph.klein@ukr.de		Klein, Christoph A./0000-0001-7128-1725				AARONSON SA, 1968, SCIENCE, V162, P1024, DOI 10.1126/science.162.3857.1024; Alberts SR, 2012, JAMA-J AM MED ASSOC, V307, P1383, DOI 10.1001/jama.2012.385; Allred DC, 2008, CLIN CANCER RES, V14, P370, DOI 10.1158/1078-0432.CCR-07-1127; Banys M, 2012, BREAST CANCER RES TR, V131, P801, DOI 10.1007/s10549-011-1478-2; Bardi G, 1997, BRIT J CANCER, V76, P765, DOI 10.1038/bjc.1997.459; Baudis M, 2001, BIOINFORMATICS, V17, P1228, DOI 10.1093/bioinformatics/17.12.1228; BERENBLUM I, 1947, BRIT J CANCER, V1, P379, DOI 10.1038/bjc.1947.35; Bettington M, 2013, HISTOPATHOLOGY, V62, P367, DOI 10.1111/his.12055; Boecker W, 2001, J PATHOL, V195, P415, DOI 10.1002/path.982; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Brabletz T, 2001, P NATL ACAD SCI USA, V98, P10356, DOI 10.1073/pnas.171610498; Braun S, 2005, NEW ENGL J MED, V353, P793, DOI 10.1056/NEJMoa050434; CAIRNS J, 1975, NATURE, V255, P197, DOI 10.1038/255197a0; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Carr NJ, 2009, J CLIN PATHOL, V62, P516, DOI 10.1136/jcp.2008.061960; Castellarin M, 2013, J PATHOL, V229, P515, DOI 10.1002/path.4105; Cauffman G, 2009, HUM REPROD, V24, P63, DOI 10.1093/humrep/den351; Chin K, 2004, NAT GENET, V36, P984, DOI 10.1038/ng1409; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Douillard JY, 2010, J CLIN ONCOL, V28, P4697, DOI 10.1200/JCO.2009.27.4860; Engel J, 2003, EUR J CANCER, V39, P1794, DOI 10.1016/S0959-8049(03)00422-2; Engel J, 2012, CANCER METAST REV, V31, P235, DOI 10.1007/s10555-011-9343-7; Fisher B, 2002, NEW ENGL J MED, V347, P1233, DOI 10.1056/NEJMoa022152; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Ghajar CM, 2013, NAT CELL BIOL, V15, P807, DOI 10.1038/ncb2767; Gires O, 2009, NAT REV CANCER, V9, P143, DOI 10.1038/nrc2499-c1; Goss GD, 2010, J CLIN ONCOL, V28, DOI 10.1200/jco.2010.28.18_suppl.lba7005; GOTTLINGER H, 1986, HYBRIDOMA, V5, pS29; Greaves M, 2012, NATURE, V481, P306, DOI 10.1038/nature10762; Gudjonsson T, 2002, GENE DEV, V16, P693, DOI 10.1101/gad.952602; Hafner C, 2007, P NATL ACAD SCI USA, V104, P13450, DOI 10.1073/pnas.0705218104; Hafner C, 2010, P NATL ACAD SCI USA, V107, P20780, DOI 10.1073/pnas.1008365107; Heitzer E, 2013, CANCER RES, V73, P2965, DOI 10.1158/0008-5472.CAN-12-4140; Heng HHO, 2011, ADV CANCER RES, V112, P217, DOI 10.1016/B978-0-12-387688-1.00008-9; Hiratsuka S, 2008, NAT CELL BIOL, V10, P1349, DOI 10.1038/ncb1794; Holzel D, 2010, CANCER METAST REV, V29, P737, DOI 10.1007/s10555-010-9260-1; Husemann Y, 2008, CANCER CELL, V13, P58, DOI 10.1016/j.ccr.2007.12.003; Johnston LA, 2009, SCIENCE, V324, P1679, DOI 10.1126/science.1163862; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Kang YB, 2013, CANCER CELL, V23, P573, DOI 10.1016/j.ccr.2013.04.017; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Kennecke H, 2010, J CLIN ONCOL, V28, P3271, DOI 10.1200/JCO.2009.25.9820; Kitchener H, 2009, LANCET, V373, P125, DOI 10.1016/S0140-6736(08)61766-3; Klein CA, 2002, LANCET, V360, P683, DOI 10.1016/S0140-6736(02)09838-0; Klein CA, 2006, CELL CYCLE, V5, P1788, DOI 10.4161/cc.5.16.3097; Klein CA, 2011, CURR OPIN GENET DEV, V21, P42, DOI 10.1016/j.gde.2010.10.011; Klein CA, 2009, CANCER RES, V69, P5285, DOI 10.1158/0008-5472.CAN-08-4586; Klein CA, 2009, NAT REV CANCER, V9, P302, DOI 10.1038/nrc2627; Kloosterman WP, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-r103; LEE LW, 1989, AM J PATHOL, V135, P63; Levayer R, 2013, J CELL BIOL, V200, P689, DOI 10.1083/jcb.201301051; Lu TY, 2010, J BIOL CHEM, V285, P8719, DOI 10.1074/jbc.M109.077081; Magbanua MJM, 2013, CANCER RES, V73, P30, DOI 10.1158/0008-5472.CAN-11-3017; Magbanua MJM, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-78; Maley CC, 2006, NAT GENET, V38, P468, DOI 10.1038/ng1768; McAllister SS, 2008, CELL, V133, P994, DOI 10.1016/j.cell.2008.04.045; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Miranda E, 2013, CANCER-AM CANCER SOC, V119, P266, DOI 10.1002/cncr.27722; Mitelman F, 2013, MITELMAN DATABASE CH; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; MOLL R, 1982, CELL, V31, P11, DOI 10.1016/0092-8674(82)90400-7; Moreno E, 2008, NAT REV CANCER, V8, P141, DOI 10.1038/nrc2252; Mueller MM, 2006, EUR J CANCER, V42, P735, DOI 10.1016/j.ejca.2006.01.014; Naski MC, 1996, NAT GENET, V13, P233, DOI 10.1038/ng0696-233; Neuville A, 2011, HUM PATHOL, V42, P244, DOI 10.1016/j.humpath.2010.07.003; Ng VY, 2010, STEM CELLS, V28, P29, DOI 10.1002/stem.221; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; OREILLY MS, 1994, CELL, V79, P315, DOI 10.1016/0092-8674(94)90200-3; Park SY, 2010, J CLIN INVEST, V120, P636, DOI 10.1172/JCI40724; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Polzer B, 2013, NAT MED, V19, P274, DOI 10.1038/nm.3121; Rasnick D, 2002, CANCER GENET CYTOGEN, V136, P66, DOI 10.1016/S0165-4608(01)00665-3; Riethdorf S, 2008, INT J CANCER, V123, P1991, DOI 10.1002/ijc.23825; Rubin H, 2008, P NATL ACAD SCI USA, V105, P6215, DOI 10.1073/pnas.0800747105; Rudenstam CM, 2006, J CLIN ONCOL, V24, P337, DOI 10.1200/JCO.2005.01.5784; Ruggiero RA, 2011, CANCER RES, V71, P7113, DOI 10.1158/0008-5472.CAN-11-0581; Sanger N, 2011, INT J CANCER, V129, P2522, DOI 10.1002/ijc.25895; Schardt JA, 2005, CANCER CELL, V8, P227, DOI 10.1016/j.ccr.2005.08.003; SCHLIMOK G, 1987, P NATL ACAD SCI USA, V84, P8672, DOI 10.1073/pnas.84.23.8672; Schmidt-Kittler O, 2003, P NATL ACAD SCI USA, V100, P7737, DOI 10.1073/pnas.1331931100; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; Shiozawa Y, 2011, J CLIN INVEST, V121, P1298, DOI 10.1172/JCI43414; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Sosman JA, 2012, NEW ENGL J MED, V366, P707, DOI 10.1056/NEJMoa1112302; Steeg PS, 2012, NATURE, V485, pS58, DOI 10.1038/485S58a; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Stoecklein NH, 2008, CANCER CELL, V13, P441, DOI 10.1016/j.ccr.2008.04.005; Stoecklein NH, 2010, INT J CANCER, V126, P589, DOI 10.1002/ijc.24916; Tang YC, 2013, CELL, V152, P394, DOI 10.1016/j.cell.2012.11.043; Tang YC, 2011, CELL, V144, P499, DOI 10.1016/j.cell.2011.01.017; Teixeira MR, 2011, ADV CANCER RES, V112, P127, DOI 10.1016/B978-0-12-387688-1.00005-3; Theissen G, 2009, THEOR BIOSCI, V128, P43, DOI 10.1007/s12064-009-0058-z; Toyota M, 1999, P NATL ACAD SCI USA, V96, P8681, DOI 10.1073/pnas.96.15.8681; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; VANDUUREN BL, 1975, CANCER RES, V35, P502; Vermaat JS, 2012, CLIN CANCER RES, V18, P688, DOI 10.1158/1078-0432.CCR-11-1965; Veronesi U, 1999, EUR J CANCER, V35, P1320, DOI 10.1016/S0959-8049(99)00133-1; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; Weckermann D, 2009, J CLIN ONCOL, V27, P1549, DOI 10.1200/JCO.2008.17.0563; Weedon-Fekjaer H, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2092; Winawer SJ, 2006, GASTROENTEROLOGY, V130, P1872, DOI 10.1053/j.gastro.2006.03.012; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515	104	196	200	0	80	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 19	2013	501	7467					365	372		10.1038/nature12628	http://dx.doi.org/10.1038/nature12628			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219XT	24048069				2022-12-28	WOS:000324545700035
J	Denham, JW; Hauer-Jensen, M				Denham, James W.; Hauer-Jensen, Martin			Radiation induced bowel injury: a neglected problem	LANCET			English	Editorial Material							PROSTATE-CANCER; GUIDANCE		[Denham, James W.] Univ Newcastle, Sch Med & Publ Hlth, Newcastle, NSW 2308, Australia; [Hauer-Jensen, Martin] Univ Arkansas Med Sci, Div Radiat Hlth, Little Rock, AR 72205 USA	University of Newcastle; University of Arkansas System; University of Arkansas Medical Sciences	Denham, JW (corresponding author), Univ Newcastle, Sch Med & Publ Hlth, Newcastle, NSW 2308, Australia.	jim.denham@newcastle.edu.au	DENHAM, JAMES/G-7505-2013	DENHAM, JAMES/0000-0002-4177-9503				Andreyev HJN, 2012, GUT, V61, P179, DOI 10.1136/gutjnl-2011-300563; Benton BE, 2013, LANCET; Dearnaley DP, 2007, LANCET ONCOL, V8, P475, DOI 10.1016/S1470-2045(07)70143-2; Denham JW, 2012, RADIOTHER ONCOL, V105, P184, DOI 10.1016/j.radonc.2012.09.018; Keefe DM, 2007, CANCER-AM CANCER SOC, V109, P820, DOI 10.1002/cncr.22484; Movsas B, 2011, CLIN CANCER RES, V17, P222, DOI 10.1158/1078-0432.CCR-10-1402; Peterson DE, 2011, ANN ONCOL, V22, pvi78, DOI 10.1093/annonc/mdr391; Singh J, 2013, INT J RADIAT ONCOL, V85, P1018, DOI 10.1016/j.ijrobp.2012.07.2376	8	10	13	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 21	2013	382	9910					2046	2047		10.1016/S0140-6736(13)61946-7	http://dx.doi.org/10.1016/S0140-6736(13)61946-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	275OX	24067489				2022-12-28	WOS:000328687800011
J	Tierney, JE; deMenocal, PB				Tierney, Jessica E.; deMenocal, Peter B.			Abrupt Shifts in Horn of Africa Hydroclimate Since the Last Glacial Maximum	SCIENCE			English	Article							SEA-SURFACE TEMPERATURE; INDIAN MONSOON; VEGETATION RESPONSE; ARABIAN PENINSULA; CLIMATE; SAHARA; OCEAN; VARIABILITY; DYNAMICS; MIDHOLOCENE	The timing and abruptness of the initiation and termination of the Early Holocene African Humid Period are subjects of ongoing debate, with direct consequences for our understanding of abrupt climate change, paleoenvironments, and early human cultural development. Here, we provide proxy evidence from the Horn of Africa region that documents abrupt transitions into and out of the African Humid Period in northeast Africa. Similar and generally synchronous abrupt transitions at other East African sites suggest that rapid shifts in hydroclimate are a regionally coherent feature. Our analysis suggests that the termination of the African Humid Period in the Horn of Africa occurred within centuries, underscoring the nonlinearity of the region's hydroclimate.	[Tierney, Jessica E.] Woods Hole Oceanog Inst, Woods Hole, MA 02540 USA; [deMenocal, Peter B.] Lamont Doherty Earth Observ, Palisades, NY 10964 USA	Woods Hole Oceanographic Institution; Columbia University	Tierney, JE (corresponding author), Woods Hole Oceanog Inst, 266 Woods Hole Rd, Woods Hole, MA 02540 USA.	tierney@whoi.edu	; deMenocal, Peter/B-1386-2013	Tierney, Jessica/0000-0002-9080-9289; deMenocal, Peter/0000-0002-7191-717X	National Science Foundation [OCE-1203892]; National Oceanic and Atmospheric Administration [NAO80AR4320912]; Lamont-Doherty Earth Observatory (LDEO) Climate and Life Initiative; Directorate For Geosciences [1203295] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA); Lamont-Doherty Earth Observatory (LDEO) Climate and Life Initiative; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This study was supported by National Science Foundation grant OCE-1203892 to J.E.T., National Oceanic and Atmospheric Administration award NAO80AR4320912 to P.B.d.M., and the Lamont-Doherty Earth Observatory (LDEO) Climate and Life Initiative. We thank E. Hamilton and C. Johnson for assistance with the stable isotope measurements; J.-B. Stuut, G. Ganssen, and C. Cleroux for assistance with core sampling; J. Fang and T. Guilderson for assistance with the radiocarbon dating; and C. Ummenhofer for comments on the initial versions of the manuscript. We thank the Captain and crew of the R/V Pelagia for their remarkable professionalism during the penultimate leg (Cruise 178; April to May 2001) of the scientific circumnavigation of the African continent. With co-chief scientist G. Ganssen, we were able to obtain valuable samples from this remote and geopolitically challenging region. This is LDEO contribution number 7739.	Anand P, 2008, PALEOCEANOGRAPHY, V23, DOI 10.1029/2007PA001564; Anchukaitis KJ, 2013, CLIM DYNAM, V41, P1291, DOI 10.1007/s00382-012-1483-0; Bathiany S, 2012, CLIM DYNAM, V38, P1775, DOI 10.1007/s00382-011-1037-x; Berke MA, 2012, QUATERNARY SCI REV, V55, P59, DOI 10.1016/j.quascirev.2012.08.014; Black E, 2003, MON WEATHER REV, V131, P74, DOI 10.1175/1520-0493(2003)131<0074:AOSOTR>2.0.CO;2; Brovkin V, 1998, J GEOPHYS RES-ATMOS, V103, P31613, DOI 10.1029/1998JD200006; Brovkin V, 2008, SCIENCE, V322, DOI 10.1126/science.1163381; Chakraborty A, 2006, MON WEATHER REV, V134, P598, DOI 10.1175/MWR3085.1; CHARNEY JG, 1975, Q J ROY METEOR SOC, V101, P193, DOI 10.1002/qj.49710142802; Claussen M, 1999, GEOPHYS RES LETT, V26, P2037, DOI 10.1029/1999GL900494; Claussen M, 1997, GLOBAL ECOL BIOGEOGR, V6, P369, DOI 10.2307/2997337; deMenocal P, 2000, QUATERNARY SCI REV, V19, P347, DOI 10.1016/S0277-3791(99)00081-5; Fleitmann D, 2003, SCIENCE, V300, P1737, DOI 10.1126/science.1083130; Fleitmann D, 2007, QUATERNARY SCI REV, V26, P170, DOI 10.1016/j.quascirev.2006.04.012; Francus P, 2013, SEDIMENTOLOGY, V60, P911, DOI 10.1111/j.1365-3091.2012.01370.x; Friedrich M, 1999, QUATERN INT, V61, P27, DOI 10.1016/S1040-6182(99)00015-4; Garcin Y, 2012, EARTH PLANET SC LETT, V331, P322, DOI 10.1016/j.epsl.2012.03.016; Hoelzmann P, 2001, PALAEOGEOGR PALAEOCL, V169, P193, DOI 10.1016/S0031-0182(01)00211-5; Holmes JA, 2008, SCIENCE, V320, P752, DOI 10.1126/science.1158105; Hughen KA, 2004, SCIENCE, V304, P1955, DOI 10.1126/science.1092995; Jolly D, 1998, J BIOGEOGR, V25, P1007, DOI 10.1046/j.1365-2699.1998.00238.x; Jung SJA, 2004, EARTH PLANET SC LETT, V221, P27, DOI 10.1016/S0012-821X(04)00095-0; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Kropelin S, 2008, SCIENCE, V320, P765, DOI 10.1126/science.1154913; Kuper R, 2006, SCIENCE, V313, P803, DOI 10.1126/science.1130989; KUTZBACH JE, 1982, J ATMOS SCI, V39, P1177, DOI 10.1175/1520-0469(1982)039<1177:TSOTAA>2.0.CO;2; Lezine AM, 2011, QUATERNARY SCI REV, V30, P3001, DOI 10.1016/j.quascirev.2011.07.006; LONG A, 1974, AM ANTIQUITY, V39, P205, DOI 10.2307/279583; Mohtadi M, 2010, EARTH PLANET SC LETT, V292, P89, DOI 10.1016/j.epsl.2010.01.024; Parker AG, 2004, J QUATERNARY SCI, V19, P665, DOI 10.1002/jqs.880; Pausata FSR, 2011, NAT GEOSCI, V4, P474, DOI [10.1038/NGEO1169, 10.1038/ngeo1169]; Rostek F, 1997, DEEP-SEA RES PT II, V44, P1461, DOI 10.1016/S0967-0645(97)00008-8; Schefuss E, 2005, NATURE, V437, P1003, DOI 10.1038/nature03945; SHUKLA J, 1982, SCIENCE, V215, P1498, DOI 10.1126/science.215.4539.1498; Slingo J, 2005, PHILOS T R SOC A, V363, P25, DOI 10.1098/rsta.2004.1473; Stager JC, 2011, SCIENCE, V331, P1299, DOI 10.1126/science.1198322; Staubwasser M, 2002, PALEOCEANOGRAPHY, V17, DOI 10.1029/2000PA000608; Street-Perrott F. A., 1989, 46 US DEP EN; Tierney JE, 2008, SCIENCE, V322, P252, DOI 10.1126/science.1160485; Tierney JE, 2013, NATURE, V493, P389, DOI 10.1038/nature11785; Tierney JE, 2011, EARTH PLANET SC LETT, V307, P103, DOI 10.1016/j.epsl.2011.04.038; Tierney JE, 2011, QUATERNARY SCI REV, V30, P798, DOI 10.1016/j.quascirev.2011.01.017; Tierney JE, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029508; Weldeab S, 2007, SCIENCE, V316, P1303, DOI 10.1126/science.1140461; ZHANG CD, 1993, J CLIMATE, V6, P1898, DOI 10.1175/1520-0442(1993)006<1898:LSVOAD>2.0.CO;2; Zhao Y, 2005, CLIM DYNAM, V25, P777, DOI 10.1007/s00382-005-0075-7	46	162	164	3	98	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 15	2013	342	6160					843	846		10.1126/science.1240411	http://dx.doi.org/10.1126/science.1240411			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	251IY	24114782	Green Submitted			2022-12-28	WOS:000326923000034
J	Jepson, R; Craig, J; Williams, G				Jepson, Ruth; Craig, Jonathan; Williams, Gabrielle			Cranberry Products and Prevention of Urinary Tract Infections	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Jepson, Ruth] Univ Edinburgh, Scottish Collaborat Publ Hlth Res & Policy, Ctr Populat Hlth Sci, Edinburgh EH8 9DX, Midlothian, Scotland; [Craig, Jonathan; Williams, Gabrielle] Univ Sydney, Sch Publ Hlth, Sydney, NSW 2006, Australia	University of Edinburgh; University of Sydney	Jepson, R (corresponding author), Univ Edinburgh, Scottish Collaborat Publ Hlth Res & Policy, Edinburgh EH8 9DX, Midlothian, Scotland.	ruth.jepson@ed.ac.uk	Craig, Jonathan/E-2813-2013	Craig, Jonathan/0000-0002-2548-4035; Jepson, Ruth/0000-0002-9446-445X	MRC [MR/K023209/1] Funding Source: UKRI; Medical Research Council [O12345678] Funding Source: researchfish; Medical Research Council [MR/K023209/1] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Howell AB, 2005, PHYTOCHEMISTRY, V66, P2281, DOI 10.1016/j.phytochem.2005.05.022; Howell AB, 2002, JAMA-J AM MED ASSOC, V287, P3082, DOI 10.1001/jama.287.23.3082; Howell AB, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-94; Jepson RG, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001321.pub5	4	20	21	1	40	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 2	2013	310	13					1395	1396		10.1001/jama.2013.277509	http://dx.doi.org/10.1001/jama.2013.277509			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	227GB	24084925				2022-12-28	WOS:000325098100025
J	Pauklin, S; Vallier, L				Pauklin, Siim; Vallier, Ludovic			The Cell-Cycle State of Stem Cells Determines Cell Fate Propensity	CELL			English	Article							DEPENDENT KINASE; G1 PHASE; RETINOBLASTOMA PROTEIN; DIFFERENTIATION; EXPRESSION; EPIBLAST; PLURIPOTENCY; INHIBITION; FGF; PHOSPHORYLATION	Self-renewal and differentiation of stem cells are fundamentally associated with cell-cycle progression to enable tissue specification, organ homeostasis, and potentially tumorigenesis. However, technical challenges have impaired the study of the molecular interactions coordinating cell fate choice and cell-cycle progression. Here, we bypass these limitations by using the FUCCI reporter system in human pluripotent stem cells and show that their capacity of differentiation varies during the progression of their cell cycle. These mechanisms are governed by the cell-cycle regulators cyclin D1-3 that control differentiation signals such as the TGF-beta-Smad2/3 pathway. Conversely, cell-cycle manipulation using a small molecule directs differentiation of hPSCs and provides an approach to generate cell types with a clinical interest. Our results demonstrate that cell fate decisions are tightly associated with the cell-cycle machinery and reveal insights in the mechanisms synchronizing differentiation and proliferation in developing tissues.	[Pauklin, Siim; Vallier, Ludovic] Univ Cambridge, Anne McLaren Lab Regenerat Med, Wellcome Trust Med Res Council Cambridge Stem Cel, Cambridge CB2 0SZ, England; [Pauklin, Siim; Vallier, Ludovic] Univ Cambridge, Dept Surg, Cambridge CB2 0SZ, England; [Vallier, Ludovic] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England	University of Cambridge; University of Cambridge; Wellcome Trust Sanger Institute	Pauklin, S (corresponding author), Univ Cambridge, Anne McLaren Lab Regenerat Med, Wellcome Trust Med Res Council Cambridge Stem Cel, Cambridge CB2 0SZ, England.	sp579@cam.ac.uk; lv225@cam.ac.uk	vallier, ludovic/C-6368-2011	Vallier, Ludovic/0000-0002-3848-2602	MRC Senior nonclinical fellowship; Cambridge Hospitals National Institute for Health Research Biomedical Research Center; FEBS long-term fellowship; Medical Research Council [G0701448] Funding Source: researchfish; MRC [G0701448] Funding Source: UKRI	MRC Senior nonclinical fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cambridge Hospitals National Institute for Health Research Biomedical Research Center; FEBS long-term fellowship; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank Anne Ferguson-Smith and Michael Stratton for discussions and proofreading and Nigel Miller for help with cell sorting experiments. This work was supported by the MRC Senior nonclinical fellowship and the Cambridge Hospitals National Institute for Health Research Biomedical Research Center (L.V.). S.P. was funded by FEBS long-term fellowship. S.P. and L.V. conceived the research and wrote the manuscript.	Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Brown S, 2011, STEM CELLS, V29, P1176, DOI 10.1002/stem.666; Calder A, 2013, STEM CELLS DEV, V22, P279, DOI 10.1089/scd.2012.0168; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Chng ZZ, 2010, CELL STEM CELL, V6, P59, DOI 10.1016/j.stem.2009.11.015; Cho CHH, 2012, DIABETOLOGIA, V55, P3284, DOI 10.1007/s00125-012-2687-x; Coronado D, 2013, STEM CELL RES, V10, P118, DOI 10.1016/j.scr.2012.10.004; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; Diehl JA, 1997, MOL CELL BIOL, V17, P7362, DOI 10.1128/MCB.17.12.7362; Fry DW, 2004, MOL CANCER THER, V3, P1427; Fuchs E, 2009, CELL, V137, P811, DOI 10.1016/j.cell.2009.05.002; Kozar K, 2004, CELL, V118, P477, DOI 10.1016/j.cell.2004.07.025; Kretzschmar M, 1999, GENE DEV, V13, P804, DOI 10.1101/gad.13.7.804; Kuijk EW, 2012, DEVELOPMENT, V139, P871, DOI 10.1242/dev.071688; Lange C, 2010, CELL CYCLE, V9, P1893, DOI 10.4161/cc.9.10.11598; Lange C, 2009, CELL STEM CELL, V5, P320, DOI 10.1016/j.stem.2009.05.026; Li LH, 2010, SCIENCE, V327, P542, DOI 10.1126/science.1180794; Lo RS, 1999, NAT CELL BIOL, V1, P472, DOI 10.1038/70258; Matsuura I, 2004, NATURE, V430, P226, DOI 10.1038/nature02650; Mullen AC, 2011, CELL, V147, P565, DOI 10.1016/j.cell.2011.08.050; Neganova I, 2009, ONCOGENE, V28, P20, DOI 10.1038/onc.2008.358; Neganova I, 2011, STEM CELLS, V29, P651, DOI 10.1002/stem.620; Roccio M, 2013, DEVELOPMENT, V140, P459, DOI 10.1242/dev.086215; Roode M, 2012, DEV BIOL, V361, P358, DOI 10.1016/j.ydbio.2011.10.030; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Savatier P, 1996, ONCOGENE, V12, P309; SAVATIER P, 1994, ONCOGENE, V9, P809; Sela Y, 2012, STEM CELLS, V30, P1097, DOI 10.1002/stem.1078; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Vallier L, 2004, STEM CELLS, V22, P2, DOI 10.1634/stemcells.22-1-2; Vallier L, 2005, J CELL SCI, V118, P4495, DOI 10.1242/jcs.02553; Vallier L, 2009, STEM CELLS, V27, P2655, DOI 10.1002/stem.199; Vallier L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006082; Vallier L, 2009, DEVELOPMENT, V136, P1339, DOI 10.1242/dev.033951; Wianny F, 1998, DEV DYNAM, V212, P49, DOI 10.1002/(SICI)1097-0177(199805)212:1<49::AID-AJA5>3.0.CO;2-2; Xu RH, 2008, CELL STEM CELL, V3, P196, DOI 10.1016/j.stem.2008.07.001	36	376	382	5	75	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 26	2013	155	1					135	147		10.1016/j.cell.2013.08.031	http://dx.doi.org/10.1016/j.cell.2013.08.031			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	224UX	24074866	Green Published, hybrid			2022-12-28	WOS:000324916700015
J	Fuchs, CS; Tomasek, J; Yong, CJ; Dumitru, F; Passalacqua, R; Goswami, C; Safran, H; dos Santos, LV; Aprile, G; Ferry, DR; Melichar, B; Tehfe, M; Topuzov, E; Zalcberg, JR; Chau, I; Campbell, W; Sivanandan, C; Pikiel, J; Koshiji, M; Hsu, YZ; Liepa, AM; Gao, L; Schwartz, JD; Tabernero, J				Fuchs, Charles S.; Tomasek, Jiri; Yong, Cho Jae; Dumitru, Filip; Passalacqua, Rodolfo; Goswami, Chanchal; Safran, Howard; dos Santos, Lucas Vieira; Aprile, Giuseppe; Ferry, David R.; Melichar, Bohuslav; Tehfe, Mustapha; Topuzov, Eldar; Zalcberg, John Raymond; Chau, Ian; Campbell, William; Sivanandan, Choondal; Pikiel, Joanna; Koshiji, Minori; Hsu, Yanzhi; Liepa, Astra M.; Gao, Ling; Schwartz, Jonathan D.; Tabernero, Josep		REGARD Trial Investigators	Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial	LANCET			English	Article							ENDOTHELIAL GROWTH-FACTOR; HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; CLINICOPATHOLOGICAL SIGNIFICANCE; TUMOR ANGIOGENESIS; SUPPORTIVE CARE; FACTOR RECEPTOR; CANCER; CHEMOTHERAPY; EXPRESSION; BEVACIZUMAB	Background Vascular endothelial growth factor (VEGF) and VEGF receptor-2 (VEGFR-2)-mediated signalling and angiogenesis can contribute to the pathogenesis and progression of gastric cancer. We aimed to assess whether ramucirumab, a monoclonal antibody VEGFR-2 antagonist, prolonged survival in patients with advanced gastric cancer. Methods We did an international, randomised, double-blind, placebo-controlled, phase 3 trial between Oct 6, 2009, and Jan 26, 2012, at 119 centres in 29 countries in North America, Central and South America, Europe, Asia, Australia, and Africa. Patients aged 24-87 years with advanced gastric or gastro-oesophageal junction adenocarcinoma and disease progression after first-line platinum-containing or fluoropyrimidine-containing chemotherapy were randomly assigned (2: 1), via a central interactive voice-response system, to receive best supportive care plus either ramucirumab 8 mg/kg or placebo, intravenously once every 2 weeks. The study sponsor, participants, and investigators were masked to treatment assignment. The primary endpoint was overall survival. Analysis was by intention to treat. This trial is registered with ClinicalTrials.gov, number NCT00917384. Findings 355 patients were assigned to receive ramucirumab (n=238) or placebo (n=117). Median overall survival was 5.2 months (IQR 2.3-9.9) in patients in the ramucirumab group and 3.8 months (1.7-7.1) in those in the placebo group (hazard ratio [HR] 0.776, 95% CI 0.603-0.998; p=0.047). The survival benefit with ramucirumab remained unchanged after multivariable adjustment for other prognostic factors (multivariable HR 0.774, 0.605-0.991; p=0.042). Rates of hypertension were higher in the ramucirumab group than in the placebo group (38 [16%] vs nine [8%]), whereas rates of other adverse events were mostly similar between groups (223 [94%] vs 101 [88%]). Five (2%) deaths in the ramucirumab group and two (2%) in the placebo group were considered to be related to study drug. Interpretation Ramucirumab is the first biological treatment given as a single drug that has survival benefits in patients with advanced gastric or gastro-oesophageal junction adenocarcinoma progressing after first-line chemotherapy. Our findings validate VEGFR-2 signalling as an important therapeutic target in advanced gastric cancer.	[Fuchs, Charles S.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Tomasek, Jiri] Masaryk Mem Canc Inst, Dept Complex Oncol Care, Brno, Czech Republic; [Yong, Cho Jae] Yonsei Univ, Coll Med, Gangnam Severance Hosp, Dept Med Oncol, Seoul, South Korea; [Dumitru, Filip] Emergency Cty Hosp Dr Constantin Opris, Dept Oncol, Baia Mare, Romania; [Passalacqua, Rodolfo] Ist Ospitalieri Cremona, Div Med Oncol, Cremona, Italy; [Goswami, Chanchal] BP Poddar Hosp & Med Res, Dept Med Oncol, Kolkata, W Bengal, India; [Safran, Howard] Brown Univ, Dept Med, Oncol Grp, Providence, RI 02912 USA; [dos Santos, Lucas Vieira] Hosp Canc Barretos & Hemomed, Inst Oncol Hematol, Gastrointestinal Oncol Div, Dept Oncol, Sao Paulo, Brazil; [Aprile, Giuseppe] Univ Udine, Dept Oncol, I-33100 Udine, Italy; [Aprile, Giuseppe] Gen Hosp, Udine, Italy; [Ferry, David R.] New Cross Hosp, Dept Med Oncol, Wolverhampton, W Midlands, England; [Melichar, Bohuslav] Palacky Univ, Sch Med, Dept Oncol, CR-77147 Olomouc, Czech Republic; [Melichar, Bohuslav] Teaching Hosp, Olomouc, Czech Republic; [Tehfe, Mustapha] CHUM, Hop Notre Dame, Dept Med Oncol, Montreal, PQ, Canada; [Topuzov, Eldar] Northwest State Med Univ II Mechnikov, Minist Healthcare Russian Federat, SBEIHPE, Moscow, Russia; [Zalcberg, John Raymond] Peter MacCallum Canc Ctr, Div Canc Med, East Melbourne, Vic, Australia; [Zalcberg, John Raymond] Univ Melbourne, Fac Med, Dept Med, Melbourne, Vic 3010, Australia; [Zalcberg, John Raymond] Univ Melbourne, Fac Med, Dept Oncol, Melbourne, Vic 3010, Australia; [Chau, Ian] Royal Marsden Hosp, Dept Med, London SW3 6JJ, England; [Chau, Ian] Royal Marsden Hosp, Dept Med, Surrey, England; [Campbell, William] Hosp Herrera Llerandi Clin Med, Dept Oncol, Guatemala City, Guatemala; [Sivanandan, Choondal] Reg Canc Ctr, Div Canc Res, Thiruvananthapuram, Kerala, India; [Pikiel, Joanna] Wojewodzkie Ctr Onkol Gdansk, Gdansk, Poland; [Koshiji, Minori; Hsu, Yanzhi; Gao, Ling; Schwartz, Jonathan D.] ImClone Syst LLC, Bridgewater, NJ USA; [Liepa, Astra M.] Eli Lilly & Co, Indianapolis, IN 46285 USA; [Tabernero, Josep] Univ Autonoma Barcelona, Vall dHebron Univ Hosp, Dept Med Oncol, E-08193 Barcelona, Spain	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Masaryk Memorial Cancer Institute; Yonsei University; Yonsei University Health System; Brown University; Hospital de Cancer de Barretos; University of Udine; New Cross Hospital; Palacky University Olomouc; University Hospital Olomouc; Universite de Montreal; Peter Maccallum Cancer Center; University of Melbourne; University of Melbourne; Royal Marsden NHS Foundation Trust; Royal Marsden NHS Foundation Trust; Eli Lilly; Eli Lilly; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut d'Oncologia (VHIO)	Fuchs, CS (corresponding author), Dana Farber Canc Inst, Gastrointestinal Oncol Div, Boston, MA 02215 USA.	cfuchs@partners.org	Schwartsmann, Gilberto/G-4256-2016; Topuzov, Eldar E/O-9523-2015; Santos, Lucas/K-3407-2013; Tabernero, Josep/AAG-5026-2019; Chau, Ian/ABC-2023-2020; Zemanova, Milada/M-1921-2017; Amoroso, Vito/P-6179-2019	Schwartsmann, Gilberto/0000-0002-7850-1644; Topuzov, Eldar E/0000-0002-1700-1128; Santos, Lucas/0000-0002-2221-6692; Tabernero, Josep/0000-0002-2495-8139; Chau, Ian/0000-0003-0286-8703; Zemanova, Milada/0000-0002-1904-1035; Cho, Jae Yong/0000-0002-0926-1819; Amoroso, Vito/0000-0001-5357-5703; Zalcberg, John/0000-0002-6624-0782	ImClone Systems	ImClone Systems(Eli Lilly)	ImClone Systems.	AARONSON NK, 1993, J NATL CANCER I, V85, P365, DOI 10.1093/jnci/85.5.365; Bang YJ, 2010, LANCET, V376, P1302; Blumenschein GR, 2012, J CLIN ONCOL, V30, P3287, DOI 10.1200/JCO.2011.40.3774; Cabuk D, 2007, ONCOLOGY-BASEL, V72, P111, DOI 10.1159/000111118; Cancer Therapy Evaluation Program, 2009, COMM TERM CRIT ADV E; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; DEMETS DL, 1982, BIOMETRIKA, V69, P661; Ford H, 2013, 10 ANN GASTR CANC S, pLBA4; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jung YD, 2002, EUR J CANCER, V38, P1133, DOI 10.1016/S0959-8049(02)00013-8; Juttner S, 2006, J CLIN ONCOL, V24, P228, DOI 10.1200/JCO.2004.00.3467; Kang JH, 2012, J CLIN ONCOL, V30, P1513, DOI 10.1200/JCO.2011.39.4585; Kim SE, 2009, GUT LIVER, V3, P88, DOI 10.5009/gnl.2009.3.2.88; Li H, 2011, CANCER-AM CANCER SOC, V117, P3135, DOI 10.1002/cncr.25893; Lieto E, 2008, ANN SURG ONCOL, V15, P69, DOI 10.1245/s10434-007-9596-0; Murukesh N, 2010, BRIT J CANCER, V102, P8, DOI 10.1038/sj.bjc.6605483; Oh SY, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-123; Ohtsu A, 2011, J CLIN ONCOL, V29, P3968, DOI 10.1200/JCO.2011.36.2236; Okines AFC, 2011, ONCOLOGIST, V16, P844, DOI 10.1634/theoncologist.2010-0387; Osoba D, 1998, J CLIN ONCOL, V16, P139, DOI 10.1200/JCO.1998.16.1.139; Paterson AL, 2013, GUT, V62, P1415, DOI 10.1136/gutjnl-2012-302039; Seto M, 2009, MOL CARCINOGEN, V48, P703, DOI 10.1002/mc.20516; Song Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017687; Song ZJ, 2002, WORLD J GASTROENTERO, V8, P591, DOI 10.3748/wjg.v8.i4.591; Spratlin JL, 2010, J CLIN ONCOL, V28, P780, DOI 10.1200/JCO.2009.23.7537; Suzuki S, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-659; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Thuss-Patience PC, 2011, EUR J CANCER, V47, P2306, DOI 10.1016/j.ejca.2011.06.002; Waddell TS, 2012, J CLIN ONCOL, V30, DOI 10.1200/jco.2012.30.18_suppl.lba4000; Wagner AD, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004064.pub3; Zhao HC, 2006, WORLD J GASTROENTERO, V12, P7598, DOI 10.3748/wjg.v12.i47.7598	31	1454	1536	9	155	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 4	2014	383	9911					31	39		10.1016/S0140-6736(13)61719-5	http://dx.doi.org/10.1016/S0140-6736(13)61719-5			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	284SP	24094768				2022-12-28	WOS:000329341200033
J	ten Broek, RPG; Stommel, MWJ; Strik, C; van Laarhoven, CJHM; Keus, F; van Goor, H				ten Broek, Richard P. G.; Stommel, Martijn W. J.; Strik, Chema; van Laarhoven, Cornelis J. H. M.; Keus, Frederik; van Goor, Harry			Benefits and harms of adhesion barriers for abdominal surgery: a systematic review and meta-analysis	LANCET			English	Review							ICODEXTRIN 4-PERCENT SOLUTION; POLYCYSTIC OVARIAN SYNDROME; SMALL-BOWEL OBSTRUCTION; BIORESORBABLE MEMBRANE; CARBOXYMETHYLCELLULOSE MEMBRANE; POSTOPERATIVE ADHESIONS; COLORECTAL-CANCER; RANDOMIZED-TRIAL; DOUBLE-BLIND; PREVENTION	Background Formation of adhesions after peritoneal surgery results in high morbidity. Barriers to prevent adhesion are seldom applied, despite their ability to reduce the severity of adhesion formation. We evaluated the benefits and harms of four adhesion barriers that have been approved for clinical use. Methods In this systematic review and meta-analysis, we searched PubMed, CENTRAL, and Embase for randomised clinical trials assessing use of oxidised regenerated cellulose, hyaluronate carboxy methylcellulose, icodextrin, or polyethylene glycol in abdominal surgery. Two researchers independently identified reports and extracted data. We compared use of a barrier with no barrier for nine predefined outcomes, graded for clinical relevance. The primary outcome was reoperation for adhesive small bowel obstruction. We assessed systematic error, random error, and design error with the error matrix approach. This study is registered with PROSPERO, number CRD42012003321. Findings Our search returned 1840 results, from which 28 trials (5191 patients) were included in our meta-analysis. The risks of systematic and random errors were low. No trials reported data for the effect of oxidised regenerated cellulose or polyethylene glycol on reoperations for adhesive small bowel obstruction. Oxidised regenerated cellulose reduced the incidence of adhesions (relative risk [RR] 0.51, 95% CI 0.31-0.86). Some evidence suggests that hyaluronate carboxymethylcellulose reduces the incidence of reoperations for adhesive small bowel obstruction (RR 0.49, 95% CI 0.28-0.88). For icodextrin, reoperation for adhesive small bowel obstruction did not differ significantly between groups (RR 0.33, 95% CI 0.03-3.11). No barriers were associated with an increase in serious adverse events. Interpretation Oxidised regenerated cellulose and hyaluronate carboxymethylcellulose can safely reduce clinically relevant consequences of adhesions.	[ten Broek, Richard P. G.; Stommel, Martijn W. J.; Strik, Chema; van Laarhoven, Cornelis J. H. M.; van Goor, Harry] Radboud Univ Nijmegen, Med Ctr, Dept Surg, NL-6500 HB Nijmegen, Netherlands; [Keus, Frederik] Univ Groningen, Univ Med Ctr Groningen, Dept Crit Care, Groningen, Netherlands	Radboud University Nijmegen; University of Groningen	ten Broek, RPG (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Surg, POB 9101, NL-6500 HB Nijmegen, Netherlands.	richard_tenbroek@hotmail.com	Stommel, Martijn WJ/P-6725-2015; van Goor, H./H-8035-2014; Broek, Richard PG ten/M-9038-2016; van Laarhoven, C.J.H.M./H-8065-2014	Stommel, Martijn WJ/0000-0002-4257-5254; van Goor, H./0000-0003-0323-4876; Broek, Richard PG ten/0000-0002-4012-7968; 				Ahmad G, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006583.pub2; [Anonymous], 2011, REF MAN REVMAN COMP; AZZIZ R, 1993, SURG GYNECOL OBSTET, V177, P135; Banasiewicz T, 2011, COL DIS C 6 SCI ANN, P56; Beck DE, 1997, EUR J SURG, V163, P49; Becker JM, 1996, J AM COLL SURGEONS, V183, P297; Burns JW, 1997, EUR J SURG, V163, P40; Catena F, 2012, J GASTROINTEST SURG, V16, P382, DOI 10.1007/s11605-011-1736-y; De Wilde RL, POSTMARKET STUDY ADH; De Wilde RL, 2012, GYNECOL SURG, V9, P365, DOI 10.1007/s10397-012-0764-2; Demco L, 2004, J AM ASSOC GYN LAP, V11, P181, DOI 10.1016/S1074-3804(05)60195-8; Diamond MP, 2010, SURG INNOV, V17, P183, DOI 10.1177/1553350610379869; Diamond MP, 1996, FERTIL STERIL, V66, P904, DOI 10.1016/S0015-0282(16)58716-0; DIMITRIJEVICH SD, 1990, CARBOHYD RES, V198, P331; diZerega GS, 2002, HUM REPROD, V17, P1031, DOI 10.1093/humrep/17.4.1031; Dunn R, 2001, FERTIL STERIL, V75, P411, DOI 10.1016/S0015-0282(00)01677-0; Dupre A, 2013, ANN SURG, V258, P30, DOI 10.1097/SLA.0b013e3182854949; Ellis H, 1999, LANCET, V353, P1476, DOI 10.1016/S0140-6736(98)09337-4; Fazio VW, 2006, DIS COLON RECTUM, V49, P1, DOI 10.1007/s10350-005-0268-5; Franklin Robert R., 1995, Obstetrics and Gynecology, V86, P335; GREENBLATT EM, 1993, FERTIL STERIL, V60, P766; Guyatt GH, 2008, BMJ-BRIT MED J, V336, P995, DOI 10.1136/bmj.39490.551019.BE; Hayashi S, 2008, ANN SURG, V247, P766, DOI 10.1097/SLA.0b013e3181656d4e; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Hosie K, 2001, DRUG DELIV, V8, P9; Inoue M, 2005, J PEDIATR SURG, V40, P1301, DOI 10.1016/j.jpedsurg.2005.05.015; Johns DA, 2003, J AM ASSOC GYN LAP, V10, P334, DOI 10.1016/S1074-3804(05)60257-5; Keckstein J, 1996, HUM REPROD, V11, P579, DOI 10.1093/HUMREP/11.3.579; Keus F, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008318; Keus F, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-90; Koning GG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052599; Kossi J, 2009, COLORECTAL DIS, V11, P168, DOI 10.1111/j.1463-1318.2008.01562.x; Kumar S, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005080.pub2; Kusunoki M, 2005, SURG TODAY, V35, P940, DOI 10.1007/s00595-005-3061-0; LARSSON B, 1985, ACTA OBSTET GYN SCAN, V64, P437, DOI 10.3109/00016348509155163; LARSSON B, 1995, FERTIL STERIL, V63, P709; LI TC, 1994, BRIT J OBSTET GYNAEC, V101, P335, DOI 10.1111/j.1471-0528.1994.tb13621.x; LINSKY CB, 1987, J REPROD MED, V32, P17; Mais V, 1995, HUM REPROD, V10, P3133, DOI 10.1093/oxfordjournals.humrep.a135873; MAIS V, 1995, OBSTET GYNECOL, V86, P512, DOI 10.1016/S0029-7844(95)80007-7; Menzies D, 2006, ANN ROY COLL SURG, V88, P375, DOI 10.1308/003588406X114730; Mettler L, 2008, HUM REPROD, V23, P1093, DOI 10.1093/humrep/den080; Mettler L, 2004, FERTIL STERIL, V82, P398, DOI 10.1016/j.fertnstert.2003.12.046; Metwally M, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001298.pub3; Montori VM, 2005, JAMA-J AM MED ASSOC, V294, P2203, DOI 10.1001/jama.294.17.2203; Olsen KO, 2002, GASTROENTEROLOGY, V122, P15, DOI 10.1053/gast.2002.30345; Park CM, 2009, INT J COLORECTAL DIS, V24, P305, DOI 10.1007/s00384-008-0602-1; Salum M, 2006, Tech Coloproctol, V10, P187, DOI 10.1007/s10151-006-0278-x; Salum M, 2006, TECH COLOPROCTOL, V10, P190; Saravelos H, 1996, HUM REPROD, V11, P992; Schreinemacher MHF, 2010, WORLD J SURG, V34, P2805, DOI 10.1007/s00268-010-0778-8; SEKIBA K, 1992, OBSTET GYNECOL, V79, P518; Sikirica V, 2011, BMC SURG, V11, DOI 10.1186/1471-2482-11-13; Spanjersberg WR, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007635.pub2; Sutton C, 2005, GYNECOL SURG, V2, P287, DOI 10.1007/s10397-005-0126-4; Takeuchi H, 2005, J REPROD MED, V50, P571; Tang CL, 2006, ANN SURG, V243, P449, DOI 10.1097/01.sla.0000207837.71831.a2; ten Broek RPG, 2012, GYNECOL SURG, V9, P29, DOI 10.1007/s10397-011-0698-0; ten Broek RPG, 2013, ANN SURG, V258, P98, DOI 10.1097/SLA.0b013e31826f4969; ten Broek RPG, 2012, ANN SURG, V256, P280, DOI 10.1097/SLA.0b013e31826029a8; Tinelli A, 2011, FERTIL STERIL, V95, P1780, DOI 10.1016/j.fertnstert.2010.12.049; Tjandra JJ, 2008, DIS COLON RECTUM, V51, P956, DOI 10.1007/s10350-007-9181-4; Trew G, 2011, HUM REPROD, V26, P2015, DOI 10.1093/humrep/der135; Tzianabos AO, 1999, ARCH SURG-CHICAGO, V134, P1254, DOI 10.1001/archsurg.134.11.1254; van der Wal JBC, 2011, ANN SURG, V253, P1118, DOI 10.1097/SLA.0b013e318217e99c; van Geldrop H, 1994, FERTIL STERIL S, P273; van Goor H, 2007, COLORECTAL DIS, V9, P25, DOI 10.1111/j.1463-1318.2007.01358.x; Verco SJS, 2000, HUM REPROD, V15, P1764, DOI 10.1093/humrep/15.8.1764; Vrijland WW, 2002, ANN SURG, V235, P193, DOI 10.1097/00000658-200202000-00006; Wilson MS, 2007, COLORECTAL DIS, V9, P60, DOI 10.1111/j.1463-1318.2007.01360.x; Wiseman DM, 1999, J INVEST SURG, V12, P141; WISEMAN DM, 1992, J REPROD MED, V37, P766	72	174	178	4	44	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 4	2014	383	9911					48	59		10.1016/S0140-6736(13)61687-6	http://dx.doi.org/10.1016/S0140-6736(13)61687-6			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	284SP	24075279				2022-12-28	WOS:000329341200035
J	Kidd, DC; Castano, E				Kidd, David Comer; Castano, Emanuele			Reading Literary Fiction Improves Theory of Mind	SCIENCE			English	Article							HIGH-FUNCTIONING AUTISM; ASPERGER-SYNDROME; SIMULATION; EXPOSURE; EMPATHY; OTHERS; ADULTS	Understanding others' mental states is a crucial skill that enables the complex social relationships that characterize human societies. Yet little research has investigated what fosters this skill, which is known as Theory of Mind (ToM), in adults. We present five experiments showing that reading literary fiction led to better performance on tests of affective ToM (experiments 1 to 5) and cognitive ToM (experiments 4 and 5) compared with reading nonfiction (experiments 1), popular fiction (experiments 2 to 5), or nothing at all (experiments 2 and 5). Specifically, these results show that reading literary fiction temporarily enhances ToM. More broadly, they suggest that ToM may be influenced by engagement with works of art.	[Kidd, David Comer; Castano, Emanuele] New Sch Social Res, New York, NY 10011 USA	The New School	Kidd, DC (corresponding author), New Sch Social Res, 80 5th Ave, New York, NY 10011 USA.	kiddd305@newschool.edu; castanoe@newschool.edu	Castano, Emanuele/C-8757-2018	Castano, Emanuele/0000-0003-1709-590X	New School for Social Research	New School for Social Research	Data are available in spreadsheet format from authors by request. This research was funded by a Prize Fellowship and a Dissertation Fellowship by the New School for Social Research to the first author, and a Faculty Development Award by the New School for Social Research to the second author. We are grateful to Andrew Marzoni for his insight into literary criticism and pointing us toward Barthes's S/Z (19).	Acheson DJ, 2008, BEHAV RES METHODS, V40, P278, DOI 10.3758/BRM.40.1.278; Bakhtin M.M., 1963, PROBLEMS DOSTOEVSKYS; Bal PM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055341; Baron-Cohen S, 2001, J CHILD PSYCHOL PSYC, V42, P241, DOI 10.1111/1469-7610.00715; Barthes Roland, 1974, SZ ESSAY; Batson C. D., 1998, HDB SOCIAL PSYCHOL, V2, P282, DOI DOI 10.1002/0471264385.WEI0519; Billington J, 2011, CRIT SURV, V23, P67, DOI 10.3167/cs.2011.230306; Bruner JS, 1986, ACTUAL MINDS POSSIBL, DOI DOI 10.4159/9780674029019; Bushman BJ, 2009, PSYCHOL SCI, V20, P273, DOI 10.1111/j.1467-9280.2009.02287.x; Castano E., 2012, OXFORD HDB PERSONALI, P419; Converse BA, 2008, EMOTION, V8, P725, DOI 10.1037/a0013283; de Waal FBM, 2012, SCIENCE, V336, P874, DOI 10.1126/science.1220999; Djikic M, 2013, SCI STUDY LIT, V3, P28, DOI [10.1075/ssol.3.1.06dji, DOI 10.1075/SSOL.3.1.06DJI]; Furman L., 2012, PEN O HENRY PRIZE ST; Gerrig RJ, 2004, POETICS TODAY, V25, P265, DOI 10.1215/03335372-25-2-265; Green MC, 2000, J PERS SOC PSYCHOL, V79, P701, DOI 10.1037/0022-3514.79.5.701; Hoppenstand G., 1998, POPULAR FICTION ANTH; Humphrey N, 1983, CONSCIOUSNESS REGAIN; Mar RA, 2008, PERSPECT PSYCHOL SCI, V3, P173, DOI 10.1111/j.1745-6924.2008.00073.x; Mar RA, 2006, J RES PERS, V40, P694, DOI 10.1016/j.jrp.2005.08.002; Mar RA, 2009, COMMUNICATIONS-GER, V34, P407, DOI 10.1515/COMM.2009.025; McLellan MF, 1996, LANCET, V348, P109, DOI 10.1016/S0140-6736(96)03521-0; MIALL DS, 1994, DISCOURSE PROCESS, V17, P337, DOI 10.1080/01638539409544873; MIALL DS, 1994, POETICS, V22, P389, DOI 10.1016/0304-422X(94)00011-5; Miall DS, 1999, DISCOURSE PROCESS, V28, P121, DOI 10.1080/01638539909545076; Mosle S., 2012, NY TIMES; Nowicki S., 2010, MANUAL RECEPTIVE TES; Pennebaker J. W., 2007, LING INQ WORD COUNT; Saxe R, 2004, ANNU REV PSYCHOL, V55, P87, DOI 10.1146/annurev.psych.55.090902.142044; Schiappa E, 2005, COMMUN MONOGR, V72, P92, DOI 10.1080/0363775052000342544; Sebastian CL, 2012, SOC COGN AFFECT NEUR, V7, P53, DOI 10.1093/scan/nsr023; Shamay-Tsoory SG, 2008, J AUTISM DEV DISORD, V38, P1451, DOI 10.1007/s10803-007-0515-9; Shamay-Tsoory SG, 2007, NEUROPSYCHOLOGIA, V45, P3054, DOI 10.1016/j.neuropsychologia.2007.05.021; Shamay-Tsoory SG, 2011, NEUROSCIENTIST, V17, P18, DOI 10.1177/1073858410379268; Shamay-Tsoory SG, 2010, CORTEX, V46, P668, DOI 10.1016/j.cortex.2009.04.008; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063	36	590	595	21	310	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 18	2013	342	6156					377	380		10.1126/science.1239918	http://dx.doi.org/10.1126/science.1239918			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	235XG	24091705				2022-12-28	WOS:000325755100050
J	Rodriguez, I				Rodriguez, Ivan			Singular Expression of Olfactory Receptor Genes	CELL			English	Review							ODORANT RECEPTORS; SENSORY NEURONS; AXON GUIDANCE; MOUSE; CHOICE; FEEDBACK; FAMILY; ORGAN; CIS	Understanding the mechanisms of monogenic and monoallelic transcription of the large repertoire of olfactory receptor genes represents a challenging task. A picture is now emerging in which odorant receptor choice and stabilization involve an escape from silencing followed by the activation of an unconventional feedback loop.	Univ Geneva, Dept Genet & Evolut, CH-1205 Geneva, Switzerland	University of Geneva	Rodriguez, I (corresponding author), Univ Geneva, Dept Genet & Evolut, CH-1205 Geneva, Switzerland.	ivan.rodriguez@unige.ch		rodriguez, ivan/0000-0002-6468-0565				BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Dalton RP, 2013, CELL, V155, P321, DOI 10.1016/j.cell.2013.09.033; Eggan E, 2004, NATURE, V428, P44, DOI 10.1038/nature02375; Feinstein P, 2004, CELL, V117, P833, DOI 10.1016/j.cell.2004.05.013; Fuss SH, 2007, CELL, V130, P373, DOI 10.1016/j.cell.2007.06.023; Imai T, 2006, SCIENCE, V314, P657, DOI 10.1126/science.1131794; Khan M, 2011, CELL, V147, P907, DOI 10.1016/j.cell.2011.09.049; Lewcock JW, 2004, P NATL ACAD SCI USA, V101, P1069, DOI 10.1073/pnas.0307986100; Li JS, 2004, NATURE, V428, P393, DOI 10.1038/nature02433; Liberles SD, 2009, P NATL ACAD SCI USA, V106, P9842, DOI 10.1073/pnas.0904464106; Lomvardas S, 2006, CELL, V126, P403, DOI 10.1016/j.cell.2006.06.035; Lyons DB, 2013, CELL, V154, P325, DOI 10.1016/j.cell.2013.06.039; Magklara A, 2011, CELL, V145, P555, DOI 10.1016/j.cell.2011.03.040; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Nguyen MQ, 2007, CELL, V131, P1009, DOI 10.1016/j.cell.2007.10.050; Nishizumi H, 2007, P NATL ACAD SCI USA, V104, P20067, DOI 10.1073/pnas.0706544105; Pacifico R, 2012, CELL REP, V2, P76, DOI 10.1016/j.celrep.2012.06.006; Riviere S, 2009, NATURE, V459, P574, DOI 10.1038/nature08029; Roppolo D, 2007, EMBO J, V26, P3423, DOI 10.1038/sj.emboj.7601782; Serizawa S, 2003, SCIENCE, V302, P2088, DOI 10.1126/science.1089122; Shykind BM, 2004, CELL, V117, P801, DOI 10.1016/j.cell.2004.05.015; Tian HK, 2008, MOL CELL NEUROSCI, V38, P484, DOI 10.1016/j.mcn.2008.04.006; Vassalli A, 2002, NEURON, V35, P681, DOI 10.1016/S0896-6273(02)00793-6; Vassalli A, 2011, MOL CELL NEUROSCI, V46, P381, DOI 10.1016/j.mcn.2010.11.001	24	43	43	1	43	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 10	2013	155	2					274	277		10.1016/j.cell.2013.09.032	http://dx.doi.org/10.1016/j.cell.2013.09.032			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	235LH	24120129	Bronze			2022-12-28	WOS:000325719800005
J	Taqueti, VR				Taqueti, Viviany R.			No Easy Fixes	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								Ms. D. has received 10 drug-eluting stents, primarily for atypical chest discomfort, with one stenting begetting another. In our system, it's somehow easier to provide 10 state-of-the-art stents than access to a generic pill and social, financial, and psychiatric support. Ms. D., a middle-aged Jamaican-American woman from the Hyde Park neighborhood of Boston, sits amidst many other patients in the waiting room. It's not evident from her outward appearance, but her coronary arteries house 10 drug-eluting stents. Six of them had been placed over the course of a year, now 6 years ago, when she underwent seven cardiac catheterizations at the age of 49. Yes, Ms. D. has terrible coronary artery disease. Yes, with a body-mass index of 41, she is morbidly obese, with type 2 diabetes, high blood pressure, and high cholesterol. Nonetheless, given that she was a nonsmoking ...	[Taqueti, Viviany R.] Brigham & Womens Hosp, Div Cardiovasc Med, Boston, MA 02115 USA; [Taqueti, Viviany R.] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Taqueti, VR (corresponding author), Brigham & Womens Hosp, Div Cardiovasc Med, 75 Francis St, Boston, MA 02115 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL094301] Funding Source: NIH RePORTER; NHLBI NIH HHS [T32 HL094301] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837	1	0	0	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 10	2013	369	15					1392	1393		10.1056/NEJMp1303484	http://dx.doi.org/10.1056/NEJMp1303484			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	231QE	24106933	Green Accepted			2022-12-28	WOS:000325431500005
J	Baker, CR; Hanson-Smith, V; Johnson, AD				Baker, Christopher R.; Hanson-Smith, Victor; Johnson, Alexander D.			Following Gene Duplication, Paralog Interference Constrains Transcriptional Circuit Evolution	SCIENCE			English	Article							DNA-BINDING; BOX PROTEIN; ARGININE; MCM1; SPECIFICITY; METABOLISM; COFACTORS	Most models of gene duplication assume that the ancestral functions of the preduplication gene are independent and can therefore be neatly partitioned between descendant paralogs. However, many gene products, such as transcriptional regulators, are components within cooperative assemblies; here, we show that a natural consequence of duplication and divergence of such proteins can be competitive interference between the paralogs. Our example is based on the duplication of the essential MADS-box transcriptional regulator Mcm1, which is found in all fungi and regulates a large set of genes. We show that a set of historical amino acid sequence substitutions minimized paralog interference in contemporary species and, in doing so, increased the molecular complexity of this gene regulatory network. We propose that paralog interference is a common constraint on gene duplicate evolution, and its resolution, which can generate additional regulatory complexity, is needed to stabilize duplicated genes in the genome.	[Baker, Christopher R.; Hanson-Smith, Victor; Johnson, Alexander D.] Univ Calif San Francisco, Dept Immunol & Microbiol, San Francisco, CA 94143 USA; [Baker, Christopher R.; Hanson-Smith, Victor; Johnson, Alexander D.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Johnson, AD (corresponding author), Univ Calif San Francisco, Dept Immunol & Microbiol, San Francisco, CA 94143 USA.	ajohnson@cgl.ucsf.edu			NIH [RO1 GM057049]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037049, R01GM057049, F32GM108299] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank B. Tuch for assistance and comments; O. Homann for assistance on experimental techniques; and C. Nobile, C. Dalal, S. Devika, R. Bennett, L. Mera, and T. Sorrells for comments. This work was funded by grant RO1 GM057049 from the NIH.	Acton TB, 2000, MOL CELL BIOL, V20, P1, DOI 10.1128/MCB.20.1.1-11.2000; Amar N, 2000, MOL CELL BIOL, V20, P2087, DOI 10.1128/MCB.20.6.2087-2097.2000; Baker CR, 2011, P NATL ACAD SCI USA, V108, P7493, DOI 10.1073/pnas.1019177108; BENDER A, 1987, CELL, V50, P681, DOI 10.1016/0092-8674(87)90326-6; BOONCHIRD C, 1991, MOL GEN GENET, V226, P154, DOI 10.1007/BF00273599; Bridgham JT, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000191; Dennis MY, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.033; Finnigan GC, 2012, NATURE, V481, P360, DOI 10.1038/nature10724; Force A, 1999, GENETICS, V151, P1531; Harms MJ, 2010, CURR OPIN STRUC BIOL, V20, P360, DOI 10.1016/j.sbi.2010.03.005; HAYES TE, 1988, GENE DEV, V2, P1713, DOI 10.1101/gad.2.12b.1713; Innan H, 2010, NAT REV GENET, V11, P97, DOI 10.1038/nrg2689; Jamai A, 2002, MOL CELL BIOL, V22, P5741, DOI 10.1128/MCB.22.16.5741-5752.2002; Lynch M, 2003, SCIENCE, V302, P1401, DOI 10.1126/science.1089370; Mead J, 2002, MOL CELL BIOL, V22, P4607, DOI 10.1128/MCB.22.13.4607-4621.2002; MESSENGUY F, 1991, MOL CELL BIOL, V11, P2852, DOI 10.1128/MCB.11.5.2852; Messenguy F, 2003, GENE, V316, P1, DOI 10.1016/S0378-1119(03)00747-9; MESSENGUY F, 1993, MOL CELL BIOL, V13, P2586, DOI 10.1128/MCB.13.4.2586; Tan S, 1998, NATURE, V391, P660, DOI 10.1038/35563; Tsong AE, 2003, CELL, V115, P389, DOI 10.1016/S0092-8674(03)00885-7; Tuch BB, 2008, PLOS BIOL, V6, P352, DOI 10.1371/journal.pbio.0060038; Wagner A, 2003, P ROY SOC B-BIOL SCI, V270, P457, DOI 10.1098/rspb.2002.2269; Wagner A, 2002, GENOME BIOL, V3	23	74	74	1	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 4	2013	342	6154					104	108		10.1126/science.1240810	http://dx.doi.org/10.1126/science.1240810			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	227PP	24092741	Green Accepted			2022-12-28	WOS:000325126100055
J	Bauch, CT; Galvani, AP				Bauch, Chris T.; Galvani, Alison P.			Social Factors in Epidemiology	SCIENCE			English	Editorial Material							SPREAD; IMPACT		[Bauch, Chris T.; Galvani, Alison P.] Univ Waterloo, Dept Appl Math, Waterloo, ON N2L 3G1, Canada; [Galvani, Alison P.] Yale Univ, Sch Publ Hlth, New Haven, CT 06520 USA	University of Waterloo; Yale University	Bauch, CT (corresponding author), Univ Waterloo, Dept Appl Math, Waterloo, ON N2L 3G1, Canada.	alison.galvani@yale.edu			CIHR Funding Source: Medline; NIGMS NIH HHS [U01 GM15627, U01 GM105627, U01 GM087719] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM087719, U01GM105627] Funding Source: NIH RePORTER	CIHR(Canadian Institutes of Health Research (CIHR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Basu S, 2008, P NATL ACAD SCI USA, V105, P19018, DOI 10.1073/pnas.0808114105; Bauch CT, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002452; Christakis NA, 2007, NEW ENGL J MED, V357, P370, DOI 10.1056/NEJMsa066082; Crepaz N, 2004, JAMA-J AM MED ASSOC, V292, P224, DOI 10.1001/jama.292.2.224; d'Onofrio A, 2011, J THEOR BIOL, V273, P63, DOI 10.1016/j.jtbi.2010.12.029; Funk S, 2009, P NATL ACAD SCI USA, V106, P6872, DOI 10.1073/pnas.0810762106; Kahan DM, 2013, SCIENCE, V342, P53, DOI 10.1126/science.1245724; Liu JZ, 2012, J R SOC INTERFACE, V9, P68, DOI 10.1098/rsif.2011.0001; May RM, 2008, NATURE, V451, P893, DOI 10.1038/451893a; O'Farrell John, 2007, UTTERLY IMPARTIAL HI; Reluga TC, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000793; Salathe M, 2013, NEW ENGL J MED, V369, P401, DOI 10.1056/NEJMp1307752; WHO, 2013, EP CURV SEV AC RESP; Williams WW, 2013, MMWR-MORBID MORTAL W, V62, P66	14	141	147	4	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 4	2013	342	6154					47	49		10.1126/science.1244492	http://dx.doi.org/10.1126/science.1244492			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	227PP	24092718	Green Accepted			2022-12-28	WOS:000325126100036
J	Pandharipande, PP; Girard, TD; Jackson, JC; Morandi, A; Thompson, JL; Pun, BT; Brummel, NE; Hughes, CG; Vasilevskis, EE; Shintani, AK; Moons, KG; Geevarghese, SK; Canonico, A; Hopkins, RO; Bernard, GR; Dittus, RS; Ely, EW				Pandharipande, P. P.; Girard, T. D.; Jackson, J. C.; Morandi, A.; Thompson, J. L.; Pun, B. T.; Brummel, N. E.; Hughes, C. G.; Vasilevskis, E. E.; Shintani, A. K.; Moons, K. G.; Geevarghese, S. K.; Canonico, A.; Hopkins, R. O.; Bernard, G. R.; Dittus, R. S.; Ely, E. W.		BRAIN-ICU Study Investigators	Long-Term Cognitive Impairment after Critical Illness	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INTENSIVE-CARE-UNIT; MECHANICALLY VENTILATED PATIENTS; FUNCTIONAL DISABILITY; REPEATABLE BATTERY; DELIRIUM DURATION; SURVIVORS; RISK; RELIABILITY; SEDATION; VALIDITY	BackgroundSurvivors of critical illness often have a prolonged and disabling form of cognitive impairment that remains inadequately characterized. MethodsWe enrolled adults with respiratory failure or shock in the medical or surgical intensive care unit (ICU), evaluated them for in-hospital delirium, and assessed global cognition and executive function 3 and 12 months after discharge with the use of the Repeatable Battery for the Assessment of Neuropsychological Status (population age-adjusted mean [SD] score, 10015, with lower values indicating worse global cognition) and the Trail Making Test, Part B (population age-, sex-, and education-adjusted mean score, 5010, with lower scores indicating worse executive function). Associations of the duration of delirium and the use of sedative or analgesic agents with the outcomes were assessed with the use of linear regression, with adjustment for potential confounders. ResultsOf the 821 patients enrolled, 6% had cognitive impairment at baseline, and delirium developed in 74% during the hospital stay. At 3 months, 40% of the patients had global cognition scores that were 1.5 SD below the population means (similar to scores for patients with moderate traumatic brain injury), and 26% had scores 2 SD below the population means (similar to scores for patients with mild Alzheimer's disease). Deficits occurred in both older and younger patients and persisted, with 34% and 24% of all patients with assessments at 12 months that were similar to scores for patients with moderate traumatic brain injury and scores for patients with mild Alzheimer's disease, respectively. A longer duration of delirium was independently associated with worse global cognition at 3 and 12 months (P=0.001 and P=0.04, respectively) and worse executive function at 3 and 12 months (P=0.004 and P=0.007, respectively). Use of sedative or analgesic medications was not consistently associated with cognitive impairment at 3 and 12 months. ConclusionsPatients in medical and surgical ICUs are at high risk for long-term cognitive impairment. A longer duration of delirium in the hospital was associated with worse global cognition and executive function scores at 3 and 12 months. (Funded by the National Institutes of Health and others; BRAIN-ICU ClinicalTrials.gov number, NCT00392795.) In this study, patients treated in ICUs were at high risk for new cognitive impairment during 12 months of follow-up, with 24% of patients having deficits similar in severity to those in Alzheimer's disease. A longer duration of delirium was associated with worse cognitive scores. Survivors of critical illness frequently have a prolonged and poorly understood form of cognitive dysfunction,(1)-(4) which is characterized by new deficits (or exacerbations of preexisting mild deficits) in global cognition or executive function. This long-term cognitive impairment after critical illness may be a growing public health problem, given the large number of acutely ill patients being treated in intensive care units (ICUs) globally.(5) Among older adults, cognitive decline is associated with institutionalization,(6) hospitalization,(7) and considerable annual societal costs.(8),(9) Yet little is known about the epidemiology of long-term cognitive impairment after critical illness. Delirium, a form of acute brain ...	[Pandharipande, P. P.; Hughes, C. G.] Vanderbilt Univ, Sch Med, Dept Anesthesiol, Div Crit Care, Nashville, TN 37212 USA; [Pandharipande, P. P.; Hughes, C. G.] Tennessee Valley Healthcare Syst, Anesthesia Serv, Dept Vet Affairs, Nashville, TN USA; [Girard, T. D.; Brummel, N. E.; Bernard, G. R.; Ely, E. W.] Vanderbilt Univ, Sch Med, Dept Med, Div Allergy Pulm & Crit Care Med, Nashville, TN 37212 USA; [Girard, T. D.; Pun, B. T.; Brummel, N. E.; Vasilevskis, E. E.; Dittus, R. S.; Ely, E. W.] Vanderbilt Univ, Sch Med, Ctr Hlth Serv Res, Nashville, TN 37212 USA; [Girard, T. D.; Vasilevskis, E. E.; Dittus, R. S.; Ely, E. W.] Tennessee Valley Healthcare Syst, GRECC, Dept Vet Affairs, Nashville, TN USA; [Jackson, J. C.] Vanderbilt Univ, Sch Med, Div Allergy Pulm & Crit Care Med, Dept Med,Ctr Hlth Serv Res, Nashville, TN 37212 USA; [Jackson, J. C.] Vanderbilt Univ, Sch Med, Dept Psychiat, Nashville, TN 37212 USA; [Jackson, J. C.] Tennessee Valley Healthcare Syst, Res Serv, Dept Vet Affairs, Nashville, TN USA; [Morandi, A.] Hosp Ancelle, Rehabil & Aged Care Unit, Cremona, Italy; [Morandi, A.] Geriatr Res Grp, Brescia, Italy; [Thompson, J. L.; Shintani, A. K.; Moons, K. G.] Vanderbilt Univ, Sch Med, Dept Biostat, Nashville, TN 37212 USA; Vanderbilt Univ, Sch Med, Dept Anesthesiol, Div Crit Care, Nashville, TN 37212 USA; [Vasilevskis, E. E.; Dittus, R. S.] Vanderbilt Univ, Sch Med, Dept Med, Div Gen Internal Med & Publ Hlth, Nashville, TN 37212 USA; [Moons, K. G.] Univ Med Ctr, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Geevarghese, S. K.] Vanderbilt Univ, Sch Med, Dept Surg, Div Hepatobiliary Surg & Liver Transplantat, Nashville, TN 37212 USA; [Canonico, A.] St Thomas Hosp, Nashville, TN USA; [Hopkins, R. O.] Intermt Med Ctr, Dept Med, Pulm & Crit Care Div, Murray, KY USA; [Hopkins, R. O.] Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA; [Hopkins, R. O.] Brigham Young Univ, Neurosci Ctr, Provo, UT 84602 USA	Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; Vanderbilt University; Vanderbilt University; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; Vanderbilt University; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; Vanderbilt University; Vanderbilt University; Vanderbilt University; Utrecht University; Utrecht University Medical Center; Vanderbilt University; Saint Thomas Hospital; Brigham Young University; Brigham Young University	Pandharipande, PP (corresponding author), 1211 21st Ave S,MAB Ste 526, Nashville, TN 37212 USA.	pratik.pandharipande@vanderbilt.edu	Ely, E. Wesley/Z-2018-2019; Brummel, Nathan/AAB-5466-2020; Girard, Timothy/I-3008-2019; Vasilevskis, Eduard/AAA-3065-2019	Ely, E. Wesley/0000-0003-3957-2172; Girard, Timothy/0000-0002-9833-4871; Vasilevskis, Eduard/0000-0001-8165-5321; Thompson, Jennifer/0000-0001-8833-837X; Brummel, Nathan/0000-0003-4308-0015; Pandharipande, Pratik/0000-0002-1389-8580	National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL087738, R01HL111111] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG035117, R01AG027472, K23AG040157, K23AG034257, K23AG031322] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funded by the National Institutes of Health and others	Adhikari NKJ, 2010, LANCET, V376, P1339, DOI 10.1016/S0140-6736(10)60446-1; Aguero-Torres H, 2001, J CLIN EPIDEMIOL, V54, P795, DOI 10.1016/S0895-4356(00)00371-1; Barr J, 2013, CRIT CARE MED, V41, P263, DOI 10.1097/CCM.0b013e3182783b72; BERG L, 1988, PSYCHOPHARMACOL BULL, V24, P637; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chodosh J, 2004, J AM GERIATR SOC, V52, P1456, DOI 10.1111/j.1532-5415.2004.52407.x; Cunningham C, 2011, BIOCHEM SOC T, V39, P945, DOI 10.1042/BST0390945; Dubois MJ, 2001, INTENS CARE MED, V27, P1297, DOI 10.1007/s001340101017; Ehlenbach WJ, 2010, JAMA-J AM MED ASSOC, V303, P763, DOI 10.1001/jama.2010.167; Ely EW, 2001, JAMA-J AM MED ASSOC, V286, P2703, DOI 10.1001/jama.286.21.2703; Ely EW, 2004, JAMA-J AM MED ASSOC, V291, P1753, DOI 10.1001/jama.291.14.1753; Ferreira FL, 2001, JAMA-J AM MED ASSOC, V286, P1754, DOI 10.1001/jama.286.14.1754; Girard TD, 2010, CRIT CARE MED, V38, P1513, DOI 10.1097/CCM.0b013e3181e47be1; Gunther ML, 2012, CRIT CARE MED, V40, P2022, DOI 10.1097/CCM.0b013e318250acc0; Harrell F.E., 2015, REGRESSION MODELING, DOI [10.1007/978-3-319-19425-7, DOI 10.1007/978-3-319-19425-7, 10.1007/978-1-4757-3462-1]; Herridge MS, 2011, NEW ENGL J MED, V364, P1293, DOI 10.1056/NEJMoa1011802; Hobson VL, 2010, INT J GERIATR PSYCH, V25, P525, DOI 10.1002/gps.2382; Hopkins RO, 2005, AM J RESP CRIT CARE, V171, P340, DOI 10.1164/rccm.200406-763OC; Hopkins RO, 1999, AM J RESP CRIT CARE, V160, P50, DOI 10.1164/ajrccm.160.1.9708059; Iwashyna TJ, 2010, JAMA-J AM MED ASSOC, V304, P1787, DOI 10.1001/jama.2010.1553; Jackson JC, 2003, CRIT CARE MED, V31, P1226, DOI 10.1097/01.CCM.0000059996.30263.94; Jorm AF, 2004, INT PSYCHOGERIATR, V16, P275, DOI 10.1017/S1041610204000390; Kamdar BB, 2013, CRIT CARE MED, V41, P800, DOI 10.1097/CCM.0b013e3182746442; Langa KM, 2001, J GEN INTERN MED, V16, P770, DOI 10.1111/j.1525-1497.2001.10123.x; Little R. J. A., 1987, STAT ANAL MISSING DA; Little RJ, 2012, NEW ENGL J MED, V367, P1355, DOI 10.1056/NEJMsr1203730; Llewellyn DJ, 2008, BMC NEUROL, V8, DOI 10.1186/1471-2377-8-12; McKay C, 2007, ARCH CLIN NEUROPSYCH, V22, P91, DOI 10.1016/j.acn.2006.11.003; Morandi A, 2012, CRIT CARE MED, V40, P2182, DOI 10.1097/CCM.0b013e318250acdc; Pandharipande P, 2006, ANESTHESIOLOGY, V104, P21, DOI 10.1097/00000542-200601000-00005; Pisani MA, 2009, AM J RESP CRIT CARE, V180, P1092, DOI 10.1164/rccm.200904-0537OC; Randolph C, 1998, J CLIN EXP NEUROPSYC, V20, P310, DOI 10.1076/jcen.20.3.310.823; Randolph C., 1998, REPEATABLE BATTERY A; Reitan RM, 1985, HALSTEAD REITAN NEUR; Riker RR, 2009, JAMA-J AM MED ASSOC, V301, P489, DOI 10.1001/jama.2009.56; Rockwood K, 2002, STROKE, V33, P1605, DOI 10.1161/01.STR.0000017878.85274.44; Schweickert WD, 2009, LANCET, V373, P1874, DOI 10.1016/S0140-6736(09)60658-9; Sessler CN, 2002, AM J RESP CRIT CARE, V166, P1338, DOI 10.1164/rccm.2107138; Shehabi Y, 2012, AM J RESP CRIT CARE, V186, P724, DOI 10.1164/rccm.201203-0522OC; van Gool WA, 2010, LANCET, V375, P773, DOI 10.1016/S0140-6736(09)61158-2	40	1417	1462	6	144	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 3	2013	369	14					1306	1316		10.1056/NEJMoa1301372	http://dx.doi.org/10.1056/NEJMoa1301372			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	227KI	24088092	Green Accepted, Bronze			2022-12-28	WOS:000325111200008
J	Holmes, D				Holmes, David			Bill Schwab: at the cutting edge of trauma care	LANCET			English	Biographical-Item																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 28	2013	382	9898					1087	1087		10.1016/S0140-6736(13)62010-3	http://dx.doi.org/10.1016/S0140-6736(13)62010-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	228SG	24075039				2022-12-28	WOS:000325208100013
J	Bish, DL; Blake, DF; Vaniman, DT; Chipera, SJ; Morris, RV; Ming, DW; Treiman, AH; Sarrazin, P; Morrison, SM; Downs, RT; Achilles, CN; Yen, AS; Bristow, TF; Crisp, JA; Morookian, JM; Farmer, JD; Rampe, EB; Stolper, EM; Spanovich, N				Bish, D. L.; Blake, D. F.; Vaniman, D. T.; Chipera, S. J.; Morris, R. V.; Ming, D. W.; Treiman, A. H.; Sarrazin, P.; Morrison, S. M.; Downs, R. T.; Achilles, C. N.; Yen, A. S.; Bristow, T. F.; Crisp, J. A.; Morookian, J. M.; Farmer, J. D.; Rampe, E. B.; Stolper, E. M.; Spanovich, N.		MSL Sci Team	X-ray Diffraction Results from Mars Science Laboratory: Mineralogy of Rocknest at Gale Crater	SCIENCE			English	Article							GUSEV CRATER; COLUMBIA HILLS; DUST; SPECTROMETER; CALIBRATION; CHEMISTRY; CURIOSITY; SOIL	The Mars Science Laboratory rover Curiosity scooped samples of soil from the Rocknest aeolian bedform in Gale crater. Analysis of the soil with the Chemistry and Mineralogy (CheMin) x-ray diffraction (XRD) instrument revealed plagioclase (similar to An57), forsteritic olivine (similar to Fo62), augite, and pigeonite, with minor K-feldspar, magnetite, quartz, anhydrite, hematite, and ilmenite. The minor phases are present at, or near, detection limits. The soil also contains 27 +/- 14 weight percent x-ray amorphous material, likely containing multiple Fe3+- and volatile-bearing phases, including possibly a substance resembling hisingerite. The crystalline component is similar to the normative mineralogy of certain basaltic rocks from Gusev crater on Mars and of martian basaltic meteorites. The amorphous component is similar to that found on Earth in places such as soils on the Mauna Kea volcano, Hawaii.	[Bish, D. L.] Indiana Univ, Dept Geol Sci, Bloomington, IN 47405 USA; [Blake, D. F.; Bristow, T. F.] NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; [Vaniman, D. T.] Planetary Sci Inst, Tucson, AZ 85719 USA; [Chipera, S. J.] Chesapeake Energy, Oklahoma City, OK 73154 USA; [Morris, R. V.; Ming, D. W.; Rampe, E. B.] NASA, Lyndon B Johnson Space Ctr, Houston, TX 77058 USA; [Treiman, A. H.] Lunar & Planetary Inst, Houston, TX 77058 USA; [Sarrazin, P.] In Xitu, Campbell, CA 95008 USA; [Morrison, S. M.; Downs, R. T.] Univ Arizona, Dept Geol, Tucson, AZ 85721 USA; [Achilles, C. N.] United Technol Corp Aerosp Syst, Engn & Sci Contract Grp, Houston, TX 77058 USA; [Yen, A. S.; Crisp, J. A.; Morookian, J. M.; Spanovich, N.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Farmer, J. D.] Arizona State Univ, Dept Geol Sci, Tempe, AZ 85287 USA; [Stolper, E. M.] CALTECH, Pasadena, CA 91125 USA	Indiana University System; Indiana University Bloomington; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; University of Arizona; Raytheon Technologies; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Arizona State University; Arizona State University-Tempe; California Institute of Technology	Bish, DL (corresponding author), Indiana Univ, Dept Geol Sci, Bloomington, IN 47405 USA.	bish@indiana.edu	Steele, Andrew/A-3573-2013; Rodriguez-Manfredi, Jose/L-8001-2014; Zorzano, María-Paz/F-2184-2015; Glavin, Daniel P/D-6194-2012; FABRE, Cécile/B-5827-2012; Navarro-González, Rafael/D-1748-2009; Stipp, Susan L.S./B-8494-2019; Malakhov, Alexey Vladimirovich/F-7953-2017; Lemmon, Mark T/E-9983-2010; Teinturier, Samuel/AAS-8663-2020; Floyd, Melissa/D-4626-2012; GEFFROY, Claude/AAB-9152-2019; Muller, Jan-Peter/Q-8886-2019; Balic-Zunic, Tonci/A-6362-2013; Prats, Benito/F-9467-2019; Franz, Heather B/F-3508-2012; Harri, Ari-Matti/C-7142-2012; Crisp, Joy/H-8287-2016; Bish, David/AAY-7618-2020; De Pablo, Miguel Ángel/J-6442-2014; Benna, Mehdi/F-3489-2012; Martin-Torres, Javier/G-6329-2015; Ramos, Miguel/K-2230-2014; Gómez, Felipe/L-7315-2014; szopa, cyril/C-6865-2015; Hayes, Alexander G/P-2024-2014; Blanco, Juan Jose/E-3627-2014; Gomez-Elvira, Javier/K-5829-2014; Dworkin, Jason P./C-9417-2012; Avalos, Juan Jose Blanco/AAB-9447-2021; Rodriguez-Manfredi, Jose/AAG-9826-2021; Farmer, Jack D/B-9343-2019; Vicenzi, Edward/T-9430-2017; Gasnault, Olivier/F-4327-2010	Steele, Andrew/0000-0001-9643-2841; Rodriguez-Manfredi, Jose/0000-0003-0461-9815; Zorzano, María-Paz/0000-0002-4492-9650; Glavin, Daniel P/0000-0001-7779-7765; FABRE, Cécile/0000-0001-8627-4050; Navarro-González, Rafael/0000-0002-6078-7621; Stipp, Susan L.S./0000-0001-7009-643X; Malakhov, Alexey Vladimirovich/0000-0003-4292-7077; Lemmon, Mark T/0000-0002-4504-5136; Teinturier, Samuel/0000-0003-1755-9524; GEFFROY, Claude/0000-0002-2731-9658; Muller, Jan-Peter/0000-0002-5077-3736; Balic-Zunic, Tonci/0000-0003-1687-1233; Prats, Benito/0000-0003-3869-3351; Harri, Ari-Matti/0000-0001-8541-2802; Crisp, Joy/0000-0002-3202-4416; De Pablo, Miguel Ángel/0000-0002-4496-2741; Martin-Torres, Javier/0000-0001-6479-2236; Ramos, Miguel/0000-0003-3648-6818; Gómez, Felipe/0000-0001-9977-7060; szopa, cyril/0000-0002-0090-4056; Hayes, Alexander G/0000-0001-6397-2630; Blanco, Juan Jose/0000-0002-8666-0696; Gomez-Elvira, Javier/0000-0002-9068-9846; Dworkin, Jason P./0000-0002-3961-8997; Avalos, Juan Jose Blanco/0000-0002-8666-0696; Rodriguez-Manfredi, Jose/0000-0003-0461-9815; Vicenzi, Edward/0000-0003-2085-6546; Morrison, Shaunna/0000-0002-1712-8057; Gasnault, Olivier/0000-0002-6979-9012	NASA Mars Science Laboratory Mission; National Aeronautics and Space Administration; Science and Technology Facilities Council [ST/J005193/1] Funding Source: researchfish; UK Space Agency [ST/J005339/1, ST/I003118/1] Funding Source: researchfish	NASA Mars Science Laboratory Mission; National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); UK Space Agency	Support from the NASA Mars Science Laboratory Mission is gratefully acknowledged. Some of this research was carried out at the Jet Propulsion Laboratory, California Institute of Technology, under a contract with the National Aeronautics and Space Administration. XRD data presented here are archived in the Planetary Data System (PDS, pds.nasa.gov).	Achilles C. N., 2013, PRESENTED AT THE 44T; Archer Jr P. D., 2013, PRESENTED AT THE 44T; Blake DF, 2013, SCIENCE, V341, DOI 10.1126/science.1239505; Blake D. F., 2013, PRESENTED AT THE 44T; Blake D, 2012, SPACE SCI REV, V170, P341, DOI 10.1007/s11214-012-9905-1; Chipera SJ, 2002, J APPL CRYSTALLOGR, V35, P744, DOI 10.1107/S0021889802017405; Christensen PR, 2004, SCIENCE, V306, P1733, DOI 10.1126/science.1104909; CHUNG FH, 1974, J APPL CRYSTALLOGR, V7, P526, DOI 10.1107/S0021889874010387; CLARK BC, 1982, J GEOPHYS RES, V87, P59, DOI 10.1029/JB087iB12p10059; Eckert M, 2012, ANN PHYS-BERLIN, V524, pA83, DOI 10.1002/andp.201200724; Gellert R, 2004, SCIENCE, V305, P829, DOI 10.1126/science.1099913; Gellert R, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002555; Gellert R., 2013, PRESENTED AT THE 44T; Hecht MH, 2009, SCIENCE, V325, P64, DOI 10.1126/science.1172466; Leshin LA, 2013, SCIENCE, V341, DOI 10.1126/science.1238937; McGlynn IO, 2012, J GEOPHYS RES-PLANET, V117, DOI 10.1029/2011JE003861; McSween HY, 2010, J GEOPHYS RES-PLANET, V115, DOI 10.1029/2010JE003582; Milliken RE, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL041870; Ming DW, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002560; Morris R. V., 2013, PRESENTED AT THE 44T; Morris RV, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002584; Morris RV, 2004, SCIENCE, V305, P833, DOI 10.1126/science.1100020; Morris RV, 2001, J GEOPHYS RES-PLANET, V106, P5057, DOI 10.1029/2000JE001328; Morrison S. M., 2013, PRESENTED AT THE 44T; Pike WT, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL049896; Rampe E. B., 2013, PRESENTED AT THE 44T; Ruff SW, 2004, ICARUS, V168, P131, DOI 10.1016/j.icarus.2003.11.003; Treiman A. H., 2013, PRESENTED AT THE 44T; Yen A. S., 2013, PRESENTED AT THE 44T; Yen AS, 2005, NATURE, V436, P49, DOI 10.1038/nature03637; Yingst R., 2013, PRESENTED AT THE 44T	31	271	274	0	246	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 27	2013	341	6153							1238932	10.1126/science.1238932	http://dx.doi.org/10.1126/science.1238932			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	224NS	24072925				2022-12-28	WOS:000324894600002
J	Marty, FM; Winston, DJ; Rowley, SD; Vance, E; Papanicolaou, GA; Mullane, KM; Brundage, TM; Robertson, AT; Godkin, S; Mommeja-Marin, H; Boeckh, M				Marty, Francisco M.; Winston, Drew J.; Rowley, Scott D.; Vance, Estil; Papanicolaou, Genovefa A.; Mullane, Kathleen M.; Brundage, Thomas M.; Robertson, Alice T.; Godkin, Susan; Mommeja-Marin, Herve; Boeckh, Michael		CMX001-201 Clinical Study Grp	CMX001 to Prevent Cytomegalovirus Disease in Hematopoietic-Cell Transplantation	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							REPLICATION IN-VITRO; ACYCLIC NUCLEOSIDE PHOSPHONATES; POLYOMAVIRUS BK REPLICATION; LIPID-ESTER PRODRUGS; ANTIVIRAL ACTIVITY; CYCLIC CIDOFOVIR; GANCICLOVIR PROPHYLAXIS; ALKOXYALKYL ESTERS; MARROW TRANSPLANT; VIRUS-INFECTIONS	BackgroundThe use of available antiviral agents for the prevention of cytomegalovirus (CMV) disease is limited by frequent toxic effects and the emergence of resistance. CMX001 has potent in vitro activity against CMV and other double-stranded DNA viruses. We evaluated the safety and anti-CMV activity of CMX001 in patients who had undergone allogeneic hematopoietic-cell transplantation. MethodsFrom December 2009 through June 2011, a total of 230 patients with data that could be evaluated were enrolled in the study. We randomly assigned these adult CMV-seropositive transplant recipients from 27 centers to oral administration of CMX001 or placebo. Patients were assigned in a 3:1 ratio to five sequential study cohorts according to a dose-escalating, double-blind design. Randomization was stratified according to the presence or absence of acute graft-versus-host disease and CMV DNA in plasma. Patients received the study drug after engraftment for 9 to 11 weeks, until week 13 after transplantation. Polymerase-chain-reaction analysis of CMV DNA in plasma was performed weekly. Patients in whom CMV DNA was detected at a level that required treatment discontinued the study drug and received preemptive treatment against CMV infection. The primary end point was a CMV event, defined as CMV disease or a plasma CMV DNA level greater than 200 copies per milliliter when the study drug was discontinued. The analysis was conducted in the intention-to-treat population. ResultsThe incidence of CMV events was significantly lower among patients who received CMX001 at a dose of 100 mg twice weekly than among patients who received placebo (10% vs. 37%; risk difference, -27 percentage points; 95% confidence interval, -42 to -12; P=0.002). Diarrhea was the most common adverse event in patients receiving CMX001 at doses of 200 mg weekly or higher and was dose-limiting at 200 mg twice weekly. Myelosuppression and nephrotoxicity were not observed. ConclusionsTreatment with oral CMX001 at a dose of 100 mg twice weekly significantly reduced the incidence of CMV events in recipients of hematopoietic-cell transplants. Diarrhea was dose-limiting in this population at a dose of 200 mg twice weekly. (Funded by Chimerix; CMX001-201 ClinicalTrials.gov number, NCT00942305.) A dose-finding study showed that CMX001 at an oral dose of 100 mg twice weekly, as compared with placebo, reduced the risk of cytomegalovirus events from 37% to 10% among patients who had undergone hematopoietic-cell transplantation. Cytomegalovirus (CMV) infection is a common cause of illness after allogeneic hematopoietic-cell transplantation.(1),(2) CMV seropositivity in transplant recipients is also associated with an increased risk of death after transplantation, despite preemptive and prophylactic strategies with available antiviral agents.(3)-(5) Although valganciclovir is approved for prophylaxis against CMV infection after solid-organ transplantation, its use is limited by myelosuppression, particularly after hematopoietic-cell transplantation.(3),(6)-(8) Thus, there is an unmet need for effective drugs against CMV infection that have a better safety profile. CMX001 is an orally bioavailable lipid acyclic nucleoside phosphonate that is absorbed in the small intestine and transported ...	[Marty, Francisco M.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Marty, Francisco M.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Winston, Drew J.] Univ Calif Los Angeles, Ctr Hlth Sci, Los Angeles, CA 90024 USA; [Rowley, Scott D.] Hackensack Univ, Med Ctr, Hackensack, NJ USA; [Vance, Estil] Texas Oncol Baylor Charles A Sammons Canc Ctr, Dallas, TX USA; [Papanicolaou, Genovefa A.] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; [Mullane, Kathleen M.] Univ Chicago, Med Ctr, Chicago, IL 60637 USA; [Brundage, Thomas M.; Robertson, Alice T.; Godkin, Susan; Mommeja-Marin, Herve] Chimerix, Durham, NC USA; [Boeckh, Michael] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; University of California System; University of California Los Angeles; Hackensack University Medical Center; Baylor University Medical Center; Memorial Sloan Kettering Cancer Center; University of Chicago; University of Chicago Medical Center; Fred Hutchinson Cancer Center	Marty, FM (corresponding author), Dana Farber Canc Inst, Div Infect Dis, 75 Francis St,PBB A4, Boston, MA 02115 USA.	fmarty@partners.org	Marty, Francisco M./H-7088-2019; Boeckh, Michael/AAA-1607-2022	Marty, Francisco M./0000-0002-3708-8734; Papanicolaou, Genovefa/0000-0002-2891-079X	Chimerix	Chimerix	Supported by Chimerix.	Aldern KA, 2003, MOL PHARMACOL, V63, P678, DOI 10.1124/mol.63.3.678; Beadle JR, 2002, ANTIMICROB AGENTS CH, V46, P2381, DOI 10.1128/AAC.46.8.2381-2386.2002; Bidanset DJ, 2004, J INFECT DIS, V190, P499, DOI 10.1086/421912; Boeckh M, 2004, BLOOD, V103, P2003, DOI 10.1182/blood-2003-10-3616; Boeckh M, 2003, BIOL BLOOD MARROW TR, V9, P543, DOI 10.1016/S1083-8791(03)00287-8; Boeckh M, 2009, BLOOD, V113, P5711, DOI 10.1182/blood-2008-10-143560; Ciesla SL, 2003, ANTIVIR RES, V59, P163, DOI 10.1016/S0166-3542(03)00110-4; Florescu DF, 2012, BIOL BLOOD MARROW TR, V18, P731, DOI 10.1016/j.bbmt.2011.09.007; GOODRICH JM, 1993, ANN INTERN MED, V118, P173, DOI 10.7326/0003-4819-118-3-199302010-00003; Green ML, 2012, BIOL BLOOD MARROW TR, V18, P1687, DOI 10.1016/j.bbmt.2012.05.015; Hartline CB, 2005, J INFECT DIS, V191, P396, DOI 10.1086/426831; Hostetler KY, 2009, ANTIVIR RES, V82, pA84, DOI 10.1016/j.antiviral.2009.01.005; Kern ER, 2004, ANTIMICROB AGENTS CH, V48, P3516, DOI 10.1128/AAC.48.9.3516-3522.2004; Kern ER, 2002, ANTIMICROB AGENTS CH, V46, P991, DOI 10.1128/AAC.46.4.991-995.2002; Ljungman P, 2002, CLIN INFECT DIS, V34, P1094, DOI 10.1086/339329; Lurain NS, 2010, CLIN MICROBIOL REV, V23, P689, DOI 10.1128/CMR.00009-10; Marty FM, 2011, LANCET INFECT DIS, V11, P343; Marty FM, 2007, BLOOD, V110, P490, DOI 10.1182/blood-2007-01-069294; Marty FM, 2011, LANCET INFECT DIS, V11, P284, DOI 10.1016/S1473-3099(11)70024-X; National Cancer Institute, 2010, NIH PUBLICATION, V09-5410; Painter GR, 2004, TRENDS BIOTECHNOL, V22, P423, DOI 10.1016/j.tibtech.2004.06.008; Painter W, 2012, ANTIMICROB AGENTS CH, V56, P2726, DOI 10.1128/AAC.05983-11; Paolino K, 2011, J CLIN VIROL, V50, P167, DOI 10.1016/j.jcv.2010.10.016; PRZEPIORKA D, 1995, BONE MARROW TRANSPL, V15, P825; Quenelle DC, 2007, ANTIMICROB AGENTS CH, V51, P3940, DOI 10.1128/AAC.00184-07; Quenelle DC, 2010, J INFECT DIS, V202, P1492, DOI 10.1086/656717; Randhawa P, 2006, ANTIMICROB AGENTS CH, V50, P1564, DOI 10.1128/AAC.50.4.1564-1566.2006; Randhawa P, 2008, ANTIMICROB AGENTS CH, V52, P1519, DOI 10.1128/AAC.01241-07; Rice AD, 2011, VIRUSES-BASEL, V3, P63, DOI 10.3390/v3020063; Rinaldo CH, 2010, ANTIMICROB AGENTS CH, V54, P4714, DOI 10.1128/AAC.00974-10; Smith IL, 1998, J INFECT DIS, V177, P1140; Smith IL, 1997, J INFECT DIS, V176, P69, DOI 10.1086/514041; Williams-Aziz SL, 2005, ANTIMICROB AGENTS CH, V49, P3724, DOI 10.1128/AAC.49.9.3724-3733.2005; WINSTON DJ, 1993, ANN INTERN MED, V118, P179, DOI 10.7326/0003-4819-118-3-199302010-00004	34	254	265	0	19	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 26	2013	369	13					1227	1236		10.1056/NEJMoa1303688	http://dx.doi.org/10.1056/NEJMoa1303688			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	224LT	24066743				2022-12-28	WOS:000324888200009
J	Bowling, CB; Sharma, P; Fox, CS; O'Hare, AM; Muntner, P				Bowling, C. Barrett; Sharma, Pradeep; Fox, Caroline S.; O'Hare, Ann M.; Muntner, Paul			Prevalence of Reduced Estimated Glomerular Filtration Rate Among the Oldest Old From 1988-1994 Through 2005-2010	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							CHRONIC KIDNEY-DISEASE; AGE		[Bowling, C. Barrett] Vet Affairs Med Ctr, Birmingham Atlanta Geriatr Res Educ & Clin Ctr, Atlanta, GA 30033 USA; [Sharma, Pradeep; Muntner, Paul] Univ Alabama Birmingham, Sch Publ Hlth, Dept Epidemiol, Birmingham, AL USA; [Fox, Caroline S.] NHLBI, Ctr Populat Studies, Bethesda, MD 20892 USA; [O'Hare, Ann M.] VA Puget Sound Hlth Care Syst, Dept Med, Seattle, WA USA	Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System; University of Alabama System; University of Alabama Birmingham; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System	Bowling, CB (corresponding author), Atlanta Vet Affairs Med Ctr, 1670 Clairmont Rd 11B, Decatur, GA 30033 USA.	cbbowli@emory.edu	Sharma, Pradeep/N-5439-2019		NHLBI NIH HHS [Y1-HC-8039] Funding Source: Medline; NIA NIH HHS [R03 AG042336, R03AG042336-01] Funding Source: Medline; CSRD VA [IK2 CX000856] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006094] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R03AG042336] Funding Source: NIH RePORTER; Veterans Affairs [IK2CX000856] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); CSRD VA; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Veterans Affairs(US Department of Veterans Affairs)		Bowling CB, 2011, CLIN J AM SOC NEPHRO, V6, P2822, DOI 10.2215/CJN.06770711; Centers for Disease Control and Prevention, NAT HLTH NUTR EX SUR; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Hallan SI, 2012, JAMA-J AM MED ASSOC, V308, P2349, DOI 10.1001/jama.2012.16817; Institute of Medicine (US) Committee on the Future Health Care Workforce for Older Americans, 2008, RET AG AM BUILD HLTH, DOI DOI 10.17226/12089; Selvin E, 2007, AM J KIDNEY DIS, V50, P918, DOI 10.1053/j.ajkd.2007.08.020	6	24	24	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 25	2013	310	12					1284	1286		10.1001/jama.2013.252441	http://dx.doi.org/10.1001/jama.2013.252441			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	222SO	24065016	Bronze, Green Accepted			2022-12-28	WOS:000324751800026
J	Schubnel, A; Brunet, F; Hilairet, N; Gasc, J; Wang, YB; Green, HW				Schubnel, Alexandre; Brunet, Fabrice; Hilairet, Nadege; Gasc, Julien; Wang, Yanbin; Green, Harry W., II			Deep-Focus Earthquake Analogs Recorded at High Pressure and Temperature in the Laboratory	SCIENCE			English	Article							INVERSION; MECHANISM; OLIVINE; RUPTURE	Phase transformations of metastable olivine might trigger deep-focus earthquakes (400 to 700 kilometers) in cold subducting lithosphere. To explore the feasibility of this mechanism, we performed laboratory deformation experiments on germanium olivine (Mg2GeO4) under differential stress at high pressure (P = 2 to 5 gigapascals) and within a narrow temperature range (T = 1000 to 1250 kelvin). We found that fractures nucleate at the onset of the olivine-to-spinel transition. These fractures propagate dynamically (at a nonnegligible fraction of the shear wave velocity) so that intense acoustic emissions are generated. Similar to deep-focus earthquakes, these acoustic emissions arise from pure shear sources and obey the Gutenberg-Richter law without following Omori's law. Microstructural observations prove that dynamic weakening likely involves superplasticity of the nanocrystalline spinel reaction product at seismic strain rates.	[Schubnel, Alexandre] Ecole Normale Super, Geol Lab, CNRS, UMR 8538, F-75005 Paris, France; [Brunet, Fabrice] Univ Grenoble 1, CNRS, Inst Sci Terre, F-73370 Grenoble, France; [Hilairet, Nadege; Gasc, Julien; Wang, Yanbin] Univ Chicago, GeoSoilEnviroCARS, Argonne, IL 60439 USA; [Green, Harry W., II] Univ Calif Riverside, Dept Earth Sci, Riverside, CA 92507 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite Gustave-Eiffel; Universite de Savoie; University of Chicago; University of California System; University of California Riverside	Schubnel, A (corresponding author), Ecole Normale Super, Geol Lab, CNRS, UMR 8538, F-75005 Paris, France.	aschubnel@geologie.ens.fr	Hilairet, Nadege/F-6245-2011; Gasc, Julien/Q-2688-2018	Hilairet, Nadege/0000-0002-5652-9128; Gasc, Julien/0000-0003-4914-5289; Wang, Yanbin/0000-0001-5716-3183; Brunet, Fabrice/0000-0002-0929-8398	Institut National des Sciences de l'Univers; L'Agence Nationale de la Recherche; National Science Foundation-Earth Sciences [EAR-1128799]; U.S. Department of Energy-Geosciences [DE-FG02-94ER14466]; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; National Science Foundation [EAR-0968456]	Institut National des Sciences de l'Univers; L'Agence Nationale de la Recherche(French National Research Agency (ANR)); National Science Foundation-Earth Sciences(National Science Foundation (NSF)); U.S. Department of Energy-Geosciences(United States Department of Energy (DOE)); U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF))	We thank A. Addad, D. Deldicque, I. Esteve, E. Larue, and Y. Pinquier for technical support and three reviewers for their constructive remarks, which helped to improve this work. This work was funded through Institut National des Sciences de l'Univers (project "Deep Quakes") and L'Agence Nationale de la Recherche (project "DELF"). GeoSoilEnviroCARS is supported by the National Science Foundation-Earth Sciences (EAR-1128799) and U.S. Department of Energy-Geosciences (DE-FG02-94ER14466). Use of the Advanced Proton Source was supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under contract DE-AC02-06CH11357. Part of the AE technical development was made possible by the National Science Foundation grant EAR-0968456 (Y.W.). Data are available in the supplementary materials.	Antolik M, 1999, J GEOPHYS RES-SOL EA, V104, P863, DOI 10.1029/1998JB900042; Bina CR, 2001, PHYS EARTH PLANET IN, V127, P51, DOI 10.1016/S0031-9201(01)00221-7; BOULLIER AM, 1975, CONTRIB MINERAL PETR, V50, P93, DOI 10.1007/BF00373329; BURNLEY PC, 1991, J GEOPHYS RES-SOLID, V96, P425, DOI 10.1029/90JB01937; BYERLEE J, 1978, PURE APPL GEOPHYS, V116, P586, DOI 10.1007/BF00876526; Di Toro G, 2011, NATURE, V471, P494, DOI 10.1038/nature09838; Frohlich C, 2006, DEEP EARTHQUAKES, P1, DOI 10.2277/ 0521828694; Gasc J, 2011, PHYS EARTH PLANET IN, V189, P121, DOI 10.1016/j.pepi.2011.08.003; GREEN HW, 1989, NATURE, V341, P733, DOI 10.1038/341733a0; GREEN HW, 1990, NATURE, V348, P720, DOI 10.1038/348720a0; GREEN HW, 1992, GEOPHYS RES LETT, V19, P789, DOI 10.1029/92GL00751; Griggs D, 1969, ORIGIN DEEP FOCUS EA, P23; GUTENBERG B, 1955, NATURE, V176, P795, DOI 10.1038/176795a0; Hilairet N, 2012, J GEOPHYS RES-SOL EA, V117, DOI 10.1029/2011JB008498; Hiraga T, 2010, NATURE, V468, P1091, DOI 10.1038/nature09685; HUDSON JA, 1989, J GEOPHYS RES-SOLID, V94, P765, DOI 10.1029/JB094iB01p00765; IIDAKA T, 1992, NATURE, V356, P593, DOI 10.1038/356593a0; Kanamori H, 1998, SCIENCE, V279, P839, DOI 10.1126/science.279.5352.839; Kawakatsu H, 2011, EARTH PLANET SC LETT, V303, P1, DOI 10.1016/j.epsl.2011.01.008; KIRBY SH, 1987, J GEOPHYS RES-SOLID, V92, P13789, DOI 10.1029/JB092iB13p13789; Marone C, 1998, ANNU REV EARTH PL SC, V26, P643, DOI 10.1146/annurev.earth.26.1.643; Myhill R, 2013, GEOPHYS J INT, V192, P837, DOI 10.1093/gji/ggs054; Ougier-Simonin A, 2011, INT J ENG SCI, V49, P105, DOI 10.1016/j.ijengsci.2010.06.026; Passelegue FX, 2013, SCIENCE, V340, P1208, DOI 10.1126/science.1235637; Paterson M.S., 2005, EXPT ROCK DEFORMATIO; Prieto GA, 2012, TECTONOPHYSICS, V570, P42, DOI 10.1016/j.tecto.2012.07.019; Riggs EM, 2005, J GEOPHYS RES-SOL EA, V110, DOI 10.1029/2004JB003391; SCHOLZ CH, 1968, B SEISMOL SOC AM, V58, P399; WIENS DA, 1993, NATURE, V364, P790, DOI 10.1038/364790a0	29	87	90	2	109	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 20	2013	341	6152					1377	1380		10.1126/science.1240206	http://dx.doi.org/10.1126/science.1240206			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	220PK	24052305				2022-12-28	WOS:000324597200042
J	Silverman, E				Silverman, Ed			The line between scientific uncertainty and promotion of snake oil	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Pharmalot, Millburn, NJ USA		Silverman, E (corresponding author), Pharmalot, Millburn, NJ USA.	pharmalot@gmail.com						Raghu G, 2004, NEW ENGL J MED, V350, P125, DOI 10.1056/NEJMoa030511; Silverman E, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f320	2	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 20	2013	347								f5687	10.1136/bmj.f5687	http://dx.doi.org/10.1136/bmj.f5687			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	223TB	24055923				2022-12-28	WOS:000324831800002
J	Vilcinskas, A; Stoecker, K; Schmidtberg, H; Rohrich, CR; Vogel, H				Vilcinskas, Andreas; Stoecker, Kilian; Schmidtberg, Henrike; Roehrich, Christian R.; Vogel, Heiko			Response to Comments on "Invasive Harlequin Ladybird Carries Biological Weapons Against Native Competitors"	SCIENCE			English	Editorial Material							GUERIN-MENEVILLE COLEOPTERA; INTERSPECIFIC PREDATION; COCCINELLIDAE; CANNIBALISM; BEETLE; MICROSPORIDIUM		[Vilcinskas, Andreas] Univ Giessen, Inst Phytopathol & Appl Zool, D-35392 Giessen, Germany; [Stoecker, Kilian] Bundeswehr Inst Microbiol, D-80937 Munich, Germany; [Vilcinskas, Andreas; Stoecker, Kilian; Schmidtberg, Henrike; Roehrich, Christian R.] Fraunhofer Inst Mol Biol & Appl Ecol, D-35394 Giessen, Germany; [Vogel, Heiko] Max Planck Inst Chem Ecol, D-07745 Jena, Germany	Justus Liebig University Giessen; Bundeswehr Institute of Microbiology (IMB); Fraunhofer Gesellschaft; Max Planck Society	Vilcinskas, A (corresponding author), Univ Giessen, Inst Phytopathol & Appl Zool, Heinrich Buff Ring 26-32, D-35392 Giessen, Germany.	andreas.vilcinskas@agrar.uni-giessen.de						AGARWALA BK, 1992, ECOL ENTOMOL, V17, P303, DOI 10.1111/j.1365-2311.1992.tb01062.x; AVANISH K GUPTA, 2006, Insect Science, V13, P119; Cottrell TE, 2007, ENVIRON ENTOMOL, V36, P390, DOI 10.1603/0046-225X(2007)36[390:PBAALL]2.0.CO;2; de Jong PW, 2013, SCIENCE, V341, DOI 10.1126/science.1241745; Gagnon AE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028061; Hironori Y, 1997, ENTOMOPHAGA, V42, P153, DOI 10.1007/BF02769893; Pervez A, 2006, BIOL CONTROL, V38, P307, DOI 10.1016/j.biocontrol.2006.04.013; Reynolds SE, 2013, SCIENCE, V340, P816, DOI 10.1126/science.1238998; Rohrich CR, 2012, BIOL LETTERS, V8, P308, DOI 10.1098/rsbl.2011.0760; Saito T, 2008, J INVERTEBR PATHOL, V99, P294, DOI 10.1016/j.jip.2008.08.005; Saito T, 2006, BIOL CONTROL, V39, P427, DOI 10.1016/j.biocontrol.2006.06.012; Sloggett JJ, 2010, J EXP BIOL, V213, P237, DOI 10.1242/jeb.037127; Solter LF, 2013, SCIENCE, V341, DOI 10.1126/science.1241600; Vilcinskas A, 2013, SCIENCE, V340, P862, DOI 10.1126/science.1234032; Vilcinskas A, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2113; Ware RL, 2008, BIOCONTROL, V53, P169, DOI 10.1007/s10526-007-9135-8	16	1	1	2	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 20	2013	341	6152								10.1126/science.1242484	http://dx.doi.org/10.1126/science.1242484			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	220PK	24052293				2022-12-28	WOS:000324597200024
J	Bateman, BT; Bykov, K; Choudhry, NK; Schneeweiss, S; Gagne, JJ; Polinski, JM; Franklin, JM; Doherty, M; Fischer, MA; Rassen, JA				Bateman, Brian T.; Bykov, Katsiaryna; Choudhry, Niteesh K.; Schneeweiss, Sebastian; Gagne, Joshua J.; Polinski, Jennifer M.; Franklin, Jessica M.; Doherty, Michael; Fischer, Michael A.; Rassen, Jeremy A.			Type of stress ulcer prophylaxis and risk of nosocomial pneumonia in cardiac surgical patients: cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PROTON-PUMP INHIBITORS; VENTILATOR-ASSOCIATED PNEUMONIA; INSTRUMENTAL VARIABLE ANALYSIS; COMMUNITY-ACQUIRED PNEUMONIA; CRITICALLY III PATIENTS; 2 RECEPTOR ANTAGONISTS; ADMINISTRATIVE DATA; HEART-SURGERY; OMEPRAZOLE; CIMETIDINE	Objective To examine the relation between the type of stress ulcer prophylaxis administered and the risk of postoperative pneumonia in patients undergoing coronary artery bypass grafting. Design Retrospective cohort study. Setting Premier Research Database. Participants: 21 214 patients undergoing coronary artery bypass graft surgery between 2004 and 2010; 9830 (46.3%) started proton pump inhibitors and 11 384 (53.7%) started H-2 receptor antagonists in the immediate postoperative period. Main outcome measure Occurrence of postoperative pneumonia, assessed using appropriate diagnostic codes. Results Overall, 492 (5.0%) of the 9830 patients receiving a proton pump inhibitor and 487 (4.3%) of the 11 384 patients receiving an H2 receptor antagonist developed postoperative pneumonia during the index hospital admission. After propensity score adjustment, an elevated risk of pneumonia associated with treatment with proton pump inhibitors compared with H2 receptor antagonists remained (relative risk 1.19, 95% confidence interval 1.03 to 1.38). In the instrumental variable analysis, use of a proton pump inhibitor (compared with an H-2 receptor antagonist) was associated with an increased risk of pneumonia of 8.2 (95% confidence interval 0.5 to 15.9) cases per 1000 patients. Conclusions Patients treated with proton pump inhibitors for stress ulcer had a small increase in the risk of postoperative pneumonia compared with patients treated with H-2 receptor antagonists; this risk remained after confounding was accounted for using multiple analytic approaches.	[Bateman, Brian T.; Bykov, Katsiaryna; Choudhry, Niteesh K.; Schneeweiss, Sebastian; Gagne, Joshua J.; Polinski, Jennifer M.; Franklin, Jessica M.; Doherty, Michael; Fischer, Michael A.; Rassen, Jeremy A.] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02115 USA; [Bateman, Brian T.; Bykov, Katsiaryna; Choudhry, Niteesh K.; Schneeweiss, Sebastian; Gagne, Joshua J.; Polinski, Jennifer M.; Franklin, Jessica M.; Doherty, Michael; Fischer, Michael A.; Rassen, Jeremy A.] Harvard Univ, Sch Med, Boston, MA USA; [Bateman, Brian T.] Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02120 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Bateman, BT (corresponding author), Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, 75 Francis St, Boston, MA 02115 USA.	bbateman@partners.org	Schneeweiss, Sebastian/C-2125-2013	Schneeweiss, Sebastian/0000-0003-2575-467X; Rassen, Jeremy/0000-0003-4369-7381; Franklin, Jessica/0000-0002-8941-4116; Bykov, Katsiaryna/0000-0003-3336-5412	Agency for Healthcare Research and Quality [K01 HS018088]; Agency for Healthcare Research and Quality; Harvard-Brigham Drug Safety and Risk Management Research Center; Food and Drug Administration; WHISCON LLC; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K01HS018088] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Harvard-Brigham Drug Safety and Risk Management Research Center; Food and Drug Administration(United States Department of Health & Human Services); WHISCON LLC; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	JAR is a recipient of a career development award from the Agency for Healthcare Research and Quality (K01 HS018088). Competing interests: All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: SS is principal investigator of the Brigham and Women's Hospital DEcIDE Center on Comparative Effectiveness Research and the DEcIDE Methods Center, both funded by the Agency for Healthcare Research and Quality, and of the Harvard-Brigham Drug Safety and Risk Management Research Center funded by the Food and Drug Administration; SS is a paid consultant to WHISCON LLC and Booz & Co, and he is principal investigator of investigator initiated grants to the Brigham and Women's Hospital from Pfizer, Novartis, and Boehringer-Ingelheim unrelated to the topic of this study; JAR is a paid consultant to WHISCON LLC; no other relationships or activities that could appear to have influenced the submitted work.	Alhazzani W, 2013, CRIT CARE MED, V41, P693, DOI 10.1097/CCM.0b013e3182758734; Aronsky D, 2005, AM J MED QUAL, V20, P319, DOI 10.1177/1062860605280358; AYBAY C, 1995, GEN PHARMACOL-VASC S, V26, P1413, DOI 10.1016/0306-3623(94)00301-3; Barkun AN, 2012, AM J GASTROENTEROL, V107, P507, DOI 10.1038/ajg.2011.474; Beaulieu M, 2008, J CRIT CARE, V23, P513, DOI 10.1016/j.jcrc.2007.11.003; Bouza E, 2003, CRIT CARE MED, V31, P1964, DOI [10.1097/01.ccm.0000084807.15352.93, 10.1097/01.CCM.0000084807.15352.93]; Brookhart MA, 2006, EPIDEMIOLOGY, V17, P373, DOI 10.1097/01.ede.0000222026.42077.ee; Brookhart MA, 2010, PHARMACOEPIDEM DR S, V19, P537, DOI 10.1002/pds.1908; Capodicasa E, 1999, IMMUNOPHARM IMMUNOT, V21, P357, DOI 10.3109/08923979909052768; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; DONOWITZ LG, 1986, INFECT CONT HOSP EP, V7, P23, DOI 10.1017/S0195941700063748; DRIKS MR, 1987, NEW ENGL J MED, V317, P1376, DOI 10.1056/NEJM198711263172204; DUMOULIN GC, 1982, LANCET, V1, P242; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Rodriguez LAG, 2009, EPIDEMIOLOGY, V20, P800, DOI 10.1097/EDE.0b013e3181b5f27d; Gulmez SE, 2007, ARCH INTERN MED, V167, P950, DOI 10.1001/archinte.167.9.950; Herzig SJ, 2009, JAMA-J AM MED ASSOC, V301, P2120, DOI 10.1001/jama.2009.722; Hortal J, 2009, CRIT CARE, V13, DOI 10.1186/cc7896; Kedika RR, 2009, DIGEST DIS SCI, V54, P2312, DOI 10.1007/s10620-009-0951-9; Kollef MH, 1997, CHEST, V112, P666, DOI 10.1378/chest.112.3.666; Kulik A, 2008, CIRCULATION, V118, P1785, DOI 10.1161/CIRCULATIONAHA.108.799445; Laheij RJF, 2004, JAMA-J AM MED ASSOC, V292, P1955, DOI 10.1001/jama.292.16.1955; Lau JY, 2007, NEW ENGL J MED, V356, P1631, DOI 10.1056/NEJMoa065703; Leal-Noval SR, 2000, CRIT CARE MED, V28, P935, DOI 10.1097/00003246-200004000-00004; Lin S, 2006, DIGEST DIS SCI, V51, P2377, DOI 10.1007/s10620-006-9326-7; Lindenauer PK, 2005, NEW ENGL J MED, V353, P349, DOI 10.1056/NEJMoa041895; Lindenauer PK, 2004, JAMA-J AM MED ASSOC, V291, P2092, DOI 10.1001/jama.291.17.2092; Miano TA, 2009, CHEST, V136, P440, DOI 10.1378/chest.08-1634; Pawar M, 2003, J CARDIOTHOR VASC AN, V17, P22, DOI 10.1053/jcan.2003.4; Rassen JA, 2009, AM J EPIDEMIOL, V169, P273, DOI 10.1093/aje/kwn299; Redelmeier DA, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c2608; ROMANO PS, 1993, J CLIN EPIDEMIOL, V46, P1075, DOI 10.1016/0895-4356(93)90103-8; ROMANO PS, 1993, J CLIN EPIDEMIOL, V46, P1081; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3rd ed; Sarkar M, 2008, ANN INTERN MED, V149, P391, DOI 10.7326/0003-4819-149-6-200809160-00005; Schneeweiss S, 2008, NEW ENGL J MED, V358, P771, DOI 10.1056/NEJMoa0707571; Schneeweiss S, 2006, PHARMACOEPIDEM DR S, V15, P291, DOI 10.1002/pds.1200; Skull SA, 2008, EPIDEMIOL INFECT, V136, P232, DOI 10.1017/S0950268807008564; Sturmer T, 2010, AM J EPIDEMIOL, V172, P843, DOI 10.1093/aje/kwq198; Thorens J, 1996, GUT, V39, P54, DOI 10.1136/gut.39.1.54; Zedtwitz-Liebenstein K, 2002, CRIT CARE MED, V30, P1118, DOI 10.1097/00003246-200205000-00026	41	56	60	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 19	2013	347								f5416	10.1136/bmj.f5416	http://dx.doi.org/10.1136/bmj.f5416			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	223SY	24052582	Green Published, hybrid			2022-12-28	WOS:000324831500003
J	Paul, F; Wattjes, MP				Paul, Friedemann; Wattjes, Mike P.			Chronic cerebrospinal venous insufficiency in multiple sclerosis: the final curtain	LANCET			English	Editorial Material							DRAINAGE; DISEASE; MRI		[Paul, Friedemann] Charite, NeuroCure Clin Res Ctr, D-10117 Berlin, Germany; [Paul, Friedemann] Charite, Clin & Expt Multiple Sclerosis Res Ctr, Dept Neurol, D-10117 Berlin, Germany; [Wattjes, Mike P.] Vrije Univ Amsterdam, Med Ctr, MS Ctr Amsterdam, Dept Radiol Nucl Med & PET Res, Amsterdam, Netherlands	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Vrije Universiteit Amsterdam	Paul, F (corresponding author), Charite, NeuroCure Clin Res Ctr, D-10117 Berlin, Germany.	friedemann.paul@charite.de	Paul, Friedemann/ABF-9415-2020	paul, friedemann/0000-0002-6378-0070				Baracchini C, 2011, ANN NEUROL, V69, P90, DOI 10.1002/ana.22228; Doepp F, 2011, NEUROLOGY, V77, P1745, DOI 10.1212/WNL.0b013e318236f0ea; Doepp F, 2010, ANN NEUROL, V68, P173, DOI 10.1002/ana.22085; Hutchinson M, 2013, MULT SCLER J, V19, P861, DOI 10.1177/1352458513490817; Mayer CA, 2011, J NEUROL NEUROSUR PS, V82, P436, DOI 10.1136/jnnp.2010.231613; Pullman D, 2013, BMC MED ETHICS, V14, DOI 10.1186/1472-6939-14-6; PUTNAM TJ, 1947, ARCH NEURO PSYCHIATR, V57, P1; Sinnecker T, 2013, MULT SCLER J, V19, P316, DOI 10.1177/1352458512451941; Traboulsee A, 2013, LANCET; Valdueza JM, 2013, J CEREBR BLOOD F MET, V33, P657, DOI 10.1038/jcbfm.2013.31; Wattjes MP, 2011, ROFO-FORTSCHR RONTG, V183, P523, DOI 10.1055/s-0031-1273292; Wattjes MP, 2011, J NEUROL NEUROSUR PS, V82, P429, DOI 10.1136/jnnp.2010.223479; Yamout B, 2010, MULT SCLER, V16, P1341, DOI 10.1177/1352458510385268; Zamboni P, 2009, J NEUROL NEUROSUR PS, V80, P392, DOI 10.1136/jnnp.2008.157164; Zamboni P, 2006, J ROY SOC MED, V99, P589, DOI 10.1258/jrsm.99.11.589	15	7	7	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 11	2014	383	9912					106	108		10.1016/S0140-6736(13)61912-1	http://dx.doi.org/10.1016/S0140-6736(13)61912-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	287YX	24119383				2022-12-28	WOS:000329579600008
J	Harris, DL; Weston, PJ; Signal, M; Chase, JG; Harding, JE				Harris, Deborah L.; Weston, Philip J.; Signal, Matthew; Chase, J. Geoffrey; Harding, Jane E.			Dextrose gel for neonatal hypoglycaemia (the Sugar Babies Study): a randomised, double-blind, placebo-controlled trial	LANCET			English	Article							NEWBORN-INFANTS; CHILDREN; RISK; DEFINITION; PREVALENCE; MANAGEMENT	Background Neonatal hypoglycaemia is common, and a preventable cause of brain damage. Dextrose gel is used to reverse hypoglycaemia in individuals with diabetes; however, little evidence exists for its use in babies. We aimed to assess whether treatment with dextrose gel was more effective than feeding alone for reversal of neonatal hypoglycaemia in at-risk babies. Methods We undertook a randomised, double-blind, placebo-controlled trial at a tertiary centre in New Zealand between Dec 1, 2008, and Nov 31, 2010. Babies aged 35-42 weeks' gestation, younger than 48-h-old, and at risk of hypoglycaemia were randomly assigned (1:1), via computer-generated blocked randomisation, to 40% dextrose gel 200 mg/kg or placebo gel. Randomisation was stratified by maternal diabetes and birthweight. Group allocation was concealed from clinicians, families, and all study investigators. The primary outcome was treatment failure, defined as a blood glucose concentration of less than 2.6 mmol/L after two treatment attempts. Analysis was by intention to treat. The trial is registered with Australian New Zealand Clinical Trials Registry, number ACTRN12608000623392. Findings Of 514 enrolled babies, 242 (47%) became hypoglycaemic and were randomised. Five babies were randomised in error, leaving 237 for analysis: 118 (50%) in the dextrose group and 119 (50%) in the placebo group. Dextrose gel reduced the frequency of treatment failure compared with placebo (16 [14%] vs 29 [24%]; relative risk 0.57, 95% CI 0.33-0.98; p=0.04). We noted no serious adverse events. Three (3%) babies in the placebo group each had one blood glucose concentration of 0.9 mmol/L. No other adverse events took place. Interpretation Treatment with dextrose gel is inexpensive and simple to administer. Dextrose gel should be considered for first-line treatment to manage hypoglycaemia in late preterm and term babies in the first 48 h after birth.	[Harris, Deborah L.; Weston, Philip J.] Waikato Dist Hlth Board, Newborn Intens Care Unit, Hamilton, New Zealand; [Harris, Deborah L.; Harding, Jane E.] Univ Auckland, Liggins Inst, Auckland 1142, New Zealand; [Signal, Matthew; Chase, J. Geoffrey] Univ Canterbury, Dept Mech Engn, Christchurch 1, New Zealand	University of Auckland; University of Canterbury	Harding, JE (corresponding author), Univ Auckland, Liggins Inst, Private Bag 92019, Auckland 1142, New Zealand.	j.harding@auckland.ac.nz	Harding, Jane E/J-5853-2015; Chase, James G/B-1584-2012	Harding, Jane E/0000-0003-2697-1422; Chase, James G/0000-0001-9989-4849; Harris, Deborah/0000-0003-2498-9223	Waikato Medical Research Foundation; Auckland Medical Research Foundation; Maurice and Phyllis Paykel Trust; Health Research Council of New Zealand; Rebecca Roberts Scholarship	Waikato Medical Research Foundation; Auckland Medical Research Foundation; Maurice and Phyllis Paykel Trust; Health Research Council of New Zealand(Health Research Council of New Zealand); Rebecca Roberts Scholarship	Waikato Medical Research Foundation, the Auckland Medical Research Foundation, the Maurice and Phyllis Paykel Trust, the Health Research Council of New Zealand, and the Rebecca Roberts Scholarship.	Achoki R, 2010, J TROP PEDIATRICS, V56, P227, DOI 10.1093/tropej/fmp109; ANDERSON S, 1993, J TROP PEDIATRICS, V39, P273, DOI 10.1093/tropej/39.5.273; Ang I, 1990, NEW TREATMENT NEONAT; Barennes H, 2005, PEDIATRICS, V116, pE648, DOI 10.1542/peds.2004-2218; Beardsall K, 2005, ARCH DIS CHILD-FETAL, V90, pF307, DOI 10.1136/adc.2004.051979; Blencowe H, 2012, LANCET, V379, P2162, DOI 10.1016/S0140-6736(12)60820-4; BLOMQUIST HK, 1994, ACTA PAEDIATR, V83, P1122, DOI 10.1111/j.1651-2227.1994.tb18263.x; BOURCHIER D, 1992, NEW ZEAL MED J, V105, P22; Clarke W, 2009, PEDIATR DIABETES, V10, P134, DOI 10.1111/j.1399-5448.2009.00583.x; Cornblath M, 2000, PEDIATRICS, V105, P1141, DOI 10.1542/peds.105.5.1141; Dean AG, OPENEPI OPEN SOURCE; Dewey KG, 2003, PEDIATRICS, V112, P607, DOI 10.1542/peds.112.3.607; Doherty DA, 2006, INT J GYNECOL OBSTET, V95, P242, DOI 10.1016/j.ijgo.2006.06.021; Harris DL, 2012, J PEDIATR-US, V161, P787, DOI 10.1016/j.jpeds.2012.05.022; Harris DL, 2010, J PEDIATR-US, V157, P198, DOI 10.1016/j.jpeds.2010.02.003; Harris DL, 2009, J PAEDIATR CHILD H, V26, P1; Hay WW, 2009, J PEDIATR-US, V155, P612, DOI 10.1016/j.jpeds.2009.06.044; Kerstjens JM, 2012, PEDIATRICS, V130, pE265, DOI 10.1542/peds.2012-0079; KOH THHG, 1988, ARCH DIS CHILD, V63, P1353, DOI 10.1136/adc.63.11.1353; LILIEN LD, 1980, J PEDIATR-US, V97, P295, DOI 10.1016/S0022-3476(80)80499-9; LUCAS A, 1988, BRIT MED J, V297, P1304, DOI 10.1136/bmj.297.6659.1304; Ogilvy-Stuart A, 2006, PRACTICAL NEONATAL E, P7; Osier FHA, 2003, ARCH DIS CHILD, V88, P621, DOI 10.1136/adc.88.7.621; Rozance PJ, 2010, EARLY HUM DEV, V86, P275, DOI 10.1016/j.earlhumdev.2010.05.002; Signal M, 2012, DIABETES TECHNOL THE, V14, P883, DOI 10.1089/dia.2012.0111; Tait RME., 2000, ARCH DIS CHILD S, V82, pA30; Wendy Allen C, 2006, J TROP PEDIATRICS, V52, P218, DOI 10.1093/tropej/fmi106; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Williams AF, 1997, B WORLD HEALTH ORGAN, V75, P261	29	146	146	0	18	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 21	2013	382	9910					2077	2083		10.1016/S0140-6736(13)61645-1	http://dx.doi.org/10.1016/S0140-6736(13)61645-1			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	275OX	24075361	Green Submitted			2022-12-28	WOS:000328687800028
J	Seelig, JD; Jayaraman, V				Seelig, Johannes D.; Jayaraman, Vivek			Feature detection and orientation tuning in the Drosophila central complex	NATURE			English	Article							MOUSE VISUAL-CORTEX; RECEPTIVE-FIELDS; ELLIPSOID BODY; LOCUST BRAIN; NEURONS; PATTERN; ORGANIZATION; BEHAVIOR; INSECT; MEMORY	Many animals, including insects, are known to use visual landmarks to orient in their environment. In Drosophila melanogaster, behavioural genetics studies have identified a higher brain structure called the central complex as being required for the fly's innate responses to vertical visual features(1) and its short-and long-term memory for visual patterns(2-4). But whether and how neurons of the fly central complex represent visual features are unknown. Here we use two-photon calcium imaging in head-fixed walking and flying flies to probe visuomotor responses of ring neurons-a class of central complex neurons that have been implicated in landmark-driven spatial memory in walking flies(2,3) and memory for visual patterns in tethered flying flies(5). We show that dendrites of ring neurons are visually responsive and arranged retinotopically. Ring neuron receptive fields comprise both excitatory and inhibitory subfields, resembling those of simple cells in the mammalian primary visual cortex. Ring neurons show strong and, in some cases, direction-selective orientation tuning, with a notable preference for vertically oriented features similar to those that evoke innate responses in flies(1,2). Visual responses were diminished during flight, but, in contrast with the hypothesized role of the central complex in the control of locomotion(6), not modulated during walking. Taken together, these results indicate that ring neurons represent behaviourally relevant visual features in the fly's environment, enabling downstream central complex circuits to produce appropriate motor commands(6). More broadly, this study opens the door to mechanistic investigations of circuit computations underlying visually guided action selection in the Drosophila central complex.	[Seelig, Johannes D.; Jayaraman, Vivek] Howard Hughes Med Inst, Ashburn, VA 20147 USA	Howard Hughes Medical Institute	Jayaraman, V (corresponding author), Howard Hughes Med Inst, Janelia Farm Res Campus,19700 Helix Dr, Ashburn, VA 20147 USA.	vivek@janelia.hhmi.org			Howard Hughes Medical Institute	Howard Hughes Medical Institute(Howard Hughes Medical Institute)	We thank A. Nern for sharing flies and technical advice; B. Pfeiffer and G. Rubin for providing pJFRC64, pJFRC118, and pJFRC119 flies; and R. Harris for building fly lines, sharing preliminary results, and providing critical feedback on the use of fly reagents. We thank K. Hibbard, D. Hall, J. Kao and the Janelia Fly Core for fly crosses and support; E. Chiappe for initial anatomy experiments; M. Reiser and J. Truman for sharing equipment; J. Liu for technical support; V. Iyer for ScanImage support; T. Adelman for helpful suggestions; and L. Looger and the Janelia GENIE team for GCaMP5 and GCaMP6. We are grateful to A. Leonardo, M. Reiser, E. Chiappe, J. Freeman, A. Karpova, S. Huston and members of Vivek's laboratory for useful discussions and comments on the manuscript. This work was supported by the Howard Hughes Medical Institute.	Bahl A, 2013, NAT NEUROSCI, V16, P730, DOI 10.1038/nn.3386; BAUSENWEIN B, 1994, J COMP NEUROL, V340, P255, DOI 10.1002/cne.903400210; Bonin V, 2011, J NEUROSCI, V31, P18506, DOI 10.1523/JNEUROSCI.2974-11.2011; Chiappe ME, 2010, CURR BIOL, V20, P1470, DOI 10.1016/j.cub.2010.06.072; Chichilnisky EJ, 2001, NETWORK-COMP NEURAL, V12, P199, DOI 10.1088/0954-898X/12/2/306; COLLETT T, 1971, NATURE, V232, P127, DOI 10.1038/232127a0; EGELHAAF M, 1993, J NEUROSCI, V13, P4563; Freifeld L, 2013, NEURON, V78, P1075, DOI 10.1016/j.neuron.2013.04.024; Guo PY, 2013, J EXP BIOL, V216, P992, DOI 10.1242/jeb.080473; HANESCH U, 1989, CELL TISSUE RES, V257, P343, DOI 10.1007/BF00261838; Heinze S, 2007, SCIENCE, V315, P995, DOI 10.1126/science.1135531; Heinze S, 2011, NEURON, V69, P345, DOI 10.1016/j.neuron.2010.12.025; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Jenett A, 2012, CELL REP, V2, P991, DOI 10.1016/j.celrep.2012.09.011; Liu G, 2006, NATURE, V439, P551, DOI 10.1038/nature04381; Maimon G, 2010, NAT NEUROSCI, V13, P393, DOI 10.1038/nn.2492; Mu LY, 2012, J NEUROSCI, V32, P6061, DOI 10.1523/JNEUROSCI.0221-12.2012; Neuser K, 2008, NATURE, V453, P1244, DOI 10.1038/nature07003; Nicolai LJJ, 2010, P NATL ACAD SCI USA, V107, P20553, DOI 10.1073/pnas.1010198107; Niell CM, 2008, J NEUROSCI, V28, P7520, DOI 10.1523/JNEUROSCI.0623-08.2008; OCARROLL D, 1993, NATURE, V362, P541, DOI 10.1038/362541a0; Ofstad TA, 2011, NATURE, V474, P204, DOI 10.1038/nature10131; Pan YF, 2009, LEARN MEMORY, V16, P289, DOI 10.1101/lm.1331809; Peng HC, 2011, NAT METHODS, V8, P493, DOI [10.1038/NMETH.1602, 10.1038/nmeth.1602]; Pfeiffer BD, 2012, P NATL ACAD SCI USA, V109, P6626, DOI 10.1073/pnas.1204520109; Pfeiffer BD, 2010, GENETICS, V186, P735, DOI 10.1534/genetics.110.119917; Pfeiffer K, 2005, J NEUROPHYSIOL, V94, P3903, DOI 10.1152/jn.00276.2005; POGGIO T, 1973, KYBERNETIK, V12, P185, DOI 10.1007/BF00270572; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; Priebe NJ, 2012, NEURON, V75, P194, DOI 10.1016/j.neuron.2012.06.011; Reiser MB, 2008, J NEUROSCI METH, V167, P127, DOI 10.1016/j.jneumeth.2007.07.019; Renn SCP, 1999, J NEUROBIOL, V41, P189; Rosner R, 2013, J NEUROSCI, V33, P8122, DOI 10.1523/JNEUROSCI.5390-12.2013; Seelig JD, 2010, NAT METHODS, V7, P535, DOI [10.1038/NMETH.1468, 10.1038/nmeth.1468]; Strauss R, 2002, CURR OPIN NEUROBIOL, V12, P633, DOI 10.1016/S0959-4388(02)00385-9; STRUHL G, 1993, CELL, V72, P527, DOI 10.1016/0092-8674(93)90072-X; Suver MP, 2012, CURR BIOL, V22, P2294, DOI 10.1016/j.cub.2012.10.034; Swindale NV, 1998, BIOL CYBERN, V78, P45, DOI 10.1007/s004220050411; Swindale NV, 2003, CEREB CORTEX, V13, P225, DOI 10.1093/cercor/13.3.225; Trager U, 2008, J COMP NEUROL, V506, P288, DOI 10.1002/cne.21512; Wang J, 2002, NEURON, V33, P559, DOI 10.1016/S0896-6273(02)00570-6; Weber F, 2010, NEURON, V67, P629, DOI 10.1016/j.neuron.2010.07.017; Young JM, 2010, J COMP NEUROL, V518, P1500, DOI 10.1002/cne.22284; Zhang YQ, 2002, GENESIS, V34, P142, DOI 10.1002/gene.10144	44	177	177	0	77	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 14	2013	503	7475					262	+		10.1038/nature12601	http://dx.doi.org/10.1038/nature12601			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	250YX	24107996	Green Accepted			2022-12-28	WOS:000326894200051
J	Parkin, D; Appleby, J; Maynard, A				Parkin, David; Appleby, John; Maynard, Alan			Economics: the biggest fraud ever perpetrated on the world?	LANCET			English	Editorial Material									[Parkin, David] Kings Coll London, Dept Primary Care & Publ Hlth Sci, Div Hlth & Social Care Res, London, England; [Appleby, John] Kings Fund, London W1G 0AN, England; [Maynard, Alan] Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England; [Maynard, Alan] Univ York, Hull York Med Sch, York YO10 5DD, N Yorkshire, England	University of London; King's College London; University of York - UK; University of Hull; University of York - UK	Appleby, J (corresponding author), Kings Fund, London W1G 0AN, England.	j.appleby@kingsfund.org.uk						Doorslaer V, 1993, EQUITY IN THE FINANC; Horton R, 2012, RATIONALITY FOR THE; Horton R., 2012, ECONOMICS SECOND ONL; Horton R, 2012, THE ESSENCE OF ECONO; Horton R, 2012, ECONOMISTS SEE HEALT; Horton R, 2012, ECONOMISTS DENY THE; Horton R, 2012, FINALLY ITS ACCEPTAB; Horton R, 2012, THE BIG IDEA IN ECON; Horton R., 2012, THE HIGH POINTS OF E; Horton R., 2012, ONCE THERE WAS POLIT; Horton R, 2012, ECONOMISTS WRITE AS; Horton R, 2012, THE CASE AGAINST ECO; Jenkins S., 2009, OXFORD HDB EC INEQUA, P40; Newhouse JP, 1993, FREE ALL LESSONS RAN; ROBINS PK, 1985, J HUM RESOUR, V20, P567, DOI 10.2307/145685; Smith A., 1976, THEORY MORAL SENTIME; Williams A, 1979, J Epidemiol Community Health, V33, P3, DOI 10.1136/jech.33.1.3; Williams A, 1972, J PUBLIC ECON, V1, P199	18	7	7	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 12	2013	382	9900					E11	E15		10.1016/S0140-6736(13)61178-2	http://dx.doi.org/10.1016/S0140-6736(13)61178-2			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	235XP	24095177				2022-12-28	WOS:000325756400001
J	Hardison, RC; Blobel, GA				Hardison, Ross C.; Blobel, Gerd A.			GWAS to Therapy by Genome Edits?	SCIENCE			English	Editorial Material							FETAL-HEMOGLOBIN; BCL11A; DISEASE		[Hardison, Ross C.] Penn State Univ, Dept Biochem & Mol Biol, Ctr Comparat Genom & Bioinformat, University Pk, PA 16802 USA; [Blobel, Gerd A.] Childrens Hosp Philadelphia, Div Hematol, Philadelphia, PA 19104 USA; [Blobel, Gerd A.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine	Hardison, RC (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, Ctr Comparat Genom & Bioinformat, University Pk, PA 16802 USA.	rch8@psu.edu; blobel@email.chop.edu	Hardison, Ross C/G-1142-2010	Hardison, Ross C/0000-0003-4084-7516	NHGRI NIH HHS [U54 HG006998, U54HG006998, RC2 HG005573] Funding Source: Medline; NIDDK NIH HHS [R01 DK054937, R01 DK065806, R37DK058044, R56 DK065806, R01DK054937, R37 DK058044, R01DK065806] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006998, RC2HG005573] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK065806, R37DK058044, R56DK065806, R01DK054937] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bauer DE, 2013, SCIENCE, V342, P253, DOI 10.1126/science.1242088; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Cavazzana-Calvo M, 2010, NATURE, V467, P318, DOI 10.1038/nature09328; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; INGRAM VM, 1956, NATURE, V178, P792, DOI 10.1038/178792a0; Liu PT, 2003, NAT IMMUNOL, V4, P525, DOI 10.1038/ni925; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Menzel S, 2007, NAT GENET, V39, P1197, DOI 10.1038/ng2108; NAGEL RL, 1991, SEMIN HEMATOL, V28, P180; Sankaran VG, 2009, NATURE, V460, P1093, DOI 10.1038/nature08243; Sankaran VG, 2008, SCIENCE, V322, P1839, DOI 10.1126/science.1165409; Uda M, 2008, P NATL ACAD SCI USA, V105, P1620, DOI 10.1073/pnas.0711566105; Williams TN, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a011692; Xu J, 2011, SCIENCE, V334, P993, DOI 10.1126/science.1211053	15	11	13	1	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 11	2013	342	6155					206	207		10.1126/science.1245813	http://dx.doi.org/10.1126/science.1245813			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	232EV	24115432	Green Accepted			2022-12-28	WOS:000325475200034
J	Birkmeyer, JD; Finks, JF; O'Reilly, A; Oerline, M; Carlin, AM; Nunn, AR; Dimick, J; Banerjee, M; Birkmeyer, NJO				Birkmeyer, John D.; Finks, Jonathan F.; O'Reilly, Amanda; Oerline, Mary; Carlin, Arthur M.; Nunn, Andre R.; Dimick, Justin; Banerjee, Mousumi; Birkmeyer, Nancy J. O.		Michigan Bariatric Surg Collaborat	Surgical Skill and Complication Rates after Bariatric Surgery	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SITE INFECTION PREVENTION; MEDICAL-EDUCATION; DURATION; RISK; MORTALITY; QUALITY; BYPASS; PERFORMANCE	BackgroundClinical outcomes after many complex surgical procedures vary widely across hospitals and surgeons. Although it has been assumed that the proficiency of the operating surgeon is an important factor underlying such variation, empirical data are lacking on the relationships between technical skill and postoperative outcomes. MethodsWe conducted a study involving 20 bariatric surgeons in Michigan who participated in a statewide collaborative improvement program. Each surgeon submitted a single representative videotape of himself or herself performing a laparoscopic gastric bypass. Each videotape was rated in various domains of technical skill on a scale of 1 to 5 (with higher scores indicating more advanced skill) by at least 10 peer surgeons who were unaware of the identity of the operating surgeon. We then assessed relationships between these skill ratings and risk-adjusted complication rates, using data from a prospective, externally audited, clinical-outcomes registry involving 10,343 patients. ResultsMean summary ratings of technical skill ranged from 2.6 to 4.8 across the 20 surgeons. The bottom quartile of surgical skill, as compared with the top quartile, was associated with higher complication rates (14.5% vs. 5.2%, P<0.001) and higher mortality (0.26% vs. 0.05%, P=0.01). The lowest quartile of skill was also associated with longer operations (137 minutes vs. 98 minutes, P<0.001) and higher rates of reoperation (3.4% vs. 1.6%, P=0.01) and readmission (6.3% vs. 2.7%) (P<0.001). ConclusionsThe technical skill of practicing bariatric surgeons varied widely, and greater skill was associated with fewer postoperative complications and lower rates of reoperation, readmission, and visits to the emergency department. Although these findings are preliminary, they suggest that peer rating of operative skill may be an effective strategy for assessing a surgeon's proficiency. In this preliminary study, videos of gastric bypass operations submitted by 20 bariatric surgeons were rated by peer surgeons. Surgical-skill ratings were highly correlated with complication rates (14.5% for surgeons in the bottom quartile vs. 5.2% in the top quartile). A considerable body of research suggests that some surgeons have better results than others. Early studies of coronary-artery bypass surgery showed wide variation in risk-adjusted patient mortality across surgeons; studies of other procedures and other outcomes have shown similar variation among surgeons.(1)-(3) Efforts to reduce such variation have focused primarily on improving perioperative care. For example, the Surgical Care Improvement Project and related pay-for-performance programs have provided financial incentives to increase surgeons' compliance with evidence-based practices related to prophylaxis against surgical-site infection and venous thromboembolism. As of this writing, however, there is little evidence that such initiatives have improved ...	[Birkmeyer, John D.; Finks, Jonathan F.; O'Reilly, Amanda; Oerline, Mary; Dimick, Justin; Banerjee, Mousumi; Birkmeyer, Nancy J. O.] Univ Michigan, Ctr Healthcare Outcomes & Policy, Ann Arbor, MI 48109 USA; [Birkmeyer, John D.; Finks, Jonathan F.; O'Reilly, Amanda; Oerline, Mary; Dimick, Justin; Banerjee, Mousumi; Birkmeyer, Nancy J. O.] Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA; [Carlin, Arthur M.] Henry Ford Hlth Syst, Dept Surg, Detroit, MI USA; [Nunn, Andre R.] Forest Hlth Med Ctr, Ypsilanti, MI USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Henry Ford Health System; Henry Ford Hospital	Birkmeyer, JD (corresponding author), Univ Michigan, Ctr Healthcare Outcomes & Policy, N Campus Res Complex,2800 Plymouth Rd,Bldg 16-136, Ann Arbor, MI 48109 USA.	jbirkmey@umich.edu	Page, Piers/G-4917-2012; Codina-Cazador, Antonio/H-9987-2017; Callahan, Charles D/L-1641-2013; Bergkvist, David Julià/H-8886-2017	Page, Piers/0000-0003-1071-1036; Codina-Cazador, Antonio/0000-0003-3040-2716; Bergkvist, David Julià/0000-0001-7184-9405	Blue Cross Blue Shield of Michigan; Blue Care Network	Blue Cross Blue Shield of Michigan; Blue Care Network	Supported by Blue Cross Blue Shield of Michigan and Blue Care Network.	Birkmeyer JD, 2003, NEW ENGL J MED, V349, P2117, DOI 10.1056/NEJMsa035205; Birkmeyer NJO, 2010, JAMA-J AM MED ASSOC, V304, P435, DOI 10.1001/jama.2010.1034; Birkmeyer NJO, 2005, SURGERY, V138, P815, DOI 10.1016/j.surg.2005.06.037; Campbell DA, 2008, J AM COLL SURGEONS, V207, P810, DOI 10.1016/j.jamcollsurg.2008.08.018; Carty MJ, 2009, PLAST RECONSTR SURG, V124, P706, DOI 10.1097/PRS.0b013e3181b17a13; Chan MM, 2013, SURG OBES RELAT DIS, V9, P88, DOI 10.1016/j.soard.2011.09.019; Davis D, 1999, JAMA-J AM MED ASSOC, V282, P867, DOI 10.1001/jama.282.9.867; Finks JF, 2011, ANN SURG, V254, P633, DOI 10.1097/SLA.0b013e318230058c; Gawande A., 2011, NEW YORKER, P44; Gofton WT, 2012, ACAD MED, V87, P1401, DOI 10.1097/ACM.0b013e3182677805; Hall BL, 2004, Q REV EC FINANCE, V44, P410; HANNAN EL, 1990, JAMA-J AM MED ASSOC, V264, P2768, DOI 10.1001/jama.264.21.2768; Hawn MT, 2011, ANN SURG, V254, P494, DOI 10.1097/SLA.0b013e31822c6929; Hu YY, 2012, J AM COLL SURGEONS, V214, P115, DOI 10.1016/j.jamcollsurg.2011.10.009; Kessler Stefan, 2003, Acta Orthop Belg, V69, P328; Leong G, 2006, J HOSP INFECT, V63, P255, DOI 10.1016/j.jhin.2006.02.007; Livingston EH, 2010, SURG OBES RELAT DIS, V6, P587, DOI 10.1016/j.soard.2010.05.023; Martin JA, 1997, BRIT J SURG, V84, P273, DOI 10.1046/j.1365-2168.1997.02502.x; Nicholas LH, 2010, ARCH SURG-CHICAGO, V145, P999, DOI 10.1001/archsurg.2010.191; OCONNOR GT, 1991, JAMA-J AM MED ASSOC, V266, P803, DOI 10.1001/jama.266.6.803; Procter LD, 2010, J AM COLL SURGEONS, V210, P60, DOI 10.1016/j.jamcollsurg.2009.09.034; Reznick RK, 2006, NEW ENGL J MED, V355, P2664, DOI 10.1056/NEJMra054785; Share DA, 2011, HEALTH AFFAIR, V30, P636, DOI 10.1377/hlthaff.2010.0526; Stulberg JJ, 2010, JAMA-J AM MED ASSOC, V303, P2479, DOI 10.1001/jama.2010.841; Tan TW, 2012, J AM COLL SURGEONS, V215, P512, DOI 10.1016/j.jamcollsurg.2012.06.007; van Hove PD, 2010, BRIT J SURG, V97, P972, DOI 10.1002/bjs.7115; Vassiliou MC, 2007, SURG INNOV, V14, P211, DOI 10.1177/1553350607308466; Zevin B, 2013, J AM COLL SURGEONS, V216, P955, DOI 10.1016/j.jamcollsurg.2013.01.003	28	839	847	1	50	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 10	2013	369	15					1434	1442		10.1056/NEJMsa1300625	http://dx.doi.org/10.1056/NEJMsa1300625			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	231QE	24106936				2022-12-28	WOS:000325431500011
J	Zahm, JA; Padrick, SB; Chen, ZC; Pak, CW; Yunus, AA; Henry, L; Tomchick, DR; Chen, Z; Rosen, MK				Zahm, Jacob A.; Padrick, Shae B.; Chen, Zhucheng; Pak, Chi W.; Yunus, Ali A.; Henry, Lisa; Tomchick, Diana R.; Chen, Zhe; Rosen, Michael K.			The Bacterial Effector VopL Organizes Actin into Filament-like Structures	CELL			English	Article							ARP2/3 COMPLEX; MONOMERIC ACTIN; F-ACTIN; NUCLEATION; MECHANISM; PROTEINS; SPIRE; ELONGATION; PROFILIN; DOMAINS	VopL is an effector protein from Vibrio parahaemolyticus that nucleates actin filaments. VopL consists of a VopL C-terminal domain (VCD) and an array of three WASP homology 2 (WH2) motifs. Here, we report the crystal structure of the VCD dimer bound to actin. The VCD organizes three actin monomers in a spatial arrangement close to that found in the canonical actin filament. In this arrangement, WH2 motifs can be modeled into the binding site of each actin without steric clashes. The data suggest a mechanism of nucleation wherein VopL creates filament-like structures, organized by the VCD with monomers delivered by the WH2 array, that can template addition of new subunits. Similarities with Arp2/3 complex and formin proteins suggest that organization of monomers into filament-like structures is a general and central feature of actin nucleation.	[Zahm, Jacob A.; Padrick, Shae B.; Chen, Zhucheng; Pak, Chi W.; Yunus, Ali A.; Henry, Lisa; Tomchick, Diana R.; Chen, Zhe; Rosen, Michael K.] Univ Texas SW Med Ctr Dallas, Dept Biophys, Dallas, TX 75390 USA; [Zahm, Jacob A.; Padrick, Shae B.; Chen, Zhucheng; Pak, Chi W.; Yunus, Ali A.; Henry, Lisa; Rosen, Michael K.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Rosen, MK (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Biophys, Dallas, TX 75390 USA.	michael.rosen@utsouthwestern.edu	Tomchick, Diana/HGV-2018-2022; Zahm, Jacob/AFN-8950-2022	Tomchick, Diana/0000-0002-7529-4643; Padrick, Shae/0000-0002-6916-6194; Chen, Zhe/0000-0002-1668-4051	Howard Hughes Medical Institute; NIH [R01-GM56322]; Welch Foundation [I-1544]; U.S. Department of Energy Office of Biological and Environmental Research [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056322, T32GM008297] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); U.S. Department of Energy Office of Biological and Environmental Research(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. Luke Rice for discussion and assistance with crystallographic model building and refinement, Dr. Dominika Borek for assistance with crystallographic data processing, and Lynda Doolittle for assistance with actin assembly assays. Work was supported by the Howard Hughes Medical Institute and grants from the NIH (R01-GM56322) and Welch Foundation (I-1544). Results shown in this report are derived from work performed at the Argonne National Laboratory, Structural Biology Center at the Advanced Photon Source. Argonne is operated by UChicago Argonne for the U.S. Department of Energy Office of Biological and Environmental Research under contract DE-AC02-06CH11357.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alto NM, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a006114; Campellone KG, 2010, NAT REV MOL CELL BIO, V11, P237, DOI 10.1038/nrm2867; Carlier MF, 2011, INT REV CEL MOL BIO, V290, P55, DOI 10.1016/B978-0-12-386037-8.00005-3; Chhabra ES, 2009, J CELL SCI, V122, P1430, DOI 10.1242/jcs.040691; Dominguez R, 2009, CRIT REV BIOCHEM MOL, V44, P351, DOI 10.3109/10409230903277340; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fujii T, 2010, NATURE, V467, P724, DOI 10.1038/nature09372; Goode BL, 2007, ANNU REV BIOCHEM, V76, P593, DOI 10.1146/annurev.biochem.75.103004.142647; Gould CJ, 2011, CURR BIOL, V21, P384, DOI 10.1016/j.cub.2011.01.047; Haglund CM, 2011, J CELL BIOL, V195, P7, DOI 10.1083/jcb.201103148; Heimsath EG, 2012, J BIOL CHEM, V287, P3087, DOI 10.1074/jbc.M111.312207; HOLMES KC, 1990, NATURE, V347, P44, DOI 10.1038/347044a0; Hung RJ, 2011, SCIENCE, V334, P1710, DOI 10.1126/science.1211956; Kaiser DA, 1999, J CELL SCI, V112, P3779; KELLEHER JF, 1995, J CELL BIOL, V131, P385, DOI 10.1083/jcb.131.2.385; Leung DW, 2006, METHOD ENZYMOL, V406, P281, DOI 10.1016/S0076-6879(06)06021-6; Liverman ADB, 2007, P NATL ACAD SCI USA, V104, P17117, DOI 10.1073/pnas.0703196104; MACHESKY LM, 1994, J CELL BIOL, V127, P107, DOI 10.1083/jcb.127.1.107; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mullins RD, 1997, J CELL BIOL, V136, P331, DOI 10.1083/jcb.136.2.331; Nair UB, 2008, J MOL BIOL, V384, P848, DOI 10.1016/j.jmb.2008.09.082; Namgoong S, 2011, NAT STRUCT MOL BIOL, V18, P1060, DOI 10.1038/nsmb.2109; Nolen BJ, 2007, MOL CELL, V26, P449, DOI 10.1016/j.molcel.2007.04.017; Oda T, 2009, NATURE, V457, P441, DOI 10.1038/nature07685; Okada K, 2010, J CELL BIOL, V189, P1087, DOI 10.1083/jcb.201001016; OSHEA EK, 1993, CURR BIOL, V3, P658, DOI 10.1016/0960-9822(93)90063-T; Otomo T, 2005, NATURE, V433, P488, DOI 10.1038/nature03251; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Padrick SB, 2008, MOL CELL, V32, P426, DOI 10.1016/j.molcel.2008.10.012; Padrick SB, 2011, P NATL ACAD SCI USA, V108, pE472, DOI 10.1073/pnas.1100236108; Padrick SB, 2010, ANNU REV BIOCHEM, V79, P707, DOI 10.1146/annurev.biochem.77.060407.135452; Paul AS, 2009, CELL MOTIL CYTOSKEL, V66, P606, DOI 10.1002/cm.20379; POLLARD TD, 1986, ANNU REV BIOCHEM, V55, P987, DOI 10.1146/annurev.bi.55.070186.005011; Pollard TD, 2007, ANNU REV BIOPH BIOM, V36, P451, DOI 10.1146/annurev.biophys.35.040405.101936; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Potterton E, 2002, ACTA CRYSTALLOGR D, V58, P1955, DOI 10.1107/S0907444902015391; Qualmann B, 2009, TRENDS CELL BIOL, V19, P276, DOI 10.1016/j.tcb.2009.03.004; Quinlan ME, 2007, J CELL BIOL, V179, P117, DOI 10.1083/jcb.200706196; Rebowski G, 2010, J MOL BIOL, V403, P11, DOI 10.1016/j.jmb.2010.08.040; Robinson RC, 2001, SCIENCE, V294, P1679, DOI 10.1126/science.1066333; Rodal AA, 2005, NAT STRUCT MOL BIOL, V12, P26, DOI 10.1038/nsmb870; Rouiller I, 2008, J CELL BIOL, V180, P887, DOI 10.1083/jcb.200709092; Sano KI, 2002, FEBS LETT, V532, P143, DOI 10.1016/S0014-5793(02)03659-1; Schmid MF, 2004, NATURE, V431, P104, DOI 10.1038/nature02881; Sept D, 2001, BIOPHYS J, V81, P667, DOI 10.1016/S0006-3495(01)75731-1; Thompson ME, 2013, NAT STRUCT MOL BIOL, V20, P111, DOI 10.1038/nsmb.2462; Ti SC, 2011, P NATL ACAD SCI USA, V108, pE463, DOI 10.1073/pnas.1100125108; Vizcarra CL, 2011, P NATL ACAD SCI USA, V108, P11884, DOI 10.1073/pnas.1105703108; Xu XP, 2012, EMBO J, V31, P236, DOI 10.1038/emboj.2011.343; Yeung P S Marie, 2004, Foodborne Pathog Dis, V1, P74, DOI 10.1089/153531404323143594; Yu BK, 2011, NAT STRUCT MOL BIOL, V18, P1068, DOI 10.1038/nsmb.2110	52	34	35	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 10	2013	155	2					423	434		10.1016/j.cell.2013.09.019	http://dx.doi.org/10.1016/j.cell.2013.09.019			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	235LH	24120140	Green Accepted, Bronze			2022-12-28	WOS:000325719800018
J	Forsyth, J				Forsyth, Justin			Time for universality to reduce inequity	LANCET			English	Editorial Material									Save Children, London EC1M 4AR, England	Save the Children	Forsyth, J (corresponding author), Save Children, London EC1M 4AR, England.	l.brearley@savethechildren.org.uk						Rockefeller Foundation Save the Children UNICEF WHO, 2013, UN HLTH COV COMM CLO; UNICEF, 2013, UND 5 MORT; WHO, 2010, WOR HEALT REP, P1; WHO, WHAT IS UN HLTH COV; WHO, 2013, REP SECR UN HLTH COV; Xu K, 2007, HEALTH AFFAIR, V26, P972, DOI 10.1377/hlthaff.26.4.972	6	0	0	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 5	2013	382	9899					1161	1163		10.1016/S0140-6736(13)61722-5	http://dx.doi.org/10.1016/S0140-6736(13)61722-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	228SL	24055452				2022-12-28	WOS:000325209100009
J	Llor, C; Moragas, A; Bayona, C; Morros, R; Pera, H; Plana-Ripoll, O; Cots, JM; Miravitlles, M				Llor, Carl; Moragas, Ana; Bayona, Carolina; Morros, Rosa; Pera, Helena; Plana-Ripoll, Oleguer; Cots, Josep M.; Miravitlles, Marc			Efficacy of anti-inflammatory or antibiotic treatment in patients with non-complicated acute bronchitis and discoloured sputum: randomised placebo controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RESPIRATORY-TRACT INFECTIONS; PRIMARY-CARE; ACUTE COUGH; HUMAN METAPNEUMOVIRUS; AMBULATORY CARE; EXACERBATIONS; MANAGEMENT; THERAPY; MANIFESTATIONS; AMOXICILLIN	Objective To evaluate the efficacy of oral anti-inflammatory or antibiotic treatment compared with placebo in the resolution of cough in patients with uncomplicated acute bronchitis and discoloured sputum. Design Multicentre, parallel, single blinded placebo controlled, randomised clinical trial. Setting Nine primary care centres in Spain. Participants Adults aged 18 to 70 presenting symptoms associated with respiratory tract infection of less than one week's duration, with cough as the predominant symptom, the presence of discoloured sputum, and at least one other symptom of lower respiratory tract infection (dyspnoea, wheezing, chest discomfort, or chest pain). Interventions Patients were randomised to receive either ibuprofen 600 mg three times daily, amoxicillin-clavulanic acid 500 mg/125 mg three times daily, or placebo three times daily for 10 days. The duration of symptoms was measured with a diary card. Main outcome measure Number of days with frequent cough after the randomisation visit. Results 416 participants were randomised (136 to ibuprofen, 137 to antibiotic, and 143 to placebo) and 390 returned their symptom diaries fully completed. The median number of days with frequent cough was slightly lower among patients assigned to ibuprofen (9 days, 95% confidence interval 8 to 10 days) compared with those receiving amoxicillin-clavulanic acid (11 days, 10 to 12 days) or placebo (11 days, 8 to 14 days), albeit without statistically significant differences. Neither amoxicillin-clavulanic acid nor ibuprofen increased the probability of cough resolution (hazard ratio 1.03, 95% confidence interval 0.78 to 1.35 and 1.23, 0.93 to 1.61, respectively) compared with placebo. Adverse events were observed in 27 patients, and were more common in the antibiotic arm (12%) than ibuprofen or placebo arms (5% and 3%, respectively; P<0.01). Conclusion No significant differences were observed in the number of days with cough between patients with uncomplicated acute bronchitis and discoloured sputum treated with ibuprofen, amoxicillin-clavulanic acid, or placebo.	[Llor, Carl; Moragas, Ana] Univ Rovira & Virgili, Dept Gen Pathol, Primary Care Ctr Jaume 1, Tarragona 43005, Spain; [Morros, Rosa; Pera, Helena; Plana-Ripoll, Oleguer] Univ Inst Primary Care Res Jordi Gol, Barcelona, Spain; [Bayona, Carolina] Primary Care Ctr Valls Urba, Valls, Tarragona, Spain; [Morros, Rosa] Autonomous Univ Barcelona, Dept Pharmacol & Therapeut, E-08193 Barcelona, Spain; [Plana-Ripoll, Oleguer] Aarhus Univ, Dept Publ Hlth, Sect Epidemiol, DK-8000 Aarhus C, Denmark; [Cots, Josep M.] Univ Barcelona, Primary Care Ctr La Marina, Barcelona, Spain; [Miravitlles, Marc] Hosp Univ Vall dHebron, Serv Pneumol, CIBER Enfermedades Resp, Barcelona, Spain	Universitat Rovira i Virgili; Autonomous University of Barcelona; Aarhus University; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Hospital Universitari Vall d'Hebron	Llor, C (corresponding author), Cardiff Univ, Sch Med, Inst Primary Care & Publ Hlth, Cardiff CF10 3AX, S Glam, Wales.	carles.llor@urv.cat	Plana-Ripoll, Oleguer/E-1448-2015; Miravitlles, Marc/AAH-5284-2019	Plana-Ripoll, Oleguer/0000-0002-6470-7465; Miravitlles, Marc/0000-0002-9850-9520; Llor, Carl/0000-0001-6644-717X; Morros, Rosa/0000-0001-6752-8748; Moragas Moreno, Ana/0000-0002-1307-0943	Instituto de Salud Carlos III (Spanish Ministry of Health) [EC07/90333]	Instituto de Salud Carlos III (Spanish Ministry of Health)(Instituto de Salud Carlos IIISpanish Government)	This clinical trial was supported by a grant from the Instituto de Salud Carlos III (Spanish Ministry of Health) (EC07/90333). The funder had no role in the design, conduct, or analysis of this study.	ANTHONISEN NR, 1987, ANN INTERN MED, V106, P196, DOI 10.7326/0003-4819-106-2-196; Ashworth M, 2005, BRIT J GEN PRACT, V55, P603; Bastien N, 2003, J CLIN MICROBIOL, V41, P4642, DOI 10.1128/JCM.41.10.4642-4646.2003; Becker LA, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001726.pub4; Bent S, 1999, AM J MED, V107, P62, DOI 10.1016/S0002-9343(99)00167-9; Boivin G, 2002, J INFECT DIS, V186, P1330, DOI 10.1086/344319; Butler CC, 2011, EUR RESPIR J, V38, P119, DOI 10.1183/09031936.00133910; Butler CC, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b2242; Centre for Clinical Practice at NICE (UK), 2008, RESP TRACT INF ANT P; Chalmers JD, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d5840; CHOW AW, 1992, CLIN INFECT DIS, V15, pS62, DOI 10.1093/clind/15.Supplement_1.S62; Coenen S, 2006, BRIT J GEN PRACT, V56, P183; Dosh SA, 2000, J FAM PRACTICE, V49, P407; DUNLAY J, 1984, J FAM PRACTICE, V18, P719; El-Gohary M, 2013, FAM PRACT, V30, P492, DOI 10.1093/fampra/cmt034; Fischer Thomas, 2005, BMC Fam Pract, V6, P6, DOI 10.1186/1471-2296-6-6; FRANK A, 1985, RESPIRATION, V48, P122, DOI 10.1159/000194811; Freestone C, 1997, J PHARM PHARMACOL, V49, P1045, DOI 10.1111/j.2042-7158.1997.tb06039.x; Gillissen A, 2007, J PHYSIOL PHARMACOL, V58, P223; Girbino G, 1990, Riv Eur Sci Med Farmacol, V12, P359; Gonzales R, 2001, CLIN INFECT DIS, V33, P757, DOI 10.1086/322627; Gonzales R, 1999, J GEN INTERN MED, V14, P151, DOI 10.1046/j.1525-1497.1999.00306.x; Gonzales R, 1997, JAMA-J AM MED ASSOC, V278, P901, DOI 10.1001/jama.278.11.901; Goossens H, 2005, LANCET, V365, P579, DOI 10.1016/S0140-6736(05)17907-0; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Gwaltney JM, 2002, J INFECT DIS, V186, P147, DOI 10.1086/341455; HUMMERSPRADIER E, 1999, EUR J GEN PRACT, V5, P15; Johnstone KJ, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009305.pub2; Kicska G, 2003, CLIN NUCL MED, V28, P511, DOI 10.1097/00003072-200306000-00017; Kim SY, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006362.pub2; Linder JA, 2008, CLIN INFECT DIS, V47, P744, DOI 10.1086/591149; Little P, 2013, LANCET INFECT DIS, V13, P123, DOI 10.1016/S1473-3099(12)70300-6; Llor C, 2012, AM J RESP CRIT CARE, V186, P716, DOI 10.1164/rccm.201206-0996OC; Llor C, 2011, BMC PULM MED, V11, DOI 10.1186/1471-2466-11-38; Macfarlane J, 2001, THORAX, V56, P109, DOI 10.1136/thorax.56.2.109; Macfarlane JT, 2008, MED HIST, V52, P47, DOI 10.1017/S0025727300000156; Mainous AG, 1996, ARCH FAM MED, V5, P79, DOI 10.1001/archfami.5.2.79; Miravitlles M, 2008, ARCH BRONCONEUMOL, V44, P100, DOI 10.1016/S1579-2129(08)60013-0; Miravitlles M, 2012, EUR RESPIR J, V39, P1354, DOI 10.1183/09031936.00042111; Moragas A, 2012, ARCH BRONCONEUMOL, V48, P261, DOI 10.1016/j.arbres.2012.02.006; Nduba VN, 2008, THORAX, V63, P999, DOI 10.1136/thx.2008.097311; Ponsioen BP, 2005, EUR RESPIR J, V25, P147, DOI 10.1183/09031936.04.00053604; Pornsuriyasak P, 2005, RESPIROLOGY, V10, P520, DOI 10.1111/j.1440-1843.2005.00732.x; Raherison C, 2003, RESP MED, V97, P995, DOI 10.1016/S0954-6111(03)00030-1; REINER M, 1983, CURR MED RES OPIN, V8, P487, DOI 10.1185/03007998309109787; Sevilla-Sanchez D, 2010, ARCH BRONCONEUMOL, V46, P244, DOI 10.1016/j.arbres.2009.10.008; Smith SM, 2012, COCHRANE DB SYST REV; Smith SM, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001831.pub4; Snow V, 2001, ANN INTERN MED, V134, P518, DOI 10.7326/0003-4819-134-6-200103200-00020; Stanton N, 2010, EUR RESPIR J, V35, P761, DOI 10.1183/09031936.00168409; STOTT NCH, 1976, BRIT MED J, V2, P556, DOI 10.1136/bmj.2.6035.556; Woodhead M, 2011, CLIN MICROBIOL INFEC, V17, pE1, DOI 10.1111/j.1469-0691.2011.03672.x	52	28	31	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 4	2013	347								f5762	10.1136/bmj.f5762	http://dx.doi.org/10.1136/bmj.f5762			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	231PN	24097128	Green Published, hybrid			2022-12-28	WOS:000325429300001
J	Hargrove, LJ; Simon, AM; Young, AJ; Lipschutz, RD; Finucane, SB; Smith, DG; Kuiken, TA				Hargrove, Levi J.; Simon, Ann M.; Young, Aaron J.; Lipschutz, Robert D.; Finucane, Suzanne B.; Smith, Douglas G.; Kuiken, Todd A.			Robotic Leg Control with EMG Decoding in an Amputee with Nerve Transfers	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TARGETED MUSCLE REINNERVATION; TIME MYOELECTRIC CONTROL; KNEE; PROSTHESIS		[Hargrove, Levi J.; Simon, Ann M.; Young, Aaron J.; Lipschutz, Robert D.; Finucane, Suzanne B.; Kuiken, Todd A.] Rehabil Inst Chicago, Ctr Bion Med, Chicago, IL 60611 USA; [Hargrove, Levi J.; Simon, Ann M.; Lipschutz, Robert D.; Kuiken, Todd A.] Northwestern Univ, Dept Phys Med & Rehabil, Chicago, IL 60611 USA; [Young, Aaron J.; Kuiken, Todd A.] Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA; [Smith, Douglas G.] Univ Washington, Dept Orthopaed Surg, Seattle, WA 98195 USA	Shirley Ryan AbilityLab; Northwestern University; Northwestern University; University of Washington; University of Washington Seattle	Hargrove, LJ (corresponding author), Rehabil Inst Chicago, Ctr Bion Med, 345 E Super St,Rm 1309, Chicago, IL 60611 USA.	l-hargrove@northwestern.edu		Simon, Ann/0000-0002-6431-0329				[Anonymous], POW KNEE; Bellmann M, 2012, ARCH PHYS MED REHAB, V93, P541, DOI 10.1016/j.apmr.2011.10.017; Hargrove LJ, 2011, JAMA-J AM MED ASSOC, V305, P1542, DOI 10.1001/jama.2011.465; Huang H, 2009, IEEE T BIO-MED ENG, V56, P65, DOI 10.1109/TBME.2008.2003293; Kim PS, 2012, J HAND SURG-AM, V37A, P1609, DOI 10.1016/j.jhsa.2012.04.044; Kuiken TA, 2009, JAMA-J AM MED ASSOC, V301, P619, DOI 10.1001/jama.2009.116; Lawson B., 2012, IEEE T NEURAL SYST R; Song L, 2009, COMPUTER, V22, P1; Sup F, 2008, P IEEE RAS-EMBS INT, P523, DOI 10.1109/BIOROB.2008.4762811; Varol HA, 2010, IEEE T BIO-MED ENG, V57, P542, DOI 10.1109/TBME.2009.2034734; Zhou P, 2007, J NEUROPHYSIOL, V98, P2974, DOI 10.1152/jn.00178.2007	11	149	162	2	51	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 26	2013	369	13					1237	1242		10.1056/NEJMoa1300126	http://dx.doi.org/10.1056/NEJMoa1300126			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	224LT	24066744				2022-12-28	WOS:000324888200010
J	Hassanzadeh, M				Hassanzadeh, Morteza			Extramedullary Hematopoiesis in Thalassemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Iran Univ Med Sci, Tehran, Iran	Iran University of Medical Sciences	Hassanzadeh, M (corresponding author), Iran Univ Med Sci, Tehran, Iran.	morteza_hb@yahoo.com	Hassanzadeh, Morteza/ABB-8346-2020	Hassanzadeh, Morteza/0000-0002-4821-5137					0	4	4	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 26	2013	369	13					1252	1252		10.1056/NEJMicm1303084	http://dx.doi.org/10.1056/NEJMicm1303084			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	224LT	24066746				2022-12-28	WOS:000324888200012
J	Malina, D				Malina, Debra			Performance Anxiety - What Can Health Care Learn from K-12 Education?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		BERWICK DM, 1989, NEW ENGL J MED, V320, P53, DOI 10.1056/NEJM198901053200110; Institute of Medicine, 2012, BEST CAR LOW COST PA; Nichols LM, 2010, NEW ENGL J MED, V362, DOI 10.1056/NEJMp1001604; Project MET, 2010, WORK TEACH DEV FAIR; Ravitch D., 2010, DEATH LIFE GREAT AM	5	7	7	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 26	2013	369	13					1268	1272		10.1056/NEJMms1306048	http://dx.doi.org/10.1056/NEJMms1306048			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	224LT	24066750	Bronze			2022-12-28	WOS:000324888200017
J	Shulaker, MM; Hills, G; Patil, N; Wei, H; Chen, HY; PhilipWong, HS; Mitra, S				Shulaker, Max M.; Hills, Gage; Patil, Nishant; Wei, Hai; Chen, Hong-Yu; PhilipWong, H. -S.; Mitra, Subhasish			Carbon nanotube computer	NATURE			English	Article							CIRCUITS; SINGLE	The miniaturization of electronic devices has been the principal driving force behind the semiconductor industry, and has brought about major improvements in computational power and energy efficiency. Although advances with silicon-based electronics continue to be made, alternative technologies are being explored. Digital circuits based on transistors fabricated from carbon nanotubes (CNTs) have the potential to outperform silicon by improving the energy-delay product, a metric of energy efficiency, by more than an order of magnitude. Hence, CNTs are an exciting complement to existing semiconductor technologies(1,2). Owing to substantial fundamental imperfections inherent in CNTs, however, only very basic circuit blocks have been demonstrated. Here we show how these imperfections can be overcome, and demonstrate the first computer built entirely using CNT-based transistors. The CNT computer runs an operating system that is capable of multitasking: as a demonstration, we perform counting and integer-sorting simultaneously. In addition, we implement 20 different instructions from the commercial MIPS instruction set to demonstrate the generality of our CNT computer. This experimental demonstration is the most complex carbon-based electronic system yet realized. It is a considerable advance because CNTs are prominent among a variety of emerging technologies that are being considered for the next generation of highly energy-efficient electronic systems(3,4).	[Shulaker, Max M.; Hills, Gage; Wei, Hai; Chen, Hong-Yu; PhilipWong, H. -S.; Mitra, Subhasish] Stanford Univ, Stanford, CA 94305 USA; [Patil, Nishant] SK Hynix Memory Solut, San Jose, CA 95134 USA	Stanford University	Shulaker, MM (corresponding author), Stanford Univ, Gates Bldg,Room 331,353 Serra Mall, Stanford, CA 94305 USA.	maxms@stanford.edu	chen, hongyu/HHS-4314-2022; Blankert, Jean Philippe/C-3008-2017	Mitra, Subhasish/0000-0002-5572-5194; Blankert, Jean Philippe/0000-0001-5955-580X	NSF (CISE) [CNS-1059020, CCF-0726791, CCF-0702343, CCF-0643319]; FCRP [C2S2]; FCRP FENA; STARNet SONIC; Stanford Graduate Fellowship; Hertz Foundation Fellowship	NSF (CISE); FCRP; FCRP FENA; STARNet SONIC; Stanford Graduate Fellowship(Stanford University); Hertz Foundation Fellowship	We acknowledge the support of the NSF (CISE) (CNS-1059020, CCF-0726791, CCF-0702343, CCF-0643319), FCRP C2S2, FCRP FENA, STARNet SONIC and the Stanford Graduate Fellowship and the Hertz Foundation Fellowship (M. M. S.). We also acknowledge Z. Bao, A. Lin, H. (D.) Lin, M. Rosenblum, and J. Zhang for their advice and collaborations.	Appenzeller J, 2008, P IEEE, V96, P201, DOI 10.1109/JPROC.2007.911051; Bachtold A, 2001, SCIENCE, V294, P1317, DOI 10.1126/science.1065824; Cao Q, 2008, NATURE, V454, P495, DOI 10.1038/nature07110; Cao Q, 2013, NAT NANOTECHNOL, V8, P180, DOI [10.1038/nnano.2012.257, 10.1038/NNANO.2012.257]; Chang L., 2012, IEEE INT EL DEV M; Chen ZH, 2006, SCIENCE, V311, P1735, DOI 10.1126/science.1122797; Collins PC, 2001, SCIENCE, V292, P706, DOI 10.1126/science.1058782; Franklin AD, 2012, NANO LETT, V12, P758, DOI 10.1021/nl203701g; Herken R., 1995, UNIVERSAL TURING MAC; IIJIMA S, 1991, NATURE, V354, P56, DOI 10.1038/354056a0; Javey A, 2003, NATURE, V424, P654, DOI 10.1038/nature01797; Javey A., 2003, 2003 INT EL DEV M, P31; JEFFAY K, 1991, PROCEEDING : TWELFTH REAL-TIME SYSTEMS SYMPOSIUM, P129, DOI 10.1109/REAL.1991.160366; Lin A., 2010, THESIS STANFORD U; Lin GY, 2009, 2009 IEEE INTERNATIONAL CONFERENCE ON MECHATRONICS AND AUTOMATION, VOLS 1-7, CONFERENCE PROCEEDINGS, P4991, DOI 10.1109/ICMA.2009.5245984; Martel R, 1998, APPL PHYS LETT, V73, P2447, DOI 10.1063/1.122477; MCCLUSKEY EJ, 1986, LOGIC DESIGN PRINCIP; Nikonov D., 2012, P 2012 IEEE INT EL D, P24; Nurnberg PJ, 2004, LECT NOTES COMPUT SC, V3002, P1; Patil Nishant, 2008, 2008 Symposium on VLSI Technology, P205, DOI 10.1109/VLSIT.2008.4588619; Patil N., 2010, THESIS STANFORD U; Patil N, 2011, IEEE T NANOTECHNOL, V10, P744, DOI 10.1109/TNANO.2010.2076323; Patterson D. A., 1990, COMPUTER ARCHITECTUR; Shulaker M, 2013, ISSCC DIG TECH PAP I, V56, P112, DOI 10.1109/ISSCC.2013.6487660; Shulaker MM, 2011, NANO LETT, V11, P1881, DOI 10.1021/nl200063x; Tan XR, 2007, PROCEEDINGS OF 2007 IEEE INTERNATIONAL CONFERENCE ON GREY SYSTEMS AND INTELLIGENT SERVICES, VOLS 1 AND 2, P86; Tans SJ, 1998, NATURE, V393, P49, DOI 10.1038/29954; VONNEUMANN J, 1993, IEEE ANN HIST COMPUT, V15, P28; Zhang J., 2009, P IEDM, P573; Zhang J, 2012, IEEE T COMPUT AID D, V31, P453, DOI 10.1109/TCAD.2012.2187527	30	715	738	21	522	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 26	2013	501	7468					526	+		10.1038/nature12502	http://dx.doi.org/10.1038/nature12502			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223RP	24067711				2022-12-28	WOS:000324826300053
J	de Jong, PW; van Lenteren, JC; Raak-van den Berg, CL				de Jong, Peter W.; van Lenteren, Joop C.; Raak-van den Berg, C. Lidwien			Comment on "Invasive Harlequin Ladybird Carries Biological Weapons Against Native Competitors"	SCIENCE			English	Editorial Material							INTRAGUILD PREDATION; HARMONIA-AXYRIDIS; COCCINELLIDAE; COLEOPTERA		[de Jong, Peter W.; van Lenteren, Joop C.; Raak-van den Berg, C. Lidwien] Wageningen Univ, Entomol Lab, NL-6700 EH Wageningen, Netherlands	Wageningen University & Research	de Jong, PW (corresponding author), Wageningen Univ, Entomol Lab, POB 8031, NL-6700 EH Wageningen, Netherlands.	Peter.deJong@wur.nl	van Lenteren, Joop/J-1748-2014; Raak-van den Berg, Lidwien/A-3383-2013	van Lenteren, Joop/0000-0003-3620-1392; 				Cottrell TE, 2007, ENVIRON ENTOMOL, V36, P390, DOI 10.1603/0046-225X(2007)36[390:PBAALL]2.0.CO;2; Durieux D, 2012, J INSECT PHYSIOL, V58, P801, DOI 10.1016/j.jinsphys.2012.03.006; Hodek Ivo, 2012, P275; Pell JK, 2008, BIOCONTROL, V53, P147, DOI 10.1007/s10526-007-9125-x; Raak-van Den Berg CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040681; Reynolds SE, 2013, SCIENCE, V340, P816, DOI 10.1126/science.1238998; Roy HE, 2012, DIVERS DISTRIB, V18, P717, DOI 10.1111/j.1472-4642.2012.00883.x; Vilcinskas A, 2013, SCIENCE, V340, P862, DOI 10.1126/science.1234032; Yasuda H, 2001, J INSECT BEHAV, V14, P373, DOI 10.1023/A:1011175430247	9	1	1	1	99	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 20	2013	341	6152								10.1126/science.1241745	http://dx.doi.org/10.1126/science.1241745			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	220PK	24052290	Bronze			2022-12-28	WOS:000324597200021
J	Solter, LF; Kyei-Poku, GK; Johny, S				Solter, Leellen F.; Kyei-Poku, George K.; Johny, Shajahan			Comment on "Invasive Harlequin Ladybird Carries Biological Weapons Against Native Competitors"	SCIENCE			English	Editorial Material							COCCINELLA-SEPTEMPUNCTATA COLEOPTERA; HOST-SPECIFICITY; MICROSPORIDIA		[Solter, Leellen F.] Univ Illinois, Illinois Nat Hist Survey, Prairie Res Inst, Champaign, IL 61820 USA; [Kyei-Poku, George K.; Johny, Shajahan] Canadian Forest Serv, Great Lakes Forestry Ctr, Sault Ste Marie, ON P6A 2E5, Canada	Illinois Natural History Survey; University of Illinois System; University of Illinois Urbana-Champaign; Natural Resources Canada; Canadian Forest Service; Great Lakes Forestry Centre	Solter, LF (corresponding author), Univ Illinois, Illinois Nat Hist Survey, Prairie Res Inst, Champaign, IL 61820 USA.	lsolter@illinois.edu						Davidson LN, 2010, ENVIRON ENTOMOL, V39, P576, DOI 10.1603/EN08308; Evans EW, 1999, OECOLOGIA, V121, P107, DOI 10.1007/s004420050911; Kajita Y, 2010, OECOLOGIA, V163, P313, DOI 10.1007/s00442-009-1551-2; Katsanis A, 2013, BIOCONTROL, V58, P73, DOI 10.1007/s10526-012-9470-2; Koch RL, 2008, BIOCONTROL, V53, P23, DOI 10.1007/s10526-007-9121-1; Marin J, 2010, ZOOL SCR, V39, P591, DOI 10.1111/j.1463-6409.2010.00450.x; Rieder JP, 2008, ECOL ENTOMOL, V33, P53, DOI 10.1111/j.1365-2311.2007.00934.x; Solter LF, 2012, INSECT PATHOLOGY, 2ND EDITION, P221, DOI 10.1016/B978-0-12-384984-7.00007-5; Solter LF, 2010, J INVERTEBR PATHOL, V105, P1, DOI 10.1016/j.jip.2010.04.009; Solter LF, 1998, J INVERTEBR PATHOL, V71, P207, DOI 10.1006/jipa.1997.4740; Solter LF, 1997, J INVERTEBR PATHOL, V69, P135, DOI 10.1006/jipa.1996.4650; Triltsch H, 1999, EUR J ENTOMOL, V96, P355; Troemel ER, 2008, PLOS BIOL, V6, P2736, DOI 10.1371/journal.pbio.0060309; Vavra J, 2013, ADV PARASIT, V82, P253, DOI 10.1016/B978-0-12-407706-5.00004-6; Vilcinskas A, 2013, SCIENCE, V340, P862, DOI 10.1126/science.1234032	15	7	7	1	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 20	2013	341	6152								10.1126/science.1241600	http://dx.doi.org/10.1126/science.1241600			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	220PK	24052291				2022-12-28	WOS:000324597200022
J	Fitzgerald, K; Frank-Kamenetsky, M; Shulga-Morskaya, S; Liebow, A; Bettencourt, BR; Sutherland, JE; Hutabarat, RM; Clausen, VA; Karsten, V; Cehelsky, J; Nochur, SV; Kotelianski, V; Horton, J; Mant, T; Chiesa, J; Ritter, J; Munisamy, M; Vaishnaw, AK; Gollob, JA; Simon, A				Fitzgerald, Kevin; Frank-Kamenetsky, Maria; Shulga-Morskaya, Svetlana; Liebow, Abigail; Bettencourt, Brian R.; Sutherland, Jessica E.; Hutabarat, Renta M.; Clausen, Valerie A.; Karsten, Verena; Cehelsky, Jeffrey; Nochur, Saraswathy V.; Kotelianski, Victor; Horton, Jay; Mant, Timothy; Chiesa, Joseph; Ritter, James; Munisamy, Malathy; Vaishnaw, Akshay K.; Gollob, Jared A.; Simon, Amy			Effect of an RNA interference drug on the synthesis of proprotein convertase subtilisin/kexin type 9 (PCSK9) and the concentration of serum LDL cholesterol in healthy volunteers: a randomised, single-blind, placebo-controlled, phase 1 trial	LANCET			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; DOUBLE-STRANDED-RNA; MONOCLONAL-ANTIBODY; CARDIOVASCULAR-DISEASE; PLASMA-CHOLESTEROL; AMG 145; STATINS; HYPERCHOLESTEROLEMIA; ATORVASTATIN; METAANALYSIS	Background Proprotein convertase subtilisin/kexin type 9 (PCSK9) binds to LDL receptors, leading to their degradation. Genetics studies have shown that loss-of-function mutations in PCSK9 result in reduced plasma LDL cholesterol and decreased risk of coronary heart disease. We aimed to investigate the safety and efficacy of ALN-PCS, a small interfering RNA that inhibits PCSK9 synthesis, in healthy volunteers with raised cholesterol who were not on lipid-lowering treatment. Methods We did a randomised, single-blind, placebo-controlled, phase 1 dose-escalation study in healthy adult volunteers with serum LDL cholesterol of 3.00 mmol/L or higher. Participants were randomly assigned in a 3: 1 ratio by computer algorithm to receive one dose of intravenous ALN-PCS (with doses ranging from 0.015 to 0.400 mg/kg) or placebo. The primary endpoint was safety and tolerability of ALN-PCS. Secondary endpoints were the pharmacokinetic characteristics of ALN-PCS and its pharmacodynamic effects on PCSK9 and LDL cholesterol. Study participants were masked to treatment assignment. Analysis was per protocol and we used ANCOVA to analyse pharmacodynamic endpoint data. This trial is registered with ClinicalTrials.gov, number NCT01437059. Findings Of 32 participants, 24 were randomly allocated to receive a single dose of ALN-PCS (0.015 mg/kg [n=3], 0.045 mg/kg [n=3], 0.090 mg/kg [n=3], 0.150 mg/kg [n=3], 0.250 mg/kg [n=6], or 0.400 mg/kg [n=6]) and eight to placebo. The proportions of patients affected by treatment-emergent adverse events were similar in the ALN-PCS and placebo groups (19 [79%] vs seven [88%]). ALN-PCS was rapidly distributed, with peak concentration and area under the curve (0 to last measurement) increasing in a roughly dose-proportional way across the dose range tested. In the group given 0.400 mg/kg of ALN-PCS, treatment resulted in a mean 70% reduction in circulating PCSK9 plasma protein (p<0.0001) and a mean 40% reduction in LDL cholesterol from baseline relative to placebo (p<0.0001). Interpretation Our results suggest that inhibition of PCSK9 synthesis by RNA interference (RNAi) provides a potentially safe mechanism to reduce LDL cholesterol concentration in healthy individuals with raised cholesterol. These results support the further assessment of ALN-PCS in patients with hypercholesterolaemia, including those being treated with statins. This study is the first to show an RNAi drug being used to affect a clinically validated endpoint (ie, LDL cholesterol) in human beings.	[Fitzgerald, Kevin; Frank-Kamenetsky, Maria; Shulga-Morskaya, Svetlana; Liebow, Abigail; Bettencourt, Brian R.; Sutherland, Jessica E.; Hutabarat, Renta M.; Clausen, Valerie A.; Karsten, Verena; Cehelsky, Jeffrey; Nochur, Saraswathy V.; Kotelianski, Victor; Vaishnaw, Akshay K.; Gollob, Jared A.; Simon, Amy] Alnylam Pharmaceut, Cambridge, MA 02446 USA; [Horton, Jay] Univ Texas South Western, Dallas, TX USA; [Mant, Timothy; Ritter, James] Guys Hosp, Quintiles Drug Res Unit, London SE1 9RT, England; [Chiesa, Joseph; Munisamy, Malathy] Covance Clin Res Unit, Leeds, W Yorkshire, England	Guy's & St Thomas' NHS Foundation Trust; IQVIA	Fitzgerald, K (corresponding author), Alnylam Pharmaceut, Cambridge, MA 02446 USA.	kfitzgerald@alnylam.com			Alnylam Pharmaceuticals; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL020948] Funding Source: NIH RePORTER	Alnylam Pharmaceuticals; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Alnylam Pharmaceuticals.	Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Adams S. P., 2012, COCHRANE DB SYST REV, V12; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Banerjee Y, 2012, NEW ENGL J MED, V366, P2425; Barros SA, 2012, ADV DRUG DELIVER REV, V64, P1730, DOI 10.1016/j.addr.2012.06.007; Careskey HE, 2008, J LIPID RES, V49, P394, DOI 10.1194/jlr.M700437-JLR200; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Costet P, 2010, ATHEROSCLEROSIS, V212, P246, DOI 10.1016/j.atherosclerosis.2010.05.027; Davidson MH, 2005, AM J CARDIOL, V96, P556, DOI 10.1016/j.amjcard.2005.04.019; Davignon Jean, 2009, Trans Am Clin Climatol Assoc, V120, P163; Delahoy PJ, 2009, CLIN THER, V31, P236, DOI 10.1016/j.clinthera.2009.02.017; Dias CS, 2012, J AM COLL CARDIOL, V60, P1888, DOI 10.1016/j.jacc.2012.08.986; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Foley KA, 2003, AM J CARDIOL, V92, P79, DOI 10.1016/S0002-9149(03)00474-0; Foody JM, 2010, J CLIN LIPIDOL, V4, P126, DOI 10.1016/j.jacl.2010.01.007; Frank-Kamenetsky M, 2008, P NATL ACAD SCI USA, V105, P11915, DOI 10.1073/pnas.0805434105; Genest J, 2009, CAN J CARDIOL, V25, P567, DOI 10.1016/S0828-282X(09)70715-9; Grundy Scott M, 2004, J Am Coll Cardiol, V44, P720, DOI 10.1016/j.jacc.2004.07.001; Hooper AJ, 2007, ATHEROSCLEROSIS, V193, P445, DOI 10.1016/j.atherosclerosis.2006.08.039; Hooper AJ, 2013, EXPERT OPIN BIOL TH, V13, P429, DOI 10.1517/14712598.2012.748743; Horton JD, 2007, TRENDS BIOCHEM SCI, V32, P71, DOI 10.1016/j.tibs.2006.12.008; Horton JD, 2009, J LIPID RES, V50, pS172, DOI 10.1194/jlr.R800091-JLR200; Jayaraman M, 2012, ANGEW CHEM INT EDIT, V51, P8529, DOI 10.1002/anie.201203263; Kearney PM, 2008, LANCET, V371, P117, DOI 10.1016/S0140-6736(08)60104-X; Lakoski SG, 2009, J CLIN ENDOCR METAB, V94, P2537, DOI 10.1210/jc.2009-0141; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Milazzo L, 2012, NEW ENGL J MED, V366, P2425, DOI 10.1056/NEJMc1204929; Poirier S, 2009, J BIOL CHEM, V284, P28856, DOI 10.1074/jbc.M109.037085; Raal F, 2012, CIRCULATION, V126, P2408, DOI 10.1161/CIRCULATIONAHA.112.144055; Rashid S, 2005, P NATL ACAD SCI USA, V102, P5374, DOI 10.1073/pnas.0501652102; Roth EM, 2012, NEW ENGL J MED, V367, P1891, DOI 10.1056/NEJMoa1201832; Sniderman A, 2012, J CLIN LIPIDOL, V6, P303, DOI 10.1016/j.jacl.2012.05.004; Stein EA, 2012, NEW ENGL J MED, V366, P1108, DOI 10.1056/NEJMoa1105803; Sullivan D, 2012, JAMA-J AM MED ASSOC, V308, P2497, DOI 10.1001/jama.2012.25790; Tabernero J, 2013, CANCER DISCOV, V3, P406, DOI 10.1158/2159-8290.CD-12-0429; Thomas JE, 2010, DRUG AGING, V27, P959, DOI 10.2165/11539550-000000000-00000; Vaishnaw Akshay K, 2010, Silence, V1, P14, DOI 10.1186/1758-907X-1-14; Welder G, 2010, J LIPID RES, V51, P2714, DOI 10.1194/jlr.M008144; Zhao ZZ, 2006, AM J HUM GENET, V79, P514, DOI 10.1086/507488	39	398	431	5	95	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 4	2014	383	9911					60	68		10.1016/S0140-6736(13)61914-5	http://dx.doi.org/10.1016/S0140-6736(13)61914-5			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	284SP	24094767	Green Accepted			2022-12-28	WOS:000329341200036
J	Simons, BD				Simons, Benjamin D.			Getting Your Gut into Shape	SCIENCE			English	Editorial Material							MORPHOGENESIS; VILLI; MECHANISM		[Simons, Benjamin D.] Univ Cambridge, Cavendish Lab, Dept Phys, Cambridge CB3 0HE, England; [Simons, Benjamin D.] Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst, Cambridge CB2 1QN, England; [Simons, Benjamin D.] Univ Cambridge, Wellcome Trust Med Res Council Stem Cell Inst, Cambridge CB2 1TN, England	University of Cambridge; University of Cambridge; University of Cambridge	Simons, BD (corresponding author), Univ Cambridge, Cavendish Lab, Dept Phys, JJ Thomson Ave, Cambridge CB3 0HE, England.	bds10@cam.ac.uk	Simons, Benjamin/AAY-8920-2020	Simons, Benjamin/0000-0002-3875-7071	Wellcome Trust [079249, 092096] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BURGESS DR, 1975, J EMBRYOL EXP MORPH, V34, P723; Clevers H, 2013, CELL, V154, P274, DOI 10.1016/j.cell.2013.07.004; COULOMBRE AJ, 1958, J EMBRYOL EXP MORPH, V6, P403; Dervaux J, 2011, J MECH PHYS SOLIDS, V59, P538, DOI 10.1016/j.jmps.2010.12.015; Goriely A, 2010, IMA J APPL MATH, V75, P549, DOI 10.1093/imamat/hxq021; Heisenberg CP, 2013, CELL, V153, P948, DOI 10.1016/j.cell.2013.05.008; Hilton WA, 1902, AM J ANAT, V1, P459, DOI 10.1002/aja.1000010406; Kucken M, 2005, J THEOR BIOL, V235, P71, DOI 10.1016/j.jtbi.2004.12.020; LAMBERT RK, 1994, J APPL PHYSIOL, V77, P1206, DOI 10.1152/jappl.1994.77.3.1206; RICHMAN DP, 1975, SCIENCE, V189, P18, DOI 10.1126/science.1135626; Sato T, 2013, SCIENCE, V340, P1190, DOI 10.1126/science.1234852; Shyer AE, 2013, SCIENCE, V342, P212, DOI 10.1126/science.1238842; Taber L.A., 1995, APPL MECH REV, V48, P487, DOI [10.1115/1.3005109, DOI 10.1115/1.3005109]; Thompson D. W., 1917, GROWTH FORM; Wolpert C. T. L., 2011, PRINCIPLES DEV; Zorn AM, 2009, ANNU REV CELL DEV BI, V25, P221, DOI 10.1146/annurev.cellbio.042308.113344	16	6	6	1	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 11	2013	342	6155					203	204		10.1126/science.1245288	http://dx.doi.org/10.1126/science.1245288			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	232EV	24115430				2022-12-28	WOS:000325475200032
J	Dye, C; Raviglione, M				Dye, Christopher; Raviglione, Mario			Weigh all TB risks	NATURE			English	Editorial Material									[Dye, Christopher] WHO, CH-1211 Geneva, Switzerland; [Raviglione, Mario] WHO, Global TB Programme HIV AIDS TB Malaria & Neglect, CH-1211 Geneva, Switzerland	World Health Organization; World Health Organization	Dye, C (corresponding author), WHO, CH-1211 Geneva, Switzerland.	dyec@who.int; raviglionem@who.int	Dye, Christopher/AIC-4659-2022	Dye, Christopher/0000-0002-2957-1793; RAVIGLIONE, Mario/0000-0002-9331-2067				[Anonymous], GLOB TUB CONTR WHO R; Dye C, 2013, ANNU REV PUBL HEALTH, V34, P271, DOI 10.1146/annurev-publhealth-031912-114431; Dye C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021161; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; United Nations, 2013, NEW GLOB PARTN ER PO	5	10	10	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 10	2013	502	7470					S13	S13		10.1038/502S13a	http://dx.doi.org/10.1038/502S13a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RU	24108075				2022-12-28	WOS:000325436100007
J	Edmans, J; Bradshaw, L; Franklin, M; Gladman, J; Conroy, S				Edmans, Judi; Bradshaw, Lucy; Franklin, Matthew; Gladman, John; Conroy, Simon			Specialist geriatric medical assessment for patients discharged from hospital acute assessment units: randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							FRAIL OLDER-PEOPLE; MINI-MENTAL STATE; INTERFACE GERIATRICS; SCREENING TOOL; METAANALYSIS; EMERGENCY; VALIDITY; OUTCOMES; VISIT; RISK	Objective To evaluate the effect of specialist geriatric medical management on the outcomes of at risk older people discharged from acute medical assessment units. Design Individual patient randomised controlled trial comparing intervention with usual care. Setting Two hospitals in Nottingham and Leicester, UK. Participants 433 patients aged 70 or over who were discharged within 72 hours of attending an acute medical assessment unit and at risk of decline as indicated by a score of at least 2 on the Identification of Seniors At Risk tool. Intervention Assessment made on the acute medical assessment unit and further outpatient management by specialist physicians in geriatric medicine, including advice and support to primary care services. Main outcome measures The primary outcome was the number of days spent at home (for those admitted from home) or days spent in the same care home (if admitted from a care home) in the 90 days after randomisation. Secondary outcomes were determined at 90 days and included mortality, institutionalisation, dependency, mental wellbeing, quality of life, and health and social care resource use. Results The two groups were well matched for baseline characteristics, and withdrawal rates were similar in both groups (5%). Mean days at home over 90 days' follow-up were 80.2 days in the control group and 79.7 in the intervention group. The 95% confidence interval for the difference in means was -4.6 to 3.6 days (P=0.31). No significant differences were found for any of the secondary outcomes. Conclusions This specialist geriatric medical intervention applied to an at risk population of older people attending and being discharged from acute medical units had no effect on patients' outcomes or subsequent use of secondary care or long term care.	[Edmans, Judi; Bradshaw, Lucy; Gladman, John] Univ Nottingham, Queens Med Ctr, Div Rehabil & Ageing, Sch Med, Nottingham NG7 2UH, England; [Franklin, Matthew] Univ Nottingham, Sch Med, Queens Med Ctr, Div Social Res Med & Hlth, Nottingham NG7 2UH, England; [Conroy, Simon] Leicester Royal Infirm, Univ Hosp Leicester, Leicester LE1 5WW, Leics, England	University of Nottingham; University of Nottingham; University Hospitals of Leicester NHS Trust; University of Leicester	Conroy, S (corresponding author), Leicester Royal Infirm, Univ Hosp Leicester, Room 034,Level 5,Windsor Bldg, Leicester LE1 5WW, Leics, England.	spc3@le.ac.uk	Conroy, Simon/B-8832-2009; Franklin, Matthew/J-8109-2019; Gladman, John/M-7429-2015	Franklin, Matthew/0000-0002-2774-9439; Conroy, Simon/0000-0002-4306-6064; Gladman, John/0000-0002-8506-7786	National Institute for Health Research (NIHR) [RP-PG-0407-10147]; National Institute for Health Research [RP-PG-0407-10147] Funding Source: researchfish	National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	This article presents independent research funded by the National Institute for Health Research (NIHR) under its Programme Grants for Applied Research funding scheme (RP-PG-0407-10147). The views expressed in this article are those of the authors and not necessarily those of the NHS, the NIHR, or the Department of Health.	[Anonymous], 2012, SILVER BOOK QUALITY; Baztan JJ, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b50; Beswick AD, 2008, LANCET, V371, P725, DOI 10.1016/S0140-6736(08)60342-6; Brazier JE, 1996, QUAL LIFE RES, V5, P195, DOI 10.1007/BF00434741; Cleves MA, 1997, J CLIN EPIDEMIOL, V50, P903, DOI 10.1016/S0895-4356(97)00091-7; Coast J, 2008, QUAL LIFE RES, V17, P967, DOI 10.1007/s11136-008-9372-z; CONROY S, 2010, MED CRISES OLDER PEO; Conroy S, 2010, BRIT J HOSP MED, V71, P98, DOI 10.12968/hmed.2010.71.2.46488; Conroy SP, 2011, AGE AGEING, V40, P436, DOI 10.1093/ageing/afr060; Conroy SP, 2013, AGE AGEING; Dendukuri N, 2004, J AM GERIATR SOC, V52, P290, DOI 10.1111/j.1532-5415.2004.52073.x; Deschodt M, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-48; DICK JPR, 1984, J NEUROL NEUROSUR PS, V47, P496, DOI 10.1136/jnnp.47.5.496; Edmans J, 2012, MED CRISES OLDER PEO; Edmans J, 2013, AGE AGEING; Edmans J, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-200; Ellis G, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6553; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fox MT, 2012, J AM GERIATR SOC, V60, P2237, DOI 10.1111/jgs.12028; Gladman J, 2007, INTERFACE PRIMARY SE, V4; Gladman J, 2012, MED CRISES OLDER PEO; Gladman JRF, 2010, MED CRISES OLDER PEO, V3; GOLDBERG DP, 1979, PSYCHOL MED, V9, P139, DOI 10.1017/S0033291700021644; McCusker J, 1999, J AM GERIATR SOC, V47, P1229, DOI 10.1111/j.1532-5415.1999.tb05204.x; McCusker J, 2000, ANN EMERG MED, V36, P438, DOI 10.1067/mem.2000.110822; Percival F, 2010, EVALUATION CONSULTAN; STUCK AE, 1993, LANCET, V342, P1032, DOI 10.1016/0140-6736(93)92884-V; Wade D T, 1988, Int Disabil Stud, V10, P64; Woodard J, 2009, J NUTR HLTH AGING S1, V13, pS477; Woodard J, 2010, AGE AGEING, V39, pi36	30	45	45	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 8	2013	347								f5874	10.1136/bmj.f5874	http://dx.doi.org/10.1136/bmj.f5874			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	235OJ	24103444	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000325728600006
J	Rochaix, JD				Rochaix, Jean-David			Fine-Tuning Photosynthesis	SCIENCE			English	Editorial Material							K+ CHANNEL; DELTA-PH; PROTON		[Rochaix, Jean-David] Univ Geneva, Dept Mol Biol, CH-1211 Geneva 4, Switzerland; [Rochaix, Jean-David] Univ Geneva, Dept Plant Biol, CH-1211 Geneva 4, Switzerland	University of Geneva; University of Geneva	Rochaix, JD (corresponding author), Univ Geneva, Dept Mol Biol, 30 Quai Ernest Ansermet, CH-1211 Geneva 4, Switzerland.	jean-david.rochaix@unige.ch	Rochaix, Jean-David/ABC-5243-2020		NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041858, R01NS061642] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS061642, R01 NS041858] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Avenson TJ, 2004, P NATL ACAD SCI USA, V101, P5530, DOI 10.1073/pnas.0401269101; Becker D, 2004, P NATL ACAD SCI USA, V101, P15621, DOI 10.1073/pnas.0401502101; Carraretto L, 2013, SCIENCE, V342, P114, DOI 10.1126/science.1242113; Cruz JA, 2001, BIOCHEMISTRY-US, V40, P1226, DOI 10.1021/bi0018741; Fischer S, 1999, FEBS LETT, V457, P327, DOI 10.1016/S0014-5793(99)01060-1; HOPE AB, 1994, PHOTOSYNTH RES, V42, P111, DOI 10.1007/BF02187122; Kramer DM, 2003, TRENDS PLANT SCI, V8, P27, DOI 10.1016/S1360-1385(02)00010-9; MITCHELL P, 1966, BIOL REV, V41, P445, DOI 10.1111/j.1469-185X.1966.tb01501.x; Niyogi KK, 1999, ANNU REV PLANT PHYS, V50, P333, DOI 10.1146/annurev.arplant.50.1.333; Sacksteder CA, 2000, P NATL ACAD SCI USA, V97, P14283, DOI 10.1073/pnas.97.26.14283	10	15	15	3	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 4	2013	342	6154					50	51		10.1126/science.1244943	http://dx.doi.org/10.1126/science.1244943			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	227PP	24092720	Green Accepted			2022-12-28	WOS:000325126100038
J	Shchukin, D; Mohwald, H				Shchukin, Dmitry; Moehwald, Helmuth			A Coat of Many Functions	SCIENCE			English	Editorial Material									[Shchukin, Dmitry] Univ Liverpool, Dept Chem, Stephenson Inst Renewable Energy, Liverpool L69 7ZD, Merseyside, England; [Moehwald, Helmuth] Max Planck Inst Colloids & Interfaces, Dept Interfaces, D-14476 Golm, Germany	University of Liverpool; Max Planck Society	Shchukin, D (corresponding author), Univ Liverpool, Dept Chem, Stephenson Inst Renewable Energy, Liverpool L69 7ZD, Merseyside, England.	d.shchukin@liverpool.ac.uk	Shchukin, Dmitry/AAO-3955-2020; Moehwald, Helmuth/B-8265-2014	Shchukin, Dmitry/0000-0002-2936-804X; Moehwald, Helmuth/0000-0001-7833-3786				Blaiszik BJ, 2010, ANNU REV MATER RES, V40, P179, DOI 10.1146/annurev-matsci-070909-104532; Borisova D, 2013, ACS APPL MATER INTER, V5, P80, DOI 10.1021/am302141y; Huang MX, 2011, J MATER CHEM, V21, P11123, DOI 10.1039/c1jm10794a; Javier AM, 2008, LANGMUIR, V24, P12517, DOI 10.1021/la802448z; Kartsonakis IA, 2012, CORROS SCI, V65, P481, DOI 10.1016/j.corsci.2012.08.052; Kolesnikova TA, 2010, ADV FUNCT MATER, V20, P1189, DOI 10.1002/adfm.200902233; Schneider G, 2004, NANO LETT, V4, P1833, DOI 10.1021/nl0490826; Shchukin DG, 2004, ADV MATER, V16, P671, DOI 10.1002/adma.200306466; Shchukin DG, 2007, SMALL, V3, P926, DOI 10.1002/smll.200700064; Tao X, 2004, CHEM-EUR J, V10, P3397, DOI 10.1002/chem.200400024; Tedim J, 2010, ACS APPL MATER INTER, V2, P1528, DOI 10.1021/am100174t; White S. R., 2001, SCIENCE, V409, P794	12	100	107	3	169	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 27	2013	341	6153					1458	1459		10.1126/science.1242895	http://dx.doi.org/10.1126/science.1242895			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	224NS	24072911				2022-12-28	WOS:000324894600033
J	Messier, SP; Mihalko, SL; Legault, C; Miller, GD; Nicklas, BJ; DeVita, P; Beavers, DP; Hunter, DJ; Lyles, MF; Eckstein, F; Williamson, JD; Carr, JJ; Guermazi, A; Loeser, RF				Messier, Stephen P.; Mihalko, Shannon L.; Legault, Claudine; Miller, Gary D.; Nicklas, Barbara J.; DeVita, Paul; Beavers, Daniel P.; Hunter, David J.; Lyles, Mary F.; Eckstein, Felix; Williamson, Jeff D.; Carr, J. Jeffery; Guermazi, Ali; Loeser, Richard F.			Effects of Intensive Diet and Exercise on Knee Joint Loads, Inflammation, and Clinical Outcomes Among Overweight and Obese Adults With Knee Osteoarthritis The IDEA Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INDUCED WEIGHT-LOSS; OLDER-ADULTS; IMPORTANT DIFFERENCE; ARTHRITIS; CARTILAGE; MARKERS; MUSCLE; PAIN; PROGRESSION; SYMPTOMS	IMPORTANCE Knee osteoarthritis (OA), a common cause of chronic pain and disability, has biomechanical and inflammatory origins and is exacerbated by obesity. OBJECTIVE To determine whether a >= 10% reduction in body weight induced by diet, with or without exercise, would improve mechanistic and clinical outcomes more than exercise alone. DESIGN, SETTING, AND PARTICIPANTS Single-blind, 18-month, randomized clinical trial at Wake Forest University between July 2006 and April 2011. The diet and exercise interventions were center-based with options for the exercise groups to transition to a home-based program. Participants were 454 overweight and obese older community-dwelling adults (age >= 55 years with body mass index of 27-41) with pain and radiographic knee OA. INTERVENTIONS Intensive diet-induced weight loss plus exercise, intensive diet-induced weight loss, or exercise. MAIN OUTCOMES AND MEASURES Mechanistic primary outcomes: knee joint compressive force and plasma IL-6 levels; secondary clinical outcomes: self-reported pain (range, 0-20), function (range, 0-68), mobility, and health-related quality of life (range, 0-100). RESULTS At 18 months, 399 participants (88%) completed the study. Compared with exercise participants, knee compressive forces were lower in diet participants and IL-6 levels were lower in diet and diet + exercise participants. [GRAPHICS] CONCLUSIONS AND RELEVANCE Among overweight and obese adults with knee OA, after 18 months, participants in the diet + exercise and diet groups had more weight loss and greater reductions in IL-6 levels than those in the exercise group; those in the diet group had greater reductions in knee compressive force than those in the exercise group.	[Messier, Stephen P.; Mihalko, Shannon L.; Miller, Gary D.; Nicklas, Barbara J.; Loeser, Richard F.] Wake Forest Univ, Dept Hlth & Exercise Sci, Winston Salem, NC 27109 USA; [Legault, Claudine; Beavers, Daniel P.] Wake Forest Sch Med, Div Publ Hlth Sci, Winston Salem, NC USA; [Messier, Stephen P.; Nicklas, Barbara J.; Lyles, Mary F.; Williamson, Jeff D.] Wake Forest Sch Med, Sect Gerontol & Geriatr Med, Winston Salem, NC USA; [DeVita, Paul] E Carolina Univ, Dept Kinesiol, Greenville, NC USA; [Hunter, David J.] Univ Sydney, Dept Rheumatol, Northern Clin Sch, Sydney, NSW 2006, Australia; [Eckstein, Felix] Paracelsus Med Univ, Inst Anat & Musculoskeletal Res, Salzburg, Austria; [Eckstein, Felix] Chondrometrics, Ainring, Germany; [Carr, J. Jeffery] Wake Forest Sch Med, Dept Radiol, Winston Salem, NC USA; [Guermazi, Ali] Boston Univ, Sch Med, Dept Radiol, Boston, MA 02118 USA; [Loeser, Richard F.] Wake Forest Sch Med, Sect Mol Med, Winston Salem, NC USA	Wake Forest University; Wake Forest University; Wake Forest University; University of North Carolina; East Carolina University; University of Sydney; Paracelsus Private Medical University; Chondrometrics GmbH; Wake Forest University; Boston University; Wake Forest University	Messier, SP (corresponding author), Wake Forest Univ, Dept Hlth & Exercise Sci, JB Snow Biomech Lab, Winston Salem, NC 27109 USA.	messier@wfu.edu	Carr, John Jeffrey/A-1938-2012; Carr, John/AAN-7531-2021; Nicklas, Barbara/AAA-2781-2020; Beavers, Daniel P/G-5338-2016	Carr, John Jeffrey/0000-0002-4398-8237; Carr, John/0000-0002-4398-8237; 	National Institutes of Health from the National Institute of Arthritis and Musculoskeletal and Skin Diseases [R01 AR052528-01]; National Institute on Aging [P30 AG21332]; National Center for Research Resources [M01-RR00211]; General Nutrition Centers; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000211] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052528] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG021332] Funding Source: NIH RePORTER	National Institutes of Health from the National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); General Nutrition Centers; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Support for this study was provided by grants from the National Institutes of Health-R01 AR052528-01 from the National Institute of Arthritis and Musculoskeletal and Skin Diseases, P30 AG21332 from the National Institute on Aging, M01-RR00211 from the National Center for Research Resources-and by General Nutrition Centers.	Aaboe J, 2011, OSTEOARTHR CARTILAGE, V19, P822, DOI 10.1016/j.joca.2011.03.006; [Anonymous], 984083 NAT HEART LUN; Arokoski JPA, 2000, SCAND J MED SCI SPOR, V10, P186, DOI 10.1034/j.1600-0838.2000.010004186.x; BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191; Bandura A., 1997, SELF EFFICACY EXERCI, P36, DOI 10.1007/SpringerReference_223312; BELLAMY N, 1988, J RHEUMATOL, V15, P1833; Bellamy N, 1988, J ORTHOP RHEUMATOL, V1, P95; Bliddal H, 2011, ANN RHEUM DIS, V70, P1798, DOI 10.1136/ard.2010.142018; Brandt KD, 2009, MED CLIN N AM, V93, P1, DOI 10.1016/j.mcna.2008.08.009; Centers for Disease Control and Prevention (CDC), 2010, MMWR Morb Mortal Wkly Rep, V59, P1261; Chomentowski P, 2009, J GERONTOL A-BIOL, V64, P575, DOI 10.1093/gerona/glp007; Dechartres A, 2011, ANN INTERN MED, V155, P39, DOI 10.7326/0003-4819-155-1-201107050-00006; DeVita P, 2001, J APPL BIOMECH, V17, P297, DOI 10.1123/jab.17.4.297; Dishman RK, 2006, OBESITY, V14, P345, DOI 10.1038/oby.2006.46; Dougados M, 2000, OSTEOARTHR CARTILAGE, V8, P395, DOI 10.1053/joca.2000.0361; Enright PL, 1998, AM J RESP CRIT CARE, V158, P1384, DOI 10.1164/ajrccm.158.5.9710086; Esposito K, 2003, JAMA-J AM MED ASSOC, V289, P1799, DOI 10.1001/jama.289.14.1799; Esposito K, 2004, JAMA-J AM MED ASSOC, V292, P1440, DOI 10.1001/jama.292.12.1440; Ettinger WH, 1997, JAMA-J AM MED ASSOC, V277, P25, DOI 10.1001/jama.277.1.25; Farrar JT, 2000, PAIN, V88, P287, DOI 10.1016/S0304-3959(00)00339-0; FELSON DT, 1988, ANN INTERN MED, V109, P18, DOI 10.7326/0003-4819-109-1-18; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fregly BJ, 2012, J ORTHOP RES, V30, P503, DOI 10.1002/jor.22023; Griffin TM, 2005, EXERC SPORT SCI REV, V33, P195, DOI 10.1097/00003677-200510000-00008; Guilak F, 2004, CLIN ORTHOP RELAT R, P17, DOI 10.1097/01.blo.0000131233.83640.91; GUILAK F, 1997, BASIC ORTHOPAEDIC BI; HIMANN JE, 1988, MED SCI SPORT EXER, V20, P161, DOI 10.1249/00005768-198820020-00010; Hunter DJ, 2009, MED CLIN N AM, V93, P83, DOI 10.1016/j.mcna.2008.08.008; Institute of Medicine, DIET REF INT EN CARB; KELLGREN JH, 1957, ANN RHEUM DIS, V16, P494, DOI 10.1136/ard.16.4.494; Lawrence RC, 2008, ARTHRITIS RHEUM, V58, P26, DOI 10.1002/art.23176; Leung YY, 2011, J RHEUMATOL, V38, P2077, DOI 10.3899/jrheum.101256; Lin YC, 2010, J BIOMECH, V43, P945, DOI 10.1016/j.jbiomech.2009.10.048; Livshits G, 2009, ARTHRITIS RHEUM-US, V60, P2037, DOI 10.1002/art.24598; Loeser RF, 2012, ARTHRITIS RHEUM-US, V64, P1697, DOI 10.1002/art.34453; McAlindon T, 2013, JAMA-J AM MED ASSOC, V309, P155, DOI 10.1001/jama.2012.164487; Messier SP, 2011, OSTEOARTHR CARTILAGE, V19, P272, DOI 10.1016/j.joca.2010.11.010; Messier SP, 2004, ARTHRITIS RHEUM-US, V50, P1501, DOI 10.1002/art.20256; Messier SP, 2005, ARTHRITIS RHEUM, V52, P2026, DOI 10.1002/art.21139; Messier SP, 2008, MED SCI SPORT EXER, V40, P1873, DOI 10.1249/MSS.0b013e31817ed272; Messier SP, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-208; Messier SP, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-93; Moseley JB, 2002, NEW ENGL J MED, V347, P81, DOI 10.1056/NEJMoa013259; Nicklas BJ, 2004, AM J CLIN NUTR, V79, P544; Otterness IG, 2000, OSTEOARTHR CARTILAGE, V8, P180, DOI 10.1053/joca.1999.0288; Penninx BWJH, 2001, ARCH INTERN MED, V161, P2309, DOI 10.1001/archinte.161.19.2309; Scheef L, 2012, PAIN, V153, P1702, DOI 10.1016/j.pain.2012.05.008; Turk DC, 2011, LANCET, V377, P2226, DOI 10.1016/S0140-6736(11)60402-9; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Winby CR, 2009, J BIOMECH, V42, P2294, DOI 10.1016/j.jbiomech.2009.06.019; Zhang W, 2008, OSTEOARTHR CARTILAGE, V16, P137, DOI 10.1016/j.joca.2007.12.013	51	464	477	7	110	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 25	2013	310	12					1263	1273		10.1001/jama.2013.277669	http://dx.doi.org/10.1001/jama.2013.277669			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	222SO	24065013	Green Accepted, Green Submitted			2022-12-28	WOS:000324751800023
J	Kim, T; Vidal, GS; Djurisic, M; William, CM; Birnbaum, ME; Garcia, KC; Hyman, BT; Shatz, CJ				Kim, Taeho; Vidal, George S.; Djurisic, Maja; William, Christopher M.; Birnbaum, Michael E.; Garcia, K. Christopher; Hyman, Bradley T.; Shatz, Carla J.			Human LilrB2 Is a beta-Amyloid Receptor and Its Murine Homolog PirB Regulates Synaptic Plasticity in an Alzheimer's Model	SCIENCE			English	Article							OCULAR-DOMINANCE PLASTICITY; PRION PROTEIN; MOUSE MODEL; MYELIN; DEPRESSION; COFILIN; DISEASE; DEPRIVATION; INHIBITION; IMPAIRMENT	Soluble beta-amyloid (A beta) oligomers impair synaptic plasticity and cause synaptic loss associated with Alzheimer's disease (AD). We report that murine PirB (paired immunoglobulin-like receptor B) and its human ortholog LilrB2 (leukocyte immunoglobulin-like receptor B2), present in human brain, are receptors for A beta oligomers, with nanomolar affinity. The first two extracellular immunoglobulin (Ig) domains of PirB and LilrB2 mediate this interaction, leading to enhanced cofilin signaling, also seen in human AD brains. In mice, the deleterious effect of A beta oligomers on hippocampal long-term potentiation required PirB, and in a transgenic model of AD, PirB not only contributed to memory deficits present in adult mice, but also mediated loss of synaptic plasticity in juvenile visual cortex. These findings imply that LilrB2 contributes to human AD neuropathology and suggest therapeutic uses of blocking LilrB2 function.	[Kim, Taeho; Vidal, George S.; Djurisic, Maja; Shatz, Carla J.] Stanford Univ, James H Clark Ctr, Dept Biol & Neurobiol, Stanford, CA 94305 USA; [Kim, Taeho; Vidal, George S.; Djurisic, Maja; Shatz, Carla J.] Stanford Univ, James H Clark Ctr, Dept BioX, Stanford, CA 94305 USA; [William, Christopher M.; Hyman, Bradley T.] Massachusetts Gen Hosp, Neuropathol Serv, Charlestown, MA 02129 USA; [Birnbaum, Michael E.; Garcia, K. Christopher] Stanford Univ, Sch Med, Howard Hughes Med Inst, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Birnbaum, Michael E.; Garcia, K. Christopher] Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA	Stanford University; Stanford University; Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; Stanford University; Stanford University	Kim, T (corresponding author), Stanford Univ, James H Clark Ctr, Dept Biol & Neurobiol, Stanford, CA 94305 USA.	tkim808@stanford.edu; cshatz@stanford.edu		Vidal, George/0000-0002-8623-7476; Birnbaum, Michael/0000-0002-2281-3518; William, Christopher/0000-0001-8933-1639	NIH [NS069375, EY02858, 5T32EY020485, K08NS069811, 5R01AG041507]; G. Harold and Leila Y. Mathers Charitable Foundation; Ellison Medical Foundation; Regina Casper Stanford Graduate Fellowship; Alzheimer Disease Research Center (NIH) [5P50AG005134]; NSF; HHMI; NATIONAL EYE INSTITUTE [R01EY002858, T32EY020485, R37EY002858] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH071666, T32MH020016] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS069375, K08NS069811] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG041507, P50AG005134] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); G. Harold and Leila Y. Mathers Charitable Foundation; Ellison Medical Foundation(Lawrence Ellison Foundation); Regina Casper Stanford Graduate Fellowship; Alzheimer Disease Research Center (NIH); NSF(National Science Foundation (NSF)); HHMI(Howard Hughes Medical Institute); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank the Human Brain and Spinal Fluid Resource Center for providing human brain specimens; P. Kemper, C. Chechelski, and N. Sotelo-Kury for assistance with mouse husbandry; M. Stern for technical assistance; and C. Cepko (Harvard) for providing the pCAGIG vector. We also thank M. Frosch (MGH/Harvard) and M. Shamloo (Stanford Behavioral and Functional Neuroscience Laboratory, NIH grant NS069375) for helpful suggestions and advice. Supported by NIH grant EY02858 (C.J.S.), the G. Harold and Leila Y. Mathers Charitable Foundation (C.J.S.), the Ellison Medical Foundation (C.J.S.), NIH grant 5T32EY020485 (T.K.), a Regina Casper Stanford Graduate Fellowship (G.S.V.), NIH grant K08NS069811 (C.M.W.), NIH grant 5R01AG041507 (B.T.H.), an Alzheimer Disease Research Center pilot grant (NIH grant 5P50AG005134 to C.M.W.), NSF predoctoral fellowship (M.E.B.), and HHMI (K.C.G.). B.T.H. is on the Scientific Advisory Board of Neurophage and is a consultant and collaborator with Takeda Pharmaceutical Company, Bristol Meyer Squibb, Acumen, AZTherapeutics, Siemens, Sanofi, Neotope, and Fidelity Biosciences, none of which were involved in this study. C.J.S. and T.K. are inventors on a patent application assigned to the Board of Trustees of the Leland Stanford Junior University on methods and compositions for inhibiting the effects of beta-amyloid oligomers (U.S. provisional application no. 61/777,835).	Adelson JD, 2012, NEURON, V73, P1100, DOI 10.1016/j.neuron.2012.01.020; Atwal JK, 2008, SCIENCE, V322, P967, DOI 10.1126/science.1161151; Cisse M, 2011, NATURE, V469, P47, DOI 10.1038/nature09635; Crozier RA, 2007, P NATL ACAD SCI USA, V104, P1383, DOI 10.1073/pnas.0609596104; Faizi M, 2012, BRAIN BEHAV, V2, P142, DOI 10.1002/brb3.41; Fujita Y, 2011, EMBO J, V30, P1389, DOI 10.1038/emboj.2011.55; Garcia-Alloza M, 2006, NEUROBIOL DIS, V24, P516, DOI 10.1016/j.nbd.2006.08.017; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; Jankowsky JL, 2004, HUM MOL GENET, V13, P159, DOI 10.1093/hmg/ddh019; Kam TI, 2013, J CLIN INVEST, V123, P2791, DOI 10.1172/JCI66827; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Kessels HW, 2010, NATURE, V466, pE3, DOI 10.1038/nature09217; Knafo S, 2009, CEREB CORTEX, V19, P586, DOI 10.1093/cercor/bhn111; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Li SM, 2009, NEURON, V62, P788, DOI 10.1016/j.neuron.2009.05.012; Lindhagen-Persson M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013928; Ma G, 2011, IMMUNITY, V34, P385, DOI 10.1016/j.immuni.2011.02.004; McClean PL, 2011, J NEUROSCI, V31, P6587, DOI 10.1523/JNEUROSCI.0529-11.2011; McGee AW, 2005, SCIENCE, V309, P2222, DOI 10.1126/science.1114362; Meberg PJ, 1998, CELL MOTIL CYTOSKEL, V39, P172, DOI 10.1002/(SICI)1097-0169(1998)39:2<172::AID-CM8>3.0.CO;2-8; Oleinik NV, 2010, ONCOGENE, V29, P6233, DOI 10.1038/onc.2010.356; Palop JJ, 2010, NAT NEUROSCI, V13, P812, DOI 10.1038/nn.2583; Perez-Cruz C, 2011, J NEUROSCI, V31, P3926, DOI 10.1523/JNEUROSCI.6142-10.2011; Raiker SJ, 2010, J NEUROSCI, V30, P12432, DOI 10.1523/JNEUROSCI.0895-10.2010; Rust MB, 2010, EMBO J, V29, P1889, DOI 10.1038/emboj.2010.72; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Sheng M, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005777; Smith GB, 2009, PHILOS T R SOC B, V364, P357, DOI 10.1098/rstb.2008.0198; Starkey HDV, 2012, J MOL NEUROSCI, V48, P111, DOI 10.1007/s12031-012-9783-8; Syken J, 2006, SCIENCE, V313, P1795, DOI 10.1126/science.1128232; Takai T, 2005, IMMUNOLOGY, V115, P433, DOI 10.1111/j.1365-2567.2005.02177.x; Um JW, 2012, NAT NEUROSCI, V15, P1227, DOI 10.1038/nn.3178; Wang XN, 2012, J ALZHEIMERS DIS, V30, P665, DOI 10.3233/JAD-2012-101869; William CM, 2012, J NEUROSCI, V32, P8004, DOI 10.1523/JNEUROSCI.5369-11.2012; Wu HY, 2010, J NEUROSCI, V30, P2636, DOI 10.1523/JNEUROSCI.4456-09.2010; Wu J, 2011, CELL, V147, P615, DOI 10.1016/j.cell.2011.09.036; Zheng JK, 2012, NATURE, V485, P656, DOI 10.1038/nature11095	39	269	286	2	121	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 20	2013	341	6152					1399	1404		10.1126/science.1242077	http://dx.doi.org/10.1126/science.1242077			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	220PK	24052308	Green Accepted			2022-12-28	WOS:000324597200048
J	Holmes, KJ				Holmes, K. John			Pushing the climate frontier	NATURE			English	Editorial Material									US Natl Res Council, Board Energy & Environm Syst, Washington, DC USA	National Academies of Sciences, Engineering & Medicine	Holmes, KJ (corresponding author), US Natl Res Council, Board Energy & Environm Syst, Washington, DC USA.	jholmes@nas.edu						Gilpin W, 1860, CENTRAL GOLD REGION; Holmes KJ, 2001, ENVIRON MANAGE, V27, P177, DOI 10.1007/s002670010142; Powell John Wesley, 1890, CENTURY, V40, P111; Powell JW., 1878, MAP UTAH TERRITORY R; United States Army Corps of Engineers, 1897, PREL EX RES SIT WYOM; USGS, 1891, 12 USGS 2; USGS, 1902, 23 USGS; Van Hise CR, 1910, CONSERVATION NATURAL; Warrick R.A., 1980, CLIMATIC CONSTRAINTS	9	1	1	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 19	2013	501	7467					310	311		10.1038/501310a	http://dx.doi.org/10.1038/501310a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	219XT	24058935	Bronze			2022-12-28	WOS:000324545700015
J	Orme, R; Hill, C; Allahabadia, A; Harrison, B; Grech, E				Orme, Rachel; Hill, Catherine; Allahabadia, Amit; Harrison, Barney; Grech, Ever			An unusual cause of breathlessness	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							THYROID-SURGERY; COMPLICATIONS; RISK		[Orme, Rachel; Hill, Catherine; Allahabadia, Amit; Harrison, Barney; Grech, Ever] No Gen Hosp, South Yorkshire Cardiothorac Ctr, Sheffield S5 7AU, S Yorkshire, England	Northern General Hospital	Grech, E (corresponding author), No Gen Hosp, South Yorkshire Cardiothorac Ctr, Sheffield S5 7AU, S Yorkshire, England.	ever.grech@sth.nhs.uk						Bergenfelz A, 2008, LANGENBECK ARCH SURG, V393, P667, DOI 10.1007/s00423-008-0366-7; Burkey SH, 2001, SURGERY, V130, P914, DOI 10.1067/msy.2001.118384; Godballe C, 2009, EUR ARCH OTO-RHINO-L, V266, P1945, DOI 10.1007/s00405-009-0949-0; Greenblatt DY, 2009, WORLD J SURG, V33, P255, DOI 10.1007/s00268-008-9837-9; Hardy RG, 2009, ANN ROY COLL SURG, V91, P8, DOI 10.1308/003588409X359196; Landry CS, 2012, ARCH SURG-CHICAGO, V147, P338, DOI 10.1001/archsurg.2011.1406; Leyre P, 2008, LANGENBECK ARCH SURG, V393, P733, DOI 10.1007/s00423-008-0362-y; Reeve T, 2000, WORLD J SURG, V24, P971, DOI 10.1007/s002680010160; WINGERT DJ, 1986, AM J SURG, V152, P606, DOI 10.1016/0002-9610(86)90435-6; Zakaria Hazem M, 2011, Oman Med J, V26, P34, DOI 10.5001/omj.2011.09	10	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 19	2013	347								f5318	10.1136/bmj.f5318	http://dx.doi.org/10.1136/bmj.f5318			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	223SY	24052581				2022-12-28	WOS:000324831500002
J	Solberg, K				Solberg, Kristin			Jonas Gahr Store: health as a collective responsibility	LANCET			English	Biographical-Item																			0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 29	2014	383	9923					E15	E15		10.1016/S0140-6736(13)61867-X	http://dx.doi.org/10.1016/S0140-6736(13)61867-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE4MH	24075362				2022-12-28	WOS:000333956000001
J	Adolph, TE; Tomczak, MF; Niederreiter, L; Ko, HJ; Bock, J; Martinez-Naves, E; Glickman, JN; Tschurtschenthaler, M; Hartwig, J; Hosomi, S; Flak, MB; Cusick, JL; Kohno, K; Iwawaki, T; Billmann-Born, S; Raine, T; Bharti, R; Lucius, R; Kweon, MN; Marciniak, SJ; Choi, A; Hagen, SJ; Schreiber, S; Rosenstiel, P; Kaser, A; Blumberg, RS				Adolph, Timon E.; Tomczak, Michal F.; Niederreiter, Lukas; Ko, Hyun-Jeong; Boeck, Janne; Martinez-Naves, Eduardo; Glickman, Jonathan N.; Tschurtschenthaler, Markus; Hartwig, John; Hosomi, Shuhei; Flak, Magdalena B.; Cusick, Jennifer L.; Kohno, Kenji; Iwawaki, Takao; Billmann-Born, Susanne; Raine, Tim; Bharti, Richa; Lucius, Ralph; Kweon, Mi-Na; Marciniak, Stefan J.; Choi, Augustine; Hagen, Susan J.; Schreiber, Stefan; Rosenstiel, Philip; Kaser, Arthur; Blumberg, Richard S.			Paneth cells as a site of origin for intestinal inflammation	NATURE			English	Article							ENDOPLASMIC-RETICULUM STRESS; GENOME-WIDE ASSOCIATION; FACTOR-KAPPA-B; ER STRESS; SUSCEPTIBILITY LOCI; EPITHELIAL-CELLS; CROHN-DISEASE; GENE ATG16L1; AUTOPHAGY; ACTIVATION	The recognition of autophagy related 16-like 1 (ATG16L1) as a genetic risk factor has exposed the critical role of autophagy in Crohn's disease(1). Homozygosity for the highly prevalent ATG16L1 risk allele, or murine hypomorphic (HM) activity, causes Paneth cell dysfunction(2,3). As Atg16l1(HM) mice do not develop spontaneous intestinal inflammation, the mechanism(s) by which ATG16L1 contributes to disease remains obscure. Deletion of the unfolded protein response (UPR) transcription factor X-box binding protein-1 (Xbp1) in intestinal epithelial cells, the human orthologue of which harbours rare inflammatory bowel disease risk variants, results in endoplasmic reticulum (ER) stress, Paneth cell impairment and spontaneous enteritis4. Unresolved ER stress is a common feature of inflammatory bowel disease epithelium(4,5), and several genetic risk factors of Crohn's disease affect Paneth cells(2,4,6-9). Here we show that impairment in either UPR (Xbp1(Delta IEC)) or autophagy function (Atg16l1(Delta IEC) or Atg7(Delta IEC)) in intestinal epithelial cells results in each other's compensatory engagement, and severe spontaneous Crohn's-disease-like transmural ileitis if both mechanisms are compromised. Xbp1DIEC mice show autophagosome formation in hypomorphic Paneth cells, which is linked to ER stress via protein kinase RNA-like endoplasmic reticulum kinase (PERK), elongation initiation factor 2 alpha (eIF2 alpha) and activating transcription factor 4 (ATF4). Ileitis is dependent on commensal microbiota and derives from increased intestinal epithelial cell death, inositol requiring enzyme 1 alpha (IRE1 alpha)-regulated NF-kappa B activation and tumour-necrosis factor signalling, which are synergistically increased when autophagy is deficient. ATG16L1 restrains IRE1a activity, and augmentation of autophagy in intestinal epithelial cells ameliorates ER stress-induced intestinal inflammation and eases NF-kappa B overactivation and intestinal epithelial cell death. ER stress, autophagy induction and spontaneous ileitis emerge from Paneth-cell-specific deletion of Xbp1. Genetically and environmentally controlled UPR function within Paneth cells may therefore set the threshold for the development of intestinal inflammation upon hypomorphic ATG16L1 function and implicate ileal Crohn's disease as a specific disorder of Paneth cells.	[Adolph, Timon E.; Niederreiter, Lukas; Tschurtschenthaler, Markus; Raine, Tim; Kaser, Arthur] Univ Cambridge, Addenbrookes Hosp, Dept Med, Div Gastroenterol & Hepatol, Cambridge CB2 0QQ, England; [Tomczak, Michal F.; Ko, Hyun-Jeong; Hosomi, Shuhei; Flak, Magdalena B.; Cusick, Jennifer L.; Blumberg, Richard S.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Gastroenterol,Dept Med, Boston, MA 02115 USA; [Boeck, Janne; Billmann-Born, Susanne; Bharti, Richa; Schreiber, Stefan; Rosenstiel, Philip] Univ Kiel, Inst Clin Mol Biol, D-24105 Kiel, Germany; [Martinez-Naves, Eduardo] Univ Complutense Madrid, Fac Med, Dept Microbiol & Immunol, E-28040 Madrid, Spain; [Glickman, Jonathan N.] Miraca Life Sci, GI Pathol Div, Newton, MA 02464 USA; [Tschurtschenthaler, Markus] Med Univ Innsbruck, Dept Med, A-6020 Innsbruck, Austria; [Hartwig, John] Harvard Univ, Brigham & Womens Hosp, Sch Med, Translat Med Div,Dept Med, Boston, MA 02115 USA; [Kohno, Kenji] Nara Inst Sci & Technol NAIST, Grad Sch Biol Sci, Lab Mol & Cell Genet, Nara 6300192, Japan; [Iwawaki, Takao] Gunma Univ, Adv Sci Res Leaders Dev Unit, Maebashi, Gunma 3718511, Japan; [Iwawaki, Takao] RIKEN, Adv Sci Inst, Iwawaki Initiat Res Unit, Wako, Saitama 3510198, Japan; [Lucius, Ralph] Univ Kiel, Anat Inst, D-24098 Kiel, Germany; [Kweon, Mi-Na] Int Vaccine Inst, Div Sci Lab, Mucosal Immunol Sect, Seoul 151818, South Korea; [Marciniak, Stefan J.] Univ Cambridge, Dept Med, Cambridge Inst Med Res CIMR, Cambridge CB2 0XY, England; [Choi, Augustine] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Pulm & Crit Care Med,Dept Med, Boston, MA 02115 USA; [Hagen, Susan J.] Beth Israel Deaconess Med Ctr, Dept Surg, Boston, MA 02215 USA	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Kiel; Complutense University of Madrid; Medical University of Innsbruck; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Nara Institute of Science & Technology; Gunma University; RIKEN; University of Kiel; International Vaccine Institute; University of Cambridge; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center	Blumberg, RS (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Gastroenterol,Dept Med, 75 Francis St, Boston, MA 02115 USA.	ak729@cam.ac.uk; rblumberg@partners.org	Parry, Lee/A-9623-2011; Lucius, Ralph/B-1614-2010; MARTINEZ-NAVES, EDUARDO/Y-6177-2019; Flak, Magdalena/AAG-5272-2020; Flak, Magdalena B/M-7106-2016; Kohno, Kenji/AAZ-6573-2020; Rosenstiel, Philip/A-5137-2009; Tschurtschenthaler, Markus/O-8931-2019	Parry, Lee/0000-0002-4467-9196; Flak, Magdalena/0000-0002-8238-9835; Flak, Magdalena B/0000-0002-8238-9835; Kohno, Kenji/0000-0002-3503-6551; Rosenstiel, Philip/0000-0002-9692-8828; Tschurtschenthaler, Markus/0000-0002-0060-4790; MARTINEZ-NAVES, EDUARDO/0000-0001-8136-9042; Iwawaki, Takao/0000-0001-8753-1979; Raine, Tim/0000-0002-5855-9873; Marciniak, Stefan/0000-0001-8472-7183; Glickman, Jonathan/0000-0003-0910-2655	NIH [DK044319, DK051362, DK053056, DK088199]; Harvard Digestive Diseases Center (HDDC) [DK0034854]; European Research Council under the European Community/ERC [260961]; National Institute for Health Research Cambridge Biomedical Research Centre; Austrian Science Fund; Ministry of Science [P21530-B18, START Y446-B18]; Addenbrooke's Charitable Trust; BMBF NGFN Animal Model grant; DFG Cluster of Excellence Inflammation at Interfaces; EU; Hans-Dietrich Bruhn Memorial Foundation; DFG [RO2994/5-1, SFB 877]; Inflammatory Bowel Disease Working Group; Crohn's and Colitis Foundation of America; European Crohn's and Colitis Organization; Crohn's in Childhood Research Association; National Research Foundation of Korea; Korean government [KRF-2008-357-E00022, 2011-0009018]; Grants-in-Aid for Scientific Research [24390049] Funding Source: KAKEN; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK044319, R56DK053056, P30DK034854, R01DK051362, R01DK053056, R37DK044319, R01DK088199] Funding Source: NIH RePORTER; Austrian Science Fund (FWF) [P 21530] Funding Source: researchfish; Medical Research Council [G0601840, G1002610] Funding Source: researchfish; MRC [G0601840, G1002610] Funding Source: UKRI	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Digestive Diseases Center (HDDC); European Research Council under the European Community/ERC(European Research Council (ERC)); National Institute for Health Research Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); Austrian Science Fund(Austrian Science Fund (FWF)); Ministry of Science(Ministry of Science, ICT & Future Planning, Republic of Korea); Addenbrooke's Charitable Trust; BMBF NGFN Animal Model grant(Federal Ministry of Education & Research (BMBF)); DFG Cluster of Excellence Inflammation at Interfaces(German Research Foundation (DFG)); EU(European Commission); Hans-Dietrich Bruhn Memorial Foundation; DFG(German Research Foundation (DFG)); Inflammatory Bowel Disease Working Group; Crohn's and Colitis Foundation of America; European Crohn's and Colitis Organization; Crohn's in Childhood Research Association; National Research Foundation of Korea(National Research Foundation of Korea); Korean government(Korean Government); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank L. Glimcher, A. Goldberg, J. Yuan, M. Parkes, A. Franke, H. Tilg, M. Pasparakis, K. Vlantis, A.-H. Lee and C. L. Bevins for discussion of the project, are grateful to J. Gordon, L. Hooper and K. Rajewsky for providing critical reagents, and thank O. Will for initial handling of the Atg16l1 colony and help with DSS colitis. A. Kaser began work for this study at the Department of Internal Medicine II, Innsbruck Medical University, A-6020 Innsbruck, Austria. This work was supported by NIH grants DK044319, DK051362, DK053056, DK088199, the Harvard Digestive Diseases Center (HDDC) (DK0034854) (R. S. B.); the European Research Council under the European Community's Seventh Framework Programme (FP7/2007-2013)/ERC Grant agreement no. 260961 (A. K.); the National Institute for Health Research Cambridge Biomedical Research Centre (A. K.); the Austrian Science Fund and Ministry of Science P21530-B18 and START Y446-B18 (A. K.); the Addenbrooke's Charitable Trust (A. K. and L.N.); BMBF NGFN Animal Model grant (P. R.), the DFG Cluster of Excellence Inflammation at Interfaces (S. S. and P. R.); EU SysmedIBD grant (P. R), the Hans-Dietrich Bruhn Memorial Foundation (R. B.); DFG grants RO2994/5-1 (P. R.) and SFB 877 project B9 (P. R. and S. S.); fellowships from Inflammatory Bowel Disease Working Group (M. F. T.), Crohn's and Colitis Foundation of America (M. B. F.), European Crohn's and Colitis Organization (T. E. A.), Crohn's in Childhood Research Association (A. K. and L.N.), National Research Foundation of Korea funded by the Korean government KRF-2008-357-E00022 no. 2011-0009018 (H. -J.K.).	Baert L, 2008, APPL ENVIRON MICROB, V74, P543, DOI 10.1128/AEM.01039-07; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Bertolotti A, 2001, J CLIN INVEST, V107, P585, DOI 10.1172/JCI11476; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; BRY L, 1994, P NATL ACAD SCI USA, V91, P10335, DOI 10.1073/pnas.91.22.10335; Cadwell K, 2008, NATURE, V456, P259, DOI 10.1038/nature07416; Cadwell K, 2010, CELL, V141, P1135, DOI 10.1016/j.cell.2010.05.009; Cao SS, 2013, GASTROENTEROLOGY, V144, P989, DOI 10.1053/j.gastro.2013.01.023; Carchman EH, 2011, HEPATOLOGY, V53, P2053, DOI 10.1002/hep.24324; Cleynen I., 2012, GUT; Deuring J. J., 2013, GUT; Fujita N, 2008, MOL BIOL CELL, V19, P2092, DOI 10.1091/mbc.E07-12-1257; Fujita N, 2009, J BIOL CHEM, V284, P32602, DOI 10.1074/jbc.M109.037671; Garabedian EM, 1997, J BIOL CHEM, V272, P23729, DOI 10.1074/jbc.272.38.23729; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Hempel SL, 1999, FREE RADICAL BIO MED, V27, P146, DOI 10.1016/S0891-5849(99)00061-1; Hu P, 2006, MOL CELL BIOL, V26, P3071, DOI 10.1128/MCB.26.8.3071-3084.2006; Iwawaki T, 2009, P NATL ACAD SCI USA, V106, P16657, DOI 10.1073/pnas.0903775106; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kaneko M, 2003, BIOL PHARM BULL, V26, P931, DOI 10.1248/bpb.26.931; Kaser A, 2008, CELL, V134, P743, DOI 10.1016/j.cell.2008.07.021; Kaser A, 2010, ANNU REV IMMUNOL, V28, P573, DOI 10.1146/annurev-immunol-030409-101225; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Kuballa P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003391; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Madison BB, 2002, J BIOL CHEM, V277, P33275, DOI 10.1074/jbc.M204935200; Maloy KJ, 2011, NATURE, V474, P298, DOI 10.1038/nature10208; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Mizushima N, 2003, J CELL SCI, V116, P1679, DOI 10.1242/jcs.00381; Novoa I, 2003, EMBO J, V22, P1180, DOI 10.1093/emboj/cdg112; Parkes M, 2007, NAT GENET, V39, P830, DOI 10.1038/ng2061; Pierce JW, 1997, J BIOL CHEM, V272, P21096, DOI 10.1074/jbc.272.34.21096; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Rogler G, 1998, GASTROENTEROLOGY, V115, P357, DOI 10.1016/S0016-5085(98)70202-1; Rouschop KMA, 2010, J CLIN INVEST, V120, P127, DOI 10.1172/JCI40027; Sarkar S, 2009, METHOD ENZYMOL, V453, P83, DOI 10.1016/S0076-6879(08)04005-6; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; SATOH Y, 1990, J ELECTRON MICR TECH, V16, P69, DOI 10.1002/jemt.1060160109; Shimshek DR, 2002, GENESIS, V32, P19, DOI 10.1002/gene.10023; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Tashiro E, 2007, J ANTIBIOT, V60, P547, DOI 10.1038/ja.2007.69; Treton X, 2011, GASTROENTEROLOGY, V141, P1024, DOI 10.1053/j.gastro.2011.05.033; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Vaishnava S, 2008, P NATL ACAD SCI USA, V105, P20858, DOI 10.1073/pnas.0808723105; VIDAL K, 1993, J IMMUNOL METHODS, V166, P63, DOI 10.1016/0022-1759(93)90329-6; Wehkamp J, 2005, P NATL ACAD SCI USA, V102, P18129, DOI 10.1073/pnas.0505256102; Wei YJ, 2008, AUTOPHAGY, V4, P949, DOI 10.4161/auto.6788; Yang L, 2010, CELL METAB, V11, P467, DOI 10.1016/j.cmet.2010.04.005; Zhao F, 2010, DEV BIOL, V338, P268, DOI 10.1016/j.ydbio.2009.12.008	50	465	487	8	130	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 14	2013	503	7475					272	+		10.1038/nature12599	http://dx.doi.org/10.1038/nature12599			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	250YX	24089213	Green Accepted, Green Submitted			2022-12-28	WOS:000326894200053
J	Puthucheary, ZA; Rawal, J; McPhail, M; Connolly, B; Ratnayake, G; Chan, P; Hopkinson, NS; Padhke, R; Dew, T; Sidhu, PS; Velloso, C; Seymour, J; Agley, CC; Selby, A; Limb, M; Edwards, LM; Smith, K; Rowlerson, A; Rennie, MJ; Moxham, J; Harridge, SDR; Hart, N; Montgomery, HE				Puthucheary, Zudin A.; Rawal, Jaikitry; McPhail, Mark; Connolly, Bronwen; Ratnayake, Gamunu; Chan, Pearl; Hopkinson, Nicholas S.; Padhke, Rahul; Dew, Tracy; Sidhu, Paul S.; Velloso, Cristiana; Seymour, John; Agley, Chibeza C.; Selby, Anna; Limb, Marie; Edwards, Lindsay M.; Smith, Kenneth; Rowlerson, Anthea; Rennie, Michael John; Moxham, John; Harridge, Stephen D. R.; Hart, Nicholas; Montgomery, Hugh E.			Acute Skeletal Muscle Wasting in Critical Illness	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INTENSIVE-CARE-UNIT; ACUTE LUNG INJURY; EDEN RANDOMIZED-TRIAL; ILL PATIENTS; PROTEIN-SYNTHESIS; FUNCTIONAL DISABILITY; PARENTERAL-NUTRITION; FOLLOW-UP; DISEASE; TURNOVER	IMPORTANCE Survivors of critical illness demonstrate skeletal muscle wasting with associated functional impairment. OBJECTIVE To perform a comprehensive prospective characterization of skeletal muscle wasting, defining the pathogenic roles of altered protein synthesis and breakdown. DESIGN, SETTING, AND PARTICIPANTS Sixty-three critically ill patients (59% male; mean age: 54.7 years [95% CI, 50.0-59.6 years]) with an Acute Physiology and Chronic Health Evaluation II score of 23.5 (95% CI, 21.9-25.2) were prospectively recruited within 24 hours following intensive care unit (ICU) admission from August 2009 to April 2011 at a university teaching and a community hospital in England. Patients were recruited if older than 18 years and were anticipated to be intubated for longer than 48 hours, to spend more than 7 days in critical care, and to survive ICU stay. MAIN OUTCOMES AND MEASURES Muscle loss was determined through serial ultrasound measurement of the rectus femoris cross-sectional area (CSA) on days 1, 3, 7, and 10. In a subset of patients, the fiber CSA area was quantified along with the ratio of protein to DNA on days 1 and 7. Histopathological analysis was performed. In addition, muscle protein synthesis, breakdown rates, and respective signaling pathways were characterized. RESULTS There were significant reductions in the rectus femoris CSA observed at day 10 (-17.7%[95% CI, -25.9% to 8.1%]; P < .001). In the 28 patients assessed by all 3 measurement methods on days 1 and 7, the rectus femoris CSA decreased by 10.3%(95% CI, 6.1% to 14.5%), the fiber CSA by 17.5%(95% CI, 5.8% to 29.3%), and the ratio of protein to DNA by 29.5%(95% CI, 13.4% to 45.6%). Decrease in the rectus femoris CSA was greater in patients who experienced multiorgan failure by day 7 (-15.7%; 95% CI, -27.7% to 11.4%) compared with single organ failure (-3.0%; 95% CI, -5.3% to 2.1%) (P < .001), even by day 3 (-8.7%[95% CI, -59.3% to 50.6%] vs -1.8%[95% CI, -12.3% to 10.5%], respectively; P = .03). Myofiber necrosis occurred in 20 of 37 patients (54.1%). Protein synthesis measured by the muscle protein fractional synthetic rate was depressed in patients on day 1 (0.035%/hour; 95% CI, 0.023% to 0.047%/hour) compared with rates observed in fasted healthy controls (0.039%/hour; 95% CI, 0.029% to 0.048%/hour) (P = .57) and increased by day 7 (0.076%[95% CI, 0.032%-0.120%/hour]; P = .03) to rates associated with fed controls (0.065%/hour [95% CI, 0.049% to 0.080%/hour]; P = .30), independent of nutritional load. Leg protein breakdown remained elevated throughout the study (8.5 [95% CI, 4.7 to 12.3] to 10.6 [95% CI, 6.8 to 14.4] mu mol of phenylalanine/min/ideal body weight x 100; P = .40). The pattern of intracellular signaling supported increased breakdown (n = 9, r = -0.83, P = .005) and decreased synthesis (n = 9, r = -0.69, P = .04). CONCLUSIONS AND RELEVANCE Among these critically ill patients, muscle wasting occurred early and rapidly during the first week of critical illness and was more severe among those with multiorgan failure compared with single organ failure. These findings may provide insights into skeletal muscle wasting in critical illness.	[Puthucheary, Zudin A.; Rawal, Jaikitry; Chan, Pearl; Montgomery, Hugh E.] UCL, Inst Hlth & Human Performance, London WC1E 6AU, England; [McPhail, Mark] Imperial Coll London St Marys Hosp NHS Trust, London, England; [Puthucheary, Zudin A.; Connolly, Bronwen; Ratnayake, Gamunu; Hart, Nicholas] Guys & St Thomas NHS Fdn Trust, Comprehens Biomed Res Ctr, London, England; [Puthucheary, Zudin A.; Connolly, Bronwen; Ratnayake, Gamunu; Hart, Nicholas] Kings Coll London, London, England; [Puthucheary, Zudin A.; Ratnayake, Gamunu; Velloso, Cristiana; Agley, Chibeza C.; Edwards, Lindsay M.; Rowlerson, Anthea; Harridge, Stephen D. R.] Kings Coll London, Ctr Human & Aerosp Physiol Sci, London, England; [Hopkinson, Nicholas S.] Univ London Imperial Coll Sci Technol & Med, Royal Brompton Hosp, London, England; [Padhke, Rahul] UCL, Dept Neurol, Natl Hosp Neurol & Neurosurg, London WC1E 6AU, England; [Puthucheary, Zudin A.; McPhail, Mark; Dew, Tracy; Sidhu, Paul S.; Seymour, John; Moxham, John] Kings Coll Hosp NHS Trust, London, England; [Selby, Anna; Limb, Marie; Smith, Kenneth; Rennie, Michael John] Univ Nottingham, Dept Clin Physiol, Nottingham NG7 2RD, England; [Puthucheary, Zudin A.; Connolly, Bronwen; Ratnayake, Gamunu; Hart, Nicholas] Guys & St Thomas NHS Fdn Trust, St Thomas Hosp, Lane Fox Clin Resp Physiol Res Unit, London, England; [Puthucheary, Zudin A.; Connolly, Bronwen; Ratnayake, Gamunu; Moxham, John; Hart, Nicholas] Kings Coll London, Div Asthma Allergy & Lung Biol, London, England	University of London; University College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of London; King's College London; Imperial College London; Royal Brompton Hospital; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; King's College Hospital NHS Foundation Trust; King's College Hospital; University of Nottingham; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Puthucheary, ZA (corresponding author), UCL, 74 Huntley St,Room 443, London WC1E 6AU, England.	zudin.puthucheary.09@ucl.ac.uk	Hart, Nicholas/O-7076-2015; Montgomery, Hugh/L-1229-2019; Chan, Pearl/HGU-0471-2022; Montgomery, Hugh/C-2592-2008	Hart, Nicholas/0000-0002-6863-585X; Montgomery, Hugh/0000-0001-8797-5019; Hopkinson, Nicholas/0000-0003-3235-0454; Selby, Anna/0000-0003-1098-5782; Smith, Ken/0000-0001-8971-6635; Harridge, Stephen/0000-0002-8203-0769; Puthucheary, Zudin/0000-0003-4267-1892; Sidhu, Paul/0000-0003-1928-4077	National Institute of Health Research (NIHR); Wellcome Trust UK; European Society of Intensive Care Medicine; NIHR Clinical Research Facility at Guy's and St Thomas' NHS Foundation Trust; NIHR Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust; King's College London; Whittington Hospital NHS Trust; MRC [MR/K00414X/1] Funding Source: UKRI; Medical Research Council [MR/K00414X/1] Funding Source: researchfish; National Institute for Health Research [DRF-2010-03-114, ACF-2010-17-001] Funding Source: researchfish	National Institute of Health Research (NIHR)(National Institute for Health Research (NIHR)); Wellcome Trust UK(Wellcome Trust); European Society of Intensive Care Medicine; NIHR Clinical Research Facility at Guy's and St Thomas' NHS Foundation Trust; NIHR Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust; King's College London; Whittington Hospital NHS Trust; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	Dr Puthucheary is funded by a doctorate fellowship from the National Institute of Health Research (NIHR). Dr McPhail received funding from Wellcome Trust UK as part of a postdoctoral training fellowship. Additional funding was received from the European Society of Intensive Care Medicine, the NIHR Clinical Research Facility at Guy's and St Thomas' NHS Foundation Trust and NIHR Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust and King's College London, and the Whittington Hospital NHS Trust.	Biolo G, 2002, J CLIN ENDOCR METAB, V87, P3378, DOI 10.1210/jc.87.7.3378; Bohe J, 2001, J PHYSIOL-LONDON, V532, P575, DOI 10.1111/j.1469-7793.2001.0575f.x; Casaer MP, 2011, NEW ENGL J MED, V365, P506, DOI 10.1056/NEJMoa1102662; Constantin D, 2011, J PHYSIOL-LONDON, V589, P3883, DOI 10.1113/jphysiol.2011.206193; deGodoy I, 1996, AM J RESP CRIT CARE, V153, P633, DOI 10.1164/ajrccm.153.2.8564110; DEVINE BJ, 1974, DRUG INTEL CLIN PHAR, V8, P650, DOI 10.1177/106002807400801104; DIETRICHSON P, 1987, J NEUROL NEUROSUR PS, V50, P1461, DOI 10.1136/jnnp.50.11.1461; Essen P, 1998, CRIT CARE MED, V26, P92, DOI 10.1097/00003246-199801000-00022; Gosker HR, 2003, EUR RESPIR J, V22, P280, DOI 10.1183/09031936.03.00012803; Hart N, 2013, AM J RESP CRIT CARE, V188, P523, DOI 10.1164/rccm.201306-1162ED; HAUPTMANN S, 1994, VIRCHOWS ARCH, V424, P653, DOI 10.1007/BF01069747; Heidegger CP, 2013, LANCET, V381, P385, DOI 10.1016/S0140-6736(12)61351-8; HELLIWELL TR, 1991, J PATHOL, V164, P307, DOI 10.1002/path.1711640406; Herridge MS, 2011, NEW ENGL J MED, V364, P1293, DOI 10.1056/NEJMoa1011802; Iwashyna TJ, 2010, JAMA-J AM MED ASSOC, V304, P1787, DOI 10.1001/jama.2010.1553; Klaude M, 2012, CLIN SCI, V122, P133, DOI 10.1042/CS20110233; Latronico N, 1996, LANCET, V347, P1579, DOI 10.1016/S0140-6736(96)91074-0; Lone NI, 2012, AM J RESP CRIT CARE, V186, P640, DOI 10.1164/rccm.201201-0059OC; National Institute for Health and Care Excellence, 2009, CRIT ILLN REH CG83; Needham DM, 2013, AM J RESP CRIT CARE, V188, P567, DOI 10.1164/rccm.201304-0651OC; Needham DM, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1532; Ochala J, 2011, J PHYSIOL-LONDON, V589, P2007, DOI 10.1113/jphysiol.2010.202044; Paddon-Jones D, 2006, J CLIN ENDOCR METAB, V91, P4836, DOI 10.1210/jc.2006-0651; Preedy VR, 2001, EUR J NEUROL, V8, P677, DOI 10.1046/j.1468-1331.2001.00303.x; Puthucheary Z, 2012, AM J RESP CRIT CARE, V185, P911, DOI 10.1164/rccm.201107-1320OE; RENNIE MJ, 1985, BRIT MED BULL, V41, P257, DOI 10.1093/oxfordjournals.bmb.a072060; Rice TW, 2012, JAMA-J AM MED ASSOC, V307, P795, DOI 10.1001/jama.2012.137; Sandri M, 2008, PHYSIOLOGY, V23, P160, DOI 10.1152/physiol.00041.2007; Seymour JM, 2010, EUR RESPIR J, V36, P81, DOI 10.1183/09031936.00104909; Seymour JM, 2009, THORAX, V64, P418, DOI 10.1136/thx.2008.103986; Stein A, 1997, KIDNEY INT, V52, P1089, DOI 10.1038/ki.1997.433; Vesali RF, 2010, CLIN SCI, V118, P421, DOI 10.1042/CS20090332; Vescovo G, 1996, HEART, V76, P337, DOI 10.1136/hrt.76.4.337; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/s001340050156; Weiss G, 2005, NEW ENGL J MED, V352, P1011, DOI 10.1056/NEJMra041809; Wilkes EA, 2009, AM J CLIN NUTR, V90, P1343, DOI 10.3945/ajcn.2009.27543; Williams JP, 2012, AM J CLIN NUTR, V96, P1064, DOI 10.3945/ajcn.112.045708	37	966	1028	2	49	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 16	2013	310	15					1591	1600		10.1001/jama.2013.278481	http://dx.doi.org/10.1001/jama.2013.278481			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	234EP	24108501	Green Submitted, Bronze			2022-12-28	WOS:000325624800022
J	Bernhardt, ES				Bernhardt, Emily S.			Cleaner Lakes Are Dirtier Lakes	SCIENCE			English	Editorial Material							NITROGEN REMOVAL; PHOSPHORUS		Duke Univ, Dept Biol, Durham, NC 27708 USA	Duke University	Bernhardt, ES (corresponding author), Duke Univ, Dept Biol, Durham, NC 27708 USA.	ebernhar@duke.edu	Bernhardt, Emily S/D-9940-2011; Bernhardt, Emily/B-4541-2010	Bernhardt, Emily S/0000-0003-3031-621X; 				Bruesewitz DA, 2011, ECOSYSTEMS, V14, P341, DOI 10.1007/s10021-011-9413-2; Carpenter SR, 1998, ECOL APPL, V8, P559, DOI 10.1890/1051-0761(1998)008[0559:NPOSWW]2.0.CO;2; Conley DJ, 2009, SCIENCE, V323, P1014, DOI 10.1126/science.1167755; Finlay JC, 2013, SCIENCE, V342, P247, DOI 10.1126/science.1242575; Harrison JA, 2009, BIOGEOCHEMISTRY, V93, P143, DOI 10.1007/s10533-008-9272-x; Hedin LO, 1996, SCI AM, V275, P88, DOI 10.1038/scientificamerican1296-88; JANSSON M, 1994, AMBIO, V23, P320; Jeppesen E, 2005, FRESHWATER BIOL, V50, P1747, DOI 10.1111/j.1365-2427.2005.01415.x; Klausmeier CA, 2004, NATURE, V429, P171, DOI 10.1038/nature02454; McCrackin ML, 2011, GLOBAL BIOGEOCHEM CY, V25, DOI 10.1029/2010GB003897; McCrackin ML, 2010, ECOLOGY, V91, P528, DOI 10.1890/08-2210.1; SMITH VH, 1983, SCIENCE, V221, P669, DOI 10.1126/science.221.4611.669; Wild M, 2005, SCIENCE, V308, P847, DOI 10.1126/science.1103215	13	39	46	13	159	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 11	2013	342	6155					205	206		10.1126/science.1245279	http://dx.doi.org/10.1126/science.1245279			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	232EV	24115431				2022-12-28	WOS:000325475200033
J	Finlay, JC; Small, GE; Sterner, RW				Finlay, Jacques C.; Small, Gaston E.; Sterner, Robert W.			Human Influences on Nitrogen Removal in Lakes	SCIENCE			English	Article							CYCLE; DENITRIFICATION; EUTROPHICATION; TRANSFORMATION; ECOSYSTEMS; RETENTION; WATERS	Human activities have increased the availability of reactive nitrogen in many ecosystems, leading to negative impacts on human health, biodiversity, and water quality. Freshwater ecosystems, including lakes, streams, and wetlands, are a large global sink for reactive nitrogen, but factors that determine the efficacy of freshwater nitrogen removal rates are poorly known. Using a global lake data set, we show that the availability of phosphorus, a limiting nutrient, affects both annual nitrogen removal rate and efficiency. This result indicates that increased phosphorus inputs from human activities have stimulated nitrogen removal processes in many lakes. Recent management-driven reductions in phosphorus availability promote water column accumulation and export of nitrogen from large lakes, an unintended consequence of single-element management that argues for greater control of nitrogen as well as phosphorus sources.	[Finlay, Jacques C.; Small, Gaston E.; Sterner, Robert W.] Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities	Finlay, JC (corresponding author), Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA.	jfinlay@umn.edu	Finlay, Jacques/B-6081-2011	Finlay, Jacques/0000-0002-7968-7030; Sterner, Robert/0000-0003-2292-6122	NSF [OCE-0927512]; Directorate For Geosciences [0927512] Funding Source: National Science Foundation; Div Of Chem, Bioeng, Env, & Transp Sys [1209402] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Div Of Chem, Bioeng, Env, & Transp Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	Data used in the analyses on nitrogen removal and the sources of these data are described in the supplementary materials (table S3). This research was supported by NSF under grant OCE-0927512.	Baron JS, 2013, BIOGEOCHEMISTRY, V114, P71, DOI 10.1007/s10533-012-9788-y; Burnham K.P., 2002, MODEL SELECTION MULT, VSecond edition; Carpenter SR, 1998, ECOL APPL, V8, P559, DOI 10.1890/1051-0761(1998)008[0559:NPOSWW]2.0.CO;2; Cole JJ, 2007, ECOSYSTEMS, V10, P171, DOI 10.1007/s10021-006-9013-8; DAVISON W, 1995, NATURE, V377, P504, DOI 10.1038/377504a0; Elser JJ, 2009, SCIENCE, V326, P835, DOI 10.1126/science.1176199; Galloway JN, 2008, SCIENCE, V320, P889, DOI 10.1126/science.1136674; Gerdeaux D, 2006, ACTA OECOL, V30, P161, DOI 10.1016/j.actao.2006.02.007; Harrison JA, 2009, BIOGEOCHEMISTRY, V93, P143, DOI 10.1007/s10533-008-9272-x; HOHENER P, 1993, AQUAT SCI, V55, P112, DOI 10.1007/BF00877440; Howarth R, 2011, FRONT ECOL ENVIRON, V9, P18, DOI 10.1890/100008; Jeppesen E, 2005, FRESHWATER BIOL, V50, P1747, DOI 10.1111/j.1365-2427.2005.01415.x; Kaste O, 2005, CAN J FISH AQUAT SCI, V62, P312, DOI 10.1139/F04-233; PETERSON BJ, 1985, SCIENCE, V229, P1383, DOI 10.1126/science.229.4720.1383; Saunders DL, 2001, HYDROBIOLOGIA, V443, P205, DOI 10.1023/A:1017506914063; Schindler DW, 2006, LIMNOL OCEANOGR, V51, P356, DOI 10.4319/lo.2006.51.1_part_2.0356; Schindler DW, 2012, P ROY SOC B-BIOL SCI, V279, P4322, DOI 10.1098/rspb.2012.1032; Schlesinger WH, 2009, P NATL ACAD SCI USA, V106, P203, DOI 10.1073/pnas.0810193105; Seitzinger S, 2006, ECOL APPL, V16, P2064, DOI 10.1890/1051-0761(2006)016[2064:DALAWA]2.0.CO;2; SEITZINGER SP, 1988, LIMNOL OCEANOGR, V33, P702, DOI 10.4319/lo.1988.33.4_part_2.0702; Small GE, 2014, HYDROBIOLOGIA, V731, P95, DOI 10.1007/s10750-013-1569-7; Suddick EC, 2013, BIOGEOCHEMISTRY, V114, P1, DOI 10.1007/s10533-012-9795-z; Tartari G, 1997, WATER AIR SOIL POLL, V99, P523, DOI 10.1023/A:1018360010991; Taylor PG, 2010, NATURE, V464, P1178, DOI 10.1038/nature08985; Vitousek PM, 2009, SCIENCE, V324, P1519, DOI 10.1126/science.1170261; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431; Weyhenmeyer GA, 2007, LIMNOL OCEANOGR, V52, P1346, DOI 10.4319/lo.2007.52.4.1346	27	234	252	21	554	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 11	2013	342	6155					247	250		10.1126/science.1242575	http://dx.doi.org/10.1126/science.1242575			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232EV	24115440				2022-12-28	WOS:000325475200045
J	Manley, BJ; Owen, LS; Doyle, LW; Andersen, CC; Cartwright, DW; Pritchard, MA; Donath, SM; Davis, PG				Manley, Brett J.; Owen, Louise S.; Doyle, Lex W.; Andersen, Chad C.; Cartwright, David W.; Pritchard, Margo A.; Donath, Susan M.; Davis, Peter G.			High-Flow Nasal Cannulae in Very Preterm Infants after Extubation	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							POSITIVE AIRWAY PRESSURE; RESPIRATORY SUPPORT; NURSERIES; THERAPY; OXYGEN	BackgroundThe use of high-flow nasal cannulae is an increasingly popular alternative to nasal continuous positive airway pressure (CPAP) for noninvasive respiratory support of very preterm infants (gestational age, <32 weeks) after extubation. However, data on the efficacy or safety of such cannulae in this population are lacking. MethodsIn this multicenter, randomized, noninferiority trial, we assigned 303 very preterm infants to receive treatment with either high-flow nasal cannulae (5 to 6 liters per minute) or nasal CPAP (7 cm of water) after extubation. The primary outcome was treatment failure within 7 days. Noninferiority was determined by calculating the absolute difference in the risk of the primary outcome; the margin of noninferiority was 20 percentage points. Infants in whom treatment with high-flow nasal cannulae failed could be treated with nasal CPAP; infants in whom nasal CPAP failed were reintubated. ResultsThe use of high-flow nasal cannulae was noninferior to the use of nasal CPAP, with treatment failure occurring in 52 of 152 infants (34.2%) in the nasal-cannulae group and in 39 of 151 infants (25.8%) in the CPAP group (risk difference, 8.4 percentage points; 95% confidence interval, -1.9 to 18.7). Almost half the infants in whom treatment with high-flow nasal cannulae failed were successfully treated with CPAP without reintubation. The incidence of nasal trauma was significantly lower in the nasal-cannulae group than in the CPAP group (P=0.01), but there were no significant differences in rates of serious adverse events or other complications. ConclusionsAlthough the result for the primary outcome was close to the margin of noninferiority, the efficacy of high-flow nasal cannulae was similar to that of CPAP as respiratory support for very preterm infants after extubation. (Funded by the National Health and Medical Research Council; Australian New Zealand Clinical Trials Network number, ACTRN12610000166077.) This study compared high-flow nasal cannulae with nasal continuous positive airway pressure (CPAP) for noninvasive respiratory support of very preterm infants after extubation. The efficacy of high-flow nasal cannulae was similar to that of nasal CPAP. In the United States, approximately 75,000 infants were classified as very preterm (gestational age, <32 weeks) in 2011.(1) Very preterm infants have substantially higher mortality and morbidity than term infants, partly because they are more prone to respiratory failure and often require mechanical ventilation through an endotracheal tube after birth. Once they recover from their acute breathing problems, the best way to achieve successful extubation from mechanical ventilation is controversial. Nasal continuous positive airway pressure (CPAP) is known to be superior to no positive-pressure support(2) and is the current standard of care for noninvasive respiratory support of very preterm infants. ...	[Manley, Brett J.; Owen, Louise S.; Doyle, Lex W.; Davis, Peter G.] Royal Womens Hosp, Newborn Res Ctr, Melbourne, Vic, Australia; [Manley, Brett J.; Owen, Louise S.; Doyle, Lex W.; Davis, Peter G.] Univ Melbourne, Dept Obstet & Gynaecol, Melbourne, Vic, Australia; [Doyle, Lex W.; Donath, Susan M.] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia; [Manley, Brett J.; Owen, Louise S.; Doyle, Lex W.; Davis, Peter G.] Crit Care & Neurosci Theme, Melbourne, Vic, Australia; [Donath, Susan M.] Murdoch Childrens Res Inst, Clin Epidemiol & Biostat Unit, Melbourne, Vic, Australia; [Andersen, Chad C.] Womens & Childrens Hosp, Dept Neonatal Med, Adelaide, SA, Australia; [Cartwright, David W.; Pritchard, Margo A.] Royal Brisbane & Womens Hosp, Womens Serv, Brisbane, Qld, Australia; [Cartwright, David W.; Pritchard, Margo A.] Royal Brisbane & Womens Hosp, Newborn Serv, Brisbane, Qld, Australia; [Cartwright, David W.] Univ Queensland, Dept Paediat & Child Hlth, Brisbane, Qld, Australia; [Pritchard, Margo A.] Univ Queensland, Clin Res Ctr, Brisbane, Qld, Australia	University of Melbourne; University of Melbourne; Murdoch Children's Research Institute; Womens & Childrens Hospital Australia; Royal Brisbane & Women's Hospital; Royal Brisbane & Women's Hospital; University of Queensland; University of Queensland	Manley, BJ (corresponding author), Royal Womens Hosp, Newborn Res Ctr, Level 7,20 Flemington Rd, Parkville, Vic 3052, Australia.	brett.manley@thewomens.org.au	Cartwright, David W/M-7330-2013; Cartwright, David W/M-3202-2016; Pritchard, Margo A/G-5188-2010; Doyle, Lex/AAJ-5205-2021; Rusconi, Franca/K-2346-2016; Gagliardi, Luigi/K-2144-2016	Pritchard, Margo A/0000-0002-1058-9117; Doyle, Lex/0000-0002-7667-7312; Rusconi, Franca/0000-0002-9544-6472; Gagliardi, Luigi/0000-0001-6074-8975; Manley, Brett/0000-0003-0212-7956; Donath, Susan/0000-0003-2489-3977	Centre for Clinical Research Excellence grant from National Health and Medical Research Council [606789, 546519]	Centre for Clinical Research Excellence grant from National Health and Medical Research Council	Supported by a program grant (606789) and a Centre for Clinical Research Excellence grant (546519) from the National Health and Medical Research Council.	Campbell DM, 2006, J PERINATOL, V26, P546, DOI 10.1038/sj.jp.7211561; Collins CL, 2012, J PEDIAT, V162; Davis PG, 1999, J PAEDIATR CHILD H, V35, P367, DOI 10.1046/j.1440-1754.1999.00375.x; Finer NN, 2009, J PEDIATR-US, V154, P160, DOI 10.1016/j.jpeds.2008.08.021; Finer NN, 2005, PEDIATRICS, V116, P1216, DOI 10.1542/peds.2005-1741; Hamilton B. E., 2012, NATL VITAL STAT REPO, V61; Hochwald OO H, 2010, J NEONATAL PERINATAL, V3, P187; Holleman-Duray D, 2007, J PERINATOL, V27, P776, DOI 10.1038/sj.jp.7211825; Hough JL, 2012, J PAEDIATR CHILD H, V48, P106, DOI 10.1111/j.1440-1754.2011.02070.x; Kubicka ZJ, 2008, PEDIATRICS, V121, P82, DOI 10.1542/peds.2007-0957; Manley BJ, 2012, NEONATOLOGY, V102, P300, DOI 10.1159/000341754; Manley BJ, 2012, J PAEDIATR CHILD H, V48, P16, DOI 10.1111/j.1440-1754.2011.02186.x; Miller SM, 2010, J PERINATOL, V30, P805, DOI 10.1038/jp.2010.38; Nath P, 2010, PEDIATR INT, V52, P893, DOI 10.1111/j.1442-200X.2010.03274.x; Piaggio G, 2006, JAMA-J AM MED ASSOC, V295, P1152, DOI 10.1001/jama.295.10.1152; Shaffer TH, 2012, PEDIATR PULM, V47, P837, DOI 10.1002/ppul.22610; Shoemaker MT, 2007, J PERINATOL, V27, P85, DOI 10.1038/sj.jp.7211647; Spence KL, 2007, J PERINATOL, V27, P772, DOI 10.1038/sj.jp.7211828; Wilkinson DJ, 2008, J PERINATOL, V28, P42, DOI 10.1038/sj.jp.7211879; Wilkinson D, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006405.pub2	20	220	237	0	33	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 10	2013	369	15					1425	1433		10.1056/NEJMoa1300071	http://dx.doi.org/10.1056/NEJMoa1300071			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	231QE	24106935	Green Published			2022-12-28	WOS:000325431500010
J	Altit, G; Milot, M				Altit, Gabriel; Milot, Marcel			Peristaltic Waves in Pyloric Stenosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								A 5-week-old full-term male infant presented to our institution with a history of multiple episodes of projectile, nonbilious vomiting. Laboratory investigations revealed a hypokalemic, hypochloremic metabolic alkalosis. On physical examination, an olive-shaped mass that was 2 cm long was palpated in the lower inner aspect of the right upper quadrant, and abdominal peristaltic waves were observed (see Video). Ultrasonography showed pyloric stenosis. Infantile pyloric stenosis causes gastric-outlet obstruction caused by hypertrophy of the pylorus. The diagnosis is currently made on the basis of the clinical history and ultrasonographic measurements of pyloric thickness. The classic pathognomonic signs of this disorder (a ...	[Altit, Gabriel] Univ Montreal, Montreal, PQ, Canada; [Milot, Marcel] Univ Sherbrooke, Saguenay, PQ, Canada	Universite de Montreal; University of Sherbrooke	Altit, G (corresponding author), Univ Montreal, Montreal, PQ, Canada.	gabriel.altit@umontreal.ca	Altit, Gabriel/ABB-9033-2020	Altit, Gabriel/0000-0001-5141-0964					0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 3	2013	369	14					E18	E18		10.1056/NEJMicm1214572	http://dx.doi.org/10.1056/NEJMicm1214572			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	227KI	24088114				2022-12-28	WOS:000325111200001
J	Nitschke, L				Nitschke, Lars			Suppressing the Antibody Response with Siglec Ligands	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CD22; ANTIGEN; BINDING	Production of antibodies to self-antigens is a risk factor for autoimmune disease. A potential strategy to suppress production of specific antibodies by B cells may involve stimulation of a class of repressor receptors, the sialic acid-binding immunoglobulin-like lectins. When stimulated by antigens, B cells produce antibodies a crucial response against pathogens and the basis of all successful vaccines. The dark side of this immune response is that it can be directed against self-antigens, potentially resulting in autoimmune disease. Autoreactive B cells are largely eliminated in the bone marrow, but some escape the bone marrow and are found in the periphery as polyreactive or autoreactive B cells. However, a second mechanism guards against autoimmune mayhem: inhibitory receptors expressed on the surface of B cells for example, the sialic acid-binding immunoglobulin-like lectins (Siglecs) prevent autoimmune reactions. Macauley ...	Univ Erlangen Nurnberg, Div Genet, Dept Biol, D-91054 Erlangen, Germany	University of Erlangen Nuremberg	Nitschke, L (corresponding author), Univ Erlangen Nurnberg, Div Genet, Dept Biol, D-91054 Erlangen, Germany.							Kelm S, 2002, J EXP MED, V195, P1207, DOI 10.1084/jem.20011783; Kelm S, 2013, ANGEW CHEM INT EDIT, V52, P3616, DOI 10.1002/anie.201207267; Macauley MS, 2013, J CLIN INVEST, V123, P3074, DOI 10.1172/JCI69187; Pfrengle F, 2013, J IMMUNOL, V191, P1724, DOI 10.4049/jimmunol.1300921; Schweizer A, 2012, EUR J IMMUNOL, V42, P2792, DOI 10.1002/eji.201242574	5	6	7	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 3	2013	369	14					1373	1374		10.1056/NEJMcibr1308953	http://dx.doi.org/10.1056/NEJMcibr1308953			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	227KI	24088100				2022-12-28	WOS:000325111200018
J	Bershteyn, M; Kriegstein, AR				Bershteyn, Marina; Kriegstein, Arnold R.			Cerebral Organoids in a Dish: Progress and Prospects	CELL			English	Editorial Material							PLURIPOTENT STEM-CELLS	A three-dimensional culture of cortical tissues derived from pluripotent stem cells offers an opportunity to model human brain development and disorders. In a recent issue of Nature, Lancaster et al. describe a new method for generating cerebral organoids in a dish and use it to model microcephaly.	[Bershteyn, Marina; Kriegstein, Arnold R.] Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA; [Bershteyn, Marina; Kriegstein, Arnold R.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Kriegstein, Arnold R.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Kriegstein, AR (corresponding author), Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, 35 Med Ctr Way, San Francisco, CA 94143 USA.	kriegsteina@stemcell.ucsf.edu			NINDS NIH HHS [R01 NS072630] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS072630] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Eiraku M, 2008, CELL STEM CELL, V3, P519, DOI 10.1016/j.stem.2008.09.002; Espuny-Camacho I, 2013, NEURON, V77, P440, DOI 10.1016/j.neuron.2012.12.011; Gaspard N, 2008, NATURE, V455, P351, DOI 10.1038/nature07287; Hansen DV, 2010, NATURE, V464, P554, DOI 10.1038/nature08845; Lancaster M.A., 2013, NATURE; Mariani J, 2012, P NATL ACAD SCI USA, V109, P12770, DOI 10.1073/pnas.1202944109; Sasai Y, 2013, CELL STEM CELL, V12, P520, DOI 10.1016/j.stem.2013.04.009; Shi YC, 2012, NAT NEUROSCI, V15, P477, DOI 10.1038/nn.3041; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019	10	38	38	1	41	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 26	2013	155	1					19	20		10.1016/j.cell.2013.09.010	http://dx.doi.org/10.1016/j.cell.2013.09.010			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	224UX	24074857	Green Accepted, Bronze			2022-12-28	WOS:000324916700005
J	Neri, F; Krepelova, A; Incarnato, D; Maldotti, M; Parlato, C; Galvagni, F; Matarese, F; Stunnenberg, HG; Oliviero, S				Neri, Francesco; Krepelova, Anna; Incarnato, Danny; Maldotti, Mara; Parlato, Caterina; Galvagni, Federico; Matarese, Filomena; Stunnenberg, Hendrik G.; Oliviero, Salvatore			Dnmt3L Antagonizes DNA Methylation at Bivalent Promoters and Favors DNA Methylation at Gene Bodies in ESCs	CELL			English	Article							DE-NOVO METHYLATION; HISTONE H3; DYNAMIC REGULATION; POLYCOMB; CHROMATIN; METHYLTRANSFERASE; PLURIPOTENT; PROTEIN; 5-HYDROXYMETHYLCYTOSINE; BINDING	The de novo DNA methyltransferase 3-like (Dnmt3L) is a catalytically inactive DNA methyltransferase that cooperates with Dnmt3a and Dnmt3b to methylate DNA. Dnmt3L is highly expressed in mouse embryonic stem cells (ESCs), but its function in these cells is unknown. Through genome-wide analysis of Dnmt3L knockdown in ESCs, we found that Dnmt3L is a positive regulator of methylation at the gene bodies of housekeeping genes and, more surprisingly, is also a negative regulator of methylation at promoters of bivalent genes. Dnmt3L is required for the differentiation of ESCs into primordial germ cells (PGCs) through the activation of the homeotic gene Rhox5. We demonstrate that Dnmt3L interacts with the Polycomb PRC2 complex in competition with the DNA methyltransferases Dnmt3a and Dnmt3b to maintain low methylation levels at the H3K27me3 regions. Thus, in ESCs, Dnmt3L counteracts the activity of de novo DNA methylases to maintain hypomethylation at promoters of bivalent developmental genes.	[Neri, Francesco; Krepelova, Anna; Incarnato, Danny; Maldotti, Mara; Parlato, Caterina; Oliviero, Salvatore] Human Genet Fdn HuGeF, I-10126 Turin, Italy; [Krepelova, Anna; Incarnato, Danny; Galvagni, Federico; Oliviero, Salvatore] Univ Siena, Dipartimento Biotecnol Chim & Farm, I-53100 Siena, Italy; [Matarese, Filomena; Stunnenberg, Hendrik G.] Nijmegen Ctr Mol Life Sci, Dept Mol Biol, NL-6500 HB Nijmegen, Netherlands	University of Siena; Radboud University Nijmegen	Oliviero, S (corresponding author), Human Genet Fdn HuGeF, Via Nizza 52, I-10126 Turin, Italy.	salvatore.oliviero@hugef-torino.org	Galvagni, Federico/F-9186-2013; Stunnenberg, Hendrik G./D-6875-2012; oliviero, salvatore/R-6657-2019; Neri, Francesco/A-3321-2014	Stunnenberg, Hendrik G./0000-0002-0066-1576; oliviero, salvatore/0000-0002-3405-765X; Neri, Francesco/0000-0003-3903-1974; PARLATO, CATERINA/0000-0001-5304-3117; Maldotti, Mara/0000-0002-3299-9053; Krepelova, Anna/0000-0002-2775-1336	Associazione Italiana Ricerca sul Cancro (AIRC); Regione Toscana programma salute	Associazione Italiana Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Regione Toscana programma salute(Regione Toscana)	This work was supported by the Associazione Italiana Ricerca sul Cancro (AIRC) and Regione Toscana programma salute. We thank Dr. S. Yamanaka (Kyoto University, Japan) for providing the anti-Dnmt3L antibody, Dr. En Li (Novartis, China) for providing the Dnmt3a<SUP>-/-</SUP>Dnmt3b<SUP>-/-</SUP>ESCs and Dr. Dies Meijer for providing the Avi-tag plasmid and BirA ESCs.	Bartke T, 2010, CELL, V143, P470, DOI 10.1016/j.cell.2010.10.012; Bestor TH, 2000, HUM MOL GENET, V9, P2395, DOI 10.1093/hmg/9.16.2395; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Borgel J, 2010, NAT GENET, V42, P1093, DOI 10.1038/ng.708; Bourc'his D, 2001, SCIENCE, V294, P2536, DOI 10.1126/science.1065848; Bourc'his D, 2004, NATURE, V431, P96, DOI 10.1038/nature02886; Brinkman AB, 2012, GENOME RES, V22, P1128, DOI 10.1101/gr.133728.111; Chedin F, 2002, P NATL ACAD SCI USA, V99, P16916, DOI 10.1073/pnas.262443999; Chen ZX, 2005, J CELL BIOCHEM, V95, P902, DOI 10.1002/jcb.20447; Driegen S, 2005, TRANSGENIC RES, V14, P477, DOI 10.1007/s11248-005-7220-2; Ficz G, 2011, NATURE, V473, P398, DOI 10.1038/nature10008; Fouse SD, 2008, CELL STEM CELL, V2, P160, DOI 10.1016/j.stem.2007.12.011; Galvagni F, 2001, J MOL BIOL, V306, P985, DOI 10.1006/jmbi.2000.4335; Gowher H, 2005, J BIOL CHEM, V280, P13341, DOI 10.1074/jbc.M413412200; Hata K, 2002, DEVELOPMENT, V129, P1983; Hawkins RD, 2010, CELL STEM CELL, V6, P479, DOI 10.1016/j.stem.2010.03.018; Hayashi K, 2011, CELL, V146, P519, DOI 10.1016/j.cell.2011.06.052; Jia D, 2007, NATURE, V449, P248, DOI 10.1038/nature06146; Jurkowska RZ, 2011, J BIOL CHEM, V286, P24200, DOI 10.1074/jbc.M111.254987; Jurkowska RZ, 2011, CHEMBIOCHEM, V12, P206, DOI 10.1002/cbic.201000195; Kaneda M, 2004, NATURE, V429, P900, DOI 10.1038/nature02633; Kareta MS, 2006, J BIOL CHEM, V281, P25893, DOI 10.1074/jbc.M603140200; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Li E, 2002, NAT REV GENET, V3, P662, DOI 10.1038/nrg887; Li Q, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-63; Lienert F, 2011, NAT GENET, V43, P1091, DOI 10.1038/ng.946; Lindroth AM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000145; MacLean JA, 2011, MOL CELL BIOL, V31, P1275, DOI 10.1128/MCB.00734-10; MacLean JA, 2010, REPRODUCTION, V140, P195, DOI 10.1530/REP-10-0100; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Matarese F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.95; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Mohn F, 2008, MOL CELL, V30, P755, DOI 10.1016/j.molcel.2008.05.007; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Neri F, 2012, MOL CELL BIOL, V32, P840, DOI 10.1128/MCB.06148-11; Ohm JE, 2007, NAT GENET, V39, P237, DOI 10.1038/ng1972; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Ooi SKT, 2007, NATURE, V448, P714, DOI 10.1038/nature05987; Pasini D, 2007, MOL CELL BIOL, V27, P3769, DOI 10.1128/MCB.01432-06; Pastor WA, 2011, NATURE, V473, P394, DOI 10.1038/nature10102; Pontier DB, 2011, HUM GENET, V130, P223, DOI 10.1007/s00439-011-1008-7; Rush Margaret, 2009, Epigenetics, V4, P404; Schlesinger Y, 2007, NAT GENET, V39, P232, DOI 10.1038/ng1950; Schuettengruber B, 2009, DEVELOPMENT, V136, P3531, DOI 10.1242/dev.033902; Shen XH, 2008, MOL CELL, V32, P491, DOI 10.1016/j.molcel.2008.10.016; Simmer F, 2012, EPIGENETICS-US, V7, P1355, DOI 10.4161/epi.22562; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; Suetake I, 2004, J BIOL CHEM, V279, P27816, DOI 10.1074/jbc.M400181200; Turbendian HK, 2013, DEVELOPMENT, V140, P1639, DOI 10.1242/dev.093260; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; West JA, 2009, NATURE, V460, P909, DOI 10.1038/nature08210; Widschwendter M, 2007, NAT GENET, V39, P157, DOI 10.1038/ng1941; Wu H, 2010, SCIENCE, V329, P444, DOI 10.1126/science.1190485; Zhang Y, 2010, NUCLEIC ACIDS RES, V38, P4246, DOI 10.1093/nar/gkq147	55	120	122	0	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 26	2013	155	1					121	134		10.1016/j.cell.2013.08.056	http://dx.doi.org/10.1016/j.cell.2013.08.056			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	224UX	24074865	Bronze, Green Submitted			2022-12-28	WOS:000324916700014
J	Watson, AJ; Ledwell, JR; Messias, MJ; King, BA; Mackay, N; Meredith, MP; Mills, B; Garabato, ACN				Watson, Andrew J.; Ledwell, James R.; Messias, Marie-Jose; King, Brian A.; Mackay, Neill; Meredith, Michael P.; Mills, Benjamin; Garabato, Alberto C. Naveira			Rapid cross-density ocean mixing at mid-depths in the Drake Passage measured by tracer release	NATURE			English	Article							SOUTHERN-OCEAN; SULFUR-HEXAFLUORIDE; SPATIAL VARIABILITY; CIRCULATION; DISSIPATION; TOPOGRAPHY	Diapycnal mixing (across density surfaces) is an important process in the global ocean overturning circulation(1-3). Mixing in the interior of most of the ocean, however, is thought to have a magnitude just one-tenth of that required to close the global circulation by the downward mixing of less dense waters(4). Some of this deficit is made up by intense near-bottom mixing occurring in restricted 'hot-spots' associated with rough ocean-floor topography(5,6), but it is not clear whether the waters at mid-depth, 1,000 to 3,000 metres, are returned to the surface by cross-densitymixing or by along-density flows(7). Here we show that diapycnal mixing of mid-depth (similar to 1,500 metres) waters undergoes a sustained 20-fold increase as the Antarctic Circumpolar Current flows through the Drake Passage, between the southern tip of South America and Antarctica. Our results are based on an open-ocean tracer release of trifluoromethyl sulphur pentafluoride. We ascribe the increased mixing to turbulence generated by the deep-reaching Antarctic Circumpolar Current as it flows over rough bottom topography in the Drake Passage. Scaled to the entire circumpolar current, the mixing we observe is compatible with there being a southern component to the global overturning in which about 20 sverdrups (1 Sv = 10(6) m(3) s(-1)) upwell in the Southern Ocean, with cross-density mixing contributing a significant fraction (20 to 30 per cent) of this total, and the remainder upwelling along constant-density surfaces. The great majority of the diapycnal flux is the result of interaction with restricted regions of rough ocean-floor topography.	[Watson, Andrew J.; Messias, Marie-Jose; Mackay, Neill; Mills, Benjamin] Univ E Anglia, Sch Environm Sci, Norwich NR4 7TJ, Norfolk, England; [Ledwell, James R.] Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA; [King, Brian A.; Garabato, Alberto C. Naveira] Natl Oceanog Ctr, Southampton SO14 3ZH, Hants, England; [Meredith, Michael P.] British Antarctic Survey, Cambridge CB3 0ET, England; [Meredith, Michael P.] Scottish Assoc Marine Sci, Oban PA37 1QA, Argyll, Scotland; [Garabato, Alberto C. Naveira] Univ Southampton, Natl Oceanog Ctr, Southampton SO14 3ZH, Hants, England	University of East Anglia; Woods Hole Oceanographic Institution; NERC National Oceanography Centre; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; UHI Millennium Institute; NERC National Oceanography Centre; University of Southampton	Watson, AJ (corresponding author), Univ Exeter, Coll Life & Environm Sci, Laver Bldg, Exeter EX4 4QE, Devon, England.	andrew.watson@exeter.ac.uk	Garabato, Alberto Naveira/AAQ-1114-2020	Garabato, Alberto Naveira/0000-0001-6071-605X; Messias, Marie-Jose/0000-0002-3852-2854; Mills, Benjamin/0000-0002-9141-0931; Watson, Andrew/0000-0002-9654-8147; Meredith, Michael/0000-0002-7342-7756	UK Natural Environment Research Council; US National Science Foundation; Royal Society; Natural Environment Research Council [bas0100028, NE/E005985/2, NE/E007058/1, NE/E005985/1, noc010012] Funding Source: researchfish; Directorate For Geosciences [1232962] Funding Source: National Science Foundation; NERC [NE/E007058/1, bas0100028, NE/E005985/2, NE/E005985/1] Funding Source: UKRI	UK Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); US National Science Foundation(National Science Foundation (NSF)); Royal Society(Royal Society of London); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank the officers and staff of the RV Thomas Thompson, RRS James Cook and RRS James Clark Ross for their assistance in making the observations at sea. We thank the UK Natural Environment Research Council and the US National Science Foundation for funding the DIMES experiment. A.J.W. thanks the Royal Society for support.	Bevington PR., 2002, DATA REDUCTION ERROR; Busenberg E, 2008, WATER RESOUR RES, V44, DOI 10.1029/2007WR006150; Falco P, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006349; Garabato ACN, 2004, SCIENCE, V303, P210, DOI 10.1126/science.1090929; GREGG MC, 1989, J GEOPHYS RES-OCEANS, V94, P9686, DOI 10.1029/JC094iC07p09686; Ho DT, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032799; Kunze E, 2006, J PHYS OCEANOGR, V36, P1553, DOI 10.1175/JPO2926.1; Laurent LS, 2012, J PHYS OCEANOGR, V42, P2143, DOI 10.1175/JPO-D-12-027.1; LAW CS, 1994, MAR CHEM, V48, P57, DOI 10.1016/0304-4203(94)90062-0; Ledwell JR, 2011, J PHYS OCEANOGR, V41, P241, DOI 10.1175/2010JPO4557.1; Ledwell JR, 2000, NATURE, V403, P179, DOI 10.1038/35003164; Ledwell JR, 1998, J GEOPHYS RES-OCEANS, V103, P21499, DOI 10.1029/98JC01738; LEDWELL JR, 1993, NATURE, V364, P701, DOI 10.1038/364701a0; Lumpkin R, 2007, J PHYS OCEANOGR, V37, P2550, DOI 10.1175/JPO3130.1; Marshall J, 2012, NAT GEOSCI, V5, P171, DOI [10.1038/ngeo1391, 10.1038/NGEO1391]; McClean JL, 2011, OCEAN MODEL, V39, P10, DOI 10.1016/j.ocemod.2011.02.011; Meijers AJS, 2011, J ATMOS OCEAN TECH, V28, P548, DOI 10.1175/2010JTECHO790.1; Munk W, 1998, DEEP-SEA RES PT I, V45, P1977, DOI 10.1016/S0967-0637(98)00070-3; MUNK W., 1966, DEEP SEA RES OCEANOG, V13, P707, DOI [10.1016/0011-7471(66)90602-4, DOI 10.1016/0011-7471(66)90602-4]; Nikurashin M, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL046576; Nikurashin M, 2010, J PHYS OCEANOGR, V40, P2025, DOI 10.1175/2010JPO4315.1; Nikurashin M, 2010, J PHYS OCEANOGR, V40, P1055, DOI 10.1175/2009JPO4199.1; ORSI AH, 1995, DEEP-SEA RES PT I, V42, P641, DOI 10.1016/0967-0637(95)00021-W; POLZIN KL, 1995, J PHYS OCEANOGR, V25, P306, DOI 10.1175/1520-0485(1995)025<0306:FPOTD>2.0.CO;2; Polzin KL, 1997, SCIENCE, V276, P93, DOI 10.1126/science.276.5309.93; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.1093/biomet/52.3-4.591; Sloyan BM, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023568; Smethie WM, 2000, J GEOPHYS RES-OCEANS, V105, P1105, DOI 10.1029/1999JC900233; Toggweiler JR, 1998, J PHYS OCEANOGR, V28, P1832, DOI 10.1175/1520-0485(1998)028<1832:OTOSLS>2.0.CO;2; WANNINKHOF R, 1991, J GEOPHYS RES-OCEANS, V96, P8733, DOI 10.1029/91JC00104; Waterman S, 2013, J PHYS OCEANOGR, V43, P259, DOI 10.1175/JPO-D-11-0194.1; Webb DJ, 2001, NATURE, V409, P37, DOI 10.1038/35051171; Wu LX, 2011, NAT GEOSCI, V4, P363, DOI [10.1038/ngeo1156, 10.1038/NGEO1156]; Zika JD, 2009, J PHYS OCEANOGR, V39, P2926, DOI 10.1175/2009JPO4052.1	34	48	48	0	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 19	2013	501	7467					408	+		10.1038/nature12432	http://dx.doi.org/10.1038/nature12432			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219XT	24048070	Green Accepted			2022-12-28	WOS:000324545700043
J	Martorell, B; Vocadlo, L; Brodholt, J; Wood, IG				Martorell, Benjami; Vocadlo, Lidunka; Brodholt, John; Wood, Ian G.			Strong Premelting Effect in the Elastic Properties of hcp-Fe Under Inner-Core Conditions	SCIENCE			English	Article							AB-INITIO CALCULATIONS; SHEAR MODULUS; MELTING BEHAVIOR; WAVE VELOCITIES; HIGH-PRESSURE; TEMPERATURE; ALLOY; POINT; LIMIT; IRON	The observed shear-wave velocity V-S in Earth's core is much lower than expected from mineralogical models derived from both calculations and experiments. A number of explanations have been proposed, but none sufficiently explain the seismological observations. Using ab initio molecular dynamics simulations, we obtained the elastic properties of hexagonal close-packed iron (hcp-Fe) at 360 gigapascals up to its melting temperature T-m. We found that Fe shows a strong nonlinear shear weakening just before melting (when T/T-m > 0.96), with a corresponding reduction in V-S. Because temperatures range from T/T-m = 1 at the inner-outer core boundary to T/T-m approximate to 0.99 at the center, this strong nonlinear effect on V-S should occur in the inner core, providing a compelling explanation for the low V-S observed.	[Martorell, Benjami; Vocadlo, Lidunka; Brodholt, John; Wood, Ian G.] UCL, Dept Earth Sci, London WC1E 6BT, England	University of London; University College London	Martorell, B (corresponding author), UCL, Dept Earth Sci, Mortimer St, London WC1E 6BT, England.	b.massip@ucl.ac.uk	Vocadlo, Lidunka/C-4197-2008; Brodholt, John P/B-7136-2011	Brodholt, John P/0000-0001-7395-5834; Vocadlo, Lidunka/0000-0002-2577-0277; Martorell Masip, Benjami/0000-0002-7759-8042	Natural Environment Research Council [NE/H003975/1]; NERC [NE/H003975/1, hpc010001] Funding Source: UKRI; Natural Environment Research Council [hpc010001] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Supported by Natural Environment Research Council grant NE/H003975/1 (L. V.). Calculations were performed in the HECTOR supercomputer facility. Computer code VASP is available at www.vasp.at. The data presented in this paper are given in the main text and in the supplementary materials. B. M. performed research, analyzed data, and wrote the paper. L. V. designed research, analyzed data, and wrote the paper. J.B. analyzed data and wrote the paper. I. G. W. designed the research, analyzed data, and wrote the paper.	Alfe D., 2002, PHYS REV B, V65; Alfe D, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.060101; Antonangeli D, 2004, EARTH PLANET SC LETT, V225, P243, DOI 10.1016/j.epsl.2004.06.004; Antonangeli D, 2010, EARTH PLANET SC LETT, V295, P292, DOI 10.1016/j.epsl.2010.04.018; BIRCH F, 1964, J GEOPHYS RES, V69, P4377, DOI 10.1029/JZ069i020p04377; Cao AM, 2005, SCIENCE, V308, P1453, DOI 10.1126/science.1109134; Delogu F, 2006, J PHYS-CONDENS MAT, V18, P5639, DOI 10.1088/0953-8984/18/24/006; Delogu F, 2006, J PHYS CHEM B, V110, P12645, DOI 10.1021/jp061225k; Delogu F, 2006, J PHYS CHEM B, V110, P3281, DOI 10.1021/jp0544078; DZIEWONSKI AM, 1981, PHYS EARTH PLANET IN, V25, P297, DOI 10.1016/0031-9201(81)90046-7; GUINAN MW, 1974, J PHYS CHEM SOLIDS, V35, P1501, DOI 10.1016/S0022-3697(74)80278-7; Kantor AP, 2007, PHYS EARTH PLANET IN, V164, P83, DOI 10.1016/j.pepi.2007.06.006; Lu K, 1998, PHYS REV LETT, V80, P4474, DOI 10.1103/PhysRevLett.80.4474; Manai G, 2007, J MATER SCI, V42, P6672, DOI 10.1007/s10853-007-1522-0; Manai G, 2007, PHYSICA B, V392, P288, DOI 10.1016/j.physb.2006.11.048; Mao Z, 2012, P NATL ACAD SCI USA, V109, P10239, DOI 10.1073/pnas.1207086109; Martorell B, 2013, EARTH PLANET SC LETT, V365, P143, DOI 10.1016/j.epsl.2013.01.007; Morard G, 2011, HIGH ENERG DENS PHYS, V7, P141, DOI 10.1016/j.hedp.2011.02.001; Nadal MH, 2007, J ALLOY COMPD, V444, P265, DOI 10.1016/j.jallcom.2006.10.054; Nadal MH, 2003, J APPL PHYS, V93, P2472, DOI 10.1063/1.1539913; Nelson D., 2002, DEFECTS AND GEOMETRY; Poirier J. P., 2000, INTRODUCTION TO THE, P230; POIRIER JP, 1994, PHYS EARTH PLANET IN, V85, P319, DOI 10.1016/0031-9201(94)90120-1; Sha XW, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL042224; Sha XW, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.094105; Sola E, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.078501; Sorkin V, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.174103; Sorkin V, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.174102; Varshni YP, 1970, PHYS REV B-SOLID ST, V2, P3952, DOI 10.1103/PhysRevB.2.3952; Vocadlo L, 2007, EARTH PLANET SC LETT, V254, P227, DOI 10.1016/j.epsl.2006.09.046; Vocadlo L, 2009, EARTH PLANET SC LETT, V288, P534, DOI 10.1016/j.epsl.2009.10.015	31	81	83	0	69	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 25	2013	342	6157					466	468		10.1126/science.1243651	http://dx.doi.org/10.1126/science.1243651			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239RH	24114785	Green Submitted			2022-12-28	WOS:000326042600039
J	Pampliega, O; Orhon, I; Patel, B; Sridhar, S; Diaz-Carretero, A; Beau, I; Codogno, P; Satir, BH; Satir, P; Cuervo, AM				Pampliega, Olatz; Orhon, Idil; Patel, Bindi; Sridhar, Sunandini; Diaz-Carretero, Antonio; Beau, Isabelle; Codogno, Patrice; Satir, Birgit H.; Satir, Peter; Cuervo, Ana Maria			Functional interaction between autophagy and ciliogenesis	NATURE			English	Article							PRIMARY CILIUM; COMPLEX; FIBROBLASTS; DISEASE; LEVEL; CELLS	Nutrient deprivation is a stimulus shared by both autophagy and the formation of primary cilia. The recently discovered role of primary cilia in nutrient sensing and signalling motivated us to explore the possible functional interactions between this signalling hub and autophagy. Here we show that part of the molecular machinery involved in ciliogenesis also participates in the early steps of the autophagic process. Signalling from the cilia, such as that from the Hedgehog pathway, induces autophagy by acting directly on essential autophagy-related proteins strategically located in the base of the cilium by ciliary trafficking proteins. Whereas abrogation of ciliogenesis partially inhibits autophagy, blockage of autophagy enhances primary cilia growth and cilia-associated signalling during normal nutritional conditions. We propose that basal autophagy regulates ciliary growth through the degradation of proteins required for intraflagellar transport. Compromised ability to activate the autophagic response may underlie some common ciliopathies.	[Pampliega, Olatz; Patel, Bindi; Sridhar, Sunandini; Diaz-Carretero, Antonio; Cuervo, Ana Maria] Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10461 USA; [Orhon, Idil; Codogno, Patrice] INSERM, U845, F-75014 Paris, France; [Orhon, Idil; Codogno, Patrice] Paris Descartes Univ, F-75014 Paris, France; [Orhon, Idil; Beau, Isabelle; Codogno, Patrice] INSERM, U984, F-92296 Chatenay Malabry, France; [Orhon, Idil; Beau, Isabelle; Codogno, Patrice] Univ Paris Sud, F-92296 Chatenay Malabry, France; [Satir, Birgit H.; Satir, Peter; Cuervo, Ana Maria] Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10461 USA; [Cuervo, Ana Maria] Albert Einstein Coll Med, Inst Aging Studies, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Cuervo, AM (corresponding author), Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10461 USA.	peter.satir@einstein.yu.edu; ana-maria.cuervo@einstein.yu.edu	Beau, Isabelle/M-4423-2017; Pampliega, Olatz/A-9204-2015; orhon, idil/AAB-1940-2020; Pampliega, Olatz/K-9037-2019	Beau, Isabelle/0000-0002-3352-6813; Pampliega, Olatz/0000-0002-7924-6374; orhon, idil/0000-0002-0779-8719; Pampliega, Olatz/0000-0002-7924-6374; Cuervo, Ana Maria/0000-0002-0771-700X	National Institute of Health National Institute on Aging [AG031782, AG038072]; National Institute of Diabetes and Digestive and Kidney Diseases [DK098408]; Institut National de la Sante et de la Recherche Medicale; Institut National du Cancer and L'Agence Nationale de la Recherche; Basque Government; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK098408] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG021904, P30AG038072, P01AG031782] Funding Source: NIH RePORTER	National Institute of Health National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Institut National du Cancer and L'Agence Nationale de la Recherche(French National Research Agency (ANR)); Basque Government(Basque Government); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank N. Mizushima and G. Pazour for providing MEFs and I. R. Veland and S. T. Christensen for providing the plasmid for expression of GFP-inversin. We also thank the personnel at the Analytical Imaging Facility for their technical assistance with TEM, J. Kraut and N. Rodriguez for their early assistance in cilia staining optimization and S. Kaushik for critically reviewing this manuscript. This work was supported by grants from the National Institute of Health National Institute on Aging AG031782 and AG038072, National Institute of Diabetes and Digestive and Kidney Diseases DK098408 (to A. M. C.), Institut National de la Sante et de la Recherche Medicale (to P. C. and I. B.), Institut National du Cancer and L'Agence Nationale de la Recherche (to P. C.), and the generous support of Robert and Renee Belfer (to A. M. C.). O.P. was supported by a Basque Government Postdoctoral Fellowship.	AUTERI JS, 1983, J CELL PHYSIOL, V115, P167, DOI 10.1002/jcp.1041150210; Boehlke C, 2010, NAT CELL BIOL, V12, P1115, DOI 10.1038/ncb2117; Finetti F, 2009, NAT CELL BIOL, V11, P1332, DOI 10.1038/ncb1977; Follit JA, 2009, CELL MOTIL CYTOSKEL, V66, P457, DOI 10.1002/cm.20346; Hamasaki M, 2013, CURR OPIN CELL BIOL, V25, P455, DOI 10.1016/j.ceb.2013.03.004; Huang BQ, 2006, AM J PHYSIOL-GASTR L, V291, pG500, DOI 10.1152/ajpgi.00064.2006; Jimenez-Sanchez M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2212; Kiprilov EN, 2008, J CELL BIOL, V180, P897, DOI 10.1083/jcb.200706028; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Li HJ, 2012, AM J PHYSIOL-HEART C, V303, pH1319, DOI 10.1152/ajpheart.00160.2012; Liem KF, 2012, J CELL BIOL, V197, P789, DOI 10.1083/jcb.201110049; MARZELLA L, 1982, J CELL BIOL, V93, P144, DOI 10.1083/jcb.93.1.144; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Onodera J, 2005, J BIOL CHEM, V280, P31582, DOI 10.1074/jbc.M506736200; Pazour GJ, 2002, CURR BIOL, V12, pR378, DOI 10.1016/S0960-9822(02)00877-1; Petralia RS, 2013, BIOL OPEN, V2, P499, DOI 10.1242/bio.20134275; Ravikumar B, 2010, NAT CELL BIOL, V12, P747, DOI 10.1038/ncb2078; Richey EA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043118; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; Satir P, 2012, DEV DYNAM, V241, P426, DOI 10.1002/dvdy.23713; Satir P, 2010, J CELL SCI, V123, P499, DOI 10.1242/jcs.050377; Schneider L, 2005, CURR BIOL, V15, P1861, DOI 10.1016/j.cub.2005.09.012; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Sridhar S, 2013, EMBO J, V32, P324, DOI 10.1038/emboj.2012.341; Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697; Taschner M, 2012, DIFFERENTIATION, V83, pS12, DOI 10.1016/j.diff.2011.11.001; Veland IR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060193; WADA K, 1986, CHEM PHARM BULL, V34, P1688; Wang Y, 2013, HEPATOLOGY, V58, P995, DOI 10.1002/hep.26394; Yang ZF, 2010, CURR OPIN CELL BIOL, V22, P124, DOI 10.1016/j.ceb.2009.11.014	30	287	309	3	79	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 10	2013	502	7470					194	+		10.1038/nature12639	http://dx.doi.org/10.1038/nature12639			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RU	24089209	Green Accepted			2022-12-28	WOS:000325436100042
J	Russell, DG; Nathan, CF				Russell, David G.; Nathan, Carl F.			Graduation time	NATURE			English	Editorial Material									[Russell, David G.] Cornell Univ, Coll Vet Med, Dept Microbiol & Immunol, Ithaca, NY 14853 USA; [Nathan, Carl F.] Weill Cornell Med Coll, Dept Microbiol & Immunol, New York, NY 10065 USA	Cornell University; Cornell University	Russell, DG (corresponding author), Cornell Univ, Coll Vet Med, Dept Microbiol & Immunol, Ithaca, NY 14853 USA.		Russell, David G/D-4533-2009; Russell, David G/N-5280-2019	Russell, David G/0000-0002-9748-750X; Russell, David G/0000-0002-9748-750X					0	4	4	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 10	2013	502	7470					S7	S7		10.1038/502S7a	http://dx.doi.org/10.1038/502S7a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RU	24108080	Bronze			2022-12-28	WOS:000325436100004
J	Oettle, H; Neuhaus, P; Hochhaus, A; Hartmann, JT; Gellert, K; Ridwelski, K; Niedergethmann, M; Zulke, C; Fahlke, J; Arning, MB; Sinn, M; Hinke, A; Riess, H				Oettle, Helmut; Neuhaus, Peter; Hochhaus, Andreas; Hartmann, Joerg Thomas; Gellert, Klaus; Ridwelski, Karsten; Niedergethmann, Marco; Zuelke, Carl; Fahlke, Joerg; Arning, Michael B.; Sinn, Marianne; Hinke, Axel; Riess, Hanno			Adjuvant Chemotherapy With Gemcitabine and Long-term Outcomes Among Patients With Resected Pancreatic Cancer The CONKO-001 Randomized Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PHASE-III TRIAL; CURATIVE RESECTION; COMBINATION CHEMOTHERAPY; THERAPY; CHEMORADIOTHERAPY; 5-FLUOROURACIL; ADENOCARCINOMA; FLUOROURACIL; CARCINOMA; SURVIVAL	IMPORTANCE The prognosis for patients with pancreatic cancer is poor, even after resection with curative intent. Gemcitabine-based chemotherapy is standard treatment for advanced pancreatic cancer, but its effect on survival in the adjuvant setting has not been demonstrated. OBJECTIVE To analyze whether previously reported improvement in disease-free survival with adjuvant gemcitabine therapy translates into improved overall survival. DESIGN, SETTING, AND PATIENTS CONKO-001 (Charite Onkologie 001), a multicenter, open-label, phase 3 randomized trial to evaluate the efficacy and toxicity of gemcitabine in patients with pancreatic cancer after complete tumor resection. Patients with macroscopically completely removed pancreatic cancer entered the study between July 1998 and December 2004 in 88 hospitals in Germany and Austria. Follow-up ended in September 2012. INTERVENTIONS After stratification for tumor stage, nodal status, and resection status, patients were randomly assigned to either adjuvant gemcitabine treatment (1g/m(2) d 1, 8, 15, q 4 weeks) for 6 months or to observation alone. MAIN OUTCOMES AND MEASURES The primary end point was disease-free survival. Secondary end points included treatment safety and overall survival, with overall survival defined as the time from date of randomization to death. Patients lost to follow-up were censored on the date of their last follow-up. RESULTS A total of 368 patients were randomized, and 354 were eligible for intention-to-treat-analysis. By September 2012, 308 patients (87.0% [95% CI, 83.1%-90.1%]) had relapsed and 316 patients (89.3% [95% CI, 85.6%-92.1%]) had died. The median follow-up time was 136 months. The median disease-free survival was 13.4 (95% CI, 11.6-15.3) months in the treatment group compared with 6.7 (95% CI, 6.0-7.5) months in the observation group (hazard ratio, 0.55 [95% CI, 0.44-0.69]; P<.001). Patients randomized to adjuvant gemcitabine treatment had prolonged overall survival compared with those randomized to observation alone (hazard ratio, 0.76 [95% CI, 0.61-0.95]; P=.01), with 5-year overall survival of 20.7% (95% CI, 14.7%-26.6%) vs 10.4% (95% CI, 5.9%-15.0%), respectively, and 10-year overall survival of 12.2% (95% CI, 7.3%-17.2%) vs 7.7% (95% CI, 3.6%-11.8%). CONCLUSIONS AND RELEVANCE Among patients with macroscopic complete removal of pancreatic cancer, the use of adjuvant gemcitabine for 6 months compared with observation alone resulted in increased overall survival as well as disease-free survival. These findings provide strong support for the use of gemcitabine in this setting.	[Oettle, Helmut; Sinn, Marianne; Riess, Hanno] Charite, Med Klin Schwerpunkt Hamatol Onkol & Tumorimmunol, Campus Virchow Klinikum, D-13353 Berlin, Germany; [Neuhaus, Peter] Charite, Klin Allgemein Visceral & Transplantat Chirurg, D-13353 Berlin, Germany; [Hochhaus, Andreas] Univ Klinikum Jena, Klin Innere Med Hamatol Onkol 2, Jena, Germany; [Hartmann, Joerg Thomas] Univ Kiel, Klin Innere Hamatol Onkol 2, Univ Klinikum Schleswig Holstein, Kiel, Germany; [Gellert, Klaus] Oskar Ziethen Krankenhaus, Klin Allgemein Viszeralchirurg, Berlin, Germany; [Ridwelski, Karsten] Stadt Klinikum Magdeburg, Klin Allgemein & Viszeralchirurg, Magdeburg, Germany; [Niedergethmann, Marco] Univ Med Mannheim, Chirurg Klin, Mannheim, Germany; [Zuelke, Carl] Marienhosp Gelsenkirchen GmbH, Klin Chirurg Allgemein & Viszeralchirurg, Gelsenkirchen, Germany; [Fahlke, Joerg] Univ Klinikum Magdeburg, Klin Allgemein Viszeral & Gefasschirurg, Magdeburg, Germany; [Arning, Michael B.] GlaxoSmithKline, Oncol Med Dev Ctr, Collegeville, PA USA; [Hinke, Axel] WiSP Res Inst, Langenfeld, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Friedrich Schiller University of Jena; University of Kiel; Schleswig Holstein University Hospital; Ruprecht Karls University Heidelberg; St. Marien Hospital; University Hospital Magdeburg; GlaxoSmithKline	Oettle, H (corresponding author), Charite, Dept Med Oncol & Hematol, Campus Virchow Klinikum, Augustenburger Pl 1, D-13353 Berlin, Germany.	helmut.oettle@charite.de		Hochhaus, Andreas/0000-0003-0626-0834	Lilly Germany; German Cancer Society (section AIO); Charite-Universitatsmedizin Berlin	Lilly Germany(Eli Lilly); German Cancer Society (section AIO); Charite-Universitatsmedizin Berlin	This trial was supported in part by a grant from Lilly Germany. The study was further supported by the German Cancer Society (section AIO) and promoted by a research grant from the Charite-Universitatsmedizin Berlin.	BAKKEVOLD KE, 1993, EUR J CANCER, V29A, P698, DOI 10.1016/S0959-8049(05)80349-1; Burris HA, 1997, J CLIN ONCOL, V15, P2403, DOI 10.1200/JCO.1997.15.6.2403; Chua YJ, 2005, J CLIN ONCOL, V23, P4532, DOI 10.1200/JCO.2005.17.954; Conroy T, 2011, NEW ENGL J MED, V364, P1817, DOI 10.1056/NEJMoa1011923; COX DR, 1972, J R STAT SOC B, V34, P187; Fukutomi A, 2013, J CLIN ONCOL S, V31; Garcia-Manteiga J, 2003, CLIN CANCER RES, V9, P5000; Ghaneh P, 2007, DRUGS, V67, P2487, DOI 10.2165/00003495-200767170-00002; Hammel P, 2013, J CLIN ONCOL, V31; KALSER MH, 1985, ARCH SURG-CHICAGO, V120, P899; Klinkenbijl JH, 1999, ANN SURG, V230, P776, DOI 10.1097/00000658-199912000-00006; Kosuge T, 2006, JPN J CLIN ONCOL, V36, P159, DOI 10.1093/jjco/hyi234; Neoptolemos JP, 2010, JAMA-J AM MED ASSOC, V304, P1073, DOI 10.1001/jama.2010.1275; Neoptolemos JP, 2001, LANCET, V358, P1576, DOI 10.1016/S0140-6736(01)06651-X; Neoptolemos JP, 2013, J CLIN ONCOL S, V31; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; Oettle H, 2007, DRUGS, V67, P2293, DOI 10.2165/00003495-200767160-00001; Oettle H, 2007, JAMA-J AM MED ASSOC, V297, P267, DOI 10.1001/jama.297.3.267; PETO R, 1972, J R STAT SOC SER A-G, V135, P185, DOI 10.2307/2344317; Poplin E, 2013, J CLIN ONCOL S, V31; Regine WF, 2008, JAMA-J AM MED ASSOC, V299, P1019, DOI 10.1001/jama.299.9.1019; Regine WF, 2011, ANN SURG ONCOL, V18, P1319, DOI 10.1245/s10434-011-1630-6; Sener SF, 1999, J AM COLL SURGEONS, V189, P1, DOI 10.1016/S1072-7515(99)00075-7; Sperti C, 1997, WORLD J SURG, V21, P195, DOI 10.1007/s002689900215; Takada T, 2002, CANCER, V95, P1685, DOI 10.1002/cncr.10831; Ueno H, 2009, BRIT J CANCER, V101, P908, DOI 10.1038/sj.bjc.6605256; Van Laethem JL, 2010, J CLIN ONCOL, V28, P4450, DOI 10.1200/JCO.2010.30.3446; Von Hoff DD, 2013, J CLIN ONCOL, V31, DOI 10.1200/jco.2013.31.4_suppl.lba148; Welch SA, 2007, J CLIN ONCOL, V25, P2159, DOI 10.1200/JCO.2006.09.9788	29	1088	1125	1	32	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 9	2013	310	14					1473	1481		10.1001/jama.2013.279201	http://dx.doi.org/10.1001/jama.2013.279201			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	230PK	24104372	Bronze			2022-12-28	WOS:000325354100023
J	Correia, AW; Peters, JL; Levy, JI; Melly, S; Dominici, F				Correia, Andrew W.; Peters, Junenette L.; Levy, Jonathan I.; Melly, Steven; Dominici, Francesca			Residential exposure to aircraft noise and hospital admissions for cardiovascular diseases: multi-airport retrospective study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							BLOOD-PRESSURE; AIR-POLLUTION; HYPERTENSION; MORTALITY; HEALTH; ACCURACY; SYSTEM; IMPACT	Objective To investigate whether exposure to aircraft noise increases the risk of hospitalization for cardiovascular diseases in older people (>= 65 years) residing near airports. Design Multi-airport retrospective study of approximately 6 million older people residing near airports in the United States. We superimposed contours of aircraft noise levels (in decibels, dB) for 89 airports for 2009 provided by the US Federal Aviation Administration on census block resolution population data to construct two exposure metrics applicable to zip code resolution health insurance data: population weighted noise within each zip code, and 90th centile of noise among populated census blocks within each zip code. Setting 2218 zip codes surrounding 89 airports in the contiguous states. Participants 6 027 363 people eligible to participate in the national medical insurance (Medicare) program (aged >= 65 years) residing near airports in 2009. Main outcome measures Percentage increase in the hospitalization admission rate for cardiovascular disease associated with a 10 dB increase in aircraft noise, for each airport and on average across airports adjusted by individual level characteristics (age, sex, race), zip code level socioeconomic status and demographics, zip code level air pollution (fine particulate matter and ozone), and roadway density. Results Averaged across all airports and using the 90th centile noise exposure metric, a zip code with 10 dB higher noise exposure had a 3.5% higher (95% confidence interval 0.2% to 7.0%) cardiovascular hospital admission rate, after controlling for covariates. Conclusions Despite limitations related to potential misclassification of exposure, we found a statistically significant association between exposure to aircraft noise and risk of hospitalization for cardiovascular diseases among older people living near airports.	[Correia, Andrew W.] NMR Grp, Somerville, NJ USA; [Peters, Junenette L.; Levy, Jonathan I.] Boston Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA USA; [Melly, Steven] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA; [Dominici, Francesca] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA	Boston University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Dominici, F (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA.	fdominic@hsph.harvard.edu	Levy, Jon/B-4542-2011	Levy, Jon/0000-0002-1116-4006; /0000-0003-4542-4563	Federal Aviation Administration, under FAA award [09-C-NE-HU, 10-C-NE-BU]	Federal Aviation Administration, under FAA award	This study was supported by the Federal Aviation Administration, under FAA award No 09-C-NE-HU amendment No 004 and 10-C-NE-BU amendment No 002. The sponsor provided the noise contours, but had no role in the analysis or interpretation of data; in the writing of the reports; or in the decision to submit the article for publication. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the funder.	Babisch W., 2011, BURDEN DIS ENV NOISE; Babisch Wolfgang, 2006, Noise Health, V8, P1; Babisch W, 2009, NOISE HEALTH, V11, P161, DOI 10.4103/1463-1741.53363; Baicker K, 2004, HEALTH AFFAIR, V23, pVAR33, DOI 10.1377/hlthaff.var.33; Bates D., 2012, LINEAR MIXED MODEL I; Beelen R, 2009, OCCUP ENVIRON MED, V66, P243, DOI 10.1136/oem.2008.042358; Bluhm G, 2011, NOISE HEALTH, V13, P212, DOI 10.4103/1463-1741.80152; Button K., 2010, TRANSPORT EC; de Kluizenaar Y, 2007, J OCCUP ENVIRON MED, V49, P484, DOI 10.1097/JOM.0b013e318058a9ff; Dominici F, 2006, EPIDEMIOLOGY, V17, pS19, DOI 10.1097/00001648-200611001-00004; Dominici F, 2006, JAMA-J AM MED ASSOC, V295, P1127, DOI 10.1001/jama.295.10.1127; Eriksson C, 2007, EPIDEMIOLOGY, V18, P716, DOI 10.1097/EDE.0b013e3181567e77; Eriksson C, 2010, ENVIRON RES, V110, P764, DOI 10.1016/j.envres.2010.09.001; Federal Aviation Administration, 2007, INT NOIS MOD INM VER; Floud S, 2011, OCCUP ENVIRON MED, V68, P518, DOI 10.1136/oem.2010.058586; Franssen E.A., 2002, ENVIRON IMPACT ASSES, V22, P633, DOI [DOI 10.1016/S0195-9255(02)00015-X, 10.1016/S0195-9255(02)00015-X]; Franssen EAM, 2004, OCCUP ENVIRON MED, V61, P405, DOI 10.1136/oem.2002.005488; FRERICHS RR, 1980, AM J PUBLIC HEALTH, V70, P357, DOI 10.2105/AJPH.70.4.357; Grassi G, 2006, HYPERTENS RES, V29, P839, DOI 10.1291/hypres.29.839; Greiser E, 2007, EPIDEMIOLOGY, V18, pS33; Haralabidis AS, 2008, EUR HEART J, V29, P658, DOI 10.1093/eurheartj/ehn013; Haralabidis AS, 2011, J EPIDEMIOL COMMUN H, V65, P535, DOI 10.1136/jech.2009.102954; Hatfield J., 2001, Noise Health, V3, P1; Havranek EP, 2004, ARCH INTERN MED, V164, P1186, DOI 10.1001/archinte.164.11.1186; Heisterkamp SH, 2000, STAT MED, V19, P2569, DOI 10.1002/1097-0258(20000915/30)19:17/18<2569::AID-SIM588>3.0.CO;2-K; Huss A, 2010, EPIDEMIOLOGY, V21, P829, DOI 10.1097/EDE.0b013e3181f4e634; Ising H, 2004, Noise Health, V6, P5; Jarup L, 2008, ENVIRON HEALTH PERSP, V116, P329, DOI 10.1289/ehp.10775; Kiyota Y, 2004, AM HEART J, V148, P99, DOI 10.1016/j.ahj.2004.02.013; KNIPSCHILD P, 1977, INT ARCH OCC ENV HEA, V40, P185, DOI 10.1007/BF01842081; Losina E, 2003, J CLIN EPIDEMIOL, V56, P515, DOI 10.1016/S0895-4356(03)00056-8; Mancia G, 2007, J HYPERTENS, V25, P909, DOI 10.1097/HJH.0b013e328048d004; Mancia G, 2006, J HYPERTENS, V24, pS17, DOI 10.1097/01.hjh.0000220099.12154.c1; Matsui T, 2004, J SOUND VIB, V277, P469, DOI 10.1016/j.jsv.2004.03.007; Meecham W C, 1979, Br J Audiol, V13, P77, DOI 10.3109/03005367909078881; Miedema HME, 2000, J ACOUST SOC AM, V107, P3245, DOI 10.1121/1.429396; Nelson P, 2004, J TRANSP ECON POLICY, V38, P1; Rosenlund M, 2001, OCCUP ENVIRON MED, V58, P769, DOI 10.1136/oem.58.12.769; Selander J, 2009, ENVIRON HEALTH PERSP, V117, P1713, DOI 10.1289/ehp.0900933; Spreng M., 2000, Noise Health, V2, P59; Stansfeld S, 2011, NOISE HEALTH, V13, P229, DOI 10.4103/1463-1741.80159; Vander Hoorn S, 2004, COMP QUANTIFICATION, P2129; Wakefield J, 2006, BIOSTATISTICS, V7, P438, DOI 10.1093/biostatistics/kxj017; Zhou YJ, 2010, ANN APPL STAT, V4, P1451, DOI 10.1214/09-AOAS325	44	88	89	0	48	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 8	2013	347								f5561	10.1136/bmj.f5561	http://dx.doi.org/10.1136/bmj.f5561			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	235OJ	24103538	hybrid, Green Published			2022-12-28	WOS:000325728600002
J	Watts, G				Watts, Geoff			Jeremy Farrar: Wellcome arrival from southeast Asia	LANCET			English	Biographical-Item																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 5	2013	382	9899					1167	1167		10.1016/S0140-6736(13)62047-4	http://dx.doi.org/10.1016/S0140-6736(13)62047-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	228SL	24095187				2022-12-28	WOS:000325209100013
J	Bennett, JW; Pybus, BS; Yadava, A; Tosh, D; Sousa, JC; McCarthy, WF; Deye, G; Melendez, V; Ockenhouse, CF				Bennett, Jason W.; Pybus, Brandon S.; Yadava, Anjali; Tosh, Donna; Sousa, Jason C.; McCarthy, William F.; Deye, Gregory; Melendez, Victor; Ockenhouse, Christian F.			Primaquine Failure and Cytochrome P-450 2D6 in Plasmodium vivax Malaria	NEW ENGLAND JOURNAL OF MEDICINE			English	Letter								Primaquine is used to eradicate the hepatic or hypnozoite form of Plasmodium vivax that may lead to relapse of infection. Host genetic factors may play a role in the activity of primaquine therapy.To the Editor: Primaquine is the only medication approved by the Food and Drug Administration to eradicate the hypnozoites of Plasmodium vivax, but relapses of P. vivax malaria due to drug failure occur.(1) Human cytochrome P-450 isoenzyme 2D6 (CYP2D6) may be a key enzyme involved in metabolizing primaquine into redox-active metabolites against hypnozoites in the liver.(2),(3) As part of a phase 1 clinical trial of a vaccine against P. vivax (Study of VMP001 and AS01B in Healthy Malaria-Naive Adults; ClinicalTrials.gov number, NCT01157897), 33 participants were exposed to P. vivax sporozoites from the bites of infected mosquitoes. Parasitemia developed in ...	[Bennett, Jason W.; Pybus, Brandon S.; Yadava, Anjali; Tosh, Donna; Sousa, Jason C.; Deye, Gregory; Melendez, Victor; Ockenhouse, Christian F.] Walter Reed Army Inst Res, Silver Spring, MD 20910 USA; [McCarthy, William F.] US Army Med Mat Dev Act, Frederick, MD USA	United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); United States Department of Defense; United States Army	Bennett, JW (corresponding author), Walter Reed Army Inst Res, Silver Spring, MD 20910 USA.	jason.w.bennett.mil@mail.mil	Sousa, Jason/A-9177-2011; Deye, Gregory/AAL-7961-2021					Baird JK, 2004, CLIN INFECT DIS, V39, P1336, DOI 10.1086/424663; De Gregori M, 2010, CURR DRUG METAB, V11, P276, DOI 10.2174/138920010791196274; Gaedigk A, 2008, CLIN PHARMACOL THER, V83, P234, DOI 10.1038/sj.clpt.6100406; Pybus BS, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-259; Vale N, 2009, EUR J MED CHEM, V44, P937, DOI 10.1016/j.ejmech.2008.08.011	5	191	194	0	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 3	2013	369	14					1381	1382		10.1056/NEJMc1301936	http://dx.doi.org/10.1056/NEJMc1301936			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	227KI	24088113				2022-12-28	WOS:000325111200022
J	Butt, CA				Butt, Carrie A.			Dark Passage Dorothy Dehner	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 2	2013	310	13					1324	1325		10.1001/jama.2013.5340	http://dx.doi.org/10.1001/jama.2013.5340			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	227GB	24084901				2022-12-28	WOS:000325098100001
J	Granger, K				Granger, Kate			PERSONAL VIEW Healthcare staff must properly introduce themselves to patients	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												kategranger@doctors.org.uk							0	17	17	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 2	2013	347								f5833	10.1136/bmj.f5833	http://dx.doi.org/10.1136/bmj.f5833			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	231OU	24089426				2022-12-28	WOS:000325427400009
J	Cooper, AL; Kazis, LE; Dore, DD; Mor, V; Trivedi, AN				Cooper, Alicia L.; Kazis, Lewis E.; Dore, David D.; Mor, Vincent; Trivedi, Amal N.			Underreporting High-Risk Prescribing Among Medicare Advantage Plans	ANNALS OF INTERNAL MEDICINE			English	Article							QUALITY-OF-CARE	Background: Although Medicare Advantage plans are required to report clinical performance using Healthcare Effectiveness Data and Information Set (HEDIS) quality indicators, the accuracy of plan-reported performance rates is unknown. Objective: To compare calculated and reported rates of high-risk prescribing among Medicare Advantage plans. Design: Cross-sectional comparison. Setting: 172 Medicare Advantage plans. Patients: A random sample of beneficiaries in 172 Medicare Advantage plans in 2006 (n = 177 227) and 2007 (n = 173 655). Measurements: Plan-reported HEDIS rates of high-risk prescribing among elderly persons were compared with rates calculated from Medicare Advantage plans' Part D claims by using the same measure specifications and source population. Results: The mean rate of high-risk prescribing derived from Part D claims was 26.9% (95% CI, 25.9% to 28.0%), whereas the mean plan-reported rate was 21.1% (CI, 20.0% to 22.3%). Approximately 95% of plans underreported rates of high-risk prescribing relative to calculated rates derived from Part D claims. The differences in the calculated and reported rates negatively affected quality rankings for the plans that most accurately reported rates. For example, the 9 plans that reported rates of high-risk prescribing within 1 percentage point of calculated rates were ranked 43.4 positions lower when reported rates were used instead of calculated rates. Among 103 680 individuals present in both the sample of Part D claims and HEDIS data in 2006, Medicare Advantage plans incorrectly excluded 10.3% as ineligible for the HEDIS high-risk prescribing measure. Among those correctly included in the high-risk prescribing denominator, the reported rate of high-risk prescribing was 21.9% and the calculated rate was 26.2%. Limitation: A single quality measure was assessed. Conclusion: Medicare Advantage plans underreport rates of high-risk prescribing, suggesting a role for routine audits to ensure the validity of publicly reported quality measures. Primary Funding Source: Health Assessment Lab and National Institute on Aging.	Dept Vermont Hlth Access, Williston, VT USA; Brown Univ, Providence Vet Affairs Med Ctr, Providence, RI 02912 USA; [Trivedi, Amal N.] Brown Univ, Dept Hlth Serv Policy & Practice, Providence, RI 02912 USA; Boston Univ, Sch Publ Hlth, Ctr Assessment Pharmaceut Practices, Boston, MA USA; Edith Nourse Rogers Mem Vet Adm Hosp, Vet Affairs Med Ctr, Ctr Hlth Qual Outcomes & Econ Res, Bedford, MA 01730 USA	Brown University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Providence VA Medical Center; Brown University; Boston University; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Trivedi, AN (corresponding author), Brown Univ, Dept Hlth Serv Policy & Practice, Box G-S121-6, Providence, RI 02912 USA.	amal_trivedi@brown.edu		Dore, David/0000-0003-0810-6662	Health Assessment Lab; National Institute on Aging; NATIONAL INSTITUTE ON AGING [RC1AG036158] Funding Source: NIH RePORTER	Health Assessment Lab; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Health Assessment Lab and National Institute on Aging.	[Anonymous], 2008, HEDIS 2008 PAT LEV D; [Anonymous], 2007, HEDIS 2007 PAT LEV D; [Anonymous], 2008, MED HLTH OUTC SURV 2; [Anonymous], 2008, HOSP QUAL DAT ISS CH; [Anonymous], 2006, HOSP QUAL DAT CMS NE; [Anonymous], 2011, HEDIS COMPL AUD PROG; Berwick DM, 2002, JAMA-J AM MED ASSOC, V288, P1523, DOI 10.1001/jama.288.12.1523; Fung CH, 2008, ANN INTERN MED, V148, P111, DOI 10.7326/0003-4819-148-2-200801150-00006; Health Care Financing Administration US Department of Health and Human Services, 1998, MED HEDIS 3 0 1998 D; Jacobson G, 2011, MEDICARE ADVANTAGE P; Kaiser Family Foundation, 2013, TOT MED ADV MA ENR; Kern LM, 2013, ANN INTERN MED, V158, P77, DOI 10.7326/0003-4819-158-2-201301150-00001; Narins CR, 2005, ARCH INTERN MED, V165, P83, DOI 10.1001/archinte.165.1.83; Pawlson LG, 2007, AM J MANAG CARE, V13, P553; Trivedi AN, 2005, NEW ENGL J MED, V353, P692, DOI 10.1056/NEJMsa051207; Werner RM, 2005, JAMA-J AM MED ASSOC, V293, P1239, DOI 10.1001/jama.293.10.1239; Zhang YT, 2010, NEW ENGL J MED, V363, P1985, DOI 10.1056/NEJMp1010220	17	11	11	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819			ANN INTERN MED	Ann. Intern. Med.	OCT 1	2013	159	7					456	U162		10.7326/0003-4819-159-7-201310010-00005	http://dx.doi.org/10.7326/0003-4819-159-7-201310010-00005			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	234FQ	24081286	Green Accepted			2022-12-28	WOS:000325628000003
J	McCulloch, P; Nagendran, M; Campbell, WB; Price, A; Jani, A; Birkmeyer, JD; Gray, M				McCulloch, Peter; Nagendran, Myura; Campbell, W. Bruce; Price, Andrew; Jani, Anant; Birkmeyer, John D.; Gray, Muir			Strategies to reduce variation in the use of surgery	LANCET			English	Article							KNEE REPLACEMENT; PHYSICIAN REIMBURSEMENT; INTRACRANIAL ANEURYSMS; CAROTID-ENDARTERECTOMY; FINANCIAL INCENTIVES; SURGICAL-PROCEDURES; NEED REGULATIONS; UNITED-STATES; DECISION AIDS; TOTAL HIP	Provision rates for surgery vary widely in relation to identifiable need, suggesting that reduction of this variation might be appropriate. The definition of unwarranted variation is difficult because the boundaries of acceptable practice are wide, and information about patient preference is lacking. Very little direct research evidence exists on the modification of variations in surgery rates, so inferences must be drawn from research on the alteration of overall rates. The available evidence has large gaps, which suggests that some proposed strategies produce only marginal change. Micro-level interventions target decision making that affects individuals, whereas macro-level interventions target health-care systems with the use of financial, regulatory, or incentivisation strategies. Financial and regulatory changes can have major effects on provision rates, but these effects are often complex and can include unintended adverse effects. The net effects of micro-level strategies (such as improvement of evidence and dissemination of evidence, and support for shared decision making) can be smaller, but better directed. Further research is needed to identify what level of variation in surgery rates is appropriate in a specific context, and how variation can be reduced where desirable.	[McCulloch, Peter; Nagendran, Myura] Univ Oxford, Nuffield Dept Surg Sci, Oxford, England; [Price, Andrew] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford, England; [Campbell, W. Bruce] Natl Inst Hlth & Care Excellence, Intervent Procedures Advisory Comm, London, England; [Jani, Anant; Gray, Muir] Dept Hlth, QIPP Right Care Program, Oxford, England; [Birkmeyer, John D.] Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA	University of Oxford; University of Oxford; National Institute for Health & Care Excellence; University of Michigan System; University of Michigan	McCulloch, P (corresponding author), John Radcliffe Hosp, Nuffield Dept Surg Sci, Oxford OX3 9DU, England.	peter.mcculloch@nds.ox.ac.uk		Nagendran, Myura/0000-0002-4656-5096; McCulloch, Peter/0000-0002-3210-8273				Beard DJ, 2012, KNEE, V19, P886, DOI 10.1016/j.knee.2012.05.005; Berwanger O, 2012, JAMA-J AM MED ASSOC, V307, P2041, DOI 10.1001/jama.2012.413; Bickell NA, 2008, JNCI-J NATL CANCER I, V100, P1717, DOI 10.1093/jnci/djn387; Birkmeyer JD, 1998, SURGERY, V124, P917, DOI 10.1067/msy.1998.90268; Birkmeyer JD, 2013, LANCET, V382, P1121, DOI 10.1016/S0140-6736(13)61215-5; Black N, 2002, QUAL SAF HEALTH CARE, V11, P121, DOI 10.1136/qhc.11.2.121; BMJ Group NHS, 2013, SHAR DEC MAK; Brinjikji W, 2011, AM J NEURORADIOL, V32, P1071, DOI 10.3174/ajnr.A2453; Coory M, 2008, LUNG CANCER, V60, P14, DOI 10.1016/j.lungcan.2008.01.008; Costa ML, 2009, ACTA OBSTET GYN SCAN, V88, P793, DOI 10.1080/00016340903002857; Coulter A., 2011, MAKING SHARED DECISI; Crandall W, 2011, INFLAMM BOWEL DIS, V17, P450, DOI 10.1002/ibd.21394; Deyo RA, 2000, MED CARE, V38, P959, DOI 10.1097/00005650-200009000-00009; Dieleman Marjolein, 2003, Hum Resour Health, V1, P10, DOI 10.1186/1478-4491-1-10; Dimick JB, 2013, JAMA-J AM MED ASSOC, V309, P792, DOI 10.1001/jama.2013.755; Elliott SP, 2010, J NATL CANCER I, V102, P1826, DOI 10.1093/jnci/djq417; Ells LJ, 2007, OBES SURG, V17, P400, DOI 10.1007/s11695-007-9070-x; Fitch K., 2001, RAND UCLA APPROPRIAT; Foster DG, 2011, OBSTET GYNECOL, V117, P566, DOI 10.1097/AOG.0b013e3182056309; Franco LM, 2004, SOC SCI MED, V58, P343, DOI 10.1016/S0277-9536(03)00203-X; Goldberg H I, 2001, Eff Clin Pract, V4, P95; Grimshaw J, 2006, J GEN INTERN MED, V21, pS14, DOI 10.1111/j.1525-1497.2006.00357.x; Grumbach K, 2002, HEALTH AFFAIR, V21, P13, DOI 10.1377/hlthaff.21.5.13; Halliday AW, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b1847; Hicks V, 2001, PAY NONPAY INCENTIVE; Ho V, 2007, AM HEART J, V154, P767, DOI 10.1016/j.ahj.2007.06.031; Hong YC, 2012, AM J MANAG CARE, V18, pE35; HOSHINO K, 1993, BIOETHICS, V7, P234, DOI 10.1111/j.1467-8519.1993.tb00289.x; Iorio R, 2008, J BONE JOINT SURG AM, V90A, P1598, DOI 10.2106/JBJS.H.00067; Ivers N, 2012, COCHRANE DB SYST REV, V6, DOI DOI 10.1002/14651858.CD000259.PUB3; Jayadev C, 2012, KNEE, V19, P746, DOI 10.1016/j.knee.2012.02.001; Kennedy ADM, 2002, JAMA-J AM MED ASSOC, V288, P2701, DOI 10.1001/jama.288.21.2701; Lau KKW, 2013, J THORAC ONCOL, V8, P68, DOI 10.1097/JTO.0b013e3182762315; Laubach W, 2007, INT J PUBLIC HEALTH, V52, P54, DOI 10.1007/s00038-006-5021-x; Lawson EH, 2011, ARCH SURG-CHICAGO, V146, P1433, DOI 10.1001/archsurg.2011.581; Lee H, 2013, LANCET, V381, P534, DOI 10.1016/S0140-6736(13)60277-9; LEGORRETA AP, 1993, JAMA-J AM MED ASSOC, V270, P1429, DOI 10.1001/jama.270.12.1429; Levine PB, 1996, J HEALTH ECON, V15, P555, DOI 10.1016/S0167-6296(96)00495-X; Livingston EH, 2010, ARCH SURG-CHICAGO, V145, P993, DOI 10.1001/archsurg.2010.218; Manongi Rachel N, 2006, Hum Resour Health, V4, P6, DOI 10.1186/1478-4491-4-6; Mason J, 2001, BMJ-BRIT MED J, V323, P1096, DOI 10.1136/bmj.323.7321.1096; Mathauer Inke, 2006, Hum Resour Health, V4, P24, DOI 10.1186/1478-4491-4-24; Meng Q, 2012, LANCET, V379, P805, DOI 10.1016/S0140-6736(12)60278-5; Molyneux A, 2002, LANCET, V360, P1267, DOI 10.1016/S0140-6736(02)11314-6; Molyneux AJ, 2005, LANCET, V366, P809, DOI 10.1016/S0140-6736(05)67214-5; Murray E, 2001, BMJ-BRIT MED J, V323, P493, DOI 10.1136/bmj.323.7311.493; Murthy L, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009401.pub2; National Joint Registry, 2011, 8 NAT JOINT REG; NHS, 2013, RIGHTCARE SHAR DEC M; NICE, 2008, STROK DIAGN IN MAN A, V68; O'Connor AM, 2009, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001431.pub2, 10.1002/14651858.CD001431.pub3, 10.1002/14651858.CD001431.pub4]; Pink DH, 2011, DRIVE SURPRISING TRU; Pockney P, 2004, J PUBLIC HEALTH-UK, V26, P264, DOI 10.1093/pubmed/fdh152; Popescu I, 2006, JAMA-J AM MED ASSOC, V295, P2141, DOI 10.1001/jama.295.18.2141; Raymond EG, 2007, OBSTET GYNECOL, V109, P181, DOI 10.1097/01.AOG.0000250904.06923.4a; Rerkasem K, 2011, COCHRANE DB SYST REV, V4; Rogers EM., 1983, DIFFUSION INNOVATION; Roos N P, 2001, Healthc Manage Forum, V14, P11; Ross JS, 2007, CIRCULATION, V115, P1012, DOI 10.1161/CIRCULATIONAHA.106.658377; Rothwell PM, 2004, LANCET, V363, P915, DOI 10.1016/S0140-6736(04)15785-1; Rothwell PM, 2003, LANCET, V361, P107, DOI 10.1016/S0140-6736(03)12228-3; Rudarakanchana N, 2012, BRIT J SURG, V99, P209, DOI 10.1002/bjs.7810; Scarborough JE, 2008, J AM COLL SURGEONS, V206, P678, DOI 10.1016/j.jamcollsurg.2007.11.016; Seshamani M, 2006, MED CARE, V44, P527, DOI 10.1097/01.mlr.0000215886.49343.c6; Shafrin J, 2010, HEALTH ECON, V19, P562, DOI 10.1002/hec.1495; Shrank W, 2005, ARCH OPHTHALMOL-CHIC, V123, P1733, DOI 10.1001/archopht.123.12.1733; SIBLEY JC, 1982, NEW ENGL J MED, V306, P511, DOI 10.1056/NEJM198203043060904; Smith AJ, 2012, LANCET, V380, P1759, DOI 10.1016/S0140-6736(12)60989-1; Smith GL, 2009, J AM COLL SURGEONS, V209, P425, DOI 10.1016/j.jamcollsurg.2009.06.363; Sundararaman T, 2011, B WORLD HEALTH ORGAN, V89, P73, DOI 10.2471/BLT.09.070862; Tung YC, 2010, STROKE, V41, P504, DOI 10.1161/STROKEAHA.109.568956; Voleti PB, 2012, J ARTHROPLASTY, V27, P1844, DOI 10.1016/j.arth.2012.05.023	72	76	76	0	17	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 28	2013	382	9898					1130	1139		10.1016/S0140-6736(13)61216-7	http://dx.doi.org/10.1016/S0140-6736(13)61216-7			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	228SG	24075053				2022-12-28	WOS:000325208100029
J	Morantz-Sanchez, R				Morantz-Sanchez, Regina			The art of medicine	LANCET			English	Editorial Material									Univ Michigan, Dept Hist, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Morantz-Sanchez, R (corresponding author), Univ Michigan, Dept Hist, Ann Arbor, MI 48109 USA.	reginann@umich.edu						Bittel C., 2009, MARY PUTNAM JACOBI A; Cassell J., 1998, THE WOMAN IN THE SUR; Morantz-Sanchez R, 1999, CONDUCT UNBECOMING A; Morantz-Sanchez R., 1985, SYMPATHY AND SCIENCE; More Ellen S., 1999, RESTORING THE BALANC; Moscucci Ornella, 1990, THE SCIENCE OF WOMAN; Peitzman Steven Jay, 2000, NEW UNTRIED COURSE W	7	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 28	2013	382	9898					1088	1089		10.1016/S0140-6736(13)62011-5	http://dx.doi.org/10.1016/S0140-6736(13)62011-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	228SG	24083309	Bronze			2022-12-28	WOS:000325208100014
J	Taleff, EM; Pedrazas, NA				Taleff, Eric M.; Pedrazas, Nicholas A.			A New Route for Growing Large Grains in Metals	SCIENCE			English	Editorial Material							GROWTH; MOTION		[Taleff, Eric M.; Pedrazas, Nicholas A.] Univ Texas Austin, Dept Mech Engn, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Taleff, EM (corresponding author), Univ Texas Austin, Dept Mech Engn, Austin, TX 78712 USA.	taleff@mail.utexas.edu						Cahn JW, 2006, ACTA MATER, V54, P4953, DOI 10.1016/j.actamat.2006.08.004; Cahn JW, 2004, ACTA MATER, V52, P4887, DOI 10.1016/j.actamat.2004.02.048; Ciulik J, 2009, SCRIPTA MATER, V61, P895, DOI 10.1016/j.scriptamat.2009.07.021; Holm EA, 2010, SCIENCE, V328, P1138, DOI 10.1126/science.1187833; Humphreys FJ, 2004, RECRYSTALLIZATION RE, V2nd, P368; Li SF, 2013, J APPL CRYSTALLOGR, V46, P512, DOI 10.1107/S0021889813005268; Natl. Res. Counc, 2008, INT COMP MAT ENG TRA; Nieh T. G., 2007, SUPERPLASTICITY META, P40; Omori T, 2013, SCIENCE, V341, P1500, DOI 10.1126/science.1238017; Rupert TJ, 2009, SCIENCE, V326, P1686, DOI 10.1126/science.1178226; Shvindlerman L. S., 1999, CRC MAT SCI TECHNOL; The Minerals Metals & Materials Society, 2013, INT COMP MAT ENG ICM; WASHBURN J, 1952, JOM-J MIN MET MAT S, V4, P1076, DOI 10.1007/BF03397774; Winning M, 2001, ACTA MATER, V49, P211, DOI 10.1016/S1359-6454(00)00321-9; Worthington DL, 2013, METALL MATER TRANS A, V44A, P5025, DOI 10.1007/s11661-013-1865-x; WU MY, 1987, METALL TRANS A, V18, P451, DOI 10.1007/BF02648806	16	18	19	0	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 27	2013	341	6153					1461	1462		10.1126/science.1245056	http://dx.doi.org/10.1126/science.1245056			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	224NS	24072912				2022-12-28	WOS:000324894600035
J	Lipsitz, LA				Lipsitz, Lewis A.			A 91-Year-Old Woman With Difficult-to-Control Hypertension A Clinical Review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							HIGH BLOOD-PRESSURE; ISOLATED SYSTOLIC HYPERTENSION; CARDIOVASCULAR MORBIDITY; COGNITIVE FUNCTION; RANDOMIZED TRIAL; DOUBLE-BLIND; MORTALITY; OLD; HYDROCHLOROTHIAZIDE; SURVIVAL	IMPORTANCE Hypertension is common among people older than 65 years, affecting nearly two-thirds of men and three-fourths of women by age 75 years. Treatment goals and medication selection for this population may differ from those for younger patients. OBJECTIVE To discuss the presentation, pathophysiology, and optimal treatment of hypertension among elderly persons. EVIDENCE REVIEW MEDLINE was searched from 1990 to 2013. A hand search of bibliographies from guidelines and review articles from 2000 to 2013 was also used to identify studies of hypertension treatment in patients older than 65 years. FINDINGS Hypertension in elderly people differs from that in younger people in that (1) hypertension is predominantly systolic because of vascular stiffness; (2) it is associated with reduced baroreflex sensitivity, which increases blood pressure variability and vulnerability to hypotension during common daily activities; (3) it is associated with cognitive and functional decline as well as adverse cardiovascular outcomes; and (4) hypertension may be beneficial in frail people older than 85 years. Treatment of healthy patients up to age 85 years with most antihypertensive medications reduces cardiovascular morbidity and mortality and possibly cognitive and functional decline. CONCLUSION AND RELEVANCE Although patients in their 90s have not been studied, any ambulatory and independent patient older than 80 years should have multiple blood pressure measurements taken during their usual daily activities, and if these show persistent hypertension, these patients should be treated judiciously.	[Lipsitz, Lewis A.] Hebrew SeniorLife, Inst Aging Res, Boston, MA 02131 USA; [Lipsitz, Lewis A.] Beth Israel Deaconess Med Ctr, Div Gerontol, Boston, MA 02215 USA; [Lipsitz, Lewis A.] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Hebrew SeniorLife; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Lipsitz, LA (corresponding author), Hebrew SeniorLife, Inst Aging Res, 1200 Ctr St, Boston, MA 02131 USA.	lipsitz@hsl.harvard.edu			National Institute on Aging [AG025037]; NATIONAL INSTITUTE ON AGING [R01AG025037, R37AG025037] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Clinical Crossroads receives no external support. Dr Lipsitz is supported by grant AG025037 from the National Institute on Aging and holds the Irving and Edyth S. Usen and Family Chair in Geriatric Medicine at Hebrew SeniorLife.	[Anonymous], 1991, JAMA, V265, P3255; Aronow WS, 2011, CIRCULATION, V123, pE616, DOI [10.1161/CIR.0b013e318222d03f, 10.1161/CIR.0b013e31821daaf6]; Beckett NS, 2008, NEW ENGL J MED, V358, P1887, DOI 10.1056/NEJMoa0801369; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; COOPE JR, 1987, BRIT MED J, V294, P179, DOI 10.1136/bmj.294.6565.179-a; Cooper-DeHoff RM, 2010, JAMA-J AM MED ASSOC, V304, P61, DOI 10.1001/jama.2010.884; DAHLOF B, 1991, LANCET, V338, P1281, DOI 10.1016/0140-6736(91)92589-T; Dahlof B, 2002, LANCET, V359, P995, DOI 10.1016/S0140-6736(02)08089-3; Denardo SJ, 2010, AM J MED, V123, P719, DOI 10.1016/j.amjmed.2010.02.014; Dorresteijn JAN, 2012, HYPERTENSION, V59, P14, DOI 10.1161/HYPERTENSIONAHA.111.179143; FROHLICH ED, 1988, ANN INTERN MED, V109, P612, DOI 10.7326/0003-4819-109-8-612; Furberg CD, 2000, JAMA-J AM MED ASSOC, V283, P1967; Guo ZC, 1997, AM J PUBLIC HEALTH, V87, P623, DOI 10.2105/AJPH.87.4.623; Hajjar I, 2011, CIRCULATION, V123, P858, DOI 10.1161/CIRCULATIONAHA.110.978114; Jamerson K, 2008, NEW ENGL J MED, V359, P2417, DOI 10.1056/NEJMoa0806182; Jatos Study Grp, 2008, HYPERTENS RES, V31, P2115, DOI 10.1291/hypres.31.2115; JONSSON PV, 1990, ARCH INTERN MED, V150, P1518, DOI 10.1001/archinte.150.7.1518; Kannel WB, 1997, AM HEART J, V134, P758, DOI 10.1016/S0002-8703(97)70061-9; Kaplan NM, 2011, HYPERTENSION, V58, P994, DOI 10.1161/HYPERTENSIONAHA.111.183525; LANGER RD, 1991, AM J EPIDEMIOL, V134, P29, DOI 10.1093/oxfordjournals.aje.a115990; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; LIPSITZ LA, 1989, J GERONTOL, V44, pM179, DOI 10.1093/geronj/44.6.M179; Lipsitz LA, 2005, HYPERTENSION, V45, P216, DOI 10.1161/01.HYP.0000153094.09615.11; Lloyd-Jones D, 2009, CIRCULATION, V119, pE21, DOI 10.1161/CIRCULATIONAHA.108.191261; Masuo K, 1996, AM J HYPERTENS, V9, P263, DOI 10.1016/0895-7061(95)00348-7; MATTILA K, 1988, BRIT MED J, V296, P887, DOI 10.1136/bmj.296.6626.887; MEADE TW, 1992, BMJ-BRIT MED J, V304, P405; Odden MC, 2012, ARCH INTERN MED, V172, P1162, DOI 10.1001/archinternmed.2012.2555; Ogihara T, 2010, HYPERTENSION, V56, P196, DOI 10.1161/HYPERTENSIONAHA.109.146035; OMALLEY K, 1988, J HYPERTENS, V6, pS105; Peters R, 2008, LANCET NEUROL, V7, P683, DOI 10.1016/S1474-4422(08)70143-1; Peterzan MA, 2012, HYPERTENSION, V59, P1104, DOI 10.1161/HYPERTENSIONAHA.111.190637; Rastas S, 2006, J AM GERIATR SOC, V54, P912, DOI 10.1111/j.1532-5415.2006.00742.x; Sabayan B, 2013, STROKE, V44, P15, DOI 10.1161/STROKEAHA.112.663062; Staessen JA, 1997, LANCET, V350, P757, DOI 10.1016/S0140-6736(97)05381-6; Tzourio C, 1999, NEUROLOGY, V53, P1948, DOI 10.1212/WNL.53.9.1948; Wang JG, 2000, ARCH INTERN MED, V160, P211, DOI 10.1001/archinte.160.2.211; Whelton PK, 1998, JAMA-J AM MED ASSOC, V279, P839, DOI 10.1001/jama.279.11.839; Wing LMH, 2003, NEW ENGL J MED, V348, P583, DOI 10.1056/NEJMoa021716; 1979, JAMA-J AM MED ASSOC, V242, P2572	40	9	9	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 25	2013	310	12					1274	1280		10.1001/jama.2013.277027	http://dx.doi.org/10.1001/jama.2013.277027			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	222SO	24065014	Green Accepted			2022-12-28	WOS:000324751800024
J	Machel, G; Pires, E; Carlsson, G				Machel, Graca; Pires, Emilia; Carlsson, Gunilla			The world we want: an end to child marriage	LANCET			English	Editorial Material							COUNTRIES		[Machel, Graca] Partnership Maternal Newborn & Child Hlth, CH-1211 Geneva 27, Switzerland; [Machel, Graca] Elders Founders Girls Not Brides Global Partnersh, London, England; [Carlsson, Gunilla] Minist Int Dev Cooperat Sweden, Stockholm, Sweden		Machel, G (corresponding author), Partnership Maternal Newborn & Child Hlth, CH-1211 Geneva 27, Switzerland.	pmnch-chair@who.int						Chandra-Mouli V, 2013, J ADOLESCENT HEALTH, V52, P517, DOI 10.1016/j.jadohealth.2013.03.002; High-Level Panel of Eminent Persons on the Post-2015 Development Agenda, 2013, NEW GLOB PARTN ER PO; Kishor S., 2004, PROFILING DOMESTIC V; Raj A, 2013, VIOLENCE AGAINST WOM, V19, P536, DOI 10.1177/1077801213487747; UN, 2013, 68 SESS GEN ASS NEW; UNFPA, 2012, MARR TOO YOUNG END C; UNICEF, 2013, STAT WORLDS CHILDR 2; UNICEF, UNICEF SUPP CAMP END; United Nations Children's Fund (UNICEF), 2005, EARL MARR HARMF TRAD; WHO (World Health Organization), 2011, GUID PREV EARL PREGN	10	5	5	0	12	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 21	2013	382	9897					1005	1006		10.1016/S0140-6736(13)61944-3	http://dx.doi.org/10.1016/S0140-6736(13)61944-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	222PB	24054525				2022-12-28	WOS:000324742200006
J	Nerlekar, N; Tung, M; Rehmani, H; Wong, DTL; Meredith, IT; Harper, RW				Nerlekar, Nitesh; Tung, Matthew; Rehmani, Hassan; Wong, Dennis T. L.; Meredith, Ian T.; Harper, Richard W.			Peripheral air embolism	LANCET			English	Editorial Material									[Nerlekar, Nitesh; Tung, Matthew; Wong, Dennis T. L.; Meredith, Ian T.; Harper, Richard W.] Monash Univ, Monash Med Ctr, Dept Med, Monash Cardiovasc Res Ctr, Clayton, Vic 3168, Australia; [Nerlekar, Nitesh; Tung, Matthew; Wong, Dennis T. L.; Meredith, Ian T.; Harper, Richard W.] MonashHEART, Clayton, Vic 3168, Australia; [Rehmani, Hassan] Monash Hlth, Discipline Med, Melbourne, Vic, Australia	Monash University	Nerlekar, N (corresponding author), Monash Univ, Monash Med Ctr, Dept Med, Monash Cardiovasc Res Ctr, 246 Clayton Rd, Clayton, Vic 3168, Australia.	nitesh.nerlekar@gmail.com		Nerlekar, Nitesh/0000-0002-3437-8648				Kariya S, 2010, JPN J RADIOL, V28, P473, DOI 10.1007/s11604-010-0447-8; Muth CM, 2000, NEW ENGL J MED, V342, P476, DOI 10.1056/NEJM200002173420706; SCHMIDT PJ, 1958, NEW ENGL J MED, V258, P424, DOI 10.1056/NEJM195802272580904; Sviri S, 2004, Crit Care Resusc, V6, P271	4	2	2	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 21	2013	382	9897					1070	1070		10.1016/S0140-6736(13)61900-5	http://dx.doi.org/10.1016/S0140-6736(13)61900-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	222PB	24054536				2022-12-28	WOS:000324742200027
J	Andreyev, HJN; Benton, BE; Lalji, A; Norton, C; Mohammed, K; Gage, H; Pennert, K; Lindsay, JO				Andreyev, H. Jervoise N.; Benton, Barbara E.; Lalji, Amyn; Norton, Christine; Mohammed, Kabir; Gage, Heather; Pennert, Kjell; Lindsay, James O.			Algorithm-based management of patients with gastrointestinal symptoms in patients after pelvic radiation treatment (ORBIT): a randomised controlled trial	LANCET			English	Article							VAIZEY INCONTINENCE QUESTIONNAIRE; BOWEL-DISEASE QUESTIONNAIRE; URINARY-TRACT SYMPTOMS; RADIOTHERAPY; ASSOCIATION; THERAPY; VALUES	Background Chronic gastrointestinal symptoms after pelvic radiotherapy are common, multifactorial in cause, and affect patients' quality of life. We assessed whether such patients could be helped if a practitioner followed an investigative and management algorithm, and whether outcomes differed by whether a nurse or a gastroenterologist led this algorithm-based care. Methods For this three-arm randomised controlled trial we recruited patients (aged >= 18 years) from clinics in London, UK, with new-onset gastrointestinal symptoms persisting 6 months after pelvic radiotherapy. Using a computer-generated randomisation sequence, we randomly allocated patients to one of three groups (1:1:1; stratified by tumour site [urological, gynaecological, or gastrointestinal], and degree of bowel dysfunction [IBDQ-B score <60 vs 60-70]): usual care (a detailed self-help booklet), gastroenterologist-led algorithm-based treatment, or nurse-led algorithm-based treatment. The primary endpoint was change in Inflammatory Bowel Disease Questionnaire-Bowel subset score (IBDQ-B) at 6 months, analysed by intention to treat. This trial is registered with ClinicalTrials.gov, number NCT00737230. Findings Between Nov 26, 2007, and Dec 12, 2011, we enrolled and randomly allocated 218 patients to treatment: 80 to the nurse group, 70 to the gastroenterologist group, and 68 to the booklet group (figure). Most had a baseline IBDQ-B score indicating moderate-to-severe symptoms. We recorded the following pair-wise mean difference in change in IBDQ-B score between groups: nurse versus booklet 4.12 (95% CI 0.04-8.19; p=0.04), gastroenterologist versus booklet 5.47 (1.14-9.81; p=0.01). Outcomes in the nurse group were not inferior to outcomes in the gastroenterologist group (mean difference 1.36, one sided 95% CI -1.48). Interpretation Patients given targeted intervention following a detailed clinical algorithm had better improvements in radiotherapy-induced gastrointestinal symptoms than did patients given usual care. Our findings suggest that, for most patients, this algorithm-based care can be given by a trained nurse.	[Andreyev, H. Jervoise N.; Benton, Barbara E.; Lalji, Amyn] Royal Marsden NHS Fdn Trust, Gastrointestinal Unit, London SW3 6JJ, England; [Mohammed, Kabir; Pennert, Kjell] Royal Marsden NHS Fdn Trust, Stat Unit, London SW3 6JJ, England; [Norton, Christine] Kings Coll London, London WC2R 2LS, England; [Norton, Christine] Imperial Coll Healthcare NHS Trust, London, England; [Gage, Heather] Univ Surrey, Deptartment Econ, Guildford GU2 5XH, Surrey, England; [Lindsay, James O.] Queen Mary Univ London, Barts & London Sch Med & Dent, Digest Dis Clin Acad Unit, London, England	Royal Marsden NHS Foundation Trust; Royal Marsden NHS Foundation Trust; University of London; King's College London; Imperial College London; University of Surrey; University of London; Queen Mary University London	Andreyev, HJN (corresponding author), Royal Marsden NHS Fdn Trust, Gastrointestinal Unit, Fulham Rd, London SW3 6JJ, England.	j@andreyev.demon.co.uk		Gage, Heather/0000-0002-2049-9406; Lalji, Amyn/0000-0003-2988-9117	National Institute for Health Research; National Institute for Health Research [PB-PG-0706-10175] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	The National Institute for Health Research.	Andreyev HJN, 2007, CLIN ONCOL-UK, V19, P790, DOI 10.1016/j.clon.2007.08.011; Andreyev HJN, 2012, GUT, V61, P179, DOI 10.1136/gutjnl-2011-300563; Andreyev HJN, 2010, LANCET ONCOL, V11, P310, DOI 10.1016/S1470-2045(10)70026-7; Andreyev HJN, 2005, INT J RADIAT ONCOL, V62, P1464, DOI 10.1016/j.ijrobp.2004.12.087; ANDREYEV HJN, 2003, CLIN ONCOL, V15, pS12; Andreyev J, 2007, LANCET ONCOL, V8, P1007, DOI 10.1016/S1470-2045(07)70341-8; [Anonymous], 1995, Int J Radiat Oncol Biol Phys, V31, P1049; Armes J, 2009, J CLIN ONCOL, V27, P6172, DOI 10.1200/JCO.2009.22.5151; Bacon CG, 2002, CANCER-AM CANCER SOC, V94, P862, DOI 10.1002/cncr.10248; Belling R, 2009, COCHRANE DB SYST REV, V4; Benton B, 2011, CLIN ONCOL-UK, V23, P538, DOI 10.1016/j.clon.2011.03.006; Bergmark K, 2002, ACTA OBSTET GYN SCAN, V81, P443, DOI 10.1034/j.1600-0412.2002.810512.x; Birgisson H, 2007, ACTA ONCOL, V46, P504, DOI 10.1080/02841860701348670; Brookes ST, 2002, BRIT MED J, V324, P1059, DOI 10.1136/bmj.324.7345.1059; Capp A, 2009, RADIOTHER ONCOL, V90, P400, DOI 10.1016/j.radonc.2008.09.019; Department of Health, NAT CANC SURV IN VIS; Dibley L, 2010, BR J GEN PRACT, V60, P891; Dunberger G, 2010, EUR J CANCER, V46, P606, DOI 10.1016/j.ejca.2009.10.023; Gambino KK, 2009, J CARDIOVASC NURS, V24, P132, DOI 10.1097/JCN.0b013e318197aa0f; Gami B, 2003, ALIMENT PHARM THER, V18, P987, DOI 10.1046/j.1365-2036.2003.01760.x; Gillespie C, 2007, ALIMENT PHARM THER, V26, P555, DOI 10.1111/j.1365-2036.2007.03405.x; Gray AM, 2006, MED DECIS MAKING, V26, P18, DOI 10.1177/0272989X05284108; GUYATT G, 1989, GASTROENTEROLOGY, V96, P804, DOI 10.1016/0016-5085(89)90905-0; Harris V, 2012, INT J RADIAT ONCOL, V84, pE601, DOI 10.1016/j.ijrobp.2012.07.2368; Hauer-Jensen M, 2003, SEMIN RADIAT ONCOL, V13, P357, DOI 10.1016/S1053-4296(03)00032-8; Henson CC, 2012, SUPPORT CARE CANCER, V20, P2129, DOI 10.1007/s00520-011-1323-5; Henson CC, 2013, SUPPORT CARE CANCER, V21, P2255, DOI 10.1007/s00520-013-1782-y; Hlavaty T, 2006, INFLAMM BOWEL DIS, V12, P199, DOI 10.1097/01.MIB.0000217768.75519.32; Jackson S, 1996, BRIT J UROL, V77, P805, DOI 10.1046/j.1464-410X.1996.00186.x; Jensen PT, 2004, PSYCHO-ONCOLOGY, V13, P577, DOI 10.1002/pon.757; Khalid U, 2006, INT J RADIAT ONCOL, V64, P1432, DOI 10.1016/j.ijrobp.2005.10.007; Laurant M, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001271.pub2; Macmillan Cancer Support, 2012, MAN LAT EFF PELV RAD; Macmillan Cancer Support, 2012, CANC CLIN NURS SPEC; Maeda Y, 2011, RADIOTHER ONCOL, V98, P145, DOI 10.1016/j.radonc.2010.12.004; Mundt JC, 2002, BRIT J PSYCHIAT, V180, P461, DOI 10.1192/bjp.180.5.461; Norton C, 2003, GASTROENTEROLOGY, V125, P1320, DOI 10.1016/j.gastro.2003.09.039; Norton C, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002111.pub3; Olopade FA, 2005, BRIT J CANCER, V92, P1663, DOI 10.1038/sj.bjc.6602552; Sullivan PB, 2006, ARCH DIS CHILD, V91, P499, DOI 10.1136/adc.2005.087486; Vaizey CJ, 1999, GUT, V44, P77, DOI 10.1136/gut.44.1.77; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Wells M, 2008, J CLIN NURS, V17, P1428, DOI 10.1111/j.1365-2702.2007.01976.x	43	90	95	2	14	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 21	2013	382	9910					2084	2092		10.1016/S0140-6736(13)61648-7	http://dx.doi.org/10.1016/S0140-6736(13)61648-7			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	275OX	24067488				2022-12-28	WOS:000328687800029
J	Ayanian, JZ				Ayanian, John Z.			Michigan's Approach to Medicaid Expansion and Reform	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								Michigan's approach to expanding and reforming Medicaid may be a model for other Republican-dominated states that might choose to expand coverage for low-income adults, introduce market-oriented reforms, and limit the impact on their budget. A cornerstone of the Affordable Care Act (ACA) is the expansion of Medicaid coverage in 2014 to adults with incomes up to 133% of the federal poverty level (approximately $15,500 for a single adult in 2014). The proportion of these low-income adults under 65 years of age who are uninsured exceeds 40% nationally. Individual insurance is prohibitively expensive for most adults with low incomes, and employer-sponsored insurance is often unaffordable or not offered to the members of this population who work. Extending Medicaid coverage to more low-income adults can have important benefits for their access to care, health outcomes, and financial ...	[Ayanian, John Z.] Univ Michigan, Inst Healthcare Policy & Innovat, Ann Arbor, MI 48109 USA; [Ayanian, John Z.] Univ Michigan, Sch Med, Div Gen Med, Ann Arbor, MI 48109 USA; [Ayanian, John Z.] Univ Michigan, Sch Publ Hlth, Dept Hlth Management & Policy, Ann Arbor, MI 48109 USA; [Ayanian, John Z.] Univ Michigan, Gerald R Ford Sch Publ Policy, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Ayanian, JZ (corresponding author), Univ Michigan, Inst Healthcare Policy & Innovat, Ann Arbor, MI 48109 USA.							Baicker K, 2013, NEW ENGL J MED, V368, P1713, DOI 10.1056/NEJMsa1212321; Holahan J, 2013, COST NOT EXPANDING M; Sommers BD, 2012, NEW ENGL J MED, V367, P1025, DOI 10.1056/NEJMsa1202099; Udow-Phillips M, 2012, ACAS MED EXPANSION M	4	37	37	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 7	2013	369	19					1773	1775		10.1056/NEJMp1310910	http://dx.doi.org/10.1056/NEJMp1310910			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	247HF	24066713				2022-12-28	WOS:000326607800002
J	Annane, D; Siami, S; Jaber, S; Martin, C; Elatrous, S; Declere, AD; Preiser, JC; Outin, H; Troche, G; Charpentier, C; Trouillet, JL; Kimmoun, A; Forceville, X; Darmon, M; Lesur, O; Regnier, J; Abroug, F; Berger, P; Clec'h, C; Cousson, J; Thibault, L; Chevret, S				Annane, Djillali; Siami, Shidasp; Jaber, Samir; Martin, Claude; Elatrous, Souheil; Declere, Adrien Descorps; Preiser, Jean Charles; Outin, Herve; Troche, Gilles; Charpentier, Claire; Trouillet, Jean Louis; Kimmoun, Antoine; Forceville, Xavier; Darmon, Michael; Lesur, Olivier; Regnier, Jean; Abroug, Fekri; Berger, Philippe; Clec'h, Christophe; Cousson, Joel; Thibault, Laure; Chevret, Sylvie		CRISTAL Investigators	Effects of Fluid Resuscitation With Colloids vs Crystalloids on Mortality in Critically Ill Patients Presenting With Hypovolemic Shock The CRISTAL Randomized Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HYDROXYETHYL STARCH; ACUTE PHYSIOLOGY; KIDNEY INJURY; SEPSIS; SALINE; SCORE; CLASSIFICATION; ASSOCIATION; ALBUMIN	IMPORTANCE Evidence supporting the choice of intravenous colloid vs crystalloid solutions for management of hypovolemic shock remains unclear. OBJECTIVE To test whether use of colloids compared with crystalloids for fluid resuscitation alters mortality in patients admitted to the intensive care unit (ICU) with hypovolemic shock. DESIGN, SETTING, AND PARTICIPANTS A multicenter, randomized clinical trial stratified by case mix (sepsis, trauma, or hypovolemic shock without sepsis or trauma). Therapy in the Colloids Versus Crystalloids for the Resuscitation of the Critically Ill (CRISTAL) trial was open label but outcome assessment was blinded to treatment assignment. Recruitment began in February 2003 and ended in August 2012 of 2857 sequential ICU patients treated at 57 ICUs in France, Belgium, North Africa, and Canada; follow-up ended in November 2012. INTERVENTIONS Colloids (n = 1414; gelatins, dextrans, hydroxyethyl starches, or 4% or 20% of albumin) or crystalloids (n = 1443; isotonic or hypertonic saline or Ringer lactate solution) for all fluid interventions other than fluid maintenance throughout the ICU stay. MAIN OUTCOMES AND MEASURES The primary outcome was death within 28 days. Secondary outcomes included 90-day mortality; and days alive and not receiving renal replacement therapy, mechanical ventilation, or vasopressor therapy. RESULTS Within 28 days, there were 359 deaths (25.4%) in colloids group vs 390 deaths (27.0%) in crystalloids group (relative risk [RR], 0.96 [95% CI, 0.88 to 1.04]; P = .26). Within 90 days, there were 434 deaths (30.7%) in colloids group vs 493 deaths (34.2%) in crystalloids group (RR, 0.92 [95% CI, 0.86 to 0.99]; P = .03). Renal replacement therapy was used in 156 (11.0%) in colloids group vs 181 (12.5%) in crystalloids group (RR, 0.93 [95% CI, 0.83 to 1.03]; P = .19). There were more days alive without mechanical ventilation in the colloids group vs the crystalloids group by 7 days (mean: 2.1 vs 1.8 days, respectively; mean difference, 0.30 [95% CI, 0.09 to 0.48] days; P = .01) and by 28 days (mean: 14.6 vs 13.5 days; mean difference, 1.10 [95% CI, 0.14 to 2.06] days; P = .01) and alive without vasopressor therapy by 7 days (mean: 5.0 vs 4.7 days; mean difference, 0.30 [95% CI, -0.03 to 0.50] days; P = .04) and by 28 days (mean: 16.2 vs 15.2 days; mean difference, 1.04 [95% CI, -0.04 to 2.10] days; P = .03). CONCLUSIONS AND RELEVANCE Among ICU patients with hypovolemia, the use of colloids vs crystalloids did not result in a significant difference in 28-day mortality. Although 90-day mortality was lower among patients receiving colloids, this finding should be considered exploratory and requires further study before reaching conclusions about efficacy.	[Annane, Djillali] Hop Raymond Poincare, Garches, France; [Siami, Shidasp] CH Etampes, Etampes, France; [Jaber, Samir] CHU Montpelier, Montpellier, France; [Martin, Claude] AP HM Hop Nord, Marseille, France; [Elatrous, Souheil] EPS Taher Sfar Mahdia, Mahdia, Tunisia; [Declere, Adrien Descorps] Antoine Beclere, Clamart, France; [Preiser, Jean Charles] CHU Liege, Liege, Belgium; [Outin, Herve] CHI Poissy St Germain, Poissy, France; [Troche, Gilles] CH Andre Mignot, Versailles, France; [Charpentier, Claire] Hop Cent, Nancy, France; [Trouillet, Jean Louis] Pitie Salpetriere, Paris, France; [Kimmoun, Antoine] Hop Brabois, Nancy, France; [Forceville, Xavier] CH Meaux, Meaux, France; [Darmon, Michael; Chevret, Sylvie] Hop St Louis, Paris, France; [Lesur, Olivier] CH Sherbrooke, Sherbrooke, PQ, Canada; [Regnier, Jean] CH Roche Sur Yon, Roche Sur Yon, France; [Abroug, Fekri] CHU Monastir, Monastir, Tunisia; [Berger, Philippe] CH Chalons Champagne, Champagne, France; [Clec'h, Christophe] Hop Avicenne, F-93009 Bobigny, France; [Cousson, Joel] CHU Reims, Reims, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Raymond-Poincare - APHP; Universite de Montpellier; CHU de Montpellier; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Antoine-Beclere - APHP; University of Liege; Hospital Chi of Poissy Saint Germain; Centre Hospitalier de Versailles; CHU de Nancy; CHU de Nancy; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; CHD Vendee; Universite de Monastir; Hopital Fattouma Bourguiba; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Universite Paris 13; CHU de Reims	Annane, D (corresponding author), Univ Versailles, 104 Blvd Raymond Poincare, F-92380 Garches, France.	djillali.annane@rpc.aphp.fr	Preiser, Jean-Charles/AAL-2355-2021; Kimmoun, Antoine/ADQ-2174-2022; Abroug, Fekri/ABI-6564-2022; Abroug, Fekri/ADJ-0934-2022; Annane, Djillali/R-7947-2019	Preiser, Jean-Charles/0000-0003-3163-0390; Abroug, Fekri/0000-0002-5626-5329; Darmon, Michael/0000-0003-4198-8038; chevret, sylvie/0000-0001-6449-4730; Troche, Gilles/0000-0002-8150-6630	French Ministry of Health, Programme Hospitalier de Recherche Clinique [AOM 01 020]	French Ministry of Health, Programme Hospitalier de Recherche Clinique	The study was funded by the French Ministry of Health, Programme Hospitalier de Recherche Clinique 2001 and 2010 (AOM 01 020).	[Anonymous], COCHRANE DATABASE SY; [Anonymous], 1992, DESIGN ANAL SEQUENTI; BONE RC, 1992, CRIT CARE MED, V20, P864, DOI 10.1097/00003246-199206000-00025; Cox B. G, 1972, FUNDAMENTAL MECHANIS, P13; Delaney AP, 2011, CRIT CARE MED, V39, P386, DOI 10.1097/CCM.0b013e3181ffe217; Dellinger RP, 2013, CRIT CARE MED, V41, P580, DOI 10.1097/CCM.0b013e31827e83af; Finfer S, 2004, NEW ENGL J MED, V350, P2247; Finfer S, 2010, CRIT CARE, V14, DOI 10.1186/cc9293; Kim Y, 2000, J TRAUMA, V48, P280, DOI 10.1097/00005373-200002000-00014; KNAUS WA, 1981, CRIT CARE MED, V9, P591, DOI 10.1097/00003246-198108000-00008; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; Martin GS, 2004, AM J RESP CRIT CARE, V170, P1247, DOI 10.1164/rccm.200208-909ST; MCCABE WR, 1962, ARCH INTERN MED, V110, P847, DOI 10.1001/archinte.1962.03620240029006; Myburgh JA, 2012, NEW ENGL J MED, V367, P1901, DOI 10.1056/NEJMoa1209759; Oliveira RP, 2002, CRIT CARE, V6, P418, DOI 10.1186/cc1541; Perel P, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000567.pub6; Perner A, 2012, NEW ENGL J MED, V367, P124, DOI 10.1056/NEJMoa1204242; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/s001340050156; WEINBERG PF, 1984, AM REV RESPIR DIS, V130, P791; Yunos NM, 2012, JAMA-J AM MED ASSOC, V308, P1566, DOI 10.1001/jama.2012.13356; Zarychanski R, 2013, JAMA-J AM MED ASSOC, V309, P678, DOI 10.1001/jama.2013.430	22	391	417	1	64	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 6	2013	310	17					1809	1817		10.1001/jama.2013.280502	http://dx.doi.org/10.1001/jama.2013.280502			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	246PH	24108515	Bronze			2022-12-28	WOS:000326550900014
J	Bollongino, R; Nehlich, O; Richards, MP; Orschiedt, J; Thomas, MG; Sell, C; Fajkosova, Z; Powell, A; Burger, J				Bollongino, Ruth; Nehlich, Olaf; Richards, Michael P.; Orschiedt, Joerg; Thomas, Mark G.; Sell, Christian; Fajkosova, Zuzana; Powell, Adam; Burger, Joachim			2000 Years of Parallel Societies in Stone Age Central Europe	SCIENCE			English	Article							ISOTOPE EVIDENCE; DIET; TRANSITION; HISTORY	Debate on the ancestry of Europeans centers on the interplay between Mesolithic foragers and Neolithic farmers. Foragers are generally believed to have disappeared shortly after the arrival of agriculture. To investigate the relation between foragers and farmers, we examined Mesolithic and Neolithic samples from the Blatterhohle site. Mesolithic mitochondrial DNA sequences were typical of European foragers, whereas the Neolithic sample included additional lineages that are associated with early farmers. However, isotope analyses separate the Neolithic sample into two groups: one with an agriculturalist diet and one with a forager and freshwater fish diet, the latter carrying mitochondrial DNA sequences typical of Mesolithic hunter-gatherers. This indicates that the descendants of Mesolithic people maintained a foraging lifestyle in Central Europe for more than 2000 years after the arrival of farming societies.	[Bollongino, Ruth; Sell, Christian; Fajkosova, Zuzana; Powell, Adam; Burger, Joachim] Johannes Gutenberg Univ Mainz, Palaeogenet Grp, Inst Anthropol, D-55099 Mainz, Germany; [Nehlich, Olaf; Richards, Michael P.] Univ British Columbia, Dept Anthropol, Vancouver, BC V6T 1Z1, Canada; [Nehlich, Olaf; Richards, Michael P.] Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, D-04103 Leipzig, Germany; [Richards, Michael P.] Univ Durham, Dept Archaeol, Durham DH1 3LE, England; [Orschiedt, Joerg] Free Univ Berlin, Inst Prehistor Archaeol, D-14195 Berlin, Germany; [Thomas, Mark G.] UCL, Res Dept Genet Evolut & Environm, London WC1E 6BT, England	Johannes Gutenberg University of Mainz; University of British Columbia; Max Planck Society; Durham University; Free University of Berlin; University of London; University College London	Bollongino, R (corresponding author), Johannes Gutenberg Univ Mainz, Palaeogenet Grp, Inst Anthropol, D-55099 Mainz, Germany.	bollongi@uni-mainz.de	Hofmanová, Zuzana/M-6666-2019; Nehlich, Olaf/A-3767-2010; Thomas, Mark G/A-2219-2012; Richards, Michael/O-3717-2016	Hofmanová, Zuzana/0000-0003-1336-4455; Nehlich, Olaf/0000-0002-4993-5013; Thomas, Mark G/0000-0002-2452-981X; Richards, Michael/0000-0001-5274-8887	German Research Foundation [DFG: Or 98/6-1, NE1666/1-1]; BEAN project of the Marie Curie Initial Training Networks Theme [289966]; Max Planck Society; Social Sciences and Humanities Research Council of Canada; European Union [226506]; University of Mainz	German Research Foundation(German Research Foundation (DFG)); BEAN project of the Marie Curie Initial Training Networks Theme; Max Planck Society(Max Planck SocietyFoundation CELLEX); Social Sciences and Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC)); European Union(European Commission); University of Mainz	We thank S. Shennan for discussion and comments on the manuscript and R. Blank, M. Baales, B. Gehlen, W. Schon, and A. Zimmermann for information and discussion. M. Unterlander and A. Schulz helped to generate the data. This study has been partly financed by the German Research Foundation (DFG: Or 98/6-1 and NE1666/1-1), the BEAN project of the Marie Curie Initial Training Networks Theme (grant no. 289966), the Max Planck Society and the Social Sciences and Humanities Research Council of Canada, the Synthesis Project of the European Union Seventh Framework Programme (grant no. 226506), and funds of the University of Mainz to J.B. Genetic sequences are deposited in GenBank (www.ncbi.nlm.nih.gov/), accession numbers KF523384 to KF523407.	Bentley RA, 2009, HUM BIOL, V81, P159, DOI 10.3378/027.081.0304; Bogaard A, 2007, J ARCHAEOL SCI, V34, P335, DOI 10.1016/j.jas.2006.04.009; Bonsall C., 1997, J EUROPEAN ARCHAEOLO, V5, P50, DOI DOI 10.1179/096576697800703575; Bramanti B, 2009, SCIENCE, V326, P137, DOI 10.1126/science.1176869; Eder J. F., 1988, Michigan Papers on South and Southeast Asia, Center for South and Southeast Asian Studies, University of Michigan, P37; Fiedler L., 1994, FUHRER HESSISCHEN VO; Fu QM, 2013, CURR BIOL, V23, P553, DOI 10.1016/j.cub.2013.02.044; GREGG SA, 1988, FORAGER FARMERS POPU; Gronenborn D, 1999, J WORLD PREHIST, V13, P123, DOI 10.1023/A:1022374312372; Headland T.N., 1991, BANDS STATES INTERAC, P333; Keeley L. H., 1992, TRANSITIONS AGR PREH, P81; Lightfoot E, 2011, ANTIQUITY, V85, P73, DOI 10.1017/S0003598X00067442; Malmstrom H, 2009, CURR BIOL, V19, P1758, DOI 10.1016/j.cub.2009.09.017; Mateiciucova I., 2008, TALKING STONES CHIPP; Nehlich O, 2010, J ARCHAEOL SCI, V37, P1131, DOI 10.1016/j.jas.2009.12.013; Nehlich O, 2009, J ARCHAEOL SCI, V36, P1791, DOI 10.1016/j.jas.2009.04.008; Oelze VM, 2011, J ARCHAEOL SCI, V38, P270, DOI 10.1016/j.jas.2010.08.027; Orschiedt J, 2012, NOTAE PRAEHISTORICAE, V32, P73; PETERSON JT, 1978, AM ANTHROPOL, V80, P335, DOI 10.1525/aa.1978.80.2.02a00050; Pinhasi R, 2012, TRENDS GENET, V28, P496, DOI 10.1016/j.tig.2012.06.006; Richards MP, 2000, J ARCHAEOL SCI, V27, P1, DOI 10.1006/jasc.1999.0520; Shennan S, 2009, HUM BIOL, V81, P339, DOI 10.3378/027.081.0312; Turnbull C., 1965, WAYWARD SERVANTS 2 W; Vartmontfort B, 2008, J ANTHROPOL ARCHAEOL, V27, P149, DOI 10.1016/j.jaa.2008.03.002; Verdu P, 2013, MOL BIOL EVOL, V30, P918, DOI 10.1093/molbev/mss328; Whittle A., 1996, EUROPE NEOLITHIC CRE	26	124	124	0	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 25	2013	342	6157					479	481		10.1126/science.1245049	http://dx.doi.org/10.1126/science.1245049			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	239RH	24114781				2022-12-28	WOS:000326042600043
J	Heyde, M				Heyde, Markus			Structure and Motion of a 2D Glass	SCIENCE			English	Editorial Material							2-DIMENSIONAL SILICA GLASS; ATOMIC ARRANGEMENT; SINGLE-MOLECULE		Max Planck Gesell, Fritz Haber Inst, D-14195 Berlin, Germany	Max Planck Society; Fritz Haber Institute of the Max Planck Society	Heyde, M (corresponding author), Max Planck Gesell, Fritz Haber Inst, Faradayweg 4-6, D-14195 Berlin, Germany.	heyde@fhi-berlin.mpg.de	Heyde, Markus/F-9150-2013; Freund, Hans-Joachim/AAQ-8810-2020	Heyde, Markus/0000-0002-7049-0485; Freund, Hans-Joachim/0000-0001-5188-852X				de Oteyza DG, 2013, SCIENCE, V340, P1434, DOI 10.1126/science.1238187; Huang PY, 2013, SCIENCE, V342, P224, DOI 10.1126/science.1242248; Huang PY, 2012, NANO LETT, V12, P1081, DOI 10.1021/nl204423x; Lichtenstein L, 2012, J PHYS CHEM C, V116, P20426, DOI 10.1021/jp3062866; Lichtenstein L, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.106101; Lichtenstein L, 2012, ANGEW CHEM INT EDIT, V51, P404, DOI 10.1002/anie.201107097; Nakamura E, 2013, ANGEW CHEM INT EDIT, V52, P236, DOI 10.1002/anie.201205693; Raberg W, 1997, ANGEW CHEM INT EDIT, V36, P2646, DOI 10.1002/anie.199726461; ROSE H, 1990, OPTIK, V85, P19; Schroeder T, 2000, SURF REV LETT, V7, P7, DOI 10.1016/S0218-625X(00)00003-8; WIESENDANGER R, 1987, SURF SCI, V181, P46, DOI 10.1016/0039-6028(87)90140-3; Wintterlin J, 1997, SCIENCE, V278, P1931, DOI 10.1126/science.278.5345.1931; Zachariasen WH, 1932, J AM CHEM SOC, V54, P3841, DOI 10.1021/ja01349a006; Zallen R., 1983, PHYS AMORPHOUS SOLID	14	16	16	0	92	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 11	2013	342	6155					201	202		10.1126/science.1245217	http://dx.doi.org/10.1126/science.1245217			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232EV	24115428				2022-12-28	WOS:000325475200030
J	Brennan, CW; Verhaak, RGW; McKenna, A; Campos, B; Noushmehr, H; Salama, SR; Zheng, SY; Chakravarty, D; Sanborn, JZ; Berman, SH; Beroukhim, R; Bernard, B; Wu, CJ; Genovese, G; Shmulevich, I; Barnholtz-Sloan, J; Zou, LH; Vegesna, R; Shukla, SA; Ciriello, G; Yung, WK; Zhang, W; Sougnez, C; Mikkelsen, T; Aldape, K; Bigner, DD; Van Meir, EG; Prados, M; Sloan, A; Black, KL; Eschbacher, J; Finocchiaro, G; Friedman, W; Andrews, DW; Guha, A; Iacocca, M; O'Neill, BP; Foltz, G; Myers, J; Weisenberger, DJ; Penny, R; Kucherlapati, R; Perou, CM; Hayes, DN; Gibbs, R; Marra, M; Mills, GB; Lander, E; Spellman, P; Wilson, R; Sander, C; Weinstein, J; Meyerson, M; Gabriel, S; Laird, PW; Haussler, D; Getz, G; Chin, L				Brennan, Cameron W.; Verhaak, Roel G. W.; McKenna, Aaron; Campos, Benito; Noushmehr, Houtan; Salama, Sofie R.; Zheng, Siyuan; Chakravarty, Debyani; Sanborn, J. Zachary; Berman, Samuel H.; Beroukhim, Rameen; Bernard, Brady; Wu, Chang-Jiun; Genovese, Giannicola; Shmulevich, Ilya; Barnholtz-Sloan, Jill; Zou, Lihua; Vegesna, Rahulsimham; Shukla, Sachet A.; Ciriello, Giovanni; Yung, W. K.; Zhang, Wei; Sougnez, Carrie; Mikkelsen, Tom; Aldape, Kenneth; Bigner, Darell D.; Van Meir, Erwin G.; Prados, Michael; Sloan, Andrew; Black, Keith L.; Eschbacher, Jennifer; Finocchiaro, Gaetano; Friedman, William; Andrews, David W.; Guha, Abhijit; Iacocca, Mary; O'Neill, Brian P.; Foltz, Greg; Myers, Jerome; Weisenberger, Daniel J.; Penny, Robert; Kucherlapati, Raju; Perou, Charles M.; Hayes, D. Neil; Gibbs, Richard; Marra, Marco; Mills, Gordon B.; Lander, Eric; Spellman, Paul; Wilson, Richard; Sander, Chris; Weinstein, John; Meyerson, Matthew; Gabriel, Stacey; Laird, Peter W.; Haussler, David; Getz, Gad; Chin, Lynda		TCGA Res Network	The Somatic Genomic Landscape of Glioblastoma	CELL			English	Article							COPY-NUMBER ALTERATION; DRIVER MUTATIONS; EGFR; EXPRESSION; PATHWAYS; GLIOMAS; KINASE; PDGFRA; GENES; GRADE	We describe the landscape of somatic genomic alterations based on multidimensional and comprehensive characterization of more than 500 glioblastoma tumors (GBMs). We identify several novel mutated genes as well as complex rearrangements of signature receptors, including EGFR and PDGFRA. TERT promoter mutations are shown to correlate with elevated mRNA expression, supporting a role in telomerase reactivation. Correlative analyses confirm that the survival advantage of the proneural subtype is conferred by the G-CIMP phenotype, and MGMT DNA methylation may be a predictive biomarker for treatment response only in classical subtype GBM. Integrative analysis of genomic and proteomic profiles challenges the notion of therapeutic inhibition of a pathway as an alternative to inhibition of the target itself. These data will facilitate the discovery of therapeutic and diagnostic target candidates, the validation of research and clinical observations and the generation of unanticipated hypotheses that can advance our molecular understanding of this lethal cancer.	[Brennan, Cameron W.; Chakravarty, Debyani; Berman, Samuel H.] Mem Sloan Kettering Canc Ctr, Brain Tumor Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA; [Brennan, Cameron W.] Weill Cornell Med Ctr, Dept Neurol Surg, Mem Sloan Kettering Canc Ctr, Dept Neurosurg, New York, NY 10065 USA; [Verhaak, Roel G. W.; Zheng, Siyuan; Vegesna, Rahulsimham; Weinstein, John] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA; [McKenna, Aaron; Beroukhim, Rameen; Zou, Lihua; Sougnez, Carrie; Lander, Eric; Meyerson, Matthew; Gabriel, Stacey; Getz, Gad; Chin, Lynda] Broad Inst Harvard & MIT, Canc Program, Cambridge, MA 02142 USA; [Campos, Benito; Beroukhim, Rameen; Shukla, Sachet A.; Meyerson, Matthew] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Campos, Benito] Univ Heidelberg Hosp, Dept Neurosurg, Div Expt Neurosurg, D-69120 Heidelberg, Germany; [Noushmehr, Houtan; Weisenberger, Daniel J.; Laird, Peter W.] Univ So Calif, Keck Sch Med, Univ Southern Calif Epigenome Ctr, Los Angeles, CA 90033 USA; [Noushmehr, Houtan] Univ Sao Paulo, Fac Med Ribeirao Preto, Ctr Integrat Syst Biol, Dept Genet, BR-14049900 Sao Paulo, Brazil; [Salama, Sofie R.; Sanborn, J. Zachary; Haussler, David] Univ Calif Santa Cruz, Dept Biomol Engn, Santa Cruz, CA 95064 USA; [Salama, Sofie R.; Sanborn, J. Zachary; Haussler, David] Univ Calif Santa Cruz, Ctr Biomol Sci & Engn, Santa Cruz, CA 95064 USA; [Bernard, Brady; Shmulevich, Ilya] Inst Syst Biol, Seattle, WA 98109 USA; [Verhaak, Roel G. W.; Wu, Chang-Jiun; Genovese, Giannicola; Chin, Lynda] Univ Texas MD Anderson Canc Ctr, Dept Genom Med, Houston, TX 77030 USA; [Barnholtz-Sloan, Jill] Case Western Reserve Univ, Sch Med, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA; [Ciriello, Giovanni; Sander, Chris] Mem Sloan Kettering Canc Ctr, Computat Biol Ctr, New York, NY 10065 USA; [Yung, W. K.] Univ Texas MD Anderson Canc Ctr, Dept Neurooncol, Houston, TX 77030 USA; [Zhang, Wei; Aldape, Kenneth] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Mikkelsen, Tom] Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA; [Mikkelsen, Tom] Henry Ford Hosp, Dept Neurosurg, Detroit, MI 48202 USA; [Bigner, Darell D.] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; [Van Meir, Erwin G.] Emory Univ, Winship Canc Inst, Dept Neurosurg, Atlanta, GA 30322 USA; [Van Meir, Erwin G.] Emory Univ, Winship Canc Inst, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA; [Van Meir, Erwin G.] Emory Univ, Sch Med, Atlanta, GA 30322 USA; [Prados, Michael] Univ Calif San Francisco, Dept Neurosurg, San Francisco, CA 94143 USA; [Sloan, Andrew] Univ Hosp Case Med Ctr, Seidman Canc Ctr, Dept Neurosurg, Cleveland, OH 44106 USA; [Black, Keith L.] Cedars Sinai Med Ctr, Dept Neurosurg, Los Angeles, CA 90048 USA; [Eschbacher, Jennifer] St Josephs Hosp, Dept Pathol, Phoenix, AZ 85013 USA; [Finocchiaro, Gaetano] Ist Neurol Besta, Dept Neurooncol, I-20133 Milan, Italy; [Friedman, William] Univ Florida, Dept Neurosurg, Gainesville, FL 32610 USA; [Andrews, David W.] Thomas Jefferson Univ, Dept Neurol Surg, Philadelphia, PA 19107 USA; [Guha, Abhijit] Toronto Western Hosp, Dept Neurosurg, Toronto, ON M5T 2S8, Canada; [Iacocca, Mary] Helen F Graham Canc Ctr, Christiana Care, Dept Pathol, Newark, DE 19713 USA; [O'Neill, Brian P.] Mayo Clin, Dept Neurol, Rochester, MN 55905 USA; [O'Neill, Brian P.] Mayo Clin, Ctr Canc, Rochester, MN 55905 USA; [Foltz, Greg] Swedish Neurosci Inst, Ivy Brain Tumor Ctr, Seattle, WA 98122 USA; [Myers, Jerome] Penrose St Francis Hlth Serv, Dept Pathol, Colorado Springs, CO 80907 USA; [Penny, Robert] Int Genom Consortium, Phoenix, AZ 85004 USA; [Kucherlapati, Raju] Brigham & Womens Hosp, Boston, MA 02215 USA; [Kucherlapati, Raju] Harvard Univ, Sch Med, Boston, MA 02215 USA; [Perou, Charles M.; Hayes, D. Neil] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Gibbs, Richard] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Marra, Marco] BC Canc Agcy, Canadas Michael Smith Genome Sci Ctr, Vancouver, BC V5Z 4S6, Canada; [Mills, Gordon B.] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA; [Spellman, Paul] Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97239 USA; [Wilson, Richard] Washington Univ, Genome Inst, St Louis, MO 63110 USA; [Haussler, David] Univ Calif Santa Cruz, Howard Hughes Med Inst, Santa Cruz, CA 95064 USA	Memorial Sloan Kettering Cancer Center; Cornell University; Memorial Sloan Kettering Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; Ruprecht Karls University Heidelberg; University of Southern California; Universidade de Sao Paulo; University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; Institute for Systems Biology (ISB); University of Texas System; UTMD Anderson Cancer Center; Case Western Reserve University; Memorial Sloan Kettering Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Henry Ford Health System; Henry Ford Hospital; Henry Ford Health System; Henry Ford Hospital; Duke University; Emory University; Emory University; Emory University; University of California System; University of California San Francisco; Case Western Reserve University; Case Western Reserve University Hospital; Cedars Sinai Medical Center; St. Joseph's Hospital and Medical Center; IRCCS Istituto Neurologico Besta; State University System of Florida; University of Florida; Jefferson University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Christiana Care Health System; Helen F. Graham Cancer Center & Research Institute; Mayo Clinic; Mayo Clinic; Swedish Medical Center; International Genomics Consortium; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of North Carolina; University of North Carolina Chapel Hill; Baylor College of Medicine; British Columbia Cancer Agency; University of Texas System; UTMD Anderson Cancer Center; Oregon Health & Science University; Washington University (WUSTL); Howard Hughes Medical Institute; University of California System; University of California Santa Cruz	Brennan, CW (corresponding author), Mem Sloan Kettering Canc Ctr, Brain Tumor Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA.	cbrennan@mskcc.org; lchin@mdanderson.org	N, Houtan/C-9692-2013; Chen, Ken/AAU-1432-2021; Miller, Ryan/B-9365-2008; Barnholtz-Sloan, Jill/A-4817-2011; Zheng, sy/GRS-3136-2022; Weisenberger, Daniel/AAA-8314-2020; Schumacher, Steven/E-9821-2013; Gao, JianJiong/B-5673-2016; Salama, Sofie/K-6412-2019; Brennan, Cameron/R-7082-2019; Pollo, Bianca/K-5347-2018; Finocchiaro, Gaetano/AAG-6791-2020; Marra, Marco A/B-5987-2008; Sloan, Andrew/AAE-9842-2020; Verhaak, Roel/ABE-7058-2020; Prados, Michael/N-5220-2019; Friedman, William/GLR-1220-2022; Lee, Semin/S-2629-2016; Wilson, Richard K./AAF-4139-2019; Perou, Charles M/H-9934-2014; Skanderup, Anders Jacobsen/K-1081-2013; Laird, Peter W/G-8683-2012; Van Den Berg, David J/G-8598-2017; Ostrom, Quinn/F-1820-2018; Kucherlapati, Raju/ABC-8807-2021; Eoli, Marica/K-7748-2016; DiMeco, Francesco/Q-3785-2016; maderna, emanuela/F-1420-2019	N, Houtan/0000-0003-4051-8114; Chen, Ken/0000-0003-4013-5279; Miller, Ryan/0000-0002-0096-8762; Barnholtz-Sloan, Jill/0000-0001-6190-9304; Weisenberger, Daniel/0000-0001-8303-2603; Schumacher, Steven/0000-0002-6819-5647; Gao, JianJiong/0000-0002-5739-1781; Brennan, Cameron/0000-0003-4064-8891; Pollo, Bianca/0000-0002-5523-4256; Marra, Marco A/0000-0001-7146-7175; Lee, Semin/0000-0002-9015-6046; Wilson, Richard K./0000-0002-1992-1358; Perou, Charles M/0000-0001-9827-2247; Skanderup, Anders Jacobsen/0000-0001-6847-4980; Laird, Peter W/0000-0001-9117-3641; Van Den Berg, David J/0000-0002-5404-5218; Ostrom, Quinn/0000-0003-3469-7558; Eoli, Marica/0000-0003-4744-9377; Genovese, Giannicola/0000-0003-1392-9954; Van Meir, Erwin G./0000-0003-2444-7707; Triche, Tim/0000-0001-5665-946X; Bogler, Oliver/0000-0002-3700-0480; Lash, Alex/0000-0003-3787-1590; Black, Keith/0000-0002-0546-4934; Chakravarty, Debyani/0000-0001-8629-5732; DiMeco, Francesco/0000-0001-6213-5793; Cibulskis, Kristian/0000-0003-1343-1582; Bootwalla, Moiz/0000-0001-6158-7114; Hoadley, Katherine/0000-0002-1216-477X; Zheng, Siyuan/0000-0002-1031-9424; Harshyne, Larry/0000-0002-8699-3028; Auman, James/0000-0002-9328-8829; maderna, emanuela/0000-0002-5736-3166; Park, Peter/0000-0001-9378-960X; Heiman, David/0000-0001-7895-4259; Gutmann, David/0000-0002-3127-5045; Lipp, Eric/0000-0002-4372-5533; Tarnuzzer, Roy/0000-0002-3725-4173; Yachnis, Anthony/0000-0002-6971-0698; Stuart, Joshua/0000-0002-2171-565X; Weinstein, John/0000-0001-9401-6908; Gehlenborg, Nils/0000-0003-0327-8297; Meyerson, Matthew/0000-0002-9133-8108; Salama, Sofie/0000-0001-6999-7193; Jensen, Mark/0000-0001-5215-101X; Raghunathan, Aditya/0000-0001-6198-7441; Finocchiaro, Gaetano/0000-0003-3583-4040; Chen, Peng-Chieh ( Jessica )/0000-0002-2060-1765; Pot, David/0000-0002-1480-9826; Fuller, Gregory/0000-0001-9447-2647; Berens, Michael/0000-0002-3382-6787; Ciriello, Giovanni/0000-0003-2021-8683	USA National Institutes of Health [U24CA143883, U24CA143858, U24C A143840, U24CA143799, U24CA143835, U24CA143845, U24CA143882, U24 CA143867, U24CA143866];  [U24CA143848];  [U24CA144025];  [U24CA143843];  [U54HG003067];  [U54HG003079];  [U54HG003273];  [U24CA126543];  [U24CA12 6544];  [U24CA126546];  [U24CA126551];  [U24CA126554];  [U24CA126561];  [U24CA 126563];  [U24CA143731]; NATIONAL CANCER INSTITUTE [P30CA015083, U24CA126563, U24CA143867, U24CA143883, U24CA126561, U24CA126543, U24CA143845, U24CA144025, U24CA126551, U24CA126554, U24CA143848, P30CA008748, P50CA108961, U24CA143866, U24CA143835, R01CA163722, U24CA143840, P50CA098258, U24CA143843, U24CA143882, U24CA143858, P30CA016672, U24CA126546, U24CA126544, U24CA143799] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003079, U54HG003067, U54HG003273] Funding Source: NIH RePORTER	USA National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; ; ; ; ; ; ; ; ; ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	The TCGA research network contributed collectively to this study. Biospecimens were provided by the Tissue Source Sites and processed by the Biospecimen Core Resource. Data generation and analyses were performed by the Genome Sequencing Centers, Cancer Genome Characterization Centers, and Genome Data Analysis Centers. All data were released through the Data Coordinating Center. Project activities were coordinated by NCI and NHGRI Project Teams. This work was supported by the following grants from the USA National Institutes of Health: U24CA143883, U24CA143858, U24C A143840, U24CA143799, U24CA143835, U24CA143845, U24CA143882, U24 CA143867, U24CA143866, U24CA143848, U24CA144025, U24CA143843, U54HG003067, U54HG003079, U54HG003273, U24CA126543, U24CA12 6544, U24CA126546, U24CA126551, U24CA126554, U24CA126561, U24CA 126563, and U24CA143731.	Bady P, 2012, ACTA NEUROPATHOL, V124, P547, DOI 10.1007/s00401-012-1016-2; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Berger MF, 2012, NATURE, V485, P502, DOI 10.1038/nature11071; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Brennan C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007752; CALLAGHAN T, 1993, ONCOGENE, V8, P2939; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Chen AJ, 2012, GENE DEV, V26, P1459, DOI 10.1101/gad.189001.112; Cho J, 2011, CANCER RES, V71, P7587, DOI 10.1158/0008-5472.CAN-11-0821; Ciriello G, 2012, GENOME RES, V22, P398, DOI 10.1101/gr.125567.111; Dolecek TA, 2012, NEURO-ONCOLOGY, V14, pv1, DOI 10.1093/neuonc/nos218; Dunn GP, 2012, GENE DEV, V26, P756, DOI 10.1101/gad.187922.112; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Holmes KM, 2012, P NATL ACAD SCI USA, V109, P3475, DOI 10.1073/pnas.1120375109; Ichimura K, 2009, NEURO-ONCOLOGY, V11, P341, DOI 10.1215/15228517-2009-025; Imielinski M, 2012, CELL, V150, P1107, DOI 10.1016/j.cell.2012.08.029; Inda MD, 2010, GENE DEV, V24, P1731, DOI 10.1101/gad.1890510; Kannan K, 2012, ONCOTARGET, V3, P1194; Killela PJ, 2013, P NATL ACAD SCI USA, V110, P6021, DOI 10.1073/pnas.1303607110; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; KURAHASHI H, 1995, HUM MOL GENET, V4, P541, DOI 10.1093/hmg/4.4.541; Kuttler F, 2007, SEMIN CANCER BIOL, V17, P56, DOI 10.1016/j.semcancer.2006.10.007; Liu XY, 2012, ACTA NEUROPATHOL, V124, P615, DOI 10.1007/s00401-012-1031-3; Lovejoy CA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002772; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Ohgaki H, 2007, AM J PATHOL, V170, P1445, DOI 10.2353/ajpath.2007.070011; Ozawa T, 2010, GENE DEV, V24, P2205, DOI 10.1101/gad.1972310; Park SY, 2009, NAT STRUCT MOL BIOL, V16, P23, DOI 10.1038/nsmb.1533; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Schittenhelm J, 2009, MODERN PATHOL, V22, P1600, DOI 10.1038/modpathol.2009.132; Schwartzentruber J, 2012, NATURE, V482, P226, DOI [10.1038/nature10833, 10.1007/s13311-012-0137-6]; Shono T, 2001, CANCER RES, V61, P4375; Singh D, 2012, SCIENCE, V337, P1231, DOI 10.1126/science.1220834; Snuderl M, 2011, CANCER CELL, V20, P810, DOI 10.1016/j.ccr.2011.11.005; Sturm D, 2012, CANCER CELL, V22, P425, DOI 10.1016/j.ccr.2012.08.024; Sumazin P, 2011, CELL, V147, P370, DOI 10.1016/j.cell.2011.09.041; Szerlip NJ, 2012, P NATL ACAD SCI USA, V109, P3041, DOI 10.1073/pnas.1114033109; Tay Y, 2011, CELL, V147, P344, DOI 10.1016/j.cell.2011.09.029; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Vivanco I, 2012, CANCER DISCOV, V2, P458, DOI 10.1158/2159-8290.CD-11-0284; Wiegand KC, 2010, NEW ENGL J MED, V363, P1532, DOI 10.1056/NEJMoa1008433; Zheng SC, 2011, NEURO-ONCOLOGY, V13, P280, DOI 10.1093/neuonc/noq190; Zheng SY, 2013, GENE DEV, V27, P1462, DOI 10.1101/gad.213686.113	50	2898	2944	12	306	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 10	2013	155	2					462	477		10.1016/j.cell.2013.09.034	http://dx.doi.org/10.1016/j.cell.2013.09.034			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	235LH	24120142	Green Published, Green Accepted, Green Submitted, Bronze			2022-12-28	WOS:000325719800021
J	Dong, XT; Liu, OW; Howell, AS; Shen, K				Dong, Xintong; Liu, Oliver W.; Howell, Audrey S.; Shen, Kang			An Extracellular Adhesion Molecule Complex Patterns Dendritic Branching and Morphogenesis	CELL			English	Article							DROSOPHILA SENSORY NEURONS; SELF-AVOIDANCE; CAENORHABDITIS-ELEGANS; C-ELEGANS; DSCAM; L1; ORGANIZATION; HOMOLOG; SPECIFICITY; RETINA	Robust dendrite morphogenesis is a critical step in the development of reproducible neural circuits. However, little is known about the extracellular cues that pattern complex dendrite morphologies. In the model nematode Caenorhabditis elegans, the sensory neuron PVD establishes stereotypical, highly branched dendrite morphology. Here, we report the identification of a tripartite ligand-receptor complex of membrane adhesion molecules that is both necessary and sufficient to instruct spatially restricted growth and branching of PVD dendrites. The ligand complex SAX-7/L1CAM and MNR-1 function at defined locations in the surrounding hypodermal tissue, whereas DMA-1 acts as the cognate receptor on PVD. Mutations in this complex lead to dramatic defects in the formation, stabilization, and organization of the dendritic arbor. Ectopic expression of SAX-7 and MNR-1 generates a predictable, unnaturally patterned dendritic tree in a DMA-1-dependent manner. Both in vivo and in vitro experiments indicate that all three molecules are needed for interaction.	[Dong, Xintong; Liu, Oliver W.; Howell, Audrey S.; Shen, Kang] Stanford Univ, Dept Biol, Howard Hughes Med Inst, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University	Shen, K (corresponding author), Stanford Univ, Dept Biol, Howard Hughes Med Inst, 385 Serra Mall, Stanford, CA 94305 USA.	kangshen@stanford.edu		Dong, Xintong/0000-0002-6887-8712	Howard Hughes Medical Institute; NIH [1R01NS082208]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS082208] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the Caenorhabditis Genetics Center for the sax-7(nj48) strain, and the laboratory of H. Beulow for sharing unpublished information. We also thank C. Yu for helping in forward genetic screens, C. Gao and the laboratories of L. Luo, E. Ozkan, and K.C. Garcia for technical assistance, and G. Maro, C.A. Taylor, and V. Ericson for thoughtful comments on the manuscript. This work was supported by the Howard Hughes Medical Institute and the NIH (1R01NS082208).	Aguirre-Chen C, 2011, DEVELOPMENT, V138, P507, DOI 10.1242/dev.060939; BRENNER S, 1974, GENETICS, V77, P71; Brummendorf T, 1998, CURR OPIN NEUROBIOL, V8, P87, DOI 10.1016/S0959-4388(98)80012-3; Hall DH, 2011, TRENDS NEUROSCI, V34, P443, DOI 10.1016/j.tins.2011.07.004; Han C, 2012, NEURON, V73, P64, DOI 10.1016/j.neuron.2011.10.036; Hong WZ, 2009, NAT NEUROSCI, V12, P1542, DOI 10.1038/nn.2442; Jan YN, 2010, NAT REV NEUROSCI, V11, P316, DOI 10.1038/nrn2836; Kim ME, 2012, NEURON, V73, P79, DOI 10.1016/j.neuron.2011.10.033; Lefebvre JL, 2012, NATURE, V488, P517, DOI 10.1038/nature11305; Li LS, 2011, CELL, V147, P1615, DOI 10.1016/j.cell.2011.11.027; Liu OW, 2012, NAT NEUROSCI, V15, P57, DOI 10.1038/nn.2978; Matthews BJ, 2007, CELL, V129, P593, DOI 10.1016/j.cell.2007.04.013; McCarter J, 1999, DEV BIOL, V205, P111, DOI 10.1006/dbio.1998.9109; Mumm JS, 2006, NEURON, V52, P609, DOI 10.1016/j.neuron.2006.10.004; Oren-Suissa M, 2010, SCIENCE, V328, P1285, DOI 10.1126/science.1189095; Pocock R, 2008, MOL CELL NEUROSCI, V37, P56, DOI 10.1016/j.mcn.2007.08.014; Polleux F, 2000, NATURE, V404, P567, DOI 10.1038/35007001; Salzberg Y, 2013, CELL, V155, P308, DOI 10.1016/j.cell.2013.08.058; Sanes JR, 2010, NEURON, V66, P15, DOI 10.1016/j.neuron.2010.01.018; Sanes JR, 2009, ANNU REV CELL DEV BI, V25, P161, DOI 10.1146/annurev.cellbio.24.110707.175402; Sasakura H, 2005, EMBO J, V24, P1477, DOI 10.1038/sj.emboj.7600621; Schurmann G, 2001, MOL BIOL CELL, V12, P1765, DOI 10.1091/mbc.12.6.1765; Smith CJ, 2013, NEURON, V79, P266, DOI 10.1016/j.neuron.2013.05.009; Smith CJ, 2012, NAT NEUROSCI, V15, P731, DOI 10.1038/nn.3065; Smith CJ, 2010, DEV BIOL, V345, P18, DOI 10.1016/j.ydbio.2010.05.502; Soba P, 2007, NEURON, V54, P403, DOI 10.1016/j.neuron.2007.03.029; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; Tursun B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004625; VanCamp G, 1996, HUM MUTAT, V8, P391, DOI 10.1002/(SICI)1098-1004(1996)8:4<391::AID-HUMU19>3.0.CO;2-Y; VITS L, 1994, NAT GENET, V7, P408, DOI 10.1038/ng0794-408; Wojtowicz WM, 2004, CELL, V118, P619, DOI 10.1016/j.cell.2004.08.021; Yamagata M, 2008, NATURE, V451, P465, DOI 10.1038/nature06469; Yamagata M, 2012, J NEUROSCI, V32, P14402, DOI 10.1523/JNEUROSCI.3193-12.2012; Yasunaga K, 2010, DEV CELL, V18, P621, DOI 10.1016/j.devcel.2010.02.010; Zallen JA, 1999, DEVELOPMENT, V126, P3679; ZORIO DAR, 1994, NATURE, V372, P270, DOI 10.1038/372270a0	36	103	106	1	30	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 10	2013	155	2					296	307		10.1016/j.cell.2013.08.059	http://dx.doi.org/10.1016/j.cell.2013.08.059			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	235LH	24120131	Green Accepted, Bronze			2022-12-28	WOS:000325719800008
J	Hawn, MT; Graham, LA; Richman, JS; Itani, KMF; Henderson, WG; Maddox, TM				Hawn, Mary T.; Graham, Laura A.; Richman, Joshua S.; Itani, Kamal M. F.; Henderson, William G.; Maddox, Thomas M.			Risk of Major Adverse Cardiac Events Following Noncardiac Surgery in Patients With Coronary Stents	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DRUG-ELUTING STENTS; LATE THROMBOSIS; BARE-METAL; DISCONTINUATION; INTERVENTION; IMPLANTATION; MANAGEMENT; CARE	IMPORTANCE Guidelines recommend delaying noncardiac surgery in patients after coronary stent procedures for 1 year after drug-eluting stents (DES) and for 6 weeks after bare metal stents (BMS). The evidence underlying these recommendations is limited and conflicting. OBJECTIVE To determine risk factors for adverse cardiac events in patients undergoing noncardiac surgery following coronary stent implantation. DESIGN, SETTING, AND PARTICIPANTS A national, retrospective cohort study of 41 989 Veterans Affairs (VA) and non-VA operations occurring in the 24 months after a coronary stent implantation between 2000 and 2010. Nonlinear generalized additive models examined the association between timing of surgery and stent type with major adverse cardiac events (MACE) adjusting for patient, surgery, and cardiac risk factors. A nested case-control study assessed the association between perioperative antiplatelet cessation and MACE. MAIN OUTCOMES AND MEASURES A composite 30-day MACE rate of all-cause mortality, myocardial infarction, and cardiac revascularization. RESULTS Within 24 months of 124 844 coronary stent implantations (47.6% DES, 52.4% BMS), 28 029 patients (22.5%; 95% CI, 22.2%-22.7%) underwent noncardiac operations resulting in 1980 MACE (4.7%; 95% CI, 4.5%-4.9%). Time between stent and surgery was associated with MACE (<6 weeks, 11.6%; 6 weeks to <6 months, 6.4%; 6-12 months, 4.2%; >12-24 months, 3.5%; P<.001). MACE rate by stent type was 5.1% for BMS and 4.3% for DES (P<.001). After adjustment, the 3 factors most strongly associated with MACE were nonelective surgical admission (adjusted odds ratio [AOR], 4.77; 95% CI, 4.07-5.59), history of myocardial infarction in the 6 months preceding surgery (AOR, 2.63; 95% CI, 2.32-2.98), and revised cardiac risk index greater than 2 (AOR, 2.13; 95% CI, 1.85-2.44). Of the 12 variables in the model, timing of surgery ranked fifth in explanatory importance measured by partial effects analysis. Stent type ranked last, and DES was not significantly associated with MACE (AOR, 0.91; 95% CI, 0.83-1.01). After both BMS and DES placement, the risk of MACE was stable at 6 months. A case-control analysis of 284 matched pairs found no association between antiplatelet cessation and MACE (OR, 0.86; 95% CI, 0.57-1.29). CONCLUSIONS AND RELEVANCE Among patients undergoing noncardiac surgery within 2 years of coronary stent placement, MACE were associated with emergency surgery and advanced cardiac disease but not stent type or timing of surgery beyond 6 months after stent implantation. Guideline emphasis on stent type and surgical timing for both DES and BMS should be reevaluated.	[Hawn, Mary T.; Graham, Laura A.; Richman, Joshua S.] Birmingham Vet Adm Hosp, Ctr Surg Med Acute Care Res & Transit C SMART, Birmingham, AL USA; [Hawn, Mary T.; Richman, Joshua S.] Univ Alabama Birmingham, Dept Surg, Sect Gastrointestinal Surg, Birmingham, AL 35294 USA; [Itani, Kamal M. F.] Boston Univ, Dept Surg, VA Boston Hlth Care Syst, Boston, MA 02215 USA; [Itani, Kamal M. F.] Harvard Univ, Sch Med, Boston, MA USA; [Henderson, William G.] Univ Colorado, Hlth Outcomes Program, Aurora, CO USA; [Henderson, William G.] Colorado Sch Publ Hlth, Dept Biostat & Informat, Aurora, CO USA; [Maddox, Thomas M.] VA Eastern Colorado Hlth Care Syst, Denver, CO USA; [Maddox, Thomas M.] Univ Colorado, Denver, CO 80202 USA	University of Alabama System; University of Alabama Birmingham; Boston University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Harvard University; Harvard Medical School; University of Colorado System; University of Colorado Anschutz Medical Campus; Colorado School of Public Health; University of Colorado System; University of Colorado Denver	Hawn, MT (corresponding author), Univ Alabama Birmingham, Dept Surg, Sect Gastrointestinal Surg, 1922 7th Ave S,KB 428, Birmingham, AL 35294 USA.	mhawn@uab.edu	Graham, Laura/T-8484-2017	Graham, Laura/0000-0002-7327-3793	VA Health Services Research & Development grant [IIR 09-347]; VA Career Development Awards	VA Health Services Research & Development grant; VA Career Development Awards	This study is supported by a VA Health Services Research & Development grant (No. IIR 09-347). In addition, Drs Maddox and Richman are supported by VA Career Development Awards.	Assali A, 2009, CATHETER CARDIO INTE, V74, P837, DOI 10.1002/ccd.22158; Bavry AA, 2006, AM J MED, V119, P1056, DOI 10.1016/j.amjmed.2006.01.023; Berger PB, 2010, JACC-CARDIOVASC INTE, V3, P920, DOI 10.1016/j.jcin.2010.03.021; Brilakis ES, 2013, JAMA-J AM MED ASSOC, V310, P189, DOI 10.1001/jama.2013.7086; Dehmer GJ, 2012, J AM COLL CARDIOL, V60, P2017, DOI 10.1016/j.jacc.2012.08.966; Finn AV, 2007, CIRCULATION, V115, P2435, DOI 10.1161/CIRCULATIONAHA.107.693739; Fleisher LA, 2007, J AM COLL CARDIOL, V50, P1707, DOI 10.1016/j.jacc.2007.09.001; Gandhi NK, 2011, CATHETER CARDIO INTE, V77, P972, DOI 10.1002/ccd.22744; Grines CL, 2007, CIRCULATION, V115, P813, DOI 10.1161/CIRCULATIONAHA.106.180944; Harrell F.E., 2015, REGRESSION MODELING, DOI [10.1007/978-3-319-19425-7, DOI 10.1007/978-3-319-19425-7, 10.1007/978-1-4757-3462-1]; Hawn MT, 2012, J AM COLL SURGEONS, V214, P658, DOI 10.1016/j.jamcollsurg.2011.12.011; Joner M, 2006, J AM COLL CARDIOL, V48, P193, DOI 10.1016/j.jacc.2006.03.042; Lee TH, 1999, CIRCULATION, V100, P1043, DOI 10.1161/01.CIR.100.10.1043; Malenka DJ, 2008, JAMA-J AM MED ASSOC, V299, P2868, DOI 10.1001/jama.299.24.2868; Mauri L, 2007, NEW ENGL J MED, V356, P1020, DOI 10.1056/NEJMoa067731; McFadden EP, 2004, LANCET, V364, P1519, DOI 10.1016/S0140-6736(04)17275-9; Murphy JT, 2005, ANESTH ANALG, V101, P971, DOI 10.1213/01.ANE.0000175821.42010.9F; Nasser M, 2005, CATHETER CARDIO INTE, V65, P516, DOI 10.1002/ccd.20391; Rabbitts JA, 2008, ANESTHESIOLOGY, V109, P596, DOI 10.1097/ALN.0b013e318186de1c; STOKES ME, 1991, CATEGORICAL DATA ANA; Stukel TA, 2007, JAMA-J AM MED ASSOC, V297, P278, DOI 10.1001/jama.297.3.278; To ACY, 2009, CIRC-CARDIOVASC INTE, V2, P213, DOI 10.1161/CIRCINTERVENTIONS.108.830158; Tokushige A, 2012, CIRC-CARDIOVASC INTE, V5, P237, DOI 10.1161/CIRCINTERVENTIONS.111.963728; van Kuijk JP, 2009, AM J CARDIOL, V104, P1229, DOI 10.1016/j.amjcard.2009.06.038; Vicenzi MN, 2006, BRIT J ANAESTH, V96, P686, DOI 10.1093/bja/ael083; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wijeysundera DN, 2012, CIRCULATION, V126, P1355, DOI 10.1161/CIRCULATIONAHA.112.102715; Wood S.N., 2017, GEN ADDITIVE MODELS, V2nd, DOI 10.1201/9781315370279	28	227	238	2	17	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 9	2013	310	14					1462	1472		10.1001/jama.2013.278787	http://dx.doi.org/10.1001/jama.2013.278787			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	230PK	24101118	Bronze			2022-12-28	WOS:000325354100022
J	Weiberg, A; Wang, M; Lin, FM; Zhao, HW; Zhang, ZH; Kaloshian, I; Huang, HD; Jin, HL				Weiberg, Arne; Wang, Ming; Lin, Feng-Mao; Zhao, Hongwei; Zhang, Zhihong; Kaloshian, Isgouhi; Huang, Hsien-Da; Jin, Hailing			Fungal Small RNAs Suppress Plant Immunity by Hijacking Host RNA Interference Pathways	SCIENCE			English	Article							PATHOGENIC FUNGUS; GENE; EFFECTORS; MICRORNAS; DIVERSE; ROLES; CELLS	Botrytis cinerea, the causative agent of gray mold disease, is an aggressive fungal pathogen that infects more than 200 plant species. Here, we show that some B. cinerea small RNAs (Bc-sRNAs) can silence Arabidopsis and tomato genes involved in immunity. These Bc-sRNAs hijack the host RNA interference (RNAi) machinery by binding to Arabidopsis Argonaute 1 (AGO1) and selectively silencing host immunity genes. The Arabidopsis ago1 mutant exhibits reduced susceptibility to B. cinerea, and the B. cinerea dcl1 dcl2 double mutant that can no longer produce these Bc-sRNAs displays reduced pathogenicity on Arabidopsis and tomato. Thus, this fungal pathogen transfers "virulent" sRNA effectors into host plant cells to suppress host immunity and achieve infection, which demonstrates a naturally occurring cross-kingdom RNAi as an advanced virulence mechanism.	[Weiberg, Arne; Wang, Ming; Zhao, Hongwei; Zhang, Zhihong; Jin, Hailing] Univ Calif Riverside, Dept Plant Pathol & Microbiol, Riverside, CA 92521 USA; [Weiberg, Arne; Wang, Ming; Zhao, Hongwei; Zhang, Zhihong; Kaloshian, Isgouhi; Jin, Hailing] Univ Calif Riverside, Ctr Plant Cell Biol, Riverside, CA 92521 USA; [Weiberg, Arne; Wang, Ming; Zhao, Hongwei; Zhang, Zhihong; Kaloshian, Isgouhi; Jin, Hailing] Univ Calif Riverside, Inst Integrat Genome Biol, Riverside, CA 92521 USA; [Lin, Feng-Mao; Huang, Hsien-Da] Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu 300, Taiwan; [Zhang, Zhihong] Shenyang Agr Univ, Coll Hort, Shenyang 110866, Liaoning, Peoples R China; [Kaloshian, Isgouhi] Univ Calif Riverside, Dept Nematol, Riverside, CA 92521 USA; [Huang, Hsien-Da] Natl Chiao Tung Univ, Inst Bioinformat & Syst Biol, Hsinchu 300, Taiwan	University of California System; University of California Riverside; University of California System; University of California Riverside; University of California System; University of California Riverside; National Yang Ming Chiao Tung University; Shenyang Agricultural University; University of California System; University of California Riverside; National Yang Ming Chiao Tung University	Jin, HL (corresponding author), Univ Calif Riverside, Dept Plant Pathol & Microbiol, Riverside, CA 92521 USA.	hailingj@ucr.edu	Jin, Hailing/Z-1168-2019; Zhang, Zhihong/W-1011-2017; Huang, Hsien-Da/AAA-7376-2019; Weiberg, Arne/L-1105-2015; Wang, Ming/C-5276-2017	Jin, Hailing/0000-0001-5778-5193; Zhang, Zhihong/0000-0001-5935-1567; Weiberg, Arne/0000-0003-4300-4864; Wang, Ming/0000-0002-1223-3421	NIH [R01 GM093008]; NSF [MCB-0642843, IOS-1257576]; AES-CE award [PPA-7517H]; National Science Council of the Republic of China [NSC 101-2311-B-009-003-MY3, NSC 100-2627-B-009-002]; UST-UCSD I-RiCE Program [NSC 101-2911-I-009-101]; Division Of Integrative Organismal Systems [1257576] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093008] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); AES-CE award; National Science Council of the Republic of China(Ministry of Science and Technology, Taiwan); UST-UCSD I-RiCE Program; Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Y. Qi for AGO1 antibody; J. Carrington for the AGO1 and AGO2 tagged lines; H. Vaucheret for ago1-27 mutant; M. J. Marcote for mpk1 mpk2 seeds; and P. Karlovsky for pPK2 binary vector and A. tumefaciens strain AGL1 for B. cinerea transformation and gene knockout. This work was supported by an NIH grant (R01 GM093008), an NSF Career Award (MCB-0642843), an NSF award (IOS-1257576), and an AES-CE award (PPA-7517H) to H.J.; National Science Council of the Republic of China (NSC 101-2311-B-009-003-MY3 and NSC 100-2627-B-009-002) and UST-UCSD I-RiCE Program (NSC 101-2911-I-009-101) grants to H.-D.H.	Amselem J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002230; Ashida H, 2011, CURR OPIN MICROBIOL, V14, P16, DOI 10.1016/j.mib.2010.08.014; Bozkurt TO, 2012, CURR OPIN PLANT BIOL, V15, P483, DOI 10.1016/j.pbi.2012.03.008; Ellendorff U, 2009, J EXP BOT, V60, P591, DOI 10.1093/jxb/ern306; Hilbi H, 2012, TRAFFIC, V13, P1187, DOI 10.1111/j.1600-0854.2012.01344.x; Jiang N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052734; Kale SD, 2010, CELL, V142, P284, DOI 10.1016/j.cell.2010.06.008; Katiyar-Agarwal S, 2010, ANNU REV PHYTOPATHOL, V48, P225, DOI 10.1146/annurev-phyto-073009-114457; Lee HC, 2010, MOL CELL, V38, P803, DOI 10.1016/j.molcel.2010.04.005; Liu YL, 2002, PLANT J, V31, P777, DOI 10.1046/j.1365-313X.2002.01394.x; Mi SJ, 2008, CELL, V133, P116, DOI 10.1016/j.cell.2008.02.034; Montgomery TA, 2008, CELL, V133, P128, DOI 10.1016/j.cell.2008.02.033; Morel JB, 2002, PLANT CELL, V14, P629, DOI 10.1105/tpc.010358; Nunes CC, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-288; Ortiz-Masia D, 2007, FEBS LETT, V581, P1834, DOI 10.1016/j.febslet.2007.03.075; Qutob D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2354; Rafiqi M, 2012, CURR OPIN PLANT BIOL, V15, P477, DOI 10.1016/j.pbi.2012.05.003; Rafiqi M, 2010, PLANT CELL, V22, P2017, DOI 10.1105/tpc.109.072983; Raman V, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-326; Ruiz-Ferrer V, 2009, ANNU REV PLANT BIOL, V60, P485, DOI 10.1146/annurev.arplant.043008.092111; Schornack S, 2010, P NATL ACAD SCI USA, V107, P17421, DOI 10.1073/pnas.1008491107; Schwab R, 2006, PLANT CELL, V18, P1121, DOI 10.1105/tpc.105.039834; Veronese P, 2006, PLANT CELL, V18, P257, DOI 10.1105/tpc.105.035576; Wawra S, 2012, CURR OPIN MICROBIOL, V15, P685, DOI 10.1016/j.mib.2012.10.008; Wawra S, 2012, P NATL ACAD SCI USA, V109, P2096, DOI 10.1073/pnas.1113775109; Wessner B, 2010, EXERC IMMUNOL REV, V16, P22; Zhang XM, 2011, MOL CELL, V42, P356, DOI 10.1016/j.molcel.2011.04.010; Zhou JH, 2012, MOL GENET GENOMICS, V287, P275, DOI 10.1007/s00438-012-0678-8	28	662	704	40	678	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 4	2013	342	6154					118	123		10.1126/science.1239705	http://dx.doi.org/10.1126/science.1239705			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	227PP	24092744	Green Accepted			2022-12-28	WOS:000325126100059
J	Maxmen, A				Maxmen, Amy			CROP PESTS Under attack	NATURE			English	Editorial Material																		Battisti DS, 2009, SCIENCE, V323, P240, DOI 10.1126/science.1164363; Chapman TB, 2012, ECOLOGY, V93, P2175, DOI 10.1890/11-1055.1; Huberty AF, 2004, ECOLOGY, V85, P1383, DOI 10.1890/03-0352; Kroschel J, 2013, AGR FOREST METEOROL, V170, P228, DOI 10.1016/j.agrformet.2012.06.017; Yudelman M., 1998, PEST MANAGEMENT FOOD	5	54	56	0	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 26	2013	501	7468					S15	S17		10.1038/501S15a	http://dx.doi.org/10.1038/501S15a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223RP	24067760	Bronze			2022-12-28	WOS:000324826300014
J	Thomas, MA; Roemer, GW; Donlan, CJ; Dickson, BG; Matocq, M; Malaney, J				Thomas, Michael A.; Roemer, Gary W.; Donlan, C. Josh; Dickson, Brett G.; Matocq, Marjorie; Malaney, Jason			Gene tweaking for conservation	NATURE			English	Editorial Material									[Thomas, Michael A.] Idaho State Univ, Pocatello, ID 83209 USA	Idaho; Idaho State University	Thomas, MA (corresponding author), Idaho State Univ, Pocatello, ID 83209 USA.	mthomas@isu.edu	Thomas, Michael A/B-7489-2008	Thomas, Michael A/0000-0003-2982-0291; Matocq, Marjorie/0000-0003-4829-3749				Cretekos CJ, 2008, GENE DEV, V22, P141, DOI 10.1101/gad.1620408; Donlan J, 2005, NATURE, V436, P913, DOI 10.1038/436913a; Hoegh-Guldberg O, 2008, SCIENCE, V321, P345, DOI 10.1126/science.1157897; Johnson WE, 2010, SCIENCE, V329, P1641, DOI 10.1126/science.1192891; Madsen T, 1996, BIOL CONSERV, V75, P113, DOI 10.1016/0006-3207(95)00067-4; Rebl A, 2013, MAR BIOTECHNOL, V15, P445, DOI 10.1007/s10126-013-9501-8; Redford KH, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001530; Thomas CD, 2012, NATURE, V482, pE4, DOI 10.1038/nature10858; Whitehead A, 2012, J EXP BIOL, V215, P884, DOI 10.1242/jeb.058735; Zhang JX, 2000, IN VITRO CELL DEV-PL, V36, P108, DOI 10.1007/s11627-000-0022-6	10	49	49	0	73	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 26	2013	501	7468					485	486		10.1038/501485a	http://dx.doi.org/10.1038/501485a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223RP	24073449	Bronze			2022-12-28	WOS:000324826300032
J	Rosen, CJ				Rosen, Clifford J.			Vitamin D supplementation: bones of contention	LANCET			English	Editorial Material							CLINICAL-PRACTICE; POOLED ANALYSIS; DENSITY; CALCIUM; FRACTURES; MICE		Maine Med Res Inst, Scarborough, ME 04074 USA		Rosen, CJ (corresponding author), Maine Med Res Inst, Scarborough, ME 04074 USA.	rosenc@mmc.org						Abrahamsen B, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.b5463; Avenell A, 2005, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD000227.PUB3; Bischoff-Ferrari HA, 2012, NEW ENGL J MED, V367, P40, DOI 10.1056/NEJMoa1109617; Busse B, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006286; Institute of Medicine (US) Committee to Review Dietary Reference Intakes for Vitamin D and Calcium, 2011, DIETARY REFERENCE IN; Jacques RM, 2012, J BONE MINER RES, V27, P1627, DOI 10.1002/jbmr.1644; Leslie WD, 2007, J CLIN ENDOCR METAB, V92, P77, DOI 10.1210/jc.2006-1415; Leslie WD, 2012, J CLIN ENDOCR METAB, V97, P1211, DOI 10.1210/jc.2011-2871; Lieben L, 2012, J CLIN INVEST, V122, P1803, DOI 10.1172/JCI45890; Reid IR, 2013, LANCET; Tang BMP, 2007, LANCET, V370, P657, DOI 10.1016/S0140-6736(07)61342-7; Xue YB, 2009, GASTROENTEROLOGY, V136, P1317, DOI 10.1053/j.gastro.2008.12.051	12	4	5	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 11	2014	383	9912					108	110		10.1016/S0140-6736(13)61721-3	http://dx.doi.org/10.1016/S0140-6736(13)61721-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	287YX	24119979				2022-12-28	WOS:000329579600009
J	Mourvillier, B; Tubach, F; van de Beek, D; Garot, D; Pichon, N; Georges, H; Lefevre, LM; Bollaert, PE; Boulain, T; Luis, D; Cariou, A; Girardie, P; Chelha, R; Megarbane, B; Delahaye, A; Chalumeau-Lemoine, L; Legriel, S; Beuret, P; Brivet, F; Bruel, C; Camou, F; Chatellier, D; Chillet, P; Clair, B; Constantin, JM; Duguet, A; Galliot, R; Bayle, F; Hyvernat, H; Ouchenir, K; Plantefeve, G; Quenot, JP; Richecoeur, J; Schwebel, C; Sirodot, M; Esposito-Farese, M; Le Tulzo, Y; Wolff, M				Mourvillier, Bruno; Tubach, Florence; van de Beek, Diederik; Garot, Denis; Pichon, Nicolas; Georges, Hugues; Lefevre, Laurent Martin; Bollaert, Pierre-Edouard; Boulain, Thierry; Luis, David; Cariou, Alain; Girardie, Patrick; Chelha, Riad; Megarbane, Bruno; Delahaye, Arnaud; Chalumeau-Lemoine, Ludivine; Legriel, Stephane; Beuret, Pascal; Brivet, Francois; Bruel, Cedric; Camou, Fabrice; Chatellier, Delphine; Chillet, Patrick; Clair, Bernard; Constantin, Jean-Michel; Duguet, Alexandre; Galliot, Richard; Bayle, Frederique; Hyvernat, Herve; Ouchenir, Kader; Plantefeve, Gaetan; Quenot, Jean-Pierre; Richecoeur, Jack; Schwebel, Carole; Sirodot, Michel; Esposito-Farese, Marina; Le Tulzo, Yves; Wolff, Michel			Induced Hypothermia in Severe Bacterial Meningitis A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PNEUMOCOCCAL MENINGITIS; ADULTS; BENEFIT; INJURY; DEXAMETHASONE; GUIDELINES; INDUCTION; FEATURES; THERAPY	IMPORTANCE Despite advances in care, mortality and morbidity remain high in adults with acute bacterial meningitis, particularly when due to Streptococcus pneumoniae. Induced hypothermia is beneficial in other conditions with global cerebral hypoxia. OBJECTIVE To test the hypothesis that induced hypothermia improves outcome in patients with severe bacterial meningitis. DESIGN, SETTING, AND PATIENTS An open-label, multicenter, randomized clinical trial in 49 intensive care units in France, February 2009-November 2011. In total, 130 patients were assessed for eligibility and 98 comatose adults (Glasgow Coma Scale [GCS] score of <= 8 for <12 hours) with community-acquired bacterial meningitis were randomized. INTERVENTIONS Hypothermia group received a loading dose of 4 degrees C cold saline and were cooled to 32 degrees C to 34 degrees C for 48 hours. The rewarming phase was passive. Controls received standard care. MAIN OUTCOMES AND MEASURES Primary outcome measure was the Glasgow Outcome Scale score at 3 months (a score of 5 [favorable outcome] vs a score of 1-4 [unfavorable outcome]). All patients received appropriate antimicrobial therapy and vital support. Analyses were performed on an intention-to-treat basis. The data and safety monitoring board (DSMB) reviewed severe adverse events and mortality rate every 50 enrolled patients. RESULTS After inclusion of 98 comatose patients, the trial was stopped early at the request of the DSMB because of concerns over excess mortality in the hypothermia group (25 of 49 patients [51%]) vs the control group (15 of 49 patients [31%]; relative risk [RR], 1.99; 95% CI, 1.05-3.77; P = .04). Pneumococcal meningitis was diagnosed in 77% of patients. Mean (SD) temperatures achieved 24 hours after randomization were 33.3 degrees C (0.9 degrees C) and 37.0 degrees C (0.9 degrees C) in the hypothermia and control group, respectively. At 3 months, 86% in the hypothermia group compared with 74% of controls had an unfavorable outcome (RR, 2.17; 95% CI, 0.78-6.01; P = .13). After adjustment for age, score on GCS at inclusion, and the presence of septic shock at inclusion, mortality remained higher, although not significantly, in the hypothermia group (hazard ratio, 1.76; 95% CI, 0.89-3.45; P = .10). Subgroup analysis on patients with pneumococcal meningitis showed similar results. Post hoc analysis showed a low probability to reach statistically significant difference in favor of hypothermia at the end of the 3 planned sequential analyses (probability to conclude in favor of futility, 0.977). CONCLUSIONS AND RELEVANCE Moderate hypothermia did not improve outcome in patients with severe bacterial meningitis and may even be harmful. Careful evaluation of safety issues in future trials on hypothermia are needed and may have important implications in patients presenting with septic shock or stroke.	[Mourvillier, Bruno; Wolff, Michel] Univ Paris Diderot, Sorbonne Paris Cite, Grp Hosp Bichat Claude Bernard, AP HP, Paris, France; [Tubach, Florence; Esposito-Farese, Marina] Univ Paris Diderot, Sorbonne Paris Cite, Hop Bichat, AP HP,Dept Epidemiol & Rech Clin,INSERM,CIE 801, Paris, France; [van de Beek, Diederik] Univ Amsterdam, Acad Med Ctr, Dept Neurol, Ctr Infect & Immun Amsterdam, NL-1105 AZ Amsterdam, Netherlands; [Garot, Denis] CHU Tours, Hop Bretonneau, Serv Reanimat Med, Tours, France; [Pichon, Nicolas] Ctr Hosp Univ Dupuytren, Limoges, France; [Georges, Hugues] Ctr Hosp Univ Tourcoing, Tourcoing, France; [Lefevre, Laurent Martin] Ctr Hosp Dept Les Oudaries, Serv Reanimat Polyvalente, La Roche Sur Yon, France; [Bollaert, Pierre-Edouard] Hop Cent, Ctr Hosp Univ Nancy, Serv Reanimat Med, Nancy, France; [Boulain, Thierry] Ctr Hosp Reg Orleans, Serv Reanimat Polyvalente, Orleans, France; [Luis, David] Ctr Hosp Univ Jean Verdier, AP HP, Serv Reanimat Med Chirurg, Bondy, France; [Cariou, Alain] Serv Reanimat Med, Paris, France; [Cariou, Alain] Ctr Hosp Univ Cochin St Vincent Paul Site Cochin, AP HP, Paris, France; [Girardie, Patrick] CHRU Lille, Hop Roger Salengro, Serv Reanimat Polyvalente, F-59037 Lille, France; [Chelha, Riad] Ctr Hosp Intercommunal Andre Gregoire Montreuil, Serv Reanimat Polyvalente, Montreuil, France; [Megarbane, Bruno] Ctr Hosp Univ Lariboisiere, Assistance Publ Hop, Serv Reanimat Med & Toxicol, Paris, France; [Delahaye, Arnaud] Ctr Hosp, Serv Reanimat Polyvalente, Rodez, France; [Chalumeau-Lemoine, Ludivine] Ctr Hosp Univ Tenon, AP HP, Serv Reanimat Med Chirurg, Paris, France; [Legriel, Stephane] Ctr Hosp Versailles, Serv Reanimat, Le Chesnay, France; [Beuret, Pascal] Ctr Hosp, Serv Reanimat Med Chirurg, Roanne, France; [Brivet, Francois] Ctr Hosp Univ Antoine Beclere, AP HP, Reanimat Med Ctr, Clamart, France; [Bruel, Cedric] Grp Hosp Paris St Joseph, Serv Reanimat Polyvalente, Paris, France; [Camou, Fabrice] Ctr Hosp Univ, Hop St Andre, Bordeaux, France; [Chatellier, Delphine] Ctr Hosp Univ, Serv Reanimat Med, Poitiers, France; [Chillet, Patrick] Ctr Hosp, Serv Reanimat Polyvalente, Chalons Sur Marne, France; [Clair, Bernard] AP HP, Serv Reanimat Med Chirurg, Garches, France; [Constantin, Jean-Michel] Ctr Hosp Univ Estaing, Serv Reanimat Adultes, Clermont Ferrand, France; [Constantin, Jean-Michel] Ctr Hosp Univ Estaing, USC, Clermont Ferrand, France; [Duguet, Alexandre] Ctr Hosp Univ La Pitie Salpetriere, AP HP, Serv Pneumol & Reanimat Med, Paris, France; [Galliot, Richard] Hop Foch, Suresnes, France; [Bayle, Frederique] Hop Croix Rousse, Ctr Hosp Univ, Serv Reanimat Med & Resp, F-69317 Lyon, France; [Hyvernat, Herve] Hop Archet, Serv Reanimat Med, Nice, France; [Ouchenir, Kader] Les Hop Chartres, Chartres, France; [Plantefeve, Gaetan] Ctr Hosp, Serv Reanimat Polyvalente, Dargenteuil, France; [Quenot, Jean-Pierre] Ctr Hosp Univ, Serv Reanimat Med, Dijon, France; [Richecoeur, Jack] CH Rene Dubos, Serv Reanimat Med Chirurg, Pontoise, France; [Schwebel, Carole] Hop A Michallon, Ctr Hosp Univ, Serv Reanimat Med, La Tronche, France; [Sirodot, Michel] Ctr Hosp Reg Annecy, Serv Reanimat Polyvalente, Pringy, France; [Le Tulzo, Yves] Hop Pontchaillou, Ctr Hosp Univ, Serv Reanimat Med & Infect, Rennes, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Amsterdam; Academic Medical Center Amsterdam; CHU Tours; CHU Limoges; CHU de Nancy; Centre Hospitalier Regional d'Orleans; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Jean-Verdier - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Universite de Lille - ISITE; CHU Lille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; Centre Hospitalier de Versailles; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Antoine-Beclere - APHP; Hopital Paris Saint-Joseph; UDICE-French Research Universities; Universite Paris Cite; CHU Bordeaux; CHU Poitiers; Universite de Poitiers; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Raymond-Poincare - APHP; CHU Clermont Ferrand; CHU Clermont Ferrand; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Hospital Foch; CHU Lyon; CHU Nice; CHU Dijon Bourgogne; Centre Hospitalier Rene Dubos, Pontoise; CHU Grenoble Alpes; Centre Hospitalier Annecy Genevois; CHU Rennes	Mourvillier, B (corresponding author), Grp Hosp Bichat Claude Bernard, AP HP, 46 Rue Henri Huchard, F-75018 Paris, France.	bruno.mourvillier@bch.aphp.fr	van de Beek, Diederik/Y-2713-2019; legriel, stephane/H-5735-2019; schwebel, carole/M-6189-2014; Legriel, Stephane/J-1307-2017; Boulain, Thierry/M-3309-2019	van de Beek, Diederik/0000-0002-4571-044X; legriel, stephane/0000-0003-4782-6734; Legriel, Stephane/0000-0003-4782-6734; Boulain, Thierry/0000-0003-4664-3661; Megarbane, Bruno/0000-0002-2522-2764; Camou, Fabrice/0000-0003-4715-224X; MOURVILLIER, BRUNO/0000-0001-5227-1468; QUENOT, Jean-Pierre/0000-0003-2351-682X	French Ministry of Health (Programme Hospitalier de Recherche Clinique) [PHRC-AOM06038]; IST Cardiology company; Covidien company; Netherlands Organization for Health Research and Development [917.11.358]; European Research Council [281156]	French Ministry of Health (Programme Hospitalier de Recherche Clinique); IST Cardiology company; Covidien company; Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development); European Research Council(European Research Council (ERC)European Commission)	This work was funded by a research grant from the French Ministry of Health (Programme Hospitalier de Recherche Clinique PHRC-AOM06038) and by unrestricted grants from IST Cardiology and Covidien companies. IST Cardiology provided endovascular catheters and cooling devices for 12 centers at decreased rates. Covidien provided free esophageal temperature probes for all included patients. Dr van de Beek was supported by grants 917.11.358 from the Netherlands Organization for Health Research and Development and 281156 from the European Research Council. The sponsor was the Departement a la Recherche Clinique et au Developpement, Assistance Publique-Hopitaux de Paris.	Angstwurm K, 2000, J CEREBR BLOOD F MET, V20, P834, DOI 10.1097/00004647-200005000-00010; [Anonymous], 2009, MED MALADIES INFECT, V39, P175, DOI DOI 10.1038/NGE0440; Auburtin M, 2006, CRIT CARE MED, V34, P2758, DOI 10.1097/01.CCM.0000239434.26669.65; Bassler D, 2010, JAMA-J AM MED ASSOC, V303, P1180, DOI 10.1001/jama.2010.310; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Brouwer MC, 2010, NEUROLOGY, V75, P1533, DOI 10.1212/WNL.0b013e3181f96297; Brouwer MC, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004405.pub4; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Cuthbertson BH, 2004, ANAESTHESIA, V59, P908, DOI 10.1111/j.1365-2044.2004.03748.x; de Gans J, 2002, NEW ENGL J MED, V347, P1549, DOI 10.1056/NEJMoa021334; Fayol P., 2004, Annales de Readaptation et de Medecine Physique, V47, P142, DOI 10.1016/j.annrmp.2004.01.004; Gluckman PD, 2005, LANCET, V365, P663, DOI 10.1016/S0140-6736(05)17946-X; Hansson L, 1992, Blood Press, V1, P113, DOI 10.3109/08037059209077502; Holzer M, 2002, NEW ENGL J MED, V346, P549; Iltis AS, 2005, J MED ETHICS, V31, P410, DOI 10.1136/jme.2004.008771; Irazuzta JE, 2000, BRAIN RES, V881, P88, DOI 10.1016/S0006-8993(00)02894-8; Irazuzta JE, 1999, BRAIN RES, V847, P143, DOI 10.1016/S0006-8993(99)02120-4; Irazuzta JE, 2002, CRIT CARE MED, V30, P2553, DOI 10.1097/00003246-200211000-00025; JENNETT B, 1975, LANCET, V1, P480; Lepur D, 2011, J INFECTION, V62, P172, DOI 10.1016/j.jinf.2010.10.001; McIntyre LA, 2003, JAMA-J AM MED ASSOC, V289, P2992, DOI 10.1001/jama.289.22.2992; McIntyre PB, 2012, LANCET, V380, P1703, DOI 10.1016/S0140-6736(12)61187-8; Montori VM, 2005, JAMA-J AM MED ASSOC, V294, P2203, DOI 10.1001/jama.294.17.2203; Mook-Kanamori BB, 2011, CLIN MICROBIOL REV, V24, P557, DOI 10.1128/CMR.00008-11; Nunnally ME, 2011, CRIT CARE MED, V39, P1113, DOI 10.1097/CCM.0b013e318206bab2; Pirozzo S, 2003, BRIT MED J, V327, P967, DOI 10.1136/bmj.327.7421.967; Polderman KH, 2005, CRIT CARE MED, V33, P2744, DOI 10.1097/01.CCM.0000190427.88735.19; Rowin ME, 2001, INFLAMMATION, V25, P137, DOI 10.1023/A:1011044312536; Shankaran S, 2005, NEW ENGL J MED, V353, P1574, DOI 10.1056/NEJMcps050929; Silverman Henry, 2007, Proc Am Thorac Soc, V4, P180, DOI 10.1513/pats.200701-010GC; Tunkel AR, 2004, CLIN INFECT DIS, V39, P1267, DOI 10.1086/425368; van de Beek D, 2006, NEW ENGL J MED, V354, P44, DOI 10.1056/NEJMra052116; van de Beek D, 2004, NEW ENGL J MED, V351, P1849, DOI 10.1056/NEJMoa040845; van de Beek D, 2007, J INFECTION, V55, P381, DOI 10.1016/j.jinf.2007.06.009; van de Beek D, 2012, LANCET, V380, P1693, DOI 10.1016/S0140-6736(12)61186-6; Weisfelt M, 2006, LANCET NEUROL, V5, P123, DOI 10.1016/S1474-4422(05)70288-X; Whitehead J, 1997, DESIGN ANAL SEQUENTI; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Xu LJ, 2002, J CEREBR BLOOD F MET, V22, P21, DOI 10.1097/00004647-200201000-00003	39	117	122	0	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 27	2013	310	20					2174	2183		10.1001/jama.2013.280506	http://dx.doi.org/10.1001/jama.2013.280506			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	257RS	24105303	Bronze			2022-12-28	WOS:000327404400026
J	Peek, CB; Nati, AHA; Ramsey, KM; Kuo, HY; Yu, W; Sena, LA; Ilkayeva, O; Marcheva, B; Kobayashi, Y; Omura, C; Levine, DC; Bacsik, DJ; Gius, D; Newgard, CB; Goetzman, E; Chandel, NS; Denu, JM; Mrksich, M; Bass, J				Peek, Clara Bien; Nati, Alison H. Affi; Ramsey, Kathryn Moynihan; Kuo, Hsin-Yu; Yu, Wei; Sena, Laura A.; Ilkayeva, Olga; Marcheva, Biliana; Kobayashi, Yumiko; Omura, Chiaki; Levine, Daniel C.; Bacsik, David J.; Gius, David; Newgard, Christopher B.; Goetzman, Eric; Chandel, Navdeep S.; Denu, John M.; Mrksich, Milan; Bass, Joseph			Circadian Clock NAD(+) Cycle Drives Mitochondrial Oxidative Metabolism in Mice	SCIENCE			English	Article							FATTY-ACID OXIDATION; GENE-EXPRESSION; NICOTINAMIDE; PATHWAYS; TISSUE; ACETYLATION; PROMOTES; GLUCOSE; MOUSE; CELLS	Circadian clocks are self-sustained cellular oscillators that synchronize oxidative and reductive cycles in anticipation of the solar cycle. We found that the clock transcription feedback loop produces cycles of nicotinamide adenine dinucleotide (NAD(+)) biosynthesis, adenosine triphosphate production, and mitochondrial respiration through modulation of mitochondrial protein acetylation to synchronize oxidative metabolic pathways with the 24-hour fasting and feeding cycle. Circadian control of the activity of the NAD(+)-dependent deacetylase sirtuin 3 (SIRT3) generated rhythms in the acetylation and activity of oxidative enzymes and respiration in isolated mitochondria, and NAD(+) supplementation restored protein deacetylation and enhanced oxygen consumption in circadian mutant mice. Thus, circadian control of NAD(+) bioavailability modulates mitochondrial oxidative function and organismal metabolism across the daily cycles of fasting and feeding.	[Peek, Clara Bien; Nati, Alison H. Affi; Ramsey, Kathryn Moynihan; Marcheva, Biliana; Kobayashi, Yumiko; Omura, Chiaki; Levine, Daniel C.; Bacsik, David J.; Bass, Joseph] Northwestern Univ, Feinberg Sch Med, Dept Med, Div Endocrinol Metab & Mol Med, Chicago, IL 60611 USA; [Peek, Clara Bien; Nati, Alison H. Affi; Ramsey, Kathryn Moynihan; Marcheva, Biliana; Kobayashi, Yumiko; Omura, Chiaki; Levine, Daniel C.; Bacsik, David J.; Bass, Joseph] Northwestern Univ, Dept Neurobiol, Evanston, IL 60208 USA; [Kuo, Hsin-Yu; Mrksich, Milan] Northwestern Univ, Dept Chem, Evanston, IL 60208 USA; [Kuo, Hsin-Yu; Mrksich, Milan] Northwestern Univ, Howard Hughes Med Inst, Evanston, IL 60208 USA; [Yu, Wei; Denu, John M.] Univ Wisconsin, Dept Biomol Chem, Madison, WI 53715 USA; [Yu, Wei; Denu, John M.] Univ Wisconsin, Wisconsin Inst Discovery, Madison, WI 53715 USA; [Sena, Laura A.; Chandel, Navdeep S.] Northwestern Univ, Feinberg Sch Med, Dept Med, Div Pulm & Crit Care Med, Chicago, IL 60611 USA; [Sena, Laura A.; Chandel, Navdeep S.] Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA; [Ilkayeva, Olga; Newgard, Christopher B.] Duke Univ, Med Ctr, Sarah W Stedman Nutr & Metab Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27705 USA; [Ilkayeva, Olga; Newgard, Christopher B.] Duke Univ, Med Ctr, Sarah W Stedman Nutr & Metab Ctr, Dept Med, Durham, NC 27705 USA; [Gius, David] Northwestern Univ, Feinberg Sch Med, Dept Radiat Oncol, Chicago, IL 60611 USA; [Goetzman, Eric] Univ Pittsburgh, Sch Med, Childrens Hosp Pittsburgh, Dept Pediat, Pittsburgh, PA 15224 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Northwestern University; Howard Hughes Medical Institute; Northwestern University; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Duke University; Duke University; Northwestern University; Feinberg School of Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Bass, J (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Med, Div Endocrinol Metab & Mol Med, Chicago, IL 60611 USA.	j-bass@northwestern.edu	Mrksich, Milan/G-2469-2011	Levine, Daniel/0000-0002-3453-951X; Affinati, Alison/0000-0002-4967-9240; Mrksich, Milan/0000-0002-4964-796X; Marcheva, Biliana/0000-0001-8697-2625; YU, WEI/0000-0001-9898-4607	NIH/NIAMS [5P30AR057216-05]; National Institute of Diabetes and Digestive and Kidney Diseases [F32 DK092034, F30 DK085936, T32 DK007169]; Endocrine Society; NIH [R01DK090242-03, P01DK58398, R01 AG038679, R01 CA152601-01, R01 CA152799-01A1, R01 CA168292-01A1, R01 CA16383801A1, 5P01HL071643-10, P01AG011412-16, R01HL097817-01, R01DK090625-01A1]; Merck; Janssen Pharmaceuticals; Vanda Pharmaceuticals; Matsutani America; Sirtris, a GSK company; Reset Therapeutics; NATIONAL CANCER INSTITUTE [P30CA014520, R01CA168292, R01CA152601, R01CA152799, P30CA060553] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL097817, P01HL071643, T32HL007909] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR057216] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090242, F30DK085936, R01DK090625, P01DK058398, T32DK007169, F32DK092034] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [F30ES019815] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065386, R37GM059785] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG011412, R01AG038679] Funding Source: NIH RePORTER	NIH/NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Endocrine Society; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Merck(Merck & Company); Janssen Pharmaceuticals(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Vanda Pharmaceuticals; Matsutani America; Sirtris, a GSK company; Reset Therapeutics; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank P. Schumacker, R. Allada, S. Imai, G. Barish, members of the Bass lab for discussion and comments on the manuscript; K. Lamia and P. Schumacker for Cry1<SUP>-/-</SUP>;Cry2<SUP>-/-</SUP> MEFs and Sirt3<SUP>-/-</SUP> mice, respectively; the Washington University Metabolomics Facility for nicotinamide measurements; the Northwestern University Skin Disease Research Center (NIH/NIAMS grant 5P30AR057216-05), and W. Song for technical assistance. Supported by National Institute of Diabetes and Digestive and Kidney Diseases grants F32 DK092034 (C. B. P.), F30 DK085936 (A. H. A.), and T32 DK007169 (B. M.); the Endocrine Society (D.J.B.); and NIH grants R01DK090242-03 (E. G.); P01DK58398 (C.B.N.); R01 AG038679 (J.M.D.); R01 CA152601-01, R01 CA152799-01A1, R01 CA168292-01A1, and R01 CA16383801A1 (D. G.); 5P01HL071643-10 (N.S.C.); and P01AG011412-16, R01HL097817-01, and R01DK090625-01A1 (J.B.). J.B. has financial interest in and serves as advisor to Reset Therapeutics, and has been a paid consultant for Merck, Janssen Pharmaceuticals, Vanda Pharmaceuticals, Gerson Lehrman Group, and Matsutani America. J.D. is a paid consultant for Sirtris, a GSK company. A provisional patent has been applied for by Northwestern University related to the role of the clock-NAD pathway in the mitochondrial control of cell growth, inflammation, and metabolism.	Alenghat T, 2008, NATURE, V456, P997, DOI 10.1038/nature07541; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Belenky P, 2007, CELL, V129, P473, DOI 10.1016/j.cell.2007.03.024; Bitterman KJ, 2002, J BIOL CHEM, V277, P45099, DOI 10.1074/jbc.M205670200; Canto C, 2012, CELL METAB, V15, P838, DOI 10.1016/j.cmet.2012.04.022; DAVIES SP, 1992, EUR J BIOCHEM, V203, P615, DOI 10.1111/j.1432-1033.1992.tb16591.x; Dodd AN, 2005, SCIENCE, V309, P630, DOI 10.1126/science.1115581; Feng D, 2012, MOL CELL, V47, P158, DOI 10.1016/j.molcel.2012.06.026; Goetzman ES, 2009, OBESITY, V17, P196, DOI 10.1038/oby.2008.467; Gurard-Levin ZA, 2010, ACS CHEM BIOL, V5, P863, DOI 10.1021/cb100088g; Hallows WC, 2011, MOL CELL, V41, P139, DOI 10.1016/j.molcel.2011.01.002; Hirschey MD, 2011, COLD SH Q B, V76, P267, DOI 10.1101/sqb.2011.76.010850; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; Imai SI, 2010, PHARMACOL RES, V62, P42, DOI 10.1016/j.phrs.2010.01.006; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Lamia KA, 2008, P NATL ACAD SCI USA, V105, P15172, DOI 10.1073/pnas.0806717105; Liu AC, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000023; Marcheva B, 2010, NATURE, V466, P627, DOI 10.1038/nature09253; Marroquin LD, 2007, TOXICOL SCI, V97, P539, DOI 10.1093/toxsci/kfm052; McCarthy JJ, 2007, PHYSIOL GENOMICS, V31, P86, DOI 10.1152/physiolgenomics.00066.2007; Nakahata Y, 2009, SCIENCE, V324, P654, DOI 10.1126/science.1170803; Nicholls David G, 2010, J Vis Exp, DOI 10.3791/2511; Nikiforov A, 2011, J BIOL CHEM, V286, P21767, DOI 10.1074/jbc.M110.213298; O'Neill JS, 2011, NATURE, V469, P498, DOI 10.1038/nature09702; PAIK WK, 1970, BIOCHIM BIOPHYS ACTA, V213, P513, DOI 10.1016/0005-2787(70)90058-4; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Pizarro A, 2013, NUCLEIC ACIDS RES, V41, pD1009, DOI 10.1093/nar/gks1161; Ramsey KM, 2009, SCIENCE, V324, P651, DOI 10.1126/science.1171641; Rogers GW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021746; Rudic RD, 2004, PLOS BIOL, V2, P1893, DOI 10.1371/journal.pbio.0020377; Rutter J, 2001, SCIENCE, V293, P510, DOI 10.1126/science.1060698; Shimazu T, 2010, CELL METAB, V12, P654, DOI 10.1016/j.cmet.2010.11.003; Someya S, 2010, CELL, V143, P802, DOI 10.1016/j.cell.2010.10.002; Storch KF, 2002, NATURE, V417, P78, DOI 10.1038/nature744; Tao RD, 2010, MOL CELL, V40, P893, DOI 10.1016/j.molcel.2010.12.013; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Wu JY, 2004, J CLIN INVEST, V113, P434, DOI 10.1172/JCI200419574; Yan OY, 1998, P NATL ACAD SCI USA, V95, P8660, DOI 10.1073/pnas.95.15.8660; Yang XY, 2006, CELL, V126, P801, DOI 10.1016/j.cell.2006.06.050; Yoshino J, 2011, CELL METAB, V14, P528, DOI 10.1016/j.cmet.2011.08.014; Yu W, 2012, J BIOL CHEM, V287, P14078, DOI 10.1074/jbc.M112.355206; Zhang XP, 2012, NUCLEIC ACIDS RES, V40, P3419, DOI 10.1093/nar/gkr1297	42	403	420	3	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 1	2013	342	6158					591	+		10.1126/science.1243417	http://dx.doi.org/10.1126/science.1243417			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RJ	24051248	Green Accepted			2022-12-28	WOS:000326334300040
J	Clark, RI; Tan, SWS; Pean, CB; Roostalu, U; Vivancos, V; Bronda, K; Pilatova, M; Fu, JQ; Walker, DW; Berdeaux, R; Geissmann, F; Dionne, MS				Clark, Rebecca I.; Tan, Sharon W. S.; Pean, Claire B.; Roostalu, Urmas; Vivancos, Valerie; Bronda, Kevin; Pilatova, Martina; Fu, Jingqi; Walker, David W.; Berdeaux, Rebecca; Geissmann, Frederic; Dionne, Marc S.			MEF2 Is an In Vivo Immune-Metabolic Switch	CELL			English	Article							MYOCYTE-ENHANCER FACTOR-2; TRANSCRIPTION FACTOR MEF2C; GENE-EXPRESSION; DROSOPHILA-MELANOGASTER; T-LYMPHOCYTES; HOST-DEFENSE; KINASE; ACTIVATION; PATHWAY; P38	Infections disturb metabolic homeostasis in many contexts, but the underlying connections are not completely understood. To address this, we use paired genetic and computational screens in Drosophila to identify transcriptional regulators of immunity and pathology and their associated target genes and physiologies. We show that Mef2 is required in the fat body for anabolic function and the immune response. Using genetic and biochemical approaches, we find that MEF2 is phosphorylated at a conserved site in healthy flies and promotes expression of lipogenic and glycogenic enzymes. Upon infection, this phosphorylation is lost, and the activity of MEF2 changes-MEF2 now associates with the TATA binding protein to bind a distinct TATA box sequence and promote antimicrobial peptide expression. The loss of phosphorylated MEF2 contributes to loss of anabolic enzyme expression in Gram-negative bacterial infection. MEF2 is thus a critical transcriptional switch in the adult fat body between metabolism and immunity.	[Clark, Rebecca I.; Tan, Sharon W. S.; Pean, Claire B.; Roostalu, Urmas; Vivancos, Valerie; Bronda, Kevin; Pilatova, Martina; Geissmann, Frederic; Dionne, Marc S.] Kings Coll London, Sch Med, Ctr Mol & Cellular Biol Inflammat, London SE1 1UL, England; [Clark, Rebecca I.; Tan, Sharon W. S.; Pean, Claire B.; Roostalu, Urmas; Vivancos, Valerie; Bronda, Kevin; Pilatova, Martina; Geissmann, Frederic; Dionne, Marc S.] Kings Coll London, Sch Med, Peter Gorer Dept Immunobiol, London SE1 1UL, England; [Fu, Jingqi; Berdeaux, Rebecca] Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA; [Berdeaux, Rebecca] Univ Texas Hlth Sci Ctr Houston, Grad Sch Biomed Sci, Houston, TX 77030 USA; [Clark, Rebecca I.; Walker, David W.] Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA 90095 USA; [Walker, David W.] Univ Calif Los Angeles, Mol Biol Inst, Los Angeles, CA 90095 USA	University of London; King's College London; University of London; King's College London; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Dionne, MS (corresponding author), Kings Coll London, Sch Med, Ctr Mol & Cellular Biol Inflammat, London SE1 1UL, England.	marc.dionne@kcl.ac.uk	Clark, Rebecca/J-9135-2015	Clark, Rebecca/0000-0002-1194-5048; geissmann, frederic/0000-0001-5029-2468; Roostalu, Urmas/0000-0002-7849-2055; Dionne, Marc/0000-0002-8283-1750; Berdeaux, Rebecca/0000-0002-9929-1711; Fu, Jingqi/0000-0003-3871-428X	NIDDK [R01DK092590]; NIAMS [R01AR059847]; NIA [R01AG040288, R01AG037514]; Ellison Medical Foundation [AG-NS-0470-08]; BBSRC [BB/E02128X/1]; Wellcome Trust [WT085119MA]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR059847] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK092590] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG037514, R01AG040288] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/E02128X/1] Funding Source: researchfish; Medical Research Council [G0900867] Funding Source: researchfish; MRC [G0900867] Funding Source: UKRI	NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Ellison Medical Foundation(Lawrence Ellison Foundation); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank the Vienna Drosophila RNAi Center, the Bloomington Drosophila Stock Center, Michael Taylor, Nazif Alic, Petros Ligoxygakis, Hanh Nguyen, and Richard Cripps for flies; Eileen Furlong and Bruce Paterson for antibodies; and Neal Silverman for peptidoglycan. Karen Liu, Vince Dionne, Brian Stramer, Thiago Carvalho, QueeLim Ch'ng, Joe Bateman, Rich Freiman, Mimi Shirasu-Hiza, David Schneider, and members of the Dionne, Stramer, and Geissmann laboratories provided essential discussion and comments. We would like to acknowledge funding from NIDDK (R01DK092590 to R.B.), NIAMS (R01AR059847 to R.B.), NIA (R01AG040288 and R01AG037514 to D.W.W.), and Ellison Medical Foundation (AG-NS-0470-08 to D.W.W.). Work in the Dionne lab was supported by grants from the BBSRC (BB/E02128X/1) and the Wellcome Trust (WT085119MA).	Alessi DR, 1996, FEBS LETT, V399, P333, DOI 10.1016/S0014-5793(96)01370-1; Berdeaux R, 2007, NAT MED, V13, P597, DOI 10.1038/nm1573; Blanchard FJ, 2010, J NEUROSCI, V30, P5855, DOI 10.1523/JNEUROSCI.2688-09.2010; BOUR BA, 1995, GENE DEV, V9, P730, DOI 10.1101/gad.9.6.730; Chen JM, 2010, P NATL ACAD SCI USA, V107, P20774, DOI 10.1073/pnas.1009223107; Chen W, 2002, J BIOL CHEM, V277, P49105, DOI 10.1074/jbc.M204934200; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; Clark RI, 2011, CURR BIOL, V21, P1672, DOI 10.1016/j.cub.2011.08.048; De Gregorio E, 2001, P NATL ACAD SCI USA, V98, P12590, DOI 10.1073/pnas.221458698; De Gregorio E, 2002, EMBO J, V21, P2568, DOI 10.1093/emboj/21.11.2568; Delaney JR, 2006, EMBO J, V25, P3068, DOI 10.1038/sj.emboj.7601182; DiAngelo JR, 2009, P NATL ACAD SCI USA, V106, P20853, DOI 10.1073/pnas.0906749106; Dijkers PF, 2007, CURR BIOL, V17, P2087, DOI 10.1016/j.cub.2007.11.001; Dionne MS, 2006, CURR BIOL, V16, P1977, DOI 10.1016/j.cub.2006.08.052; Dionne MS, 2003, INFECT IMMUN, V71, P3540, DOI 10.1128/IAI.71.6.3540-3550.2003; Frith MC, 2004, NUCLEIC ACIDS RES, V32, P1372, DOI 10.1093/nar/gkh299; Futschik Matthias E., 2005, Journal of Bioinformatics and Computational Biology, V3, P965, DOI 10.1142/S0219720005001375; Gottar M, 2006, CELL, V127, P1425, DOI 10.1016/j.cell.2006.10.046; Han J, 1997, NATURE, V386, P296, DOI 10.1038/386296a0; Handschin C, 2003, P NATL ACAD SCI USA, V100, P7111, DOI 10.1073/pnas.1232352100; Hedengren M, 1999, MOL CELL, V4, P827, DOI 10.1016/S1097-2765(00)80392-5; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hoskins RA, 2011, GENOME RES, V21, P182, DOI 10.1101/gr.112466.110; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hrdlicka L, 2002, GENESIS, V34, P51, DOI 10.1002/gene.10125; Kaneko T, 2004, IMMUNITY, V20, P637, DOI 10.1016/S1074-7613(04)00104-9; Khiem D, 2008, P NATL ACAD SCI USA, V105, P17067, DOI 10.1073/pnas.0804868105; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; LILLY B, 1995, SCIENCE, V267, P688, DOI 10.1126/science.7839146; Liopeta K, 2009, MOL IMMUNOL, V46, P345, DOI 10.1016/j.molimm.2008.10.025; Molkentin JD, 1995, CELL, V83, P1125, DOI 10.1016/0092-8674(95)90139-6; Moritz A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000998; Ni T, 2010, NAT METHODS, V7, P521, DOI [10.1038/nmeth.1464, 10.1038/NMETH.1464]; Pan F, 2004, J BIOL CHEM, V279, P14477, DOI 10.1074/jbc.C300487200; POLLOCK R, 1991, GENE DEV, V5, P2327, DOI 10.1101/gad.5.12a.2327; Reed DE, 2008, P NATL ACAD SCI USA, V105, P8351, DOI 10.1073/pnas.0802921105; Rynes J, 2012, MOL CELL BIOL, V32, P3949, DOI 10.1128/MCB.00429-12; Schmid CD, 2006, NUCLEIC ACIDS RES, V34, pD82, DOI 10.1093/nar/gkj146; Schneider DS, 2008, NAT REV IMMUNOL, V8, P889, DOI 10.1038/nri2432; Schwenk A, 2000, Curr Opin Clin Nutr Metab Care, V3, P285, DOI 10.1097/00075197-200007000-00008; Senger K, 2004, MOL CELL, V13, P19, DOI 10.1016/S1097-2765(03)00500-8; Shalizi A, 2006, SCIENCE, V311, P1012, DOI 10.1126/science.1122513; Tappy L, 2007, CRIT CARE MED, V35, pS531, DOI 10.1097/01.CCM.0000278062.28122.A4; Thai MV, 1998, J BIOL CHEM, V273, P14285, DOI 10.1074/jbc.273.23.14285; TRACEY KJ, 1994, ANNU REV MED, V45, P491, DOI 10.1146/annurev.med.45.1.491; Vallerie SN, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001007; Van den Berghe G, 2002, CRIT CARE CLIN, V18, P509, DOI 10.1016/S0749-0704(02)00007-6; Wang XM, 2005, J BIOL CHEM, V280, P16705, DOI 10.1074/jbc.M501819200; Wilker PR, 2008, NAT IMMUNOL, V9, P603, DOI 10.1038/ni.1609; Wu H, 2001, EMBO J, V20, P6414, DOI 10.1093/emboj/20.22.6414; Zhang CL, 2002, CELL, V110, P479, DOI 10.1016/S0092-8674(02)00861-9	52	100	102	4	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 10	2013	155	2					435	447		10.1016/j.cell.2013.09.007	http://dx.doi.org/10.1016/j.cell.2013.09.007			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	235LH	24075010	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000325719800019
J	Paridaen, JTML; Wilsch-Brauninger, M; Huttner, WB				Paridaen, Judith T. M. L.; Wilsch-Braeuninger, Michaela; Huttner, Wieland B.			Asymmetric Inheritance of Centrosome-Associated Primary Cilium Membrane Directs Ciliogenesis after Cell Division	CELL			English	Article							NEURAL PROGENITORS; NEUROGENESIS; LOCALIZATION; NEOCORTEX; ZONE	Primary cilia are key sensory organelles that are thought to be disassembled prior to mitosis. Inheritance of the mother centriole, which nucleates the primary cilium, in relation to asymmetric daughter cell behavior has previously been studied. However, the fate of the ciliary membrane upon cell division is unknown. Here, we followed the ciliary membrane in dividing embryonic neocortical stem cells and cultured cells. Ciliary membrane attached to the mother centriole was endocytosed at mitosis onset, persisted through mitosis at one spindle pole, and was asymmetrically inherited by one daughter cell, which retained stem cell character. This daughter re-established a primary cilium harboring an activated signal transducer earlier than the noninheriting daughter. Centrosomal association of ciliary membrane in dividing neural stem cells decreased at late neurogenesis when these cells differentiate. Our data imply that centrosome-associated ciliary membrane acts as a determinant for the temporal-spatial control of ciliogenesis.	[Paridaen, Judith T. M. L.; Wilsch-Braeuninger, Michaela; Huttner, Wieland B.] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany	Max Planck Society	Huttner, WB (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Pfotenhauerstr 108, D-01307 Dresden, Germany.	huttner@mpi-cbg.de	Huttner, Wieland B./P-4080-2018; Paridaen, Judith/O-1159-2015	Paridaen, Judith/0000-0003-3253-6646	EMBO long-term fellowship; DFG [SFB 655, A2, TRR 83, Tp6]; ERC [250197]; Fonds der Chemischen Industrie; DFG	EMBO long-term fellowship(European Molecular Biology Organization (EMBO)); DFG(German Research Foundation (DFG)); ERC(European Research Council (ERC)European Commission); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); DFG(German Research Foundation (DFG))	We are indebted to Jussi Helppi and team of the Animal Facility, Jan Peychl and team of the Light Microscopy Facility, and various other services and facilities of the Max Planck Institute of Molecular Cell Biology and Genetics for outstanding support. We thank Miguel Turrero Garcia for advice on organo-typic slice culture, Jula Peters for excellent technical assistance, and Stephan Saalfeld for help with the TrakEM plugin. We acknowledge Michel Bornens, Tamara Caspary, Fumio Matsuzaki, Kirk Mykytyn, and Caren Norden for their kind gift of reagents and thank Alex Sykes and Marnix Wieffer for critical reading of the manuscript. J.T.M.L.P. was supported by an EMBO long-term fellowship. W.B.H. was supported by grants from the DFG (SFB 655, A2; TRR 83, Tp6) and the ERC (250197), by the DFG-funded Center for Regenerative Therapies Dresden, and by the Fonds der Chemischen Industrie.	Aaku-Saraste E, 1997, MECH DEVELOP, V69, P71, DOI 10.1016/S0925-4773(97)00156-1; Anderson CT, 2009, CURR BIOL, V19, P1498, DOI 10.1016/j.cub.2009.07.034; Berbari NF, 2008, MOL BIOL CELL, V19, P1540, DOI 10.1091/mbc.E07-09-0942; Cevik S, 2010, J CELL BIOL, V188, P953, DOI 10.1083/jcb.200908133; Chen JK, 2002, P NATL ACAD SCI USA, V99, P14071, DOI 10.1073/pnas.182542899; Duldulao NA, 2009, DEVELOPMENT, V136, P4033, DOI 10.1242/dev.036350; Frank-Kamenetsky Maria, 2002, J Biol, V1, P10, DOI 10.1186/1475-4924-1-10; Garcia-Gonzalo FR, 2012, J CELL BIOL, V197, P697, DOI 10.1083/jcb.201111146; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Graser S, 2007, J CELL BIOL, V179, P321, DOI 10.1083/jcb.200707181; Horner VL, 2011, DEV BIOL, V355, P43, DOI 10.1016/j.ydbio.2011.04.019; Kim S, 2013, CURR OPIN CELL BIOL, V25, P506, DOI 10.1016/j.ceb.2013.04.011; Kim S, 2011, CELL CYCLE, V10, P2683, DOI 10.4161/cc.10.16.17009; Konno D, 2008, NAT CELL BIOL, V10, P93, DOI 10.1038/ncb1673; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Lancaster MA, 2012, CURR OPIN NEUROBIOL, V22, P737, DOI 10.1016/j.conb.2012.04.003; Lehtinen MK, 2011, ANNU REV CELL DEV BI, V27, P653, DOI 10.1146/annurev-cellbio-092910-154026; Louvi A, 2011, NEURON, V69, P1046, DOI 10.1016/j.neuron.2011.03.002; Mogensen MM, 2000, J CELL SCI, V113, P3013; Nachury MV, 2010, ANNU REV CELL DEV BI, V26, P59, DOI 10.1146/annurev.cellbio.042308.113337; Nigg EA, 2011, NAT CELL BIOL, V13, P1154, DOI 10.1038/ncb2345; Pelletier L, 2012, CURR OPIN CELL BIOL, V24, P541, DOI 10.1016/j.ceb.2012.05.005; Piotrowska-Nitsche Karolina, 2012, Cilia, V1, DOI 10.1186/2046-2530-1-6; Reiter JF, 2012, EMBO REP, V13, P608, DOI 10.1038/embor.2012.73; Riparbelli MG, 2012, DEV CELL, V23, P425, DOI 10.1016/j.devcel.2012.05.024; Robbins DJ, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002906; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; Seeley ES, 2010, J CELL SCI, V123, P511, DOI 10.1242/jcs.061093; Shitamukai A, 2011, J NEUROSCI, V31, P3683, DOI 10.1523/JNEUROSCI.4773-10.2011; Sillibourne JE, 2011, CYTOSKELETON, V68, P619, DOI 10.1002/cm.20536; SOROKIN S, 1962, J CELL BIOL, V15, P363, DOI 10.1083/jcb.15.2.363; SOROKIN SP, 1968, J CELL SCI, V3, P207; Tsunekawa Y, 2012, EMBO J, V31, P1879, DOI 10.1038/emboj.2012.43; Wang XQ, 2009, NATURE, V461, P947, DOI 10.1038/nature08435; Wilsch-Brauninger M, 2012, DEVELOPMENT, V139, P95, DOI 10.1242/dev.069294; Yamashita YM, 2007, SCIENCE, V315, P518, DOI 10.1126/science.1134910	37	188	192	2	62	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 10	2013	155	2					333	344		10.1016/j.cell.2013.08.060	http://dx.doi.org/10.1016/j.cell.2013.08.060			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	235LH	24120134	Bronze			2022-12-28	WOS:000325719800011
J	Marty, B; Zimmermann, L; Pujol, M; Burgess, R; Philippot, P				Marty, Bernard; Zimmermann, Laurent; Pujol, Magali; Burgess, Ray; Philippot, Pascal			Nitrogen Isotopic Composition and Density of the Archean Atmosphere	SCIENCE			English	Article							WESTERN-AUSTRALIA; EARLY EARTH; WARRAWOONA SYNCLINE; PILBARA CRATON; GOLD DEPOSITS; NORTH-POLE; 3.5 GA; EVOLUTION; ARGON; INCLUSIONS	Understanding the atmosphere's composition during the Archean eon is fundamental to unraveling ancient environmental conditions. We show from the analysis of nitrogen and argon isotopes in fluid inclusions trapped in 3.0- to 3.5-billion-year-old hydrothermal quartz that the partial pressure of N-2 of the Archean atmosphere was lower than 1.1 bar, possibly as low as 0.5 bar, and had a nitrogen isotopic composition comparable to the present-day one. These results imply that dinitrogen did not play a significant role in the thermal budget of the ancient Earth and that the Archean partial pressure of CO2 was probably lower than 0.7 bar.	[Marty, Bernard; Zimmermann, Laurent; Pujol, Magali] Univ Lorraine, CNRS, Ctr Rech Petrog & Geochim, F-54501 Vandoeuvre Les Nancy, France; [Burgess, Ray] Univ Manchester, Sch Earth Atmospher & Environm Sci, Manchester M13 9PL, Lancs, England; [Philippot, Pascal] Univ Paris Diderot, CNRS, Inst Phys Globe Paris, Sorbonne Paris Cite, F-75238 Paris 5, France	Centre National de la Recherche Scientifique (CNRS); Universite de Lorraine; University of Manchester; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	Marty, B (corresponding author), Univ Lorraine, CNRS, Ctr Rech Petrog & Geochim, 15 Rue Notre Dame Pauvres, F-54501 Vandoeuvre Les Nancy, France.	bmarty@crpg.cnrs-nancy.fr	Philippot, Pascal/AAD-4313-2020; Burgess, Ray/A-5767-2009	Burgess, Ray/0000-0001-7674-8718	Agence Nationale de la Recherche [eLife-2]; European Research Council under the European Community [267255]; Institut de Physique du Globe de Paris; Institut des Sciences de l'Univers; Geological Survey of Western Australia	Agence Nationale de la Recherche(French National Research Agency (ANR)); European Research Council under the European Community(European Research Council (ERC)); Institut de Physique du Globe de Paris; Institut des Sciences de l'Univers; Geological Survey of Western Australia	This study was supported by Agence Nationale de la Recherche Grant eLife-2 to P. P. and B. M. and by the European Research Council under the European Community's Seventh Framework Programme (FP7/2007-2013 grant agreement no. 267255 to B. M.). P. P. acknowledges the Institut de Physique du Globe de Paris, the Institut des Sciences de l'Univers, and the Geological Survey of Western Australia for supporting the Pilbara Drilling Project. We thank six anonymous reviewers and D. Catling for constructive comments. This is Centre de Recherches Petrographiques et Geochimiques contribution no. 2248 and Institut de Physique du Globe de Paris contribution no. 3424.	BUICK R, 1990, SEDIMENTOLOGY, V37, P247, DOI 10.1111/j.1365-3091.1990.tb00958.x; Burnard PG, 1999, GEOCHIM COSMOCHIM AC, V63, P1595, DOI 10.1016/S0016-7037(99)00108-8; Busigny V, 2011, GEOCHIM COSMOCHIM AC, V75, P7502, DOI 10.1016/j.gca.2011.09.049; Coltice N, 2009, CHEM GEOL, V266, P4, DOI 10.1016/j.chemgeo.2009.04.017; Foriel J, 2004, EARTH PLANET SC LETT, V228, P451, DOI 10.1016/j.epsl.2004.09.034; Goldblatt C, 2009, NAT GEOSCI, V2, P891, DOI 10.1038/NGEO692; Hamme RC, 2004, DEEP-SEA RES PT I, V51, P1517, DOI 10.1016/j.dsr.2004.06.009; Jia YF, 2004, TERRA NOVA, V16, P102, DOI 10.1111/j.1365-3121.2004.00535.x; Kasting JF, 2010, NATURE, V464, P687, DOI 10.1038/464687a; Kendrick MA, 2001, CHEM GEOL, V177, P351, DOI 10.1016/S0009-2541(00)00419-8; Lichtenegger HIM, 2010, ICARUS, V210, P1, DOI 10.1016/j.icarus.2010.06.042; Marty B, 2003, EARTH PLANET SC LETT, V206, P397, DOI 10.1016/S0012-821X(02)01108-1; Marty B., 1994, NOBLE GAS GEOCHEMIST, P191; Niemann HB, 2005, NATURE, V438, P779, DOI 10.1038/nature04122; Nishizawa M, 2007, EARTH PLANET SC LETT, V254, P332, DOI 10.1016/j.epsl.2006.11.044; Owen T., 1977, J GEOPHYS RES, V82, P4635, DOI DOI 10.1029/JS082I028P04635; Ozima M., 2022, NOBLE GAS GEOCHEMIST; Pepin RO, 2006, EARTH PLANET SC LETT, V252, P1, DOI 10.1016/j.epsl.2006.09.014; Philippot P, 2009, CR PALEVOL, V8, P649, DOI 10.1016/j.crpv.2009.06.006; Pinti DL, 2001, GEOCHIM COSMOCHIM AC, V65, P2301, DOI 10.1016/S0016-7037(01)00590-7; Pujol M, 2013, NATURE, V498, P87, DOI 10.1038/nature12152; Pujol M, 2011, EARTH PLANET SC LETT, V308, P298, DOI 10.1016/j.epsl.2011.05.053; Robert F, 2006, NATURE, V443, P969, DOI 10.1038/nature05239; SANO Y, 1990, GEOCHEM J, V24, P315, DOI 10.2343/geochemj.24.315; Tarduno JA, 2007, NATURE, V446, P657, DOI 10.1038/nature05667; Thebaud N, 2008, EARTH PLANET SC LETT, V272, P639, DOI 10.1016/j.epsl.2008.05.030; Thebaud N, 2006, CONTRIB MINERAL PETR, V152, P485, DOI 10.1007/s00410-006-0116-1; Van Kranendonk MJ, 2008, PRECAMBRIAN RES, V167, P93, DOI 10.1016/j.precamres.2008.07.003; Wordsworth R, 2013, SCIENCE, V339, P64, DOI 10.1126/science.1225759	31	117	117	3	90	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 4	2013	342	6154					101	104		10.1126/science.1240971	http://dx.doi.org/10.1126/science.1240971			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	227PP	24051244	Green Submitted			2022-12-28	WOS:000325126100054
J	Yamaguchi, Y; Suzuki, T; Mizoro, Y; Kori, H; Okada, K; Chen, YL; Fustin, JM; Yamazaki, F; Mizuguchi, N; Zhang, J; Dong, X; Tsujimoto, G; Okuno, Y; Doi, M; Okamura, H				Yamaguchi, Yoshiaki; Suzuki, Toru; Mizoro, Yasutaka; Kori, Hiroshi; Okada, Kazuki; Chen, Yulin; Fustin, Jean-Michel; Yamazaki, Fumiyoshi; Mizuguchi, Naoki; Zhang, Jing; Dong, Xin; Tsujimoto, Gozoh; Okuno, Yasushi; Doi, Masao; Okamura, Hitoshi			Mice Genetically Deficient in Vasopressin V1a and V1b Receptors Are Resistant to Jet Lag	SCIENCE			English	Article							SUPRACHIASMATIC NUCLEUS; CIRCADIAN-RHYTHMS; EXPRESSION; SYNCHRONY; STRESS	Jet-lag symptoms arise from temporal misalignment between the internal circadian clock and external solar time. We found that circadian rhythms of behavior (locomotor activity), clock gene expression, and body temperature immediately reentrained to phase-shifted light-dark cycles in mice lacking vasopressin receptors V1a and V1b (V1a(-/-)V1b(-/-)). Nevertheless, the behavior of V1a(-/-)V1b(-/-) mice was still coupled to the internal clock, which oscillated normally under standard conditions. Experiments with suprachiasmatic nucleus (SCN) slices in culture suggested that interneuronal communication mediated by V1a and V1b confers on the SCN an intrinsic resistance to external perturbation. Pharmacological blockade of V1a and V1b in the SCN of wild-type mice resulted in accelerated recovery from jet lag, which highlights the potential of vasopressin signaling as a therapeutic target for management of circadian rhythm misalignment, such as jet lag and shift work.	[Yamaguchi, Yoshiaki; Suzuki, Toru; Mizoro, Yasutaka; Okada, Kazuki; Chen, Yulin; Fustin, Jean-Michel; Yamazaki, Fumiyoshi; Mizuguchi, Naoki; Doi, Masao; Okamura, Hitoshi] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Syst Biol, Sakyo Ku, Kyoto 6068501, Japan; [Kori, Hiroshi] Ochanomizu Univ, Dept Informat Sci, Tokyo 1128620, Japan; [Kori, Hiroshi] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan; [Zhang, Jing; Dong, Xin; Okamura, Hitoshi] Kobe Univ, Grad Sch Med, Dept Brain Sci, Div Mol Brain Sci,Chuo Ku, Kobe, Hyogo 6500017, Japan; [Tsujimoto, Gozoh] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Genom Drug Discovery Sci, Kyoto 6068501, Japan; [Okuno, Yasushi] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Syst Biosci Drug Discovery, Kyoto 6068501, Japan	Kyoto University; Ochanomizu University; Japan Science & Technology Agency (JST); Kobe University; Kyoto University; Kyoto University	Okamura, H (corresponding author), Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Syst Biol, Sakyo Ku, Kyoto 6068501, Japan.	okamurah@pharm.kyoto-u.ac.jp	Kori, Hiroshi/AAD-3700-2019; Fustin, Jean-Michel/R-6621-2019; Yamaguchi, Yoshiaki/K-9418-2013; Doi, Masao/J-9267-2019	Fustin, Jean-Michel/0000-0002-6200-6075; Yamaguchi, Yoshiaki/0000-0003-4126-542X; Doi, Masao/0000-0001-6264-9217; Okamura, Hitoshi/0000-0002-3013-4881; Mizoro, Yasutaka/0000-0002-5081-4884; Suzuki, Toru/0000-0003-2973-190X	Ministry of Education, Science, Sports and Culture of Japan; Takeda Science Foundation; SRF; Kanae Science Foundation	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); SRF; Kanae Science Foundation	This work was supported in part by Grant-in-Aid for Specially Promoted Research (to H.O.) and Scientific Research on Innovative Areas "Brain Environment" (to H.O.) from the Ministry of Education, Science, Sports and Culture of Japan, and by grants from Takeda Science Foundation (to H.O.), SRF (to H.O.), and Kanae Science Foundation (to Y.Y.). H.O. and Kyoto University have applied for a patent (PCT/JP2013/064376) related to the use of V1a and V1b antagonists as circadian rhythm modulators.	Aton SJ, 2005, NAT NEUROSCI, V8, P476, DOI 10.1038/nn1419; Butler MP, 2009, J BIOL RHYTHM, V24, P340, DOI 10.1177/0748730409344800; Buxton OM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003200; Cao RF, 2013, EUR J NEUROSCI, V37, P130, DOI 10.1111/ejn.12028; CASTEL M, 1990, J COMP NEUROL, V298, P172, DOI 10.1002/cne.902980204; COMPERATORE CA, 1990, OCCUP MED, V5, P323; Doi M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1316; GROBLEWSKI TA, 1981, BRAIN RES BULL, V6, P125, DOI 10.1016/S0361-9230(81)80036-6; Harmar AJ, 2002, CELL, V109, P497, DOI 10.1016/S0092-8674(02)00736-5; Jin XW, 1999, CELL, V96, P57, DOI 10.1016/S0092-8674(00)80959-9; Kalamatianos T, 2004, J NEUROENDOCRINOL, V16, P493, DOI 10.1111/j.1365-2826.2004.01196.x; Kiessling S, 2010, J CLIN INVEST, V120, P2600, DOI 10.1172/JCI41192; Koshimizu T, 2006, P NATL ACAD SCI USA, V103, P7807, DOI 10.1073/pnas.0600875103; Kuramoto Y., 2003, CHEM OSCILLATIONS WA; Li JD, 2009, AM J PHYSIOL-REG I, V296, pR824, DOI 10.1152/ajpregu.90463.2008; Maywood ES, 2011, P NATL ACAD SCI USA, V108, P14306, DOI 10.1073/pnas.1101767108; Mohawk JA, 2011, TRENDS NEUROSCI, V34, P349, DOI 10.1016/j.tins.2011.05.003; OKAMURA H, 2007, COLD SPRING HARB SYM, V72, P551; Reddy AB, 2002, J NEUROSCI, V22, P7326; Sack RL, 2009, TRAVEL MED INFECT DI, V7, P102, DOI 10.1016/j.tmaid.2009.01.006; Scheer FAJL, 2009, P NATL ACAD SCI USA, V106, P4453, DOI 10.1073/pnas.0808180106; SCHWARTZ WJ, 1985, J NEUROSCI, V5, P2771; SWAAB DF, 1975, J NEURAL TRANSM, V36, P195, DOI 10.1007/BF01253126; Tanoue A, 2004, J CLIN INVEST, V113, P302, DOI 10.1172/JCI200419656; VANDENPOL AN, 1985, NEUROSCIENCE, V15, P1049, DOI 10.1016/0306-4522(85)90254-4; WINFREE AT, 1967, J THEOR BIOL, V16, P15, DOI 10.1016/0022-5193(67)90051-3; Yamaguchi S, 2003, SCIENCE, V302, P1408, DOI 10.1126/science.1089287; Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682; YOUNG WS, 1993, ENDOCRINOLOGY, V133, P585, DOI 10.1210/en.133.2.585	29	210	216	4	66	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 4	2013	342	6154					85	90		10.1126/science.1238599	http://dx.doi.org/10.1126/science.1238599			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	227PP	24092737				2022-12-28	WOS:000325126100050
J	O'Sullivan, BP; Orenstein, DM; Milla, CE				O'Sullivan, Brian P.; Orenstein, David M.; Milla, Carlos E.			Pricing for Orphan Drugs Will the Market Bear What Society Cannot?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CYSTIC-FIBROSIS		[O'Sullivan, Brian P.] Univ Massachusetts, Sch Med, Worcester, MA 01655 USA; [Orenstein, David M.] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA; [Milla, Carlos E.] Stanford Univ, Sch Med, Palo Alto, CA 94304 USA	University of Massachusetts System; University of Massachusetts Worcester; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Stanford University	O'Sullivan, BP (corresponding author), Univ Massachusetts, Sch Med, Dept Pediat, S5-858,55 Lake Ave N, Worcester, MA 01655 USA.	osullivb@ummhc.org						Abboud C, 2013, BLOOD, V121, P4439, DOI 10.1182/blood-2013-03-490003; Banner A, 2013, PATIENTVIEW Q, P1; Barrett PM, 2012, HUM MOL GENET, V21, pR66, DOI 10.1093/hmg/dds345; Bush A, 2012, THORAX, V67, P382, DOI 10.1136/thoraxjnl-2012-201798; Centers for Medicare & Medicaid Services (CMS), NAT HLTH EXP 2011 HI; Cystic Fibrosis Foundation, 2012, 2011 CFF ANN DAT REP; Ledford H, 2011, NATURE, V475, P275, DOI 10.1038/475275a; Rowe SM, 2012, THORAX, V67, P882, DOI 10.1136/thoraxjnl-2012-202550	8	66	67	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 2	2013	310	13					1343	1344		10.1001/jama.2013.278129	http://dx.doi.org/10.1001/jama.2013.278129			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	227GB	24084916				2022-12-28	WOS:000325098100016
J	Wissenberg, M; Lippert, FK; Folke, F; Weeke, P; Hansen, CM; Christensen, EF; Jans, H; Hansen, PA; Lang-Jensen, T; Olesen, JB; Lindhardsen, J; Fosbol, EL; Nielsen, SL; Gislason, GH; Kober, L; Torp-Pedersen, C				Wissenberg, Mads; Lippert, Freddy K.; Folke, Fredrik; Weeke, Peter; Hansen, Carolina Malta; Christensen, Erika Frischknecht; Jans, Henning; Hansen, Poul Anders; Lang-Jensen, Torsten; Olesen, Jonas Bjerring; Lindhardsen, Jesper; Fosbol, Emil L.; Nielsen, Soren L.; Gislason, Gunnar H.; Kober, Lars; Torp-Pedersen, Christian			Association of National Initiatives to Improve Cardiac Arrest Management With Rates of Bystander Intervention and Patient Survival After Out-of-Hospital Cardiac Arrest	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							AMERICAN-HEART-ASSOCIATION; PUBLIC-ACCESS DEFIBRILLATION; LONG-TERM SURVIVAL; CARDIOPULMONARY-RESUSCITATION; GUIDELINES; STATEMENT; IMPLEMENTATION; PROFESSIONALS; COMMITTEE; CPR	IMPORTANCE Out-of-hospital cardiac arrest is a major health problem associated with poor outcomes. Early recognition and intervention are critical for patient survival. Bystander cardiopulmonary resuscitation (CPR) is one factor among many associated with improved survival. OBJECTIVE To examine temporal changes in bystander resuscitation attempts and survival during a 10-year period in which several national initiatives were taken to increase rates of bystander resuscitation and improve advanced care. DESIGN, SETTING, AND PARTICIPANTS Patients with out-of-hospital cardiac arrest for which resuscitation was attempted were identified between 2001 and 2010 in the nationwide Danish Cardiac Arrest Registry. Of 29 111 patients with cardiac arrest, we excluded those with presumed noncardiac cause of arrest (n = 7390) and those with cardiac arrests witnessed by emergency medical services personnel (n = 2253), leaving a study population of 19 468 patients. MAIN OUTCOMES AND MEASURES Temporal trends in bystander CPR, bystander defibrillation, 30-day survival, and 1-year survival. RESULTS The median age of patients was 72 years; 67.4% were men. Bystander CPR increased significantly during the study period, from 21.1%(95% CI, 18.8%-23.4%) in 2001 to 44.9% (95% CI, 42.6%-47.1%) in 2010 (P<.001), whereas use of defibrillation by bystanders remained low (1.1% [95% CI, 0.6%-1.9%] in 2001 to 2.2% [95% CI, 1.5%-2.9%] in 2010; P=.003). More patients achieved survival on hospital arrival (7.9% [95% CI, 6.4%-9.5%] in 2001 to 21.8% [95% CI, 19.8%-23.8%] in 2010; P<.001). Also, 30-day survival improved (3.5% [95% CI, 2.5%-4.5%] in 2001 to 10.8% [95% CI, 9.4%-12.2%] in 2010; P<.001), as did 1-year survival (2.9% [95% CI, 2.0%-3.9%] in 2001 to 10.2% [95% CI, 8.9%-11.6%] in 2010; P<.001). Despite a decrease in the incidence of out-of-hospital cardiac arrests during the study period (40.4 to 34.4 per 100 000 persons in 2001 and 2010, respectively; P=.002), the number of survivors per 100 000 persons increased significantly (P<.001). For the entire study period, bystander CPR was positively associated with 30-day survival, regardless of witnessed status (30-day survival for nonwitnessed cardiac arrest, 4.3% [95% CI, 3.4%-5.2%] with bystander CPR and 1.0% [95% CI, 0.8%-1.3%] without; odds ratio, 4.38 [95% CI, 3.17-6.06]). For witnessed arrest the corresponding values were 19.4%(95% CI, 18.1%-20.7%) vs 6.1% (95% CI, 5.4%-6.7%); odds ratio, 3.74 (95% CI, 3.26-4.28). CONCLUSIONS AND RELEVANCE In Denmark between 2001 and 2010, an increase in survival following out-of-hospital cardiac arrest was significantly associated with a concomitant increase in bystander CPR. Because of the co-occurrence of other related initiatives, a causal relationship remains uncertain.	[Wissenberg, Mads; Folke, Fredrik; Weeke, Peter; Hansen, Carolina Malta; Olesen, Jonas Bjerring; Lindhardsen, Jesper; Gislason, Gunnar H.] Univ Copenhagen, Gentofte Hosp, Dept Cardiol, DK-2900 Hellerup, Denmark; [Fosbol, Emil L.; Kober, Lars] Copenhagen Univ Hosp, Rigshosp, Ctr Heart, Copenhagen, Denmark; [Torp-Pedersen, Christian] Aalborg Univ, Inst Hlth Sci & Technol, Aalborg, Denmark	University of Copenhagen; Herlev & Gentofte Hospital; Rigshospitalet; University of Copenhagen; Aalborg University	Wissenberg, M (corresponding author), Univ Copenhagen, Gentofte Hosp, Dept Cardiol, Niels Andersens Vej 65,Post 635, DK-2900 Hellerup, Denmark.	mads.wissenberg.joergensen@regionh.dk	Folke, Fredrik/P-3601-2014; Gislason, Gunnar/B-7561-2009; Christensen, Erika Frischknecht/H-8753-2017	Gislason, Gunnar/0000-0002-0548-402X; Christensen, Erika Frischknecht/0000-0003-3673-9694; Lippert, Freddy/0000-0002-2356-8809; Fosbol, Emil/0000-0002-2048-4167; Folke, Fredrik/0000-0002-2284-7857; Kober, Lars/0000-0002-6635-1466; Wissenberg, Mads/0000-0001-7067-3372	Danish foundation TrygFonden (Denmark); Danish Heart Foundation (Denmark); Health Insurance Foundation (Denmark); TrygFonden; Novo Nordisk Foundation	Danish foundation TrygFonden (Denmark); Danish Heart Foundation (Denmark); Health Insurance Foundation (Denmark); TrygFonden; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	This study was supported by the Danish foundation TrygFonden, the Danish Heart Foundation, and the Health Insurance Foundation (all from Denmark). The Danish Cardiac Arrest Registry and the Automated External Defibrillator (AED) Network are supported by TrygFonden, which has no commercial interests in the field of cardiac arrest. Dr Gislason is supported by an independent research scholarship from the Novo Nordisk Foundation.	Abella BS, 2008, CIRCULATION, V117, P704, DOI 10.1161/CIRCULATIONAHA.107.188486; [Anonymous], DAN LEARN CARD RES; [Anonymous], 2011, AUT EXT DEF AED PLAC; [Anonymous], SUMM VIT STAT; [Anonymous], INCR NUMB DAN CIT WH; Berdowski J, 2010, RESUSCITATION, V81, P1479, DOI 10.1016/j.resuscitation.2010.08.006; Buch P, 2003, TREATMENT OUT OF HOS; Caffrey SL, 2002, NEW ENGL J MED, V347, P1242, DOI 10.1056/NEJMoa020932; CUMMINS RO, 1991, CIRCULATION, V83, P1832, DOI 10.1161/01.CIR.83.5.1832; Davies CS, 2005, HEART, V91, P1299, DOI 10.1136/hrt.2003.032631; Field JM, 2010, CIRCULATION, V122, pS640, DOI 10.1161/CIRCULATIONAHA.110.970889; Hallstrom AP, 2004, NEW ENGL J MED, V351, P637; Hollenberg J, 2008, CIRCULATION, V118, P389, DOI 10.1161/CIRCULATIONAHA.107.734137; Holler NG, 2007, RESUSCITATION, V75, P23, DOI 10.1016/j.resuscitation.2007.03.015; Iwami T, 2009, CIRCULATION, V119, P728, DOI 10.1161/CIRCULATIONAHA.108.802058; Jacobs I, 2004, CIRCULATION, V110, P3385, DOI 10.1161/01.CIR.0000147236.85306.15; Kitamura T, 2012, CIRCULATION, V126, P2834, DOI 10.1161/CIRCULATIONAHA.112.109496; Kitamura T, 2010, NEW ENGL J MED, V362, P994, DOI 10.1056/NEJMoa0906644; Kuilman M, 1999, RESUSCITATION, V41, P25, DOI 10.1016/S0300-9572(99)00016-7; Kuramoto N, 2008, RESUSCITATION, V79, P475, DOI 10.1016/j.resuscitation.2008.07.005; Lindner TW, 2011, RESUSCITATION, V82, P1508, DOI 10.1016/j.resuscitation.2011.06.016; McNally Bryan, 2011, Morbidity and Mortality Weekly Report, V60, P1; Neumar RW, 2010, CIRCULATION, V122, pS729, DOI 10.1161/CIRCULATIONAHA.110.970988; Nichol G, 2008, JAMA-J AM MED ASSOC, V300, P1423, DOI 10.1001/jama.300.12.1423; Nielsen AM, 2013, RESUSCITATION, V84, P430, DOI 10.1016/j.resuscitation.2012.11.008; Nielsen AM, 2012, RESUSCITATION, V83, P1067, DOI 10.1016/j.resuscitation.2012.04.012; Rea TD, 2010, ANN EMERG MED, V55, P249, DOI 10.1016/j.annemergmed.2009.09.018; Rea TD, 2010, CIRCULATION, V121, P1134, DOI 10.1161/CIRCULATIONAHA.109.899799; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Sasson C, 2010, CIRC-CARDIOVASC QUAL, V3, P63, DOI 10.1161/CIRCOUTCOMES.109.889576; Vaillancourt C, 2008, CAN J EMERG MED, V10, P51, DOI 10.1017/S1481803500010010; Valenzuela TD, 2000, NEW ENGL J MED, V343, P1206, DOI 10.1056/NEJM200010263431701	33	770	783	4	38	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 2	2013	310	13					1377	1384		10.1001/jama.2013.278483	http://dx.doi.org/10.1001/jama.2013.278483			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	227GB	24084923	Bronze			2022-12-28	WOS:000325098100023
J	Qaseem, A; Holty, JEC; Owens, DK; Dallas, P; Starkey, M; Shekelle, P				Qaseem, Amir; Holty, Jon-Erik C.; Owens, Douglas K.; Dallas, Paul; Starkey, Melissa; Shekelle, Paul		Amer Coll Phys	Management of Obstructive Sleep Apnea in Adults: A Clinical Practice Guideline From the American College of Physicians	ANNALS OF INTERNAL MEDICINE			English	Article							POSITIVE AIRWAY PRESSURE; QUALITY-OF-LIFE; RANDOMIZED CONTROLLED-TRIAL; CONTROLLED CROSSOVER TRIAL; PLACEBO-CONTROLLED TRIAL; ORAL APPLIANCE THERAPY; TEMPERATURE-CONTROLLED-RADIOFREQUENCY; CHRONIC HEART-FAILURE; CPAP THERAPY; APNEA/HYPOPNEA SYNDROME	Description: The American College of Physicians (ACP) developed this guideline to present the evidence and provide clinical recommendations on the management of obstructive sleep apnea (OSA) in adults. Methods: This guideline is based on published literature from 1966 to September 2010 that was identified by using MEDLINE, the Cochrane Central Register of Controlled Trials, and the Cochrane Database of Systematic Reviews. A supplemental MEDLINE search identified additional articles through October 2012. Searches were limited to English-language publications. The clinical outcomes evaluated for this guideline included cardiovascular disease (such as heart failure, hypertension, stroke, and myocardial infarction), type 2 diabetes, death, sleep study measures (such as the Apnea-Hypopnea Index), measures of cardiovascular status (such as blood pressure), measures of diabetes status (such as hemoglobin A(1c) levels), and quality of life. This guideline grades the evidence and recommendations using ACP's clinical practice guidelines grading system. Recommendation 1: ACP recommends that all overweight and obese patients diagnosed with OSA should be encouraged to lose weight. (Grade: strong recommendation; low-quality evidence) Recommendation 2: ACP recommends continuous positive airway pressure treatment as initial therapy for patients diagnosed with OSA. (Grade: strong recommendation; moderate-quality evidence) Recommendation 3: ACP recommends mandibular advancement devices as an alternative therapy to continuous positive airway pressure treatment for patients diagnosed with OSA who prefer mandibular advancement devices or for those with adverse effects associated with continuous positive airway pressure treatment. (Grade: weak recommendation; low-quality evidence)	[Qaseem, Amir] Amer Coll Physicians, Philadelphia, PA 19106 USA; Stanford Univ, Stanford, CA 94305 USA; Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA; Virginia Tech Univ, Caril Sch Med, Roanoke, VA USA; W Los Angeles Vet Affairs Med Ctr, Los Angeles, CA 90073 USA	American College of Physicians; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; West Los Angeles VA Medical Center	Qaseem, A (corresponding author), Amer Coll Physicians, 190 N Independence Mall West, Philadelphia, PA 19106 USA.	aqaseem@acponline.org		Starkey, Melissa/0000-0002-5818-0265	ACP operating budget	ACP operating budget	Financial support for the development of this guideline comes exclusively from the ACP operating budget.	Agency for Healthcare Research and Quality, 2010, METH REF GUID EFF CO; ANAND VK, 1991, OTOLARYNG HEAD NECK, V105, P382, DOI 10.1177/019459989110500306; Anderson FE, 2003, SLEEP, V26, P721, DOI 10.1093/sleep/26.6.721; Antic NA, 2009, AM J RESP CRIT CARE, V179, P501, DOI 10.1164/rccm.200810-1558OC; Back LJJ, 2009, LARYNGOSCOPE, V119, P1621, DOI 10.1002/lary.20562; Balk EM, 2011, AHRQ PUBLICATION; Ballard RD, 2007, J CLIN SLEEP MED, V3, P706; Ballester E, 1999, AM J RESP CRIT CARE, V159, P495, DOI 10.1164/ajrccm.159.2.9804061; Barbe F, 2001, ANN INTERN MED, V134, P1015, DOI 10.7326/0003-4819-134-11-200106050-00007; Barbe F, 2012, JAMA-J AM MED ASSOC, V307, P2161, DOI 10.1001/jama.2012.4366; Barbe F, 2010, AM J RESP CRIT CARE, V181, P718, DOI 10.1164/rccm.200901-0050OC; Barnes M, 2004, AM J RESP CRIT CARE, V170, P656, DOI 10.1164/rccm.200311-1571OC; Barnes M, 2002, AM J RESP CRIT CARE, V165, P773, DOI 10.1164/ajrccm.165.6.2003166; Benazzo M, 2008, ACTA OTO-LARYNGOL, V128, P680, DOI 10.1080/00016480701636884; Bloch KE, 2000, AM J RESP CRIT CARE, V162, P246, DOI 10.1164/ajrccm.162.1.9908112; Bradshaw DA, 2006, CHEST, V130, P1369, DOI 10.1378/chest.130.5.1369; Buchner NJ, 2007, AM J RESP CRIT CARE, V176, P1274, DOI 10.1164/rccm.200611-1588OC; Campos-Rodriguez F, 2005, CHEST, V128, P624, DOI 10.1378/chest.128.2.624; Campos-Rodriguez F, 2012, ANN INTERN MED, V156, P115, DOI 10.7326/0003-4819-156-2-201201170-00006; Carley DW, 2007, SLEEP, V30, P35, DOI 10.1093/sleep/30.1.35; Ceylan K, 2009, ARCH OTOLARYNGOL, V135, P915, DOI 10.1001/archoto.2009.117; Chasens ER, 2005, WESTERN J NURS RES, V27, P307, DOI 10.1177/0193945904273283; Chervin RD, 1997, SLEEP, V20, P284, DOI 10.1093/sleep/20.4.284; Clark GT, 1996, CHEST, V109, P1477, DOI 10.1378/chest.109.6.1477; Comondore VR, 2009, LUNG, V187, P17, DOI 10.1007/s00408-008-9115-5; Conradt R, 1998, J SLEEP RES, V7, P217, DOI 10.1046/j.1365-2869.1998.00116.x; Damjanovic D, 2009, EUR RESPIR J, V33, P804, DOI 10.1183/09031936.00023408; DeMolles DA, 2004, MED CARE, V42, P764, DOI 10.1097/01.mlr.0000132353.99209.fe; Doherty LS, 2005, CHEST, V127, P2076, DOI 10.1378/chest.127.6.2076; Dolan DC, 2009, SLEEP BREATH, V13, P73, DOI 10.1007/s11325-008-0199-1; Donadio V, 2008, J SLEEP RES, V17, P458, DOI [10.1111/j.1365-2869.2008.00672.x, 10.1111/j.1365-2869.2008.00682.x, 10.1111/j.1365-2869.2008.00683.x, 10.1111/j.1365-2869.2008.00663.x, 10.1111/j.1365-2869.2008.00667.x]; Drager LF, 2007, AM J RESP CRIT CARE, V176, P706, DOI 10.1164/rccm.200703-500OC; Egea CJ, 2008, SLEEP MED, V9, P660, DOI 10.1016/j.sleep.2007.06.018; Engleman HM, 1997, THORAX, V52, P114, DOI 10.1136/thx.52.2.114; Engleman HM, 1999, AM J RESP CRIT CARE, V159, P461, DOI 10.1164/ajrccm.159.2.9803121; ENGLEMAN HM, 1994, LANCET, V343, P572, DOI 10.1016/S0140-6736(94)91522-9; Engleman HM, 1998, THORAX, V53, P341, DOI 10.1136/thx.53.5.341; Engleman HM, 1996, SLEEP, V19, P378, DOI 10.1093/sleep/19.5.378; Engleman HM, 2002, AM J RESP CRIT CARE, V166, P855, DOI 10.1164/rccm.2109023; ESCLAMADO RM, 1989, LARYNGOSCOPE, V99, P1125; Eskafi M, 2004, SWED DENT J, V28, P1; Ferguson KA, 2003, AM J RESP CRIT CARE, V167, P15, DOI 10.1164/rccm.2108050; Ferguson KA, 1996, CHEST, V109, P1269, DOI 10.1378/chest.109.5.1269; FLETCHER EC, 1991, AM REV RESPIR DIS, V143, P936, DOI 10.1164/ajrccm/143.5_Pt_1.936; Foster GD, 2009, ARCH INTERN MED, V169, P1619, DOI 10.1001/archinternmed.2009.266; Friedman M, 2004, LARYNGOSCOPE, V114, P454, DOI 10.1097/00005537-200403000-00013; Friedman M, 2007, LARYNGOSCOPE, V117, P1859, DOI 10.1097/MLG.0b013e3180f62b4d; Gagnadoux F, 2009, EUR RESPIR J, V34, P914, DOI 10.1183/09031936.00148208; Gay PC, 2003, SLEEP, V26, P864, DOI 10.1093/sleep/26.7.864; Gotsopoulos H, 2002, AM J RESP CRIT CARE, V166, P743, DOI 10.1164/rccm.200203-208OC; Gotsopoulos H, 2004, SLEEP, V27, P934, DOI 10.1093/sleep/27.5.934; Grunstein RR, 2007, SLEEP, V30, P703, DOI 10.1093/sleep/30.6.703; Guilleminault C, 2008, SLEEP, V31, P1527, DOI 10.1093/sleep/31.11.1527; HAAVISTO L, 1994, CLIN OTOLARYNGOL, V19, P243, DOI 10.1111/j.1365-2273.1994.tb01224.x; Hans MG, 1997, AM J ORTHOD DENTOFAC, V111, P562, DOI 10.1016/S0889-5406(97)70293-2; HARMON JD, 1989, SOUTHERN MED J, V82, P161, DOI 10.1097/00007611-198902000-00004; HE J, 1988, CHEST, V94, P9, DOI 10.1378/chest.94.1.9; Hoekema A, 2008, J DENT RES, V87, P882, DOI 10.1177/154405910808700917; Hoekema A, 2007, J SEX MED, V4, P1153, DOI 10.1111/j.1743-6109.2006.00341.x; Holmdahl C, 2009, SLEEP MED, V10, P869, DOI 10.1016/j.sleep.2008.08.008; Hoy CJ, 1999, AM J RESP CRIT CARE, V159, P1096, DOI 10.1164/ajrccm.159.4.9808008; Hudgel DW, 2000, SLEEP, V23, P645; Hui DSC, 2000, CHEST, V117, P1410, DOI 10.1378/chest.117.5.1410; Hui DSC, 2001, CHEST, V120, P170, DOI 10.1378/chest.120.1.170; Ip S, 2012, SYST REV, V1, DOI 10.1186/2046-4053-1-20; Izci B, 2005, RESP MED, V99, P337, DOI 10.1016/j.rmed.2004.07.007; Jennum P, 2011, THORAX, V66, P560, DOI 10.1136/thx.2010.143958; Johansson K, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4609; Johnston CD, 2002, EUR J ORTHODONT, V24, P251, DOI 10.1093/ejo/24.3.251; Kaneko Y, 2003, NEW ENGL J MED, V348, P1233, DOI 10.1056/NEJMoa022479; Kato J, 2000, CHEST, V117, P1065, DOI 10.1378/chest.117.4.1065; KATSANTONIS GP, 1988, LARYNGOSCOPE, V98, P304; KEENAN SP, 1994, CHEST, V105, P155, DOI 10.1378/chest.105.1.155; Kezirian EJ, 2004, LARYNGOSCOPE, V114, P450, DOI 10.1097/00005537-200403000-00012; Khanna R, 2003, SLEEP MED, V4, P333, DOI 10.1016/S1389-9457(03)00063-7; Khayat RN, 2008, CHEST, V134, P1162, DOI 10.1378/chest.08-0346; Kiely JL, 2004, THORAX, V59, P50; Korostovtseva LS, 2011, MED SCI MONITOR, V17, pCR146, DOI 10.12659/MSM.881448; Koutsourelakis I, 2008, EUR RESPIR J, V31, P110, DOI 10.1183/09031936.00087607; Kraiczi H, 1999, SLEEP, V22, P61; Krieger J, 1996, SLEEP, V19, pS136, DOI 10.1093/sleep/19.suppl_9.S136; Lam B, 2007, THORAX, V62, P354, DOI 10.1136/thx.2006.063644; Leidag M, 2008, J PHYSIOL PHARMACOL, V59, P401; Lettieri CJ, 2009, ANN INTERN MED, V151, P696, DOI 10.7326/0003-4819-151-10-200911170-00006; Lettieri CJ, 2009, CHEST, V136, P1263, DOI 10.1378/chest.09-0811; Lewis KE, 2006, SLEEP MED, V7, P241, DOI 10.1016/j.sleep.2005.09.007; Li HY, 2009, AM J RHINOL ALLERGY, V23, pE51, DOI 10.2500/ajra.2009.23.3358; Lin SW, 2006, LARYNGOSCOPE, V116, P1012, DOI 10.1097/01.mlg.0000217242.16814.da; Lojander J, 1996, CHEST, V110, P114, DOI 10.1378/chest.110.1.114; Lojander J, 1999, J SLEEP RES, V8, P71, DOI 10.1046/j.1365-2869.1999.00141.x; Lundkvist K, 2009, ACTA OTO-LARYNGOL, V129, P1280, DOI 10.3109/00016480802654380; Mador MJ, 2005, CHEST, V128, P2151, DOI 10.1378/chest.128.4.2151; Mansfield DR, 2004, AM J RESP CRIT CARE, V169, P361, DOI 10.1164/rccm.200306-752OC; Marin JM, 2005, LANCET, V365, P1046, DOI 10.1016/S0140-6736(05)71141-7; Marrone O, 2004, SLEEP MED, V5, P247, DOI 10.1016/j.sleep.2003.09.011; Marshall NS, 2005, THORAX, V60, P427, DOI 10.1136/thx.2004.032078; Marti S, 2002, EUR RESPIR J, V20, P1511, DOI 10.1183/09031936.02.00306502; Massie CA, 1999, CHEST, V116, P403, DOI 10.1378/chest.116.2.403; Massie CA, 2003, CHEST, V123, P1112, DOI 10.1378/chest.123.4.1112; McArdle N, 1999, AM J RESP CRIT CARE, V159, P1108, DOI 10.1164/ajrccm.159.4.9807111; Mehta A, 2001, AM J RESP CRIT CARE, V163, P1457, DOI 10.1164/ajrccm.163.6.2004213; Meurice JC, 2007, SLEEP MED, V8, P37, DOI 10.1016/j.sleep.2006.05.010; Minnerup J, 2012, STROKE, V43, P1137, DOI 10.1161/STROKEAHA.111.637611; Monasterio C, 2001, AM J RESP CRIT CARE, V164, P939, DOI 10.1164/ajrccm.164.6.2008010; Montserrat JM, 2001, AM J RESP CRIT CARE, V164, P608, DOI 10.1164/ajrccm.164.4.2006034; Morrish E, 2008, RESP MED, V102, P1231, DOI 10.1016/j.rmed.2008.04.014; Mortimore IL, 1998, THORAX, V53, P290, DOI 10.1136/thx.53.4.290; Naismith SL, 2005, J CLIN SLEEP MED, V1, P374; Nakamura H, 2009, SLEEP BIOL RHYTHMS, V7, P103, DOI 10.1111/j.1479-8425.2009.00395.x; Neill AM, 2003, EUR RESPIR J, V22, P258, DOI 10.1183/09031936.03.00035603; Nilius G, 2006, CHEST, V130, P1018, DOI 10.1378/chest.130.4.1018; Noseda A, 2004, CHEST, V126, P31, DOI 10.1378/chest.126.1.31; Palmer S, 2004, SLEEP MED, V5, P61, DOI 10.1016/S1389-9457(03)00166-7; Parra O, 2011, EUR RESPIR J, V37, P1128, DOI 10.1183/09031936.00034410; Parthasarathy S, 2006, J CLIN SLEEP MED, V2, P133; PARTINEN M, 1988, CHEST, V94, P1200, DOI 10.1378/chest.94.6.1200; PARTINEN M, 1990, CHEST, V97, P27, DOI 10.1378/chest.97.1.27; Peker Y, 2006, EUR RESPIR J, V28, P596, DOI 10.1183/09031936.06.00107805; Peker Y, 2000, AM J RESP CRIT CARE, V162, P81, DOI 10.1164/ajrccm.162.1.9905035; Peker Y, 2002, AM J RESP CRIT CARE, V166, P159, DOI 10.1164/rccm.2105124; Pepin JL, 2009, CHEST, V136, P490, DOI 10.1378/chest.08-2646; Petri N, 2008, J SLEEP RES, V17, P221, DOI 10.1111/j.1365-2869.2008.00645.x; Piper AJ, 2008, THORAX, V63, P395, DOI 10.1136/thx.2007.081315; Planes C, 2003, SLEEP, V26, P156, DOI 10.1093/sleep/26.2.156; Qaseem A, 2010, ANN INTERN MED, V153, P194, DOI 10.7326/0003-4819-153-3-201008030-00010; Randerath WJ, 2002, CHEST, V122, P569, DOI 10.1378/chest.122.2.569; Randerath WJ, 2001, AM J RESP CRIT CARE, V163, P652, DOI 10.1164/ajrccm.163.3.2006168; RANDERATH WJ, 2003, MED SCI MONITOR, V9, P353; REEVESHOCHE MK, 1995, AM J RESP CRIT CARE, V151, P443, DOI 10.1164/ajrccm.151.2.7842204; Resta O, 2004, Monaldi Arch Chest Dis, V61, P153; Richards D, 2007, SLEEP, V30, P635, DOI 10.1093/sleep/30.5.635; Robinson S, 2009, OTOLARYNG HEAD NECK, V141, P257, DOI 10.1016/j.otohns.2009.03.022; ROTH T, 1990, PROG CLIN BIOL RES, V345, P347; Ryan S, 2009, J CLIN SLEEP MED, V5, P422; Salgado Sara Moreira da Silva Trindade, 2008, J. bras. pneumol., V34, P690, DOI 10.1590/S1806-37132008000900009; Senn O, 2003, AM J RESP CRIT CARE, V168, P1506, DOI 10.1164/rccm.200304-542OC; Series F, 1997, ANN INTERN MED, V127, P588, DOI 10.7326/0003-4819-127-8_Part_1-199710150-00002; Siccoli MM, 2008, SLEEP, V31, P1551, DOI 10.1093/sleep/31.11.1551; Skinner MA, 2004, CHEST, V125, P118, DOI 10.1378/chest.125.1.118; Smith CE, 2009, PATIENT EDUC COUNS, V74, P184, DOI 10.1016/j.pec.2008.08.008; Smith LA, 2007, EUR HEART J, V28, P1221, DOI 10.1093/eurheartj/ehm131; Stepnowsky CJ, 2007, J MED INTERNET RES, V9, DOI 10.2196/jmir.9.2.e14; Suurna MV, 2008, OTOLARYNG HEAD NECK, V139, P286, DOI 10.1016/j.otohns.2008.03.012; Tan YK, 2002, EUR J ORTHODONT, V24, P239, DOI 10.1093/ejo/24.3.239; Taylor Y, 2006, SLEEP BREATH, V10, P132, DOI 10.1007/s11325-006-0059-9; Teschler H, 2000, EUR RESPIR J, V15, P990, DOI 10.1034/j.1399-3003.2000.01503.x; To KW, 2008, RESPIROLOGY, V13, P79, DOI 10.1111/j.1440-1843.2007.01138.x; Tuomilehto HPI, 2009, AM J RESP CRIT CARE, V179, P320, DOI 10.1164/rccm.200805-669OC; Veale D, 2000, EUR RESPIR J, V15, P326, DOI 10.1034/j.1399-3003.2000.15b18.x; Veasey SC, 2006, SLEEP, V29, P1036, DOI 10.1093/sleep/29.8.1036; Vennelle M, 2010, SLEEP, V33, P267, DOI 10.1093/sleep/33.2.267; Vicini C, 2010, AM J OTOLARYNG, V31, P14, DOI 10.1016/j.amjoto.2008.09.002; Walker-Engstrom ML, 2000, J SLEEP RES, V9, P303; Walker-Engstrom ML, 2002, CHEST, V121, P739, DOI 10.1378/chest.121.3.739; Weaver EM, 2004, OTOLARYNG HEAD NECK, V130, P659, DOI 10.1016/j.otohns.2003.12.012; WHYTE KF, 1988, SLEEP, V11, P463, DOI 10.1093/sleep/11.5.463; Wiese HJ, 2005, SLEEP MED, V6, P171, DOI 10.1016/j.sleep.2004.08.006; Wild MR, 2004, EUR RESPIR J, V24, P461, DOI 10.1183/09031936.04.00114603; Wilhelmsson B, 1999, ACTA OTO-LARYNGOL, V119, P503; Woodson BT, 2003, OTOLARYNG HEAD NECK, V128, P848, DOI 10.1016/S0194-5998(03)00461-3; Woodson BT, 2001, OTOLARYNG HEAD NECK, V125, P303, DOI 10.1067/mhn.2001.118958; Young T, 2005, J APPL PHYSIOL, V99, P1592, DOI 10.1152/japplphysiol.00587.2005; ZORICK F J, 1990, Henry Ford Hospital Medical Journal, V38, P223	163	207	230	1	29	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 1	2013	159	7					471	U94		10.7326/00030003-4819-159-7-201310010-00704	http://dx.doi.org/10.7326/00030003-4819-159-7-201310010-00704			18	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	234FQ	24061345				2022-12-28	WOS:000325628000005
J	Johnston, AM; West, AT; Kendrew, JM; Steyn, RS; Kalkat, MS; Graham, TR				Johnston, Andrew McDonald; West, Andrew T.; Kendrew, Jonathan M.; Steyn, Richard S.; Kalkat, Maninder S.; Graham, Tim R.			Delayed haemoptysis from explosive device fragments	LANCET			English	Editorial Material									[Johnston, Andrew McDonald; West, Andrew T.; Kendrew, Jonathan M.; Graham, Tim R.] Royal Ctr Def Med, Birmingham, W Midlands, England; [Johnston, Andrew McDonald; West, Andrew T.; Kendrew, Jonathan M.; Graham, Tim R.] Queen Elizabeth Hosp Birmingham, Birmingham B15 2WB, W Midlands, England; [Steyn, Richard S.; Kalkat, Maninder S.] Heart England Fdn Trust, Birmingham, W Midlands, England	Royal Centre for Defence Medicine; University of Birmingham; Heart of England NHS Foundation Trust	Johnston, AM (corresponding author), Queen Elizabeth Hosp Birmingham, Royal Ctr Def Med, Birmingham B15 2WB, W Midlands, England.	andy.johnston@uhb.nhs.uk	Johnston, Andy/GOK-2428-2022	Johnston, Andrew McDonald/0000-0002-0220-0589				Biocina B, 1997, EUR J CARDIO-THORAC, V11, P399, DOI 10.1016/S1010-7940(96)01124-4; Coley E, 2011, J ROY ARMY MED CORPS, V157, P243, DOI 10.1136/jramc-157-03-11; Gray R., 1994, WAR WOUNDS BASIC SUR; Langer D, 1999, J INTERN MED, V245, P405, DOI 10.1046/j.1365-2796.1999.00477.x; Ruder TD, 2012, FORENSIC SCI INT, V220, P219, DOI 10.1016/j.forsciint.2012.03.004	5	1	1	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 28	2013	382	9898					1152	1152		10.1016/S0140-6736(13)61651-7	http://dx.doi.org/10.1016/S0140-6736(13)61651-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	228SG	24075055				2022-12-28	WOS:000325208100031
J	Bocklisch, C; Pascoli, V; Wong, JCY; House, DRC; Yvon, C; de Roo, M; Tan, KR; Luscher, C				Bocklisch, Christina; Pascoli, Vincent; Wong, Jovi C. Y.; House, David R. C.; Yvon, Cedric; de Roo, Mathias; Tan, Kelly R.; Luescher, Christian			Cocaine Disinhibits Dopamine Neurons by Potentiation of GABA Transmission in the Ventral Tegmental Area	SCIENCE			English	Article							EVOKED SYNAPTIC PLASTICITY; LONG-TERM POTENTIATION; NUCLEUS-ACCUMBENS; IN-VIVO; ACTIVATION	Drug-evoked synaptic plasticity in the mesolimbic system reshapes circuit function and drives drug-adaptive behavior. Much research has focused on excitatory transmission in the ventral tegmental area (VTA) and the nucleus accumbens (NAc). How drug-evoked synaptic plasticity of inhibitory transmission affects circuit adaptations remains unknown. We found that medium spiny neurons expressing dopamine (DA) receptor type 1 (D1R-MSNs) of the NAc project to the VTA, strongly preferring the GABA neurons of the VTA. Repeated in vivo exposure to cocaine evoked synaptic potentiation at this synapse, occluding homosynaptic inhibitory long-term potentiation. The activity of the VTA GABA neurons was thus reduced and DA neurons were disinhibited. Cocaine-evoked potentiation of GABA release from D1R-MSNs affected drug-adaptive behavior, which identifies these neurons as a promising target for novel addiction treatments.	[Bocklisch, Christina; Pascoli, Vincent; Wong, Jovi C. Y.; House, David R. C.; Yvon, Cedric; de Roo, Mathias; Tan, Kelly R.; Luescher, Christian] Univ Geneva, Fac Med, Dept Basic Neurosci, CH-1211 Geneva, Switzerland; [Luescher, Christian] Univ Hosp Geneva, Dept Clin Neurosci, Neurol Clin, CH-1211 Geneva, Switzerland	University of Geneva; University of Geneva	Luscher, C (corresponding author), Univ Geneva, Fac Med, Dept Basic Neurosci, CH-1211 Geneva, Switzerland.	christian.luscher@unige.ch	Lüscher, Christian/A-2496-2011	Lüscher, Christian/0000-0001-7917-4596; De Roo, Mathias/0000-0001-9912-6954; Wong, Jovi/0000-0001-7980-9352	Swiss National Science Foundation; European Research Council; Synapsy; National Competence Center in Research; Swiss Confederation scholarship	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Research Council(European Research Council (ERC)European Commission); Synapsy; National Competence Center in Research; Swiss Confederation scholarship	We thank M. Serafin and the members of the Luscher laboratory for suggestions on the manuscript, M. Brown for support during the in vivo electrophysiology experiments, G. Miesenbock for GADCre mice, and S. Schoch for Rim1 alpha<SUP>-/-</SUP> mice. Supported by the Swiss National Science Foundation, the European Research Council, and "Synapsy," a National Competence Center in Research (C. L.) and by a Swiss Confederation scholarship (J.C.Y.W.).	Belin D, 2008, NEURON, V57, P432, DOI 10.1016/j.neuron.2007.12.019; Bellone C, 2006, NAT NEUROSCI, V9, P636, DOI 10.1038/nn1682; Bertran-Gonzalez J, 2008, J NEUROSCI, V28, P5671, DOI 10.1523/JNEUROSCI.1039-08.2008; BRODIE MS, 1990, N-S ARCH PHARMACOL, V342, P660, DOI 10.1007/BF00175709; Brown MTC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015870; Castillo PE, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005728; Castillo PE, 2002, NATURE, V415, P327, DOI 10.1038/415327a; Chandra R, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00013; Chen R, 2006, P NATL ACAD SCI USA, V103, P9333, DOI 10.1073/pnas.0600905103; Cruz HG, 2004, NAT NEUROSCI, V7, P153, DOI 10.1038/nn1181; Fields HL, 2007, ANNU REV NEUROSCI, V30, P289, DOI 10.1146/annurev.neuro.30.051606.094341; Froemke RC, 2007, NATURE, V450, P425, DOI 10.1038/nature06289; Gambino F, 2012, NEURON, V75, P490, DOI 10.1016/j.neuron.2012.05.020; Grimm JW, 2001, NATURE, V412, P141, DOI 10.1038/35084134; JOHNSON SW, 1992, J NEUROSCI, V12, P483; Letzkus JJ, 2011, NATURE, V480, P331, DOI 10.1038/nature10674; Liu QS, 2005, NATURE, V437, P1027, DOI 10.1038/nature04050; Lobo MK, 2010, SCIENCE, V330, P385, DOI 10.1126/science.1188472; Luscher C, 2011, NEURON, V69, P650, DOI 10.1016/j.neuron.2011.01.017; Mameli M, 2009, NAT NEUROSCI, V12, P1036, DOI 10.1038/nn.2367; Nagel G, 2005, CURR BIOL, V15, P2279, DOI 10.1016/j.cub.2005.11.032; Pan B, 2008, J NEUROSCI, V28, P1385, DOI 10.1523/JNEUROSCI.4033-07.2008; Pascoli V, 2012, NATURE, V481, P71, DOI 10.1038/nature10709; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; Self DW, 1998, J NEUROSCI, V18, P1848; Sesack SR, 2010, NEUROPSYCHOPHARMACOL, V35, P27, DOI 10.1038/npp.2009.93; Smidt MP, 1997, P NATL ACAD SCI USA, V94, P13305, DOI 10.1073/pnas.94.24.13305; Tan KR, 2012, NEURON, V73, P1173, DOI 10.1016/j.neuron.2012.02.015; Tan KR, 2010, NATURE, V463, P769, DOI 10.1038/nature08758; Ungless MA, 2001, NATURE, V411, P583, DOI 10.1038/35079077; Watabe-Uchida M, 2012, NEURON, V74, P858, DOI 10.1016/j.neuron.2012.03.017; WEISSKOPF MG, 1994, SCIENCE, V265, P1878, DOI 10.1126/science.7916482; Xia YF, 2011, J NEUROSCI, V31, P7811, DOI 10.1523/JNEUROSCI.1504-11.2011	33	197	202	0	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 27	2013	341	6153					1521	1525		10.1126/science.1237059	http://dx.doi.org/10.1126/science.1237059			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	224NS	24072923				2022-12-28	WOS:000324894600053
J	Luo, J; Li, PS; Zhang, S; Sun, HY; Yang, HP; Zhao, YG				Luo, Jun; Li, Peisen; Zhang, Sen; Sun, Hongyu; Yang, Hongping; Zhao, Yonggang			Low-voltage magnetoresistance in silicon	NATURE			English	Letter							LINEAR MAGNETORESISTANCE; SEMICONDUCTORS		[Luo, Jun; Sun, Hongyu; Yang, Hongping] Tsinghua Univ, Dept Mat Sci & Engn, Adv Mat Lab, Beijing Natl Ctr Electron Microscopy, Beijing 100084, Peoples R China; [Li, Peisen; Zhang, Sen; Zhao, Yonggang] Tsinghua Univ, Dept Phys, Beijing 100084, Peoples R China; [Li, Peisen; Zhang, Sen; Zhao, Yonggang] Tsinghua Univ, State Key Lab Low Dimens Quantum Phys, Beijing 100084, Peoples R China	Tsinghua University; Tsinghua University; Tsinghua University	Luo, J (corresponding author), Tsinghua Univ, Dept Mat Sci & Engn, Adv Mat Lab, Beijing Natl Ctr Electron Microscopy, Beijing 100084, Peoples R China.	jluo@mail.tsinghua.edu.cn	zhang, sen/GXH-3513-2022; Sun, Hongyu/E-8567-2011	Sun, Hongyu/0000-0002-5072-7019				Delmo MP, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3238361; Delmo MP, 2009, NATURE, V457, P1112, DOI 10.1038/nature07711; Hu JS, 2008, NAT MATER, V7, P697, DOI 10.1038/nmat2259; Husmann A, 2002, NATURE, V417, P421, DOI 10.1038/417421a; Lee M, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.066602; Parish MM, 2003, NATURE, V426, P162, DOI 10.1038/nature02073; Popovic R. S., 1991, HALL EFFECT DEVICES; Porter NA, 2012, SCI REP-UK, V2, DOI 10.1038/srep00565; Schoonus JJHM, 2009, J PHYS D APPL PHYS, V42, DOI 10.1088/0022-3727/42/18/185011; SMITH RA, 1978, SEMICONDUCTORS, pCH5; Solin SA, 2000, SCIENCE, V289, P1530, DOI 10.1126/science.289.5484.1530; Wan CH, 2011, NATURE, V477, P304, DOI 10.1038/nature10375; Xu R, 1997, NATURE, V390, P57, DOI 10.1038/36306	13	5	6	0	137	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 26	2013	501	7468					E1	E1		10.1038/nature12589	http://dx.doi.org/10.1038/nature12589			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223RP	24067718	Bronze			2022-12-28	WOS:000324826300016
J	Smith, MP; Harper, DAT				Smith, M. Paul; Harper, David A. T.			Causes of the Cambrian Explosion	SCIENCE			English	Editorial Material							EVOLUTION; ANIMALS		[Smith, M. Paul] Univ Oxford, Museum Nat Hist, Oxford OX1 3PW, England; [Harper, David A. T.] Univ Durham, Dept Earth Sci, Durham DH1 3LE, England	University of Oxford; Durham University	Smith, MP (corresponding author), Univ Oxford, Museum Nat Hist, Parks Rd, Oxford OX1 3PW, England.	paul.smith@oum.ox.ac.uk	Harper, David/AAX-7473-2020; Harper, David A.T./C-6888-2012	Harper, David/0000-0003-1315-9494; Harper, David A.T./0000-0003-1315-9494; Smith, Paul/0000-0002-5141-1577				Brasier Martin D., 2007, Memoir of the Association of Australasian Palaeontologists, V34, P377; Brennan ST, 2004, GEOLOGY, V32, P473, DOI 10.1130/g20251.1; Butterfield NJ, 2011, TRENDS ECOL EVOL, V26, P81, DOI 10.1016/j.tree.2010.11.012; Callow RHT, 2009, EARTH-SCI REV, V96, P207, DOI 10.1016/j.earscirev.2009.07.002; COOK PJ, 1984, NATURE, V308, P231, DOI 10.1038/308231a0; Erwin D. H., 2013, CAMBRIAN EXPLOSION; Erwin DH, 2002, DEVELOPMENT, V129, P3021; Erwin DH, 2011, SCIENCE, V334, P1091, DOI 10.1126/science.1206375; Lowe CJ, 2013, SCIENCE, V340, P1170, DOI 10.1126/science.1237431; Marshall CR, 2006, ANNU REV EARTH PL SC, V34, P355, DOI 10.1146/annurev.earth.33.031504.103001; Murdock DJE, 2011, CELLS TISSUES ORGANS, V194, P98, DOI 10.1159/000324245; Peters SE, 2012, NATURE, V484, P363, DOI 10.1038/nature10969; Peterson KJ, 2005, PALEOBIOLOGY, V31, P36, DOI 10.1666/0094-8373(2005)031[0036:TAMOEA]2.0.CO;2; Wood R, 2012, EARTH-SCI REV, V115, P249, DOI 10.1016/j.earscirev.2012.10.002	14	61	63	4	241	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 20	2013	341	6152					1355	1356		10.1126/science.1239450	http://dx.doi.org/10.1126/science.1239450			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	220PK	24052300	Green Accepted			2022-12-28	WOS:000324597200034
J	Lai, MC; Lombardo, MV; Baron-Cohen, S				Lai, Meng-Chuan; Lombardo, Michael V.; Baron-Cohen, Simon			Autism	LANCET			English	Article							DE-NOVO MUTATIONS; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; SPECTRUM DISORDERS; WHITE-MATTER; PSYCHIATRIC COMORBIDITY; JOINT ATTENTION; SEX-DIFFERENCES; BABY SIBLINGS; RISK-FACTORS; FOLLOW-UP	Autism is a set of heterogeneous neurodevelopmental conditions, characterised by early-onset difficulties in social communication and unusually restricted, repetitive behaviour and interests. The worldwide population prevalence is about 1%. Autism affects more male than female individuals, and comorbidity is common (>70% have concurrent conditions). Individuals with autism have atypical cognitive profiles, such as impaired social cognition and social perception, executive dysfunction, and atypical perceptual and information processing. These profiles are underpinned by atypical neural development at the systems level. Genetics has a key role in the aetiology of autism, in conjunction with developmentally early environmental factors. Large-effect rare mutations and small-effect common variants contribute to risk. Assessment needs to be multidisciplinary and developmental, and early detection is essential for early intervention. Early comprehensive and targeted behavioural interventions can improve social communication and reduce anxiety and aggression. Drugs can reduce comorbid symptoms, but do not directly improve social communication. Creation of a supportive environment that accepts and respects that the individual is different is crucial.	[Lai, Meng-Chuan; Lombardo, Michael V.; Baron-Cohen, Simon] Univ Cambridge, Dept Psychiat, Autism Res Ctr, Cambridge CB2 8AH, England; [Lai, Meng-Chuan] Natl Taiwan Univ, Coll Med, Dept Psychiat, Taipei 10764, Taiwan; [Lombardo, Michael V.] Univ Cyprus, Dept Psychol, Nicosia, Cyprus; [Baron-Cohen, Simon] Cambridgeshire & Peterborough NHS Fdn Trust, Cambridge, England	University of Cambridge; National Taiwan University; University of Cyprus	Lai, MC (corresponding author), Univ Cambridge, Dept Psychiat, Autism Res Ctr, Douglas House,18B Trumpington Rd, Cambridge CB2 8AH, England.	mcl45@cam.ac.uk	Lombardo, Michael V/J-1773-2012; Lai, Meng-Chuan/K-7407-2016	Lombardo, Michael V/0000-0001-6780-8619; Baron-Cohen, Simon/0000-0001-9217-2544; Lai, Meng-Chuan/0000-0002-9593-5508	European Autism Interventions-A Multicentre Study for Developing New Medications; Innovative Medicines Initiative [115300]; European Union's Seventh Framework Programme [FP7]; European Federation of Pharmaceutical Industries and Associations companies; Autism Speaks; Wolfson College (University of Cambridge, UK); British Academy and Jesus College (University of Cambridge, UK); Wellcome Trust; UK Medical Research Council; National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care for Cambridgeshire and Peterborough NHS Foundation Trust; Autism Research Trust; European Union ASC-Inclusion Project; Target Autism Genome; MRC [G0600977] Funding Source: UKRI; Medical Research Council [G0600977] Funding Source: researchfish	European Autism Interventions-A Multicentre Study for Developing New Medications; Innovative Medicines Initiative; European Union's Seventh Framework Programme [FP7]; European Federation of Pharmaceutical Industries and Associations companies; Autism Speaks; Wolfson College (University of Cambridge, UK); British Academy and Jesus College (University of Cambridge, UK); Wellcome Trust(Wellcome Trust); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care for Cambridgeshire and Peterborough NHS Foundation Trust; Autism Research Trust; European Union ASC-Inclusion Project; Target Autism Genome; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	All authors are supported by the European Autism Interventions-A Multicentre Study for Developing New Medications (which receives support from the Innovative Medicines Initiative Joint Undertaking [grant agreement 115300], resources of which are composed of financial contribution from the European Union's Seventh Framework Programme [FP7/2007-2013], European Federation of Pharmaceutical Industries and Associations companies, and Autism Speaks). M-CL is supported by Wolfson College (University of Cambridge, UK). MVL is supported by the British Academy and Jesus College (University of Cambridge, UK). SB-C is supported by the Wellcome Trust, the UK Medical Research Council, the National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care for Cambridgeshire and Peterborough NHS Foundation Trust, the Autism Research Trust, the European Union ASC-Inclusion Project, and Target Autism Genome. We thank Wei-Tsuen Soong and Digby Tantam for valuable discussions.	Akins RS, 2010, NEUROTHERAPEUTICS, V7, P307, DOI 10.1016/j.nurt.2010.05.002; Al-Qabandi M, 2011, PEDIATRICS, V128, pE211, DOI 10.1542/peds.2010-1881; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; Anagnostou E, 2011, CURR OPIN PEDIATR, V23, P621, DOI 10.1097/MOP.0b013e32834cba3e; [Anonymous], AUTISM SPECTRUM DISO; Apperly IA, 2012, Q J EXP PSYCHOL, V65, P825, DOI 10.1080/17470218.2012.676055; Asperger H., 1991, AUTISM ASPERGER SYND, P37, DOI [10.1017/CBO9780511526770.002, DOI 10.1017/CBO9780511526770.002]; Barger BD, 2013, J AUTISM DEV DISORD, V43, P817, DOI 10.1007/s10803-012-1621-x; Baron-Cohen S, 2012, SCI AM, V307, P72, DOI 10.1038/scientificamerican1112-72; Baron-Cohen S, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001081; Baron-Cohen S, 2009, PHILOS T R SOC B, V364, P1377, DOI 10.1098/rstb.2008.0337; Baron-Cohen S, 2009, BRIT J PSYCHIAT, V194, P500, DOI 10.1192/bjp.bp.108.059345; BARONCOHEN S, 1985, COGNITION, V21, P37, DOI 10.1016/0010-0277(85)90022-8; Baruth JM, 2013, AUTISM RES, V6, P119, DOI 10.1002/aur.1273; Begeer S, 2013, J AUTISM DEV DISORD, V43, P1151, DOI 10.1007/s10803-012-1656-z; Belmonte MK, 2004, J NEUROSCI, V24, P9228, DOI 10.1523/JNEUROSCI.3340-04.2004; Bilder D, 2013, J AUTISM DEV DISORD, V43, P1196, DOI 10.1007/s10803-012-1664-z; Billstedt E, 2005, J AUTISM DEV DISORD, V35, P351, DOI 10.1007/s10803-005-3302-5; Blumberg Stephen J, 2013, Natl Health Stat Report, P1; Boucher J, 2012, AUTISM, V16, P226, DOI 10.1177/1362361311430403; Boucher J, 2012, J CHILD PSYCHOL PSYC, V53, P219, DOI 10.1111/j.1469-7610.2011.02508.x; Braunschweig D, 2012, ARCH NEUROL-CHICAGO, V69, P693, DOI 10.1001/archneurol.2011.2506; Brock J, 2002, DEV PSYCHOPATHOL, V14, P209, DOI 10.1017/S0954579402002018; Brown AS, 2014, MOL PSYCHIATR, V19, P259, DOI 10.1038/mp.2012.197; Brugha TS, 2011, ARCH GEN PSYCHIAT, V68, P459, DOI 10.1001/archgenpsychiatry.2011.38; Callahan K, 2010, J AUTISM DEV DISORD, V40, P74, DOI 10.1007/s10803-009-0834-0; Casanova MF, 2006, NEUROSCIENTIST, V12, P435, DOI 10.1177/1073858406290375; Chakrabarti B, 2009, AUTISM RES, V2, P157, DOI 10.1002/aur.80; Charman T, 2013, CHILD ADOL MENT H-UK, V18, P52, DOI 10.1111/j.1475-3588.2012.00664.x; Chawarska K, 2013, BIOL PSYCHIAT, V74, P195, DOI 10.1016/j.biopsych.2012.11.022; Chawarska K, 2011, ARCH GEN PSYCHIAT, V68, P1021, DOI 10.1001/archgenpsychiatry.2011.106; Cheslack-Postava K, 2012, SOC SCI MED, V74, P1667, DOI 10.1016/j.socscimed.2011.06.013; Christensen J, 2013, JAMA-J AM MED ASSOC, V309, P1696, DOI 10.1001/jama.2013.2270; Chugani D. C., 2011, AUTISM SPECTRUM DISO, P566; Chung YS, 2014, SCHIZOPHRENIA BULL, V40, P602, DOI 10.1093/schbul/sbt048; Corrales M. A., 2011, AUTISM SPECTRUM DISO, P875, DOI DOI 10.1093/MED/9780195371826.003.0056; Courchesne E, 2011, JAMA-J AM MED ASSOC, V306, P2001, DOI 10.1001/jama.2011.1638; Courchesne E, 2011, BRAIN RES, V1380, P138, DOI 10.1016/j.brainres.2010.09.101; Dawson G, 2012, J AM ACAD CHILD PSY, V51, P1150, DOI 10.1016/j.jaac.2012.08.018; Dawson G, 2011, CURR OPIN PEDIATR, V23, P616, DOI 10.1097/MOP.0b013e32834cf082; DeStefano F, 2013, J PEDIATR-US, V163, P561, DOI 10.1016/j.jpeds.2013.02.001; Devlin B, 2012, CURR OPIN GENET DEV, V22, P229, DOI 10.1016/j.gde.2012.03.002; Dichter Gabriel S, 2012, Dialogues Clin Neurosci, V14, P319; Duerden EG, 2012, AUTISM RES, V5, P49, DOI 10.1002/aur.235; Dworzynski K, 2012, J AM ACAD CHILD PSY, V51, P788, DOI 10.1016/j.jaac.2012.05.018; Elison JT, 2013, AM J PSYCHIAT, V170, P899, DOI 10.1176/appi.ajp.2012.12091150; Elsabbagh M, 2013, BIOL PSYCHIAT, V74, P189, DOI 10.1016/j.biopsych.2012.11.030; Elsabbagh M, 2012, AUTISM RES, V5, P160, DOI 10.1002/aur.239; Elsabbagh M, 2012, CURR BIOL, V22, P338, DOI 10.1016/j.cub.2011.12.056; Elsabbagh M, 2010, TRENDS COGN SCI, V14, P81, DOI 10.1016/j.tics.2009.12.005; Farley MA, 2009, AUTISM RES, V2, P109, DOI 10.1002/aur.69; Farmer C, 2013, DRUGS, V73, P303, DOI 10.1007/s40265-013-0021-7; Fein D, 2013, J CHILD PSYCHOL PSYC, V54, P195, DOI 10.1111/jcpp.12037; Fisch GS, 2012, AM J MED GENET C, V160C, P91, DOI 10.1002/ajmg.c.31325; Fombonne E., 2011, AUTISM SPECTRUM DISO, P90, DOI [DOI 10.1093/MED/9780195371826.003.0007, https://doi.org/10.1093/med/9780195371826.001.0001]; Fountain C, 2012, PEDIATRICS, V129, pE1112, DOI 10.1542/peds.2011-1601; Frazier TW, 2009, BIOL PSYCHIAT, V66, P935, DOI 10.1016/j.biopsych.2009.07.022; Frith U, 2012, Q J EXP PSYCHOL, V65, P2073, DOI 10.1080/17470218.2012.697178; Gardener H, 2011, PEDIATRICS, V128, P344, DOI 10.1542/peds.2010-1036; Gardener H, 2009, BRIT J PSYCHIAT, V195, P7, DOI 10.1192/bjp.bp.108.051672; Geschwind DH, 2011, TRENDS COGN SCI, V15, P409, DOI 10.1016/j.tics.2011.07.003; Geurts HM, 2009, TRENDS COGN SCI, V13, P74, DOI 10.1016/j.tics.2008.11.006; Giarelli E, 2010, DISABIL HEALTH J, V3, P107, DOI 10.1016/j.dhjo.2009.07.001; Gillberg C., 2012, AUTISMS; Goines P, 2011, AUTISM SPECTRUM DISO, P395; Gotham K, 2012, PEDIATRICS, V130, pE1278, DOI 10.1542/peds.2011-3668; Hamilton AFD, 2013, DEV COGN NEUROS-NETH, V3, P91, DOI 10.1016/j.dcn.2012.09.008; Happe F, 2006, J AUTISM DEV DISORD, V36, P5, DOI 10.1007/s10803-005-0039-0; HAPPE FGE, 1995, CHILD DEV, V66, P843, DOI 10.2307/1131954; Happe F, 2012, GERONTOLOGY, V58, P70, DOI 10.1159/000329720; Harfterkamp M, 2012, J AM ACAD CHILD PSY, V51, P733, DOI 10.1016/j.jaac.2012.04.011; Heil KM, 2013, CURR PSYCHIAT REP, V15, DOI 10.1007/s11920-012-0334-3; Hofvander B, 2009, BMC PSYCHIATRY, V9, DOI 10.1186/1471-244X-9-35; Howlin P, 2004, J CHILD PSYCHOL PSYC, V45, P212, DOI 10.1111/j.1469-7610.2004.00215.x; Howlin P, 2013, J AM ACAD CHILD PSY, V52, P572, DOI 10.1016/j.jaac.2013.02.017; Howlin P, 2012, CAN J PSYCHIAT, V57, P275, DOI 10.1177/070674371205700502; Hsu SW, 2012, RES AUTISM SPECT DIS, V6, P836, DOI 10.1016/j.rasd.2011.09.006; Hultman CM, 2011, MOL PSYCHIATR, V16, P1203, DOI 10.1038/mp.2010.121; Idring S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041280; Johnson CP, 2007, PEDIATRICS, V120, P1183, DOI 10.1542/peds.2007-2361; Johnson MH, 2012, TRENDS COGN SCI, V16, P454, DOI 10.1016/j.tics.2012.07.001; Joshi G, 2013, J AUTISM DEV DISORD, V43, P1314, DOI 10.1007/s10803-012-1679-5; Just MA, 2012, NEUROSCI BIOBEHAV R, V36, P1292, DOI 10.1016/j.neubiorev.2012.02.007; Kaale A, 2012, J CHILD PSYCHOL PSYC, V53, P97, DOI 10.1111/j.1469-7610.2011.02450.x; Kanner L, 1943, NERV CHILD; Kasari C, 2008, J CONSULT CLIN PSYCH, V76, P125, DOI 10.1037/0022-006X.76.1.125; Kasari C, 2012, CURR PSYCHIAT REP, V14, P713, DOI 10.1007/s11920-012-0317-4; Keyes KM, 2012, INT J EPIDEMIOL, V41, P495, DOI 10.1093/ije/dyr193; Kim YS, 2011, AM J PSYCHIAT, V168, P904, DOI 10.1176/appi.ajp.2011.10101532; Klei L, 2012, MOL AUTISM, V3, DOI 10.1186/2040-2392-3-9; Kohane IS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033224; Kong A, 2012, NATURE, V488, P471, DOI 10.1038/nature11396; Kopp S, 2011, RES DEV DISABIL, V32, P2875, DOI 10.1016/j.ridd.2011.05.017; Krishnaswami S, 2011, PEDIATRICS, V127, pE1322, DOI 10.1542/peds.2011-0428; Lai MC, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001544; Lai MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020835; Lampi KM, 2013, J AUTISM DEV DISORD, V43, P2526, DOI 10.1007/s10803-013-1801-3; Landa RJ, 2012, J CHILD PSYCHOL PSYC, V53, P986, DOI 10.1111/j.1469-7610.2012.02558.x; Landa RJ, 2011, J CHILD PSYCHOL PSYC, V52, P13, DOI 10.1111/j.1469-7610.2010.02288.x; Lang R, 2012, RES AUTISM SPECT DIS, V6, P1004, DOI 10.1016/j.rasd.2012.01.006; Lombardo MV, 2010, WIRES COGN SCI, V1, P393, DOI 10.1002/wcs.45; Lombardo MV, 2010, BRAIN, V133, P611, DOI 10.1093/brain/awp306; Lotter V., 1966, SOC PSYCHIATR, V1, P124, DOI [10.1007/BF00584048, https://doi.org/10.1007/BF00584048]; Lugnegard T, 2012, COMPR PSYCHIAT, V53, P333, DOI 10.1016/j.comppsych.2011.05.014; Lugnegard T, 2011, RES DEV DISABIL, V32, P1910, DOI 10.1016/j.ridd.2011.03.025; Madsen KM, 2002, NEW ENGL J MED, V347, P1477, DOI 10.1056/NEJMoa021134; Maglione MA, 2012, PEDIATRICS, V130, pS169, DOI 10.1542/peds.2012-0900O; Mahajan R, 2012, PEDIATRICS, V130, pS125, DOI 10.1542/peds.2012-0900J; Mandell DS, 2005, PEDIATRICS, V116, P1480, DOI 10.1542/peds.2005-0185; Mattila ML, 2011, J AM ACAD CHILD PSY, V50, P583, DOI 10.1016/j.jaac.2011.04.001; Mattila ML, 2010, J AUTISM DEV DISORD, V40, P1080, DOI 10.1007/s10803-010-0958-2; McAllister AK, 2009, NEURON, V64, P9, DOI 10.1016/j.neuron.2009.09.038; McPheeters ML, 2011, PEDIATRICS, V127, pE1312, DOI 10.1542/peds.2011-0427; Messinger D, 2013, J AM ACAD CHILD PSY, V52, P300, DOI 10.1016/j.jaac.2012.12.011; Michaelson JJ, 2012, CELL, V151, P1431, DOI 10.1016/j.cell.2012.11.019; Miller DT, 2010, AM J HUM GENET, V86, P749, DOI 10.1016/j.ajhg.2010.04.006; Minshew NJ, 2010, CURR OPIN NEUROL, V23, P124, DOI 10.1097/WCO.0b013e32833782d4; Mottron L, 2013, NEUROSCI BIOBEHAV R, V37, P209, DOI 10.1016/j.neubiorev.2012.11.016; Murdoch JD, 2013, CURR OPIN GENET DEV, V23, P310, DOI 10.1016/j.gde.2013.02.003; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; Nordahl CW, 2012, ARCH GEN PSYCHIAT, V69, P53, DOI 10.1001/archgenpsychiatry.2011.145; Nordahl CW, 2011, P NATL ACAD SCI USA, V108, P20195, DOI 10.1073/pnas.1107560108; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Ohnishi T, 2000, BRAIN, V123, P1838, DOI 10.1093/brain/123.9.1838; Onore C, 2012, BRAIN BEHAV IMMUN, V26, P383, DOI 10.1016/j.bbi.2011.08.007; Ozonoff S, 2005, J CLIN CHILD ADOLESC, V34, P523, DOI 10.1207/s15374424jccp3403_8; Ozonoff S, 2010, J AM ACAD CHILD PSY, V49, P256, DOI 10.1016/j.jaac.2009.11.009; Parker SK, 2004, PEDIATRICS, V114, P793, DOI 10.1542/peds.2004-0434; Pelphrey KA, 2011, J CHILD PSYCHOL PSYC, V52, P631, DOI 10.1111/j.1469-7610.2010.02349.x; Pfaff DW, 2011, AUTISM RES, V4, P163, DOI 10.1002/aur.191; Philip RCM, 2012, NEUROSCI BIOBEHAV R, V36, P901, DOI 10.1016/j.neubiorev.2011.10.008; Pilling S, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e4082; Radua J, 2011, PSYCHOL MED, V41, P1539, DOI 10.1017/S0033291710002187; Rai D, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2059; Raznahan A, 2013, BIOL PSYCHIAT, V74, P563, DOI 10.1016/j.biopsych.2013.03.022; Reichow B, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD009260.pub2, 10.1002/14651858.CD009260.pub3]; Rimland B, 1964, INFANTILE AUTISM SYN; Roberts EM, 2007, ENVIRON HEALTH PERSP, V115, P1482, DOI 10.1289/ehp.10168; Robinson EB, 2013, P NATL ACAD SCI USA, V110, P5258, DOI 10.1073/pnas.1211070110; Roelfsema MT, 2012, J AUTISM DEV DISORD, V42, P734, DOI 10.1007/s10803-011-1302-1; Ronald A, 2011, AM J MED GENET B, V156B, P255, DOI 10.1002/ajmg.b.31159; Rubenstein JLR, 2010, CURR OPIN NEUROL, V23, P118, DOI 10.1097/WCO.0b013e328336eb13; Russell G, 2014, J AUTISM DEV DISORD, V44, P31, DOI 10.1007/s10803-013-1849-0; Russell G, 2011, SOC PSYCH PSYCH EPID, V46, P1283, DOI 10.1007/s00127-010-0294-z; RUTTER M, 1978, J AUTISM CHILD SCHIZ, V8, P139, DOI 10.1007/BF01537863; Saemundsen E, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002748; Samson F, 2012, HUM BRAIN MAPP, V33, P1553, DOI 10.1002/hbm.21307; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Sandin S, 2012, J AM ACAD CHILD PSY, V51, P477, DOI 10.1016/j.jaac.2012.02.018; Schumann C. M., 2011, AUTISM SPECTRUM DISO, P539; Schumann CM, 2004, J NEUROSCI, V24, P6392, DOI 10.1523/JNEUROSCI.1297-04.2004; Sect Complementary Integrative Med, 2012, PEDIATRICS, V129, P1186, DOI 10.1542/peds.2012-0876; Senju A, 2012, NEUROSCIENTIST, V18, P108, DOI 10.1177/1073858410397208; Shattuck PT, 2012, PEDIATRICS, V129, P1042, DOI 10.1542/peds.2011-2864; Simonoff E, 2008, J AM ACAD CHILD PSY, V47, P921, DOI 10.1097/CHI.0b013e318179964f; Simonoff E, 2013, J CHILD PSYCHOL PSYC, V54, P186, DOI 10.1111/j.1469-7610.2012.02606.x; Smith T, 2011, J AUTISM DEV DISORD, V41, P375, DOI 10.1007/s10803-010-1162-0; State MW, 2011, NAT NEUROSCI, V14, P1499, DOI 10.1038/nn.2924; Stein JL, 2013, NEURON, V77, P209, DOI 10.1016/j.neuron.2013.01.010; Sucksmith E, 2011, NEUROPSYCHOL REV, V21, P360, DOI 10.1007/s11065-011-9183-9; Suren P, 2013, JAMA-J AM MED ASSOC, V309, P570, DOI 10.1001/jama.2012.155925; Taylor JL, 2010, J AUTISM DEV DISORD, V40, P1431, DOI 10.1007/s10803-010-1005-z; Travers BG, 2012, AUTISM RES, V5, P289, DOI 10.1002/aur.1243; Via E, 2011, ARCH GEN PSYCHIAT, V68, P409, DOI 10.1001/archgenpsychiatry.2011.27; Vismara LA, 2010, ANNU REV CLIN PSYCHO, V6, P447, DOI 10.1146/annurev.clinpsy.121208.131151; Vissers ME, 2012, NEUROSCI BIOBEHAV R, V36, P604, DOI 10.1016/j.neubiorev.2011.09.003; Voineagu I, 2011, NATURE, V474, P380, DOI 10.1038/nature10110; Volk HE, 2013, JAMA PSYCHIAT, V70, P71, DOI 10.1001/jamapsychiatry.2013.266; Wan MW, 2013, J CHILD PSYCHOL PSYC, V54, P763, DOI 10.1111/jcpp.12032; Werling DM, 2013, CURR OPIN NEUROL, V26, P146, DOI 10.1097/WCO.0b013e32835ee548; White SJ, 2013, J AUTISM DEV DISORD, V43, P114, DOI 10.1007/s10803-012-1550-8; Wolff JJ, 2012, AM J PSYCHIAT, V169, P589, DOI 10.1176/appi.ajp.2011.11091447; Woolfenden S, 2012, DEV MED CHILD NEUROL, V54, P306, DOI 10.1111/j.1469-8749.2012.04223.x; Yamasue H, 2012, J NEUROSCI, V32, P14109, DOI 10.1523/JNEUROSCI.3327-12.2012; Zwaigenbaum L, 2009, PEDIATRICS, V123, P1383, DOI 10.1542/peds.2008-1606	175	1262	1337	49	728	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 8	2014	383	9920					896	910		10.1016/S0140-6736(13)61539-1	http://dx.doi.org/10.1016/S0140-6736(13)61539-1			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AC3FC	24074734				2022-12-28	WOS:000332399500030
J	Dai, W; Fu, C; Raytcheva, D; Flanagan, J; Khant, HA; Liu, XG; Rochat, RH; Haase-Pettingell, C; Piret, J; Ludtke, SJ; Nagayama, K; Schmid, MF; King, JA; Chiu, W				Dai, Wei; Fu, Caroline; Raytcheva, Desislava; Flanagan, John; Khant, Htet A.; Liu, Xiangan; Rochat, Ryan H.; Haase-Pettingell, Cameron; Piret, Jacqueline; Ludtke, Steve J.; Nagayama, Kuniaki; Schmid, Michael F.; King, Jonathan A.; Chiu, Wah			Visualizing virus assembly intermediates inside marine cyanobacteria	NATURE			English	Article							ELECTRON CRYOTOMOGRAPHY; CRYOELECTRON MICROSCOPY; BACTERIOPHAGE EPSILON15; RESOLUTION; PROCHLOROCOCCUS; CARBOXYSOMES; ORGANIZATION; ARCHITECTURE; TOMOGRAPHY; REVEAL	Cyanobacteria are photosynthetic organisms responsible for similar to 25% of organic carbon fixation on the Earth. These bacteria began to convert solar energy and carbon dioxide into bioenergy and oxygen more than two billion years ago. Cyanophages, which infect these bacteria, have an important role in regulating the marine ecosystem by controlling cyanobacteria community organization and mediating lateral gene transfer. Here we visualize the maturation process of cyanophage Syn5 inside its host cell, Synechococcus, using Zernike phase contrast electron cryo-tomography (cryoET)(1,2). This imaging modality yields dramatic enhancement of image contrast over conventional cryoET and thus facilitates the direct identification of subcellular components, including thylakoid membranes, carboxysomes and polyribosomes, as well as phages, inside the congested cytosol of the infected cell. By correlating the structural features and relative abundance of viral progeny within cells at different stages of infection, we identify distinct Syn5 assembly intermediates. Our results indicate that the procapsid releases scaffolding proteins and expands its volume at an early stage of genome packaging. Later in the assembly process, we detected full particles with a tail either with or without an additional horn. The morphogenetic pathway we describe here is highly conserved and was probably established long before that of double-stranded DNA viruses infecting more complex organisms.	[Dai, Wei; Fu, Caroline; Flanagan, John; Khant, Htet A.; Liu, Xiangan; Rochat, Ryan H.; Ludtke, Steve J.; Schmid, Michael F.; Chiu, Wah] Baylor Coll Med, Verna & Marrs Mclean Dept Biochem & Mol Biol, Natl Ctr Macromol Imaging, Houston, TX 77030 USA; [Raytcheva, Desislava; Haase-Pettingell, Cameron; King, Jonathan A.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Raytcheva, Desislava; Piret, Jacqueline] Northeastern Univ, Dept Biol, Boston, MA 02115 USA; [Rochat, Ryan H.; Ludtke, Steve J.; Schmid, Michael F.; Chiu, Wah] Baylor Coll Med, Program Struct & Computat Biol & Mol Biophys, Houston, TX 77030 USA; [Nagayama, Kuniaki] Natl Inst Nat Sci, Natl Inst Physiol Sci, Okazaki, Aichi 4448787, Japan	Baylor College of Medicine; Massachusetts Institute of Technology (MIT); Northeastern University; Baylor College of Medicine; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS)	Chiu, W (corresponding author), Baylor Coll Med, Verna & Marrs Mclean Dept Biochem & Mol Biol, Natl Ctr Macromol Imaging, Houston, TX 77030 USA.	wah@bcm.edu	Nagayama, Kuniaki/O-2522-2018; Ludtke, Steven/A-4478-2008	/0000-0003-3905-8085; Schmid, Michael/0000-0003-1077-5750; Ludtke, Steven/0000-0002-1903-1574	Robert Welch Foundation [Q1242]; National Institutes of Health [P41GM123832, AI0175208, PN2EY016525, GM080139]; National Institutes of Health through the Gulf Coast Consortia [T15LM007093]; National Institutes of Health through the MSTP [T32GM007330]; NATIONAL EYE INSTITUTE [PN2EY016525] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI075208] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080139, P41GM103832, T32GM007330] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007093] Funding Source: NIH RePORTER	Robert Welch Foundation(The Welch Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health through the Gulf Coast Consortia; National Institutes of Health through the MSTP; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This research was supported by grants from the Robert Welch Foundation (Q1242) and National Institutes of Health (P41GM123832 to W.C.; AI0175208 and PN2EY016525 to W.C. and J.A.K.; GM080139 to S.J.L.; T15LM007093 through the Gulf Coast Consortia to W.D. and R.H.R.; T32GM007330 through the MSTP to R.H.R.). We thank J. G. Galaz-Montoya and R. N. Irobalieva for editing of the manuscript.	Aksyuk AA, 2011, VIRUSES-BASEL, V3, P172, DOI 10.3390/v3030172; Baker ML, 2013, P NATL ACAD SCI USA, V110, P12301, DOI 10.1073/pnas.1309947110; Chang JT, 2010, J MOL BIOL, V402, P731, DOI 10.1016/j.jmb.2010.07.058; Chen DH, 2011, P NATL ACAD SCI USA, V108, P1355, DOI 10.1073/pnas.1015739108; Danev R, 2010, METHOD ENZYMOL, V481, P343, DOI 10.1016/S0076-6879(10)81014-6; Danev R, 2009, ULTRAMICROSCOPY, V109, P312, DOI 10.1016/j.ultramic.2008.12.006; Fuller DN, 2007, J MOL BIOL, V373, P1113, DOI 10.1016/j.jmb.2007.09.011; Fuller NJ, 2003, APPL ENVIRON MICROB, V69, P2430, DOI 10.1128/AEM.69.5.2430-2443.2003; Hegde S, 2012, J VIROL, V86, P4046, DOI 10.1128/JVI.07197-11; Henderson R, 2012, STRUCTURE, V20, P205, DOI 10.1016/j.str.2011.12.014; HENDRIX RW, 1979, NATURE, V277, P172, DOI 10.1038/277172a0; Hu B, 2013, SCIENCE, V339, P576, DOI 10.1126/science.1231887; Iancu CV, 2010, J MOL BIOL, V396, P105, DOI 10.1016/j.jmb.2009.11.019; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Liberton M, 2011, PLANT PHYSIOL, V155, P1656, DOI 10.1104/pp.110.165332; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Machado IMP, 2012, J BIOTECHNOL, V162, P50, DOI 10.1016/j.jbiotec.2012.03.005; Marko M, 2011, J STRUCT BIOL, V174, P400, DOI 10.1016/j.jsb.2011.01.005; Murata K, 2010, STRUCTURE, V18, P903, DOI 10.1016/j.str.2010.06.006; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pope WH, 2007, J MOL BIOL, V368, P966, DOI 10.1016/j.jmb.2007.02.046; PREVELIGE PE, 1988, J MOL BIOL, V202, P743, DOI 10.1016/0022-2836(88)90555-4; Raytcheva DA, 2011, J VIROL, V85, P2406, DOI 10.1128/JVI.01601-10; Rocap G, 2002, APPL ENVIRON MICROB, V68, P1180, DOI 10.1128/AEM.68.3.1180-1191.2002; Rochat RH, 2011, J VIROL, V85, P1871, DOI 10.1128/JVI.01663-10; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Schmid MF, 2008, J STRUCT BIOL, V161, P243, DOI 10.1016/j.jsb.2007.09.018; Schmid MF, 2006, J MOL BIOL, V364, P526, DOI 10.1016/j.jmb.2006.09.024; Schmid MF, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002961; Schmid MF, 2011, ADV PROTEIN CHEM STR, V82, P37, DOI 10.1016/B978-0-12-386507-6.00002-6; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Taylor KA, 2008, J STRUCT BIOL, V163, P214, DOI 10.1016/j.jsb.2008.06.004; Ting CS, 2007, J BACTERIOL, V189, P4485, DOI 10.1128/JB.01948-06	33	81	87	1	117	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 31	2013	502	7473					707	+		10.1038/nature12604	http://dx.doi.org/10.1038/nature12604			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243CC	24107993	Green Accepted			2022-12-28	WOS:000326293200053
J	Montagnac, G; Meas-Yedid, V; Irondelle, M; Castro-Castro, A; Franco, M; Shida, T; Nachury, MV; Benmerah, A; Olivo-Marin, JC; Chavrier, P				Montagnac, Guillaume; Meas-Yedid, Vannary; Irondelle, Marie; Castro-Castro, Antonio; Franco, Michel; Shida, Toshinobu; Nachury, Maxence V.; Benmerah, Alexandre; Olivo-Marin, Jean-Christophe; Chavrier, Philippe			alpha TAT1 catalyses microtubule acetylation at clathrin-coated pits	NATURE			English	Article							POSTTRANSLATIONAL MODIFICATIONS; TUBULIN; HDAC6; ACETYLTRANSFERASE; STABILIZATION; TRAFFICKING; ENDOCYTOSIS; MIGRATION; PROTEINS; INTEGRIN	In most eukaryotic cells microtubules undergo post-translational modifications such as acetylation of alpha-tubulin on lysine 40, a wide-spread modification restricted to a subset of microtubules that turns over slowly(1). This subset of stable microtubules accumulates in cell protrusions(2) and regulates cell polarization(3), migration and invasion(4-7). However, mechanisms restricting acetylation to these microtubules are unknown. Here we report that clathrin-coated pits (CCPs) control microtubule acetylation through a direct interaction of the alpha-tubulin acetyltransferase alpha TAT1 (refs 8, 9) with the clathrin adaptor AP2. We observe that about one-third of growing microtubule ends contact and pause at CCPs and that loss of CCPs decreases lysine 40 acetylation levels. We show that alpha TAT1 localizes to CCPs through a direct interaction with AP2 that is required for microtubule acetylation. In migrating cells, the polarized orientation of acetylated microtubules correlates with CCP accumulation at the leading edge(10), and interaction of alpha TAT1 with AP2 is required for directional migration. We conclude that microtubules contacting CCPs become acetylated by alpha TAT1. In migrating cells, this mechanism ensures the acetylation of microtubules oriented towards the leading edge, thus promoting directional cell locomotion and chemotaxis.	[Montagnac, Guillaume; Irondelle, Marie; Castro-Castro, Antonio; Chavrier, Philippe] Inst Curie, Res Ctr, F-75005 Paris, France; [Montagnac, Guillaume; Irondelle, Marie; Castro-Castro, Antonio; Chavrier, Philippe] CNRS, UMR 144, F-75005 Paris, France; [Meas-Yedid, Vannary; Olivo-Marin, Jean-Christophe] Inst Pasteur, CNRS, URA 2582, Unite Anal Images Quantitat, F-75015 Paris, France; [Franco, Michel] Univ Nice Sophia Antipolis, CNRS, UMR 6097, Inst Pharmacol Mol & Cellulaire, F-06560 Valbonne, France; [Shida, Toshinobu; Nachury, Maxence V.] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Benmerah, Alexandre] Hop Necker Enfants Malad, INSERM, U983, F-75015 Paris, France; [Benmerah, Alexandre] Univ Paris 05, Sorbonne Paris Cite, Inst Imagine, F-75015 Paris, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Stanford University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Montagnac, G (corresponding author), Inst Curie, Res Ctr, F-75005 Paris, France.	guillaume.montagnac@curie.fr; philippe.chavrier@curie.fr	CHAVRIER, Philippe/AAG-2645-2020; Franco, Michel/ABH-4993-2020; Nachury, Maxence/A-8759-2008; Nachury, Maxence/H-3695-2019; benmerah, alexandre/H-3742-2017; FRANCO, michel/AAA-9735-2021; Olivo-Marin, Jean-Christophe/K-4428-2015; CHAVRIER, Philippe/B-4707-2010	CHAVRIER, Philippe/0000-0002-7351-733X; Franco, Michel/0000-0003-1853-8661; Nachury, Maxence/0000-0003-4918-1562; Nachury, Maxence/0000-0003-4918-1562; benmerah, alexandre/0000-0003-0188-8016; Olivo-Marin, Jean-Christophe/0000-0001-6796-0696; CHAVRIER, Philippe/0000-0002-7351-733X	Institut Curie; CNRS; Fondation ARC pour la Recherche contre le Cancer [SL220100601356]; Institut National du Cancer [2009-1-PL BIO-12-IC-1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089933] Funding Source: NIH RePORTER	Institut Curie; CNRS(Centre National de la Recherche Scientifique (CNRS)); Fondation ARC pour la Recherche contre le Cancer; Institut National du Cancer(Institut National du Cancer (INCA) France); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors wish to thank P. Tran and C. Janke for comments on the manuscript and S. Linder for the suggestion of the three-dimensional collagen I EGF-chemotaxis assay. We thank E. Macia for purification of recombinant AP2 complex and S. Lemeer for generation of alpha-adaptin mutants. We thank the Cell and Tissue Imaging Facility and Nikon Imaging Center@Institut Curie & Centre National de la Recherche Scientifique (CNRS) for help with image acquisition. Core funding for this work was provided by the Institut Curie and the CNRS and additional support was provided by grants from Fondation ARC pour la Recherche contre le Cancer (SL220100601356) and Institut National du Cancer (2009-1-PL BIO-12-IC-1) to P.C.	Akella JS, 2010, NATURE, V467, P218, DOI 10.1038/nature09324; BULINSKI JC, 1988, J CELL BIOL, V106, P1213, DOI 10.1083/jcb.106.4.1213; CAMPBELL CH, 1983, J BIOL CHEM, V258, P2628; Castro-Castro A, 2012, EUR J CELL BIOL, V91, P950, DOI 10.1016/j.ejcb.2012.07.001; Caswell PT, 2007, DEV CELL, V13, P496, DOI 10.1016/j.devcel.2007.08.012; Chabin-Brion K, 2001, MOL BIOL CELL, V12, P2047, DOI 10.1091/mbc.12.7.2047; Collins BM, 2002, CELL, V109, P523, DOI 10.1016/S0092-8674(02)00735-3; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; de Chaumont F, 2012, NAT METHODS, V9, P690, DOI [10.1038/NMETH.2075, 10.1038/nmeth.2075]; de Chaumont F, 2011, I S BIOMED IMAGING, P234, DOI 10.1109/ISBI.2011.5872395; Efimov A, 2007, DEV CELL, V12, P917, DOI 10.1016/j.devcel.2007.04.002; ELSDALE T, 1972, J CELL BIOL, V54, P626, DOI 10.1083/jcb.54.3.626; Ezratty EJ, 2009, J CELL BIOL, V187, P733, DOI 10.1083/jcb.200904054; Ferguson S, 2009, DEV CELL, V17, P811, DOI 10.1016/j.devcel.2009.11.005; Fuller D, 2010, P NATL ACAD SCI USA, V107, P9656, DOI 10.1073/pnas.0911178107; GUNDERSEN GG, 1988, P NATL ACAD SCI USA, V85, P5946, DOI 10.1073/pnas.85.16.5946; Gundersen GG, 2002, CURR BIOL, V12, pR645, DOI 10.1016/S0960-9822(02)01156-9; Hinrichsen L, 2003, J BIOL CHEM, V278, P45160, DOI 10.1074/jbc.M307290200; Howes MT, 2010, J CELL BIOL, V190, P675, DOI 10.1083/jcb.201002119; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Kaplan OI, 2010, J CELL SCI, V123, P3966, DOI 10.1242/jcs.073908; Kelm JM, 2003, BIOTECHNOL BIOENG, V83, P173, DOI 10.1002/bit.10655; Montagnac G, 2011, CURR BIOL, V21, P574, DOI 10.1016/j.cub.2011.02.034; Perdiz D, 2011, CELL SIGNAL, V23, P763, DOI 10.1016/j.cellsig.2010.10.014; Rappoport JZ, 2003, TRAFFIC, V4, P460, DOI 10.1034/j.1600-0854.2003.00100.x; Rappoport JZ, 2003, J CELL SCI, V116, P847, DOI 10.1242/jcs.00289; Rey M, 2011, EUR J CELL BIOL, V90, P128, DOI 10.1016/j.ejcb.2010.09.004; Rowe RG, 2008, TRENDS CELL BIOL, V18, P560, DOI 10.1016/j.tcb.2008.08.007; Shida T, 2010, P NATL ACAD SCI USA, V107, P21517, DOI 10.1073/pnas.1013728107; Tanabe K, 2009, J CELL BIOL, V185, P939, DOI 10.1083/jcb.200803153; Tran ADA, 2007, J CELL SCI, V120, P1469, DOI 10.1242/jcs.03431; Watanabe T, 2005, TRENDS CELL BIOL, V15, P76, DOI 10.1016/j.tcb.2004.12.006; Witte H, 2008, J CELL BIOL, V180, P619, DOI 10.1083/jcb.200707042; Wloga D, 2010, J CELL SCI, V123, P3447, DOI 10.1242/jcs.063727	34	67	73	2	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 24	2013	502	7472					567	+		10.1038/nature12571	http://dx.doi.org/10.1038/nature12571			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	238YN	24097348	Green Accepted			2022-12-28	WOS:000325988400058
J	Ziegenfuss, JS; Grueber, WB				Ziegenfuss, Jennifer S.; Grueber, Wesley B.			SAX-7 and Menorin Light the Path for Dendrite Morphogenesis	CELL			English	Editorial Material							MECHANISMS; DOMAIN; L1	Environmental and cellular cues pattern dendritic growth and direct dendrites to their targets. However, little is known about the signals regulating interactions with the surrounding substrate. Dong et al. and Salzberg et al. now identify a tripartite ligand-receptor complex that conveys cues from the substrate necessary for the patterning of complex dendrites in C. elegans.	[Ziegenfuss, Jennifer S.; Grueber, Wesley B.] Columbia Univ, Med Ctr, Dept Physiol & Cellular Biophys, New York, NY 10032 USA; [Grueber, Wesley B.] Columbia Univ, Med Ctr, Dept Neurosci, New York, NY 10032 USA	Columbia University; Columbia University	Grueber, WB (corresponding author), Columbia Univ, Med Ctr, Dept Physiol & Cellular Biophys, 630 West 168th St,P&S 12-403, New York, NY 10032 USA.	wg2135@columbia.edu		Grueber, Wesley/0000-0001-6751-256X	NINDS NIH HHS [R01 NS061908] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS061908] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		APPEL F, 1995, J NEUROBIOL, V28, P297, DOI 10.1002/neu.480280304; Dong XT, 2013, CELL, V155, P296, DOI 10.1016/j.cell.2013.08.059; Jan YN, 2010, NAT REV NEUROSCI, V11, P316, DOI 10.1038/nrn2836; Liu OW, 2012, NAT NEUROSCI, V15, P57, DOI 10.1038/nn.2978; Parrish JZ, 2007, ANNU REV NEUROSCI, V30, P399, DOI 10.1146/annurev.neuro.29.051605.112907; Pocock R, 2008, MOL CELL NEUROSCI, V37, P56, DOI 10.1016/j.mcn.2007.08.014; Salzberg Y, 2013, CELL, V155, P308, DOI 10.1016/j.cell.2013.08.058; Silletti S, 2000, J CELL BIOL, V149, P1485, DOI 10.1083/jcb.149.7.1485	8	2	2	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 10	2013	155	2					269	271		10.1016/j.cell.2013.09.029	http://dx.doi.org/10.1016/j.cell.2013.09.029			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	235LH	24120127	Bronze			2022-12-28	WOS:000325719800003
J	Morar, P; Hodgkinson, J; Hirji, H; Gould, S				Morar, P.; Hodgkinson, J.; Hirji, H.; Gould, S.			PICTURE QUIZ Free air, but where?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							LIVER		[Morar, P.; Hodgkinson, J.; Hirji, H.; Gould, S.] Northwick Pk & St Marks Hosp, Dept Surg, North West London Hosp NHS Trust, Harrow HA1 3UJ, Middx, England	Imperial College London	Hodgkinson, J (corresponding author), Northwick Pk & St Marks Hosp, Dept Surg, North West London Hosp NHS Trust, Harrow HA1 3UJ, Middx, England.	jdh104@ic.ac.uk						Canoy DS, 2002, DIGEST LIVER DIS, V34, P322, DOI 10.1016/S1590-8658(02)80124-4; Dahnert W, 2003, RADIOLOGY REV MANUAL; Ellis H, 2001, LECT NOTES GEN SURG; FELSON B, 1950, RADIOLOGY, V55, P363, DOI 10.1148/55.3.363; Morris CR, 2008, BRIT J SURG, V95, P876, DOI 10.1002/bjs.6226; Mortele KJ, 2004, RADIOGRAPHICS, V24, P937, DOI 10.1148/rg.244035719; Murarka S, 2011, J GLOB INFECT DIS, V3, P79, DOI 10.4103/0974-777X.77300; Saber AA, 2005, AM SURGEON, V71, P261; Schauer PR, 1997, AM SURGEON, V63, P132; SMITH R, 1992, CAN J SURG, V35, P55	10	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 8	2013	347								f5860	10.1136/bmj.f5860	http://dx.doi.org/10.1136/bmj.f5860			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	235OJ	24103443				2022-12-28	WOS:000325728600005
J	Heaven, MC				Heaven, Michael C.			Turn the Molecule This Way for a Faster Reaction	SCIENCE			English	Editorial Material							3-AMINOPHENOL; CONFORMERS		Emory Univ, Dept Chem, Atlanta, GA 30322 USA	Emory University	Heaven, MC (corresponding author), Emory Univ, Dept Chem, 1515 Pierce Dr, Atlanta, GA 30322 USA.	heaven@euch4e.chem.emory.edu	Heaven, Michael/AAC-7755-2019	Heaven, Michael/0000-0003-4738-2408				Chang YP, 2013, SCIENCE, V342, P98, DOI 10.1126/science.1242271; Filsinger F, 2008, PHYS CHEM CHEM PHYS, V10, P666, DOI 10.1039/b711888k; Filsinger F, 2009, ANGEW CHEM INT EDIT, V48, P6900, DOI 10.1002/anie.200902650; Filsinger F, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3194287; Houston P. L., 2001, CHEM KINETICS REACTI; TROE J, 1987, J CHEM PHYS, V87, P2773, DOI 10.1063/1.453701; Van De Meerakker SYT, 2008, NAT PHYS, V4, P595, DOI 10.1038/nphys1031; Willitsch S, 2008, PHYS CHEM CHEM PHYS, V10, P7200, DOI 10.1039/b813408c	8	1	1	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 4	2013	342	6154					46	47		10.1126/science.1244833	http://dx.doi.org/10.1126/science.1244833			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	227PP	24092717				2022-12-28	WOS:000325126100035
J	Rais, Y; Zviran, A; Geula, S; Gafni, O; Chomsky, E; Viukov, S; Mansour, AA; Caspi, I; Krupalnik, V; Zerbib, M; Maza, I; Mor, N; Baran, D; Weinberger, L; Jaitin, DA; Lara-Astiaso, D; Blecher-Gonen, R; Shipony, Z; Mukamel, Z; Hagai, T; Gilad, S; Amann-Zalcenstein, D; Tanay, A; Amit, I; Novershtern, N; Hanna, JH				Rais, Yoach; Zviran, Asaf; Geula, Shay; Gafni, Ohad; Chomsky, Elad; Viukov, Sergey; Mansour, Abed AlFatah; Caspi, Inbal; Krupalnik, Vladislav; Zerbib, Mirie; Maza, Itay; Mor, Nofar; Baran, Dror; Weinberger, Leehee; Jaitin, Diego A.; Lara-Astiaso, David; Blecher-Gonen, Ronnie; Shipony, Zohar; Mukamel, Zohar; Hagai, Tzachi; Gilad, Shlomit; Amann-Zalcenstein, Daniela; Tanay, Amos; Amit, Ido; Novershtern, Noa; Hanna, Jacob H.			Deterministic direct reprogramming of somatic cells to pluripotency	NATURE			English	Article							DNA METHYLATION; NURD; COMPONENT; NETWORK; COMPLEX; NANOG; MBD3	Somatic cells can be inefficiently and stochastically reprogrammed into induced pluripotent stem(iPS) cells by exogenous expression of Oct4 (also called Pou5f1), Sox2, Klf4 and Myc (hereafter referred to as OSKM). The nature of the predominant rate-limiting barrier(s) preventing the majority of cells to successfully and synchronously reprogram remains to be defined. Here we show that depleting Mbd3, a core member of the Mbd3/NuRD (nucleosome remodelling and deacetylation) repressor complex, together with OSKM transduction and reprogramming in naive pluripotency promoting conditions, result in deterministic and synchronized iPS cell reprogramming (near 100% efficiency within seven days from mouse and human cells). Our findings uncover a dichotomous molecular function for the reprogramming factors, serving to reactivate endogenous pluripotency networks while simultaneously directly recruiting the Mbd3/NuRD repressor complex that potently restrains the reactivation of OSKM downstream target genes. Subsequently, the latter interactions, which are largely depleted during early pre-implantation development in vivo, lead to a stochastic and protracted reprogramming trajectory towards pluripotency in vitro. The deterministic reprogramming approach devised here offers a novel platform for the dissection of molecular dynamics leading to establishing pluripotency at unprecedented flexibility and resolution.	[Rais, Yoach; Zviran, Asaf; Geula, Shay; Gafni, Ohad; Chomsky, Elad; Viukov, Sergey; Mansour, Abed AlFatah; Caspi, Inbal; Krupalnik, Vladislav; Zerbib, Mirie; Maza, Itay; Mor, Nofar; Baran, Dror; Weinberger, Leehee; Novershtern, Noa; Hanna, Jacob H.] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel; [Jaitin, Diego A.; Lara-Astiaso, David; Blecher-Gonen, Ronnie; Amit, Ido] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel; [Shipony, Zohar; Mukamel, Zohar; Tanay, Amos] Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel; [Shipony, Zohar; Mukamel, Zohar; Tanay, Amos] Weizmann Inst Sci, Dept Comp Sci, IL-76100 Rehovot, Israel; [Hagai, Tzachi] Weizmann Inst Sci, Dept Biol Struct, IL-76100 Rehovot, Israel; [Gilad, Shlomit; Amann-Zalcenstein, Daniela] Weizmann Inst Sci, Israel Natl Ctr Personalized Med, IL-76100 Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science	Hanna, JH (corresponding author), Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel.	noa.novershtern@weizmann.ac.il; jacob.hanna@weizmann.ac.il	Hanna, Jacob/K-1339-2012; Geula, Shay Yosef/Z-3789-2019; mansour, abed/GWC-2134-2022; Hagai, Tzachi/AAL-8758-2021	Hanna, Jacob/0000-0003-2042-9974; Geula, Shay Yosef/0000-0001-8111-4410; Blecher, Ronnie/0000-0003-2847-1149; Mansour, Abed AlFatah/0000-0001-9025-6998; Novershtern, Noa/0000-0002-2244-6877; Mor, Nofar/0000-0001-5826-4533; Tzachi, Hagai/0000-0002-4575-6624	Leona M. and Harry B. Helmsley Charitable Trust; ERC [StG-281906, StG-309788]; BIRAX initiative; Israel Science Foundation; ICRF; Fritz Thyssen Stiftung; The Benoziyo Endowment fund; Alon Scholar Program; HFSP Career Development Award, an ISF-Bikura; Weizmann Dean fellowship; Weizmann Institute management	Leona M. and Harry B. Helmsley Charitable Trust; ERC(European Research Council (ERC)European Commission); BIRAX initiative; Israel Science Foundation(Israel Science Foundation); ICRF; Fritz Thyssen Stiftung; The Benoziyo Endowment fund; Alon Scholar Program; HFSP Career Development Award, an ISF-Bikura; Weizmann Dean fellowship; Weizmann Institute management	J.H.H. is supported by a generous gift from I. and P. Mantoux; and grants from the Leona M. and Harry B. Helmsley Charitable Trust, ERC (StG-281906) grant, BIRAX initiative, Israel Science Foundation (BIKURA, ICORE and Regular programs), ICRF, Fritz Thyssen Stiftung, The Benoziyo Endowment fund, Alon Scholar Program, and the Clore research prize. I. A is supported by the HFSP Career Development Award, an ISF-Bikura and the ERC (StG-309788). A. A. M. is supported by a Weizmann Dean fellowship. We thank N. Barkai and her group, K. Saha, B. Hendrich, J. Nichols and A. Surani, for reagents and advice. We thank the Weizmann Institute management for providing critical financial and infrastructural support.	Ang YS, 2011, CELL, V145, P183, DOI 10.1016/j.cell.2011.03.003; Arce G. R., 2005, NONLINEAR SIGNAL PRO; Bedell VM, 2012, NATURE, V491, P114, DOI 10.1038/nature11537; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blecher-Gonen R, 2013, NAT PROTOC, V8, P539, DOI 10.1038/nprot.2013.023; Bolch G., 2006, QUEUEING NETWORKS MA; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Duffy KR, 2012, SCIENCE, V335, P338, DOI 10.1126/science.1213230; Fisher S. R. A, 1970, STAT METHODS RES WOR, V14th; Hanna J, 2008, CELL, V133, P250, DOI 10.1016/j.cell.2008.03.028; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; Hanna J, 2009, CELL STEM CELL, V4, P513, DOI 10.1016/j.stem.2009.04.015; Hanna JH, 2010, CELL, V143, P508, DOI 10.1016/j.cell.2010.10.008; Hockemeyer D, 2008, CELL STEM CELL, V3, P346, DOI 10.1016/j.stem.2008.08.014; Hockemeyer D, 2011, NAT BIOTECHNOL, V29, P731, DOI 10.1038/nbt.1927; Hu G, 2012, CELL STEM CELL, V10, P497, DOI 10.1016/j.stem.2012.04.011; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kaji K, 2006, NAT CELL BIOL, V8, P285, DOI 10.1038/ncb1372; Kaji K, 2007, DEVELOPMENT, V134, P1123, DOI 10.1242/dev.02802; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Le Guezennec X, 2006, MOL CELL BIOL, V26, P843, DOI 10.1128/MCB.26.3.843-851.2006; Leitch HG, 2010, DEVELOPMENT, V137, P2279, DOI 10.1242/dev.050427; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Luo M, 2013, STEM CELLS, V31, P1278, DOI 10.1002/stem.1374; Mansour AA, 2012, NATURE, V488, P409, DOI 10.1038/nature11272; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Onder TT, 2012, NATURE, V483, P598, DOI 10.1038/nature10953; Pawlak M, 2011, GENE DEV, V25, P1035, DOI 10.1101/gad.2039011; Reynolds N, 2012, CELL STEM CELL, V10, P583, DOI 10.1016/j.stem.2012.02.020; Reynolds N, 2012, EMBO J, V31, P593, DOI 10.1038/emboj.2011.431; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Smith ZD, 2012, NATURE, V484, P339, DOI 10.1038/nature10960; Smith ZD, 2010, NAT BIOTECHNOL, V28, P521, DOI 10.1038/nbt.1632; Sommer CA, 2009, STEM CELLS, V27, P543, DOI 10.1634/stemcells.2008-1075; Soufi A, 2012, CELL, V151, P994, DOI 10.1016/j.cell.2012.09.045; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Stadtfeld M, 2010, NATURE, V465, P175, DOI 10.1038/nature09017; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012	40	387	408	1	237	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 3	2013	502	7469					65	+		10.1038/nature12587	http://dx.doi.org/10.1038/nature12587			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	227IM	24048479				2022-12-28	WOS:000325106000031
J	Lee, M; Saver, JL; Hong, KS; Rao, NM; Wu, YL; Ovbiagele, B				Lee, Meng; Saver, Jeffrey L.; Hong, Keun-Sik; Rao, Neal M.; Wu, Yi-Ling; Ovbiagele, Bruce			Risk-Benefit Profile of Long-Term Dual-Versus Single-Antiplatelet Therapy Among Patients With Ischemic Stroke	ANNALS OF INTERNAL MEDICINE			English	Review							EXTENDED-RELEASE DIPYRIDAMOLE; ASPIRIN PLUS DIPYRIDAMOLE; SECONDARY PREVENTION; DOUBLE-BLIND; CEREBRAL-ISCHEMIA; CONTROLLED-TRIAL; CLOPIDOGREL; ATTACK; EVENTS; DESIGN	Background: Dual-antiplatelet regimens for prevention of recurrent stroke promote antithrombotic effects but may increase the risk for hemorrhage. Purpose: To qualitatively and quantitatively examine the risk for recurrent stroke and intracranial hemorrhage (ICH) linked to long-term dual-and single-antiplatelet therapy among patients with ischemic stroke and transient ischemic attack. Data Sources: PubMed, EMBASE, and the Cochrane Central Register of Controlled Trials through March 2013 without language restrictions. Study Selection: The search identified 7 randomized, controlled trials that involved a total of 39 574 participants and reported recurrent stroke and ICH as outcome measures. Data Extraction: All data from eligible studies were independently abstracted by 2 investigators according to a standard protocol. Data Synthesis: Recurrent stroke risk did not differ between patients receiving dual-antiplatelet therapy and those receiving aspirin monotherapy (relative risk [RR], 0.89 [95% CI, 0.78 to 1.01]) or clopidogrel monotherapy (RR, 1.01 [CI, 0.93 to 1.08]). Risk for ICH did not differ between patients receiving dual-antiplatelet therapy and those receiving aspirin monotherapy (RR, 0.99 [CI, 0.70 to 1.42]) but was greater among patients receiving dual-antiplatelet therapy than among those receiving clopidogrel monotherapy (RR, 1.46 [CI, 1.17 to 1.82]). Limitation: Agents used in dual-and single-antiplatelet therapies varied across trials, and the relatively modest number of trials limited subgroup analysis. Conclusion: Compared with monotherapy, dual-antiplatelet therapy lasting more than 1 year after an index ischemic stroke or transient ischemic attack is not associated with a greater reduction in overall recurrent stroke risk. However, long-term dual-antiplatelet therapy is linked to higher risk for ICH than clopidogrel monotherapy in this patient population. Primary Funding Source: Chang Gung Memorial Hospital.	Chang Gung Mem Hosp, Chiayi, Taiwan; Univ Calif Los Angeles, Los Angeles, CA USA; Ilsan Paik Hosp, Goyang, South Korea; Med Univ S Carolina, Charleston, SC 29425 USA	Chang Gung Memorial Hospital; University of California System; University of California Los Angeles; Inje University; Medical University of South Carolina	Ovbiagele, B (corresponding author), Med Univ S Carolina, Dept Neurosci, 96 Jonathan Lucas St,CSB 301,MSC 606, Charleston, SC 29425 USA.			Saver, Jeffrey/0000-0001-9141-2251; Hong, Keun-Sik/0000-0002-4684-6111; Wu, Yi-Ling/0000-0001-9254-9399	Chang Gung Memorial Hospital; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS079179, P50NS044378] Funding Source: NIH RePORTER	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Chang Gung Memorial Hospital.	[Anonymous], 1985, Stroke, V16, P406; Arnarsdottir L, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-67; Benavente OR, 2012, NEW ENGL J MED, V367, P817, DOI 10.1056/NEJMoa1204133; Benavente OR, 2011, INT J STROKE, V6, P164, DOI 10.1111/j.1747-4949.2010.00573.x; Bhatt DL, 2006, NEW ENGL J MED, V354, P1706, DOI 10.1056/NEJMoa060989; BOUSSER MG, 1983, STROKE, V14, P5, DOI 10.1161/01.STR.14.1.5; Cadilhac DA, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-49; Connolly SJ, 2009, NEW ENGL J MED, V360, P2066, DOI 10.1056/NEJMoa0901301; De Schryver ELLM, 2001, CEREBROVASC DIS, V11, P286, DOI 10.1159/000047654; De Schryver ELLM, 2000, CEREBROVASC DIS, V10, P147, DOI 10.1159/000016044; Diener HC, 2007, CEREBROVASC DIS, V23, P368, DOI 10.1159/000100105; Diener HC, 2004, LANCET, V364, P331, DOI 10.1016/S0140-6736(04)16721-4; Diener HC, 2004, CEREBROVASC DIS, V17, P253, DOI 10.1159/000076962; Diener HC, 1996, J NEUROL SCI, V143, P1, DOI 10.1016/S0022-510X(96)00308-5; Furie KL, 2011, STROKE, V42, P227, DOI 10.1161/STR.0b013e3181f7d043; Geeganage CM, 2012, STROKE, V43, P1058, DOI 10.1161/STROKEAHA.111.637686; Gent M, 1996, LANCET, V348, P1329, DOI 10.1016/s0140-6736(96)09457-3; Geraghty OC, 2010, NEUROLOGY, V74, P1891, DOI 10.1212/WNL.0b013e3181e242bb; Halkes PHA, 2006, LANCET, V367, P1665; Hankey GJ, 2011, INT J STROKE, V6, P3, DOI 10.1111/j.1747-4949.2010.00535.x; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; Ito E, 2003, INTERNAL MED, V42, P793, DOI 10.2169/internalmedicine.42.793; Johnston SC, 2007, LANCET, V369, P283, DOI 10.1016/S0140-6736(07)60150-0; Kennedy J, 2007, LANCET NEUROL, V6, P961, DOI 10.1016/S1474-4422(07)70250-8; Kim HC, 2009, NEUROEPIDEMIOLOGY, V32, P94, DOI 10.1159/000177034; Lee HY, 2010, STROKE, V41, P739, DOI 10.1161/STROKEAHA.109.573543; Lee M, 2011, LANCET, V377, P1980, DOI 10.1016/S0140-6736(11)60708-3; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Morrow DA, 2013, STROKE, V44, P691, DOI 10.1161/STROKEAHA.111.000433; Sacco RL, 2008, NEW ENGL J MED, V359, P1238, DOI 10.1056/NEJMoa0805002; Uchiyama S, 2011, CEREBROVASC DIS, V31, P601, DOI 10.1159/000327035; Wang YJ, 2013, NEW ENGL J MED, V369, P11, DOI 10.1056/NEJMoa1215340	32	49	54	1	17	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 1	2013	159	7					463	U174		10.7326/0003-4819-159-7-201310010-00006	http://dx.doi.org/10.7326/0003-4819-159-7-201310010-00006			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	234FQ	24081287				2022-12-28	WOS:000325628000004
J	Blair, DR; Lyttle, CS; Mortensen, JM; Bearden, CF; Jensen, AB; Khiabanian, H; Melamed, R; Rabadan, R; Bernstam, EV; Brunak, S; Jensen, LJ; Nicolae, D; Shah, NH; Grossman, RL; Cox, NJ; White, KP; Rzhetsky, A				Blair, David R.; Lyttle, Christopher S.; Mortensen, Jonathan M.; Bearden, Charles F.; Jensen, Anders Boeck; Khiabanian, Hossein; Melamed, Rachel; Rabadan, Raul; Bernstam, Elmer V.; Brunak, Soren; Jensen, Lars Juhl; Nicolae, Dan; Shah, Nigam H.; Grossman, Robert L.; Cox, Nancy J.; White, Kevin P.; Rzhetsky, Andrey			A Nondegenerate Code of Deleterious Variants in Mendelian Loci Contributes to Complex Disease Risk	CELL			English	Article							TERT PROMOTER MUTATIONS; MODIFIER GENES; DISORDERS; INHERITANCE; DELETION; CELLS	Although countless highly penetrant variants have been associated with Mendelian disorders, the genetic etiologies underlying complex diseases remain largely unresolved. By mining the medical records of over 110 million patients, we examine the extent to which Mendelian variation contributes to complex disease risk. We detect thousands of associations between Mendelian and complex diseases, revealing a nondegenerate, phenotypic code that links each complex disorder to a unique collection of Mendelian loci. Using genome-wide association results, we demonstrate that common variants associated with complex diseases are enriched in the genes indicated by this "Mendelian code.'' Finally, we detect hundreds of comorbidity associations among Mendelian disorders, and we use probabilistic genetic modeling to demonstrate that Mendelian variants likely contribute nonadditively to the risk for a subset of complex diseases. Overall, this study illustrates a complementary approach for mapping complex disease loci and provides unique predictions concerning the etiologies of specific diseases.	[Blair, David R.] Univ Chicago, Comm Genet Genom & Syst Biol, Chicago, IL 60637 USA; [Lyttle, Christopher S.] Univ Chicago, Ctr Hlth & Social Sci, Chicago, IL 60637 USA; [Nicolae, Dan] Univ Chicago, Dept Stat, Chicago, IL 60637 USA; [Nicolae, Dan; Grossman, Robert L.; Cox, Nancy J.; White, Kevin P.; Rzhetsky, Andrey] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Nicolae, Dan; Cox, Nancy J.; White, Kevin P.; Rzhetsky, Andrey] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Grossman, Robert L.; White, Kevin P.; Rzhetsky, Andrey] Univ Chicago, Inst Genom & Syst Biol, Computat Inst, Chicago, IL 60637 USA; [Mortensen, Jonathan M.; Shah, Nigam H.] Stanford Ctr Biomed Informat Res, Stanford, CA 94305 USA; [Bearden, Charles F.; Bernstam, Elmer V.] Univ Texas Hlth Sci Ctr Houston, Dept Internal Med, Sch Biomed Informat, Houston, TX 77030 USA; [Jensen, Anders Boeck; Brunak, Soren; Jensen, Lars Juhl] Tech Univ Denmark, Ctr Biol Sequence Anal, DK-2800 Copenhagen, Denmark; [Khiabanian, Hossein; Melamed, Rachel; Rabadan, Raul] Columbia Univ, Ctr Computat Biol & Bioinformat, Dept Biomed Informat, New York, NY 10032 USA; [Brunak, Soren; Jensen, Lars Juhl] Univ Copenhagen, Novo Nordisk Fdn Ctr Prot Res, DK-2200 Copenhagen, Denmark	University of Chicago; University of Chicago; University of Chicago; University of Chicago; University of Chicago; University of Chicago; University of Texas System; University of Texas Health Science Center Houston; Technical University of Denmark; Columbia University; University of Copenhagen	White, KP (corresponding author), Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA.	kpwhite@uchicago.edu; arzhetsky@uchicago.edu	Jensen, Lars Juhl/C-6492-2008; Khiabanian, Hossein/N-7207-2019; rzhetsky, andrey/B-6118-2012; Rabadan, Raul/AAZ-7367-2020; Brunak, Soren/O-6621-2016; Blair, David/G-6052-2011; Grossman, Robert/B-1865-2009	Jensen, Lars Juhl/0000-0001-7885-715X; Khiabanian, Hossein/0000-0003-1446-4394; rzhetsky, andrey/0000-0001-6959-7405; Melamed, Rachel/0000-0003-3089-9806; Brunak, Soren/0000-0003-0316-5866; Blair, David/0000-0002-4658-3251; Jensen, Anders Boeck/0000-0002-5784-308X; Grossman, Robert/0000-0003-3741-5739; Rabadan, Raul/0000-0001-7946-9255; Nicolae, Dan/0000-0002-0918-4630; Blair, David/0000-0002-7455-6488	National Institutes of Health [1P50MH094267, NHLBI MAPGen U01HL108634-01, P50GM081892-01A1, 2T32GM007281-39]; Chicago Biomedical Consortium; Div Of Information & Intelligent Systems [0964613] Funding Source: National Science Foundation; Novo Nordisk Foundation Center for Protein Research [PI Lars Juhl Jensen, PI S�ren Brunak] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL108634] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG004028] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM081892, T32GM007281] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH094267] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007033] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chicago Biomedical Consortium; Div Of Information & Intelligent Systems(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE)); Novo Nordisk Foundation Center for Protein Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	We are grateful to Steven Bagley, Richard R. Hudson, Ivan Iossifov, Ravinesh Kumar, Simon Lovestone, Fabiola Rivas, Gregory Gibson, Jason Pitt, Rita Rzhetsky, Michael Wigler, and anonymous reviewers for helpful comments on earlier versions of the manuscript. GeneXplain, GmbH, provided help with annotation of Mendelian disorders. This work was supported by grants (1P50MH094267, NHLBI MAPGen U01HL108634-01, P50GM081892-01A1, and 2T32GM007281-39) from the National Institutes of Health and by a Lever Award from the Chicago Biomedical Consortium.	Ashwood P, 2010, BRAIN BEHAV IMMUN, V24, P898, DOI 10.1016/j.bbi.2010.01.008; Badano JL, 2006, NATURE, V439, P326, DOI 10.1038/nature04370; Badano JL, 2002, NAT REV GENET, V3, P779, DOI 10.1038/nrg910; Bassett AS, 2008, HUM MOL GENET, V17, P4045, DOI 10.1093/hmg/ddn307; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Calderhead B, 2009, COMPUT STAT DATA AN, V53, P4028, DOI 10.1016/j.csda.2009.07.025; Cutting GR, 2010, ANN NY ACAD SCI, V1214, P57, DOI 10.1111/j.1749-6632.2010.05879.x; DEBOULLE K, 1993, NAT GENET, V3, P31, DOI 10.1038/ng0193-31; DeHert M, 1996, AM J MED GENET, V67, P212; DESANCTIS V, 1988, ARCH DIS CHILD, V63, P58, DOI 10.1136/adc.63.1.58; Dickson SP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000294; Gamazon ER, 2010, BIOINFORMATICS, V26, P259, DOI 10.1093/bioinformatics/btp644; Hidalgo CA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000353; Horn S, 2013, SCIENCE, V339, P959, DOI 10.1126/science.1230062; Huang FW, 2013, SCIENCE, V339, P957, DOI 10.1126/science.1229259; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; KAJIWARA K, 1994, SCIENCE, V264, P1604, DOI 10.1126/science.8202715; Katsanis N, 2001, SCIENCE, V293, P2256, DOI 10.1126/science.1063525; Killela PJ, 2013, P NATL ACAD SCI USA, V110, P6021, DOI 10.1073/pnas.1303607110; Kirwan M, 2009, BBA-MOL BASIS DIS, V1792, P371, DOI 10.1016/j.bbadis.2009.01.010; Kumar RA, 2008, HUM MOL GENET, V17, P628, DOI 10.1093/hmg/ddm376; Lee DS, 2008, P NATL ACAD SCI USA, V105, P9880, DOI 10.1073/pnas.0802208105; Lee I, 2011, GENOME RES, V21, P1109, DOI 10.1101/gr.118992.110; Lemmers RJLF, 2012, NAT GENET, V44, P1370, DOI 10.1038/ng.2454; Lupski JR, 2011, CELL, V147, P32, DOI 10.1016/j.cell.2011.09.008; Lyles RH, 2002, AM J EPIDEMIOL, V155, P274, DOI 10.1093/aje/155.3.274; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Min WW, 2009, NEUROPHARMACOLOGY, V56, P463, DOI 10.1016/j.neuropharm.2008.09.017; O'Roak BJ, 2011, NAT GENET, V43, P585, DOI 10.1038/ng.835; Parmeggiani F, 2011, CURR GENOMICS, V12, P236, DOI 10.2174/138920211795860080; PODOLSKY S, 1972, LANCET, V1, P1356; RISCH N, 1990, AM J HUM GENET, V46, P222; Ristow M, 2004, J MOL MED, V82, P510, DOI 10.1007/s00109-004-0552-1; Rzhetsky A, 2007, P NATL ACAD SCI USA, V104, P11694, DOI 10.1073/pnas.0704820104; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sellers TA, 1997, J NUTR, V127, pS929, DOI 10.1093/jn/127.5.929S; Shinawi M, 2010, J MED GENET, V47, P332, DOI 10.1136/jmg.2009.073015; Sinibaldi Lorenzo, 2004, Hum Mutat, V24, P534, DOI 10.1002/humu.9292; Smoller JW, 2013, LANCET, V381, P1371, DOI 10.1016/S0140-6736(12)62129-1; Strong A, 2012, CURR ATHEROSCLER REP, V14, P211, DOI 10.1007/s11883-012-0248-x; Tabet AC, 2012, EUR J HUM GENET, V20, P540, DOI 10.1038/ejhg.2011.244; van Walraven C, 2012, J CLIN EPIDEMIOL, V65, P126, DOI 10.1016/j.jclinepi.2011.08.002; Visscher PM, 2012, AM J HUM GENET, V90, P7, DOI 10.1016/j.ajhg.2011.11.029; Vissers LELM, 2010, NAT GENET, V42, P1109, DOI 10.1038/ng.712; Wallace AS, 2011, WORLD J GASTROENTERO, V17, P4937, DOI 10.3748/wjg.v17.i45.4937; Yu TW, 2013, NEURON, V77, P259, DOI 10.1016/j.neuron.2012.11.002; Zaghloul NA, 2010, P NATL ACAD SCI USA, V107, P10602, DOI 10.1073/pnas.1000219107; Zang JB, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000758; Zhao JH, 2010, DIABETES, V59, P751, DOI 10.2337/db09-0972	49	149	151	0	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 26	2013	155	1					70	80		10.1016/j.cell.2013.08.030	http://dx.doi.org/10.1016/j.cell.2013.08.030			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	224UX	24074861	Green Accepted, Bronze			2022-12-28	WOS:000324916700010
J	Ong, CT; Van Bortle, K; Ramos, E; Corces, VG				Ong, Chin-Tong; Van Bortle, Kevin; Ramos, Edward; Corces, Victor G.			Poly(ADP-ribosyl)ation Regulates Insulator Function and Intrachromosomal Interactions in Drosophila	CELL			English	Article							GYPSY CHROMATIN INSULATOR; CCCTC-BINDING-FACTOR; NUCLEAR-ORGANIZATION; INTERACTIONS REVEALS; LINEAGE COMMITMENT; BITHORAX COMPLEX; ELEMENTS MEDIATE; GENE-EXPRESSION; CTCF-BINDING; HUMAN GENOME	Insulators mediate inter- and intrachromosomal contacts to regulate enhancer-promoter interactions and establish chromosome domains. The mechanisms by which insulator activity can be regulated to orchestrate changes in the function and three-dimensional arrangement of the genome remain elusive. Here, we demonstrate that Drosophila insulator proteins are poly(ADP-ribosyl)ated and that mutation of the poly(ADP-ribose) polymerase (Parp) gene impairs their function. This modification is not essential for DNA occupancy of insulator DNA-binding proteins dCTCF and Su(Hw). However, poly(ADP-ribosyl)ation of K566 in CP190 promotes protein-protein interactions with other insulator proteins, association with the nuclear lamina, and insulator activity in vivo. Consistent with these findings, the nuclear clustering of CP190 complexes is disrupted in Parp mutant cells. Importantly, poly(ADP-ribosyl)ation facilitates intrachromosomal interactions between insulator sites measured by 4C. These data suggest that the role of insulators in organizing the three-dimensional architecture of the genome may be modulated by poly(ADP-ribosyl)ation.	[Ong, Chin-Tong; Van Bortle, Kevin; Ramos, Edward; Corces, Victor G.] Emory Univ, Dept Biol, Atlanta, GA 30322 USA	Emory University	Corces, VG (corresponding author), Emory Univ, Dept Biol, 1510 Clifton Rd NE, Atlanta, GA 30322 USA.	vcorces@emory.edu		Ong, Chin-Tong/0000-0002-5450-4760; Corces, Victor/0000-0001-5140-4337	U.S. Public Health Service Award from National Institutes of Health [R01GM035463]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035463] Funding Source: NIH RePORTER	U.S. Public Health Service Award from National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank the Genomic Services Lab at the HudsonAlpha Institute for Biotechnology for their help in performing Illumina sequencing of ChIP-seq samples. This work was supported by U.S. Public Health Service Award R01GM035463 from the National Institutes of Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahel I, 2008, NATURE, V451, P81, DOI 10.1038/nature06420; Barges S, 2000, DEVELOPMENT, V127, P779; Bushey AM, 2009, GENE DEV, V23, P1338, DOI 10.1101/gad.1798209; Capelson M, 2005, MOL CELL, V20, P105, DOI 10.1016/j.molcel.2005.08.031; Capelson M, 2006, EMBO J, V25, P1906, DOI 10.1038/sj.emboj.7601068; Chou DM, 2010, P NATL ACAD SCI USA, V107, P18475, DOI 10.1073/pnas.1012946107; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; El-Kady A, 2005, FEBS LETT, V579, P1424, DOI 10.1016/j.febslet.2005.01.044; Farrar D, 2010, MOL CELL BIOL, V30, P1199, DOI 10.1128/MCB.00827-09; Gerasimova TI, 2007, MOL CELL, V28, P761, DOI 10.1016/j.molcel.2007.09.024; Gerasimova TI, 2000, MOL CELL, V6, P1025, DOI 10.1016/S1097-2765(00)00101-5; Gondor A, 2008, NAT PROTOC, V3, P303, DOI 10.1038/nprot.2007.540; Guo CG, 2011, NATURE, V477, P424, DOI 10.1038/nature10495; Guo Y, 2012, P NATL ACAD SCI USA, V109, P21081, DOI 10.1073/pnas.1219280110; Hagege H, 2007, NAT PROTOC, V2, P1722, DOI 10.1038/nprot.2007.243; Hou CH, 2012, MOL CELL, V48, P471, DOI 10.1016/j.molcel.2012.08.031; Kallappagoudar S, 2010, MOL CELL PROTEOMICS, V9, P2005, DOI 10.1074/mcp.M110.001362; Kharchenko PV, 2011, NATURE, V471, P480, DOI 10.1038/nature09725; Kotova E, 2010, P NATL ACAD SCI USA, V107, P6406, DOI 10.1073/pnas.0914152107; Krishnakumar R, 2008, SCIENCE, V319, P819, DOI 10.1126/science.1149250; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lanzuolo C, 2007, NAT CELL BIOL, V9, P1167, DOI 10.1038/ncb1637; Lei EP, 2006, NAT GENET, V38, P936, DOI 10.1038/ng1850; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lin YC, 2012, NAT IMMUNOL, V13, P1196, DOI 10.1038/ni.2432; Liu Z, 2011, CELL, V146, P720, DOI 10.1016/j.cell.2011.08.005; MacPherson MJ, 2009, MOL CELL BIOL, V29, P714, DOI 10.1128/MCB.00825-08; Merkenschlager M, 2013, CELL, V152, P1285, DOI 10.1016/j.cell.2013.02.029; Mohan M, 2007, EMBO J, V26, P4203, DOI 10.1038/sj.emboj.7601851; Monahan K, 2012, P NATL ACAD SCI USA, V109, P9125, DOI 10.1073/pnas.1205074109; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; O'Connor M, 1993, Methods Mol Biol, V18, P75, DOI 10.1385/0-89603-245-0:75; Pai CY, 2004, MOL CELL, V16, P737, DOI 10.1016/j.molcel.2004.11.004; Parelho V, 2008, CELL, V132, P422, DOI 10.1016/j.cell.2008.01.011; Petesch SJ, 2012, MOL CELL, V45, P64, DOI 10.1016/j.molcel.2011.11.015; Phillips-Cremins JE, 2013, CELL, V153, P1281, DOI 10.1016/j.cell.2013.04.053; Phillips-Cremins JE, 2013, MOL CELL, V50, P461, DOI 10.1016/j.molcel.2013.04.018; Raab JR, 2012, EMBO J, V31, P330, DOI 10.1038/emboj.2011.406; Rubio ED, 2008, P NATL ACAD SCI USA, V105, P8309, DOI 10.1073/pnas.0801273105; Schwartz YB, 2012, GENOME RES, V22, P2188, DOI 10.1101/gr.138156.112; Sexton T, 2012, CELL, V148, P458, DOI 10.1016/j.cell.2012.01.010; Stedman W, 2008, EMBO J, V27, P654, DOI 10.1038/emboj.2008.1; van Bortle K, 2012, TRANSCR-AUSTIN, V3, P277, DOI 10.4161/trns.21579; Van Bortle K, 2013, CURR OPIN GENET DEV, V23, P212, DOI 10.1016/j.gde.2012.11.003; Van Bortle K, 2012, GENOME RES, V22, P2176, DOI 10.1101/gr.136788.111; Vidakovic M, 2004, J CELL BIOCHEM, V93, P1155, DOI 10.1002/jcb.20289; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; Witcher M, 2009, MOL CELL, V34, P271, DOI 10.1016/j.molcel.2009.04.001; Wood AM, 2011, MOL CELL, V44, P29, DOI 10.1016/j.molcel.2011.07.035; Xu ZX, 2011, NAT STRUCT MOL BIOL, V18, P372, DOI 10.1038/nsmb.1993; Yu WQ, 2004, NAT GENET, V36, P1105, DOI 10.1038/ng1426; Yusufzai TM, 2004, MOL CELL, V13, P291, DOI 10.1016/S1097-2765(04)00029-2; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	53	57	57	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 26	2013	155	1					148	159		10.1016/j.cell.2013.08.052	http://dx.doi.org/10.1016/j.cell.2013.08.052			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	224UX	24055367	Bronze, Green Accepted			2022-12-28	WOS:000324916700016
J	Rivera, CM; Ren, B				Rivera, Chloe M.; Ren, Bing			Mapping Human Epigenomes	CELL			English	Review							DNA METHYLATION; CHROMATIN STATE; SINGLE-MOLECULE; HISTONE MODIFICATIONS; NUCLEOSOME POSITIONS; DYNAMIC REGULATION; TET PROTEINS; GENOME; TRANSCRIPTION; ENHANCERS	As the second dimension to the genome, the epigenome contains key information specific to every type of cells. Thousands of human epigenome maps have been produced in recent years thanks to rapid development of high throughput epigenome mapping technologies. In this review, we discuss the current epigenome mapping toolkit and utilities of epigenome maps. We focus particularly on mapping of DNA methylation, chromatin modification state, and chromatin structures, and emphasize the use of epigenome maps to delineate human gene regulatory sequences and developmental programs. We also provide a perspective on the progress of the epigenomics field and challenges ahead.	[Rivera, Chloe M.; Ren, Bing] Univ Calif San Diego, Sch Med, UCSD Moores Canc Ctr, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; [Rivera, Chloe M.] Univ Calif San Diego, Sch Med, UCSD Moores Canc Ctr, Inst Genom Med,Biomed Sci Grad Program, La Jolla, CA 92093 USA; [Ren, Bing] Univ Calif San Diego, Sch Med, UCSD Moores Canc Ctr, Inst Genom Med,Dept Cellular & Mol Med, La Jolla, CA 92093 USA	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Ren, B (corresponding author), Univ Calif San Diego, Sch Med, UCSD Moores Canc Ctr, Ludwig Inst Canc Res, 9500 Gilman Dr, La Jolla, CA 92093 USA.	biren@ucsd.edu			Ludwig Institute for Cancer Research, NIH [U01ES017166, U54 HG006997]; California Institute for Regenerative Medicine [RN2-00905]; National Institute of General Medical Sciences [T32 GM008666]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006997] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES017166] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008666] Funding Source: NIH RePORTER	Ludwig Institute for Cancer Research, NIH; California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We apologize to those authors whose works are not covered here owing to space limitations. We thank Peter Jones, Bradley Bernstein, Fred Tyson, John Satterlee, and members of the Ren Lab for their comments on earlier versions of this manuscript. This work is supported by funds from the Ludwig Institute for Cancer Research, NIH (grants U01ES017166 and U54 HG006997), and the California Institute for Regenerative Medicine (RN2-00905) to B.R. C.M.R. was supported in part by the UCSD Genetics Training Program through an institutional training grant from the National Institute of General Medical Sciences, T32 GM008666.	Aday AW, 2011, DEV BIOL, V357, P450, DOI 10.1016/j.ydbio.2011.03.007; Adey A, 2012, GENOME RES, V22, P1139, DOI 10.1101/gr.136242.111; Adli M, 2011, NAT PROTOC, V6, P1656, DOI 10.1038/nprot.2011.402; Akhtar W, 2013, CELL, V154, P914, DOI 10.1016/j.cell.2013.07.018; Badeaux AI, 2013, NAT REV MOL CELL BIO, V14, P211, DOI 10.1038/nrm3545; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Beck S, 2012, CANCER RES, V72, P6319, DOI 10.1158/0008-5472.CAN-12-3658; Bell O, 2011, NAT REV GENET, V12, P554, DOI 10.1038/nrg3017; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Bernstein BE, 2010, NAT BIOTECHNOL, V28, P1045, DOI 10.1038/nbt1010-1045; Bibikova M, 2011, GENOMICS, V98, P288, DOI 10.1016/j.ygeno.2011.07.007; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bock C, 2012, NAT REV GENET, V13, P705, DOI 10.1038/nrg3273; Bonasio R, 2010, SCIENCE, V330, P612, DOI 10.1126/science.1191078; Booth MJ, 2012, SCIENCE, V336, P934, DOI 10.1126/science.1220671; Boyle AP, 2008, CELL, V132, P311, DOI 10.1016/j.cell.2007.12.014; Brinkman AB, 2012, GENOME RES, V22, P1128, DOI 10.1101/gr.133728.111; Brogaard K, 2012, NATURE, V486, P496, DOI 10.1038/nature11142; Brown JM, 2008, J CELL BIOL, V182, P1083, DOI 10.1083/jcb.200803174; Buecker C, 2012, TRENDS GENET, V28, P276, DOI 10.1016/j.tig.2012.02.008; Calo E, 2013, MOL CELL, V49, P825, DOI 10.1016/j.molcel.2013.01.038; CLARK SJ, 1994, NUCLEIC ACIDS RES, V22, P2990, DOI 10.1093/nar/22.15.2990; Clarke J, 2009, NAT NANOTECHNOL, V4, P265, DOI [10.1038/NNANO.2009.12, 10.1038/nnano.2009.12]; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; CRICK F, 1970, NATURE, V227, P561, DOI 10.1038/227561a0; de Wit E., 2013, NATURE; de Wit E, 2012, GENE DEV, V26, P11, DOI 10.1101/gad.179804.111; Degner JF, 2012, NATURE, V482, P390, DOI 10.1038/nature10808; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Dekker J, 2013, NAT REV GENET, V14, P390, DOI 10.1038/nrg3454; DeMare LE, 2013, GENOME RES, V23, P1224, DOI 10.1101/gr.156570.113; Diep D, 2012, NAT METHODS, V9, P270, DOI [10.1038/nmeth.1871, 10.1038/NMETH.1871]; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dostie J, 2006, GENOME RES, V16, P1299, DOI 10.1101/gr.5571506; Down TA, 2008, NAT BIOTECHNOL, V26, P779, DOI 10.1038/nbt1414; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Egelhofer TA, 2011, NAT STRUCT MOL BIOL, V18, P91, DOI 10.1038/nsmb.1972; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Feinberg AP, 2007, NATURE, V447, P433, DOI 10.1038/nature05919; Felsenfeld G, 2003, NATURE, V421, P448, DOI 10.1038/nature01411; Ficz G, 2011, NATURE, V473, P398, DOI 10.1038/nature10008; Flusberg BA, 2010, NAT METHODS, V7, P461, DOI [10.1038/NMETH.1459, 10.1038/nmeth.1459]; Frazer KA, 2009, NAT REV GENET, V10, P241, DOI 10.1038/nrg2554; Gaffney DJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003036; Garraway LA, 2013, CELL, V153, P17, DOI 10.1016/j.cell.2013.03.002; Gerstein MB, 2012, NATURE, V489, P91, DOI 10.1038/nature11245; Gifford CA, 2013, CELL, V153, P1149, DOI 10.1016/j.cell.2013.04.037; Giresi PG, 2007, GENOME RES, V17, P877, DOI 10.1101/gr.5533506; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Handoko L, 2011, NAT GENET, V43, P630, DOI 10.1038/ng.857; Hawkins RD, 2010, CELL STEM CELL, V6, P479, DOI 10.1016/j.stem.2010.03.018; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heintzman ND, 2009, CURR OPIN GENET DEV, V19, P541, DOI 10.1016/j.gde.2009.09.006; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Hellman A, 2007, SCIENCE, V315, P1141, DOI 10.1126/science.1136352; Henikoff S, 2008, SCIENCE, V322, P853, DOI 10.1126/science.322.5903.853a; Hindorff L., 2013, CATALOG PUBLISHED GE; Hoffman MM, 2013, NUCLEIC ACIDS RES, V41, P827, DOI 10.1093/nar/gks1284; HOLLIDAY R, 1990, BIOL REV, V65, P431, DOI 10.1111/j.1469-185X.1990.tb01233.x; Hon GC, 2013, NAT GENET, V45, P1198, DOI 10.1038/ng.2746; Huang Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008888; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Ji H, 2010, NATURE, V467, P338, DOI 10.1038/nature09367; Jin SG, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq223; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Jones PA, 2005, CANCER RES, V65, P11241, DOI 10.1158/0008-5472.CAN-05-3865; Jones PA, 2008, NATURE, V454, P711, DOI 10.1038/454711a; Kalhor R, 2012, NAT BIOTECHNOL, V30, P90, DOI 10.1038/nbt.2057; Kelly TK, 2012, GENOME RES, V22, P2497, DOI 10.1101/gr.143008.112; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Laird PW, 2010, NAT REV GENET, V11, P191, DOI 10.1038/nrg2732; Lander ES, 2011, NATURE, V470, P187, DOI 10.1038/nature09792; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Landt SG, 2012, GENOME RES, V22, P1813, DOI 10.1101/gr.136184.111; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lee TI, 2013, CELL, V152, P1237, DOI 10.1016/j.cell.2013.02.014; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Li GL, 2012, CELL, V148, P84, DOI 10.1016/j.cell.2011.12.014; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Madhani HD, 2008, SCIENCE, V322, P43, DOI 10.1126/science.322.5898.43b; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Mavrich TN, 2008, GENOME RES, V18, P1073, DOI 10.1101/gr.078261.108; Meissner A, 2005, NUCLEIC ACIDS RES, V33, P5868, DOI 10.1093/nar/gki901; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Mikkelsen TS, 2010, CELL, V143, P156, DOI 10.1016/j.cell.2010.09.006; Murphy PJ, 2013, P NATL ACAD SCI USA, V110, P7772, DOI 10.1073/pnas.1218495110; Narlikar GJ, 2013, CELL, V154, P490, DOI 10.1016/j.cell.2013.07.011; Neph S, 2012, CELL, V150, P1274, DOI 10.1016/j.cell.2012.04.040; Neph S, 2012, NATURE, V489, P83, DOI 10.1038/nature11212; Ng JH, 2013, DEV CELL, V24, P324, DOI 10.1016/j.devcel.2012.12.011; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Ong CT, 2011, NAT REV GENET, V12, P283, DOI 10.1038/nrg2957; Pastor WA, 2013, NAT REV MOL CELL BIO, V14, P341, DOI 10.1038/nrm3589; Pastor WA, 2011, NATURE, V473, P394, DOI 10.1038/nature10102; Patwardhan RP, 2012, NAT BIOTECHNOL, V30, P265, DOI 10.1038/nbt.2136; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Phillips-Cremins JE, 2013, CELL, V153, P1281, DOI 10.1016/j.cell.2013.04.053; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Rada-Iglesias A, 2012, CELL STEM CELL, V11, P633, DOI 10.1016/j.stem.2012.07.006; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Raiber EA, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-8-r69; Rajagopal N, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002968; Ram O, 2011, CELL, V147, P1628, DOI 10.1016/j.cell.2011.09.057; Ramalingam S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-2-107; Rhee HS, 2011, CELL, V147, P1408, DOI 10.1016/j.cell.2011.11.013; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Robertson AB, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr051; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Roy S, 2010, SCIENCE, V330, P1787, DOI 10.1126/science.1198374; Sajan SA, 2012, ANNU REV GENOM HUM G, V13, P59, DOI 10.1146/annurev-genom-090711-163818; Sanyal A, 2012, NATURE, V489, P109, DOI 10.1038/nature11279; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Serre D, 2010, NUCLEIC ACIDS RES, V38, P391, DOI 10.1093/nar/gkp992; Sheffield NC, 2013, GENOME RES, V23, P777, DOI 10.1101/gr.152140.112; Shen L, 2013, CELL, V153, P692, DOI 10.1016/j.cell.2013.04.002; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; Smallwood A, 2013, CURR OPIN CELL BIOL, V25, P387, DOI 10.1016/j.ceb.2013.02.005; Smith ZD, 2013, NAT REV GENET, V14, P204, DOI 10.1038/nrg3354; Song CX, 2013, CELL, V153, P678, DOI 10.1016/j.cell.2013.04.001; Song CX, 2012, NAT BIOTECHNOL, V30, P1107, DOI 10.1038/nbt.2398; Song CX, 2011, NAT BIOTECHNOL, V29, P68, DOI 10.1038/nbt.1732; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; Statham AL, 2012, GENOME RES, V22, P1120, DOI 10.1101/gr.132076.111; Stergachis AB, 2013, CELL, V154, P888, DOI 10.1016/j.cell.2013.07.020; Szulwach KE, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002154; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Tan MJ, 2011, CELL, V146, P1015, DOI 10.1016/j.cell.2011.08.008; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Tian ZX, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-10-r86, 10.1186/gb-2012-13-10-R86]; van Steensel B, 2010, NAT BIOTECHNOL, V28, P1089, DOI 10.1038/nbt.1680; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; WADDINGTON CH, 1959, NATURE, V183, P1654, DOI 10.1038/1831654a0; Wamstad JA, 2012, CELL, V151, P206, DOI 10.1016/j.cell.2012.07.035; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; WATSON JD, 1953, NATURE, V171, P964, DOI 10.1038/171964b0; Wei Z, 2013, CELL STEM CELL, V13, P36, DOI 10.1016/j.stem.2013.05.010; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Whyte WA, 2012, NATURE, V482, P221, DOI 10.1038/nature10805; Williams K, 2011, NATURE, V473, P343, DOI 10.1038/nature10066; Williamson I, 2012, DEVELOPMENT, V139, P3157, DOI 10.1242/dev.081174; Won KJ, 2013, NUCLEIC ACIDS RES, V41, P4423, DOI 10.1093/nar/gkt143; Xie MC, 2013, NAT GENET, V45, P836, DOI 10.1038/ng.2649; Xie W, 2013, CELL, V153, P1134, DOI 10.1016/j.cell.2013.04.022; Yu M, 2012, CELL, V149, P1368, DOI 10.1016/j.cell.2012.04.027; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178; Zhao Z, 2006, NAT GENET, V38, P1341, DOI 10.1038/ng1891; Zhu J, 2013, CELL, V152, P642, DOI 10.1016/j.cell.2012.12.033; Ziller MJ, 2013, NATURE, V500, P477, DOI 10.1038/nature12433	158	350	364	5	144	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 26	2013	155	1					39	55		10.1016/j.cell.2013.09.011	http://dx.doi.org/10.1016/j.cell.2013.09.011			17	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	224UX	24074860	Bronze, Green Accepted			2022-12-28	WOS:000324916700008
J	Diringer, E				Diringer, Elliot			A patchwork of emissions cuts	NATURE			English	Editorial Material									Ctr Climate & Energy Solut C2ES, Arlington, VA USA		Diringer, E (corresponding author), Ctr Climate & Energy Solut C2ES, Arlington, VA USA.	diringere@c2es.org							0	12	13	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 19	2013	501	7467					307	309		10.1038/501307a	http://dx.doi.org/10.1038/501307a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	219XT	24058934	Bronze			2022-12-28	WOS:000324545700014
J	Loxterkamp, D				Loxterkamp, David			Humanism in the time of metrics-an essay by David Loxterkamp	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							HEALTH; MORTALITY; SMOKING	With the advent of pay for performance and quality standards, family doctors are now in the business of data reporting. We are paid to report "quality measures" and meet their targets. In the United States, where lawmakers, employers, and patients agree that the cost of healthcare is unsustainable, the government and industry are joining forces to enact structural and payment forms like meaningful use of electronic health records, pay for performance, and the patient centered medical home, which aims to transform the delivery of primary care. These programs reward healthcare providers with new computer systems and added management fees with the expectation of lower costs and measurable improvements in health. But this shift of our gaze to patients' physiology and chemistry, and to our performance in managing it has unintended consequences.	Seaport Family Practice PA, Belfast, ME 04915 USA		Loxterkamp, D (corresponding author), Seaport Family Practice PA, 15 Salmond St, Belfast, ME 04915 USA.	davidloxterkamp@gmail.com						Berry W, 1994, C SPIR HEAL LOUISV K; Brody H, 2000, J FAM PRACTICE, V49, P649; Brown DW, 2009, AM J PREV MED, V37, P389, DOI 10.1016/j.amepre.2009.06.021; Christakis NA, 2008, NEW ENGL J MED, V358, P2249, DOI 10.1056/NEJMsa0706154; Christakis NA, 2007, NEW ENGL J MED, V357, P370, DOI 10.1056/NEJMsa066082; Cullough D, 2009, MY MOTHER YOUR MOTHE; Cushman WC, 2010, NEW ENGL J MED, V362, P1575, DOI 10.1056/NEJMoa1001286; Duane M, COMMON SENSE; Felitti Vincent J, 2002, Perm J, V6, P44; Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905; Fowler JH, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2338; Frey JJ, 2007, JAMA-J AM MED ASSOC, V297, P1751, DOI 10.1001/jama.297.16.1751; Furberg CD, 2002, JAMA-J AM MED ASSOC, V288, P2981; Gerstein HC, 2011, NEW ENGL J MED, V364, P818, DOI 10.1056/NEJMoa1006524; Goldfine AB, 2011, NEW ENGL J MED, V365, P481, DOI 10.1056/NEJMp1106688; Harris G., 2011, NY TIMES; Krogsboll LT, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7191; Langewitz W, 2002, BRIT MED J, V325, P682, DOI 10.1136/bmj.325.7366.682; Lehrer J., 2010, NEW YORKER 1205; Manary MP, 2013, NEW ENGL J MED, V368, P201, DOI 10.1056/NEJMp1211775; Parker-Pope T., 2011, NY TIMES; Rhoades DR, 2001, FAM MED, V33, P528; Schroeder SA, 2013, NEW ENGL J MED, V368, P389, DOI 10.1056/NEJMe1213751; Solberg LI, 2006, AM J PREV MED, V31, P52; Spector M., 2013, NEW YORKER; Stergiopoulos K, 2012, ARCH INTERN MED, V172, P312, DOI 10.1001/archinternmed.2011.1484; Topol EJ, 2012, CREATIVE DESTRUCTION; TURNER JA, 1994, JAMA-J AM MED ASSOC, V271, P1609, DOI 10.1001/jama.271.20.1609; Xierali IM, 2013, ANN FAM MED, V11, P14, DOI 10.1370/afm.1461	29	8	8	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 19	2013	347								f5539	10.1136/bmj.f5539	http://dx.doi.org/10.1136/bmj.f5539			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	223SY	24052583	Bronze			2022-12-28	WOS:000324831500004
J	Buse, K; Hawkes, S				Buse, Kent; Hawkes, Sarah			Health post-2015: evidence and power	LANCET			English	Editorial Material							DISEASE		[Buse, Kent] UNAIDS, CH-1211 Geneva 27, Switzerland; [Hawkes, Sarah] UCL, London, England	UNAIDS; University of London; University College London	Buse, K (corresponding author), UNAIDS, CH-1211 Geneva 27, Switzerland.	BuseK@unaids.org	Buse, Kent/AAK-6688-2020; Hawkes, Sarah/AAK-7375-2020	Buse, Kent/0000-0002-5485-0110; Hawkes, Sarah/0000-0003-1062-3538				Beaglehole R, 2011, LANCET, V377, P1438, DOI 10.1016/S0140-6736(11)60393-0; Horton R, 2013, LANCET, V381, P1972, DOI 10.1016/S0140-6736(13)61168-X; Leadership Council of the Sustainable Development Solutions Network, 2013, ACT AG SUST DEV REP; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Lukes S., 1974, POWER RADICAL VIEW; Moodie R, 2013, LANCET, V381, P670, DOI 10.1016/S0140-6736(12)62089-3; Sidibe M, 2013, LANCET, V381, P2147, DOI 10.1016/S0140-6736(13)61413-0; Task Team for the Global Thematic Consultation on Health in the Post-2015 Development Agenda, 2013, REP GLOB THEM CONS H; United Nations, 2013, NEW GLOB PARTN ER PO; WHO, 2011, GLOBAL STATUS REPORT; Zeltner T., 2000, TOBACCO CO STRATEGIE	12	16	16	0	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 22	2014	383	9918					678	+		10.1016/S0140-6736(13)61945-5	http://dx.doi.org/10.1016/S0140-6736(13)61945-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AB2WR	24055453				2022-12-28	WOS:000331653300008
J	Wilson, SR; The, L; Batia, LM; Beattie, K; Katibah, GE; McClain, SP; Pellegrino, M; Estandian, DM; Bautista, DM				Wilson, Sarah R.; The, Lydia; Batia, Lyn M.; Beattie, Katherine; Katibah, George E.; McClain, Shannan P.; Pellegrino, Maurizio; Estandian, Daniel M.; Bautista, Diana M.			The Epithelial Cell-Derived Atopic Dermatitis Cytokine TSLP Activates Neurons to Induce Itch	CELL			English	Article							THYMIC STROMAL LYMPHOPOIETIN; OPERATED CA2+ ENTRY; CRAC CHANNEL; HUMAN KERATINOCYTES; NETHERTON SYNDROME; DISEASE SEVERITY; TRP CHANNELS; HUMAN SKIN; RECEPTOR; MICE	Atopic dermatitis (AD) is a chronic itch and inflammatory disorder of the skin that affects one in ten people. Patients suffering from severe AD eventually progress to develop asthma and allergic rhinitis, in a process known as the "atopic march." Signaling between epithelial cells and innate immune cells via the cytokine thymic stromal lymphopoietin (TSLP) is thought to drive AD and the atopic march. Here, we report that epithelial cells directly communicate to cutaneous sensory neurons via TSLP to promote itch. We identify the ORAI1/NFAT calcium signaling pathway as an essential regulator of TSLP release from keratinocytes, the primary epithelial cells of the skin. TSLP then acts directly on a subset of TRPA1-positive sensory neurons to trigger robust itch behaviors. Our results support a model whereby calcium-dependent TSLP release by keratinocytes activates both primary afferent neurons and immune cells to promote inflammatory responses in the skin and airways.	[Wilson, Sarah R.; The, Lydia; Batia, Lyn M.; Beattie, Katherine; Katibah, George E.; McClain, Shannan P.; Pellegrino, Maurizio; Estandian, Daniel M.; Bautista, Diana M.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Wilson, Sarah R.; Bautista, Diana M.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Bautista, DM (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	dbautista@berkeley.edu			National Institutes of Health [AR059385, DOD007123A]; National Science Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR059385] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD007123] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We are grateful to Drs. Hariharan and Heald and lab members for critical comments on the manuscript. We thank K. Gerhold, J. Meeuwsen, T. Morita, M. Newton and M. Tsunozaki for behavior data analyses. This work was supported by National Institutes of Health grants AR059385 and DOD007123A (D.M.B.) and National Science Foundation Fellowships (S.R.W., L.T.). We thank the Neurobiology course at the Marine Biological Laboratory for pilot experiments.	Al-Daraji WI, 2002, J INVEST DERMATOL, V118, P779, DOI 10.1046/j.1523-1747.2002.01709.x; ALMERS W, 1985, FEBS LETT, V192, P13, DOI 10.1016/0014-5793(85)80033-8; Andoh T, 2001, J INVEST DERMATOL, V117, P1621, DOI 10.1046/j.0022-202x.2001.01585.x; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Bautista DM, 2013, ANNU REV PHYSIOL, V75, P181, DOI 10.1146/annurev-physiol-030212-183811; Bogiatzi SI, 2012, J ALLERGY CLIN IMMUN, V130, P233, DOI 10.1016/j.jaci.2012.04.038; Briot A, 2010, J INVEST DERMATOL, V130, P2736, DOI 10.1038/jid.2010.233; Briot A, 2009, J EXP MED, V206, P1135, DOI 10.1084/jem.20082242; Cahalan MD, 2009, NAT CELL BIOL, V11, P669, DOI 10.1038/ncb0609-669; Cevikbas F, 2007, CURR OPIN ALLERGY CL, V7, P365, DOI 10.1097/ACI.0b013e3282a644d2; Chang WC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029387; Dai Y, 2007, J CLIN INVEST, V117, P1979, DOI 10.1172/JCI30951; DeHaven WI, 2008, J BIOL CHEM, V283, P19265, DOI 10.1074/jbc.M801535200; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Feske S, 2010, PFLUG ARCH EUR J PHY, V460, P417, DOI 10.1007/s00424-009-0777-5; Fitzsimons C, 2001, INFLAMM RES, V50, pS100; Fogg MI, 2003, J ALLERGY CLIN IMMUN, V112, P796, DOI 10.1016/S0091-6749(03)01715-9; Gerhold KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055001; Gusarova GA, 2011, MOL CELL BIOL, V31, P3546, DOI 10.1128/MCB.05114-11; Gwack Y, 2007, CELL CALCIUM, V42, P145, DOI 10.1016/j.ceca.2007.03.007; Halfter UM, 2005, BIOCHEM J, V388, P17, DOI 10.1042/BJ20041236; He R, 2010, ANN NY ACAD SCI, V1183, P13, DOI 10.1111/j.1749-6632.2009.05128.x; Holgate ST, 2007, TRENDS IMMUNOL, V28, P248, DOI 10.1016/j.it.2007.04.007; Hovnanian A, 2013, CELL TISSUE RES, V351, P289, DOI 10.1007/s00441-013-1558-1; Ikoma A, 2003, ARCH DERMATOL, V139, P1455, DOI 10.1001/archderm.139.11.1455; Ikoma A, 2006, NAT REV NEUROSCI, V7, P535, DOI 10.1038/nrn1950; Imamachi N, 2009, P NATL ACAD SCI USA, V106, P11330, DOI 10.1073/pnas.0905605106; Jariwala SP, 2011, CLIN EXP ALLERGY, V41, P1515, DOI 10.1111/j.1365-2222.2011.03797.x; Jessup HK, 2008, J IMMUNOL, V181, P4311, DOI 10.4049/jimmunol.181.6.4311; Kanda N, 2005, J PHARMACOL EXP THER, V315, P796, DOI 10.1124/jpet.105.091645; Kouzaki H, 2009, J IMMUNOL, V183, P1427, DOI 10.4049/jimmunol.0900904; Lee CH, 2011, CURR PROBL DERMATOL, V41, P136, DOI 10.1159/000323307; Li M, 2005, P NATL ACAD SCI USA, V102, P14795, DOI 10.1073/pnas.0507385102; Lis A, 2007, CURR BIOL, V17, P794, DOI 10.1016/j.cub.2007.03.065; Liu BY, 2013, FASEB J, V27, P3549, DOI 10.1096/fj.13-229948; Liu Q, 2009, CELL, V139, P1353, DOI 10.1016/j.cell.2009.11.034; Locksley RM, 2010, CELL, V140, P777, DOI 10.1016/j.cell.2010.03.004; McCoy ES, 2013, NEURON, V78, P138, DOI 10.1016/j.neuron.2013.01.030; McCoy ES, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036355; Moniaga CS, 2013, AM J PATHOL, V182, P841, DOI 10.1016/j.ajpath.2012.11.039; Owsianik G, 2006, ANNU REV PHYSIOL, V68, P685, DOI 10.1146/annurev.physiol.68.040204.101406; Pandey A, 2000, NAT IMMUNOL, V1, P59, DOI 10.1038/76923; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; RAE J, 1991, J NEUROSCI METH, V37, P15, DOI 10.1016/0165-0270(91)90017-T; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Ross SE, 2011, CURR OPIN NEUROBIOL, V21, P880, DOI 10.1016/j.conb.2011.10.012; Schechter NM, 1998, J CELL PHYSIOL, V176, P365, DOI 10.1002/(SICI)1097-4652(199808)176:2<365::AID-JCP15>3.0.CO;2-2; Steinhoff M, 2003, J NEUROSCI, V23, P6176; TOBIN D, 1992, J ALLERGY CLIN IMMUN, V90, P613, DOI 10.1016/0091-6749(92)90134-N; Tominaga M, 2009, J DERMATOL SCI, V55, P40, DOI 10.1016/j.jdermsci.2009.03.007; Ui H, 2006, EUR J PHARMACOL, V530, P172, DOI 10.1016/j.ejphar.2005.11.021; Wilson SR, 2013, J NEUROSCI, V33, P9283, DOI 10.1523/JNEUROSCI.5318-12.2013; Wilson SR, 2011, NAT NEUROSCI, V14, P595, DOI 10.1038/nn.2789; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Ying S, 2005, J IMMUNOL, V174, P8183, DOI 10.4049/jimmunol.174.12.8183; Yoo J, 2005, J EXP MED, V202, P541, DOI 10.1084/jem.20041503; Zhang SYL, 2008, J BIOL CHEM, V283, P17662, DOI 10.1074/jbc.M801536200; Zhu Y, 2009, INT IMMUNOPHARMACOL, V9, P1332, DOI 10.1016/j.intimp.2009.08.006; Ziegler SF, 2013, ADV PHARMACOL, V66, P129, DOI 10.1016/B978-0-12-404717-4.00004-4	60	579	610	9	100	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 10	2013	155	2					285	295		10.1016/j.cell.2013.08.057	http://dx.doi.org/10.1016/j.cell.2013.08.057			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	235LH	24094650	Bronze, Green Accepted			2022-12-28	WOS:000325719800007
J	Bekelman, JE; Epstein, AJ; Emanuel, EJ				Bekelman, Justin E.; Epstein, Andrew J.; Emanuel, Ezekiel J.			Single- vs Multiple-Fraction Radiotherapy for Bone Metastases From Prostate Cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Bekelman, Justin E.] Univ Penn, Perelman Sch Med, Dept Radiat Oncol, Philadelphia, PA 19104 USA; [Epstein, Andrew J.] Philadelphia Vet Affairs Med Ctr, Ctr Hlth Equ Res & Promot, Philadelphia, PA USA; [Emanuel, Ezekiel J.] Univ Penn, Perelman Sch Med, Dept Med Eth & Hlth Policy, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Pennsylvania; Pennsylvania Medicine; Philadelphia Veterans Affairs Medical Center; University of Pennsylvania; Pennsylvania Medicine	Bekelman, JE (corresponding author), Univ Penn, Perelman Sch Med, 3400 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	bekelman@uphs.upenn.edu		Epstein, Andrew/0000-0001-5078-6564	NATIONAL CANCER INSTITUTE [K07CA163616] Funding Source: NIH RePORTER; NCI NIH HHS [K07 CA163616, K07-CA163616] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Brown ML, 2002, MED CARE, V40, P104; Elshaug AG, 2013, JAMA-J AM MED ASSOC, V309, P775, DOI 10.1001/jama.2013.828; Fairchild A, 2009, INT J RADIAT ONCOL, V75, P1501, DOI 10.1016/j.ijrobp.2008.12.084; Hartsell WF, 2005, JNCI-J NATL CANCER I, V97, P798, DOI 10.1093/jnci/dji139; POTOSKY AL, 1993, MED CARE, V31, P732; Sze WM, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD004721	6	69	69	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 9	2013	310	14					1501	1502		10.1001/jama.2013.277081	http://dx.doi.org/10.1001/jama.2013.277081			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	230PK	24104375	Green Accepted			2022-12-28	WOS:000325354100027
J	Spence, D				Spence, Des			Bad medicine: non-ST elevation myocardial infarction	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							POPULATION; DIAGNOSIS; TRENDS					destwo@yahoo.co.uk						Abbott JD, 2007, AM J CARDIOL, V100, P190, DOI 10.1016/j.amjcard.2007.02.083; Bassand JP, 2007, EUR HEART J, V28, P1598, DOI 10.1093/eurheartj/ehm161; Eggers KM, 2013, J AM COLL CARDIOL, V61, P1906, DOI 10.1016/j.jacc.2012.12.048; Enbergs A, 2000, EUR HEART J, V21, P45, DOI 10.1053/euhj.1999.1763; Irfan A, 2013, AM J MED, V126, P781, DOI 10.1016/j.amjmed.2013.02.031; Jennings SM, 2012, HEART, V98, P1285, DOI 10.1136/heartjnl-2012-301822; Moynihan R, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3502; Shave R, 2007, MED SCI SPORT EXER, V39, P2099, DOI 10.1249/mss.0b013e318153ff78; Tanindi A, 2011, VASC HEALTH RISK MAN, V7, P597, DOI 10.2147/VHRM.S24509; VANSTAA TP, 2013, HEART; Wu JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067611; Yeh RW, 2010, NEW ENGL J MED, V362, P2155, DOI 10.1056/NEJMoa0908610	12	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 9	2013	347								f5967	10.1136/bmj.f5967	http://dx.doi.org/10.1136/bmj.f5967			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	235ON	24108160				2022-12-28	WOS:000325729100008
J	Hoff, G; Bretthauer, M; Garborg, K; Eide, TJ				Hoff, Geir; Bretthauer, Michael; Garborg, Kjetil; Eide, Tor Jac			New polyps, old tricks: controversy about removing benign bowel lesions	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							OCCULT BLOOD-TEST; COLORECTAL-CANCER; SERRATED POLYPS; UNRESECTED POLYPS; RANDOMIZED-TRIAL; FOLLOW-UP; RISK; POLYPECTOMY; COLON; SURVEILLANCE		[Hoff, Geir] Telemark Hosp, Skien, Norway; [Hoff, Geir; Bretthauer, Michael; Eide, Tor Jac] Univ Oslo, N-0316 Oslo, Norway; [Bretthauer, Michael] Oslo Univ Hosp, Oslo, Norway; [Bretthauer, Michael; Garborg, Kjetil] Sorlandet Hosp, Kristiansand, Norway; [Bretthauer, Michael] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	Telemark Hospital Trust; University of Oslo; University of Oslo; Harvard University; Harvard T.H. Chan School of Public Health	Hoff, G (corresponding author), Telemark Hosp, Skien, Norway.	hofg@online.no		Garborg, Kjetil/0000-0002-5484-5995				ARTHUR JF, 1968, J CLIN PATHOL, V21, P735, DOI 10.1136/jcp.21.6.735; Atkin WS, 2012, ENDOSCOPY, V44, pSE151, DOI 10.1055/s-0032-1309821; Atkin WS, 2002, LANCET, V359, P1291, DOI 10.1016/s0140-6736(02)08268-5; BOND JH, 1993, ANN INTERN MED, V119, P836, DOI 10.7326/0003-4819-119-8-199310150-00010; Bretthauer M, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e2864; EIDE TJ, 1986, INT J CANCER, V38, P173, DOI 10.1002/ijc.2910380205; Elmunzer BJ, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001352; Ensari A, 2012, VIRCHOWS ARCH, V461, P495, DOI 10.1007/s00428-012-1319-7; Esmarch F, 1887, DTSCH CHIRURG; Gupta S, 2008, AM J MED SCI, V336, P407, DOI 10.1097/MAJ.0b013e31817d2402; Heldwein W, 2005, ENDOSCOPY, V37, P1116, DOI 10.1055/s-2005-870512; Hewitson P, 2008, AM J GASTROENTEROL, V103, P1541, DOI 10.1111/j.1572-0241.2008.01875.x; Hiraoka S, 2010, GASTROENTEROLOGY, V139, P1503, DOI 10.1053/j.gastro.2010.07.011; HOFF G, 1986, SCAND J GASTROENTERO, V21, P853, DOI 10.3109/00365528609011130; Hofstad B, 1996, GUT, V39, P449, DOI 10.1136/gut.39.3.449; Kahi CJ, 2012, GASTROINTEST ENDOSC, V75, P515, DOI 10.1016/j.gie.2011.08.021; KRONBORG O, 1983, SCAND J GASTROENTERO, V18, P1089, DOI 10.3109/00365528309181846; Lieberman DA, 2012, GASTROENTEROLOGY, V143, P844, DOI 10.1053/j.gastro.2012.06.001; MATEK W, 1985, ENDOSCOPY, V17, P175, DOI 10.1055/s-2007-1018494; Mori Y, 2013, ENDOSCOPY, V45, P98, DOI 10.1055/s-0032-1325932; Noffsinger AE, 2009, ANNU REV PATHOL-MECH, V4, P343, DOI 10.1146/annurev.pathol.4.110807.092317; Parente F, 2013, ENDOSCOPY, V45, P27, DOI 10.1055/s-0032-1325800; Rex DK, 2012, AM J GASTROENTEROL, V107, P1315, DOI 10.1038/ajg.2012.161; Rosty C, 2013, J GASTROENTEROL, V48, P287, DOI 10.1007/s00535-012-0720-y; Segnan N, 2005, JNCI-J NATL CANCER I, V97, P347, DOI 10.1093/jnci/dji050; Snover DC, 2010, WHO CLASSIFICATION T, P160; STRYKER SJ, 1987, GASTROENTEROLOGY, V93, P1009, DOI 10.1016/0016-5085(87)90563-4	27	8	8	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 8	2013	347								f5843	10.1136/bmj.f5843	http://dx.doi.org/10.1136/bmj.f5843			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	235OJ	24103540				2022-12-28	WOS:000325728600004
J	Kahan, DM				Kahan, Dan M.			A Risky Science Communication Environment for Vaccines	SCIENCE			English	Editorial Material							VACCINATION; HEALTH		Yale Univ, Sch Law, New Haven, CT 06520 USA	Yale University	Kahan, DM (corresponding author), Yale Univ, Sch Law, POB 20815, New Haven, CT 06520 USA.	dan.kahan@yale.edu						Black CL, 2013, MMWR-MORBID MORTAL W, V62, P733; CDC, 2005, MMWR-MORBID MORTAL W, V54, pRR; Colgrove J, 2006, NEW ENGL J MED, V355, P2389, DOI 10.1056/NEJMp068248; Curtis CR, 2013, MMWR-MORBID MORTAL W, V62, P685; Darling N., 2008, Morbidity and Mortality Weekly Report, V57, P961; Devorak P., 2011, WASHINGTON POST; Frank A., 2013, NEW YORK TIMES  0821, pA27; Gollust SE, 2010, HEALTH AFFAIR, V29, P2041, DOI 10.1377/hlthaff.2010.0174; Gostin LO, 2007, JAMA-J AM MED ASSOC, V297, P1921, DOI 10.1001/jama.297.17.1921; HERSHEY JC, 1994, ORGAN BEHAV HUM DEC, V59, P177, DOI 10.1006/obhd.1994.1055; Kahan DM, 2012, NAT CLIM CHANGE, V2, P732, DOI 10.1038/NCLIMATE1547; Kahan DM, 2010, LAW HUMAN BEHAV, V34, P501, DOI 10.1007/s10979-009-9201-0; Lanska DJ, 1998, J PUBLIC HEALTH POL, V19, P160, DOI 10.2307/3343296; National Public Radio, 2011, TALK OF THE NATION; Slovic P., 2010, THE FEELING OF RISK	15	83	83	1	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 4	2013	342	6154					53	54		10.1126/science.1245724	http://dx.doi.org/10.1126/science.1245724			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	227PP	24092722				2022-12-28	WOS:000325126100040
J	Morriswood, B; Warren, G				Morriswood, Brooke; Warren, Graham			Stalemate in the Golgi Battle	SCIENCE			English	Editorial Material									Univ Vienna, A-1010 Vienna, Austria	University of Vienna		graham.warren@mfpl.ac.at	Morriswood, Brooke/AAY-9714-2020	Morriswood, Brooke/0000-0001-7031-3801				Glick BS, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005215; Lavieu G, 2013, ELIFE, V2, DOI 10.7554/eLife.00558; Losev E, 2006, NATURE, V441, P1002, DOI 10.1038/nature04717; Matsuura-Tokita K, 2006, NATURE, V441, P1007, DOI 10.1038/nature04737; Nakamura N, 2012, CURR OPIN CELL BIOL, V24, P467, DOI 10.1016/j.ceb.2012.05.009; Pfeffer SR, 2010, P NATL ACAD SCI USA, V107, P19614, DOI 10.1073/pnas.1011016107; Rivera VM, 2000, SCIENCE, V287, P826, DOI 10.1126/science.287.5454.826; Rizzo R, 2013, J CELL BIOL, V201, P1027, DOI 10.1083/jcb.201211147; Rollins CT, 2000, P NATL ACAD SCI USA, V97, P7096, DOI 10.1073/pnas.100101997	9	9	9	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 27	2013	341	6153					1465	1466		10.1126/science.1245656	http://dx.doi.org/10.1126/science.1245656			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	224NS	24051247				2022-12-28	WOS:000324894600038
J	Zhang, XZ; Wan, CH; Gao, XL; Wang, JM; Tan, XY				Zhang, X. Z.; Wan, C. H.; Gao, X. L.; Wang, J. M.; Tan, X. Y.			Low-voltage magnetoresistance in silicon Reply	NATURE			English	Letter									[Zhang, X. Z.; Wan, C. H.; Gao, X. L.; Wang, J. M.; Tan, X. Y.] Tsinghua Univ, Dept Mat Sci & Engn, Adv Mat Lab, Beijing 100084, Peoples R China; [Zhang, X. Z.; Wan, C. H.; Gao, X. L.; Wang, J. M.; Tan, X. Y.] Tsinghua Univ, Beijing Natl Ctr Electron Microscopy, Beijing 100084, Peoples R China	Tsinghua University; Tsinghua University	Zhang, XZ (corresponding author), Tsinghua Univ, Dept Mat Sci & Engn, Adv Mat Lab, Beijing 100084, Peoples R China.	xzzhang@tsinghua.edu.cn	Wan, Caihua/AAU-6980-2020					Baker DR, 1999, PHYS REV B, V59, P13927, DOI 10.1103/PhysRevB.59.13927; Hu JS, 2008, NAT MATER, V7, P697, DOI 10.1038/nmat2259; Luo J, 2013, NATURE, V501, pE1, DOI 10.1038/nature12589; Parish MM, 2003, NATURE, V426, P162, DOI 10.1038/nature02073; Wan CH, 2011, NATURE, V477, P304, DOI 10.1038/nature10375	5	1	1	2	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 26	2013	501	7468					E1	E2		10.1038/nature12590	http://dx.doi.org/10.1038/nature12590			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223RP	24067717				2022-12-28	WOS:000324826300017
J	Yang, YP; Muzny, DM; Reid, JG; Bainbridge, MN; Willis, A; Ward, PA; Braxton, A; Beuten, J; Xia, F; Niu, ZY; Hardison, M; Person, R; Bekheirnia, MR; Leduc, MS; Kirby, A; Pham, P; Scull, J; Wang, M; Ding, Y; Plon, SE; Lupski, JR; Beaudet, AL; Gibbs, RA; Eng, CM				Yang, Yaping; Muzny, Donna M.; Reid, Jeffrey G.; Bainbridge, Matthew N.; Willis, Alecia; Ward, Patricia A.; Braxton, Alicia; Beuten, Joke; Xia, Fan; Niu, Zhiyv; Hardison, Matthew; Person, Richard; Bekheirnia, Mir Reza; Leduc, Magalie S.; Kirby, Amelia; Peter Pham; Scull, Jennifer; Wang, Min; Ding, Yan; Plon, Sharon E.; Lupski, James R.; Beaudet, Arthur L.; Gibbs, Richard A.; Eng, Christine M.			Clinical Whole-Exome Sequencing for the Diagnosis of Mendelian Disorders	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CHROMATIN-REMODELING COMPLEX; ACMG RECOMMENDATIONS; DEVELOPMENTAL DELAY; HUMAN GENOME; MUTATIONS; MICROARRAY; STANDARDS; DATABASE; HEALTH; ARID1B	BackgroundWhole-exome sequencing is a diagnostic approach for the identification of molecular defects in patients with suspected genetic disorders. MethodsWe developed technical, bioinformatic, interpretive, and validation pipelines for whole-exome sequencing in a certified clinical laboratory to identify sequence variants underlying disease phenotypes in patients. ResultsWe present data on the first 250 probands for whom referring physicians ordered whole-exome sequencing. Patients presented with a range of phenotypes suggesting potential genetic causes. Approximately 80% were children with neurologic phenotypes. Insurance coverage was similar to that for established genetic tests. We identified 86 mutated alleles that were highly likely to be causative in 62 of the 250 patients, achieving a 25% molecular diagnostic rate (95% confidence interval, 20 to 31). Among the 62 patients, 33 had autosomal dominant disease, 16 had autosomal recessive disease, and 9 had X-linked disease. A total of 4 probands received two nonoverlapping molecular diagnoses, which potentially challenged the clinical diagnosis that had been made on the basis of history and physical examination. A total of 83% of the autosomal dominant mutant alleles and 40% of the X-linked mutant alleles occurred de novo. Recurrent clinical phenotypes occurred in patients with mutations that were highly likely to be causative in the same genes and in different genes responsible for genetically heterogeneous disorders. ConclusionsWhole-exome sequencing identified the underlying genetic defect in 25% of consecutive patients referred for evaluation of a possible genetic condition. (Funded by the National Human Genome Research Institute.)	[Yang, Yaping; Willis, Alecia; Ward, Patricia A.; Braxton, Alicia; Beuten, Joke; Xia, Fan; Niu, Zhiyv; Hardison, Matthew; Person, Richard; Bekheirnia, Mir Reza; Leduc, Magalie S.; Kirby, Amelia; Scull, Jennifer; Plon, Sharon E.; Lupski, James R.; Beaudet, Arthur L.; Eng, Christine M.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Plon, Sharon E.; Lupski, James R.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Muzny, Donna M.; Reid, Jeffrey G.; Bainbridge, Matthew N.; Peter Pham; Wang, Min; Ding, Yan; Lupski, James R.; Gibbs, Richard A.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Eng, CM (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, NAB 2015, Houston, TX 77030 USA.	ceng@bcm.edu	niu, zhiyv/A-6558-2009; Leduc, Magalie/R-9884-2019; Pinheiro, Maísa/E-7424-2012		National Human Genome Research Institute; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003273, U01HG006485] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K12DK083014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007526] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funded by the National Human Genome Research Institute.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Bainbridge MN, 2013, GENOME MED, V5, DOI 10.1186/gm415; Bainbridge MN, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-7-r68; Bainbridge MN, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002243; BAIRD PA, 1988, AM J HUM GENET, V42, P677; Boone PM, 2010, HUM MUTAT, V31, P1326, DOI 10.1002/humu.21360; Cheung SW, 2005, GENET MED, V7, P422, DOI 10.1097/01.GIM.0000170992.63691.32; de Ligt J, 2012, NEW ENGL J MED, V367, P1921, DOI 10.1056/NEJMoa1206524; Deardorff MA, 2012, NATURE, V489, P313, DOI 10.1038/nature11316; Gahl WA, 2012, GENET MED, V14, P51, DOI 10.1038/gim.0b013e318232a005; Gonzaga-Jauregui C, 2012, ANNU REV MED, V63, P35, DOI 10.1146/annurev-med-051010-162644; Green RC, 2013, GENET MED, V15, P565, DOI 10.1038/gim.2013.73; Hamdan FF, 2009, NEW ENGL J MED, V360, P599, DOI 10.1056/NEJMoa0805392; Hoyer J, 2012, AM J HUM GENET, V90, P565, DOI 10.1016/j.ajhg.2012.02.007; Kohane IS, 2012, GENET MED, V14, P399, DOI 10.1038/gim.2011.68; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu XM, 2011, HUM MUTAT, V32, P894, DOI 10.1002/humu.21517; Lupski JR, 2013, GENOME MED, V5, DOI 10.1186/gm461; Lupski JR, 2010, NEW ENGL J MED, V362, P1181, DOI 10.1056/NEJMoa0908094; March of Dimes Birth Defects Foundation, 2006, GLOB REP BIRTH DEF H; Miller DT, 2010, AM J HUM GENET, V86, P749, DOI 10.1016/j.ajhg.2010.04.006; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Pletcher BA, 2008, GENET MED, V10, P33, DOI [10.1097/GIM.0b013e31815f6eac, 10.1097/GIM.0b013e31815f247c]; Rauch A, 2012, LANCET, V380, P1674, DOI 10.1016/S0140-6736(12)61480-9; Richards CS, 2008, GENET MED, V10, P294, DOI 10.1097/GIM.0b013e31816b5cae; Santen GWE, 2012, NAT GENET, V44, P379, DOI 10.1038/ng.2217; Shaffer LG, 2005, GENET MED, V7, P650, DOI 10.1097/01.gim.0000186545.83160.1e; Shen YF, 2010, GENOME RES, V20, P273, DOI 10.1101/gr.096388.109; Shevell M, 2003, NEUROLOGY, V60, P367, DOI 10.1212/01.WNL.0000031431.81555.16; Stankiewicz P, 2010, ANNU REV MED, V61, P437, DOI 10.1146/annurev-med-100708-204735; Stenson PD, 2009, GENOME MED, V1, DOI 10.1186/gm13; Tarpey PS, 2009, NAT GENET, V41, P535, DOI 10.1038/ng.367; Tidyman WE, 2009, CURR OPIN GENET DEV, V19, P230, DOI 10.1016/j.gde.2009.04.001; Tsurusaki Y, 2012, NAT GENET, V44, P376, DOI 10.1038/ng.2219; Vissers LELM, 2010, NAT GENET, V42, P1109, DOI 10.1038/ng.712	35	1306	1368	5	143	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 17	2013	369	16					1502	1511		10.1056/NEJMoa1306555	http://dx.doi.org/10.1056/NEJMoa1306555			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	267MJ	24088041	Green Accepted, Bronze			2022-12-28	WOS:000328101700007
J	He, GB; Dhar, D; Nakagawa, H; Font-Burgada, J; Ogata, H; Jiang, YH; Shalapour, S; Seki, E; Yost, SE; Jepsen, K; Frazer, KA; Harismendy, O; Hatziapostolou, M; Iliopoulos, D; Suetsugu, A; Hoffman, RM; Tateishi, R; Koike, K; Karin, M				He, Guobin; Dhar, Debanjan; Nakagawa, Hayato; Font-Burgada, Joan; Ogata, Hisanobu; Jiang, Yuhong; Shalapour, Shabnam; Seki, Ekihiro; Yost, Shawn E.; Jepsen, Kristen; Frazer, Kelly A.; Harismendy, Olivier; Hatziapostolou, Maria; Iliopoulos, Dimitrios; Suetsugu, Atsushi; Hoffman, Robert M.; Tateishi, Ryosuke; Koike, Kazuhiko; Karin, Michael			Identification of Liver Cancer Progenitors Whose Malignant Progression Depends on Autocrine IL-6 Signaling	CELL			English	Article							DISEASED MOUSE-LIVER; HEPATOCELLULAR-CARCINOMA; STEM-CELLS; MET RECEPTOR; INTERLEUKIN-6; HEPATOCYTES; EXPRESSION; HEPATOCARCINOGENESIS; TRANSPLANTATION; CIRRHOSIS	Hepatocellular carcinoma (HCC) is a slowly developing malignancy postulated to evolve from premalignant lesions in chronically damaged livers. However, it was never established that premalignant lesions actually contain tumor progenitors that give rise to cancer. Here, we describe isolation and characterization of HCC progenitor cells (HcPCs) from different mouse HCC models. Unlike fully malignant HCC, HcPCs give rise to cancer only when introduced into a liver undergoing chronic damage and compensatory proliferation. Although HcPCs exhibit a similar transcriptomic profile to bipotential hepatobiliary progenitors, the latter do not give rise to tumors. Cells resembling HcPCs reside within dysplastic lesions that appear several months before HCC nodules. Unlike early hepatocarcinogenesis, which depends on paracrine IL-6 production by inflammatory cells, due to upregulation of LIN28 expression, HcPCs had acquired autocrine IL-6 signaling that stimulates their in vivo growth and malignant progression. This may be a general mechanism that drives other IL-6-producing malignancies.	[He, Guobin; Dhar, Debanjan; Nakagawa, Hayato; Font-Burgada, Joan; Ogata, Hisanobu; Jiang, Yuhong; Shalapour, Shabnam; Karin, Michael] Univ Calif San Diego, Sch Med, Dept Pharmacol, Lab Gene Regulat & Signal Transduct, San Diego, CA 92093 USA; [He, Guobin; Dhar, Debanjan; Nakagawa, Hayato; Font-Burgada, Joan; Ogata, Hisanobu; Jiang, Yuhong; Shalapour, Shabnam; Karin, Michael] Univ Calif San Diego, Sch Med, Dept Pathol, Lab Gene Regulat & Signal Transduct, San Diego, CA 92093 USA; [Seki, Ekihiro] Univ Calif San Diego, Sch Med, Dept Med, San Diego, CA 92093 USA; [Suetsugu, Atsushi; Hoffman, Robert M.] Univ Calif San Diego, Sch Med, Dept Surg, San Diego, CA 92093 USA; [Yost, Shawn E.] Univ Calif San Diego, Sch Med, Bioinformat Grad Program, San Diego, CA 92093 USA; [Yost, Shawn E.; Jepsen, Kristen; Frazer, Kelly A.; Harismendy, Olivier] Univ Calif San Diego, Sch Med, Radys Childrens Hosp, San Diego, CA 92093 USA; [Yost, Shawn E.; Jepsen, Kristen; Frazer, Kelly A.; Harismendy, Olivier] Univ Calif San Diego, Sch Med, Dept Pediat, San Diego, CA 92093 USA; [Frazer, Kelly A.; Harismendy, Olivier; Karin, Michael] Univ Calif San Diego, Sch Med, Moores UCSD Canc Ctr, San Diego, CA 92093 USA; [Frazer, Kelly A.; Harismendy, Olivier] Univ Calif San Diego, Sch Med, Clin & Translat Res Inst, San Diego, CA 92093 USA; [Frazer, Kelly A.] Univ Calif San Diego, Sch Med, Inst Genom Med, San Diego, CA 92093 USA; [Hatziapostolou, Maria; Iliopoulos, Dimitrios] Univ Calif Los Angeles, Ctr Syst Biomed, Div Digest Dis, Los Angeles, CA 90095 USA; [Hatziapostolou, Maria; Iliopoulos, Dimitrios] Univ Calif Los Angeles, David Geffen Sch Med, Inst Mol Med, Los Angeles, CA 90095 USA; [Suetsugu, Atsushi; Hoffman, Robert M.] AntiCancer Inc, San Diego, CA 92111 USA; [Nakagawa, Hayato; Tateishi, Ryosuke; Koike, Kazuhiko] Univ Tokyo, Dept Gastroenterol, Tokyo 1138655, Japan; [Ogata, Hisanobu] Kyushu Univ, Grad Sch Med Sci, Dept Med & Clin Sci, Fukuoka 8128582, Japan	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Anti Cancer Inc; University of Tokyo; Kyushu University	Karin, M (corresponding author), Univ Calif San Diego, Sch Med, Dept Pharmacol, Lab Gene Regulat & Signal Transduct, 9500 Gilman Dr, San Diego, CA 92093 USA.	karinoffice@ucsd.edu	Dhar, Debanjan/P-3072-2015; Iliopoulos, Dimitrios/AAE-9106-2019; Harismendy, Olivier/AAM-2072-2021; Tateishi, Ryosuke/G-7758-2014; Hatziapostolou, Maria/N-1820-2015; Nakagawa, Hayato/I-2837-2012; Seki, Ekihiro/K-2481-2016	Harismendy, Olivier/0000-0002-8098-9888; Tateishi, Ryosuke/0000-0003-3021-2517; Hatziapostolou, Maria/0000-0003-2493-7028; Nakagawa, Hayato/0000-0002-6973-5094; Seki, Ekihiro/0000-0002-9472-6085; Yost, Shawn/0000-0001-6653-1056; Frazer, Kelly/0000-0002-6060-8902	Superfund Basic Research Program [P42ES010337]; NIH [CA118165, CA155120]; Wellcome Trust [WT086755]; American Diabetes Association [7-08-MN-29]; Center for Translational Science [UL1RR031980, UL1TR000100]; National Center for Research Resources IMAT program [N12R1CA155615]; Damon Runyon Cancer Research Foundation; American Liver Foundation; Daiichi Sankyo Foundation of Life Science; California Institute for Regenerative Medicine Stem Cell Training Grant II [TG2-01154]; Kanzawa Medical Research Foundation; German Research Foundation (DFG) [SH721/1-1]; National Childhood Cancer Foundation; Ben and Wanda Hildyard Chair for Mitochondrial and Metabolic Diseases; NATIONAL CANCER INSTITUTE [P30CA023100, R01CA155120, R01CA118165, R21CA155615] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000100] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR031980] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES010337] Funding Source: NIH RePORTER	Superfund Basic Research Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); American Diabetes Association(American Diabetes Association); Center for Translational Science; National Center for Research Resources IMAT program; Damon Runyon Cancer Research Foundation; American Liver Foundation; Daiichi Sankyo Foundation of Life Science; California Institute for Regenerative Medicine Stem Cell Training Grant II; Kanzawa Medical Research Foundation(Kanzawa Medical Research Foundation); German Research Foundation (DFG)(German Research Foundation (DFG)); National Childhood Cancer Foundation; Ben and Wanda Hildyard Chair for Mitochondrial and Metabolic Diseases; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We acknowledge the Biogem facility at UCSD for their assistance with transcriptome analysis and A. Arian, K. Iwaisako, Y. Hiroshima, and H. Matsui for technical assistance. We thank Dr. J. Hidalgo (Universitat Autonoma de Barcelona, Spain) for the Il6<SUP>F/F</SUP> mice. Research was supported by the Superfund Basic Research Program (P42ES010337), NIH (CA118165 and CA155120), Wellcome Trust (WT086755), American Diabetes Association (7-08-MN-29), the Center for Translational Science (UL1RR031980 and UL1TR000100), the National Center for Research Resources IMAT program (N12R1CA155615), and postdoctoral research fellowships from the Damon Runyon Cancer Research Foundation (G.H.), American Liver Foundation (D.D.), Daiichi Sankyo Foundation of Life Science (H.N.), California Institute for Regenerative Medicine Stem Cell Training Grant II (TG2-01154) fellowship (J.F.-B.), Kanzawa Medical Research Foundation (H.O.), the German Research Foundation (DFG, SH721/1-1 to S.S.), and a Young Investigator Award from the National Childhood Cancer Foundation, "CureSearch" (D.D.). M.K. is an ACS Research Professor and is a recipient of the Ben and Wanda Hildyard Chair for Mitochondrial and Metabolic Diseases.	BANNASCH P, 1984, J CANCER RES CLIN, V108, P11, DOI 10.1007/BF00390968; BLADT F, 1995, NATURE, V376, P768, DOI 10.1038/376768a0; DEVIERE J, 1989, CLIN EXP IMMUNOL, V77, P221; Dorrell C, 2011, GENE DEV, V25, P1193, DOI 10.1101/gad.2029411; Duncan AW, 2009, GASTROENTEROLOGY, V137, P466, DOI 10.1053/j.gastro.2009.05.044; Eferl R, 2003, CELL, V112, P181, DOI 10.1016/S0092-8674(03)00042-4; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; Grivennikov S, 2008, CANCER CELL, V13, P7, DOI 10.1016/j.ccr.2007.12.020; Gu DQ, 2002, TRANSPLANTATION, V73, P1818, DOI 10.1097/00007890-200206150-00020; Guichard C, 2012, NAT GENET, V44, P694, DOI 10.1038/ng.2256; Guo XD, 2012, DIAGN PATHOL, V7, DOI 10.1186/1746-1596-7-44; Haridass D, 2009, AM J PATHOL, V175, P1483, DOI 10.2353/ajpath.2009.090117; Hatziapostolou M, 2011, CELL, V147, P1233, DOI 10.1016/j.cell.2011.10.043; He GB, 2010, CANCER CELL, V17, P286, DOI 10.1016/j.ccr.2009.12.048; Hruban RH, 2007, GASTROENTEROL CLIN N, V36, P831, DOI 10.1016/j.gtc.2007.08.012; Hydroglou P, 2007, GASTROENTEROL CLIN N, V36, P867, DOI 10.1016/j.gtc.2007.08.010; Ichinohe N, 2012, CELL TRANSPLANT, V21, P11, DOI 10.3727/096368911X580626; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; Inokuchi S, 2010, P NATL ACAD SCI USA, V107, P844, DOI 10.1073/pnas.0909781107; Ji JF, 2009, NEW ENGL J MED, V361, P1437, DOI 10.1056/NEJMoa0901282; KAKUMU S, 1993, GASTROENTEROL JPN, V28, P18; Kang JS, 2007, CANCER RES, V67, P11141, DOI 10.1158/0008-5472.CAN-07-1369; Laconi E, 1998, AM J PATHOL, V153, P319, DOI 10.1016/S0002-9440(10)65574-5; Maeda S, 2005, CELL, V121, P977, DOI 10.1016/j.cell.2005.04.014; Marquardt JU, 2010, SEMIN LIVER DIS, V30, P26, DOI 10.1055/s-0030-1247130; Meyer K, 2003, CARCINOGENESIS, V24, P975, DOI 10.1093/carcin/bgg040; Mikhail S, 2011, INT J HEPATOL, V2011, DOI 10.4061/2011/486954; Naugler WE, 2007, SCIENCE, V317, P121, DOI 10.1126/science.1140485; Nguyen LV, 2012, NAT REV CANCER, V12, P133, DOI 10.1038/nrc3184; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Park EJ, 2010, CELL, V140, P197, DOI 10.1016/j.cell.2009.12.052; PITOT HC, 1990, ANNU REV PHARMACOL, V30, P465; Porta C, 2008, ANN ONCOL, V19, P353, DOI 10.1093/annonc/mdm448; Quintana A, 2013, BRAIN BEHAV IMMUN, V27, P162, DOI 10.1016/j.bbi.2012.10.011; RHIM JA, 1994, SCIENCE, V263, P1149, DOI 10.1126/science.8108734; Sansone P, 2007, J CLIN INVEST, V117, P3988, DOI 10.1172/JCI32533; Seki S, 2000, CLIN CANCER RES, V6, P3469; Sell S, 2008, J CLIN ONCOL, V26, P2800, DOI 10.1200/JCO.2007.15.5945; Shin S, 2011, GENE DEV, V25, P1185, DOI 10.1101/gad.2027811; Soresi M, 2006, WORLD J GASTROENTERO, V12, P2563, DOI 10.3748/wjg.v12.i16.2563; Su Q, 1997, VIRCHOWS ARCH, V431, P391, DOI 10.1007/s004280050116; SU Y, 1990, BIOCHEM BIOPH RES CO, V170, P892, DOI 10.1016/0006-291X(90)92175-Y; TAKAYAMA T, 1990, LANCET, V336, P1150, DOI 10.1016/0140-6736(90)92768-D; Terris B, 2010, J HEPATOL, V52, P280, DOI 10.1016/j.jhep.2009.10.026; TSUTSUMI M, 1989, HEPATOLOGY, V10, P437, DOI 10.1002/hep.1840100407; Verna L, 1996, PHARMACOL THERAPEUT, V71, P57, DOI 10.1016/0163-7258(96)00062-9; Viswanathan SR, 2010, CELL, V140, P445, DOI 10.1016/j.cell.2010.02.007; Wang R, 2001, J CELL BIOL, V153, P1023, DOI 10.1083/jcb.153.5.1023; Weglarz TC, 2000, AM J PATHOL, V157, P1963, DOI 10.1016/S0002-9440(10)64835-3; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Yamashita T, 2008, CANCER RES, V68, P1451, DOI 10.1158/0008-5472.CAN-07-6013; Yang ZF, 2008, CANCER CELL, V13, P153, DOI 10.1016/j.ccr.2008.01.013; Zheng TS, 2011, CANCER LETT, V302, P91, DOI 10.1016/j.canlet.2010.12.008; Zhu Z, 2010, INT J CANCER, V126, P2067, DOI 10.1002/ijc.24868; Zoller M, 2009, NAT REV CANCER, V9, P40, DOI 10.1038/nrc2543	55	318	344	1	76	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 10	2013	155	2					384	396		10.1016/j.cell.2013.09.031	http://dx.doi.org/10.1016/j.cell.2013.09.031			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	235LH	24120137	Green Accepted, Bronze			2022-12-28	WOS:000325719800015
J	Kamerow, D				Kamerow, Douglas			YANKEE DOODLING Regulating medical apps: which ones and how much?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									RTI Int, Res Triangle Pk, NC 27709 USA	Research Triangle Institute	Kamerow, D (corresponding author), RTI Int, Res Triangle Pk, NC 27709 USA.	dkamerow@rti.org		Kamerow, Douglas/0000-0001-7000-9957				Abroms LC, 2011, AM J PREV MED, V40, P279, DOI 10.1016/j.amepre.2010.10.032; Associated Press, 2013, WASHINGTON POST; R-G Jahns, 2013, RESEARCH2GUIDAN 0307; Tavemise Sabrina, 2013, NY TIMES, pA12; US Food and Drug Administration, 2018, APPROVAL PACKAGE APP	5	18	18	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 8	2013	347								f6009	10.1136/bmj.f6009	http://dx.doi.org/10.1136/bmj.f6009			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	235OJ	24103694				2022-12-28	WOS:000325728600007
J	Evans, JA				Evans, James A.			Future Science	SCIENCE			English	Editorial Material									Univ Chicago, Dept Sociol, Chicago, IL 60637 USA	University of Chicago	Evans, JA (corresponding author), Univ Chicago, Dept Sociol, Chicago, IL 60637 USA.	jevans@uchicago.edu			Direct For Social, Behav & Economic Scie [0915730] Funding Source: National Science Foundation	Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))		Acuna DE, 2012, NATURE, V489, P201, DOI 10.1038/489201a; Arbesman S, 2012, HALF LIFE FACTS WHY; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bianconi G, 2001, EUROPHYS LETT, V54, P436, DOI 10.1209/epl/i2001-00260-6; Evans J, 2010, SCIENCE, V329, P399, DOI 10.1126/science.1189416; Evans JA, 2011, SCIENCE, V331, P721, DOI 10.1126/science.1201765; Jones BF, 2009, REV ECON STUD, V76, P283, DOI 10.1111/j.1467-937X.2008.00531.x; King RD, 2009, SCIENCE, V324, P85, DOI 10.1126/science.1165620; Lane J, 2009, SCIENCE, V324, P1273, DOI 10.1126/science.1175335; Newman MEJ, 2009, EPL-EUROPHYS LETT, V86, DOI 10.1209/0295-5075/86/68001; Stringer MJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001683; Wang DS, 2013, SCIENCE, V342, P127, DOI 10.1126/science.1237825	12	13	13	2	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 4	2013	342	6154					44	45		10.1126/science.1245218	http://dx.doi.org/10.1126/science.1245218			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	227PP	24092715				2022-12-28	WOS:000325126100033
J	Hurley, R				Hurley, Richard			MEDICINE AND THE MEDIA Are new technologies in infertility treatment always good news?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												rhurley@bmj.com						[Anonymous], 2013, BBC RADIO 4     0925; Borland F, 2013, DAILY MAIL; Campbell A, 2013, REPROD BIOMED ONLINE, V27, P140, DOI 10.1016/j.rbmo.2013.04.013; Devlin H, 2013, TIMES; Donnelly L., 2013, DAILY TELEGRAPH; Human Fertilisation and Embryology Authority, LAT UK IVF FIG 2010; Johnson J, 2013, DAILY MAIL; Liverpool Women's NHS Foundation Trust, 2013, LIV WOM BEC 1 EUR OF; Macklon NS, 2013, TIMES; Mastenbroek S, 2007, NEW ENGL J MED, V357, P9, DOI 10.1056/NEJMoa067744; National Institute for Health and Care Excellence, 2013, CG156 NICE; Science Media Centre, 2013, EXP REACT NEW IVF ST	12	2	2	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 4	2013	347								f6004	10.1136/bmj.f6004	http://dx.doi.org/10.1136/bmj.f6004			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	231PN	24097131				2022-12-28	WOS:000325429300008
J	de Groot, M; Kollen, BJ				de Groot, Marieke; Kollen, Boudewijn J.			Course of bereavement over 8-10 years in first degree relatives and spouses of people who committed suicide: longitudinal community based cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RANDOMIZED CONTROLLED-TRIAL; PREVENT COMPLICATED GRIEF; TRAUMATIC GRIEF; BEHAVIOR; THERAPY; RISK; NEUROTICISM; DISORDERS; SURVIVORS; IDEATION	Objective To identify factors predicting the long term course of complicated grief, depression, and suicide ideation in a community based sample of relatives bereaved through suicide. Design Longitudinal cohort study. Included in the multilevel regression models were sociodemographic and personality features, mental health history, records of received help, long term complicated grief, depression, and suicide ideation. Setting Community based sample located in the northern part of the Netherlands. Participants 153 first degree relatives and spouses of 74 people who had committed suicide. Main outcome measures Complicated grief, depression, and suicide ideation assessed at 2.5 months, 13 months and 96-120 months (8-10 years) by means of self report questionnaires. Results Complicated grief, depression, and suicide ideation were mutually associated in relatives and spouses of people who had committed suicide. A history of attempted suicide was associated with long term suicide ideation (odds ratio 5.5, 95% confidence interval 1.8 to 16.7; P=0.003). Depression was more likely to be predicted by female sex and low mastery, whereas complicated grief was more likely to be predicted by the trauma of losing a child. The risk of both complicated grief and depression decreased over time; for complicated grief the change corresponded with a Cohen's d effect size of 0.36 at 13 months and 0.89 at 96-120 months; for depression these figures were 0.28 at 13 months and 0.94 at 96-120 months. The long term course of bereavement was not affected by family based cognitive behavioural therapy, support from a general practitioner, and/or mental healthcare. Mutual support was associated with an increased risk of complicated grief: B regression coefficient=6.4 (95% confidence interval 1.8 to 11.0; P=0.006). Throughout this long term study, selection bias might have affected some outcomes. Conclusion In relatives bereaved by suicide, suicide ideation is associated with an increased risk of long term complicated grief and depression. The risk of complicated grief and depression decreases over time. Although mutual support is associated with an increased risk of complicated grief, we could not draw conclusions about a causal relation.	[de Groot, Marieke] Univ Groningen, Univ Med Ctr Groningen, NL-9700 RB Groningen, Netherlands; [Kollen, Boudewijn J.] Univ Groningen, Univ Med Ctr Groningen, Dept Gen Practice Med, NL-9700 RB Groningen, Netherlands; [de Groot, Marieke] Vrije Univ Amsterdam, NL-1081 BT Amsterdam, Netherlands; [de Groot, Marieke] EMGO Inst Heath & Care Res, Amsterdam, Netherlands	University of Groningen; University of Groningen; Vrije Universiteit Amsterdam	de Groot, M (corresponding author), Univ Groningen, Univ Med Ctr Groningen, POB 30-001, NL-9700 RB Groningen, Netherlands.	m.h.de.groot@med.umcg.nl			ZONMW (Netherlands Organisation for Health Research and Development) [60-60100-98-052]	ZONMW (Netherlands Organisation for Health Research and Development)(Netherlands Organization for Health Research and Development)	This study was funded by ZONMW (Netherlands Organisation for Health Research and Development) No 60-60100-98-052.	Agerbo E, 2005, J EPIDEMIOL COMMUN H, V59, P407, DOI 10.1136/jech.2004.024950; Bernal M, 2007, J AFFECT DISORDERS, V101, P27, DOI 10.1016/j.jad.2006.09.018; Boelen PA, 2003, DEATH STUD, V27, P227, DOI 10.1080/07481180302889; Boelen PA, 2006, BEHAV RES THER, V44, P1657, DOI 10.1016/j.brat.2005.12.006; Boelen PA, 2006, CLIN PSYCHOL-SCI PR, V13, P109, DOI 10.1111/j.1468-2850.2006.00013.x; Brown GK, 2005, JAMA-J AM MED ASSOC, V294, P563, DOI 10.1001/jama.294.5.563; Cerel J, 2009, SUICIDE LIFE-THREAT, V39, P269, DOI 10.1521/suli.2009.39.3.269; De Groot MH, 2006, SUICIDE LIFE-THREAT, V36, P418, DOI 10.1521/suli.2006.36.4.418; de Groot M, 2007, BMJ-BRIT MED J, V334, P994, DOI 10.1136/bmj.39161.457431.55; de Groot M, 2010, SUICIDE LIFE-THREAT, V40, P425, DOI 10.1521/suli.2010.40.5.425; de Groot M, 2009, FAM PRACT, V26, P372, DOI 10.1093/fampra/cmp046; Ellis TE, 2008, INT J COGN THER, V1, P47, DOI 10.1680/ijct.2008.1.1.47; EYSENCK SBG, 1964, LIFE SCI, V3, P1103, DOI 10.1016/0024-3205(64)90125-0; Gopinath S, 2007, J AFFECT DISORDERS, V101, P57, DOI 10.1016/j.jad.2006.10.023; Hawton K, 2009, LANCET, V373, P1372, DOI 10.1016/S0140-6736(09)60372-X; Kissane DW, 1996, AM J PSYCHIAT, V153, P650; Lichtenthal WG, 2004, CLIN PSYCHOL REV, V24, P637, DOI 10.1016/j.cpr.2004.07.002; Mann JJ, 1999, AM J PSYCHIAT, V156, P181; McDaid C, 2008, BRIT J PSYCHIAT, V193, P438, DOI 10.1192/bjp.bp.107.040824; McMenamy JM, 2008, SUICIDE LIFE-THREAT, V38, P375, DOI 10.1521/suli.2008.38.4.375; Middel Berrie, 2002, Int J Integr Care, V2, pe15; Neeleman J, 2004, PSYCHOL MED, V34, P521, DOI 10.1017/S0033291703001193; Nolen-Hoeksema S., 2001, HDB BEREAVEMENT RES, P545, DOI DOI 10.1037/10436-023; PAYKEL ES, 1974, BRIT J PSYCHIAT, V124, P460, DOI 10.1192/bjp.124.5.460; PEARLIN LI, 1978, J HEALTH SOC BEHAV, V19, P2, DOI 10.2307/2136319; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Prigerson HG, 1999, AM J PSYCHIAT, V156, P1994; Prigerson HG, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000121; Qin P, 2002, LANCET, V360, P1126, DOI 10.1016/S0140-6736(02)11197-4; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rosenberg M., 1965, MEASUREMENT SELF EST, P16; Seedat S, 2009, ARCH GEN PSYCHIAT, V66, P785, DOI 10.1001/archgenpsychiatry.2009.36; Stroebe M. S., 2007, J CONSULT CLIN PSYCH, V73, P617; Stroebe M, 2007, LANCET, V370, P1960, DOI 10.1016/S0140-6736(07)61816-9; Stroebe W., 2001, HDB BEREAVEMENT RES, P349, DOI DOI 10.1037/10436-015; Szanto K, 2006, J CLIN PSYCHIAT, V67, P233, DOI 10.4088/JCP.v67n0209; WHO, 2003, MORT DAT; Wittouck C, 2011, CLIN PSYCHOL REV, V31, P69, DOI 10.1016/j.cpr.2010.09.005; World Health Organization, 1992, SCHED CLIN ASS NEUR	39	32	33	1	23	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 2	2013	347								f5519	10.1136/bmj.f5519	http://dx.doi.org/10.1136/bmj.f5519			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	231OU	24089424	Green Published, hybrid			2022-12-28	WOS:000325427400007
J	Olfson, M; Pincus, HA; Pardes, H				Olfson, Mark; Pincus, Harold A.; Pardes, Herbert			Investing in Evidence-Based Care for the Severely Mentally Ill	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							METAANALYSIS; CLOZAPINE		[Olfson, Mark; Pincus, Harold A.; Pardes, Herbert] Columbia Univ, Coll Phys & Surg, Dept Psychiat, New York State Psychiat Inst, New York, NY 10032 USA; [Pincus, Harold A.; Pardes, Herbert] NewYork Presbyterian Hosp & Healthcare Syst, New York, NY USA	Columbia University; New York State Psychiatry Institute; NewYork-Presbyterian Hospital	Olfson, M (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Psychiat, New York State Psychiat Inst, 1051 Riverside Dr, New York, NY 10032 USA.	mo49@columbia.edu	Olfson, Mark/AAA-8547-2021					Bond GR, 2008, PSYCHIATR REHABIL J, V31, P280, DOI 10.2975/31.4.2008.280.290; Cipriani A, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3646; Fakra E, 2012, EXPERT OPIN PHARMACO, V13, P1923, DOI 10.1517/14656566.2012.709235; Garfield RL, 2011, AM J PSYCHIAT, V168, P486, DOI 10.1176/appi.ajp.2010.10060792; Manuel JI, 2012, PSYCHIAT SERV, V63, P1146, DOI 10.1176/appi.ps.201100435; Roll JM, 2013, PSYCHIAT SERV, V64, P80, DOI 10.1176/appi.ps.201200071; Woltmann E, 2012, AM J PSYCHIAT, V169, P790, DOI 10.1176/appi.ajp.2012.11111616	7	9	9	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 2	2013	310	13					1345	1346		10.1001/jama.2013.278065	http://dx.doi.org/10.1001/jama.2013.278065			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	227GB	24084917				2022-12-28	WOS:000325098100017
J	Buist, M; Middleton, S				Buist, Michael; Middleton, Sarah			What went wrong with the quality and safety agenda? An essay by Michael Buist and Sarah Middleton	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ADVERSE EVENTS; HEALTH-CARE; HOSPITALS; TRENDS; RATES; TIME		[Buist, Michael] Univ Tasmania, Sch Med, Ctr Hlth Serv Res, Hobart, Tas 7000, Australia; [Middleton, Sarah] Univ Tasmania, Rural Clin Sch, Burnie, Tas 7320, Australia	University of Tasmania; University of Tasmania	Buist, M (corresponding author), Univ Tasmania, Sch Med, Ctr Hlth Serv Res, Hobart, Tas 7000, Australia.	Michael.Buist@utas.edu.au						Australian Commission on Safety and Quality in Health Care, NAT STAND ACCR; Baines RJ, 2013, BMJ QUAL SAF, V22, P290, DOI 10.1136/bmjqs-2012-001126; Buist MD, 1999, MED J AUSTRALIA, V171, P22, DOI 10.5694/j.1326-5377.1999.tb123492.x; Buist M, 2007, BMJ-BRIT MED J, V335, P1210, DOI 10.1136/bmj.39385.534236.47; Buist MD, 2010, JT COMM J QUAL PATIE, V36, P334, DOI 10.1016/S1553-7250(10)36050-8; Classen DC, 2011, HEALTH AFFAIR, V30, P581, DOI 10.1377/hlthaff.2011.0190; Habersberger PG, 1995, AGE             0607, P22; Hamilton JD, 1999, MED J AUSTRALIA, V171, P22; Haynes AB, 2009, NEW ENGL J MED, V360, P491, DOI 10.1056/NEJMsa0810119; Landrigan CP, 2010, NEW ENGL J MED, V363, P2124, DOI 10.1056/NEJMsa1004404; McNeil JJ, 1995, MED J AUSTRALIA, V163, P472, DOI 10.5694/j.1326-5377.1995.tb124692.x; Mid Staffordshire NHS Foundation Trust, 2013, FIN REP; Morello RT, 2013, BMJ QUAL SAF, V22, P11, DOI 10.1136/bmjqs-2011-000582; National Expert Advisory Group on Safety and Quality in Australian Health Care, 1998, INT REP COMM QUAL EN; REASON R, 1990, HUMAN ERROR; Shearer B, 2012, BMJ QUAL SAF, V21, P569, DOI 10.1136/bmjqs-2011-000692; Shojania KG, 2013, BMJ QUAL SAF, V22, P273, DOI 10.1136/bmjqs-2013-001935; Stewart J, 2008, MED EDUC, V42, P938, DOI 10.1111/j.1365-2923.2008.03123.x; Vincent CA, 1999, MED J AUSTRALIA, V170, P404, DOI 10.5694/j.1326-5377.1999.tb127810.x; Wilson RM, 1995, MED J AUSTRALIA, V163, P458, DOI 10.5694/j.1326-5377.1995.tb124691.x	20	8	8	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 30	2013	347								f5800	10.1136/bmj.f5800	http://dx.doi.org/10.1136/bmj.f5800			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	231NY	24081817				2022-12-28	WOS:000325425000001
J	Krabbenhoft, DP; Sunderland, EM				Krabbenhoft, David P.; Sunderland, Elsie M.			Global Change and Mercury	SCIENCE			English	Editorial Material							EMISSIONS		[Krabbenhoft, David P.] US Geol Survey, Middleton, WI 53562 USA; [Sunderland, Elsie M.] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Cambridge, MA 02138 USA; [Sunderland, Elsie M.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA	United States Department of the Interior; United States Geological Survey; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University	Krabbenhoft, DP (corresponding author), US Geol Survey, 8505 Res Way, Middleton, WI 53562 USA.	dpkrabbe@usgs.gov	Sunderland, Elsie M/D-5511-2014	Sunderland, Elsie M/0000-0003-0386-9548				Amos HM, 2013, GLOBAL BIOGEOCHEM CY, V27, P410, DOI 10.1002/gbc.20040; Benoit JM, 2003, ACS SYM SER, V835, P262; Blum JD, 2013, NAT GEOSCI, V6, P879, DOI [10.1038/ngeo1918, 10.1038/NGEO1918]; Fitzgerald WF, 1998, ENVIRON SCI TECHNOL, V32, P1, DOI 10.1021/es970284w; Hararuk O, 2013, BIOGEOSCIENCES, V10, P2393, DOI 10.5194/bg-10-2393-2013; Harris RC, 2007, P NATL ACAD SCI USA, V104, P16586, DOI 10.1073/pnas.0704186104; Karagas MR, 2012, ENVIRON HEALTH PERSP, V120, P799, DOI 10.1289/ehp.1104494; Mason RP, 2012, ENVIRON RES, V119, P101, DOI 10.1016/j.envres.2012.03.013; Parks JM, 2013, SCIENCE, V339, P1332, DOI 10.1126/science.1230667; Rafaj P, 2013, ATMOS ENVIRON, V79, P472, DOI 10.1016/j.atmosenv.2013.06.042; Serrano O, 2013, GLOBAL BIOGEOCHEM CY, V27, P21, DOI 10.1029/2012GB004296; Stern GA, 2012, SCI TOTAL ENVIRON, V414, P22, DOI 10.1016/j.scitotenv.2011.10.039; Streets DG, 2011, ENVIRON SCI TECHNOL, V45, P10485, DOI 10.1021/es202765m; Streets DG, 2009, ENVIRON SCI TECHNOL, V43, P2983, DOI 10.1021/es802474j; United Nations Environment Programme, 2013, GLOBAL MERCURY ASSES	15	220	231	14	236	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 27	2013	341	6153					1457	1458		10.1126/science.1242838	http://dx.doi.org/10.1126/science.1242838			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	224NS	24072910				2022-12-28	WOS:000324894600032
J	Wijchers, PJ; de Laat, W				Wijchers, Patrick J.; de Laat, Wouter			For Genomes to Stay in Shape, Insulators Must Be up to PAR	CELL			English	Editorial Material							CTCF; BINDING	Insulators drive nuclear organization by blocking or facilitating interactions between DNA regulatory elements. Ong et al. show that poly(ADP-ribosyl) ation of insulator binding proteins modulates their ability to physically interact with distant regulatory elements, implicating posttranslational modifications of nonhistone proteins in genome architecture.	[Wijchers, Patrick J.; de Laat, Wouter] Hubrecht Inst KNAW, NL-3584 CT Utrecht, Netherlands; [Wijchers, Patrick J.; de Laat, Wouter] Univ Med Ctr Utrecht, NL-3584 CT Utrecht, Netherlands	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center	de Laat, W (corresponding author), Hubrecht Inst KNAW, Uppsalalaan 8, NL-3584 CT Utrecht, Netherlands.	w.delaat@hubrecht.eu		de Laat, Wouter/0000-0002-6393-595X				Bell AC, 1999, CELL, V98, P387, DOI 10.1016/S0092-8674(00)81967-4; Bickmore WA, 2013, CELL, V152, P1270, DOI 10.1016/j.cell.2013.02.001; Gaszner M, 2006, NAT REV GENET, V7, P703, DOI 10.1038/nrg1925; Handoko L, 2011, NAT GENET, V43, P630, DOI 10.1038/ng.857; Kraus WL, 2008, CURR OPIN CELL BIOL, V20, P294, DOI 10.1016/j.ceb.2008.03.006; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; Ong CT, 2013, CELL, V155, P148, DOI 10.1016/j.cell.2013.08.052; Splinter E, 2006, GENE DEV, V20, P2349, DOI 10.1101/gad.399506; Witcher M, 2009, MOL CELL, V34, P271, DOI 10.1016/j.molcel.2009.04.001; Yu WQ, 2004, NAT GENET, V36, P1105, DOI 10.1038/ng1426	10	0	0	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 26	2013	155	1					15	16		10.1016/j.cell.2013.09.012	http://dx.doi.org/10.1016/j.cell.2013.09.012			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	224UX	24074855	Bronze			2022-12-28	WOS:000324916700003
J	Walker, N; Yenokyan, G; Friberg, IK; Bryce, J				Walker, Neff; Yenokyan, Gayane; Friberg, Ingrid K.; Bryce, Jennifer			Patterns in coverage of maternal, newborn, and child health interventions: projections of neonatal and under-5 mortality to 2035	LANCET			English	Article							REGRESSION; COUNTDOWN; MODELS	Background Urgent calls have been made for improved understanding of changes in coverage of maternal, newborn, and child health interventions, and their country-level determinants. We examined historical trends in coverage of interventions with proven effectiveness, and used them to project rates of child and neonatal mortality in 2035 in 74 Countdown to 2015 priority countries. Methods We investigated coverage of all interventions for which evidence was available to suggest effective reductions in maternal and child mortality, for which indicators have been defined, and data have been obtained through household surveys. We reanalysed coverage data from 312 nationally-representative household surveys done between 1990 and 2011 in 69 countries, including 58 Countdown countries. We developed logistic Loess regression models for patterns of coverage change for each intervention, and used k-means cluster analysis to divide interventions into three groups with different historical patterns of coverage change. Within each intervention group, we examined performance of each country in achieving coverage gains. We constructed models that included baseline coverage, region, gross domestic product, conflict, and governance to examine country-specific annual percentage coverage change for each group of indicators. We used the Lives Saved Tool (LiST) to predict mortality rates of children younger than 5 years (henceforth, under 5) and in the neonatal period in 2035 for Countdown countries if trends in coverage continue unchanged (historical trends scenario) and if each country accelerates intervention coverage to the highest level achieved by a Countdown country with similar baseline coverage level (best performer scenario). Results Odds of coverage of three interventions (antimalarial treatment, skilled attendant at birth, and use of improved sanitation facilities) have decreased since 1990, with a mean annual decrease of 5.5% (SD 2.7%). Odds of coverage of four interventions-all related to the prevention of malaria-have increased rapidly, with a mean annual increase of 27.9% (7.3%). Odds of coverage of other interventions have slowly increased, with a mean annual increase of 5.3% (3.5%). Rates of coverage change varied widely across countries; we could not explain the differences by measures of gross domestic product, conflict, or governance. On the basis of LiST projections, we predicted that the number of Countdown countries with an under-5 mortality rate of fewer than 20 deaths per 1000 livebirths per year would increase from four (5%) of the 74 in 2010, to nine (12%) by 2035 under the historical trends scenario, and to 15 (20%) under the best performer scenario. The number of countries with neonatal mortality rates of fewer than 11 per 1000 livebirths per year would increase from three (4%) in 2010, to ten (14%) by 2035 under the historical trends scenario, and 67 (91%) under the best performer scenario. The number of under-5 deaths per year would decrease from an estimated 7.6 million in 2010, to 5.4 million (28% decrease) if historical trends continue, and to 2.3 million (71% decrease) under the best performer scenario. Interpretation Substantial reductions in child deaths are possible, but only if intensified efforts to achieve intervention coverage are implemented successfully within each of the Countdown countries.	[Walker, Neff; Friberg, Ingrid K.; Bryce, Jennifer] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Inst Int Programs, Baltimore, MD 21205 USA; [Yenokyan, Gayane] Johns Hopkins Bloomberg Sch Publ Hlth, Johns Hopkins Biostat Ctr, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Walker, N (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Inst Int Programs, Baltimore, MD 21205 USA.	pneffwalker@yahoo.com		Yenokyan, Gayane/0000-0003-1482-5612	Bill & Melinda Gates Foundation	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	The Bill & Melinda Gates Foundation.	*AIDS2031 CONS, 2010, AIDS TAK LONG TERM V; Ajene A, METRICS MEASURING CH; Amouzou A, 2012, LANCET, V380, P1169, DOI 10.1016/S0140-6736(12)61376-2; BALL GH, 1967, BEHAV SCI, V12, P153, DOI 10.1002/bs.3830120210; Barros AJD, 2012, LANCET, V379, P1225, DOI 10.1016/S0140-6736(12)60113-5; Bryce J, 2013, PLOS MED; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; Commission on Information and Accountability for Women's and Children's Health, 2011, KEEP PROM MEAS RES; Fox M, 2011, BMC PUBLIC HLTH S3, V11, pS1; Garnett GP, 2011, LANCET, V378, P515, DOI 10.1016/S0140-6736(10)61505-X; Joint United Nations Programme on HIV/ AIDS, 2012, GLOB REP UNAIDS REP; Kaufmann D., 2011, WORLDWIDE GOVERNANCE; Lee LA, 2013, VACCINE, V31, pB61, DOI 10.1016/j.vaccine.2012.11.035; Matsubayashi T, 2009, DIR DEV, P173; Requejo J, 2012, COUNTDOWN 2015 BUILD; Sachdev HPS, 2010, DEV USE LIVES SAVED; Schabenberger, INTRO GLIMMIX PROCED; Steyerberg EW, 2001, J CLIN EPIDEMIOL, V54, P774, DOI 10.1016/S0895-4356(01)00341-9; The World Bank, GDP CURR US; UNICEF, CHILD SURV; Uppsala Universitet Department of Peace and Conflict Research, 2012, UCDP DAT; Verbeke G, 2000, LINEAR MIXED MODELS; Walker N, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-S3-S1; WHO/UNICEF, 2013, WHO UNICEF JOINT MON; World Bank Group, 2012, WORLDW GOV IND PROJ; World Health Organization United Nations Children's Fund, 2012, WHO UNICEF EST IMM C	26	55	57	0	17	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 21	2013	382	9897					1029	1038		10.1016/S0140-6736(13)61748-1	http://dx.doi.org/10.1016/S0140-6736(13)61748-1			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	222PB	24054534				2022-12-28	WOS:000324742200023
J	Pedersen, ME; Snieckute, G; Kagias, K; Nehammer, C; Multhaupt, HAB; Couchman, JR; Pocock, R				Pedersen, Mikael Egebjerg; Snieckute, Goda; Kagias, Konstantinos; Nehammer, Camilla; Multhaupt, Hinke A. B.; Couchman, John R.; Pocock, Roger			An Epidermal MicroRNA Regulates Neuronal Migration Through Control of the Cellular Glycosylation State	SCIENCE			English	Article							CAENORHABDITIS-ELEGANS; HEPARAN-SULFATE; EARLY EMBRYOGENESIS; GLYPICAN LON-2; PROTEOGLYCANS; EXPRESSION; HOMOLOG; PROTEIN	An appropriate balance in glycosylation of proteoglycans is crucial for their ability to regulate animal development. Here, we report that the Caenorhabditis elegans microRNA mir-79, an ortholog of mammalian miR-9, controls sugar-chain homeostasis by targeting two proteins in the proteoglycan biosynthetic pathway: a chondroitin synthase (SQV-5; squashed vulva-5) and a uridine 5'-diphosphate-sugar transporter (SQV-7). Loss of mir-79 causes neurodevelopmental defects through SQV-5 and SQV-7 dysregulation in the epidermis. This results in a partial shutdown of heparan sulfate biosynthesis that impinges on a LON-2/glypican pathway and disrupts neuronal migration. Our results identify a regulatory axis controlled by a conserved microRNA that maintains proteoglycan homeostasis in cells.	[Pedersen, Mikael Egebjerg; Snieckute, Goda; Kagias, Konstantinos; Nehammer, Camilla; Pocock, Roger] Univ Copenhagen, Biotech Res & Innovat Ctr, Copenhagen, Denmark; [Multhaupt, Hinke A. B.; Couchman, John R.] Univ Copenhagen, Dept Biomed Sci, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen	Pocock, R (corresponding author), Univ Copenhagen, Biotech Res & Innovat Ctr, Ole Maaloes Vej 5, Copenhagen, Denmark.	roger.pocock@bric.ku.dk	Pocock, Roger/AAQ-8526-2020	Pocock, Roger/0000-0002-5515-3608; Egebjerg, Mikael Mandrup/0000-0001-5258-2442; Snieckute, Goda/0000-0003-0738-0926	NIH Office of Research Infrastructure Programs [P40 OD010440]; European Research Council (ERC) [260807]; Lundbeck Foundation [R118-A11481, R44-A4407]; Danish National Research Foundation; Novo Nordisk Foundation; Lundbeck Foundation [R118-2012-11481] Funding Source: researchfish; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	NIH Office of Research Infrastructure Programs(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Research Council (ERC)(European Research Council (ERC)European Commission); Lundbeck Foundation(Lundbeckfonden); Danish National Research Foundation(Danmarks Grundforskningsfond); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Lundbeck Foundation(Lundbeckfonden); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank O. Hobert, H. Buelow, P. Brodersen, and A. Lund for comments on the manuscript and T. Gumienny for lon-2 strains and reagents. Some strains used in this study were provided by the Caenorhabditis Genetics Center, which is funded by NIH Office of Research Infrastructure Programs (P40 OD010440). This work was supported by grants from the European Research Council (ERC Starting Grant no. 260807 to R.P.), the Lundbeck Foundation (Project nos. R118-A11481 to R.P. and R44-A4407 to J.R.C.), the Danish National Research Foundation, and the Novo Nordisk Foundation (to J.R.C.).	Adler CE, 2006, NAT NEUROSCI, V9, P511, DOI 10.1038/nn1666; Bellaiche Y, 1998, NATURE, V394, P85, DOI 10.1038/27932; Berninsone P, 2001, P NATL ACAD SCI USA, V98, P3738, DOI 10.1073/pnas.061593098; Bulow HE, 2008, CURR BIOL, V18, P1978, DOI 10.1016/j.cub.2008.11.023; Bulow HE, 2006, ANNU REV CELL DEV BI, V22, P375, DOI 10.1146/annurev.cellbio.22.010605.093433; Bulow HE, 2004, NEURON, V41, P723, DOI 10.1016/S0896-6273(04)00084-4; Couchman J R, 1984, Prog Clin Biol Res, V151, P31; Couchman JR, 2010, ANNU REV CELL DEV BI, V26, P89, DOI 10.1146/annurev-cellbio-100109-104126; DAVID G, 1992, J CELL BIOL, V119, P961, DOI 10.1083/jcb.119.4.961; DESAI C, 1988, NATURE, V336, P638, DOI 10.1038/336638a0; Forsberg M, 2012, J BIOL CHEM, V287, P10853, DOI 10.1074/jbc.M111.337030; Gumienny TL, 2007, CURR BIOL, V17, P159, DOI 10.1016/j.cub.2006.11.065; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Herman T, 1999, P NATL ACAD SCI USA, V96, P968, DOI 10.1073/pnas.96.3.968; Hwang HY, 2003, NATURE, V423, P439, DOI 10.1038/nature01634; Kato M, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-r54; Kinnunen T, 2005, P NATL ACAD SCI USA, V102, P1507, DOI 10.1073/pnas.0401591102; Kitagawa H, 2001, J BIOL CHEM, V276, P4834, DOI 10.1074/jbc.C000835200; KJELLEN L, 1991, ANNU REV BIOCHEM, V60, P443, DOI 10.1146/annurev.bi.60.070191.002303; Lehrbach NJ, 2009, NAT STRUCT MOL BIOL, V16, P1016, DOI 10.1038/nsmb.1675; LIDHOLT K, 1992, P NATL ACAD SCI USA, V89, P2267, DOI 10.1073/pnas.89.6.2267; Mizuguchi S, 2003, NATURE, V423, P443, DOI 10.1038/nature01635; Pocock R, 2008, NAT NEUROSCI, V11, P894, DOI 10.1038/nn.2152; Selva EM, 2001, NAT CELL BIOL, V3, P809, DOI 10.1038/ncb0901-809; Sun AX, 2013, CURR OPIN CELL BIOL, V25, P215, DOI 10.1016/j.ceb.2012.12.007; Taneja-Bageshwar S, 2012, DEV BIOL, V371, P66, DOI 10.1016/j.ydbio.2012.08.006; Tian J, 2010, AM J HUM GENET, V87, P768, DOI 10.1016/j.ajhg.2010.11.005	27	57	63	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 20	2013	341	6152					1404	1408		10.1126/science.1242528	http://dx.doi.org/10.1126/science.1242528			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	220PK	24052309				2022-12-28	WOS:000324597200049
J	Shaw, D				Shaw, David			The right to participate in high-risk research	LANCET			English	Editorial Material							ETHICS; TRIALS		Univ Basel, Inst Biomed Eth, CH-4056 Basel, Switzerland	University of Basel	Shaw, D (corresponding author), Univ Basel, Inst Biomed Eth, CH-4056 Basel, Switzerland.	david.shaw@unibas.ch						British Parachute Association, SAF; *CIOMS, 2002, INT ETH GUID BIOM RE; Cousino MK, 2012, J CLIN ONCOL, V30, P4367, DOI 10.1200/JCO.2012.42.3004; Edwards SJL, 2004, J MED ETHICS, V30, P88, DOI 10.1136/jme.2002.000166; Joffe S, 2001, J NATL CANCER I, V93, P139, DOI 10.1093/jnci/93.2.139; Le Tourneau C, 2009, JNCI-J NATL CANCER I, V101, P708, DOI 10.1093/jnci/djp079; London AJ, 2007, J MED PHILOS, V32, P99, DOI 10.1080/03605310701255727; Miller FG, 2009, J MED ETHICS, V35, P445, DOI 10.1136/jme.2008.026062; Rid A, 2010, JAMA-J AM MED ASSOC, V304, P1472, DOI 10.1001/jama.2010.1414; Shaw D, 2013, SWISS MED WKLY, V143, DOI 10.4414/smw.2013.13792; Young CC, 1998, PHYSICIAN SPORTSMED, V26, P75, DOI 10.3810/psm.1998.05.1017	11	19	19	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 15	2014	383	9921					1009	1011		10.1016/S0140-6736(13)61575-5	http://dx.doi.org/10.1016/S0140-6736(13)61575-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AD8MR	24054815				2022-12-28	WOS:000333520700031
J	Larson, HJ				Larson, Heidi J.			The Minamata Convention on Mercury: risk in perspective	LANCET			English	Editorial Material									Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine	Larson, HJ (corresponding author), Univ London London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.	heidi.larson@lshtm.ac.uk	Larson, Heidi J./N-1018-2017	Larson, Heidi J./0000-0002-8477-7583				American Academy of Pediatrics, 2012, BAN ALL MERC BAS PRO; Grandjean P, 1999, PUBLIC HEALTH REP, V114, P512, DOI 10.1093/phr/114.6.512; Larson H, POIS POLL NOT ALL ME; Mahaffey KR, 2011, NUTR REV, V69, P493, DOI 10.1111/j.1753-4887.2011.00415.x; McCurry J, 2006, LANCET, V367, P99, DOI 10.1016/S0140-6736(06)67944-0; Orenstein WA, 2013, PEDIATRICS, V131, P149, DOI 10.1542/peds.2012-1760; Spiegel SJ, 2005, LANCET, V366, P2070, DOI 10.1016/S0140-6736(05)67868-3; Sunderland EM, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-2; United Nations Environment Programme, 2012, RED MERC US ART SMAL; United Nations Environment Programme, 2013, MERC TIM ACT; United Nations Environmental Programme, 2013, REP INT NEG COMM PRE	11	18	18	0	32	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 18	2014	383	9913					198	199		10.1016/S0140-6736(13)62000-0	http://dx.doi.org/10.1016/S0140-6736(13)62000-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	294FC	24119424				2022-12-28	WOS:000330027500010
J	Ilson, DH				Ilson, David H.			Angiogenesis in gastric cancer: hitting the target?	LANCET			English	Editorial Material							PHASE-III TRIAL; ADVANCED ESOPHAGOGASTRIC CANCER; 1ST-LINE THERAPY; OPEN-LABEL; CHEMOTHERAPY; CAPECITABINE; OXALIPLATIN; CISPLATIN; BEVACIZUMAB; SURGERY		Mem Sloan Kettering Canc Ctr, New York, NY 10011 USA	Memorial Sloan Kettering Cancer Center	Ilson, DH (corresponding author), Mem Sloan Kettering Canc Ctr, New York, NY 10011 USA.	ilsond@mskcc.org						Al-Batran SE, 2008, J CLIN ONCOL, V26, P1435, DOI 10.1200/JCO.2007.13.9378; Bang YJ, 2012, LANCET, V379, P315, DOI 10.1016/S0140-6736(11)61873-4; Bang YJ, 2010, LANCET, V376, P687, DOI 10.1016/S0140-6736(10)61121-X; Cunningham D, 2008, NEW ENGL J MED, V358, P36, DOI 10.1056/NEJMoa073149; Cunningham D, 2006, NEW ENGL J MED, V355, P11, DOI 10.1056/NEJMoa055531; Fuchs CS, 2013, LANCET; Kang YK, 2009, ANN ONCOL, V20, P666, DOI 10.1093/annonc/mdn717; Koizumi W, 2008, LANCET ONCOL, V9, P215, DOI 10.1016/S1470-2045(08)70035-4; Lordick F, 2013, LANCET ONCOL, V14, P490, DOI 10.1016/S1470-2045(13)70102-5; Macdonald JS, 2001, NEW ENGL J MED, V345, P725, DOI 10.1056/NEJMoa010187; Maru D, 2013, CLIN CANCER RES, V19, P2824, DOI 10.1158/1078-0432.CCR-12-3409; Ohtsu A, 2011, J CLIN ONCOL, V29, P3968, DOI 10.1200/JCO.2011.36.2236; Sasako M, 2011, J CLIN ONCOL, V29, P4387, DOI 10.1200/JCO.2011.36.5908; Van Cutsem E, 2006, J CLIN ONCOL, V24, P4991, DOI 10.1200/JCO.2006.06.8429; Van Cutsem E, 2012, J CLIN ONCOL, V30, P2119, DOI 10.1200/JCO.2011.39.9824; Waddell T, 2013, LANCET ONCOL, V14, P481, DOI 10.1016/S1470-2045(13)70096-2	16	27	27	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 4	2014	383	9911					4	6		10.1016/S0140-6736(13)61892-9	http://dx.doi.org/10.1016/S0140-6736(13)61892-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	284SP	24094766				2022-12-28	WOS:000329341200007
J	Vannier, JB; Sandhu, S; Petalcorin, MIR; Wu, XL; Nabi, Z; Ding, H; Boulton, SJ				Vannier, Jean-Baptiste; Sandhu, Sumit; Petalcorin, Mark I. R.; Wu, Xiaoli; Nabi, Zinnatun; Ding, Hao; Boulton, Simon J.			RTEL1 Is a Replisome-Associated Helicase That Promotes Telomere and Genome-Wide Replication	SCIENCE			English	Article							DNA-REPLICATION; MUTATIONS; REPAIR	Regulator of telomere length 1 (RTEL1) is an essential DNA helicase that disassembles telomere loops (T loops) and suppresses telomere fragility to maintain the integrity of chromosome ends. We established that RTEL1 also associates with the replisome through binding to proliferating cell nuclear antigen (PCNA). Mouse cells disrupted for the RTEL1-PCNA interaction (PIP mutant) exhibited accelerated senescence, replication fork instability, reduced replication fork extension rates, and increased origin usage. Although T-loop disassembly at telomeres was unaffected in the mutant cells, telomere replication was compromised, leading to fragile sites at telomeres. RTEL1-PIP mutant mice were viable, but loss of the RTEL1-PCNA interaction accelerated the onset of tumorigenesis in p53-deficient mice. We propose that RTEL1 plays a critical role in both telomere and genome-wide replication, which is crucial for genetic stability and tumor avoidance.	[Vannier, Jean-Baptiste; Petalcorin, Mark I. R.; Boulton, Simon J.] Canc Res UK, London Res Inst, DNA Damage Response Lab, S Mimms EN6 3LD, Herts, England; [Sandhu, Sumit; Wu, Xiaoli; Nabi, Zinnatun; Ding, Hao] Univ Manitoba, Dept Biochem & Med Genet, Winnipeg, MB R3E 3J7, Canada; [Ding, Hao] Manitoba Inst Child Hlth, Winnipeg, MB R3E 3P4, Canada	Cancer Research UK; University of Manitoba	Ding, H (corresponding author), Univ Manitoba, Dept Biochem & Med Genet, Winnipeg, MB R3E 3J7, Canada.	dingh@cc.umanitoba.ca; simon.boulton@cancer.org.uk		Petalcorin, Mark/0000-0001-8211-9440	Cancer Research UK; European Research Council (ERC); Royal Society Wolfson Research Merit Award; Canada Research Chair program; Canada Institute of Health Research; Manitoba Institute of Child Health; Terry Fox Research Institute; ERC; Natural Sciences and Engineering Research Council of Canada; Manitoba Health Research Council; Cancer Research UK [11581] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); European Research Council (ERC)(European Research Council (ERC)European Commission); Royal Society Wolfson Research Merit Award(Royal Society of London); Canada Research Chair program(Canada Research Chairs); Canada Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Manitoba Institute of Child Health; Terry Fox Research Institute; ERC(European Research Council (ERC)European Commission); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Manitoba Health Research Council; Cancer Research UK(Cancer Research UK)	We thank the Protein Analysis and Proteomics group at London Reasearch Institute for mass spectrometry and J. Mendez for MCM2 antibody. Research in the DNA damage response lab of S. J. B. is funded by Cancer Research UK and by a European Research Council (ERC) Advanced Investigator Grant (RecMitMei). S. J. B. is a recipient of a Royal Society Wolfson Research Merit Award. The laboratory of H. D. is supported by Canada Research Chair program, Canada Institute of Health Research, Manitoba Institute of Child Health, and Terry Fox Research Institute. J.-B.V. is funded by a long-term fellowship from ERC, and S. S. and Z.N. are supported by the fellowships from Natural Sciences and Engineering Research Council of Canada (to S. S.) and the Manitoba Health Research Council (to Z.N.).	Ballew BJ, 2013, HUM GENET, V132, P473, DOI 10.1007/s00439-013-1265-8; Barber LJ, 2008, CELL, V135, P261, DOI 10.1016/j.cell.2008.08.016; Chapman JR, 2012, MOL CELL, V47, P497, DOI 10.1016/j.molcel.2012.07.029; Chuang LC, 2009, MOL CELL, V35, P206, DOI 10.1016/j.molcel.2009.06.014; Ding H, 2004, CELL, V117, P873, DOI 10.1016/j.cell.2004.05.026; Egan KM, 2011, J NEURO-ONCOL, V104, P535, DOI 10.1007/s11060-010-0506-0; Essers J, 2005, MOL CELL BIOL, V25, P9350, DOI 10.1128/MCB.25.21.9350-9359.2005; Gari K, 2012, SCIENCE, V337, P243, DOI 10.1126/science.1219664; Gilbertson RJ, 2008, ANNU REV PATHOL-MECH, V3, P341, DOI 10.1146/annurev.pathmechdis.3.121806.151518; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Le Guen T, 2013, HUM MOL GENET, V22, P3239, DOI 10.1093/hmg/ddt178; Montagnoli A, 2008, NAT CHEM BIOL, V4, P357, DOI 10.1038/nchembio.90; Sfeir A, 2009, CELL, V138, P90, DOI 10.1016/j.cell.2009.06.021; Shete S, 2009, NAT GENET, V41, P899, DOI 10.1038/ng.407; Uringa EJ, 2012, MOL BIOL CELL, V23, P2782, DOI 10.1091/mbc.E12-03-0179; Vannier JB, 2012, CELL, V149, P795, DOI 10.1016/j.cell.2012.03.030; Walne AJ, 2013, AM J HUM GENET, V92, P448, DOI 10.1016/j.ajhg.2013.02.001; Youds JL, 2010, SCIENCE, V327, P1254, DOI 10.1126/science.1183112	18	142	146	1	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 11	2013	342	6155					239	242		10.1126/science.1241779	http://dx.doi.org/10.1126/science.1241779			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232EV	24115439				2022-12-28	WOS:000325475200043
J	Callaway, E				Callaway, Ewen			Control issues	NATURE			English	Editorial Material																		Dye C, 2012, INDIAN J MED RES, V135, P737; Gardy JL, 2011, NEW ENGL J MED, V364, P730, DOI 10.1056/NEJMoa1003176; Pareek M, 2012, EMERG INFECT DIS, V18, P1422, DOI 10.3201/eid1809.120128; The World Bank, 2013, INC TUB PER 100 000; Zumla A, 2011, LANCET, V377, P10, DOI 10.1016/S0140-6736(10)62176-9	5	0	0	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 10	2013	502	7470					S16	S17		10.1038/502S16a	http://dx.doi.org/10.1038/502S16a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RU	24108077	Bronze			2022-12-28	WOS:000325436100009
J	de Lange, C				de Lange, Catherine			Waiting for results	NATURE			English	Editorial Material							TUBERCULOSIS											Lawn SD, 2012, LANCET INFECT DIS, V12, P201, DOI 10.1016/S1473-3099(11)70251-1; Padmapriyadarsini C, 2011, INDIAN J MED RES, V134, P850, DOI 10.4103/0971-5916.92630; World Health Organization, 2013, WHO MON XPERT MTB RI	3	4	4	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 10	2013	502	7470					S10	S12		10.1038/502S10a	http://dx.doi.org/10.1038/502S10a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RU	24108074	Bronze			2022-12-28	WOS:000325436100006
J	Maxmen, A				Maxmen, Amy			A combined effort	NATURE			English	Editorial Material							TUBERCULOSIS											Frymark, 2010, EVIDENCE BASED SYSTE; Lessem E., 2013, 22261 IBASETAG; Pethe K, 2013, NAT MED, V19, P1157, DOI 10.1038/nm.3262; Pethe K, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1060; Vilcheze C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2898; World Health Organization, 2013, TUB FACTSH 104	6	4	4	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 10	2013	502	7470					S4	S6		10.1038/502S4a	http://dx.doi.org/10.1038/502S4a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RU	24108079	Bronze			2022-12-28	WOS:000325436100003
J	Spencer, SL; Cappell, SD; Tsai, FC; Overton, KW; Wang, CL; Meyer, T				Spencer, Sabrina L.; Cappell, Steven D.; Tsai, Feng-Chiao; Overton, K. Wesley; Wang, Clifford L.; Meyer, Tobias			The Proliferation-Quiescence Decision Is Controlled by a Bifurcation in CDK2 Activity at Mitotic Exit	CELL			English	Article							CELL-CYCLE CONTROL; RESTRICTION POINT; RETINOBLASTOMA PROTEIN; GENE-PRODUCT; DEPHOSPHORYLATION; DIFFERENTIATION; CANCER	Tissue homeostasis in metazoans is regulated by transitions of cells between quiescence and proliferation. The hallmark of proliferating populations is progression through the cell cycle, which is driven by cyclin-dependent kinase (CDK) activity. Here, we introduce a live-cell sensor for CDK2 activity and unexpectedly found that proliferating cells bifurcate into two populations as they exit mitosis. Many cells immediately commit to the next cell cycle by building up CDK2 activity from an intermediate level, while other cells lack CDK2 activity and enter a transient state of quiescence. This bifurcation is directly controlled by the CDK inhibitor p21 and is regulated by mitogens during a restriction window at the end of the previous cell cycle. Thus, cells decide at the end of mitosis to either start the next cell cycle by immediately building up CDK2 activity or to enter a transient G0-like state by suppressing CDK2 activity.	[Spencer, Sabrina L.; Cappell, Steven D.; Tsai, Feng-Chiao; Meyer, Tobias] Stanford Univ, Dept Chem & Syst Biol, Stanford, CA 94305 USA; [Overton, K. Wesley; Wang, Clifford L.] Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA	Stanford University; Stanford University	Spencer, SL (corresponding author), Stanford Univ, Dept Chem & Syst Biol, Stanford, CA 94305 USA.	spencer1@stanford.edu; tobias1@stanford.edu	Cappell, Steven/O-4072-2018	Cappell, Steven/0000-0002-2885-7327; Meyer, Tobias/0000-0003-4339-3804; SPENCER, SABRINA/0000-0002-5798-3007; Tsai, Feng-Chiao/0000-0001-9615-6023; Overton, Wes/0000-0002-0768-3778	Damon Runyon Cancer Research Foundation [DRG-[2043-10], DRG-[2141-12]]; American Cancer Society Robert and Mary Ann Forsland Postdoctoral Fellowship [PF-13-304-01-CCG]; NIH [CA120732, MH095087]; NATIONAL CANCER INSTITUTE [R21CA120732, R33CA120732] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030179] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH095087] Funding Source: NIH RePORTER	Damon Runyon Cancer Research Foundation; American Cancer Society Robert and Mary Ann Forsland Postdoctoral Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank Jia-Yun Chen, Sean Collins, James Ferrell, Xuedong Liu, Julien Sage, Matthew Scott, and John Albeck for helpful discussions; Matthew Clutter, Garry Nolan, Ben Ho Park, Kyuho Han, and Akiko Seki for reagents; and the Stanford Shared FACS Facility for cell sorting. S.L.S and S.D.C were supported by the Damon Runyon Cancer Research Foundation (DRG-[2043-10] and DRG-[2141-12]). S.L.S was also supported by an American Cancer Society Robert and Mary Ann Forsland Postdoctoral Fellowship (PF-13-304-01-CCG). T.M. was supported by NIH grants CA120732 and MH095087.	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Bachman KE, 2004, CANCER BIOL THER, V3, P221, DOI 10.4161/cbt.3.2.666; BUCHKOVICH K, 1989, CELL, V58, P1097, DOI 10.1016/0092-8674(89)90508-4; CHEN PL, 1989, CELL, V58, P1193, DOI 10.1016/0092-8674(89)90517-5; Coller HA, 2007, NAT REV MOL CELL BIO, V8, P667, DOI 10.1038/nrm2223; Coudreuse D, 2010, NATURE, V468, P1074, DOI 10.1038/nature09543; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; DOU QP, 1993, CANCER RES, V53, P1493; DULIC V, 1992, SCIENCE, V257, P1958, DOI 10.1126/science.1329201; Gu JM, 2004, MOL BIOL CELL, V15, P3320, DOI 10.1091/mbc.E04-03-0227; Hahn AT, 2009, CELL CYCLE, V8, P1044, DOI 10.4161/cc.8.7.8042; Hitomi M, 1999, MOL CELL BIOL, V19, P4623; Hochegger H, 2008, NAT REV MOL CELL BIO, V9, P910, DOI 10.1038/nrm2510; Iwamoto M, 2010, CHEM BIOL, V17, P981, DOI 10.1016/j.chembiol.2010.07.009; KOFF A, 1992, SCIENCE, V257, P1689, DOI 10.1126/science.1388288; Lanni JS, 1998, MOL CELL BIOL, V18, P1055, DOI 10.1128/MCB.18.2.1055; LUDLOW JW, 1990, CELL, V60, P387, DOI 10.1016/0092-8674(90)90590-B; LUDLOW JW, 1993, MOL CELL BIOL, V13, P367, DOI 10.1128/MCB.13.1.367; Massague J, 2004, NATURE, V432, P298, DOI 10.1038/nature03094; O'Farrell PH, 2011, PHILOS T R SOC B, V366, P3498, DOI 10.1098/rstb.2011.0079; OHTSUBO M, 1995, MOL CELL BIOL, V15, P2612; PARDEE AB, 1974, P NATL ACAD SCI USA, V71, P1286, DOI 10.1073/pnas.71.4.1286; PRESCOTT DM, 1968, CANCER RES, V28, P1815; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Trimarchi JM, 2002, NAT REV MOL CELL BIO, V3, P11, DOI 10.1038/nrm714; Uetake Y, 2010, CURR BIOL, V20, P1666, DOI 10.1016/j.cub.2010.08.018; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; Yao G, 2008, NAT CELL BIOL, V10, P476, DOI 10.1038/ncb1711; ZETTERBERG A, 1995, CURR OPIN CELL BIOL, V7, P835, DOI 10.1016/0955-0674(95)80067-0; ZETTERBERG A, 1985, P NATL ACAD SCI USA, V82, P5365, DOI 10.1073/pnas.82.16.5365	30	355	356	1	42	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 10	2013	155	2					369	383		10.1016/j.cell.2013.08.062	http://dx.doi.org/10.1016/j.cell.2013.08.062			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	235LH	24075009	Bronze, Green Accepted			2022-12-28	WOS:000325719800014
J	Goldacre, B; Carroll, D				Goldacre, Ben; Carroll, David			Guidelines for collaboration with industry should be transparent	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Goldacre, Ben] London Sch Hyg & Trop Med, London, England; [Carroll, David] Queens Univ Belfast, St Thomas Hosp, Belfast BT7 1NN, Antrim, North Ireland	University of London; London School of Hygiene & Tropical Medicine; Queens University Belfast	Goldacre, B (corresponding author), London Sch Hyg & Trop Med, London, England.	ben.goldacre@lshtm.ac.uk		Goldacre, Ben/0000-0002-5127-4728				Arie S., 2013, BMJ-BRIT MED J, V347, pf6066; British Medical Association, 2013, BMA WITHDR PHARM STA; Ethical Standards in Health and Life Sciences Group, 2012, LIFE SCI; Ethical Standards in Health and Life Sciences Group, LIFE SCI; Horton R, 2013, LANCET, V381, P358, DOI 10.1016/S0140-6736(13)60139-7; Huser V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068409; Mathieu S, 2009, JAMA-J AM MED ASSOC, V302, P977, DOI 10.1001/jama.2009.1242; Prayle AP, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d7373; Song F, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14080; Spurling GK, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000352; Yates TA, 2012, BMJ-BRIT MED J, V344, pe2927	11	2	2	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 9	2013	347								f6100	10.1136/bmj.f6100	http://dx.doi.org/10.1136/bmj.f6100			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	235ON	24108171				2022-12-28	WOS:000325729100021
J	Hansell, AL; Blangiardo, M; Fortunato, L; Floud, S; de Hoogh, K; Fecht, D; Ghosh, RE; Laszlo, HE; Pearson, C; Beale, L; Beevers, S; Gulliver, J; Best, N; Richardson, S; Elliott, P				Hansell, Anna L.; Blangiardo, Marta; Fortunato, Lea; Floud, Sarah; de Hoogh, Kees; Fecht, Daniela; Ghosh, Rebecca E.; Laszlo, Helga E.; Pearson, Clare; Beale, Linda; Beevers, Sean; Gulliver, John; Best, Nicky; Richardson, Sylvia; Elliott, Paul			Aircraft noise and cardiovascular disease near Heathrow airport in London: small area study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ROAD TRAFFIC NOISE; LONG-TERM EXPOSURE; BLOOD-PRESSURE; HEART-DISEASE; AIR-POLLUTION; HYPERTENSION; MORTALITY; RISK	Objective To investigate the association of aircraft noise with risk of stroke, coronary heart disease, and cardiovascular disease in the general population. Design Small area study. Setting 12 London boroughs and nine districts west of London exposed to aircraft noise related to Heathrow airport in London. Population About 3.6 million residents living near Heathrow airport. Risks for hospital admissions were assessed in 12 110 census output areas (average population about 300 inhabitants) and risks for mortality in 2378 super output areas (about 1500 inhabitants). Main outcome measures Risk of hospital admissions for, and mortality from, stroke, coronary heart disease, and cardiovascular disease, 2001-05. Results Hospital admissions showed statistically significant linear trends (P<0.001 to P<0.05) of increasing risk with higher levels of both daytime (average A weighted equivalent noise 7 am to 11 pm, L-Aeq, 16(h)) and night time (11 pm to 7 am, L-night) aircraft noise. When areas experiencing the highest levels of daytime aircraft noise were compared with those experiencing the lowest levels (>63 dB v <= 51 dB), the relative risk of hospital admissions for stroke was 1.24 (95% confidence interval 1.08 to 1.43), for coronary heart disease was 1.21 (1.12 to 1.31), and for cardiovascular disease was 1.14 (1.08 to 1.20) adjusted for age, sex, ethnicity, deprivation, and a smoking proxy (lung cancer mortality) using a Poisson regression model including a random effect term to account for residual heterogeneity. Corresponding relative risks for mortality were of similar magnitude, although with wider confidence limits. Admissions for coronary heart disease and cardiovascular disease were particularly affected by adjustment for South Asian ethnicity, which needs to be considered in interpretation. All results were robust to adjustment for particulate matter (PM10) air pollution, and road traffic noise, possible for London boroughs (population about 2.6 million). We could not distinguish between the effects of daytime or night time noise as these measures were highly correlated. Conclusion High levels of aircraft noise were associated with increased risks of stroke, coronary heart disease, and cardiovascular disease for both hospital admissions and mortality in areas near Heathrow airport in London. As well as the possibility of causal associations, alternative explanations such as residual confounding and potential for ecological bias should be considered.	[Hansell, Anna L.; Blangiardo, Marta; Fortunato, Lea; Floud, Sarah; de Hoogh, Kees; Fecht, Daniela; Ghosh, Rebecca E.; Laszlo, Helga E.; Pearson, Clare; Beale, Linda; Gulliver, John; Best, Nicky; Richardson, Sylvia; Elliott, Paul] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Epidemiol & Biostat, UK Small Area Hlth Stat Unit,MRC PHE Ctr Environm, London W2 1PG, England; [Hansell, Anna L.] Imperial Coll Healthcare NHS Trust, London, England; [Beevers, Sean] Kings Coll London, MRC PHE Ctr Environm & Hlth, Environm Res Grp, London, England; [Richardson, Sylvia] MRC Biostat Unit, Cambridge, England	Imperial College London; Imperial College London; University of London; King's College London; MRC Biostatistics Unit	Elliott, P (corresponding author), Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Epidemiol & Biostat, UK Small Area Hlth Stat Unit,MRC PHE Ctr Environm, London W2 1PG, England.	p.elliott@imperial.ac.uk	Pearson, Clare/S-6372-2019; de Hoogh, Kees/ABE-1274-2021; Pearson, Clare/H-9030-2013; Richardson, Sylvia T/G-4691-2015	Pearson, Clare/0000-0002-1941-4735; Richardson, Sylvia T/0000-0003-1998-492X; Laszlo, Helga Elvira/0000-0003-2098-3991; Fecht, Daniela/0000-0002-0738-0013; Ghosh, Rebecca/0000-0001-6009-3040; Floud, Sarah/0000-0002-6078-9117; Elliott, Paul/0000-0002-7511-5684; Gulliver, John/0000-0003-3423-2013	Public Health England as part of the MRC-PHE Centre for Environment and Health; UK Medical Research Council; European Network for Noise and Health (ENNAH) [226442]; National Institute for Health Research (NIHR) Biomedical Research Centre at Imperial College Healthcare NHS Trust; Imperial College London; EU FP7; Medical Research Council [G0801056, MC_UP_0801/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10136] Funding Source: researchfish; MRC [MC_UP_0801/1, G0801056] Funding Source: UKRI	Public Health England as part of the MRC-PHE Centre for Environment and Health(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Network for Noise and Health (ENNAH); National Institute for Health Research (NIHR) Biomedical Research Centre at Imperial College Healthcare NHS Trust; Imperial College London(General Electric); EU FP7(European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The work of the UK Small Area Health Statistics Unit is funded by Public Health England as part of the MRC-PHE Centre for Environment and Health, funded also by the UK Medical Research Council. Support was received from the European Network for Noise and Health (ENNAH), EU FP7 grant No 226442. PE acknowledges support from the National Institute for Health Research (NIHR) Biomedical Research Centre at Imperial College Healthcare NHS Trust and Imperial College London. PE is an NIHR senior investigator. The funders had no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the article; and in the decision to submit the article for publication. The advisory group provided advice on methodology but was not involved in the analyses, interpretation of results, or writing of the paper. The views expressed are those of the authors and not necessarily those of the NHS, NIHR, or Department of Health.	ANDREN L, 1980, ACTA MED SCAND, V207, P493; [Anonymous], RES REP HLTH EFF I; Babisch W, 2003, Noise Health, V5, P1; Babisch WF, 2005, EPIDEMIOLOGY, V16, P33, DOI 10.1097/01.ede.0000147104.84424.24; Babisch W, 2009, NOISE HEALTH, V11, P161, DOI 10.4103/1463-1741.53363; Babisch Wolfgang, 2002, Noise Health, V4, P1; Babisch W, 2009, ENVIRON INT, V35, P1169, DOI 10.1016/j.envint.2009.07.012; BALARAJAN R, 1991, BMJ-BRIT MED J, V302, P560, DOI 10.1136/bmj.302.6776.560; Berglund B., 1999, GUIDELINES COMMUNITY; Best N, 2009, EPIDEMIOLOGY, V20, P400, DOI 10.1097/EDE.0b013e31819d90f9; Carstairs V., 1991, DEPRIVATION HLTH SCO; Critchley JB, 1990, USE LEQ AIRCRAFT NOI; Department of Transport. Welsh Office, 1988, CALC ROAD TRAFF NOIS; ELLIOTT P, 2005, CORONARY HEART DIS E, P751; Eriksson C, 2007, EPIDEMIOLOGY, V18, P716, DOI 10.1097/EDE.0b013e3181567e77; Eriksson C, 2010, ENVIRON RES, V110, P764, DOI 10.1016/j.envres.2010.09.001; Floud S, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-89; Gan WQ, 2012, AM J EPIDEMIOL, V175, P898, DOI 10.1093/aje/kwr424; Haralabidis AS, 2008, EUR HEART J, V29, P658, DOI 10.1093/eurheartj/ehn013; Holand S, 1999, J HYPERTENS, V17, P1893, DOI 10.1097/00004872-199917121-00018; Huss A, 2010, EPIDEMIOLOGY, V21, P829, DOI 10.1097/EDE.0b013e3181f4e634; Ising H., 2000, Noise Health, V2, P7; Jarup L, 2008, ENVIRON HEALTH PERSP, V116, P329, DOI 10.1289/ehp.10775; Lee J, 2012, 1201 ERCD; Lusk SL, 2004, ARCH ENVIRON HEALTH, V59, P392, DOI 10.3200/AEOH.59.8.392-399; MEDOFF HS, 1945, AM J PHYSIOL, V143, P300, DOI 10.1152/ajplegacy.1945.143.2.300; Miedema HME, 1998, J ACOUST SOC AM, V104, P3432, DOI 10.1121/1.423927; Ollerhead JB, 1999, 9842 CIV AV AUTH; Rosenlund M, 2001, OCCUP ENVIRON MED, V58, P769, DOI 10.1136/oem.58.12.769; Selander J, 2009, EPIDEMIOLOGY, V20, P272, DOI 10.1097/EDE.0b013e31819463bd; Sorensen M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039283; Sorensen M, 2011, EUR HEART J, V32, P737, DOI 10.1093/eurheartj/ehq466; Tomei G, 2010, SCI TOTAL ENVIRON, V408, P681, DOI 10.1016/j.scitotenv.2009.10.071; van Kempen E, 2012, J HYPERTENS, V30, P1075, DOI 10.1097/HJH.0b013e328352ac54; World Health Organization, 2011, BURD DIS ENV NOIS; YEAKEL EH, 1948, AM J PHYSIOL, V155, P118, DOI 10.1152/ajplegacy.1948.155.1.118	36	131	131	1	46	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 8	2013	347								f5432	10.1136/bmj.f5432	http://dx.doi.org/10.1136/bmj.f5432			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	235OJ	24103537	Green Published, hybrid			2022-12-28	WOS:000325728600001
J	Stephens, SL; Agee, JK; Fule, PZ; North, MP; Romme, WH; Swetnam, TW; Turner, MG				Stephens, S. L.; Agee, J. K.; Fule, P. Z.; North, M. P.; Romme, W. H.; Swetnam, T. W.; Turner, M. G.			Managing Forests and Fire in Changing Climates	SCIENCE			English	Editorial Material							WILDFIRE; INCREASE; FUELS		[Stephens, S. L.] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Agee, J. K.] Univ Washington, Seattle, WA 98195 USA; [Fule, P. Z.] No Arizona Univ, Flagstaff, AZ 86011 USA; [North, M. P.] US Forest Serv, USDA, Pacific Southwest Res Stn, Davis, CA 95618 USA; [Romme, W. H.] Colorado State Univ, Ft Collins, CO 80523 USA; [Swetnam, T. W.] Univ Arizona, Tucson, AZ 85721 USA; [Turner, M. G.] Univ Wisconsin, Madison, WI 53706 USA	University of California System; University of California Berkeley; University of Washington; University of Washington Seattle; Northern Arizona University; United States Department of Agriculture (USDA); United States Forest Service; Colorado State University; University of Arizona; University of Wisconsin System; University of Wisconsin Madison	Stephens, SL (corresponding author), Univ Calif Berkeley, Berkeley, CA 94720 USA.	sstephens@berkeley.edu	Turner, Monica G/B-2099-2010; Romme, William H./C-7317-2016; North, Malcolm/AAW-8897-2020	Turner, Monica G/0000-0003-1903-2822; North, Malcolm/0000-0002-9090-784X				Attiwill P, 2013, FOREST ECOL MANAG, V294, P1, DOI 10.1016/j.foreco.2012.12.025; Balch JK, 2013, GLOBAL CHANGE BIOL, V19, P173, DOI 10.1111/gcb.12046; Chapin FS, 2008, BIOSCIENCE, V58, P531, DOI 10.1641/B580609; Flannigan M, 2009, GLOBAL CHANGE BIOL, V15, P549, DOI 10.1111/j.1365-2486.2008.01660.x; Hughes TP, 2013, TRENDS ECOL EVOL, V28, P149, DOI 10.1016/j.tree.2012.08.022; Iverson LR, 2013, LANDSCAPE ECOL, V28, P879, DOI 10.1007/s10980-013-9885-x; Littell JS, 2009, ECOL APPL, V19, P1003, DOI 10.1890/07-1183.1; McCaffrey S. M., 2012, GEN TECH REP NRS 104; Moriondo M, 2006, CLIM RES, V31, P85, DOI 10.3354/cr031085; Moritz MA, 2012, ECOSPHERE, V3, DOI 10.1890/ES11-00345.1; North M, 2012, J FOREST, V110, P392, DOI 10.5849/jof.12-021; Schoennagel T, 2004, BIOSCIENCE, V54, P661, DOI 10.1641/0006-3568(2004)054[0661:TIOFFA]2.0.CO;2; Stephens SL, 2012, BIOSCIENCE, V62, P549, DOI 10.1525/bio.2012.62.6.6; Westerling AL, 2006, SCIENCE, V313, P940, DOI 10.1126/science.1128834; Westerling AL, 2011, P NATL ACAD SCI USA, V108, P13165, DOI 10.1073/pnas.1110199108; Williams AP, 2013, NAT CLIM CHANGE, V3, P292, DOI [10.1038/nclimate1693, 10.1038/NCLIMATE1693]	16	311	320	38	334	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 4	2013	342	6154					41	42		10.1126/science.1240294	http://dx.doi.org/10.1126/science.1240294			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	227PP	24092714				2022-12-28	WOS:000325126100032
J	Bulun, SE				Bulun, Serdar E.			Uterine Fibroids	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							TRANSFORMING GROWTH FACTOR-BETA-3; AROMATASE EXPRESSION; BETA-CATENIN; ULIPRISTAL ACETATE; LEIOMYOMA TISSUES; GENE-EXPRESSION; SIDE POPULATION; CELLS; WOMEN; MED12	Uterine fibroids are common, benign tumors that cause considerable morbidity. Insights into the biologic and genetic mechanisms underlying these tumors at the cellular level are pointing the way to novel treatment approaches. Uterine fibroids (leiomyomas) represent the most common tumor in women. These lesions disrupt the functions of the uterus and cause excessive uterine bleeding, anemia, defective implantation of an embryo, recurrent pregnancy loss, preterm labor, obstruction of labor, pelvic discomfort, and urinary incontinence and may mimic or mask malignant tumors. By the time they reach 50 years of age, nearly 70% of white women and more than 80% of black women will have had at least one fibroid; severe symptoms develop in 15 to 30% of these women.(1),(2) Uterine fibroids in black women are significantly larger at diagnosis than those ...	[Bulun, Serdar E.] Northwestern Univ, Dept Obstet & Gynecol, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Bulun, SE (corresponding author), Northwestern Mem Hosp, 250 E Super St,Ste 03-2306, Chicago, IL 60611 USA.	s-bulun@northwestern.edu						Arango NA, 2005, DEV BIOL, V288, P276, DOI 10.1016/j.ydbio.2005.09.045; Arici A, 2000, FERTIL STERIL, V73, P1006, DOI 10.1016/S0015-0282(00)00418-0; Baird DD, 2003, AM J OBSTET GYNECOL, V188, P100, DOI 10.1067/mob.2003.99; BULUN SE, 1994, J CLIN ENDOCR METAB, V78, P736, DOI 10.1210/jc.78.3.736; Cardozo ER, 2012, AM J OBSTET GYNECOL, V206, DOI [10.1016/j.ajog.2011.12.002, 10.1016/j.ajog.2012.08.020]; CARR BR, 1993, J CLIN ENDOCR METAB, V76, P1217, DOI 10.1210/jc.76.5.1217; Catherino WH, 2004, GENE CHROMOSOME CANC, V40, P204, DOI 10.1002/gcc.20035; Catherino WH, 2011, FERTIL STERIL, V95, P9, DOI 10.1016/j.fertnstert.2010.08.049; Cha PC, 2011, NAT GENET, V43, P447, DOI 10.1038/ng.805; Chang HL, 2010, REPROD SCI, V17, P158, DOI 10.1177/1933719109348924; De Vivo A, 2011, ULTRASOUND OBST GYN, V37, P361, DOI 10.1002/uog.8826; Dodge JE, 2002, GENE, V289, P41, DOI 10.1016/S0378-1119(02)00469-9; Donnez J, 2012, NEW ENGL J MED, V366, P421, DOI 10.1056/NEJMoa1103180; Donnez J, 2012, NEW ENGL J MED, V366, P409, DOI 10.1056/NEJMoa1103182; Faerstein E, 2001, AM J EPIDEMIOL, V153, P1, DOI 10.1093/aje/153.1.1; FILICORI M, 1983, AM J OBSTET GYNECOL, V147, P726, DOI 10.1016/0002-9378(83)90463-5; FRIEDMAN AJ, 1993, J CLIN ENDOCR METAB, V76, P1439, DOI 10.1210/jc.76.6.1439; Gilden M, 2012, FERTIL STERIL, V98, P1557, DOI 10.1016/j.fertnstert.2012.07.1132; Guo X, 2012, CELL, V151, P927, DOI 10.1016/j.cell.2012.11.003; Halder SK, 2011, J CLIN ENDOCR METAB, V96, pE754, DOI 10.1210/jc.2010-2131; Hammond SM, 2008, CELL, V135, P1013, DOI 10.1016/j.cell.2008.11.026; Hodge JC, 2007, HUM MOL GENET, V16, pR7, DOI 10.1093/hmg/ddm043; Hodge JC, 2012, HUM MOL GENET, V21, P2312, DOI 10.1093/hmg/dds051; Hoekstra AV, 2009, J CLIN ENDOCR METAB, V94, P1768, DOI 10.1210/jc.2008-2093; Huang SD, 2012, CELL, V151, P937, DOI 10.1016/j.cell.2012.10.035; Imir AG, 2007, J CLIN ENDOCR METAB, V92, P1979, DOI 10.1210/jc.2006-2482; Ishikawa H, 2008, J CLIN ENDOCR METAB, V93, P981, DOI 10.1210/jc.2007-2507; Ishikawa H, 2010, ENDOCRINOLOGY, V151, P2433, DOI 10.1210/en.2009-1225; Ishikawa H, 2009, J CLIN ENDOCR METAB, V94, P1752, DOI 10.1210/jc.2008-2327; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Kim JJ, 2012, MOL CELL ENDOCRINOL, V358, P223, DOI 10.1016/j.mce.2011.05.044; Kim S, 2006, J BIOL CHEM, V281, P14066, DOI 10.1074/jbc.M602696200; Laping NJ, 2007, CLIN CANCER RES, V13, P3087, DOI 10.1158/1078-0432.CCR-06-1811; Laughlin SK, 2010, FERTIL STERIL, V94, P2421, DOI 10.1016/j.fertnstert.2010.03.035; Lee BS, 2001, J CLIN ENDOCR METAB, V86, P913, DOI 10.1210/jc.86.2.913; Li SF, 2003, GYNECOL ONCOL, V90, P123, DOI 10.1016/S0090-8258(03)00194-X; Lin XY, 2007, DEV BIOL, V303, P536, DOI 10.1016/j.ydbio.2006.11.034; LINDER D, 1965, SCIENCE, V150, P67, DOI 10.1126/science.150.3692.67; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Makinen N, 2011, SCIENCE, V334, P252, DOI 10.1126/science.1208930; Markowski DN, 2012, INT J CANCER, V131, P1528, DOI 10.1002/ijc.27424; Markowski DN, 2011, ANTICANCER RES, V31, P753; Marsh EE, 2006, OBSTET GYN CLIN N AM, V33, P59, DOI 10.1016/j.ogc.2005.12.001; Marshall LM, 1997, OBSTET GYNECOL, V90, P967, DOI 10.1016/S0029-7844(97)00534-6; Mas A, 2012, FERTIL STERIL, V98, P741, DOI 10.1016/j.fertnstert.2012.04.044; Mason HR, 2004, MOL HUM REPROD, V10, P181, DOI 10.1093/molehr/gah028; McGuire MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033251; Meadows KL, 2011, EXP MOL PATHOL, V91, P434, DOI 10.1016/j.yexmp.2011.03.007; Mehine M, 2013, NEW ENGL J MED, V369, P43, DOI 10.1056/NEJMoa1302736; Mesquita FS, 2010, BIOL REPROD, V82, P341, DOI 10.1095/biolreprod.108.075887; Mosimann C, 2009, NAT REV MOL CELL BIO, V10, P276, DOI 10.1038/nrm2654; MURPHY AA, 1993, J CLIN ENDOCR METAB, V76, P513, DOI 10.1210/jc.76.2.513; Navarro A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033284; Norian JM, 2012, MATRIX BIOL, V31, P57, DOI 10.1016/j.matbio.2011.09.001; Ono M, 2007, P NATL ACAD SCI USA, V104, P18700, DOI 10.1073/pnas.0704472104; Ono M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036935; PARKER WH, 1994, OBSTET GYNECOL, V83, P414; Parsanezhad ME, 2010, FERTIL STERIL, V93, P192, DOI 10.1016/j.fertnstert.2008.09.064; Peddada SD, 2008, P NATL ACAD SCI USA, V105, P19887, DOI 10.1073/pnas.0808188105; Peng Y, 2008, MOL CANCER RES, V6, P663, DOI 10.1158/1541-7786.MCR-07-0370; Perot G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040015; Ravegnini G, 2013, MODERN PATHOL, V26, P743, DOI 10.1038/modpathol.2012.203; Rocha PP, 2010, DEVELOPMENT, V137, P2723, DOI 10.1242/dev.053660; ROSATI P, 1992, J ULTRAS MED, V11, P511; Sinclair DC, 2011, J CLIN ENDOCR METAB, V96, P412, DOI 10.1210/jc.2010-1450; Sumitani H, 2000, ENDOCRINOLOGY, V141, P3852, DOI 10.1210/en.141.10.3852; Szotek PP, 2007, STEM CELLS, V25, P1317, DOI 10.1634/stemcells.2006-0204; Tai CT, 2003, MOL REPROD DEV, V64, P172, DOI 10.1002/mrd.10248; Tanwar PS, 2009, BIOL REPROD, V81, P545, DOI 10.1095/biolreprod.108.075648; Tomlinson IPM, 2002, NAT GENET, V30, P406, DOI 10.1038/ng849; Varghese BV, 2013, P NATL ACAD SCI USA, V110, P2187, DOI 10.1073/pnas.1215759110; Walker CL, 2005, SCIENCE, V308, P1589, DOI 10.1126/science.1112063; Williams ARW, 2007, HUM REPROD, V22, P1696, DOI 10.1093/humrep/dem026; Yin P, 2007, J CLIN ENDOCR METAB, V92, P4459, DOI 10.1210/jc.2007-0725; Yin P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029021; Yin P, 2010, CANCER RES, V70, P1722, DOI 10.1158/0008-5472.CAN-09-2612	76	354	378	8	96	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 3	2013	369	14					1344	1355		10.1056/NEJMra1209993	http://dx.doi.org/10.1056/NEJMra1209993			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	227KI	24088094				2022-12-28	WOS:000325111200012
J	Raebel, MA; Newcomer, SR; Reifler, LM; Boudreau, D; Elliott, TE; DeBar, L; Ahmed, A; Pawloski, PA; Fisher, D; Donahoo, WT; Bayliss, EA				Raebel, Marsha A.; Newcomer, Sophia R.; Reifler, Liza M.; Boudreau, Denise; Elliott, Thomas E.; DeBar, Lynn; Ahmed, Ameena; Pawloski, Pamala A.; Fisher, David; Donahoo, W. Troy; Bayliss, Elizabeth A.			Chronic Use of Opioid Medications Before and After Bariatric Surgery	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CHRONIC NONCANCER PAIN; Y GASTRIC BYPASS; WEIGHT-LOSS; UNITED-STATES; MORTALITY; OVERDOSE; SOCIETY; TERM	IMPORTANCE Obesity is associated with chronic noncancer pain. It is not known if opioid use for chronic pain in obese individuals undergoing bariatric surgery is reduced. OBJECTIVES To determine opioid use following bariatric surgery in patients using opioids chronically for pain control prior to their surgery and to determine the effect of preoperative depression, chronic pain, or postoperative changes in body mass index (BMI) on changes in postoperative chronic opioid use. DESIGN, SETTING, AND PARTICIPANTS Retrospective cohort study in a distributed health network (10 demographically and geographically varied US health care systems) of 11 719 individuals aged 21 years and older, who had undergone bariatric surgery between 2005 and 2009, and were assessed 1 year before and after surgery, with latest follow-up by December 31, 2010. MAIN OUTCOMES AND MEASURES Opioid use, measured as morphine equivalents 1 year before and 1 year after surgery, excluding the first 30 postoperative days. Chronic opioid use is defined as 10 or more opioid dispensings over 90 or more days or as dispensings of at least a 120-day supply of opioids during the year prior to surgery. RESULTS Before surgery, 8% (95% CI, 7%-8%; n = 933) of bariatric patients were chronic opioid users. Of these individuals, 77% (95% CI, 75%-80%; n = 723) continued chronic opioid use in the year following surgery. Mean daily morphine equivalents for the 933 bariatric patients who were chronic opioid users before surgery were 45.0 mg (95% CI, 40.0-50.1) preoperatively and 51.9 mg (95% CI, 46.0-57.8) postoperatively (P<.001). For this group with chronic opiate use prior to surgery, change in morphine equivalents before vs after surgery did not differ between individuals with loss of more than 50% excess BMI vs those with 50% or less (>50% BMI loss: adjusted incidence rate ratio [adjusted IRR, 1.17; 95% CI, 1.07-1.28] vs <= 50% BMI loss [adjusted IRR, 1.03; 95% CI, 0.93-1.14] model interaction, P=.06). In other subgroup analyses of preoperative chronic opioid users, changes in morphine equivalents before vs after surgery did not differ between those with or without preoperative diagnosis of depression or chronic pain (depression only [n = 75; IRR, 1.08; 95% CI, 0.90-1.30]; chronic pain only [n = 440; IRR, 1.17; 95% CI, 1.08-1.27]; both depression and chronic pain [n = 226; IRR, 1.11; 95% CI, 0.96-1.28]; neither depression nor chronic pain [n = 192; IRR, 1.22; 95% CI, 0.98-1.51); and P values for model interactions when compared with neither were P=.42 for depression, P=.76 for pain, and P=.48 for both. CONCLUSIONS AND RELEVANCE In this cohort of patients who underwent bariatric surgery, 77% of patients who were chronic opioid users before surgery continued chronic opioid use in the year following surgery, and the amount of chronic opioid use was greater postoperatively than preoperatively. These findings suggest the need for better pain management in these patients following surgery.	[Raebel, Marsha A.; Newcomer, Sophia R.; Reifler, Liza M.; Bayliss, Elizabeth A.] Kaiser Permanente Colorado, Inst Hlth Res, Denver, CO 80237 USA; [Raebel, Marsha A.] Univ Colorado, Skaggs Sch Pharm & Pharmaceut Sci, Aurora, CO USA; [Boudreau, Denise] Grp Hlth Res Inst, Seattle, WA USA; [Elliott, Thomas E.] Essentia Inst Rural Hlth, Duluth, MN USA; [DeBar, Lynn] Kaiser Permanente Ctr Hlth Res, Portland, OR USA; [Ahmed, Ameena; Fisher, David] Permanente Med Grp Inc, San Francisco, CA USA; [Pawloski, Pamala A.] HealthPartners Inst Educ & Res, Minneapolis, MN USA; [Donahoo, W. Troy] Colorado Permanente Med Grp, Denver, CO USA; [Donahoo, W. Troy; Bayliss, Elizabeth A.] Univ Colorado, Sch Med, Aurora, CO USA	Kaiser Permanente; University of Colorado System; University of Colorado Anschutz Medical Campus; Kaiser Permanente; Permanente Medical Groups; Permanente Medical Groups; University of Colorado System; University of Colorado Anschutz Medical Campus	Raebel, MA (corresponding author), Kaiser Permanente Colorado, Inst Hlth Res, POB 378066, Denver, CO 80237 USA.	marsha.a.raebel@kp.org	Donahoo, Troy/AAK-3486-2021	Pawloski, Pamala/0000-0002-1005-5764; Donahoo, William/0000-0002-2126-860X; Elliott, Thomas/0000-0002-8570-4933	AHRQ [1R01HS019912]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS019912] Funding Source: NIH RePORTER	AHRQ(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	This project was supported by grant 1R01HS019912 from AHRQ.	Adams TD, 2012, JAMA-J AM MED ASSOC, V308, P1122, DOI 10.1001/2012.jama.11164; [Anonymous], **DROPPED REF**; Boudreau D, 2009, PHARMACOEPIDEM DR S, V18, P1166, DOI 10.1002/pds.1833; Braden JB, 2008, J PAIN, V9, P1026, DOI 10.1016/j.jpain.2008.06.002; Braden JB, 2010, ARCH INTERN MED, V170, P1425, DOI 10.1001/archinternmed.2010.273; Chang G, 2007, MED CLIN N AM, V91, P199, DOI 10.1016/j.mcna.2006.10.003; Chou R, 2009, J PAIN, V10, P131, DOI 10.1016/j.jpain.2008.10.009; CHU LF, 2009, MOL BASIS CLIN IMPLI, P114; Coleman KJ, 2010, OBES SURG, V20, P1385, DOI 10.1007/s11695-010-0223-y; Diatchenko L, 2005, HUM MOL GENET, V14, P135, DOI 10.1093/hmg/ddi013; Dodet P, 2013, CLIN J PAIN, V29, P43, DOI 10.1097/AJP.0b013e31824786ad; Dunn KM, 2010, ANN INTERN MED, V152, P85, DOI 10.7326/0003-4819-152-2-201001190-00006; Eriksen J, 2006, PAIN, V125, P172, DOI 10.1016/j.pain.2006.06.009; Finnerup NB, 2010, PAIN, V150, P573, DOI 10.1016/j.pain.2010.06.019; Fischer B, 2013, PHARMACOEPIDEM DR S, V22, P438, DOI 10.1002/pds.3404; Gomes T, 2011, ARCH INTERN MED, V171, P686, DOI 10.1001/archinternmed.2011.117; Hooper MM, 2007, INT J OBESITY, V31, P114, DOI 10.1038/sj.ijo.0803349; Ives TJ, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-46; Jones CM, 2013, JAMA-J AM MED ASSOC, V309, P657, DOI 10.1001/jama.2013.272; Josbeno DA, 2010, SURG OBES RELAT DIS, V6, P361, DOI 10.1016/j.soard.2008.08.003; Khoueir P, 2009, SPINE J, V9, P454, DOI 10.1016/j.spinee.2009.02.003; Korenkov M, 2007, OBES SURG, V17, P679, DOI 10.1007/s11695-007-9118-y; Liebschutz JM, 2010, J PAIN, V11, P1047, DOI 10.1016/j.jpain.2009.10.012; Mainous AG, 2013, AM J GASTROENTEROL, V108, P1218, DOI 10.1038/ajg.2012.365; Martell BA, 2007, ANN INTERN MED, V146, P116, DOI 10.7326/0003-4819-146-2-200701160-00006; Martin BC, 2011, J GEN INTERN MED, V26, P1450, DOI 10.1007/s11606-011-1771-0; Merskey H, 1994, CLASSIFICATION CHRON, DOI DOI 10.1016/0304-3959(86)90113-2; Noble M, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006605.pub2; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Saber AA, 2008, OBES SURG, V18, P652, DOI 10.1007/s11695-008-9505-z; Salgado W, 2012, OBES SURG, V22, P519, DOI 10.1007/s11695-011-0480-4; Sasse KC, 2008, OBES SURG, V18, P530, DOI 10.1007/s11695-007-9335-4; Sullivan MD, 2010, PAIN, V150, P332, DOI 10.1016/j.pain.2010.05.020; Trescot AM, 2008, PAIN PHYSICIAN, V11, pS5; Turk D. C, 2001, BONICAS MANAGEMENT P, P18; Von Korff M, 2008, CLIN J PAIN, V24, P521, DOI 10.1097/AJP.0b013e318169d03b; WOODROW KM, 1972, PSYCHOSOM MED, V34, P548, DOI 10.1097/00006842-197211000-00007	37	158	158	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 2	2013	310	13					1369	1376		10.1001/jama.2013.278344	http://dx.doi.org/10.1001/jama.2013.278344			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	227GB	24084922	Bronze			2022-12-28	WOS:000325098100022
J	Richardson, R				Richardson, Ruth			The art of medicine	LANCET			English	Editorial Material									The Lancet, London NW1 7BY, England		Richardson, R (corresponding author), The Lancet, London NW1 7BY, England.								0	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 28	2013	382	9898					E8	E9		10.1016/S0140-6736(13)62023-1	http://dx.doi.org/10.1016/S0140-6736(13)62023-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	228SG	24083310				2022-12-28	WOS:000325208100001
J	Reinhardt, K; Dowling, DK; Morrow, EH				Reinhardt, Klaus; Dowling, Damian K.; Morrow, Edward H.			Mitochondrial Replacement, Evolution, and the Clinic	SCIENCE			English	Editorial Material							GENE-THERAPY; DISEASE; MTDNA		[Reinhardt, Klaus] Univ Tubingen, D-72076 Tubingen, Germany; [Reinhardt, Klaus] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England; [Dowling, Damian K.] Monash Univ, Sch Biol Sci, Clayton, Vic 3800, Australia; [Morrow, Edward H.] Univ Sussex, Sch Life Sci, Evolut Behav & Environm Grp, Brighton BN1 9QG, E Sussex, England	Eberhard Karls University of Tubingen; University of Sheffield; Monash University; University of Sussex	Reinhardt, K (corresponding author), Univ Tubingen, D-72076 Tubingen, Germany.	k.reinhardt@uni-tuebingen.de	Morrow, Edward H/Q-6730-2019; Dowling, Damian/C-9016-2009	Morrow, Edward H/0000-0002-1853-7469; Dowling, Damian/0000-0003-2209-3458				Craven L, 2010, NATURE, V465, P82, DOI 10.1038/nature08958; Frank SA, 1996, NATURE, V383, P224, DOI 10.1038/383224a0; Gemmell NJ, 2004, TRENDS ECOL EVOL, V19, P238, DOI 10.1016/j.tree.2004.02.002; Haites N, 2011, SCI REV SAFETY EFFIC; HFEA, MIT PUBL CONS 2012; HFEA, HFEA LAUNCH PUBL CON; Innocenti P, 2011, SCIENCE, V332, P845, DOI 10.1126/science.1201157; Nuffield Council on Bioethics, 2012, NOV TECHN PREV MIT D; Paull D, 2013, NATURE, V493, P632, DOI 10.1038/nature11800; Sato A, 2005, P NATL ACAD SCI USA, V102, P16765, DOI 10.1073/pnas.0506197102; Tachibana M, 2013, NATURE, V493, P627, DOI 10.1038/nature11647; Tachibana M, 2009, NATURE, V461, P367, DOI 10.1038/nature08368; Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606; Woodson JD, 2008, NAT REV GENET, V9, P383, DOI 10.1038/nrg2348	14	118	118	5	108	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 20	2013	341	6152					1345	1346		10.1126/science.1237146	http://dx.doi.org/10.1126/science.1237146			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	220PK	24052294				2022-12-28	WOS:000324597200027
J	Junttila, MR; de Sauvage, FJ				Junttila, Melissa R.; de Sauvage, Frederic J.			Influence of tumour micro-environment heterogeneity on therapeutic response	NATURE			English	Review							ENDOTHELIAL GROWTH-FACTOR; ANTI-VEGF THERAPY; METASTATIC COLORECTAL-CANCER; SPONTANEOUS MAMMARY-TUMORS; RANDOMIZED PHASE-II; BREAST-CANCER; LUNG-CANCER; CHEMOTHERAPY RESPONSE; MICROVESSEL DENSITY; STROMA PROMOTES	Tumour formation involves the co-evolution of neoplastic cells together with extracellular matrix, tumour vasculature and immune cells. Successful outgrowth of tumours and eventual metastasis is not determined solely by genetic alterations in tumour cells, but also by the fitness advantage such mutations confer in a given environment. As fitness is context dependent, evaluating tumours as complete organs, and not simply as masses of transformed epithelial cells, becomes paramount. The dynamic tumour topography varies drastically even throughout the same lesion. Heterologous cell types within tumours can actively influence therapeutic response and shape resistance.	[Junttila, Melissa R.; de Sauvage, Frederic J.] Genentech Inc, Dept Mol Biol, San Francisco, CA 94080 USA	Roche Holding; Genentech	de Sauvage, FJ (corresponding author), Genentech Inc, Dept Mol Biol, 1 DNA Way, San Francisco, CA 94080 USA.	desauvage.fred@gene.com	de Sauvage, Frederic/ABE-8400-2020	de Sauvage, Frederic/0000-0002-5275-2584				Ammirante M, 2010, NATURE, V464, P302, DOI 10.1038/nature08782; Arlen PM, 2006, CLIN CANCER RES, V12, P1260, DOI 10.1158/1078-0432.CCR-05-2059; Barcellos-Hoff MH, 2000, CANCER RES, V60, P1254; Bargou R, 2008, SCIENCE, V321, P974, DOI 10.1126/science.1158545; Bayne LJ, 2012, CANCER CELL, V21, P822, DOI 10.1016/j.ccr.2012.04.025; Bean J, 2007, P NATL ACAD SCI USA, V104, P20932, DOI 10.1073/pnas.0710370104; Beatty GL, 2011, SCIENCE, V331, P1612, DOI 10.1126/science.1198443; Bennouna J, 2013, LANCET ONCOL, V14, P29, DOI 10.1016/S1470-2045(12)70477-1; Bergers G, 2000, NAT CELL BIOL, V2, P737, DOI 10.1038/35036374; Berlin J, 2013, CLIN CANCER RES, V19, P258, DOI 10.1158/1078-0432.CCR-12-1800; Blagoev KB, 2013, CELL REP, V3, P277, DOI 10.1016/j.celrep.2013.01.015; Boni A, 2010, CANCER RES, V70, P5213, DOI 10.1158/0008-5472.CAN-10-0118; Brischwein K, 2007, J IMMUNOTHER, V30, P798, DOI 10.1097/CJI.0b013e318156750c; Buckanovich RJ, 2008, NAT MED, V14, P28, DOI 10.1038/nm1699; Calabrese C, 2007, CANCER CELL, V11, P69, DOI 10.1016/j.ccr.2006.11.020; Calle EE, 2004, NAT REV CANCER, V4, P579, DOI 10.1038/nrc1408; Catenacci D. V. T., 2012, J CLIN ONCOLOGY M, V30, P4022; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Cheever MA, 2008, CLIN CANCER RES, V14, P5692, DOI 10.1158/1078-0432.CCR-08-1266; Chung AS, 2012, J PATHOL, V227, P404, DOI 10.1002/path.4052; Ciampricotti M, 2012, NAT MED, V18, P344, DOI 10.1038/nm.2652; Coussens LM, 1999, GENE DEV, V13, P1382, DOI 10.1101/gad.13.11.1382; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; Crawford Y, 2009, CANCER CELL, V15, P21, DOI 10.1016/j.ccr.2008.12.004; de Groot JF, 2010, NEURO-ONCOLOGY, V12, P233, DOI 10.1093/neuonc/nop027; de Visser KE, 2005, CANCER CELL, V7, P411, DOI 10.1016/j.ccr.2005.04.014; DeNardo DG, 2011, CANCER DISCOV, V1, P54, DOI 10.1158/2159-8274.CD-10-0028; Deng GR, 1996, SCIENCE, V274, P2057, DOI 10.1126/science.274.5295.2057; Des Guetz G, 2006, BRIT J CANCER, V94, P1823, DOI 10.1038/sj.bjc.6603176; DeSilva DR, 1998, J IMMUNOL, V160, P4175; DOTTO GP, 1988, P NATL ACAD SCI USA, V85, P6389, DOI 10.1073/pnas.85.17.6389; Ebos JML, 2009, CANCER CELL, V15, P232, DOI 10.1016/j.ccr.2009.01.021; Egeblad M, 2010, DEV CELL, V18, P884, DOI 10.1016/j.devcel.2010.05.012; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Ferrara N, 2004, NAT REV DRUG DISCOV, V3, P391, DOI 10.1038/nrd1381; Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483; Fiegl H, 2006, CANCER RES, V66, P29, DOI 10.1158/0008-5472.CAN-05-2508; Finak G, 2008, NAT MED, V14, P518, DOI 10.1038/nm1764; Frederick DT, 2013, CLIN CANCER RES, V19, P1225, DOI 10.1158/1078-0432.CCR-12-1630; Fridman WH, 2012, NAT REV CANCER, V12, P298, DOI 10.1038/nrc3245; Friedman HS, 2009, J CLIN ONCOL, V27, P4733, DOI 10.1200/JCO.2008.19.8721; Fujita H, 2010, PANCREAS, V39, P1254, DOI 10.1097/MPA.0b013e3181dbf647; Gabrilovich DI, 1999, CLIN CANCER RES, V5, P2963; Gabrilovich DI, 2012, NAT REV IMMUNOL, V12, P253, DOI 10.1038/nri3175; Giantonio BJ, 2007, J CLIN ONCOL, V25, P1539, DOI 10.1200/JCO.2006.09.6305; Gilbert LA, 2010, CELL, V143, P355, DOI 10.1016/j.cell.2010.09.043; Hamzah J, 2008, NATURE, V453, P410, DOI 10.1038/nature06868; Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022; Hegde PS, 2013, CLIN CANCER RES, V19, P929, DOI 10.1158/1078-0432.CCR-12-2535; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Hu M, 2005, NAT GENET, V37, P899, DOI 10.1038/ng1596; Hurwitz HI, 2005, J CLIN ONCOL, V23, P3502, DOI 10.1200/JCO.2005.10.017; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Johansson A, 2012, P NATL ACAD SCI USA, V109, P7841, DOI 10.1073/pnas.1118296109; Jubb AM, 2011, BRIT J CANCER, V104, P1877, DOI 10.1038/bjc.2011.147; Kalluri R, 2003, NAT REV CANCER, V3, P422, DOI 10.1038/nrc1094; Kantoff PW, 2010, NEW ENGL J MED, V363, P411, DOI 10.1056/NEJMoa1001294; Kaye SB, 2012, CLIN CANCER RES, V18, P6509, DOI 10.1158/1078-0432.CCR-12-1796; Kindler HL, 2005, J CLIN ONCOL, V23, P8033, DOI 10.1200/JCO.2005.01.9661; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Krishnamurthy S, 2010, CANCER RES, V70, P9969, DOI 10.1158/0008-5472.CAN-10-1712; Krtolica A, 2001, P NATL ACAD SCI USA, V98, P12072, DOI 10.1073/pnas.211053698; Lake RA, 2005, NAT REV CANCER, V5, P397, DOI 10.1038/nrc1613; Lambrechts D, 2013, J CLIN ONCOL, V31, P1219, DOI 10.1200/JCO.2012.46.2762; Landsberg J, 2012, NATURE, V490, P412, DOI 10.1038/nature11538; Lu J, 2013, CANCER CELL, V23, P171, DOI 10.1016/j.ccr.2012.12.021; Lu KV, 2012, CANCER CELL, V22, P21, DOI 10.1016/j.ccr.2012.05.037; Madden J, INFINITY REPORTS UPD; Mantovani A, 2010, CURR OPIN IMMUNOL, V22, P231, DOI 10.1016/j.coi.2010.01.009; Mao Q, 2013, J CANCER RES CLIN, V139, P211, DOI 10.1007/s00432-012-1310-3; Meads MB, 2009, NAT REV CANCER, V9, P665, DOI 10.1038/nrc2714; Meert AP, 2002, BRIT J CANCER, V87, P694, DOI 10.1038/sj.bjc.6600551; Mellman I, 2011, NATURE, V480, P480, DOI 10.1038/nature10673; Michael M, 1999, J CLIN ONCOL, V17, P1802, DOI 10.1200/JCO.1999.17.6.1802; Miles D, 2011, J CLIN ONCOL, V29, P83, DOI 10.1200/JCO.2010.30.2794; Motz GT, 2011, NAT REV IMMUNOL, V11, P702, DOI 10.1038/nri3064; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Nelson BH, 2010, J IMMUNOL, V185, P4977, DOI 10.4049/jimmunol.1001323; Nielsen JS, 2012, CLIN CANCER RES, V18, P3281, DOI 10.1158/1078-0432.CCR-12-0234; Ohuchida K, 2004, CANCER RES, V64, P3215, DOI 10.1158/0008-5472.CAN-03-2464; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Paez-Ribes M, 2009, CANCER CELL, V15, P220, DOI 10.1016/j.ccr.2009.01.027; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Patocs A, 2007, NEW ENGL J MED, V357, P2543, DOI 10.1056/NEJMoa071825; Perren TJ, 2011, NEW ENGL J MED, V365, P2484, DOI 10.1056/NEJMoa1103799; Phan VT, 2013, P NATL ACAD SCI USA, V110, P6079, DOI 10.1073/pnas.1303302110; Polanska UM, 2013, J CELL PHYSIOL, V228, P1651, DOI 10.1002/jcp.24347; Provenzano PP, 2012, CANCER CELL, V21, P418, DOI 10.1016/j.ccr.2012.01.007; Pylayeva-Gupta Y, 2012, CANCER CELL, V21, P836, DOI 10.1016/j.ccr.2012.04.024; Qiu W, 2008, NAT GENET, V40, P650, DOI 10.1038/ng.117; Quante M, 2011, CANCER CELL, V19, P257, DOI 10.1016/j.ccr.2011.01.020; Rinn JL, 2006, PLOS GENET, V2, P1084, DOI 10.1371/journal.pgen.0020119; Robert C, 2011, NEW ENGL J MED, V364, P2517, DOI 10.1056/NEJMoa1104621; Rosenberg RD, 1999, NEW ENGL J MED, V340, P1555, DOI 10.1056/NEJM199905203402007; Rosenberg SA, 2008, NAT REV CANCER, V8, P299, DOI 10.1038/nrc2355; Rudnick JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024605; Sandler A, 2006, NEW ENGL J MED, V355, P2542, DOI 10.1056/NEJMoa061884; Schmidt M, 2008, CANCER RES, V68, P5405, DOI 10.1158/0008-5472.CAN-07-5206; Sequist LV, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002003; Shojaei F, 2007, NAT BIOTECHNOL, V25, P911, DOI 10.1038/nbt1323; Shojaei F, 2009, P NATL ACAD SCI USA, V106, P6742, DOI 10.1073/pnas.0902280106; Shrimali RK, 2010, CANCER RES, V70, P6171, DOI 10.1158/0008-5472.CAN-10-0153; Singh M, 2012, NAT BIOTECHNOL, V30, P648, DOI 10.1038/nbt.2286; Singh M, 2012, J PATHOL, V227, P417, DOI 10.1002/path.4053; Straussman R, 2012, NATURE, V487, P500, DOI 10.1038/nature11183; Sun Y, 2012, NAT MED, V18, P1359, DOI 10.1038/nm.2890; Tewari KS, 2013, J CLIN ONCOL S, V31; Theunissen JW, 2009, CANCER RES, V69, P6007, DOI 10.1158/0008-5472.CAN-09-0756; Tosolini M, 2011, CANCER RES, V71, P1263, DOI 10.1158/0008-5472.CAN-10-2907; Tredan O, 2007, J NATL CANCER I, V99, P1441, DOI 10.1093/jnci/djm135; Uzzan B, 2004, CANCER RES, V64, P2941, DOI 10.1158/0008-5472.CAN-03-1957; Van der Veldt AAM, 2012, CANCER CELL, V21, P82, DOI 10.1016/j.ccr.2011.11.023; Vihinen P, 2002, INT J CANCER, V99, P157, DOI 10.1002/ijc.10329; Vredenburgh JJ, 2007, J CLIN ONCOL, V25, P4722, DOI 10.1200/JCO.2007.12.2440; Wagle N, 2011, J CLIN ONCOL, V29, P3085, DOI 10.1200/JCO.2010.33.2312; Wilson TR, 2012, NATURE, V487, P505, DOI 10.1038/nature11249; Xu JY, 2013, CANCER RES, V73, P2782, DOI 10.1158/0008-5472.CAN-12-3981; Yamashita M, 2012, BREAST CANCER-TOKYO, V19, P170, DOI 10.1007/s12282-010-0234-5; Yang FC, 2008, CELL, V135, P437, DOI 10.1016/j.cell.2008.08.041; Yang JC, 2003, NEW ENGL J MED, V349, P427, DOI 10.1056/NEJMoa021491; Yang L, 2004, CANCER CELL, V6, P409, DOI 10.1016/j.ccr.2004.08.031; Yang SX, 2008, CLIN CANCER RES, V14, P5893, DOI 10.1158/1078-0432.CCR-07-4762; Zitvogel L, 2008, NAT REV IMMUNOL, V8, P59, DOI 10.1038/nri2216; Zitvogel L, 2012, NAT MED, V18, P346, DOI 10.1038/nm.2690	125	1617	1670	38	633	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 19	2013	501	7467					346	354		10.1038/nature12626	http://dx.doi.org/10.1038/nature12626			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219XT	24048067				2022-12-28	WOS:000324545700033
J	Rompolas, P; Mesa, KR; Greco, V				Rompolas, Panteleimon; Mesa, Kailin R.; Greco, Valentina			Spatial organization within a niche as a determinant of stem-cell fate	NATURE			English	Article							HAIR FOLLICLE BULGE; LABEL-RETAINING CELLS; SELF-RENEWAL; WOUND REPAIR; IN-VIVO; HOMEOSTASIS; DISTINCT; SKIN; LGR5; IDENTIFICATION	Stem-cell niches in mammalian tissues are often heterogeneous and compartmentalized; however, whether distinct niche locations determine different stem-cell fates remains unclear. To test this hypothesis, here we use the mouse hair follicle niche and combine intravital microscopy with genetic lineage tracing to re-visit the same stem-cell lineages, from their exact place of origin, throughout regeneration in live mice. Using this method, we show directly that the position of a stem cell within the hair follicle niche can predict whether it is likely to remain uncommitted, generate precursors or commit to a differentiated fate. Furthermore, using laser ablation we demonstrate that hair follicle stem cells are dispensable for regeneration, and that epithelial cells, which do not normally participate in hair growth, re-populate the lost stem-cell compartment and sustain hair regeneration. This study provides a general model for niche-induced fate determination in adult tissues.	[Rompolas, Panteleimon; Mesa, Kailin R.; Greco, Valentina] Yale Univ, Sch Med, Dept Genet, Dept Dermatol,Yale Stem Cell Ctr,Yale Canc Ctr, New Haven, CT 06510 USA	Yale University	Greco, V (corresponding author), Yale Univ, Sch Med, Dept Genet, Dept Dermatol,Yale Stem Cell Ctr,Yale Canc Ctr, New Haven, CT 06510 USA.	valentina.greco@yale.edu		Rompolas, Panteleimon/0000-0001-9135-7651; Mesa, Kailin/0000-0003-4452-9048	New York Stem Cell Foundation; American Cancer Society [RGS-12-059-01-DCC]; National Institute of Arthritis and Musculoskeletal and Skin Diseases [1RO1AR063663-01]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR063663] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007223] Funding Source: NIH RePORTER	New York Stem Cell Foundation; American Cancer Society(American Cancer Society); National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to S. King, S. Guo and A. Horwich for critical feedback on the manuscript. We thank E. Fuchs for the K14-H2BGFP, Lef1-RFP and pTRE-H2BGFP mice, A. Glick for the K5-tTA mice and G. Gu for the K19-CreER mice. We thank D. Gonzalez and A. Haberman for technical support with intravital microscopy. P. R. is a New York Stem Cell Foundation-Druckenmiller Fellow. This work was supported by The New York Stem Cell Foundation and by grants to V. G. from the American Cancer Society (RGS-12-059-01-DCC) and the National Institute of Arthritis and Musculoskeletal and Skin Diseases (1RO1AR063663-01).	Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barroca V, 2009, NAT CELL BIOL, V11, P190, DOI 10.1038/ncb1826; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Buczacki SJA, 2013, NATURE, V495, P65, DOI 10.1038/nature11965; Chi W, 2013, DEVELOPMENT, V140, P1676, DOI 10.1242/dev.090662; Claudinot S, 2005, P NATL ACAD SCI USA, V102, P14677, DOI 10.1073/pnas.0507250102; Copley MR, 2012, CELL STEM CELL, V10, P690, DOI 10.1016/j.stem.2012.05.006; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; Diamond I, 2000, J INVEST DERMATOL, V115, P788, DOI 10.1046/j.1523-1747.2000.00144.x; Ding L, 2013, NATURE, V495, P231, DOI 10.1038/nature11885; Fuchs E, 2009, CELL, V137, P811, DOI 10.1016/j.cell.2009.05.002; Greco V, 2010, DEVELOPMENT, V137, P1585, DOI 10.1242/dev.041103; Greco V, 2009, CELL STEM CELL, V4, P155, DOI 10.1016/j.stem.2008.12.009; Greenbaum A, 2013, NATURE, V495, P227, DOI 10.1038/nature11926; Hsu YC, 2011, CELL, V144, P92, DOI 10.1016/j.cell.2010.11.049; Ito M, 2005, NAT MED, V11, P1351, DOI 10.1038/nm1328; Ito M, 2004, DIFFERENTIATION, V72, P548, DOI 10.1111/j.1432-0436.2004.07209008.x; JAHODA CAB, 1984, NATURE, V311, P560, DOI 10.1038/311560a0; Jaks V, 2008, NAT GENET, V40, P1291, DOI 10.1038/ng.239; Kaufman CK, 2003, GENE DEV, V17, P2108, DOI 10.1101/gad.1115203; Kopp HG, 2005, PHYSIOLOGY, V20, P349, DOI 10.1152/physiol.00025.2005; Legue E, 2005, DEVELOPMENT, V132, P4143, DOI 10.1242/dev.01975; Li LH, 2010, SCIENCE, V327, P542, DOI 10.1126/science.1180794; Liu YP, 2003, J INVEST DERMATOL, V121, P963, DOI 10.1046/j.1523-1747.2003.12600.x; Lo Celso C, 2009, NATURE, V457, P92, DOI 10.1038/nature07434; Lopez-Garcia C, 2010, SCIENCE, V330, P822, DOI 10.1126/science.1196236; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Means AL, 2008, GENESIS, V46, P318, DOI 10.1002/dvg.20397; Morris RJ, 2004, NAT BIOTECHNOL, V22, P411, DOI 10.1038/nbt950; Muller-Rover S, 2001, J INVEST DERMATOL, V117, P3, DOI 10.1046/j.0022-202x.2001.01377.x; Nystul T, 2007, CELL STEM CELL, V1, P277, DOI 10.1016/j.stem.2007.07.009; Plikus MV, 2012, SEMIN CELL DEV BIOL, V23, P946, DOI 10.1016/j.semcdb.2012.10.001; Rendl M, 2005, PLOS BIOL, V3, P1910, DOI 10.1371/journal.pbio.0030331; Rompolas P, 2012, NATURE, V487, P496, DOI 10.1038/nature11218; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Sato T, 2009, NAT MED, V15, P696, DOI 10.1038/nm.1973; Scadden DT, 2006, NATURE, V441, P1075, DOI 10.1038/nature04957; Sequeira I, 2012, DEVELOPMENT, V139, P3741, DOI 10.1242/dev.081091; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Spradling AC, 2008, COLD SH Q B, V73, P49, DOI 10.1101/sqb.2008.73.023; Takeda N, 2011, SCIENCE, V334, P1420, DOI 10.1126/science.1213214; Trempus CS, 2003, J INVEST DERMATOL, V120, P501, DOI 10.1046/j.1523-1747.2003.12088.x; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Van Keymeulen A, 2012, J CELL BIOL, V197, P575, DOI 10.1083/jcb.201201041; Vasioukhin V, 1999, P NATL ACAD SCI USA, V96, P8551, DOI 10.1073/pnas.96.15.8551; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Xie YC, 2009, NATURE, V457, P97, DOI 10.1038/nature07639; Youssef KK, 2010, NAT CELL BIOL, V12, P299, DOI 10.1038/ncb2031; Zhang YV, 2009, CELL STEM CELL, V5, P267, DOI 10.1016/j.stem.2009.06.004	49	270	273	1	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 24	2013	502	7472					513	+		10.1038/nature12602	http://dx.doi.org/10.1038/nature12602			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	238YN	24097351	Green Accepted, Green Published			2022-12-28	WOS:000325988400046
J	Deshmukh, VA; Tardif, V; Lyssiotis, CA; Green, CC; Kerman, B; Kim, HJ; Padmanabhan, K; Swoboda, JG; Ahmad, I; Kondo, T; Gage, FH; Theofilopoulos, AN; Lawson, BR; Schultz, PG; Lairson, LL				Deshmukh, Vishal A.; Tardif, Virginie; Lyssiotis, Costas A.; Green, Chelsea C.; Kerman, Bilal; Kim, Hyung Joon; Padmanabhan, Krishnan; Swoboda, Jonathan G.; Ahmad, Insha; Kondo, Toru; Gage, Fred H.; Theofilopoulos, Argyrios N.; Lawson, Brian R.; Schultz, Peter G.; Lairson, Luke L.			A regenerative approach to the treatment of multiple sclerosis	NATURE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; MUSCARINIC RECEPTOR SUBTYPES; CENTRAL-NERVOUS-SYSTEM; EMBRYONIC STEM-CELLS; OLIGODENDROCYTE DIFFERENTIATION; PROGENITOR CELLS; THYROID-HORMONE; PRECURSOR CELLS; MYELIN REPAIR; SPINAL-CORD	Progressive phases of multiple sclerosis are associated with inhibited differentiation of the progenitor cell population that generates the mature oligodendrocytes required for remyelination and disease remission. To identify selective inducers of oligodendrocyte differentiation, we performed an image-based screen for myelin basic protein (MBP) expression using primary rat optic-nerve-derived progenitor cells. Here we show that among the most effective compounds identifed was benztropine, which significantly decreases clinical severity in the experimental autoimmune encephalomyelitis (EAE) model of relapsing-remitting multiple sclerosis when administered alone or in combination with approved immunosuppressive treatments for multiple sclerosis. Evidence from a cuprizone-inducedmodel of demyelination, in vitro and in vivo T-cell assays and EAE adoptive transfer experiments indicated that the observed efficacy of this drug results directly from an enhancement of remyelination rather than immune suppression. Pharmacological studies indicate that benztropine functions by a mechanism that involves direct antagonism of M1 and/or M3 muscarinic receptors. These studies should facilitate the development of effective new therapies for the treatment of multiple sclerosis that complement established immunosuppressive approaches.	[Deshmukh, Vishal A.; Lyssiotis, Costas A.; Green, Chelsea C.; Swoboda, Jonathan G.; Ahmad, Insha; Schultz, Peter G.; Lairson, Luke L.] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Tardif, Virginie; Theofilopoulos, Argyrios N.; Lawson, Brian R.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Kerman, Bilal; Kim, Hyung Joon; Padmanabhan, Krishnan; Gage, Fred H.] Salk Inst Biol Sci, Lab Genet, La Jolla, CA 92037 USA; [Kondo, Toru] Hokkaido Univ, Inst Med Genet, Div Stem Cell Biol, Kita Ku, Sapporo, Hokkaido 0600815, Japan; [Schultz, Peter G.; Lairson, Luke L.] Calif Inst Biomed Res, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute; Salk Institute; Hokkaido University	Lawson, BR (corresponding author), Scripps Res Inst, Dept Immunol & Microbial Sci, 10550 North Torrey Pines Rd, La Jolla, CA 92037 USA.	blawson@scripps.edu; schultz@scripps.edu; llairson@scripps.edu	TARDIF, Virginie/U-4383-2019; Lyssiotis, Costas A/AAI-1923-2019; Kerman, Bilal Ersen/W-7237-2019; Tardif, Virginie/M-9665-2019	TARDIF, Virginie/0000-0001-5604-6524; Lyssiotis, Costas A/0000-0001-9309-6141; Kerman, Bilal Ersen/0000-0003-1106-3288; Lairson, Luke/0000-0001-6701-996X	Skaggs Institute for Chemical Biology; California Institute for Regenerative Medicine [TR3-05617, TG2-01165]; National Science Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053228, R37AR039555, R21AR065384] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K99MH101634, R00MH101634] Funding Source: NIH RePORTER	Skaggs Institute for Chemical Biology; California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the Skaggs Institute for Chemical Biology and the California Institute for Regenerative Medicine grant TR3-05617 (to P. G. S), the California Institute for Regenerative Medicine (TG2-01165) and National Science Foundation pre-doctoral fellowships (to V. A. D and C. A. L, respectively). We are grateful to T. Hasnat, M. Chadwell, W. Kiosses and M. Wood for technical support. This is manuscript number 21786 of The Scripps Research Institute.	Agoston GE, 1997, J MED CHEM, V40, P4329, DOI 10.1021/jm970525a; Aharoni R, 2011, J AUTOIMMUN, V37, P228, DOI 10.1016/j.jaut.2011.06.003; Baer AS, 2009, BRAIN, V132, P465, DOI 10.1093/brain/awn334; BARRES BA, 1992, CELL, V70, P31, DOI 10.1016/0092-8674(92)90531-G; BARRES BA, 1994, DEVELOPMENT, V120, P1097; Belachew S, 2003, J CELL BIOL, V161, P169, DOI 10.1083/jcb.200210110; Billon N, 2001, DEV BIOL, V235, P110, DOI 10.1006/dbio.2001.0293; Brinkmann V, 2002, J BIOL CHEM, V277, P21453, DOI 10.1074/jbc.C200176200; Buckley CE, 2010, NEUROPHARMACOLOGY, V59, P149, DOI 10.1016/j.neuropharm.2010.04.014; Calza L, 2010, J MOL ENDOCRINOL, V44, P13, DOI 10.1677/JME-09-0067; Chang A, 2002, NEW ENGL J MED, V346, P165, DOI 10.1056/NEJMoa010994; Chari DM, 2003, J NEUROSCI RES, V73, P787, DOI 10.1002/jnr.10700; De Angelis F, 2012, DEV NEUROBIOL, V72, P713, DOI 10.1002/dneu.20976; Durelli L, 2002, LANCET, V359, P1453, DOI 10.1016/S0140-6736(02)08430-1; ESHLEMAN AJ, 1994, MOL PHARMACOL, V45, P312; FELDER CC, 1995, FASEB J, V9, P619, DOI 10.1096/fasebj.9.8.7768353; Fernandez M, 2004, P NATL ACAD SCI USA, V101, P16363, DOI 10.1073/pnas.0407262101; Franklin RJM, 2002, NAT REV NEUROSCI, V3, P705, DOI 10.1038/nrn917; Franklin RJM, 2008, NAT REV NEUROSCI, V9, P839, DOI 10.1038/nrn2480; GARD AL, 1990, NEURON, V5, P615, DOI 10.1016/0896-6273(90)90216-3; Gaspard N, 2009, NAT PROTOC, V4, P1454, DOI 10.1038/nprot.2009.157; Gensert JM, 1997, NEURON, V19, P197, DOI 10.1016/S0896-6273(00)80359-1; HART IK, 1989, J CELL BIOL, V109, P3411, DOI 10.1083/jcb.109.6.3411; Horner PJ, 2000, J NEUROSCI, V20, P2218; Huang JK, 2011, NAT NEUROSCI, V14, P45, DOI 10.1038/nn.2702; Ibanez C, 2003, PROG NEUROBIOL, V71, P49, DOI 10.1016/j.pneurobio.2003.09.002; Izrael M, 2007, MOL CELL NEUROSCI, V34, P310, DOI 10.1016/j.mcn.2006.11.008; Joubert L, 2010, J NEUROSCI RES, V88, P2546, DOI 10.1002/jnr.22434; Kappos L, 2006, NEW ENGL J MED, V355, P1124, DOI 10.1056/NEJMoa052643; Kawashima K, 2008, J PHARMACOL SCI, V106, P167, DOI 10.1254/jphs.FM0070073; Kondo T, 2000, EMBO J, V19, P1998, DOI 10.1093/emboj/19.9.1998; Kremer D, 2011, ANN NEUROL, V69, P602, DOI 10.1002/ana.22415; Kuhlmann T, 2008, BRAIN, V131, P1749, DOI 10.1093/brain/awn096; Lawson BR, 2007, J IMMUNOL, V178, P5366, DOI 10.4049/jimmunol.178.8.5366; Liu LP, 2010, J NEUROSCI, V30, P9074, DOI 10.1523/JNEUROSCI.1238-10.2010; Matsushima GK, 2001, BRAIN PATHOL, V11, P107; MCKEARNEY JW, 1982, PSYCHOPHARMACOLOGY, V77, P156, DOI 10.1007/BF00431939; Mi S, 2007, NAT MED, V13, P1228, DOI 10.1038/nm1664; Mix E, 2008, J NEUROL, V255, P7, DOI 10.1007/s00415-008-6003-0; NORONHA A, 1993, J NEUROIMMUNOL, V46, P145, DOI 10.1016/0165-5728(93)90244-S; Nunes MC, 2003, NAT MED, V9, P439, DOI 10.1038/nm837; OWENS T, 1995, NEUROL CLIN, V13, P51, DOI 10.1016/S0733-8619(18)30061-6; Pang Y, 2012, BRAIN BEHAV, V2, P53, DOI 10.1002/brb3.33; Patel JR, 2011, FEBS LETT, V585, P3730, DOI 10.1016/j.febslet.2011.04.037; Pfeiffer Steve E., 1993, Trends in Cell Biology, V3, P191, DOI 10.1016/0962-8924(93)90213-K; Ragheb F, 2001, J NEUROCHEM, V77, P1396, DOI 10.1046/j.1471-4159.2001.00356.x; Steelman AJ, 2012, NEUROSCI RES, V72, P32, DOI 10.1016/j.neures.2011.10.002; Steinman L, 2005, TRENDS IMMUNOL, V26, P565, DOI 10.1016/j.it.2005.08.014; Stern JNH, 2010, P NATL ACAD SCI USA, V107, P17280, DOI 10.1073/pnas.1010263107; Stidworthy MF, 2004, BRAIN, V127, P1928, DOI 10.1093/brain/awh217; Taveggia C, 2010, NAT REV NEUROL, V6, P276, DOI 10.1038/nrneurol.2010.37; Tokumoto YM, 2001, EMBO J, V20, P5261, DOI 10.1093/emboj/20.18.5261; Wang SL, 2001, NEURON, V29, P603, DOI 10.1016/S0896-6273(01)00237-9; Wolswijk G, 1998, J NEUROSCI, V18, P601	54	337	352	5	162	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 17	2013	502	7471					327	+		10.1038/nature12647	http://dx.doi.org/10.1038/nature12647			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235GY	24107995	Green Accepted			2022-12-28	WOS:000325706300044
J	van Dijk, FS; Zillikens, MC; Micha, D; Riessland, M; Marcelis, CLM; de Die-Smulders, CE; Milbradt, J; Franken, AA; Harsevoort, AJ; Lichtenbelt, KD; Pruijs, HE; Rubio-Gozalbo, ME; Zwertbroek, R; Moutaouakil, Y; Egthuijsen, J; Hammerschmidt, M; Bijman, R; Semeins, CM; Bakker, AD; Everts, V; Klein-Nulend, J; Campos-Obando, N; Hofman, A; te Meerman, GJ; Verkerk, AJMH; Uitterlinden, AG; Maugeri, A; Sistermans, EA; Waisfisz, Q; Meijers-Heijboer, H; Wirth, B; Simon, MEH; Pals, G				van Dijk, Fleur S.; Zillikens, M. Carola; Micha, Dimitra; Riessland, Markus; Marcelis, Carlo L. M.; de Die-Smulders, Christine E.; Milbradt, Janine; Franken, Anton A.; Harsevoort, Arjan J.; Lichtenbelt, Klaske D.; Pruijs, Hans E.; Rubio-Gozalbo, M. Estela; Zwertbroek, Rolf; Moutaouakil, Youssef; Egthuijsen, Jaqueline; Hammerschmidt, Matthias; Bijman, Renate; Semeins, Cor M.; Bakker, Astrid D.; Everts, Vincent; Klein-Nulend, Jenneke; Campos-Obando, Natalia; Hofman, Albert; te Meerman, Gerard J.; Verkerk, Annemieke J. M. H.; Uitterlinden, Andre G.; Maugeri, Alessandra; Sistermans, Erik A.; Waisfisz, Quinten; Meijers-Heijboer, Hanne; Wirth, Brunhilde; Simon, Marleen E. H.; Pals, Gerard			PLS3 Mutations in X-Linked Osteoporosis with Fractures	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACTIN; PLASTIN	Plastin 3 (PLS3), a protein involved in the formation of filamentous actin (F-actin) bundles, appears to be important in human bone health, on the basis of pathogenic variants in PLS3 in five families with X-linked osteoporosis and osteoporotic fractures that we report here. The bone-regulatory properties of PLS3 were supported by in vivo analyses in zebrafish. Furthermore, in an additional five families (described in less detail) referred for diagnosis or ruling out of osteogenesis imperfecta type I, a rare variant (rs140121121) in PLS3 was found. This variant was also associated with a risk of fracture among elderly heterozygous women that was two times as high as that among noncarriers, which indicates that genetic variation in PLS3 is a novel etiologic factor involved in common, multi-factorial osteoporosis.	[van Dijk, Fleur S.; Micha, Dimitra; Moutaouakil, Youssef; Egthuijsen, Jaqueline; Bijman, Renate; Maugeri, Alessandra; Sistermans, Erik A.; Waisfisz, Quinten; Meijers-Heijboer, Hanne; Pals, Gerard] Vrije Univ Amsterdam, Med Ctr, Dept Clin Genet, Ctr Connect Tissue Res, NL-1007 MB Amsterdam, Netherlands; [Zillikens, M. Carola; Campos-Obando, Natalia; Verkerk, Annemieke J. M. H.; Uitterlinden, Andre G.] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands; [Hofman, Albert; Uitterlinden, Andre G.] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Simon, Marleen E. H.] Erasmus MC, Dept Clin Genet, Rotterdam, Netherlands; [Marcelis, Carlo L. M.] Radboud Univ Nijmegen, Med Ctr, Dept Genet, NL-6525 ED Nijmegen, Netherlands; [de Die-Smulders, Christine E.] Maastricht Univ, Med Ctr, Dept Clin Genet, Maastricht, Netherlands; [Rubio-Gozalbo, M. Estela] Maastricht Univ, Med Ctr, Dept Pediat, Maastricht, Netherlands; [Rubio-Gozalbo, M. Estela] Maastricht Univ, Med Ctr, Dept Pediat & Lab Genet Metab Dis, Maastricht, Netherlands; [Franken, Anton A.] Isala Clin Zwolle, Dept Internal Med, Zwolle, Netherlands; [Harsevoort, Arjan J.] Isala Clin Zwolle, Dept Orthoped, Zwolle, Netherlands; [Lichtenbelt, Klaske D.] Univ Med Ctr Utrecht, Dept Med Genet, Utrecht, Netherlands; [Pruijs, Hans E.] Wilhelmina Childrens Hosp, Univ Med Ctr Utrecht, Dept Pediat Orthoped, Utrecht, Netherlands; [Zwertbroek, Rolf] Westfries Gasthuis, Dept Internal Med, Hoorn, Netherlands; [Semeins, Cor M.; Bakker, Astrid D.; Everts, Vincent; Klein-Nulend, Jenneke] Univ Amsterdam, Acad Ctr Dent Amsterdam, Dept Oral Cell Biol, Amsterdam, Netherlands; [Semeins, Cor M.; Bakker, Astrid D.; Everts, Vincent; Klein-Nulend, Jenneke] Vrije Univ Amsterdam, MOVE Res Inst Amsterdam, Amsterdam, Netherlands; [te Meerman, Gerard J.] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, NL-9700 AB Groningen, Netherlands; [Riessland, Markus; Milbradt, Janine; Wirth, Brunhilde] Univ Cologne, Inst Genet, Inst Human Genet, Cologne, Germany; [Riessland, Markus; Milbradt, Janine; Wirth, Brunhilde] Univ Cologne, Ctr Mol Med Cologne, D-50931 Cologne, Germany; [Hammerschmidt, Matthias] Univ Cologne, Dept Dev Biol, D-50931 Cologne, Germany	Vrije Universiteit Amsterdam; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Radboud University Nijmegen; Maastricht University; Maastricht University; Maastricht University; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; Academic Center for Dentistry Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; University of Groningen; University of Cologne; University of Cologne; University of Cologne	Pals, G (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Clin Genet, Ctr Connect Tissue Res, POB 7057, NL-1007 MB Amsterdam, Netherlands.	g.pals@vumc.nl; g.pals@vumc.nl	Bakker, Astrid Diana/AAD-1286-2019; Wirth, Brunhilde/H-3192-2019; Sistermans, Erik/B-1109-2009; Marcelis, C.L.M./L-4504-2015; Riessland, Markus/AAM-6708-2021; Micha, Dimitra/U-4979-2019; Rubio-Gozalbo, M Estela/H-1833-2011	Sistermans, Erik/0000-0001-7187-4563; Marcelis, C.L.M./0000-0001-7095-4641; Micha, Dimitra/0000-0001-7890-4411; Waisfisz, Quinten/0000-0002-7384-9182; Wirth, Brunhilde/0000-0003-4051-5191; Pals, Gerard/0000-0003-4091-7115; Verkerk, Annemieke JMH/0000-0002-7523-3656; Riessland, Markus/0000-0003-2592-5045	Erasmus Medical Center; Erasmus University, Rotterdam; Netherlands Organization of Scientific Research (NWO) [175.010.2005.011, 911-03-012]; Research Institute for Diseases in the Elderly [014-93-015, RIDE2]; Ministry of Education, Culture, and Science; Ministry for Health, Welfare, and Sports; Directorate-General XII of the European Commission; NWO [050-060-810]; Netherlands Consortium of Healthy Aging; Municipality of Rotterdam; European Union [2012-305121]; Deutsche Forschungsgemeinschaft [Wi945-14/1]	Erasmus Medical Center; Erasmus University, Rotterdam; Netherlands Organization of Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Research Institute for Diseases in the Elderly; Ministry of Education, Culture, and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry for Health, Welfare, and Sports; Directorate-General XII of the European Commission; NWO(Netherlands Organization for Scientific Research (NWO)); Netherlands Consortium of Healthy Aging; Municipality of Rotterdam; European Union(European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Supported by grants to the Rotterdam Study from Erasmus Medical Center and Erasmus University, Rotterdam; the Netherlands Organization of Scientific Research (NWO) Investments (175.010.2005.011 and 911-03-012); the Research Institute for Diseases in the Elderly (014-93-015 and RIDE2); the Ministry of Education, Culture, and Science; the Ministry for Health, Welfare, and Sports; Directorate-General XII of the European Commission; the Netherlands Genomics Initiative and NWO Project (050-060-810); the Netherlands Consortium of Healthy Aging; and the Municipality of Rotterdam. The zebrafish studies were supported by grants from the European Union Program FP7 Program (2012-305121), Deutsche Forschungsgemeinschaft (Wi945-14/1, to Dr. Wirth), and SMA-Europe (to Dr. Riessland). The col1a1:eGFP transgenic line was a gift from Dr. Shannon Fisher to Dr. Hammerschmidt's laboratory.	Ackermann B, 2013, HUM MOL GENET, V22, P1328, DOI 10.1093/hmg/dds540; Ameziane N, 2012, ANEMIA, V2012, DOI 10.1155/2012/132856; Bacabac RG, 2006, FASEB J, V20, P858, DOI 10.1096/fj.05-4966.com; Bonewald LF, 2011, J BONE MINER RES, V26, P229, DOI 10.1002/jbmr.320; Clarke L, 2012, NAT METHODS, V9, P1, DOI [10.1038/NMETH.1974, 10.1038/nmeth.1974]; Clayton D, 2008, BIOSTATISTICS, V9, P593, DOI 10.1093/biostatistics/kxn007; DEARRUDA MV, 1990, J CELL BIOL, V111, P1069, DOI 10.1083/jcb.111.3.1069; Delanote V, 2005, ACTA PHARMACOL SIN, V26, P769, DOI 10.1111/j.1745-7254.2005.00145.x; Estrada K, 2012, NAT GENET, V44, P491, DOI 10.1038/ng.2249; Hartikka H, 2005, J BONE MINER RES, V20, P783, DOI 10.1359/JBMR.050101; Hofman A, 2011, EUR J EPIDEMIOL, V26, P657, DOI 10.1007/s10654-011-9610-5; Kague E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047394; Kamioka H, 2004, J BONE MINER RES, V19, P471, DOI 10.1359/JBMR.040128; KANIS JA, 1994, J BONE MINER RES, V9, P1137, DOI 10.1002/jbmr.5650090802; Keupp K, 2013, AM J HUM GENET, V92, P565, DOI 10.1016/j.ajhg.2013.02.010; Laine CM, 2013, NEW ENGL J MED, V368, P1809, DOI 10.1056/NEJMoa1215458; Laine CM, 2012, AM J MED GENET A, V158A, P1252, DOI 10.1002/ajmg.a.35278; Mulvihill BM, 2010, CLIN BIOMECH, V25, P491, DOI 10.1016/j.clinbiomech.2010.01.006; Oprea GE, 2008, SCIENCE, V320, P524, DOI 10.1126/science.1155085; Shwartz Y, 2012, DEV BIOL, V370, P154, DOI 10.1016/j.ydbio.2012.07.026; Sillence DO, 1980, BONE DYSPLASIA GENET; Tanaka-Kamioka K, 1998, J BONE MINER RES, V13, P1555, DOI 10.1359/jbmr.1998.13.10.1555; van der Pauw MTM, 2000, J PERIODONTAL RES, V35, P335, DOI 10.1034/j.1600-0765.2000.035006335.x; van Dijk FS, 2013, EUR J HUM GENET, V21, DOI 10.1038/ejhg.2012.210; Weinbaum S, 2011, CELL MOL BIOENG, V4, P510, DOI 10.1007/s12195-011-0179-6	25	131	134	0	25	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 17	2013	369	16					1529	1536		10.1056/NEJMoa1308223	http://dx.doi.org/10.1056/NEJMoa1308223			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	267MJ	24088043	Green Published			2022-12-28	WOS:000328101700010
J	Walsh, CA				Walsh, Christopher A.			Peter Huttenlocher (1931-2013) OBITUARY	NATURE			English	Biographical-Item									[Walsh, Christopher A.] Howard Hughes Med Inst, Boston, MA 02115 USA; [Walsh, Christopher A.] Boston Childrens Hosp, Boston, MA USA; [Walsh, Christopher A.] Harvard Univ, Sch Med, Boston, MA USA	Howard Hughes Medical Institute; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Walsh, CA (corresponding author), Howard Hughes Med Inst, Boston, MA 02115 USA.	christopher.walsh@childrens.harvard.edu						HUTTENLOCHER PR, PUBLICATION LIST	1	6	6	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 10	2013	502	7470					172	172		10.1038/502172a	http://dx.doi.org/10.1038/502172a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RU	24108045	Bronze			2022-12-28	WOS:000325436100032
J	Zhu, M; Yu, XB; Ahlberg, PE; Choo, B; Lu, J; Qiao, T; Qu, QM; Zhao, WJ; Jia, LT; Blom, H; Zhu, YA				Zhu, Min; Yu, Xiaobo; Ahlberg, Per Erik; Choo, Brian; Lu, Jing; Qiao, Tuo; Qu, Qingming; Zhao, Wenjin; Jia, Liantao; Blom, Henning; Zhu, You'an			A Silurian placoderm with osteichthyan-like marginal jaw bones	NATURE			English	Article							FISHES; PTYCTODONTIDA; INFORMATION; INFERENCE; MRBAYES; ORIGIN	The gnathostome (jawed vertebrate) crown group comprises two extant clades with contrasting character complements. Notably, Chondrichthyes (cartilaginous fish) lack the large dermal bones that characterize Osteichthyes (bony fish and tetrapods). The polarities of these differences, and the morphology of the last common ancestor of crown gnathostomes, are the subject of continuing debate. Here we describe a three-dimensionally preserved 419-million-year-old placoderm fish from the Silurian of China that represents the first stem gnathostome with dermal marginal jaw bones (premaxilla, maxilla and dentary), features previously restricted to Osteichthyes. A phylogenetic analysis places the new form near the top of the gnathostome stem group but does not fully resolve its relationships to other placoderms. The analysis also assigns all acanthodians to the chondrichthyan stem group. These results suggest that the last common ancestor of Chondrichthyes and Osteichthyes had a macromeric dermal skeleton, and provide a new framework for studying crown gnathostome divergence.	[Zhu, Min; Yu, Xiaobo; Choo, Brian; Lu, Jing; Qiao, Tuo; Zhao, Wenjin; Jia, Liantao; Zhu, You'an] Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Vertebrate Evolut & Human Origins, Beijing 100044, Peoples R China; [Yu, Xiaobo] Kean Univ, Dept Biol Sci, Union, NJ 07083 USA; [Ahlberg, Per Erik; Qu, Qingming; Blom, Henning] Uppsala Univ, Dept Organismal Biol, Evolutionary Biol Ctr, Subdept Evolut & Dev, S-75236 Uppsala, Sweden	Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; Uppsala University	Zhu, M (corresponding author), Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Vertebrate Evolut & Human Origins, Beijing 100044, Peoples R China.	zhumin@ivpp.ac.cn	Qiao, Tuo/AAJ-6317-2021; Zhu, Min/E-8728-2012; min, zhu/AAL-6712-2021; Yu, Xiaobo/G-7160-2011; Qu, Qingming/R-7194-2016	Qiao, Tuo/0000-0002-0488-7265; Zhu, Min/0000-0002-4786-0898; Yu, Xiaobo/0000-0001-9600-7888; Qu, Qingming/0000-0002-8291-8493; Choo, Brian/0000-0002-9983-0762; Zhao, Wenjin/0000-0002-9649-2171; Ahlberg, Per/0000-0001-9054-2900	Major State Basic Research Projects of MST of China [2012CB821902]; National Natural Science Foundation of China [40930208]; ERC [233111]; Knut and Alice Wallenberg Foundation	Major State Basic Research Projects of MST of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); ERC(European Research Council (ERC)European Commission); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation)	We thank M.-M. Chang, J. Long, G. Young, D. Goujet and J.-Q. Wang for discussions, X.-F. Lu, J. Zhang and C.-H. Xiong for specimen preparation, Y.-M. Hou for X-ray micro-computerized tomography. This work was supported by the Major State Basic Research Projects (2012CB821902) of MST of China, and the National Natural Science Foundation of China (40930208). P. E. A. and Q. Q. were supported by ERC Advanced Investigator Grant 233111 and a Wallenberg Scholarship from the Knut and Alice Wallenberg Foundation, both awarded to P.E.A.	[Anonymous], 2011, RISE FISHES 500 MILL; Botella H, 2007, NATURE, V448, P583, DOI 10.1038/nature05989; Brazeau MD, 2009, NATURE, V457, P305, DOI 10.1038/nature07436; Burrow CJ, 2011, PALAEONTOLOGY, V54, P207, DOI 10.1111/j.1475-4983.2010.01003.x; Davis SP, 2012, NATURE, V486, P247, DOI 10.1038/nature11080; Denison R., 1978, Handbook of Paleoichthyology, V2, P1; FOREY PL, 1986, ZOOL J LINN SOC-LOND, V86, P43, DOI 10.1111/j.1096-3642.1986.tb01807.x; Friedman M, 2010, J VERTEBR PALEONTOL, V30, P36, DOI 10.1080/02724630903409071; Gardiner B.G., 1984, Bulletin of the British Museum (Natural History) Geology, V37, P173; Gardiner B.G., 1984, Journal of Vertebrate Paleontology, V4, P379; Goujet D., 1973, Palaeontographica Abt A, V143, P73; Goujet D, 2001, SYST ASSOC SPEC VOL, V61, P209; Goujet D, 1984, POISSONS PLACODERMES; Goujet D.F., 1984, Proceedings of the Linnean Society of New South Wales, V107, P211; Gross W., 1962, C INT CTR NATL RECHE, V104, P69; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Janvier P., 1996, EARLY VERTEBRATES; Jarvik E., 1980, BASIC STRUCTURE EVOL, V1; Johanson Z, 2002, LETHAIA, V35, P169, DOI 10.1080/002411602320184024; Liu Yu-hai, 1991, P139; Maddison W.P., 2008, MESQUITE MODULAR SYS; MAISEY J G, 1986, Cladistics, V2, P201, DOI 10.1111/j.1096-0031.1986.tb00462.x; Miles R. S., 1971, PALAEOZOIC FISHES; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Schaeffer B., 1975, PROBLEMES ACTUELS PA, V218, P101; Schultze HP, 2001, SYST ASSOC SPEC VOL, V61, P315; SCHULTZE HP, 1993, SKULL, V2, P189; Sorenson M. D., 1999, TREEROT PROGRAM DOCU, V2; Stensio E., 1963, Kungliga Svenska Vetenskapsakademiens Handlingar (4), V9, P1; Swofford D.L., 2003, PAUP VERSION 40 B10; Trinajstic K, 2012, J VERTEBR PALEONTOL, V32, P757, DOI 10.1080/02724634.2012.661379; Young GC, 2010, ANNU REV EARTH PL SC, V38, P523, DOI 10.1146/annurev-earth-040809-152507; YOUNG GC, 1986, ZOOL J LINN SOC-LOND, V88, P1, DOI 10.1111/j.1096-3642.1986.tb00876.x; YOUNG GC, 1979, ZOOL J LINN SOC-LOND, V66, P309, DOI 10.1111/j.1096-3642.1979.tb01912.x; Zhao Wen-Jin, 2010, Palaeoworld, V19, P4, DOI 10.1016/j.palwor.2009.11.007; Zhu M, 2001, SYST ASSOC SPEC VOL, V61, P289; Zhu M, 1999, NATURE, V397, P607, DOI 10.1038/17594; Zhu Min, 2012, Vertebrata Palasiatica, V50, P1; Zhu M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035103; Zhu M, 2009, NATURE, V458, P469, DOI 10.1038/nature07855	40	185	198	2	101	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 10	2013	502	7470					188	+		10.1038/nature12617	http://dx.doi.org/10.1038/nature12617			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RU	24067611				2022-12-28	WOS:000325436100041
J	Firstenberg, O; Peyronel, T; Liang, QY; Gorshkov, AV; Lukin, MD; Vuletic, V				Firstenberg, Ofer; Peyronel, Thibault; Liang, Qi-Yu; Gorshkov, Alexey V.; Lukin, Mikhail D.; Vuletic, Vladan			Attractive photons in a quantum nonlinear medium	NATURE			English	Article							ELECTROMAGNETICALLY INDUCED TRANSPARENCY; STRONGLY INTERACTING PHOTONS; PHASE-SHIFTS; OPTICS; CAVITY; ATOMS; GATE	The fundamental properties of light derive from its constituent particles-massless quanta (photons) that do not interact with one another(1). However, it has long been known that the realization of coherent interactions between individual photons, akin to those associated with conventional massive particles, could enable a wide variety of novel scientific and engineering applications(2,3). Here we demonstrate a quantum nonlinear medium inside which individual photons travel as massive particles with strong mutual attraction, such that the propagation of photon pairs is dominated by a two-photon bound state(4-7). We achieve this through dispersive coupling of light to strongly interacting atoms in highly excited Rydberg states. We measure the dynamical evolution of the two-photon wave-function using time-resolved quantum state tomography, and demonstrate a conditional phase shift(8) exceeding one radian, resulting in polarization-entangled photon pairs. Particular applications of this technique include all-optical switching, deterministic photonic quantum logic and the generation of strongly correlated states of light(9).	[Firstenberg, Ofer; Lukin, Mikhail D.] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Peyronel, Thibault; Liang, Qi-Yu; Vuletic, Vladan] MIT, Dept Phys, Cambridge, MA 02139 USA; [Peyronel, Thibault; Liang, Qi-Yu; Vuletic, Vladan] MIT, Elect Res Lab, Cambridge, MA 02139 USA; [Gorshkov, Alexey V.] CALTECH, Inst Quantum Informat & Matter, Pasadena, CA 91125 USA	Harvard University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); California Institute of Technology	Lukin, MD (corresponding author), Harvard Univ, Dept Phys, Cambridge, MA 02138 USA.	lukin@fas.harvard.edu; vuletic@mit.edu	Firstenberg, Ofer/A-6381-2015; Liang, Qiyu/D-9523-2012; Gorshkov, Alexey V/A-9848-2008; Vuletic, Vladan/M-8736-2019	Firstenberg, Ofer/0000-0001-8905-9954; Gorshkov, Alexey V/0000-0003-0509-3421; 	NSF; CUA; DARPA; AFOSR Quantum Memories MURI Foundation; Packard Foundation; HQOC; Lee A. DuBridge Foundation; IQIM, an NSF Physics Frontiers Center; Gordon and Betty Moore Foundation	NSF(National Science Foundation (NSF)); CUA; DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); AFOSR Quantum Memories MURI Foundation; Packard Foundation(The David & Lucile Packard Foundation); HQOC; Lee A. DuBridge Foundation; IQIM, an NSF Physics Frontiers Center(National Science Foundation (NSF)); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation)	We thank H. P. Buchler, T. Pohl, J. Otterbach, P. Strack, M. Gullans and S. Choi for discussions. This work was supported by the NSF, the CUA, DARPA and the AFOSR Quantum Memories MURI and the Packard Foundations. O.F. acknowledges support from the HQOC. A. V. G. and M. D. L. thank KITP for hospitality. A. V. G. acknowledges funding from the Lee A. DuBridge Foundation and the IQIM, an NSF Physics Frontiers Center with support of the Gordon and Betty Moore Foundation.	Adamson RBA, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.043601; Chang DE, 2008, NAT PHYS, V4, P884, DOI 10.1038/nphys1074; Chang DE, 2007, NAT PHYS, V3, P807, DOI 10.1038/nphys708; Chen W, 2013, SCIENCE, V341, P768, DOI 10.1126/science.1238169; CHENG Z, 1995, PHYS REV LETT, V75, P3430, DOI 10.1103/PhysRevLett.75.3430; DEUTSCH IH, 1992, PHYS REV LETT, V69, P3627, DOI 10.1103/PhysRevLett.69.3627; Drummond PD, 1997, PHYS REV A, V56, pR1107, DOI 10.1103/PhysRevA.56.R1107; Dudin YO, 2012, SCIENCE, V336, P887, DOI 10.1126/science.1217901; Fleischhauer M, 2005, REV MOD PHYS, V77, P633, DOI 10.1103/RevModPhys.77.633; Fushman I, 2008, SCIENCE, V320, P769, DOI 10.1126/science.1154643; Gorshkov AV, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.133602; Heidemann R, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.163601; Imamoglu A, 1997, PHYS REV LETT, V79, P1467, DOI 10.1103/PhysRevLett.79.1467; James DFV, 2001, PHYS REV A, V64, DOI 10.1103/PhysRevA.64.052312; KASAPI A, 1995, PHYS REV LETT, V74, P2447, DOI 10.1103/PhysRevLett.74.2447; Kirchmair G, 2013, NATURE, V495, P205, DOI 10.1038/nature11902; Lukin MD, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.037901; Maxwell D, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.103001; MILBURN GJ, 1989, PHYS REV LETT, V62, P2124, DOI 10.1103/PhysRevLett.62.2124; Parigi V, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.233602; Petrosyan D, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.213601; Peyronel T, 2012, NATURE, V488, P57, DOI 10.1038/nature11361; Pritchard JD, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.193603; Rajapakse RM, 2009, PHYS REV A, V80, DOI 10.1103/PhysRevA.80.013810; Rauschenbeutel A, 1999, PHYS REV LETT, V83, P5166, DOI 10.1103/PhysRevLett.83.5166; Saffman M, 2010, REV MOD PHYS, V82, P2313, DOI 10.1103/RevModPhys.82.2313; Scully M.O., 1997, QUANTUM OPT; Sevincli S, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.153001; Shen JT, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.153003; TURCHETTE QA, 1995, PHYS REV LETT, V75, P4710, DOI 10.1103/PhysRevLett.75.4710; Venkataraman V, 2013, NAT PHOTONICS, V7, P138, DOI [10.1038/NPHOTON.2012.283, 10.1038/nphoton.2012.283]	31	288	290	4	176	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 3	2013	502	7469					71	+		10.1038/nature12512	http://dx.doi.org/10.1038/nature12512			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	227IM	24067613	Green Submitted			2022-12-28	WOS:000325106000032
J	ten Broek, RPG; Issa, Y; van Santbrink, EJP; Bouvy, ND; Kruitwagen, RFPM; Jeekel, J; Bakkum, EA; Rovers, MM; van Goor, H				ten Broek, Richard P. G.; Issa, Yama; van Santbrink, Evert J. P.; Bouvy, Nicole D.; Kruitwagen, Roy F. P. M.; Jeekel, Johannes; Bakkum, Erica A.; Rovers, Maroeska M.; van Goor, Harry			Burden of adhesions in abdominal and pelvic surgery: systematic review and met-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SMALL-BOWEL OBSTRUCTION; CONSEQUENCES; READMISSIONS; MORBIDITY; COLECTOMY; RESECTION; CANCER; TRIAL	Objective To estimate the disease burden of the most important complications of postoperative abdominal adhesions: small bowel obstruction, difficulties at reoperation, infertility, and chronic pain. Design Systematic review and meta-analyses. Data sources Searches of PubMed, Embase, and Central, from January 1990 to December 2012, without restrictions to publication status or language. Study selection All types of studies reporting on the incidence of adhesion related complications were considered. Data extraction and analysis The primary outcome was the incidence of adhesive small bowel obstruction in patients with a history of abdominal surgery. Secondary outcomes were the incidence of small bowel obstruction by any cause, difference in operative time, enterotomy during adhesiolysis, and pregnancy rate after abdominal surgery. Subgroup and sensitivity analyses were done to study the robustness of the results. A random effects model was used to account for heterogeneity between studies. Results We identified 196 eligible papers. Heterogeneity was considerable for almost all meta-analyses. The origin of heterogeneity could not be explained by study design, study quality, publication date, anatomical site of operation, or operative technique. The incidence of small bowel obstruction by any cause after abdominal surgery was 9% (95% confidence interval 7% to 10%; I-2=99%). the incidence of adhesive small bowel obstruction was 2% (2% to 3%; I-2=93%); presence of adhesions was generally confirmed by emergent reoperation. In patients with a known cause of small bowel obstruction, adhesions were the single most common cause (56%, 49% to 64%; I-2=96%). Operative time was prolonged by 15 minutes (95% confidence interval 9.3 to 21.1 minutes; I-2=85%) in patients with previous surgery. Use of adhesiolysis resulted in a 6% (4% to 8%; I-2=89%) incidence of iatrogenic bowel injury. The pregnancy rate after colorectal surgery in patients with inflammatory bowel disease was 50% (37% to 63%; I-2=94%), which was significantly lower than the pregnancy rate in medically treated patients (82%, 70% to 94%; I-2=97%). Conclusions This review provides detailed and systematically analysed knowledge of the disease burden of adhesions. Complications of postoperative adhesion formation are frequent, have a large negative effect on patients' health, and increase workload in clinical practice. The quantitative effects should be interpreted with caution owing to large heterogeneity.	[ten Broek, Richard P. G.; Issa, Yama; van Goor, Harry] Radboud Univ Nijmegen, Med Ctr, Dept Surg, NL-6500 HB Nijmegen, Netherlands; [van Santbrink, Evert J. P.] Reinier de Graaf Grp, Dept Reprod Med, Voorburg, Netherlands; [Bouvy, Nicole D.] Maastricht Univ, Med Ctr, Dept Surg, Maastricht, Netherlands; [Kruitwagen, Roy F. P. M.] Maastricht Univ, Med Ctr, Dept Obstet & Gynaecol, Maastricht, Netherlands; [Kruitwagen, Roy F. P. M.] Maastricht Univ, Med Ctr, Sch Oncol & Dev Biol, GROW, Maastricht, Netherlands; [Jeekel, Johannes] Erasmus MC, Dept Neurosci, Rotterdam, Netherlands; [Bakkum, Erica A.] Onze Lieve Vrouwe Gasthuis Amsterdam, Dept Obstet & Gynaecol, Amsterdam, Netherlands; [Rovers, Maroeska M.] Radboud Univ Nijmegen, Med Ctr, Dept Operating Rooms, NL-6500 HB Nijmegen, Netherlands; [Rovers, Maroeska M.] Radboud Univ Nijmegen, Med Ctr, Dept Hlth Evidence, NL-6500 HB Nijmegen, Netherlands	Radboud University Nijmegen; Reinier de Graaf Hospital; Maastricht University; Maastricht University; Maastricht University; Erasmus University Rotterdam; Erasmus MC; Radboud University Nijmegen; Radboud University Nijmegen	ten Broek, RPG (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Surg, POB 9101, NL-6500 HB Nijmegen, Netherlands.	richard_tenbroek@hotmail.com	van Goor, H./H-8035-2014; Broek, Richard PG ten/M-9038-2016; Bouvy, Nicole/AAD-2844-2021; Rovers, Maroeska/F-2969-2014	van Goor, H./0000-0003-0323-4876; Broek, Richard PG ten/0000-0002-4012-7968; Rovers, Maroeska/0000-0002-3095-170X; Kruitwagen, Roy F.P.M./0000-0002-1305-9541; Issa, Yama/0000-0002-0191-8871				Ahmad G, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006583.pub2; Beck DE, 1999, DIS COLON RECTUM, V42, P241, DOI 10.1007/BF02237135; De Wilde RL, 2012, GYNECOL SURG, V9, P365, DOI 10.1007/s10397-012-0764-2; Ellis H, 2004, HOSP MED, V65, P348, DOI 10.12968/hosp.2004.65.6.13736; Ellis H, 1999, LANCET, V353, P1476, DOI 10.1016/S0140-6736(98)09337-4; Fazio VW, 2006, DIS COLON RECTUM, V49, P1, DOI 10.1007/s10350-005-0268-5; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Kumar S, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005080.pub2; Leung TTW, 2009, ANN SURG, V250, P51, DOI 10.1097/SLA.0b013e3181ad64a7; Lower AM, 2004, HUM REPROD, V19, P1877, DOI 10.1093/humrep/deh321; MacLean AR, 2002, ANN SURG, V235, P200, DOI 10.1097/00000658-200202000-00007; Ng SSM, 2009, DIS COLON RECTUM, V52, P558, DOI 10.1007/DCR.0b013e31819ec20c; Nieuwenhuijzen M, 1998, BRIT J SURG, V85, P1242; Olsen KO, 2002, GASTROENTEROLOGY, V122, P15, DOI 10.1053/gast.2002.30345; Parikh JA, 2008, AM SURGEON, V74, P1001; Parker MC, 2007, COLORECTAL DIS, V9, P66, DOI 10.1111/j.1463-1318.2007.01342.x; Parker MC, 2001, DIS COLON RECTUM, V44, P822, DOI 10.1007/BF02234701; Schreinemacher MHF, 2010, WORLD J SURG, V34, P2805, DOI 10.1007/s00268-010-0778-8; Taylor GW, 2010, BRIT J SURG, V97, P70, DOI 10.1002/bjs.6742; ten Broek RPG, 2013, HUM REPROD UPDATE, V19, P12, DOI 10.1093/humupd/dms032; ten Broek RPG, 2013, ANN SURG, V258, P98, DOI 10.1097/SLA.0b013e31826f4969; Trew G, 2009, GYNECOL SURG, V6, P25, DOI 10.1007/s10397-008-0409-7; van der Krabben AA, 2000, BRIT J SURG, V87, P467, DOI 10.1046/j.1365-2168.2000.01394.x; van Goor H, 2007, COLORECTAL DIS, V9, P25, DOI 10.1111/j.1463-1318.2007.01358.x	24	282	291	4	38	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 3	2013	347								f5588	10.1136/bmj.f5588	http://dx.doi.org/10.1136/bmj.f5588			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	231OX	24092941	Green Published, hybrid			2022-12-28	WOS:000325427700001
J	Gregersen, PK; Manjarrez-Orduno, N				Gregersen, Peter K.; Manjarrez-Orduno, Nataly			FOXO in the Hole: Leveraging GWAS for Outcome and Function	CELL			English	Editorial Material								GWAS studies of autoimmune disorders have yielded hundreds of replicated associations, but moving from genetic association to functional studies with potential clinical relevance is a challenge. Leveraging GWAS data, Lee et al. now identify FOXO3 activity as predictive of disease severity in Crohn's disease and rheumatoid arthritis as well as malaria, likely by acting through regulation of cytokine production in monocytes.	[Gregersen, Peter K.; Manjarrez-Orduno, Nataly] Feinstein Inst Med Res, Robert S Boas Ctr Genom & Human Genet, Manhasset, NY 11030 USA	Northwell Health	Gregersen, PK (corresponding author), Feinstein Inst Med Res, Robert S Boas Ctr Genom & Human Genet, 350 Community Dr, Manhasset, NY 11030 USA.	peterg@nshs.edu		Manjarrez Orduno, Nataly/0000-0002-7569-1673				Cho JH, 2011, NEW ENGL J MED, V365, P1612, DOI 10.1056/NEJMra1100030; Dejean AS, 2009, NAT IMMUNOL, V10, P504, DOI 10.1038/ni.1729; Gregersen PK, 2012, CURR OPIN IMMUNOL, V24, P538, DOI 10.1016/j.coi.2012.09.003; Hedrick SM, 2009, NAT IMMUNOL, V10, P1057, DOI 10.1038/ni.1784; Lee JC, 2013, CELL, V155, P57, DOI 10.1016/j.cell.2013.08.034; Litvak V, 2012, NATURE, V490, P421, DOI 10.1038/nature11428; McCarthy JJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005785; McKinney EF, 2010, NAT MED, V16, P586, DOI 10.1038/nm.2130; Plenge RM, 2013, NAT GENET, V45, P468, DOI 10.1038/ng.2623	9	8	8	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 26	2013	155	1					11	12		10.1016/j.cell.2013.08.050	http://dx.doi.org/10.1016/j.cell.2013.08.050			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	224UX	24074853	Bronze			2022-12-28	WOS:000324916700001
J	Ozcan, U				Ozcan, Umut			Mitofusins: Mighty Regulators of Metabolism	CELL			English	Editorial Material							MITOCHONDRIAL FUSION	Mitochondria are central regulators of cellular metabolism but how their function in a subset of cells affects whole-body energy balance is less understood. Two studies in this issue of Cell identify how diet-dependent modulation of mitochondrial fusion in specific neuronal circuits impact the metabolic status of an animal.	Harvard Univ, Sch Med, Boston Childrens Hosp, Div Endocrinol, Boston, MA 02130 USA	Harvard University; Boston Children's Hospital; Harvard Medical School	Ozcan, U (corresponding author), Harvard Univ, Sch Med, Boston Childrens Hosp, Div Endocrinol, Boston, MA 02130 USA.	umut.ozcan@childrens.harvard.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK098496, R01DK081009] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01DK098496, R01DK081009, R01 DK098496] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Dietrich MO, 2013, CELL, V155, P188, DOI 10.1016/j.cell.2013.09.004; ERNSTER L, 1981, J CELL BIOL, V91, pS227, DOI 10.1083/jcb.91.3.227s; Eura Y, 2003, J BIOCHEM, V134, P333, DOI 10.1093/jb/mvg150; Green DR, 1998, CELL, V94, P695, DOI 10.1016/S0092-8674(00)81728-6; Horvath TL, 2010, P NATL ACAD SCI USA, V107, P14875, DOI 10.1073/pnas.1004282107; Ishihara N, 2004, J CELL SCI, V117, P6535, DOI 10.1242/jcs.01565; PALADE GE, 1953, J HISTOCHEM CYTOCHEM, V1, P188, DOI 10.1177/1.4.188; Pinto S, 2004, SCIENCE, V304, P110, DOI 10.1126/science.1089459; Santel A, 2003, J CELL SCI, V116, P2763, DOI 10.1242/jcs.00479; Schneeberger M, 2013, CELL, V155, P172, DOI 10.1016/j.cell.2013.09.003	10	9	10	0	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 26	2013	155	1					17	18		10.1016/j.cell.2013.09.013	http://dx.doi.org/10.1016/j.cell.2013.09.013			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	224UX	24074856	Bronze			2022-12-28	WOS:000324916700004
J	Gabbai, FP				Gabbai, Francois P.			Lewis Acids with a Difference	SCIENCE			English	Editorial Material							HYDRODEFLUORINATION; FLUORIDE		Texas A&M Univ, Dept Chem, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Gabbai, FP (corresponding author), Texas A&M Univ, Dept Chem, College Stn, TX 77843 USA.	francois@tamu.edu	Gabbai, Francois P./B-7575-2014	Gabbai, Francois P./0000-0003-4788-2998	Direct For Mathematical & Physical Scien [1300371] Funding Source: National Science Foundation	Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))		Caputo CB, 2013, SCIENCE, V341, P1374, DOI 10.1126/science.1241764; Chen EYX, 2000, CHEM REV, V100, P1391, DOI 10.1021/cr980462j; Douvris C, 2008, SCIENCE, V321, P1188, DOI 10.1126/science.1159979; Erker G, 2005, DALTON T, P1883, DOI 10.1039/b503688g; Hudnall TW, 2008, J AM CHEM SOC, V130, P10890, DOI 10.1021/ja804492y; Ke IS, 2012, J AM CHEM SOC, V134, P15309, DOI 10.1021/ja308194w; Kornath A, 2003, INORG CHEM, V42, P2894, DOI 10.1021/ic020663c; Krossing I, 2004, CHEM-EUR J, V10, P5017, DOI 10.1002/chem.200400087; Olah GA, 2005, J ORG CHEM, V70, P2413, DOI 10.1021/jo040285o; Piers WE, 2005, ADV ORGANOMET CHEM, V52, P1, DOI 10.1016/S0065-3055(04)52001-4; Reed CA, 2010, ACCOUNTS CHEM RES, V43, P121, DOI 10.1021/ar900159e; SCHMIDBA.H, 1972, ANGEW CHEM INT EDIT, V11, P144, DOI 10.1002/anie.197201442; Stephan DW, 2009, DALTON T, P3129, DOI 10.1039/b819621d	13	13	13	0	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 20	2013	341	6152					1348	1349		10.1126/science.1244423	http://dx.doi.org/10.1126/science.1244423			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	220PK	24052295				2022-12-28	WOS:000324597200029
J	Clay-Williams, R				Clay-Williams, Robyn			Military rather than civil aviation holds the answers for safer healthcare	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ New S Wales, Fac Med, Australian Inst Hlth Innovat, Ctr Clin Governance Res, Sydney, NSW 2052, Australia	University of New South Wales Sydney	Clay-Williams, R (corresponding author), Univ New S Wales, Fac Med, Australian Inst Hlth Innovat, Ctr Clin Governance Res, Sydney, NSW 2052, Australia.	r.clay-williams@unsw.edu.au	Clay-Williams, Robyn/Y-1883-2019	Clay-Williams, Robyn/0000-0002-6107-7445				Braithwaite J, 2010, QUAL SAF HEALTH CARE, V19, P14, DOI 10.1136/qshc.2009.033928; Clay-Williams R, 2013, RESILIENT HLTH CARE; Gaba D. M., 2001, Simulation & Gaming, V32, P175, DOI 10.1177/104687810103200206; Haynes AB, 2009, NEW ENGL J MED, V360, P491, DOI 10.1056/NEJMsa0810119; Helmreich R, 1996, BALLIERES CLIN ANAES, V10, P277, DOI DOI 10.1016/S0950-3501(96)80017-1; Salas E, 2009, JT COMM J QUAL PATIE, V35, P398, DOI 10.1016/S1553-7250(09)35056-4; Sari ABA, 2007, BMJ-BRIT MED J, V334, P79, DOI 10.1136/bmj.39031.507153.AE; Sexton JB, 2000, BMJ-BRIT MED J, V320, P745, DOI 10.1136/bmj.320.7237.745; Wadhera RK, 2010, J THORAC CARDIOV SUR, V139, P312, DOI 10.1016/j.jtcvs.2009.10.048	9	0	0	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 19	2013	347								f5570	10.1136/bmj.f5570	http://dx.doi.org/10.1136/bmj.f5570			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	223SY	24052584				2022-12-28	WOS:000324831500005
J	Patel, K				Patel, Kinesh			Parking the issue	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												kinesh_patel@yahoo.co.uk							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 19	2013	347								f5617	10.1136/bmj.f5617	http://dx.doi.org/10.1136/bmj.f5617			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	223SY	24052585				2022-12-28	WOS:000324831500006
J	Mumtaz, Z; Salway, S; Bhatti, A; McIntyre, L				Mumtaz, Zubia; Salway, Sarah; Bhatti, Afshan; McIntyre, Lynn			Addressing invisibility, inferiority, and powerlessness to achieve gains in maternal health for ultra-poor women	LANCET			English	Editorial Material									[Mumtaz, Zubia] Univ Alberta, Sch Publ Hlth, Edmonton, AB T6G 1C9, Canada; [Salway, Sarah] Univ Sheffield, Sch Hlth & Related Res, Sch Publ Hlth Res, Natl Inst Hlth Res, Sheffield, S Yorkshire, England; [Bhatti, Afshan] Real Med Fdn, Islamabad, Pakistan; [McIntyre, Lynn] Univ Calgary, Fac Med, Calgary, AB T2N 1N4, Canada	University of Alberta; University of Sheffield; University of Calgary	Mumtaz, Z (corresponding author), Univ Alberta, Sch Publ Hlth, Edmonton Clin Hlth Acad 3 309, Edmonton, AB T6G 1C9, Canada.	zubia.mumtaz@ualberta.ca			Canadian Institutes of Health Research Funding Source: Medline	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))		Aliani S., CASTE PAKISTAN ELEPH; Barros AJD, 2012, LANCET, V379, P1225, DOI 10.1016/S0140-6736(12)60113-5; CHAMBERS R, 1995, ENVIRON URBAN, V7, P173, DOI 10.1177/095624789500700106; CSDH, 2008, CLOS GAP GEN HLTH EQ; Farmer PE, 2006, PLOS MED, V3, P1686, DOI 10.1371/journal.pmed.0030449; Galtung J., 1969, J PEACE RES, V6, P167, DOI DOI 10.1177/002234336900600301; Ghazdar H., 2007, EC POLIT WKLY, V42, P86; Hafeez A, 2011, J PAK MED ASSOC, V61, P210; Hulme D., 2001, 2 CPRC; Kabeer N, 2010, CAN MDGS PROVIDE PAT; Langer A, 2013, LANCET, V381, P601, DOI 10.1016/S0140-6736(13)60259-7; Lozano R, 2011, LANCET, V378, P1139, DOI 10.1016/S0140-6736(11)61337-8; Mahmood A, IMPROVING MATERNAL N; Mumtaz Z, 2011, BMC INT HEALTH HUM R, V11, DOI 10.1186/1472-698X-11-S2-S4; United Nations, 2000, UN MILL DECL GEN ASS; World Health Organization, MAK PREGN SAF CRIT R; World Health Organization, TRENDS MAT MORT 1990	17	14	14	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 22	2014	383	9922					1095	1097		10.1016/S0140-6736(13)61646-3	http://dx.doi.org/10.1016/S0140-6736(13)61646-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AD8MV	24095178				2022-12-28	WOS:000333521200035
J	Wong, DTL; Soh, SY; Nerlekar, N; Meredith, IT; Malaiapan, Y				Wong, Dennis T. L.; Soh, Siang Yong; Nerlekar, Nitesh; Meredith, Ian T.; Malaiapan, Yuvaraj			Identification of concomitant ruptured plaque and intracoronary thrombus by optical coherence tomography	LANCET			English	Editorial Material									[Wong, Dennis T. L.] Monash Univ, Monash Med Ctr, Dept Med, Monash Cardiovasc Res Ctr, Clayton, Vic 3168, Australia; [Wong, Dennis T. L.] Southern Hlth, Monash Heart, Clayton, Vic, Australia	Monash University	Wong, DTL (corresponding author), Monash Univ, Monash Med Ctr, Dept Med, Monash Cardiovasc Res Ctr, 246 Clayton Rd, Clayton, Vic 3168, Australia.	drdenniswong@yahoo.com.au		Nerlekar, Nitesh/0000-0002-3437-8648					0	8	8	1	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 8	2014	383	9916					E11	E11		10.1016/S0140-6736(13)60806-5	http://dx.doi.org/10.1016/S0140-6736(13)60806-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AA5KH	24075280				2022-12-28	WOS:000331136400001
J	Peralta, EA; Soong, K; England, RJ; Colby, ER; Wu, Z; Montazeri, B; McGuinness, C; McNeur, J; Leedle, KJ; Walz, D; Sozer, EB; Cowan, B; Schwartz, B; Travish, G; Byer, RL				Peralta, E. A.; Soong, K.; England, R. J.; Colby, E. R.; Wu, Z.; Montazeri, B.; McGuinness, C.; McNeur, J.; Leedle, K. J.; Walz, D.; Sozer, E. B.; Cowan, B.; Schwartz, B.; Travish, G.; Byer, R. L.			Demonstration of electron acceleration in a laser-driven dielectric microstructure	NATURE			English	Article								The enormous size and cost of current state-of-the-art accelerators based on conventional radio-frequency technology has spawned great interest in the development of new acceleration concepts that are more compact and economical. Micro-fabricated dielectric laser accelerators (DLAs) are an attractive approach, because such dielectric microstructures can support accelerating fields one to two orders of magnitude higher than can radio-frequency cavity-based accelerators. DLAs use commercial lasers as a power source, which are smaller and less expensive than the radio-frequency klystrons that power today's accelerators. In addition, DLAs are fabricated via low-cost, lithographic techniques that can be used for mass production. However, despite several DLA structures having been proposed recently(1-4), no successful demonstration of acceleration in these structures has so far been shown. Here we report high-gradient (beyond 250 MeV m(-1)) acceleration of electrons in a DLA. Relativistic (60-MeV) electrons are energy-modulated over 563 +/- 104 optical periods of a fused silica grating structure, powered by a 800-nm-wavelength mode-locked Ti:sapphire laser. The observed results are in agreement with analytical models and electrodynamic simulations. By comparison, conventional modern linear accelerators operate at gradients of 10-30 MeV m(-1), and the first linear radio-frequency cavity accelerator was ten radio-frequency periods (one metre) long with a gradient of approximately 1.6 MeV m(-1) (ref. 5). Our results set the stage for the development of future multi-staged DLA devices composed of integrated on-chip systems. This would enable compact table-top accelerators on the MeV-GeV (10(6)-10(9) eV) scale for security scanners and medical therapy, university-scale X-ray light sources for biological and materials research, and portable medical imaging devices, and would substantially reduce the size and cost of a future collider on the multi-TeV (10(12) eV) scale.	[Peralta, E. A.; Soong, K.; McGuinness, C.; Byer, R. L.] Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA; [England, R. J.; Colby, E. R.; Wu, Z.; Walz, D.] SLAC Natl Accelerator Lab, Menlo Pk, CA 94025 USA; [Montazeri, B.; Leedle, K. J.] Stanford Univ, Dept Elect Engn, Stanford, CA 94305 USA; [McNeur, J.; Sozer, E. B.; Travish, G.] Univ Calif Los Angeles, Dept Phys & Astron, Los Angeles, CA 90024 USA; [Cowan, B.; Schwartz, B.] Tech X Corp, Boulder, CO 80303 USA	Stanford University; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Stanford University; University of California System; University of California Los Angeles; Tech-X Corporation	Byer, RL (corresponding author), Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA.	rlbyer@stanford.edu	Sozer, Esin B/AAA-5318-2020; Travish, Gil/H-4937-2011; Wu, Ziran/G-2308-2014	Travish, Gil/0000-0002-4787-0949; Wu, Ziran/0000-0003-2009-991X; Sozer, Esin/0000-0002-6244-3670	US DoE [DE-FG03-92ER40693]; DARPA [N66001-11-1-4199]; NSF [ECS-9731293]; US Defense Threat Reduction Agency (DTRA) [HDTRA1-09-1-0043]	US DoE(United States Department of Energy (DOE)); DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NSF(National Science Foundation (NSF)); US Defense Threat Reduction Agency (DTRA)(United States Department of DefenseDefense Threat Reduction Agency)	We thank R. Noble, J. Spencer, O. Solgaard and J. Harris for discussions, J. Nelson, D. McCormick and K. Jobe for technical assistance at SLAC, and M. Tang, M. Mansourpour, N. Latta, M. Stevens, J. Conway and U. Thumser for technical assistance at the Stanford Nanofabrication Facility (SNF). This work was supported by the US DoE (grant no. DE-FG03-92ER40693) and DARPA (grant no. N66001-11-1-4199). Device fabrication took place at SNF, which is supported by the NSF under grant ECS-9731293. Work by G. T., J. M. and E. B. S. supported by US Defense Threat Reduction Agency (DTRA) grant HDTRA1-09-1-0043.	Breuer J., PHYS REV LE IN PRESS; Colby E.R., 2011, P 2011 PARTICLE ACCE, P262; Cowan BM, 2008, PHYS REV SPEC TOP-AC, V11, DOI 10.1103/PhysRevSTAB.11.011301; Duris JP, 2012, PHYS REV SPEC TOP-AC, V15, DOI 10.1103/PhysRevSTAB.15.061301; Ganter R, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.064801; GINZTON EL, 1948, REV SCI INSTRUM, V19, P89, DOI 10.1063/1.1741225; Lin XE, 2001, PHYS REV SPEC TOP-AC, V4, DOI 10.1103/PhysRevSTAB.4.051301; MARSHALL TC, 1985, FREE ELECT LASERS, P24; Mizrahi A, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.016505; MIZUNO K, 1987, NATURE, V328, P45, DOI 10.1038/328045a0; Moulton PF, 2009, IEEE J SEL TOP QUANT, V15, P85, DOI 10.1109/JSTQE.2008.2010719; PALMER RB, 1972, J APPL PHYS, V43, P3014, DOI 10.1063/1.1661650; Peralta EA, 2012, AIP CONF PROC, V1507, P169, DOI 10.1063/1.4773690; PIESTRUP MA, 1975, J APPL PHYS, V46, P132, DOI 10.1063/1.321334; Plettner T, 2008, NUCL INSTRUM METH A, V593, P63, DOI 10.1016/j.nima.2008.04.063; Plettner T, 2006, PHYS REV SPEC TOP-AC, V9, DOI 10.1103/PhysRevSTAB.9.111301; Plettner T, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.134801; Plettner T, 2011, J MOD OPTIC, V58, P1518, DOI 10.1080/09500340.2011.611914; Roberts Thomas J., 2007, 2007 IEEE Particle Accelerator Conference, P3468, DOI 10.1109/PAC.2007.4440461; Sears CMS, 2008, PHYS REV SPEC TOP-AC, V11, DOI 10.1103/PhysRevSTAB.11.061301; SHIMODA K, 1962, APPL OPTICS, V1, P33, DOI 10.1364/AO.1.000033; Siemann RH, 2004, PHYS REV SPEC TOP-AC, V7, DOI 10.1103/PhysRevSTAB.7.061303; Soong K, 2012, AIP CONF PROC, V1507, P511, DOI 10.1063/1.4773749; TAKEDA Y, 1968, NUCL INSTRUM METHODS, V62, P306, DOI 10.1016/0029-554X(68)90378-9; Thompson MC, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.214801; vanSteenbergen A, 1996, PHYS REV LETT, V77, P2690, DOI 10.1103/PhysRevLett.77.2690; WARNER C, 1954, PHYS REV, V93, P406, DOI 10.1103/PhysRev.93.406	27	312	315	11	186	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 7	2013	503	7474					91	+		10.1038/nature12664	http://dx.doi.org/10.1038/nature12664			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247AS	24077116				2022-12-28	WOS:000326585600037
J	Konno, H; Konno, K; Barber, GN				Konno, Hiroyasu; Konno, Keiko; Barber, Glen N.			Cyclic Dinucleotides Trigger ULK1 (ATG1) Phosphorylation of STING to Prevent Sustained Innate Immune Signaling	CELL			English	Article							TOLL-LIKE RECEPTORS; GMP-AMP SYNTHASE; DNA SENSOR; CGAS; 2ND-MESSENGER; AUTOPHAGY; PATHWAY; DISEASE; ADAPTER; FAMILY	Activation of the stimulator of interferon genes (STING) pathway by microbial or self-DNA, as well as cyclic dinucleotides (CDNs), results in the induction of numerous genes that suppress pathogen replication and facilitate adaptive immunity. However, sustained gene transcription is rigidly prevented to avoid lethal STING-dependent proinflammatory disease by mechanisms that remain unknown. We demonstrate here that, after autophagy-dependent STING delivery of TANK-binding kinase 1 (TBK1) to endosomal/lysosomal compartments and activation of transcription factors interferon regulatory factor 3 (IRF3) and NF-kB, STING is subsequently phosphorylated by serine/threonine UNC-51-like kinase (ULK1/ATG1), and IRF3 function is suppressed. ULK1 activation occurred following disassociation from its repressor AMP activated protein kinase (AMPK) and was elicited by CDNs generated by the cGAMP synthase, cGAS. Thus, although CDNs may initially facilitate STING function, they subsequently trigger negative-feedback control of STING activity, thus preventing the persistent transcription of innate immune genes.	[Konno, Hiroyasu; Konno, Keiko; Barber, Glen N.] Univ Miami, Sch Med, Dept Cell Biol, Miami, FL 33136 USA; [Konno, Hiroyasu; Konno, Keiko; Barber, Glen N.] Univ Miami, Sch Med, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA	University of Miami; University of Miami	Barber, GN (corresponding author), Univ Miami, Sch Med, Dept Cell Biol, Miami, FL 33136 USA.	gbarber@med.miami.edu			 [R01AI079336];  [UO1AI083015]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI083015, R01AI079336] Funding Source: NIH RePORTER	; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Delia Gutman for technical assistance, Biju Issac for gene array analysis, and George McNamara for confocal microscopy analysis. This work was funded in part by grants R01AI079336 and UO1AI083015.	Abe T, 2013, MOL CELL, V50, P5, DOI 10.1016/j.molcel.2013.01.039; Ablasser A, 2013, NATURE, V498, P380, DOI 10.1038/nature12306; Ahn J, 2012, P NATL ACAD SCI USA, V109, P19386, DOI 10.1073/pnas.1215006109; Alers S, 2012, MOL CELL BIOL, V32, P2, DOI 10.1128/MCB.06159-11; Alexander A, 2011, FEBS LETT, V585, P952, DOI 10.1016/j.febslet.2011.03.010; Blasius AL, 2010, IMMUNITY, V32, P305, DOI 10.1016/j.immuni.2010.03.012; Burdette DL, 2011, NATURE, V478, P515, DOI 10.1038/nature10429; Civril F, 2013, NATURE, V498, P332, DOI 10.1038/nature12305; Diner EJ, 2013, CELL REP, V3, P1355, DOI 10.1016/j.celrep.2013.05.009; Fu D, 2011, P NATL ACAD SCI USA, V108, P1403, DOI 10.1073/pnas.1018376108; Gall A, 2012, IMMUNITY, V36, P120, DOI 10.1016/j.immuni.2011.11.018; Gao P, 2013, CELL, V153, P1094, DOI 10.1016/j.cell.2013.04.046; Hardie DG, 2012, CHEM BIOL, V19, P1222, DOI 10.1016/j.chembiol.2012.08.019; Henault J, 2012, IMMUNITY, V37, P986, DOI 10.1016/j.immuni.2012.09.014; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Jin L, 2008, MOL CELL BIOL, V28, P5014, DOI 10.1128/MCB.00640-08; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kranzusch PJ, 2013, CELL REP, V3, P1362, DOI 10.1016/j.celrep.2013.05.008; Mizushima N, 2010, CURR OPIN CELL BIOL, V22, P132, DOI 10.1016/j.ceb.2009.12.004; Saitoh T, 2009, P NATL ACAD SCI USA, V106, P20842, DOI 10.1073/pnas.0911267106; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Sun WX, 2009, P NATL ACAD SCI USA, V106, P8653, DOI 10.1073/pnas.0900850106; Tamura T, 2008, ANNU REV IMMUNOL, V26, P535, DOI 10.1146/annurev.immunol.26.021607.090400; Tanaka Y, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002521; Tooze SA, 2010, IUBMB LIFE, V62, P503, DOI 10.1002/iub.334; Woodward JJ, 2010, SCIENCE, V328, P1703, DOI 10.1126/science.1189801; Zhang X, 2013, MOL CELL, V51, P226, DOI 10.1016/j.molcel.2013.05.022; Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003	29	405	431	3	84	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 24	2013	155	3					688	698		10.1016/j.cell.2013.09.049	http://dx.doi.org/10.1016/j.cell.2013.09.049			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	246WQ	24119841	Bronze, Green Accepted			2022-12-28	WOS:000326571800021
J	Almeida, J; Schobesberger, S; Kurten, A; Ortega, IK; Kupiainen-Maatta, O; Praplan, AP; Adamov, A; Amorim, A; Bianchi, F; Breitenlechner, M; David, A; Dommen, J; Donahue, NM; Downard, A; Dunne, E; Duplissy, J; Ehrhart, S; Flagan, RC; Franchin, A; Guida, R; Hakala, J; Hansel, A; Heinritzi, M; Henschel, H; Jokinen, T; Junninen, H; Kajos, M; Kangasluoma, J; Keskinen, H; Kupc, A; Kurten, T; Kvashin, AN; Laaksonen, A; Lehtipalo, K; Leiminger, M; Leppa, J; Loukonen, V; Makhmutov, V; Mathot, S; McGrath, MJ; Nieminen, T; Olenius, T; Onnela, A; Petaja, T; Riccobono, F; Riipinen, I; Rissanen, M; Rondo, L; Ruuskanen, T; Santos, FD; Sarnela, N; Schallhart, S; Schnitzhofer, R; Seinfeld, JH; Simon, M; Sipila, M; Stozhkov, Y; Stratmann, F; Tome, A; Trostl, J; Tsagkogeorgas, G; Vaattovaara, P; Viisanen, Y; Virtanen, A; Vrtala, A; Wagner, PE; Weingartner, E; Wex, H; Williamson, C; Wimmer, D; Ye, PL; Yli-Juuti, T; Carslaw, KS; Kulmala, M; Curtius, J; Baltensperger, U; Worsnop, DR; Vehkamaki, H; Kirkby, J				Almeida, Joao; Schobesberger, Siegfried; Kuerten, Andreas; Ortega, Ismael K.; Kupiainen-Maatta, Oona; Praplan, Arnaud P.; Adamov, Alexey; Amorim, Antonio; Bianchi, Federico; Breitenlechner, Martin; David, Andre; Dommen, Josef; Donahue, Neil M.; Downard, Andrew; Dunne, Eimear; Duplissy, Jonathan; Ehrhart, Sebastian; Flagan, Richard C.; Franchin, Alessandro; Guida, Roberto; Hakala, Jani; Hansel, Armin; Heinritzi, Martin; Henschel, Henning; Jokinen, Tuija; Junninen, Heikki; Kajos, Maija; Kangasluoma, Juha; Keskinen, Helmi; Kupc, Agnieszka; Kurten, Theo; Kvashin, Alexander N.; Laaksonen, Ari; Lehtipalo, Katrianne; Leiminger, Markus; Leppa, Johannes; Loukonen, Ville; Makhmutov, Vladimir; Mathot, Serge; McGrath, Matthew J.; Nieminen, Tuomo; Olenius, Tinja; Onnela, Antti; Petaja, Tuukka; Riccobono, Francesco; Riipinen, Ilona; Rissanen, Matti; Rondo, Linda; Ruuskanen, Taina; Santos, Filipe D.; Sarnela, Nina; Schallhart, Simon; Schnitzhofer, Ralf; Seinfeld, John H.; Simon, Mario; Sipila, Mikko; Stozhkov, Yuri; Stratmann, Frank; Tome, Antonio; Troestl, Jasmin; Tsagkogeorgas, Georgios; Vaattovaara, Petri; Viisanen, Yrjo; Virtanen, Annele; Vrtala, Aron; Wagner, Paul E.; Weingartner, Ernest; Wex, Heike; Williamson, Christina; Wimmer, Daniela; Ye, Penglin; Yli-Juuti, Taina; Carslaw, Kenneth S.; Kulmala, Markku; Curtius, Joachim; Baltensperger, Urs; Worsnop, Douglas R.; Vehkamaki, Hanna; Kirkby, Jasper			Molecular understanding of sulphuric acid-amine particle nucleation in the atmosphere	NATURE			English	Article							MASS-SPECTROMETER; FORMATION EVENTS; AEROSOL; DIMETHYLAMINE; AMMONIA; WATER	Nucleation of aerosol particles from trace atmospheric vapours is thought to provide up to half of global cloud condensation nuclei(1). Aerosols can cause a net cooling of climate by scattering sunlight and by leading to smaller but more numerous cloud droplets, which makes clouds brighter and extends their lifetimes(2). Atmospheric aerosols derived from human activities are thought to have compensated for a large fraction of the warming caused by greenhouse gases(2). However, despite its importance for climate, atmospheric nucleation is poorly understood. Recently, it has been shown that sulphuric acid and ammonia cannot explain particle formation rates observed in the lower atmosphere(3). It is thought that amines may enhance nucleation(4-16), but until now there has been no direct evidence for amine ternary nucleation under atmospheric conditions. Here we use the CLOUD (Cosmics Leaving OUtdoor Droplets) chamber at CERN and find that dimethylamine above three parts per trillion by volume can enhance particle formation rates more than 1,000-fold compared with ammonia, sufficient to account for the particle formation rates observed in the atmosphere. Molecular analysis of the clusters reveals that the faster nucleation is explained by a base-stabilization mechanism involving acid-amine pairs, which strongly decrease evaporation. The ion-induced contribution is generally small, reflecting the high stability of sulphuric acid-dimethylamine clusters and indicating that galactic cosmic rays exert only a small influence on their formation, except at low overall formation rates. Our experimental measurements are well reproduced by a dynamical model based on quantum chemical calculations of binding energies of molecular clusters, without any fitted parameters. These results show that, in regions of the atmosphere near amine sources, both amines and sulphur dioxide should be considered when assessing the impact of anthropogenic activities on particle formation.	[Almeida, Joao; Kuerten, Andreas; Ehrhart, Sebastian; Leiminger, Markus; Rondo, Linda; Simon, Mario; Williamson, Christina; Wimmer, Daniela; Curtius, Joachim; Kirkby, Jasper] Goethe Univ Frankfurt, Inst Atmospher & Environm Sci, D-60438 Frankfurt, Germany; [Almeida, Joao; David, Andre; Guida, Roberto; Mathot, Serge; Onnela, Antti; Kirkby, Jasper] CERN, CH-1211 Geneva, Switzerland; [Schobesberger, Siegfried; Ortega, Ismael K.; Kupiainen-Maatta, Oona; Adamov, Alexey; Duplissy, Jonathan; Franchin, Alessandro; Hakala, Jani; Henschel, Henning; Jokinen, Tuija; Junninen, Heikki; Kajos, Maija; Kangasluoma, Juha; Lehtipalo, Katrianne; Loukonen, Ville; Nieminen, Tuomo; Olenius, Tinja; Petaja, Tuukka; Rissanen, Matti; Ruuskanen, Taina; Sarnela, Nina; Schallhart, Simon; Sipila, Mikko; Wimmer, Daniela; Yli-Juuti, Taina; Kulmala, Markku; Worsnop, Douglas R.; Vehkamaki, Hanna] Univ Helsinki, Dept Phys, FI-00014 Helsinki, Finland; [Praplan, Arnaud P.; Bianchi, Federico; Dommen, Josef; Riccobono, Francesco; Troestl, Jasmin; Weingartner, Ernest; Baltensperger, Urs] Paul Scherrer Inst, Lab Atmospher Chem, CH-5232 Villigen, Switzerland; [Amorim, Antonio; Santos, Filipe D.; Tome, Antonio] Univ Lisbon, SIM, P-1749016 Lisbon, Portugal; [Amorim, Antonio; Santos, Filipe D.; Tome, Antonio] Univ Beira Interior, P-1749016 Lisbon, Portugal; [Breitenlechner, Martin; Hansel, Armin; Heinritzi, Martin; Schnitzhofer, Ralf] Ionicon Analyt GmbH, A-6020 Innsbruck, Austria; [Breitenlechner, Martin; Hansel, Armin; Heinritzi, Martin; Schnitzhofer, Ralf] Univ Innsbruck, Inst Ion & Appl Phys, A-6020 Innsbruck, Austria; [Donahue, Neil M.; Ye, Penglin] Carnegie Mellon Univ, Ctr Atmospher Particle Studies, Pittsburgh, PA 15213 USA; [Downard, Andrew; Flagan, Richard C.; Seinfeld, John H.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; [Dunne, Eimear; Carslaw, Kenneth S.] Univ Leeds, Sch Earth & Environm, Leeds LS2 9JT, W Yorkshire, England; [Keskinen, Helmi; Laaksonen, Ari; Vaattovaara, Petri; Virtanen, Annele; Worsnop, Douglas R.] Univ Eastern Finland, FI-70211 Kuopio, Finland; [Kupc, Agnieszka; Vrtala, Aron; Wagner, Paul E.] Univ Vienna, Fac Phys, A-1090 Vienna, Austria; [Kurten, Theo] Univ Helsinki, Dept Chem, FI-00014 Helsinki, Finland; [Kvashin, Alexander N.; Makhmutov, Vladimir; Stozhkov, Yuri] PN Lebedev Phys Inst, Solar & Cosm Ray Res Lab, Moscow 119991, Russia; [Laaksonen, Ari; Leppa, Johannes; Viisanen, Yrjo; Worsnop, Douglas R.] Finnish Meteorol Inst, FI-00101 Helsinki, Finland; [McGrath, Matthew J.] Kyoto Univ, Grad Sch Sci, Dept Biophys, Kyoto 6068502, Japan; [Nieminen, Tuomo; Sipila, Mikko; Kulmala, Markku] Univ Helsinki, Helsinki Inst Phys, FI-00014 Helsinki, Finland; [Riipinen, Ilona] Univ Stockholm, Dept Appl Environm Sci, SE-10961 Stockholm, Sweden; [Stratmann, Frank; Tsagkogeorgas, Georgios; Wex, Heike] Leibniz Inst Tropospher Res, D-04318 Leipzig, Germany; [Worsnop, Douglas R.] Aerodyne Res Inc, Billerica, MA 01821 USA	Goethe University Frankfurt; European Organization for Nuclear Research (CERN); University of Helsinki; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Universidade de Lisboa; Universidade da Beira Interior; University of Innsbruck; Carnegie Mellon University; California Institute of Technology; University of Leeds; University of Eastern Finland; University of Vienna; University of Helsinki; Russian Academy of Sciences; Russian Academy of Science Lebedev Physical Institute; Finnish Meteorological Institute; Kyoto University; Helsinki Institute of Physics; University of Helsinki; Stockholm University; Leibniz Institut fur Tropospharenforschung (TROPOS); Aerodyne Research	Kirkby, J (corresponding author), Goethe Univ Frankfurt, Inst Atmospher & Environm Sci, D-60438 Frankfurt, Germany.	jasper.kirkby@cern.ch	Petäjä, Tuukka/A-8009-2008; Riipinen, Ilona/ABD-5564-2021; Worsnop, Douglas R/D-2817-2009; Viisanen, Yrjö/CAG-3818-2022; Vehkamäki, Hanna/A-8262-2008; Sarnela, Nina/AAE-1372-2020; Stozhkov, Yuri/M-7433-2015; Schobesberger, Siegfried/L-4454-2014; Simon, Mario/AGI-2749-2022; Kurtén, Theo C/G-2120-2012; Olenius, Tinja/GNP-2324-2022; Makhmutov, Vladimir/N-2086-2015; Franchin, Alessandro/AAH-3069-2019; Hansel, Armin/F-3915-2010; Tinoco Mendes, Andre David/D-4314-2011; Sipilä, Mikko/G-3024-2010; Duplissy, Jonathan/A-1723-2010; Bianchi, Federico/G-8428-2012; Yli-Juuti, Taina/O-9496-2018; kangasluoma, juha/W-7450-2019; Kürten, Andreas/O-3851-2019; Yuri, Stozhkov/ABG-7096-2021; Kirkby, Jasper/A-4973-2012; Wex, Heike/X-5882-2018; Carslaw, Ken S/C-8514-2009; Henschel, Henning/A-5060-2012; Riipinen, Ilona/I-9379-2012; Donahue, Neil M/A-2329-2008; Dunne, Eimear M/H-1567-2014; Virtanen, Annele/E-7699-2010; Curtius, Joachim/A-2681-2011; Praplan, Arnaud P./F-8357-2011; Santos, Filipe/M-7709-2013; Kulmala, Markku T/I-7671-2016; Jokinen, Tuija/B-3365-2014; Amorim, Antonio/C-8460-2013; Franchin, Alessandro/GVR-8219-2022; Tome, Antonio R/A-5681-2013; Williamson, Christina J/D-1484-2016; Laaksonen, Ari/B-5094-2011; Nieminen, Tuomo J/D-1618-2011; Breitenlechner, Martin/AAA-3402-2021; Weingartner, Ernest/B-6793-2009; Kangasluoma, Juha/AAY-7941-2021; Adamov, Alexey/V-2477-2018; Nieminen, Tuomo/AAB-8686-2020; Junninen, Heikki/C-2157-2014; Ortega Colomer, Ismael Kenneth/A-7930-2008	Petäjä, Tuukka/0000-0002-1881-9044; Worsnop, Douglas R/0000-0002-8928-8017; Viisanen, Yrjö/0000-0002-9660-3281; Vehkamäki, Hanna/0000-0002-5018-1255; Stozhkov, Yuri/0000-0003-1917-0328; Schobesberger, Siegfried/0000-0002-5777-4897; Kurtén, Theo C/0000-0002-6416-4931; Makhmutov, Vladimir/0000-0002-2242-1055; Hansel, Armin/0000-0002-1062-2394; Tinoco Mendes, Andre David/0000-0001-5854-7699; Sipilä, Mikko/0000-0002-8594-7003; Duplissy, Jonathan/0000-0001-8819-0264; Bianchi, Federico/0000-0003-2996-3604; Kürten, Andreas/0000-0002-8955-4450; Kirkby, Jasper/0000-0003-2341-9069; Wex, Heike/0000-0003-2129-9323; Carslaw, Ken S/0000-0002-6800-154X; Henschel, Henning/0000-0001-7196-661X; Donahue, Neil M/0000-0003-3054-2364; Dunne, Eimear M/0000-0001-7085-8473; Virtanen, Annele/0000-0002-2917-5344; Curtius, Joachim/0000-0003-3153-4630; Praplan, Arnaud P./0000-0002-9944-3084; Santos, Filipe/0000-0001-7316-1479; Kulmala, Markku T/0000-0003-3464-7825; Jokinen, Tuija/0000-0002-1280-1396; Amorim, Antonio/0000-0003-0638-2321; Tome, Antonio R/0000-0001-9144-7120; Williamson, Christina J/0000-0002-5188-9378; Laaksonen, Ari/0000-0002-1657-2383; Weingartner, Ernest/0000-0002-2427-4634; Kangasluoma, Juha/0000-0002-1639-1187; Nieminen, Tuomo/0000-0002-2713-715X; Junninen, Heikki/0000-0001-7178-9430; Ehrhart, Sebastian/0000-0002-6517-5341; Breitenlechner, Martin/0000-0002-2382-6660; Simon, Mario/0000-0002-4900-7460; Trostl, Jasmin/0000-0002-2807-0348; Sarnela, Nina/0000-0003-1874-3235; Leiminger, Markus/0000-0003-3343-5425; Kupc/Straus, Agnieszka/0000-0002-7996-2506; Ortega Colomer, Ismael Kenneth/0000-0002-9299-2013; Keskinen, Helmi/0000-0003-3614-0542; Lehtipalo, Katrianne/0000-0002-1660-2706; Rissanen, Matti/0000-0003-0463-8098; McGrath, Matthew/0000-0003-3431-8466	EC [215072, 316662, 57360, 227463]; German Federal Ministry of Education and Research [01LK0902A, 01LK1222A]; Swiss National Science Foundation [200020_135307, 206620_130527]; Academy of Finland [1118615, 135054, 133872, 251427, 139656, 139995, 137749, 141217, 141451]; Finnish Funding Agency for Technology and Innovation; Vaisala Foundation; Nessling Foundation; Austrian Science Fund (FWF) [P19546, L593]; Portuguese Foundation for Science and Technology [CERN/FP/116387/2010]; Swedish Research Council, Vetenskapsradet [2011-5120]; Presidium of the Russian Academy of Sciences; Russian Foundation for Basic Research [08-02-91006-CERN, 12-02-91522-CERN]; US National Science Foundation [AGS1136479, CHE1012293]; Austrian Science Fund (FWF) [L 593] Funding Source: researchfish; Directorate For Geosciences [1136479] Funding Source: National Science Foundation; Division Of Chemistry [1012293] Funding Source: National Science Foundation	EC(European CommissionEuropean Commission Joint Research Centre); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Academy of Finland(Academy of Finland); Finnish Funding Agency for Technology and Innovation(Finnish Funding Agency for Technology & Innovation (TEKES)); Vaisala Foundation; Nessling Foundation; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); Swedish Research Council, Vetenskapsradet(Swedish Research Council); Presidium of the Russian Academy of Sciences(Russian Academy of Sciences); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); US National Science Foundation(National Science Foundation (NSF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Division Of Chemistry(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank J.-L. Agostini, P. Carrie, L.-P. De Menezes, F. Josa, I. Krasin, R. Kristic, O. S. Maksumov, S. V. Mizin, R. Sitals, A. Wasem and M. Wilhelmsson for their contributions to the experiment, and D. Hanson and P. McMurry for discussions on their unpublished measurements of ambient gas-phase amines. We thank the CSC Centre for Scientific Computing in Espoo, Finland, for computer time, and J. Pierce and P. Paasonen for discussions. We thank CERN for supporting CLOUD with technicalandfinancial resources, and for providinga particlebeamfromtheCERN Proton Synchrotron. This research received funding from the EC Seventh Framework Programme (Marie Curie Initial Training Network 'CLOUD-ITN' no. 215072, MC-ITN 'CLOUD-TRAIN' no. 316662, ERC-Starting 'MOCAPAF' grant 57360 and ERC-Advanced 'ATMNUCLE' grant 227463), the German Federal Ministry of Education and Research (projects 01LK0902A and 01LK1222A), the Swiss National Science Foundation (projects 200020_135307 and 206620_130527), the Academy of Finland (Center of Excellence project 1118615), the Academy of Finland (135054, 133872, 251427, 139656, 139995, 137749, 141217 and 141451), the Finnish Funding Agency for Technology and Innovation, the Vaisala Foundation, the Nessling Foundation, the Austrian Science Fund (FWF; projects P19546 and L593), the Portuguese Foundation for Science and Technology (project CERN/FP/116387/2010), the Swedish Research Council, Vetenskapsradet (grant 2011-5120), the Presidium of the Russian Academy of Sciences and Russian Foundation for Basic Research (grants 08-02-91006-CERN and 12-02-91522-CERN), and the US National Science Foundation (grants AGS1136479 and CHE1012293).	Andreae MO, 2005, NATURE, V435, P1187, DOI 10.1038/nature03671; Berndt T, 2010, ATMOS CHEM PHYS, V10, P7101, DOI 10.5194/acp-10-7101-2010; Chen M, 2012, P NATL ACAD SCI USA, V109, P18713, DOI 10.1073/pnas.1210285109; Creamean JM, 2011, ENVIRON SCI TECHNOL, V45, P8208, DOI 10.1021/es103692f; Facchini MC, 2008, ENVIRON SCI TECHNOL, V42, P9116, DOI 10.1021/es8018385; Ge XL, 2011, ATMOS ENVIRON, V45, P524, DOI 10.1016/j.atmosenv.2010.10.012; Graus M, 2010, J AM SOC MASS SPECTR, V21, P1037, DOI 10.1016/j.jasms.2010.02.006; GRONBERG L, 1992, CHEMOSPHERE, V24, P1533, DOI 10.1016/0045-6535(92)90273-T; Hanson DR, 2006, J PHYS CHEM A, V110, P9525, DOI 10.1021/jp062844w; Hanson DR, 2011, ENVIRON SCI TECHNOL, V45, P8881, DOI 10.1021/es201819a; Iida K, 2009, AEROSOL SCI TECH, V43, P81, DOI 10.1080/02786820802488194; Junninen H, 2010, ATMOS MEAS TECH, V3, P1039, DOI 10.5194/amt-3-1039-2010; Kerminen VM, 2002, J AEROSOL SCI, V33, P609, DOI 10.1016/S0021-8502(01)00194-X; Kirkby J, 2011, NATURE, V476, P429, DOI 10.1038/nature10343; Kuang C, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009253; Kurten A, 2011, ATMOS MEAS TECH, V4, P437, DOI 10.5194/amt-4-437-2011; Kurten A, 2012, J PHYS CHEM A, V116, P6375, DOI 10.1021/jp212123n; Kulmala M, 2007, SCIENCE, V318, P89, DOI 10.1126/science.1144124; Kulmala M, 2013, SCIENCE, V339, P943, DOI 10.1126/science.1227385; Kulmala M, 2008, ATMOS RES, V90, P132, DOI 10.1016/j.atmosres.2008.01.005; Kurten T, 2008, ATMOS CHEM PHYS, V8, P4095, DOI 10.5194/acp-8-4095-2008; Laakso L, 2004, ATMOS CHEM PHYS, V4, P2353, DOI 10.5194/acp-4-2353-2004; Loukonen V, 2010, ATMOS CHEM PHYS, V10, P4961, DOI 10.5194/acp-10-4961-2010; Makela JM, 2001, TELLUS B, V53, P380, DOI 10.1034/j.1600-0889.2001.d01-27.x; Merikanto J, 2009, ATMOS CHEM PHYS, V9, P8601, DOI 10.5194/acp-9-8601-2009; Murphy SM, 2007, ATMOS CHEM PHYS, V7, P2313, DOI 10.5194/acp-7-2313-2007; Nielsen CJ, 2012, CHEM SOC REV, V41, P6684, DOI 10.1039/c2cs35059a; Ortega IK, 2012, ATMOS CHEM PHYS, V12, P225, DOI 10.5194/acp-12-225-2012; Paasonen P, 2010, ATMOS CHEM PHYS, V10, P11223, DOI 10.5194/acp-10-11223-2010; Perraud VP, 2020, ENVIRON SCI-PROC IMP, V22, P305, DOI 10.1039/c9em00431a; Petaja T, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.228302; Praplan AP, 2012, ATMOS MEAS TECH, V5, P2161, DOI 10.5194/amt-5-2161-2012; Sipila M, 2010, SCIENCE, V327, P1243, DOI 10.1126/science.1180315; Smith JN, 2010, P NATL ACAD SCI USA, V107, P6634, DOI 10.1073/pnas.0912127107; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Vanhanen J, 2011, AEROSOL SCI TECH, V45, P533, DOI 10.1080/02786826.2010.547889; Wimmer D., 2013, ATMOS MEAS TECH DISC, V6, P2151; Yu H, 2012, ENVIRON CHEM, V9, P190, DOI 10.1071/EN12020; Yu H, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL050099; Zhao J, 2011, ATMOS CHEM PHYS, V11, P10823, DOI 10.5194/acp-11-10823-2011; Zollner JH, 2012, ATMOS CHEM PHYS, V12, P4399, DOI 10.5194/acp-12-4399-2012	41	597	607	20	685	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 17	2013	502	7471					359	+		10.1038/nature12663	http://dx.doi.org/10.1038/nature12663			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235GY	24097350	Green Submitted, Green Accepted, Green Published, hybrid			2022-12-28	WOS:000325706300050
J	Bae, BI; Walsh, CA				Bae, Byoung-il; Walsh, Christopher A.			What Are Mini-Brains?	SCIENCE			English	Editorial Material									[Bae, Byoung-il] Childrens Hosp, Broad Inst MIT & Harvard, Div Genet & Genom, Manton Ctr Orphan Dis, Boston, MA 02115 USA; Childrens Hosp, Broad Inst MIT & Harvard, Howard Hughes Med Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Boston Children's Hospital; Massachusetts Institute of Technology (MIT); Broad Institute; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Bae, BI (corresponding author), Childrens Hosp, Broad Inst MIT & Harvard, Div Genet & Genom, Manton Ctr Orphan Dis, 300 Longwood Ave, Boston, MA 02115 USA.	christopher.walsh@childrens.harvard.edu		BAE, BYOUNG-IL/0000-0002-9958-678X	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Barrera JA, 2010, DEV CELL, V18, P913, DOI 10.1016/j.devcel.2010.05.017; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517; Lizarraga SB, 2010, DEVELOPMENT, V137, P1907, DOI 10.1242/dev.040410; Lui JH, 2011, CELL, V146, P18, DOI 10.1016/j.cell.2011.06.030; Sasai Y, 2013, CELL STEM CELL, V12, P520, DOI 10.1016/j.stem.2013.04.009; Sasai Y, 2013, NATURE, V493, P318, DOI 10.1038/nature11859; Siegenthaler JA, 2009, CELL, V139, P597, DOI 10.1016/j.cell.2009.10.004	8	11	11	1	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 11	2013	342	6155					200	201		10.1126/science.1245812	http://dx.doi.org/10.1126/science.1245812			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	232EV	24115427				2022-12-28	WOS:000325475200029
J	Brandt, G; Haak, W; Adler, CJ; Roth, C; Szecsenyi-Nagy, A; Karimnia, S; Moller-Rieker, S; Meller, H; Ganslmeier, R; Friederich, S; Dresely, V; Nicklisch, N; Pickrell, JK; Sirocko, F; Reich, D; Cooper, A; Alt, KW				Brandt, Guido; Haak, Wolfgang; Adler, Christina J.; Roth, Christina; Szecsenyi-Nagy, Anna; Karimnia, Sarah; Moeller-Rieker, Sabine; Meller, Harald; Ganslmeier, Robert; Friederich, Susanne; Dresely, Veit; Nicklisch, Nicole; Pickrell, Joseph K.; Sirocko, Frank; Reich, David; Cooper, Alan; Alt, Kurt W.		Genographic Consortium	Ancient DNA Reveals Key Stages in the Formation of Central European Mitochondrial Genetic Diversity	SCIENCE			English	Article							HUNTER-GATHERERS; ORIGINS	The processes that shaped modern European mitochondrial DNA (mtDNA) variation remain unclear. The initial peopling by Palaeolithic hunter-gatherers similar to 42,000 years ago and the immigration of Neolithic farmers into Europe similar to 8000 years ago appear to have played important roles but do not explain present-day mtDNA diversity. We generated mtDNA profiles of 364 individuals from prehistoric cultures in Central Europe to perform a chronological study, spanning the Early Neolithic to the Early Bronze Age (5500 to 1550 calibrated years before the common era). We used this transect through time to identify four marked shifts in genetic composition during the Neolithic period, revealing a key role for Late Neolithic cultures in shaping modern Central European genetic diversity.	[Brandt, Guido; Roth, Christina; Szecsenyi-Nagy, Anna; Karimnia, Sarah; Moeller-Rieker, Sabine; Nicklisch, Nicole; Alt, Kurt W.] Johannes Gutenberg Univ Mainz, Inst Anthropol, D-55128 Mainz, Germany; [Haak, Wolfgang; Cooper, Alan] Univ Adelaide, Australian Ctr Ancient DNA, Adelaide, SA 5005, Australia; [Adler, Christina J.] Univ Sydney, Westmead Millennium Inst, Fac Dent, Inst Dent Res, Sydney, NSW 5006, Australia; [Meller, Harald; Ganslmeier, Robert; Friederich, Susanne; Dresely, Veit] State Off Heritage Management & Archaeol Saxony A, D-06114 Halle, Saale, Germany; [Pickrell, Joseph K.; Reich, David] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Sirocko, Frank] Johannes Gutenberg Univ Mainz, Inst Geosci, D-55128 Mainz, Germany	Johannes Gutenberg University of Mainz; University of Adelaide; University of Sydney; Westmead Institute for Medical Research; Harvard University; Harvard Medical School; Johannes Gutenberg University of Mainz	Brandt, G (corresponding author), Johannes Gutenberg Univ Mainz, Inst Anthropol, Colonel Kleinmann Weg 2, D-55128 Mainz, Germany.	brandtg@uni-mainz.de; wolfgang.haak@adelaide.edu.au	Comas, David/D-5382-2014; Haak, Wolfgang/C-2362-2014; Haak, Wolfgang/Z-4947-2019; Cooper, Alan/E-8171-2012; Santos, Fabrício Rodrigues/H-2370-2011; Balanovsky, Oleg/G-1549-2014	Comas, David/0000-0002-5075-0956; Haak, Wolfgang/0000-0003-2475-2007; Haak, Wolfgang/0000-0003-2475-2007; Cooper, Alan/0000-0002-7738-7851; Santos, Fabrício Rodrigues/0000-0001-9088-1750; Adler, Christina/0000-0002-4731-5291; Szecsenyi-Nagy, Anna/0000-0003-2095-738X; Quintana-Murci, Lluis/0000-0003-2429-6320; Matisoo-Smith, Elizabeth/0000-0002-3500-8307; mele, marta/0000-0001-8874-6453; Royyuru, Ajay/0000-0003-4440-4755	German Research Foundation; National Geographic Society; IBM; Waitt Family Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100233] Funding Source: NIH RePORTER	German Research Foundation(German Research Foundation (DFG)); National Geographic Society(National Geographic Society); IBM(International Business Machines (IBM)); Waitt Family Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Sequence data have been deposited in GenBank (www.ncbi.nlm.nih.gov/genbank) under the accession numbers KF600801 to KF601193. The skeletal remains investigated in this study are archived in the State Museum of Prehistory of Saxony-Anhalt, Halle (Saale), Germany. We thank R. Schwarz, L. Weyrich, C. Knipper, J. Tuke, N. Patterson, I. Lazaridis, and E. Banffy for reading and critical discussion of the Manuscript; O. Balanovsky for providing population data from Russia, Ukraine, and Belarus; C. Metzner-Nebelsick and V. Hubensack for archaeological information about the Leau, Rocken, and Plotzkau sites; J. Osthof and G. Krizsma for informatics support; and B. Bramanti for investigations of the Benzingerode site. This research was supported by the German Research Foundation, the Geocycles Earth System Research Center at the University of Mainz, and the Genographic Project. The Genographic Project is supported by funding from the National Geographic Society, IBM, and the Waitt Family Foundation.	Achilli A, 2004, AM J HUM GENET, V75, P910, DOI 10.1086/425590; AMMERMAN AJ, 1984, NEOLITHIC TRANSITION; Behrens H., 1973, VEROFFENTLICHUNGEN L, V27; Bogucki P. I., 2004, ANCIENT EUROPE 8000, p1221p; Bramanti B, 2009, SCIENCE, V326, P137, DOI 10.1126/science.1176869; Brotherton P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2656; Cunliffe B.W., 2008, EUROPE OCEANS THEMES; Der Sarkissian Clio, 2013, PLoS Genet, V9, pe1003296, DOI 10.1371/journal.pgen.1003296; Fu QM, 2013, CURR BIOL, V23, P553, DOI 10.1016/j.cub.2013.02.044; Gamba C, 2012, MOL ECOL, V21, P45, DOI 10.1111/j.1365-294X.2011.05361.x; Haak W, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000536; Haak W, 2008, P NATL ACAD SCI USA, V105, P18226, DOI 10.1073/pnas.0807592105; Hervella M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034417; Keyser C, 2009, HUM GENET, V126, P395, DOI 10.1007/s00439-009-0683-0; Krause J, 2010, CURR BIOL, V20, P231, DOI 10.1016/j.cub.2009.11.068; Lacan M, 2011, P NATL ACAD SCI USA, V108, P9788, DOI 10.1073/pnas.1100723108; Lalueza-Fox C, 2004, P ROY SOC B-BIOL SCI, V271, P941, DOI 10.1098/rspb.2004.2698; Malmstrom H, 2009, CURR BIOL, V19, P1758, DOI 10.1016/j.cub.2009.09.017; Pinhasi R, 2012, TRENDS GENET, V28, P496, DOI 10.1016/j.tig.2012.06.006; Richards M, 2000, AM J HUM GENET, V67, P1251, DOI 10.1016/S0002-9297(07)62954-1; Skoglund P, 2012, SCIENCE, V336, P466, DOI 10.1126/science.1216304; Soares P, 2010, CURR BIOL, V20, pR174, DOI 10.1016/j.cub.2009.11.054; Whittle A., 2007, GOING MESOLITHIC NEO	23	205	208	0	95	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 11	2013	342	6155					257	261		10.1126/science.1241844	http://dx.doi.org/10.1126/science.1241844			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232EV	24115443	Green Accepted, Green Submitted			2022-12-28	WOS:000325475200048
J	Salzberg, Y; Diaz-Balzac, CA; Ramirez-Suarez, NJ; Attreed, M; Tecle, E; Desbois, M; Kaprielian, Z; Bulow, HE				Salzberg, Yehuda; Diaz-Balzac, Carlos A.; Ramirez-Suarez, Nelson J.; Attreed, Matthew; Tecle, Eillen; Desbois, Muriel; Kaprielian, Zaven; Buelow, Hannes E.			Skin-Derived Cues Control Arborization of Sensory Dendrites in Caenorhabditis elegans	CELL			English	Article							C-ELEGANS; SELF-AVOIDANCE; DROSOPHILA; GENE; MECHANISMS; EXPRESSION; MOLECULES; GUIDANCE; HOMOLOG; NEURONS	Sensory dendrites depend on cues from their environment to pattern their growth and direct them toward their correct target tissues. Yet, little is known about dendrite-substrate interactions during dendrite morphogenesis. Here, we describe MNR-1/menorin, which is part of the conserved Fam151 family of proteins and is expressed in the skin to control the elaboration of "menorah"-like dendrites of mechanosensory neurons in Caenorhabditis elegans. We provide biochemical and genetic evidence that MNR-1 acts as a contact-dependent or short-range cue in concert with the neural cell adhesion molecule SAX-7/L1CAM in the skin and through the neuronal leucine-rich repeat transmembrane receptor DMA-1 on sensory dendrites. Our data describe an unknown pathway that provides spatial information from the skin substrate to pattern sensory dendrite development nonautonomously.	[Salzberg, Yehuda; Diaz-Balzac, Carlos A.; Ramirez-Suarez, Nelson J.; Attreed, Matthew; Tecle, Eillen; Desbois, Muriel; Buelow, Hannes E.] Yeshiva Univ Albert Einstein Coll Med, Dept Genet, Bronx, NY 10461 USA; [Kaprielian, Zaven] Yeshiva Univ Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10461 USA; [Kaprielian, Zaven; Buelow, Hannes E.] Yeshiva Univ Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Bulow, HE (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Genet, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	hannes.buelow@einstein.yu.edu	Desbois, Muriel/AAD-3598-2022; Diaz-Balzac, Carlos/AGE-0313-2022	Desbois, Muriel/0000-0002-8070-2525; Diaz-Balzac, Carlos/0000-0002-4723-1282; Tecle, Eillen/0000-0003-4253-1128; Salzberg, Yehuda/0000-0003-0605-8038; Kaprielian, Zaven/0000-0003-3364-3806; Ramirez, Nelson/0000-0001-7394-860X	NIH [T32GM007288, F31HD066967, T32GM007491, F31 NS076243, T32GM07491, 5R01HD055380, R21NS081505, P30HD071593, P30CA013330]; Fulbright fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD055380, P30HD071593, F31HD066967] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA013330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007491, T32GM007288] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS076243, R21NS081505] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fulbright fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Kang Shen (Stanford University) for communicating results prior to publication; N. Baker, S. Emmons, A. Melendez, R. Townley, and members of the Bulow laboratory for discussions and comments on the manuscript; Ji Sze, O. Hobert, and J. Culotti for DNA clones; the Caenorhabditis Genetics Center, L. Chen, and S. Mitani for strains; C. Rubin for the alpha-mCherry antibody; M. Akabas for the use of his cell culture facility; B. Calder and A. Fiser for advice on bioinformatic analyses; M. Lazaro-Pena for injections; S. Bhatt and B. Gonzalez for constructing strains; and C. Crocker for artwork. This work was funded in part by the NIH (T32GM007288 and F31HD066967 to C.A.D.-B., T32GM007491 and F31 NS076243 to M.A., T32GM07491 to E.T., 5R01HD055380 and R21NS081505 to H.E.B., and P30HD071593 and P30CA013330 to Albert Einstein College of Medicine). N.R. is the recipient of a Fulbright fellowship. H.E.B. is an Alfred P. Sloan fellow.	Abedin M, 2008, SCIENCE, V319, P946, DOI 10.1126/science.1151084; Aguirre-Chen C, 2011, DEVELOPMENT, V138, P507, DOI 10.1242/dev.060939; Chen LH, 2010, DEV DYNAM, V239, P1490, DOI 10.1002/dvdy.22269; Corty MM, 2009, DEVELOPMENT, V136, P1049, DOI 10.1242/dev.014423; Doitsidou M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015435; Dong XT, 2013, CELL, V155, P296, DOI 10.1016/j.cell.2013.08.059; DUERR JS, 2006, WORMBOOK, V19, P1; Fares H, 2001, GENETICS, V159, P133; Fujisawa K, 2007, SCIENCE, V317, P1934, DOI 10.1126/science.1144874; Hadwiger G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010161; Halevi S, 2002, EMBO J, V21, P1012, DOI 10.1093/emboj/21.5.1012; Hall DH, 2011, TRENDS NEUROSCI, V34, P443, DOI 10.1016/j.tins.2011.07.004; Han C, 2012, NEURON, V73, P64, DOI 10.1016/j.neuron.2011.10.036; Honig MG, 2005, DEV BIOL, V282, P257, DOI 10.1016/j.ydbio.2005.03.013; Jan YN, 2010, NAT REV NEUROSCI, V11, P316, DOI 10.1038/nrn2836; Kaufmann WE, 2000, CEREB CORTEX, V10, P981, DOI 10.1093/cercor/10.10.981; Kim E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053419; Kim ME, 2012, NEURON, V73, P79, DOI 10.1016/j.neuron.2011.10.033; Kulkarni VA, 2012, MOL CELL NEUROSCI, V50, P10, DOI 10.1016/j.mcn.2012.03.005; Li LS, 2011, CELL, V147, P1615, DOI 10.1016/j.cell.2011.11.027; Liu OW, 2012, NAT NEUROSCI, V15, P57, DOI 10.1038/nn.2978; MARTIN P, 1989, DEVELOPMENT, V106, P335; McAllister AK, 1997, NEURON, V18, P767, DOI 10.1016/S0896-6273(00)80316-5; McKay SJ, 2003, COLD SPRING HARB SYM, V68, P159, DOI 10.1101/sqb.2003.68.159; Moresco EMY, 2005, J NEUROSCI, V25, P6105, DOI 10.1523/JNEUROSCI.1432-05.2005; Oren-Suissa M, 2010, SCIENCE, V328, P1285, DOI 10.1126/science.1189095; Parrish JZ, 2007, ANNU REV NEUROSCI, V30, P399, DOI 10.1146/annurev.neuro.29.051605.112907; Pocock R, 2008, MOL CELL NEUROSCI, V37, P56, DOI 10.1016/j.mcn.2007.08.014; Ruiz-Trillo I, 2007, TRENDS GENET, V23, P113, DOI 10.1016/j.tig.2007.01.005; Schmid RS, 2008, CURR OPIN NEUROBIOL, V18, P245, DOI 10.1016/j.conb.2008.07.015; Smith CJ, 2013, NEURON, V79, P266, DOI 10.1016/j.neuron.2013.05.009; Smith CJ, 2012, NAT NEUROSCI, V15, P731, DOI 10.1038/nn.3065; Smith CJ, 2010, DEV BIOL, V345, P18, DOI 10.1016/j.ydbio.2010.05.502; Tsalik EL, 2003, DEV BIOL, V263, P81, DOI 10.1016/S0012-1606(03)00447-0; Wang F, 2012, CURR BIOL, V22, P373, DOI 10.1016/j.cub.2012.01.040; Wang XL, 2008, J CELL BIOL, V180, P233, DOI 10.1083/jcb.200704178; WAY JC, 1989, GENE DEV, V3, P1823, DOI 10.1101/gad.3.12a.1823; Yamamoto M, 2006, CURR BIOL, V16, P1678, DOI 10.1016/j.cub.2006.06.061	38	103	106	0	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 10	2013	155	2					308	320		10.1016/j.cell.2013.08.058	http://dx.doi.org/10.1016/j.cell.2013.08.058			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	235LH	24120132	Green Accepted, Bronze			2022-12-28	WOS:000325719800009
J	Manning, WJ				Manning, Warren J.			Asymptomatic Aortic Stenosis in the Elderly A Clinical Review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							LEFT-VENTRICULAR HYPERTROPHY; CORONARY-ARTERY-DISEASE; VALVE IMPLANTATION; TRANSCATHETER; REPLACEMENT; PROGRESSION; OUTCOMES; CALCIFICATION; METAANALYSIS; ASSOCIATION	IMPORTANCE Aortic stenosis is the most common form of valvular heart disease. Progression of aortic stenosis is very slow and highly variable. Decisions about when to perform valve surgery are made by subjective assessment of patient symptoms and objective measures of the valve and ventricular function by transthoracic echocardiography. OBJECTIVE To review current concepts regarding the development, progression, and assessment of aortic stenosis; the appropriate monitoring intervals for transthoracic echocardiography; and the indications for valve procedures. EVIDENCE REVIEW Guidelines and literature search. FINDINGS Angina, exertional syncope, and heart failure are key symptoms indicating a need for intervention. The frequency of valvular monitoring by transthoracic echocardiography is guided by the disease severity. Despite evidence of severe disease, valve procedures can safely be deferred if patients experience no symptoms and have normal left ventricular ejection fraction. Asymptomatic patients with severe aortic stenosis may subconsciously curtail their activities to avoid symptoms. Apparently, asymptomatic patients can undergo a carefully monitored exercise stress test to confirm both their asymptomatic status and hemodynamic response to exercise. Bioprosthetic valves are a good replacement alternative for older patients who are good surgical candidates and who have no need for warfarin therapy. For patients who are at high or very high risk of cardiac surgery, transcutaneous aortic valve implantation is an increasing available and preferred over medical management. CONCLUSIONS AND RELEVANCE Asymptomatic patients with severe aortic stenosis require frequent monitoring of their subjective symptoms combined with objective measurement of aortic valve gradient and ventricular function by transthoracic echocardiography. Although conventional surgical replacement remains the mainstay of therapy for aortic stenosis, transcutaneous aortic valve implantation options are evolving.	[Manning, Warren J.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Med,Cardiovasc Div, Boston, MA 02215 USA; [Manning, Warren J.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Radiol, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Manning, WJ (corresponding author), Beth Israel Deaconess Med Ctr, Div Cardiovasc, 330 Brookline Ave, Boston, MA 02215 USA.	wmanning@bidmc.har-vard.edu			Philips Medical Systems	Philips Medical Systems	The author has completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest and reports that he has received a research grant from Philips Medical Systems. Several years after this presentation, Dr Manning became a site coinvestigator for the Medtronic CoreValve System and has received travel reimbursement for an investigator meeting.	Ambler G, 2005, CIRCULATION, V112, P224, DOI 10.1161/CIRCULATIONAHA.104.515049; [Anonymous], 2012, COMMUNICATION; [Anonymous], 2012, PRAC DAB ET MES SHOU; Azevedo CF, 2010, J AM COLL CARDIOL, V56, P278, DOI 10.1016/j.jacc.2009.12.074; Bauer F, 2008, HEART, V94, P1440, DOI 10.1136/hrt.2007.121442; Bellamy MF, 2002, J AM COLL CARDIOL, V40, P1723, DOI 10.1016/S0735-1097(02)02496-8; Chieffo A, 2013, J AM COLL CARDIOL, V61, P830, DOI 10.1016/j.jacc.2012.11.050; Cowell SJ, 2005, NEW ENGL J MED, V352, P2389, DOI 10.1056/NEJMoa043876; DAVIES SW, 1991, EUR HEART J, V12, P10, DOI 10.1093/oxfordjournals.eurheartj.a059815; Debl K, 2005, INVEST RADIOL, V40, P631, DOI 10.1097/01.rli.0000178362.67085.fd; Douglas PS, 2011, J AM COLL CARDIOL, V57, P1126, DOI 10.1016/j.jacc.2010.11.002; Dweck MR, 2012, CIRCULATION, V125, P76, DOI 10.1161/CIRCULATIONAHA.111.051052; EXADACTYLOS N, 1984, BRIT HEART J, V51, P121; Feuchtner GM, 2007, AM J ROENTGENOL, V189, P197, DOI 10.2214/AJR.07.2069; Gibbons RJ, 2003, CIRCULATION, V107, P2979, DOI 10.1161/01.CIR.0000063682.20730.A5; Hammermeister K, 2000, J AM COLL CARDIOL, V36, P1152, DOI 10.1016/S0735-1097(00)00834-2; Kodali SK, 2012, NEW ENGL J MED, V366, P1686, DOI 10.1056/NEJMoa1200384; Kupari M, 2005, EUR HEART J, V26, P1790, DOI 10.1093/eurheartj/ehi290; Kvidal P, 2000, J AM COLL CARDIOL, V35, P747, DOI 10.1016/S0735-1097(99)00584-7; Leon MB, 2010, NEW ENGL J MED, V363, P1597, DOI 10.1056/NEJMoa1008232; Makkar RR, 2012, NEW ENGL J MED, V366, P1696, DOI 10.1056/NEJMoa1202277; Meijboom WB, 2006, J AM COLL CARDIOL, V48, P1658, DOI 10.1016/j.jacc.2006.06.054; NHLBI Works Group, NHLBI WORKS GROUP CA; Nkomo VT, 2006, LANCET, V368, P1005, DOI 10.1016/S0140-6736(06)69208-8; O'Connor K, 2010, AM J CARDIOL, V106, P1157, DOI 10.1016/j.amjcard.2010.06.029; Palta S, 2000, CIRCULATION, V101, P2497, DOI 10.1161/01.CIR.101.21.2497; Pellikka PA, 2005, CIRCULATION, V111, P3290, DOI 10.1161/CIRCULATIONAHA.104.495903; Price J, 2012, J AM COLL CARDIOL, V60, P1710, DOI 10.1016/j.jacc.2012.06.039; Rafique AM, 2009, AM J CARDIOL, V104, P972, DOI 10.1016/j.amjcard.2009.05.044; Rajamannan NM, 2003, CIRCULATION, V107, P2181, DOI 10.1161/01.CIR.0000070591.21548.69; Rodes-Cabau J, 2012, J AM COLL CARDIOL, V60, P1864, DOI 10.1016/j.jacc.2012.08.960; Ross J Jr, 1968, Circulation, V38, P61; Rossebo AB, 2008, NEW ENGL J MED, V359, P1343, DOI 10.1056/NEJMoa0804602; Stewart BF, 1997, J AM COLL CARDIOL, V29, P630, DOI 10.1016/S0735-1097(96)00563-3; Vahanian A, 2012, EUR HEART J, V33, P2451, DOI 10.1093/eurheartj/ehs109; Vasques F, 2012, AM HEART J, V163, P477, DOI 10.1016/j.ahj.2011.12.005; Warkentin TE, 2002, NEW ENGL J MED, V347, P858, DOI 10.1056/NEJM200209123471122; Warnes CA, 2008, J AM COLL CARDIOL, V52, pE1, DOI 10.1016/j.jacc.2008.10.001; Wilson W, 2007, J AM DENT ASSOC, V138, P739, DOI 10.1161/CIRCULATIONAHA.106.183095	39	45	47	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 9	2013	310	14					1490	1497		10.1001/jama.2013.279194	http://dx.doi.org/10.1001/jama.2013.279194			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	230PK	24104373				2022-12-28	WOS:000325354100025
J	Rossignol, LN; Paasche-Orlow, MK				Rossignol, Lisa N.; Paasche-Orlow, Michael K.			Empowering Patients Who Have Specific Learning Disabilities	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Rossignol, Lisa N.] Univ New Mexico, Dept Sociol, Albuquerque, NM 87131 USA; [Paasche-Orlow, Michael K.] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA	University of New Mexico; Boston University	Rossignol, LN (corresponding author), Univ New Mexico, Dept Sociol, MSC05 3080,1 Univ New Mexico, Albuquerque, NM 87131 USA.	lnrossignol@gmail.com	Paasche-Orlow, Michael/ABF-7919-2020	Paasche-Orlow, Michael/0000-0002-9276-7190				[Anonymous], GUID LEARN DIS PRIM; Hale J, 2010, LEARN DISABILITY Q, V33, P223, DOI 10.1177/073194871003300310; National Center for Education Statistics website, CHAR PUBL PRIV BUR I; Office of Elementary and Secondary Education; Office of Special Education and Rehabilitative Services U.S. Department of Education, 2007, Fed Regist, V72, P17747; Shah RP, 2013, ACAD PEDIATR, V13, P430, DOI 10.1016/j.acap.2013.03.003; Silver LB, 2010, GUIDE LEARNING DISAB; Volandes AE, 2007, AM J BIOETHICS, V7, P5, DOI 10.1080/15265160701638520	7	2	2	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 9	2013	310	14					1445	1446		10.1001/jama.2013.278068	http://dx.doi.org/10.1001/jama.2013.278068			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	230PK	24052008				2022-12-28	WOS:000325354100016
J	Chang, YP; Dlugolecki, K; Kupper, J; Rosch, D; Wild, D; Willitsch, S				Chang, Yuan-Pin; Dlugolecki, Karol; Kuepper, Jochen; Roesch, Daniel; Wild, Dieter; Willitsch, Stefan			Specific Chemical Reactivities of Spatially Separated 3-Aminophenol Conformers with Cold Ca+ Ions	SCIENCE			English	Article							GAS-PHASE; CONFORMATION; SPECTROSCOPY; ISOMERIZATION; COLLISIONS; MOLECULES; CHEMISTRY; CONSTANTS; KINETICS; CAPTURE	Many molecules exhibit multiple rotational isomers (conformers) that interconvert thermally and are difficult to isolate. Consequently, a precise characterization of their role in chemical reactions has proven challenging. We have probed the reactivity of specific conformers by using an experimental technique based on their spatial separation in a molecular beam by electrostatic deflection. The separated conformers react with a target of Coulomb-crystallized ions in a trap. In the reaction of Ca+ with 3-aminophenol, we find a twofold larger rate constant for the cis compared with the trans conformer (differentiated by the O-H bond orientation). This result is explained by conformer-specific differences in the long-range ion-molecule interaction potentials. Our approach demonstrates the possibility of controlling reactivity through selection of conformational states.	[Chang, Yuan-Pin; Dlugolecki, Karol; Kuepper, Jochen] DESY Deutsch Elektronen Synchrotron, Ctr Free Electron Laser Sci, D-22607 Hamburg, Germany; [Kuepper, Jochen] Univ Hamburg, Hamburg Ctr Ultrafast Imaging, D-22761 Hamburg, Germany; [Kuepper, Jochen] Univ Hamburg, Dept Phys, D-22761 Hamburg, Germany; [Roesch, Daniel; Wild, Dieter; Willitsch, Stefan] Univ Basel, Dept Chem, CH-4056 Basel, Switzerland	Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); University of Hamburg; University of Hamburg; University of Basel	Kupper, J (corresponding author), DESY Deutsch Elektronen Synchrotron, Ctr Free Electron Laser Sci, Notkestr 85, D-22607 Hamburg, Germany.	jochen.kuepper@cfel.de; stefan.willitsch@unibas.ch	Chang, Yuan-Pin/GNW-4630-2022; Küpper, Jochen/A-5564-2008; Chang, Yuan-Pin/L-5734-2013	Chang, Yuan-Pin/0000-0002-2205-6262; Küpper, Jochen/0000-0003-4395-9345; Chang, Yuan-Pin/0000-0002-2205-6262; Rosch, Daniel/0000-0003-2749-3784; Willitsch, Stefan/0000-0002-8376-0579	excellence cluster "The Hamburg Center for Ultrafast Imaging-Structure, Dynamics and Control of Matter at the Atomic Scale" of the Deutsche Forschungsgemeinschaft; Swiss National Science Foundation [PP00P2_140834]; University of Basel	excellence cluster "The Hamburg Center for Ultrafast Imaging-Structure, Dynamics and Control of Matter at the Atomic Scale" of the Deutsche Forschungsgemeinschaft; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); University of Basel	This work has been supported by the excellence cluster "The Hamburg Center for Ultrafast Imaging-Structure, Dynamics and Control of Matter at the Atomic Scale" of the Deutsche Forschungsgemeinschaft, the Swiss National Science Foundation grant no. PP00P2_140834, and the University of Basel.	Broadley SL, 2007, PHYS CHEM CHEM PHYS, V9, P4357, DOI 10.1039/b704920j; CLARY DC, 1985, MOL PHYS, V54, P605, DOI 10.1080/00268978500100461; de Vries MS, 2007, ANNU REV PHYS CHEM, V58, P585, DOI 10.1146/annurev.physchem.57.032905.104722; Dian BC, 2004, SCIENCE, V303, P1169, DOI 10.1126/science.1093731; Dian BC, 2008, SCIENCE, V320, P924, DOI 10.1126/science.1155736; ELLER K, 1991, CHEM REV, V91, P1121, DOI 10.1021/cr00006a002; Filsinger F, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.133003; Filsinger F, 2008, PHYS CHEM CHEM PHYS, V10, P666, DOI 10.1039/b711888k; Filsinger F, 2011, PHYS CHEM CHEM PHYS, V13, P2076, DOI 10.1039/c0cp01585g; Filsinger F, 2009, ANGEW CHEM INT EDIT, V48, P6900, DOI 10.1002/anie.200902650; Filsinger F, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3194287; Gilijamse JJ, 2006, SCIENCE, V313, P1617, DOI 10.1126/science.1131867; Hall FHJ, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.233202; Harvey JN, 1997, CHEM PHYS LETT, V278, P391, DOI 10.1016/S0009-2614(97)01112-3; Henson AB, 2012, SCIENCE, V338, P234, DOI 10.1126/science.1229141; Khriachtchev L, 2009, J PHYS CHEM A, V113, P8143, DOI 10.1021/jp903775k; Kim MH, 2007, SCIENCE, V315, P1561, DOI 10.1126/science.1136453; Kirste M, 2012, SCIENCE, V338, P1060, DOI [10.1126/science.1229549, 10.1126/science.1227491]; Nielsen JH, 2011, PHYS CHEM CHEM PHYS, V13, P18971, DOI 10.1039/c1cp21143a; Ospelkaus S, 2010, SCIENCE, V327, P853, DOI 10.1126/science.1184121; Park ST, 2002, NATURE, V415, P306, DOI 10.1038/415306a; Quemener G, 2012, CHEM REV, V112, P4949, DOI 10.1021/cr300092g; Rizzo TR, 2009, INT REV PHYS CHEM, V28, P481, DOI 10.1080/01442350903069931; Robinson TW, 2004, J PHYS CHEM A, V108, P4420, DOI 10.1021/jp037577y; ROWE BR, 1987, INT J MASS SPECTROM, V80, P239, DOI 10.1016/0168-1176(87)87033-7; Ryzhov V, 1999, J AM CHEM SOC, V121, P2259, DOI 10.1021/ja983272z; Schwarz H, 2011, ANGEW CHEM INT EDIT, V50, P10096, DOI 10.1002/anie.201006424; Simons JP, 2005, INT REV PHYS CHEM, V24, P489, DOI 10.1080/01442350500415107; STOECKLIN T, 1992, J CHEM SOC FARADAY T, V88, P901, DOI 10.1039/ft9928800901; Taatjes CA, 2013, SCIENCE, V340, P177, DOI 10.1126/science.1234689; Tong X, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.143001; Trippel S, 2012, PHYS REV A, V86, DOI 10.1103/PhysRevA.86.033202; TROE J, 1987, J CHEM PHYS, V87, P2773, DOI 10.1063/1.453701; van de Meerakker SYT, 2012, CHEM REV, V112, P4828, DOI 10.1021/cr200349r; Willitsch S, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.043203; Willitsch S, 2012, INT REV PHYS CHEM, V31, P175, DOI 10.1080/0144235X.2012.667221; Willitsch S, 2008, PHYS CHEM CHEM PHYS, V10, P7200, DOI 10.1039/b813408c; Zhao X, 2006, J PHYS CHEM A, V110, P10607, DOI 10.1021/jp062625a	38	112	112	0	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 4	2013	342	6154					98	101		10.1126/science.1242271	http://dx.doi.org/10.1126/science.1242271			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	227PP	24092740	Green Submitted			2022-12-28	WOS:000325126100053
J	Hirsch, IB; Molitch, ME				Hirsch, Irl B.; Molitch, Mark E.			Glycemic Management in a Patient with Type 2 Diabetes	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							2 INHIBITORS; METAANALYSIS; MELLITUS; EFFICACY; SAFETY	Which of the newer drugs is best for a patient with diabetes who needs to get her glycated hemoglobin level down to 7.0%? See our latest Clinical Decisions article on managing complicated diabetes; vote and comment at NEJM.org. StageAgnes is a 51-year-old widow with hypertension who received a diagnosis of type 2 diabetes a decade ago. She has been worried about her diabetes since then because she has not been able to gain complete control over it. Her glycated hemoglobin level was 7.0% for 1 year but gradually increased to 9.0%. For the past 2 years, she has been taking metformin. She is maintaining her weight at 165 pounds (75 kg), but she is not able to lose weight. Agnes goes to the gym and walks on a treadmill three times a week, but she jokes ...	[Hirsch, Irl B.; Molitch, Mark E.] Northwestern Univ, Div Endocrinol Metab & Mol Med, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Hirsch, IB (corresponding author), Northwestern Univ, Div Endocrinol Metab & Mol Med, Feinberg Sch Med, Chicago, IL 60611 USA.							Abdul-Ghani MA, 2011, ENDOCR REV, V32, P515, DOI 10.1210/er.2010-0029; Harja E, 2013, DIABETES TECHNOL THE, V15, P609, DOI 10.1089/dia.2013.0177; Inzucchi SE, 2013, DIABETES CARE, V36, P490, DOI 10.2337/dc13-er02; Nathan DM, 2013, DIABETES CARE, V36, P2254, DOI 10.2337/dc13-0356; Nauck MA, 2007, DIABETES OBES METAB, V9, P194, DOI 10.1111/j.1463-1326.2006.00704.x; Patil HR, 2012, AM J CARDIOL, V110, P826, DOI 10.1016/j.amjcard.2012.04.061; Qaseem A, 2012, ANN INTERN MED, V156, P218, DOI 10.7326/0003-4819-156-3-201202070-00011; Rosenstock J, 2012, DIABETES CARE, V35, P1232, DOI 10.2337/dc11-1926; Stein SA, 2013, EXPERT OPIN DRUG SAF, V12, P153, DOI 10.1517/14740338.2013.752813; Vasilakou D, 2013, ANN INTERN MED, V159, P262, DOI 10.7326/0003-4819-159-4-201308200-00007	10	5	7	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 3	2013	369	14					1370	1372		10.1056/NEJMclde1311497	http://dx.doi.org/10.1056/NEJMclde1311497			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	227KI	24088099				2022-12-28	WOS:000325111200017
J	Drife, JO				Drife, James Owen			IN AND OUT OF HOSPITAL Flying a desk	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												J.O.Drife@leeds.ac.uk							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 2	2013	347								f5832	10.1136/bmj.f5832	http://dx.doi.org/10.1136/bmj.f5832			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	231OU	24089425				2022-12-28	WOS:000325427400008
J	Lukatskaya, MR; Mashtalir, O; Ren, CE; Dall'Agnese, Y; Rozier, P; Taberna, PL; Naguib, M; Simon, P; Barsoum, MW; Gogotsi, Y				Lukatskaya, Maria R.; Mashtalir, Olha; Ren, Chang E.; Dall'Agnese, Yohan; Rozier, Patrick; Taberna, Pierre Louis; Naguib, Michael; Simon, Patrice; Barsoum, Michel W.; Gogotsi, Yury			Cation Intercalation and High Volumetric Capacitance of Two-Dimensional Titanium Carbide	SCIENCE			English	Article							TRANSITION-METAL CARBIDES; ELECTROCHEMICAL CAPACITORS; ENERGY-STORAGE; CHARGE STORAGE; CARBON-FILMS; GRAPHENE; SUPERCAPACITORS; ACTIVATION; ELECTRODE; TI3ALC2	The intercalation of ions into layered compounds has long been exploited in energy storage devices such as batteries and electrochemical capacitors. However, few host materials are known for ions much larger than lithium. We demonstrate the spontaneous intercalation of cations from aqueous salt solutions between two-dimensional (2D) Ti3C2 MXene layers. MXenes combine 2D conductive carbide layers with a hydrophilic, primarily hydroxyl-terminated surface. A variety of cations, including Na+, K+, NH4+, Mg2+, and Al3+, can also be intercalated electrochemically, offering capacitance in excess of 300 farads per cubic centimeter (much higher than that of porous carbons). This study provides a basis for exploring a large family of 2D carbides and carbonitrides in electrochemical energy storage applications using single- and multivalent ions.	[Lukatskaya, Maria R.; Mashtalir, Olha; Ren, Chang E.; Dall'Agnese, Yohan; Naguib, Michael; Barsoum, Michel W.; Gogotsi, Yury] Drexel Univ, Dept Mat Sci & Engn, Philadelphia, PA 19104 USA; [Lukatskaya, Maria R.; Mashtalir, Olha; Ren, Chang E.; Dall'Agnese, Yohan; Naguib, Michael; Gogotsi, Yury] Drexel Univ, AJ Drexel Nanotechnol Inst, Philadelphia, PA 19104 USA; [Dall'Agnese, Yohan; Rozier, Patrick; Taberna, Pierre Louis; Simon, Patrice] Univ Toulouse 3, CIRIMAT UMR CNRS 5085, F-31062 Toulouse, France; [Dall'Agnese, Yohan; Simon, Patrice] FR CNRS 3459, RS2E, Paris, France	Drexel University; Drexel University; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National Polytechnique de Toulouse; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS)	Gogotsi, Y (corresponding author), Drexel Univ, Dept Mat Sci & Engn, Philadelphia, PA 19104 USA.	gogotsi@drexel.edu	Rozier, Patrick/C-6738-2011; Gogotsi, Yury/B-2167-2008; SIMON, Patrice/N-6777-2016; Lukatskaya, Maria R./A-8118-2012; Zhu, Huazhang/O-7601-2016; Naguib, Michael/A-7315-2012	Gogotsi, Yury/0000-0001-9423-4032; SIMON, Patrice/0000-0002-0461-8268; Lukatskaya, Maria R./0000-0002-2794-4322; Naguib, Michael/0000-0002-4952-9023; Taberna, Pierre-Louis/0000-0002-5310-0481	U.S. Department of Energy, Office of Vehicle Technologies, Batteries for Advanced Transportation Technologies (BATT) Program [DE-AC02-05CH11231, 6951370]; U.S. Department of Energy, Energy Storage Systems Research Program, through Sandia National Laboratory; European Research Council [ERC-2011-AdG, 291543-IONACES]; Chair of Excellence "Embedded multi-functional nanomaterials" from the EADS Foundation; Partner University Fund of the Embassy of France	U.S. Department of Energy, Office of Vehicle Technologies, Batteries for Advanced Transportation Technologies (BATT) Program(United States Department of Energy (DOE)); U.S. Department of Energy, Energy Storage Systems Research Program, through Sandia National Laboratory(United States Department of Energy (DOE)); European Research Council(European Research Council (ERC)European Commission); Chair of Excellence "Embedded multi-functional nanomaterials" from the EADS Foundation; Partner University Fund of the Embassy of France	We thank B. Duployer and J. Come at Paul Sabatier University for help in electrochemical experiments, V. N. Mochalin and M. Beidaghi for helpful discussions, and the Centralized Research Facility of Drexel University for access to XRD and SEM equipment. MXene synthesis was funded by the U.S. Department of Energy, Office of Vehicle Technologies, Batteries for Advanced Transportation Technologies (BATT) Program, under contract DE-AC02-05CH11231, subcontract 6951370. M.R.L. was supported by the U.S. Department of Energy, Energy Storage Systems Research Program, through Sandia National Laboratory. P.S. was supported by the European Research Council (advanced grant ERC-2011-AdG, project 291543-IONACES) and the Chair of Excellence "Embedded multi-functional nanomaterials" from the EADS Foundation. Collaboration between Drexel University and Paul Sabatier University was supported by the Partner University Fund of the Embassy of France.	Augustyn V, 2013, NAT MATER, V12, P518, DOI [10.1038/nmat3601, 10.1038/NMAT3601]; Barsoum MW, 2001, AM SCI, V89, P334, DOI 10.1511/2001.4.334; Chmiola J, 2010, SCIENCE, V328, P480, DOI 10.1126/science.1184126; Come J, 2012, J ELECTROCHEM SOC, V159, pA1368, DOI 10.1149/2.003208jes; Conway BE, 2013, ELECTROCHEMICAL SUPE; Ghodbane O, 2012, J POWER SOURCES, V206, P454, DOI 10.1016/j.jpowsour.2012.01.103; Heon M, 2011, ENERG ENVIRON SCI, V4, P135, DOI 10.1039/c0ee00404a; Khazaei M, 2013, ADV FUNCT MATER, V23, P2185, DOI 10.1002/adfm.201202502; Kurtoglu M, 2012, MRS COMMUN, V2, P133, DOI 10.1557/mrc.2012.25; Lang XY, 2011, NAT NANOTECHNOL, V6, P232, DOI 10.1038/nnano.2011.13; Li D, 2008, NAT NANOTECHNOL, V3, P101, DOI 10.1038/nnano.2007.451; Mai LQ, 2013, SCI REP-UK, V3, DOI 10.1038/srep01718; Mashtalir O, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2664; Mashtalir O, 2013, MATER CHEM PHYS, V139, P147, DOI 10.1016/j.matchemphys.2013.01.008; Miller JR, 2012, SCIENCE, V335, P1312, DOI 10.1126/science.1219134; Murali S, 2013, NANO ENERGY, V2, P764, DOI 10.1016/j.nanoen.2013.01.007; Naguib M, 2012, ACS NANO, V6, P1322, DOI 10.1021/nn204153h; Naguib M, 2011, ADV MATER, V23, P4248, DOI 10.1002/adma.201102306; Naoi K, 2013, ACCOUNTS CHEM RES, V46, P1075, DOI 10.1021/ar200308h; Rauda IE, 2013, ACCOUNTS CHEM RES, V46, P1113, DOI 10.1021/ar300167h; Ruch PW, 2010, CARBON, V48, P1880, DOI 10.1016/j.carbon.2010.01.032; Simon P, 2008, NAT MATER, V7, P845, DOI 10.1038/nmat2297; Stankovich S, 2006, NATURE, V442, P282, DOI 10.1038/nature04969; Sun ZJ, 2012, J POWER SOURCES, V216, P425, DOI 10.1016/j.jpowsour.2012.05.087; Tang Q, 2012, J AM CHEM SOC, V134, P16909, DOI 10.1021/ja308463r; Zhao X, 2012, ACS NANO, V6, P5404, DOI 10.1021/nn3012916; Zhu YW, 2011, SCIENCE, V332, P1537, DOI 10.1126/science.1200770	27	2567	2630	242	5239	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 27	2013	341	6153					1502	1505		10.1126/science.1241488	http://dx.doi.org/10.1126/science.1241488			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	224NS	24072919	Green Submitted			2022-12-28	WOS:000324894600047
J	Koboldt, DC; Steinberg, KM; Larson, DE; Wilson, RK; Mardis, ER				Koboldt, Daniel C.; Steinberg, Karyn Meltz; Larson, David E.; Wilson, Richard K.; Mardis, Elaine R.			The Next-Generation Sequencing Revolution and Its Impact on Genomics	CELL			English	Review							DE-NOVO MUTATIONS; KERNEL ASSOCIATION TEST; CELL LUNG-CANCER; RARE VARIANTS; SOMATIC MUTATIONS; COMMON DISEASES; GENE-MUTATIONS; HIGH-ALTITUDE; EGF RECEPTOR; EXOME	Genomics is a relatively new scientific discipline, having DNA sequencing as its core technology. As technology has improved the cost and scale of genome characterization over sequencing's 40-year history, the scope of inquiry has commensurately broadened. Massively parallel sequencing has proven revolutionary, shifting the paradigm of genomics to address biological questions at a genome-wide scale. Sequencing now empowers clinical diagnostics and other aspects of medical care, including disease risk, therapeutic identification, and prenatal testing. This Review explores the current state of genomics in the massively parallel sequencing era.	[Koboldt, Daniel C.; Steinberg, Karyn Meltz; Larson, David E.; Wilson, Richard K.; Mardis, Elaine R.] Washington Univ, Sch Med, Genome Inst, St Louis, MO 63108 USA	Washington University (WUSTL)	Mardis, ER (corresponding author), Washington Univ, Sch Med, Genome Inst, St Louis, MO 63108 USA.	emardis@wustl.edu	Wilson, Richard K./AAF-4139-2019; Mardis, Elaine/W-2202-2019	Wilson, Richard K./0000-0002-1992-1358; Meltz Steinberg, Karyn/0000-0002-8676-3337; Larson, David/0000-0001-7934-5906	NHGRI NIH HHS [U54 HG003079] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003079] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Albert TJ, 2007, NAT METHODS, V4, P903, DOI 10.1038/NMETH1111; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Austin ED, 2012, CIRC-CARDIOVASC GENE, V5, P336, DOI 10.1161/CIRCGENETICS.111.961888; Bailey-Wilson JE, 2011, HUM HERED, V72, P228, DOI 10.1159/000334381; Bamshad MJ, 2011, NAT REV GENET, V12, P745, DOI 10.1038/nrg3031; Berndt SI, 2013, NAT GENET, V45, P501, DOI 10.1038/ng.2606; Bigham A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001116; Bigham Abigail W., 2009, Human Genomics, V4, P79; Bilguvar K, 2010, NATURE, V467, P207, DOI 10.1038/nature09327; Bolze A, 2010, AM J HUM GENET, V87, P873, DOI 10.1016/j.ajhg.2010.10.028; Bowden DW, 2010, HUM MOL GENET, V19, P4112, DOI 10.1093/hmg/ddq327; Byun M, 2010, J EXP MED, V207, P2307, DOI 10.1084/jem.20101597; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Cartwright RA, 2012, STAT APPL GENET MOL, V11, DOI 10.2202/1544-6115.1713; Chen H, 2013, GENET EPIDEMIOL, V37, P196, DOI 10.1002/gepi.21703; Chesi A, 2013, NAT NEUROSCI, V16, P851, DOI 10.1038/nn.3412; Churchill JD, 2013, INVEST OPHTH VIS SCI, V54, P1411, DOI 10.1167/iovs.12-11541; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Cohen JC, 2006, P NATL ACAD SCI USA, V103, P1810, DOI 10.1073/pnas.0508483103; Conrad DF, 2011, NAT GENET, V43, P712, DOI 10.1038/ng.862; Cortes A, 2013, HUM MOL GENET, V22, P2283, DOI 10.1093/hmg/ddt062; Coventry A, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1130; Dawson SJ, 2013, NEW ENGL J MED, V368, P1199, DOI 10.1056/NEJMoa1213261; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Diehl F, 2005, P NATL ACAD SCI USA, V102, P16368, DOI 10.1073/pnas.0507904102; Diehl F, 2008, NAT MED, V14, P985, DOI 10.1038/nm.1789; Ding L, 2012, NATURE, V481, P506, DOI 10.1038/nature10738; Emde AK, 2012, BIOINFORMATICS, V28, P619, DOI 10.1093/bioinformatics/bts019; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Fan HC, 2012, NATURE, V487, P320, DOI 10.1038/nature11251; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Forbes SA, 2010, NUCLEIC ACIDS RES, V38, pD652, DOI 10.1093/nar/gkp995; Forshew T, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003726; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Gibson G, 2012, NAT REV GENET, V13, P135, DOI 10.1038/nrg3118; Gilissen C, 2012, EUR J HUM GENET, V20, P490, DOI 10.1038/ejhg.2011.258; Gilissen C, 2010, AM J HUM GENET, V87, P418, DOI 10.1016/j.ajhg.2010.08.004; Girard SL, 2011, NAT GENET, V43, P860, DOI 10.1038/ng.886; Girotti MR, 2013, CANCER DISCOV, V3, P158, DOI 10.1158/2159-8290.CD-12-0386; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; Haack TB, 2010, NAT GENET, V42, P1131, DOI 10.1038/ng.706; Han F, 2010, HUM HERED, V70, P42, DOI 10.1159/000288704; HARRINGTON CR, 1995, NEUROSCI LETT, V183, P35, DOI 10.1016/0304-3940(94)11108-U; Hodges E, 2007, NAT GENET, V39, P1522, DOI 10.1038/ng.2007.42; Hoischen A, 2010, NAT GENET, V42, P483, DOI 10.1038/ng.581; Ionita-Laza I, 2013, AM J HUM GENET, V92, P841, DOI 10.1016/j.ajhg.2013.04.015; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; Johnson JO, 2010, NEURON, V68, P857, DOI 10.1016/j.neuron.2010.11.036; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Kinde I, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004952; Kitzman JO, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004323; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Koboldt DC, 2009, BIOINFORMATICS, V25, P2283, DOI 10.1093/bioinformatics/btp373; Kong A, 2012, NATURE, V488, P471, DOI 10.1038/nature11396; Krawitz PM, 2010, NAT GENET, V42, P827, DOI 10.1038/ng.653; Lalonde E, 2010, HUM MUTAT, V31, P918, DOI 10.1002/humu.21293; Leary RJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004742; Lee S, 2012, BIOSTATISTICS, V13, P762, DOI 10.1093/biostatistics/kxs014; Lee S, 2012, AM J HUM GENET, V91, P224, DOI 10.1016/j.ajhg.2012.06.007; Leone MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064408; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Li BS, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002944; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509; Lin DY, 2011, AM J HUM GENET, V89, P354, DOI [10.1016/j.ajhg.2011.07.015., 10.1016/j.ajhg.2011.07.015]; Liu DJJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001156; Lo YMD, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001720; Lo YMD, 1997, LANCET, V350, P485, DOI 10.1016/S0140-6736(97)02174-0; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Madsen B.E., 2009, PLOS GENET, V5; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Mardis ER, 2013, ANNU REV ANAL CHEM, V6, P287, DOI 10.1146/annurev-anchem-062012-092628; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McKusick VA, 2007, AM J HUM GENET, V80, P588, DOI 10.1086/514346; Morgenthaler S, 2007, MUTAT RES-FUND MOL M, V615, P28, DOI 10.1016/j.mrfmmm.2006.09.003; Musunuru K, 2010, NEW ENGL J MED, V363, P2220, DOI 10.1056/NEJMoa1002926; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; Neale BM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001322; Nelson MR, 2012, SCIENCE, V337, P100, DOI 10.1126/science.1217876; Ng SB, 2010, NAT GENET, V42, P790, DOI 10.1038/ng.646; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Nik-Zainal S, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.023; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Oualkacha K, 2013, GENET EPIDEMIOL, V37, P366, DOI 10.1002/gepi.21725; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; PERICAKVANCE MA, 1991, AM J HUM GENET, V48, P1034; Prahallad A, 2012, NATURE, V483, P100, DOI 10.1038/nature10868; Price AL, 2010, NAT REV GENET, V11, P459, DOI 10.1038/nrg2813; Price AL, 2010, AM J HUM GENET, V86, P832, DOI 10.1016/j.ajhg.2010.04.005; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Rivera CM, 2013, CELL, V155, P39, DOI 10.1016/j.cell.2013.09.011; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Saunders CT, 2012, BIOINFORMATICS, V28, P1811, DOI 10.1093/bioinformatics/bts271; Scheinfeldt LB, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-1-r1; Schork NJ, 2009, CURR OPIN GENET DEV, V19, P212, DOI 10.1016/j.gde.2009.04.010; Sequist LV, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002003; Shen YF, 2010, GENOME RES, V20, P273, DOI 10.1101/gr.096388.109; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Swisher EM, 2005, AM J OBSTET GYNECOL, V193, P662, DOI 10.1016/j.ajog.2005.01.054; Takeuchi F, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000433; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Timms AE, 2013, JAMA PSYCHIAT, V70, P582, DOI 10.1001/jamapsychiatry.2013.1195; Vilarino-Guell C, 2011, AM J HUM GENET, V89, P162, DOI 10.1016/j.ajhg.2011.06.001; Vissers LELM, 2010, NAT GENET, V42, P1109, DOI 10.1038/ng.712; Walsh T, 2010, AM J HUM GENET, V87, P90, DOI 10.1016/j.ajhg.2010.05.010; Wang JL, 2010, BRAIN, V133, P3510, DOI 10.1093/brain/awq323; Wang SR, 2013, J CLIN ENDOCR METAB, V98, pE1428, DOI 10.1210/jc.2013-1534; Weedon MN, 2011, AM J HUM GENET, V89, P308, DOI 10.1016/j.ajhg.2011.07.002; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Wu XF, 2013, CANCER RES, V73, P4028, DOI 10.1158/0008-5472.CAN-12-4033; Xu B, 2012, NAT GENET, V44, P1365, DOI 10.1038/ng.2446; Yamazaki K, 2005, HUM MOL GENET, V14, P3499, DOI 10.1093/hmg/ddi379; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394; Zhang QY, 2011, GENET EPIDEMIOL, V35, P679, DOI 10.1002/gepi.20618; Zhu XF, 2010, GENET EPIDEMIOL, V34, P171, DOI 10.1002/gepi.20449; Zimprich A, 2011, AM J HUM GENET, V89, P168, DOI 10.1016/j.ajhg.2011.06.008	121	590	658	11	307	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 26	2013	155	1					27	38		10.1016/j.cell.2013.09.006	http://dx.doi.org/10.1016/j.cell.2013.09.006			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	224UX	24074859	Green Accepted, Bronze			2022-12-28	WOS:000324916700007
J	Savage, N				Savage, Neil			MODELLING Predictive yield	NATURE			English	Editorial Material																		Asseng S, 2013, NAT CLIM CHANGE, V3, P827, DOI [10.1038/NCLIMATE1916, 10.1038/nclimate1916]	1	3	3	1	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 26	2013	501	7468					S10	S11		10.1038/501S10a	http://dx.doi.org/10.1038/501S10a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223RP	24067758	Bronze			2022-12-28	WOS:000324826300005
J	Ladizinski, B; Lee, KC				Ladizinski, Barry; Lee, Kachiu C.			Necrotic Black Eschars on the Lower Extremities in a 57-Year-Old Woman With Ovarian Cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CALCIPHYLAXIS		[Ladizinski, Barry] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Lee, Kachiu C.] Brown Univ, Dept Dermatol, Providence, RI 02903 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Brown University	Lee, KC (corresponding author), Brown Univ, Dept Dermatol, 593 Eddy St,Ste 10, Providence, RI 02903 USA.	kachiu@gmail.com						Essary LR, 2000, AM J CLIN PATHOL, V113, P280, DOI 10.1309/AGLF-X21H-Y37W-50KL; Fine A, 2002, KIDNEY INT, V61, P2210, DOI 10.1046/j.1523-1755.2002.00375.x; Lee KC, 2012, MAYO CLIN PROC, V87, P581, DOI 10.1016/j.mayocp.2012.03.010; Nigwekar SU, 2008, CLIN J AM SOC NEPHRO, V3, P1139, DOI 10.2215/CJN.00530108; Sibai H, 2012, J CLIN ONCOL, V30, pE88, DOI 10.1200/JCO.2011.39.4551	5	3	3	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 25	2013	310	12					1281	1282		10.1001/jama.2013.277797	http://dx.doi.org/10.1001/jama.2013.277797			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	222SO	24065015				2022-12-28	WOS:000324751800025
J	Froen, JF; Temmerman, M				Froen, J. Frederik; Temmerman, Marleen			What works in saving children: the essentials	LANCET			English	Editorial Material							INTERVENTIONS; MORTALITY; NEWBORN		[Froen, J. Frederik] Norwegian Inst Publ Hlth, Dept Int Publ Hlth, N-0403 Oslo, Norway; [Temmerman, Marleen] WHO, Dept Reprod Hlth & Res, CH-1211 Geneva, Switzerland	Norwegian Institute of Public Health (NIPH); World Health Organization	Froen, JF (corresponding author), Norwegian Inst Publ Hlth, Dept Int Publ Hlth, N-0403 Oslo, Norway.	frederik.froen@fhi.no		Froen Froen, Jahn Frederik/0000-0001-9390-8509				[Anonymous], 2012, LOND SUMM; Bhutto ZA, 2011, LANCET, V377, P1523, DOI 10.1016/S0140-6736(10)62269-6; Campbell OMR, 2006, LANCET, V368, P1284, DOI 10.1016/S0140-6736(06)69381-1; Darmstadt GL, 2005, LANCET, V365, P977, DOI 10.1016/S0140-6736(05)71088-6; Norwegian Institute of Public Health, HARM REPR HLTH REG H; Requejo J., 2013, ACCOUNTABILITY MATER; The Partnership for Maternal Newborn and Child Health, 2011, MAT NEWB CHILD HLTH; UNICEF, 2015, COMMITTING CHILD SUR; Venis S, 2003, LANCET, V361, P2172, DOI 10.1016/S0140-6736(03)13787-7; Walker N, 2013, LANCET, V382, P1029, DOI 10.1016/S0140-6736(13)61748-1; Winfrey W, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S32; World Health Organization UNICEF, 2013, END PREV CHILD DEATH	12	0	0	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 21	2013	382	9897					1006	1008		10.1016/S0140-6736(13)61942-X	http://dx.doi.org/10.1016/S0140-6736(13)61942-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	222PB	24054526				2022-12-28	WOS:000324742200007
J	Basaria, S				Basaria, Shehzad			Male hypogonadism	LANCET			English	Article							TESTOSTERONE REPLACEMENT THERAPY; SYMPTOMATIC ANDROGEN DEFICIENCY; HORMONE-BINDING-GLOBULIN; LOW SERUM TESTOSTERONE; OLDER MEN; BODY-COMPOSITION; DOUBLE-BLIND; HYPOGONADOTROPIC HYPOGONADISM; TRANSDERMAL TESTOSTERONE; ERECTILE DYSFUNCTION	Male hypogonadism is a clinical syndrome that results from failure to produce physiological concentrations of testosterone, normal amounts of sperm, or both. Hypogonadism may arise from testicular disease (primary hypogonadism) or dysfunction of the hypothalamic-pituitary unit (secondary hypogonadism). Clinical presentations vary dependent on the time of onset of androgen deficiency, whether the defect is in testosterone production or spermatogenesis, associated genetic factors, or history of androgen therapy. The clinical diagnosis of hypogonadism is made on the basis of signs and symptoms consistent with androgen deficiency and low morning testosterone concentrations in serum on multiple occasions. Several testosterone-replacement therapies are approved for treatment and should be selected according to the patient's preference, cost, availability, and formulation-specific properties. Contraindications to testosterone-replacement therapy include prostate and breast cancers, uncontrolled congestive heart failure, severe lower-urinary-tract symptoms, and erythrocytosis. Treatment should be monitored for benefits and adverse effects.	Harvard Univ, Sch Med, Sect Mens Hlth Aging & Metab, Div Endocrinol,Brigham & Womens Hosp, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Basaria, S (corresponding author), Harvard Univ, Sch Med, Sect Mens Hlth Aging & Metab, Div Endocrinol,Brigham & Womens Hosp, 221 Longwood Ave,BLI 541, Boston, MA 02115 USA.	sbasaria@partners.org		Basaria, Shehzad/0000-0003-1749-8549	Abbott Pharmaceuticals	Abbott Pharmaceuticals(Abbott Laboratories)	I have previously received research support for investigator-initiated studies from Abbott Pharmaceuticals and consulted for Eli Lilly.	ALEXANDER GM, 1991, HORM BEHAV, V25, P367, DOI 10.1016/0018-506X(91)90008-6; Amory JK, 2004, J CLIN ENDOCR METAB, V89, P503, DOI 10.1210/jc.2003-031110; Araujo AB, 2004, J CLIN ENDOCR METAB, V89, P5920, DOI 10.1210/jc.2003-031719; Araujo AB, 2007, J CLIN ENDOCR METAB, V92, P4241, DOI 10.1210/jc.2007-1245; Arver S, 1997, CLIN ENDOCRINOL, V47, P727, DOI 10.1046/j.1365-2265.1997.3071113.x; Aversa A, 2003, CLIN ENDOCRINOL, V58, P632, DOI 10.1046/j.1365-2265.2003.01764.x; Bachman E, 2010, J CLIN ENDOCR METAB, V95, P4743, DOI 10.1210/jc.2010-0864; Balasubramanian R, 2011, MOL CELL ENDOCRINOL, V346, P4, DOI 10.1016/j.mce.2011.07.012; Basaria S, 2001, J CLIN ENDOCR METAB, V86, P5108, DOI 10.1210/jc.86.11.5108; Basaria S, 2010, NEW ENGL J MED, V363, P109, DOI 10.1056/NEJMoa1000485; Basaria S, 2010, J CLIN ENDOCR METAB, V95, P1533, DOI 10.1210/jc.2009-1579; Basu R, 2007, DIABETES CARE, V30, P1972, DOI 10.2337/dc07-0359; BEARD CM, 1977, MAYO CLIN PROC, V52, P3; BEHRE HM, 1994, CLIN ENDOCRINOL, V40, P341; Benito M, 2005, J BONE MINER RES, V20, P1785, DOI 10.1359/JBMR.050606; Bhasin S, 2003, J ANDROL, V24, P299; Bhasin S, 2010, J CLIN ENDOCR METAB, V95, P2536, DOI 10.1210/jc.2009-2354; Bliesener N, 2005, J CLIN ENDOCR METAB, V90, P203, DOI 10.1210/jc.2004-0929; Bojesen A, 2003, J CLIN ENDOCR METAB, V88, P622, DOI 10.1210/jc.2002-021491; Bolona ER, 2007, MAYO CLIN PROC, V82, P20, DOI 10.4065/82.1.20; BREMNER WJ, 1983, J CLIN ENDOCR METAB, V56, P1278, DOI 10.1210/jcem-56-6-1278; BUENA F, 1993, FERTIL STERIL, V59, P1118; Buvat J, 1997, J UROLOGY, V158, P1764, DOI 10.1016/S0022-5347(01)64123-5; Calof OM, 2005, J GERONTOL A-BIOL, V60, P1451, DOI 10.1093/gerona/60.11.1451; CARTER HB, 1995, UROLOGY, V45, P591, DOI 10.1016/S0090-4295(99)80049-1; CARTER JN, 1978, NEW ENGL J MED, V299, P847, DOI 10.1056/NEJM197810192991602; Cherrier MM, 2005, NEUROLOGY, V64, P290, DOI 10.1212/01.WNL.0000149639.25136.CA; Cherrier MM, 2005, NEUROLOGY, V64, P2063, DOI 10.1212/01.WNL.0000165995.98986.F1; Citron JT, 1996, J UROLOGY, V155, P529, DOI 10.1016/S0022-5347(01)66441-3; Coviello AD, 2008, J CLIN ENDOCR METAB, V93, P914, DOI 10.1210/jc.2007-1692; Creutzberg EC, 2003, CHEST, V124, P1733, DOI 10.1378/chest.124.5.1733; Cross JJL, 1999, CLIN RADIOL, V54, P317, DOI 10.1016/S0009-9260(99)90562-7; Crowley W F Jr, 1985, Recent Prog Horm Res, V41, P473; Cunningham GR, 2011, J CLIN ENDOCR METAB, V96, P38, DOI 10.1210/jc.2010-0266; CUNNINGHAM GR, 1990, J CLIN ENDOCR METAB, V70, P792, DOI 10.1210/jcem-70-3-792; Daniell HW, 2006, J PAIN, V7, P200, DOI 10.1016/j.jpain.2005.10.009; Dhindsa S, 2004, J CLIN ENDOCR METAB, V89, P5462, DOI 10.1210/jc.2004-0804; Dobs AS, 1999, J CLIN ENDOCR METAB, V84, P3469, DOI 10.1210/jc.84.10.3469; Dobs AS, 1996, J CLIN ENDOCR METAB, V81, P4108, DOI 10.1210/jc.81.11.4108; DRINKA PJ, 1995, J AM GERIATR SOC, V43, P899, DOI 10.1111/j.1532-5415.1995.tb05534.x; Edelstein D, 2007, EXPERT OPIN PHARMACO, V8, P2991, DOI 10.1517/14656566.8.17.2991; English KM, 2000, CIRCULATION, V102, P1906, DOI 10.1161/01.CIR.102.16.1906; Ficarra V, 2006, EUR UROL, V49, P258, DOI 10.1016/j.eururo.2005.11.023; FINKELSTEIN JS, 1987, ANN INTERN MED, V106, P354, DOI 10.7326/0003-4819-106-3; FOWLER JE, 1981, J UROLOGY, V126, P372, DOI 10.1016/S0022-5347(17)54531-0; GLASS AR, 1977, J CLIN ENDOCR METAB, V45, P1211, DOI 10.1210/jcem-45-6-1211; GORMLEY GJ, 1992, NEW ENGL J MED, V327, P1185, DOI 10.1056/NEJM199210223271701; Haddad RM, 2007, MAYO CLIN PROC, V82, P29; Hak AE, 2002, J CLIN ENDOCR METAB, V87, P3632, DOI 10.1210/jc.87.8.3632; Hall SA, 2008, J CLIN ENDOCR METAB, V93, P3870, DOI 10.1210/jc.2008-0021; HANDELSMAN DJ, 1990, J CLIN ENDOCR METAB, V71, P216, DOI 10.1210/jcem-71-1-216; Handelsman DJ, 1998, BAILLIERE CLIN ENDOC, V12, P485, DOI 10.1016/S0950-351X(98)80248-6; Harman SM, 2001, J CLIN ENDOCR METAB, V86, P724, DOI 10.1210/jc.86.2.724; Huhtaniemi IT, 2012, EUR J ENDOCRINOL, V166, P983, DOI 10.1530/EJE-11-1051; Isidori AM, 2005, CLIN ENDOCRINOL, V63, P280, DOI 10.1111/j.1365-2265.2005.02339.x; Isidori AM, 2005, CLIN ENDOCRINOL, V63, P381, DOI 10.1111/j.1365-2265.2005.02350.x; Jain P, 2000, J UROLOGY, V164, P371, DOI 10.1016/S0022-5347(05)67363-6; Jones TH, 2011, DIABETES CARE, V34, P828, DOI 10.2337/dc10-1233; Kalm LM, 2005, J NUTR, V135, P1347, DOI 10.1093/jn/135.6.1347; Kapoor D, 2006, EUR J ENDOCRINOL, V154, P899, DOI 10.1530/eje.1.02166; Katznelson L, 1996, J CLIN ENDOCR METAB, V81, P4358, DOI 10.1210/jc.81.12.4358; Kelleher S, 2004, J CLIN ENDOCR METAB, V89, P3813, DOI 10.1210/jc.2004-0143; Kenny AM, 2002, J GERONTOL A-BIOL, V57, pM321, DOI 10.1093/gerona/57.5.M321; Khaw KT, 2007, CIRCULATION, V116, P2694, DOI 10.1161/CIRCULATIONAHA.107.719005; Khera M, 2009, J SEX MED, V6, P1165, DOI 10.1111/j.1743-6109.2009.01161.x; Kobayashi M, 2008, UROL INT, V80, P186, DOI 10.1159/000112612; Korbonits M, 2004, J CLIN ENDOCR METAB, V89, P2039, DOI 10.1210/jc.2003-030319; KORENMAN SG, 1990, J CLIN ENDOCR METAB, V71, P963, DOI 10.1210/jcem-71-4-963; Krasnoff JB, 2010, J CLIN ENDOCR METAB, V95, P2790, DOI 10.1210/jc.2009-2680; KRAUSS DJ, 1991, J UROLOGY, V146, P1566, DOI 10.1016/S0022-5347(17)38168-5; Krausz C, 2001, J CLIN ENDOCR METAB, V86, P2638, DOI 10.1210/jc.86.6.2638; KWAN M, 1983, J CLIN ENDOCR METAB, V57, P557, DOI 10.1210/jcem-57-3-557; Lanfranco F, 2004, LANCET, V364, P273, DOI 10.1016/S0140-6736(04)16678-6; Laughlin GA, 2008, J CLIN ENDOCR METAB, V93, P68, DOI 10.1210/jc.2007-1792; LIU L, 1988, J CLIN ENDOCR METAB, V67, P1140, DOI 10.1210/jcem-67-6-1140; Liu PY, 2003, J CLIN ENDOCR METAB, V88, P3605, DOI 10.1210/jc.2003-030236; MACADAMS MR, 1986, ANN INTERN MED, V104, P648, DOI 10.7326/0003-4819-104-5-648; Maki PM, 2007, J CLIN ENDOCR METAB, V92, P4107, DOI 10.1210/jc.2006-1805; Malkin CJ, 2006, EUR HEART J, V27, P57, DOI 10.1093/eurheartj/ehi443; MANNI A, 1985, J CLIN ENDOCR METAB, V61, P705, DOI 10.1210/jcem-61-4-705; MATSUMOTO AM, 1985, CLIN ENDOCRINOL, V22, P713, DOI 10.1111/j.1365-2265.1985.tb00161.x; Mazer NA, 2009, STEROIDS, V74, P512, DOI 10.1016/j.steroids.2009.01.008; Meistrich ML, 2008, REPRODUCTION, V136, P691, DOI 10.1530/REP-08-0096; MEISTRICH ML, 1986, BRIT J CANCER, V53, P89; Fernandez-Balsells MM, 2010, J CLIN ENDOCR METAB, V95, P2560, DOI 10.1210/jc.2009-2575; MILENKOVIC I, 1994, P NATL ACAD SCI USA, V91, P1244, DOI 10.1073/pnas.91.4.1244; Moffat SD, 2007, NEUROBIOL AGING, V28, P914, DOI 10.1016/j.neurobiolaging.2006.04.001; Mulligan T, 2006, INT J CLIN PRACT, V60, P762, DOI 10.1111/j.1742-1241.2006.00992.x; Nachtigall LB, 1997, NEW ENGL J MED, V336, P410, DOI 10.1056/NEJM199702063360604; Page ST, 2008, ENDOCR REV, V29, P465, DOI 10.1210/er.2007-0041; Pitteloud N, 2005, J CLIN ENDOCR METAB, V90, P2636, DOI 10.1210/jc.2004-2190; PONT A, 1982, ARCH INTERN MED, V142, P2137, DOI 10.1001/archinte.142.12.2137; Pryor JL, 1997, NEW ENGL J MED, V336, P534, DOI 10.1056/NEJM199702203360802; QUIGLEY CA, 1995, ENDOCR REV, V16, P271, DOI 10.1210/er.16.3.271; Ramasamy R, 2009, J UROLOGY, V182, P1108, DOI 10.1016/j.juro.2009.05.019; REID IR, 1985, BRIT MED J, V291, P574, DOI 10.1136/bmj.291.6495.574; Riggs BL, 2002, ENDOCR REV, V23, P279, DOI 10.1210/er.23.3.279; Roddam AW, 2008, J NATL CANCER I, V100, P170, DOI 10.1093/jnci/djm323; Rosen RC, 2011, CLIN ENDOCRINOL, V74, P248, DOI 10.1111/j.1365-2265.2010.03925.x; Rosner W, 2007, J CLIN ENDOCR METAB, V92, P405, DOI 10.1210/jc.2006-1864; Sarosdy MF, 2007, CANCER-AM CANCER SOC, V109, P536, DOI 10.1002/cncr.22438; Sartorius G, 2009, ANN CLIN BIOCHEM, V46, P137, DOI 10.1258/acb.2008.008171; SCHILSKY RL, 1980, ANN INTERN MED, V93, P109, DOI 10.7326/0003-4819-93-1-109; Schnabel PG, 2007, CLIN ENDOCRINOL, V66, P579, DOI 10.1111/j.1365-2265.2007.02781.x; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Selvin E, 2007, DIABETES CARE, V30, P234, DOI 10.2337/dc06-1579; Shabsigh R, 2008, J UROLOGY, V179, pS97, DOI 10.1016/j.juro.2008.03.145; Shahani S, 2009, J ENDOCRINOL INVEST, V32, P704, DOI 10.1007/BF03345745; Shahani S, 2008, J CLIN ENDOCR METAB, V93, P2042, DOI 10.1210/jc.2007-2595; SIEMONS LJ, 1987, J CLIN ENDOCR METAB, V65, P585, DOI 10.1210/jcem-65-3-585; Sih R, 1997, J CLIN ENDOCR METAB, V82, P1661, DOI 10.1210/jc.82.6.1661; SKAKKEBAEK NE, 1981, CLIN ENDOCRINOL, V14, P49, DOI 10.1111/j.1365-2265.1981.tb00364.x; Snyder PJ, 1999, J CLIN ENDOCR METAB, V84, P2647, DOI 10.1210/jc.84.8.2647; SNYDER PJ, 1980, J CLIN ENDOCR METAB, V51, P1335, DOI 10.1210/jcem-51-6-1335; Snyder PJ, 2000, J CLIN ENDOCR METAB, V85, P2670, DOI 10.1210/jc.85.8.2670; Spitzer M, 2012, ANN INTERN MED, V157, P681, DOI 10.7326/0003-4819-157-10-201211200-00004; SPRATT DI, 1993, J CLIN ENDOCR METAB, V76, P1548, DOI 10.1210/jc.76.6.1548; Srinivas-Shankar U, 2010, J CLIN ENDOCR METAB, V95, P639, DOI 10.1210/jc.2009-1251; Steidle C, 2003, J CLIN ENDOCR METAB, V88, P2673, DOI 10.1210/jc.2002-021058; Swerdlow AJ, 2005, J NATL CANCER I, V97, P1204, DOI 10.1093/jnci/dji240; Tanrikut C, 2011, BJU INT, V108, P1480, DOI 10.1111/j.1464-410X.2010.10030.x; Ternavasio-de La Vega HG, 2010, MEDICINE, V89, P96, DOI 10.1097/MD.0b013e3181d63191; THOMAS WEG, 1984, LANCET, V2, P1357; Tracz MJ, 2006, J CLIN ENDOCR METAB, V91, P2011, DOI 10.1210/jc.2006-0036; Travison TG, 2007, J CLIN ENDOCR METAB, V92, P549, DOI 10.1210/jc.2006-1859; Vermeulen A, 1999, J CLIN ENDOCR METAB, V84, P3666, DOI 10.1210/jc.84.10.3666; Vuong C, 2010, ENDOCR REV, V31, P98, DOI 10.1210/er.2009-0009; Wang C, 2000, J CLIN ENDOCR METAB, V85, P964, DOI 10.1210/jc.85.3.964; Wang C, 2000, J CLIN ENDOCR METAB, V85, P2839, DOI 10.1210/jc.85.8.2839; Wang C, 2004, J CLIN ENDOCR METAB, V89, P3821, DOI 10.1210/jc.2003-031866; Wang C, 1996, J CLIN ENDOCR METAB, V81, P3578, DOI 10.1210/jc.81.10.3578; Wang C, 2011, CLIN ENDOCRINOL, V75, P836, DOI 10.1111/j.1365-2265.2011.04152.x; Wang C, 2010, J ANDROL, V31, P457, DOI 10.2164/jandrol.109.009597; WETSEL WC, 1992, P NATL ACAD SCI USA, V89, P4149, DOI 10.1073/pnas.89.9.4149; Wikstrom AM, 2011, BEST PRACT RES CL EN, V25, P239, DOI 10.1016/j.beem.2010.09.006; Wilson DE, 1998, CLIN THER, V20, P299, DOI 10.1016/S0149-2918(98)80093-3; WOOLF PD, 1985, J CLIN ENDOCR METAB, V60, P444, DOI 10.1210/jcem-60-3-444; Wu FCW, 2003, ENDOCR REV, V24, P183, DOI 10.1210/er.2001-0025; Wu FCW, 2010, NEW ENGL J MED, V363, P123, DOI 10.1056/NEJMoa0911101; Zarrour FA, 2009, J PSYCHIATR PRACT, V15, P289, DOI 10.1097/01.pra.0000358315.88931.fc; Zitzmann M, 2006, J CLIN ENDOCR METAB, V91, P4335, DOI 10.1210/jc.2006-0401; ZUMOFF B, 1990, J CLIN ENDOCR METAB, V71, P929, DOI 10.1210/jcem-71-4-929	142	171	185	6	35	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 5	2014	383	9924					1250	1263		10.1016/S0140-6736(13)61126-5	http://dx.doi.org/10.1016/S0140-6736(13)61126-5			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE6LO	24119423				2022-12-28	WOS:000334104600029
J	Hankey, GJ				Hankey, Graeme J.			Training caregivers of disabled patients after stroke	LANCET			English	Editorial Material							BURDEN; DETERMINANTS; SURVIVORS; CARE; LIFE		[Hankey, Graeme J.] Univ Western Australia, Sir Charles Gairdner Hosp, Dept Neurol, Perth, WA 6009, Australia; [Hankey, Graeme J.] Univ Western Australia, Sch Med & Pharmacol, Perth, WA 6009, Australia	University of Western Australia; University of Western Australia	Hankey, GJ (corresponding author), Univ Western Australia, Sir Charles Gairdner Hosp, Dept Neurol, Perth, WA 6009, Australia.	graeme.hankey@uwa.edu.au	Hankey, Graeme J/H-4968-2014	Hankey, Graeme J/0000-0002-6044-7328				Davalos A, 2012, LANCET, V380, P349, DOI 10.1016/S0140-6736(12)60813-7; Dewey HM, 2002, STROKE, V33, P1028, DOI 10.1161/01.STR.0000013067.24300.B0; Forster A, 2013, LANCET; Forster A, 2015, INT J STROKE, V10, P259, DOI 10.1111/ijs.12038; Carod-Artal FJ, 2009, CEREBROVASC DIS, V28, P472, DOI 10.1159/000236525; Kalra L, 2004, BMJ-BRIT MED J, V328, P1099, DOI 10.1136/bmj.328.7448.1099; Legg LA, 2011, COCHRANE DB SYST REV, V10; Luengo-Fernandez R, 2013, STROKE, V44, P2854, DOI 10.1161/STROKEAHA.113.001584; McCullagh E, 2005, STROKE, V36, P2181, DOI 10.1161/01.STR.0000181755.23914.53; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Rigby H, 2009, INT J STROKE, V4, P285, DOI 10.1111/j.1747-4949.2009.00289.x; Rigby H, 2009, INT J STROKE, V4, P152, DOI 10.1111/j.1747-4949.2009.00287.x; Zhang J., 2012, COCHRANE DB SYST REV, V5	13	5	5	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 21	2013	382	9910					2043	2044		10.1016/S0140-6736(13)61688-8	http://dx.doi.org/10.1016/S0140-6736(13)61688-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	275OX	24054814				2022-12-28	WOS:000328687800009
J	Hui, DS				Hui, David S.			Tracking the transmission and evolution of MERS-CoV	LANCET			English	Editorial Material							RESPIRATORY-SYNDROME CORONAVIRUS; MOLECULAR EPIDEMIOLOGY; AMOY GARDENS; SARS; PLASMA; SERUM; RNA		[Hui, David S.] Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China; [Hui, David S.] Chinese Univ Hong Kong, Stanley Ho Ctr Emerging Infect Dis, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong	Hui, DS (corresponding author), Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China.	dschui@cuhk.edu.hk	Hui, David Shu-Cheong/O-2754-2015	Hui, David Shu-Cheong/0000-0003-4382-2445				Assiri A, 2013, NEW ENGL J MED, V369, P407, DOI 10.1056/NEJMoa1306742; Chim SSC, 2003, LANCET, V362, P1807, DOI 10.1016/S0140-6736(03)14901-X; Chiu RWK, 2003, NEW ENGL J MED, V349, P1875, DOI 10.1056/NEJM200311063491923; Cotten M, 2013, LANCET; Guan Y, 2004, LANCET, V363, P99, DOI 10.1016/S0140-6736(03)15259-2; Guery B, 2013, LANCET, V381, P2265, DOI 10.1016/S0140-6736(13)60982-4; Memish ZA, 2013, EMERG INFECT DIS, V19, P1819, DOI 10.3201/eid1911.131172; Memish ZA, 2013, NEW ENGL J MED, V368, P2487, DOI 10.1056/NEJMoa1303729; Ng EKO, 2003, CLIN CHEM, V49, P2085, DOI 10.1373/clinchem.2003.024588; Ng EKO, 2003, CLIN CHEM, V49, P1976, DOI 10.1373/clinchem.2003.024125; Reusken CBEM, 2013, LANCET INFECT DIS, V13, P859, DOI 10.1016/S1473-3099(13)70164-6; Tahir M, 2013, EUROSURVEILLANCE, V18, P4; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721	13	4	5	0	14	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 14	2013	382	9909					1962	1964		10.1016/S0140-6736(13)61955-8	http://dx.doi.org/10.1016/S0140-6736(13)61955-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	269EI	24055454	Green Published, hybrid			2022-12-28	WOS:000328223700009
J	Hammer, SM; Sobieszczyk, ME; Janes, H; Karuna, ST; Mulligan, MJ; Grove, D; Koblin, BA; Buchbinder, SP; Keefer, MC; Tomaras, GD; Frahm, N; Hural, J; Anude, C; Graham, BS; Enama, ME; Adams, E; DeJesus, E; Novak, RM; Frank, I; Bentley, C; Ramirez, S; Fu, R; Koup, RA; Mascola, JR; Nabel, GJ; Montefiori, DC; Kublin, J; McElrath, MJ; Corey, L; Gilbert, PB				Hammer, Scott M.; Sobieszczyk, Magdalena E.; Janes, Holly; Karuna, Shelly T.; Mulligan, Mark J.; Grove, Doug; Koblin, Beryl A.; Buchbinder, Susan P.; Keefer, Michael C.; Tomaras, Georgia D.; Frahm, Nicole; Hural, John; Anude, Chuka; Graham, Barney S.; Enama, Mary E.; Adams, Elizabeth; DeJesus, Edwin; Novak, Richard M.; Frank, Ian; Bentley, Carter; Ramirez, Shelly; Fu, Rong; Koup, Richard A.; Mascola, John R.; Nabel, Gary J.; Montefiori, David C.; Kublin, James; McElrath, M. Juliana; Corey, Lawrence; Gilbert, Peter B.		HVTN 505 Study Team	Efficacy Trial of a DNA/rAd5 HIV-1 Preventive Vaccine	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DOUBLE-BLIND; MALE CIRCUMCISION; INFECTION; SAFETY; IMMUNOGENICITY; TRANSMISSION; PROPHYLAXIS; ANTIBODIES; IMMUNITY; BINDING	BackgroundA safe and effective vaccine for the prevention of human immunodeficiency virus type 1 (HIV-1) infection is a global priority. We tested the efficacy of a DNA prime-recombinant adenovirus type 5 boost (DNA/rAd5) vaccine regimen in persons at increased risk for HIV-1 infection in the United States. MethodsAt 21 sites, we randomly assigned 2504 men or transgender women who have sex with men to receive the DNA/rAd5 vaccine (1253 participants) or placebo (1251 participants). We assessed HIV-1 acquisition from week 28 through month 24 (termed week 28+ infection), viral-load set point (mean plasma HIV-1 RNA level 10 to 20 weeks after diagnosis), and safety. The 6-plasmid DNA vaccine (expressing clade B Gag, Pol, and Nef and Env proteins from clades A, B, and C) was administered at weeks 0, 4, and 8. The rAd5 vector boost (expressing clade B Gag-Pol fusion protein and Env glycoproteins from clades A, B, and C) was administered at week 24. ResultsIn April 2013, the data and safety monitoring board recommended halting vaccinations for lack of efficacy. The primary analysis showed that week 28+ infection had been diagnosed in 27 participants in the vaccine group and 21 in the placebo group (vaccine efficacy, -25.0%; 95% confidence interval, -121.2 to 29.3; P=0.44), with mean viral-load set points of 4.46 and 4.47 HIV-1 RNA log(10) copies per milliliter, respectively. Analysis of all infections during the study period (41 in the vaccine group and 31 in the placebo group) also showed lack of vaccine efficacy (P=0.28). The vaccine regimen had an acceptable side-effect profile. ConclusionsThe DNA/rAd5 vaccine regimen did not reduce either the rate of HIV-1 acquisition or the viral-load set point in the population studied. (Funded by the National Institute of Allergy and Infectious Diseases; ClinicalTrials.gov number, NCT00865566.)	[Hammer, Scott M.] Columbia Univ, Med Ctr, Div Infect Dis, New York, NY 10032 USA	Columbia University	Hammer, SM (corresponding author), Columbia Univ, Med Ctr, Div Infect Dis, 630 W 168th St, New York, NY 10032 USA.	smh48@cumc.columbia.edu	Mulligan, Mark/V-9275-2019; Corey, Lawrence/AAE-1796-2020; Tomaras, Georgia/J-5041-2016; Graham, Barney S./AAC-5898-2019; Mascola, John/AAI-7193-2021	Corey, Lawrence/0000-0002-2179-2436; Graham, Barney S./0000-0001-8112-0853; Rouphael, Nadine/0000-0002-2512-7919; Yin, Michael T/0000-0002-9346-9056; Kublin, James/0000-0003-1279-3741	National Institute of Allergy and Infectious Diseases of the NIH [UM1AI68614, UM1AI068618, UM1AI68635, UM1AI069496, UM1AI69452, UM1AI069412, UM1AI069470, UM1AI069481, UM1AI069439, UM1AI069534, UM1AI069511, UM1AI069554, UM1AI069418, UM1AI069532, UM1AI069424, UM1AI069501, UM1AI036219, HHSN272200800014C]; National Center for Advancing Translational Sciences, NIH [UL1TR000040]; NIH Intramural Research Program, Emory Center for AIDS Research [P30AI50409]; Harvard Center for AIDS Research [P30AI06354]; Baylor-University of Texas Houston Center for AIDS Research [UM1AI036211]; Colorado Clinical Translational Science Institute [TR000154]; National Center for Advancing Translational Science, NIH [UL1TR000451]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000451, UL1TR000040, UL1TR001082, UL1TR000154, UL1TR001105, KL2TR001103] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI069439, ZIAAI005035, ZIAAI005073, UM1AI069501, UM1AI069534, UM1AI069470, UM1AI069496, UM1AI069418, UM1AI068614, UM1AI069412, UM1AI069481, P30AI050409, UM1AI069554, UM1AI068635, UM1AI069511, P30AI036219, UM1AI069452, P30AI027763, P30AI036211, UM1AI069424, UM1AI068618] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Center for Advancing Translational Sciences, NIH; NIH Intramural Research Program, Emory Center for AIDS Research; Harvard Center for AIDS Research; Baylor-University of Texas Houston Center for AIDS Research; Colorado Clinical Translational Science Institute; National Center for Advancing Translational Science, NIH; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by grants from the National Institute of Allergy and Infectious Diseases of the NIH (UM1AI68614, UM1AI068618, UM1AI68635, UM1AI069496, UM1AI69452, UM1AI069412, UM1AI069470, UM1AI069481, UM1AI069439, UM1AI069534, UM1AI069511, UM1AI069554, UM1AI069418, UM1AI069532, UM1AI069424, UM1AI069501, and UM1AI036219 and contract HHSN272200800014C), Columbia University's Clinical and Translational Science Award from the National Center for Advancing Translational Sciences, NIH (UL1TR000040), the NIH Intramural Research Program, Emory Center for AIDS Research (P30AI50409), the Harvard Center for AIDS Research (P30AI06354), the Baylor-University of Texas Houston Center for AIDS Research (UM1AI036211), the Colorado Clinical Translational Science Institute (TR000154), and the National Center for Advancing Translational Science, NIH (UL1TR000451).	Ackerman M, 2013, NEW ENGL J MED, V369, P389, DOI 10.1056/NEJMcibr1304437; [Anonymous], 2012, GLOBAL REPORT UNAIDS; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Auvert B, 2006, PLOS MED, V3, P705, DOI 10.1371/journal.pmed.0030226; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Catanzaro AT, 2009, J INFECT DIS, V200, P1352; Catanzaro AT, 2007, VACCINE, V25, P4085, DOI 10.1016/j.vaccine.2007.02.050; Churchyard GJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021225; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; Duerr A, 2012, J INFECT DIS, V206, P258, DOI 10.1093/infdis/jis342; El-Sadr WM, 2013, JAIDS-J ACQ IMM DEF, V63, pS115, DOI 10.1097/QAI.0b013e318299c3d9; Flynn MN, 2005, J INFECT DIS, V191, P654, DOI 10.1086/428404; Graham BS, 2006, J INFECT DIS, V194, P1650, DOI 10.1086/509259; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Gray GE, 2011, LANCET INFECT DIS, V11, P507, DOI 10.1016/S1473-3099(11)70098-6; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Horton H, 2007, J IMMUNOL METHODS, V323, P39, DOI 10.1016/j.jim.2007.03.002; Jaoko W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012873; Kibuuka H, 2010, J INFECT DIS, V201, P600, DOI 10.1086/650299; Letvin NL, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002351; Liao HX, 2013, IMMUNITY, V38, P176, DOI 10.1016/j.immuni.2012.11.011; Little R, 2004, STAT SINICA, V14, P949; McElrath MJ, 2008, LANCET, V372, P1894, DOI 10.1016/S0140-6736(08)61592-5; Montefiori David C., 2009, V485, P395, DOI 10.1007/978-1-59745-170-3_26; Peiperl L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013579; Pitisuttithum P, 2006, J INFECT DIS, V194, P1661, DOI 10.1086/508748; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Seaman MS, 2010, J VIROL, V84, P1439, DOI 10.1128/JVI.02108-09; Tavel JA, 2007, JAIDS-J ACQ IMM DEF, V44, P601, DOI 10.1097/QAI.0b013e3180417cb6; Thigpen MC, 2012, NEW ENGL J MED, V367, P423, DOI 10.1056/NEJMoa1110711; Tomaras GD, 2013, P NATL ACAD SCI USA, V110, P9019, DOI 10.1073/pnas.1301456110; Tomaras GD, 2008, J VIROL, V82, P12449, DOI 10.1128/JVI.01708-08	35	408	432	4	41	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 28	2013	369	22					2083	2092		10.1056/NEJMoa1310566	http://dx.doi.org/10.1056/NEJMoa1310566			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	258OB	24099601	Green Accepted, Bronze			2022-12-28	WOS:000327467500006
J	Jezouin, S; Parmentier, FD; Anthore, A; Gennser, U; Cavanna, A; Jin, Y; Pierre, F				Jezouin, S.; Parmentier, F. D.; Anthore, A.; Gennser, U.; Cavanna, A.; Jin, Y.; Pierre, F.			Quantum Limit of Heat Flow Across a Single Electronic Channel	SCIENCE			English	Article							THERMAL CONDUCTANCE; TRANSPORT; NOISE; PHYSICS	Quantum physics predicts that there is a fundamental maximum heat conductance across a single transport channel and that this thermal conductance quantum, G(Q), is universal, independent of the type of particles carrying the heat. Such universality, combined with the relationship between heat and information, signals a general limit on information transfer. We report on the quantitative measurement of the quantum-limited heat flow for Fermi particles across a single electronic channel, using noise thermometry. The demonstrated agreement with the predicted GQ establishes experimentally this basic building block of quantum thermal transport. The achieved accuracy of below 10% opens access to many experiments involving the quantum manipulation of heat.	[Jezouin, S.; Parmentier, F. D.; Anthore, A.; Gennser, U.; Cavanna, A.; Jin, Y.; Pierre, F.] CNRS, Lab Photon & Nanostruct, UPR20, F-91460 Marcoussis, France; [Anthore, A.] Univ Paris Diderot, Sorbonne Paris Cite, Dept Phys, F-75013 Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	Anthore, A (corresponding author), CNRS, Lab Photon & Nanostruct, UPR20, Route Nozay, F-91460 Marcoussis, France.	anne.anthore@lpn.cnrs.fr; frederic.pierre@lpn.cnrs.fr	Pierre, Frederic/J-3119-2016; Gennser, Ulf/F-2728-2019; Parmentier, François/GZG-3568-2022	Pierre, Frederic/0000-0003-1243-6808; Parmentier, François/0000-0003-1301-3305; Gennser, Ulf/0000-0003-2423-2140; Parmentier, Francois/0000-0001-9319-565X; Anthore, Anne/0000-0002-5870-3513	European Research Council [ERC-2010-StG-20091028, 259033]	European Research Council(European Research Council (ERC)European Commission)	We gratefully acknowledge the contribution of V. Andreani to the noise measurement setup. This work was supported by the European Research Council (ERC-2010-StG-20091028, no. 259033).	ANDERSON PW, 1980, PHYS REV B, V22, P3519, DOI 10.1103/PhysRevB.22.3519; Blanter YM, 2000, PHYS REV LETT, V84, P1280, DOI 10.1103/PhysRevLett.84.1280; Blencowe MP, 2000, PHYS REV A, V62, DOI 10.1103/PhysRevA.62.052104; BUTCHER PN, 1990, J PHYS-CONDENS MAT, V2, P4869, DOI 10.1088/0953-8984/2/22/008; BUTTIKER M, 1990, PHYS REV LETT, V65, P2901, DOI 10.1103/PhysRevLett.65.2901; BUTTIKER M, 1986, PHYS REV LETT, V57, P1761, DOI 10.1103/PhysRevLett.57.1761; Chiatti O, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.056601; Dubi Y, 2011, REV MOD PHYS, V83, P131, DOI 10.1103/RevModPhys.83.131; Giazotto F, 2006, REV MOD PHYS, V78, P217, DOI 10.1103/RevModPhys.78.217; Giazotto F, 2012, NATURE, V492, P401, DOI 10.1038/nature11702; Greiner A, 1997, PHYS REV LETT, V78, P1114, DOI 10.1103/PhysRevLett.78.1114; Jezouin S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2810; Kane CL, 1996, PHYS REV LETT, V76, P3192, DOI 10.1103/PhysRevLett.76.3192; Kane CL, 1997, PHYS REV B, V55, P15832, DOI 10.1103/PhysRevB.55.15832; Krive IV, 1999, PHYS REV B, V60, P1429, DOI 10.1103/PhysRevB.60.1429; LANDAUER R, 1975, Z PHYS B CON MAT, V21, P247, DOI 10.1007/BF01313304; Liang YX, 2012, J LOW TEMP PHYS, V167, P632, DOI 10.1007/s10909-012-0479-9; MAYNARD R, 1985, PHYS REV B, V32, P5440, DOI 10.1103/PhysRevB.32.5440; Meschke M, 2006, NATURE, V444, P187, DOI 10.1038/nature05276; MOLENKAMP LW, 1992, PHYS REV LETT, V68, P3765, DOI 10.1103/PhysRevLett.68.3765; PENDRY JB, 1983, J PHYS A-MATH GEN, V16, P2161, DOI 10.1088/0305-4470/16/10/012; Pierre F, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.085413; Rego LGC, 1999, PHYS REV B, V59, P13080, DOI 10.1103/PhysRevB.59.13080; Schmidt DR, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.045901; Schwab K, 2000, NATURE, V404, P974, DOI 10.1038/35010065; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; SIVAN U, 1986, PHYS REV B, V33, P551, DOI 10.1103/PhysRevB.33.551; Timofeev AV, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.200801; VANWEES BJ, 1988, PHYS REV LETT, V60, P848, DOI 10.1103/PhysRevLett.60.848; WELLSTOOD FC, 1994, PHYS REV B, V49, P5942, DOI 10.1103/PhysRevB.49.5942; WHARAM DA, 1988, J PHYS C SOLID STATE, V21, pL209, DOI 10.1088/0022-3719/21/8/002; Yung CS, 2002, APPL PHYS LETT, V81, P31, DOI 10.1063/1.1491300	32	185	185	2	69	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 1	2013	342	6158					601	604		10.1126/science.1241912	http://dx.doi.org/10.1126/science.1241912			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RJ	24091707	Green Submitted			2022-12-28	WOS:000326334300043
J	Holmes, D				Holmes, David			Tom Walley: leading light of HTA in the UK	LANCET			English	Biographical-Item																			0	0	0	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 12	2013	382	9900					1241	1241		10.1016/S0140-6736(13)62084-X	http://dx.doi.org/10.1016/S0140-6736(13)62084-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	235XP	24120191				2022-12-28	WOS:000325756400014
J	Li, Y; Lu, JF; Han, YH; Fan, XX; Ding, SW				Li, Yang; Lu, Jinfeng; Han, Yanhong; Fan, Xiaoxu; Ding, Shou-Wei			RNA Interference Functions as an Antiviral Immunity Mechanism in Mammals	SCIENCE			English	Article							DEFENSE-MECHANISM; NODAMURA-VIRUS; SUPPRESSION; HIV-1; REPLICATION; INDUCTION; PROTEINS	Diverse eukaryotic hosts produce virus-derived small interfering RNAs (siRNAs) to direct antiviral immunity by RNA interference (RNAi). However, it remains unknown whether the mammalian RNAi pathway has a natural antiviral function. Here, we show that infection of hamster cells and suckling mice by Nodamura virus (NoV), a mosquito-transmissible RNA virus, requires RNAi suppression by its B2 protein. Loss of B2 expression or its suppressor activity leads to abundant production of viral siRNAs and rapid clearance of the mutant viruses in mice. However, viral small RNAs detected during virulent infection by NoV do not have the properties of canonical siRNAs. These findings have parallels with the induction and suppression of antiviral RNAi by the related Flock house virus in fruit flies and nematodes and reveal a mammalian antiviral immunity mechanism mediated by RNAi.	[Li, Yang; Lu, Jinfeng; Han, Yanhong; Fan, Xiaoxu; Ding, Shou-Wei] Univ Calif Riverside, Dept Plant Pathol & Microbiol, Riverside, CA 92521 USA; [Li, Yang; Lu, Jinfeng; Han, Yanhong; Fan, Xiaoxu; Ding, Shou-Wei] Univ Calif Riverside, Inst Integrat Genome Biol, Riverside, CA 92521 USA; [Lu, Jinfeng; Ding, Shou-Wei] Univ Calif Riverside, Grad Program Genet Genom & Bioinformat, Riverside, CA 92521 USA	University of California System; University of California Riverside; University of California System; University of California Riverside; University of California System; University of California Riverside	Ding, SW (corresponding author), Univ Calif Riverside, Dept Plant Pathol & Microbiol, Riverside, CA 92521 USA.	shou-wei.ding@ucr.edu	Ding, Shou Wei/AAC-2533-2020; Li, Yang/GVT-7396-2022	Li, Yang/0000-0002-6065-4706; Ding, SW/0000-0002-4697-8413; han, yan-hong/0000-0003-1636-4047	China Scholarship Council; NIH [AI52447, GM94396]; College of Natural and Agricultural Sciences, University of California, Riverside; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052447] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094396, RC1GM091896] Funding Source: NIH RePORTER	China Scholarship Council(China Scholarship Council); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); College of Natural and Agricultural Sciences, University of California, Riverside; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Jovel, J. Mai, X, Wang, Q. Wu, W.-X. Li, I.-C. Huang, G. Wang, and J. Pedra for technical assistance or advice; K. Johnson, A. Ball, and C. Basler for cDNA clones; and O. Voinnet for comments on the manuscript. X. F. was supported by China Scholarship Council. This study was supported by NIH grants AI52447 and GM94396 and College of Natural and Agricultural Sciences, University of California, Riverside (to S.-W.D.).	Aliyari R, 2008, CELL HOST MICROBE, V4, P387, DOI 10.1016/j.chom.2008.09.001; BALL LA, 1992, J VIROL, V66, P2326, DOI 10.1128/JVI.66.4.2326-2334.1992; Bennasser Y, 2005, IMMUNITY, V22, P607, DOI 10.1016/j.immuni.2005.03.010; Bitko V, 2001, BMC Microbiol, V1, P34, DOI 10.1186/1471-2180-1-34; Chao JA, 2005, NAT STRUCT MOL BIOL, V12, P952, DOI 10.1038/nsmb1005; Deleris A, 2006, SCIENCE, V313, P68, DOI 10.1126/science.1128214; Diaz-Pendon JA, 2007, PLANT CELL, V19, P2053, DOI 10.1105/tpc.106.047449; Ding SW, 2010, NAT REV IMMUNOL, V10, P632, DOI 10.1038/nri2824; Drinnenberg IA, 2011, SCIENCE, V333, P1592, DOI 10.1126/science.1209575; Fabozzi G, 2011, J VIROL, V85, P2512, DOI 10.1128/JVI.01160-10; Felix MA, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000586; Galiana-Arnoux D, 2006, NAT IMMUNOL, V7, P590, DOI 10.1038/ni1335; Goubau D, 2013, IMMUNITY, V38, P855, DOI 10.1016/j.immuni.2013.05.007; Guo XY, 2012, J VIROL, V86, P11645, DOI 10.1128/JVI.01501-12; Haasnoot J, 2007, PLOS PATHOG, V3, P794, DOI 10.1371/journal.ppat.0030086; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Han YH, 2011, J VIROL, V85, P13153, DOI 10.1128/JVI.05518-11; Johnson KL, 2003, VIROLOGY, V305, P436, DOI 10.1006/viro.2002.1769; Li HW, 2002, SCIENCE, V296, P1319, DOI 10.1126/science.1070948; Li WX, 2004, P NATL ACAD SCI USA, V101, P1350, DOI 10.1073/pnas.0308308100; Lu R, 2005, NATURE, V436, P1040, DOI 10.1038/nature03870; Maillard PV, 2013, SCIENCE, V342, P235, DOI 10.1126/science.1241930; Parameswaran P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000764; Qian S, 2009, P NATL ACAD SCI USA, V106, P605, DOI 10.1073/pnas.0806822106; Schneemann A., 2005, VIRUS TAXONOMY, P865; Schnettler E, 2009, EMBO REP, V10, P258, DOI 10.1038/embor.2009.6; Segers GC, 2007, P NATL ACAD SCI USA, V104, P12902, DOI 10.1073/pnas.0702500104; Sullivan CS, 2005, J VIROL, V79, P7371, DOI 10.1128/JVI.79.12.7371-7379.2005; Wang XH, 2006, SCIENCE, V312, P452, DOI 10.1126/science.1125694; Wilkins C, 2005, NATURE, V436, P1044, DOI 10.1038/nature03957	30	263	273	2	124	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 11	2013	342	6155					231	234		10.1126/science.1241911	http://dx.doi.org/10.1126/science.1241911			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232EV	24115437	Green Accepted			2022-12-28	WOS:000325475200041
J	Israelsen, WJ; Dayton, TL; Davidson, SM; Fiske, BP; Hosios, AM; Bellinger, G; Li, J; Yu, YM; Sasaki, M; Horner, JW; Burga, LN; Xie, JX; Jurczak, MJ; DePinho, RA; Clish, CB; Jacks, T; Kibbey, RG; Wulf, GM; Di Vizio, D; Mills, GB; Cantley, LC; Vander Heiden, MG				Israelsen, William J.; Dayton, Talya L.; Davidson, Shawn M.; Fiske, Brian P.; Hosios, Aaron M.; Bellinger, Gary; Li, Jie; Yu, Yimin; Sasaki, Mika; Horner, James W.; Burga, Laura N.; Xie, Jianxin; Jurczak, Michael J.; DePinho, Ronald A.; Clish, Clary B.; Jacks, Tyler; Kibbey, Richard G.; Wulf, Gerburg M.; Di Vizio, Dolores; Mills, Gordon B.; Cantley, Lewis C.; Vander Heiden, Matthew G.			PKM2 Isoform-Specific Deletion Reveals a Differential Requirement for Pyruvate Kinase in Tumor Cells	CELL			English	Article							GENE-TRANSCRIPTION; HNRNP PROTEINS; M2 ISOFORM; CANCER; GROWTH; METABOLISM; PROMOTES; ACTIVATION; MICE; PHOSPHORYLATION	The pyruvate kinase M2 isoform (PKM2) is expressed in cancer and plays a role in regulating anabolic metabolism. To determine whether PKM2 is required for tumor formation or growth, we generated mice with a conditional allele that abolishes PKM2 expression without disrupting PKM1 expression. PKM2 deletion accelerated mammary tumor formation in a Brca1-loss-driven model of breast cancer. PKM2 null tumors displayed heterogeneous PKM1 expression, with PKM1 found in nonproliferating tumor cells and no detectable pyruvate kinase expression in proliferating cells. This suggests that PKM2 is not necessary for tumor cell proliferation and implies that the inactive state of PKM2 is associated with the proliferating cell population within tumors, whereas nonproliferating tumor cells require active pyruvate kinase. Consistent with these findings, variable PKM2 expression and heterozygous PKM2 mutations are found in human tumors. These data suggest that regulation of PKM2 activity supports the different metabolic requirements of proliferating and nonproliferating tumor cells.	[Israelsen, William J.; Dayton, Talya L.; Davidson, Shawn M.; Fiske, Brian P.; Hosios, Aaron M.; Bellinger, Gary; Yu, Yimin; Jacks, Tyler; Vander Heiden, Matthew G.] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Li, Jie; Mills, Gordon B.] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA; [Sasaki, Mika; Burga, Laura N.; Wulf, Gerburg M.; Cantley, Lewis C.] Beth Israel Deaconess Med Ctr, Div Signal Transduct, Dept Med, Boston, MA 02115 USA; [Horner, James W.; DePinho, Ronald A.; Vander Heiden, Matthew G.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Xie, Jianxin] Cell Signaling Technol, Danvers, MA 01923 USA; [Jurczak, Michael J.; Kibbey, Richard G.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA; [Clish, Clary B.] Broad Inst, Cambridge, MA 02142 USA; [Kibbey, Richard G.] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06510 USA; [Di Vizio, Dolores] Cedars Sinai Med Ctr, Div Canc Biol & Therapeut, Los Angeles, CA 90048 USA; [Di Vizio, Dolores] Boston Childrens Hosp, Urol Dis Res Ctr, Boston, MA 02115 USA; [Di Vizio, Dolores] Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA; [Cantley, Lewis C.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	Massachusetts Institute of Technology (MIT); University of Texas System; UTMD Anderson Cancer Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Dana-Farber Cancer Institute; Yale University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Yale University; Cedars Sinai Medical Center; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Vander Heiden, MG (corresponding author), MIT, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	mvh@mit.edu	Cantley, Lewis C/D-1800-2014; Burga, Laura/AAT-9385-2020; Clish, Clary B/ABB-9374-2021; Clish, Clary/AAB-7124-2019; Wulf, Gerburg/AAS-6713-2021	Cantley, Lewis C/0000-0002-1298-7653; Clish, Clary B/0000-0001-8259-9245; DePinho, Ronald/0000-0002-5625-577X; Israelsen, William/0000-0002-3653-9353; Dayton, Talya/0000-0002-7994-7963; Fiske, Brian/0000-0001-5891-4268; Jurczak, Michael/0000-0002-6335-6915	NIH [R01CA168653, 5P01CA117969, P30CA147882, 5P30CA14051, 5K08CA136983, DK059635, R01DK092606, R00CA131472, R01GM056203]; ADA grant [7-12-BS-09]; Belfer Foundation; Smith Family Foundation; Burroughs Wellcome Fund; Damon Runyon Cancer Research Foundation; Stern family; NATIONAL CANCER INSTITUTE [K08CA136983, P30CA147882, P30CA014051, P30CA016672, P50CA098258, P01CA117969, R00CA131472, R01CA168653] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK092606, U2CDK059635, U24DK059635] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056203] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ADA grant; Belfer Foundation; Smith Family Foundation; Burroughs Wellcome Fund(Burroughs Wellcome Fund); Damon Runyon Cancer Research Foundation; Stern family; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Chu-Xia Deng for sharing the BRCA1 mouse model; Luigi Terracciano and Luigi Tornillo for providing the multitissue TMA; and Cynthia Clower, Sarah-Maria Fendt, Andrea J. Howell, Vivian M. Liu, Sophia Lunt, Katherine R. Mattaini, Benjamin A. Olenchock, and Kerry Pierce for technical assistance. Eric L. Bell provided advice and reagents. Denise G. Crowley, Michael Brown, and Kathleen S. Cormier assisted with histology. This work was supported, in part, by NIH grants R01CA168653, 5P01CA117969, P30CA147882, 5P30CA14051, 5K08CA136983, DK059635, R01DK092606, R00CA131472, and R01GM056203 and ADA grant 7-12-BS-09. R.A.D. and J.W.H. acknowledge support from the Belfer Foundation. M.G.V.H. acknowledges additional support from the Smith Family Foundation, the Burroughs Wellcome Fund, the Damon Runyon Cancer Research Foundation, and the Stern family. C.B.C. is a shareholder in Agios Pharmaceuticals. M.G.V.H. is a shareholder and Scientific Advisory Board member at Agios Pharmaceuticals. L.C.C. owns equity in and receives compensation from Agios Pharmaceuticals and serves on the Board of Directors and Scientific Advisory Board.	Allali-Hassani A, 2009, BIOCHEM J, V424, P15, DOI 10.1042/BJ20090723; Anastasiou D, 2012, NAT CHEM BIOL, V8, P839, DOI 10.1038/NCHEMBIO.1060; Anastasiou D, 2011, SCIENCE, V334, P1278, DOI 10.1126/science.1211485; Ayala JE, 2010, DIS MODEL MECH, V3, P525, DOI 10.1242/dmm.006239; Baumhoer D, 2008, AM J CLIN PATHOL, V129, P899, DOI 10.1309/HCQWPWD50XHD2DW6; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chaneton B, 2012, NATURE, V491, P458, DOI 10.1038/nature11540; Chaneton B, 2012, TRENDS BIOCHEM SCI, V37, P309, DOI 10.1016/j.tibs.2012.04.003; Chen M, 2012, NAT STRUCT MOL BIOL, V19, P346, DOI 10.1038/nsmb.2219; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Christofk HR, 2008, NATURE, V452, P181, DOI 10.1038/nature06667; Clower CV, 2010, P NATL ACAD SCI USA, V107, P1894, DOI 10.1073/pnas.0914845107; Commisso C, 2013, NATURE, V497, P633, DOI 10.1038/nature12138; Cortes-Cros M, 2013, P NATL ACAD SCI USA, V110, P489, DOI 10.1073/pnas.1212780110; David CJ, 2010, NATURE, V463, P364, DOI 10.1038/nature08697; Dombrauckas JD, 2005, BIOCHEMISTRY-US, V44, P9417, DOI 10.1021/bi0474923; Gao XL, 2012, MOL CELL, V45, P598, DOI 10.1016/j.molcel.2012.01.001; Goldberg MS, 2012, J EXP MED, V209, P217, DOI 10.1084/jem.20111487; Heiden MGV, 2010, SCIENCE, V329, P1492, DOI 10.1126/science.1188015; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hitosugi T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000431; IMAMURA K, 1972, J BIOCHEM-TOKYO, V71, P1043, DOI 10.1093/oxfordjournals.jbchem.a129852; Jain M, 2012, SCIENCE, V336, P1040, DOI 10.1126/science.1218595; Jurczak MJ, 2012, J BIOL CHEM, V287, P2558, DOI 10.1074/jbc.M111.316760; Keller KE, 2012, SCIENCE, V338, P1069, DOI 10.1126/science.1224409; Liang H, 2012, GENOME RES, V22, P2120, DOI 10.1101/gr.137596.112; Luo WB, 2011, CELL, V145, P732, DOI 10.1016/j.cell.2011.03.054; Lv L, 2011, MOL CELL, V42, P719, DOI 10.1016/j.molcel.2011.04.025; Maquat LE, 2004, NAT REV MOL CELL BIO, V5, P89, DOI 10.1038/nrm1310; Mazurek S, 2011, INT J BIOCHEM CELL B, V43, P969, DOI 10.1016/j.biocel.2010.02.005; NOGUCHI T, 1986, J BIOL CHEM, V261, P3807; Parnell KM, 2013, MOL CANCER THER, V12, P1453, DOI 10.1158/1535-7163.MCT-13-0026; Schraml P, 1999, CLIN CANCER RES, V5, P1966; Sonveaux P, 2008, J CLIN INVEST, V118, P3930, DOI 10.1172/JCI36843; Vander Heiden MG, 2001, MOL CELL BIOL, V21, P5899, DOI 10.1128/MCB.21.17.5899-5912.2001; Varghese B, 2010, MOL ENDOCRINOL, V24, P2356, DOI 10.1210/me.2010-0219; VAUPEL P, 1989, CANCER RES, V49, P6449; Wang ZX, 2012, J MOL CELL BIOL, V4, P79, DOI 10.1093/jmcb/mjr030; Xu XL, 1999, NAT GENET, V22, P37, DOI 10.1038/8743; Yang WW, 2012, NAT CELL BIOL, V14, P1295, DOI 10.1038/ncb2629; Yang WW, 2012, CELL, V150, P685, DOI 10.1016/j.cell.2012.07.018; Yang WW, 2011, NATURE, V480, P118, DOI 10.1038/nature10598	43	346	359	4	85	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 10	2013	155	2					397	409		10.1016/j.cell.2013.09.025	http://dx.doi.org/10.1016/j.cell.2013.09.025			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	235LH	24120138	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000325719800016
J	Boughey, JC; Suman, VJ; Mittendorf, EA; Ahrendt, GM; Wilke, LG; Taback, B; Leitch, AM; Kuerer, HM; Bowling, M; Flippo-Morton, TS; Byrd, DR; Ollila, DW; Julian, TB; McLaughlin, SA; McCall, L; Symmans, WF; Le-Petross, HT; Haffty, BG; Buchholz, TA; Nelson, H; Hunt, KK				Boughey, Judy C.; Suman, Vera J.; Mittendorf, Elizabeth A.; Ahrendt, Gretchen M.; Wilke, Lee G.; Taback, Bret; Leitch, A. Marilyn; Kuerer, Henry M.; Bowling, Monet; Flippo-Morton, Teresa S.; Byrd, David R.; Ollila, David W.; Julian, Thomas B.; McLaughlin, Sarah A.; McCall, Linda; Symmans, W. Fraser; Le-Petross, Huong T.; Haffty, Bruce G.; Buchholz, Thomas A.; Nelson, Heidi; Hunt, Kelly K.		Alliance Clinical Trials Oncology	Sentinel Lymph Node Surgery After Neoadjuvant Chemotherapy in Patients With Node-Positive Breast Cancer The ACOSOG Z1071 (Alliance) Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PREOPERATIVE CHEMOTHERAPY; AXILLARY DISSECTION; BIOPSY; LYMPHADENECTOMY	IMPORTANCE Sentinel lymph node (SLN) surgery provides reliable nodal staging information with less morbidity than axillary lymph node dissection (ALND) for patients with clinically node-negative (cN0) breast cancer. The application of SLN surgery for staging the axilla following chemotherapy for women who initially had node-positive cN1 breast cancer is unclear because of high false-negative results reported in previous studies. OBJECTIVE To determine the false-negative rate (FNR) for SLN surgery following chemotherapy in women initially presenting with biopsy-proven cN1 breast cancer. DESIGN, SETTING, AND PATIENTS The American College of Surgeons Oncology Group (ACOSOG) Z1071 trial enrolled women from 136 institutions from July 2009 to June 2011 who had clinical T0 through T4, N1 through N2, M0 breast cancer and received neoadjuvant chemotherapy. Following chemotherapy, patients underwent both SLN surgery and ALND. Sentinel lymph node surgery using both blue dye (isosulfan blue or methylene blue) and a radiolabeled colloid mapping agent was encouraged. MAIN OUTCOMES AND MEASURES The primary end point was the FNR of SLN surgery after chemotherapy in women who presented with cN1 disease. We evaluated the likelihood that the FNR in patients with 2 or more SLNs examined was greater than 10%, the rate expected for women undergoing SLN surgery who present with cN0 disease. RESULTS Seven hundred fifty-six women were enrolled in the study. Of 663 evaluable patients with cN1 disease, 649 underwent chemotherapy followed by both SLN surgery and ALND. An SLN could not be identified in 46 patients (7.1%). Only 1 SLN was excised in 78 patients (12.0%). Of the remaining 525 patients with 2 or more SLNs removed, no cancer was identified in the axillary lymph nodes of 215 patients, yielding a pathological complete nodal response of 41.0% (95% CI, 36.7%-45.3%). In 39 patients, cancer was not identified in the SLNs but was found in lymph nodes obtained with ALND, resulting in an FNR of 12.6% (90% Bayesian credible interval, 9.85%-16.05%). CONCLUSIONS AND RELEVANCE Among women with cN1 breast cancer receiving neoadjuvant chemotherapy who had 2 or more SLNs examined, the FNR was not found to be 10% or less. Given this FNR threshold, changes in approach and patient selection that result in greater sensitivity would be necessary to support the use of SLN surgery as an alternative to ALND.	[Boughey, Judy C.; Nelson, Heidi] Mayo Clin, Dept Surg, Rochester, MN USA; [Suman, Vera J.] Mayo Clin, Dept Hlth Sci Res, Rochester, MN USA; [Mittendorf, Elizabeth A.; Kuerer, Henry M.; Hunt, Kelly K.] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA; [Symmans, W. Fraser] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Le-Petross, Huong T.] Univ Texas MD Anderson Canc Ctr, Dept Diagnost Radiol, Houston, TX 77030 USA; [Buchholz, Thomas A.] Univ Texas MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA; [Ahrendt, Gretchen M.] Univ Pittsburgh, Magee Womens Hosp, Med Ctr, Dept Surg, Pittsburgh, PA 15213 USA; [Wilke, Lee G.] Univ ofWisconsin Madison, Dept Surg, Madison, WI USA; [Taback, Bret] Columbia Univ, Med Ctr, Dept Surg, New York, NY USA; [Leitch, A. Marilyn] Univ Texas SW Med Ctr Dallas, Dept Surg, Dallas, TX 75390 USA; [Bowling, Monet] Indiana Univ, Dept Surg, Indianapolis, IN 46204 USA; [Flippo-Morton, Teresa S.] Carolinas Med Ctr, Dept Surg, Charlotte, NC 28203 USA; [Byrd, David R.] Univ Washington, Dept Surg, Seattle, WA 98195 USA; [Ollila, David W.] Univ N Carolina, Dept Surg, Chapel Hill, NC USA; [Julian, Thomas B.] Allegheny Gen Hosp, Allegheny Canc Ctr, Dept Surg, Pittsburgh, PA 15212 USA; [McLaughlin, Sarah A.] Mayo Clin, Dept Surg, Jacksonville, FL 32224 USA; [McCall, Linda] Amer Coll Surg, Oncol Grp, Ctr Stat, Durham, NC USA; [Haffty, Bruce G.] Canc Inst New Jersey, Dept Radiat Oncol, New Brunswick, NJ USA	Mayo Clinic; Mayo Clinic; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Columbia University; University of Texas System; University of Texas Southwestern Medical Center Dallas; Indiana University System; Indiana University-Purdue University Indianapolis; Carolinas Medical Center; University of Washington; University of Washington Seattle; University of North Carolina; University of North Carolina Chapel Hill; Allegheny General Hospital; Mayo Clinic; American College of Surgeons; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey	Hunt, KK (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Unit 1484, 1400 Pressler St, Houston, TX 77030 USA.	khunt@mdanderson.org	Le-Petross, Huong/ABA-3508-2020	Buchholz, Thomas/0000-0002-7859-5572	National Cancer Institute [U10 CA76001]; NATIONAL CANCER INSTITUTE [U10CA076001, U10CA180882, U10CA180821, U10CA086004, P30CA015083, P30CA016672] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grant U10 CA76001 from the National Cancer Institute awarded to the American College of Surgeons Oncology Group (ACOSOG).	Balch GC, 2003, ANN SURG ONCOL, V10, P616, DOI 10.1245/ASO.2003.05.012; Berry DA, 1996, BAYESIAN BIOSTATISTI; Brady Elizabeth W, 2002, Breast J, V8, P97, DOI 10.1046/j.1524-4741.2002.08205.x; Hennessy BT, 2005, J CLIN ONCOL, V23, P9304, DOI 10.1200/JCO.2005.02.5023; Hunt KK, 2009, ANN SURG, V250, P558, DOI 10.1097/SLA.0b013e3181b8fd5e; Krag DN, 2007, LANCET ONCOL, V8, P881, DOI 10.1016/S1470-2045(07)70278-4; Mamounas EP, 2005, J CLIN ONCOL, V23, P2694, DOI 10.1200/JCO.2005.05.188; Mamounas EP, 2005, J CLIN ONCOL, V23, P4808; Miller AR, 2002, ANN SURG ONCOL, V9, P243, DOI 10.1007/BF02573061; Piato JRM, 2003, EUR J SURG ONCOL, V29, P118, DOI 10.1053/ejso.2002.1349; Reitsamer R, 2003, J SURG ONCOL, V84, P63, DOI 10.1002/jso.10294; Schwartz Gordon F, 2003, Breast J, V9, P374, DOI 10.1046/j.1524-4741.2003.09502.x; Shen J, 2007, CANCER-AM CANCER SOC, V109, P1255, DOI 10.1002/cncr.22540; Spiegelhalter DJ, 2004, BAYESIAN APPROACHES, DOI DOI 10.1002/0470092602; Stearns V, 2002, ANN SURG ONCOL, V9, P235, DOI 10.1245/aso.2002.9.3.235; Veronesi U, 2003, NEW ENGL J MED, V349, P546, DOI 10.1056/NEJMoa012782; Xing Y, 2006, BRIT J SURG, V93, P539, DOI 10.1002/bjs.5209	17	827	877	0	44	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 9	2013	310	14					1455	1461		10.1001/jama.2013.278932	http://dx.doi.org/10.1001/jama.2013.278932			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	230PK	24101169	Green Accepted, Bronze			2022-12-28	WOS:000325354100021
J	Jiang, JM; Wakimoto, H; Seidman, JG; Seidman, CE				Jiang, Jianming; Wakimoto, Hiroko; Seidman, J. G.; Seidman, Christine E.			Allele-Specific Silencing of Mutant Myh6 Transcripts in Mice Suppresses Hypertrophic Cardiomyopathy	SCIENCE			English	Article							GENE-TRANSFER; MOUSE MODEL; PROGRESS; DISEASE	Dominant mutations in sarcomere proteins such as the myosin heavy chains (MHC) are the leading genetic causes of human hypertrophic cardiomyopathy (HCM) and dilated cardiomyopathy. We found that expression of the HCM-causing cardiac MHC gene (Myh6) R403Q mutation in mice can be selectively silenced by an RNA interference (RNAi) cassette delivered by an adeno-associated virus vector. RNAi-transduced MHC403/+ mice developed neither hypertrophy nor myocardial fibrosis, the pathologic manifestations of HCM, for at least 6 months. Because inhibition of HCM was achieved by only a 25% reduction in the levels of the mutant transcripts, we suggest that the variable clinical phenotype in HCM patients reflects allele-specific expression and that partial silencing of mutant transcripts may have therapeutic benefit.	[Jiang, Jianming; Wakimoto, Hiroko; Seidman, J. G.; Seidman, Christine E.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Wakimoto, Hiroko] Boston Childrens Hosp, Dept Cardiol, Boston, MA 02115 USA; [Jiang, Jianming; Wakimoto, Hiroko; Seidman, Christine E.] Brigham & Womens Hosp, Div Cardiovasc Med, Boston, MA 02115 USA; [Jiang, Jianming; Seidman, Christine E.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Brigham & Women's Hospital; Howard Hughes Medical Institute	Seidman, CE (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	cseidman@genetics.med.harvard.edu	jiang, jianming/B-3421-2012	jiang, jianming/0000-0003-3251-2716	NIH [U01HL098166, R01HL084553]; Howard Hughes Medical Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL066582, U01HL098166, R01HL084553] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank J. Gorham, D. Conner, and S. DePalma for technical and bioinformatic assistance, and C. Cepko for assistance with viral protocols. Supported by NIH grants U01HL098166 and R01HL084553 (J. G. S. and C. E. S.) and the Howard Hughes Medical Institute (C. E. S.). The authors (J. J., C. E. S., J. G. S., and H. W.) and Harvard Medical School plan a patent application related to the use of short hairpin RNAs as therapies for human genetic cardiomyopathies. C. E. S. and J. G. S. are founders of and own shares in MyoKardia, a biotechnology company developing small molecules that target the sarcomere for treatment of inherited cardiomyopathy.	Bish LT, 2008, HUM GENE THER, V19, P1359, DOI 10.1089/hum.2008.123; Christodoulou D. C., 2011, CURR PROTOC MOL BIOL, V94, P4121, DOI DOI 10.1002/0471142727.MB0412S94; de Fougerolles A, 2007, NAT REV DRUG DISCOV, V6, P443, DOI 10.1038/nrd2310; Elmariah Sammy, 2012, Curr Treat Options Cardiovasc Med, V14, P665, DOI 10.1007/s11936-012-0206-5; Fatkin D, 2000, J CLIN INVEST, V106, P1351, DOI 10.1172/JCI11093; Gao GP, 2005, CURR GENE THER, V5, P285, DOI 10.2174/1566523054065057; GEISTERFERLOWRANCE AAT, 1990, CELL, V62, P999, DOI 10.1016/0092-8674(90)90274-I; GeisterferLowrance AAT, 1996, SCIENCE, V272, P731, DOI 10.1126/science.272.5262.731; Ho CY, 2012, CIRCULATION, V125, P1432, DOI 10.1161/CIRCULATIONAHA.110.017277; Ho CY, 2002, CIRCULATION, V105, P2992, DOI 10.1161/01.CIR.0000019070.70491.6D; Jones WK, 1996, J CLIN INVEST, V98, P1906, DOI 10.1172/JCI118992; Kim JB, 2007, SCIENCE, V316, P1481, DOI 10.1126/science.1137325; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Lopes LR, 2013, HEART, V99, P1800, DOI 10.1136/heartjnl-2013-303939; Maron BJ, 2013, LANCET, V381, P242, DOI 10.1016/S0140-6736(12)60397-3; Maron BJ, 2009, CIRCULATION, V119, P1085, DOI 10.1161/CIRCULATIONAHA.108.804617; Mingozzi F, 2011, NAT REV GENET, V12, P341, DOI 10.1038/nrg2988; Prasad KMR, 2011, GENE THER, V18, P43, DOI 10.1038/gt.2010.105; Rodriguez-Lebron E, 2006, GENE THER, V13, P576, DOI 10.1038/sj.gt.3302702; Seidman JG, 2001, CELL, V104, P557, DOI 10.1016/S0092-8674(01)00242-2; Semsarian C, 2002, J CLIN INVEST, V109, P1013, DOI 10.1172/JCI200214677; Spirito P, 1997, NEW ENGL J MED, V336, P775, DOI 10.1056/NEJM199703133361107; Teekakirikul P, 2012, J CELL BIOL, V199, P417, DOI 10.1083/jcb.201207033; Teekakirikul P, 2010, J CLIN INVEST, V120, P3520, DOI 10.1172/JCI42028; Tripathi S, 2011, BASIC RES CARDIOL, V106, P1041, DOI 10.1007/s00395-011-0205-9; Tyska MJ, 2000, CIRC RES, V86, P737, DOI 10.1161/01.RES.86.7.737; Yu DB, 2012, CELL, V150, P895, DOI 10.1016/j.cell.2012.08.002	27	118	137	1	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 4	2013	342	6154					111	114		10.1126/science.1236921	http://dx.doi.org/10.1126/science.1236921			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	227PP	24092743	Green Accepted			2022-12-28	WOS:000325126100057
J	Bernat, JL				Bernat, James L.			Life or Death for the Dead-Donor Rule?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CARE; DONATION	Several scholars have proposed permitting dying patients who are beyond harm to donate organs before death. But such a shift away from the dead-donor rule could lead to lost trust in physicians, reduced confidence in the organ-donation system, and a decline in organ donation. The increasing disproportion between the supply of donor organs and the demand for transplants as well as the tragic deaths of patients awaiting organs have encouraged the development of creative solutions to increase the donor supply. In the domain of donation from deceased donors, the protocols for organ donation after the circulatory determination of death (DCDD) have been one such response. Most U.S. organ-procurement organizations have seen organs from DCDD protocols account for a growing percentage of all organs donated from deceased donors (see graph). In England, DCDD organs currently constitute a greater percentage than organs donated after the determination ...	[Bernat, James L.] Geisel Sch Med Dartmouth, Dept Neurol, Hanover, NH 03755 USA; [Bernat, James L.] Geisel Sch Med Dartmouth, Dept Med, Hanover, NH USA	Dartmouth College; Dartmouth College	Bernat, JL (corresponding author), Geisel Sch Med Dartmouth, Dept Neurol, Hanover, NH 03755 USA.							Bastami S, 2013, CRIT CARE MED, V41, P897, DOI 10.1097/CCM.0b013e31827585fe; Bernat JL, 2013, NAT REV NEUROL, V9, P164, DOI 10.1038/nrneurol.2013.12; Miller FG, 2010, J MED PHILOS, V35, P299, DOI 10.1093/jmp/jhq019; Morrissey PE, 2012, AM J BIOETHICS, V12, P1, DOI 10.1080/15265161.2012.671886; Robertson JA, 1999, HASTINGS CENT REP, V29, P6, DOI 10.2307/3527865	5	43	44	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 3	2013	369	14					1289	1291		10.1056/NEJMp1308078	http://dx.doi.org/10.1056/NEJMp1308078			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	227KI	24088089				2022-12-28	WOS:000325111200004
J	Erkens, GB; Hanelt, I; Goudsmits, JMH; Slotboom, DJ; van Oijen, AM				Erkens, Guus B.; Hanelt, Inga; Goudsmits, Joris M. H.; Slotboom, Dirk Jan; van Oijen, Antoine M.			Unsynchronised subunit motion in single trimeric sodium-coupled aspartate transporters	NATURE			English	Article							PYROCOCCUS-HORIKOSHII; INDIVIDUAL SUBUNITS; IMAGE REGISTRATION; HOMOLOG; DYNAMICS; CONDUCTANCE; TRANSLATION; SUBSTRATE; GLT(PH)	Excitatory amino acid transporters (EAATs) are secondary transport proteins that mediate the uptake of glutamate and other amino acids(1). EAATs fulfil an important role in neuronal signal transmission by clearing the excitatory neurotransmitters from the synaptic cleft after depolarization of the postsynaptic neuron. An intensively studied model system for understanding the transport mechanism of EAATs is the archaeal aspartate transporter Glt(Ph)(2-6). Each subunit in the homotrimeric Glt(Ph) supports the coupled translocation of one aspartate molecule and three Na+ ions(2) as well as an uncoupled flux of Cl- ions(7). Recent crystal structures of Glt(Ph)(3,5,6,8) revealed three possible conformations for the subunits, but it is unclear whether the motions of individual subunits are coordinated to support transport. Here, we report the direct observation of conformational dynamics in individual Glt(Ph) trimers embedded in the membrane by applying single-molecule fluorescence resonance energy transfer (FRET). By analysing the transporters in a lipid bilayer instead of commonly used detergent micelles, we achieve conditions that approximate the physiologically relevant ones. From the kinetics of FRET level transitions we conclude that the three Glt(Ph) subunits undergo conformational changes stochastically and independently of each other.	[Erkens, Guus B.; Hanelt, Inga; Goudsmits, Joris M. H.; Slotboom, Dirk Jan; van Oijen, Antoine M.] Univ Groningen, Zernike Inst Adv Mat, NL-9747 AG Groningen, Netherlands; [Hanelt, Inga; Slotboom, Dirk Jan; van Oijen, Antoine M.] Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, NL-9747 AG Groningen, Netherlands; [Slotboom, Dirk Jan; van Oijen, Antoine M.] Univ Groningen, Ctr Synthet Biol, NL-9747 AG Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen	van Oijen, AM (corresponding author), Univ Groningen, Zernike Inst Adv Mat, Nijenborgh 4, NL-9747 AG Groningen, Netherlands.	d.j.slotboom@rug.nl; a.m.van.oijen@rug.nl	van Oijen, Antoine/I-3167-2014; Hänelt, Inga/N-2982-2016; Institute, Zernike/W-7033-2019	van Oijen, Antoine/0000-0002-1794-5161; Hänelt, Inga/0000-0003-1495-3163; 	Netherlands Organization for Scientific Research (NWO) [Vici 680-47-607, Vidi 700.54.423, Vici 865.11.001]; European Research Council (ERC Starting) [281098]; European Research Council (ERC) [282083]; Deutsche Forschungsgemeinschaft [HA 6322/1-1]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); European Research Council (ERC Starting); European Research Council (ERC)(European Research Council (ERC)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The authors would like to thank M. Punter for developing software and algorithms for data analysis, V. Krasnikov for his help with the design, construction and maintenance of the single-molecule fluorescence microscopes and I. Kusters for sharing experience on liposome tethering and single-molecule imaging of membrane proteins. A.M.v.O. acknowledges funding from the Netherlands Organization for Scientific Research (NWO; Vici 680-47-607) and the European Research Council (ERC Starting 281098). D.J.S. acknowledges funding from the Netherlands Organization for Scientific Research (NWO; Vidi 700.54.423, Vici 865.11.001) and the European Research Council (ERC Starting 282083). I. H. acknowledges the Deutsche Forschungsgemeinschaft (HA 6322/1-1) for providing funding.	Akyuz N., 2013, NATURE; Blanchard SC, 2004, P NATL ACAD SCI USA, V101, P12893, DOI 10.1073/pnas.0403884101; Boudker O, 2007, NATURE, V445, P387, DOI 10.1038/nature05455; Cordes T, 2009, J AM CHEM SOC, V131, P5018, DOI 10.1021/ja809117z; Dorwart MR, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000555; Floyd DL, 2010, BIOPHYS J, V99, P360, DOI 10.1016/j.bpj.2010.04.049; Georgieva ER, 2013, NAT STRUCT MOL BIOL, V20, P215, DOI 10.1038/nsmb.2494; Grewer C, 2005, BIOCHEMISTRY-US, V44, P11913, DOI 10.1021/bi050987n; Groeneveld M, 2010, BIOCHEMISTRY-US, V49, P3511, DOI 10.1021/bi100430s; Guizar-Sicairos M, 2008, OPT LETT, V33, P156, DOI 10.1364/OL.33.000156; Hanelt I, 2013, NAT STRUCT MOL BIOL, V20, P210, DOI 10.1038/nsmb.2471; Hedde PN, 2009, NAT METHODS, V6, P689, DOI 10.1038/nmeth1009-689; Joo C, 2008, ANNU REV BIOCHEM, V77, P51, DOI 10.1146/annurev.biochem.77.070606.101543; Kanner BI, 2008, CHEM REV, V108, P1654, DOI 10.1021/cr078246a; Kapanidis AN, 2005, ACCOUNTS CHEM RES, V38, P523, DOI 10.1021/ar0401348; Koch HP, 2007, J NEUROSCI, V27, P2943, DOI 10.1523/JNEUROSCI.0118-07.2007; Koch HP, 2005, J NEUROSCI, V25, P1730, DOI 10.1523/JNEUROSCI.4138-04.2005; Reddy BS, 1996, IEEE T IMAGE PROCESS, V5, P1266, DOI 10.1109/83.506761; Reyes N, 2009, NATURE, V462, P880, DOI 10.1038/nature08616; Ryan RM, 2007, NAT STRUCT MOL BIOL, V14, P365, DOI 10.1038/nsmb1230; Ryan RM, 2009, J BIOL CHEM, V284, P17540, DOI 10.1074/jbc.M109.005926; Tanner NA, 2010, METHOD ENZYMOL, V475, P259, DOI 10.1016/S0076-6879(10)75011-4; van der Heide T, 2000, P NATL ACAD SCI USA, V97, P7102, DOI 10.1073/pnas.97.13.7102; Verdon G, 2012, NAT STRUCT MOL BIOL, V19, P355, DOI 10.1038/nsmb.2233; Verhalen B, 2012, J BIOL CHEM, V287, P1112, DOI 10.1074/jbc.M111.301192; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018; Zhao YF, 2011, NATURE, V474, P109, DOI 10.1038/nature09971; Zhao YF, 2010, NATURE, V465, P188, DOI 10.1038/nature09057	28	95	95	0	73	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 3	2013	502	7469					119	+		10.1038/nature12538	http://dx.doi.org/10.1038/nature12538			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	227IM	24091978				2022-12-28	WOS:000325106000043
J	Hunter, DJ; Reddy, KS				Hunter, David J.; Reddy, K. Srinath			Noncommunicable Diseases	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							SUGAR-SWEETENED BEVERAGES; RISK-FACTORS; CARDIOVASCULAR MEDICINES; TOBACCO CONTROL; GLOBAL BURDEN; HEALTH-CARE; MORTALITY; CANCER; AFFORDABILITY; AVAILABILITY	Cardiovascular disease, cancer, chronic pulmonary disease, and diabetes are conditions that, to a large extent, do not result directly from infection. The toll from these noncommunicable diseases is the subject of this review in the Global Health series. The United Nations has held only two meetings of heads of state on a health-related issue. The first, in 2001, was on human immunodeficiency virus infection and the acquired immunodeficiency syndrome. The second, in September 2011, was on noncommunicable diseases. Although noncommunicable diseases were ignored during the framing of the Millennium Development Goals in 2000, their leading and growing contribution to preventable deaths and disability across the globe has compelled policymakers to pay attention and initiate action. The United Nations and the World Health Organization (WHO) have called for a 25% reduction by 2025 in mortality from noncommunicable diseases among ...	[Hunter, David J.] Harvard Univ, Dept Epidemiol, Sch Publ Hlth, Boston, MA 02115 USA; [Hunter, David J.] Harvard Univ, Dept Nutr, Sch Publ Hlth, Boston, MA 02115 USA; [Reddy, K. Srinath] Publ Hlth Fdn India, New Delhi, India; [Reddy, K. Srinath] WHO, Geneva, NY USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Public Health Foundation of India; World Health Organization	Hunter, DJ (corresponding author), Harvard Univ, Dept Epidemiol, Sch Publ Hlth, 677 Huntington Ave, Boston, MA 02115 USA.	dhunter@hsph.harvard.edu		Reddy, K Srinath/0000-0003-3416-3548	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES002109] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Abegunde DO, 2007, B WORLD HEALTH ORGAN, V85, P432, DOI 10.2471/BLT.06.032177; [Anonymous], 2013, B WORLD HEALTH ORGAN, V91, P6, DOI 10.2471/BLT.13.020113; [Anonymous], 2013, NONC DIS; [Anonymous], 2013, POST2015 CONS HLTH C; [Anonymous], 2011, CAUS SPEC MORT 2008; [Anonymous], 2012, 65 WORLD HLTH ASS CL; Barker DJP, 2012, PUBLIC HEALTH, V126, P185, DOI 10.1016/j.puhe.2011.11.014; Bloom DE, 2011, GLOBAL EC BURDEN NON, DOI DOI 10.1192/BJP.184.5.393; Bloom DE, 2011, BURDEN BEST BUYS RED; Bonita R, 2013, LANCET, V381, P575, DOI 10.1016/S0140-6736(12)61993-X; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Coleman R, 1998, B WORLD HEALTH ORGAN, V76, P633; de Ruyter JC, 2012, NEW ENGL J MED, V367, P1397, DOI 10.1056/NEJMoa1203034; Ebbeling CB, 2012, NEW ENGL J MED, V367, P1407, DOI 10.1056/NEJMoa1203388; Ezzati M, 2013, NEW ENGL J MED, V369, P954, DOI 10.1056/NEJMra1203528; Ezzati M, 2012, SCIENCE, V337, P1482, DOI 10.1126/science.1227001; Farmer P, 2010, LANCET, V376, P1186, DOI 10.1016/S0140-6736(10)61152-X; Farzadfar F, 2012, LANCET, V379, P47, DOI 10.1016/S0140-6736(11)61349-4; Ford ES, 2011, ANNU REV PUBL HEALTH, V32, P5, DOI 10.1146/annurev-publhealth-031210-101211; Frenk J, 2012, LANCET, V380, P862, DOI 10.1016/S0140-6736(12)61341-5; Glantz S, 2012, LANCET, V379, P1269, DOI 10.1016/S0140-6736(11)60615-6; Heeley E, 2009, STROKE, V40, P2149, DOI 10.1161/STROKEAHA.108.540054; Husten CG, 2013, LANCET, V381, P1570, DOI 10.1016/S0140-6736(13)60735-7; Jemal A, 2008, JNCI-J NATL CANCER I, V100, P1672, DOI 10.1093/jnci/djn389; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Joshi P, 2007, JAMA-J AM MED ASSOC, V297, P286, DOI 10.1001/jama.297.3.286; Kishore SP, 2011, J AM COLL CARDIOL, V57, P1980, DOI 10.1016/j.jacc.2010.12.029; Krishna S, 2009, TELEMED J E-HEALTH, V15, P231, DOI 10.1089/tmj.2008.0099; Lawes CMM, 2003, J HYPERTENS, V21, P707, DOI 10.1097/01.hjh.0000052492.18130.07; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Mathew A, 2009, ASIAN PAC J CANCER P, V10, P645; Mendis S, 2007, B WORLD HEALTH ORGAN, V85, P279, DOI 10.2471/BLT.06.033647; mHealth for development, 2009, MHEALTH DEV OPP MOB; Murray CJL, 2013, NEW ENGL J MED, V369, P448, DOI 10.1056/NEJMra1201534; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Myers ML, 2013, TOB CONTROL, V22, P45, DOI 10.1136/tobaccocontrol-2012-050891; National Center for Health Statistics, 2012, HLTH US 2011 SPEC FE; O'Brien M, 2013, LANCET ONCOL, V14, pE176, DOI 10.1016/S1470-2045(12)70343-1; Plymoth A, 2009, CANCER LETT, V286, P15, DOI 10.1016/j.canlet.2009.08.024; Seckeler Michael D, 2011, Clin Epidemiol, V3, P67, DOI 10.2147/CLEP.S12977; United Nations General Assembly, 2011, POL DECL HIGH LEV M; van Mourik MSM, 2010, BMC CARDIOVASC DISOR, V10, DOI 10.1186/1471-2261-10-25; Venkatesh R, 2005, BRIT J OPHTHALMOL, V89, P1079, DOI 10.1136/bjo.2004.063479; Wald NJ, 2010, POSTGRAD MED J, V86, P257, DOI 10.1136/hrt.2009.186429; WHO, 2011, GLOB STAT REP NONC D; Yusuf S, 2009, LANCET, V373, P1341, DOI 10.1016/S0140-6736(09)60611-5	47	279	297	3	67	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 3	2013	369	14					1336	1343		10.1056/NEJMra1109345	http://dx.doi.org/10.1056/NEJMra1109345			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	227KI	24088093	Bronze			2022-12-28	WOS:000325111200011
J	McCartney, M				McCartney, Margaret			TOO MUCH MEDICINE Where's the evidence for NHS health checks?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				[Anonymous], 2008, BBC NEWS; [Anonymous], 2013, NHS HLTH CHECK E B; Artac M, 2013, PREV MED, V57, P129, DOI 10.1016/j.ypmed.2013.05.002; Department of Health, 2008, PUTT PREV 1 VASC CHE; Ireland T., 2010, VASC CHECKS MAY DITC; Krogsboll LT, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009009.pub2; National Institute for Health and Care Excellence (NICE), 2010, PREV CARD DIS; Public Health England, 2013, NHS HLTH CHECK IMPL; Public Health England, 2013, NHS HLTH CHECK OUR A; Simmons RK, 2012, LANCET, V380, P1741, DOI 10.1016/S0140-6736(12)61422-6; Smith S, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002219; STEAD LF, 2008, COCHRANE DB SYST REV, V4; UK National Screening Committee, 2007, UKNSC POL VASC RISK; UK National Screening Committee University of Leicester, 2012, HDB VASC RISK ASS RI	14	14	14	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 2	2013	347								f5834	10.1136/bmj.f5834	http://dx.doi.org/10.1136/bmj.f5834			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	231OU	24089427				2022-12-28	WOS:000325427400010
J	Ly, TT; Nicholas, JA; Retterath, A; Lim, EM; Davis, EA; Jones, TW				Ly, Trang T.; Nicholas, Jennifer A.; Retterath, Adam; Lim, Ee Mun; Davis, Elizabeth A.; Jones, Timothy W.			Effect of Sensor-Augmented Insulin Pump Therapy and Automated Insulin Suspension vs Standard Insulin Pump Therapy on Hypoglycemia in Patients With Type 1 Diabetes A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							AWARENESS; ADOLESCENTS; REDUCTION; CHILDREN; RESPONSES; DURATION; ADULTS	IMPORTANCE Hypoglycemia is a critical obstacle to the care of patients with type 1 diabetes. Sensor-augmented insulin pump with automated low-glucose insulin suspension has the potential to reduce the incidence of major hypoglycemic events. OBJECTIVE To determine the incidence of severe and moderate hypoglycemia with sensor-augmented pump with low-glucose suspension compared with standard insulin pump therapy. DESIGN, SETTING, AND PARTICIPANTS A randomized clinical trial involving 95 patients with type 1 diabetes, recruited from December 2009 to January 2012 in Australia. INTERVENTIONS Patients were randomized to insulin pump only or automated insulin suspension for 6 months. MAIN OUTCOMES AND MEASURES The primary outcome was the combined incidence of severe (hypoglycemic seizure or coma) and moderate hypoglycemia (an event requiring assistance for treatment). In a subgroup, counterregulatory hormone responses to hypoglycemia were assessed using the hypoglycemic clamp technique. RESULTS Of the 95 patients randomized, 49 were assigned to the standard-pump (pump-only) therapy and 46 to the low-glucose suspension group. The mean (SD) age was 18.6 (11.8) years; duration of diabetes, 11.0 (8.9) years; and duration of pump therapy, 4.1 (3.4) years. The baseline rate of severe and moderate hypoglycemic events in the pump-only group was 20.7 vs 129.6 events per 100 patient months in the low-glucose suspension group. After 6 months of treatment, the event rates decreased from 28 to 16 in the pump-only group vs 175 to 35 in the low-glucose suspension group. The adjusted incidence rate per 100 patient-months was 34.2 (95% CI, 22.0-53.3) for the pump-only group vs 9.5 (95% CI, 5.2-17.4) for the low-glucose suspension group. The incidence rate ratio was 3.6 (95% CI, 1.7-7.5; P < .001). There was no change in glycated hemoglobin in either group: mean, 7.4 (95% CI, 7.2-7.6) to 7.4 (95% CI, 7.2-7.7) in the pump-only group vs mean, 7.6 (95%, CI, 7.4-7.9) to 7.5 (95% CI, 7.3-7.7) in the low-glucose suspension group. Counterregulatory hormone responses to hypoglycemia were not changed. There were no episodes of diabetic ketoacidosis or hyperglycemia with ketosis. CONCLUSIONS AND RELEVANCE Sensor-augmented pump therapy with automated insulin suspension reduced the combined rate of severe and moderate hypoglycemia in patients with type 1 diabetes.	[Ly, Trang T.; Nicholas, Jennifer A.; Davis, Elizabeth A.; Jones, Timothy W.] Princess Margaret Hosp Children, Dept Endocrinol & Diabet, Perth, WA 6840, Australia; [Ly, Trang T.; Nicholas, Jennifer A.; Retterath, Adam; Davis, Elizabeth A.; Jones, Timothy W.] Univ Western Australia, Ctr Child Hlth Res, Telethon Inst Child Hlth Res, Perth, WA 6009, Australia; [Ly, Trang T.; Davis, Elizabeth A.; Jones, Timothy W.] Univ Western Australia, Sch Paediat & Child Hlth, Perth, WA 6009, Australia; [Lim, Ee Mun] Queen Elizabeth II Med Ctr, PathWest Lab Med, Nedlands, WA, Australia; [Lim, Ee Mun] Sir Charles Gairdner Hosp, Dept Endocrinol & Diabet, Nedlands, WA 6009, Australia	University of Western Australia; Telethon Kids Institute; University of Western Australia; University of Western Australia; University of Western Australia; University of Western Australia	Jones, TW (corresponding author), Princess Margaret Hosp Children, Dept Endocrinol & Diabet, GPO Box D184, Perth, WA 6840, Australia.	tim.jones@health.wa.gov.au		Davis, Elizabeth/0000-0003-4244-5473; Jones, Timothy/0000-0002-7989-1998	Juvenile Diabetes Research Foundation; Medtronic	Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Medtronic(Medtronic)	This study was partly funded by the Juvenile Diabetes Research Foundation. Insulin pumps and glucose sensors were provided by Medtronic via an unrestricted grant.	Agrawal Pratik, 2011, J Diabetes Sci Technol, V5, P1137; Barkai L, 1998, DIABETOLOGIA, V41, P898, DOI 10.1007/s001250051005; Beck RW, 2009, DIABETES CARE, V32, P1378, DOI 10.2337/dc09-0108; Bergenstal RM, 2013, NEW ENGL J MED, V369, P224, DOI 10.1056/NEJMoa1303576; Bergenstal RM, 2010, NEW ENGL J MED, V363, P311, DOI 10.1056/NEJMoa1002853; Bulsara MK, 2004, DIABETES CARE, V27, P2293, DOI 10.2337/diacare.27.10.2293; Bulsara MK, 2004, DIABETIC MED, V21, P914, DOI 10.1111/j.1464-5491.2004.01250.x; Cameron AC., 2013, REGRESSION ANAL COUN, V2nd ed, DOI 10.1017/CBO9781139013567; Choudhary P, 2011, DIABETES CARE, V34, P2023, DOI 10.2337/dc10-2411; CLARKE WL, 1995, DIABETES CARE, V18, P517, DOI 10.2337/diacare.18.4.517; CRANSTON I, 1994, LANCET, V344, P283, DOI 10.1016/S0140-6736(94)91336-6; DALY L, 1992, COMPUT BIOL MED, V22, P351, DOI 10.1016/0010-4825(92)90023-G; Danne T, 2011, DIABETES TECHNOL THE, V13, P1129, DOI 10.1089/dia.2011.0084; Davis EA, 1997, DIABETES CARE, V20, P22, DOI 10.2337/diacare.20.1.22; Garg S, 2012, DIABETES TECHNOL THE, V14, P205, DOI 10.1089/dia.2011.0292; Geddes J, 2008, DIABETIC MED, V25, P501, DOI 10.1111/j.1464-5491.2008.02413.x; Katz ML, 2012, DIABETIC MED, V29, P926, DOI 10.1111/j.1464-5491.2012.03646.x; Kirkwood BR, 2003, ESSENTIAL MED STAT; Ly TT, 2012, DIABETES CARE, V35, P1462, DOI 10.2337/dc12-0052; Ly TT, 2011, DIABETES CARE, V34, P50, DOI 10.2337/dc10-1042; Ly TT, 2009, DIABETES CARE, V32, P1802, DOI 10.2337/dc09-0541; ter Braak EWMT, 2000, DIABETES CARE, V23, P1467, DOI 10.2337/diacare.23.10.1467	22	271	273	0	20	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 25	2013	310	12					1240	1247		10.1001/jama.2013.277818	http://dx.doi.org/10.1001/jama.2013.277818			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	222SO	24065010	Bronze			2022-12-28	WOS:000324751800020
J	Tress, M; Mapesa, EU; Kossack, W; Kipnusu, WK; Reiche, M; Kremer, F				Tress, Martin; Mapesa, Emmanuel U.; Kossack, Wilhelm; Kipnusu, Wycliffe K.; Reiche, Manfred; Kremer, Friedrich			Glassy Dynamics in Condensed Isolated Polymer Chains	SCIENCE			English	Article							TRANSITION TEMPERATURE; SYNTHETIC-POLYMER; THIN-LAYERS; DEPOSITION; SCALE; FILMS	In the course of miniaturization down to the nanometer scale, much remains unknown concerning how and to what extent the properties of materials are changed. To learn more about the dynamics of condensed isolated polymer chains, we used broadband dielectric spectroscopy and a capacitor with nanostructured electrodes separated by 35 nanometers. We measured the dynamic glass transition of poly(2-vinylpyridine) and found it to be bulk-like; only segments closer than 0.5 nanometer to the substrate were weakly slowed. Our approach paves the way for numerous experiments on the dynamics of isolated molecules.	[Tress, Martin; Mapesa, Emmanuel U.; Kossack, Wilhelm; Kipnusu, Wycliffe K.; Kremer, Friedrich] Univ Leipzig, Fac Phys & Earth Sci, D-04103 Leipzig, Germany; [Reiche, Manfred] Max Planck Inst Microstruct Phys, D-06120 Halle, Saale, Germany	Leipzig University; Max Planck Society	Kremer, F (corresponding author), Univ Leipzig, Fac Phys & Earth Sci, D-04103 Leipzig, Germany.	kremer@physik.uni-leipzig.de	Kipnusu, Wycliffe/AAO-4014-2020; Kipnusu, Wycliffe Kiprop/AAB-1949-2020	Kipnusu, Wycliffe/0000-0003-0643-7716; Kossack, Wilhelm/0000-0003-1578-8454	Graduate School BuildMoNa; Deutsche Forschungsgemeinschaft (DFG) [SPP 1369]; DFG [SFB TRR 102]	Graduate School BuildMoNa; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); DFG(German Research Foundation (DFG))	We thank the Leibniz Institute of Polymer Research Dresden (IPF), especially P. Uhlamnn and A. Lederer, for conducting GPC measurements and A. Synytska for helpful discussions. Supported by the Graduate School BuildMoNa (M.T.), a Deutsche Forschungsgemeinschaft (DFG) grant within project SPP 1369 (E.U.M.), and DFG grant SFB TRR 102. A description of the sample preparation and the volume detection of the polymer coils, as well as details on the BDS and IR measurements, can be found in the supplementary materials. F.K. initiated and guided the project; M.R. was responsible for the fabrication of the nanostructured silicon wafers; M.T. and E.U.M. tested the suitability of the silicon wafers and developed the cleaning procedure; M.T. conducted the BDS experiments and AFM measurements, and analyzed the data; W.K.K. produced and filled the silica pores; W.K. performed and analyzed the IR measurements; and M.T., F.K., and E.U.M. wrote the manuscript.	Acikgoz C, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/13/135304; ADAM G, 1965, J CHEM PHYS, V43, P139, DOI 10.1063/1.1696442; BAHAR I, 1992, MACROMOLECULES, V25, P816, DOI 10.1021/ma00028a048; Capponi S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2228; Efremov MY, 2004, MACROMOLECULES, V37, P4607, DOI 10.1021/ma035909r; Ellison CJ, 2002, EUR PHYS J E, V8, P155, DOI 10.1140/epje/i2001-10057-y; Erber M, 2010, MACROMOLECULES, V43, P7729, DOI 10.1021/ma100912r; Iacob C, 2010, PHYS CHEM CHEM PHYS, V12, P13798, DOI 10.1039/c004546b; JASCHKE M, 1995, LANGMUIR, V11, P1061, DOI 10.1021/la00004a004; Kiriy A, 2003, MACROMOLECULES, V36, P8704, DOI 10.1021/ma0348270; Koh YP, 2006, J POLYM SCI POL PHYS, V44, P3518, DOI 10.1002/polb.21021; Kremer F., 2003, BROADBAND DIELECTRIC, P81; Kremer F., 2013, RECENT ADV BROADBAND, P163, DOI DOI 10.1007/978-94-007-5012-8_12; Kumaki J, 1996, J AM CHEM SOC, V118, P3321, DOI 10.1021/ja9538593; Kumaki J, 2003, J AM CHEM SOC, V125, P4907, DOI 10.1021/ja0290429; Mapesa EU, 2010, EUR PHYS J-SPEC TOP, V189, P173, DOI 10.1140/epjst/e2010-01320-2; McConney ME, 2010, POLYM REV, V50, P235, DOI 10.1080/15583724.2010.493255; Napolitano S, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1259; Roiter Y, 2005, J AM CHEM SOC, V127, P15688, DOI 10.1021/ja0558239; Russell EV, 1998, PHYS REV LETT, V81, P1461, DOI 10.1103/PhysRevLett.81.1461; Salazar RB, 2006, SMALL, V2, P1274, DOI 10.1002/smll.200600235; Serghei A, 2008, REV SCI INSTRUM, V79, DOI 10.1063/1.2839021; Tress M, 2010, MACROMOLECULES, V43, P9937, DOI 10.1021/ma102031k; Tsui OKC, 2001, MACROMOLECULES, V34, P5535, DOI 10.1021/ma000028v	24	101	101	4	202	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 20	2013	341	6152					1371	1374		10.1126/science.1238950	http://dx.doi.org/10.1126/science.1238950			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	220PK	24052303				2022-12-28	WOS:000324597200040
J	Reid, IR; Bolland, MJ; Grey, A				Reid, Ian R.; Bolland, Mark J.; Grey, Andrew			Effects of vitamin D supplements on bone mineral density: a systematic review and meta-analysis	LANCET			English	Review							RANDOMIZED CONTROLLED-TRIAL; ELDERLY-WOMEN; POSTMENOPAUSAL WOMEN; DOUBLE-BLIND; D-RECEPTOR; HYPOVITAMINOSIS-D; DIETARY CALCIUM; POOLED ANALYSIS; PREVENTION; FRACTURES	Background Findings from recent meta-analyses of vitamin D supplementation without co-administration of calcium have not shown fracture prevention, possibly because of insufficient power or inappropriate doses, or because the intervention was not targeted to deficient populations. Despite these data, almost half of older adults (older than 50 years) continue to use these supplements. Bone mineral density can be used to detect biologically significant effects in much smaller cohorts. We investigated whether vitamin D supplementation affects bone mineral density. Methods We searched Web of Science, Embase, and the Cochrane Database, from inception to July 8, 2012, for trials assessing the effects of vitamin D (D3 or D2, but not vitamin D metabolites) on bone mineral density. We included all randomised trials comparing interventions that differed only in vitamin D content, and which included adults (average age >20 years) without other metabolic bone diseases. We pooled data with a random effects meta-analysis with weighted mean differences and 95% CIs reported. To assess heterogeneity in results of individual studies, we used Cochran's Q statistic and the I-2 statistic. The primary endpoint was the percentage change in bone mineral density from baseline. Findings Of 3930 citations identified by the search strategy, 23 studies (mean duration 23.5 months, comprising 4082 participants, 92% women, average age 59 years) met the inclusion criteria. 19 studies had mainly white populations. Mean baseline serum 25-hydroxyvitamin D concentration was less than 50 nmol/L in eight studies (n=1791). In ten studies (n=2294), individuals were given vitamin D doses less than 800 IU per day. Bone mineral density was measured at one to five sites (lumbar spine, femoral neck, total hip, trochanter, total body, or forearm) in each study, so 70 tests of statistical significance were done across the studies. There were six findings of significant benefit, two of significant detriment, and the rest were non-significant. Only one study showed benefit at more than one site. Results of our meta-analysis showed a small benefit at the femoral neck (weighted mean difference 0.8%, 95% CI 0.2-1.4) with heterogeneity among trials (I-2 = 67%, p<0.00027). No effect at any other site was reported, including the total hip. We recorded a bias toward positive results at the femoral neck and total hip. Interpretation Continuing widespread use of vitamin D for osteoporosis prevention in community-dwelling adults without specific risk factors for vitamin D deficiency seems to be inappropriate.	[Reid, Ian R.; Bolland, Mark J.; Grey, Andrew] Univ Auckland, Fac Med & Hlth Sci, Dept Med, Auckland 1, New Zealand; [Reid, Ian R.; Grey, Andrew] Auckland Dist Hlth Board, Dept Endocrinol, Auckland, New Zealand	University of Auckland; Auckland District Health Board	Reid, IR (corresponding author), Univ Auckland, Fac Med & Hlth Sci, Private Bag 92019, Auckland 1, New Zealand.	i.reid@auckland.ac.nz	Bolland, Mark J/A-7554-2008	Bolland, Mark J/0000-0003-0465-2674; Reid, Ian/0000-0001-6021-5458	Health Research Council of New Zealand	Health Research Council of New Zealand(Health Research Council of New Zealand)	Health Research Council of New Zealand.	Abrahamsen B, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.b5463; Aloia JF, 2005, ARCH INTERN MED, V165, P1618, DOI 10.1001/archinte.165.14.1618; Andersen R, 2008, BRIT J NUTR, V100, P197, DOI 10.1017/S000711450789430X; Arabi A, 2012, OSTEOPOROSIS INT, V23, P971, DOI 10.1007/s00198-011-1659-1; Avenell A, 2009, COCHRANE DB SYST REV, V2; Bailey RL, 2010, J NUTR, V140, P817, DOI 10.3945/jn.109.118539; Binkley N, 2004, J CLIN ENDOCR METAB, V89, P3152, DOI 10.1210/jc.2003-031979; Binkley N, 2010, CLIN CHIM ACTA, V411, P1976, DOI 10.1016/j.cca.2010.08.018; Bischoff-Ferrari HA, 2005, JAMA-J AM MED ASSOC, V293, P2257, DOI 10.1001/jama.293.18.2257; Bischoff-Ferrari HA, 2012, NEW ENGL J MED, V367, P40, DOI 10.1056/NEJMoa1109617; Bischoff-Ferrari HA, 2009, J BONE MINER RES, V24, P935, DOI [10.1359/JBMR.081242, 10.1359/jbmr.081242]; Bolland Mark J, 2011, BMJ, V342, pd2040, DOI 10.1136/bmj.d2040; Chapuy MC, 1997, OSTEOPOROSIS INT, V7, P439, DOI 10.1007/s001980050030; CHAPUY MC, 1992, NEW ENGL J MED, V327, P1637, DOI 10.1056/NEJM199212033272305; CHRISTIANSEN C, 1980, EUR J CLIN INVEST, V10, P273, DOI 10.1111/j.1365-2362.1980.tb00033.x; Chung M, 2011, ANN INTERN MED, V155, P827, DOI 10.7326/0003-4819-155-12-201112200-00005; Chung Mei, 2009, Evid Rep Technol Assess (Full Rep), P1; Committee to review dietary reference intakes for vitamin D and calcium food and nutrition board institute of medicine, 2010, DIETARY REFERENCE IN; Cooper L, 2003, AM J CLIN NUTR, V77, P1324, DOI 10.1093/ajcn/77.5.1324; Cranney Ann, 2007, Evid Rep Technol Assess (Full Rep), P1; Dawson-Hughes B, 2005, OSTEOPOROSIS INT, V16, P713, DOI 10.1007/s00198-005-1867-7; DAWSONHUGHES B, 1991, ANN INTERN MED, V115, P505, DOI 10.7326/0003-4819-115-7-505; DAWSONHUGHES B, 1995, AM J CLIN NUTR, V61, P1140, DOI 10.1093/ajcn/61.5.1140; Ebeling PR, 2001, J CLIN ENDOCR METAB, V86, P4098, DOI 10.1210/jc.86.9.4098; El-Desouki MI, 2004, SAUDI MED J, V25, P355; Francis R, 2013, VITAMIN D BONE HLTH; Grimnes G, 2012, OSTEOPOROSIS INT, V23, P201, DOI 10.1007/s00198-011-1752-5; Harwood RH, 2004, AGE AGEING, V33, P45, DOI 10.1093/ageing/afh002; Haussler MR, 2010, J STEROID BIOCHEM, V121, P88, DOI 10.1016/j.jsbmb.2010.03.019; Higgins JPT., 2008, COCHRANE HDB SYSTEMA, V1 edn; Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385; Hunter D, 2000, J BONE MINER RES, V15, P2276, DOI 10.1359/jbmr.2000.15.11.2276; Islam MZ, 2010, BRIT J NUTR, V104, P241, DOI 10.1017/S0007114510000437; Jorde R, 2010, NUTR J, V9, DOI 10.1186/1475-2891-9-1; Komulainen M, 1999, J CLIN ENDOCR METAB, V84, P546, DOI 10.1210/jc.84.2.546; Lieben L, 2012, J CLIN INVEST, V122, P1803, DOI 10.1172/JCI45890; Lips P, 2011, BEST PRACT RES CL EN, V25, P585, DOI 10.1016/j.beem.2011.05.002; Marks HD, 2007, J STEROID BIOCHEM, V103, P513, DOI 10.1016/j.jsbmb.2006.11.014; Marwaha RK, 2011, OSTEOPOROSIS INT, V22, P2829, DOI 10.1007/s00198-010-1507-8; Masuyama R, 2003, J BONE MINER RES, V18, P1217, DOI 10.1359/jbmr.2003.18.7.1217; Maxmen A, 2011, NATURE, V475, P23, DOI 10.1038/475023a; Murad MH, 2011, J CLIN ENDOCR METAB, V96, P2997, DOI 10.1210/jc.2011-1193; Nieves JW, 2012, CALCIFIED TISSUE INT, V91, P316, DOI 10.1007/s00223-012-9638-x; OOMS ME, 1995, J CLIN ENDOCR METAB, V80, P1052, DOI 10.1210/jc.80.4.1052; OTT SM, 1989, ANN INTERN MED, V110, P267, DOI 10.7326/0003-4819-110-4-267; Papadimitropoulos E, 2002, ENDOCR REV, V23, P560, DOI 10.1210/er.2001-8002; Patel R, 2001, OSTEOPOROSIS INT, V12, P319, DOI 10.1007/s001980170122; Rastelli AL, 2011, BREAST CANCER RES TR, V129, P107, DOI 10.1007/s10549-011-1644-6; Reid IR, 2006, AM J MED, V119, P777, DOI 10.1016/j.amjmed.2006.02.038; Sanders KM, 2010, JAMA-J AM MED ASSOC, V303, P1815, DOI 10.1001/jama.2010.594; Steffensen LH, 2011, J NEUROL, V258, P1624, DOI 10.1007/s00415-011-5980-6; Tanaka H, 2004, J STEROID BIOCHEM, V89-90, P343, DOI 10.1016/j.jsbmb.2004.03.021; Tang BMP, 2007, LANCET, V370, P657, DOI 10.1016/S0140-6736(07)61342-7; Tuppurainen MT, 1998, OSTEOPOROSIS INT, V8, P32, DOI 10.1007/s001980050045; Venkatachalam S, 2003, OSTEOPOROSIS INT, V14, pS39; Verschueren SMP, 2011, J BONE MINER RES, V26, P42, DOI 10.1002/jbmr.181; Viljakainen HT, 2009, J BONE MINER RES, V24, P346, DOI [10.1359/jbmr.081009, 10.1359/JBMR.081009]; Xue YB, 2009, GASTROENTEROLOGY, V136, P1317, DOI 10.1053/j.gastro.2008.12.051; Zhu K, 2008, J BONE MINER RES, V23, P1343, DOI 10.1359/JBMR.080327; Zhu K, 2008, J CLIN ENDOCR METAB, V93, P743, DOI 10.1210/jc.2007-1466	60	365	387	5	180	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 11	2014	383	9912					146	155		10.1016/S0140-6736(13)61647-5	http://dx.doi.org/10.1016/S0140-6736(13)61647-5			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	287YX	24119980				2022-12-28	WOS:000329579600030
J	Kasahara, A; Cipolat, S; Chen, Y; Dorn, GW; Scorrano, L				Kasahara, Atsuko; Cipolat, Sara; Chen, Yun; Dorn, Gerald W., II; Scorrano, Luca			Mitochondrial Fusion Directs Cardiomyocyte Differentiation via Calcineurin and Notch Signaling	SCIENCE			English	Article							EMBRYONIC STEM-CELLS; OPTIC ATROPHY; TRANSCRIPTION; DROSOPHILA; FISSION	Mitochondrial morphology is crucial for tissue homeostasis, but its role in cell differentiation is unclear. We found that mitochondrial fusion was required for proper cardiomyocyte development. Ablation of mitochondrial fusion proteins Mitofusin 1 and 2 in the embryonic mouse heart, or gene-trapping of Mitofusin 2 or Optic atrophy 1 in mouse embryonic stem cells (ESCs), arrested mouse heart development and impaired differentiation of ESCs into cardiomyocytes. Gene expression profiling revealed decreased levels of transcription factors transforming growth factor-beta/bone morphogenetic protein, serum response factor, GATA4, and myocyte enhancer factor 2, linked to increased Ca2+-dependent calcineurin activity and Notch1 signaling that impaired ESC differentiation. Orchestration of cardiomyocyte differentiation by mitochondrial morphology reveals how mitochondria, Ca2+, and calcineurin interact to regulate Notch1 signaling.	[Kasahara, Atsuko] Univ Geneva, Dept Cell Physiol & Metab, CH-1206 Geneva, Switzerland; [Cipolat, Sara; Scorrano, Luca] Venetian Inst Mol Med, Dulbecco Telethon Inst, I-35129 Padua, Italy; [Chen, Yun; Dorn, Gerald W., II] Washington Univ, Sch Med, Dept Internal Med, Ctr Pharmacogen, St Louis, MO 63110 USA; [Scorrano, Luca] Univ Padua, Dept Biol, I-35121 Padua, Italy	University of Geneva; Fondazione Telethon; Dulbecco Telethon Institute (DTI); Veneto Institute Molecular Medicine; Washington University (WUSTL); University of Padua	Dorn, GW (corresponding author), Washington Univ, Sch Med, Dept Internal Med, Ctr Pharmacogen, St Louis, MO 63110 USA.	gdorn@DOM.wustl.edu; luca.scorrano@unipd.it	Scorrano, Luca/A-6652-2008; Scorrano, Luca/K-3967-2019	Scorrano, Luca/0000-0002-8515-8928; Scorrano, Luca/0000-0002-8515-8928	ISHR-ES/SERVIER; Associazione Italiana Ricerca sul Cancro (AIRC); Telethon [GGP06254A, GPP10005B]; AIRC; SNF [31-118171]; Oncosuisse; ERC StG [282280]; NIH [R01 HL59888]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059888] Funding Source: NIH RePORTER	ISHR-ES/SERVIER(Servier); Associazione Italiana Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Telethon(Fondazione Telethon); AIRC(Fondazione AIRC per la ricerca sul cancro); SNF; Oncosuisse; ERC StG; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank F. Radtke and R. Kopan for plasmids, B. Wehrle-Haller for help with TIRF imaging, and D. Martinvalet and N. Demaurex for helpful discussions. L. S. is a Dulbecco Telethon Institute Senior Scientist. A. K. received the ISHR-ES/SERVIER Research Fellowship, and S. C. received an Associazione Italiana Ricerca sul Cancro (AIRC) Fellowship. This work was supported by Telethon GGP06254A, GPP10005B; AIRC; SNF 31-118171; Oncosuisse; ERC StG 282280 (to L. S.); and NIH R01 HL59888 (to G. W. D.). The data presented in this paper are tabulated in the main paper and the supplementary materials.	Alavi MV, 2007, BRAIN, V130, P1029, DOI 10.1093/brain/awm005; Cereghetti GM, 2008, P NATL ACAD SCI USA, V105, P15803, DOI 10.1073/pnas.0808249105; Chen HC, 2007, CELL, V130, P548, DOI 10.1016/j.cell.2007.06.026; Chen Y, 2013, SCIENCE, V340, P471, DOI 10.1126/science.1231031; Chen Y, 2011, CIRC RES, V109, P1327, DOI 10.1161/CIRCRESAHA.111.258723; Chung Susan, 2007, Nat Clin Pract Cardiovasc Med, V4 Suppl 1, pS60, DOI 10.1038/ncpcardio0766; Costa V, 2010, EMBO MOL MED, V2, P490, DOI 10.1002/emmm.201000102; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; Dorn GW, 2011, CIRC RES, V108, P12, DOI 10.1161/CIRCRESAHA.110.236745; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Hoth M, 1997, J CELL BIOL, V137, P633, DOI 10.1083/jcb.137.3.633; KELLER GM, 1995, CURR OPIN CELL BIOL, V7, P862, DOI 10.1016/0955-0674(95)80071-9; Mandal S, 2011, STEM CELLS, V29, P486, DOI 10.1002/stem.590; Mitra K, 2012, J CELL BIOL, V197, P487, DOI 10.1083/jcb.201110058; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Nemir M, 2006, CIRC RES, V98, P1471, DOI 10.1161/01.RES.0000226497.52052.2a; Rand MD, 2000, MOL CELL BIOL, V20, P1825, DOI 10.1128/MCB.20.5.1825-1835.2000; Roti G, 2013, CANCER CELL, V23, P390, DOI 10.1016/j.ccr.2013.01.015; Shen HX, 2006, GENE DEV, V20, P675, DOI 10.1101/gad.1383706; Wasilewski M, 2012, CURR BIOL, V22, P1228, DOI 10.1016/j.cub.2012.04.054	21	228	230	2	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 8	2013	342	6159					734	737		10.1126/science.1241359	http://dx.doi.org/10.1126/science.1241359			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247UK	24091702				2022-12-28	WOS:000326647600042
J	Gerber, EE; Gallo, EM; Fontana, SC; Davis, EC; Wigley, FM; Huso, DL; Dietz, HC				Gerber, Elizabeth E.; Gallo, Elena M.; Fontana, Stefani C.; Davis, Elaine C.; Wigley, Fredrick M.; Huso, David L.; Dietz, Harry C.			Integrin-modulating therapy prevents fibrosis and autoimmunity in mouse models of scleroderma	NATURE			English	Article							PLASMACYTOID DENDRITIC CELLS; TGF-BETA; EXPRESSION; PATHOGENESIS; DISEASE; SKIN; BETA-1-INTEGRIN; CONTRIBUTES; MECHANISMS; PROTEINS	In systemic sclerosis (SSc), a common and aetiologically mysterious form of scleroderma (defined as pathological fibrosis of the skin), previously healthy adults acquire fibrosis of the skin and viscera in association with autoantibodies(1). Familial recurrence is extremely rare and causal genes have not been identified. Although the onset of fibrosis in SSc typically correlates with the production of autoantibodies, whether they contribute to disease pathogenesis or simply serve as a marker of disease remains controversial and the mechanism for their induction is largely unknown(2). The study of SSc is hindered by a lack of animal models that recapitulate the aetiology of this complex disease. To gain a foothold in the pathogenesis of pathological skin fibrosis, we studied stiff skin syndrome (SSS), a rare but tractable Mendelian disorder leading to childhood onset of diffuse skin fibrosis with autosomal dominant inheritance and complete penetrance. We showed previously that SSS is caused by heterozygous missense mutations in the gene (FBN1) encoding fibrillin-1, the main constituent of extracellular microfibrils(3). SSS mutations all localize to the only domain in fibrillin-1 that harbours an Arg-Gly-Asp (RGD) motif needed to mediate cell-matrix interactions by binding to cell-surface integrins(3). Here we show that mouse lines harbouring analogous amino acid substitutions in fibrillin-1 recapitulate aggressive skin fibrosis that is prevented by integrin-modulating therapies and reversed by antagonism of the pro-fibrotic cytokine transforming growth factor beta (TGF-beta). Mutant mice show skin infiltration of pro-inflammatory immune cells including plasmacytoid dendritic cells, T helper cells and plasma cells, and also autoantibody production; these findings are normalized by integrin-modulating therapies or TGF-beta antagonism. These results show that alterations in cell-matrix interactions are sufficient to initiate and sustain inflammatory and pro-fibrotic programmes and highlight new therapeutic strategies.	[Gerber, Elizabeth E.; Gallo, Elena M.; Fontana, Stefani C.; Dietz, Harry C.] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA; [Davis, Elaine C.] McGill Univ, Montreal, PQ H3A 2K6, Canada; [Wigley, Fredrick M.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Huso, David L.] Johns Hopkins Univ, Sch Med, Dept Mol & Comparat Pathobiol, Baltimore, MD 21205 USA; [Dietz, Harry C.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Johns Hopkins University; McGill University; Johns Hopkins University; Johns Hopkins University; Howard Hughes Medical Institute	Dietz, HC (corresponding author), Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA.	hdietz@jhmi.edu			Scleroderma Research Foundation; National Institutes of Health [RO1-AR41135, PO1-AR049698]; National Marfan Foundation; Smilow Center for Marfan Syndrome Research; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR049698, R01AR041135] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007814] Funding Source: NIH RePORTER	Scleroderma Research Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Marfan Foundation; Smilow Center for Marfan Syndrome Research; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank those who contributed skin biopsies to this study and those who provided reagents for this study, including S. Shattil, K. Flanders, C. J. Thomas, S. Patnaik and J. J. Marugan. This work was supported by grants to H. C. D. from the Scleroderma Research Foundation, the National Institutes of Health (RO1-AR41135 and PO1-AR049698), the National Marfan Foundation, the Smilow Center for Marfan Syndrome Research, and the Howard Hughes Medical Institute.	Asano Y, 2005, J IMMUNOL, V175, P7708, DOI 10.4049/jimmunol.175.11.7708; BONA C, 1994, CURR OPIN IMMUNOL, V6, P931, DOI 10.1016/0952-7915(94)90016-7; Brakebusch C, 2000, EMBO J, V19, P3990, DOI 10.1093/emboj/19.15.3990; Bratke K, 2011, ALLERGY, V66, P386, DOI 10.1111/j.1398-9995.2010.02497.x; Castelino FV, 2011, ARTHRITIS RHEUM-US, V63, P1405, DOI 10.1002/art.30262; Chen YL, 2008, ARTHRITIS RHEUM-US, V58, P577, DOI 10.1002/art.23146; Dardalhon V, 2008, NAT IMMUNOL, V9, P1347, DOI 10.1038/ni.1677; Davis EC, 1999, CONNECT TISSUE RES, V40, P113, DOI 10.3109/03008209909029107; Ding CL, 2009, J IMMUNOL, V183, P7140, DOI 10.4049/jimmunol.0901175; Doyle JJ, 2012, FEBS LETT, V586, P2003, DOI 10.1016/j.febslet.2012.05.027; Fleming JN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001452; Garfield AS, 2010, METHODS MOL BIOL, V633, P19, DOI 10.1007/978-1-59745-019-5_2; Gehrie E, 2011, METHODS MOL BIOL, V677, P127, DOI 10.1007/978-1-60761-869-0_9; Hall JC, 2010, NAT REV RHEUMATOL, V6, P40, DOI 10.1038/nrrheum.2009.237; Harris ML, 2003, CURR OPIN RHEUMATOL, V15, P778, DOI 10.1097/00002281-200311000-00016; HogenEsch H, 2006, EXP DERMATOL, V15, P808, DOI 10.1111/j.1600-0625.2006.00483.x; Jego G, 2003, IMMUNITY, V19, P225, DOI 10.1016/S1074-7613(03)00208-5; Judge DP, 2004, J CLIN INVEST, V114, P172, DOI 10.1172/JCI200420641; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Kiosses WB, 2001, NAT CELL BIOL, V3, P316, DOI 10.1038/35060120; Lakos G, 2004, METH MOLEC MED, V102, P377; Lindsay ME, 2011, NATURE, V473, P308, DOI 10.1038/nature10145; Liu SX, 2009, ARTHRITIS RHEUM-US, V60, P2817, DOI 10.1002/art.24801; Loeys BL, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000488; Maurer B, 2010, ARTHRITIS RHEUM-US, V62, P1733, DOI 10.1002/art.27443; Mayes MD, 2003, ARTHRITIS RHEUM, V48, P2246, DOI 10.1002/art.11073; Munger JS, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005017; Nakerakanti SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021911; Pampori N, 1999, J BIOL CHEM, V274, P21609, DOI 10.1074/jbc.274.31.21609; Reynolds LE, 2005, NAT MED, V11, P167, DOI 10.1038/nm1165; Saas P, 2012, CRIT REV IMMUNOL, V32, P529, DOI 10.1615/CritRevImmunol.2013005868; Saito E, 2002, J CLIN INVEST, V109, P1453, DOI 10.1172/JCI200215078; Sakkas LI, 2006, NAT CLIN PRACT RHEUM, V2, P679, DOI 10.1038/ncprheum0346; Swiecki M, 2010, IMMUNOL REV, V234, P142, DOI 10.1111/j.0105-2896.2009.00881.x; van Helden SFG, 2006, J IMMUNOL, V177, P1567, DOI 10.4049/jimmunol.177.3.1567; van Rooij E, 2008, P NATL ACAD SCI USA, V105, P13027, DOI 10.1073/pnas.0805038105; Varga J, 2009, NAT REV RHEUMATOL, V5, P200, DOI 10.1038/nrrheum.2009.26; Watarai H, 2008, P NATL ACAD SCI USA, V105, P2993, DOI 10.1073/pnas.0710351105; Zou WP, 2001, NAT MED, V7, P1339, DOI 10.1038/nm1201-1339	39	135	142	1	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 7	2013	503	7474					126	+		10.1038/nature12614	http://dx.doi.org/10.1038/nature12614			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247AS	24107997	Green Accepted			2022-12-28	WOS:000326585600045
J	Little, P; Hobbs, FDR; Moore, M; Mant, D; Williamson, I; McNulty, C; Cheng, YE; Leydon, G; McManus, R; Kelly, J; Barnett, J; Glasziou, P; Mullee, M				Little, Paul; Hobbs, F. D. Richard; Moore, Michael; Mant, David; Williamson, Ian; McNulty, Cliodna; Cheng, Ying Edith; Leydon, Geraldine; McManus, Richard; Kelly, Joanne; Barnett, Jane; Glasziou, Paul; Mullee, Mark		PRISM Investigators	Clinical score and rapid antigen detection test to guide antibiotic use for sore throats: randomised controlled trial of PRISM (primary care streptococcal management)	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RESPIRATORY-TRACT INFECTIONS; PRESCRIBING STRATEGIES; GROUP-A; GENERAL-PRACTICE; PHARYNGITIS; COMPLICATIONS; DIAGNOSIS; ADULTS; VALIDATION; PRINCIPLES	Objective To determine the effect of clinical scores that predict streptococcal infection or rapid streptococcal antigen detection tests compared with delayed antibiotic prescribing. Design Open adaptive pragmatic parallel group randomised controlled trial. Setting Primary care in United Kingdom. Patients Patients aged >= 3 with acute sore throat. Intervention An internet programme randomised patients to targeted antibiotic use according to: delayed antibiotics (the comparator group for analyses), clinical score, or antigen test used according to clinical score. During the trial a preliminary streptococcal score (score 1, n=1129) was replaced by a more consistent score (score 2, n=631; features: fever during previous 24 hours; purulence; attends rapidly (within three days after onset of symptoms); inflamed tonsils; no cough/coryza (acronym FeverPAIN). Outcomes Symptom severity reported by patients on a 7 point Likert scale (mean severity of sore throat/difficulty swallowing for days two to four after the consultation (primary outcome)), duration of symptoms, use of antibiotics. Results For score 1 there were no significant differences between groups. For score 2, symptom severity was documented in 80% (168/207 (81%) in delayed antibiotics group; 168/211 (80%) in clinical score group; 166/213 (78%) in antigen test group). Reported severity of symptoms was lower in the clinical score group (-0.33, 95% confidence interval -0.64 to -0.02; P=0.04), equivalent to one in three rating sore throat a slight versus moderate problem, with a similar reduction for the antigen test group (-0.30, -0.61 to -0.00; P=0.05). Symptoms rated moderately bad or worse resolved significantly faster in the clinical score group (hazard ratio 1.30, 95% confidence interval 1.03 to 1.63) but not the antigen test group (1.11, 0.88 to 1.40). In the delayed antibiotics group, 75/164 (46%) used antibiotics. Use of antibiotics in the clinical score group (60/161) was 29% lower (adjusted risk ratio 0.71, 95% confidence interval 0.50 to 0.95; P=0.02) and in the antigen test group (58/164) was 27% lower (0.73, 0.52 to 0.98; P=0.03). There were no significant differences in complications or reconsultations. Conclusion Targeted use of antibiotics for acute sore throat with a clinical score improves reported symptoms and reduces antibiotic use. Antigen tests used according to a clinical score provide similar benefits but with no clear advantages over a clinical score alone.	[Little, Paul; Moore, Michael; Williamson, Ian; Cheng, Ying Edith; Leydon, Geraldine; Kelly, Joanne; Barnett, Jane; Mullee, Mark] Univ Southampton, Sch Med, Aldermoore Hlth Ctr, Southampton SO16 5ST, Hants, England; [Hobbs, F. D. Richard; Mant, David; McManus, Richard] Univ Oxford, Dept Primary Care Hlth Serv, Oxford, England; [Hobbs, F. D. Richard; McManus, Richard] Univ Birmingham, Birmingham, W Midlands, England; [McNulty, Cliodna] Gloucestershire Royal Hosp, Dept Microbiol, Hlth Protect Agcy Primary Care Unit, Gloucester GL1 3NN, England; [Glasziou, Paul] Bond Univ, Fac Hlth Sci & Med, Gold Coast, Qld 4229, Australia	University of Southampton; University of Oxford; University of Birmingham; Gloucestershire Royal Hospital; Bond University	Little, P (corresponding author), Univ Southampton, Sch Med, Aldermoore Hlth Ctr, Southampton SO16 5ST, Hants, England.	p.little@soton.ac.uk	Glasziou, Paul/A-7832-2008; Moore, Michael/C-3447-2011	Glasziou, Paul/0000-0001-7564-073X; Leydon, Geraldine Marie/0000-0001-5986-3300; Moore, Michael/0000-0002-5127-4509; hobbs, richard/0000-0001-7976-7172; Little, Paul/0000-0003-3664-1873	National Institute for Health Research Heath Technology Assessment (HTA) Programme [05/10/01]; National Institute for Health Research [NF-SI-0611-10273, 05/10/01] Funding Source: researchfish	National Institute for Health Research Heath Technology Assessment (HTA) Programme; National Institute for Health Research(National Institute for Health Research (NIHR))	This project was funded by the National Institute for Health Research Heath Technology Assessment (HTA) Programme (project number 05/10/01) and will be published in full in the Health Technology Assessment journal. Further information is available at www.nets.nihr.ac.uk/projects/hta/051001. This report presents independent research commissioned by the National Institute for Health Research (NIHR). The views and opinions expressed by authors in this publication are those of the authors and do not necessarily reflect those of the NHS, the NIHR, NETSCC, the HTA programme or the Department of Health.	Bisno AL, 2002, CLIN INFECT DIS, V35, P113, DOI 10.1086/340949; BREESE BB, 1977, AM J DIS CHILD, V131, P514, DOI 10.1001/archpedi.1977.02120180028003; Centor R M, 1981, Med Decis Making, V1, P239, DOI 10.1177/0272989X8100100304; Cooper RJ, 2001, ANN INTERN MED, V134, P509, DOI 10.7326/0003-4819-134-6-200103200-00019; Del MCB, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000023.pub3; DELMAR C, 1992, MED J AUSTRALIA, V156, P572, DOI 10.5694/j.1326-5377.1992.tb121422.x; Dobbs F, 1996, BRIT J GEN PRACT, V46, P461; Dunn N, 2007, BRIT J GEN PRACT, V57, P45; Fine AM, 2012, ARCH INTERN MED, V172, P847, DOI 10.1001/archinternmed.2012.950; Lasseter GM, 2009, FAM PRACT, V26, P437, DOI 10.1093/fampra/cmp054; Lindbaek M, 2005, BRIT J GEN PRACT, V55, P615; Little P, 2001, BMJ-BRIT MED J, V322, P336, DOI 10.1136/bmj.322.7282.336; Little P, 2005, BMJ-BRIT MED J, V331, P301, DOI 10.1136/bmj.331.7512.301; Little P, 2005, JAMA-J AM MED ASSOC, V293, P3029, DOI 10.1001/jama.293.24.3029; Little P, 2002, BRIT J GEN PRACT, V52, P187; Little P, 1997, BRIT MED J, V315, P350; Little P, 1997, BMJ-BRIT MED J, V314, P722, DOI 10.1136/bmj.314.7082.722; Little P, 1999, BRIT MED J, V319, P736, DOI 10.1136/bmj.319.7212.736; McIsaac WJ, 2004, JAMA-J AM MED ASSOC, V291, P1587, DOI 10.1001/jama.291.13.1587; NICE guideline development group, PRESCR ANT SELF LIM; Pelucchi C, 2012, CLIN MICROBIOL INFEC, V18, P1, DOI 10.1111/j.1469-0691.2012.03766.x; Petersen I, 2007, BMJ-BRIT MED J, V335, P982, DOI 10.1136/bmj.39345.405243.BE; Schwartz B, 1998, PEDIATRICS, V101, P171; Sharland M, 2005, BMJ-BRIT MED J, V331, P328, DOI 10.1136/bmj.38503.706887.AE1; Worrall G, 2007, CAN FAM PHYSICIAN, V53, P667; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690; Zwart S, 2000, BRIT MED J, V320, P150, DOI 10.1136/bmj.320.7228.150	27	51	52	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 10	2013	347								f5806	10.1136/bmj.f5806	http://dx.doi.org/10.1136/bmj.f5806			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	235OO	24114306	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000325729200001
J	Tang, ZM; Lin, MG; Stowe, TR; Chen, S; Zhu, MY; Stearns, T; Franco, B; Zhong, Q				Tang, Zaiming; Lin, Mary Grace; Stowe, Timothy Richard; Chen, She; Zhu, Muyuan; Stearns, Tim; Franco, Brunella; Zhong, Qing			Autophagy promotes primary ciliogenesis by removing OFD1 from centriolar satellites	NATURE			English	Article							PRIMARY CILIA; SELECTIVE AUTOPHAGY; JOUBERT-SYNDROME; BBS PROTEINS; DISEASE; UBIQUITIN; GENE; IDENTIFICATION; DEGRADATION; MECHANISMS	The primary cilium is a microtubule-based organelle that functions in sensory and signalling pathways. Defects in ciliogenesis can lead to a group of genetic syndromes known as ciliopathies(1-3). However, the regulatory mechanisms of primary ciliogenesis in normal and cancer cells are incompletely understood. Here we demonstrate that autophagic degradation of a ciliopathy protein, OFD1 (oral-facial-digital syndrome 1), at centriolar satellites promotes primary cilium biogenesis. Autophagy is a catabolic pathway in which cytosol, damaged organelles and protein aggregates are engulfed in autophagosomes and delivered to lysosomes for destruction(4). We show that the population of OFD1 at the centriolar satellites is rapidly degraded by autophagy upon serum starvation. In autophagy-deficient Atg5 or Atg3 null mouse embryonic fibroblasts, OFD1 accumulates at centriolar satellites, leading to fewer and shorter primary cilia and a defective recruitment of BBS4 (Bardet-Biedl syndrome 4) to cilia. These defects are fully rescued by OFD1 partial knockdown that reduces the population of OFD1 at centriolar satellites. More strikingly, OFD1 depletion at centriolar satellites promotes cilia formation in both cycling cells and transformed breast cancer MCF7 cells that normally do not form cilia. This work reveals that removal of OFD1 by autophagy at centriolar satellites represents a general mechanism to promote ciliogenesis in mammalian cells. These findings define a newly recognized role of autophagy in organelle biogenesis.	[Tang, Zaiming; Zhong, Qing] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Ctr Autophagy Res, Dallas, TX 75390 USA; [Tang, Zaiming; Zhong, Qing] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Tang, Zaiming; Lin, Mary Grace; Zhong, Qing] Univ Calif Berkeley, Dept Mol & Cell Biol, Div Biochem Biophys & Struct Biol, Berkeley, CA 94720 USA; [Tang, Zaiming; Zhu, Muyuan] Zhejiang Univ, Coll Life Sci, State Key Lab Plant Physiol & Biochem, Hangzhou 310058, Zhejiang, Peoples R China; [Stowe, Timothy Richard; Stearns, Tim] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Chen, She] Natl Inst Biol Sci, Beijing 102206, Peoples R China; [Franco, Brunella] Univ Naples Federico II, Dept Translat Med Sci, Med Genet Serv, Naples, Italy; [Franco, Brunella] Telethon Inst Genet & Med TIGEM, Naples, Italy	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of California System; University of California Berkeley; Zhejiang University; Stanford University; National Institute of Biological Sciences, Beijing; University of Naples Federico II; Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM)	Zhong, Q (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Internal Med, Ctr Autophagy Res, Dallas, TX 75390 USA.	qing.zhong@utsouthwestern.edu	Zhong, Qing/GLT-4858-2022; FRANCO, Brunella/S-2882-2018	Zhong, Qing/0000-0001-6979-955X; FRANCO, Brunella/0000-0001-5588-4569; Stearns, Tim/0000-0002-0671-6582	Polycystic Kidney Disease Foundation; American Cancer Society [RSG-11-274-01-CCG]; National Cancer Institute [CA133228]; Italian Telethon Foundation [TGM11CB3]; EU [241955]; China Scholarship Council; NATIONAL CANCER INSTITUTE [R01CA133228] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052022] Funding Source: NIH RePORTER	Polycystic Kidney Disease Foundation; American Cancer Society(American Cancer Society); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Italian Telethon Foundation(Fondazione Telethon); EU(European Commission); China Scholarship Council(China Scholarship Council); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Moughon and W. Fan for initial purification of LC3 complex; N. Mizushima for Atg5<SUP>+/+</SUP> and Atg5<SUP>-/-</SUP> MEFs and M. Komatsu for Atg3<SUP>+/+</SUP> and Atg3<SUP>-/-</SUP> MEFs; H. Zhou for helpful discussions and quantitative RT-PCR data analysis; A. Kodani and J. F. Reiter for reagents, helpful discussions and technical assistance; and B. Levine for helpful discussions and critical reading of the manuscript. The electron microscopy studies were performed by C. Miller and V. Gattone II at the Indiana University School of Medicine Electron Microscopy Center that is supported by the Polycystic Kidney Disease Foundation. This work was supported by grants from the American Cancer Society (RSG-11-274-01-CCG) and National Cancer Institute (CA133228) to Q.Z. and grants from the Italian Telethon Foundation (TGM11CB3) and the EU FP7/2007-2013 Programme (Syscilia grant agreement no. 241955) to B. F. The work was partially supported by China Scholarship Council to Z.T.	Bimonte S, 2011, DEV BIOL, V349, P179, DOI 10.1016/j.ydbio.2010.09.020; Cantagrel V, 2008, AM J HUM GENET, V83, P170, DOI 10.1016/j.ajhg.2008.06.023; Chen DD, 2012, MOL CELL, V45, P629, DOI 10.1016/j.molcel.2011.12.036; Coene KLM, 2009, AM J HUM GENET, V85, P465, DOI 10.1016/j.ajhg.2009.09.002; Fan WL, 2010, AUTOPHAGY, V6, P614, DOI 10.4161/auto.6.5.12189; Feather SA, 1997, HUM MOL GENET, V6, P1163, DOI 10.1093/hmg/6.7.1163; Ferrante MI, 2006, NAT GENET, V38, P112, DOI 10.1038/ng1684; Ferrante MI, 2001, AM J HUM GENET, V68, P569, DOI 10.1086/318802; Field M, 2012, EUR J HUM GENET, V20, P806, DOI 10.1038/ejhg.2012.9; Giorgio G, 2007, MOL BIOL CELL, V18, P4397, DOI 10.1091/mbc.E07-03-0198; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Han YG, 2009, NAT MED, V15, P1062, DOI 10.1038/nm.2020; Hildebrandt F, 2011, NEW ENGL J MED, V364, P1533, DOI 10.1056/NEJMra1010172; Johansen T, 2011, AUTOPHAGY, V7, P279, DOI 10.4161/auto.7.3.14487; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Kirkin V, 2009, MOL CELL, V33, P505, DOI 10.1016/j.molcel.2009.01.020; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Lopes CAM, 2011, J CELL SCI, V124, P600, DOI 10.1242/jcs.077156; Nachury MV, 2007, CELL, V129, P1201, DOI 10.1016/j.cell.2007.03.053; Nigg EA, 2009, CELL, V139, P663, DOI 10.1016/j.cell.2009.10.036; Novak I, 2010, EMBO REP, V11, P45, DOI 10.1038/embor.2009.256; Orvedahl A, 2011, NATURE, V480, P113, DOI 10.1038/nature10546; Sang LY, 2011, CELL, V145, P513, DOI 10.1016/j.cell.2011.04.019; Seeley ES, 2009, CANCER RES, V69, P422, DOI 10.1158/0008-5472.CAN-08-1290; Singla V, 2010, DEV CELL, V18, P410, DOI 10.1016/j.devcel.2009.12.022; Sou Y, 2008, MOL BIOL CELL, V19, P4762, DOI 10.1091/mbc.E08-03-0309; Stowe TR, 2012, MOL BIOL CELL, V23, P3322, DOI 10.1091/mbc.E12-02-0134; Sun QM, 2008, P NATL ACAD SCI USA, V105, P19211, DOI 10.1073/pnas.0810452105; Thurston TLM, 2009, NAT IMMUNOL, V10, P1215, DOI 10.1038/ni.1800; Wong SY, 2009, NAT MED, V15, P1055, DOI 10.1038/nm.2011; Yuan K, 2010, J HISTOCHEM CYTOCHEM, V58, P857, DOI 10.1369/jhc.2010.955856; Zhang YX, 2009, CELL, V136, P308, DOI 10.1016/j.cell.2008.12.022; Zullo A, 2010, HUM MOL GENET, V19, P2792, DOI 10.1093/hmg/ddq180	34	263	281	7	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 10	2013	502	7470					254	+		10.1038/nature12606	http://dx.doi.org/10.1038/nature12606			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RU	24089205	Green Accepted, Green Submitted			2022-12-28	WOS:000325436100055
J	Lopez, JA; Tulip, H; Huerta, S				Lopez, Jorge A.; Tulip, Hans; Huerta, Sergio			Abnormal Gallbladder Finding in a Septic Patient With Blood Loss	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							BENZ SIGN		Univ Texas SW Med Ctr Dallas, Dallas, TX 75216 USA; VA North Texas Hlth Care Syst, Dallas, TX USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA North Texas Health Care System	Huerta, S (corresponding author), Univ Texas SW Med Ctr Dallas, VA North Texas Hlth Care Syst, 4500 S Lancaster Rd, Dallas, TX 75216 USA.	sergio.huerta@utsouthwestern.edu	Huerta, Sergio/G-3699-2013	Huerta, Sergio/0000-0001-7720-419X				Delabrousse E, 2000, J RADIOL, V81, P1639; FULTON H, 1955, GASTROENTEROLOGY, V28, P862; Griffing J C, 1971, J Miss State Med Assoc, V12, P164; HINKEL CL, 1954, AM J ROENTGENOL, V71, P979; Longley JD, 2002, CAN MED ASSOC J, V167, P172; MEYERS MA, 1973, AM J ROENTGENOL, V119, P63, DOI 10.2214/ajr.119.1.63; Niederhauser BD, 2013, J CLIN ULTRASOUND, V41, P50, DOI 10.1002/jcu.22020	7	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 9	2013	310	14					1498	1499		10.1001/jama.2013.278877	http://dx.doi.org/10.1001/jama.2013.278877			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	230PK	24104374				2022-12-28	WOS:000325354100026
J	Venters, BJ; Pugh, BF				Venters, Bryan J.; Pugh, B. Franklin			Genomic organization of human transcription initiation complexes	NATURE			English	Article							RNA-POLYMERASE-II; CORE PROMOTER ELEMENT; TATA BOX; BINDING; SEQUENCES; VISUALIZATION; CPG	The human genome is pervasively transcribed, yet only a small fraction is coding. Here we address whether this non-coding transcription arises at promoters, and detail the interactions of initiation factors TATA box binding protein (TBP), transcription factor IIB (TFIIB) and RNA polymerase (Pol) II. Using ChIP-exo (chromatin immunoprecipitation with lambda exonuclease digestion followed by high-throughput sequencing), we identify approximately 160,000 transcription initiation complexes across the human K562 genome, and more in other cancer genomes. Only about 5% associate with messenger RNA genes. The remainder associates with non-polyadenylated non-coding transcription. Regardless, Pol II moves into a transcriptionally paused state, and TBP and TFIIB remain at the promoter. Remarkably, the vast majority of locations contain the four core promoter elements-upstream TFIIB recognition element (BREu), TATA, downstream TFIIB recognition element (BREd), and initiator element (INR)-in constrained positions. All but the INR also reside at Pol III promoters, where TBP makes similar contacts. This comprehensive and high-resolution genome-wide detection of the initiation machinery produces a consolidated view of transcription initiation events from yeast to humans at Pol II/III TATA-containing/TATA-less coding and non-coding genes.	[Venters, Bryan J.; Pugh, B. Franklin] Penn State Univ, Dept Biochem & Mol Biol, Ctr Eukaryot Gene Regulat, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Pugh, BF (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, Ctr Eukaryot Gene Regulat, University Pk, PA 16802 USA.	bfp2@psu.edu	Söding, Johannes/A-3341-2013	Söding, Johannes/0000-0001-9642-8244	National Institutes of Health [GM059055]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059055] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Reja, S. Mahony, P. Albert and Y. Li for bioinformatic assistance, and M. Cousar and K.-Y. Chan-Salis for experimental support. This work was supported by National Institutes of Health grant GM059055.	Albert I, 2008, BIOINFORMATICS, V24, P1305, DOI 10.1093/bioinformatics/btn119; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Basehoar AD, 2004, CELL, V116, P699, DOI 10.1016/S0092-8674(04)00205-3; Berger MF, 2010, GENOME RES, V20, P413, DOI 10.1101/gr.103697.109; BURATOWSKI S, 1989, CELL, V56, P549, DOI 10.1016/0092-8674(89)90578-3; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Carriere L, 2012, NUCLEIC ACIDS RES, V40, P270, DOI 10.1093/nar/gkr737; Core LJ, 2008, SCIENCE, V319, P1791, DOI 10.1126/science.1150843; Deng WS, 2005, GENE DEV, V19, P2418, DOI 10.1101/gad.342405; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Eichler EE, 2010, NAT REV GENET, V11, P446, DOI 10.1038/nrg2809; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Fenouil R, 2012, GENOME RES, V22, P2399, DOI 10.1101/gr.138776.112; GEIDUSCHEK EP, 1988, ANNU REV BIOCHEM, V57, P873, DOI 10.1146/annurev.bi.57.070188.004301; GILMOUR DS, 1986, MOL CELL BIOL, V6, P3984, DOI 10.1128/MCB.6.11.3984; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Hamada M, 2001, MOL CELL BIOL, V21, P6870, DOI 10.1128/MCB.21.20.6870-6881.2001; He YP, 2008, SCIENCE, V322, P1855, DOI 10.1126/science.1163853; He Y, 2013, NATURE, V495, P481, DOI 10.1038/nature11991; Juven-Gershon T, 2010, DEV BIOL, V339, P225, DOI 10.1016/j.ydbio.2009.08.009; Kapranov P, 2007, NAT REV GENET, V8, P413, DOI 10.1038/nrg2083; Kapranov Philipp, 2012, Frontiers in Genetics, V3, P60, DOI 10.3389/fgene.2012.00060; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Kostrewa D, 2009, NATURE, V462, P323, DOI 10.1038/nature08548; Kwak H, 2013, SCIENCE, V339, P950, DOI 10.1126/science.1229386; Lagrange T, 1998, GENE DEV, V12, P34, DOI 10.1101/gad.12.1.34; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Ptashne M, 1997, NATURE, V386, P569, DOI 10.1038/386569a0; Rhee Ho Sung, 2012, Curr Protoc Mol Biol, VChapter 21, DOI 10.1002/0471142727.mb2124s100; Rhee HS, 2012, NATURE, V483, P295, DOI 10.1038/nature10799; Rhee HS, 2011, CELL, V147, P1408, DOI 10.1016/j.cell.2011.11.013; Rozenberg JM, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-67; Sainsbury S, 2013, NATURE, V493, P437, DOI 10.1038/nature11715; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; SINGER VL, 1990, GENE DEV, V4, P636, DOI 10.1101/gad.4.4.636; SMALE ST, 1989, CELL, V57, P103, DOI 10.1016/0092-8674(89)90176-1; Vannini A, 2012, MOL CELL, V45, P439, DOI 10.1016/j.molcel.2012.01.023; VERRIJZER CP, 1995, CELL, V81, P1115, DOI 10.1016/S0092-8674(05)80016-9; WHITE RJ, 1992, CELL, V71, P1041, DOI 10.1016/0092-8674(92)90398-V	42	50	53	1	76	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 3	2013	502	7469					53	+		10.1038/nature12535	http://dx.doi.org/10.1038/nature12535			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	227IM	24048476	Green Accepted			2022-12-28	WOS:000325106000029
J	Toussaint, J; Milstein, A; Shortell, S				Toussaint, John; Milstein, Arnold; Shortell, Stephen			How the Pioneer ACO Model Needs to Change Lessons From Its Best-Performing ACO	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							QUALITY-OF-CARE; WISCONSIN		[Toussaint, John] Thedacare Ctr Healthcare Value, Appleton, WI 54911 USA; [Milstein, Arnold] Stanford Univ, Sch Med, Stanford, CA 94305 USA; [Shortell, Stephen] Univ Calif Berkeley, Sch Publ Hlth, Div Hlth Policy & Management, Berkeley, CA 94720 USA	Stanford University; University of California System; University of California Berkeley	Toussaint, J (corresponding author), Thedacare Ctr Healthcare Value, 100 W Lawrence St,Ste 422, Appleton, WI 54911 USA.	jtoussaint@createvalue.org						Bielaszka-DuVernay C, 2011, HEALTH AFFAIR, V30, P422, DOI 10.1377/hlthaff.2011.0087; Colla CH, 2012, JAMA-J AM MED ASSOC, V308, P1015, DOI 10.1001/2012.jama.10812; Lamb GC, 2013, HEALTH AFFAIR, V32, P536, DOI 10.1377/hlthaff.2012.1275; Markovich P, 2012, HEALTH AFFAIR, V31, P1969, DOI 10.1377/hlthaff.2012.0358; McConnell KJ, 2013, JAMA INTERN MED, V173, P684, DOI 10.1001/jamainternmed.2013.3577; Scheffler RM., 2014, CALIFORNIA J POLITIC, V6, P249, DOI [10.5070/P2N019, DOI 10.5070/P2N019]	6	34	34	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 2	2013	310	13					1341	1342		10.1001/jama.2013.279149	http://dx.doi.org/10.1001/jama.2013.279149			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	227GB	24084915				2022-12-28	WOS:000325098100015
J	Berger, ZD; Brown, SM				Berger, Zackary D.; Brown, Samuel M.			Should Hospitals Look Like Airports?	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Johns Hopkins Sch Med, Baltimore, MD USA; Berman Inst Bioeth, Baltimore, MD USA; Intermt Med Ctr, Murray, UT USA; Univ Utah, Sch Med, Murray, UT USA	Johns Hopkins University; Johns Hopkins Medicine; Intermountain Healthcare; Intermountain Medical Center; Utah System of Higher Education; University of Utah	Berger, ZD (corresponding author), Johns Hopkins Outpatient Ctr, 601 North Caroline St,Suite 7143, Baltimore, MD 21287 USA.	zberger1@jhmi.edu	Brown, Samuel M/E-6846-2015; Berger, Zackary/AAW-5761-2020; Berger, Zackary/I-7032-2013	Brown, Samuel M/0000-0003-1206-6261; Berger, Zackary/0000-0002-5871-0342					0	0	0	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 1	2013	159	7					492	U107		10.7326/0003-4819-159-7-201310010-00010	http://dx.doi.org/10.7326/0003-4819-159-7-201310010-00010			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	234FQ	24081288				2022-12-28	WOS:000325628000008
J	Adam, S; Polo, SE; Almouzni, G				Adam, Salome; Polo, Sophie E.; Almouzni, Genevieve			Transcription Recovery after DNA Damage Requires Chromatin Priming by the H3.3 Histone Chaperone HIRA	CELL			English	Article							DOUBLE-STRAND BREAKS; HOMOLOGOUS RECOMBINATION; REPAIR; REVEALS; SITES; DEPOSITION; MUTATIONS; EXCISION; VARIANTS; DYNAMICS	Understanding how to recover fully functional and transcriptionally active chromatin when its integrity has been challenged by genotoxic stress is a critical issue. Here, by investigating how chromatin dynamics regulate transcriptional activity in response to DNA damage in human cells, we identify a pathway involving the histone chaperone histone regulator A (HIRA) to promote transcription restart after UVC damage. Our mechanistic studies reveal that HIRA accumulates at sites of UVC irradiation upon detection of DNA damage prior to repair and deposits newly synthesized H3.3 histones. This local action of HIRA depends on ubiquitylation events associated with damage recognition. Furthermore, we demonstrate that the early and transient function of HIRA in response to DNA damage primes chromatin for later reactivation of transcription. We propose that HIRA-dependent histone deposition serves as a chromatin bookmarking system to facilitate transcription recovery after genotoxic stress.	[Adam, Salome; Polo, Sophie E.; Almouzni, Genevieve] Inst Curie, Res Ctr, F-75248 Paris 5, France; [Adam, Salome; Polo, Sophie E.; Almouzni, Genevieve] CNRS, UMR 218, F-75248 Paris 5, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS)	Polo, SE (corresponding author), Univ Paris Diderot, CNRS, Epigenet & Cell Fate Ctr, UMR7216, F-75205 Paris 13, France.	sophie.polo@univ-paris-diderot.fr; genevieve.almouzni@curie.fr	Almouzni, Genevieve/ABG-1029-2021	Almouzni, Genevieve/0000-0001-5570-0723; Polo, Sophie/0000-0003-4821-9354	la Ligue Nationale contre le Cancer; European Commission Network of Excellence "Epi-GeneSys" [HEALTH-F4-2010-257082]; European Research Council Advanced Grant "Eccentric'' [2009-AdG_20090506]; French National Research Agency (Labex "DEEP''); French National Research Agency [ANR-12-JSV6-0002-01]; "Who am I''? Laboratory of Excellence [ANR-11-LABX-0071]; French Government through its "Investments for the Future'' program [ANR-11-IDEX-0005-01]; Fondation ARC; University Pierre Marie Curie; INSERM (Institut National de la Sante et de la Recherche Medicale); Marie Curie Intra-European fellowship	la Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); European Commission Network of Excellence "Epi-GeneSys"; European Research Council Advanced Grant "Eccentric''; French National Research Agency (Labex "DEEP'')(French National Research Agency (ANR)); French National Research Agency(French National Research Agency (ANR)); "Who am I''? Laboratory of Excellence; French Government through its "Investments for the Future'' program(French National Research Agency (ANR)); Fondation ARC; University Pierre Marie Curie; INSERM (Institut National de la Sante et de la Recherche Medicale)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Marie Curie Intra-European fellowship(European Commission)	We are grateful to J. Haber, M. Papamichos-Chronakis, and D. Ray-Gallet for critical reading of the manuscript and to members of UMR218 for helpful discussions. We thank E. Dunleavy and C. de Noronha for cell lines and reagents and O. Renaud, O. Leroy, and P. LeBaccon from the PICT-IBiSA imaging facility. This work was supported by la Ligue Nationale contre le Cancer (Equipe labellisee Ligue 2010), the European Commission Network of Excellence "Epi-GeneSys'' (HEALTH-F4-2010-257082), the European Research Council Advanced Grant "Eccentric'' (2009-AdG_20090506), and the French National Research Agency (Labex "DEEP'') in G. A.'s laboratory. Research in S.E.P.'s group is supported by the French National Research Agency (ANR-12-JSV6-0002-01), the "Who am I''? Laboratory of Excellence (ANR-11-LABX-0071) funded by the French Government through its "Investments for the Future'' program (ANR-11-IDEX-0005-01), and the Fondation ARC. S.A. is a recipient of a PhD fellowship from University Pierre & Marie Curie, and S. E. P. is funded by INSERM (Institut National de la Sante et de la Recherche Medicale) and a Marie Curie Intra-European fellowship.	Adam S, 2012, INT J MOL SCI, V13, P11895, DOI 10.3390/ijms130911895; Adamson B, 2012, NAT CELL BIOL, V14, P318, DOI 10.1038/ncb2426; Amin AD, 2012, BBA-GENE REGUL MECH, V1819, P264, DOI 10.1016/j.bbagrm.2011.07.008; Anderson HE, 2009, MOL CELL BIOL, V29, P5158, DOI 10.1128/MCB.00698-09; Avvakumov N, 2011, MOL CELL, V41, P502, DOI 10.1016/j.molcel.2011.02.013; Bensaude O, 2011, TRANSCR-AUSTIN, V2, P103, DOI 10.4161/trns.2.3.16172; Bodor D., 2012, CURR PROTOC CELL BIO, V55; Burgess RJ, 2013, NAT STRUCT MOL BIOL, V20, P14, DOI 10.1038/nsmb.2461; Choi SY, 2013, NUCLEIC ACIDS RES, V41, P2180, DOI 10.1093/nar/gks1319; Chou DM, 2010, P NATL ACAD SCI USA, V107, P18475, DOI 10.1073/pnas.1012946107; Chujo M, 2012, J BIOL CHEM, V287, P23440, DOI 10.1074/jbc.M112.349944; Churchman LS, 2011, NATURE, V469, P368, DOI 10.1038/nature09652; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Dantuma NP, 2006, J CELL BIOL, V173, P19, DOI 10.1083/jcb.200510071; De Koning L, 2007, NAT STRUCT MOL BIOL, V14, P997, DOI 10.1038/nsmb1318; Dunleavy EM, 2011, NUCLEUS-PHILA, V2, P146, DOI 10.4161/nucl.2.2.15211; EHMANN UK, 1978, BIOPHYS J, V22, P249, DOI 10.1016/S0006-3495(78)85487-3; Gaillard H, 2013, BBA-GENE REGUL MECH, V1829, P141, DOI 10.1016/j.bbagrm.2012.09.008; Gaillard PHL, 1996, CELL, V86, P887, DOI 10.1016/S0092-8674(00)80164-6; Giglia-Mari G, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a000745; Green CM, 2003, EMBO J, V22, P5163, DOI 10.1093/emboj/cdg478; Hanawalt PC, 2008, NAT REV MOL CELL BIO, V9, P958, DOI 10.1038/nrm2549; Hoeijmakers JHJ, 2009, NEW ENGL J MED, V361, P1475, DOI 10.1056/NEJMra0804615; Iacovoni JS, 2010, EMBO J, V29, P1446, DOI 10.1038/emboj.2010.38; Ishii T, 2010, J BIOL CHEM, V285, P41993, DOI 10.1074/jbc.M110.161661; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Jensen A, 2010, DNA REPAIR, V9, P1142, DOI 10.1016/j.dnarep.2010.08.002; Jullien J, 2012, EPIGENET CHROMATIN, V5, DOI 10.1186/1756-8935-5-17; Kapitzky L, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.107; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Loyola A, 2006, MOL CELL, V24, P309, DOI 10.1016/j.molcel.2006.08.019; Luijsterburg MS, 2011, MOL ONCOL, V5, P349, DOI 10.1016/j.molonc.2011.06.001; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Michod D, 2012, NEURON, V74, P122, DOI 10.1016/j.neuron.2012.02.021; Mone MJ, 2001, EMBO REP, V2, P1013, DOI 10.1093/embo-reports/kve224; Nakazawa Y, 2010, DNA REPAIR, V9, P506, DOI 10.1016/j.dnarep.2010.01.015; Nouspikel T, 2009, CELL MOL LIFE SCI, V66, P994, DOI 10.1007/s00018-009-8737-y; Nouspikel T, 2011, MECH AGEING DEV, V132, P355, DOI 10.1016/j.mad.2011.03.003; Pankotai T, 2012, NAT STRUCT MOL BIOL, V19, P276, DOI 10.1038/nsmb.2224; Placek BJ, 2009, J VIROL, V83, P1416, DOI 10.1128/JVI.01276-08; Polo SE, 2006, CELL, V127, P481, DOI 10.1016/j.cell.2006.08.049; Povlsen LK, 2012, NAT CELL BIOL, V14, P1089, DOI 10.1038/ncb2579; Ray-Gallet D, 2011, MOL CELL, V44, P928, DOI 10.1016/j.molcel.2011.12.006; Schneiderman JI, 2012, P NATL ACAD SCI USA, V109, P19721, DOI 10.1073/pnas.1206629109; Schwartzentruber J, 2012, NATURE, V482, P226, DOI [10.1038/nature10833, 10.1007/s13311-012-0137-6]; Shanbhag NM, 2010, CELL, V141, P970, DOI 10.1016/j.cell.2010.04.038; Skene PJ, 2013, DEVELOPMENT, V140, P2513, DOI 10.1242/dev.091439; Smerdon MJ, 1991, CURR OPIN CELL BIOL, V3, P422, DOI 10.1016/0955-0674(91)90069-B; Soria G, 2012, MOL CELL, V46, P722, DOI 10.1016/j.molcel.2012.06.002; Sturm D, 2012, CANCER CELL, V22, P425, DOI 10.1016/j.ccr.2012.08.024; Svejstrup JQ, 2010, TRENDS BIOCHEM SCI, V35, P333, DOI 10.1016/j.tibs.2010.02.001; Szenker E, 2012, CELL REP, V1, P730, DOI 10.1016/j.celrep.2012.05.006; Szenker E, 2011, CELL RES, V21, P421, DOI 10.1038/cr.2011.14; Talbert PB, 2010, NAT REV MOL CELL BIO, V11, P264, DOI 10.1038/nrm2861; Tornaletti S, 2009, CELL MOL LIFE SCI, V66, P1010, DOI 10.1007/s00018-009-8738-x; Wu G, 2012, NAT GENET, V44, P251, DOI 10.1038/ng.1102; Yang JH, 2011, P NATL ACAD SCI USA, V108, P85, DOI 10.1073/pnas.1009830108; Yang XH, 2013, J BIOL CHEM, V288, P18271, DOI 10.1074/jbc.M113.473199; Zhang X, 2012, NAT GENET, V44, P593, DOI 10.1038/ng.2228	60	187	189	2	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 26	2013	155	1					94	106		10.1016/j.cell.2013.08.029	http://dx.doi.org/10.1016/j.cell.2013.08.029			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	224UX	24074863	Bronze			2022-12-28	WOS:000324916700012
J	Crowe, SA; Dossing, LN; Beukes, NJ; Bau, M; Kruger, SJ; Frei, R; Canfield, DE				Crowe, Sean A.; Dossing, Lasse N.; Beukes, Nicolas J.; Bau, Michael; Kruger, Stephanus J.; Frei, Robert; Canfield, Donald E.			Atmospheric oxygenation three billion years ago	NATURE			English	Article							HEXAVALENT CHROMIUM; PONGOLA SUPERGROUP; OXIDATION; SULFUR; GA; ISOTOPES; FRACTIONATION; WITWATERSRAND; EVOLUTION; KINETICS	It is widely assumed that atmospheric oxygen concentrations remained persistently low (less than 10(-5) times present levels) for about the first 2 billion years of Earth's history(1). The first long-term oxygenation of the atmosphere is thought to have taken place around 2.3 billion years ago, during the Great Oxidation Event(2,3). Geochemical indications of transient atmospheric oxygenation, however, date back to 2.6-2.7 billion years ago(4-6). Here we examine the distribution of chromium isotopes and redox-sensitive metals in the approximately 3-billion-year-old Nsuze palaeosol and in the near-contemporaneous Ijzermyn iron formation from the Pongola Supergroup, South Africa. We find extensive mobilization of redox-sensitive elements through oxidative weathering. Furthermore, using our data we compute a best minimum estimate for atmospheric oxygen concentrations at that time of 331024 times present levels. Overall, our findings suggest that there were appreciable levels of atmospheric oxygen about 3 billion years ago, more than 600 million years before the Great Oxidation Event and some 300-400 million years earlier than previous indications for Earth surface oxygenation.	[Crowe, Sean A.; Dossing, Lasse N.; Canfield, Donald E.] Univ Southern Denmark, Inst Biol, DK-5230 Odense, Denmark; [Crowe, Sean A.; Dossing, Lasse N.; Canfield, Donald E.] Univ Southern Denmark, Nord Ctr Earth Evolut, DK-5230 Odense, Denmark; [Dossing, Lasse N.; Frei, Robert] Univ Copenhagen, Dept Geosci & Nat Resource Management, DK-1350 Copenhagen, Denmark; [Dossing, Lasse N.; Frei, Robert] Univ Copenhagen, Nord Ctr Earth Evolut, DK-1350 Copenhagen, Denmark; [Beukes, Nicolas J.; Kruger, Stephanus J.] Univ Johannesburg, Dept Geol, ZA-2006 Johannesburg, South Africa; [Bau, Michael] Jacobs Univ Bremen, Earth & Space Sci Program, D-28759 Bremen, Germany	University of Southern Denmark; University of Southern Denmark; University of Copenhagen; University of Copenhagen; University of Johannesburg; Jacobs University	Crowe, SA (corresponding author), Univ British Columbia, Life Sci Ctr, Dept Microbiol & Immunol, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	sean.crowe@ubc.ca	Bau, Michael/D-4457-2016; Canfield, Don/C-1735-2012; Frei, Robert/N-6798-2014	Canfield, Don/0000-0001-7602-8366; Frei, Robert/0000-0001-7708-9881; Bau, Michael/0000-0002-7746-3762	Agouron Institute Geobiology Fellowship; NSERC PDF; Danish National Research Foundation [DNRF53]; Danish Agency for Science, Technology, and Innovation; European Research Council; National Research Foundation in Pretoria	Agouron Institute Geobiology Fellowship; NSERC PDF(Natural Sciences and Engineering Research Council of Canada (NSERC)); Danish National Research Foundation(Danmarks Grundforskningsfond); Danish Agency for Science, Technology, and Innovation; European Research Council(European Research Council (ERC)European Commission); National Research Foundation in Pretoria	N. Planavsky, R. Schoenberg, S. Poulton, A. Basu, C. Jones, H. Tsikos, A. Mucci, A. O'Neill and T. Dahl are thanked for suggestions. T. Larsen, C. N. Jensen, T. Leeper and P. Soholt are acknowledged for technical support. Funding to S. A. C. was provided by an Agouron Institute Geobiology Fellowship and an NSERC PDF. Additional funding was from the Danish National Research Foundation (grant no. DNRF53), the Danish Agency for Science, Technology, and Innovation, the European Research Council and the National Research Foundation in Pretoria. The palaeosol drill core was made available by Ian Frith of AngloGold Ashanti Exploration (SA), from their core store in Carltonville, South Africa.	Alexander BW, 2008, GEOCHIM COSMOCHIM AC, V72, P378, DOI 10.1016/j.gca.2007.10.028; Anbar AD, 2007, SCIENCE, V317, P1903, DOI 10.1126/science.1140325; Beukes NJ, 1991, S AFR J GEOL, V94, P44; Canfield DE, 2000, SCIENCE, V288, P658, DOI 10.1126/science.288.5466.658; Canfield DE, 2005, ADV MAR BIOL, V48, P1; CONDIE KC, 1993, CHEM GEOL, V104, P1, DOI 10.1016/0009-2541(93)90140-E; Crowe S. A., 2011, MINERAL MAG, V75, P706; EARY LE, 1989, AM J SCI, V289, P180, DOI 10.2475/ajs.289.2.180; EARY LE, 1987, ENVIRON SCI TECHNOL, V21, P1187, DOI 10.1021/es00165a005; Ellis AS, 2002, SCIENCE, V295, P2060, DOI 10.1126/science.1068368; Farquhar J, 2007, NATURE, V449, P706, DOI 10.1038/nature06202; Frei R, 2013, PRECAMBRIAN RES, V224, P434, DOI 10.1016/j.precamres.2012.10.008; Frei R, 2009, NATURE, V461, P250, DOI 10.1038/nature08266; GRANDSTAFF DE, 1980, PRECAMBRIAN RES, V13, P1, DOI 10.1016/0301-9268(80)90056-X; Guo QJ, 2009, GEOLOGY, V37, P399, DOI 10.1130/G25423A.1; Guy BM, 2012, PRECAMBRIAN RES, V216, P208, DOI 10.1016/j.precamres.2012.06.018; Haqq-Misra J, 2011, ASTROBIOLOGY, V11, P293, DOI 10.1089/ast.2010.0572; Holland HD, 2002, GEOCHIM COSMOCHIM AC, V66, P3811, DOI 10.1016/S0016-7037(02)00950-X; Konhauser KO, 2011, NATURE, V478, P369, DOI 10.1038/nature10511; MAYNARD JB, 1992, J GEOL, V100, P279, DOI 10.1086/629632; Mukasa SB, 2013, PRECAMBRIAN RES, V224, P268, DOI 10.1016/j.precamres.2012.09.015; Nhleko N, 2003, THESIS RAND AFRIKAAN; Ohmoto H, 1996, GEOLOGY, V24, P1135, DOI 10.1130/0091-7613(1996)024<1135:EIPGPF>2.3.CO;2; Oze C, 2007, P NATL ACAD SCI USA, V104, P6544, DOI 10.1073/pnas.0701085104; Pavlov AA, 2002, ASTROBIOLOGY, V2, P27, DOI 10.1089/153110702753621321; SASS BM, 1987, INORG CHEM, V26, P2228, DOI 10.1021/ic00261a013; Schoenberg R, 2008, CHEM GEOL, V249, P294, DOI 10.1016/j.chemgeo.2008.01.009; TIPPING E, 1984, GEOCHIM COSMOCHIM AC, V48, P1353, DOI 10.1016/0016-7037(84)90069-3; Wille M, 2007, GEOCHIM COSMOCHIM AC, V71, P2417, DOI 10.1016/j.gca.2007.02.019; Zink S, 2010, GEOCHIM COSMOCHIM AC, V74, P5729, DOI 10.1016/j.gca.2010.07.015	30	433	451	16	320	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 26	2013	501	7468					535	+		10.1038/nature12426	http://dx.doi.org/10.1038/nature12426			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223RP	24067713				2022-12-28	WOS:000324826300055
J	Dalton, S				Dalton, Stephen			G1 Compartmentalization and Cell Fate Coordination	CELL			English	Editorial Material							PLURIPOTENCY; CYCLE; PHASE; NANOG	Pauklin and Vallier show that, whereas early G1 is permissive for TGF-beta-dependent endoderm differentiation, cyclin D restricts the activity of Smad2/3 in late G1, resulting in a switch from endoderm to neuroectoderm potential in pluripotent stem cells. These findings provide insight into how signaling, the cell cycle, and lineage specification are coordinated.	Univ Georgia, Dept Biochem & Mol Biol, Paul D Coverdell Ctr Biomed & Hlth Sci, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Dalton, S (corresponding author), Univ Georgia, Dept Biochem & Mol Biol, Paul D Coverdell Ctr Biomed & Hlth Sci, 500 DW Brooks Dr, Athens, GA 30602 USA.	sdalton@uga.edu		Dalton, Stephen/0000-0002-3450-1263	NIGMS NIH HHS [P01 GM085354] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Coronado D, 2013, STEM CELL RES, V10, P118, DOI 10.1016/j.scr.2012.10.004; MUMMERY CL, 1987, CELL DIFFER DEV, V20, P153, DOI 10.1016/0045-6039(87)90429-5; Pauklin S, 2013, CELL, V155, P135, DOI 10.1016/j.cell.2013.08.031; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Salomoni P, 2010, TRENDS CELL BIOL, V20, P233, DOI 10.1016/j.tcb.2010.01.006; Sela Y, 2012, STEM CELLS, V30, P1097, DOI 10.1002/stem.1078; Singh AM, 2009, CELL STEM CELL, V5, P141, DOI 10.1016/j.stem.2009.07.003; Vallier L, 2009, DEVELOPMENT, V136, P1339, DOI 10.1242/dev.033951; Xu RH, 2008, CELL STEM CELL, V3, P196, DOI 10.1016/j.stem.2008.07.001	9	14	14	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 26	2013	155	1					13	14		10.1016/j.cell.2013.09.015	http://dx.doi.org/10.1016/j.cell.2013.09.015			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	224UX	24074854	Bronze			2022-12-28	WOS:000324916700002
J	Berry, C				Berry, Cheryl			The patient's perspective: we all want private hospital rooms	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Self Management UK, London, England		Berry, C (corresponding author), Self Management UK, London, England.	cheryl.berry@selfmanagementuk.org						Pennington H, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5695	1	4	4	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 25	2013	347								f5828	10.1136/bmj.f5828	http://dx.doi.org/10.1136/bmj.f5828			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	227CW	24068729				2022-12-28	WOS:000325087200025
J	Perry, JJ; Stiell, IG; Sivilotti, MLA; Bullard, MJ; Hohl, CM; Sutherland, J; Emond, M; Worster, A; Lee, JS; Mackey, D; Pauls, M; Lesiuk, H; Symington, C; Wells, GA				Perry, Jeffrey J.; Stiell, Ian G.; Sivilotti, Marco L. A.; Bullard, Michael J.; Hohl, Corinne M.; Sutherland, Jane; Emond, Marcel; Worster, Andrew; Lee, Jacques S.; Mackey, Duncan; Pauls, Merril; Lesiuk, Howard; Symington, Cheryl; Wells, George A.			Clinical Decision Rules to Rule Out Subarachnoid Hemorrhage for Acute Headache	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CEREBROSPINAL-FLUID; PREDICTION RULES; SPECTROPHOTOMETRY; MANAGEMENT; DIAGNOSIS	IMPORTANCE Three clinical decision rules were previously derived to identify patients with headache requiring investigations to rule out subarachnoid hemorrhage. OBJECTIVE To assess the accuracy, reliability, acceptability, and potential refinement (ie, to improve sensitivity or specificity) of these rules in a new cohort of patients with headache. DESIGN, SETTING, AND PATIENTS Multicenter cohort study conducted at 10 university-affiliated Canadian tertiary care emergency departments from April 2006 to July 2010. Enrolled patients were 2131 adults with a headache peaking within 1 hour and no neurologic deficits. Physicians completed data forms after assessing eligible patients prior to investigations. MAIN OUTCOMES AND MEASURES Subarachnoid hemorrhage, defined as (1) subarachnoid blood on computed tomography scan; (2) xanthochromia in cerebrospinal fluid; or (3) red blood cells in the final tube of cerebrospinal fluid, with positive angiography findings. RESULTS Of the 2131 enrolled patients, 132 (6.2%) had subarachnoid hemorrhage. The decision rule including any of age 40 years or older, neck pain or stiffness, witnessed loss of consciousness, or onset during exertion had 98.5% (95% CI, 94.6%-99.6%) sensitivity and 27.5% (95% CI, 25.6%-29.5%) specificity for subarachnoid hemorrhage. Adding "thunderclap headache" (ie, instantly peaking pain) and "limited neck flexion on examination" resulted in the Ottawa SAH Rule, with 100% (95% CI, 97.2%-100.0%) sensitivity and 15.3% (95% CI, 13.8%-16.9%) specificity. CONCLUSIONS AND RELEVANCE Among patients presenting to the emergency department with acute nontraumatic headache that reached maximal intensity within 1 hour and who had normal neurologic examination findings, the Ottawa SAH Rule was highly sensitive for identifying subarachnoid hemorrhage. These findings apply only to patients with these specific clinical characteristics and require additional evaluation in implementation studies before the rule is applied in routine clinical care.	[Perry, Jeffrey J.; Stiell, Ian G.; Symington, Cheryl] Univ Ottawa, Ottawa Hosp Res Inst, Clin Epidemiol Program, Dept Emergency Med, Ottawa, ON, Canada; [Wells, George A.] Univ Ottawa, Ottawa Hosp Res Inst, Clin Epidemiol Program, Dept Epidemiol & Community Med, Ottawa, ON, Canada; [Lesiuk, Howard] Univ Ottawa, Ottawa Hosp Res Inst, Clin Epidemiol Program, Div Neurosurg, Ottawa, ON, Canada; [Sutherland, Jane] Univ Ottawa, Ottawa Hosp Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada; [Sivilotti, Marco L. A.] Queens Univ, Dept Emergency Med, Kingston, ON, Canada; [Sivilotti, Marco L. A.] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada; [Hohl, Corinne M.] Univ British Columbia, Dept Emergency Med, Vancouver, BC V5Z 1M9, Canada; [Emond, Marcel] Univ Laval, Dept Emergency Med, Quebec City, PQ, Canada; [Worster, Andrew] McMaster Univ, Div Emergency Med, Hamilton, ON, Canada; [Lee, Jacques S.] Univ Toronto, Div Emergency Med, Toronto, ON, Canada; [Bullard, Michael J.; Mackey, Duncan] Univ Alberta, Dept Emergency Med, Edmonton, AB, Canada; [Pauls, Merril] Univ Manitoba, Dept Emergency Med, Winnipeg, MB R3T 2N2, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute; Queens University - Canada; Queens University - Canada; University of British Columbia; Laval University; McMaster University; University of Toronto; University of Alberta; University of Manitoba	Perry, JJ (corresponding author), Ottawa Hosp, Clin Epidemiol Unit, F647,1053 Carling Ave, Ottawa, ON K1Y 4E9, Canada.	jperry@ohri.ca	Hohl, Corinne M/AAY-3325-2021; Emond, Marcel/G-5804-2014; Lee, Jacques/CAF-4380-2022; Sivilotti, Marco L.A./AAR-8892-2020	Hohl, Corinne M/0000-0002-9210-7838; Emond, Marcel/0000-0001-7158-8110; Lee, Jacques/0000-0002-9143-6285; Sivilotti, Marco L.A./0000-0001-6641-1118; Stiell, Ian/0000-0002-2583-6408; Perry, Jeffrey/0000-0003-2134-9597	Canadian Institutes for Health Research [153742]; Canadian Institutes for Health Research New Investigator Award; Ontario Ministry of Health; Vancouver Coastal Health Research Institute	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Institutes for Health Research New Investigator Award(Canadian Institutes of Health Research (CIHR)); Ontario Ministry of Health(Ministry of Health and Long-Term Care, Ontario); Vancouver Coastal Health Research Institute	This study was supported by peer-reviewed funding from the Canadian Institutes for Health Research (grant 153742). Dr Perry is supported by a Canadian Institutes for Health Research New Investigator Award and was previously supported as a Career Scientist by the Ontario Ministry of Health. Dr Stiell is a Distinguished Professor and University Health Research Chair, University of Ottawa. Dr Hohl was supported by a Mentored Clinician Scientist Award from the Vancouver Coastal Health Research Institute during the study period.	Edlow JA, 2008, ANN EMERG MED, V52, P407, DOI 10.1016/j.annemergmed.2008.07.001; Evans RW, 2000, NEUROLOGY, V55, P909, DOI 10.1212/WNL.55.7.909; KISSEL JT, 1983, ANN NEUROL, V13, P149, DOI 10.1002/ana.410130207; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Laupacis A, 1997, JAMA-J AM MED ASSOC, V277, P488, DOI 10.1001/jama.277.6.488; McBeath JG, 2000, HEADACHE, V40, P686, DOI 10.1046/j.1526-4610.2000.040008686.x; McGinn TG, 2000, JAMA-J AM MED ASSOC, V284, P79, DOI 10.1001/jama.284.1.79; Morgenstern LB, 2001, HEADACHE, V41, P537, DOI 10.1046/j.1526-4610.2001.041006537.x; Perry JJ, 2006, STROKE, V37, P2467, DOI 10.1161/01.STR.0000240689.15109.47; Perry Jeffrey J, 2002, CJEM, V4, P333; Perry JJ, 2012, CAN J NEUROL SCI, V39, P638, DOI 10.1017/S0317167100015389; Perry JJ, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4277; Perry JJ, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c5204; Perry JJ, 2009, CAN J EMERG MED, V11, P516; Sames TA, 1996, ACAD EMERG MED, V3, P16, DOI 10.1111/j.1553-2712.1996.tb03296.x; Stiell IG, 1999, ANN EMERG MED, V33, P437, DOI 10.1016/S0196-0644(99)70309-4; TEASDALE G, 1974, LANCET, V2, P81; TSEMENTZIS SA, 1985, NEUROSURGERY, V17, P908, DOI 10.1227/00006123-198512000-00007; VANDERWEE N, 1995, J NEUROL NEUROSUR PS, V58, P357, DOI 10.1136/jnnp.58.3.357; VERMEULEN M, 1990, J NEUROL NEUROSUR PS, V53, P365, DOI 10.1136/jnnp.53.5.365; Vermeulen MJ, 2007, STROKE, V38, P1216, DOI 10.1161/01.STR.0000259661.05525.9a; WASSON JH, 1985, NEW ENGL J MED, V313, P793, DOI 10.1056/NEJM198509263131306; WEIR B, 1994, CEPHALALGIA, V14, P79, DOI 10.1046/j.1468-2982.1994.1402079.x	23	128	129	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 25	2013	310	12					1248	1255		10.1001/jama.2013.278018	http://dx.doi.org/10.1001/jama.2013.278018			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	222SO	24065011	Bronze			2022-12-28	WOS:000324751800021
J	Schiff, GD				Schiff, Gordon D.			Crossing Boundaries-Violation or Obligation?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Schiff, Gordon D.] Brigham & Womens Hosp, Div Gen Internal Med, Ctr Patient Safety Res & Practice, Boston, MA 02115 USA; [Schiff, Gordon D.] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Schiff, GD (corresponding author), Brigham & Womens Hosp, Div Gen Internal Med, Ctr Patient Safety Res & Practice, 75 Francis St, Boston, MA 02115 USA.	gschiff@partners.org						American Medical Association, 2008, OPINION 10 015 THE P; Berwick DM, 2009, HEALTH AFFAIR, V28, pW555, DOI 10.1377/hlthaff.28.4.w555; Brown S, 2006, ACAD MED, V81, P577, DOI 10.1097/01.ACM.0000225224.27776.0d; GABBARD GO, 1995, JAMA-J AM MED ASSOC, V273, P1445, DOI 10.1001/jama.273.18.1445; Gabbard GO, 1995, JAMA APPEARS IN, V274, P1346; Galeano E, 2001, UPSIDE DOWN A PRIMER; Gutheil TG, 1998, AM J PSYCHIAT, V155, P409, DOI 10.1176/ajp.155.3.409	7	9	9	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 25	2013	310	12					1233	1234		10.1001/jama.2013.276133	http://dx.doi.org/10.1001/jama.2013.276133			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	222SO	24065007				2022-12-28	WOS:000324751800017
J	Caputo, CB; Hounjet, LJ; Dobrovetsky, R; Stephan, DW				Caputo, Christopher B.; Hounjet, Lindsay J.; Dobrovetsky, Roman; Stephan, Douglas W.			Lewis Acidity of Organofluorophosphonium Salts: Hydrodefluorination by a Saturated Acceptor	SCIENCE			English	Article							C-F BONDS; PHOSPHORUS; ACTIVATION; COMPLEXES; CATIONS; CO2	Prototypical Lewis acids, such as boranes, derive their reactivity from electronic unsaturation. Here, we report the Lewis acidity and catalytic application of electronically saturated phosphorus-centered electrophilic acceptors. Organofluorophosphonium salts of the formula [(C6F5)(3-x)PhxPF][B(C6F5)(4)] (x = 0 or 1; Ph, phenyl) are shown to form adducts with neutral Lewis bases and to react rapidly with fluoroalkanes to produce difluorophosphoranes. In the presence of hydrosilane, the cation [(C6F5)(3)PF](+) is shown to catalyze the hydrodefluorination of fluoroalkanes, affording alkanes and fluorosilane. The mechanism demonstrates the impressive fluoride ion affinity of this highly electron-deficient phosphonium center.	[Caputo, Christopher B.; Hounjet, Lindsay J.; Dobrovetsky, Roman; Stephan, Douglas W.] Univ Toronto, Dept Chem, Toronto, ON M5S 3H6, Canada	University of Toronto	Stephan, DW (corresponding author), Univ Toronto, Dept Chem, 80 St George St, Toronto, ON M5S 3H6, Canada.	dstephan@chem.utoronto.ca	Stephan, Douglas W/E-4393-2011; Dobrovetsky, Roman/L-6932-2017; Dobrovetsky, Roman/O-9860-2014	Stephan, Douglas W/0000-0001-8140-8355; Dobrovetsky, Roman/0000-0002-6036-4709; Caputo, Christopher/0000-0002-7523-0324; Hounjet, Lindsay/0000-0002-2229-5917	Natural Sciences and Engineering Research Council (NSERC) of Canada; Canada Research Chair; NSERC-CGS-D Scholarship	Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); NSERC-CGS-D Scholarship(Natural Sciences and Engineering Research Council of Canada (NSERC))	D.W.S. gratefully acknowledges the financial support of the Natural Sciences and Engineering Research Council (NSERC) of Canada and the award of a Canada Research Chair. C.B.C. is grateful for the support of an NSERC-CGS-D Scholarship. Metrical parameters for the solid-state structure of compound 3 are available free of charge from the Cambridge Crystallographic Data Centre under reference number CCDC-951501.	Alcarazo M, 2010, ANGEW CHEM INT EDIT, V49, P5788, DOI 10.1002/anie.201002119; BRUCE MI, 1968, J CHEM SOC A, P1459, DOI 10.1039/j19680001459; Burford N., 2005, ACS SYM SER, V917, P280; Caputo CB, 2012, ORGANOMETALLICS, V31, P27, DOI 10.1021/om200885c; Chai JD, 2008, PHYS CHEM CHEM PHYS, V10, P6615, DOI 10.1039/b810189b; CHILDS RF, 1982, CAN J CHEM, V60, P801, DOI 10.1139/v82-117; Douvris C, 2008, SCIENCE, V321, P1188, DOI 10.1126/science.1159979; Douvris C, 2010, J AM CHEM SOC, V132, P4946, DOI 10.1021/ja100605m; Grimme S, 2006, J COMPUT CHEM, V27, P1787, DOI 10.1002/jcc.20495; Gu WX, 2009, J AM CHEM SOC, V131, P11203, DOI 10.1021/ja903927c; Gudat D, 2010, ACCOUNTS CHEM RES, V43, P1307, DOI 10.1021/ar100041j; GUTMANN V, 1976, COORDIN CHEM REV, V18, P225, DOI 10.1016/S0010-8545(00)82045-7; Hair GS, 1999, J AM CHEM SOC, V121, P4922, DOI 10.1021/ja9904336; Hounjet LJ, 2013, DALTON T, V42, P2629, DOI 10.1039/c2dt32711b; Hounjet LJ, 2012, ANGEW CHEM INT EDIT, V51, P4714, DOI 10.1002/anie.201201422; Hudnall TW, 2008, J AM CHEM SOC, V130, P10890, DOI 10.1021/ja804492y; Kuehnel MF, 2013, ANGEW CHEM INT EDIT, V52, P3328, DOI 10.1002/anie.201205260; LAMBERT JB, 1994, ORGANOMETALLICS, V13, P2430, DOI 10.1021/om00018a041; Nava M, 2011, ORGANOMETALLICS, V30, P4798, DOI 10.1021/om200636u; Nova A, 2012, ORGANOMETALLICS, V31, P1245, DOI 10.1021/om2010386; Scott VJ, 2005, J AM CHEM SOC, V127, P2852, DOI 10.1021/ja0426138; Sereda O, 2009, TOP CURR CHEM, V291, P349, DOI 10.1007/978-3-642-02815-1_17; SHELDRICK WS, 1975, ACTA CRYSTALLOGR B, V31, P1776, DOI 10.1107/S0567740875006140; Shine KP, 2007, SCIENCE, V315, P1804, DOI 10.1126/science.1141677; Slattery JM, 2012, DALTON T, V41, P1808, DOI 10.1039/c1dt11636c; Stahl T, 2013, ACS CATAL, V3, P1578, DOI 10.1021/cs4003244; Stahl T, 2013, J AM CHEM SOC, V135, P1248, DOI 10.1021/ja311398j; Swamy KCK, 2006, ACCOUNTS CHEM RES, V39, P324, DOI 10.1021/ar050188x; Terada M, 2006, TETRAHEDRON, V62, P401, DOI 10.1016/j.tet.2005.09.075; WEIGERT FJ, 1980, J ORG CHEM, V45, P3476, DOI 10.1021/jo01305a022; Welch GC, 2006, SCIENCE, V314, P1124, DOI 10.1126/science.1134230; Werner T, 2009, ADV SYNTH CATAL, V351, P1469, DOI 10.1002/adsc.200900211; WITTIG G, 1954, CHEM BER-RECL, V87, P1318, DOI 10.1002/cber.19540870919	33	232	232	1	124	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 20	2013	341	6152					1374	1377		10.1126/science.1241764	http://dx.doi.org/10.1126/science.1241764			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	220PK	24052304				2022-12-28	WOS:000324597200041
J	Sanders, JS; Fabian, AC; Churazov, E; Schekochihin, AA; Simionescu, A; Walker, SA; Werner, N				Sanders, J. S.; Fabian, A. C.; Churazov, E.; Schekochihin, A. A.; Simionescu, A.; Walker, S. A.; Werner, N.			Linear Structures in the Core of the Coma Cluster of Galaxies	SCIENCE			English	Article							GAS; MOTIONS; CHANDRA	The hot x-ray-emitting plasma in galaxy clusters is predicted to have turbulent motion, which can contribute around 10% of the cluster's central energy density. We report deep Chandra X-ray Observatory observations of the Coma cluster core, showing the presence of quasi-linear high-density arms spanning 150 kiloparsecs, consisting of low-entropy material that was probably stripped from merging subclusters. Two appear to be connected with a subgroup of galaxies at a 650-kiloparsec radius that is merging into the cluster, implying coherence over several hundred million years. Such a long lifetime implies that strong isotropic turbulence and conduction are suppressed in the core, despite the unrelaxed state of the cluster. Magnetic fields are presumably responsible. The structures seen in Coma present insight into the past billion years of subcluster merger activity.	[Sanders, J. S.] Max Planck Inst Extraterr Phys, D-85748 Garching, Germany; [Sanders, J. S.; Fabian, A. C.; Walker, S. A.] Univ Cambridge, Inst Astron, Cambridge CB3 0HA, England; [Churazov, E.] Max Planck Inst Astrophys, D-85748 Garching, Germany; [Churazov, E.] Space Res Inst IKI, Moscow 117997, Russia; [Schekochihin, A. A.] Univ Oxford, Rudolf Peierls Ctr Theoret Phys, Oxford OX1 3NP, England; [Simionescu, A.; Werner, N.] Stanford Univ, Kavli Inst Particle Astrophys & Cosmol, Stanford, CA 94305 USA; [Simionescu, A.; Werner, N.] Stanford Univ, Dept Phys, Stanford, CA 94305 USA; [Simionescu, A.] Japan Aerosp Explorat Agcy, Inst Space & Astronaut Sci, Chuo Ku, Sagamihara, Kanagawa 2525210, Japan	Max Planck Society; University of Cambridge; Max Planck Society; Russian Academy of Sciences; Space Research Institute of the Russian Academy of Sciences; University of Oxford; Stanford University; Stanford University; Japan Aerospace Exploration Agency (JAXA); Institute of Space & Astronautical Science (ISAS)	Sanders, JS (corresponding author), Max Planck Inst Extraterr Phys, Giessenbachstr 1, D-85748 Garching, Germany.	jsanders@mpe.mpg.de	Churazov, Eugene/A-7783-2013; Werner, Norbert/G-2832-2019; Werner, Norbert/AAW-2434-2021	Churazov, Eugene/0000-0002-0322-884X; Werner, Norbert/0000-0003-0392-0120; Werner, Norbert/0000-0003-0392-0120; Schekochihin, Alexander/0000-0003-4421-1128; Simionescu, Aurora/0000-0002-9714-3862; Sanders, Jeremy/0000-0003-2189-4501	Royal Society; NASA by the Chandra X-ray Observatory Center [GO2-13145X]; NASA [NAS8-03060]; STFC [ST/F002505/2, ST/K000985/1, ST/I505599/1, ST/J001538/1] Funding Source: UKRI; Science and Technology Facilities Council [ST/K000985/1, ST/I505599/1, ST/J001538/1] Funding Source: researchfish	Royal Society(Royal Society of London); NASA by the Chandra X-ray Observatory Center; NASA(National Aeronautics & Space Administration (NASA)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	A.C.F. acknowledges the support of the Royal Society. We thank S. D. Brown for providing the 352-MHz radio map. Support for this work was provided by NASA through Chandra Award Number GO2-13145X issued by the Chandra X-ray Observatory Center, which is operated by the Smithsonian Astrophysical Observatory for and on behalf of NASA under contract NAS8-03060. The scientific results reported in this article are based on observations made by the Chandra X-ray Observatory and data obtained from the Chandra Data Archive, as well as observations obtained with XMM-Newton, a European Space Agency (ESA) science mission with instruments and contributions directly funded by ESA Member States and NASA. The data analyzed here can be found in the XMM-Newton Science Archive and Chandra Data Archive.	Adami C, 2005, ASTRON ASTROPHYS, V443, P17, DOI 10.1051/0004-6361:20053504; Adami C, 2009, ASTRON ASTROPHYS, V507, P1225, DOI 10.1051/0004-6361/200912228; Ade PAR, 2013, ASTRON ASTROPHYS, V554, DOI 10.1051/0004-6361/201220247; Arnaud M, 2001, ASTRON ASTROPHYS, V365, pL67, DOI 10.1051/0004-6361:20000195; BRIEL UG, 1992, ASTRON ASTROPHYS, V259, pL31; Brown S, 2011, MON NOT R ASTRON SOC, V412, P2, DOI 10.1111/j.1365-2966.2010.17738.x; BURNS JO, 1994, ASTROPHYS J, V427, pL87, DOI 10.1086/187371; Cassano R, 2010, ASTROPHYS J LETT, V721, pL82, DOI 10.1088/2041-8205/721/2/L82; Churazov E, 2012, MON NOT R ASTRON SOC, V421, P1123, DOI 10.1111/j.1365-2966.2011.20372.x; Donnelly RH, 1999, ASTROPHYS J, V513, P690, DOI 10.1086/306901; Lau ET, 2009, ASTROPHYS J, V705, P1129, DOI 10.1088/0004-637X/705/2/1129; Neumann DA, 2003, ASTRON ASTROPHYS, V400, P811, DOI 10.1051/0004-6361:20021911; Randall S, 2008, ASTROPHYS J, V688, P208, DOI 10.1086/592324; Simionescu A, 2013, ASTROPHYS J, V775, DOI 10.1088/0004-637X/775/1/4; Vazza F, 2009, ASTRON ASTROPHYS, V504, P33, DOI 10.1051/0004-6361/200912535; Vikhlinin A, 2001, ASTROPHYS J, V555, pL87, DOI 10.1086/323181; Vikhlinin A, 1997, ASTROPHYS J, V474, pL7, DOI 10.1086/310415; Vikhlinin A, 2001, ASTROPHYS J, V549, pL47, DOI 10.1086/319126; WHITE SDM, 1993, MON NOT R ASTRON SOC, V261, pL8, DOI 10.1093/mnras/261.1.L8; WILLSON MAG, 1970, MON NOT R ASTRON SOC, V151, P1; Yagi M, 2007, ASTROPHYS J, V660, P1209, DOI 10.1086/512359	22	36	36	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 20	2013	341	6152					1365	1368		10.1126/science.1238334	http://dx.doi.org/10.1126/science.1238334			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	220PK	24052301	Green Submitted			2022-12-28	WOS:000324597200038
J	Sloggett, JJ				Sloggett, John J.			Comment on "Invasive Harlequin Ladybird Carries Biological Weapons Against Native Competitors"	SCIENCE			English	Editorial Material							INTRAGUILD PREDATION; HARMONIA-AXYRIDIS; CHEMICAL ECOLOGY; PREY; COCCINELLIDAE; CANNIBALISM; COLEOPTERA; INSECTS		Maastricht Univ, Maastricht Sci Programme, NL-6200 MD Maastricht, Netherlands	Maastricht University	Sloggett, JJ (corresponding author), Maastricht Univ, Maastricht Sci Programme, POB 616, NL-6200 MD Maastricht, Netherlands.	j.sloggett@maastrichtuniversity.nl						BRAKEFIELD PM, 1985, BIOL J LINN SOC, V26, P243, DOI 10.1111/j.1095-8312.1985.tb01635.x; Dobler S, 2011, PHYTOCHEMISTRY, V72, P1593, DOI 10.1016/j.phytochem.2011.04.015; Hartmann T, 2004, PLANTA, V219, P1, DOI 10.1007/s00425-004-1249-y; Hemptinne JL, 2000, CHEMOECOLOGY, V10, P123, DOI 10.1007/PL00001813; Hironori Y, 1997, ENTOMOPHAGA, V42, P153, DOI 10.1007/BF02769893; Hurst G. D. D., 1994, THESIS; Kajita Y, 2010, OECOLOGIA, V163, P313, DOI 10.1007/s00442-009-1551-2; Sato S, 2004, AGR FOREST ENTOMOL, V6, P21, DOI 10.1111/j.1461-9555.2004.00197.x; Sloggett JJ, 2010, J EXP BIOL, V213, P237, DOI 10.1242/jeb.037127; Sloggett JJ, 2011, BIOCONTROL, V56, P643, DOI 10.1007/s10526-011-9376-4; Sloggett JJ, 2009, OIKOS, V118, P1396, DOI 10.1111/j.1600-0706.2009.17407.x; Tinsley MC, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-238; Upadhyay SK, 2012, PROTEIN J, V31, P439, DOI 10.1007/s10930-012-9423-8; Vilcinskas A, 2013, SCIENCE, V340, P862, DOI 10.1126/science.1234032; Ware RL, 2008, BIOCONTROL, V53, P169, DOI 10.1007/s10526-007-9135-8	15	0	0	0	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 20	2013	341	6152								10.1126/science.1241827	http://dx.doi.org/10.1126/science.1241827			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	220PK	24052292				2022-12-28	WOS:000324597200023
J	Uthman, OA; van der Windt, DA; Jordan, JL; Dziedzic, KS; Healey, EL; Peat, GM; Foster, NE				Uthman, Olalekan A.; van der Windt, Danielle A.; Jordan, Joanne L.; Dziedzic, Krysia S.; Healey, Emma L.; Peat, George M.; Foster, Nadine E.			Exercise for lower limb osteoarthritis: systematic review incorporating trial sequential analysis and network meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Review							RANDOMIZED CONTROLLED-TRIAL; LAND-BASED EXERCISE; EVIDENCE-BASED RECOMMENDATIONS; QUALITY-OF-LIFE; KNEE OSTEOARTHRITIS; OLDER-ADULTS; TAI-CHI; AQUATIC EXERCISE; PHYSICAL-ACTIVITY; META-REGRESSION	Objective To determine whether there is sufficient evidence to conclude that exercise interventions are more effective than no exercise control and to compare the effectiveness of different exercise interventions in relieving pain and improving function in patients with lower limb osteoarthritis. Data sources Nine electronic databases searched from inception to March 2012. Study selection Randomised controlled trials comparing exercise interventions with each other or with no exercise control for adults with knee or hip osteoarthritis. Data extraction Two reviewers evaluated eligibility and methodological quality. Main outcomes extracted were pain intensity and limitation of function. Trial sequential analysis was used to investigate reliability and conclusiveness of available evidence for exercise interventions. Bayesian network meta-analysis was used to combine both direct (within trial) and indirect (between trial) evidence on treatment effectiveness. Results 60 trials (44 knee, two hip, 14 mixed) covering 12 exercise interventions and with 8218 patients met inclusion criteria. Sequential analysis showed that as of 2002 sufficient evidence had been accrued to show significant benefit of exercise interventions over no exercise control. For pain relief, strengthening, flexibility plus strengthening, flexibility plus strengthening plus aerobic, aquatic strengthening, and aquatic strengthening plus flexibility, exercises were significantly more effective than no exercise control. A combined intervention of strengthening, flexibility, and aerobic exercise was also significantly more effective than no exercise control for improving limitation in function (standardised mean difference -0.63, 95% credible interval -1.16 to -0.10). Conclusions As of 2002 sufficient evidence had accumulated to show significant benefit of exercise over no exercise in patients with osteoarthritis, and further trials are unlikely to overturn this result. An approach combining exercises to increase strength, flexibility, and aerobic capacity is likely to be most effective in the management of lower limb osteoarthritis. The evidence is largely from trials in patients with knee osteoarthritis.	[Uthman, Olalekan A.; van der Windt, Danielle A.; Jordan, Joanne L.; Dziedzic, Krysia S.; Healey, Emma L.; Peat, George M.; Foster, Nadine E.] Keele Univ, Arthritis Res UK Primary Care Ctr, Keele ST5 5BG, Staffs, England; [Uthman, Olalekan A.] Univ Warwick, Warwick Med Sch, Div Hlth Sci, Warwick Ctr Appl Hlth Res & Delivery WCAHRD, Coventry CV4 7AL, W Midlands, England	Keele University; University of Warwick	van der Windt, DA (corresponding author), Keele Univ, Arthritis Res UK Primary Care Ctr, Keele ST5 5BG, Staffs, England.	d.van.der.windt@keele.ac.uk	Uthman, Olalekan/N-5584-2019; Jordan, Joanne/E-8186-2014; Peat, George/AAE-5869-2020	Uthman, Olalekan/0000-0002-8567-3081; Jordan, Joanne/0000-0002-7191-2977; Peat, George/0000-0002-9008-0184; Foster, Nadine/0000-0003-4429-9756	National Institute for Health Research (NIHR) [RP-PG-0407-10386]; National Institute for Health Research [NF-SI-0509-10183, NIHR-RP-011-015, RP-PG-0407-10386] Funding Source: researchfish	National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	This study was funded by the National Institute for Health Research (NIHR) under its programme grants for applied research programme (grant reference No RP-PG-0407-10386). The NIHR had no role in the conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review of the manuscript. The conclusions and views expressed in this article are those of the authors and not necessarily those of the NHS, NIHR, or Department of Health.	Aglamis B, 2008, J BACK MUSCULOSKELET, V21, P121; ALTMAN RD, 1995, J RHEUMATOL, V22, P42; Aoki O, 2009, J PHYS THER SCI, V21, P113, DOI 10.1589/jpts.21.113; Artus M, 2010, RHEUMATOLOGY, V49, P2346, DOI 10.1093/rheumatology/keq245; Baker KR, 2001, J RHEUMATOL, V28, P1655; Bartels EM, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005523.pub2; Bautch JC, 1997, ARTHRIT CARE RES, V10, P48, DOI 10.1002/art.1790100108; Bellamy N, 1997, J RHEUMATOL, V24, P799; BELLAMY N, 1995, J RHEUMATOL, V22, P49; Bennell KL, 2010, OSTEOARTHR CARTILAGE, V18, P621, DOI 10.1016/j.joca.2010.01.010; Bennell KL, 2011, J SCI MED SPORT, V14, P4, DOI 10.1016/j.jsams.2010.08.002; Bennell KL, 2005, ANN RHEUM DIS, V64, P906, DOI 10.1136/ard.2004.026526; Borjesson M, 1996, Physiother Res Int, V1, P89; Brismee JM, 2007, CLIN REHABIL, V21, P99, DOI 10.1177/0269215506070505; Brok J, 2008, J CLIN EPIDEMIOL, V61, P763, DOI 10.1016/j.jclinepi.2007.10.007; Brooks SP, 1998, J COMPUT GRAPH STAT, V7, P434, DOI 10.2307/1390675; Caldwell DM, 2005, BMJ-BRIT MED J, V331, P897, DOI 10.1136/bmj.331.7521.897; Centre for Reviews and Dissemination, 2012, 40 CRD U YORK; Chaipinyo K, 2009, AUST J PHYSIOTHER, V55, P25, DOI 10.1016/S0004-9514(09)70057-1; Cochrane T, 2005, HEALTH TECHNOL ASSES, V9, pIII; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Cooper NJ, 2012, EPIDEMIOL REV, V34, P32, DOI 10.1093/epirev/mxr015; Dias Rosangela Correa, 2003, Physiother Res Int, V8, P121; Dias S, 2011, 3 NICE DSU NICE DEC; DiBonaventura MD, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-30; Escalante Y, 2011, J SCI MED SPORT, V14, P190, DOI 10.1016/j.jsams.2010.10.004; Escalante Y, 2010, J BACK MUSCULOSKELET, V23, P175, DOI 10.3233/BMR-2010-0267; Ettinger WH, 1997, JAMA-J AM MED ASSOC, V277, P25, DOI 10.1001/jama.277.1.25; Farr JN, 2010, PHYS THER, V90, P356, DOI 10.2522/ptj.20090041; Foley A, 2003, ANN RHEUM DIS, V62, P1162, DOI 10.1136/ard.2002.005272; Fransen M, 2010, OSTEOARTHR CARTILAGE, V18, P613, DOI 10.1016/j.joca.2010.01.003; Fransen M, 2001, J RHEUMATOL, V28, P156; Fransen M, 2009, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858; Fransen M, 2008, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD004376.PUB2; Fransen M, 2007, ARTHRIT RHEUM-ARTHR, V57, P407, DOI 10.1002/art.22621; Fransen M, 2009, J RHEUMATOL, V36, P1109, DOI 10.3899/jrheum.090058; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Gill SD, 2009, ARCH PHYS MED REHAB, V90, P388, DOI 10.1016/j.apmr.2008.09.561; Gupta S, 2005, RHEUMATOLOGY, V44, P1531, DOI 10.1093/rheumatology/kei049; Gur H, 2002, ARCH PHYS MED REHAB, V83, P308, DOI 10.1053/apmr.2002.30620; Halbert J, 2001, ARTHRIT RHEUM-ARTHR, V45, P228, DOI 10.1002/1529-0131(200106)45:3<228::AID-ART253>3.0.CO;2-2; Hale LA, 2012, ARCH PHYS MED REHAB, V93, P27, DOI 10.1016/j.apmr.2011.08.004; Hartman CA, 2000, J AM GERIATR SOC, V48, P1553, DOI 10.1111/j.1532-5415.2000.tb03863.x; Hay EM, 2006, BRIT MED J, V333, P995, DOI 10.1136/BMJ.38977.590752.0B; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Higgins JPT, 2011, STAT MED, V30, P903, DOI 10.1002/sim.4088; Hinman RS, 2007, PHYS THER, V87, P32, DOI 10.2522/ptj.20060006; Hopman-Rock M, 2000, J RHEUMATOL, V27, P1947; Hozo SP., 2005, BMC MED RES METHODOL, V5, P1, DOI [10.1186/1471-2288-5-13, DOI 10.1186/1471-2288-5-13]; Huang MH, 2005, ARCH PHYS MED REHAB, V86, P1545, DOI 10.1016/j.apmr.2005.02.007; Huang MH, 2003, SEMIN ARTHRITIS RHEU, V32, P398, DOI 10.1053/sarh.2003.50021; Hughes SL, 2006, GERONTOLOGIST, V46, P801, DOI 10.1093/geront/46.6.801; Hurley MV, 2007, ARTHRIT RHEUM-ARTHR, V57, P1211, DOI 10.1002/art.22995; Iwamoto J, 2011, WORLD J ORTHOP, V2, P37, DOI 10.5312/wjo.v2.i5.37; Juni P, 2006, BEST PRACT RES CL RH, V20, P721, DOI 10.1016/j.berh.2006.05.002; Keefe FJ, 2004, PAIN, V110, P539, DOI 10.1016/j.pain.2004.03.022; KOVAR PA, 1992, ANN INTERN MED, V116, P529, DOI 10.7326/0003-4819-116-7-529; Krahn U, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-35; Lambert PC, 2002, J CLIN EPIDEMIOL, V55, P86, DOI 10.1016/S0895-4356(01)00414-0; Le TK, 2012, PAIN PRACT, V12, P633, DOI 10.1111/j.1533-2500.2012.00535.x; Lee HJ, 2009, CLIN REHABIL, V23, P504, DOI 10.1177/0269215508101746; Lim JY, 2010, PM&R, V2, P723, DOI 10.1016/j.pmrj.2010.04.004; Lin DH, 2009, J ORTHOP SPORT PHYS, V39, P450, DOI 10.2519/jospt.2009.2923; Lu G, 2004, STAT MED, V23, P3105, DOI 10.1002/sim.1875; Lund H, 2008, J REHABIL MED, V40, P137, DOI 10.2340/16501977-0134; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; McCarthy CJ, 2002, ARTHRITIS RHEUM-US, V46, pS143; Messier SP, 2004, ARTHRITIS RHEUM-US, V50, P1501, DOI 10.1002/art.20256; Mikesky AE, 2006, ARTHRIT RHEUM-ARTHR, V55, P690, DOI 10.1002/art.22245; MINOR MA, 1989, ARTHRITIS RHEUM, V32, P1396, DOI 10.1002/anr.1780321108; Murphy LB, 2010, OSTEOARTHR CARTILAGE, V18, P1372, DOI 10.1016/j.joca.2010.08.005; Murphy L, 2008, ARTHRIT RHEUM-ARTHR, V59, P1207, DOI 10.1002/art.24021; National Collaborating Centre for Chronic Conditions, 2008, OST NAT CLIN GUID CA; Nuesch E, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3244; O'Reilly SC, 1999, ANN RHEUM DIS, V58, P15, DOI 10.1136/ard.58.1.15; Patrick DL, 2001, MED CARE, V39, P413, DOI 10.1097/00005650-200105000-00002; Peloquin L, 1999, JCR-J CLIN RHEUMATOL, V5, P126, DOI 10.1097/00124743-199906000-00004; Pogue JM, 1997, CONTROL CLIN TRIALS, V18, P580, DOI 10.1016/S0197-2456(97)00051-2; Quilty B, 2003, J RHEUMATOL, V30, P1311; Rannou F, 2010, BEST PRACT RES CL RH, V24, P93, DOI 10.1016/j.berh.2009.08.013; Ravaud P, 2004, ANN RHEUM DIS, V63, P703, DOI 10.1136/ard.2003.009803; Roddy E, 2005, RHEUMATOLOGY, V44, P67, DOI 10.1093/rheumatology/keh399; Rogind H, 1998, ARCH PHYS MED REHAB, V79, P1421, DOI 10.1016/S0003-9993(98)90238-6; Salanti G, 2008, STAT METHODS MED RES, V17, P279, DOI 10.1177/0962280207080643; Salanti G, 2011, J CLIN EPIDEMIOL, V64, P163, DOI 10.1016/j.jclinepi.2010.03.016; Salanti G, 2009, J CLIN EPIDEMIOL, V62, P857, DOI 10.1016/j.jclinepi.2008.10.001; Salli A, 2010, ISOKINET EXERC SCI, V18, P201, DOI 10.3233/IES-2010-0385; Schilke JM, 1996, NURS RES, V45, P68, DOI 10.1097/00006199-199603000-00002; Schmid CH, 2004, J CLIN EPIDEMIOL, V57, P683, DOI 10.1016/j.jclinepi.2003.12.001; Silva LE, 2008, PHYS THER, V88, P12, DOI 10.2522/ptj.20060040; Song Fujian, 2011, BMJ, V343, pd4909, DOI 10.1136/bmj.d4909; Spiegelhalter DJ, 2003, WINBUGS VERSION 1 4; Stener-Victorin E, 2004, CLIN J PAIN, V20, P179, DOI 10.1097/00002508-200405000-00008; Tak E, 2005, J RHEUMATOL, V32, P1106; Talbot LA, 2003, J AM GERIATR SOC, V51, P387, DOI 10.1046/j.1532-5415.2003.51113.x; Thomas KS, 2002, BMJ-BRIT MED J, V325, P752, DOI 10.1136/bmj.325.7367.752; Thompson SG, 2002, STAT MED, V21, P1559, DOI 10.1002/sim.1187; Thorlund K., 2011, USER MANUAL TRIAL SE; Thorstensson CA, 2005, BMC MUSCULOSKEL DIS, V6, DOI 10.1186/1471-2474-6-27; Topp R, 2002, ARCH PHYS MED REHAB, V83, P1187, DOI 10.1053/apmr.2002.33988; United States Bone and Joint Initiative, 2011, BURD MUSC US; van Baar ME, 2001, ANN RHEUM DIS, V60, P1123, DOI 10.1136/ard.60.12.1123; van der Tweel I, 2010, CLIN TRIALS, V7, P136, DOI 10.1177/1740774509360994; Wang CC, 2009, ARTHRIT RHEUM-ARTHR, V61, P1545, DOI 10.1002/art.24832; Wang TJ, 2007, J ADV NURS, V57, P141, DOI 10.1111/j.1365-2648.2006.04102.x; Wang TJ, 2011, J CLIN NURS, V20, P2609, DOI 10.1111/j.1365-2702.2010.03675.x; Weng MC, 2009, KAOHSIUNG J MED SCI, V25, P306, DOI 10.1016/S1607-551X(09)70521-2; Wetterslev J, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-86; Williamson L, 2007, RHEUMATOLOGY, V46, P1445, DOI 10.1093/rheumatology/kem119; Yennan P, 2010, ASIAN BIOMED, V4, P739, DOI 10.2478/abm-2010-0096; Zhang W, 2008, OSTEOARTHR CARTILAGE, V16, P137, DOI 10.1016/j.joca.2007.12.013; Zhang W, 2005, ANN RHEUM DIS, V64, P669, DOI 10.1136/ard.2004.028886; Zhang W, 2010, OSTEOARTHR CARTILAGE, V18, P476, DOI 10.1016/j.joca.2010.01.013	113	200	209	1	68	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 20	2013	347								f5555	10.1136/bmj.f5555	http://dx.doi.org/10.1136/bmj.f5555			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	223TB	24055922	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000324831800001
J	Burnett, JR; Hooper, AJ				Burnett, John R.; Hooper, Amanda J.			Running interference to lower cholesterol	LANCET			English	Editorial Material							MONOCLONAL-ANTIBODY; PCSK9; LDL; HYPERCHOLESTEROLEMIA; STATIN		[Burnett, John R.; Hooper, Amanda J.] Univ Western Australia, Perth, WA 6009, Australia; [Burnett, John R.; Hooper, Amanda J.] Royal Perth Hosp, PathWest Lab Med WA, Dept Clin Biochem, Perth, WA 6847, Australia	University of Western Australia; Royal Perth Hospital	Burnett, JR (corresponding author), Univ Western Australia, Perth, WA 6009, Australia.	john.burnett@health.wa.gov.au	Hooper, Amanda J/H-7757-2014					Alborn WE, 2007, CLIN CHEM, V53, P1814, DOI 10.1373/clinchem.2007.091280; Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5; Careskey HE, 2008, J LIPID RES, V49, P394, DOI 10.1194/jlr.M700437-JLR200; CenterWatch. The Medicines Company, 2013, CENTERWATCH NEWS ONL; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Fitzgerald K, 2013, LANCET; Giugliano RP, 2012, LANCET, V380, P2007, DOI 10.1016/S0140-6736(12)61770-X; Hooper AJ, 2007, ATHEROSCLEROSIS, V193, P445, DOI 10.1016/j.atherosclerosis.2006.08.039; Lambert G, 2012, J LIPID RES, V53, P2515, DOI 10.1194/jlr.R026658; Reiner Z, 2011, EUR HEART J, V32, P1769, DOI [10.1093/eurheartj/ehr158, 10.1016/j.atherosclerosis.2011.06.012]; Smith SC, 2011, CIRCULATION, V124, P2458, DOI 10.1161/CIR.0b013e318235eb4d; Stein EA, 2012, LANCET, V380, P29, DOI 10.1016/S0140-6736(12)60771-5; Stein EA, 2012, NEW ENGL J MED, V366, P1108, DOI 10.1056/NEJMoa1105803; Zhao ZZ, 2006, AM J HUM GENET, V79, P514, DOI 10.1086/507488	14	8	8	2	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 4	2014	383	9911					10	12		10.1016/S0140-6736(13)61910-8	http://dx.doi.org/10.1016/S0140-6736(13)61910-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	284SP	24094769				2022-12-28	WOS:000329341200010
J	Ablasser, A; Schmid-Burgk, JL; Hemmerling, I; Horvath, GL; Schmidt, T; Latz, E; Hornung, V				Ablasser, Andrea; Schmid-Burgk, Jonathan L.; Hemmerling, Inga; Horvath, Gabor L.; Schmidt, Tobias; Latz, Eicke; Hornung, Veit			Cell intrinsic immunity spreads to bystander cells via the intercellular transfer of cGAMP	NATURE			English	Article							CYCLIC GMP-AMP; TRANSCRIPTION FACTOR; DNA SENSOR; INTERFERON; 2ND-MESSENGER; COMMUNICATION; DINUCLEOTIDE; RESPONSES; ADAPTER	The innate immune defence of multicellular organisms against microbial pathogens requires cellular collaboration. Information exchange allowing immune cells to collaborate is generally attributed to soluble protein factors secreted by pathogen-sensing cells. Cytokines, such as type I interferons (IFNs), serve to alert noninfected cells to the possibility of pathogen challenge(1). Moreover, in conjunction with chemokines they can instruct specialized immune cells to contain and eradicate microbial infection. Several receptors and signalling pathways exist that couple pathogen sensing to the induction of cytokines, whereas cytosolic recognition of nucleic acids seems to be exquisitely important for the activation of type I IFNs, master regulators of antiviral immunity(2). Cytosolic DNA is sensed by the receptor cyclic GMP-AMP (cGAMP) synthase (cGAS), which catalyses the synthesis of the second messenger cGAMP(2'-5')(3-8). This molecule in turn activates the endoplasmic reticulum (ER)-resident receptor STING(9-11), thereby inducing an antiviral state and the secretion of type I IFNs. Here we find in murine and human cells that cGAS-synthesized cGAMP (2'-5') is transferred from producing cells to neighbouring cells through gap junctions, where it promotes STING activation and thus antiviral immunity independently of type I IFN signalling. In line with the limited cargo specificity of connexins, the proteins that assemble gap junction channels, most connexins tested were able to confer this bystander immunity, thus indicating a broad physiological relevance of this local immune collaboration. Collectively, these observations identify cGAS-triggered cGAMP(2'-5') transfer as a novel host strategy that serves to rapidly convey antiviral immunity in a transcription-independent, horizontal manner.	[Ablasser, Andrea; Schmid-Burgk, Jonathan L.; Hemmerling, Inga; Schmidt, Tobias; Hornung, Veit] Univ Bonn, Univ Hosp, Inst Clin Chem & Clin Pharmacol, D-53127 Bonn, Germany; [Horvath, Gabor L.; Latz, Eicke] Univ Bonn, Univ Hosp, Inst Innate Immun, D-53127 Bonn, Germany; [Latz, Eicke] Univ Massachusetts, Sch Med, Div Infect Dis & Immunol, Dept Med, Worcester, MA 01605 USA	University of Bonn; University of Bonn; University of Massachusetts System; University of Massachusetts Worcester	Hornung, V (corresponding author), Univ Bonn, Univ Hosp, Inst Clin Chem & Clin Pharmacol, D-53127 Bonn, Germany.	veit.hornung@uni-bonn.de	Hornung, Veit/C-3565-2012; Horvath, Gabor L/J-3917-2014; Latz, Eicke/H-3951-2014; Schmid-Burgk, Jonathan/GSN-3512-2022	Hornung, Veit/0000-0002-4150-194X; Horvath, Gabor L/0000-0003-0309-595X; Latz, Eicke/0000-0003-1488-5666; Schmidt, Tobias/0000-0003-3102-3515; Schmid-Burgk, Jonathan/0000-0003-0988-2487	Studienstiftung des Deutschen Volkes; BONFOR; excellence cluster ImmunoSensation; German Research Foundation [SFB670, SFB704]; European Research Council [ERC 243046]	Studienstiftung des Deutschen Volkes; BONFOR; excellence cluster ImmunoSensation; German Research Foundation(German Research Foundation (DFG)); European Research Council(European Research Council (ERC)European Commission)	We thank M. Pellegrin for providing us with LL171 cells; W. Kastenmuller for MVA NP-S-GFP; J. Bennink for vaccinia virus; K.-P. Hopfner for recombinant cGAS; and K. Willecke for connexin expression constructs and anti-CX43 antibody. J.L.S.-B. is supported by the Studienstiftung des Deutschen Volkes. I.H. is supported by a BONFOR-funded thesis project. A.A., E.L. and V.H. are supported by the excellence cluster ImmunoSensation. V.H. is supported by grants from the German Research Foundation (SFB670 and SFB704) and the European Research Council (ERC 243046).	Ablasser A, 2013, NATURE, V498, P380, DOI 10.1038/nature12306; Ablasser A, 2013, CELL RES, V23, P585, DOI 10.1038/cr.2013.28; Ablasser A, 2009, NAT IMMUNOL, V10, P1065, DOI 10.1038/ni.1779; BUTTERWECK A, 1994, J MEMBRANE BIOL, V141, P247; Cavlar T, 2013, EMBO J, V32, P1440, DOI 10.1038/emboj.2013.86; Civril F, 2013, NATURE, V498, P332, DOI 10.1038/nature12305; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Diner EJ, 2013, CELL REP, V3, P1355, DOI 10.1016/j.celrep.2013.05.009; Gall A, 2012, IMMUNITY, V36, P120, DOI 10.1016/j.immuni.2011.11.018; Gao P, 2013, CELL, V153, P1094, DOI 10.1016/j.cell.2013.04.046; Goubau D, 2013, IMMUNITY, V38, P855, DOI 10.1016/j.immuni.2013.05.007; Hamada N, 2007, J RADIAT RES, V48, P87, DOI 10.1269/jrr.06084; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Juul MH, 2000, CELL ADHES COMMUN, V7, P501, DOI 10.3109/15419060009040307; Kasper CA, 2010, IMMUNITY, V33, P804, DOI 10.1016/j.immuni.2010.10.015; Kastenmuller W, 2013, IMMUNITY, V38, P502, DOI 10.1016/j.immuni.2012.11.012; Laird DW, 2006, BIOCHEM J, V394, P527, DOI 10.1042/BJ20051922; Langlois S, 2008, MOL BIOL CELL, V19, P912, DOI 10.1091/mbc.E07-06-0596; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Patel SJ, 2009, P NATL ACAD SCI USA, V106, P12867, DOI 10.1073/pnas.0809292106; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Schmid-Burgk JL, 2013, NAT BIOTECHNOL, V31, P76, DOI 10.1038/nbt.2460; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Sun WX, 2009, P NATL ACAD SCI USA, V106, P8653, DOI 10.1073/pnas.0900850106; UZE G, 1994, J MOL BIOL, V243, P245, DOI 10.1006/jmbi.1994.1651; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Zhang X, 2013, MOL CELL, V51, P226, DOI 10.1016/j.molcel.2013.05.022; Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003	30	365	390	5	90	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 28	2013	503	7477					530	+		10.1038/nature12640	http://dx.doi.org/10.1038/nature12640			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	258MU	24077100	Green Accepted			2022-12-28	WOS:000327464200044
J	Goodman, DB; Church, GM; Kosuri, S				Goodman, Daniel B.; Church, George M.; Kosuri, Sriram			Causes and Effects of N-Terminal Codon Bias in Bacterial Genes	SCIENCE			English	Article							TRANSLATIONAL EFFICIENCY; USAGE; EXPRESSION; SELECTION; DESIGN	Most amino acids are encoded by multiple codons, and codon choice has strong effects on protein expression. Rare codons are enriched at the N terminus of genes in most organisms, although the causes and effects of this bias are unclear. Here, we measure expression from >14,000 synthetic reporters in Escherichia coli and show that using N-terminal rare codons instead of common ones increases expression by similar to 14-fold (median 4-fold). We quantify how individual N-terminal codons affect expression and show that these effects shape the sequence of natural genes. Finally, we demonstrate that reduced RNA structure and not codon rarity itself is responsible for expression increases. Our observations resolve controversies over the roles of N-terminal codon bias and suggest a straightforward method for optimizing heterologous gene expression in bacteria.	[Goodman, Daniel B.; Church, George M.; Kosuri, Sriram] Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA; [Goodman, Daniel B.; Church, George M.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Goodman, Daniel B.] Harvard MIT Hlth Sci & Technol, Cambridge, MA 02139 USA	Harvard University; Harvard Medical School; Harvard University	Church, GM (corresponding author), Wyss Inst Biol Inspired Engn, 3 Blackfan Circle, Boston, MA 02115 USA.	gchurch@genetics.med.harvard.edu; sri.kosuri@wyss.harvard.edu		Kosuri, Sriram/0000-0002-4661-0600; church, george/0000-0001-6232-9969; Goodman, Daniel/0000-0003-3759-6883	U.S. Department of Energy [DE-FG02-02ER63445]; NSF SynBERC [SA5283-11210]; Office of Naval Research [N000141010144]; Agilent Technologies; Wyss Institute; NSF	U.S. Department of Energy(United States Department of Energy (DOE)); NSF SynBERC(National Science Foundation (NSF)); Office of Naval Research(Office of Naval Research); Agilent Technologies; Wyss Institute; NSF(National Science Foundation (NSF))	We thank J. C. Way, E. R. Daugharthy, and R. T. Sauer for comments. The research was supported by the U.S. Department of Energy (DE-FG02-02ER63445 to G. M. C.), NSF SynBERC (SA5283-11210 to G. M. C.), Office of Naval Research (N000141010144 to G. M. C. and S. K.), Agilent Technologies, Wyss Institute, and an NSF Graduate Research Fellowship to D. B. G. Data can be accessed on the National Center for Biotechnology Information, NIH, Sequence Read Archive (SRA) (SRP029609). pGERC reporter can be obtained from AddGene (#47441). Accession numbers: The Project accession at the SRA is SRP029609. The sample accession is SRS477429. There are three experiments, one for DNA, one for RNA, one for FlowSeq: RNA, SRX346948; DNA, SRX346944; and FlowSeq, SRX346268.	Allert M, 2010, J MOL BIOL, V402, P905, DOI 10.1016/j.jmb.2010.08.010; Bentele K, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.32; Coleman JR, 2008, SCIENCE, V320, P1784, DOI 10.1126/science.1155761; DESMIT MH, 1990, P NATL ACAD SCI USA, V87, P7668, DOI 10.1073/pnas.87.19.7668; dos Reis M, 2004, NUCLEIC ACIDS RES, V32, P5036, DOI 10.1093/nar/gkh834; GOUY M, 1982, NUCLEIC ACIDS RES, V10, P7055, DOI 10.1093/nar/10.22.7055; Gu WJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000664; HARTL DL, 1994, GENETICS, V138, P227; Komar AA, 2009, TRENDS BIOCHEM SCI, V34, P16, DOI 10.1016/j.tibs.2008.10.002; Kosuri S, 2013, P NATL ACAD SCI USA, V110, P14024, DOI 10.1073/pnas.1301301110; Kudla G, 2009, SCIENCE, V324, P255, DOI 10.1126/science.1170160; LeProust EM, 2010, NUCLEIC ACIDS RES, V38, P2522, DOI 10.1093/nar/gkq163; Li GW, 2012, NATURE, V484, P538, DOI 10.1038/nature10965; Navon S, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r12; Pechmann S, 2013, NAT STRUCT MOL BIOL, V20, P237, DOI 10.1038/nsmb.2466; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Plotkin JB, 2011, NAT REV GENET, V12, P32, DOI 10.1038/nrg2899; Shah P, 2013, CELL, V153, P1589, DOI 10.1016/j.cell.2013.05.049; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Subramaniam AR, 2013, P NATL ACAD SCI USA, V110, P2419, DOI 10.1073/pnas.1211077110; Tuller T, 2010, CELL, V141, P344, DOI 10.1016/j.cell.2010.03.031; Tuller T, 2010, P NATL ACAD SCI USA, V107, P3645, DOI 10.1073/pnas.0909910107; Voges D, 2004, BIOCHEM BIOPH RES CO, V318, P601, DOI 10.1016/j.bbrc.2004.04.064; Welch M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007002; Yamazaki Yukiko, 2008, V416, P385, DOI 10.1007/978-1-59745-321-9_26; Zadeh JN, 2011, J COMPUT CHEM, V32, P170, DOI 10.1002/jcc.21596; Zhou M, 2013, NATURE, V495, P111, DOI 10.1038/nature11833	28	361	379	1	124	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 25	2013	342	6157					475	479		10.1126/science.1241934	http://dx.doi.org/10.1126/science.1241934			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239RH	24072823				2022-12-28	WOS:000326042600042
J	Ruff, CC; Ugazio, G; Fehr, E				Ruff, C. C.; Ugazio, G.; Fehr, E.			Changing Social Norm Compliance with Noninvasive Brain Stimulation	SCIENCE			English	Article							LATERAL PREFRONTAL CORTEX; NEURAL FOUNDATIONS; DECISION-MAKING; IMPULSE CONTROL; PUNISHMENT; FAIRNESS; COOPERATION	All known human societies have maintained social order by enforcing compliance with social norms. The biological mechanisms underlying norm compliance are, however, hardly understood. We show that the right lateral prefrontal cortex (rLPFC) is involved in both voluntary and sanction-induced norm compliance. Both types of compliance could be changed by varying the neural excitability of this brain region with transcranial direct current stimulation, but they were affected in opposite ways, suggesting that the stimulated region plays a fundamentally different role in voluntary and sanction-based compliance. Brain stimulation had a particularly strong effect on compliance in the context of socially constituted sanctions, whereas it left beliefs about what the norm prescribes and about subjectively expected sanctions unaffected. Our findings suggest that rLPFC activity is a key biological prerequisite for an evolutionarily and socially important aspect of human behavior.	[Ruff, C. C.; Ugazio, G.; Fehr, E.] Univ Zurich, Dept Econ, Lab Social & Neural Syst Res SNS Lab, Zurich, Switzerland; [Ugazio, G.] Univ Vienna, Social Cognit & Affect Neurosci Unit, Vienna, Austria	University of Zurich; University of Vienna	Ruff, CC (corresponding author), Univ Zurich, Dept Econ, Lab Social & Neural Syst Res SNS Lab, Zurich, Switzerland.	christian.ruff@econ.uzh.ch; ernst.fehr@econ.uzh.ch	Ruff, Christian C/N-9552-2016	Ruff, Christian C/0000-0002-3964-2364	European Research Council; Swiss National Science Foundation (SNSF) [CRSII3_141965, 51NF40_144609]; SNSF	European Research Council(European Research Council (ERC)European Commission); Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); SNSF(Swiss National Science Foundation (SNSF))	C.C.R. and E. F. designed the research, C. C. R. and G. U. conducted the research, C. C. R. and G. U. analyzed data with input from E. F., and C. C. R. and E. F. wrote the paper with comments by G. U. We thank K. Treiber and A. Schlaepfer for their assistance with data collection. This study was supported by a European Research Council grant to E. F. (Foundations of Economic Preferences), Swiss National Science Foundation (SNSF) grants to C. C. R. and E. F. (CRSII3_141965 and 51NF40_144609), and the SNSF-funded Swiss National Center of Competence in Research Affective Sciences.	Aron AR, 2004, TRENDS COGN SCI, V8, P170, DOI 10.1016/j.tics.2004.02.010; Bechara A, 2005, CURR OPIN NEUROL, V18, P734, DOI 10.1097/01.wco.0000194141.56429.3c; Boyd R, 2003, P NATL ACAD SCI USA, V100, P3531, DOI 10.1073/pnas.0630443100; Buckholtz JW, 2012, NAT NEUROSCI, V15, P655, DOI 10.1038/nn.3087; Buckholtz JW, 2008, NEURON, V60, P930, DOI 10.1016/j.neuron.2008.10.016; Camerer C.F., 2011, BEHAV GAME THEORY EX, DOI 10.1257/jep.9.2.209; Crockett MJ, 2013, J NEUROSCI, V33, P3505, DOI 10.1523/JNEUROSCI.2761-12.2013; Croxson PL, 2005, J NEUROSCI, V25, P8854, DOI 10.1523/JNEUROSCI.1311-05.2005; de Quervain DJF, 2004, SCIENCE, V305, P1254, DOI 10.1126/science.1100735; Driver J, 2009, TRENDS COGN SCI, V13, P319, DOI 10.1016/j.tics.2009.04.007; Dunbar RIM, 2012, TRENDS COGN SCI, V16, P101, DOI 10.1016/j.tics.2011.11.013; Duncan J, 2010, TRENDS COGN SCI, V14, P172, DOI 10.1016/j.tics.2010.01.004; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Fehr E, 2004, EVOL HUM BEHAV, V25, P63, DOI 10.1016/S1090-5138(04)00005-4; Figner B, 2010, NAT NEUROSCI, V13, P538, DOI 10.1038/nn.2516; Fischbacher U, 2001, ECON LETT, V71, P397, DOI 10.1016/S0165-1765(01)00394-9; FORSYTHE R, 1994, GAME ECON BEHAV, V6, P347, DOI 10.1006/game.1994.1021; Henrich J, 2001, AM ECON REV, V91, P73, DOI 10.1257/aer.91.2.73; King-Casas B, 2008, SCIENCE, V321, P806, DOI 10.1126/science.1156902; Knoch D, 2006, SCIENCE, V314, P829, DOI 10.1126/science.1129156; Loeber R, 2000, DEV PSYCHOPATHOL, V12, P737, DOI 10.1017/S0954579400004107; Mathew S, 2011, P NATL ACAD SCI USA, V108, P11375, DOI 10.1073/pnas.1105604108; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Montague PR, 2007, NEURON, V56, P14, DOI 10.1016/j.neuron.2007.09.020; Nitsche MA, 2000, J PHYSIOL-LONDON, V527, P633, DOI 10.1111/j.1469-7793.2000.t01-1-00633.x; Raine A, 2006, SOC COGN AFFECT NEUR, V1, P203, DOI 10.1093/scan/nsl033; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; Sober E., 1998, OTHERS EVOLUTION PSY; Spitzer M, 2007, NEURON, V56, P185, DOI 10.1016/j.neuron.2007.09.011; Steinbeis N, 2012, NEURON, V73, P1040, DOI 10.1016/j.neuron.2011.12.027; Xue G, 2012, P NATL ACAD SCI USA, V109, P4401, DOI 10.1073/pnas.1111927109	31	179	184	2	87	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 25	2013	342	6157					482	484		10.1126/science.1241399	http://dx.doi.org/10.1126/science.1241399			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	239RH	24091703	Green Accepted			2022-12-28	WOS:000326042600044
J	Papazian, L; Roch, A; Charles, PE; Penot-Ragon, C; Perrin, G; Roulier, P; Goutorbe, P; Lefrant, JY; Wiramus, S; Jung, B; Perbet, S; Hernu, R; Nau, A; Baldesi, O; Allardet-Servent, J; Baumstarck, K; Jouve, E; Moussa, M; Hraiech, S; Guervilly, C; Forel, JM				Papazian, Laurent; Roch, Antoine; Charles, Pierre-Emmanuel; Penot-Ragon, Christine; Perrin, Gilles; Roulier, Philippe; Goutorbe, Philippe; Lefrant, Jean-Yves; Wiramus, Sandrine; Jung, Boris; Perbet, Sebastien; Hernu, Romain; Nau, Andre; Baldesi, Olivier; Allardet-Servent, Jerome; Baumstarck, Karine; Jouve, Elisabeth; Moussa, Myriam; Hraiech, Sami; Guervilly, Christophe; Forel, Jean-Marie		STATIN-VAP Study Grp	Effect of Statin Therapy on Mortality in Patients With Ventilator-Associated Pneumonia A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE LUNG INJURY; CRITICALLY-ILL; MURINE MODEL; SIMVASTATIN; SEPSIS; ATORVASTATIN; CARE; INFECTIONS; PHARMACOKINETICS; MULTICENTER	IMPORTANCE Observational studies have reported that statin use may be associated with improved outcomes of various infections. Ventilator-associated pneumonia (VAP) is the most common infection in the intensive care unit (ICU) and is associated with substantial mortality. OBJECTIVE To determine whether statin therapy can decrease day-28 mortality in patients with VAP. DESIGN, SETTING, AND PARTICIPANTS Randomized, placebo-controlled, double-blind, parallel-group, multicenter trial performed in 26 intensive care units in France from January 2010to March 2013. For power to detect an 8% absolute reduction in the day-28 mortality rate, we planned to enroll 1002 patients requiring invasive mechanical ventilation for more than 2 days and having suspected VAP, defined as a modified Clinical Pulmonary Infection Score of 5 or greater. The futility stopping rules were an absolute increase in day-28 mortality of at least 2.7% with simvastatin compared with placebo after enrollment of the first 251 patients. INTERVENTIONS Participants were randomized to receive simvastatin (60 mg) or placebo, started on the same day as antibiotic therapy and given until ICU discharge, death, or day 28, whichever occurred first. MAIN OUTCOMES AND MEASURES Primary outcome was day-28 mortality. Day-14, ICU, and hospital mortality rates were determined, as well as duration of mechanical ventilation and Sequential Organ Failure Assessment (SOFA) scores on days 3, 7, and 14. RESULTS The study was stopped for futility at the first scheduled interim analysis after enrollment of 300 patients, of whom all but 7% in the simvastatin group and 11% in the placebo group were naive to statin therapy at ICU admission. Day-28 mortality was not lower in the simvastatin group (21.2% [95% CI, 15.4% to 28.6%) than in the placebo group (15.2% [95% CI, 10.2% to 22.1%]; P = .10; hazard ratio, 1.45 [95% CI, 0.83 to 2.51]); the between-group difference was 6.0% (95% CI, -3.0% to 14.9%). In statin-naive patients, day-28 mortality was 21.5% (95% CI, 15.4% to 29.1%) with simvastatin and 13.8% (95% CI, 8.8% to 21.0%) with placebo (P = .054) (between-group difference, 7.7% [95% CI, -1.8% to 16.8%). There were no significant differences regarding day-14, ICU, or hospital mortality rates; duration of mechanical ventilation; or changes in SOFA score. CONCLUSIONS AND RELEVANCE In adults with suspected VAP, adjunctive simvastatin therapy compared with placebo did not improve day-28 survival. These findings do not support the use of statins with the goal of improving VAP outcomes.	[Papazian, Laurent; Roch, Antoine; Moussa, Myriam; Hraiech, Sami; Guervilly, Christophe; Forel, Jean-Marie] Aix Marseile Univ, Hop Nord, Assistance Publ Hop Marseille, Reanimat Detresses Resp & Infect Serv,UMR CNRS 72, F-13015 Marseille, France; [Charles, Pierre-Emmanuel] CHU Dijon, Serv Reanimat Med, Dijon, France; [Penot-Ragon, Christine] Pharm Hop Sud, Hop Sud, Assistance Publ Hop Marseille, Marseille, France; [Perrin, Gilles] Hop Enfants La Timone, Assistance Publ Hop Marseille, Marseille, France; [Roulier, Philippe] Ctr Hosp Perpignan, Serv Reanimat, Perpignan, France; [Goutorbe, Philippe] Hop Instruct Armees St Anne, Hop St Anne, Serv Reanimat, F-83800 Toulon, France; [Lefrant, Jean-Yves] CHU Nimes, Serv Reanimat, Div Anesthesie, Nimes, France; [Wiramus, Sandrine] Hop Nord Marseille, Assistance Publ Hop Marseille, Marseille, France; [Jung, Boris] CHU Montpellier, Dept Anesthesie Reanimat St Eloi, Montpellier, France; [Jung, Boris] INSERM, U1046, Montpellier, France; [Perbet, Sebastien] Hop Estaing, Serv Reanimat Adulte, Clermont Ferrand, France; [Hernu, Romain] Hosp Civils Lyon, Hop Edouard Herriot, Serv Reanimat Med, Lyon, France; [Nau, Andre] Hop Instruct Armees St Anne, Hop Laveran, Serv Reanimat, Marseille, France; [Baldesi, Olivier] Ctr Hosp Aix En Provence, Serv Reanimat, Aix En Provence, France; [Allardet-Servent, Jerome] Hop Ambroise Pare, Serv Reanimat, Marseille, France; [Baumstarck, Karine] Aix Marseille Univ, Fac Med, Assitance Publ Hop Marseille, Unite Aide Methodol Rech Clin, Marseille, France; [Jouve, Elisabeth] Hop Enfants La Timone, Assistance Publ Hop Marseille, CIC Ctr Pharmacol Clin & Evaluat Therapeut, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; CHU Dijon Bourgogne; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Hospital Instruction Of Armees Sainte-Anne; Universite de Montpellier; CHU de Nimes; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite de Montpellier; CHU de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; CHU Clermont Ferrand; CHU Lyon; Hospital Instruction Of Armees Sainte-Anne; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Papazian, L (corresponding author), Hop Nord Marseille, Reanimat Detresses Resp & Infect Serv, Chemin Bourrely, F-13015 Marseille, France.	laurent.papazian@ap-hm.fr	guervilly, christophe/C-1083-2016; Jung, Boris/AAK-5066-2021; Leone, Marc/P-4835-2016; Jouve, Elisabeth/GSN-9120-2022; Seguin, Philippe/P-9487-2019	Jung, Boris/0000-0003-2522-1531; Leone, Marc/0000-0002-3097-758X; Jouve, Elisabeth/0000-0002-4873-6522; Seguin, Philippe/0000-0002-7774-4257; ALLARDET-SERVENT, Jerome/0000-0002-6464-2382; Baumstarck, Karine/0000-0003-3602-6766; Charles, Pierre-Emmanuel/0000-0002-0201-9544; QUENOT, Jean-Pierre/0000-0003-2351-682X; Guervilly, Christophe/0000-0001-9066-6591	French Ministry of Health	French Ministry of Health	This study was supported by a grant from the French Ministry of Health (Programme Hospitalier de Recherche Clinique 2007).	Almog Y, 2004, CIRCULATION, V110, P880, DOI 10.1161/01.CIR.0000138932.17956.F1; Angus DC, 2004, LANCET, V363, P1314, DOI 10.1016/S0140-6736(04)16007-8; Catron DM, 2004, INFECT IMMUN, V72, P1036, DOI 10.1128/IAI.72.2.1036-1042.2004; Chalmers JD, 2008, AM J MED, V121, P1002, DOI 10.1016/j.amjmed.2008.06.030; Chastre J, 2002, AM J RESP CRIT CARE, V165, P867, DOI 10.1164/ajrccm.165.7.2105078; Cilla DD, 1996, J CLIN PHARMACOL, V36, P604, DOI 10.1002/j.1552-4604.1996.tb04224.x; Cook DJ, 1998, ANN INTERN MED, V129, P433, DOI 10.7326/0003-4819-129-6-199809150-00002; Craig TR, 2011, AM J RESP CRIT CARE, V183, P620, DOI 10.1164/rccm.201003-0423OC; Douglas I, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1642; Erkkila L, 2005, ANTIMICROB AGENTS CH, V49, P3959, DOI 10.1128/AAC.49.9.3959-3962.2005; Fagon JY, 2000, ANN INTERN MED, V132, P621, DOI 10.7326/0003-4819-132-8-200004180-00004; Frost FJ, 2007, CHEST, V131, P1006, DOI 10.1378/chest.06-1997; Giusti-Paiva A, 2004, SHOCK, V21, P271, DOI 10.1097/10.shk.0000115756.74059.ce; Gupta R, 2007, JAMA-J AM MED ASSOC, V297, P1455, DOI 10.1001/jama.297.13.1455; Hackam DG, 2006, LANCET, V367, P413, DOI 10.1016/S0140-6736(06)68041-0; Heyland D, 2006, NEW ENGL J MED, V355, P2619, DOI 10.1056/NEJMoa052904; Janda S, 2010, J CRIT CARE, V25; Kruger P, 2013, AM J RESP CRIT CARE, V187, P743, DOI 10.1164/rccm.201209-1718OC; Kruger PS, 2011, AM J RESP CRIT CARE, V183, P774, DOI 10.1164/rccm.201006-0955OC; Kruger PS, 2009, INTENS CARE MED, V35, P717, DOI 10.1007/s00134-008-1358-3; LAN KKG, 1983, BIOMETRIKA, V70, P659, DOI 10.2307/2336502; Luna CM, 2003, CRIT CARE MED, V31, P676, DOI 10.1097/01.CCM.0000055380.86458.1E; Majumdar SR, 2006, BMJ-BRIT MED J, V333, P999, DOI 10.1136/BMJ.38992.565972.7C; Makris D, 2011, CRIT CARE MED, V39, P2440, DOI 10.1097/CCM.0b013e318225742c; McKenney JM, 2006, AM J CARDIOL, V97, p89C, DOI 10.1016/j.amjcard.2006.02.030; Merx MW, 2005, CIRCULATION, V112, P117, DOI 10.1161/CIRCULATIONAHA.104.502195; Merx MW, 2004, CIRCULATION, V109, P2560, DOI 10.1161/01.CIR.0000129774.09737.5B; Mortensen EM, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-82; Mortensen EM, 2012, CLIN INFECT DIS, V55, P1466, DOI 10.1093/cid/cis733; Novack V, 2009, INTENS CARE MED, V35, P1255, DOI 10.1007/s00134-009-1429-0; PAN HY, 1990, J CLIN PHARMACOL, V30, P1128, DOI 10.1002/j.1552-4604.1990.tb01856.x; Patel JM, 2012, CRIT CARE, V16, DOI 10.1186/cc11895; Pleiner J, 2004, CIRCULATION, V110, P3349, DOI 10.1161/01.CIR.0000147774.90396.ED; Schlienger RG, 2007, PHARMACOTHERAPY, V27, P325, DOI 10.1592/phco.27.3.325; Shyamsundar M, 2009, AM J RESP CRIT CARE, V179, P1107, DOI 10.1164/rccm.200810-1584OC; Stefanec T, 2002, CLIN INFECT DIS, V34, P1158, DOI 10.1086/339763; Steiner S, 2005, CIRCULATION, V111, P1841, DOI 10.1161/01.CIR.0000158665.27783.0C; Terblanche M, 2007, LANCET INFECT DIS, V7, P358, DOI 10.1016/S1473-3099(07)70111-1; Tleyjeh IM, 2009, ARCH INTERN MED, V169, P1658, DOI 10.1001/archinternmed.2009.286; van den Hoek HL, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d7281; Vandermeer ML, 2012, J INFECT DIS, V205, P13, DOI 10.1093/infdis/jir695; Vincent JL, 1998, CRIT CARE MED, V26, P1793, DOI 10.1097/00003246-199811000-00016; WEINBERG PF, 1984, AM REV RESPIR DIS, V130, P791; Yasuda H, 2006, KIDNEY INT, V69, P1535, DOI 10.1038/sj.ki.5000300; Yende S, 2011, CRIT CARE MED, V39, P1871, DOI 10.1097/CCM.0b013e31821b8290	45	140	145	0	17	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 23	2013	310	16					1692	1700		10.1001/jama.2013.280031	http://dx.doi.org/10.1001/jama.2013.280031			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	238LR	24108510	Bronze			2022-12-28	WOS:000325948500025
J	Webster, CR; Mahaffy, PR; Atreya, SK; Flesch, GJ; Farley, KA				Webster, Christopher R.; Mahaffy, Paul R.; Atreya, Sushil K.; Flesch, Gregory J.; Farley, Kenneth A.		MSL Sci Team	Low Upper Limit to Methane Abundance on Mars	SCIENCE			English	Article							MARTIAN DUST DEVILS; OXIDANT ENHANCEMENT; ATMOSPHERE; ORIGIN; SEARCH; STORMS; LIFE	By analogy with Earth, methane in the Martian atmosphere is a potential signature of ongoing or past biological activity. During the past decade, Earth-based telescopic observations reported "plumes" of methane of tens of parts per billion by volume (ppbv), and those from Mars orbit showed localized patches, prompting speculation of sources from subsurface bacteria or nonbiological sources. From in situ measurements made with the Tunable Laser Spectrometer (TLS) on Curiosity using a distinctive spectral pattern specific to methane, we report no detection of atmospheric methane with a measured value of 0.18 +/- 0.67 ppbv corresponding to an upper limit of only 1.3 ppbv (95% confidence level), which reduces the probability of current methanogenic microbial activity on Mars and limits the recent contribution from extraplanetary and geologic sources.	[Webster, Christopher R.; Flesch, Gregory J.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Mahaffy, Paul R.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Atreya, Sushil K.] Univ Michigan, Dept Atmospher Ocean & Space Sci, Ann Arbor, MI 48109 USA; [Farley, Kenneth A.] CALTECH, Dept Geol & Planetary Sci, Pasadena, CA 91125 USA	California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University of Michigan System; University of Michigan; California Institute of Technology	Webster, CR (corresponding author), CALTECH, Jet Prop Lab, 4800 Oak Grove Dr, Pasadena, CA 91109 USA.	chris.r.webster@jpl.nasa.gov	FABRE, Cécile/B-5827-2012; Hayes, Alexander G/P-2024-2014; Dworkin, Jason P./C-9417-2012; Benna, Mehdi/F-3489-2012; Muller, Jan-Peter/Q-8886-2019; Glavin, Daniel P/D-6194-2012; Rodriguez-Manfredi, Jose/L-8001-2014; Malakhov, Alexey Vladimirovich/F-7953-2017; Avalos, Juan Jose Blanco/AAB-9447-2021; Franz, Heather B/F-3508-2012; Prats, Benito/F-9467-2019; Navarro-González, Rafael/D-1748-2009; Webster, Chris/M-9315-2019; Gomez-Elvira, Javier/K-5829-2014; Blanco, Juan Jose/E-3627-2014; Farley, Kenneth/AAE-7735-2020; Balic-Zunic, Tonci/A-6362-2013; De Pablo, Miguel Ángel/J-6442-2014; GEFFROY, Claude/AAB-9152-2019; Zorzano, María-Paz/F-2184-2015; Stipp, Susan L.S./B-8494-2019; Gómez, Felipe/L-7315-2014; szopa, cyril/C-6865-2015; Ramos, Miguel/K-2230-2014; Teinturier, Samuel/AAS-8663-2020; Rodriguez-Manfredi, Jose/AAG-9826-2021; Steele, Andrew/A-3573-2013; Lemmon, Mark T/E-9983-2010; Martin-Torres, Javier/G-6329-2015; Harri, Ari-Matti/C-7142-2012; Vicenzi, Edward/T-9430-2017	FABRE, Cécile/0000-0001-8627-4050; Hayes, Alexander G/0000-0001-6397-2630; Dworkin, Jason P./0000-0002-3961-8997; Muller, Jan-Peter/0000-0002-5077-3736; Glavin, Daniel P/0000-0001-7779-7765; Rodriguez-Manfredi, Jose/0000-0003-0461-9815; Malakhov, Alexey Vladimirovich/0000-0003-4292-7077; Avalos, Juan Jose Blanco/0000-0002-8666-0696; Prats, Benito/0000-0003-3869-3351; Navarro-González, Rafael/0000-0002-6078-7621; Gomez-Elvira, Javier/0000-0002-9068-9846; Blanco, Juan Jose/0000-0002-8666-0696; Balic-Zunic, Tonci/0000-0003-1687-1233; De Pablo, Miguel Ángel/0000-0002-4496-2741; GEFFROY, Claude/0000-0002-2731-9658; Zorzano, María-Paz/0000-0002-4492-9650; Stipp, Susan L.S./0000-0001-7009-643X; Gómez, Felipe/0000-0001-9977-7060; szopa, cyril/0000-0002-0090-4056; Ramos, Miguel/0000-0003-3648-6818; Teinturier, Samuel/0000-0003-1755-9524; Rodriguez-Manfredi, Jose/0000-0003-0461-9815; Steele, Andrew/0000-0001-9643-2841; Lemmon, Mark T/0000-0002-4504-5136; Martin-Torres, Javier/0000-0001-6479-2236; Harri, Ari-Matti/0000-0001-8541-2802; Vicenzi, Edward/0000-0003-2085-6546; Wilson, Sharon/0000-0001-8872-8546; Farley, Kenneth/0000-0002-7846-7546	National Aeronautics and Space Administration (NASA); UK Space Agency [ST/I003118/1] Funding Source: researchfish	National Aeronautics and Space Administration (NASA)(National Aeronautics & Space Administration (NASA)); UK Space Agency	The research described here was carried out in part at the Jet Propulsion Laboratory, California Institute of Technology, under a contract with the National Aeronautics and Space Administration (NASA). Data described in the paper are further described in the supplementary materials and have been submitted to NASA's Planetary Data System under an arrangement with the Mars Science Laboratory project.	Atreya SK, 2007, PLANET SPACE SCI, V55, P358, DOI 10.1016/j.pss.2006.02.005; Atreya SK, 2006, ASTROBIOLOGY, V6, P439, DOI 10.1089/ast.2006.6.439; Atreya SK, 2011, PLANET SPACE SCI, V59, P133, DOI 10.1016/j.pss.2010.10.008; Christensen P. R., 2003, EOS T S, V84; Delory GT, 2006, ASTROBIOLOGY, V6, P451, DOI 10.1089/ast.2006.6.451; Encrenaz T, 2011, ASTRON ASTROPHYS, V530, DOI 10.1051/0004-6361/201116820; Farrell W. M., 2006, J GEOPHYS RES, V33; Fonti S, 2010, ASTRON ASTROPHYS, V512, DOI 10.1051/0004-6361/200913178; Formisano V, 2004, SCIENCE, V306, P1758, DOI 10.1126/science.1101732; Geminale A, 2011, PLANET SPACE SCI, V59, P137, DOI 10.1016/j.pss.2010.07.011; Kerr RA, 2012, SCIENCE, V338, P733, DOI 10.1126/science.338.6108.733; Krashnopolsky VA, 2004, ICARUS, V172, P537, DOI 10.1016/j.icarus.2004.07.004; Krasnopolsky V. A., 2011, EPSC ABSTR, V6, P49; Krasnopolsky VA, 2006, ICARUS, V180, P359, DOI 10.1016/j.icarus.2005.10.015; Krasnopolsky VA, 2012, ICARUS, V217, P144, DOI 10.1016/j.icarus.2011.10.019; Lefevre F, 2009, NATURE, V460, P720, DOI 10.1038/nature08228; Mahaffy PR, 2012, SPACE SCI REV, V170, P401, DOI 10.1007/s11214-012-9879-z; Michelsen HA, 1999, GEOPHYS RES LETT, V26, P291, DOI 10.1029/1998GL900282; Mumma MJ, 2009, SCIENCE, V323, P1041, DOI 10.1126/science.1165243; Villanueva GL, 2013, ICARUS, V223, P11, DOI 10.1016/j.icarus.2012.11.013; Webster CR, 2013, SCIENCE, V341, P260, DOI 10.1126/science.1237961; Wong AS, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE002003; Zahnle K, 2011, ICARUS, V212, P493, DOI 10.1016/j.icarus.2010.11.027	24	90	93	1	128	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 18	2013	342	6156					355	357		10.1126/science.1242902	http://dx.doi.org/10.1126/science.1242902			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235XG	24051245				2022-12-28	WOS:000325755100043
J	Smith, JM				Smith, Jeanette M.			Study, North Conway, New Hampshire David Johnson	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 9	2013	310	14					1430	1431		10.1001/jama.2013.5353	http://dx.doi.org/10.1001/jama.2013.5353			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	230PK	24104357				2022-12-28	WOS:000325354100001
J	Khurana, E; Fu, Y; Colonna, V; Mu, XJ; Kang, HM; Lappalainen, T; Sboner, A; Lochovsky, L; Chen, JM; Harmanci, A; Das, J; Abyzov, A; Balasubramanian, S; Beal, K; Chakravarty, D; Challis, D; Chen, Y; Clarke, D; Clarke, L; Cunningham, F; Evani, US; Flicek, P; Fragoza, R; Garrison, E; Gibbs, R; Guemues, ZH; Herrero, J; Kitabayashi, N; Kong, Y; Lage, K; Liluashvili, V; Lipkin, SM; MacArthur, DG; Marth, G; Muzny, D; Pers, TH; Ritchie, GRS; Rosenfeld, JA; Sisu, C; Wei, XM; Wilson, M; Xue, YL; Yu, FL; Dermitzakis, ET; Yu, HY; Rubin, MA; Tyler-Smith, C; Gerstein, M				Khurana, Ekta; Fu, Yao; Colonna, Vincenza; Mu, Xinmeng Jasmine; Kang, Hyun Min; Lappalainen, Tuuli; Sboner, Andrea; Lochovsky, Lucas; Chen, Jieming; Harmanci, Arif; Das, Jishnu; Abyzov, Alexej; Balasubramanian, Suganthi; Beal, Kathryn; Chakravarty, Dimple; Challis, Daniel; Chen, Yuan; Clarke, Declan; Clarke, Laura; Cunningham, Fiona; Evani, Uday S.; Flicek, Paul; Fragoza, Robert; Garrison, Erik; Gibbs, Richard; Guemues, Zeynep H.; Herrero, Javier; Kitabayashi, Naoki; Kong, Yong; Lage, Kasper; Liluashvili, Vaja; Lipkin, Steven M.; MacArthur, Daniel G.; Marth, Gabor; Muzny, Donna; Pers, Tune H.; Ritchie, Graham R. S.; Rosenfeld, Jeffrey A.; Sisu, Cristina; Wei, Xiaomu; Wilson, Michael; Xue, Yali; Yu, Fuli; Dermitzakis, Emmanouil T.; Yu, Haiyuan; Rubin, Mark A.; Tyler-Smith, Chris; Gerstein, Mark		1000 Genomes Project Consortium	Integrative Annotation of Variants from 1092 Humans: Application to Cancer Genomics	SCIENCE			English	Article							TERT PROMOTER MUTATIONS; NATURAL-SELECTION; POSITIVE SELECTION; COPY NUMBER; ELEMENTS; NETWORK; REGIONS	Interpreting variants, especially noncoding ones, in the increasing number of personal genomes is challenging. We used patterns of polymorphisms in functionally annotated regions in 1092 humans to identify deleterious variants; then we experimentally validated candidates. We analyzed both coding and noncoding regions, with the former corroborating the latter. We found regions particularly sensitive to mutations ("ultrasensitive") and variants that are disruptive because of mechanistic effects on transcription-factor binding (that is, "motif-breakers"). We also found variants in regions with higher network centrality tend to be deleterious. Insertions and deletions followed a similar pattern to single-nucleotide variants, with some notable exceptions (e. g., certain deletions and enhancers). On the basis of these patterns, we developed a computational tool (FunSeq), whose application to similar to 90 cancer genomes reveals nearly a hundred candidate noncoding drivers.	[Khurana, Ekta; Fu, Yao; Mu, Xinmeng Jasmine; Lochovsky, Lucas; Chen, Jieming; Harmanci, Arif; Abyzov, Alexej; Balasubramanian, Suganthi; Sisu, Cristina; Wilson, Michael; Gerstein, Mark] Yale Univ, Program Computat Biol & Bioinformat, New Haven, CT 06520 USA; [Khurana, Ekta; Harmanci, Arif; Abyzov, Alexej; Balasubramanian, Suganthi; Kong, Yong; Sisu, Cristina; Gerstein, Mark] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Colonna, Vincenza; Chen, Yuan; Xue, Yali; Tyler-Smith, Chris] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Colonna, Vincenza] CNR, Inst Genet & Biophys, I-80131 Naples, Italy; [Kang, Hyun Min] Univ Michigan, Ctr Stat Genet, Ann Arbor, MI 48109 USA; [Lappalainen, Tuuli; Dermitzakis, Emmanouil T.] Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland; [Lappalainen, Tuuli; Dermitzakis, Emmanouil T.] Univ Geneva, iGE3, CH-1211 Geneva, Switzerland; [Lappalainen, Tuuli; Dermitzakis, Emmanouil T.] Swiss Inst Bioinformat, CH-1211 Geneva, Switzerland; [Sboner, Andrea; Chakravarty, Dimple; Kitabayashi, Naoki; Rubin, Mark A.] Weill Cornell Med Coll, Inst Precis Med, New York, NY 10065 USA; [Sboner, Andrea; Chakravarty, Dimple; Kitabayashi, Naoki; Rubin, Mark A.] Weill Cornell Med Coll, Dept Pathol & Lab Med, New York, NY 10065 USA; New York Presbyterian Hosp, New York, NY 10065 USA; [Sboner, Andrea; Guemues, Zeynep H.; Liluashvili, Vaja] Weill Cornell Med Coll, HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsau, New York, NY 10021 USA; [Chen, Jieming] Yale Univ, Integrated Grad Program Phys & Engn Biol, New Haven, CT 06520 USA; [Das, Jishnu; Yu, Haiyuan] Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY 14853 USA; [Das, Jishnu; Fragoza, Robert; Wei, Xiaomu; Yu, Haiyuan] Cornell Univ, Inst Cell & Mol Biol, Ithaca, NY 14853 USA; [Beal, Kathryn; Clarke, Laura; Cunningham, Fiona; Flicek, Paul; Herrero, Javier; Ritchie, Graham R. S.] European Bioinformat Inst, European Mol Biol Lab, Cambridge CB10 1SD, England; [Challis, Daniel; Evani, Uday S.; Gibbs, Richard; Muzny, Donna; Yu, Fuli] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Clarke, Declan] Yale Univ, Dept Chem, New Haven, CT 06520 USA; [Fragoza, Robert] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA; [Garrison, Erik; Marth, Gabor] Boston Coll, Dept Biol, Chestnut Hill, MA 02467 USA; [Guemues, Zeynep H.; Liluashvili, Vaja] Weill Cornell Med ical Coll, Dept Physiol & Biophys, New York, NY 10065 USA; [Kong, Yong] Yale Univ, Keck Biotechnol Resource Lab, New Haven, CT 06511 USA; [Lage, Kasper] Massachusetts Gen Hosp, MassGeneral Hosp Children, Pediat Surg Res Labs, Boston, MA 02114 USA; [Lage, Kasper; MacArthur, Daniel G.] Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Lage, Kasper] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Lage, Kasper; Pers, Tune H.] Tech Univ Denmark, Dept Syst Biol, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark; [Lage, Kasper] Univ Copenhagen, Ctr Prot Res, Copenhagen, Denmark; [Lipkin, Steven M.; Wei, Xiaomu] Weill Cornell Med Coll, Dept Med, New York, NY 10065 USA; [MacArthur, Daniel G.] Broad Inst Harvard & Massachusetts Inst Technol M, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Pers, Tune H.] Childrens Hosp, Div Endocrinol, Boston, MA 02115 USA; [Pers, Tune H.] Childrens Hosp, Ctr Basic & Translat Obes Res, Boston, MA 02115 USA; [Pers, Tune H.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Rosenfeld, Jeffrey A.] Rutgers New Jersey Med Sch, Dept Med, Newark, NJ 07101 USA; [Rosenfeld, Jeffrey A.] Rutgers State Univ, IST High Performance & Res Comp, Newark, NJ 07101 USA; [Rosenfeld, Jeffrey A.] Amer Museum Nat Hist, Sackler Inst Comparat Genom, New York, NY 10024 USA; [Wilson, Michael] Yale Univ, Ctr Child Study, New Haven, CT 06520 USA; [Gerstein, Mark] Yale Univ, Dept Comp Sci, New Haven, CT 06520 USA	Yale University; Yale University; Wellcome Trust Sanger Institute; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); University of Michigan System; University of Michigan; University of Geneva; University of Geneva; Swiss Institute of Bioinformatics; Cornell University; Cornell University; NewYork-Presbyterian Hospital; Cornell University; Yale University; Cornell University; Cornell University; University of Texas System; University of Texas Austin; European Molecular Biology Laboratory (EMBL); Baylor College of Medicine; Yale University; Cornell University; Boston College; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Yale University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Technical University of Denmark; University of Copenhagen; Cornell University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University Newark; Rutgers State University New Brunswick; American Museum of Natural History (AMNH); Yale University; Yale University	Tyler-Smith, C (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge CB10 1SA, England.	cts@sanger.ac.uk; mark.gerstein@yale.edu	Mu, Xinmeng/P-2562-2016; Ye, Kai/B-3640-2012; Kalra, D/H-6661-2019; Altshuler, David M/A-4476-2009; Kong, Yong/B-5105-2014; Mills, Ryan/F-4225-2010; Sisu, Cristina/K-8994-2019; Li, Yingrui/K-1064-2015; Sboner, Andrea/C-6487-2008; Rodriguez-Flores, Juan L/AAJ-7565-2020; Das, Jishnu/AAK-4950-2020; Lappalainen, Tuuli/AAE-6532-2020; Wang, Jun/A-7261-2013; Wilson, Richard K./AAF-4139-2019; Chakravarty, Dimple/N-3325-2014; Moreno-Estrada, Andres/AAP-4657-2021; Moreno-Estrada, Andres/R-3950-2017; Abyzov, Alexej/M-4284-2013; Evani, Uday/AAA-8112-2022; Garcia-Montero, Andres C/B-6558-2017; Das, Jishnu/C-6924-2015; Angius, Andrea/P-9549-2015; Herrero, Javier/H-6971-2019; Abyzov, Alexej/AAT-4615-2020; Browning, Brian L/A-1178-2010; Myers, Simon/A-6792-2015; Coin, Lachlan/A-9001-2014; Taras, Oleksyk/J-8805-2013; Colonna, Vincenza/H-2021-2014; Cooper, David N./H-4384-2011	Mu, Xinmeng/0000-0002-8079-0828; Kalra, D/0000-0001-5254-4067; Altshuler, David M/0000-0002-7250-4107; Kong, Yong/0000-0002-2881-5274; Mills, Ryan/0000-0003-3425-6998; Sisu, Cristina/0000-0001-9371-0797; Sboner, Andrea/0000-0001-6915-3070; Rodriguez-Flores, Juan L/0000-0002-0394-8062; Das, Jishnu/0000-0002-5747-064X; Lappalainen, Tuuli/0000-0002-7746-8109; Wilson, Richard K./0000-0002-1992-1358; Chakravarty, Dimple/0000-0002-8588-8461; Moreno-Estrada, Andres/0000-0001-8329-8292; Moreno-Estrada, Andres/0000-0001-8329-8292; Garcia-Montero, Andres C/0000-0003-4360-1386; Das, Jishnu/0000-0002-5747-064X; Angius, Andrea/0000-0003-2596-6461; Herrero, Javier/0000-0001-7313-717X; Browning, Brian L/0000-0001-6454-6633; Sherry, Stephen/0000-0002-7982-076X; Leinonen, Rasko/0000-0002-2639-7187; Frankish, Adam/0000-0002-4333-628X; Myers, Simon/0000-0002-2585-9626; CUCCA, Francesco/0000-0002-7414-1995; Walter, Klaudia/0000-0003-4448-0301; Coin, Lachlan/0000-0002-4300-455X; Kim, Kicheol/0000-0003-3667-9900; Sebat, Jonathan/0000-0002-9087-526X; MacArthur, Daniel/0000-0002-5771-2290; Shriver, Mark/0000-0003-0006-0479; McLaren, William/0000-0001-6218-1116; Hodgkinson, Alan/0000-0003-1636-491X; Angius, Andrea/0000-0001-9372-1162; Wilson, Michael/0000-0001-5892-6074; Fuchsberger, Christian/0000-0002-5918-8947; Clarke, Laura/0000-0002-5989-6898; Streeter, Ian/0000-0003-4024-3552; Taras, Oleksyk/0000-0002-8148-3918; Harrow, Jennifer/0000-0003-0338-3070; Colonna, Vincenza/0000-0002-3966-0474; maschio, andrea/0000-0002-4238-9144; Kulesha, Eugene/0000-0002-4285-6232; Chinwalla, Asif/0000-0001-7831-3996; Keinan, Alon/0000-0002-9760-1122; MCLELLAN, MICHAEL/0000-0002-2703-8784; Schaffner, Stephen/0000-0001-6699-3568; Borodina, Tatiana/0000-0002-6978-016X; Pers, Tune/0000-0003-0207-4831; Gumus, Zeynep/0000-0002-7364-2202; Radhakrishnan, Rajesh/0000-0001-7170-699X; Bustamante, Carlos D./0000-0002-4187-7920; Sandoval, Karla/0000-0002-6175-2463; Schneider, Valerie/0000-0002-3442-1888; Ritchie, Graham/0000-0002-6456-9736; Rubin, Mark/0000-0002-8321-9950; Abyzov, Alexej/0000-0001-5405-6729; Chen, Jieming/0000-0003-3767-9486; Michaelson, Jacob/0000-0001-9713-0992; Clark, Andrew/0000-0001-7159-8511; Keane, Thomas/0000-0001-7532-6898; Balasubramanian, Suganthi/0000-0003-2243-5948; Flicek, Paul/0000-0002-3897-7955; Cooper, David N./0000-0002-8943-8484; Tabrizi, Shervin/0000-0003-2780-8432; Eberle, Michael/0000-0001-8965-1253	Danish Council for Independent Research Medical Sciences; European Molecular Biology Laboratory; Wellcome Trust [WT085532, WT095908]; Wellcome-Trust Sanger Institute [098051]; National Cancer Institute (NCI) [R01CA152057]; Early Detection Research Network NCI [U01 CA111275]; Prostate Cancer Foundation [HG005718, HG007000]; National Human Genome Research Institute [R01HG4719, U01HG6513]; National Institute of General Medical Sciences [GM104424]; NATIONAL CANCER INSTITUTE [R01CA167824, R01CA166661, U01CA111275, R01CA152057] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000457] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003050] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003079, R01HG002898, R01HG004719, U01HG005718, U01HG006513, U41HG007000] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097358, R01GM104424] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [P20MD006899, G12MD007579] Funding Source: NIH RePORTER	Danish Council for Independent Research Medical Sciences(Det Frie Forskningsrad (DFF)); European Molecular Biology Laboratory; Wellcome Trust(Wellcome TrustEuropean Commission); Wellcome-Trust Sanger Institute(Wellcome Trust); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Early Detection Research Network NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Prostate Cancer Foundation; National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	We thank G. Boysen and C. O'Reilly for help with SNV experimental validation, K. Yip for target-gene identification, and Z. Liu for Web site design. T. H. P. is supported by the Danish Council for Independent Research Medical Sciences (FSS). Funding at the European Bioinformatics Institute is provided by European Molecular Biology Laboratory and the Wellcome Trust (WT085532 and WT095908). C.T.-S. acknowledges grant 098051 from the Wellcome-Trust Sanger Institute. Funding for the Institute for Precision Medicine (Weill Cornell Medical College/New York Presbyterian) is provided by National Cancer Institute (NCI) grant R01CA152057 (A. S., M. G., and M. A. R.) and Early Detection Research Network NCI U01 CA111275 (M. A. R.). M. A. R. also thanks the Prostate Cancer Foundation. M. G. also acknowledges grants HG005718 and HG007000. G. M. acknowledges National Human Genome Research Institute grants R01HG4719 and U01HG6513. H.Y. and S. M. L. are supported by NCI grant CA167824, National Institute of General Medical Sciences grant GM104424, and a Clinical and Translational Science Center Pilot Award and Cornell Seed Grant for intercampus collaborations. H. M. K., T. L., A. S., L. L., J.C., A. H., and J.D. contributed equally.	Akiyama M, 2005, J CLIN INVEST, V115, P1777, DOI 10.1172/JCI24834; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Baca SC, 2013, CELL, V153, P666, DOI 10.1016/j.cell.2013.03.021; Barbieri CE, 2012, NAT GENET, V44, P685, DOI 10.1038/ng.2279; Barreiro LB, 2008, NAT GENET, V40, P340, DOI 10.1038/ng.78; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Berger MF, 2011, NATURE, V470, P214, DOI 10.1038/nature09744; Carroll SB, 2008, CELL, V134, P25, DOI 10.1016/j.cell.2008.06.030; Chen R, 2012, CELL, V148, P1293, DOI 10.1016/j.cell.2012.02.009; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Fraser HB, 2002, SCIENCE, V296, P750, DOI 10.1126/science.1068696; Gerstein MB, 2012, NATURE, V489, P91, DOI 10.1038/nature11245; Grossman SR, 2013, CELL, V152, P703, DOI 10.1016/j.cell.2013.01.035; Hamblin MT, 2000, AM J HUM GENET, V66, P1669, DOI 10.1086/302879; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Haygood R, 2007, NAT GENET, V39, P1140, DOI 10.1038/ng2104; Hermanns P, 2005, HUM MOL GENET, V14, P3723, DOI 10.1093/hmg/ddi403; Hernandez RD, 2011, SCIENCE, V331, P920, DOI 10.1126/science.1198878; Horn S, 2013, SCIENCE, V339, P959, DOI 10.1126/science.1230062; Huang FW, 2013, SCIENCE, V339, P957, DOI 10.1126/science.1229259; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; Khurana E, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002886; Killela PJ, 2013, P NATL ACAD SCI USA, V110, P6021, DOI 10.1073/pnas.1303607110; Kim PM, 2007, P NATL ACAD SCI USA, V104, P20274, DOI 10.1073/pnas.0710183104; Lee W, 2009, HUM GENET, V126, P481, DOI 10.1007/s00439-009-0677-y; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Mills RE, 2011, NATURE, V470, P59, DOI 10.1038/nature09708; Mu XJ, 2011, NUCLEIC ACIDS RES, V39, P7058, DOI 10.1093/nar/gkr342; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; Ohashi J, 2004, AM J HUM GENET, V74, P1198, DOI 10.1086/421330; Rausch T, 2012, CELL, V148, P59, DOI 10.1016/j.cell.2011.12.013; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; Solis C, 2001, J CLIN INVEST, V107, P753, DOI 10.1172/JCI10642; Stenson PD, 2009, GENOME MED, V1, DOI 10.1186/gm13; Vernot B, 2012, GENOME RES, V22, P1689, DOI 10.1101/gr.134890.111; Visel A, 2010, NATURE, V464, P409, DOI 10.1038/nature08801; Wang XJ, 2012, NAT BIOTECHNOL, V30, P159, DOI 10.1038/nbt.2106; Ward LD, 2012, NAT BIOTECHNOL, V30, P1095, DOI 10.1038/nbt.2422; Ward LD, 2012, SCIENCE, V337, P1675, DOI 10.1126/science.1225057; Xue YL, 2009, GENETICS, V183, P1065, DOI 10.1534/genetics.109.107722; Yip KY, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r48; Yngvadottir B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-237; Zhang ZD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r26	48	254	260	1	98	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 4	2013	342	6154					84	+	1235587	10.1126/science.1235587	http://dx.doi.org/10.1126/science.1235587			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	227PP	24092746	Green Accepted, Green Published			2022-12-28	WOS:000325126100049
J	Agodoa, L; Anderson, C; Asselbergs, FW; Baigent, C; Black, H; Brenner, B; Brown, M; Bulpitt, C; Byington, R; Chalmers, J; Collins, R; Cutler, J; Dahlof, B; Davis, B; de Zeeuw, D; Dens, J; Estacio, R; Fagard, R; Fox, K; Fukui, T; Hansson, L; Holman, R; Hunsicker, L; Imai, Y; Ishii, M; Kanno, Y; Kostis, J; Kuramoto, K; Lewis, E; Lievre, M; Lindholm, LH; Liu, L; Lubsen, J; Lueders, S; MacMahon, S; Malacco, E; Mancia, G; Matsuzaki, M; Neal, B; Nissen, S; Ohkubo, T; Ogihara, T; Pepine, C; Pfeffer, M; Pitt, B; Poole-Wilson, P; Poulter, N; Rahman, M; Remme, W; Remuzzi, G; Rodgers, A; Ruggenenti, P; Saruta, T; Schrader, J; Schrier, R; Sever, P; Sleight, P; Staessen, J; Suzuki, H; Teo, K; van Gilst, WH; Viberti, G; Wang, J; Whelton, P; Wing, L; Yui, Y; Yusuf, S; Zanchetti, A; Barzi, F; Chalmers, J; Heritier, S; Li, N; MacMahon, S; Neal, B; Ninomiya, T; Perkovic, V; Turnbull, F; Woodward, M; Baigent, C; Perkovic, V; Turnbull, F; Wilson, K; Kearney, ACP; Gallagher, M; Agodoa, L; Brenner, B; Hunsicker, L; Rahman, M; Remuzzi, G; Ruggenenti, P; Whelton, P; Ninomiya, T; Perkovic, V; Turnbull, F; Neal, B; Barzi, F; Cass, A; Baigent, C; Chalmers, J; Li, N; Woodward, M; MacMahon, S				Agodoa, L.; Anderson, C.; Asselbergs, F. W.; Baigent, C.; Black, H.; Brenner, B.; Brown, M.; Bulpitt, C.; Byington, R.; Chalmers, J.; Collins, R.; Cutler, J.; Dahlof, B.; Davis, B.; de Zeeuw, D.; Dens, J.; Estacio, R.; Fagard, R.; Fox, K.; Fukui, T.; Hansson, L.; Holman, R.; Hunsicker, L.; Imai, Y.; Ishii, M.; Kanno, Y.; Kostis, J.; Kuramoto, K.; Lewis, E.; Lievre, M.; Lindholm, L. H.; Liu, L.; Lubsen, J.; Lueders, S.; MacMahon, S.; Malacco, E.; Mancia, G.; Matsuzaki, M.; Neal, B.; Nissen, S.; Ohkubo, T.; Ogihara, T.; Pepine, C.; Pfeffer, M.; Pitt, B.; Poole-Wilson, P.; Poulter, N.; Rahman, M.; Remme, W.; Remuzzi, G.; Rodgers, A.; Ruggenenti, P.; Saruta, T.; Schrader, J.; Schrier, R.; Sever, P.; Sleight, P.; Staessen, J.; Suzuki, H.; Teo, K.; van Gilst, W. H.; Viberti, G.; Wang, J.; Whelton, P.; Wing, L.; Yui, Y.; Yusuf, S.; Zanchetti, A.; Barzi, F.; Chalmers, J.; Heritier, S.; Li, N.; MacMahon, S.; Neal, B.; Ninomiya, T.; Perkovic, V.; Turnbull, F.; Woodward, M.; Baigent, C.; Perkovic, V.; Turnbull, F.; Wilson, K.; Kearney, A. Cass P.; Gallagher, M.; Agodoa, L.; Brenner, B.; Hunsicker, L.; Rahman, M.; Remuzzi, G.; Ruggenenti, P.; Whelton, P.; Ninomiya, T.; Perkovic, V.; Turnbull, F.; Neal, B.; Barzi, F.; Cass, A.; Baigent, C.; Chalmers, J.; Li, N.; Woodward, M.; MacMahon, S.		Blood Pressure Lowering Treatment; Renal Working Grp	Blood pressure lowering and major cardiovascular events in people with and without chronic kidney disease: meta-analysis of randomised controlled trials	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CONVERTING-ENZYME-INHIBITORS; PLACEBO-CONTROLLED TRIAL; DOUBLE-BLIND; PUBLICATION BIAS; RENAL OUTCOMES; RISK-FACTOR; HYPERTENSION; CORONARY; ATHEROSCLEROSIS; PROGRESSION	Objective To define the cardiovascular effects of lowering blood pressure in people with chronic kidney disease. Design Collaborative prospective meta-analysis of randomised trials. Data sources and eligibility Participating randomised trials of drugs to lower blood pressure compared with placebo or each other or that compare different blood pressure targets, with at least 1000 patient years of follow-up per arm. Main outcome measures Major cardiovascular events (stroke, myocardial infarction, heart failure, or cardiovascular death) in composite and individually and all cause death. Participants 26 trials (152 290 participants), including 30 295 individuals with reduced estimated glomerular filtration rate (eGFR), which was defined as eGFR <60 mL/min/1.73m(2). Data extraction Individual participant data were available for 23 trials, with summary data from another three. Meta-analysis according to baseline kidney function was performed. Pooled hazard ratios per 5 mm Hg lower blood pressure were estimated with a random effects model. Results Compared with placebo, blood pressure lowering regimens reduced the risk of major cardiovascular events by about a sixth per 5 mm Hg reduction in systolic blood pressure in individuals with (hazard ratio 0.83, 95% confidence interval 0.76 to 0.90) and without reduced eGFR (0.83, 0.79 to 0.88), with no evidence for any difference in effect (P=1.00 for homogeneity). The results were similar irrespective of whether blood pressure was reduced by regimens based on angiotensin converting enzyme inhibitors, calcium antagonists, or diuretics/beta blockers. There was no evidence that the effects of different drug classes on major cardiovascular events varied between patients with different eGFR (all P>0.60 for homogeneity). Conclusions Blood pressure lowering is an effective strategy for preventing cardiovascular events among people with moderately reduced eGFR. There is little evidence from these overviews to support the preferential choice of particular drug classes for the prevention of cardiovascular events in chronic kidney disease.	[Perkovic, V.] Univ Sydney, George Inst Global Hlth, Level 13,321 Kent St, Sydney, NSW 2000, Australia	George Institute for Global Health; University of Sydney	Perkovic, V (corresponding author), Univ Sydney, George Inst Global Hlth, Level 13,321 Kent St, Sydney, NSW 2000, Australia.	VPerkovic@george.org.au	Staessen, Jan A/A-1065-2011; van Gilst, Wiek/R-1806-2019; Perkovic, Vlado/AAY-1933-2021; Woodward, Mark/L-6817-2017; Woodward, Mark/D-8492-2015; de Zeeuw, Dick/E-9080-2014; Barzi, Federica/AAI-7465-2021; Asselbergs, Folkert W./ABD-6752-2021	Staessen, Jan A/0000-0002-3026-1637; van Gilst, Wiek/0000-0003-2968-8585; de Zeeuw, Dick/0000-0003-3434-7777; Barzi, Federica/0000-0001-7427-0167; Asselbergs, Folkert W./0000-0002-1692-8669; Perkovic, Vlado/0000-0002-4257-7620; Yusuf, Salim/0000-0003-4776-5601; Neal, Bruce/0000-0002-0490-7465; Chalmers, John/0000-0002-9931-0580; Woodward, Mark/0000-0001-9800-5296	National Health and Medical Research Council of Australia; Banyu Life Science Foundation; Foundation for High Blood Pressure Research Council of Australia; National Health and Medical Research Council program grant; Heart Foundation of Australia Career Development Fellowship; National Heart Foundation of Australia Career Development Fellowship; Australian Research Council; National National Health and Medical Research Council of Australia; Fogarty International Clinical Research Fellowship; National Health and Medical Research Council Australia-China Exchange Fellowship	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Banyu Life Science Foundation; Foundation for High Blood Pressure Research Council of Australia; National Health and Medical Research Council program grant(National Health and Medical Research Council (NHMRC) of Australia); Heart Foundation of Australia Career Development Fellowship; National Heart Foundation of Australia Career Development Fellowship(National Heart Foundation of Australia); Australian Research Council(Australian Research Council); National National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Fogarty International Clinical Research Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); National Health and Medical Research Council Australia-China Exchange Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This project was funded by the National Health and Medical Research Council of Australia. The funding body had no input into the design, conduct or interpretation of the study. T Ninomiya was supported by a fellowship awarded by the Banyu Life Science Foundation and by an International Society of Hypertension Visiting Postdoctoral Fellowship awarded by the Foundation for High Blood Pressure Research Council of Australia. V Perkovic was supported by a National Health and Medical Research Council program grant and a Heart Foundation of Australia Career Development Fellowship. F Turnbull was supported by a National Heart Foundation of Australia Career Development Fellowship. A Cass was supported by National Health and Medical Research Council of Australia Senior and Principal Research Fellowships. B Neal was supported by fellowships awarded by the Australian Research Council and the National National Health and Medical Research Council of Australia, and the Collaboration Coordinating Centre by Program and Project Grants provided by the National Health and Medical Research Council of Australia. N Li was supported by a Fogarty International Clinical Research Fellowship and National Health and Medical Research Council Australia-China Exchange Fellowship.	Agodoa L, 2007, J HYPERTENS, V25, P951; Agodoa LY, 2001, JAMA-J AM MED ASSOC, V285, P2719, DOI 10.1001/jama.285.21.2719; Ahmed Ikhlaaq, 2012, BMJ, V344, pd7762, DOI 10.1136/bmj.d7762; [Anonymous], 1998, J Hypertens, V16, P127; Appel LJ, 2010, NEW ENGL J MED, V363, P918, DOI 10.1056/NEJMoa0910975; Asselbergs FW, 2004, CIRCULATION, V110, P2809, DOI 10.1161/01.CIR.0000146378.65439.7A; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Baigent C, 2011, LANCET, V377, P2181, DOI 10.1016/S0140-6736(11)60739-3; Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; Chadban SJ, 2003, J AM SOC NEPHROL, V14, pS131, DOI 10.1097/01.ASN.0000070152.11927.4A; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Coresh J, 2003, AM J KIDNEY DIS, V41, P1, DOI 10.1053/ajkd.2003.50007; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Estacio RO, 1998, NEW ENGL J MED, V338, P645, DOI 10.1056/NEJM199803053381003; Fox KM, 2003, LANCET, V362, P782; Furberg CD, 2002, JAMA-J AM MED ASSOC, V288, P2981; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Hansson L, 2000, LANCET, V356, P359, DOI 10.1016/S0140-6736(00)02526-5; Hansson L, 1999, LANCET, V353, P611, DOI 10.1016/S0140-6736(98)05012-0; Hansson L, 1999, LANCET, V354, P1751, DOI 10.1016/S0140-6736(99)10327-1; Hansson L, 1998, LANCET, V351, P1755, DOI 10.1016/S0140-6736(98)04311-6; Heerspink HL, 2009, LANCET, V373, P1009, DOI 10.1016/S0140-6736(09)60212-9; Jamerson K, 2008, NEW ENGL J MED, V359, P2417, DOI 10.1056/NEJMoa0806182; Kuramoto K, 1999, HYPERTENSION, V34, P1129; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Lewis EJ, 2001, NEW ENGL J MED, V345, P851, DOI 10.1056/NEJMoa011303; MACMAHON S, 1990, LANCET, V335, P765, DOI 10.1016/0140-6736(90)90878-9; MacMahon S, 2000, J AM COLL CARDIOL, V36, P438, DOI 10.1016/S0735-1097(00)00736-1; Manjunath G, 2003, J AM COLL CARDIOL, V41, P47, DOI 10.1016/S0735-1097(02)02663-3; Mann JFE, 2001, ANN INTERN MED, V134, P629, DOI 10.7326/0003-4819-134-8-200104170-00007; Marre M, 2004, BRIT MED J, V328, P495, DOI 10.1136/bmj.37970.629537.0D; Patel A, 2007, LANCET, V370, P829, DOI 10.1016/S0140-6736(07)61303-8; Perkovic V, 2008, KIDNEY INT, V73, P473, DOI 10.1038/sj.ki.5002701; Perkovic V, 2007, J AM SOC NEPHROL, V18, P2766, DOI 10.1681/ASN.2007020256; Pitt B, 2000, CIRCULATION, V102, P1503, DOI 10.1161/01.CIR.102.13.1503; PROGRESS Collaborat Grp, 2001, LANCET, V358, P1556; Ruggenenti P, 2004, NEW ENGL J MED, V351, P1941, DOI 10.1056/NEJMoa042167; Sarnak MJ, 2005, ANN INTERN MED, V142, P342, DOI 10.7326/0003-4819-142-5-200503010-00009; Sarnak MJ, 2003, HYPERTENSION, V42, P1050, DOI 10.1161/01.HYP.0000102971.85504.7c; Schrier RW, 2002, KIDNEY INT, V61, P1086, DOI 10.1046/j.1523-1755.2002.00213.x; Solomon SD, 2006, CIRCULATION, V114, P26, DOI 10.1161/CIRCULATIONAHA.105.592733; Staessen JA, 1997, LANCET, V350, P757, DOI 10.1016/S0140-6736(97)05381-6; Stearne MR, 1998, BRIT MED J, V317, P713; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Strippoli GF, 2006, COCHRANE DB SYST REV, V18, DOI DOI 10.1002/14651858.CD006257; Teo KK, 2000, CIRCULATION, V102, P1748; Tierney JF, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-16; Turnbull F, 2003, LANCET, V362, P1527; Wing LMH, 2003, NEW ENGL J MED, V348, P583, DOI 10.1056/NEJMoa021716; Wolf G, 2002, AM J KIDNEY DIS, V39, P1, DOI 10.1053/ajkd.2002.29865; Wright JT, 2002, JAMA-J AM MED ASSOC, V288, P2421, DOI 10.1001/jama.288.19.2421; Yui Y, 2004, HYPERTENS RES, V27, P181, DOI 10.1291/hypres.27.181; Zanchetti A, 1998, J HYPERTENS, V16, P1667, DOI 10.1097/00004872-199816110-00014; Zanchetti A, 2002, CIRCULATION, V106, P2422, DOI 10.1161/01.CIR.0000039288.86470.DD	55	142	146	0	19	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 3	2013	347								f5680	10.1136/bmj.f5680	http://dx.doi.org/10.1136/bmj.f5680			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	231OX	24092942	Green Published, hybrid			2022-12-28	WOS:000325427700002
J	Hunt, LP; Ben-Shlomo, Y; Clark, EM; Dieppe, P; Judge, A; MacGregor, AJ; Tobias, JH; Vernon, K; Blom, AW				Hunt, Linda P.; Ben-Shlomo, Yoav; Clark, Emma M.; Dieppe, Paul; Judge, Andrew; MacGregor, Alex J.; Tobias, Jon H.; Vernon, Kelly; Blom, Ashley W.		Natl Joint Registry England Wales	90-day mortality after 409 096 total hip replacements for osteoarthritis, from the National Joint Registry for England and Wales: a retrospective analysis	LANCET			English	Article							EARLY POSTOPERATIVE MORTALITY; RISK-FACTORS; ARTHROPLASTY; COMPLICATIONS; MORBIDITY; POSTERIOR; TRENDS; DEATH	Background Death within 90 days after total hip replacement is rare but might be avoidable dependent on patient and treatment factors. We assessed whether a secular decrease in death caused by hip replacement has occurred in England and Wales and whether modifi able perioperative factors exist that could reduce deaths. Methods We took data about hip replacements done in England and Wales between April, 2003, and December, 2011, from the National Joint Registry for England and Wales. Patient identifi ers were used to link these data to the national mortality database and the Hospital Episode Statistics database to obtain details of death, sociodemographics, and comorbidity. We assessed mortality within 90 days of operation by Kaplan-Meier analysis and assessed the role of patient and treatment factors by Cox proportional hazards model. Findings 409 096 primary hip replacements were done to treat osteoarthritis. 1743 patients died within 90 days of surgery during 8 years, with a substantial secular decrease in mortality, from 0.56% in 2003 to 0.29% in 2011, even after adjustment for age, sex, and comorbidity. Several modifi able clinical factors were associated with decreased mortality according to an adjusted model: posterior surgical approach (hazard ratio [HR] 0.82, 95% CI 0.73-0.92; p=0.001), mechanical thromboprophylaxis (0.85, 0.74-0.99; p=0.036), chemical thromboprophylaxis with heparin with or without aspirin (0.79, 0.66-0.93; p=0.005), and spinal versus general anaesthetic (0.85, 0.74-0.97; p=0.019). Type of prosthesis was unrelated to mortality. Being overweight was associated with lower mortality (0.76, 0.62-0.92; p=0.006). Interpretation Postoperative mortality after hip joint replacement has fallen substantially. Widespread adoption of four simple clinical management strategies (posterior surgical approach, mechanical and chemical prophylaxis, and spinal anaesthesia) could, if causally related, reduce mortality further.	[Hunt, Linda P.; Clark, Emma M.; Tobias, Jon H.; Vernon, Kelly; Blom, Ashley W.] Univ Bristol, Sch Clin Sci, Musculoskeletal Res Unit, Bristol, Avon, England; [Ben-Shlomo, Yoav] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Dieppe, Paul] Univ Exeter, Sch Med, Exeter, Devon, England; [Judge, Andrew] Univ Oxford, NIHR Musculoskeletal Biomed Res Unit, Oxford, England; [MacGregor, Alex J.] Norwich Med Sch, Norwich, Norfolk, England	University of Bristol; University of Bristol; University of Exeter; University of Oxford; University of East Anglia	Blom, AW (corresponding author), Univ Bristol, Sch Clin Sci, Musculoskeletal Res Unit, Bristol, Avon, England.	ashley.blom@nbt.nhs.uk	Ben-Shlomo, Yoav/ABD-2004-2021; Tobias, Jon/E-2832-2014	Ben-Shlomo, Yoav/0000-0001-6648-3007; Tobias, Jon/0000-0002-7475-3932; Judge, Andrew/0000-0003-3015-0432; Blom, Ashley/0000-0002-9940-1095; MacGregor, Alex/0000-0003-2163-2325	National Joint Registry for England and Wales	National Joint Registry for England and Wales	National Joint Registry for England and Wales.	Barrett J, 2005, J BONE JOINT SURG AM, V87A, P1965, DOI 10.2106/JBJS.D.02440; Blom A, 2006, ACTA ORTHOP, V77, P347, DOI 10.1080/17453670610046244; Bozic KJ, 2012, J BONE JOINT SURG AM, V94A, P794, DOI 10.2106/JBJS.K.00072; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Christensen K, 2009, LANCET, V374, P1196, DOI 10.1016/S0140-6736(09)61460-4; Hamer M, 2013, PREV MED, V57, P12, DOI 10.1016/j.ypmed.2013.02.012; Jimenez-Garcia R, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-43; Jolles BM, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003828.pub3; Kirksey M, 2012, ANESTH ANALG, V115, P321, DOI 10.1213/ANE.0b013e31825b6824; Lie SA, 2002, ACTA ORTHOP SCAND, V73, P392, DOI 10.1080/00016470216312; Liu SS, 2009, INT ORTHOP, V33, P643, DOI 10.1007/s00264-008-0549-4; Memtsoudis SG, 2012, J ORTHOP RES, V30, P1811, DOI 10.1002/jor.22139; Memtsoudis SG, 2010, J ARTHROPLASTY, V25, P19, DOI 10.1016/j.arth.2008.11.010; National Joint Registry for England Wales Northern Ireland and the Isle of Man, 2012, 9 NAT JOINT REG ENGL; Parvizi J, 2001, J BONE JOINT SURG AM, V83A, P1524, DOI 10.2106/00004623-200110000-00010; Pedersen AB, 2011, J BONE JOINT SURG BR, V93B, P172, DOI 10.1302/0301-620X.93B2.25629; Pugely AJ, 2013, J BONE JOINT SURG AM, V95A, P193, DOI [10.2106/JBJS.K.01682, 10.2106/JBJS.L.01440]; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Singh JA, 2012, J ARTHROPLASTY, V27, P1417, DOI 10.1016/j.arth.2012.03.008; Singh JA, 2011, J RHEUMATOL, V38, P1507, DOI 10.3899/jrheum.110280; Weale AE, 1996, J BONE JOINT SURG BR, V78B, P899, DOI 10.1302/0301-620X78B6.6603	21	204	212	0	27	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 28	2013	382	9898					1097	1104		10.1016/S0140-6736(13)61749-3	http://dx.doi.org/10.1016/S0140-6736(13)61749-3			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	228SG	24075049				2022-12-28	WOS:000325208100025
J	Issa, K; Mont, MA				Issa, Kimona; Mont, Michael A.			Total hip replacement: mortality and risks	LANCET			English	Editorial Material							90-DAY MORTALITY; ARTHROPLASTY		[Issa, Kimona; Mont, Michael A.] Sinai Hosp, Rubin Inst Adv Orthoped, Ctr Joint Preservat & Replacement, Baltimore, MD 21215 USA; [Issa, Kimona] Seton Hall Univ, St Josephs Reg Med Ctr, Dept Orthopaed Surg, Paterson, NJ USA	Sinai Hospital of Baltimore; Seton Hall University	Mont, MA (corresponding author), Sinai Hosp, Rubin Inst Adv Orthoped, Ctr Joint Preservat & Replacement, 2401 W Belvedere Ave, Baltimore, MD 21215 USA.	mmont@lifebridgehealth.org	Issa, Kimona/J-2944-2014	Issa, Kimona/0000-0001-8130-1144				Aynardi M, 2009, CLIN ORTHOP RELAT R, V467, P213, DOI 10.1007/s11999-008-0528-5; Bozic KJ, 2009, J BONE JOINT SURG AM, V91A, P1614, DOI 10.2106/JBJS.H.01220; CRITCHLEY LAH, 1994, BRIT J ANAESTH, V73, P464, DOI 10.1093/bja/73.4.464; Hunt LP, 2013, LANCET, V382, P1097, DOI 10.1016/S0140-6736(13)61749-3; Huo MH, 2012, J BONE JOINT SURG AM, V94A, P1721, DOI 10.2106/JBJS.L.00620; Issa K, 2014, J ARTHROPLASTY, V29, P162, DOI 10.1016/j.arth.2013.04.028; Jacobs JJ, 2012, J BONE JOINT SURG AM, V94A, P746, DOI [10.2106/JBJS.K.01602, 10.2106/JBJS.9408.ebo746]; Juelsgaard P, 1998, EUR J ANAESTH, V15, P656, DOI 10.1097/00003643-199811000-00006; Nunley RM, 2003, J ARTHROPLASTY, V18, P278, DOI 10.1054/arth.2003.50095; Parvizi J, 2006, J ARTHROPLASTY, V21, P931, DOI 10.1016/j.arth.2006.02.080; Singh JA, 2012, J ARTHROPLASTY, V27, P1417, DOI 10.1016/j.arth.2012.03.008; Singh JA, 2011, ANN RHEUM DIS, V70, P2082, DOI 10.1136/ard.2010.148726; Tarity TD, 2006, J ARTHROPLASTY, V21, P60, DOI 10.1016/j.arth.2006.05.016	13	3	3	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 28	2013	382	9898					1074	1076		10.1016/S0140-6736(13)61891-7	http://dx.doi.org/10.1016/S0140-6736(13)61891-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	228SG	24075035				2022-12-28	WOS:000325208100006
J	Orru, V; Steri, M; Sole, G; Sidore, C; Virdis, F; Dei, M; Lai, S; Zoledziewska, M; Busonero, F; Mulas, A; Floris, M; Mentzen, WI; Urru, SAM; Olla, S; Marongiu, M; Piras, MG; Lobina, M; Maschio, A; Pitzalis, M; Urru, MF; Marcelli, M; Cusano, R; Deidda, F; Serra, V; Oppo, M; Pilu, R; Reinier, F; Berutti, R; Pireddu, L; Zara, I; Porcu, E; Kwong, A; Brennan, C; Tarrier, B; Lyons, R; Kang, HM; Uzzau, S; Atzeni, R; Valentini, M; Firinu, D; Leoni, L; Rotta, G; Naitza, S; Angius, A; Congia, M; Whalen, MB; Jones, CM; Schlessinger, D; Abecasis, GR; Fiorillo, E; Sanna, S; Cucca, F				Orru, Valeria; Steri, Maristella; Sole, Gabriella; Sidore, Carlo; Virdis, Francesca; Dei, Mariano; Lai, Sandra; Zoledziewska, Magdalena; Busonero, Fabio; Mulas, Antonella; Floris, Matteo; Mentzen, Wieslawa I.; Urru, Silvana A. M.; Olla, Stefania; Marongiu, Michele; Piras, Maria G.; Lobina, Monia; Maschio, Andrea; Pitzalis, Maristella; Urru, Maria F.; Marcelli, Marco; Cusano, Roberto; Deidda, Francesca; Serra, Valentina; Oppo, Manuela; Pilu, Rosella; Reinier, Frederic; Berutti, Riccardo; Pireddu, Luca; Zara, Ilenia; Porcu, Eleonora; Kwong, Alan; Brennan, Christine; Tarrier, Brendan; Lyons, Robert; Kang, Hyun M.; Uzzau, Sergio; Atzeni, Rossano; Valentini, Maria; Firinu, Davide; Leoni, Lidia; Rotta, Gianluca; Naitza, Silvia; Angius, Andrea; Congia, Mauro; Whalen, Michael B.; Jones, Chris M.; Schlessinger, David; Abecasis, Goncalo R.; Fiorillo, Edoardo; Sanna, Serena; Cucca, Francesco			Genetic Variants Regulating Immune Cell Levels in Health and Disease	CELL			English	Article							GENOME-WIDE ASSOCIATION; CD4 T-CELLS; SUSCEPTIBILITY LOCI; MULTIPLE-SCLEROSIS; DIABETES-MELLITUS; HUMAN IMMUNOLOGY; DENDRITIC CELLS; SELF-TOLERANCE; POPULATION; EXPRESSION	The complex network of specialized cells and molecules in the immune system has evolved to defend against pathogens, but inadvertent immune system attacks on "self'' result in autoimmune disease. Both genetic regulation of immune cell levels and their relationships with autoimmunity are largely undetermined. Here, we report genetic contributions to quantitative levels of 95 cell types encompassing 272 immune traits, in a cohort of 1,629 individuals from four clustered Sardinian villages. Wefirst estimated trait heritability, showing that it can be substantial, accounting for up to 87% of the variance (mean 41%). Next, by assessing similar to 8.2 million variants that we identified and confirmed in an extended set of 2,870 individuals, 23 independent variants at 13 loci associated with at least one trait. Notably, variants at three loci (HLA, IL2RA, and SH2B3/ATXN2) overlap with known autoimmune disease associations. These results connect specific cellular phenotypes to specific genetic variants, helping to explicate their involvement in disease.	[Orru, Valeria; Steri, Maristella; Sole, Gabriella; Sidore, Carlo; Virdis, Francesca; Dei, Mariano; Lai, Sandra; Zoledziewska, Magdalena; Busonero, Fabio; Mulas, Antonella; Mentzen, Wieslawa I.; Olla, Stefania; Marongiu, Michele; Piras, Maria G.; Lobina, Monia; Maschio, Andrea; Pitzalis, Maristella; Cusano, Roberto; Deidda, Francesca; Serra, Valentina; Pilu, Rosella; Porcu, Eleonora; Naitza, Silvia; Angius, Andrea; Whalen, Michael B.; Fiorillo, Edoardo; Sanna, Serena; Cucca, Francesco] CNR, IRGB, I-09042 Monserrato, Italy; [Sidore, Carlo; Maschio, Andrea; Kwong, Alan; Kang, Hyun M.; Abecasis, Goncalo R.] Univ Michigan, Ctr Stat Genet, Ann Arbor, MI 48109 USA; [Sidore, Carlo; Mulas, Antonella; Lobina, Monia; Serra, Valentina; Berutti, Riccardo; Porcu, Eleonora; Uzzau, Sergio; Cucca, Francesco] Univ Sassari, Dipartimento Sci Biomed, I-07100 Sassari, Italy; [Floris, Matteo; Urru, Silvana A. M.; Urru, Maria F.; Marcelli, Marco; Cusano, Roberto; Deidda, Francesca; Oppo, Manuela; Pilu, Rosella; Reinier, Frederic; Berutti, Riccardo; Pireddu, Luca; Zara, Ilenia; Atzeni, Rossano; Valentini, Maria; Leoni, Lidia; Angius, Andrea; Jones, Chris M.] CRS4, I-09010 Cagliari, Italy; [Pireddu, Luca] Univ Cagliari, I-09010 Cagliari, Italy; [Uzzau, Sergio] Porto Conte Ric Srl, Lab Prote, I-07041 Tramariglio, Alghero, Italy; [Firinu, Davide] Univ Cagliari, Dipartimento Allergol & Immunol, I-09124 Cagliari, Italy; [Rotta, Gianluca] BD Biosci Italia, I-20090 Milan, Italy; [Congia, Mauro] Univ Cagliari, Dipartimento Sci Biomed & Biotecnol, I-09124 Cagliari, Italy; [Schlessinger, David] NIA, Genet Lab, Baltimore, MD 21224 USA; [Brennan, Christine; Tarrier, Brendan; Lyons, Robert] Univ Michigan, Sch Med, Sequencing Core, Ann Arbor, MI 48109 USA	Consiglio Nazionale delle Ricerche (CNR); Istituto di Ricerca Genetica e Biomedica (IRGB-CNR); University of Michigan System; University of Michigan; University of Sassari; University of Cagliari; Porto Conte Ricerche; University of Cagliari; University of Cagliari; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Michigan System; University of Michigan	Fiorillo, E (corresponding author), CNR, IRGB, I-09042 Monserrato, Italy.	edoardo.fiorillo@irgb.cnr.it; serena.sanna@irgb.cnr.it; francesco.cucca@irgb.cnr.it	Uzzau, Sergio/F-3233-2015; marcelli, marco/AGR-6853-2022; sanna, serena/H-3009-2019; Valeria, Orru/AAY-3805-2020; NAITZA, SILVIA/AAB-8775-2022; Fiorillo, Edoardo/AAY-3804-2020; Floris, Matteo/ABH-1274-2020; Steri, Maristella/AAX-8760-2020; Piras, Maria Grazia/P-2061-2018; Maschio, Andrea/AAX-8185-2020; Mulas, Antonella/B-4231-2015; Sidore, Carlo/AAV-7967-2020; Lobina, Monia/P-1690-2018; Dei, Mariano/AAY-3870-2020; Congia, Mauro/AAC-2718-2019; Angius, Andrea/P-9549-2015; Deidda, Francesca/P-1541-2018; Naitza, Silvia/D-5620-2017; firinu, davide/AAF-4366-2020; Lai, Sandra/AAY-4176-2020; Angius, Andrea/B-8966-2015; Sole, Gabriella/I-4820-2013; Serra, Valentina/Q-2925-2018	Uzzau, Sergio/0000-0001-6246-2794; sanna, serena/0000-0002-3768-1749; NAITZA, SILVIA/0000-0002-0108-757X; Floris, Matteo/0000-0003-4385-9336; Steri, Maristella/0000-0001-5869-3872; Piras, Maria Grazia/0000-0001-9004-0900; Sidore, Carlo/0000-0001-7504-7477; Lobina, Monia/0000-0003-3620-3160; Angius, Andrea/0000-0003-2596-6461; Deidda, Francesca/0000-0003-3447-7440; Sole, Gabriella/0000-0001-5292-5038; maschio, andrea/0000-0002-4238-9144; Zoledziewska, Magdalena/0000-0002-3033-6133; Serra, Valentina/0000-0002-5782-8752; Angius, Andrea/0000-0001-9372-1162; WHALEN, MICHAELBERNARD/0000-0001-7300-8511; Firinu, Davide/0000-0002-5768-391X; LAI, SANDRA/0000-0003-4198-9989; Dei, Mariano/0000-0002-7404-508X; Valentini, Maria/0000-0002-4288-8621; Pireddu, Luca/0000-0002-4663-5613; Cusano, Roberto/0000-0001-5543-7881; Rotta, Gianluca/0000-0002-5613-9453; CUCCA, Francesco/0000-0002-7414-1995; Congia, Mauro/0000-0003-1688-304X; Orru, Valeria/0000-0002-6047-4625; urru, silvana anna maria/0000-0001-6213-1290; Mulas, Antonella/0000-0002-6856-1483; Marongiu, Michele/0000-0002-7289-9815; Atzeni, Rossano/0000-0003-0020-0013; Pitzalis, Maristella/0000-0003-4975-6987	Intramural Research Program of the NIH, National Institute on Aging [N01-AG-1-2109, HHSN271201100005C]; Italian grants [FISM 2011/R/13]; Farmaci e Reti Biotecnologiche di Qualita [FaReBio2011]; MIUR/CNR; National Human Genome Research Institute [HG005581, HG005552, HG007022]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [RC2HG005552, U01HG006513, RC2HG005581, R01HG007022] Funding Source: NIH RePORTER	Intramural Research Program of the NIH, National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Italian grants; Farmaci e Reti Biotecnologiche di Qualita; MIUR/CNR(Ministry of Education, Universities and Research (MIUR)Consiglio Nazionale delle Ricerche (CNR)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work is dedicated to the memory of Professor Antonio Cao, mentor and leader, who passed away while this manuscript was in preparation. We thank all of the volunteers who generously participated in this study and made this research possible. We thank John Todd and Marcella Devoto for critical revisions of the manuscript, Manuela Sironi and Rachele Cagliani for advice on balancing selection tests, Luiz Pereira for web server implementation, and Manuela Uda for her previous leadership on the ProgeNIA/SardiNIA study. This research was supported, in part, by the Intramural Research Program of the NIH, National Institute on Aging, with contracts N01-AG-1-2109 and HHSN271201100005C; by Italian grants FISM 2011/R/13 "Approccio razionale per la ricerca di composti per la cura della sclerosi multipla basato sull'analisi dei target biologici individuati dagli studi di associazione sull'intero genoma in Sardegna'' and FaReBio2011 "Farmaci e Reti Biotecnologiche di Qualita` ''; by funds MIUR/CNR for rare diseases and molecular screening, PNR- CNR Aging Program 2012-2014, Giovani Ricercatori 2007 (D. lgs 502/92) from the Italian Ministry of Health to F.C.; and by National Human Genome Research Institute grants HG005581, HG005552, and HG007022 to G.R.A.	Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Auer PL, 2012, AM J HUM GENET, V91, P794, DOI 10.1016/j.ajhg.2012.08.031; Barreiro LB, 2010, NAT REV GENET, V11, P17, DOI 10.1038/nrg2698; Barrett JC, 2009, NAT GENET, V41, P1330, DOI 10.1038/ng.483; Bayes B, 2007, TRANSPL P, V39, P2248, DOI 10.1016/j.transproceed.2007.06.021; Borsellino G, 2007, BLOOD, V110, P1225, DOI 10.1182/blood-2006-12-064527; Buchholz VR, 2011, CURR OPIN IMMUNOL, V23, P549, DOI 10.1016/j.coi.2011.05.002; Chalmin F, 2012, IMMUNITY, V36, P362, DOI 10.1016/j.immuni.2011.12.019; Chatenoud L, 2010, NAT REV ENDOCRINOL, V6, P149, DOI 10.1038/nrendo.2009.275; Chen WM, 2007, AM J HUM GENET, V81, P913, DOI 10.1086/521580; Cortes A, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3204; Davis MM, 2008, IMMUNITY, V29, P835, DOI 10.1016/j.immuni.2008.12.003; Dendrou CA, 2009, NAT GENET, V41, P1011, DOI 10.1038/ng.434; Devalliere J, 2011, BIOCHEM PHARMACOL, V82, P1391, DOI 10.1016/j.bcp.2011.06.023; Enciso-Mora V, 2010, NAT GENET, V42, P1126, DOI 10.1038/ng.696; Fletcher JM, 2009, J IMMUNOL, V183, P7602, DOI 10.4049/jimmunol.0901881; Gorlova O, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002178; Hamza TH, 2010, NAT GENET, V42, P781, DOI 10.1038/ng.642; Huang J, 2012, EUR J HUM GENET, V20, P801, DOI 10.1038/ejhg.2012.3; Li GL, 2012, CELL, V148, P84, DOI 10.1016/j.cell.2011.12.014; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; Lowe CE, 2007, NAT GENET, V39, P1074, DOI 10.1038/ng2102; Mackay F, 2009, NAT REV IMMUNOL, V9, P491, DOI 10.1038/nri2572; Maecker HT, 2012, NAT REV IMMUNOL, V12, P191, DOI 10.1038/nri3158; Marrosu MG, 2001, HUM MOL GENET, V10, P2907, DOI 10.1093/hmg/10.25.2907; McGovern DPB, 2010, NAT GENET, V42, P332, DOI 10.1038/ng.549; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; Nalls MA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002113; Ohnmacht C, 2009, J EXP MED, V206, P549, DOI 10.1084/jem.20082394; Okada Y, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002067; Pilia G, 2006, PLOS GENET, V2, P1207, DOI 10.1371/journal.pgen.0020132; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Pulte ED, 2007, THROMB RES, V121, P309, DOI 10.1016/j.thromres.2007.04.008; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Sansoni P, 2008, EXP GERONTOL, V43, P61, DOI 10.1016/j.exger.2007.06.008; Shevach EM, 2000, ANNU REV IMMUNOL, V18, P423, DOI 10.1146/annurev.immunol.18.1.423; Steinman RM, 2007, NATURE, V449, P419, DOI 10.1038/nature06175; Takada K, 2009, J EXP MED, V206, P2253, DOI 10.1084/jem.20082553; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Trynka G, 2011, NAT GENET, V43, P1193, DOI 10.1038/ng.998; Uda M, 2008, P NATL ACAD SCI USA, V105, P1620, DOI 10.1073/pnas.0711566105; Vendrame F, 2010, DIABETES, V59, P947, DOI 10.2337/db09-0498; Voight BF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002793; Wing K, 2010, NAT IMMUNOL, V11, P7, DOI 10.1038/ni.1818; Wu ZP, 2010, J IMMUNOL, V185, P231, DOI 10.4049/jimmunol.0903625	45	214	218	0	38	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 26	2013	155	1					242	256		10.1016/j.cell.2013.08.041	http://dx.doi.org/10.1016/j.cell.2013.08.041			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	224UX	24074872	Green Accepted, Bronze			2022-12-28	WOS:000324916700023
J	Sollenberger, JF; Holloway, RG				Sollenberger, Julia F.; Holloway, Robert G., Jr.			The Evolving Role and Value of Libraries and Librarians in Health Care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							SERVICES		[Sollenberger, Julia F.] Univ Rochester, Edward G Miner Lib, Rochester, NY 14642 USA; [Holloway, Robert G., Jr.] Univ Rochester, Sch Med & Dent, Dept Neurol, Rochester, NY 14642 USA	University of Rochester; University of Rochester	Sollenberger, JF (corresponding author), Univ Rochester, Edward G Miner Lib, 601 Elmwood Ave, Rochester, NY 14642 USA.	julia_sollenberger@urmc.rochester.edu		Sollenberger, Julia/0000-0002-6993-953X				Aitken EM, 2011, ACAD MED, V86, P1508, DOI 10.1097/ACM.0b013e31823595cd; Association of Academic Health Sciences Libraries, 2010, ANN STAT MED SCH LIB; Association of Academic Health Sciences Libraries (AAHSL), 2013, ANN STAT MED SCH LIB; Banks DE, 2007, J MED LIBR ASSOC, V95, P381, DOI 10.3163/1536-5050.95.4.381; Brettle A, 2011, HEALTH INFO LIBR J, V28, P3, DOI 10.1111/j.1471-1842.2010.00925.x; Marshall JG, 2013, J MED LIBR ASSOC, V101, P38, DOI 10.3163/1536-5050.101.1.007; McGowan J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003785; Oliver KB, 2011, J MED LIBR ASSOC, V99, P237, DOI 10.3163/1536-5050.99.3.011; Sievert M, 2011, J HOSP LIBRARIANSHIP, V11, P140, DOI [10.1080/15323269.2011.558882, DOI 10.1080/15323269.2011.558882]	9	25	29	0	21	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 25	2013	310	12					1231	1232		10.1001/jama.2013.277050	http://dx.doi.org/10.1001/jama.2013.277050			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	222SO	24065006				2022-12-28	WOS:000324751800016
J	Horwich, A; Nicol, D; Huddart, R				Horwich, Alan; Nicol, David; Huddart, Robert			Testicular germ cell tumours	BMJ-BRITISH MEDICAL JOURNAL			English	Review							HIGH-DOSE CHEMOTHERAPY; LONG-TERM; EUROPEAN ORGANIZATION; CISPLATIN CHEMOTHERAPY; ADJUVANT TREATMENT; RANDOMIZED-TRIAL; SEXUAL FUNCTION; CANCER; SEMINOMA; RISK		[Horwich, Alan; Huddart, Robert] Royal Marsden Hosp, Sutton SM2 5PT, Surrey, England; [Horwich, Alan; Huddart, Robert] Inst Canc Res, Sutton SM2 5PT, Surrey, England; [Nicol, David] Royal Marsden Hosp, London SW3 6JJ, England	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust	Horwich, A (corresponding author), Royal Marsden Hosp, Div Radiotherapy & Imaging, Downs Rd, Sutton SM2 5PT, Surrey, England.	alan.horwich@icr.ac.uk	Nicol, David L/M-6809-2016	Nicol, David L/0000-0002-5623-7467; huddart, robert/0000-0003-3604-1990; Nicol, David/0000-0003-0107-6990				Adshead J, 2001, BJU INT, V88, P559, DOI 10.1046/j.1464-4096.2001.02392.x; Albers P, 2008, J CLIN ONCOL, V26, P2966, DOI 10.1200/JCO.2007.12.0899; [Anonymous], 2011, MAN AD TEST GERM CEL; Aparicio J, 2011, J CLIN ONCOL, V29, P4677, DOI 10.1200/JCO.2011.36.0503; Beyer J, 2010, J CLIN ONCOL, V28, P4906, DOI 10.1200/JCO.2009.26.8128; Bokemeyer C, 2002, J CLIN ONCOL, V20, P1864, DOI 10.1200/JCO.2002.07.062; Cancer Research UK, 2011, TEST CANC INC STAT; Christian JA, 2003, J CLIN ONCOL, V21, P871, DOI 10.1200/JCO.2003.05.155; Cullen MH, 1996, J CLIN ONCOL, V14, P1106, DOI 10.1200/JCO.1996.14.4.1106; Cummins S, 2010, EUR UROL, V57, P673, DOI 10.1016/j.eururo.2009.06.006; de Wit R, 2001, J CLIN ONCOL, V19, P1629, DOI 10.1200/JCO.2001.19.6.1629; Dogra VS, 2003, RADIOLOGY, V227, P18, DOI 10.1148/radiol.2271001744; Feldman DR, 2010, J CLIN ONCOL, V28, P1706, DOI 10.1200/JCO.2009.25.1561; Fossa SD, 1999, J CLIN ONCOL, V17, P1146, DOI 10.1200/JCO.1999.17.4.1146; Gietema JA, 2005, J CLIN ONCOL, V25, P4370; Gilligan TD, 2010, J CLIN ONCOL, V28, P3388, DOI 10.1200/JCO.2009.26.4481; Glendenning JL, 2010, CANCER-AM CANCER SOC, V116, P2322, DOI 10.1002/cncr.24981; Greenfield DM, 2010, CANCER-AM CANCER SOC, V116, P1592, DOI 10.1002/cncr.24898; Haugnes HS, 2012, J CLIN ONCOL, V30, P3752, DOI 10.1200/JCO.2012.43.4431; Herrstedt J, 2009, ANN ONCOL, V20, P156, DOI 10.1093/annonc/mdp160; Horwich A, 2006, LANCET, V367, P754, DOI 10.1016/S0140-6736(06)68305-0; Huddart RA, 2005, BRIT J CANCER, V93, P200, DOI 10.1038/sj.bjc.6602677; Huddart RA, 2003, J CLIN ONCOL, V21, P1513, DOI 10.1200/JCO.2003.04.173; Huyghe E, 2007, EUR UROL, V52, P1710, DOI 10.1016/j.eururo.2007.06.003; Jones WG, 2005, J CLIN ONCOL, V23, P1200, DOI 10.1200/JCO.2005.08.003; Kaye SB, 1998, J CLIN ONCOL, V16, P692, DOI 10.1200/JCO.1998.16.2.692; Kollmannsberger C, 2010, ANN ONCOL, V21, P1296, DOI 10.1093/annonc/mdp473; Lampe H, 1997, J CLIN ONCOL, V15, P239, DOI 10.1200/JCO.1997.15.1.239; McGlynn KA, 2009, FUTURE ONCOL, V5, P1389, DOI [10.2217/fon.09.116, 10.2217/FON.09.116]; Mead GM, 2005, BRIT J CANCER, V93, P178, DOI 10.1038/sj.bjc.6602682; Mead GM, 1997, J CLIN ONCOL, V15, P594; MOLLER MB, 1994, EUR J CANCER, V30A, P1760, DOI 10.1016/0959-8049(94)00311-R; Motzer RJ, 2007, J CLIN ONCOL, V25, P247, DOI 10.1200/JCO.2005.05.4528; Moynihan C, 2009, J CLIN ONCOL, V27, P2144, DOI 10.1200/JCO.2008.16.1901; O'Sullivan JM, 2003, ANN ONCOL, V14, P91, DOI 10.1093/annonc/mdg020; Oldenburg J, 2006, J CLIN ONCOL, V24, P5503, DOI 10.1200/JCO.2006.08.1836; Oliver RTD, 2011, J CLIN ONCOL, V29, P957, DOI 10.1200/JCO.2009.26.4655; READ G, 1992, J CLIN ONCOL, V10, P1762, DOI 10.1200/JCO.1992.10.11.1762; Robinson D, 2007, BRIT J CANCER, V96, P529, DOI 10.1038/sj.bjc.6603589; Rochester M, 2008, ANN ROY COLL SURG, V90, P565, DOI 10.1308/003588408X301055; Singhera M, 2012, EXPERT REV ANTICANC, V12, P185, DOI [10.1586/era.11.212, 10.1586/ERA.11.212]; Trama A, 2012, EUR J CANCER, V48, P159, DOI 10.1016/j.ejca.2011.08.020; Travis LB, 2010, JNCI-J NATL CANCER I, V102, P1130; Vergouwe Y, 2003, J CLIN ONCOL, V21, P4092, DOI 10.1200/JCO.2003.01.094; Zagars GK, 2004, J CLIN ONCOL, V22, P640, DOI 10.1200/JCO.2004.05.205	45	24	24	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 24	2013	347								f5526	10.1136/bmj.f5526	http://dx.doi.org/10.1136/bmj.f5526			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	227CT	24065428				2022-12-28	WOS:000325086800003
J	Eggermont, AMM; Spatz, A; Robert, C				Eggermont, Alexander M. M.; Spatz, Alan; Robert, Caroline			Cutaneous melanoma	LANCET			English	Article							COLONY-STIMULATING FACTOR; HIGH-RISK MELANOMA; STAGE-IV MELANOMA; PHASE-III TRIAL; METASTATIC MELANOMA; ADJUVANT THERAPY; BRAF-MUTANT; SOLID TUMORS; OPEN-LABEL; PEGYLATED INTERFERON-ALPHA-2B	In the past decade, major advances have been made in the understanding of melanoma. New predisposition genes have been reported and key somatic events, such as BRAF mutation, directly translated into therapeutic management. Surgery for localised melanoma and regional lymph node metastases is the standard of care. Sentinel-node biopsy provides precise staging, but has not been reported to affect survival. The effect of lymph-node dissection on survival is a topic of investigation. Two distinct approaches have emerged to try to extend survival in patients with metastatic melanoma: immunomodulation with anti-CTLA4 monoclonal antibodies, and targeted therapy with BRAF inhibitors or MEK inhibitors for BRAF-mutated melanoma. The combination of BRAF inhibitors and MEK inhibitors might improve progression-free survival further and, possibly, increase overall survival. Response patterns differ substantially-anti-CTLA4 immunotherapy can induce long-term responses, but only in a few patients, whereas targeted drugs induce responses in most patients, but nearly all of them relapse because of pre-existing or acquired resistance. Thus, the long-term prognosis of metastatic melanoma remains poor. Anti-PD1 and anti-PDL1 antibodies have emerged as breakthrough drugs for melanoma that have high response rates and long durability. Biomarkers that have predictive value remain elusive in melanoma, although emerging data for adjuvant therapy indicate that interferon sensitivity is associated with ulceration of the primary melanoma. Intense investigation continues for clinical and biological markers that predict clinical benefit of immunotherapeutic drugs, such as interferon alfa or anti-CTLA4 antibodies, and the mechanisms that lead to resistance of targeted drugs.	[Eggermont, Alexander M. M.; Robert, Caroline] Gustave Roussy Canc Inst, Melanoma Unit, F-94805 Villejuif, France; [Eggermont, Alexander M. M.; Robert, Caroline] Gustave Roussy Canc Inst, INSERM, U981, F-94805 Villejuif, France; [Eggermont, Alexander M. M.] Erasmus Univ, Med Ctr, Rotterdam, Netherlands; [Spatz, Alan] McGill Univ, Dept Pathol, Montreal, PQ, Canada; [Spatz, Alan] Sir Mortimer B Davis Jewish Hosp, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada	UNICANCER; Gustave Roussy; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Erasmus University Rotterdam; Erasmus MC; McGill University; Lady Davis Institute; McGill University	Eggermont, AMM (corresponding author), Gustave Roussy Canc Inst, Melanoma Unit, F-94805 Villejuif, France.	alexander.eggermont@igr.fr	Robert, Caroline/G-6157-2018; SPATZ, ALAN/B-8645-2009	Robert, Caroline/0000-0002-9493-0238; SPATZ, ALAN/0000-0003-3020-1420				Amanuel B, 2012, PATHOLOGY, V44, P357, DOI 10.1097/PAT.0b013e3283532565; Arnault JP, 2012, CLIN CANCER RES, V18, P263, DOI 10.1158/1078-0432.CCR-11-1344; Atkins MB, 1999, J CLIN ONCOL, V17, P2105, DOI 10.1200/JCO.1999.17.7.2105; Attia P, 2005, J CLIN ONCOL, V23, P6043, DOI 10.1200/JCO.2005.06.205; Autier P, 2000, BRIT J CANCER, V83, P1243, DOI 10.1054/bjoc.2000.1429; Autier P, 1999, JNCI-J NATL CANCER I, V91, P1304, DOI 10.1093/jnci/91.15.1304; Autier P, 2011, CURR OPIN ONCOL, V23, P189, DOI 10.1097/CCO.0b013e3283436e5d; Avril MF, 2004, J CLIN ONCOL, V22, P1118, DOI 10.1200/JCO.2004.04.165; Balch CM, 2010, J CLIN ONCOL, V28, P2452, DOI 10.1200/JCO.2009.27.1627; Balch CM, 2009, J CLIN ONCOL, V27, P6199, DOI 10.1200/JCO.2009.23.4799; Beadling C, 2008, CLIN CANCER RES, V14, P6821, DOI 10.1158/1078-0432.CCR-08-0575; Berger MF, 2012, NATURE, V485, P502, DOI 10.1038/nature11071; Bertolotto C, 2011, NATURE, V480, P94, DOI 10.1038/nature10539; Besser MJ, 2010, CLIN CANCER RES, V16, P2646, DOI 10.1158/1078-0432.CCR-10-0041; Bishop DT, 2009, NAT GENET, V41, P920, DOI 10.1038/ng.411; Boniol M, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4757; Bouwhuis MG, 2010, J CLIN ONCOL, V28, P2460, DOI 10.1200/JCO.2009.24.6264; Bouwhuis MG, 2009, JNCI-J NATL CANCER I, V101, P869, DOI 10.1093/jnci/djp132; Braam KI, 2012, PEDIATR BLOOD CANCER, V58, P665, DOI 10.1002/pbc.24023; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Broekaert SMC, 2010, PIGM CELL MELANOMA R, V23, P763, DOI 10.1111/j.1755-148X.2010.00778.x; Carvajal RD, 2011, JAMA-J AM MED ASSOC, V305, P2327, DOI 10.1001/jama.2011.746; Chapman PB, 2012, J CLIN ONCOL, V30; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Colombino M, 2012, J CLIN ONCOL, V30, P2522, DOI 10.1200/JCO.2011.41.2452; Corcoran RB, 2011, ONCOTARGET, V2, P336; Curado M, 2007, CANCER INCIDENCE IN; Curtin JA, 2005, NEW ENGL J MED, V353, P2135, DOI 10.1056/NEJMoa050092; Curtin JA, 2006, J CLIN ONCOL, V24, P4340, DOI 10.1200/JCO.2006.06.2984; Cust AE, 2011, INT J CANCER, V128, P2425, DOI 10.1002/ijc.25576; Dalle S, 2011, NEW ENGL J MED, V365, P1448, DOI 10.1056/NEJMc1108651; Das Thakur M, 2013, NATURE, V494, P251, DOI 10.1038/nature11814; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; de Vries E, 2005, BRIT J DERMATOL, V152, P481, DOI [10.1111/j.1365-2133.2005.06386.x, 10.1111/J.1365-2133.2005.06386.X]; Demenais F, 2010, JNCI-J NATL CANCER I, V102, P1568, DOI 10.1093/jnci/djq363; Deroose JP, 2012, ANN SURG ONCOL, V19, P627, DOI 10.1245/s10434-011-2030-7; Eggermonf AMM, 2009, EUR J CANCER, V45, P2087, DOI 10.1016/j.ejca.2009.05.004; Eggermont AM, 2008, J CLIN ONCOL, V26, DOI 10.1200/jco.2008.26.15_suppl.9004; Eggermont AMM, 2008, LANCET, V372, P117, DOI 10.1016/S0140-6736(08)61033-8; Eggermont AMM, 2007, SEMIN ONCOL, V34, P509, DOI 10.1053/j.seminoncol.2007.09.003; Eggermont AMM, 2012, J CLIN ONCOL, V30, P3810, DOI 10.1200/JCO.2011.41.3799; Eggermont AMM, 2012, EUR J CANCER, V48, P218, DOI 10.1016/j.ejca.2011.09.028; Eggermont AMM, 2010, SEMIN ONCOL, V37, P455, DOI 10.1053/j.seminoncol.2010.09.009; Eggermont AMM, 2005, LANCET, V366, P1189, DOI 10.1016/S0140-6736(05)67482-X; Eggermont AMM, 2004, EUR J CANCER, V40, P1825, DOI 10.1016/j.ejca.2004.04.030; Elder DE, 2006, MODERN PATHOL, V19, pS4, DOI 10.1038/modpathol.3800515; Elliott B, 2007, CLIN CANCER RES, V13, P3825, DOI 10.1158/1078-0432.CCR-07-0358; Erdmann F, 2013, INT J CANCER, V132, P385, DOI 10.1002/ijc.27616; Falchook GS, 2012, LANCET, V379, P1893, DOI 10.1016/S0140-6736(12)60398-5; Faries MB, 2009, CLIN CANCER RES, V15, P7029, DOI 10.1158/1078-0432.CCR-09-1540; Flaherty KT, 2012, NEW ENGL J MED, V367, P107, DOI 10.1056/NEJMoa1203421; Flaherty LE, 2012, J CLIN ONCOL, V30; Gandini S, 2005, EUR J CANCER, V41, P2040, DOI 10.1016/j.ejca.2005.03.034; Geller AC, 2002, JAMA-J AM MED ASSOC, V288, P1719, DOI 10.1001/jama.288.14.1719; Greaves WO, 2013, J MOL DIAGN, V15, P220, DOI 10.1016/j.jmoldx.2012.10.002; Green AC, 2011, J CLIN ONCOL, V29, P257, DOI 10.1200/JCO.2010.28.7078; Green DR, 2009, NAT REV IMMUNOL, V9, P353, DOI 10.1038/nri2545; Grunhagen DJ, 2004, ANN SURG, V240, P939, DOI 10.1097/01.sla.0000146147.89667.ed; Guitera P, 2012, J INVEST DERMATOL, V132, P2386, DOI 10.1038/jid.2012.172; Guo J, 2011, J CLIN ONCOL, V29, P2904, DOI 10.1200/JCO.2010.33.9275; Halait H, 2012, DIAGN MOL PATHOL, V21, P1, DOI 10.1097/PDM.0b013e31823b216f; Hamid O, 2013, NEW ENGL J MED, V369, P134, DOI 10.1056/NEJMoa1305133; Hansson J, 2011, LANCET ONCOL, V12, P144, DOI 10.1016/S1470-2045(10)70288-6; Hauschild A, 2012, LANCET, V380, P358, DOI 10.1016/S0140-6736(12)60868-X; Hauschild A, 2009, J CLIN ONCOL, V27, P2823, DOI 10.1200/JCO.2007.15.7636; Haydu LE, 2010, HISTOPATHOLOGY, V56, P768, DOI 10.1111/j.1365-2559.2010.03546.x; Hery C, 2010, AM J EPIDEMIOL, V172, P762, DOI 10.1093/aje/kwq238; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Hodi FS, 2013, J CLIN ONCOL, V31; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Hoos A, 2010, JNCI-J NATL CANCER I, V102, P1388, DOI 10.1093/jnci/djq310; Johnston RL, 2009, DIGEST DIS SCI, V54, P2538, DOI 10.1007/s10620-008-0641-z; Karim-Kos HE, 2008, EUR J CANCER, V44, P1345, DOI 10.1016/j.ejca.2007.12.015; Kaufman HL, 2010, ANN SURG ONCOL, V17, P718, DOI 10.1245/s10434-009-0809-6; Kirkwood JM, 2001, J CLIN ONCOL, V19, P2370, DOI 10.1200/JCO.2001.19.9.2370; Korn EL, 2008, J CLIN ONCOL, V26, P527, DOI 10.1200/JCO.2007.12.7837; Krauze MT, 2011, SEMIN IMMUNOPATHOL, V33, P385, DOI 10.1007/s00281-011-0247-y; Kroon HM, 2009, ANN SURG, V249, P1008, DOI 10.1097/SLA.0b013e3181a77ce5; Kruit AH, 2013, J CLIN ONCOL, DOI [10.1200/JCO.2012.43.7111, DOI 10.1200/JCO.2012.43.7111]; Ku GY, 2010, CANCER-AM CANCER SOC, V116, P1767, DOI 10.1002/cncr.24951; Linos E, 2009, J INVEST DERMATOL, V129, P1666, DOI 10.1038/jid.2008.423; Lipsker D, 2007, BRIT J DERMATOL, V157, P338, DOI 10.1111/j.1365-2133.2007.08029.x; Liu W, 2007, J INVEST DERMATOL, V127, P900, DOI 10.1038/sj.jid.5700632; Long GV, 2013, AM J SURG PATHOL, V37, P61, DOI 10.1097/PAS.0b013e31826485c0; Long GV, 2012, LANCET ONCOL, V13, P1087, DOI 10.1016/S1470-2045(12)70431-X; Long GV, 2011, J CLIN ONCOL, V29, P1239, DOI 10.1200/JCO.2010.32.4327; Lutzky J, 2010, J CLIN ONCOL, V28, DOI 10.1200/jco.2010.28.15_suppl.8560; McMasters KM, 2010, ANN SURG, V252, P460, DOI 10.1097/SLA.0b013e3181f20bb1; Menard C, 2008, CLIN CANCER RES, V14, P5242, DOI 10.1158/1078-0432.CCR-07-4797; Menzies AM, 2012, CLIN CANCER RES, V18, P3242, DOI 10.1158/1078-0432.CCR-12-0052; Minor DR, 2012, CLIN CANCER RES, V18, P1457, DOI 10.1158/1078-0432.CCR-11-1987; Mocellin S, 2010, JNCI-J NATL CANCER I, V102, P493, DOI 10.1093/jnci/djq009; Morton DL, 2007, J CLIN ONCOL, V25; Morton DL, 2007, NEW ENGL J MED, V356, P419; Morton DL, 2006, NEW ENGL J MED, V355, P1307, DOI 10.1056/NEJMoa060992; National Cancer Institute, SURVEILLANCE EPIDEMI; Patnaik A, 2012, J CLIN ONCOL, V30; Pawlik TM, 2005, J CLIN ONCOL, V23, P4588, DOI 10.1200/JCO.2005.12.245; Platz A, 2008, MOL ONCOL, V1, P395, DOI 10.1016/j.molonc.2007.12.003; Postow MA, 2012, NEW ENGL J MED, V366, P925, DOI 10.1056/NEJMoa1112824; Poulikakos PI, 2010, NATURE, V464, P427, DOI 10.1038/nature08902; Raimondi S, 2008, INT J CANCER, V122, P2753, DOI 10.1002/ijc.23396; Restifo NP, 2012, NAT REV IMMUNOL, V12, P269, DOI 10.1038/nri3191; Ribas A, 2013, J CLIN ONCOL, V31, P616, DOI 10.1200/JCO.2012.44.6112; Ribas A, 2010, SEMIN ONCOL, V37, P450, DOI 10.1053/j.seminoncol.2010.09.010; Robert C, 2005, LANCET ONCOL, V6, P491, DOI 10.1016/S1470-2045(05)70243-6; Robert C, 2011, NEW ENGL J MED, V364, P2517, DOI 10.1056/NEJMoa1104621; Robert C, 2011, CURR OPIN ONCOL, V23, P177, DOI 10.1097/CCO.0b013e3283436e8c; Rosenberg SA, 2008, NAT REV CANCER, V8, P299, DOI 10.1038/nrc2355; Russo V, 2012, TRENDS MOL MED, V18, P193, DOI 10.1016/j.molmed.2011.12.003; Salerni G, 2012, J AM ACAD DERMATOL, V67, P836, DOI 10.1016/j.jaad.2012.01.028; Samaik AA, 2011, CLIN CANCER RES, V17, P896, DOI 10.1158/1078-0432.CCR-10-2463; Schwartzentruber DJ, 2011, NEW ENGL J MED, V364, P2119, DOI 10.1056/NEJMoa1012863; Senzer NN, 2009, J CLIN ONCOL, V27, P5763, DOI 10.1200/JCO.2009.24.3675; Shi HB, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1727; Slingluff CL, 2009, CLIN CANCER RES, V15, P7036, DOI 10.1158/1078-0432.CCR-09-1544; Sosman JA, 2011, CANCER-AM CANCER SOC, V117, P4740, DOI 10.1002/cncr.26111; Soufir N, 2007, J DERMATOL SCI, V46, P61, DOI 10.1016/j.jdermsci.2006.11.016; Spatz A, 2003, EUR J CANCER, V39, P1861, DOI 10.1016/S0959-8049(03)00325-3; Stang A, 2006, EUR J CANCER, V42, P660, DOI 10.1016/j.ejca.2005.11.027; Straussman R, 2012, NATURE, V487, P500, DOI 10.1038/nature11183; Su F, 2012, NEW ENGL J MED, V366, P207, DOI 10.1056/NEJMoa1105358; Sznol M, 2013, J CLIN ONCOL, V31; Testori A, 2009, ANN ONCOL, V20, P22, DOI 10.1093/annonc/mdp257; Thompson JF, 2011, J CLIN ONCOL, V29, P2199, DOI 10.1200/JCO.2010.31.5812; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Topalian SL, 2012, CURR OPIN IMMUNOL, V24, P207, DOI 10.1016/j.coi.2011.12.009; Tsao H, 2012, GENE DEV, V26, P1131, DOI 10.1101/gad.191999.112; Ulluo-Montoya F, 2013, J CLIN ONCOL, DOI [10.1200/JCO.2012.44.3762, DOI 10.1200/JCO.2012.44.3762]; van Akkooi ACJ, 2008, ANN SURG, V248, P949, DOI 10.1097/SLA.0b013e31818fefe0; van der Ploeg APT, 2011, J CLIN ONCOL, V29, P2206, DOI 10.1200/JCO.2010.31.6760; Van Raamsdonk CD, 2009, NATURE, V457, P599, DOI 10.1038/nature07586; Villanueva J, 2010, CANCER CELL, V18, P683, DOI 10.1016/j.ccr.2010.11.023; Voit C, 2010, J CLIN ONCOL, V28, P847, DOI 10.1200/JCO.2009.25.7428; Voit CA, 2009, J CLIN ONCOL, V27, P4994, DOI 10.1200/JCO.2008.19.0033; Wang SQ, 2010, SEMIN CUTAN MED SURG, V29, P174, DOI 10.1016/j.sder.2010.06.006; Weber JS, 2008, J CLIN ONCOL, V26, P5950, DOI 10.1200/JCO.2008.16.1927; Webster AC, 2010, BMJ-BRIT MED J, V340, pc570; Wheatley K, 2003, CANCER TREAT REV, V29, P241, DOI 10.1016/S0305-7372(03)00074-4; Wheatley K, 2007, J CLIN ONCOL, V25, P4693, DOI 10.1200/JCO.2007.13.3389; Whiteman DC, 2003, J NATL CANCER I, V95, P806, DOI 10.1093/jnci/95.11.806; Willmore-Payne C, 2006, HUM PATHOL, V37, P520, DOI 10.1016/j.humpath.2006.01.003; Wilmott JS, 2012, MOL CANCER THER, V11, P2704, DOI 10.1158/1535-7163.MCT-12-0530; Winnepenninckx VR, 2006, JNCI-J NATL CANCER I, V98, P472, DOI 10.1093/jnci/djj103; Wolchok JD, 2013, NEW ENGL J MED, V369, P122, DOI 10.1056/NEJMoa1302369; Wolchok JD, 2010, LANCET ONCOL, V11, P155, DOI 10.1016/S1470-2045(09)70334-1; Wolchok JD, 2009, CLIN CANCER RES, V15, P7412, DOI 10.1158/1078-0432.CCR-09-1624; Yokoyama S, 2011, NATURE, V480, P99, DOI 10.1038/nature10630; Yurkovetsky ZR, 2007, CLIN CANCER RES, V13, P2422, DOI 10.1158/1078-0432.CCR-06-1805; Zimmer L, 2012, J CLIN ONCOL, V30, P2375, DOI 10.1200/JCO.2011.41.1660	150	377	390	6	103	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 1	2014	383	9919					816	827		10.1016/S0140-6736(13)60802-8	http://dx.doi.org/10.1016/S0140-6736(13)60802-8			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AC3EV	24054424				2022-12-28	WOS:000332398700029
J	Moyer, VA				Moyer, Virginia A.		US Preventive Serv Task Force	Medications for Risk Reduction of Primary Breast Cancer in Women: U. S. Preventive Services Task Force Recommendation Statement	ANNALS OF INTERNAL MEDICINE			English	Article							SURGICAL ADJUVANT BREAST; CONTINUING OUTCOMES RELEVANT; RANDOMIZED CLINICAL-TRIAL; VERTEBRAL FRACTURE RISK; BOWEL PROJECT P-1; POSTMENOPAUSAL WOMEN; MULTIPLE OUTCOMES; RALOXIFENE EVALUATION; CARDIOVASCULAR EVENTS; FOLLOW-UP	Description: Update of the 2002 U. S. Preventive Services Task Force (USPSTF) recommendation on the use of medications for breast cancer risk reduction. Methods: The USPSTF reviewed evidence on the effectiveness, adverse effects, and subgroup variations of medications to reduce the risk for breast cancer-specifically, the selective estrogen receptor modulators tamoxifen and raloxifene. The USPSTF also reviewed a meta-analysis of placebo-controlled trials to understand the relative benefits and harms of tamoxifen and raloxifene. Population: This recommendation applies to asymptomatic women aged 35 years or older without a prior diagnosis of breast cancer, ductal carcinoma in situ, or lobular carcinoma in situ. Recommendation: The USPSTF recommends that clinicians engage in shared, informed decision making with women who are at in-creased risk for breast cancer about medications to reduce their risk. For women who are at increased risk for breast cancer and at low risk for adverse medication effects, clinicians should offer to prescribe risk-reducing medications, such as tamoxifen or raloxifene. (B recommendation) The USPSTF recommends against the routine use of medications, such as tamoxifen or raloxifene, for risk reduction of primary breast cancer in women who are not at increased risk for breast cancer. (D recommendation)	[Moyer, Virginia A.; US Preventive Serv Task Force] US Prevent Serv Task Force, Rockville, MD USA		Moyer, VA (corresponding author), US Prevent Serv Task Force, Rockville, MD USA.			Pignone, Michael/0000-0002-6657-7342	USPSTF	USPSTF	The USPSTF is an independent, voluntary body. The U. S. Congress mandates that the Agency for Healthcare Research and Quality support the operations of the USPSTF.	American Cancer Society, 2013, MED RED BREAST CANC; Armstrong K, 2006, ARCH INTERN MED, V166, P2260, DOI 10.1001/archinte.166.20.2260; Barrett-Connor E, 2002, JAMA-J AM MED ASSOC, V287, P847, DOI 10.1001/jama.287.7.847; Barrett-Connor E, 2004, J BONE MINER RES, V19, P1270, DOI 10.1359/JBMR.040406; Barrett-Connor E, 2006, NEW ENGL J MED, V355, P125, DOI 10.1056/NEJMoa062462; Brewster AM, 2005, CANCER, V103, P1147, DOI 10.1002/cncr.20882; Cauley JA, 2001, BREAST CANCER RES TR, V65, P125, DOI 10.1023/A:1006478317173; Chalas E, 2005, AM J OBSTET GYNECOL, V192, P1230, DOI 10.1016/j.ajog.2004.12.083; Chlebowski RT, 2007, JNCI-J NATL CANCER I, V99, P1695, DOI 10.1093/jnci/djm224; Colditz GA, 2000, AM J EPIDEMIOL, V152, P950, DOI 10.1093/aje/152.10.950; Cummings SR, 1999, JAMA-J AM MED ASSOC, V281, P2189, DOI 10.1001/jama.281.23.2189; Cuzick J, 2002, LANCET, V360, P817; Cuzick J, 2007, JNCI-J NATL CANCER I, V99, P272, DOI 10.1093/jnci/djk049; Day R, 2001, ANN NY ACAD SCI, V949, P143; Day R, 2001, J NATL CANCER I, V93, P1615, DOI 10.1093/jnci/93.21.1615; Decensi A, 2005, CIRCULATION, V111, P650, DOI 10.1161/01.CIR.0000154545.84124.AC; Delmas PD, 2003, BONE, V33, P522, DOI 10.1016/S8756-3282(03)00241-2; Delmas PD, 2002, J CLIN ENDOCR METAB, V87, P3609, DOI 10.1210/jc.87.8.3609; Duvernoy CS, 2005, MENOPAUSE, V12, P444, DOI 10.1097/01.GME.0000151653.02620.89; Ettinger B, 1999, JAMA-J AM MED ASSOC, V282, P637, DOI 10.1001/jama.282.7.637; Fisher B, 2005, JNCI-J NATL CANCER I, V97, P1652, DOI 10.1093/jnci/dji372; Fisher B, 1998, J NATL CANCER I, V90, P1371, DOI 10.1093/jnci/90.18.1371; Freedman AN, 2011, J CLIN ONCOL, V29, P2327, DOI 10.1200/JCO.2010.33.0258; Gail MH, 1999, J NATL CANCER I, V91, P1829, DOI 10.1093/jnci/91.21.1829; Grady D, 2004, OBSTET GYNECOL, V104, P837, DOI 10.1097/01.AOG.0000137349.79204.b8; Grady D, 2008, J NATL CANCER I, V100, P854, DOI 10.1093/jnci/djn153; Johnell O, 2004, J FAM PRACTICE, V53, P789; Keech CA, 2005, CURR MED RES OPIN, V21, P135, DOI 10.1185/030079904X18045; Levine M, 2001, CAN MED ASSOC J, V164, P1681; Lippman ME, 2006, CLIN CANCER RES, V12, P5242, DOI 10.1158/1078-0432.CCR-06-0688; Martino S, 2004, J NATL CANCER I, V96, P1751, DOI 10.1093/jnci/djh319; National Cancer Institute, 2013, BREAST CANC; National Cancer Institute, 2013, SEER STAT FACT SHEET; National Institute for Health and Care Excellence, 2013, FAM BREAST CANC CLAS; Nelson HD, 2009, AHRQ PUBLICATION, V10-05142-EF-1; Nelson HD, 2013, ANN INTERN MED, V158, P604, DOI 10.7326/0003-4819-158-8-201304160-00005; Nelson HD, 2009, ANN INTERN MED, V151, P703, DOI [10.7326/0000605-200911170-00147, 10.7326/0003-4819-151-10-200911170-00147]; Owens WL, 2011, J ONCOL PRACT, V7, P85, DOI 10.1200/JOP.2010.000107; Powles T, 1998, LANCET, V352, P98; Powles TJ, 2007, JNCI-J NATL CANCER I, V99, P283, DOI 10.1093/jnci/djk050; Silverman SL, 2004, J AM GERIATR SOC, V52, P1543, DOI 10.1111/j.1532-5415.2004.52420.x; Siris ES, 2005, J BONE MINER RES, V20, P1514, DOI 10.1359/JBMR.050509; Tice JA, 2008, ANN INTERN MED, V148, P337, DOI 10.7326/0003-4819-148-5-200803040-00004; Veronesi U, 1998, LANCET, V352, P93; Veronesi U, 2003, J NATL CANCER I, V95, P160, DOI 10.1093/jnci/95.2.160; Veronesi U, 2007, J NATL CANCER I, V99, P727, DOI 10.1093/jnci/djk154; Visvanathan K, 2013, J CLIN ONCOL, V31, P2942, DOI 10.1200/JCO.2013.49.3122; Vogel Victor G., 2010, Journal of the National Cancer Institute Monographs, P181, DOI 10.1093/jncimonographs/lgq041; Vogel VG, 2010, CANCER PREV RES, V3, P696, DOI 10.1158/1940-6207.CAPR-10-0076; Vogel VG, 2006, JAMA-J AM MED ASSOC, V295, P2727, DOI 10.1001/jama.295.23.joc60074	50	107	109	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 19	2013	159	10					698	+		10.7326/0003-4819-159-10-201311190-00718	http://dx.doi.org/10.7326/0003-4819-159-10-201311190-00718			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	276FB	24061412				2022-12-28	WOS:000328732700018
J	Goujon, C; Moncorge, O; Bauby, H; Doyle, T; Ward, CC; Schaller, T; Hue, S; Barclay, WS; Schulz, R; Malim, MH				Goujon, Caroline; Moncorge, Olivier; Bauby, Helene; Doyle, Tomas; Ward, Christopher C.; Schaller, Torsten; Hue, Stephane; Barclay, Wendy S.; Schulz, Reiner; Malim, Michael H.			Human MX2 is an interferon-induced post-entry inhibitor of HIV-1 infection	NATURE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; PRIMARY HUMAN MACROPHAGES; INFLUENZA-VIRUS; NUCLEAR IMPORT; HUMAN-CELLS; IN-VIVO; ANTIVIRAL FUNCTION; NONDIVIDING CELLS; PROTEIN; EXPRESSION	Animal cells harbour multiple innate effector mechanisms that inhibit virus replication. For the pathogenic retrovirus human immunodeficiency virus type 1 (HIV-1), these include widely expressed restriction factors(1), such as APOBEC3 proteins(2), TRIM5-alpha(3), BST2 (refs 4, 5) and SAMHD1 (refs 6, 7), as well as additional factors that are stimulated by type 1 interferon (IFN)(8-14). Here we use both ectopic expression and gene-silencing experiments to define the human dynamin-like, IFN-induced myxovirus resistance 2 (MX2, also known as MXB) protein as a potent inhibitor of HIV-1 infection and as a key effector of IFN-alpha-mediated resistance to HIV-1 infection. MX2 suppresses infection by all HIV-1 strains tested, has equivalent or reduced effects on divergent simian immunodeficiency viruses, and does not inhibit other retroviruses such as murine leukaemia virus. The Capsid region of the viral Gag protein dictates susceptibility to MX2, and the block to infection occurs at a late post-entry step, with both the nuclear accumulation and chromosomal integration of nascent viral complementary DNA suppressed. Finally, human MX1 (also known as MXA), a closely related protein that has long been recognized as a broadly acting inhibitor of RNA and DNA viruses, including the orthomyxovirus influenza A virus(15,16), does not affect HIV-1, whereas MX2 is ineffective against influenza virus. MX2 is therefore a cell-autonomous, anti-HIV-1 resistance factor whose purposeful mobilization may represent a new therapeutic approach for the treatment of HIV/AIDS.	[Goujon, Caroline; Bauby, Helene; Doyle, Tomas; Ward, Christopher C.; Schaller, Torsten; Malim, Michael H.] Kings Coll London, Dept Infect Dis, London SE1 9RT, England; [Moncorge, Olivier; Barclay, Wendy S.] Univ London Imperial Coll Sci Technol & Med, Div Infect Dis, Virol Sect, London W2 1PG, England; [Hue, Stephane] UCL, Div Infect & Immun, Ctr Med Mol Virol, London WC1 6RT, England; [Schulz, Reiner] Kings Coll London, Dept Med & Mol Genet, London SE1 9RT, England	University of London; King's College London; Imperial College London; University of London; University College London; University of London; King's College London	Malim, MH (corresponding author), Kings Coll London, Dept Infect Dis, London SE1 9RT, England.	michael.malim@kcl.ac.uk	Moncorge, Olivier/E-3233-2017; Bauby, Hélène/C-8965-2014; Goujon, Caroline/B-3914-2014; Schulz, Reiner/A-5940-2011; Schaller, Torsten/ABC-9153-2020	Moncorge, Olivier/0000-0003-0512-1824; Bauby, Hélène/0000-0003-1419-7652; Goujon, Caroline/0000-0001-8571-1108; Schulz, Reiner/0000-0001-5047-7921; Schaller, Torsten/0000-0001-9597-4112; Barclay, Wendy/0000-0002-3948-0895; Ward, Christopher/0000-0001-7120-3700; Hue, Stephane/0000-0002-8580-6905; Malim, Michael/0000-0002-7699-2064	UK Medical Research Council; National Institutes of Health [DA033773]; European Commission [PIEF-GA-2009-237501]; Wellcome Trust; Department of Health via a National Institute for Health Research comprehensive Biomedical Research Centre; King's College London; King's College Hospital NHS Foundation Trust; MRC [G1000196, G1001081] Funding Source: UKRI; Engineering and Physical Sciences Research Council [836374] Funding Source: researchfish; Medical Research Council [G1000196, G1001081] Funding Source: researchfish; National Institute for Health Research [ACF-2011-17-013] Funding Source: researchfish; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA033773] Funding Source: NIH RePORTER	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Commission(European CommissionEuropean Commission Joint Research Centre); Wellcome Trust(Wellcome TrustEuropean Commission); Department of Health via a National Institute for Health Research comprehensive Biomedical Research Centre(National Institute for Health Research (NIHR)); King's College London; King's College Hospital NHS Foundation Trust; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We wish to thank L. Apolonia, A. Cimarelli, B. Hahn, T. Hatziioannou, J. Kappes, P. Mangeot, S. Papaioannou, N. Parrish, N. Sherer and C. Swanson for the provision of reagents and for discussions, and M. Mirza, E. Papouli, Q. Oscar Y. Li and G. Pacini for technical assistance. This work was supported by the UK Medical Research Council, the National Institutes of Health (DA033773), the European Commission's Seventh Framework Programme (FP7/2007-2013) under grant agreement no. PIEF-GA-2009-237501 (to C.G.), a Wellcome Trust Research Training Fellowship (to T.D.) and the Department of Health via a National Institute for Health Research comprehensive Biomedical Research Centre award to Guy's and St. Thomas' NHS Foundation Trust in partnership with King's College London and King's College Hospital NHS Foundation Trust.	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Asmuth DM, 2010, J INFECT DIS, V201, P1686, DOI 10.1086/652420; Bamming D, 2009, J BIOL CHEM, V284, P9700, DOI 10.1074/jbc.M807365200; Bitzegeio J, 2013, J VIROL, V87, P3549, DOI 10.1128/JVI.03219-12; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017; Cauldwell AV, 2013, J VIROL, V87, P1278, DOI 10.1128/JVI.02597-12; Cordeil S, 2013, J VIROL, V87, P2587, DOI 10.1128/JVI.02553-12; Donnelly MLL, 2001, J GEN VIROL, V82, P1013, DOI 10.1099/0022-1317-82-5-1013; Fouchier RAM, 1997, EMBO J, V16, P4531, DOI 10.1093/emboj/16.15.4531; Gaddis NC, 2004, J VIROL, V78, P12041, DOI 10.1128/JVI.78.21.12041-12046.2004; Gao S, 2011, IMMUNITY, V35, P514, DOI 10.1016/j.immuni.2011.07.012; Goujon C, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-23; Goujon C, 2010, J VIROL, V84, P9254, DOI 10.1128/JVI.00854-10; Haller O, 2011, J INTERF CYTOK RES, V31, P79, DOI 10.1089/jir.2010.0076; HO DD, 1985, LANCET, V1, P602; Hrecka K, 2011, NATURE, V474, P658, DOI 10.1038/nature10195; Jarrosson-Wuilleme L, 2006, J VIROL, V80, P1152, DOI 10.1128/JVI.80.3.1152-1159.2006; Kim BH, 2012, CELL HOST MICROBE, V12, P432, DOI 10.1016/j.chom.2012.09.007; King MC, 2004, P NATL ACAD SCI USA, V101, P8957, DOI 10.1073/pnas.0403167101; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Lee K, 2010, CELL HOST MICROBE, V7, P221, DOI 10.1016/j.chom.2010.02.007; Malim MH, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006940; Mangeot PE, 2002, MOL THER, V5, P283, DOI 10.1006/mthe.2002.0541; Mangeot PE, 2011, MOL THER, V19, P1656, DOI 10.1038/mt.2011.138; Markusic D, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni062; Melen K, 1996, J BIOL CHEM, V271, P23478, DOI 10.1074/jbc.271.38.23478; MEYLAN PRA, 1993, VIROLOGY, V193, P138, DOI 10.1006/viro.1993.1110; Mitchell PS, 2012, CELL HOST MICROBE, V12, P598, DOI 10.1016/j.chom.2012.09.005; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; NEUMANN G, 1995, J GEN VIROL, V76, P1709, DOI 10.1099/0022-1317-76-7-1709; Newman ENC, 2005, CURR BIOL, V15, P166, DOI 10.1016/j.cub.2004.12.068; O'Doherty U, 2002, J VIROL, V76, P10942, DOI 10.1128/JVI.76.21.10942-10950.2002; O'Rourke JP, 2002, J VIROL, V76, P1510, DOI 10.1128/JVI.76.3.1510-1515.2002; Ochsenbauer C, 2012, J VIROL, V86, P2715, DOI 10.1128/JVI.06157-11; PAVLOVIC J, 1990, J VIROL, V64, P3370, DOI 10.1128/JVI.64.7.3370-3375.1990; Pear WS, 1998, BLOOD, V92, P3780, DOI 10.1182/blood.V92.10.3780.422k15_3780_3792; Pertel T, 2011, NATURE, V472, P361, DOI 10.1038/nature09976; Pillai SK, 2012, P NATL ACAD SCI USA, V109, P3035, DOI 10.1073/pnas.1111573109; PITOSSI F, 1993, J VIROL, V67, P6726, DOI 10.1128/JVI.67.11.6726-6732.1993; Ponten A, 1997, J VIROL, V71, P2591, DOI 10.1128/JVI.71.4.2591-2599.1997; RYANGRAHAM MA, 1995, VIROLOGY, V213, P158, DOI 10.1006/viro.1995.1556; Saenz DT, 2005, J VIROL, V79, P15175, DOI 10.1128/JVI.79.24.15175-15188.2005; SAKAI H, 1992, ARCH VIROL, V125, P1, DOI 10.1007/BF01309624; Sauter D, 2009, CELL HOST MICROBE, V6, P409, DOI 10.1016/j.chom.2009.10.004; Sayah DM, 2004, NATURE, V430, P569, DOI 10.1038/nature02777; Schaller T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002439; Schindler M, 2003, J VIROL, V77, P10548, DOI 10.1128/JVI.77.19.10548-10556.2003; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Shah VB, 2013, J VIROL, V87, P422, DOI 10.1128/JVI.07177-11; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Shi W, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq871; SIMON JHM, 1995, J VIROL, V69, P4166, DOI 10.1128/JVI.69.7.4166-4172.1995; Soares MA, 1997, VIROLOGY, V228, P394, DOI 10.1006/viro.1996.8387; Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343; Trichas G, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-40; Van Damme N, 2008, CELL HOST MICROBE, V3, P245, DOI 10.1016/j.chom.2008.03.001; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; YEE JK, 1994, P NATL ACAD SCI USA, V91, P9564, DOI 10.1073/pnas.91.20.9564	61	408	419	4	90	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 24	2013	502	7472					559	+		10.1038/nature12542	http://dx.doi.org/10.1038/nature12542			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	238YN	24048477	Green Accepted			2022-12-28	WOS:000325988400056
J	Church, G				Church, George			Improving genome understanding	NATURE			English	Editorial Material									[Church, George] Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Church, G (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.	gmc@harvard.edu		church, george/0000-0001-6232-9969					0	5	5	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 10	2013	502	7470					143	143		10.1038/502143a	http://dx.doi.org/10.1038/502143a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RU	24108012	Bronze			2022-12-28	WOS:000325436100012
J	Kanai, R; Ogawa, H; Vilsen, B; Cornelius, F; Toyoshima, C				Kanai, Ryuta; Ogawa, Haruo; Vilsen, Bente; Cornelius, Flemming; Toyoshima, Chikashi			Crystal structure of a Na+-bound Na+,K+-ATPase preceding the E1P state	NATURE			English	Article							CYTOPLASMIC-BINDING SITES; RAT-KIDNEY NA+,K+-ATPASE; SODIUM-POTASSIUM PUMP; ALPHA-SUBUNIT; TRANSMEMBRANE SEGMENT; CALCIUM-PUMP; K+-ATPASE; TERMINAL TYROSINES; CATION-BINDING; NA,K-ATPASE	Na+,K+-ATPase pumps three Na+ ions out of cells in exchange for two K+ taken up from the extracellular medium per ATP molecule hydrolysed, thereby establishing Na+ and K+ gradients across the membrane in all animal cells. These ion gradients are used in many fundamental processes, notably excitation of nerve cells. Here we describe 2.8 angstrom-resolution crystal structures of this ATPase from pig kidney with bound Na+, ADP and aluminium fluoride, a stable phosphate analogue, with and without oligomycin that promotes Na+ occlusion. These crystal structures represent a transition state preceding the phosphorylated intermediate (E1P) in which three Na+ ions are occluded. Details of the Na+-binding sites show how this ATPase functions as a Na+-specific pump, rejecting K+ and Ca2+, even though its affinity for Na+ is low (millimolar dissociation constant). A mechanism for sequential, cooperative Na+ binding can now be formulated in atomic detail.	[Kanai, Ryuta; Ogawa, Haruo; Toyoshima, Chikashi] Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan; [Vilsen, Bente; Cornelius, Flemming] Aarhus Univ, Dept Biomed, DK-8000 Aarhus C, Denmark	University of Tokyo; Aarhus University	Toyoshima, C (corresponding author), Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan.	ct@iam.u-tokyo.ac.jp	Toyoshima, Chikashi/R-4153-2019; Cornelius, Flemming/C-1912-2019	Cornelius, Flemming/0000-0003-1566-0020; Vilsen, Bente/0000-0002-4727-9382; Toyoshima, Chikashi/0000-0001-9640-0778	Ministry of Education, Culture, Sports, Science and Technology of Japan [2009B0025]; Lundbeck Foundation; Novo Nordisk Foundation; Fabrikant Vilhelm Pedersen og Hustrus Legat; Danish Medical Research Council; FI/Danish-Japanese cooperation program from the Danish Agency for Science Technology and Innovation; Lundbeck Foundation [R118-2012-11726, R48-2009-4638] Funding Source: researchfish	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Fabrikant Vilhelm Pedersen og Hustrus Legat; Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); FI/Danish-Japanese cooperation program from the Danish Agency for Science Technology and Innovation; Lundbeck Foundation(Lundbeckfonden)	We thank S. Hasegawa and H. Okumura of the Japan Synchrotron Radiation Research Institute (JASRI) for data collection at BL41XU of SPring-8, and J. Petersen, A. M. Beck Sorensen and A. Lillevang for technical assistance with membrane purification. We are grateful to D. B. McIntosh for help in improving the manuscript, and J. Tsueda for help in preparing figures. This work is a part of a long-term project (2009B0025) at SPring-8 and was supported by a Specially Promoted Project Grant from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to C. T.) as well as by research grants from the Lundbeck Foundation (to B. V.), the Novo Nordisk Foundation, Fabrikant Vilhelm Pedersen og Hustrus Legat (to B. V. and F. C.), the Danish Medical Research Council (to B. V. and F. C.) and the FI/Danish-Japanese cooperation program from the Danish Agency for Science Technology and Innovation (to F.C.).	Abe K, 2009, EMBO J, V28, P1637, DOI 10.1038/emboj.2009.102; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ALBERS RW, 1967, ANNU REV BIOCHEM, V36, P727, DOI 10.1146/annurev.bi.36.070167.003455; Apell HJ, 2001, J MEMBRANE BIOL, V180, P1, DOI 10.1007/s002320010053; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BROWN ID, 1976, ACTA CRYSTALLOGR B, V32, P1957, DOI 10.1107/S0567740876006869; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CLARKE DM, 1989, NATURE, V339, P476, DOI 10.1038/339476a0; CORNELIUS F, 1988, BIOCHIM BIOPHYS ACTA, V944, P223, DOI 10.1016/0005-2736(88)90435-X; Einholm AP, 2010, J BIOL CHEM, V285, P26245, DOI 10.1074/jbc.M110.123976; ESMANN M, 1985, BIOCHEM BIOPH RES CO, V127, P857, DOI 10.1016/S0006-291X(85)80022-X; Fabiola F, 2002, PROTEIN SCI, V11, P1415, DOI 10.1110/ps.4890102; Glynn I. M., 1985, ENZYMES BIOL MEMBR, P35; GUARDIA E, 1991, J CHEM PHYS, V95, P2823, DOI 10.1063/1.460934; Hayward S, 1999, PROTEINS, V36, P425, DOI 10.1002/(SICI)1097-0134(19990901)36:4<425::AID-PROT6>3.3.CO;2-J; Ho BK, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-49; Imagawa T, 2005, J BIOL CHEM, V280, P18736, DOI 10.1074/jbc.M500137200; Jacobsen MD, 2002, BIOCHEMISTRY-US, V41, P1451, DOI 10.1021/bi015891h; JEWELLMOTZ EA, 1993, BIOCHEMISTRY-US, V32, P13523, DOI 10.1021/bi00212a018; JORGENSEN PL, 1974, BIOCHIM BIOPHYS ACTA, V356, P36, DOI 10.1016/0005-2736(74)90292-2; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kuntzweiler TA, 1996, J BIOL CHEM, V271, P29682, DOI 10.1074/jbc.271.47.29682; Laursen M, 2013, P NATL ACAD SCI USA, V110, P10958, DOI 10.1073/pnas.1222308110; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; Meier S, 2010, J GEN PHYSIOL, V135, P115, DOI 10.1085/jgp.200910301; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; Morth JP, 2011, NAT REV MOL CELL BIO, V12, P60, DOI 10.1038/nrm3031; Morth JP, 2009, PHILOS T R SOC B, V364, P217, DOI 10.1098/rstb.2008.0201; Nayal M, 1996, J MOL BIOL, V256, P228, DOI 10.1006/jmbi.1996.0081; Ogawa H, 2009, P NATL ACAD SCI USA, V106, P13742, DOI 10.1073/pnas.0907054106; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pedersen PA, 1998, BIOCHEMISTRY-US, V37, P17818, DOI 10.1021/bi981898w; Pintschovius J, 1999, BIOPHYS J, V76, P827, DOI 10.1016/S0006-3495(99)77246-2; POST RL, 1972, J BIOL CHEM, V247, P6530; Schack VR, 2008, J BIOL CHEM, V283, P27982, DOI 10.1074/jbc.M803506200; Schack VR, 2012, J BIOL CHEM, V287, P2191, DOI 10.1074/jbc.M111.323022; Schneeberger A, 2001, J MEMBRANE BIOL, V179, P263, DOI 10.1007/s002320010051; SCHULZ S, 1995, EUR BIOPHYS J BIOPHY, V23, P413, DOI 10.1007/BF00196828; Shinoda T, 2009, NATURE, V459, P446, DOI 10.1038/nature07939; Sorensen TLM, 2004, SCIENCE, V304, P1672, DOI 10.1126/science.1099366; Toustrup-Jensen MS, 2009, J BIOL CHEM, V284, P18715, DOI 10.1074/jbc.M109.015099; Toyoshima C, 2004, NATURE, V430, P529, DOI 10.1038/nature02680; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Toyoshima C, 2013, NATURE, V495, P260, DOI 10.1038/nature11899; Toyoshima C, 2011, STRUCTURE, V19, P1732, DOI 10.1016/j.str.2011.10.016; Vedovato N, 2010, J GEN PHYSIOL, V136, P63, DOI 10.1085/jgp.201010407; VILSEN B, 1993, BIOCHEMISTRY-US, V32, P13340, DOI 10.1021/bi00211a048; VILSEN B, 1995, BIOCHEMISTRY-US, V34, P1455, DOI 10.1021/bi00004a041; Vilsen B, 1997, ANN NY ACAD SCI, V834, P297, DOI 10.1111/j.1749-6632.1997.tb52260.x; Winther AML, 2013, NATURE, V495, P265, DOI 10.1038/nature11900; Yaragatupalli S, 2009, P NATL ACAD SCI USA, V106, P15507, DOI 10.1073/pnas.0903752106	51	209	212	2	116	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 10	2013	502	7470					201	+		10.1038/nature12578	http://dx.doi.org/10.1038/nature12578			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RU	24089211				2022-12-28	WOS:000325436100043
J	Kenyon, C; Bonorchis, K; Corcoran, C; Meintjes, G; Locketz, M; Lehloenya, R; Vismer, HF; Naicker, P; Prozesky, H; van Wyk, M; Bamford, C; du Plooy, M; Imrie, G; Dlamini, S; Borman, AM; Colebunders, R; Yansouni, CP; Mendelson, M; Govender, NP				Kenyon, Chris; Bonorchis, Kim; Corcoran, Craig; Meintjes, Graeme; Locketz, Michael; Lehloenya, Rannakoe; Vismer, Hester F.; Naicker, Preneshni; Prozesky, Hans; van Wyk, Marelize; Bamford, Colleen; du Plooy, Moira; Imrie, Gail; Dlamini, Sipho; Borman, Andrew M.; Colebunders, Robert; Yansouni, Cedric P.; Mendelson, Marc; Govender, Nelesh P.			A Dimorphic Fungus Causing Disseminated Infection in South Africa	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LUNG	BackgroundThe genus emmonsia contains three species that are associated with human disease. Emmonsia crescens and Emmonsia parva are the agents that cause adiaspiromycosis, and one human case of Emmonsia pasteuriana infection has been described. We report a fungal pathogen within the genus emmonsia that is most closely related to E. pasteuriana in human immunodeficiency virus (HIV)-infected adults in South Africa. MethodsBetween July 2008 and July 2011, we conducted enhanced surveillance to identify the cause of systemic, dimorphic fungal infections in patients presenting to Groote Schuur Hospital and other hospitals affiliated with the University of Cape Town, Cape Town, South Africa. DNA sequencing was used to identify pathogenic fungi. ResultsA total of 24 cases of dimorphic fungal infection were diagnosed, 13 of which were caused by an emmonsia species. All 13 patients were HIV-infected, with a median CD4+ T-cell count of 16 cells per cubic millimeter (interquartile range, 10 to 44), and all had evidence of disseminated fungal disease. Three patients died soon after presentation, but the others had a good response to a variety of antifungal agents and antiretroviral therapy. Phylogenetic analysis of five genes (LSU, ITS1-2, and the genes encoding actin, -tubulin, and intein PRP8) revealed that this fungus belongs in the genus emmonsia and is most closely related to E. pasteuriana. ConclusionsThe findings suggest that these isolates of an emmonsia species represent a new species of dimorphic fungus that is pathogenic to humans. The species appears to be an important cause of infections in Cape Town. In the context of immunologic failure associated with advanced HIV infection, a novel dimorphic fungus in the genus emmonsia is identified as an important cause of human disease. This report describes 13 cases of infection with this organism in Cape Town, South Africa. The human immunodeficiency virus (HIV) pandemic in sub-Saharan Africa has resulted in an epidemic of opportunistic fungal diseases, some of which are caused by new and emerging fungal pathogens.(1) Much remains to be learned about the endemic fungi of sub-Saharan Africa. For example, considerable differences have been noted between the African and North American varieties of Histoplasma capsulatum and Blastomyces dermatitidis.(2) The genus emmonsia contains three species associated with human disease. Emmonsia crescens and Emmonsia parva are the agents of adiaspiromycosis, a pulmonary disease of small mammals and occasionally of humans.(3)Emmonsia pasteuriana infection has been described in a ...	[Kenyon, Chris; Meintjes, Graeme; Dlamini, Sipho; Mendelson, Marc] Groote Schuur Hosp, Dept Med, Div Infect Dis & HIV Med, ZA-7925 Cape Town, South Africa; [Corcoran, Craig] Groote Schuur Hosp, Dept Clin Lab Sci, Div Med Virol, Natl Hlth Lab Serv, ZA-7925 Cape Town, South Africa; [Lehloenya, Rannakoe] Groote Schuur Hosp, Div Dermatol, Dept Med, ZA-7925 Cape Town, South Africa; [Bamford, Colleen] Groote Schuur Hosp, Div Med Microbiol, Natl Hlth Lab Serv, ZA-7925 Cape Town, South Africa; [Locketz, Michael] Univ Cape Town, Natl Hlth Lab Serv, Div Anat Pathol, ZA-7925 Cape Town, South Africa; [Meintjes, Graeme] Tygerberg Hosp, Inst Infect Dis & Mol Med, Cape Town, South Africa; Tygerberg Hosp, Div Med Microbiol, Dept Pathol, Natl Hlth Lab Serv, Cape Town, South Africa; [Naicker, Preneshni] Univ Stellenbosch, Cape Town, South Africa; [Prozesky, Hans] Univ Stellenbosch, Dept Med, Div Infect Dis, Cape Town, South Africa; [Prozesky, Hans] Tygerberg Hosp, Cape Town, South Africa; [Bonorchis, Kim] Natl Hlth Lab Serv, Green Point, South Africa; [Vismer, Hester F.; Imrie, Gail] MRC, Programme Mycotoxins & Expt Carcinogenesis, PROMEC Unit, Tygerberg, South Africa; [du Plooy, Moira] Ampath Natl Reference Lab, Dept Clin Microbiol, Centurion, South Africa; [van Wyk, Marelize; Govender, Nelesh P.] Univ Witwatersrand, Natl Inst Communicable Dis, Ctr Opportunist Trop & Hosp Infect, Natl Hlth Lab Serv, Johannesburg, South Africa; [Govender, Nelesh P.] Univ Witwatersrand, Fac Hlth Sci, Johannesburg, South Africa; [Kenyon, Chris; Colebunders, Robert] Inst Trop Med, Div HIV Med, B-2000 Antwerp, Belgium; [Meintjes, Graeme] Univ London Imperial Coll Sci Technol & Med, Dept Med, London, England; [Borman, Andrew M.] Hlth Protect Agcy UK, Natl Mycol Reference Lab, Bristol, Avon, England; [Yansouni, Cedric P.] McGill Univ Hlth Ctr, Div Infect Dis, Montreal, PQ, Canada; [Yansouni, Cedric P.] McGill Univ Hlth Ctr, Dept Med Microbiol, Montreal, PQ, Canada	University of Cape Town; University of Cape Town; University of Cape Town; University of Cape Town; University of Cape Town; Tygerberg Hospital; University of Cape Town; Tygerberg Hospital; University of Cape Town; Stellenbosch University; Stellenbosch University; Tygerberg Hospital; National Health Laboratory Service; National Institute for Communicable Diseases (NICD); University of Witwatersrand; University of Witwatersrand; Institute of Tropical Medicine (ITM); Imperial College London; Health Protection Agency; McGill University; McGill University	Kenyon, C (corresponding author), Groote Schuur Hosp, Dept Med, Main Rd, ZA-7925 Cape Town, South Africa.	chriskenyon0@gmail.com	Borman, Andy/H-3663-2019; Locketz, Michael/AAE-5493-2020; Govender, Nelesh/ABI-6429-2020; Prozesky, Hans Walter/ABE-6956-2020; Lehloenya, Rannakoe J/C-5672-2012	Borman, Andy/0000-0003-0585-5721; Prozesky, Hans Walter/0000-0001-9715-3449; Govender, Nelesh/0000-0001-7869-9462; Meintjes, Graeme/0000-0003-1196-4414; Locketz, Michael/0000-0002-3917-3895; /0000-0002-4765-3469; Lehloenya, Rannakoe J/0000-0002-1281-1789; Kenyon, Chris/0000-0002-2557-8998; Mendelson, Marc/0000-0001-6668-3893				Ampel NM, 1996, EMERG INFECT DIS, V2, P109, DOI 10.3201/eid0202.960205; ENGLAND DM, 1993, AM J SURG PATHOL, V17, P876, DOI 10.1097/00000478-199309000-00003; Gori S, 1998, J MYCOL MED, V8, P57; Gueho E, 1997, MYCOSES, V40, P69, DOI 10.1111/j.1439-0507.1997.tb00191.x; Shaikh N, 2006, SAMJ S AFR MED J, V96, P538; Teixeira MM, 2009, MOL PHYLOGENET EVOL, V52, P273, DOI 10.1016/j.ympev.2009.04.005; Wellinghausen N, 2003, INT J MED MICROBIOL, V293, P441, DOI 10.1078/1438-4221-00281	7	84	88	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 10	2013	369	15					1416	1424		10.1056/NEJMoa1215460	http://dx.doi.org/10.1056/NEJMoa1215460			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	231QE	24106934				2022-12-28	WOS:000325431500009
J	Zappe, H				Zappe, Hans			Bridging the market gap	NATURE			English	Editorial Material							UNITED-STATES; TECHNOLOGY-TRANSFER; INDUSTRY; CENTERS		Univ Freiburg, Dept Microsyst Engn, Freiburg, Germany	University of Freiburg	Zappe, H (corresponding author), Univ Freiburg, Dept Microsyst Engn, Freiburg, Germany.	zappe@imtek.uni-freiburg.de		Zappe, Hans/0000-0003-4603-8613				Bradley SR, 2013, J TECHNOL TRANSFER, V38, P349, DOI 10.1007/s10961-013-9309-8; Czarnitzki D, 2007, RES EVALUAT, V16, P311, DOI 10.3152/095820207X254439; Grimpe C, 2010, J TECHNOL TRANSFER, V35, P637, DOI 10.1007/s10961-009-9140-4; Kenney M, 2004, RES POLICY, V33, P691, DOI 10.1016/j.respol.2003.11.001; MARAZITA CF, 1991, TECHNOL FORECAST SOC, V39, P397, DOI 10.1016/0040-1625(91)90078-T; Okamuro H, 2013, J TECHNOL TRANSFER, V38, P273, DOI 10.1007/s10961-012-9253-z; Perkmann M, 2013, RES POLICY, V42, P423, DOI 10.1016/j.respol.2012.09.007; Wu W, 2007, WORLD DEV, V35, P1075, DOI 10.1016/j.worlddev.2006.05.011; 2008, NATURE, V453, P830	9	5	5	1	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 26	2013	501	7468					483	485		10.1038/501483a	http://dx.doi.org/10.1038/501483a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	223RP	24073448	Bronze			2022-12-28	WOS:000324826300031
J	Malhotra, A				Malhotra, Aseem			Too much angioplasty	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							FRACTIONAL FLOW RESERVE; ACUTE CORONARY SYNDROMES; MYOCARDIAL-INFARCTION; MEDICAL THERAPY; ARTERY-DISEASE; STRATEGIES		Royal Free Hosp, London, England	University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School	Malhotra, A (corresponding author), Royal Free Hosp, London, England.	aseem_malhotra@hotmail.com						Cannon CP, 2001, NEW ENGL J MED, V344, P1879, DOI 10.1056/NEJM200106213442501; Cortez FM, 2013, WASHINGTON POST; Curzon N., 2013, DOES ROUTINE PRESSUR; De Bruyne B, 2012, NEW ENGL J MED, V367, P991, DOI 10.1056/NEJMoa1205361; Fearon WF, 2012, TCT 2012 24 OCT MIAM; Fox KAA, 2002, LANCET, V360, P743, DOI 10.1016/S0140-6736(02)09894-X; Koo BK, 2011, J AM COLL CARDIOL, V58, P1989, DOI 10.1016/j.jacc.2011.06.066; Libby P, 2013, NEW ENGL J MED, V368, P2004, DOI 10.1056/NEJMra1216063; Maquet, PAT INF BALL PUMP TH; Mehta SR, 2005, JAMA-J AM MED ASSOC, V293, P2908, DOI 10.1001/jama.293.23.2908; Rothberg MB, 2010, ANN INTERN MED, V153, P307, DOI 10.7326/0003-4819-153-5-201009070-00005; Stergiopoulos K, 2012, ARCH INTERN MED, V172, P312, DOI 10.1001/archinternmed.2011.1484; Thiele H, 2013, LANCET, V382, P1638, DOI 10.1016/S0140-6736(13)61783-3; Thiele H, 2012, NEW ENGL J MED, V367, P1287, DOI 10.1056/NEJMoa1208410; Tonino PAL, 2009, NEW ENGL J MED, V360, P213, DOI 10.1056/NEJMoa0807611; Wallentin L, 1999, LANCET, V354, P708	16	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 24	2013	347								f5741	10.1136/bmj.f5741	http://dx.doi.org/10.1136/bmj.f5741			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	227CT	24065554				2022-12-28	WOS:000325086800007
J	Bryce, J; Victora, CG; Black, RE				Bryce, Jennifer; Victora, Cesar G.; Black, Robert E.			The unfinished agenda in child survival	LANCET			English	Review							COMMUNITY CASE-MANAGEMENT; MIDDLE-INCOME COUNTRIES; HEALTH INTERVENTIONS; SYSTEMATIC ANALYSIS; TIME TRENDS; MORTALITY; DIARRHEA; EQUITY; UNDERNUTRITION; STRATEGIES	10 years ago, The Lancet published a Series about child survival. In this Review, we examine progress in the past decade in child survival, with a focus on epidemiology, interventions and intervention coverage, strategies of health programmes, equity, evidence, accountability, and global leadership. Knowledge of child health epidemiology has greatly increased, and although more and better interventions are available, they still do not reach large numbers of mothers and children. Child survival should remain at the heart of global goals in the post-2015 era. Many countries are now making good progress and need the time and support required to finish the task. The global health community should show its steadfast commitment to child survival by amassing knowledge and experience as a basis for ever more effective programmes. Leadership and accountability for child survival should be strengthened and shared among the UN system; governments in high-income, middle-income, and low-income countries; and non-governmental organisations.	[Bryce, Jennifer; Black, Robert E.] Johns Hopkins Bloomberg Sch Publ Hlth, Inst Int Programs, Baltimore, MD 21205 USA; [Victora, Cesar G.] Univ Fed Pelotas, Postgrad Program Epidemiol, Pelotas, Brazil	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Universidade Federal de Pelotas	Bryce, J (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Inst Int Programs, Baltimore, MD 21205 USA.	jbrycedanby@aol.com	Victora, Cesar Gomes/Y-2455-2019; Victora, Cesar G/D-4476-2013	Victora, Cesar Gomes/0000-0002-2465-2180; Victora, Cesar G/0000-0002-2465-2180				Alliance GAVI, 2010, GAVI ALL MON EV FRAM; Amouzou A, 2013, TROP MED INT HEALTH, V18, P1231, DOI 10.1111/tmi.12167; [Anonymous], 2010, LANCET, V375, P526, DOI 10.1016/S0140-6736(10)60056-6; [Anonymous], COUNTD COUNTR LEV; Bassani DG, 2010, LANCET, V376, P1853, DOI 10.1016/S0140-6736(10)61461-4; Beaglehole R, 2013, LANCET, V381, P602, DOI 10.1016/S0140-6736(13)60101-4; Bhutta ZA, 2013, LANCET, V381, P1417, DOI 10.1016/S0140-6736(13)60648-0; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; Blencowe H, 2012, LANCET, V379, P2162, DOI 10.1016/S0140-6736(12)60820-4; Briggs CJ, 2006, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD003318.PUB2; Brugha R, 1998, HEALTH POLICY PLANN, V13, P107, DOI 10.1093/heapol/13.2.107; Bryce J, 2005, HEALTH POLICY PLANN, V20, pI5, DOI 10.1093/heapol/czi055; Bryce J, 2005, LANCET, V365, P2193, DOI 10.1016/S0140-6736(05)66777-3; Bryce J, 2003, LANCET, V362, P159, DOI 10.1016/S0140-6736(03)13870-6; Bryce J, 2006, LANCET, V368, P817, DOI 10.1016/S0140-6736(06)69299-4; Bryce J, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001423; Bryce J, 2010, INT J EPIDEMIOL, V39, P40, DOI 10.1093/ije/dyq020; Canadian International Development Agency, CAT IN SAV MILL LIV; Carrera C, 2012, LANCET, V380, P1341, DOI 10.1016/S0140-6736(12)61378-6; Chandramohan D, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-22; Chinbuah MA, 2012, AM J TROP MED HYG, V87, P11, DOI 10.4269/ajtmh.2012.12-0078; Chopra M, 2012, LANCET, V380, P1331, DOI 10.1016/S0140-6736(12)61423-8; Claeson M, 2003, LANCET, V362, P323, DOI 10.1016/S0140-6736(03)13977-3; Colvin CJ, 2013, SOC SCI MED, V86, P66, DOI 10.1016/j.socscimed.2013.02.031; Commission on Information and Accountability for Women's and Children's Health, 2011, KEEP PROM MEAS RES; Costello A, 2005, LANCET, V366, P603, DOI 10.1016/S0140-6736(05)66703-7; Darmstadt GL, 2008, HEALTH POLICY PLANN, V23, P101, DOI 10.1093/heapol/czn001; de Sousa A, 2012, B WORLD HEALTH ORGAN, V90, P183, DOI 10.2471/BLT.11.093989; DICKERSIN K, 1990, JAMA-J AM MED ASSOC, V263, P1385, DOI 10.1001/jama.263.10.1385; Dudley L, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003318.pub3; Engle PL, 2007, LANCET, V369, P229, DOI 10.1016/S0140-6736(07)60112-3; Engle PL, 2011, LANCET, V378, P1339, DOI 10.1016/S0140-6736(11)60889-1; Erlanger TE, 2004, MED VET ENTOMOL, V18, P153, DOI 10.1111/j.0269-283X.2004.00491.x; Every Woman Every Child, 2019, WHAT IS EV WOM EV CH; Feng Xing Lin, 2012, J Glob Health, V2, P010405, DOI 10.7189/jogh.02.010405; Frenk J, 2013, NEW ENGL J MED, V368, P936, DOI 10.1056/NEJMra1109339; Friberg I, BMC PUBLIC IN PRESS; Gakidou E, 2010, LANCET, V376, P959, DOI 10.1016/S0140-6736(10)61257-3; Galarraga O, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-S1-S5; Gillespie S, 2013, LANCET, V382, P552, DOI 10.1016/S0140-6736(13)60842-9; Gilroy KE, 2013, HEALTH POLICY PLANN, V28, P573, DOI 10.1093/heapol/czs095; Hafner T, 2013, HEALTH POLICY PLANN, V28, P41, DOI 10.1093/heapol/czs023; Hancioglu A, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001391; Harper S, 2010, MILBANK Q, V88, P4, DOI 10.1111/j.1468-0009.2010.00587.x; Health Systems Global, GLOB S; High-Level Panel of Eminent Persons on the Post-2015 Development Agenda, 2013, NEW GLOB PARTN ER PO; Hill K, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001303; Hsu J, 2012, LANCET, V380, P1157, DOI 10.1016/S0140-6736(12)61415-9; International Health Partnership Plus, AL BETT RES; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; Kalter Henry D, 2011, Popul Health Metr, V9, P45, DOI 10.1186/1478-7954-9-45; Katz J, 2013, LANCET, V382, P417, DOI 10.1016/S0140-6736(13)60993-9; Kilian A, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-299; Labrique A, 2013, INT J MED INFORM, V82, P467, DOI 10.1016/j.ijmedinf.2012.11.016; Lagarde M, 2007, JAMA-J AM MED ASSOC, V298, P1900, DOI 10.1001/jama.298.16.1900; Larson CP, 2012, HEALTH POLICY PLANN, V27, P102, DOI 10.1093/heapol/czr015; Lawn JE, 2011, LANCET, V377, P1448, DOI 10.1016/S0140-6736(10)62187-3; Lindblade KA, 2005, TROP MED INT HEALTH, V10, P1141, DOI 10.1111/j.1365-3156.2005.01501.x; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Marsh D. R., 2012, American Journal of Tropical Medicine and Hygiene, V87, P1; Masanja H, 2008, LANCET, V371, P1276, DOI 10.1016/S0140-6736(08)60562-0; Mukanga D, 2012, AM J TROP MED HYG, V87, P21, DOI 10.4269/ajtmh.2012.11-0816; Partnership for Maternal Newborn and Child Health, 2011, GLOB REV KEY INT REL; Partnership for Maternal Newborn & Child Health, 66 WORLD HLTH ASS 20; Pulkki-Brannstrom Anni-Maria, 2012, Cost Eff Resour Alloc, V10, P5, DOI 10.1186/1478-7547-10-5; Requejo J, 2013, BEHALF COUNTDOWN 201; Ricca J, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S35; Rudan I, 2005, LANCET, V365, P2031, DOI 10.1016/S0140-6736(05)66697-4; Scaling Up Nutrition, 2010, SCALING NUTR FRAMEWO; Taylor A, 1998, BMJ-BRIT MED J, V316, P1117, DOI 10.1136/bmj.316.7138.1117; UN Commission on Life-Saving Commodities for Women and Children, 2012, COMM REP SEPT 2012; UNICEF, 2012, TRENDS UND 5 MORT RA; UNICEF, 2012, UND 5 MORT DASHB; UNICEF, INV CAS CHILD SURV O; United Nations-Department of Economic and Social Affairs (DESA), 2011, SEX DIFF CHILDH MORT; van Ekdom L, 2011, B WORLD HEALTH ORGAN, V89, P267, DOI 10.2471/BLT.10.081059; Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4; Victora CG, 2012, LANCET, V380, P1149, DOI 10.1016/S0140-6736(12)61427-5; Victora CG, 2011, LANCET, V377, P85, DOI 10.1016/S0140-6736(10)60810-0; Victora CG, 2009, B WORLD HEALTH ORGAN, V87, P83, DOI 10.2471/BLT.09.062828; Victora CG, 2003, LANCET, V362, P233, DOI 10.1016/S0140-6736(03)13917-7; Waage J, 2010, LANCET, V376, P991, DOI 10.1016/S0140-6736(10)61196-8; Wagstaff A, 2004, AM J PUBLIC HEALTH, V94, P726, DOI 10.2105/AJPH.94.5.726; Walker CLF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S16; Walker N, 2013, LANCET, V382, P1029, DOI 10.1016/S0140-6736(13)61748-1; WHO, 2010, WORLD MALARIA REPORT 2010, P1; WHO, GLOB HLTH EXP DAT CH; WHO, 2012, HLTH POST2015 DEV AG; WHO Commission on Social Determinants of Health World Health Organization, 2008, CLOS GAP GEN HLTH EQ; Winch PJ, 2008, J HEALTH POPUL NUTR, V26, P151; World Bank, 2004, WORLD DEV REP 2005 B; World Health Organization, 2008, INTEGRATED HLTH SERV; World Health Organization, 2021, LANCET; Yates R, 2009, LANCET, V373, P2078, DOI 10.1016/S0140-6736(09)60258-0	96	49	49	0	17	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 21	2013	382	9897					1049	1059		10.1016/S0140-6736(13)61753-5	http://dx.doi.org/10.1016/S0140-6736(13)61753-5			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	222PB	24054535				2022-12-28	WOS:000324742200025
J	Corder, G; Doolen, S; Donahue, RR; Winter, MK; Jutras, BL; He, Y; Hu, X; Wieskopf, JS; Mogil, JS; Storm, DR; Wang, ZJ; McCarson, KE; Taylor, BK				Corder, G.; Doolen, S.; Donahue, R. R.; Winter, M. K.; Jutras, B. L.; He, Y.; Hu, X.; Wieskopf, J. S.; Mogil, J. S.; Storm, D. R.; Wang, Z. J.; McCarson, K. E.; Taylor, B. K.			Constitutive mu-Opioid Receptor Activity Leads to Long-Term Endogenous Analgesia and Dependence	SCIENCE			English	Article							ADENYLYL-CYCLASE; CENTRAL SENSITIZATION; INFLAMMATORY PAIN; POTENTIATION; HYPERALGESIA; ACTIVATION; WITHDRAWAL; INCREASES; NALOXONE; PROTEIN	Opioid receptor antagonists increase hyperalgesia in humans and animals, which indicates that endogenous activation of opioid receptors provides relief from acute pain; however, the mechanisms of long-term opioid inhibition of pathological pain have remained elusive. We found that tissue injury produced mu-opioid receptor (MOR) constitutive activity (MORCA) that repressed spinal nociceptive signaling for months. Pharmacological blockade during the posthyperalgesia state with MOR inverse agonists reinstated central pain sensitization and precipitated hallmarks of opioid withdrawal (including adenosine 3',5'-monophosphate overshoot and hyperalgesia) that required N-methyl-D-aspartate receptor activation of adenylyl cyclase type 1. Thus, MORCA initiates both analgesic signaling and a compensatory opponent process that generates endogenous opioid dependence. Tonic MORCA suppression of withdrawal hyperalgesia may prevent the transition from acute to chronic pain.	[Corder, G.; Doolen, S.; Donahue, R. R.; Taylor, B. K.] Univ Kentucky, Dept Physiol, Lexington, KY 40536 USA; [Winter, M. K.; McCarson, K. E.] Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66160 USA; [Jutras, B. L.] Univ Kentucky, Dept Microbiol Immunol & Mol Genet, Lexington, KY 40536 USA; [He, Y.; Hu, X.; Wang, Z. J.] Univ Illinois, Dept Biopharmaceut Sci, Chicago, IL 60612 USA; [Wieskopf, J. S.; Mogil, J. S.] McGill Univ, Dept Psychol, Montreal, PQ H3A 1B1, Canada; [Wieskopf, J. S.; Mogil, J. S.] McGill Univ, Alan Edwards Ctr Res Pain, Montreal, PQ H3A 1B1, Canada; [Storm, D. R.] Univ Washington, Sch Med, Dept Pharmacol, Seattle, WA 98195 USA	University of Kentucky; University of Kansas; University of Kansas Medical Center; University of Kentucky; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; McGill University; McGill University; University of Washington; University of Washington Seattle	Taylor, BK (corresponding author), Univ Kentucky, Dept Physiol, Lexington, KY 40536 USA.	brad.taylor@uky.edu	Donahue, Renee/AAI-3512-2020; Hu, Xiaoyu/AAO-7197-2020; Mogil, Jeffrey/AAA-9611-2019	Mogil, Jeffrey/0000-0003-1359-5720; McCarson, Kenneth/0000-0002-0175-7297; Donahue, Renee/0000-0002-3344-5650; Jutras, Brandon/0000-0002-7989-1031	NIH [F31DA032496, HD02528, R01NS45954, 5K02DA19656]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD002528] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000117] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045954] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K02DA019656, F31DA032496] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The authors thank H. L. Fields, A. I. Basbaum, L. Hough, J. C. Marvizon, E. Bilsky, W. Sadee, G. Scherrer, K. Westlund High, M. Werner, J. Dahl, and B. Solway for critical discussions and J. Grasch, L. Martin, and R. Griggs for technical assistance and blinding. This work was supported by NIH grants F31DA032496 (G.C.), HD02528 (M.K.W. and K.E.M.), R01NS45954 (B.K.T.), and 5K02DA19656 (B.K.T.). Author contributions: G.C. and B.K.T. formulated the hypotheses, designed, analyzed and coordinated all experiments. G.C. performed surgeries, behavioral pharmacology, histology, and fluorescence imaging and analyzed the data. G.C. and B.L.J. carried out the biochemical studies and G.C. analyzed the data. S.D. and G.C. carried out Ca<SUP>2+</SUP> imagining experiments and analyzed the data. M.K.W., K.E.M., G.C., and B.K.T. designed the [<SUP>35</SUP>S]GTP-gamma-S binding studies; M.K.W. collected the data; and G.C., K.E.M., and B.K.T. analyzed the data. D.R.S. supplied the AC1<SUP>-/-</SUP> breeders. Z.J.W., G.C., and B.K.T. designed the conditioned place preference experiments, and Y.H. and X.H. conducted experiments and analyzed the data. J.S.M., J.S.W., G.C., and B.K.T. designed the Mouse Grimace Scale experiments, and J.W. conducted the experiments. R.R.D. conducted the plantar incision studies. G.C. and B.K.T. wrote the manuscript.	Angst MS, 2006, ANESTHESIOLOGY, V104, P570, DOI 10.1097/00000542-200603000-00025; Asiedu MN, 2011, J NEUROSCI, V31, P6646, DOI 10.1523/JNEUROSCI.6286-10.2011; AvidorReiss T, 1997, J BIOL CHEM, V272, P5040, DOI 10.1074/jbc.272.8.5040; BASBAUM AI, 1984, ANNU REV NEUROSCI, V7, P309, DOI 10.1146/annurev.ne.07.030184.001521; Benrath J, 2004, ANESTHESIOLOGY, V100, P1545, DOI 10.1097/00000542-200406000-00030; CHETKOVICH DM, 1993, J NEUROCHEM, V61, P1933, DOI 10.1111/j.1471-4159.1993.tb09836.x; Christie MJ, 2008, BRIT J PHARMACOL, V154, P384, DOI 10.1038/bjp.2008.100; COSTA T, 1989, P NATL ACAD SCI USA, V86, P7321, DOI 10.1073/pnas.86.19.7321; De Felice M, 2010, BRAIN, V133, P2475, DOI 10.1093/brain/awq159; Doolen S, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-56; Drdla R, 2009, SCIENCE, V325, P207, DOI 10.1126/science.1171759; Drdla-Schutting R, 2012, SCIENCE, V335, P235, DOI 10.1126/science.1211726; He Y, 2012, J PAIN, V13, P598, DOI 10.1016/j.jpain.2012.03.011; Heinl C, 2011, J NEUROSCI, V31, P16748, DOI 10.1523/JNEUROSCI.3491-11.2011; Ikeda H, 2006, SCIENCE, V312, P1659, DOI 10.1126/science.1127233; Kauer JA, 2007, NAT REV NEUROSCI, V8, P844, DOI 10.1038/nrn2234; Kenakin T, 2004, TRENDS PHARMACOL SCI, V25, P186, DOI 10.1016/j.tips.2004.02.012; Kenakin T, 2001, FASEB J, V15, P598, DOI 10.1096/fj.00-0438rev; Kest B, 2002, NEUROSCIENCE, V115, P463, DOI 10.1016/S0306-4522(02)00458-X; King T, 2009, NAT NEUROSCI, V12, P1364, DOI 10.1038/nn.2407; KOOB GF, 1992, TRENDS NEUROSCI, V15, P186, DOI 10.1016/0166-2236(92)90171-4; Lam H, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-24; LaneLadd SB, 1997, J NEUROSCI, V17, P7890; Latremoliere A, 2009, J PAIN, V10, P895, DOI 10.1016/j.jpain.2009.06.012; Li S, 2006, MOL PHARMACOL, V70, P1742, DOI 10.1124/mol.106.025783; Liu JG, 2001, J BIOL CHEM, V276, P37779; Liu JG, 2001, MOL PHARMACOL, V60, P53, DOI 10.1124/mol.60.1.53; Lu HC, 2003, NAT NEUROSCI, V6, P939, DOI 10.1038/nn1106; Luo C, 2008, PAIN, V140, P358, DOI 10.1016/j.pain.2008.09.008; Mazei-Robison MS, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a012070; Meye FJ, 2012, J NEUROSCI, V32, P16120, DOI 10.1523/JNEUROSCI.1572-12.2012; Nestler EJ, 1997, SCIENCE, V278, P58, DOI 10.1126/science.278.5335.58; Ossipov MH, 2010, J CLIN INVEST, V120, P3779, DOI 10.1172/JCI43766; Pogatzki EM, 2003, ANESTHESIOLOGY, V99, P1023, DOI 10.1097/00000542-200310000-00041; Raehal KM, 2005, J PHARMACOL EXP THER, V313, P1150, DOI 10.1124/jpet.104.082966; Rivat C, 2002, ANESTHESIOLOGY, V96, P381, DOI 10.1097/00000542-200202000-00025; Rivat C, 2007, NEUROPSYCHOPHARMACOL, V32, P2217, DOI 10.1038/sj.npp.1301340; Ruscheweyh R, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-20; Sadee W, 2005, LIFE SCI, V76, P1427, DOI 10.1016/j.lfs.2004.10.024; Seifert R, 2002, N-S ARCH PHARMACOL, V366, P381, DOI 10.1007/s00210-002-0588-0; Shoblock JR, 2007, NEUROSCIENCE, V149, P642, DOI 10.1016/j.neuroscience.2007.05.011; Shoblock JR, 2006, NEUROPSYCHOPHARMACOL, V31, P171, DOI 10.1038/sj.npp.1300782; SUFKA KJ, 1994, PAIN, V58, P355, DOI 10.1016/0304-3959(94)90130-9; Terman GW, 2001, J NEUROPHYSIOL, V85, P485, DOI 10.1152/jn.2001.85.2.485; Wang DX, 2004, J PHARMACOL EXP THER, V308, P512, DOI 10.1124/jpet.103.054049; Wang HS, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001269; WANG Z, 1994, LIFE SCI, V54, pPL339, DOI 10.1016/0024-3205(94)90022-1; Wei F, 2002, NEURON, V36, P713, DOI 10.1016/S0896-6273(02)01019-X; Xu H, 2008, J NEUROSCI, V28, P7445, DOI 10.1523/JNEUROSCI.1812-08.2008; Zachariou V, 2008, BIOL PSYCHIAT, V63, P1013, DOI 10.1016/j.biopsych.2007.11.021; Zhuo M, 2012, DRUG DISCOV TODAY, V17, P573, DOI 10.1016/j.drudis.2012.01.009	51	149	154	3	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 20	2013	341	6152					1394	1399		10.1126/science.1239403	http://dx.doi.org/10.1126/science.1239403			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	220PK	24052307	Green Accepted			2022-12-28	WOS:000324597200047
J	Zhang, J; Chen, PC; Yuan, BK; Ji, W; Cheng, ZH; Qiu, XH				Zhang, Jun; Chen, Pengcheng; Yuan, Bingkai; Ji, Wei; Cheng, Zhihai; Qiu, Xiaohui			Real-Space Identification of Intermolecular Bonding with Atomic Force Microscopy	SCIENCE			English	Article							CHEMICAL-BONDS; RESOLUTION	We report a real-space visualization of the formation of hydrogen bonding in 8-hydroxyquinoline (8-hq) molecular assemblies on a Cu(111) substrate, using noncontact atomic force microscopy (NC-AFM). The atomically resolved molecular structures enable a precise determination of the characteristics of hydrogen bonding networks, including the bonding sites, orientations, and lengths. The observation of bond contrast was interpreted by ab initio density functional calculations, which indicated the electron density contribution from the hybridized electronic state of the hydrogen bond. Intermolecular coordination between the dehydrogenated 8-hq and Cu adatoms was also revealed by the submolecular resolution AFM characterization. The direct identification of local bonding configurations by NC-AFM would facilitate detailed investigations of intermolecular interactions in complex molecules with multiple active sites.	[Zhang, Jun; Chen, Pengcheng; Yuan, Bingkai; Cheng, Zhihai; Qiu, Xiaohui] Chinese Acad Sci, Natl Ctr Nanosci & Technol, Key Lab Standardizat & Measurement Nanotechnol, Beijing 100190, Peoples R China; [Ji, Wei] Renmin Univ China, Dept Phys, Beijing 100872, Peoples R China	Chinese Academy of Sciences; National Center for Nanoscience & Technology - China; Renmin University of China	Ji, W (corresponding author), Renmin Univ China, Dept Phys, Beijing 100872, Peoples R China.	wji@ruc.edu.cn; chengzh@nanoctr.cn; xhqiu@nanoctr.cn	cheng, zhihai/B-9526-2014; Zhang, Jun/GFO-7061-2022; Ji, Wei/G-6097-2010; Zhang, Jun/GLN-6254-2022	cheng, zhihai/0000-0003-4938-4490; Zhang, Jun/0000-0002-9831-6796; Ji, Wei/0000-0001-5249-6624; Zhang, Jun/0000-0002-9831-6796; Chen, Pengcheng/0000-0003-2018-5594	Ministry of Science and Technology of China [2012CB933001, 2012CB932704]; Natural Science Foundation of China [21173058, 21203038, 11274308, 11004244]; Beijing Natural Science Foundation [2112019]; Renmin University of China from Central Government [12XNLJ03]; Program for New Century Excellent Talents in Universities	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Renmin University of China from Central Government; Program for New Century Excellent Talents in Universities(Program for New Century Excellent Talents in University (NCET))	This project is partially supported by the Ministry of Science and Technology of China (grants 2012CB933001 and 2012CB932704), the Natural Science Foundation of China (grants 21173058, 21203038, 11274308, and 11004244), the Beijing Natural Science Foundation (grant 2112019), and the Basic Research Funds in Renmin University of China from the Central Government (grant no. 12XNLJ03). W.J. was supported by the Program for New Century Excellent Talents in Universities. Calculations were performed at the Physics Lab for High-Performance Computing of Renmin University of China and Shanghai Supercomputer Center. We thank W. Ho, P. Grutter, and L. Gross for valuable discussion and technical advice.	Albrecht F, 2013, J AM CHEM SOC, V135, P9200, DOI 10.1021/ja404084p; Barth JV, 2005, NATURE, V437, P671, DOI 10.1038/nature04166; Carrasco J, 2012, NAT MATER, V11, P667, DOI [10.1038/NMAT3354, 10.1038/nmat3354]; de Oteyza DG, 2013, SCIENCE, V340, P1434, DOI 10.1126/science.1238187; Desiraju GR, 2011, ANGEW CHEM INT EDIT, V50, P52, DOI 10.1002/anie.201002960; Gross L, 2012, SCIENCE, V337, P1326, DOI 10.1126/science.1225621; Gross L, 2011, NAT CHEM, V3, P273, DOI [10.1038/NCHEM.1008, 10.1038/nchem.1008]; Gross L, 2010, NAT CHEM, V2, P821, DOI [10.1038/NCHEM.765, 10.1038/nchem.765]; Gross L, 2009, SCIENCE, V325, P1110, DOI 10.1126/science.1176210; GUO XC, 1995, SURF SCI, V341, pL1065, DOI 10.1016/0039-6028(95)00822-5; Hunter CA, 2004, ANGEW CHEM INT EDIT, V43, P5310, DOI 10.1002/anie.200301739; Jones G, 2006, SURF SCI, V600, pL224, DOI 10.1016/j.susc.2006.05.053; Lee HJ, 1999, SCIENCE, V286, P1719, DOI 10.1126/science.286.5445.1719; Liljeroth P, 2007, SCIENCE, V317, P1203, DOI 10.1126/science.1144366; Mohn F, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.266102; Moll N, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/8/083023; Muller-Dethlefs K, 2000, CHEM REV, V100, P143, DOI 10.1021/cr9900331; SILVI B, 1994, NATURE, V371, P683, DOI 10.1038/371683a0; Steiner T, 2002, ANGEW CHEM INT EDIT, V41, P48, DOI 10.1002/1521-3773(20020104)41:1<48::AID-ANIE48>3.0.CO;2-U; Temirov R, 2006, NATURE, V444, P350, DOI 10.1038/nature05270; Weiss C, 2010, J AM CHEM SOC, V132, P11864, DOI 10.1021/ja104332t; Welker J, 2012, SCIENCE, V336, P444, DOI 10.1126/science.1219850	22	306	317	37	943	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 1	2013	342	6158					611	614		10.1126/science.1242603	http://dx.doi.org/10.1126/science.1242603			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RJ	24072819				2022-12-28	WOS:000326334300046
J	Kunisaki, Y; Bruns, I; Scheiermann, C; Ahmed, J; Pinho, S; Zhang, DC; Mizoguchi, T; Wei, QZ; Lucas, D; Ito, K; Mar, JC; Bergman, A; Frenette, PS				Kunisaki, Yuya; Bruns, Ingmar; Scheiermann, Christoph; Ahmed, Jalal; Pinho, Sandra; Zhang, Dachuan; Mizoguchi, Toshihide; Wei, Qiaozhi; Lucas, Daniel; Ito, Keisuke; Mar, Jessica C.; Bergman, Aviv; Frenette, Paul S.			Arteriolar niches maintain haematopoietic stem cell quiescence	NATURE			English	Article							SELF-RENEWAL; PROGENITOR CELLS; EXPRESSION; MICRODOMAINS; OSTEOPONTIN; COMPONENT; DORMANCY; POOL	Cell cycle quiescence is a critical feature contributing to haematopoietic stem cell (HSC) maintenance. Although various candidate stromal cells have been identified as potential HSC niches, the spatial localization of quiescent HSCs in the bone marrow remains unclear. Here, using a novel approach that combines whole-mount confocal immunofluorescence imaging techniques and computational modelling to analyse significant three-dimensional associations in the mouse bone marrow among vascular structures, stromal cells and HSCs, we show that quiescent HSCs associate specifically with small arterioles that are preferentially found in endosteal bone marrow. These arterioles are ensheathed exclusively by rare NG2 (also known as CSPG4)(+) pericytes, distinct from sinusoid-associated leptin receptor (LEPR)(+) cells. Pharmacological or genetic activation of the HSC cell cycle alters the distribution of HSCs from NG2(+) periarteriolar niches to LEPR+ perisinusoidal niches. Conditional depletion of NG2(+) cells induces HSC cycling and reduces functional long-term repopulating HSCs in the bone marrow. These results thus indicate that arteriolar niches are indispensable for maintaining HSC quiescence.	[Kunisaki, Yuya; Bruns, Ingmar; Scheiermann, Christoph; Ahmed, Jalal; Pinho, Sandra; Zhang, Dachuan; Mizoguchi, Toshihide; Wei, Qiaozhi; Lucas, Daniel; Ito, Keisuke; Frenette, Paul S.] Albert Einstein Coll Med, Ruth L & David S Gottesman Inst Stem Cell & Regen, Bronx, NY 10461 USA; [Kunisaki, Yuya; Bruns, Ingmar; Scheiermann, Christoph; Pinho, Sandra; Zhang, Dachuan; Mizoguchi, Toshihide; Wei, Qiaozhi; Ito, Keisuke; Frenette, Paul S.] Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA; [Bruns, Ingmar] Univ Dusseldorf, Dept Hematol Oncol & Clin Immunol, D-40225 Dusseldorf, Germany; [Ahmed, Jalal] Mt Sinai Sch Med, New York, NY 10029 USA; [Lucas, Daniel; Ito, Keisuke; Frenette, Paul S.] Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA; [Mar, Jessica C.; Bergman, Aviv] Albert Einstein Coll Med, Dept Syst & Computat Biol, Bronx, NY 10461 USA; [Mar, Jessica C.] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Heinrich Heine University Dusseldorf; Icahn School of Medicine at Mount Sinai; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Frenette, PS (corresponding author), Albert Einstein Coll Med, Ruth L & David S Gottesman Inst Stem Cell & Regen, Bronx, NY 10461 USA.	paul.frenette@einstein.yu.edu	Pinho, Sandra/GWC-8029-2022; Frenette, Paul S/J-8272-2012; Zhang, Dachuan/GZA-8781-2022; Lucas, Daniel/ABB-6893-2021; Scheiermann, Christoph/B-8261-2014	Frenette, Paul S/0000-0003-0862-9922; Lucas, Daniel/0000-0002-0147-5425; Scheiermann, Christoph/0000-0002-9212-0995; Zhang, Dachuan/0000-0002-1746-275X; Mar, Jessica/0000-0002-5147-9299; Pinho, Sandra/0000-0002-5241-7364; Bruns, Ingmar/0000-0001-6316-8378	New York Stem Cell Foundation-Druckenmiller Fellowship; German Research Foundation (DFG) (Emmy-Noether-Program); National Institutes of Health (R01 grants) [DK056638, HL069438, HL097700];  [T32 063754]; NATIONAL CANCER INSTITUTE [R00CA139009] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL116340, R01HL069438, R01HL097700] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK098263, R01DK100689, R01DK056638] Funding Source: NIH RePORTER	New York Stem Cell Foundation-Druckenmiller Fellowship; German Research Foundation (DFG) (Emmy-Noether-Program)(German Research Foundation (DFG)); National Institutes of Health (R01 grants); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank P. P. Pandolfi for providing Pml<SUP>-/-</SUP> mice and D. Rowe, J. Butler and S. Rafii for providing Col2.3-GFP mice. We are grateful to L. Tesfa and O. Uche for technical assistance with sorting. S. P. is supported by a New York Stem Cell Foundation-Druckenmiller Fellowship and C. S. by the German Research Foundation (DFG) (Emmy-Noether-Program). J. A. was supported by Training Grant T32 063754. This work was enabled by the National Institutes of Health (R01 grants DK056638, HL069438, HL097700) to P.S.F.	Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Baldridge MT, 2010, NATURE, V465, P793, DOI 10.1038/nature09135; Bhattacharya D, 2009, J EXP MED, V206, P2837, DOI 10.1084/jem.20090778; Birbrair A, 2013, STEM CELL RES, V10, P67, DOI 10.1016/j.scr.2012.09.003; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Chi JT, 2003, P NATL ACAD SCI USA, V100, P10623, DOI 10.1073/pnas.1434429100; Chiang EY, 2007, NAT METHODS, V4, P219, DOI 10.1038/nmeth1018; Ding L, 2013, NATURE, V495, P231, DOI 10.1038/nature11885; Ding L, 2012, NATURE, V481, P457, DOI 10.1038/nature10783; Eaves C. J., 2008, CURR PROTOC IMMUNOL, V22; Ema H, 2012, BLOOD, V120, P2174, DOI 10.1182/blood-2012-04-424507; Essers MAG, 2009, NATURE, V458, P904, DOI 10.1038/nature07815; Frenette PS, 2013, ANNU REV IMMUNOL, V31, P285, DOI 10.1146/annurev-immunol-032712-095919; Greenbaum AM, 2011, LEUKEMIA, V25, P211, DOI 10.1038/leu.2010.248; Greenbaum A, 2013, NATURE, V495, P227, DOI 10.1038/nature11926; Hooper AT, 2009, CELL STEM CELL, V4, P263, DOI 10.1016/j.stem.2009.01.006; Hsu YC, 2011, CELL, V144, P92, DOI 10.1016/j.cell.2010.11.049; Ito K, 2008, NATURE, V453, P1072, DOI 10.1038/nature07016; Kalajzic Z, 2002, BONE, V31, P654, DOI 10.1016/S8756-3282(02)00912-2; Katayama Y, 2006, CELL, V124, P407, DOI 10.1016/j.cell.2005.10.041; Kawamoto T, 2003, ARCH HISTOL CYTOL, V66, P123, DOI 10.1679/aohc.66.123; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Li LH, 2010, SCIENCE, V327, P542, DOI 10.1126/science.1180794; Li XM, 2009, CIRCULATION, V120, P1910, DOI 10.1161/CIRCULATIONAHA.109.871574; Liu FL, 2008, J CLIN INVEST, V118, P946, DOI 10.1172/JCI32704; Mendez-Ferrer S, 2008, NATURE, V452, P442, DOI 10.1038/nature06685; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Mignone JL, 2004, J COMP NEUROL, V469, P311, DOI 10.1002/cne.10964; Naveiras O, 2009, NATURE, V460, P259, DOI 10.1038/nature08099; Nilsson SK, 2005, BLOOD, V106, P1232, DOI 10.1182/blood-2004-11-4422; Nombela-Arrieta C, 2013, NAT CELL BIOL, V15, P533, DOI 10.1038/ncb2730; Omatsu Y, 2010, IMMUNITY, V33, P387, DOI 10.1016/j.immuni.2010.08.017; Orford KW, 2008, NAT REV GENET, V9, P115, DOI 10.1038/nrg2269; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Passegue E, 2005, J EXP MED, V202, P1599, DOI 10.1084/jem.20050967; Sato T, 2009, NAT MED, V15, P696, DOI 10.1038/nm.1973; Shen ZM, 2012, NAT METHODS, V9, P273, DOI [10.1038/NMETH.1857, 10.1038/nmeth.1857]; Sipkins DA, 2005, NATURE, V435, P969, DOI 10.1038/nature03703; Stier S, 2005, J EXP MED, V201, P1781, DOI 10.1084/jem.20041992; Sugimura R, 2012, CELL, V150, P351, DOI 10.1016/j.cell.2012.05.041; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Takaku T, 2010, BLOOD, V116, pE41, DOI 10.1182/blood-2010-02-268466; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Winkler IG, 2012, NAT MED, V18, P1651, DOI 10.1038/nm.2969; Yamazaki S, 2011, CELL, V147, P1146, DOI 10.1016/j.cell.2011.09.053; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041; Zhu XQ, 2011, DEVELOPMENT, V138, P745, DOI 10.1242/dev.047951	48	777	796	7	94	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 31	2013	502	7473					637	+		10.1038/nature12612	http://dx.doi.org/10.1038/nature12612			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243CC	24107994	Green Accepted			2022-12-28	WOS:000326293200038
J	Guenther, UP; Yandek, LE; Niland, CN; Campbell, FE; Anderson, D; Anderson, VE; Harris, ME; Jankowsky, E				Guenther, Ulf-Peter; Yandek, Lindsay E.; Niland, Courtney N.; Campbell, Frank E.; Anderson, David; Anderson, Vernon E.; Harris, Michael E.; Jankowsky, Eckhard			Hidden specificity in an apparently nonspecific RNA-binding protein	NATURE			English	Article							RIBONUCLEASE-P; TRANSCRIPTION FACTORS; QUANTITATIVE-ANALYSIS; ENZYME SPECIFICITY; LANDSCAPES; HOLOENZYME; KINETICS; SEQUENCE; RECOGNITION; CATALYSIS	Nucleic-acid-binding proteins are generally viewed as either specific or nonspecific, depending on characteristics of their binding sites in DNA or RNA(1,2). Most studies have focused on specific proteins, which identify cognate sites by binding with highest affinities to regions with defined signatures in sequence, structure or both(1-4). Proteins that bind to sites devoid of defined sequence or structure signatures are considered nonspecific(1,2,5). Substrate binding by these proteins is poorly understood, and it is not known to what extent seemingly nonspecific proteins discriminate between different binding sites, aside from those sequestered by nucleic acid structures(6). Here we systematically examine substrate binding by the apparently nonspecific RNA-binding protein C5, and find clear discrimination between different binding site variants. C5 is the protein subunit of the transfer RNA processing ribonucleoprotein enzyme RNase P from Escherichia coli. The protein binds 59 leaders of precursor tRNAs at a site without sequence or structure signatures. We measure functional binding of C5 to all possible sequence variants in its substrate binding site, using a high-throughput sequencing kinetics approach (HITS-KIN) that simultaneously follows processing of thousands of RNA species. C5 binds different substrate variants with affinities varying by orders of magnitude. The distribution of functional affinities of C5 for all substrate variants resembles affinity distributions of highly specific nucleic acid binding proteins. Unlike these specific proteins, C5 does not bind its physiological RNA targets with the highest affinity, but with affinities near the median of the distribution, a region that is not associated with a sequence signature. We delineate defined rules governing substrate recognition by C5, which reveal specificity that is hidden in cellular substrates for RNase P. Our findings suggest that apparently nonspecific and specific RNA-binding modes may not differ fundamentally, but represent distinct parts of common affinity distributions.	[Guenther, Ulf-Peter; Campbell, Frank E.; Jankowsky, Eckhard] Case Western Reserve Univ, Ctr RNA Mol Biol, Cleveland, OH 44106 USA; [Guenther, Ulf-Peter; Yandek, Lindsay E.; Niland, Courtney N.; Anderson, Vernon E.; Harris, Michael E.; Jankowsky, Eckhard] Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA; [Anderson, David] CUNY, Baruch Coll, Zicklin Sch Business, Dept Management, New York, NY 10010 USA	Case Western Reserve University; Case Western Reserve University; City University of New York (CUNY) System; Baruch College (CUNY)	Harris, ME (corresponding author), Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA.	meh2@case.edu; exj13@case.edu	Anderson, Vernon/W-2673-2019	Anderson, Vernon Emmett/0000-0002-1699-7621; Jankowsky, Eckhard/0000-0001-7677-7412	US National Institutes of Health (NIH) [GM067700, GM099720, CSTA UL1RR024989, GM056740, GM096000, T32 GM008056]; DFG; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024989] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067700, R01GM099720, T32GM008056, R01GM096000, R01GM056740] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DFG(German Research Foundation (DFG)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We particularly thank T. Nilsen for comments on the manuscript. We are grateful to G. Stormo for discussion, M. Adams for support with the Illumina sequencing, and H.-C. Lin for technical assistance. This work was supported by the US National Institutes of Health (NIH) (GM067700, GM099720 and CSTA UL1RR024989 to E.J.; GM056740 and GM096000 to M.E.H.; T32 GM008056 to C.N.N.). U.-P.G. received a DFG fellowship.	Badis G, 2009, SCIENCE, V324, P1720, DOI 10.1126/science.1162327; BENDEL RB, 1977, J AM STAT ASSOC, V72, P46, DOI 10.2307/2286904; Campbell ZT, 2012, CELL REP, V1, P570, DOI 10.1016/j.celrep.2012.04.003; CHA S, 1968, MOL PHARMACOL, V4, P621; Chan PP, 2009, NUCLEIC ACIDS RES, V37, pD93, DOI 10.1093/nar/gkn787; Christian EL, 1998, BIOCHEMISTRY-US, V37, P17618, DOI 10.1021/bi982050a; Cleland WW, 2006, ISOTOPE EFFECTS CHEM, P915; CORNISHBOWDEN A, 1984, J THEOR BIOL, V108, P451, DOI 10.1016/S0022-5193(84)80045-4; Fersht A., 1985, ENZYME STRUCTURE MEC; Forsdyke DR, 2007, J THEOR BIOL, V248, P745, DOI 10.1016/j.jtbi.2007.07.008; Guo X, 2006, J MOL BIOL, V360, P190, DOI 10.1016/j.jmb.2006.05.001; Gupta A, 2011, J MOL BIOL, V409, P574, DOI 10.1016/j.jmb.2011.04.007; HERSCHLAG D, 1988, BIOORG CHEM, V16, P62, DOI 10.1016/0045-2068(88)90038-7; Kurz JC, 2000, CURR OPIN CHEM BIOL, V4, P553, DOI 10.1016/S1367-5931(00)00131-9; LaRiviere FJ, 2001, SCIENCE, V294, P165, DOI 10.1126/science.1064242; Leontis NB, 2006, CURR OPIN STRUC BIOL, V16, P279, DOI 10.1016/j.sbi.2006.05.009; Lorenz C, 2010, NUCLEIC ACIDS RES, V38, P3794, DOI 10.1093/nar/gkq032; Maerkl SJ, 2007, SCIENCE, V315, P233, DOI 10.1126/science.1131007; Northrop DB, 1999, ADV ENZYMOL RAMB, V73, P25, DOI 10.1002/9780470123195.ch2; NORTHROP DB, 1983, ANAL BIOCHEM, V132, P457, DOI 10.1016/0003-2697(83)90034-9; Nutiu R, 2011, NAT BIOTECHNOL, V29, P659, DOI 10.1038/nbt.1882; Pitt JN, 2010, SCIENCE, V330, P376, DOI 10.1126/science.1192001; Ray D, 2009, NAT BIOTECHNOL, V27, P667, DOI 10.1038/nbt.1550; Reiter NJ, 2010, NATURE, V468, P784, DOI 10.1038/nature09516; Rowe W, 2010, J R SOC INTERFACE, V7, P397, DOI 10.1098/rsif.2009.0193; Rueda D, 2005, BIOCHEMISTRY-US, V44, P16130, DOI 10.1021/bi0519093; SantaLucia J, 1997, BIOPOLYMERS, V44, P309, DOI 10.1002/(SICI)1097-0282(1997)44:3<309::AID-BIP8>3.3.CO;2-Y; SCHELLENBERGER V, 1993, BIOCHEMISTRY-US, V32, P4344, DOI 10.1021/bi00067a025; Singh R, 2005, NAT STRUCT MOL BIOL, V12, P645, DOI 10.1038/nsmb961; Smith JK, 2007, BIOPOLYMERS, V87, P329, DOI 10.1002/bip.20846; Snoussi K, 2001, BIOCHEMISTRY-US, V40, P8898, DOI 10.1021/bi010385d; Stormo GD, 2010, NAT REV GENET, V11, P751, DOI 10.1038/nrg2845; STORMO GD, 1986, NUCLEIC ACIDS RES, V14, P6661, DOI 10.1093/nar/14.16.6661; Sun L, 2010, J MOL BIOL, V395, P1019, DOI 10.1016/j.jmb.2009.11.027; VONHIPPEL PH, 1986, P NATL ACAD SCI USA, V83, P1608; Zhao Y, 2011, NAT BIOTECHNOL, V29, P480, DOI 10.1038/nbt.1893; Zhuang FL, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1263	38	63	63	2	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 17	2013	502	7471					385	+		10.1038/nature12543	http://dx.doi.org/10.1038/nature12543			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235GY	24056935	Green Accepted			2022-12-28	WOS:000325706300056
J	Behar, M; Barken, D; Werner, SL; Hoffmann, A				Behar, Marcelo; Barken, Derren; Werner, Shannon L.; Hoffmann, Alexander			The Dynamics of Signaling as a Pharmacological Target	CELL			English	Article							NF-KAPPA-B; GENE-EXPRESSION; TEMPORAL CONTROL; CELL FATE; KINASE; SPECIFICITY; INHIBITION; ACTIVATION; INFLAMMATION; MECHANISMS	Highly networked signaling hubs are often associated with disease, but targeting them pharmacologically has largely been unsuccessful in the clinic because of their functional pleiotropy. Motivated by the hypothesis that a dynamic signaling code confers functional specificity, we investigated whether dynamic features may be targeted pharmacologically to achieve therapeutic specificity. With a virtual screen, we identified combinations of signaling hub topologies and dynamic signal profiles that are amenable to selective inhibition. Mathematical analysis revealed principles that may guide stimulus-specific inhibition of signaling hubs, even in the absence of detailed mathematical models. Using the NFkB signaling module as a test bed, we identified perturbations that selectively affect the response to cytokines or pathogen components. Together, our results demonstrate that the dynamics of signaling may serve as a pharmacological target, and we reveal principles that delineate the opportunities and constraints of developing stimulus-specific therapeutic agents aimed at pleiotropic signaling hubs.	[Behar, Marcelo; Barken, Derren; Werner, Shannon L.; Hoffmann, Alexander] Univ Calif San Diego, Dept Chem & Biochem, Signaling Syst Lab, La Jolla, CA 92093 USA; [Behar, Marcelo; Hoffmann, Alexander] Univ Calif San Diego, San Diego Ctr Syst Biol, La Jolla, CA 92093 USA; [Behar, Marcelo; Hoffmann, Alexander] Univ Calif Los Angeles, Computat Biosci Inst, Los Angeles, CA 90025 USA; [Behar, Marcelo; Hoffmann, Alexander] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90025 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Hoffmann, A (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, Signaling Syst Lab, La Jolla, CA 92093 USA.	ahoffmann@ucla.edu			NIH [P50 GM085764, R01 GM 089976, R01 GM072024, R01 CA141722, R01 GM071573]; Cancer Research Institute; NATIONAL CANCER INSTITUTE [R01CA141722] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM071862, R01GM089976, R01GM072024, R01GM071573, P50GM085764] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge helpful discussions with members of the San Diego Center of Systems Biology, critical reading by P. Loriaux (UCSD), and helpful suggestions by an anonymous reviewer. The work presented here was supported by grants from the NIH P50 GM085764, R01 GM 089976, R01 GM072024, R01 CA141722, R01 GM071573, and a postdoctoral research fellowship from the Cancer Research Institute.	Bardwell L, 2006, BIOCHEM SOC T, V34, P837, DOI 10.1042/BST0340837; Becker V, 2012, ADV EXP MED BIOL, V736, P313, DOI 10.1007/978-1-4419-7210-1_18; Behar M, 2007, P NATL ACAD SCI USA, V104, P16146, DOI 10.1073/pnas.0703894104; Behar M, 2013, BIOPHYS J, V105, P231, DOI 10.1016/j.bpj.2013.05.013; Behar M, 2010, CURR OPIN GENET DEV, V20, P684, DOI 10.1016/j.gde.2010.09.007; Berger SI, 2011, WIRES SYST BIOL MED, V3, P129, DOI 10.1002/wsbm.114; Bitterman PB, 2012, CELL CYCLE, V11, P1097, DOI 10.4161/cc.11.6.19610; Brennan P, 1996, BIOCHEM J, V320, P975, DOI 10.1042/bj3200975; Chalmers CJ, 2007, CELL SIGNAL, V19, P695, DOI 10.1016/j.cellsig.2006.09.001; Chavali S, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-78; Cohen P, 2002, NAT REV DRUG DISCOV, V1, P309, DOI 10.1038/nrd773; DiDonato JA, 2012, IMMUNOL REV, V246, P379, DOI 10.1111/j.1600-065X.2012.01099.x; Force T, 2007, NAT REV CANCER, V7, P332, DOI 10.1038/nrc2106; Frelin C, 2005, BLOOD, V105, P804, DOI 10.1182/blood-2004-04-1463; Gandhi TKB, 2006, NAT GENET, V38, P285, DOI 10.1038/ng1747; Gao C, 2010, CELL SIGNAL, V22, P717, DOI 10.1016/j.cellsig.2009.11.021; Ghoreschi K, 2009, NAT IMMUNOL, V10, P356, DOI 10.1038/ni.1701; Haney S, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-119; Hao N, 2008, J BIOL CHEM, V283, P33798, DOI 10.1074/jbc.C800179200; Hoffmann A, 2006, IMMUNOL REV, V210, P171, DOI 10.1111/j.0105-2896.2006.00375.x; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Karin M, 2008, CELL RES, V18, P334, DOI 10.1038/cr.2008.30; Kearns JD, 2006, J CELL BIOL, V173, P659, DOI 10.1083/jcb.200510155; KLUSSMANN E, 2008, PROTEIN PROTEIN INTE; Komarova NL, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100031; Kubota H, 2012, MOL CELL, V46, P820, DOI 10.1016/j.molcel.2012.04.018; Lin WW, 2007, J CLIN INVEST, V117, P1175, DOI 10.1172/JCI31537; Ma'ayan A, 2007, MT SINAI J MED, V74, P27, DOI 10.1002/msj.20002; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Oda K, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100057; Park SH, 2003, SCIENCE, V299, P1061, DOI 10.1126/science.1076979; Purvis JE, 2013, CELL, V152, P945, DOI 10.1016/j.cell.2013.02.005; Purvis JE, 2012, SCIENCE, V336, P1440, DOI 10.1126/science.1218351; Roering Michael, 2012, Critical Reviews in Oncogenesis, V17, P97; Schneider A, 2012, BIOESSAYS, V34, P542, DOI 10.1002/bies.201100172; Schrofelbauer B, 2012, MOL CELL, V47, P111, DOI 10.1016/j.molcel.2012.04.020; Seki E, 2012, GASTROENTEROLOGY, V143, P307, DOI 10.1053/j.gastro.2012.06.004; Sung MH, 2004, MOL PHARMACOL, V66, P70, DOI 10.1124/mol.66.1.70; Sung MH, 2008, MOL PHARMACOL, V74, P1215, DOI 10.1124/mol.108.049114; Weinberg RA, 2007, BIOL CANC; Werner SL, 2005, SCIENCE, V309, P1857, DOI 10.1126/science.1113319; Zalatan JG, 2012, SCIENCE, V337, P1218, DOI 10.1126/science.1220683; Zhang X, 2008, TRENDS BIOTECHNOL, V26, P295, DOI 10.1016/j.tibtech.2008.02.008	43	94	96	0	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 10	2013	155	2					448	461		10.1016/j.cell.2013.09.018	http://dx.doi.org/10.1016/j.cell.2013.09.018			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	235LH	24120141	Green Accepted, Bronze			2022-12-28	WOS:000325719800020
J	Dalton, RP; Lyons, DB; Lomvardas, S				Dalton, Ryan P.; Lyons, David B.; Lomvardas, Stavros			Co-Opting the Unfolded Protein Response to Elicit Olfactory Receptor Feedback	CELL			English	Article							MAMMALIAN ODORANT RECEPTORS; PLASMA-CELL DIFFERENTIATION; TRANSCRIPTION FACTOR XBP-1; FUNCTIONAL EXPRESSION; GENE-EXPRESSION; SENSORY NEURONS; TRANSLATIONAL CONTROL; MOUSE; ATF5; SURVIVAL	Olfactory receptor (OR) expression requires the transcriptional activation of 1 out of 1,000s of OR alleles and a feedback signal that preserves this transcriptional choice. The mechanism by which olfactory sensory neurons (OSNs) detect ORs to signal to the nucleus remains elusive. Here, we show that OR proteins generate this feedback by activating the unfolded protein response (UPR). OR expression induces Perk-mediated phosphorylation of the translation initiation factor eif2 alpha causing selective translation of activating transcription factor 5 (ATF5). ATF5 induces the transcription of adenylyl cyclase 3 (Adcy3), which relieves the UPR. Our data provide a role for the UPR in defining neuronal identity and cell fate commitment and support a two-step model for the feedback signal: (1) OR protein, as a stress stimulus, alters the translational landscape of the OSN and induces Adcy3 expression; (2), Adcy3 relieves that stress, restores global translation, and makes OR choice permanent.	[Dalton, Ryan P.; Lyons, David B.; Lomvardas, Stavros] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94158 USA; [Dalton, Ryan P.; Lomvardas, Stavros] Univ Calif San Francisco, Grad Program Neurosci, San Francisco, CA 94158 USA; [Lyons, David B.; Lomvardas, Stavros] Univ Calif San Francisco, Tetrad Grad Program, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Lomvardas, S (corresponding author), Univ Calif San Francisco, Dept Anat, San Francisco, CA 94158 USA.	stavros.lomvardas@ucsf.edu		Lyons, David/0000-0002-5721-4080; Lomvardas, Stavros/0000-0002-7668-3026	McKnight Endowment fund for Neuroscience; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007810] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD006667] Funding Source: NIH RePORTER	McKnight Endowment fund for Neuroscience; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We would like to thank Drs. Richard Axel, Nirao Shah, Peter Walter, Zachary Knight, and Gilad Barnea and members of the Lomvardas lab for input, suggestions and discussions and for critical comments on the manuscript. Natalia Zyma, Zoe Evans, and Shohei Kitano provided excellent technical assistance for this project. We are also grateful to Dr. David Ron for allowing us access to the Perk KO mice and to Dr. Peter Walter for transferring Perk +/- mice to our colony and for inspiring this project. Finally we would like to thank Dr. Townes and Dr. Glimcher for the ATF4 and Xbp1 KO mice, respectively. This project was funded by a scholar award from the McKnight Endowment fund for Neuroscience.	Barnea G, 2004, SCIENCE, V304, P1468, DOI 10.1126/science.1096146; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; Clowney EJ, 2012, CELL, V151, P724, DOI 10.1016/j.cell.2012.09.043; Clowney EJ, 2011, GENOME RES, V21, P1249, DOI 10.1101/gr.120162.110; Colquitt BM, 2013, P NATL ACAD SCI USA, V110, P14682, DOI 10.1073/pnas.1302759110; Dey S, 2011, P NATL ACAD SCI USA, V108, P16651, DOI 10.1073/pnas.1018140108; Feinstein P, 2004, CELL, V117, P817, DOI 10.1016/j.cell.2004.05.011; Feinstein P, 2004, CELL, V117, P833, DOI 10.1016/j.cell.2004.05.013; Fleischmann A, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001568; Hansen MB, 2002, GENOMICS, V80, P344, DOI 10.1006/geno.2002.6838; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Imai T, 2006, SCIENCE, V314, P657, DOI 10.1126/science.1131794; Iwakoshi NN, 2003, NAT IMMUNOL, V4, P321, DOI 10.1038/ni907; Iwakoshi NN, 2003, IMMUNOL REV, V194, P29, DOI 10.1034/j.1600-065X.2003.00057.x; Lewcock JW, 2004, P NATL ACAD SCI USA, V101, P1069, DOI 10.1073/pnas.0307986100; Lomvardas S, 2006, CELL, V126, P403, DOI 10.1016/j.cell.2006.06.035; Lyons DB, 2013, CELL, V154, P325, DOI 10.1016/j.cell.2013.06.039; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Magklara A, 2013, TRENDS CELL BIOL, V23, P449, DOI 10.1016/j.tcb.2013.04.005; Magklara A, 2011, CELL, V145, P555, DOI 10.1016/j.cell.2011.03.040; Matsunami H, 2005, CHEM SENSES, V30, pI95, DOI 10.1093/chemse/bjh131; Matsunami H, 2009, ANN NY ACAD SCI, V1170, P153, DOI 10.1111/j.1749-6632.2009.03888.x; Nguyen MQ, 2007, CELL, V131, P1009, DOI 10.1016/j.cell.2007.10.050; Niimura Y, 2005, P NATL ACAD SCI USA, V102, P6039, DOI 10.1073/pnas.0501922102; PACE U, 1985, NATURE, V316, P255, DOI 10.1038/316255a0; Reimold AM, 2001, NATURE, V412, P300, DOI 10.1038/35085509; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Saito H, 2004, CELL, V119, P679, DOI 10.1016/j.cell.2004.11.021; Sammeta N, 2007, J COMP NEUROL, V502, P1138, DOI 10.1002/cne.21365; Sammeta N, 2010, J COMP NEUROL, V518, P1825, DOI 10.1002/cne.22305; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Serizawa S, 2003, SCIENCE, V302, P2088, DOI 10.1126/science.1089122; Shykind BM, 2004, CELL, V117, P801, DOI 10.1016/j.cell.2004.05.015; SPEAKE B K, 1980, Biochemical Society Transactions, V8, P166; Wang SZ, 2012, P NATL ACAD SCI USA, V109, P18589, DOI 10.1073/pnas.1210479109; Watatani Y, 2008, J BIOL CHEM, V283, P2543, DOI 10.1074/jbc.M707781200; Zhang XM, 2002, NAT NEUROSCI, V5, P124, DOI 10.1038/nn800; Zhou DH, 2008, J BIOL CHEM, V283, P7064, DOI 10.1074/jbc.M708530200; Zhuang HY, 2007, J BIOL CHEM, V282, P15284, DOI 10.1074/jbc.M700386200	41	84	85	0	16	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 10	2013	155	2					321	332		10.1016/j.cell.2013.09.033	http://dx.doi.org/10.1016/j.cell.2013.09.033			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	235LH	24120133	Green Accepted, Bronze			2022-12-28	WOS:000325719800010
J	Doksani, Y; Wu, JY; de Lange, T; Zhuang, XW				Doksani, Ylli; Wu, John Y.; de Lange, Titia; Zhuang, Xiaowei			Super-Resolution Fluorescence Imaging of Telomeres Reveals TRF2-Dependent T-loop Formation	CELL			English	Article							END-PROTECTION PROBLEM; DNA-DAMAGE RESPONSE; MAMMALIAN TELOMERES; DYSFUNCTIONAL TELOMERES; HOLLIDAY JUNCTIONS; NUCLEAR-MATRIX; POT1 PROTEINS; IN-VITRO; TRF2; COMPLEX	We have applied a super-resolution fluorescence imaging method, stochastic optical reconstruction microscopy (STORM), to visualize the structure of functional telomeres and telomeres rendered dysfunctional through removal of shelterin proteins. The STORM images showed that functional telomeres frequently exhibit a t-loop configuration. Conditional deletion of individual components of shelterin showed that TRF2 was required for the formation and/or maintenance of t-loops, whereas deletion of TRF1, Rap1, or the POT1 proteins (POT1a and POT1b) had no effect on the frequency of t-loop occurrence. Within the shelterin complex, TRF2 uniquely serves to protect telomeres from two pathways that are initiated on free DNA ends: classical nonhomologous end-joining (NHEJ) and ATM-dependent DNA damage signaling. The TRF2-dependent remodeling of telomeres into t-loop structures, which sequester the ends of chromosomes, can explain why NHEJ and the ATM signaling pathway are repressed when TRF2 is present.	[Doksani, Ylli; de Lange, Titia] Rockefeller Univ, Lab Cell Biol & Genet, New York, NY 10065 USA; [Wu, John Y.] Harvard Univ, Howard Hughes Med Inst, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Wu, John Y.; Zhuang, Xiaowei] Harvard Univ, Howard Hughes Med Inst, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Zhuang, Xiaowei] Harvard Univ, Howard Hughes Med Inst, Dept Phys, Cambridge, MA 02138 USA	Rockefeller University; Harvard University; Howard Hughes Medical Institute; Harvard University; Howard Hughes Medical Institute; Harvard University; Howard Hughes Medical Institute	de Lange, T (corresponding author), Rockefeller Univ, Lab Cell Biol & Genet, New York, NY 10065 USA.	delange@mail.rockefeller.edu; zhuang@chemistry.harvard.edu	de Lange, Titia/B-8263-2011	de Lange, Titia/0000-0002-9267-367X; Doksani, Ylli/0000-0002-2392-5722	National Science Foundation; NIH [AG016642, GM049046, GM068518, GM096450]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068518, R01GM096450, R01GM049046, R37GM049046] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG016642] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We are grateful to members of the de Lange and Zhuang labs for comments on this manuscript. Y.D. is an Ellison Medical Foundation/AFAR Fellow of the Life Sciences Research Foundation. J.Y.W. was supported as a National Science Foundation Graduate Research fellow. This work was supported by grants from the NIH to T.d.L. (AG016642 and GM049046) and to X.Z. (GM068518 and GM096450). T.d.L. is an American Cancer Society Research Professor. X.Z. is a Howard Hughes Medical Institute Investigator.	Amiard S, 2007, NAT STRUCT MOL BIOL, V14, P147, DOI 10.1038/nsmb1192; Arat NO, 2012, J BIOL CHEM, V287, P41583, DOI 10.1074/jbc.M112.415984; Artandi SE, 2010, CARCINOGENESIS, V31, P9, DOI 10.1093/carcin/bgp268; Azzalin CM, 2007, SCIENCE, V318, P798, DOI 10.1126/science.1147182; Bates M, 2007, SCIENCE, V317, P1749, DOI 10.1126/science.1146598; Bianchi A, 1999, EMBO J, V18, P5735, DOI 10.1093/emboj/18.20.5735; Bianchi A, 1997, EMBO J, V16, P1785, DOI 10.1093/emboj/16.7.1785; Callegari AJ, 2007, CELL CYCLE, V6, P660, DOI 10.4161/cc.6.6.3984; Celli GB, 2005, NAT CELL BIOL, V7, P712, DOI 10.1038/ncb1275; Chapman JR, 2013, MOL CELL, V49, P858, DOI 10.1016/j.molcel.2013.01.002; Cotta-Ramusino C, 2011, SCIENCE, V332, P1313, DOI 10.1126/science.1203430; de Lange T, 2009, SCIENCE, V326, P948, DOI 10.1126/science.1170633; DELANGE T, 1992, EMBO J, V11, P717, DOI 10.1002/j.1460-2075.1992.tb05104.x; Denchi EL, 2007, NATURE, V448, P1068, DOI 10.1038/nature06065; Diotti R, 2011, NUCLEUS-PHILA, V2, P119, DOI 10.4161/nucl.2.2.15135; Feuerhahn S, 2010, FEBS LETT, V584, P3812, DOI 10.1016/j.febslet.2010.07.032; Gong Y, 2010, MOL CELL, V40, P377, DOI 10.1016/j.molcel.2010.10.016; Griffith J, 1998, J MOL BIOL, V278, P79, DOI 10.1006/jmbi.1998.1686; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; Guo X, 2007, EMBO J, V26, P4709, DOI 10.1038/sj.emboj.7601893; Hockemeyer D, 2008, GENE DEV, V22, P1773, DOI 10.1101/gad.1679208; Hockemeyer D, 2006, CELL, V126, P63, DOI 10.1016/j.cell.2006.04.044; Huang B, 2008, SCIENCE, V319, P810, DOI 10.1126/science.1153529; Huang B, 2010, CELL, V143, P1047, DOI 10.1016/j.cell.2010.12.002; Huang B, 2008, NAT METHODS, V5, P1047, DOI 10.1038/nmeth.1274; Karlseder J, 1999, SCIENCE, V283, P1321, DOI 10.1126/science.283.5406.1321; Kibe T, 2010, MOL CELL BIOL, V30, P1059, DOI 10.1128/MCB.01498-09; KIPLING D, 1990, NATURE, V347, P400, DOI 10.1038/347400a0; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Luderus ME, 1996, J CELL BIOL, V135, P867, DOI 10.1083/jcb.135.4.867; Martinez P, 2010, NAT CELL BIOL, V12, P768, DOI 10.1038/ncb2081; Martinez P, 2009, GENE DEV, V23, P2060, DOI 10.1101/gad.543509; McClintock B, 1941, GENETICS, V26, P234; McClintock B., 1938, COLLECTED PAPERS B M, P1; Nam EA, 2011, BIOCHEM J, V436, P527, DOI 10.1042/BJ20102162; Nikitina T, 2004, J CELL BIOL, V166, P161, DOI 10.1083/jcb.200403118; Nora GJ, 2010, NUCLEIC ACIDS RES, V38, P3984, DOI 10.1093/nar/gkq144; O'Sullivan RJ, 2010, NAT REV MOL CELL BIO, V11, P171, DOI 10.1038/nrm2848; Okamoto K, 2013, NATURE, V494, P502, DOI 10.1038/nature11873; ORRWEAVER TL, 1981, P NATL ACAD SCI-BIOL, V78, P6354, DOI 10.1073/pnas.78.10.6354; Palm W, 2009, MOL CELL BIOL, V29, P471, DOI 10.1128/MCB.01352-08; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Pierron G, 1999, CHROMOSOME RES, V7, P581, DOI 10.1023/A:1009253917125; Pipkin ME, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl006; Poulet A, 2009, EMBO J, V28, P641, DOI 10.1038/emboj.2009.11; Rai R, 2010, EMBO J, V29, P2598, DOI 10.1038/emboj.2010.142; Savage SA, 2010, GENET MED, V12, P753, DOI 10.1097/GIM.0b013e3181f415b5; Sfeir A, 2012, SCIENCE, V336, P593, DOI 10.1126/science.1218498; Sfeir A, 2010, SCIENCE, V327, P1657, DOI 10.1126/science.1185100; Sfeir A, 2009, CELL, V138, P90, DOI 10.1016/j.cell.2009.06.021; Smogorzewska A, 2002, CURR BIOL, V12, P1635, DOI 10.1016/S0960-9822(02)01179-X; Stansel RM, 2001, EMBO J, V20, P5532; Stracker TH, 2011, NAT REV MOL CELL BIO, V12, P90, DOI 10.1038/nrm3047; Takai KK, 2011, MOL CELL, V44, P647, DOI 10.1016/j.molcel.2011.08.043; Tejera AM, 2010, DEV CELL, V18, P775, DOI [10.1016/j.devcel.2010.03.011, 10.1016/j.devce1.2010.03.011]; van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0; Verdun RE, 2006, CELL, V127, P709, DOI 10.1016/j.cell.2006.09.034; Wu P, 2012, CELL, V150, P39, DOI 10.1016/j.cell.2012.05.026; Zimmermann M, 2013, SCIENCE, V339, P700, DOI 10.1126/science.1231573	59	298	307	3	159	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 10	2013	155	2					345	356		10.1016/j.cell.2013.09.048	http://dx.doi.org/10.1016/j.cell.2013.09.048			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	235LH	24120135	Bronze, Green Accepted			2022-12-28	WOS:000325719800012
J	Loh, E; Kugelberg, E; Tracy, A; Zhang, Q; Gollan, B; Ewles, H; Chalmers, R; Pelicic, V; Tang, CM				Loh, Edmund; Kugelberg, Elisabeth; Tracy, Alexander; Zhang, Qian; Gollan, Bridget; Ewles, Helen; Chalmers, Ronald; Pelicic, Vladimir; Tang, Christoph M.			Temperature triggers immune evasion by Neisseria meningitidis	NATURE			English	Article							POLYSIALIC ACID CAPSULE; UPPER RESPIRATORY-TRACT; INFLUENZA-A; VIRUS-INFECTION; BIOSYNTHESIS; GENES; COMPLEMENT; MECHANISMS; EXPRESSION; RESISTANCE	Neisseria meningitidis has several strategies to evade complement-mediated killing, and these contribute to its ability to cause septicaemic disease and meningitis. However, the meningococcus is primarily an obligate commensal of the human nasopharynx, and it is unclear why the bacterium has evolved exquisite mechanisms to avoid host immunity. Here we demonstrate that mechanisms of meningococcal immune evasion and resistance against complement increase in response to an increase in ambient temperature. We have identified three independent RNA thermosensors located in the 5' untranslated regions of genes necessary for capsule biosynthesis, the expression of factor H binding protein, and sialylation of lipopolysaccharide, which are essential for meningococcal resistance against immune killing(1,2). Therefore increased temperature (which occurs during inflammation) acts as a 'danger signal' for the meningococcus, enhancing its defence against human immune killing. Infection with viral pathogens, such as influenza, leads to inflammation in the nasopharynx with an increased temperature and recruitment of immune effectors(3,4). Thermoregulation of immune defence could offer an adaptive advantage to the meningococcus during co-infection with other pathogens, and promote the emergence of virulence in an otherwise commensal bacterium.	[Loh, Edmund; Tracy, Alexander; Tang, Christoph M.] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Kugelberg, Elisabeth; Zhang, Qian; Gollan, Bridget; Ewles, Helen; Pelicic, Vladimir; Tang, Christoph M.] Univ London Imperial Coll Sci Technol & Med, Ctr Mol Microbiol & Infect, London SW7 2AZ, England; [Chalmers, Ronald] Univ Nottingham, Sch Biomed Sci, Nottingham NG7 2NR, England	University of Oxford; Imperial College London; University of Nottingham	Tang, CM (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, Sir Parks Rd, Oxford OX1 3RE, England.	christoph.tang@path.ox.ac.uk	Pelicic, Vladimir/N-3755-2017; Pelicic, Vladimir/ABD-3102-2021	Pelicic, Vladimir/0000-0002-9456-4995; Pelicic, Vladimir/0000-0002-9456-4995; Tracy, Alexander/0000-0003-4109-3568; Loh, Edmund/0000-0001-7050-566X; Kugelberg, Elisabeth/0000-0002-8302-3595; chalmers, ronald/0000-0002-1395-7173	Wellcome Trust; Medical Research Council; Oxford Martin School; Swedish Research Council [524-2010-6726]; EMBO; MRC [MR/J006874/1, G0900888] Funding Source: UKRI; Medical Research Council [G0900888] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Oxford Martin School; Swedish Research Council(Swedish Research CouncilEuropean Commission); EMBO(European Molecular Biology Organization (EMBO)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Work in C.M.T.'s laboratory is funded by Programme Grants from the Wellcome Trust and the Medical Research Council, and by the Oxford Martin School. E. L. was supported by an International Postdoctoral fellowship from the Swedish Research Council (Dnr: 524-2010-6726) and E. K. was supported by an EMBO long-term fellowship. We are grateful to J. Johansson, S. Busby and other members of the Tang group for discussions, and to B. Kallipolitis for providing E. coli 30S ribosomes.	BJORNSON AB, 1991, AM REV RESPIR DIS, V143, P1062, DOI 10.1164/ajrccm/143.5_Pt_1.1062; Bohme K, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002518; CARTWRIGHT KAV, 1991, LANCET, V338, P554, DOI 10.1016/0140-6736(91)91112-8; Chalmers RM, 1996, EMBO J, V15, P5112, DOI 10.1002/j.1460-2075.1996.tb00892.x; COLE P, 1954, J Laryngol Otol, V68, P295, DOI 10.1017/S0022215100049690; GANGULI S, 1994, J BACTERIOL, V176, P4583, DOI 10.1128/JB.176.15.4583-4589.1994; Gentile D, 1998, CLIN DIAGN LAB IMMUN, V5, P604, DOI 10.1128/CDLI.5.5.604-608.1998; HAMMERSCHMIDT S, 1994, MOL MICROBIOL, V11, P885, DOI 10.1111/j.1365-2958.1994.tb00367.x; HOE NP, 1993, J BACTERIOL, V175, P7901, DOI 10.1128/JB.175.24.7901-7909.1993; Johansson J, 2002, CELL, V110, P551, DOI 10.1016/S0092-8674(02)00905-4; Uria MJ, 2008, J EXP MED, V205, P1423, DOI 10.1084/jem.20072577; Kahler CM, 1998, INFECT IMMUN, V66, P5939, DOI 10.1128/IAI.66.12.5939-5947.1998; Kugelberg E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009413; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Lijek RS, 2012, CURR OPIN IMMUNOL, V24, P417, DOI 10.1016/j.coi.2012.05.005; Morita M, 1999, J BACTERIOL, V181, P401, DOI 10.1128/JB.181.2.401-410.1999; Rameix-Welti MA, 2009, INFECT IMMUN, V77, P3588, DOI 10.1128/IAI.00155-09; Schneider MC, 2007, TRENDS MICROBIOL, V15, P233, DOI 10.1016/j.tim.2007.03.005; Schneider MC, 2006, J IMMUNOL, V176, P7566, DOI 10.4049/jimmunol.176.12.7566; Schneider MC, 2009, NATURE, V458, P890, DOI 10.1038/nature07769; Stephens DS, 2007, LANCET, V369, P2196, DOI 10.1016/S0140-6736(07)61016-2; STEPHENS DS, 1993, J INFECT DIS, V167, P475, DOI 10.1093/infdis/167.2.475; Tzeng YL, 2001, INFECT IMMUN, V69, P2502, DOI 10.1128/IAI.69.4.2502-2511.2001; van der Ende A, 2000, INFECT IMMUN, V68, P6685, DOI 10.1128/IAI.68.12.6685-6690.2000; von Loewenich FD, 2001, INT J MED MICROBIOL, V291, P361, DOI 10.1078/1438-4221-00142	25	99	99	3	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 10	2013	502	7470					237	+		10.1038/nature12616	http://dx.doi.org/10.1038/nature12616			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RU	24067614	Green Accepted			2022-12-28	WOS:000325436100051
J	Arnheim-Dahlstom, L; Pasternak, B; Svanstrom, H; Sparen, P; Hviid, A				Arnheim-Dahlstrom, Lisen; Pasternak, Bjorn; Svanstrom, Henrik; Sparen, Par; Hviid, Anders			Autoimmune, neurological, and venous thromboembolic adverse events after immunisation of adolescent girls with quadrivalent human papillomavirus vaccine in Denmark and Sweden: cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SAFETY; REGISTER; SURVEILLANCE; METAANALYSIS; EXPERIENCE; CHILDHOOD; DISEASES	Objective To assess the risk of serious adverse events after vaccination of adolescent girls with quadrivalent human papillomavirus (qHPV) vaccine. Design Register based cohort study. Setting Denmark and Sweden, October 2006 to December 2010. Participants 997 585 girls aged 10-17, among whom 296 826 received a total of 696 420 qHPV vaccine doses. Main outcome measures Incident hospital diagnosed autoimmune, neurological, and venous thromboembolic events (53 different outcomes) up to 180 days after each qHPV vaccine dose. Only events with at least five vaccine exposed cases were considered for further assessment. Rate ratios adjusted for age, country, calendar year, and parental country of birth, education, and socioeconomic status were estimated, comparing vaccinated and unvaccinated person time. For outcomes where the rate ratio was significantly increased, we regarded three criteria as signal strengthening: analysis based on 20 or more vaccine exposed cases (reliability), rate ratio 3.0 or more (strength), and significantly increased rate ratio in country specific analyses (consistency). We additionally assessed clustering of events in time and estimated rate ratios for a risk period that started on day 181. Results Among the 53 outcomes, at least five vaccine exposed cases occurred in 29 and these were analysed further. Whereas the rate ratios for 20 of 23 autoimmune events were not significantly increased, exposure to qHPV vaccine was significantly associated with Behcet's syndrome, Raynaud's disease, and type 1 diabetes. Each of these three outcomes fulfilled only one of three predefined signal strengthening criteria. Furthermore, the pattern of distribution in time after vaccination was random for all three and the rate ratios for these outcomes in the period from day 181 after vaccination were similar to the rate ratios in the primary risk period. The rate ratios for five neurological events were not significantly increased and there were inverse associations with epilepsy (rate ratio 0.66, 95% confidence interval 0.54 to 0.80) and paralysis (0.56, 0.35 to 0.90). There was no association between exposure to qHPV vaccine and venous thromboembolism (0.86, 0.55 to 1.36). Conclusions This large cohort study found no evidence supporting associations between exposure to qHPV vaccine and autoimmune, neurological, and venous thromboembolic adverse events. Although associations for three autoimmune events were initially observed, on further assessment these were weak and not temporally related to vaccine exposure. Furthermore, the findings need to be interpreted considering the multiple outcomes assessed.	[Arnheim-Dahlstrom, Lisen; Sparen, Par] Karolinska Inst, Dept Med Epidemiol & Biostat, S-17177 Stockholm, Sweden; [Pasternak, Bjorn; Svanstrom, Henrik; Hviid, Anders] Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen, Denmark	Karolinska Institutet; Statens Serum Institut	Arnheim-Dahlstom, L (corresponding author), Karolinska Inst, Dept Med Epidemiol & Biostat, S-17177 Stockholm, Sweden.	lisen.arnheim.dahlstrom@ki.se	Hviid, Anders/AAH-4319-2020; Pasternak, Bjorn/H-5739-2012	Hviid, Anders/0000-0002-7509-9127; Pasternak, Bjorn/0000-0002-2097-8466; Sparen, Par/0000-0002-5184-8971	Swedish Foundation for Strategic Research; Danish Medical Research Council	Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by a grant from the Swedish Foundation for Strategic Research and the Danish Medical Research Council. The funding bodies had no role in the study design; the collection, analysis, and interpretation of the data; the writing of the article; and the decision to submit it for publication. All authors are independent from the funding agencies.	Block SL, 2010, PEDIATR INFECT DIS J, V29, P95, DOI 10.1097/INF.0b013e3181b77906; Callreus T, 2009, VACCINE, V27, P2954, DOI 10.1016/j.vaccine.2009.02.106; Chao C, 2012, J INTERN MED, V271, P193, DOI 10.1111/j.1365-2796.2011.02467.x; Chao C, 2012, HUM VACC IMMUNOTHER, V8, P1302, DOI 10.4161/hv.21268; Descamps D, 2009, HUM VACCINES, V5, P332, DOI 10.4161/hv.5.5.7211; Farrington CP, 1996, AM J EPIDEMIOL, V143, P1165; Fridman Simard S, 2013, J NATL CANC IN PRESS; Gee J, 2011, VACCINE, V29, P8279, DOI 10.1016/j.vaccine.2011.08.106; Hviid A, 2006, EXPERT REV VACCINES, V5, P641, DOI 10.1586/14760584.5.5.641; Kildemoes HW, 2011, SCAND J PUBLIC HEALT, V39, P38, DOI 10.1177/1403494810394717; Klein NP, 2012, ARCH PEDIAT ADOL MED, V166, P1140, DOI 10.1001/archpediatrics.2012.1451; Laz TH, 2012, VACCINE, V30, P3534, DOI 10.1016/j.vaccine.2012.03.067; Lu BB, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-13; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; Ludvigsson JF, 2009, EUR J EPIDEMIOL, V24, P659, DOI 10.1007/s10654-009-9350-y; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Medical Products Agency, OCC NARC CAT CHILDR; Medical Products Agency, 2012, VACC HUM PAP HPV VAC; Nohynek H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033536; Pedersen CB, 2006, DAN MED BULL, V53, P441; Rasmussen TA, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e5823; Salmon DA, 2013, LANCET, V381, P1461, DOI 10.1016/S0140-6736(12)62189-8; Siegrist CA, 2007, CAN MED ASSOC J, V177, P1352, DOI 10.1503/cmaj.071134; Slade BA, 2009, JAMA-J AM MED ASSOC, V302, P750, DOI 10.1001/jama.2009.1201; Trim K, 2012, OBSTET GYNECOL INT, V2012, DOI 10.1155/2012/921236; van't Klooster TM, 2011, VACCINE, V29, P4601, DOI 10.1016/j.vaccine.2011.04.050; Wettermark B, 2007, PHARMACOEPIDEM DR S, V16, P726, DOI 10.1002/pds.1294; Wraith DC, 2003, LANCET, V362, P1659, DOI 10.1016/S0140-6736(03)14802-7	28	178	186	0	20	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 9	2013	347								f5906	10.1136/bmj.f5906	http://dx.doi.org/10.1136/bmj.f5906			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	235ON	24108159	Green Published, hybrid			2022-12-28	WOS:000325729100007
J	Tolar, J; Wagner, JE				Tolar, Jakub; Wagner, John E.			Allogeneic blood and bone marrow cells for the treatment of severe epidermolysis bullosa: repair of the extracellular matrix	LANCET			English	Article							PLURIPOTENT STEM-CELLS; VII COLLAGEN; GENE-THERAPY; REVERTANT MOSAICISM; EPITHELIAL-CELLS; SKIN; TRANSPLANTATION; FIBROBLASTS; DISEASE; COL7A1	Contrary to the prevailing professional opinion of the past few decades, recent experimental and clinical data support the fact that protein replacement therapy by allogeneic blood and marrow transplantation is not limited to freely diffusible molecules such as enzymes, but also large structural proteins such as collagens. A prime example is the cross-correction of type VII collagen deficiency in generalised severe recessive dystrophic epidermolysis bullosa, in which blood and marrow transplantation can attenuate the mucocutaneous manifestations of the disease and improve patients' quality of life. Although allogeneic blood and marrow transplantation can improve the integrity of the skin and mucous membranes, today's accomplishments are only the first steps on the long pathway to cure. Future strategies will be built on the lessons learned from these first transplant studies.	[Tolar, Jakub; Wagner, John E.] Univ Minnesota, Sch Med, Dept Pediat, Div Blood & Marrow Transplantat, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Wagner, JE (corresponding author), Univ Minnesota, Sch Med, 420 Delaware St SE,MMC 366, Minneapolis, MN 55455 USA.	wagne002@umn.edu		Tolar, Jakub/0000-0002-0957-4380	National Institutes of Health [R01 AR063070, R01AR059947]; US Department of Defense [W81XWH-12-1-0609]; Epidermolysis Bullosa Research Fund; Jackson Gabriel Silver Foundation; DEBRA; University of Minnesota Academic Health Center; Pioneering Unique Cures for Kids Foundation; Liao Family Fund; Sarah Moreland Fund; Children's Cancer Research Fund (Minneapolis, MN, USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR059947, R01AR063070] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Defense(United States Department of Defense); Epidermolysis Bullosa Research Fund; Jackson Gabriel Silver Foundation; DEBRA; University of Minnesota Academic Health Center; Pioneering Unique Cures for Kids Foundation; Liao Family Fund; Sarah Moreland Fund; Children's Cancer Research Fund (Minneapolis, MN, USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported in part by grants from the National Institutes of Health (R01 AR063070 and R01AR059947), US Department of Defense (W81XWH-12-1-0609), Epidermolysis Bullosa Research Fund, Jackson Gabriel Silver Foundation, DEBRA, University of Minnesota Academic Health Center, Pioneering Unique Cures for Kids Foundation, Liao Family Fund, Sarah Moreland Fund, and the Children's Cancer Research Fund (Minneapolis, MN, USA). We could not have completed this work without the generous support of many people, but especially John A McGrath (St John's Institute of Dermatology, King's College, London, UK) who reviewed the results, challenged our assumptions, and provided a measure of objectivity to our interpretation of the data. We also thank Alain Hovnanian (Inserm U781, Imagine Institut, Necker Hospital for Sick Children, Paris, France) and Katsuto Tamai (Department of Dermatology, Osaka University, Osaka, Japan) who with McGrath reviewed every patient record to verify the appropriateness for enrolment onto the trial; Colleen Delaney, who continues to chair the Data Safety and Monitoring Board for this trial; Douglas R Keene (Microimaging Center at the Shriner's Hospital for Children, Portland, OR, USA) for doing nearly all the electron microscopic studies; Megan Riddle (University of Minnesota, MN, USA) for immunofluorescence imaging; and David Woodley and Mei Chen (Keck School of Medicine, University of Southern California, Los Angeles, CA, USA) for assessments of anti-C7 antibodies.	Abdul-Wahab A, 2012, IMMUNOTHERAPY-UK, V4, P1859, DOI [10.2217/imt.12.120, 10.2217/IMT.12.120]; Alexeev V, 2011, CYTOTHERAPY, V13, P30, DOI 10.3109/14653249.2010.518609; Almaani N, 2010, J INVEST DERMATOL, V130, P1937, DOI 10.1038/jid.2010.64; Amabile G, 2013, BLOOD, V121, P1255, DOI 10.1182/blood-2012-06-434407; Appelbaum FR, 2007, NEW ENGL J MED, V357, P1472, DOI 10.1056/NEJMp078166; Araki R, 2013, NATURE, V494, P100, DOI 10.1038/nature11807; Bilousova G, 2011, J INVEST DERMATOL, V131, P857, DOI 10.1038/jid.2010.364; Blanpain C, 2009, NAT REV MOL CELL BIO, V10, P207, DOI 10.1038/nrm2636; Bogdanove AJ, 2011, SCIENCE, V333, P1843, DOI 10.1126/science.1204094; Bonfanti P, 2010, NATURE, V466, P978, DOI 10.1038/nature09269; Bruckner-Tuderman L, 2010, CELL TISSUE RES, V339, P1, DOI 10.1007/s00441-009-0891-x; Bruckner-Tuderman L, 2010, NEW ENGL J MED, V363, P680, DOI 10.1056/NEJMe1004319; Bruckner-Tuderman L, 2010, DERMATOL CLIN, V28, P107, DOI 10.1016/j.det.2009.10.020; Burdick JA, 2011, NAT METHODS, V8, P915, DOI 10.1038/nmeth.1745; Cavazzana-Calvo Marina, 2005, Annu Rev Med, V56, P585, DOI 10.1146/annurev.med.56.090203.104142; Chen M, 2002, NAT GENET, V32, P670, DOI 10.1038/ng1041; Chino T, 2008, AM J PATHOL, V173, P803, DOI 10.2353/ajpath.2008.070977; Conget P, 2010, CYTOTHERAPY, V12, P429, DOI 10.3109/14653241003587637; Dawkins Richard, 1976, SELFISH GENE; De Luca M, 2009, BRIT J DERMATOL, V161, P19, DOI 10.1111/j.1365-2133.2009.09243.x; Fine JD, 2008, J AM ACAD DERMATOL, V58, P931, DOI 10.1016/j.jaad.2008.02.004; Fine JD, 2010, ANN NY ACAD SCI, V1194, P213, DOI 10.1111/j.1749-6632.2010.05463.x; Fritsch A, 2008, J CLIN INVEST, V118, P1669, DOI 10.1172/JCI34292; Handel EM, 2011, CURR GENE THER, V11, P28, DOI 10.2174/156652311794520120; Heinonen S, 1999, J CELL SCI, V112, P3641; HOBBS JR, 1981, LANCET, V2, P709; Hsu YC, 2011, CELL, V144, P92, DOI 10.1016/j.cell.2010.11.049; Ito K, 2009, AM J PATHOL, V175, P2508, DOI 10.2353/ajpath.2009.090347; Itoh M, 2011, P NATL ACAD SCI USA, V108, P8797, DOI 10.1073/pnas.1100332108; Kern JS, 2009, MOL THER, V17, P1605, DOI 10.1038/mt.2009.144; Khan FM, 2010, BIOL BLOOD MARROW TR, V16, P1658, DOI 10.1016/j.bbmt.2010.07.012; Kiel MJ, 2008, BLOOD, V111, P4413, DOI 10.1182/blood-2007-12-129601; Krause DS, 2001, CELL, V105, P369, DOI 10.1016/S0092-8674(01)00328-2; Lai-Cheong JE, 2011, TRENDS MOL MED, V17, P140, DOI 10.1016/j.molmed.2010.11.003; Lara-Corrales I, 2010, PEDIATR DERMATOL, V27, P229, DOI 10.1111/j.1525-1470.2010.01086.x; Lu CP, 2012, CELL, V150, P136, DOI 10.1016/j.cell.2012.04.045; Mavilio F, 2006, NAT MED, V12, P1397, DOI 10.1038/nm1504; Mellerio JE, 2010, DERMATOL CLIN, V28, P267, DOI 10.1016/j.det.2010.01.004; Moiani A, 2012, J CLIN INVEST, V122, P1653, DOI 10.1172/JCI61852; Murata H, 2007, BLOOD, V109, P2663, DOI 10.1182/blood-2006-07-033902; Murauer EM, 2011, J INVEST DERMATOL, V131, P74, DOI 10.1038/jid.2010.249; Nagy N, 2011, J INVEST DERMATOL, V131, P1771, DOI 10.1038/jid.2011.85; Naldini L, 2011, NAT REV GENET, V12, P301, DOI 10.1038/nrg2985; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Ortiz-Urda S, 2003, J CLIN INVEST, V111, P251, DOI 10.1172/JCI200317193; Osborn MJ, 2013, MOL THER, V21, P1151, DOI 10.1038/mt.2013.56; Otsuru S, 2012, BLOOD, V120, P1933, DOI 10.1182/blood-2011-12-400085; Park D, 2012, FRONT BIOSCI-LANDMRK, V17, P30, DOI 10.2741/3913; Pasmooij AMG, 2012, DISCOV MED, V14, P167; Pasmooij AMG, 2010, J INVEST DERMATOL, V130, P2407, DOI 10.1038/jid.2010.163; Pasteur L., 1854, CHAMPS OBSERVATION H; Petrof G, 2013, EXP DERMATOL, V22, P433, DOI 10.1111/exd.12152; Petrova A, 2010, BRIT J DERMATOL, V163, P1149, DOI 10.1111/j.1365-2133.2010.09981.x; Pope E, 2013, ADV SKIN WOUND CARE, V26, P177, DOI 10.1097/01.ASW.0000428864.72412.b7; Prockop DJ, 2009, MOL THER, V17, P939, DOI 10.1038/mt.2009.62; Remington J, 2009, MOL THER, V17, P26, DOI 10.1038/mt.2008.234; Rivat C, 2012, HUM GENE THER, V23, P668, DOI 10.1089/hum.2012.116; Saleh MA, 2011, J DERMATOL SCI, V62, P169, DOI 10.1016/j.jdermsci.2011.03.003; Sasaki M, 2008, J IMMUNOL, V180, P2581, DOI 10.4049/jimmunol.180.4.2581; Tamai K, 2011, P NATL ACAD SCI USA, V108, P6609, DOI 10.1073/pnas.1016753108; THOMAS ED, 1957, NEW ENGL J MED, V257, P491, DOI 10.1056/NEJM195709122571102; Titeux M, 2010, MOL THER, V18, P1509, DOI 10.1038/mt.2010.91; Titeux M, 2010, DERMATOL CLIN, V28, P361, DOI 10.1016/j.det.2010.02.003; Tolar J, 2008, BONE MARROW TRANSPL, V41, P531, DOI 10.1038/sj.bmt.1705934; Tolar J, 2013, J INVEST DERMATOL, V133, P562, DOI 10.1038/jid.2012.278; Tolar J, 2011, STEM CELLS, V29, P900, DOI 10.1002/stem.647; Tolar J, 2011, J INVEST DERMATOL, V131, P848, DOI 10.1038/jid.2010.346; Tolar J, 2009, BLOOD, V113, P1167, DOI 10.1182/blood-2008-06-161299; Uitto J, 2012, J INVEST DERMATOL, V132, P820, DOI [10.1038/jid.2011.389, 10.1038/skinbio.2012.6]; Uitto J, 2011, J INVEST DERMATOL, V131, P1597, DOI 10.1038/jid.2011.125; Uitto J, 2010, J INVEST DERMATOL, V130, P1778, DOI 10.1038/jid.2010.90; Wagers AJ, 2012, CELL STEM CELL, V10, P362, DOI 10.1016/j.stem.2012.02.018; Wagner JE, 2010, NEW ENGL J MED, V363, P629, DOI 10.1056/NEJMoa0910501; Watt FM, 2013, NAT REV MOL CELL BIO, V14, P467, DOI 10.1038/nrm3620; Wong T, 2008, J INVEST DERMATOL, V128, P2179, DOI 10.1038/jid.2008.78; Woodley DT, 2007, MOL THER, V15, P628, DOI 10.1038/sj.mt.6300041; Woodley DT, 2004, MOL THER, V10, P318, DOI 10.1016/j.ymthe.2004.05.016; Wu SM, 2011, NAT CELL BIOL, V13, P497, DOI 10.1038/ncb0511-497; Yan WF, 2010, DERMATOL CLIN, V28, P367, DOI 10.1016/j.det.2010.01.015; Yasuda Masahito, 2013, Methods Mol Biol, V989, P143, DOI 10.1007/978-1-62703-330-5_12; Zhao TB, 2011, NATURE, V474, P212, DOI 10.1038/nature10135	81	51	56	1	23	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 5	2013	382	9899					1214	1223		10.1016/S0140-6736(13)61897-8	http://dx.doi.org/10.1016/S0140-6736(13)61897-8			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	228SL	24095195	Green Accepted			2022-12-28	WOS:000325209100026
J	Graham, MJ; Frederick, J; Byars-Winston, A; Hunter, AB; Handelsman, J				Graham, Mark J.; Frederick, Jennifer; Byars-Winston, Angela; Hunter, Anne-Barrie; Handelsman, Jo			Increasing Persistence of College Students in STEM	SCIENCE			English	Editorial Material							UNDERGRADUATE RESEARCH; SCIENTISTS; DIVERSITY; GENOMICS		[Graham, Mark J.; Frederick, Jennifer; Handelsman, Jo] Yale Univ, Ctr Sci Teaching, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Graham, Mark J.] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06511 USA; [Byars-Winston, Angela] Univ Wisconsin, Sch Med & Publ Hlth, Dept Med, Madison, WI 53705 USA; [Hunter, Anne-Barrie] Univ Colorado, Boulder, CO 80309 USA	Yale University; Yale University; University of Wisconsin System; University of Wisconsin Madison; University of Colorado System; University of Colorado Boulder	Handelsman, J (corresponding author), Yale Univ, Ctr Sci Teaching, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.	jo.handelsman@yale.edu		BYARS-WINSTON, ANGELA/0000-0002-2616-1748	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R13GM090574] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [1R13GM090574-01] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		[Anonymous], 2012, ENGAGE EXCEL PRODUCI; BANDURA A, 1989, AM PSYCHOL, V44, P1175, DOI 10.1037/0003-066X.44.9.1175; Byars-Winston A, 2011, CBE-LIFE SCI EDUC, V10, P357, DOI 10.1187/cbe.10-12-0145; DWECK CS, 1986, AM PSYCHOL, V41, P1040, DOI 10.1037/0003-066X.41.10.1040; Estrada M, 2011, J EDUC PSYCHOL, V103, P206, DOI 10.1037/a0020743; Haak DC, 2011, SCIENCE, V332, P1213, DOI 10.1126/science.1204820; Handelsman J, 2007, SCI TEACHING; Hatfull GF, 2006, PLOS GENET, V2, P835, DOI 10.1371/journal.pgen.0020092; Hewitt Nancy M., 1997, TALKING LEAVING; Hunter AB, 2007, SCI EDUC, V91, P36, DOI 10.1002/sce.20173; Light G., 2013, MAKING SCI; Lopatto D, 2008, SCIENCE, V322, P684, DOI 10.1126/science.1165351; Matsui John, 2003, Cell Biol Educ, V2, P117, DOI 10.1187/cbe.02-10-0050; Moss-Racusin CA, 2012, P NATL ACAD SCI USA, V109, P16474, DOI 10.1073/pnas.1211286109; Nagda BA, 1998, REV HIGH EDUC, V22, P55; National Academy of Sciences National Academy of Engineering Institute of Medicine, 2011, EXP UND RES MIN PART; Pfund C, 2009, SCIENCE, V324, P470, DOI 10.1126/science.1170015; Russell SH, 2007, SCIENCE, V316, P548, DOI 10.1126/science.1140384; Summers MF, 2006, SCIENCE, V311, P1870, DOI 10.1126/science.1125257; Thiry H, 2011, J HIGH EDUC-UK, V82, P357, DOI 10.1080/00221546.2011.11777209	20	338	340	1	156	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 27	2013	341	6153					1455	1456		10.1126/science.1240487	http://dx.doi.org/10.1126/science.1240487			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	224NS	24072909				2022-12-28	WOS:000324894600031
J	Schneeberger, M; Dietrich, MO; Sebastian, D; Imbernon, M; Castano, C; Garcia, A; Esteban, Y; Gonzalez-Franquesa, A; Rodriguez, IC; Bortolozzi, A; Garcia-Roves, PM; Gomis, R; Nogueiras, R; Horvath, TL; Zorzano, A; Claret, M				Schneeberger, Marc; Dietrich, Marcelo O.; Sebastian, David; Imbernon, Monica; Castano, Carlos; Garcia, Ainhoa; Esteban, Yaiza; Gonzalez-Franquesa, Alba; Castrillon Rodriguez, Ignacio; Bortolozzi, Analia; Garcia-Roves, Pablo M.; Gomis, Ramon; Nogueiras, Ruben; Horvath, Tamas L.; Zorzano, Antonio; Claret, Marc			Mitofusin 2 in POMC Neurons Connects ER Stress with Leptin Resistance and Energy Imbalance	CELL			English	Article							ENDOPLASMIC-RETICULUM STRESS; DIET-INDUCED OBESITY; MITOCHONDRIAL FUSION; HOMEOSTASIS REGULATION; SKELETAL-MUSCLE; AGRP NEURONS; FOOD-INTAKE; MFN2; METABOLISM; INSULIN	Mitofusin 2 (MFN2) plays critical roles in both mitochondrial fusion and the establishment of mitochondria- endoplasmic reticulum (ER) interactions. Hypothalamic ER stress has emerged as a causative factor for the development of leptin resistance, but the underlying mechanisms are largely unknown. Here, we show that mitochondria-ER contacts in anorexigenic pro-opiomelanocortin (POMC) neurons in the hypothalamus are decreased in diet-induced obesity. POMC-specific ablation of Mfn2 resulted in loss of mitochondria-ER contacts, defective POMC processing, ER stress-induced leptin resistance, hyperphagia, reduced energy expenditure, and obesity. Pharmacological relieve of hypothalamic ER stress reversed these metabolic alterations. Our data establish MFN2 in POMC neurons as an essential regulator of systemic energy balance by fine-tuning the mitochondrial-ER axis homeostasis and function. This previously unrecognized role for MFN2 argues for a crucial involvement in mediating ER stress-induced leptin resistance.	[Schneeberger, Marc; Castano, Carlos; Garcia, Ainhoa; Esteban, Yaiza; Gonzalez-Franquesa, Alba; Garcia-Roves, Pablo M.; Gomis, Ramon; Claret, Marc] Inst Invest Biomed August Pi & Sunyer IDIBAPS, Diabet & Obes Res Lab, Barcelona 08036, Spain; [Schneeberger, Marc; Gomis, Ramon] Univ Barcelona, Sch Med, Hosp Clin, Dept Endocrinol & Nutr, E-08036 Barcelona, Spain; [Schneeberger, Marc; Sebastian, David; Castano, Carlos; Garcia, Ainhoa; Esteban, Yaiza; Castrillon Rodriguez, Ignacio; Garcia-Roves, Pablo M.; Gomis, Ramon; Zorzano, Antonio; Claret, Marc] Ctr Invest Biomed Red Diabet & Enfermedades Metab, Barcelona 08036, Spain; [Dietrich, Marcelo O.; Horvath, Tamas L.] Yale Univ, Sch Med, Comparat Med Sect, Program Integrat Cell Signaling & Neurobiol Metab, New Haven, CT 06520 USA; [Dietrich, Marcelo O.] Univ Fed Rio Grande do Sul, Dept Biochem, BR-90035 Porto Alegre, RS, Brazil; [Sebastian, David; Castrillon Rodriguez, Ignacio; Zorzano, Antonio] Inst Res Biomed IRB Barcelona, Barcelona 08028, Spain; [Sebastian, David; Castrillon Rodriguez, Ignacio; Zorzano, Antonio] Univ Barcelona, Fac Biol, Dept Bioquim & Biol Mol, E-08028 Barcelona, Spain; [Imbernon, Monica; Nogueiras, Ruben] Univ Santiago de Compostela, Inst Invest Sanitaria, Sch Med, Dept Physiol, Santiago De Compostela 15782, Spain; [Imbernon, Monica; Nogueiras, Ruben] Ctr Invest Biomed Red Fisiopatol Obesidad & Nutr, Santiago De Compostela 15782, Spain; [Bortolozzi, Analia] IIBB CSIC IDIBAPS, Dept Neurochem & Neuropharmacol, Barcelona 08036, Spain; [Bortolozzi, Analia] Ctr Invest Biomed Red Salud Mental CIBERSAM, Barcelona 08036, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; Yale University; Universidade Federal do Rio Grande do Sul; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; University of Barcelona; Universidade de Santiago de Compostela; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas de Barcelona (IIBB); University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM	Claret, M (corresponding author), Inst Invest Biomed August Pi & Sunyer IDIBAPS, Diabet & Obes Res Lab, Barcelona 08036, Spain.	mclaret@clinic.ub.es	Pane, Marc Schneeberger/ABG-7816-2020; Gonzalez-Franquesa, Alba/G-1691-2015; Zorzano, Antonio/R-5479-2018; Schneeberger Pane, Marc/ABC-2627-2021; Bortolozzi, Analia/R-6159-2018; Dietrich, Marcelo/A-9928-2009; Roves, Pablo Garcia/A-7113-2015; Nogueiras, Ruben/AAS-9427-2021; García Alamán, Ainhoa/AFP-1866-2022; Sebastián, David/ABH-1574-2020; Esteban, Yaiza/AAD-8116-2020; Castaño, Carlos/AAS-3591-2021; Garcia-Roves, Pablo M./X-4585-2018	Gonzalez-Franquesa, Alba/0000-0001-9081-753X; Schneeberger Pane, Marc/0000-0001-7369-104X; Bortolozzi, Analia/0000-0002-2069-9192; Dietrich, Marcelo/0000-0001-9781-2221; Nogueiras, Ruben/0000-0002-9976-9930; García Alamán, Ainhoa/0000-0002-1703-7905; Castaño, Carlos/0000-0003-1671-7826; Esteban, Yaiza/0000-0002-7283-5977; Imbernon, Monica/0000-0003-4359-4817; Claret, Marc/0000-0001-7766-9296; Sebastian, David/0000-0002-7260-3869; Garcia-Roves, Pablo M./0000-0002-8371-2067	RecerCaixa Grant [2010ACUP_ 00275]; EFSD/Lilly Fellowship Award; Ministerio de Ciencia e Innovacion (MICINN), Instituto de Salud Carlos III (ISCIII) Grant [PI10/01074]; MICINN Grant [SAF2010-19527, BFU2011-24679]; Ministerio de Economia y Competitividad (MINECO) Grant [BFU2012-35255]; Xunta de Galicia Grant [EM2012/039, 2012-CP069]; CIBERobn; European Community's Seventh Framework Programme Grant [ERC-2011-StGOBESITY53- 281408]; MINECO Grant [SAF2008-03803]; Generalitat de Catalunya Grant [2009SGR915]; CIBERDEM; INTERREG IVB- SUDOE-FEDER (DIOMED) [SOE1/P1/E178]; European Commission; MITIN Grant [HEALTH-F4-2008223450]; ISCIII Grant [PI10/00290]; NIH [DP1DK006850, R01AG040236, P01NS062686]; American Diabetes Association, Helmholtz society (ICEMED); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil [401476/2012-0]; University of Barcelona; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [DP1DK098058] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS062686] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG040236] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD006850] Funding Source: NIH RePORTER	RecerCaixa Grant; EFSD/Lilly Fellowship Award; Ministerio de Ciencia e Innovacion (MICINN), Instituto de Salud Carlos III (ISCIII) Grant; MICINN Grant(Spanish Government); Ministerio de Economia y Competitividad (MINECO) Grant; Xunta de Galicia Grant(Xunta de Galicia); CIBERobn; European Community's Seventh Framework Programme Grant; MINECO Grant(Spanish Government); Generalitat de Catalunya Grant(Generalitat de Catalunya); CIBERDEM; INTERREG IVB- SUDOE-FEDER (DIOMED); European Commission(European CommissionEuropean Commission Joint Research Centre); MITIN Grant; ISCIII Grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association, Helmholtz society (ICEMED); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); University of Barcelona; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We are grateful to Dr Gregory S Barsh (Stanford University) for providing Pomc-cre mice, Dr Maria Calvo and Anna Bosch from the Confocal microscopy unit (SCT-UB), Merce` Monfar (UPV-CBATEG), and members from the Diabetes and Obesity Lab. This work has been supported by: RecerCaixa Grant 2010ACUP_ 00275 (M. C.); EFSD/Lilly Fellowship Award (M. C.); Ministerio de Ciencia e Innovacion (MICINN), Instituto de Salud Carlos III (ISCIII) Grant PI10/01074 (M. C.); MICINN Grant SAF2010-19527 (R.G.); Ministerio de Economia y Competitividad (MINECO) Grant BFU2012-35255 (RN); Xunta de Galicia Grant EM2012/039 and 2012-CP069 (R. N.); CIBERobn (R. N.); European Community's Seventh Framework Programme Grant ERC-2011-StGOBESITY53- 281408 (R. N.); MINECO Grant SAF2008-03803 (A. Z.); Generalitat de Catalunya Grant 2009SGR915 (A. Z.); CIBERDEM (A. Z.); INTERREG IVB- SUDOE-FEDER (DIOMED, SOE1/P1/E178) (A. Z.); European Commission Seventh Framework Programme (FP7), MITIN Grant HEALTH-F4-2008223450 (A. Z.); MICINN Grant BFU2011-24679 (P. M. G.-R.); ISCIII Grant PI10/00290 (A. B.). T. L. H. and M. O. D. are supported by NIH (DP1DK006850, R01AG040236, P01NS062686), American Diabetes Association, Helmholtz society (ICEMED) and by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (401476/2012-0, Brazil). M. S. is a recipient of an undergraduate grant from the University of Barcelona. M. C. is a recipient of a Miguel Servet contract (CP09/00233) from MICINN-ISCIII. P. M. G.-R. is a recipient of a Ramon y Cajal contract (RYC-2009-05158) from MICINN. Some of these grants are cofinanced by the European Regional Development Fund "A way to build Europe.'' This work was carried out in part at the Esther Koplowitz Centre, Barcelona.	Al-Qassab H, 2009, CELL METAB, V10, P343, DOI 10.1016/j.cmet.2009.09.008; Bach D, 2005, DIABETES, V54, P2685, DOI 10.2337/diabetes.54.9.2685; Bach D, 2003, J BIOL CHEM, V278, P17190, DOI 10.1074/jbc.M212754200; Bjorbaek C, 2009, J INVEST MED, V57, P789, DOI 10.2310/JIM.0b013e3181bb0d49; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; Chen HC, 2007, CELL, V130, P548, DOI 10.1016/j.cell.2007.06.026; Claret M, 2007, J CLIN INVEST, V117, P2325, DOI 10.1172/JCI31516; Claret M, 2011, DIABETES, V60, P735, DOI 10.2337/db10-1055; Czyzyk TA, 2012, FASEB J, V26, P3483, DOI 10.1096/fj.12-208041; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; Diano S, 2011, NAT MED, V17, P1121, DOI 10.1038/nm.2421; Dieguez C, 2011, NEUROENDOCRINOLOGY, V94, P1, DOI 10.1159/000328122; Dietrich MO, 2013, CELL, V155, P188, DOI 10.1016/j.cell.2013.09.004; Gamber KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030485; Gyengesi E, 2012, CURR NEUROPHARMACOL, V10, P344, DOI 10.2174/157015912804143496; Hernandez-Alvarez MI, 2009, DIABETOLOGIA, V52, P1618, DOI 10.1007/s00125-009-1403-y; Hosoi T, 2008, MOL PHARMACOL, V74, P1610, DOI 10.1124/mol.108.050070; Hernandez-Alvarez MI, 2010, DIABETES CARE, V33, P645, DOI 10.2337/dc09-1305; Kitamura T, 2006, NAT MED, V12, P534, DOI 10.1038/nm1392; Lee S, 2012, HUM MOL GENET, V21, P4827, DOI 10.1093/hmg/dds352; Mandl J, 2009, TRENDS ENDOCRIN MET, V20, P194, DOI 10.1016/j.tem.2009.01.003; Misko AL, 2012, J NEUROSCI, V32, P4145, DOI 10.1523/JNEUROSCI.6338-11.2012; Munzberg H, 2003, ENDOCRINOLOGY, V144, P2121, DOI 10.1210/en.2002-221037; Myers MG, 2012, NATURE, V491, P357, DOI 10.1038/nature11705; Ngoh GA, 2012, J BIOL CHEM, V287, P20321, DOI 10.1074/jbc.M112.359174; Novak A, 2000, GENESIS, V28, P147, DOI 10.1002/1526-968X(200011/12)28:3/4<147::AID-GENE90>3.0.CO;2-G; Ozcan L, 2009, CELL METAB, V9, P35, DOI 10.1016/j.cmet.2008.12.004; Papanicolaou KN, 2012, AM J PHYSIOL-HEART C, V302, pH167, DOI 10.1152/ajpheart.00833.2011; Papanicolaou KN, 2011, MOL CELL BIOL, V31, P1309, DOI 10.1128/MCB.00911-10; Pham AH, 2012, HUM MOL GENET, V21, P4817, DOI 10.1093/hmg/dds311; Rowland AA, 2012, NAT REV MOL CELL BIO, V13, P607, DOI 10.1038/nrm3440; Sebastian D, 2012, P NATL ACAD SCI USA, V109, P5523, DOI 10.1073/pnas.1108220109; Sisley S, 2011, REV ENDOCR METAB DIS, V12, P219, DOI 10.1007/s11154-011-9189-x; Wallingford N, 2009, J CLIN INVEST, V119, P2291, DOI 10.1172/JCI37209; Wardlaw SL, 2011, EUR J PHARMACOL, V660, P213, DOI 10.1016/j.ejphar.2010.10.107; Williams KW, 2012, NAT NEUROSCI, V15, P1350, DOI 10.1038/nn.3217; Won JC, 2009, OBESITY, V17, P1861, DOI 10.1038/oby.2009.194; Xu AW, 2005, J CLIN INVEST, V115, P951, DOI 10.1172/JCI200524301; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855; Zhang XQ, 2008, CELL, V135, P61, DOI 10.1016/j.cell.2008.07.043; Zorzano A, 2010, SEMIN CELL DEV BIOL, V21, P566, DOI 10.1016/j.semcdb.2010.01.002	41	368	377	2	42	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 26	2013	155	1					172	187		10.1016/j.cell.2013.09.003	http://dx.doi.org/10.1016/j.cell.2013.09.003			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	224UX	24074867	Green Submitted, Bronze, Green Accepted			2022-12-28	WOS:000324916700018
J	Pi, HJ; Hangya, B; Kvitsiani, D; Sanders, JI; Huang, ZJ; Kepecs, A				Pi, Hyun-Jae; Hangya, Balazs; Kvitsiani, Duda; Sanders, Joshua I.; Huang, Z. Josh; Kepecs, Adam			Cortical interneurons that specialize in disinhibitory control	NATURE			English	Article							GABAERGIC NEURONS; IMMUNOREACTIVE INTERNEURONS; DISYNAPTIC INHIBITION; MOLECULAR COMPOSITION; TRANSGENIC MICE; PYRAMIDAL CELLS; VISUAL-CORTEX; INNERVATION; SELECTIVITY; ACTIVATION	In the mammalian cerebral cortex the diversity of interneuronal subtypes underlies a division of labour subserving distinct modes of inhibitory control(1-7). A unique mode of inhibitory control may be provided by inhibitory neurons that specifically suppress the firing of other inhibitory neurons. Such disinhibition could lead to the selective amplification of local processing and serve the important computational functions of gating and gain modulation(8,9). Although several interneuron populations are known to target other interneurons to varying degrees(10-15), little is known about interneurons specializing in disinhibition and their in vivo function. Here we show that a class of interneurons that express vasoactive intestinal polypeptide (VIP) mediates disinhibitory control in multiple areas of neocortex and is recruited by reinforcement signals. By combining optogenetic activation with single-cell recordings, we examined the functional role of VIP interneurons in awake mice, and investigated the underlying circuit mechanisms in vitro in auditory and medial prefrontal cortices. We identified a basic disinhibitory circuit module in which activation of VIP interneurons transiently suppresses primarily somatostatin- and a fraction of parvalbumin-expressing inhibitory interneurons that specialize in the control of the input and output of principal cells, respectively(3,6,16,17). During the performance of an auditory discrimination task, reinforcement signals (reward and punishment) strongly and uniformly activated VIP neurons in auditory cortex, and in turn VIP recruitment increased the gain of a functional subpopulation of principal neurons. These results reveal a specific cell type and microcircuit underlying disinhibitory control in cortex and demonstrate that it is activated under specific behavioural conditions.	[Pi, Hyun-Jae; Hangya, Balazs; Kvitsiani, Duda; Sanders, Joshua I.; Huang, Z. Josh; Kepecs, Adam] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Hangya, Balazs] Hungarian Acad Sci, Inst Expt Med, Lab Cerebral Cortex Res, H-1083 Budapest, Hungary	Cold Spring Harbor Laboratory; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine	Kepecs, A (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	kepecs@cshl.edu	Hangya, Balazs/H-5964-2019; Core, Vector/CAF-4832-2022	Hangya, Balazs/0000-0003-2709-7407; Kvitsiani, Duda/0000-0003-3175-1774; Kepecs, Adam/0000-0003-0049-8120; Huang, Z. Josh/0000-0003-0592-028X	NIH NINDS [R01NS075531]; Klingenstein Foundation; John Merck Foundation; Sloan Foundation; NIH NIMH [U01MH078844]; Swartz Foundation; EU; Robert Lee and Clara Guthrie Patterson Trust; Human Frontier Science Program; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH078844] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS075531] Funding Source: NIH RePORTER	NIH NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Klingenstein Foundation(Klingenstein Philanthropies); John Merck Foundation; Sloan Foundation(Alfred P. Sloan Foundation); NIH NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Swartz Foundation; EU(European Commission); Robert Lee and Clara Guthrie Patterson Trust; Human Frontier Science Program(Human Frontier Science Program); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to B. Mensh, S. Ranade, N. Spruston and A. M. Zador for comments and discussions; S. Ranade and R. Eifert for assistance for microdrive design; S. G. Koh, A. Reid, H. Li and Y. Kim for help with experimental setup; A. M. Zador for use of in vitro electrophysiology equipment; B. Burbach for technical assistance; and J. Kuhl for help with figures. This research was supported by grants from NIH NINDS R01NS075531, the Klingenstein, John Merck, and Sloan Foundations to A.K. and from NIH NIMH U01MH078844 to Z.J.H. B.H. received support from the Swartz Foundation and Marie Curie International Outgoing Fellowship within the EU Seventh Framework Programme for Research and Technological Development. D.K. received support from The Robert Lee and Clara Guthrie Patterson Trust Postdoctoral Fellowship and Human Frontier Science Program.	Acsady L, 1996, NEUROSCIENCE, V73, P317, DOI 10.1016/0306-4522(95)00609-5; Alitto HJ, 2013, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00079; Arroyo S, 2012, J NEUROSCI, V32, P3859, DOI 10.1523/JNEUROSCI.0115-12.2012; Ascoli GA, 2008, NAT REV NEUROSCI, V9, P557, DOI 10.1038/nrn2402; Carandini M, 1997, J NEUROSCI, V17, P8621; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Chattopadhyaya B, 2004, J NEUROSCI, V24, P9598, DOI 10.1523/JNEUROSCI.1851-04.2004; Csicsvari J, 1998, NEURON, V21, P179, DOI 10.1016/S0896-6273(00)80525-5; David C, 2007, EUR J NEUROSCI, V25, P2329, DOI 10.1111/j.1460-9568.2007.05496.x; Gentet LJ, 2012, NAT NEUROSCI, V15, P607, DOI 10.1038/nn.3051; Hajos N, 1996, EUR J NEUROSCI, V8, P1415, DOI 10.1111/j.1460-9568.1996.tb01604.x; Isaacson JS, 2011, NEURON, V72, P231, DOI 10.1016/j.neuron.2011.09.027; Jiang XL, 2013, NAT NEUROSCI, V16, P210, DOI 10.1038/nn.3305; Kapfer C, 2007, NAT NEUROSCI, V10, P743, DOI 10.1038/nn1909; Katona I, 2006, J NEUROSCI, V26, P5628, DOI 10.1523/JNEUROSCI.0309-06.2006; Kawaguchi Y, 1997, J NEUROPHYSIOL, V78, P1743, DOI 10.1152/jn.1997.78.3.1743; Kvitsiani D, 2013, NATURE, V498, P363, DOI 10.1038/nature12176; Lee SH, 2012, NATURE, V488, P379, DOI 10.1038/nature11312; Letzkus JJ, 2011, NATURE, V480, P331, DOI 10.1038/nature10674; Lorincz A, 2008, J NEUROSCI, V28, P14329, DOI 10.1523/JNEUROSCI.4833-08.2008; Lovett-Barron M, 2012, NAT NEUROSCI, V15, P423, DOI 10.1038/nn.3024; Madisen L, 2012, NAT NEUROSCI, V15, P793, DOI 10.1038/nn.3078; Oliva AA, 2000, J NEUROSCI, V20, P3354, DOI 10.1523/JNEUROSCI.20-09-03354.2000; Paspalas CD, 2001, BRAIN RES, V891, P158, DOI 10.1016/S0006-8993(00)03193-0; Pfeffer CK, 2013, NAT NEUROSCI, V16, P1068, DOI 10.1038/nn.3446; Rudy B, 2011, DEV NEUROBIOL, V71, P45, DOI 10.1002/dneu.20853; Salinas Emilio, 2000, Neuron, V27, P15, DOI 10.1016/S0896-6273(00)00004-0; Schmitzer-Torbert N, 2005, NEUROSCIENCE, V131, P1, DOI 10.1016/j.neuroscience.2004.09.066; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Silberberg G, 2007, NEURON, V53, P735, DOI 10.1016/j.neuron.2007.02.012; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Taniguchi H, 2011, NEURON, V71, P995, DOI 10.1016/j.neuron.2011.07.026; Varga V, 2008, J PHYSIOL-LONDON, V586, P3893, DOI 10.1113/jphysiol.2008.155242; Williford T, 2006, J NEUROPHYSIOL, V96, P40, DOI 10.1152/jn.01207.2005; Xu H, 2013, NEURON, V77, P155, DOI 10.1016/j.neuron.2012.11.004; Xu XM, 2010, J COMP NEUROL, V518, P389, DOI 10.1002/cne.22229; Zhang F, 2011, CELL, V147, P1446, DOI 10.1016/j.cell.2011.12.004	37	642	648	3	117	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 28	2013	503	7477					521	+		10.1038/nature12676	http://dx.doi.org/10.1038/nature12676			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	258MU	24097352	Green Accepted			2022-12-28	WOS:000327464200042
J	Pose, D; Verhage, L; Ott, F; Yant, L; Mathieu, J; Angenent, GC; Immink, RGH; Schmid, M				Pose, David; Verhage, Leonie; Ott, Felix; Yant, Levi; Mathieu, Johannes; Angenent, Gerco C.; Immink, Richard G. H.; Schmid, Markus			Temperature-dependent regulation of flowering by antagonistic FLM variants	NATURE			English	Article							MADS-BOX GENE; CIRCADIAN CLOCK; FUNCTIONAL-ANALYSIS; FLORAL TRANSITION; ARABIDOPSIS; IDENTIFICATION; REPRESSOR; TIME; VERNALIZATION; RESPONSES	The appropriate timing of flowering is crucial for plant reproductive success. It is therefore not surprising that intricate genetic networks have evolved to perceive and integrate both endogenous and environmental signals, such as carbohydrate and hormonal status, photoperiod and temperature(1,2). In contrast to our detailed understanding of the vernalization pathway, little is known about how flowering time is controlled in response to changes in the ambient growth temperature. In Arabidopsis thaliana, the MADS-box transcription factor genes FLOWERING LOCUS M (FLM) and SHORT VEGETATIVE PHASE (SVP) have key roles in this process(3,4). FLM is subject to temperature-dependent alternative splicing(3). Here we report that the two main FLM protein splice variants, FLM-beta and FLM-delta, compete for interaction with the floral repressor SVP. The SVP-FLM-beta complex is predominately formed at low temperatures and prevents precocious flowering. By contrast, the competing SVP-FLM-delta complex is impaired in DNA binding and acts as a dominant-negative activator of flowering at higher temperatures. Our results show a new mechanism that controls the timing of the floral transition in response to changes in ambient temperature. A better understanding of how temperature controls the molecular mechanisms of flowering will be important to cope with current changes in global climate(5,6).	[Pose, David; Ott, Felix; Yant, Levi; Mathieu, Johannes; Schmid, Markus] Max Planck Inst Dev Biol, Dept Mol Biol, D-72076 Tubingen, Germany; [Verhage, Leonie; Angenent, Gerco C.; Immink, Richard G. H.] Plant Res Int, Biosci, NL-6708 PB Wageningen, Netherlands; [Verhage, Leonie; Angenent, Gerco C.] Wageningen Univ, Mol Biol Lab, NL-6708 PB Wageningen, Netherlands	Max Planck Society; Wageningen University & Research	Schmid, M (corresponding author), Max Planck Inst Dev Biol, Dept Mol Biol, Spemannstr 35, D-72076 Tubingen, Germany.	markus.schmid@tuebingen.mpg.de	Immink, Richard G.H./A-9825-2011; Schmid, Markus/I-4384-2015; Yant, Levi/ABH-1275-2020; Posé, David/A-3424-2014	Schmid, Markus/0000-0002-0068-2967; Posé, David/0000-0003-3332-4661; Verhage, Leonie/0000-0001-6402-3605; Immink, Richard/0000-0002-0182-4138; Yant, Levi/0000-0003-3442-0217	ERA-NET PLANT GENOMICS collaborative project BLOOM-NET; Deutsche Forschungsgemeinschaft [SCHM 1560/7-1]; MPI for Developmental Biology; BLOOM-NET related NWO grant; NWO/TTI-Green Genetics THERMOFLOW grant	ERA-NET PLANT GENOMICS collaborative project BLOOM-NET; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); MPI for Developmental Biology; BLOOM-NET related NWO grant; NWO/TTI-Green Genetics THERMOFLOW grant	We thank F. Hohnstein, J. Weirich, C. Martin-Pizarro, J. Busscher-Lange, C. Lanz and J. Reixinger for technical assistance, A. Srikanth for BiFC vectors, and P. Huijser and B. Davies for seeds. Supported through the ERA-NET PLANT GENOMICS collaborative project BLOOM-NET by a grant from the Deutsche Forschungsgemeinschaft (SCHM 1560/7-1) and the MPI for Developmental Biology to M.S., a BLOOM-NET related NWO grant to R.G.H.I. and G.C.A., and a NWO/TTI-Green Genetics THERMOFLOW grant to R.G.H.I., G.C.A. and L.V.	Balasubramanian S, 2006, PLOS GENET, V2, P980, DOI 10.1371/journal.pgen.0020106; CHOUARD P, 1960, ANNU REV PLANT PHYS, V11, P191, DOI 10.1146/annurev.pp.11.060160.001203; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; de Felippes FF, 2010, METHODS MOL BIOL, V592, P255, DOI 10.1007/978-1-60327-005-2_17; de Folter S, 2005, PLANT CELL, V17, P1424, DOI 10.1105/tpc.105.031831; Franklin KA, 2011, P NATL ACAD SCI USA, V108, P20231, DOI 10.1073/pnas.1110682108; Gu XF, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2947; Immink RGH, 2012, PLANT PHYSIOL, V160, P433, DOI 10.1104/pp.112.202614; James AB, 2012, PLANT CELL, V24, P961, DOI 10.1105/tpc.111.093948; James P, 1996, GENETICS, V144, P1425; Jiao YL, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.76; Jones MA, 2012, PLANT CELL, V24, P4066, DOI 10.1105/tpc.112.104828; Kumar SV, 2012, NATURE, V484, P242, DOI 10.1038/nature10928; Kumar SV, 2010, CELL, V140, P136, DOI 10.1016/j.cell.2009.11.006; Lee JH, 2007, GENE DEV, V21, P397, DOI 10.1101/gad.1518407; Mann ME, 2008, P NATL ACAD SCI USA, V105, P13252, DOI 10.1073/pnas.0805721105; Marcott SA, 2013, SCIENCE, V339, P1198, DOI 10.1126/science.1228026; Masiero S, 2004, DEVELOPMENT, V131, P5981, DOI 10.1242/dev.01517; Mendez-Vigo B, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003289; Michaels SD, 1999, PLANT CELL, V11, P949, DOI 10.1105/tpc.11.5.949; Moyroud E, 2011, PLANT CELL, V23, P1293, DOI 10.1105/tpc.111.083329; Pose D, 2012, CURR OPIN PLANT BIOL, V15, P45, DOI 10.1016/j.pbi.2011.09.002; Riechmann JL, 1996, P NATL ACAD SCI USA, V93, P4793, DOI 10.1073/pnas.93.10.4793; Rosloski SM, 2013, PLANT MOL BIOL, V81, P57, DOI 10.1007/s11103-012-9982-2; Scortecci K, 2003, PLANT MOL BIOL, V52, P915, DOI 10.1023/A:1025426920923; Scortecci KC, 2001, PLANT J, V26, P229, DOI 10.1046/j.1365-313x.2001.01024.x; Severing EI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030524; Sheldon CC, 1999, PLANT CELL, V11, P445, DOI 10.1105/tpc.11.3.445; Srikanth A, 2011, CELL MOL LIFE SCI, V68, P2013, DOI 10.1007/s00018-011-0673-y; Tao Z, 2012, PLANT J, V70, P549, DOI 10.1111/j.1365-313X.2012.04919.x; van Dijk ADJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001017; Wang XX, 2012, PLANT CELL, V24, P3278, DOI 10.1105/tpc.112.100081; Werner JD, 2005, P NATL ACAD SCI USA, V102, P2460, DOI 10.1073/pnas.0409474102; Yant L, 2010, PLANT CELL, V22, P2156, DOI 10.1105/tpc.110.075606	35	281	298	12	213	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 21	2013	503	7476					414	+		10.1038/nature12633	http://dx.doi.org/10.1038/nature12633			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KG	24067612				2022-12-28	WOS:000327163200045
J	Dona, E; Barry, JD; Valentin, G; Quirin, C; Khmelinskii, A; Kunze, A; Durdu, S; Newton, LR; Fernandez-Minan, A; Huber, W; Knop, M; Gilmour, D				Dona, Erika; Barry, Joseph D.; Valentin, Guillaume; Quirin, Charlotte; Khmelinskii, Anton; Kunze, Andreas; Durdu, Sevi; Newton, Lionel R.; Fernandez-Minan, Ana; Huber, Wolfgang; Knop, Michael; Gilmour, Darren			Directional tissue migration through a self-generated chemokine gradient	NATURE			English	Article							COLLECTIVE CELL-MIGRATION; LATERAL-LINE; CXCR7; RECEPTOR; GUIDANCE; TARGET; LIGAND; CXCL12	The directed migration of cell collectives is a driving force of embryogenesis(1-3). The predominant view in the field is that cells in embryos navigate along pre-patterned chemoattractant gradients(2). One hypothetical way to free migrating collectives from the requirement of long-range gradients would be through the self-generation of local gradients that travel with them(4,5), a strategy that potentially allows self-determined directionality. However, a lack of tools for the visualization of endogenous guidance cues has prevented the demonstration of such self-generated gradients in vivo. Here we define the in vivo dynamics of one key guidance molecule, the chemokine Cxcl12a, by applying a fluorescent timer approach to measure ligand-triggered receptor turnover in living animals. Using the zebrafish lateral line primordium as a model, we show that migrating cell collectives can self-generate gradients of chemokine activity across their length via polarized receptor-mediated internalization. Finally, by engineering an external source of the atypical receptor Cxcr7 that moves with the primordium, we show that a self-generated gradient mechanism is sufficient to direct robust collective migration. This study thus provides, to our knowledge, the first in vivo proof for self-directed tissue migration through local shaping of an extracellular cue and provides a framework for investigating self-directed migration in many other contexts including cancer invasion(6).	[Dona, Erika; Barry, Joseph D.; Valentin, Guillaume; Quirin, Charlotte; Kunze, Andreas; Durdu, Sevi; Newton, Lionel R.; Fernandez-Minan, Ana; Huber, Wolfgang; Gilmour, Darren] EMBL Heidelberg, D-69117 Heidelberg, Germany; [Khmelinskii, Anton; Knop, Michael] Heidelberg Univ, Zentrum Mol Biol, Deutsch Krebsforschungszentrum, DKFZ ZMBH Allianz, D-69120 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Gilmour, D (corresponding author), EMBL Heidelberg, Meyerhofstr 1, D-69117 Heidelberg, Germany.	gilmour@embl.de	Valentin, Guillaume/AAL-9185-2020; Khmelinskii, Anton/B-2830-2008	Dona, Erika/0000-0001-9268-3619; Valentin, Guillaume/0000-0003-4596-6282; Durdu, Sevi/0000-0001-9746-6779; Gilmour, Darren/0000-0001-7613-090X; Khmelinskii, Anton/0000-0002-0256-5190; Huber, Wolfgang/0000-0002-0474-2218; Barry, Joseph/0000-0002-1177-5771; Fernandez-Minan, Ana/0000-0002-9502-6785; Kunze, Andreas/0000-0002-4955-1052	European Commission's FP7 Network of Excellence 'Systems Microscopy'; Marie Curie FP6; European Molecular Biology Organization; Deutsche Forschungsgemeinschaft [SFB 488]	European Commission's FP7 Network of Excellence 'Systems Microscopy'; Marie Curie FP6; European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We are grateful to J. Ellenberg, F. Peri and S. De Renzis for comments on the manuscript, S. Streichan and the Gilmour laboratory for suggestions. We thank R. Koester and M. Distel for the lateral line Gal4-driver, E. Busch-Nentwich and D. Stemple for the cxcr7 mutant identified by the Zebrafish Mutation Project, the European Molecular Biology Laboratory (EMBL) Monoclonal Antibody Facility for Cxcr7 and Cxcr4b antibodies, the EMBL Advanced Light Microscopy Facility for imaging assistance, B. Klaus from the EMBL Centre for Statistical Data Analysis for advice and A. Gruia for fish care. We acknowledge funding from the European Commission's FP7 Network of Excellence 'Systems Microscopy' (W. H. and J. D. B.), Marie Curie FP6 (A. F.-M.), European Molecular Biology Organization (A.Kh) and Deutsche Forschungsgemeinschaft SFB 488 (D.G.).	Boldajipour B, 2008, CELL, V132, P463, DOI 10.1016/j.cell.2007.12.034; Canals M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034192; Dambly-Chaudiere C, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-23; David NB, 2002, P NATL ACAD SCI USA, V99, P16297, DOI 10.1073/pnas.252339399; Distel M, 2009, P NATL ACAD SCI USA, V106, P13365, DOI 10.1073/pnas.0903060106; Friedl P, 2012, NAT CELL BIOL, V14, P777, DOI 10.1038/ncb2548; Friedl P, 2009, NAT REV MOL CELL BIO, V10, P445, DOI 10.1038/nrm2720; Ghysen A, 2007, GENE DEV, V21, P2118, DOI 10.1101/gad.1568407; Gilmour D, 2004, NAT NEUROSCI, V7, P491, DOI 10.1038/nn1235; Haas P, 2006, DEV CELL, V10, P673, DOI 10.1016/j.devcel.2006.02.019; Hernandez L, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3074; Kettleborough RNW, 2013, NATURE, V496, P494, DOI 10.1038/nature11992; Khmelinskii A, 2012, NAT BIOTECHNOL, V30, P708, DOI 10.1038/nbt.2281; Knaut H, 2003, NATURE, V421, P279, DOI 10.1038/nature01338; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; Lee E, 2013, PIGM CELL MELANOMA R, V26, P58, DOI 10.1111/pcmr.12024; Levoye A, 2009, BLOOD, V113, P6085, DOI 10.1182/blood-2008-12-196618; Luker KE, 2012, ONCOGENE, V31, P4750, DOI 10.1038/onc.2011.633; Minina S, 2007, CURR BIOL, V17, P1164, DOI 10.1016/j.cub.2007.05.073; Montell DJ, 2008, SCIENCE, V322, P1502, DOI 10.1126/science.1164073; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Nakayama M, 2013, NAT CELL BIOL, V15, P249, DOI 10.1038/ncb2679; Naumann U, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009175; Pau G, 2010, BIOINFORMATICS, V26, P979, DOI 10.1093/bioinformatics/btq046; Peri F, 2008, CELL, V133, P916, DOI 10.1016/j.cell.2008.04.037; Preibisch S, 2009, BIOINFORMATICS, V25, P1463, DOI 10.1093/bioinformatics/btp184; Rajagopal S, 2010, P NATL ACAD SCI USA, V107, P628, DOI 10.1073/pnas.0912852107; Rorth P, 2011, DEV CELL, V20, P9, DOI 10.1016/j.devcel.2010.12.014; Scherber C, 2012, INTEGR BIOL-UK, V4, P259, DOI 10.1039/c2ib00106c; Siekmann AF, 2009, GENE DEV, V23, P2272, DOI 10.1101/gad.1813509; Streichan SJ, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/4/045004; Valentin G, 2007, CURR BIOL, V17, P1026, DOI 10.1016/j.cub.2007.05.020; Weijer CJ, 2009, J CELL SCI, V122, P3215, DOI 10.1242/jcs.036517; Westerfield M., 1993, ZEBRAFISH BOOK GUIDE; Zhang YM, 2000, NAT BIOTECHNOL, V18, P1314, DOI 10.1038/82449	35	232	239	2	98	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 14	2013	503	7475					285	+		10.1038/nature12635	http://dx.doi.org/10.1038/nature12635			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	250YX	24067609				2022-12-28	WOS:000326894200056
J	Palomaki, TA; Teufel, JD; Simmonds, RW; Lehnert, KW				Palomaki, T. A.; Teufel, J. D.; Simmonds, R. W.; Lehnert, K. W.			Entangling Mechanical Motion with Microwave Fields	SCIENCE			English	Article							CONTINUOUS VARIABLE SYSTEMS; QUANTUM GROUND-STATE; LIGHT; INFORMATION; RESONATOR; CRITERION; NOISE	When two physical systems share the quantum property of entanglement, measurements of one system appear to determine the state of the other. This peculiar property is used in optical, atomic, and electrical systems in an effort to exceed classical bounds when processing information. We extended the domain of this quantum resource by entangling the motion of a macroscopic mechanical oscillator with a propagating electrical signal and by storing one half of the entangled state in the mechanical oscillator. This result demonstrates an essential requirement for using compact and low-loss micromechanical oscillators in a quantum processor, can be extended to sense forces beyond the standard quantum limit, and may enable tests of quantum theory.	[Palomaki, T. A.; Lehnert, K. W.] NIST, JILA, Boulder, CO 80309 USA; [Palomaki, T. A.; Lehnert, K. W.] Univ Colorado, Boulder, CO 80309 USA; [Palomaki, T. A.; Lehnert, K. W.] Univ Colorado, Dept Phys, Boulder, CO 80309 USA; [Teufel, J. D.; Simmonds, R. W.] NIST, Boulder, CO 80305 USA	National Institute of Standards & Technology (NIST) - USA; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; National Institute of Standards & Technology (NIST) - USA	Palomaki, TA (corresponding author), NIST, JILA, Boulder, CO 80309 USA.	tauno.palomaki@jila.colorado.edu	Teufel, John D/A-8898-2010; Lehnert, Konrad W/O-7555-2019; Lehnert, Konrad/B-7577-2009	Teufel, John D/0000-0002-1873-9941; Lehnert, Konrad W/0000-0002-0750-9649; Lehnert, Konrad/0000-0002-0750-9649; Simmonds, Raymond/0000-0003-2217-2965	National Science Foundation [1125844]; Defense Advanced Research Projects Agency QuEST program; Gordon and Betty Moore Foundation [GBMF3503]	National Science Foundation(National Science Foundation (NSF)); Defense Advanced Research Projects Agency QuEST program(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation)	We thank H.-S. Ku, J. Kerckhoff, J. Harlow, and S. Clancy for helpful discussions. This material is based on work supported by the National Science Foundation under grant 1125844, the Defense Advanced Research Projects Agency QuEST program, and the Gordon and Betty Moore Foundation through grant GBMF3503 to K.W.L.	Audenaert K, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.027901; Barzanjeh S, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.130503; Bowen WP, 2004, PHYS REV A, V69, DOI 10.1103/PhysRevA.69.012304; Braunstein SL, 2005, REV MOD PHYS, V77, P513, DOI 10.1103/RevModPhys.77.513; Brooks DWC, 2012, NATURE, V488, P476, DOI 10.1038/nature11325; Chen YB, 2013, J PHYS B-AT MOL OPT, V46, DOI 10.1088/0953-4075/46/10/104001; Duan LM, 2000, PHYS REV LETT, V84, P2722, DOI 10.1103/PhysRevLett.84.2722; Eichler C, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.113601; Einstein A, 1935, PHYS REV, V47, P0777, DOI 10.1103/PhysRev.47.777; Flurin E, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.183901; Furusawa A, 1998, SCIENCE, V282, P706, DOI 10.1126/science.282.5389.706; Hofer SG, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.170404; Hofer SG, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.052327; Massel F, 2011, NATURE, V480, P351, DOI 10.1038/nature10628; Menzel EP, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.250502; O'Connell AD, 2010, NATURE, V464, P697, DOI 10.1038/nature08967; OU ZY, 1992, PHYS REV LETT, V68, P3663, DOI 10.1103/PhysRevLett.68.3663; Palomaki TA, 2013, NATURE, V495, P210, DOI 10.1038/nature11915; Purdy TP, 2013, SCIENCE, V339, P801, DOI 10.1126/science.1231282; Safavi-Naeini AH, 2013, NATURE, V500, P185, DOI 10.1038/nature12307; Serafini A, 2004, J PHYS B-AT MOL OPT, V37, pL21, DOI 10.1088/0953-4075/37/2/L02; Simon R, 2000, PHYS REV LETT, V84, P2726, DOI 10.1103/PhysRevLett.84.2726; Teufel JD, 2011, NATURE, V475, P359, DOI 10.1038/nature10261; Tian L, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.233602; Tsang M, 2012, PHYS REV X, V2, DOI 10.1103/PhysRevX.2.031016; Vidal G, 2002, PHYS REV A, V65, DOI 10.1103/PhysRevA.65.032314; Wang YD, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.253601; Wasilewski W, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.133601; Weedbrook C, 2012, REV MOD PHYS, V84, P621, DOI 10.1103/RevModPhys.84.621; Wolf MM, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.047904; Woolley MJ, 2013, PHYS REV A, V87, DOI 10.1103/PhysRevA.87.063846; Zhang J, 2003, PHYS REV A, V68, DOI 10.1103/PhysRevA.68.013808	32	445	448	2	114	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 8	2013	342	6159					710	713		10.1126/science.1244563	http://dx.doi.org/10.1126/science.1244563			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247UK	24091706				2022-12-28	WOS:000326647600035
J	Wharam, JF; Ross-Degnan, D; Rosenthal, MB				Wharam, J. Frank; Ross-Degnan, Dennis; Rosenthal, Meredith B.			The ACA and High-Deductible Insurance - Strategies for Sharpening a Blunt Instrument	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Wharam, J. Frank; Ross-Degnan, Dennis] Harvard Univ, Sch Med, Dept Populat Med, Boston, MA 02114 USA; [Wharam, J. Frank; Ross-Degnan, Dennis] Harvard Univ, Sch Publ Hlth, Harvard Pilgrim Hlth Care Inst, Boston, MA 02115 USA; [Rosenthal, Meredith B.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard Pilgrim Health Care; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Wharam, JF (corresponding author), Harvard Univ, Sch Med, Dept Populat Med, Boston, MA 02114 USA.			Wharam, James/0000-0003-2053-0757; Rosenthal, Meredith/0000-0003-3410-0184				Bundorf MK., 2012, CONSUMER DIRECTED HL; Chicago Tribune, 2012, CHICAGO TRIBUNE; Claxton G, 2012, FOCUS HLTH REFORM; Swartz K, 2010, 20 SYNTH PROJ; The Kaiser Family Foundation and Health Research & Educational Trust, 2013, 2013 EMPL HLTH BEN S	5	58	58	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 17	2013	369	16					1481	1484		10.1056/NEJMp1309490	http://dx.doi.org/10.1056/NEJMp1309490			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	267MJ	24088042				2022-12-28	WOS:000328101700002
J	Hoerner, C; Stearns, T				Hoerner, Christian; Stearns, Tim			Remembrance of Cilia Past	CELL			English	Editorial Material							ASYMMETRY	The primary cilium is thought to be disassembled prior to mitosis, freeing the centrosomes to participate in the mitotic spindle. In this issue, Paridaen et al. demonstrate that a remnant of the ciliary membrane remains attached to the mother centriole and is asymmetrically inherited in the developing neocortex.	[Hoerner, Christian; Stearns, Tim] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Stearns, Tim] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA	Stanford University; Stanford University	Stearns, T (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	stearns@stanford.edu		Stearns, Tim/0000-0002-0671-6582; Hoerner, Christian/0000-0002-8685-1126	NIGMS NIH HHS [R01 GM052022] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anderson CT, 2009, CURR BIOL, V19, P1498, DOI 10.1016/j.cub.2009.07.034; Garcia-Gonzalo FR, 2012, J CELL BIOL, V197, P697, DOI 10.1083/jcb.201111146; Habib SJ, 2013, SCIENCE, V339, P1445, DOI 10.1126/science.1231077; Januschke J, 2013, NAT CELL BIOL, V15, P241, DOI 10.1038/ncb2671; Nigg EA, 2011, NAT CELL BIOL, V13, P1154, DOI 10.1038/ncb2345; Paridaen JTML, 2013, CELL, V155, P333, DOI 10.1016/j.cell.2013.08.060; Pelletier L, 2012, CURR OPIN CELL BIOL, V24, P541, DOI 10.1016/j.ceb.2012.05.005; Piotrowska-Nitsche Karolina, 2012, Cilia, V1, DOI 10.1186/2046-2530-1-6; RIEDER CL, 1979, J ULTRA MOL STRUCT R, V68, P173, DOI 10.1016/S0022-5320(79)90152-7; SOROKIN S, 1962, J CELL BIOL, V15, P363, DOI 10.1083/jcb.15.2.363	10	5	5	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 10	2013	155	2					271	273		10.1016/j.cell.2013.09.027	http://dx.doi.org/10.1016/j.cell.2013.09.027			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	235LH	24120128	Bronze			2022-12-28	WOS:000325719800004
J	Bilimoria, KY; Chung, J; Ju, MH; Haut, ER; Bentrem, DJ; Ko, CY; Baker, DW				Bilimoria, Karl Y.; Chung, Jeanette; Ju, Mila H.; Haut, Elliott R.; Bentrem, David J.; Ko, Clifford Y.; Baker, David W.			Evaluation of Surveillance Bias and the Validity of the Venous Thromboembolism Quality Measure	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CANCER-SPECIFIC VARIABLES; DEEP-VEIN THROMBOSIS; TRAUMA DATA-BANK; HOSPITAL CHARACTERISTICS; PERFORMANCE; OUTCOMES; COMPLICATIONS	IMPORTANCE Postoperative venous thromboembolism (VTE) rates are widely reported quality metrics soon to be used in pay-for-performance programs. Surveillance bias occurs when some clinicians use imaging studies to detect VTE more frequently than other clinicians. Because they look more, they find more VTE events, paradoxically worsening their hospital's VTE quality measure performance. A surveillance bias may influence VTE measurement if (1) greater hospital VTE prophylaxis adherence fails to result in lower measured VTE rates, (2) hospitals with characteristics suggestive of higher quality (eg, more accreditations) have greater VTE prophylaxis adherence rates but worse VTE event rates, and (3) higher hospital VTE imaging utilization use rates are associated with higher measured VTE event rates. OBJECTIVE To examine whether a surveillance bias influences the validity of reported VTE rates. DESIGN, SETTING, AND PARTICIPANTS 2010 Hospital Compare and American Hospital Association data from 2838 hospitals were merged. Next, 2009-2010 Medicare claims data for 954 926 surgical patient discharges from 2786 hospitals who were undergoing 1 of 11 major operations were used to calculate VTE imaging (duplex ultrasonography, chest computed tomography/magnetic resonance imaging, and ventilation-perfusion scans) and VTE event rates. MAIN OUTCOMES AND MEASURES The association between hospital VTE prophylaxis adherence and risk-adjusted VTE event rates was examined. The relationship between a summary score of hospital structural characteristics reflecting quality (hospital size, numbers of accreditations/quality initiatives) and performance on VTE prophylaxis and risk-adjusted VTE measures was examined. Hospital-level VTE event rates were compared across VTE diagnostic imaging rate quartiles and with a quantile regression. RESULTS Greater hospital VTE prophylaxis adherence rates were weakly associated with worse risk-adjusted VTE event rates (r(2) = 4.2%; P=.03). Hospitals with increasing structural quality scores had higher VTE prophylaxis adherence rates (93.3% vs 95.5%, lowest vs highest quality quartile; P<.001) but worse risk-adjusted VTE rates (4.8 vs 6.4 per 1000, lowest vs highest quality quartile; P<.001). Mean VTE diagnostic imaging rates ranged from 32 studies per 1000 in the lowest imaging use quartile to 167 per 1000 in the highest quartile (P<.001). Risk-adjusted VTE rates increased significantly with VTE imaging use rates in a stepwise fashion, from 5.0 per 1000 in the lowest quartile to 13.5 per 1000 in the highest quartile (P<.001). CONCLUSIONS AND RELEVANCE Hospitals with higher quality scores had higher VTE prophylaxis rates but worse risk-adjusted VTE rates. Increased hospital VTE event rates were associated with increasing hospital VTE imaging use rates. Surveillance bias limits the usefulness of the VTE quality measure for hospitals working to improve quality and patients seeking to identify a high-quality hospital.	[Bilimoria, Karl Y.; Chung, Jeanette; Ju, Mila H.; Bentrem, David J.] Northwestern Univ, Feinberg Sch Med, Dept Surg, Surg Outcomes & Qual Improvement Ctr, Chicago, IL 60611 USA; [Bilimoria, Karl Y.; Chung, Jeanette; Ju, Mila H.; Bentrem, David J.] Northwestern Univ, Feinberg Sch Med, Ctr Healthcare Studies, Chicago, IL 60611 USA; [Bilimoria, Karl Y.; Chung, Jeanette; Ju, Mila H.; Bentrem, David J.] NW Mem Hosp, Chicago, IL 60611 USA; [Haut, Elliott R.] Johns Hopkins Univ, Sch Med, Dept Surg, Baltimore, MD 21205 USA; [Haut, Elliott R.] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA; [Haut, Elliott R.] Johns Hopkins Univ, Sch Med, Dept Emergency Med, Baltimore, MD USA; [Bentrem, David J.] Jesse Brown VA Med Ctr, Dept Surg, Chicago, IL USA; [Ko, Clifford Y.] Univ Calif Los Angeles, Dept Surg, Los Angeles, CA 90024 USA; [Baker, David W.] Northwestern Univ, Dept Med, Div Gen Internal Med & Geriatr, Chicago, IL 60611 USA; [Baker, David W.] Northwestern Univ, Inst Publ Hlth & Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern Memorial Hospital; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center; University of California System; University of California Los Angeles; Northwestern University; Northwestern University	Bilimoria, KY (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Surg, Surg Outcomes & Qual Improvement Ctr, 676 St Clair St,Arkes Pavil Ste 6-650, Chicago, IL 60611 USA.	k-bilimoria@northwestern.edu	Haut, Elliott R./J-3948-2019	Haut, Elliott/0000-0001-7075-771X	AHRQ [R21HS021857, 1K08HS017952-01]; Center Development Award from Northwestern University and Northwestern Memorial Hospital; National Institutes of Health [5T32HL094293]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K08HS017952, R21HS021857] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL094293] Funding Source: NIH RePORTER	AHRQ(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Center Development Award from Northwestern University and Northwestern Memorial Hospital; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by AHRQ R21HS021857 and a Center Development Award from Northwestern University and Northwestern Memorial Hospital to Dr Bilimoria. Dr Ju is supported by National Institutes of Health 5T32HL094293. Dr Haut is supported by a career development award 1K08HS017952-01 from the AHRQ.	Agency for Healthcare Research and Quality, PATIENT SAFETY INDIC; Altom LK, 2012, AM J SURG, V204, P591, DOI 10.1016/j.amjsurg.2012.07.006; [Anonymous], 2011, J THROMB THROMBOLYS, V32, P209, DOI 10.1007/s11239-011-0583-8; Baker DW, 2011, ANN INTERN MED, V155, P638, DOI 10.7326/0003-4819-155-9-201111010-00015; Bilimoria KY, 2009, J CLIN ONCOL, V27, P4177, DOI 10.1200/JCO.2008.21.7018; Brand CA, 2012, INT J QUAL HEALTH C, V24, P483, DOI 10.1093/intqhc/mzs044; Centers for Medicare & Medicaid Services, HOSPITAL VALUE BASED; CUZICK J, 1985, STAT MED, V4, P87, DOI 10.1002/sim.4780040112; Friese CR, 2010, SURGERY, V147, P602, DOI 10.1016/j.surg.2009.03.014; Gould MK, 2012, CHEST, V141, pE227S, DOI 10.1378/chest.11-2297; Haut ER, 2011, JAMA-J AM MED ASSOC, V305, P2462, DOI 10.1001/jama.2011.822; Haut ER, 2011, J TRAUMA, V70, P27, DOI 10.1097/TA.0b013e3182077d55; Joint Commission, SPECIFICATIONS MANUA; Kardooni S, 2008, J TRAUMA, V64, P273, DOI 10.1097/TA.0b013e31816335ae; Lehrman WG, 2010, MED CARE RES REV, V67, P38, DOI 10.1177/1077558709341323; Lin MY, 2010, JAMA-J AM MED ASSOC, V304, P2035, DOI 10.1001/jama.2010.1637; Magill SS, 2012, CLIN INFECT DIS, V54, P378, DOI 10.1093/cid/cir833; McAndrew CM, 2010, CLIN ORTHOP RELAT R, V468, P178, DOI 10.1007/s11999-009-0929-0; Merkow RP, 2013, ANN SURG ONCOL, V20, P1766, DOI 10.1245/s10434-013-2867-z; Merkow RP, 2013, CANCER-AM CANCER SOC, V119, P1412, DOI 10.1002/cncr.27891; Misra M, 2004, NEUROSURGERY, V54, P1099, DOI 10.1227/01.NEU.0000119352.71531.29; Nicholas LH, 2010, ARCH SURG-CHICAGO, V145, P999, DOI 10.1001/archsurg.2010.191; Pierce CA, 2008, J TRAUMA, V64, P932, DOI 10.1097/TA.0b013e318166b808; SACKETT DL, 1979, J CHRON DIS, V32, P51, DOI 10.1016/0021-9681(79)90012-2; Schmaltz SP, 2011, J HOSP MED, V6, P454, DOI 10.1002/jhm.905; Vartak S, 2008, MED CARE, V46, P25, DOI 10.1097/MLR.0b013e3181484927; Wu EC, 2000, OBES SURG, V10, P7, DOI 10.1381/09608920060674021; Wu N, 2009, AM J MED QUAL, V24, P229, DOI 10.1177/1062860609332510	28	149	149	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 9	2013	310	14					1482	1489		10.1001/jama.2013.280048	http://dx.doi.org/10.1001/jama.2013.280048			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	230PK	24100354	Bronze			2022-12-28	WOS:000325354100024
J	Wilne, SH; Dineen, RA; Dommett, RM; Chu, TPC; Walker, DA				Wilne, S. H.; Dineen, R. A.; Dommett, R. M.; Chu, T. P. C.; Walker, D. A.			Identifying brain tumours in children and young adults	BMJ-BRITISH MEDICAL JOURNAL			English	Review							CHILDHOOD-CANCER; PRIMARY-CARE; RADIOTHERAPY; MEDULLOBLASTOMA; COMPLICATIONS; ASTROCYTOMAS; CHEMOTHERAPY; MULTICENTER; DIAGNOSIS; SURVIVORS		[Wilne, S. H.] Nottingham Univ Hosp NHS Trust, Queens Med Ctr, Dept Paediat Oncol, Nottingham NG7 2UH, England; [Dineen, R. A.; Chu, T. P. C.; Walker, D. A.] Univ Nottingham, Fac Med & Hlth Sci, Nottingham NG7 2RD, England; [Dommett, R. M.] Univ Bristol, Sch Clin Sci, Natl Inst Hlth Res, Bristol, Avon, England	Nottingham University Hospital NHS Trust; University of Nottingham; University of Nottingham; University of Bristol	Wilne, SH (corresponding author), Nottingham Univ Hosp NHS Trust, Queens Med Ctr, Dept Paediat Oncol, Nottingham NG7 2UH, England.	sophie.wilne@nuh.nhs.uk	Dineen, Robert/S-7192-2019	Dineen, Robert/0000-0002-9523-2546	National Institute for Health Research [CL-2010-25-001] Funding Source: researchfish; The Brain Tumour Charity [17/119] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR)); The Brain Tumour Charity		Banerjee J, 2009, NEURO-ONCOLOGY, V11, P543, DOI 10.1215/15228517-2008-122; Batchelder PL, 2010, NEURO-ONCOLOGY, V12, pII79; Brodin NP, 2012, CANCER-AM CANCER SOC, V118, P5432, DOI 10.1002/cncr.27536; Cancer Research UK, CHILD CANC SURV STAT; Cancer Research UK, CANC INC AG; Childhood Cancer Research Group, 2010, SURV CHILDH CANC GRE; Chou SY, 1999, NEUROSURG CLIN N AM, V10, P587, DOI 10.1016/S1042-3680(18)30160-8; Dommett RM, 2012, BRIT J CANCER, V106, P982, DOI 10.1038/bjc.2011.600; Dommett RJ, 2013, BRIT J GEN PRACT, V63, DOI 10.3399/bjgp13X660742; Elliss-Brookes L, 2012, BRIT J CANCER, V107, P1220, DOI 10.1038/bjc.2012.408; Franz DN, 2013, LANCET, V381, P125, DOI 10.1016/S0140-6736(12)61134-9; Korones DN, 2008, PEDIATR BLOOD CANCER, V50, P227, DOI 10.1002/pbc.21154; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Low JA, 2010, J CLIN ONCOL, V28, P5321, DOI 10.1200/JCO.2010.27.9943; Mathews JD, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2360; Merchant TE, 2008, PEDIATR BLOOD CANCER, V51, P110, DOI 10.1002/pbc.21530; National Institute for Health and Care Excellence, 2005, CG27 NAT I HLTH CAR; Nazemi KJ, 2011, J PEDIATR REHAB MED, V4, P37, DOI 10.3233/PRM-2011-0151; Packer RJ, 2006, J CLIN ONCOL, V24, P4202, DOI 10.1200/JCO.2006.06.4980; Picard D, 2012, LANCET ONCOL, V13, P838, DOI 10.1016/S1470-2045(12)70257-7; Pruitt DW, 2011, J PEDIATR REHAB MED, V4, P59, DOI 10.3233/PRM-2011-0154; Reimers TS, 2003, MED PEDIATR ONCOL, V40, P26, DOI 10.1002/mpo.10211; Stiller C. A., 2004, BRAIN SPINAL TUMORS, P35; Stiller CA, 1995, EUR J CANCER, V31A, P2028, DOI 10.1016/0959-8049(95)00428-9; von Bueren AO, 2011, NEURO-ONCOLOGY, V13, P669, DOI 10.1093/neuonc/nor025; Warrington NM, 2007, CANCER RES, V67, P8588, DOI 10.1158/0008-5472.CAN-06-2220; Wilne S, 2007, LANCET ONCOL, V8, P685, DOI 10.1016/S1470-2045(07)70207-3; Wilne S, 2012, EUR J PEDIATR, V171, P87, DOI 10.1007/s00431-011-1485-7; Wilne S, 2010, ARCH DIS CHILD, V95, P534, DOI 10.1136/adc.2009.162057; Yule SM, 2001, ARCH DIS CHILD, V84, P61, DOI 10.1136/adc.84.1.61	30	14	15	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 9	2013	347								f5844	10.1136/bmj.f5844	http://dx.doi.org/10.1136/bmj.f5844			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	235ON	24108155				2022-12-28	WOS:000325729100003
J	Fukuhara, T; Schauss, P; Endres, M; Hild, S; Cheneau, M; Bloch, I; Gross, C				Fukuhara, Takeshi; Schauss, Peter; Endres, Manuel; Hild, Sebastian; Cheneau, Marc; Bloch, Immanuel; Gross, Christian			Microscopic observation of magnon bound states and their dynamics	NATURE			English	Article							ATOMIC MOTT INSULATOR; OPTICAL LATTICE; HEISENBERG FERROMAGNET; QUANTUM; CHAIN; COCL2.2H2O; SOLITONS; BOSONS	The existence of bound states of elementary spin waves (magnons) in one-dimensional quantum magnets was predicted almost 80 years ago(1). Identifying signatures of magnon bound states has so far remained the subject of intense theoretical research(2-5), and their detection has proved challenging for experiments. Ultracold atoms offer an ideal setting in which to find such bound states by tracking the spin dynamics with single-spin and single-site resolution(6,7) following a local excitation(8). Here we use in situ correlation measurements to observe two-magnon bound states directly in a one-dimensional Heisenberg spin chain comprising ultracold bosonic atoms in an optical lattice. We observe the quantum dynamics of free and bound magnon states through time-resolved measurements of two spin impurities. The increased effective mass of the compound magnon state results in slower spin dynamics as compared to single-magnon excitations. We also determine the decay time of bound magnons, which is probably limited by scattering on thermal fluctuations in the system. Our results provide a new way of studying fundamental properties of quantum magnets and, more generally, properties of interacting impurities in quantum many-body systems.	[Fukuhara, Takeshi; Schauss, Peter; Endres, Manuel; Hild, Sebastian; Cheneau, Marc; Bloch, Immanuel; Gross, Christian] Max Planck Inst Quantum Opt, D-85748 Garching, Germany; [Cheneau, Marc] Univ Paris Sud, CNRS, Inst Opt, Lab Charles Fabry,Grad Sch, F-91127 Palaiseau, France; [Bloch, Immanuel] Univ Munich, Fak Phys, D-80799 Munich, Germany	Max Planck Society; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; University of Munich	Fukuhara, T (corresponding author), Max Planck Inst Quantum Opt, D-85748 Garching, Germany.	takeshi.fukuhara@mpq.mpg.de	Schauss, Peter/AAV-1298-2020; Fukuhara, Takeshi/A-6254-2014; Cheneau, Marc/O-9312-2014; Bloch, Immanuel/G-3174-2010; Bloch, Immanuel/N-9169-2019; Gross, Christian/P-5475-2014	Schauss, Peter/0000-0002-8505-5195; Fukuhara, Takeshi/0000-0002-6702-9882; Cheneau, Marc/0000-0001-7261-566X; Bloch, Immanuel/0000-0002-0679-4759; Gross, Christian/0000-0003-2292-5234	MPG; DFG; EU; JSPS	MPG(Max Planck Society); DFG(German Research Foundation (DFG)); EU(European Commission); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We thank H. G. Evertz, M. Haque, J.-S. Caux and W. Zwerger for discussions. We thank J. Zeiher for proofreading the manuscript. This work was supported by MPG, DFG, EU (NAMEQUAM, AQUTE, Marie Curie Fellowship to M. C.) and JSPS (Postdoctoral Fellowship for Research Abroad to T.F.).	Altman E, 2003, NEW J PHYS, V5, DOI 10.1088/1367-2630/5/1/113; Bakr WS, 2010, SCIENCE, V329, P547, DOI 10.1126/science.1192368; Batchelor MT, 2007, PHYS TODAY, V60, P36, DOI 10.1063/1.2709557; Bethe H, 1931, Z PHYS, V71, P205, DOI 10.1007/BF01341708; Bose S, 2007, CONTEMP PHYS, V48, P13, DOI 10.1080/00107510701342313; DATE M, 1966, PHYS REV LETT, V16, P1111, DOI 10.1103/PhysRevLett.16.1111; Duan LM, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.090402; Venegas-Andraca SE, 2012, QUANTUM INF PROCESS, V11, P1015, DOI 10.1007/s11128-012-0432-5; Folling S, 2007, NATURE, V448, P1029, DOI 10.1038/nature06112; FOGEDBY HC, 1980, J PHYS C SOLID STATE, V13, pL195, DOI 10.1088/0022-3719/13/9/005; Fukuhara T, 2013, NAT PHYS, V9, P235, DOI [10.1038/nphys2561, 10.1038/NPHYS2561]; Ganahl M, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.077206; Garcia-Ripoll JJ, 2003, NEW J PHYS, V5, DOI 10.1088/1367-2630/5/1/376; HANUS J, 1963, PHYS REV LETT, V11, P336, DOI 10.1103/PhysRevLett.11.336; Hoefer MA, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.041605; HOOGERBEETS R, 1984, J PHYS C SOLID STATE, V17, P2595, DOI 10.1088/0022-3719/17/14/016; Imambekov A, 2012, REV MOD PHYS, V84, P1253, DOI 10.1103/RevModPhys.84.1253; Karabach M, 1997, COMPUT PHYS, V11, P36; Kohno M, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.037203; Kuklov AB, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.100401; Lahini Y, 2012, PHYS REV A, V86, DOI 10.1103/PhysRevA.86.011603; Nishida Y, 2013, NAT PHYS, V9, P93, DOI 10.1038/nphys2523; Pereira RG, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.027206; Pertot D, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.200402; SCHNEIDER T, 1981, PHYS REV B, V24, P5327, DOI 10.1103/PhysRevB.24.5327; Sherson JF, 2010, NATURE, V467, P68, DOI 10.1038/nature09378; Subrahmanyam V, 2004, PHYS REV A, V69, DOI 10.1103/PhysRevA.69.034304; TAKAHASHI M, 1971, PROG THEOR PHYS, V46, P401, DOI 10.1143/PTP.46.401; TORRANCE JB, 1969, PHYS REV, V187, P595, DOI 10.1103/PhysRev.187.595; Trotzky S, 2008, SCIENCE, V319, P295, DOI 10.1126/science.1150841; Weitenberg C, 2011, NATURE, V471, P319, DOI 10.1038/nature09827; Winkler K, 2006, NATURE, V441, P853, DOI 10.1038/nature04918; WORTIS M, 1963, PHYS REV, V132, P85, DOI 10.1103/PhysRev.132.85	35	305	306	5	120	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 3	2013	502	7469					76	+		10.1038/nature12541	http://dx.doi.org/10.1038/nature12541			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	227IM	24067608	Green Accepted, Green Submitted			2022-12-28	WOS:000325106000033
J	Michalski, JR; Bleacher, JE				Michalski, Joseph R.; Bleacher, Jacob E.			Supervolcanoes within an ancient volcanic province in Arabia Terra, Mars	NATURE			English	Article							THERMOKARST LAKES; THARSIS REGION; HISTORY; CRUST; DISPERSAL; MERIDIANI; OUTCROPS; SULFUR; LAVA	Several irregularly shaped craters located within Arabia Terra, Mars, represent a new type of highland volcanic construct and together constitute a previously unrecognized Martian igneous province. Similar to terrestrial supervolcanoes, these low-relief paterae possess a range of geomorphic features related to structural collapse, effusive volcanism and explosive eruptions. Extruded lavas contributed to the formation of enigmatic highland ridged plains in Arabia Terra. Outgassed sulphur and erupted fine-grained pyroclastics from these calderas probably fed the formation of altered, layered sedimentary rocks and fretted terrain found throughout the equatorial region. The discovery of a new type of volcanic construct in the Arabia volcanic province fundamentally changes the picture of ancient volcanism and climate evolution on Mars. Other eroded topographic basins in the ancient Martian highlands that have been dismissed as degraded impact craters should be reconsidered as possible volcanic constructs formed in an early phase of widespread, disseminated magmatism on Mars.	[Michalski, Joseph R.] Planetary Sci Inst, Tucson, AZ 85719 USA; [Michalski, Joseph R.] Nat Hist Museum, Dept Earth Sci, London SW7 5BD, England; [Bleacher, Jacob E.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA	Natural History Museum London; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center	Michalski, JR (corresponding author), Planetary Sci Inst, Tucson, AZ 85719 USA.	michalski@psi.edu	Bleacher, Jacob E/D-1051-2012; Michalski, Joseph/AAU-5631-2020	Bleacher, Jacob E/0000-0002-8499-4828; Michalski, Joseph/0000-0002-4543-6452	NASA Mars Data Analysis programme	NASA Mars Data Analysis programme	We thank H. Frey, B. Hynek, S. Wright, J. Zimbelman and L. Tornabene for discussions that improved the quality of the manuscript. Funding was provided by the NASA Mars Data Analysis programme.	Acocella V, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027434; Bandfield JL, 2013, ICARUS, V222, P188, DOI 10.1016/j.icarus.2012.10.023; Bibring JP, 2006, SCIENCE, V312, P400, DOI 10.1126/science.1122659; Bleacher JE, 2009, J VOLCANOL GEOTH RES, V185, P96, DOI 10.1016/j.jvolgeores.2009.04.008; Bleacher JE, 2007, J GEOPHYS RES-PLANET, V112, DOI 10.1029/2006JE002873; Bouchier A., 2008, THESIS COLORADO SCH; Clifford SM, 2010, J GEOPHYS RES-PLANET, V115, DOI 10.1029/2009JE003462; Edgett KS, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL016515; Ehlmann BL, 2011, NATURE, V479, P53, DOI 10.1038/nature10582; French B.M., 1998, LPI CONTRIBUTION, V954; Gaillard F, 2013, SPACE SCI REV, V174, P251, DOI 10.1007/s11214-012-9947-4; Gendrin A, 2005, SCIENCE, V307, P1587, DOI 10.1126/science.1109087; Golombek MP, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2006JE002754; GREELEY R, 1981, REV GEOPHYS, V19, P13, DOI 10.1029/RG019i001p00013; Halevy I, 2007, SCIENCE, V318, P1903, DOI 10.1126/science.1147039; Hauber E, 2009, J VOLCANOL GEOTH RES, V185, P69, DOI 10.1016/j.jvolgeores.2009.04.015; Head JW, 2003, NATURE, V426, P797, DOI 10.1038/nature02114; Hodges C.A., 1994, US GEOLOGICAL SURVEY, P1; Hynek BM, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002062; Hynek BM, 2004, NATURE, V431, P156, DOI 10.1038/nature02902; Irwin RP, 2004, J GEOPHYS RES-PLANET, V109, DOI 10.1029/2004JE002248; Johnson SS, 2008, J GEOPHYS RES-PLANET, V113, DOI 10.1029/2007JE002962; Kerber L., 2013, 44 LUN PLAN SCI CCON; Kerber L, 2012, ICARUS, V219, P358, DOI 10.1016/j.icarus.2012.03.016; King PL, 2010, ELEMENTS, V6, P107, DOI 10.2113/gselements.6.2.107; Lammer H, 2013, SPACE SCI REV, V174, P113, DOI 10.1007/s11214-012-9943-8; Malin MC, 2000, SCIENCE, V290, P1927, DOI 10.1126/science.290.5498.1927; MALIN MC, 1977, J GEOPHYS RES, V82, P376, DOI 10.1029/JB082i002p00376; McCollom TM, 2005, NATURE, V438, P1129, DOI 10.1038/nature04390; McGill GE, 2000, J GEOPHYS RES-PLANET, V105, P6945, DOI 10.1029/1999JE001175; Miller CF, 2008, ELEMENTS, V4, P11, DOI 10.2113/GSELEMENTS.4.1.11; Neumann G. A., 2009, J GEOPHYS RES, V109; Niu FJ, 2011, GEOMORPHOLOGY, V132, P222, DOI 10.1016/j.geomorph.2011.05.011; Richardson JA, 2013, J VOLCANOL GEOTH RES, V252, P1, DOI 10.1016/j.jvolgeores.2012.11.007; Richter D. H., 1970, 539E US GEOL SURV; Robbins SJ, 2012, J GEOPHYS RES-PLANET, V117, DOI 10.1029/2011JE003966; Sejourne A, 2011, PLANET SPACE SCI, V59, P412, DOI 10.1016/j.pss.2011.01.007; SHARP RP, 1973, J GEOPHYS RES, V78, P4073, DOI 10.1029/JB078i020p04073; SLEEP NH, 1994, J GEOPHYS RES-PLANET, V99, P5639, DOI 10.1029/94JE00216; Soare RJ, 2008, EARTH PLANET SC LETT, V272, P382, DOI 10.1016/j.epsl.2008.05.010; Stovall WK, 2009, B VOLCANOL, V71, P767, DOI 10.1007/s00445-009-0263-0; Tian F, 2010, EARTH PLANET SC LETT, V295, P412, DOI 10.1016/j.epsl.2010.04.016; WALKER GPL, 1991, B VOLCANOL, V53, P546, DOI 10.1007/BF00298155; Watters TR, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE001934; Williams DA, 2009, PLANET SPACE SCI, V57, P895, DOI 10.1016/j.pss.2008.08.010; Wilson L, 2001, J GEOPHYS RES-PLANET, V106, P1423, DOI 10.1029/2000JE001280; WILSON L, 1994, REV GEOPHYS, V32, P221, DOI 10.1029/94RG01113; Wilson L, 2007, J VOLCANOL GEOTH RES, V163, P83, DOI 10.1016/j.jvolgeores.2007.03.007; Xiao L, 2012, EARTH PLANET SC LETT, V323, P9, DOI 10.1016/j.epsl.2012.01.027; Zuber MT, 2001, NATURE, V412, P220, DOI 10.1038/35084163	50	55	55	0	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 3	2013	502	7469					47	+		10.1038/nature12482	http://dx.doi.org/10.1038/nature12482			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	227IM	24091975				2022-12-28	WOS:000325106000028
J	Kiriakidou, M				Kiriakidou, Marianthi			Systemic Lupus Erythematosus	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							DOUBLE-BLIND; MYCOPHENOLATE-MOFETIL; MAINTENANCE THERAPY; LONG-TERM; PULSE METHYLPREDNISOLONE; DISEASE-ACTIVITY; CONTROLLED TRIAL; NEPHRITIS; SAFETY; MANIFESTATIONS							Tsao, Betty/0000-0001-7938-5975				Alarcon GS, 1999, LUPUS, V8, P197, DOI 10.1191/096120399678847704; ALBERT DA, 1979, ARTHRITIS RHEUM-US, V22, P945, DOI 10.1002/art.1780220901; Anderka MT, 2009, AM J MED GENET A, V149A, P1241, DOI 10.1002/ajmg.a.32685; Andrade-Ortega L, 2010, REUMATOL CLIN, V6, P250, DOI 10.1016/j.reuma.2009.11.004; Arbuckle MR, 2003, NEW ENGL J MED, V349, P1526, DOI 10.1056/NEJMoa021933; Badsha H, 2002, LUPUS, V11, P508, DOI 10.1191/0961203302lu243oa; Ball EMA, 2012, RHEUMATOLOGY, V51, P771, DOI 10.1093/rheumatology/ker381; Ben-Zvi I, 2012, CLIN REV ALLERG IMMU, V42, P145, DOI 10.1007/s12016-010-8243-x; Bernatsky S, 2006, ARTHRITIS RHEUM-US, V54, P2550, DOI 10.1002/art.21955; Bomback AS, 2010, J AM SOC NEPHROL, V21, P2028, DOI 10.1681/ASN.2010050472; Buttgereit F, 2002, ANN RHEUM DIS, V61, P718, DOI 10.1136/ard.61.8.718; Carneiro JRM, 1999, J RHEUMATOL, V26, P1275; Cervera R, 2003, MEDICINE, V82, P299, DOI 10.1097/01.md.0000091181.93122.55; Chang AY, 2011, CURR RHEUMATOL REP, V13, P300, DOI 10.1007/s11926-011-0180-z; Chen W, 2012, LUPUS, V21, P944, DOI 10.1177/0961203312442259; Contreras G, 2004, NEW ENGL J MED, V350, P971, DOI 10.1056/NEJMoa031855; Costedoat-Chalumeau N, 2003, ARTHRITIS RHEUM, V48, P3207, DOI 10.1002/art.11304; da Silva JAP, 2011, CLIN EXP RHEUMATOL, V29, pS99; Demas KL, 2009, CURR OPIN RHEUMATOL, V21, P102, DOI 10.1097/BOR.0b013e328323daad; Deng Y, 2010, NAT REV RHEUMATOL, V6, P683, DOI 10.1038/nrrheum.2010.176; Dhala A, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/854941; Dooley MA, 2011, NEW ENGL J MED, V365, P1886, DOI 10.1056/NEJMoa1014460; Duran S, 2008, ARTHRIT RHEUM-ARTHR, V59, P1332, DOI 10.1002/art.24020; EDWARDS JCW, 1987, ANN RHEUM DIS, V46, P773, DOI 10.1136/ard.46.10.773; Farrell DF, 2012, CLIN OPHTHALMOL, V6, P377, DOI 10.2147/OPTH.S27731; Fortin PR, 2008, ARTHRIT RHEUM-ARTHR, V59, P1796, DOI 10.1002/art.24068; Furie R, 2011, ARTHRITIS RHEUM-US, V63, P3918, DOI 10.1002/art.30613; Gabriel S, 1999, J RHEUMATOL, V26, P203; Gonzalez-Lopez L, 2004, LUPUS, V13, P105, DOI 10.1191/0961203304lu509oa; Gourley MF, 1996, ANN INTERN MED, V125, P549, DOI 10.7326/0003-4819-125-7-199610010-00003; Hahn BH, 2012, ARTHRIT CARE RES, V64, P797, DOI 10.1002/acr.21664; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Hochstadt Aviram, 2011, Harefuah, V150, P542; Houssiau FA, 2010, ANN RHEUM DIS, V69, P2083, DOI 10.1136/ard.2010.131995; Illei GG, 2001, ANN INTERN MED, V135, P248, DOI 10.7326/0003-4819-135-4-200108210-00009; Islam MN, 2012, INT J RHEUM DIS, V15, P62, DOI 10.1111/j.1756-185X.2011.01665.x; Jais X, 2008, ARTHRITIS RHEUM-US, V58, P521, DOI 10.1002/art.23303; Kamanamool N, 2010, MEDICINE, V89, P227, DOI 10.1097/MD.0b013e3181e93d00; Kamen DL, 2010, CLIN CHEST MED, V31, P479, DOI 10.1016/j.ccm.2010.05.001; Kovacs B, 2000, ANN RHEUM DIS, V59, P120, DOI 10.1136/ard.59.2.120; Lee YH, 2011, LUPUS, V20, P636, DOI 10.1177/0961203310389486; MACKWORTHYOUNG CG, 1988, ANN RHEUM DIS, V47, P496, DOI 10.1136/ard.47.6.496; Pego-Reigosa JM, 2009, BEST PRACT RES CL RH, V23, P469, DOI 10.1016/j.berh.2009.01.002; Merrill JT, 2010, ARTHRITIS RHEUM-US, V62, P222, DOI 10.1002/art.27233; Mok CC, 2013, ARTHRITIS RHEUM-US, V65, P2154, DOI 10.1002/art.38006; Mok CC, 2013, ANN RHEUM DIS, V72, P659, DOI 10.1136/annrheumdis-2012-201393; Moroni G, 2006, CLIN J AM SOC NEPHRO, V1, P925, DOI 10.2215/CJN.02271205; Natekar A, 2011, CAN FAM PHYSICIAN, V57, P1401; Navarra SV, 2011, LANCET, V377, P721, DOI 10.1016/S0140-6736(10)61354-2; Neumann R, 1995, Retina, V15, P201; Patel P, 2002, DERMATOL CLIN, V20, P373, DOI 10.1016/S0733-8635(02)00016-5; Peponis V, 2006, LUPUS, V15, P3, DOI 10.1191/0961203306lu2250rr; PETRI M, 1994, AM J MED, V96, P254, DOI 10.1016/0002-9343(94)90151-1; Petri M, 2012, ARTHRITIS RHEUM-US, V64, P2677, DOI 10.1002/art.34473; Radhakrishnan J, 2010, KIDNEY INT, V77, P152, DOI 10.1038/ki.2009.412; Rovin BH, 2012, ARTHRITIS RHEUM-US, V64, P1215, DOI 10.1002/art.34359; SEIBOLD JR, 1980, ARTHRITIS RHEUM, V23, P958, DOI 10.1002/art.1780230816; Sestak AL, 2011, ANN RHEUM DIS, V70, pI37, DOI 10.1136/ard.2010.138057; Spetie DN, 2004, KIDNEY INT, V66, P2411, DOI 10.1111/j.1523-1755.2004.66030.x; Sun Siquan, 2007, Inflammation & Allergy Drug Targets, V6, P223; Touma Z, 2011, J RHEUMATOL, V38, P69, DOI 10.3899/jrheum.100130; Tseng CE, 2006, ARTHRITIS RHEUM-US, V54, P3623, DOI 10.1002/art.22198; van Vollenhoven RF, 2012, ANN RHEUM DIS, V71, P1343, DOI 10.1136/annrheumdis-2011-200937; Vila LM, 2006, ARTHRIT RHEUM-ARTHR, V55, P799, DOI 10.1002/art.22224; WEINRIB L, 1990, SEMIN ARTHRITIS RHEU, V20, P48, DOI 10.1016/0049-0172(90)90094-V; Yap DYH, 2012, NEPHROLOGY, V17, P352, DOI 10.1111/j.1440-1797.2012.01574.x	66	24	25	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 1	2013	159	7					ITC1	ITC416		10.7326/0003-4819-159-7-201310010-01004	http://dx.doi.org/10.7326/0003-4819-159-7-201310010-01004			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	V44NS	24081299				2022-12-28	WOS:000209756300001
J	Wagner, J; Gabler, NB; Ratcliffe, SJ; Brown, SES; Strom, BL; Halpern, SD				Wagner, Jason; Gabler, Nicole B.; Ratcliffe, Sarah J.; Brown, Sydney E. S.; Strom, Brian L.; Halpern, Scott D.			Outcomes Among Patients Discharged From Busy Intensive Care Units	ANNALS OF INTERNAL MEDICINE			English	Article							CRITICALLY-ILL PATIENTS; READMISSION RATE; BED NUMBERS; STATES; MORTALITY; ASSOCIATION; MEDICINE; SERVICES; QUALITY; CRISIS	Background: Strains on the capacities of intensive care units (ICUs) may influence the quality of ICU-to-floor transitions. Objective: To determine how 3 metrics of ICU capacity strain (ICU census, new admissions, and average acuity) measured on days of patient discharges influence ICU length of stay (LOS) and post-ICU discharge outcomes. Design: Retrospective cohort study from 2001 to 2008. Setting: 155 ICUs in the United States. Patients: 200 730 adults discharged from ICUs to hospital floors. Measurements: Associations between ICU capacity strain metrics and discharged patient ICU LOS, 72-hour ICU readmissions, subsequent in-hospital death, post-ICU discharge LOS, and hospital discharge destination. Results: Increases in the 3 strain variables on the days of ICU discharge were associated with shorter preceding ICU LOS (all P < 0.001) and increased odds of ICU readmissions (all P < 0.050). Going from the 5th to 95th percentiles of strain was associated with a 6.3-hour reduction in ICU LOS (95% CI, 5.3 to 7.3 hours) and a 1.0% increase in the odds of ICU readmission (CI, 0.6% to 1.5%). No strain variable was associated with increased odds of subsequent death, reduced odds of being discharged home from the hospital, or longer total hospital LOS. Limitation: Long-term outcomes could not be measured. Conclusion: When ICUs are strained, triage decisions seem to be affected such that patients are discharged from the ICU more quickly and, perhaps consequentially, have slightly greater odds of being readmitted to the ICU. However, short-term patient outcomes are unaffected. These results suggest that bed availability pressures may encourage physicians to discharge patients from the ICU more efficiently and that ICU readmissions are unlikely to be causally related to patient outcomes. Primary Funding Source: Agency for Healthcare Research and Quality; National Heart, Lung, and Blood Institute; and Society of Critical Care Medicine.	Univ Penn, Leonard Davis Inst, Ctr Hlth Incent & Behav Econ, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Wagner, J (corresponding author), Univ Penn, Perelman Sch Med, Div Pulm Allergy & Crit Care Med, 839 W Gates Bldg,3600 Spruce St, Philadelphia, PA 19104 USA.	jason.wagner@uphs.upenn.edu	Ratcliffe, Sarah J/GYR-1110-2022	Ratcliffe, Sarah J/0000-0002-6644-8284; Brown, Sydney/0000-0003-0374-0824	Agency for Healthcare Research and Quality; National Heart, Lung, and Blood Institute; Society of Critical Care Medicine; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K08HS018406] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F30HL107020, T32HL098054] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Society of Critical Care Medicine; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Agency for Healthcare Research and Quality; National Heart, Lung, and Blood Institute; and Society of Critical Care Medicine.	Angus DC, 2006, CRIT CARE MED, V34, P1016, DOI 10.1097/01.CCM.0000206105.05626.15; Angus DC, 2000, JAMA-J AM MED ASSOC, V284, P2762, DOI 10.1001/jama.284.21.2762; Angus DC, 1998, CRIT CARE MED, V26, P1779, DOI 10.1097/00003246-199811000-00008; Baker DR, 2009, CRIT CARE MED, V37, P2882, DOI 10.1097/CCM.0b013e3181b01caf; Brody H, 2012, NEW ENGL J MED, V366, P1949, DOI 10.1056/NEJMp1203365; Brown SES, 2012, AM J RESP CRIT CARE, V185, P955, DOI 10.1164/rccm.201109-1720OC; Chalfin DB, 2007, CRIT CARE MED, V35, P1477, DOI 10.1097/01.CCM.0000266585.74905.5A; Chrusch CA, 2009, CRIT CARE MED, V37, P2753, DOI 10.1097/CCM.0b013e3181a57b0c; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; Cooper GS, 1999, MED CARE, V37, P399, DOI 10.1097/00005650-199904000-00009; Cooper RA, 2004, ANN INTERN MED, V141, P705, DOI 10.7326/0003-4819-141-9-200411020-00012; Gershengorn HB, 2012, CRIT CARE MED, V40, P2009, DOI 10.1097/CCM.0b013e31824e9eae; Glance LG, 2006, CRIT CARE MED, V34, P1925, DOI 10.1097/01.CCM.0000226415.93237.84; Halpern NA, 2004, CRIT CARE MED, V32, P1254, DOI 10.1097/01.CCM.0000128577.31689.4C; Halpern NA, 2010, CRIT CARE MED, V38, P65, DOI 10.1097/CCM.0b013e3181b090d0; Halpern SD, 2011, CURR OPIN CRIT CARE, V17, P648, DOI 10.1097/MCC.0b013e32834c7a53; Higgins TL, 2007, CRIT CARE MED, V35, P827, DOI 10.1097/01.CCM.0000257337.63529.9F; Howell MD, 2011, CURR OPIN CRIT CARE, V17, P626, DOI 10.1097/MCC.0b013e32834b3e6e; Kahn JM, 2006, CURR OPIN CRIT CARE, V12, P399, DOI 10.1097/01.ccx.0000244117.08753.38; Kelley MA, 2004, CHEST, V125, P1514, DOI 10.1378/chest.125.4.1514; Kelley MA, 2008, CRIT CARE MED, V36, P1385, DOI 10.1097/CCM.0b013e31816a0bd3; Kramer AA, 2013, CRIT CARE MED, V41, P24, DOI 10.1097/CCM.0b013e3182657b8a; Kramer AA, 2012, CRIT CARE MED, V40, P3, DOI 10.1097/CCM.0b013e31822d751e; Levy MM, 2008, ANN INTERN MED, V148, P801, DOI 10.7326/0003-4819-148-11-200806030-00002; Localio AR, 2001, ANN INTERN MED, V135, P112, DOI 10.7326/0003-4819-135-2-200107170-00012; Luce JM, 2002, AM J RESP CRIT CARE, V165, P750, DOI 10.1164/ajrccm.165.6.2109045; Pronovost PJ, 2002, JAMA-J AM MED ASSOC, V288, P2151, DOI 10.1001/jama.288.17.2151; Rhodes A, 2012, INTENS CARE MED, V38, P1647, DOI 10.1007/s00134-012-2627-8; Roberts RR, 1999, JAMA-J AM MED ASSOC, V281, P644, DOI 10.1001/jama.281.7.644; Seymour CW, 2012, ARCH INTERN MED, V172, P1226, DOI 10.1001/archinternmed.2012.3773; Seymour CW, 2012, HEALTH SERV RES, V47, P2060, DOI 10.1111/j.1475-6773.2012.01402.x; SINGER DE, 1983, NEW ENGL J MED, V309, P1155, DOI 10.1056/NEJM198311103091905; STRAUSS MJ, 1986, JAMA-J AM MED ASSOC, V255, P1143, DOI 10.1001/jama.255.9.1143; Truog RD, 2006, CRIT CARE MED, V34, P958, DOI 10.1097/01.CCM.0000206116.10417.D9; Vranas KR, 2012, AM J RESP CRIT CARE, V185, pA1608; Walther SM, 2001, INTENS CARE MED, V27, P700, DOI 10.1007/s001340100899; Ward NS, 2008, CRIT CARE MED, V36, P471, DOI 10.1097/CCM.0B013E3181629511; Wunsch H, 2012, CHEST, V141, P1393, DOI 10.1378/chest.11-2819; Wunsch H, 2009, AM J RESP CRIT CARE, V180, P875, DOI 10.1164/rccm.200902-0201OC; Young MJ, 2012, CRIT CARE MED, V40, P261, DOI 10.1097/CCM.0b013e31822d750d; Zimmerman JE, 2010, J CRIT CARE, V25, P205, DOI 10.1016/j.jcrc.2009.06.010	41	94	96	0	10	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 1	2013	159	7					447	U151		10.7326/0003-4819-159-7-201310010-00004	http://dx.doi.org/10.7326/0003-4819-159-7-201310010-00004			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	234FQ	24081285	Green Accepted			2022-12-28	WOS:000325628000002
J	Myburgh, JA; Mythen, MG				Myburgh, John A.; Mythen, Michael G.			Resuscitation Fluids	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							HYDROXYETHYL STARCH; 0.9-PERCENT SALINE; RENAL-FUNCTION; SEVERE SEPSIS; MORTALITY; MANAGEMENT; SURGERY; INJURY; PRESSURE; EXCHANGE		[Myburgh, John A.] Univ New S Wales, Div Crit Care & Trauma, George Inst Global Hlth, Sydney, NSW, Australia; [Myburgh, John A.] St George Hosp, Dept Intens Care Med, Sydney, NSW 2217, Australia; [Mythen, Michael G.] Univ Coll London Hosp, Biomed Res Ctr, Natl Inst Hlth Res, London, England	George Institute for Global Health; University of New South Wales Sydney; University of Sydney; St George Hospital; University College London Hospitals NHS Foundation Trust; University of London; University College London	Myburgh, JA (corresponding author), St George Hosp, Dept Intens Care Med, Gray St, Sydney, NSW 2217, Australia.	jmyburgh@georgeinstitute.org.au		Myburgh, John/0000-0003-4088-7016	Fresenius Kabi; Aqix; Baxter; B. Braun; Beacon Pharmaceuticals; Cosmed; Cranlea; Deltex; Edwards; Imacor; LiDCO; Masimo; Medgraphics; Orion Pharma; Pulsion; Vitalograph	Fresenius Kabi; Aqix; Baxter; B. Braun; Beacon Pharmaceuticals; Cosmed; Cranlea; Deltex; Edwards; Imacor; LiDCO; Masimo; Medgraphics; Orion Pharma; Pulsion; Vitalograph	Dr. Myburgh reports receiving travel support and lecture fees, as well as grant support to his institution, from Fresenius Kabi; and Dr. Mythen, receiving consulting fees paid to himself and his institution by Aqix, grant support to his institution from Fresenius Kabi, lecture fees and travel support from Baxter, B. Braun, and Fresenius Kabi, and fees for the development and presentation of educational materials from B. Braun. Dr. Mythen also reports organizing nonprofit educational conferences for the Evidence-Based Perioperative Medicine (EBPOM) project, which has received financial support from Baxter, B. Braun, Beacon Pharmaceuticals, Cosmed, Cranlea, Deltex, Edwards, Fresenius Kabi, Imacor, LiDCO, Masimo, Medgraphics, Orion Pharma, Pulsion, and Vitalograph. No other potential conflict of interest relevant to this article was reported.	American College of Surgeons Committee on Trauma, 2012, ADV TRAUM LIF SUPP A, V9th; [Anonymous], COCHRANE DATABASE SY; [Anonymous], 2011, BRIT CONSENSUS GUIDE; Arlati S, 2007, RESUSCITATION, V72, P371, DOI 10.1016/j.resuscitation.2006.07.010; Awad S, 2008, CLIN NUTR, V27, P179, DOI 10.1016/j.clnu.2008.01.008; Bayer O, 2011, CRIT CARE MED, V39, P1335, DOI 10.1097/CCM.0b013e318212096a; Boyd JH, 2011, CRIT CARE MED, V39, P259, DOI 10.1097/CCM.0b013e3181feeb15; Brandstrup B, 2012, BRIT J ANAESTH, V109, P191, DOI 10.1093/bja/aes163; Bunn F, 2012, COCHRANE DB SYST REV, V7; Chua HR, 2012, J CRIT CARE, V27, P138, DOI 10.1016/j.jcrc.2012.01.007; Cooper DJ, 2004, JAMA-J AM MED ASSOC, V291, P1350, DOI 10.1001/jama.291.11.1350; Cooper DJ, 2013, J NEUROTRAUMA; Corcoran T, 2012, ANESTH ANALG, V114, P640, DOI 10.1213/ANE.0b013e318240d6eb; Cordemans C, 2012, ANN INTENSIVE CARE, V2, DOI 10.1186/2110-5820-2-S1-S1; Dellinger RP, 2008, CRIT CARE MED, V36, P1394; Finfer S, 2004, NEW ENGL J MED, V350, P2247; Finfer S, 2006, BRIT MED J, V333, P1044, DOI 10.1136/bmj.38985.398704.7C; Finfer S, 2011, INTENS CARE MED, V37, P86, DOI 10.1007/s00134-010-2039-6; Finfer S, 2010, CRIT CARE, V14, DOI 10.1186/cc9293; Funk DJ, 2013, CRIT CARE MED, V41, P255, DOI 10.1097/CCM.0b013e3182772ab6; Guidet B, 2012, CRIT CARE, V16, DOI 10.1186/cc11358; Guidet B, 2010, CRIT CARE, V14, DOI 10.1186/cc9230; Hadimioglu N, 2008, ANESTH ANALG, V107, P264, DOI 10.1213/ane.0b013e3181732d64; Handy JM, 2008, BRIT J ANAESTH, V101, P141, DOI 10.1093/bja/aen148; Hartog CS, 2011, INTENS CARE MED, V37, P1725, DOI 10.1007/s00134-011-2385-z; James MFM, 2011, BRIT J ANAESTH, V107, P693, DOI 10.1093/bja/aer229; Kellum JA, 2004, CRIT CARE, V8, P331, DOI 10.1186/cc2900; Krogh A, 1932, J CLIN INVEST, V11, P63, DOI 10.1172/JCI100408; LEE JA, 1981, ANAESTHESIA, V36, P1115, DOI 10.1111/j.1365-2044.1981.tb08698.x; Lee WL, 2010, NEW ENGL J MED, V363, P689, DOI 10.1056/NEJMcibr1007320; Levick JR, 2010, CARDIOVASC RES, V87, P198, DOI 10.1093/cvr/cvq062; Lewins R, 1832, LONDON MED GAZ, P257; Maitland K, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-68; Maitland K, 2011, NEW ENGL J MED, V364, P2483, DOI 10.1056/NEJMoa1101549; McSwain NE, 2011, J TRAUMA, V70, pS2, DOI 10.1097/TA.0b013e31821b201d; Morgan TJ, 2004, INTENS CARE MED, V30, P1432, DOI 10.1007/s00134-004-2176-x; Murphy CV, 2009, CHEST, V136, P102, DOI 10.1378/chest.08-2706; Myburgh J, 2007, NEW ENGL J MED, V357, P874; Myburgh JA, 2012, NEW ENGL J MED, V367, P1901, DOI 10.1056/NEJMoa1209759; Perner A, 2012, NEW ENGL J MED, V367, P124, DOI 10.1056/NEJMoa1204242; Persichini R, 2012, CRIT CARE MED, V40, P3146, DOI 10.1097/CCM.0b013e318260c6c3; Roberts I, 1998, BMJ-BRIT MED J, V317, P235; Shaw AD, 2012, ANN SURG, V255, P821, DOI 10.1097/SLA.0b013e31825074f5; Starling E H, 1896, J Physiol, V19, P312; Weinbaum S, 2007, ANNU REV BIOMED ENG, V9, P121, DOI 10.1146/annurev.bioeng.9.060906.151959; Wiedemann HP, 2006, NEW ENGL J MED, V354, P2564; Woodcock TE, 2012, BRIT J ANAESTH, V108, P384, DOI 10.1093/bja/aer515; Yunos NM, 2012, JAMA-J AM MED ASSOC, V308, P1566, DOI 10.1001/jama.2012.13356	50	354	387	1	35	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 26	2013	369	13					1243	1251		10.1056/NEJMra1208627	http://dx.doi.org/10.1056/NEJMra1208627			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	224LT	24066745				2022-12-28	WOS:000324888200011
J	Papitto, A; Ferrigno, C; Bozzo, E; Rea, N; Pavan, L; Burderi, L; Burgay, M; Campana, S; Di Salvo, T; Falanga, M; Filipovic, MD; Freire, PCC; Hessels, JWT; Possenti, A; Ransom, SM; Riggio, A; Romano, P; Sarkissian, JM; Stairs, IH; Stella, L; Torres, DF; Wieringa, MH; Wong, GF				Papitto, A.; Ferrigno, C.; Bozzo, E.; Rea, N.; Pavan, L.; Burderi, L.; Burgay, M.; Campana, S.; Di Salvo, T.; Falanga, M.; Filipovic, M. D.; Freire, P. C. C.; Hessels, J. W. T.; Possenti, A.; Ransom, S. M.; Riggio, A.; Romano, P.; Sarkissian, J. M.; Stairs, I. H.; Stella, L.; Torres, D. F.; Wieringa, M. H.; Wong, G. F.			Swings between rotation and accretion power in a binary millisecond pulsar	NATURE			English	Article							X-RAY TRANSIENTS; NEUTRON-STARS; EVOLUTION; EMISSION; SPIN; ORBIT	It is thought that neutron stars in low-mass binary systems can accrete matter and angular momentum from the companion star and be spun-up to millisecond rotational periods(1-3). During the accretion stage, the system is called a low-mass X-ray binary, and bright X-ray emission is observed. When the rate of mass transfer decreases in the later evolutionary stages, these binaries host a radio millisecond pulsar(4,5) whose emission is powered by the neutron star's rotating magnetic field(6). This evolutionary model is supported by the detection of millisecond X-ray pulsations from several accreting neutron stars(7,8) and also by the evidence for a past accretion disc in a rotation-powered millisecond pulsar(9). It has been proposed that a rotation-powered pulsar may temporarily switch on(10-12) during periods of low mass inflow(13) in some such systems. Only indirect evidence for this transition has hitherto been observed(14-18). Here we report observations of accretion-powered, millisecond X-ray pulsations from a neutron star previously seen as a rotation-powered radio pulsar. Within a few days after a month-long X-ray outburst, radio pulses were again detected. This not only shows the evolutionary link between accretion and rotation-powered millisecond pulsars, but also that some systems can swing between the two states on very short timescales.	[Papitto, A.; Rea, N.; Torres, D. F.] Fac Sci, Inst Space Sci ICE IEEC CSIC, E-08193 Barcelona, Spain; [Ferrigno, C.; Bozzo, E.; Pavan, L.] Univ Geneva, Dept Astron, ISDC, CH-1290 Versoix, Switzerland; [Burderi, L.; Riggio, A.] Univ Cagliari, Dipartimento Fis, SP Monserrato Sestu, I-09042 Monserrato, Italy; [Burgay, M.; Possenti, A.] INAF Osservatorio Astron Cagliari, I-09012 Capoterra, Italy; [Campana, S.] INAF Osservatorio Astron Brera, I-23807 Merate, Lecco, Italy; [Di Salvo, T.] Univ Palermo, Dipartimento Fis & Chim, I-90123 Palermo, Italy; [Falanga, M.] Int Space Sci Inst, CH-3012 Bern, Switzerland; [Filipovic, M. D.; Wong, G. F.] Univ Western Sydney, Penrith, NSW 1797, Australia; [Freire, P. C. C.] Max Planck Inst Radioastron, D-53121 Bonn, Germany; [Hessels, J. W. T.] ASTRON, NL-7990 AA Dwingeloo, Netherlands; [Hessels, J. W. T.] Univ Amsterdam, Astron Inst Anton Pannekoek, NL-1098 XH Amsterdam, Netherlands; [Ransom, S. M.] NRAO, Charlottesville, VA 22901 USA; [Romano, P.] INAF Ist Astrofis Spaziale & Fis Cosm, I-90146 Palermo, Italy; [Sarkissian, J. M.; Wong, G. F.] CSIRO Astron & Space Sci, Epping, NSW 1710, Australia; [Stairs, I. H.] Univ British Columbia, Dept Phys & Astron, Vancouver, BC V6T 1Z1, Canada; [Stella, L.] INAF Osservatorio Astron Roma, I-00040 Monte Porzio Catone, Roma, Italy; [Torres, D. F.] ICREA, Barcelona 08010, Spain; [Wieringa, M. H.] CSIRO Astron & Space Sci, Narrabri, NSW 2390, Australia	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencias del Espacio (ICE); Institut d'Estudis Espacials de Catalunya (IEEC); University of Geneva; University of Cagliari; Istituto Nazionale Astrofisica (INAF); Istituto Nazionale Astrofisica (INAF); University of Palermo; Western Sydney University; Max Planck Society; University of Amsterdam; National Radio Astronomy Observatory (NRAO); Istituto Nazionale Astrofisica (INAF); Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of British Columbia; Istituto Nazionale Astrofisica (INAF); ICREA; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Papitto, A (corresponding author), Fac Sci, Inst Space Sci ICE IEEC CSIC, Campus UAB,Torre C5,2A Planta, E-08193 Barcelona, Spain.	papitto@ice.csic.es	Torres, Diego F/ABD-7940-2020; Ferrigno, Carlo/H-4139-2012; Campana, Sergio/AAL-6012-2020; Di Salvo, Tiziana/F-3973-2012; Torres, Diego F./AAF-7931-2019; Freire, Paulo/ABE-8926-2021; Di Salvo, Tiziana/AAF-9047-2019; Filipovic, Miroslav/AAN-9577-2020; Hessels, Jason/GTO-3261-2022; Di Salvo, Tiziana/AAC-1584-2019; Rea, Nanda/I-2853-2015; Torres, Diego F./O-9422-2016; Riggio, Alessandro/AAX-7994-2020; Riggio, Alessandro/D-3174-2012	Campana, Sergio/0000-0001-6278-1576; Di Salvo, Tiziana/0000-0002-3220-6375; Torres, Diego F./0000-0002-1522-9065; Freire, Paulo/0000-0003-1307-9435; Di Salvo, Tiziana/0000-0002-3220-6375; Filipovic, Miroslav/0000-0002-4990-9288; Hessels, Jason/0000-0003-2317-1446; Rea, Nanda/0000-0003-2177-6388; Torres, Diego F./0000-0002-1522-9065; Riggio, Alessandro/0000-0002-6145-9224; Riggio, Alessandro/0000-0002-6145-9224; Burgay, Marta/0000-0002-8265-4344; Pavan, Lucia/0000-0001-7867-2411; Wieringa, Mark/0000-0002-7721-8660; Papitto, Alessandro/0000-0001-6289-7413; Burderi, Luciano/0000-0001-5458-891X; Stella, Luigi/0000-0002-0018-1687; Ferrigno, Carlo/0000-0003-1429-1059; Romano, Patrizia/0000-0003-0258-7469; Ransom, Scott/0000-0001-5799-9714	CEA/Irfu (France); IN2P3/CNRS (France); CNES (France); INAF (Italy); NWO (The Netherlands); NSERC (Canada); Juan de la Cierva Research Fellowship; Sardinia Regional Government [ESF 2007-13]; Friedrich Wilhelm Bessel Award of the Alexander von Humboldt Foundation;  [AYA2012-39303];  [SGR2009-811];  [iLINK2011-0303]; ICREA Funding Source: Custom	CEA/Irfu (France)(French Atomic Energy Commission); IN2P3/CNRS (France)(Centre National de la Recherche Scientifique (CNRS)); CNES (France)(Centre National D'etudes Spatiales); INAF (Italy)(Istituto Nazionale Astrofisica (INAF)); NWO (The Netherlands)(Netherlands Organization for Scientific Research (NWO)Netherlands Government); NSERC (Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Juan de la Cierva Research Fellowship; Sardinia Regional Government(Regione Sardegna); Friedrich Wilhelm Bessel Award of the Alexander von Humboldt Foundation; ; ; ; ICREA(ICREA)	This letter is based on ToO observations made with XMM-Newton, Chandra, INTEGRAL, Swift, ATCA, WSRT, GBT and PKS. We thank the respective directors and operation teams for their support. Work was done in the framework of grants AYA2012-39303, SGR2009-811 and iLINK2011-0303, and with the support of CEA/Irfu, IN2P3/CNRS and CNES (France), INAF (Italy), NWO (The Netherlands) and NSERC (Canada). A.Pa. is supported by a Juan de la Cierva Research Fellowship. A. R. acknowledges Sardinia Regional Government for financial support (P.O.R. Sardegna ESF 2007-13). D. F. T. was additionally supported by a Friedrich Wilhelm Bessel Award of the Alexander von Humboldt Foundation. L. P. thanks the Societe Academique de Geneve and the Swiss Society for Astrophysics and Astronomy. We acknowledge the use of data supplied by the UK Swift Science Data Centre at the University of Leicester. A.Pa. thanks S. Giannetti, D. Lai, R. V. E. Lovelace, M. M. Romanova and T. Tauris for discussions, and S. D. Wolf for operational support.	ALPAR MA, 1982, NATURE, V300, P728, DOI 10.1038/300728a0; Archibald AM, 2009, SCIENCE, V324, P1411, DOI 10.1126/science.1172740; BACKER DC, 1982, NATURE, V300, P615, DOI 10.1038/300615a0; Begin S., 2006, THESIS U BRIT COLUMB; BHATTACHARYA D, 1991, PHYS REP, V203, P1, DOI 10.1016/0370-1573(91)90064-S; Bisnovatyi-Kogan G. S., 1974, Soviet Astronomy, V18, P217; Bogdanov S, 2011, ASTROPHYS J, V730, DOI 10.1088/0004-637X/730/2/81; Burderi L, 2003, ASTRON ASTROPHYS, V404, pL43, DOI 10.1051/0004-6361:20030669; Burderi L, 2001, ASTROPHYS J, V560, pL71, DOI 10.1086/324220; Burgay M, 2003, ASTROPHYS J, V589, P902, DOI 10.1086/374690; Campana S, 1998, ASTRON ASTROPHYS REV, V8, P279, DOI 10.1007/s001590050012; Chakrabarty D, 1998, NATURE, V394, P346, DOI 10.1038/28561; Chakrabarty D, 2003, NATURE, V424, P42, DOI 10.1038/nature01732; Di Salvo T, 2008, MON NOT R ASTRON SOC, V389, P1851, DOI 10.1111/j.1365-2966.2008.13709.x; FRUCHTER AS, 1988, NATURE, V333, P237, DOI 10.1038/333237a0; Gaensler BM, 1999, ASTROPHYS J, V522, pL117, DOI 10.1086/312238; Harris WE, 1996, ASTRON J, V112, P1487, DOI 10.1086/118116; LEAHY DA, 1983, ASTROPHYS J, V272, P256, DOI 10.1086/161288; LEWIN WHG, 1992, SPACE SCI REV, V62, P223, DOI 10.1007/BF00196124; Manchester RN, 2005, ASTRON J, V129, P1993, DOI 10.1086/428488; PACINI F, 1967, NATURE, V216, P567, DOI 10.1038/216567a0; Papitto A, 2011, ASTRON ASTROPHYS, V528, DOI 10.1051/0004-6361/201014837; Papitto A, 2009, ASTRON ASTROPHYS, V493, pL39, DOI 10.1051/0004-6361:20081; Patruno A, 2010, ASTROPHYS J, V722, P909, DOI 10.1088/0004-637X/722/1/909; RADHAKRISHNAN V, 1982, CURR SCI INDIA, V51, P1096; RUDERMAN M, 1989, ASTROPHYS J, V336, P507, DOI 10.1086/167029; STELLA L, 1994, ASTROPHYS J, V423, pL47, DOI 10.1086/187232; vanParadijs J, 1996, ASTROPHYS J, V464, pL139, DOI 10.1086/310100; Wijnands R, 1998, NATURE, V394, P344, DOI 10.1038/28557	30	296	301	1	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 26	2013	501	7468					517	520		10.1038/nature12470	http://dx.doi.org/10.1038/nature12470			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223RP	24067710	Green Submitted, Green Published			2022-12-28	WOS:000324826300051
J	Yan, B; Moses, SA; Gadway, B; Covey, JP; Hazzard, KRA; Rey, AM; Jin, DS; Ye, J				Yan, Bo; Moses, Steven A.; Gadway, Bryce; Covey, Jacob P.; Hazzard, Kaden R. A.; Rey, Ana Maria; Jin, Deborah S.; Ye, Jun			Observation of dipolar spin-exchange interactions with lattice-confined polar molecules	NATURE			English	Article							QUANTUM; MAGNETISM	With the production of polar molecules in the quantum regime(1,2), long-range dipolar interactions are expected to facilitate understanding of strongly interacting many-body quantum systems and to realize lattice spin models(3) for exploring quantum magnetism. In ordinary atomic systems, where contact interactions require wavefunction overlap, effective spin interactions on a lattice can be mediated by tunnelling, through a process referred to as superexchange; however, the coupling is relatively weak and is limited to nearest-neighbour interactions(4,5). In contrast, dipolar interactions exist even in the absence of tunnelling and extend beyond nearest neighbours. This allows coherent spin dynamics to persist even for gases with relatively high entropy and low lattice filling. Measured effects of dipolar interactions in ultracold molecular gases have been limited to the modification of inelastic collisions and chemical reactions(6,7). Here we use dipolar interactions of polar molecules pinned in a three-dimensional optical lattice to realize a lattice spin model. Spin is encoded in rotational states of molecules that are prepared and probed by microwaves. Resonant exchange of rotational angular momentum between two molecules realizes a spin-exchange interaction. The dipolar interactions are apparent in the evolution of the spin coherence, which shows oscillations in addition to an overall decay of the coherence. The frequency of these oscillations, the strong dependence of the spin coherence time on the lattice filling factor and the effect of a multipulse sequence designed to reverse dynamics due to two-body exchange interactions all provide evidence of dipolar interactions. Furthermore, we demonstrate the suppression of loss in weak lattices due to a continuous quantum Zeno mechanism(8). Measurements of these tunnelling-induced losses allow us to determine the lattice filling factor independently. Our work constitutes an initial exploration of the behaviour of many-body spin models with direct, long-range spin interactions and lays the groundwork for future studies of many-body dynamics in spin lattices.	[Yan, Bo; Moses, Steven A.; Gadway, Bryce; Covey, Jacob P.; Hazzard, Kaden R. A.; Rey, Ana Maria; Jin, Deborah S.; Ye, Jun] NIST, JILA, Boulder, CO 80309 USA; [Yan, Bo; Moses, Steven A.; Gadway, Bryce; Covey, Jacob P.; Hazzard, Kaden R. A.; Rey, Ana Maria; Jin, Deborah S.; Ye, Jun] Univ Colorado, Boulder, CO 80309 USA; [Yan, Bo; Moses, Steven A.; Gadway, Bryce; Covey, Jacob P.; Hazzard, Kaden R. A.; Rey, Ana Maria; Jin, Deborah S.; Ye, Jun] Univ Colorado, Dept Phys, Boulder, CO 80309 USA	National Institute of Standards & Technology (NIST) - USA; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Jin, DS (corresponding author), NIST, JILA, Boulder, CO 80309 USA.	jin@jilau1.colorado.edu; ye@jila.colorado.edu	Yan, Bo/B-3810-2012; Ye, Jun/C-3312-2011; Yan, Bo/B-3810-2012	Yan, Bo/0000-0002-5708-2460; Ye, Jun/0000-0003-0076-2112; Yan, Bo/0000-0001-7235-5554	NIST; NSF; AFOSR-ARO (MURI); ARO; DOE; ARO-DARPA-OLE; NDSEG	NIST(National Institute of Standards & Technology (NIST) - USA); NSF(National Science Foundation (NSF)); AFOSR-ARO (MURI); ARO; DOE(United States Department of Energy (DOE)); ARO-DARPA-OLE(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NDSEG	We thank B. Zhu, M. Foss-Feig, G. Quemener and M. Lukin for discussions. We acknowledge funding for this work from the NIST, NSF, AFOSR-ARO (MURI), ARO, DOE and ARO-DARPA-OLE. S. A. M. is supported by an NDSEG Graduate Fellowship. B. G. and K. R. A. H. are National Research Council postdoctoral fellows. K. R. A. H. and A. M. R. thank the KITP for hospitality.	Aikawa K, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.210401; Barnett R, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.190401; Baur SK, 2010, PHYS REV A, V82, DOI 10.1103/PhysRevA.82.023626; Britton JW, 2012, NATURE, V484, P489, DOI 10.1038/nature10981; Carr LD, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/5/055049; Chotia A, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.080405; de Miranda MHG, 2011, NAT PHYS, V7, P502, DOI [10.1038/NPHYS1939, 10.1038/nphys1939]; de Paz A, 2013, PHYS REV A, V87, DOI 10.1103/PhysRevA.87.051609; Gorshkov AV, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.115301; Greif D, 2013, SCIENCE, V340, P1307, DOI 10.1126/science.1236362; Hazzard KRA, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.075301; Islam R, 2013, SCIENCE, V340, P583, DOI 10.1126/science.1232296; ITANO WM, 1990, PHYS REV A, V41, P2295, DOI 10.1103/PhysRevA.41.2295; Lahaye T, 2009, REP PROG PHYS, V72, DOI 10.1088/0034-4885/72/12/126401; Lee PA, 2006, REV MOD PHYS, V78, P17, DOI 10.1103/RevModPhys.78.17; Lu MW, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.215301; Martin MJ, 2013, SCIENCE, V341, P632, DOI 10.1126/science.1236929; Maurer PC, 2012, SCIENCE, V336, P1283, DOI 10.1126/science.1220513; Maze JR, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.094303; Micheli A, 2006, NAT PHYS, V2, P341, DOI 10.1038/nphys287; Neyenhuis B, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.230403; Ni KK, 2008, SCIENCE, V322, P231, DOI 10.1126/science.1163861; Ni KK, 2010, NATURE, V464, P1324, DOI 10.1038/nature08953; Nipper J, 2012, PHYS REV X, V2, DOI 10.1103/PhysRevX.2.031011; Ospelkaus S, 2010, SCIENCE, V327, P853, DOI 10.1126/science.1184121; Ospelkaus S, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.030402; Potter AC, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.220406; Quemener G, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.062703; Syassen N, 2008, SCIENCE, V320, P1329, DOI 10.1126/science.1155309; Trotzky S, 2008, SCIENCE, V319, P295, DOI 10.1126/science.1150841; WAUGH JS, 1968, PHYS REV LETT, V20, P180, DOI 10.1103/PhysRevLett.20.180; Witzel WM, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.161306; Yao NY, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.266804	33	569	569	10	134	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 26	2013	501	7468					521	+		10.1038/nature12483	http://dx.doi.org/10.1038/nature12483			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223RP	24048478	Green Submitted			2022-12-28	WOS:000324826300052
J	Thadhani, R; Tamez, H; Solomon, SD				Thadhani, Ravi; Tamez, Hector; Solomon, Scott D.			Vitamin D Therapy and Cardiac Function in Chronic Kidney Disease Reply	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							LEFT-VENTRICULAR MASS; HYPERTENSION; HYPERTROPHY; LOSARTAN		[Thadhani, Ravi; Tamez, Hector] Massachusetts Gen Hosp, Div Nephrol, Boston, MA 02114 USA; [Solomon, Scott D.] Brigham & Womens Hosp, Div Cardiovasc Med, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital	Thadhani, R (corresponding author), Massachusetts Gen Hosp, Div Nephrol, Boston, MA 02114 USA.	thadhani.r@mgh.harvard.edu	Solomon, Scott/I-5789-2013					Devereux RB, 2004, CIRCULATION, V110, P1456, DOI 10.1161/01.CIR.0000141573.44737.5A; LEVY D, 1990, NEW ENGL J MED, V322, P1561, DOI 10.1056/NEJM199005313222203; Schiller N B, 1989, J Am Soc Echocardiogr, V2, P358; Solomon SD, 2009, CIRCULATION, V119, P530, DOI 10.1161/CIRCULATIONAHA.108.826214; Verdecchia P, 2001, J AM COLL CARDIOL, V38, P1829, DOI 10.1016/S0735-1097(01)01663-1	5	2	2	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 6	2012	307	21					2254	2254		10.1001/jama.2012.4176	http://dx.doi.org/10.1001/jama.2012.4176			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	952OL	24104200				2022-12-28	WOS:000304801700008
J	Tracy, SK; Hartz, DL; Tracy, MB; Allen, J; Forti, A; Hall, B; White, J; Lainchbury, A; Stapleton, H; Beckmann, M; Bisits, A; Homer, C; Foureur, M; Welsh, A; Kildea, S				Tracy, Sally K.; Hartz, Donna L.; Tracy, Mark B.; Allen, Jyai; Forti, Amanda; Hall, Bev; White, Jan; Lainchbury, Anne; Stapleton, Helen; Beckmann, Michael; Bisits, Andrew; Homer, Caroline; Foureur, Maralyn; Welsh, Alec; Kildea, Sue			Caseload midwifery care versus standard maternity care for women of any risk: M@NGO, a randomised controlled trial	LANCET			English	Article							TO-ONE MIDWIFERY; CESAREAN-SECTION; TRENDS; BIRTH	Background Women at low risk of pregnancy complications benefit from continuity of midwifery care, but no trial evidence exists for women with identified risk factors. We aimed to assess the clinical and cost outcomes of caseload midwifery care for women irrespective of risk factors. Methods In this unblinded, randomised, controlled, parallel-group trial, pregnant women at two metropolitan teaching hospitals in Australia were randomly assigned to either caseload midwifery care or standard maternity care by a telephone-based computer randomisation service. Women aged 18 years and older were eligible if they were less than 24 weeks pregnant at the first booking visit. Those who booked with another care provider, had a multiple pregnancy, or planned to have an elective caesarean section were excluded. Women allocated to caseload care received antenatal, intrapartum, and postnatal care from a named caseload midwife (or back-up caseload midwife). Controls received standard care with rostered midwives in discrete wards or clinics. The participant and the clinician were not masked to assignment. The main primary outcome was the proportion of women who had a caesarean section. The other primary maternal outcomes were the proportions who had an instrumental or unassisted vaginal birth, and the proportion who had epidural analgesia during labour. Primary neonatal outcomes were Apgar scores, preterm birth, and admission to neonatal intensive care. We analysed all outcomes by intention to treat. The trial is registered with the Australian New Zealand Clinical Trials Registry, number ACTRN12609000349246. Findings Publicly insured women were screened at the participating hospitals between Dec 8, 2008, and May 31, 2011. 1748 pregnant women were randomly assigned, 871 to caseload and 877 to standard care. The proportion of caesarean sections did not differ between the groups (183 [21%] in the caseload group vs 204 [23%] in the standard care group; odds ratio [OR] 0.88, 95% CI 0.70-1.10; p=0.26). The proportion of women who had elective caesarean sections (before onset of labour) differed significantly between caseload and standard care (69 [8%] vs 94 [11%]; OR 0.72, 95% CI 0.52-0.99; p=0.05). Proportions of instrumental birth were similar (172 [20%] vs 171 [19%]; p=0.90), as were the proportions of unassisted vaginal births (487 [56%] vs 454 [52%]; p=0.08) and epidural use (314 [36%] vs 304 [35%]; p=0.54). Neonatal outcomes did not differ between the groups. Total cost of care per woman was AUS$566.74 (95% 106.17-1027.30; p=0.02) less for caseload midwifery than for standard maternity care. Interpretation Our results show that for women of any risk, caseload midwifery is safe and cost-effective.	[Tracy, Sally K.; Hartz, Donna L.; Hall, Bev] Univ Sydney, Royal Hosp Women, Midwifery & Womens Hlth Res Unit, Randwick, NSW 2031, Australia; [Tracy, Mark B.] Univ Sydney, Westmead Hosp, Neonatal Intens Care Unit, Westmead, NSW 2145, Australia; [Allen, Jyai; Forti, Amanda; Stapleton, Helen; Kildea, Sue] Australian Catholic Univ, Mater Res & Mater Mothers Hosp, Midwifery Res Unit, Brisbane, Qld, Australia; [Beckmann, Michael] Mater Res & Mater Mothers Hosp, Womens Hlth Serv, Brisbane, Qld, Australia; [Beckmann, Michael] Mater Res & Mater Mothers Hosp, Newborn Serv, Brisbane, Qld, Australia; [White, Jan; Lainchbury, Anne] Royal Hosp Women, Sydney, NSW, Australia; [Bisits, Andrew; Welsh, Alec] Univ New S Wales, Royal Hosp Women, Dept Obstet & Maternal Fetal Med, Kensington, NSW 2033, Australia; [Homer, Caroline; Foureur, Maralyn] Univ Technol Sydney, Fac Hlth, Ctr Midwifery Child & Family Hlth, Sydney, NSW 2007, Australia	University of Sydney; University of Sydney; Australian Catholic University; Mater Research; Mater Research; Mater Research; University of New South Wales Sydney; University of Technology Sydney	Tracy, SK (corresponding author), Univ Sydney, Royal Hosp Women, Midwifery & Womens Hlth Res Unit, Randwick, NSW 2031, Australia.	sally.tracy@sydney.edu.au	Homer, Caroline S. E./J-2101-2014; Foureur, Maralyn/ABC-2997-2021; Foureur, Maralyn/I-9672-2014; Beckmann, Michael/L-4760-2013; Kildea, Sue/I-1548-2014; Beckmann, Mike/ABB-4964-2020	Homer, Caroline S. E./0000-0002-7454-3011; Foureur, Maralyn/0000-0002-0454-0165; Beckmann, Michael/0000-0001-7319-6938; Kildea, Sue/0000-0001-8591-4968; Tracy, Mark/0000-0001-5648-468X; Allen, Jyai/0000-0003-3196-0883; Welsh, Alec/0000-0002-7389-0513; Tracy, Sally Katherine/0000-0002-3753-5362; Hartz, Donna/0000-0002-4964-2106	National Health and Medical Research Council (Australia)	National Health and Medical Research Council (Australia)(National Health and Medical Research Council (NHMRC) of Australia)	Funding National Health and Medical Research Council (Australia).	Australian College of Midwives, 2008, NATIONAL MIDWIFERY G; Beasley S, 2012, AUST NZ J OBSTET GYN, V52, P576, DOI 10.1111/ajo.12003; Braithwaite J, 2009, QUAL SAF HEALTH CARE, V18, P37, DOI 10.1136/qshc.2007.023317; Brew BK, 2012, PEDIAT ALLERG IMM-UK, V23, P75, DOI 10.1111/j.1399-3038.2011.01229.x; Cardwell CR, 2008, DIABETOLOGIA, V51, P726, DOI 10.1007/s00125-008-0941-z; Chantry CJ, 2006, PEDIATRICS, V117, P425, DOI 10.1542/peds.2004-2283; Dahlen HG, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001723; Declercq E, 2011, BIRTH-ISS PERINAT C, V38, P99, DOI 10.1111/j.1523-536X.2010.00459.x; Guilliland K, 1995, THE MIDWIFERY MARTNE; Hartz DL, 2012, AUST HEALTH REV, V36, P169, DOI 10.1071/AH11012; Hatem M, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004667.pub2; Hyde MJ, 2012, BIOL REV, V87, P229, DOI 10.1111/j.1469-185X.2011.00195.x; IECEU, 2017, 34 IECEU; Knight M, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-55; Kramer MS, 2001, JAMA-J AM MED ASSOC, V285, P413, DOI 10.1001/jama.285.4.413; Li Z, 2011, AUSTRALIAS MOTHERS A; Macfarlane Fraser, 2011, J Health Organ Manag, V25, P55; McLachlan HL, 2012, BJOG-INT J OBSTET GY, V119, P1483, DOI 10.1111/j.1471-0528.2012.03446.x; Moher David, 2010, BMJ, V340, pc869, DOI [10.1016/j.jclinepi.2010.03.004, 10.1136/bmj.c869]; N Shaffordshire Changing Childbirth, 2000, MIDWIFERY, V16, P295; New South Wales Health, 2010, MATERNITY TOWARDS NO; NHS Insititute for Innovation and Improvement, 2011, PROMOTING NORMAL BIR; O'Leary CM, 2007, BJOG-INT J OBSTET GY, V114, P855, DOI 10.1111/j.1471-0528.2007.01307.x; Page L, 1999, J PUBLIC HEALTH MED, V21, P243, DOI 10.1093/pubmed/21.3.243; Page L, 2003, J MIDWIFERY WOM HEAL, V48, P119, DOI 10.1016/S1526-9523(02)00425-7; Pairman S., 1999, NZ COLL MIDWIVES J, V21, P6; Schlinzig T, 2009, ACTA PAEDIATR, V98, P1096, DOI 10.1111/j.1651-2227.2009.01371.x; Tracy SK, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-82; Turnbull D, 1996, LANCET, V348, P213; UK MRC, 2008, DEVELOPING AND EVALU; US Department of Health and Human Services, 2010, HEALTHY PEOPLE 2010; Weng SF, 2012, ARCH DIS CHILD, V97, P1019, DOI 10.1136/archdischild-2012-302263	32	183	183	0	31	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 23	2013	382	9906					1723	1732		10.1016/S0140-6736(13)61406-3	http://dx.doi.org/10.1016/S0140-6736(13)61406-3			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	259PX	24050808				2022-12-28	WOS:000327539900029
J	Libuda, DE; Uzawa, S; Meyer, BJ; Villeneuve, AM				Libuda, Diana E.; Uzawa, Satoru; Meyer, Barbara J.; Villeneuve, Anne M.			Meiotic chromosome structures constrain and respond to designation of crossover sites	NATURE			English	Article							SYNAPTONEMAL COMPLEX; CROSSING-OVER; C-ELEGANS; CAENORHABDITIS-ELEGANS; CHIASMA FORMATION; STRAND-EXCHANGE; SYNAPSIS; MEIOSIS; RECOMBINATION; INTERFERENCE	Crossover recombination events between homologous chromosomes are required to form chiasmata, temporary connections between homologues that ensure their proper segregation at meiosis I-1. Despite this requirement for crossovers and an excess of the double-strand DNA breaks that are the initiating events for meiotic recombination, most organisms make very few crossovers per chromosome pair(2). Moreover, crossovers tend to inhibit the formation of other crossovers nearby on the same chromosome pair, a poorly understood phenomenon known as crossover interference(3,4). Here we show that the synaptonemal complex, a meiosis-specific structure that assembles between aligned homologous chromosomes, both constrains and is altered by crossover recombination events. Using a cytological marker of crossover sites in Caenorhabditis elegans(5), we show that partial depletion of the synaptonemal complex central region proteins attenuates crossover interference, increasing crossovers and reducing the effective distance over which interference operates, indicating that synaptonemal complex proteins limit crossovers. Moreover, we show that crossovers are associated with a local 0.4-0.5-micrometre increase in chromosome axis length. We propose that meiotic crossover regulation operates as a self-limiting system in which meiotic chromosome structures establish an environment that promotes crossover formation, which in turn alters chromosome structure to inhibit other crossovers at additional sites.	[Libuda, Diana E.; Villeneuve, Anne M.] Stanford Univ, Dept Dev Biol, Sch Med, Stanford, CA 94305 USA; [Uzawa, Satoru; Meyer, Barbara J.] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Uzawa, Satoru; Meyer, Barbara J.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Villeneuve, Anne M.] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA	Stanford University; Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Stanford University	Villeneuve, AM (corresponding author), Stanford Univ, Dept Dev Biol, Sch Med, Stanford, CA 94305 USA.	annev@stanford.edu		Meyer, Barbara/0000-0002-6530-4588; Libuda, Diana/0000-0002-4944-1814	National Institutes of Health (NIH) [P40 OD010440, K99 HD076165, R01 GM067268]; Helen Hay Whitney Foundation; Katharine McCormick Advanced Postdoctoral Fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K99HD076165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067268] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Helen Hay Whitney Foundation; Katharine McCormick Advanced Postdoctoral Fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank A. Dernburg and M. Zetka for antibodies and the CGC (funded by National Institutes of Health (NIH) P40 OD010440) for strains. We thank K. Hillers and K. Zawadzki for comments on the manuscript. This work was supported by a Helen Hay Whitney Foundation Postdoctoral Fellowship, a Katharine McCormick Advanced Postdoctoral Fellowship, and NIH K99 HD076165 to D.E.L. and by NIH R01 GM067268 to A.M.V. B.J.M. is an investigator of the Howard Hughes Medical Institute.	Bishop DK, 2004, CELL, V117, P9, DOI 10.1016/S0092-8674(04)00297-1; Borner GV, 2004, CELL, V117, P29, DOI 10.1016/S0092-8674(04)00292-2; Chen H, 1996, J STRUCT BIOL, V116, P56, DOI 10.1006/jsbi.1996.0010; Chen SY, 2008, DEV CELL, V15, P401, DOI 10.1016/j.devcel.2008.07.006; Colaiacovo MP, 2003, DEV CELL, V5, P463, DOI 10.1016/S1534-5807(03)00232-6; Cole F, 2012, NAT CELL BIOL, V14, P424, DOI 10.1038/ncb2451; de Boer E, 2006, P NATL ACAD SCI USA, V103, P9607, DOI 10.1073/pnas.0600418103; Dernburg AF, 1998, CELL, V94, P387, DOI 10.1016/S0092-8674(00)81481-6; EGEL R, 1978, HEREDITY, V41, P233, DOI 10.1038/hdy.1978.92; Fung JC, 2004, CELL, V116, P795, DOI 10.1016/S0092-8674(04)00249-1; Goodyer W, 2008, DEV CELL, V14, P263, DOI 10.1016/j.devcel.2007.11.016; Hayashi M, 2010, GENETICS, V186, P45, DOI 10.1534/genetics.110.115501; Hillers KJ, 2003, CURR BIOL, V13, P1641, DOI 10.1016/j.cub.2003.08.026; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Macqueen AJ, 2005, CELL, V123, P1037, DOI 10.1016/j.cell.2005.09.034; MacQueen AJ, 2002, GENE DEV, V16, P2428, DOI 10.1101/gad.1011602; MAGUIRE MP, 1988, GENOME, V30, P469, DOI 10.1139/g88-078; Martinez-Perez E, 2005, GENE DEV, V19, P2727, DOI 10.1101/gad.1338505; Martinez-Perez E, 2009, CURR OPIN GENET DEV, V19, P105, DOI 10.1016/j.gde.2009.02.005; MCPEEK MS, 1995, GENETICS, V139, P1031; Mets DG, 2009, CELL, V139, P73, DOI 10.1016/j.cell.2009.07.035; Muller HJ, 1916, AM NAT, V50, P193, DOI 10.1086/279534; Page SL, 2003, SCIENCE, V301, P785, DOI 10.1126/science.1086605; Phillips CM, 2005, CELL, V123, P1051, DOI 10.1016/j.cell.2005.09.035; Reynolds A, 2013, NAT GENET, V45, P269, DOI 10.1038/ng.2541; Rosu S, 2011, SCIENCE, V334, P1286, DOI 10.1126/science.1212424; SIGURDSON DC, 1986, MOL GEN GENET, V202, P212, DOI 10.1007/BF00331639; Smolikov S, 2007, GENETICS, V176, P2015, DOI 10.1534/genetics.107.072413; Storlazzi A, 1996, P NATL ACAD SCI USA, V93, P9043, DOI 10.1073/pnas.93.17.9043; Sturtevant AH, 1913, J EXP ZOOL, V14, P43, DOI 10.1002/jez.1400140104; Yokoo R, 2012, CELL, V149, P75, DOI 10.1016/j.cell.2012.01.052; Zetka MC, 1999, GENE DEV, V13, P2258, DOI 10.1101/gad.13.17.2258	32	93	95	0	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 31	2013	502	7473					703	+		10.1038/nature12577	http://dx.doi.org/10.1038/nature12577			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243CC	24107990	Green Accepted			2022-12-28	WOS:000326293200052
J	Shan, MM; Gentile, M; Yeiser, JR; Walland, AC; Bornstein, VU; Chen, K; He, B; Cassis, L; Bigas, A; Cols, M; Comerma, L; Huang, BH; Blander, JM; Xiong, HB; Mayer, L; Berin, C; Augenlicht, LH; Velcich, A; Cerutti, A				Shan, Meimei; Gentile, Maurizio; Yeiser, John R.; Walland, A. Cooper; Bornstein, Victor U.; Chen, Kang; He, Bing; Cassis, Linda; Bigas, Anna; Cols, Montserrat; Comerma, Laura; Huang, Bihui; Blander, J. Magarian; Xiong, Huabao; Mayer, Lloyd; Berin, Cecilia; Augenlicht, Leonard H.; Velcich, Anna; Cerutti, Andrea			Mucus Enhances Gut Homeostasis and Oral Tolerance by Delivering Immunoregulatory Signals	SCIENCE			English	Article							CD103(+) DENDRITIC CELLS; T-CELLS; EPITHELIAL-CELLS; BETA-CATENIN; DECTIN-1; DIFFERENTIATION; ASSOCIATION; IMMUNITY; ANTIGEN; MUCIN	A dense mucus layer in the large intestine prevents inflammation by shielding the underlying epithelium from luminal bacteria and food antigens. This mucus barrier is organized around the hyperglycosylated mucin MUC2. Here we show that the small intestine has a porous mucus layer, which permitted the uptake of MUC2 by antigen-sampling dendritic cells (DCs). Glycans associated with MUC2 imprinted DCs with anti-inflammatory properties by assembling a galectin-3-Dectin-1-Fc gamma RIIB receptor complex that activated beta-catenin. This transcription factor interfered with DC expression of inflammatory but not tolerogenic cytokines by inhibiting gene transcription through nuclear factor kappa B. MUC2 induced additional conditioning signals in intestinal epithelial cells. Thus, mucus does not merely form a nonspecific physical barrier, but also constrains the immunogenicity of gut antigens by delivering tolerogenic signals.	[Shan, Meimei; Yeiser, John R.; Walland, A. Cooper; Bornstein, Victor U.; Chen, Kang; He, Bing; Cols, Montserrat; Blander, J. Magarian; Xiong, Huabao; Mayer, Lloyd; Cerutti, Andrea] Icahn Sch Med Mt Sinai, Inst Immunol, Dept Med, New York, NY USA; [Gentile, Maurizio; Cassis, Linda; Comerma, Laura; Cerutti, Andrea] Inst Hosp Mar Invest Med IMIM, Program Inflammatory & Cardiovasc Disorders, Barcelona, Spain; [Chen, Kang] Wayne State Univ, Dept Obstet & Gynecol, Detroit, MI USA; [Bigas, Anna] IMIM, Program Canc Res, Barcelona, Spain; [Comerma, Laura] Hosp del Mar, Dept Pathol, Barcelona, Spain; [Huang, Bihui] Yale Univ, Dept Pharmacol, New Haven, CT USA; [Blander, J. Magarian] Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY USA; [Berin, Cecilia] Icahn Sch Med Mt Sinai, Inst Immunol, Dept Pediat, New York, NY USA; [Augenlicht, Leonard H.; Velcich, Anna] Albert Einstein Coll Med, Dept Med, New York, NY USA; [Cerutti, Andrea] NIH, Mucosal Immunol Studies Team MIST, Bethesda, MD 20892 USA; [Cerutti, Andrea] Catalan Inst Res & Adv Studies ICREA, Barcelona, Spain	Icahn School of Medicine at Mount Sinai; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Wayne State University; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Yale University; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Yeshiva University; National Institutes of Health (NIH) - USA; ICREA	Cerutti, A (corresponding author), Icahn Sch Med Mt Sinai, Inst Immunol, Dept Med, New York, NY USA.	andrea.cerutti@mssm.edu	Bigas, Anna/A-7457-2014; Cassis, Linda/K-9633-2014; Blesa, Laura Comerma/AAQ-9455-2020	Cassis, Linda/0000-0003-4544-9816; Blesa, Laura Comerma/0000-0002-0249-4636; berin, cecilia/0000-0002-9051-9249; Blander, Julie Magarian/0000-0001-9207-1700; Bigas, Anna/0000-0003-4801-6899; Huang, Bihui/0000-0003-3084-7096; Cerutti, Andrea/0000-0003-3026-4704	National Institute of Allergy and Infectious Diseases, NIH [AI61093, AI57653, AI95613, AI96187, AI74378, AI073899, DK072201, AI095245]; Redes Tematicas de Investigacion Cooperativa en Salud/Fondo Europeo de Desarrollo Regional [RD12/0036/0054]; ICREA Funding Source: Custom; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI095613, R01AI093577, R01AI057653, R01AI073899, R01AI074378, P01AI061093, R56AI073899, U19AI096187, R01AI095245] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK072201] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Redes Tematicas de Investigacion Cooperativa en Salud/Fondo Europeo de Desarrollo Regional; ICREA(ICREA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by the National Institute of Allergy and Infectious Diseases, NIH (AI61093, AI57653, AI95613, AI96187 and AI74378 to A. C. and AI073899, DK072201 and AI095245 to J.M.B.) and by Redes Tematicas de Investigacion Cooperativa en Salud/Fondo Europeo de Desarrollo Regional (RD12/0036/0054 to A. B). pRSETb-mRFP used for red bacteria is under a materials transfer agreement with R. Y. Tsien at the University of California, San Francisco, and Howard Hughes Medical Institute. The data presented in this manuscript are tabulated in the main paper and the supplementary materials.	Bogunovic M, 2009, IMMUNITY, V31, P513, DOI 10.1016/j.immuni.2009.08.010; Cerutti A, 2011, ANNU REV IMMUNOL, V29, P273, DOI 10.1146/annurev-immunol-031210-101317; Coombes JL, 2008, NAT REV IMMUNOL, V8, P435, DOI 10.1038/nri2335; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Deng JO, 2002, CANCER CELL, V2, P323, DOI 10.1016/S1535-6108(02)00154-X; Dennehy KM, 2009, EUR J IMMUNOL, V39, P1379, DOI 10.1002/eji.200838543; Dillon S, 2006, J CLIN INVEST, V116, P916, DOI 10.1172/JCI27203; Esteban A, 2011, P NATL ACAD SCI USA, V108, P14270, DOI 10.1073/pnas.1111415108; Farache J, 2013, IMMUNITY, V38, P581, DOI 10.1016/j.immuni.2013.01.009; Ilarregui JM, 2009, NAT IMMUNOL, V10, P981, DOI 10.1038/ni.1772; Iliev ID, 2009, MUCOSAL IMMUNOL, V2, P340, DOI 10.1038/mi.2009.13; Iliev ID, 2012, SCIENCE, V336, P1314, DOI 10.1126/science.1221789; Johansson MEV, 2011, P NATL ACAD SCI USA, V108, P4659, DOI 10.1073/pnas.1006451107; Karsten CM, 2012, NAT MED, V18, P1401, DOI 10.1038/nm.2862; Kelly EK, 2010, J IMMUNOL, V184, P5545, DOI 10.4049/jimmunol.0901293; Manicassamy S, 2010, SCIENCE, V329, P849, DOI 10.1126/science.1188510; McDole JR, 2012, NATURE, V483, P345, DOI 10.1038/nature10863; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Niess JH, 2005, SCIENCE, V307, P254, DOI 10.1126/science.1102901; Rabinovich GA, 2009, NAT REV IMMUNOL, V9, P338, DOI 10.1038/nri2536; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; Rimoldi M, 2005, NAT IMMUNOL, V6, P507, DOI 10.1038/ni1192; Strasser D, 2012, IMMUNITY, V36, P32, DOI 10.1016/j.immuni.2011.11.015; Vaishnava S, 2011, SCIENCE, V334, P255, DOI 10.1126/science.1209791; Velcich A, 2002, SCIENCE, V295, P1726, DOI 10.1126/science.1069094; Wen AY, 2010, J IMMUNOL, V185, P6413, DOI 10.4049/jimmunol.1001829; Yu CI, 2013, IMMUNITY, V38, P818, DOI 10.1016/j.immuni.2013.03.004; Zhou YF, 2010, NAT MED, V16, P1128, DOI 10.1038/nm.2201	28	374	388	16	153	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 25	2013	342	6157					447	453		10.1126/science.1237910	http://dx.doi.org/10.1126/science.1237910			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239RH	24072822	Green Submitted, Green Accepted			2022-12-28	WOS:000326042600034
J	Choi, YJ; Lee, SY				Choi, Yong Jun; Lee, Sang Yup			Microbial production of short-chain alkanes	NATURE			English	Article							ACYL CARRIER PROTEIN; FATTY-ACID SYNTHESIS; ESCHERICHIA-COLI; ARABIDOPSIS ECERIFERUM1; SYNTHASE-III; BIOSYNTHESIS; GENE; INITIATION; CHEMICALS; MUTANTS	Increasing concerns about limited fossil fuels and global environmental problems have focused attention on the need to develop sustainable biofuels from renewable resources. Although microbial production of diesel has been reported, production of another much in demand transport fuel, petrol (gasoline), has not yet been demonstrated. Here we report the development of platform Escherichia coli strains that are capable of producing short-chain alkanes (SCAs; petrol), free fatty acids (FFAs), fatty esters and fatty alcohols through the fatty acyl (acyl carrier protein (ACP)) to fatty acid to fatty acyl-CoA pathway. First, the beta-oxidation pathway was blocked by deleting the fadE gene to prevent the degradation of fatty acyl-CoAs generated in vivo. To increase the formation of short-chain fatty acids suitable for subsequent conversion to SCAs in vivo, the activity of 3-oxoacyl-ACP synthase (FabH)(1), which is inhibited by unsaturated fatty acyl-ACPs(2), was enhanced to promote the initiation of fatty acid biosynthesis by deleting the fadR gene; deletion of the fadR gene prevents upregulation of the fabA and fabB genes responsible for unsaturated fatty acids biosynthesis(3). A modified thioesterase(4) was used to convert short-chain fatty acyl-ACPs to the corresponding FFAs, which were then converted to SCAs by the sequential reactions of E. coli fatty acyl-CoA synthetase, Clostridium acetobutylicum fatty acyl-CoA reductase and Arabidopsis thaliana fatty aldehyde decarbonylase. The final engineered strain produced up to 580.8 mg l(-1) of SCAs consisting of nonane (327.8 mg l(-1)), dodecane (136.5 mg l(-1)), tridecane (64.8 mg l(-1)), 2-methyl-dodecane (42.8 mg l(-1)) and tetradecane (8.9 mg l(-1)), together with small amounts of other hydrocarbons. Furthermore, this platform strain could produce short-chain FFAs using a fadD-deleted strain, and short-chain fatty esters by introducing the Acinetobacter sp. ADP1 wax ester synthase (atfA)(5) and the E. coli mutant alcohol dehydrogenase (adhE(mut))(6).	[Choi, Yong Jun; Lee, Sang Yup] Korea Adv Inst Sci & Technol, Metab & Biomol Engn Natl Res Lab, Dept Chem & Biomol Engn, BioProc Engn Res Ctr,Program BK21, Taejon 305701, South Korea; [Choi, Yong Jun; Lee, Sang Yup] Korea Adv Inst Sci & Technol, Ctr Syst & Synthet Biotechnol, Taejon 305701, South Korea; [Lee, Sang Yup] Korea Adv Inst Sci & Technol, Bioinformat & BioProc Engn Res Ctr, Taejon 305701, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST)	Lee, SY (corresponding author), Korea Adv Inst Sci & Technol, Metab & Biomol Engn Natl Res Lab, Dept Chem & Biomol Engn, BioProc Engn Res Ctr,Program BK21, 291 Daehak Ro, Taejon 305701, South Korea.	leesy@kaist.ac.kr	Lee, Sang Yup/C-1526-2011	Lee, Sang Yup/0000-0003-0599-3091	Advanced Biomass Research and Development Center of Korea through the Global Frontier Research Program of the Ministry of Science, ICT and Future Planning (MSIP) through the National Research Foundation (NRF) [ABC-2010-0029799]; Technology Development Program to Solve Climate Changes on Systems Metabolic Engineering for Biorefineries by MSIP through NRF [NRF-2012-C1AAA001-2012M1A2A2026556]	Advanced Biomass Research and Development Center of Korea through the Global Frontier Research Program of the Ministry of Science, ICT and Future Planning (MSIP) through the National Research Foundation (NRF); Technology Development Program to Solve Climate Changes on Systems Metabolic Engineering for Biorefineries by MSIP through NRF	We would like to thank Y. H. Lee for her assistance in cloning work and S. J. Choi for performing the fermentation experiments for checking reproducibility. This work was supported by the Advanced Biomass Research and Development Center of Korea (ABC-2010-0029799) through the Global Frontier Research Program of the Ministry of Science, ICT and Future Planning (MSIP) through the National Research Foundation (NRF). Systems metabolic engineering work was supported by the Technology Development Program to Solve Climate Changes on Systems Metabolic Engineering for Biorefineries (NRF-2012-C1AAA001-2012M1A2A2026556) by MSIP through NRF.	Aarts MGM, 1995, PLANT CELL, V7, P2115, DOI 10.1105/tpc.7.12.2115; Altin O., 2004, PREPRINTS PAPERS AM, V49, p764 766; Atsumi S, 2008, NATURE, V451, P86, DOI 10.1038/nature06450; Bernard A, 2012, PLANT CELL, V24, P3106, DOI 10.1105/tpc.112.099796; Bourdenx B, 2011, PLANT PHYSIOL, V156, P29, DOI 10.1104/pp.111.172320; Choi YJ, 2012, METAB ENG, V14, P477, DOI 10.1016/j.ymben.2012.07.006; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Gary J.H., 2001, PETROLEUM REFINING T, VFourth; Han L, 1998, J BACTERIOL, V180, P4481, DOI 10.1128/JB.180.17.4481-4486.1998; Harger M, 2013, ACS SYNTH BIOL, V2, P59, DOI 10.1021/sb300061x; Heath RJ, 1996, J BIOL CHEM, V271, P1833, DOI 10.1074/jbc.271.4.1833; Holland-Staley CA, 2000, J BACTERIOL, V182, P6049, DOI 10.1128/JB.182.21.6049-6054.2000; Howard TP, 2013, P NATL ACAD SCI USA, V110, P7636, DOI 10.1073/pnas.1215966110; Jing FY, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-44; Lennen RM, 2010, BIOTECHNOL BIOENG, V106, P193, DOI 10.1002/bit.22660; Lo YC, 2005, BIOCHEMISTRY-US, V44, P1971, DOI 10.1021/bi048109x; MCNEVIN JP, 1993, GENOME, V36, P610, DOI 10.1139/g93-082; Na D, 2013, NAT BIOTECHNOL, V31, P170, DOI 10.1038/nbt.2461; NAGGERT J, 1991, J BIOL CHEM, V266, P11044; NUNN WD, 1983, J BACTERIOL, V154, P554, DOI 10.1128/JB.154.2.554-560.1983; Palmeros B, 2000, GENE, V247, P255, DOI 10.1016/S0378-1119(00)00075-5; Peralta-Yahya PP, 2012, NATURE, V488, P320, DOI 10.1038/nature11478; POLLARD MR, 1991, ARCH BIOCHEM BIOPHYS, V284, P306, DOI 10.1016/0003-9861(91)90300-8; Reiser S, 1997, J BACTERIOL, V179, P2969, DOI 10.1128/jb.179.9.2969-2975.1997; Sambrook J., 2001, MOL CLONING LAB MANU; Schirmer A, 2010, SCIENCE, V329, P559, DOI 10.1126/science.1187936; Steen EJ, 2010, NATURE, V463, P559, DOI 10.1038/nature08721; Torella JP, 2013, P NATL ACAD SCI USA, V110, P11290, DOI 10.1073/pnas.1307129110; TSAY JT, 1992, J BIOL CHEM, V267, P6807; Yuan LZ, 2006, METAB ENG, V8, P79, DOI 10.1016/j.ymben.2005.08.005; Zhang FZ, 2012, NAT BIOTECHNOL, V30, P354, DOI 10.1038/nbt.2149; Zhang HX, 2006, FEMS MICROBIOL LETT, V259, P249, DOI 10.1111/j.1574-6968.2006.00277.x; Zheng YN, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-76	33	305	327	8	330	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 24	2013	502	7472					571	+		10.1038/nature12536	http://dx.doi.org/10.1038/nature12536			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	238YN	24077097				2022-12-28	WOS:000325988400059
J	Harris, AD; Pineles, L; Belton, B; Johnson, JK; Shardell, M; Loeb, M; Newhouse, R; Dembry, L; Braun, B; Perencevich, EN; Hall, KK; Morgan, DJ				Harris, Anthony D.; Pineles, Lisa; Belton, Beverly; Johnson, J. Kristie; Shardell, Michelle; Loeb, Mark; Newhouse, Robin; Dembry, Louise; Braun, Barbara; Perencevich, Eli N.; Hall, Kendall K.; Morgan, Daniel J.		Benefits Universal Glove Gown BUGG	Universal Glove and Gown Use and Acquisition of Antibiotic-Resistant Bacteria in the ICU A Randomized Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CARE-ASSOCIATED INFECTIONS; STAPHYLOCOCCUS-AUREUS; METHICILLIN-RESISTANT; CONTACT PRECAUTIONS; INTENSIVE-CARE; TRANSMISSION; ENTEROCOCCUS; IMPACT; DECOLONIZATION; INTERVENTION	IMPORTANCE Antibiotic-resistant bacteria are associated with increased patient morbidity and mortality. It is unknown whether wearing gloves and gowns for all patient contact in the intensive care unit (ICU) decreases acquisition of antibiotic-resistant bacteria. OBJECTIVE To assess whether wearing gloves and gowns for all patient contact in the ICU decreases acquisition of methicillin-resistant Staphylococcus aureus (MRSA) or vancomycin-resistant Enterococcus (VRE) compared with usual care. DESIGN, SETTING, AND PARTICIPANTS Cluster-randomized trial in 20 medical and surgical ICUs in 20 US hospitals from January 4, 2012, to October 4, 2012. INTERVENTIONS In the intervention ICUs, all health care workers were required to wear gloves and gowns for all patient contact and when entering any patient room. MAIN OUTCOMES AND MEASURES The primary outcome was acquisition of MRSA or VRE based on surveillance cultures collected on admission and discharge from the ICU. Secondary outcomes included individual VRE acquisition, MRSA acquisition, frequency of health care worker visits, hand hygiene compliance, health care-associated infections, and adverse events. RESULTS From the 26 180 patients included, 92 241 swabs were collected for the primary outcome. Intervention ICUs had a decrease in the primary outcome of MRSA or VRE from 21.35 acquisitions per 1000 patient-days (95% CI, 17.57 to 25.94) in the baseline period to 16.91 acquisitions per 1000 patient-days (95% CI, 14.09 to 20.28) in the study period, whereas control ICUs had a decrease in MRSA or VRE from 19.02 acquisitions per 1000 patient-days (95% CI, 14.20 to 25.49) in the baseline period to 16.29 acquisitions per 1000 patient-days (95% CI, 13.48 to 19.68) in the study period, a difference in changes that was not statistically significant (difference, -1.71 acquisitions per 1000 person-days, 95% CI, -6.15 to 2.73; P = .57). For key secondary outcomes, there was no difference in VRE acquisition with the intervention (difference, 0.89 acquisitions per 1000 person-days; 95% CI, -4.27 to 6.04, P = .70), whereas for MRSA, there were fewer acquisitions with the intervention (difference, -2.98 acquisitions per 1000 person-days; 95% CI, -5.58 to -0.38; P = .046). Universal glove and gown use also decreased health care worker room entry (4.28 vs 5.24 entries per hour, difference, -0.96; 95% CI, -1.71 to -0.21, P = .02), increased room-exit hand hygiene compliance (78.3% vs 62.9%, difference, 15.4%; 95% CI, 8.99% to 21.8%; P = .02) and had no statistically significant effect on rates of adverse events (58.7 events per 1000 patient days vs 74.4 events per 1000 patient days; difference, -15.7; 95% CI, -40.7 to 9.2, P = .24). CONCLUSIONS AND RELEVANCE The use of gloves and gowns for all patient contact compared with usual care among patients in medical and surgical ICUs did not result in a difference in the primary outcome of acquisition of MRSA or VRE. Although there was a lower risk of MRSA acquisition alone and no difference in adverse events, these secondary outcomes require replication before reaching definitive conclusions.	[Harris, Anthony D.; Pineles, Lisa; Johnson, J. Kristie; Shardell, Michelle; Morgan, Daniel J.] Univ Maryland, Sch Med, Baltimore, MD 21201 USA; [Belton, Beverly; Dembry, Louise] Yale New Haven Hlth Syst Ctr Healthcare Solut, New Haven, CT USA; [Loeb, Mark] McMaster Univ, Hamilton, ON, Canada; [Newhouse, Robin] Univ Maryland, Sch Nursing, Baltimore, MD 21201 USA; [Braun, Barbara] Joint Commiss, Oak Brook Terrace, IL USA; [Perencevich, Eli N.] Univ Iowa Hlth Care, Iowa City, IA USA; [Hall, Kendall K.] Agcy Healthcare Res & Qual, Rockville, MD USA; [Morgan, Daniel J.] VA Maryland Hlth Care Syst, Baltimore, MD USA	University System of Maryland; University of Maryland Baltimore; McMaster University; University System of Maryland; University of Maryland Baltimore; University of Iowa; Agency for Healthcare Research & Quality	Harris, AD (corresponding author), Univ Maryland, Sch Med, 10 S Pine St,MSTF 330, Baltimore, MD 21201 USA.	aharris@epi.umaryland.edu	Jacob, Jesse/A-8836-2009	Munoz-Price, L. Silvia/0000-0001-8654-5746; Lissauer, Matthew/0000-0002-6008-9778; Perencevich, Eli/0000-0002-3721-3355; Warren, David/0000-0001-8679-8241; Anderson, Deverick/0000-0001-6882-5496; Herwaldt, Loreen/0000-0002-9530-6859; Pineles, Lisa/0000-0002-2377-5971	Agency for Healthcare Research and Quality (AHRQ) [HHSA290200600015]; National Institutes of Health [5K25AG034216-03, 5K24AI079040-05]; AHRQ [1K08HS18111-01]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K08HS018111] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI095357, K24AI079040] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K25AG034216] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality (AHRQ)(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHRQ(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by grants HHSA290200600015 from the Agency for Healthcare Research and Quality (AHRQ), 5K25AG034216-03 (Dr Shardell) and 5K24AI079040-05 (Dr Harris) from the National Institutes of Health, and 1K08HS18111-01 (Dr Morgan) from the AHRQ.	[Anonymous], 2009, IHI GLOBAL TRIGGER T; Bell JM, 1998, J CLIN MICROBIOL, V36, P2187, DOI 10.1128/JCM.36.8.2187-2190.1998; Boyce JM, 2002, AM J INFECT CONTROL, V30, pS1, DOI 10.1067/mic.2002.130391; Brookmeyer R, 1998, STAT MED, V17, P2121, DOI 10.1002/(SICI)1097-0258(19980930)17:18<2121::AID-SIM907>3.0.CO;2-S; Campbell MK, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5661; Climo MW, 2013, NEW ENGL J MED, V368, P533, DOI 10.1056/NEJMoa1113849; Cosgrove SE, 2003, CLIN INFECT DIS, V36, P53, DOI 10.1086/345476; DiazGranados CA, 2005, J INFECT DIS, V191, P588, DOI 10.1086/427512; Feng PJI, 2011, INFECT CONT HOSP EP, V32, P20, DOI 10.1086/657668; Harris AD, 2010, ANTIMICROB AGENTS CH, V54, P3143, DOI 10.1128/AAC.01590-09; Hayden MK, 2008, INFECT CONT HOSP EP, V29, P149, DOI 10.1086/524331; Ho J, 2010, CURR OPIN INFECT DIS, V23, P546, DOI 10.1097/QCO.0b013e32833f0d3e; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Huang SS, 2013, NEW ENGL J MED, V368, P2255, DOI 10.1056/NEJMoa1207290; Huskins WC, 2011, NEW ENGL J MED, V364, P1407, DOI 10.1056/NEJMoa1000373; Institute for Healthcare Improvement, HOW TO GUID IMPR HAN; Klar N, 2000, DESIGN ANAL CLUSTER, DOI [10.17843/rpmesp.2016.333.2293, DOI 10.17843/RPMESP.2016.333.2293]; KLEIN BS, 1989, NEW ENGL J MED, V320, P1714, DOI 10.1056/NEJM198906293202603; Klevens RM, 2007, PUBLIC HEALTH REP, V122, P160, DOI 10.1177/003335490712200205; Landrigan CP, 2010, NEW ENGL J MED, V363, P2124, DOI 10.1056/NEJMsa1004404; Lee AS, 2011, CLIN INFECT DIS, V52, P1422, DOI 10.1093/cid/cir233; McGann P, 2011, INFECT CONT HOSP EP, V32, P1116, DOI 10.1086/662380; Morgan DJ, 2013, INFECT CONT HOSP EP, V34, P69, DOI 10.1086/668775; Morgan DJ, 2012, CLIN INFECT DIS, V55, P923, DOI 10.1093/cid/cis556; Morgan DJ, 2012, CRIT CARE MED, V40, P1045, DOI 10.1097/CCM.0b013e31823bc7c8; Morgan DJ, 2009, AM J INFECT CONTROL, V37, P85, DOI 10.1016/j.ajic.2008.04.257; Richter SS, 2011, ANTIMICROB AGENTS CH, V55, P4154, DOI 10.1128/AAC.00315-11; Robinson GL, 2012, J CLIN MICROBIOL, V50, P2466, DOI 10.1128/JCM.00911-12; Safdar N, 2006, AM J INFECT CONTROL, V34, P476, DOI 10.1016/j.ajic.2006.01.011; Siegel JD, 2007, AM J INFECT CONTROL, V35, pS65, DOI 10.1016/j.ajic.2007.10.007; Siegel JD, 2007, AM J INFECT CONTROL, V35, pS165, DOI 10.1016/j.ajic.2007.10.006; Stelfox HT, 2003, JAMA-J AM MED ASSOC, V290, P1899, DOI 10.1001/jama.290.14.1899; Talbot GH, 2006, CLIN INFECT DIS, V42, P657, DOI 10.1086/499819; Thompson SG, 1997, STAT MED, V16, P2063, DOI 10.1002/(SICI)1097-0258(19970930)16:18<2063::AID-SIM642>3.0.CO;2-8; Wright MO, 2011, AM J INFECT CONTROL, V39, P64, DOI 10.1016/j.ajic.2010.12.001; Wright MO, 2010, AM J INFECT CONTROL, V38, P642, DOI 10.1016/j.ajic.2010.07.001; Wright MO, 2010, AM J INFECT CONTROL, V38, P557, DOI 10.1016/j.ajic.2010.06.003; Wright MO, 2010, AM J INFECT CONTROL, V38, P416, DOI 10.1016/j.ajic.2010.04.198; Wright MO, 2004, INFECT CONT HOSP EP, V25, P167, DOI 10.1086/502370; Yin J, 2013, PEDIATRICS, V131, pE1515, DOI 10.1542/peds.2012-3389; Yokoe DS, 2008, INFECT CONT HOSP EP, V29, pS12, DOI 10.1086/591060	41	201	206	1	29	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 16	2013	310	15					1571	1580		10.1001/jama.2013.277815	http://dx.doi.org/10.1001/jama.2013.277815			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	234EP	24097234	Green Accepted, Bronze			2022-12-28	WOS:000325624800020
J	Sagan, SM; Sarnow, P				Sagan, Selena M.; Sarnow, Peter			RNAi, Antiviral After All	SCIENCE			English	Editorial Material							GENE-EXPRESSION; INTERFERENCE; MICRORNAS; TRBP; PACT		[Sagan, Selena M.] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ H3A 2B4, Canada; [Sarnow, Peter] Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA	McGill University; Stanford University	Sagan, SM (corresponding author), McGill Univ, Dept Microbiol & Immunol, 3775 Univ St, Montreal, PQ H3A 2B4, Canada.	psarnow@stanford.edu		Sarnow, Peter/0000-0002-2043-2770; Sagan, Selena/0000-0002-8484-3632				Billy E, 2001, P NATL ACAD SCI USA, V98, P14428, DOI 10.1073/pnas.261562698; Ding SW, 2007, CELL, V130, P413, DOI 10.1016/j.cell.2007.07.039; Fabozzi G, 2011, J VIROL, V85, P2512, DOI 10.1128/JVI.01160-10; Lee HY, 2013, NUCLEIC ACIDS RES, V41, P6568, DOI 10.1093/nar/gkt361; Li Y, 2013, SCIENCE, V342, P231, DOI 10.1126/science.1241911; Maillard PV, 2013, SCIENCE, V342, P235, DOI 10.1126/science.1241930; Murchison EP, 2005, P NATL ACAD SCI USA, V102, P12135, DOI 10.1073/pnas.0505479102; Obbard DJ, 2009, PHILOS T R SOC B, V364, P99, DOI 10.1098/rstb.2008.0168; Paddison PJ, 2002, P NATL ACAD SCI USA, V99, P1443, DOI 10.1073/pnas.032652399; Parameswaran P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000764; Pfeffer S, 2005, NAT METHODS, V2, P269, DOI 10.1038/NMETH746; Seo GJ, 2013, CELL HOST MICROBE, V14, P435, DOI 10.1016/j.chom.2013.09.002; Singh M, 2011, BIOCHEMISTRY-US, V50, P4550, DOI 10.1021/bi200104h; Su H, 2009, GENE DEV, V23, P304, DOI 10.1101/gad.1749809; Sullivan CS, 2005, J VIROL, V79, P7371, DOI 10.1128/JVI.79.12.7371-7379.2005; Umbach JL, 2009, GENE DEV, V23, P1151, DOI 10.1101/gad.1793309	16	15	15	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 11	2013	342	6155					207	208		10.1126/science.1245475	http://dx.doi.org/10.1126/science.1245475			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232EV	24115433				2022-12-28	WOS:000325475200035
J	Priebe, S; Yeeles, K; Bremner, S; Lauber, C; Eldridge, S; Ashby, D; David, AS; O'Connell, N; Forrest, A; Burns, T				Priebe, Stefan; Yeeles, Ksenija; Bremner, Stephen; Lauber, Christoph; Eldridge, Sandra; Ashby, Deborah; David, Anthony S.; O'Connell, Nicola; Forrest, Alexandra; Burns, Tom			Effectiveness of financial incentives to improve adherence to maintenance treatment with antipsychotics: cluster randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SEVERE MENTAL-ILLNESS; REDUCE SUBSTANCE USE; MONETARY REINFORCEMENT; CONTINGENCY MANAGEMENT; MEDICATION ADHERENCE; HEALTH-CARE; SCHIZOPHRENIA; PEOPLE; INDIVIDUALS; ABSTINENCE	Objective To test whether offering financial incentives to patients with psychotic disorders is effective in improving adherence to maintenance treatment with antipsychotics. Design Cluster randomised controlled trial. Setting Community mental health teams in secondary psychiatric care in the United Kingdom. Participants Patients with a diagnosis of schizophrenia, schizoaffective disorder, or bipolar disorder, who were prescribed long acting antipsychotic (depot) injections but had received 75% or less of the prescribed injections. We randomly allocated 73 teams with a total of 141 patients. Primary outcome data were available for 35 intervention teams with 75 patients (96% of randomised) and for 31 control teams with 56 patients (89% of randomised). Interventions Participants in the intervention group were offered 15 pound ((sic)17; $22) for each depot injection over a 12 month period. Participants in the control condition received treatment as usual. Main outcome measure The primary outcome was the percentage of prescribed depot injections given during the 12 month intervention period. Results 73 teams with 141 consenting patients were randomised, and outcomes were assessed for 131 patients (93%).double down arrow Average baseline adherence was 69% in the intervention group and 67% in the control group. During the 12 month trial period adherence was 85% in the intervention group and 71% in the control group. The adjusted effect estimate was 11.5% (95% confidence interval 3.9% to 19.0%, P=0.003). A secondary outcome was an adherence of >= 95%, which was achieved in 28% of the intervention group and 5% of the control group (adjusted odds ratio 8.21, 95% confidence interval 2.00 to 33.67, P=0.003). Although differences in clinician rated clinical improvement between the groups failed to reach statistical significance, patients in the intervention group had more favourable subjective quality of life ratings (beta=0.71, 95% confidence interval 0.26 to 1.15, P=0.002). The number of admissions to hospital and adverse events were low in both groups and did not show substantial differences. Conclusion Offering modest financial incentives to patients with psychotic disorders is an effective method for improving adherence to maintenance treatment with antipsychotics.	[Priebe, Stefan; O'Connell, Nicola] Queen Mary Univ London, Unit Social & Community Psychiat, Newham Ctr Mental Hlth, London E13 8SP, England; [Yeeles, Ksenija; Burns, Tom] Univ Oxford, Warneford Hosp, Dept Psychiat, Oxford, England; [Bremner, Stephen; Eldridge, Sandra] Barts & London Queen Marys Sch Med & Dent, Blizard Inst, Ctr Primary Care & Publ Hlth, London, England; [Lauber, Christoph] Jura Bernois, Psychiat Serv, Bienne Seeland, Bellelay, Switzerland; [Ashby, Deborah] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, London, England; [David, Anthony S.] Kings Coll London, Inst Psychiat, Dept Psychosis Studies, London, England	University of London; Queen Mary University London; University of Oxford; University of London; Queen Mary University London; Imperial College London; University of London; King's College London	Priebe, S (corresponding author), Queen Mary Univ London, Unit Social & Community Psychiat, Newham Ctr Mental Hlth, London E13 8SP, England.	s.priebe@qmul.ac.uk	David, Anthony/O-1750-2019; Bremner, Stephen/R-4038-2016; David, Anthony S/C-1315-2011	David, Anthony/0000-0003-0967-774X; Bremner, Stephen/0000-0003-0790-7070; David, Anthony S/0000-0003-0967-774X; Yeeles, Ksenija/0000-0002-7757-0154; O'Connell, Nicola/0000-0002-5143-1797; Priebe, Stefan/0000-0001-9864-3394; Eldridge, Sandra/0000-0001-5638-2317	National Institute for Health Research Health Technology Assessment (NIHR HTA) programme [07/60/43]; National Institute for Health Research [07/60/43] Funding Source: researchfish	National Institute for Health Research Health Technology Assessment (NIHR HTA) programme(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	This trial was funded by the National Institute for Health Research Health Technology Assessment (NIHR HTA) programme (project No 07/60/43) and will be published in full in Health Technology Assessment. The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the HTA programme, NIHR, NHS, or the Department of Health. The trial is registered with ISRCTN (SRCTN77769281) and is adopted into the UKCRN and MHRN portfolios. The funder had no role in study design, data collection, data analysis, interpretation, writing of the report, or decision to submit for publication. All study researchers were independent from a funder. All authors had full access to all of the data (including statistical reports and tables) in the study and can take responsibility for the integrity of the data and the accuracy of the data analysis.	[Anonymous], 2009, STAT STAT 10 1 PROGR; Burns T, 2007, BRIT MED J, V335, P232, DOI 10.1136/bmj.39286.399514.BE; Burton A, 2010, EPIDEMIOL PSICHIAT S, V19, P233; CAREY KB, 1990, J BEHAV THER EXP PSY, V21, P205, DOI 10.1016/0005-7916(90)90008-9; Claassen D, 2007, PSYCHIATR BULL, V31, P4, DOI 10.1192/pb.31.1.4; Claassen D, 2007, J MED ETHICS, V33, P189, DOI 10.1136/jme.2006.016188; Conley RR, 2001, BIOL PSYCHIAT, V50, P898, DOI 10.1016/S0006-3223(01)01271-9; Cookson R., 2008, BMJ-BRIT MED J, V337, pa589, DOI DOI 10.1136/BMJ.A589; Drebing CE, 2005, J APPL BEHAV ANAL, V38, P359, DOI 10.1901/jaba.2005.100-03; Giuffrida A, 1997, BRIT MED J, V315, P703, DOI 10.1136/bmj.315.7110.703; Glover GR, 1999, BRIT J PSYCHIAT, V175, P544, DOI 10.1192/bjp.175.6.544; Gray R, 2006, BRIT J PSYCHIAT, V189, P508, DOI 10.1192/bjp.bp.105.019489; Guy W, 1976, ECDEU ASSESSMENT MAN, DOI DOI 10.1037/E591322011-001; Helmus TC, 2003, PSYCHOL ADDICT BEHAV, V17, P249, DOI 10.1037/0893-164X.17.3.249; Knapp M, 2004, BRIT J PSYCHIAT, V184, P509, DOI 10.1192/bjp.184.6.509; Marteau TM, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1415; McDonald HP, 2002, JAMA-J AM MED ASSOC, V288, P2868, DOI 10.1001/jama.288.22.2868; National Collaborating Centre for Mental Health, 2009, SCHIZ COR INT TREATM, P41; Nose M, 2003, BRIT J PSYCHIAT, V183, P197, DOI 10.1192/bjp.183.3.197; Novick D, 2010, PSYCHIAT RES, V176, P109, DOI 10.1016/j.psychres.2009.05.004; OLSON RP, 1972, J CONSULT CLIN PSYCH, V38, P376, DOI 10.1037/h0032910; Popay Jennie, 2008, BMJ, V337, pa594, DOI 10.1136/bmj.a594; Post EP, 2006, PSYCHIAT SERV, V57, P414, DOI 10.1176/appi.ps.57.3.414; Priebe S, 2007, BRIT J PSYCHIAT, V191, P420, DOI 10.1192/bjp.bp.107.036939; Priebe S, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-113; Priebe S, 2010, J MED ETHICS, V36, P463, DOI 10.1136/jme.2009.035071; Promberger M, 2011, J MED ETHICS, V37, P682, DOI 10.1136/jme.2010.039347; Ries RK, 2004, PSYCHIAT SERV, V55, P445, DOI 10.1176/appi.ps.55.4.445; Roll JM, 1998, EXP CLIN PSYCHOPHARM, V6, P157, DOI 10.1037/1064-1297.6.2.157; Roll JM, 2004, PSYCHIAT RES, V125, P61, DOI 10.1016/j.psychres.2003.10.003; Ryan P, 1998, STATA TECHNICAL B, V41, P43; Shaner A, 1997, PSYCHIAT SERV, V48, P807; Shaw Joanne, 2007, BMJ, V335, P233, DOI 10.1136/bmj.39286.422639.BE; Sigmon SC, 2000, EXP CLIN PSYCHOPHARM, V8, P509, DOI 10.1037//1064-1297.8.4.509; Staring ABP, 2010, PSYCHOPHARMACOL BULL, V43, P5; Tidey JW, 2012, PREV MED, V55, pS54, DOI 10.1016/j.ypmed.2011.11.010; Tidey JW, 2002, EXP CLIN PSYCHOPHARM, V10, P241, DOI 10.1037//1064-1297.10.3.241; Tracy K, 2007, AM J DRUG ALCOHOL AB, V33, P253, DOI 10.1080/00952990601174931; Vieta E, 2005, J CLIN PSYCHIAT, V66, P24; WHO, 2012, ICD 10 CLASS MENT BE; Wise J., 2010, BMJ, V340, pc2747, DOI [10.1136/bmj.c2747, DOI 10.1136/BMJ.C2747]	41	76	76	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 7	2013	347								f5847	10.1136/bmj.f5847	http://dx.doi.org/10.1136/bmj.f5847			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	235OG	24100934	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000325728300001
J	Konneker, C; Lugger, B				Koenneker, Carsten; Lugger, Beatrice			Public Science 2.0-Back to the Future	SCIENCE			English	Editorial Material									[Koenneker, Carsten] Karlsruhe Inst Technol, Fac Humanities & Social Sci, D-76128 Karlsruhe, Germany; [Koenneker, Carsten; Lugger, Beatrice] Natl Inst Sci Commun NaWik, D-76133 Karlsruhe, Germany	Helmholtz Association; Karlsruhe Institute of Technology	Konneker, C (corresponding author), Karlsruhe Inst Technol, Fac Humanities & Social Sci, D-76128 Karlsruhe, Germany.	carsten.koenneker@kit.edu; lugger@nawik.de						Bik HM, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001535; Einstein A, 2003, VEREHRTE ABWESENDE O; Einstein A., 1917, SPEZIELLE ALLGEMEINE; Engel A., 2002, COLLECTED PAPERS A E, V7, p[160, 261]; Miller-Rushing A, 2012, FRONT ECOL ENVIRON, V10, P285, DOI 10.1890/110278; Silvertown J, 2009, TRENDS ECOL EVOL, V24, P467, DOI 10.1016/j.tree.2009.03.017; Teichmann J., 1998, BERNSTEIN ZUM ELEKT; Weingart P., 2011, WISSENSCHAFT HOCHSCH, P54	8	5	5	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 4	2013	342	6154					49	50		10.1126/science.1245848	http://dx.doi.org/10.1126/science.1245848			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	227PP	24092719				2022-12-28	WOS:000325126100037
J	Nagano, T; Lubling, Y; Stevens, TJ; Schoenfelder, S; Yaffe, E; Dean, W; Laue, ED; Tanay, A; Fraser, P				Nagano, Takashi; Lubling, Yaniv; Stevens, Tim J.; Schoenfelder, Stefan; Yaffe, Eitan; Dean, Wendy; Laue, Ernest D.; Tanay, Amos; Fraser, Peter			Single-cell Hi-C reveals cell-to-cell variability in chromosome structure	NATURE			English	Article							GENE-REGULATION; NUCLEAR-ORGANIZATION; YEAST GENOME; CONFORMATION; ARCHITECTURE; TRANSCRIPTION; ASSOCIATIONS; TERRITORIES; PRINCIPLES; LANDSCAPE	Large-scale chromosome structure and spatial nuclear arrangement have been linked to control of gene expression and DNA replication and repair. Genomic techniques based on chromosome conformation capture (3C) assess contacts for millions of loci simultaneously, but do so by averaging chromosome conformations from millions of nuclei. Here we introduce single-cell Hi-C, combined with genome-wide statistical analysis and structural modelling of single-copy X chromosomes, to show that individual chromosomes maintain domain organization at the megabase scale, but show variable cell-to-cell chromosome structures at larger scales. Despite this structural stochasticity, localization of active gene domains to boundaries of chromosome territories is a hallmark of chromosomal conformation. Single-cell Hi-C data bridge current gaps between genomics and microscopy studies of chromosomes, demonstrating how modular organization underlies dynamic chromosome structure, and how this structure is probabilistically linked with genome activity patterns.	[Nagano, Takashi; Schoenfelder, Stefan; Fraser, Peter] Babraham Inst, Nucl Dynam Programme, Cambridge CB22 3AT, England; [Lubling, Yaniv; Yaffe, Eitan; Tanay, Amos] Weizmann Inst Sci, Dept Comp Sci & Appl Math, IL-76100 Rehovot, Israel; [Lubling, Yaniv; Yaffe, Eitan; Tanay, Amos] Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel; [Stevens, Tim J.; Laue, Ernest D.] Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England; [Dean, Wendy] Babraham Inst, Epigenet Programme, Cambridge CB22 3AT, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; Weizmann Institute of Science; Weizmann Institute of Science; University of Cambridge; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	Fraser, P (corresponding author), Babraham Inst, Nucl Dynam Programme, Cambridge CB22 3AT, England.	e.d.laue@bioc.cam.ac.uk; amos.tanay@weizmann.ac.il; peter.fraser@babraham.ac.uk	Dean, Wendy/GSE-3948-2022	Fraser, Peter/0000-0002-0041-1227; Laue, Ernest/0000-0002-7476-4148; Lubling, Yaniv/0000-0003-3461-9621; Yaffe, Eitan/0000-0002-2896-3349; Dean, Wendy/0000-0001-9441-5044; Stevens, Tim/0000-0001-6475-2074	Medical Research Council; Biotechnology and Biological Sciences Research Council; MODHEP project; Israel Science Foundation; Wellcome Trust; Biotechnology and Biological Sciences Research Council [BBS/E/B/0000C151, BBS/E/B/000C0404] Funding Source: researchfish; Medical Research Council [G0800036, G117/530] Funding Source: researchfish; BBSRC [BBS/E/B/000C0404, BBS/E/B/0000C151] Funding Source: UKRI; MRC [G117/530, G0800036] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MODHEP project; Israel Science Foundation(Israel Science Foundation); Wellcome Trust(Wellcome Trust); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors thank I. Clay, S. Wingett, K. Tabbada, D. Bolland, S. Walker, S. Andrews, M. Spivakov, N. Cope, L. Harewood and W. Boucher for assistance. This work was supported by the Medical Research Council, the Biotechnology and Biological Sciences Research Council (to P. F.), the MODHEP project, the Israel Science Foundation (to A. T.) and the Wellcome Trust (to E.D.L.).	Branco MR, 2006, PLOS BIOL, V4, P780, DOI 10.1371/journal.pbio.0040138; Chuang CH, 2006, CURR BIOL, V16, P825, DOI 10.1016/j.cub.2006.03.059; Chubb JR, 2002, CURR BIOL, V12, P439, DOI 10.1016/S0960-9822(02)00695-4; Cremer T, 2001, NAT REV GENET, V2, P292, DOI 10.1038/35066075; Deaton AM, 2011, GENOME RES, V21, P1074, DOI 10.1101/gr.118703.110; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dostie J, 2006, GENOME RES, V16, P1299, DOI 10.1101/gr.5571506; Duan Z, 2010, NATURE, V465, P363, DOI 10.1038/nature08973; Dundr M, 2007, J CELL BIOL, V179, P1095, DOI 10.1083/jcb.200710058; Fraser P, 2007, NATURE, V447, P413, DOI 10.1038/nature05916; Gibcus JH, 2013, MOL CELL, V49, P773, DOI 10.1016/j.molcel.2013.02.011; Heard E, 2007, CURR OPIN CELL BIOL, V19, P311, DOI 10.1016/j.ceb.2007.04.016; Jhunjhunwala S, 2008, CELL, V133, P265, DOI 10.1016/j.cell.2008.03.024; Kalhor R, 2012, NAT BIOTECHNOL, V30, P90, DOI 10.1038/nbt.2057; Lanctot C, 2007, NAT REV GENET, V8, P104, DOI 10.1038/nrg2041; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Marti-Renom MA, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002125; Misteli T, 2007, CELL, V128, P787, DOI 10.1016/j.cell.2007.01.028; Muller I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011560; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; Osborne CS, 2007, PLOS BIOL, V5, P1763, DOI 10.1371/journal.pbio.0050192; Osborne CS, 2004, NAT GENET, V36, P1065, DOI 10.1038/ng1423; Peric-Hupkes D, 2010, MOL CELL, V38, P603, DOI 10.1016/j.molcel.2010.03.016; Rapkin LM, 2012, MICRON, V43, P150, DOI 10.1016/j.micron.2011.11.007; Schoenfelder S, 2010, NAT GENET, V42, P53, DOI 10.1038/ng.496; Sexton T, 2012, CELL, V148, P458, DOI 10.1016/j.cell.2012.01.010; Simonis M, 2006, NAT GENET, V38, P1348, DOI 10.1038/ng1896; Tanizawa H, 2010, NUCLEIC ACIDS RES, V38, P8164, DOI 10.1093/nar/gkq955; van de Werken HJG, 2012, NAT METHODS, V9, P969, DOI [10.1038/NMETH.2173, 10.1038/nmeth.2173]; Yaffe E, 2011, NAT GENET, V43, P1059, DOI 10.1038/ng.947; Zhao Z, 2006, NAT GENET, V38, P1341, DOI 10.1038/ng1891	32	894	979	4	205	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 3	2013	502	7469					59	+		10.1038/nature12593	http://dx.doi.org/10.1038/nature12593			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	227IM	24067610	Green Accepted, Green Submitted			2022-12-28	WOS:000325106000030
J	Nicoletti, O; de la Pena, F; Leary, RK; Holland, DJ; Ducati, C; Midgley, PA				Nicoletti, Olivia; de la Pena, Francisco; Leary, Rowan K.; Holland, Daniel J.; Ducati, Caterina; Midgley, Paul A.			Three-dimensional imaging of localized surface plasmon resonances of metal nanoparticles	NATURE			English	Article							RECONSTRUCTION; ENERGY; TOMOGRAPHY; SUBSTRATE; MODES; GOLD; EELS	The remarkable optical properties of metal nanoparticles are governed by the excitation of localized surface plasmon resonances (LSPRs). The sensitivity of each LSPR mode, whose spatial distribution and resonant energy depend on the nanoparticle structure, composition and environment, has given rise to many potential photonic, optoelectronic, catalytic, photovoltaic, and gas-and bio-sensing applications(1-3). However, the precise interplay between the three-dimensional (3D) nanoparticle structure and the LSPRs is not always fully understood and a spectrally sensitive 3D imaging technique is needed to visualize the excitation on the nanometre scale. Here we show that 3D images related to LSPRs of an individual silver nanocube can be reconstructed through the application of electron energy-loss spectrum imaging(4), mapping the excitation across a range of orientations, with a novel combination of non-negative matrix factorization(5,6), compressed sensing(7,8) and electron tomography(9). Our results extend the idea of substrate-mediated hybridization of dipolar and quadrupolar modes predicted by theory, simulations, and electron and optical spectroscopy(10-12), and provide experimental evidence of higher-energy mode hybridization. This work represents an advance both in the understanding of the optical response of noble-metal nanoparticles and in the probing, analysis and visualization of LSPRs.	[Nicoletti, Olivia; de la Pena, Francisco; Leary, Rowan K.; Ducati, Caterina; Midgley, Paul A.] Univ Cambridge, Dept Mat Sci & Met, Cambridge CB2 3QZ, England; [Holland, Daniel J.] Univ Cambridge, Dept Chem Engn & Biotechnol, Cambridge CB2 3RA, England	University of Cambridge; University of Cambridge	Midgley, PA (corresponding author), Univ Cambridge, Dept Mat Sci & Met, Pembroke St, Cambridge CB2 3QZ, England.	pam33@cam.ac.uk	Holland, Daniel J./O-5059-2019; de la Peña, Francisco/B-3955-2017	Holland, Daniel J./0000-0002-9192-5396; de la Peña, Francisco/0000-0002-1121-6099; Midgley, Paul/0000-0002-6817-458X; Ducati, Caterina/0000-0003-3366-6442	US National Science Foundation under NSF [ECS-0335765]; ERC [259619 PHOTO EM]; Royal Society; European Union under European Research Council ERC [291522-3DIMAGE, 312483-ESTEEM2]; Microsoft Research Connections; EPSRC [EP/K008218/1, EP/K039318/1]; Engineering and Physical Sciences Research Council [EP/K008218/1] Funding Source: researchfish	US National Science Foundation under NSF(National Science Foundation (NSF)); ERC(European Research Council (ERC)European Commission); Royal Society(Royal Society of London); European Union under European Research Council ERC; Microsoft Research Connections(Microsoft); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We acknowledge the Nano Research Facility (NRF), School of Engineering and Applied Science, Washington University, St Louis, USA for the nanoparticle synthesis. The NRF is a member of the US National Nanotechnology Infrastructure Network, supported by the US National Science Foundation under NSF award no. ECS-0335765. F.d.l.P. and C. D. acknowledge funding from the ERC under grant no. 259619 PHOTO EM. C. D. acknowledges the Royal Society for funding. P. A. M. and O.N. acknowledge financial support from the European Union's Seventh Framework Programme (FP/2007-2013) under the European Research Council ERC Grant Agreement 291522-3DIMAGE and under Grant Agreement 312483-ESTEEM2 (Integrated Infrastructure Initiative - I3). D.J.H. acknowledges Microsoft Research Connections and the EPSRC (grants nos EP/K008218/1 and EP/K039318/1) for financial support. We thank A. Howie, M. Kociak, E. Ringe and S. M. Collins for discussions and FEI (in particular E. Yucelen and S. Lazar) for access to an FEI Titan Microscope at the FEI Nanoport in Eindhoven.	Agulleiro JI, 2011, BIOINFORMATICS, V27, P582, DOI 10.1093/bioinformatics/btq692; Anker JN, 2008, NAT MATER, V7, P442, DOI 10.1038/nmat2162; Arslan I, 2006, ULTRAMICROSCOPY, V106, P994, DOI 10.1016/j.ultramic.2006.05.010; Boudarham G, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.245447; Buckheit JB., 1995, WAVELETS STAT, P55, DOI [10.1007/978-1-4612-2544-7_5, DOI 10.1007/978-1-4612-2544-7_5]; Candes EJ, 2006, IEEE T INFORM THEORY, V52, P489, DOI 10.1109/TIT.2005.862083; Comon P, 2010, HANDBOOK OF BLIND SOURCE SEPARATION: INDEPENDENT COMPONENT ANALYSIS AND APPLICATIONS, P1; de Abajo FJG, 1999, PHYS REV B, V59, P3095, DOI 10.1103/PhysRevB.59.3095; de la Pena F, 2011, ULTRAMICROSCOPY, V111, P169, DOI 10.1016/j.ultramic.2010.10.001; Donoho DL, 2006, IEEE T INFORM THEORY, V52, P1289, DOI 10.1109/TIT.2006.871582; Fessler JA, 2003, IEEE T SIGNAL PROCES, V51, P560, DOI 10.1109/TSP.2002.807005; FUCHS R, 1975, PHYS REV B, V11, P1732, DOI 10.1103/PhysRevB.11.1732; de Abajo FJG, 2010, REV MOD PHYS, V82, P209, DOI 10.1103/RevModPhys.82.209; Geuquet N, 2010, ULTRAMICROSCOPY, V110, P1075, DOI 10.1016/j.ultramic.2010.01.013; GILBERT P, 1972, J THEOR BIOL, V36, P105, DOI 10.1016/0022-5193(72)90180-4; Hohenester U, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.106801; JEANGUILLAUME C, 1989, ULTRAMICROSCOPY, V28, P252, DOI 10.1016/0304-3991(89)90304-5; JOHNSON PB, 1972, PHYS REV B, V6, P4370, DOI 10.1103/PhysRevB.6.4370; Johnson WL, 2009, J PHYS CHEM C, V113, P14651, DOI 10.1021/jp903965d; Keenan MR, 2004, SURF INTERFACE ANAL, V36, P203, DOI 10.1002/sia.1657; Kneipp K, 2002, J PHYS-CONDENS MAT, V14, pR597, DOI 10.1088/0953-8984/14/18/202; Korte KE, 2008, J MATER CHEM, V18, P437, DOI 10.1039/b714072j; Lade SJ, 2005, OPT COMMUN, V253, P392, DOI 10.1016/j.optcom.2005.04.071; LANGBEIN D, 1976, J PHYS A-MATH GEN, V9, P627, DOI 10.1088/0305-4470/9/4/019; Laurberg Hans, 2008, Comput Intell Neurosci, P764206, DOI 10.1155/2008/764206; Leary R, 2013, ULTRAMICROSCOPY, V131, P70, DOI 10.1016/j.ultramic.2013.03.019; Lee DD, 1999, NATURE, V401, P788, DOI 10.1038/44565; Lin CJ, 2007, NEURAL COMPUT, V19, P2756, DOI 10.1162/neco.2007.19.10.2756; Lustig M, 2007, MAGN RESON MED, V58, P1182, DOI 10.1002/mrm.21391; Maier SA, 2005, J APPL PHYS, V98, DOI 10.1063/1.1951057; Mazzucco S, 2012, NANO LETT, V12, P1288, DOI 10.1021/nl2037672; Nelayah J, 2009, OPT LETT, V34, P1003, DOI 10.1364/OL.34.001003; Nelayah J, 2007, NAT PHYS, V3, P348, DOI 10.1038/nphys575; Nicoletti O, 2011, OPT EXPRESS, V19, P15371, DOI 10.1364/OE.19.015371; PAATERO P, 1994, ENVIRONMETRICS, V5, P111, DOI 10.1002/env.3170050203; Palik E. D., 1998, HDB OPTICAL CONSTANT, V1, P350; Ringe E, 2010, J PHYS CHEM C, V114, P12511, DOI 10.1021/jp104366r; Schuller JA, 2010, NAT MATER, V9, P193, DOI [10.1038/NMAT2630, 10.1038/nmat2630]; Sherry LJ, 2005, NANO LETT, V5, P2034, DOI 10.1021/nl0515753; Taubman DS, 2002, P IEEE, V90, P1336, DOI 10.1109/JPROC.2002.800725; Tong J, 2006, J STRUCT BIOL, V153, P55, DOI 10.1016/j.jsb.2005.10.005; Yurtsever A, 2012, SCIENCE, V335, P59, DOI 10.1126/science.1213504; Zhang SP, 2011, NANO LETT, V11, P1657, DOI 10.1021/nl200135r	43	348	349	24	708	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 3	2013	502	7469					80	+		10.1038/nature12469	http://dx.doi.org/10.1038/nature12469			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	227IM	24091976				2022-12-28	WOS:000325106000034
J	Birkmeyer, JD; Reames, BN; McCulloch, P; Carr, AJ; Campbell, WB; Wennberg, JE				Birkmeyer, John D.; Reames, Bradley N.; McCulloch, Peter; Carr, Andrew J.; Campbell, W. Bruce; Wennberg, John E.			Understanding of regional variation in the use of surgery	LANCET			English	Article							SMALL-AREA VARIATIONS; MEDICAL-PRACTICE VARIATIONS; COMPARING TOTAL MASTECTOMY; BREAST-CANCER SURGERY; HEALTH-CARE SERVICES; OF-LIFE CARE; GEOGRAPHIC-VARIATION; PROSTATE-CANCER; LAPAROSCOPIC CHOLECYSTECTOMY; CAROTID-ENDARTERECTOMY	The use of common surgical procedures varies widely across regions. Differences in illness burden, diagnostic practices, and patient attitudes about medical intervention explain only a small degree of regional variation in surgery rates. Evidence suggests that surgical variation results mainly from differences in physician beliefs about the indications for surgery, and the extent to which patient preferences are incorporated into treatment decisions. These two components of clinical decision making help to explain the so-called surgical signatures of specific procedures, and why some consistently vary more than others. Variation in clinical decision making is, in turn, affected by broad environmental factors, including technology diffusion, supply of specialists, local training frameworks, financial incentives, and regulatory factors, which vary across countries. Better scientific evidence about the comparative effectiveness of surgical and non-surgical interventions could help to mitigate regional variation, but broader dissemination of shared decision aids will be essential to reduce variation in preference-sensitive disorders.	[Birkmeyer, John D.; Reames, Bradley N.] Univ Michigan, Ctr Healthcare Outcomes & Policy, Ann Arbor, MI 48109 USA; [McCulloch, Peter] Univ Oxford, Nuffield Dept Surg Sci, Oxford, England; [Carr, Andrew J.] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford, England; [Campbell, W. Bruce] Natl Inst Hlth & Care Excellence, London, England; [Wennberg, John E.] Dartmouth Coll, Dartmouth Inst Hlth Policy & Clin Practice, Hanover, NH 03755 USA	University of Michigan System; University of Michigan; University of Oxford; University of Oxford; National Institute for Health & Care Excellence; Dartmouth College	Birkmeyer, JD (corresponding author), Ctr Healthcare Outcomes & Policy, 2800 Plymouth Rd, Ann Arbor, MI 48109 USA.	jbirkmey@umich.edu		Reames, Bradley N./0000-0001-7575-7196; McCulloch, Peter/0000-0002-3210-8273	National Institute on Ageing [5-P01-AG-019783-10]; National Cancer Institute [5 T32 CA-009672-22]; National Institute for Health Research [NF-SI-0611-10216] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [T32CA009672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG019783] Funding Source: NIH RePORTER	National Institute on Ageing(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	JDB is supported by a grant from the National Institute on Ageing (5-P01-AG-019783-10). BNR is supported by a grant from the National Cancer Institute (5 T32 CA-009672-22). We thank Mark P MacEachern (University of Michigan, Ann Arbor, MI, USA) for his assistance in constructing the literature search.	ANDERSON GM, 1993, JAMA-J AM MED ASSOC, V269, P1661; [Anonymous], 2007, DARTM ATL PROJ BRIEF; [Anonymous], 2010, NHS ATL VAR HEALTHC; Appleby J., 2011, VARIATIONS HLTH CARE; Arriagada R, 1996, J CLIN ONCOL, V14, P1558, DOI 10.1200/JCO.1996.14.5.1558; Arterburn D, 2012, HEALTH AFFAIR, V31, P2094, DOI 10.1377/hlthaff.2011.0686; Auvinen A, 2004, BJU INT, V93, P52, DOI 10.1111/j.1464-410X.2004.04554.x; Bederman SS, 2011, SPINE, V36, P481, DOI 10.1097/BRS.0b013e3181d25e6f; Birkmeyer JD, 2012, BRIT J SURG, V99, P1467, DOI 10.1002/bjs.8933; BLOOR MJ, 1978, J LARYNGOL OTOL, V92, P883, DOI 10.1017/S0022215100086266; BLOOR MJ, 1978, J LARYNGOL OTOL, V92, P791, DOI 10.1017/S0022215100086102; Busato A, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-315; Center for the Evaluative Clinical Sciences Dartmouth Medical School, 2000, DARTM ATL MUSC HLTH; CHASSIN MR, 1993, MED CARE, V31, pYS37, DOI 10.1097/00005650-199305001-00006; CHASSIN MR, 1987, JAMA-J AM MED ASSOC, V258, P2533, DOI 10.1001/jama.258.18.2533; ELLIOTT RV, 1981, JAMA-J AM MED ASSOC, V245, P595; Elwyn G, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c5146; Eslami MH, 2011, J VASC SURG, V53, P307, DOI 10.1016/j.jvs.2010.08.080; FARROW DC, 1992, NEW ENGL J MED, V326, P1097, DOI 10.1056/NEJM199204233261701; Finks JF, 2011, NEW ENGL J MED, V364, P2128, DOI 10.1056/NEJMsa1010705; FISHER B, 1985, NEW ENGL J MED, V312, P665, DOI 10.1056/NEJM198503143121101; Fisher B, 2002, NEW ENGL J MED, V347, P1233, DOI 10.1056/NEJMoa022152; Glover JA, 2008, INT J EPIDEMIOL, V37, P9, DOI 10.1093/ije/dym258; Goodman DC, 2006, HEALTH AFFAIR, V25, P521, DOI 10.1377/hlthaff.25.2.521; Green L., 1996, MIRABELLA NEW Y 1101, P154; Hanstede MMF, 2012, ACTA OBSTET GYN SCAN, V91, P220, DOI 10.1111/j.1600-0412.2011.01309.x; Hawker GA, 2001, MED CARE, V39, P206, DOI 10.1097/00005650-200103000-00002; Hollingsworth JM, 2011, ARCH SURG-CHICAGO, V146, P187, DOI 10.1001/archsurg.2010.335; Hollingsworth JM, 2010, HEALTH AFFAIR, V29, P683, DOI 10.1377/hlthaff.2008.0567; Kennedy ADM, 2002, JAMA-J AM MED ASSOC, V288, P2701, DOI 10.1001/jama.288.21.2701; Keyhani S, 2012, MED CARE, V50, P257, DOI 10.1097/MLR.0b013e3182422b0f; Lavis JN, 1998, CAN MED ASSOC J, V158, P29; LEAPE LL, 1990, JAMA-J AM MED ASSOC, V263, P669, DOI 10.1001/jama.263.5.669; Lu-Yao G, 2002, BMJ-BRIT MED J, V325, P740, DOI 10.1136/bmj.325.7367.740; Lucas FL, 2008, CIRCULATION, V118, P2797, DOI 10.1161/CIRCULATIONAHA.108.789446; McCulloch P, 2013, LANCET, V382, P1130, DOI 10.1016/S0140-6736(13)61216-7; McMahon AJ, 2000, LANCET, V356, P1632, DOI 10.1016/S0140-6736(00)03156-1; MCPHERSON K, 1982, NEW ENGL J MED, V307, P1310, DOI 10.1056/NEJM198211183072104; McPherson K, 1996, 2 LOND SCH HYG TROP; Menyhei G, 2011, EUR J VASC ENDOVASC, V41, P735, DOI 10.1016/j.ejvs.2011.02.028; Morden NE, 2012, HEALTH AFFAIR, V31, P786, DOI 10.1377/hlthaff.2011.0650; Nallamothu BK, 2007, JAMA-J AM MED ASSOC, V297, P962, DOI 10.1001/jama.297.9.962; NATTINGER AB, 1992, NEW ENGL J MED, V326, P1102, DOI 10.1056/NEJM199204233261702; Naughton C, 2006, IRISH J MED SCI, V175, P32, DOI 10.1007/BF03169170; O'Connor AM, 2009, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001431.pub2, 10.1002/14651858.CD001431.pub3, 10.1002/14651858.CD001431.pub4]; Parker L, 2010, AM J ROENTGENOL, V194, P1034, DOI 10.2214/AJR.09.3528; Patel MR, 2010, ARCH INTERN MED, V170, P1218, DOI 10.1001/archinternmed.2010.194; Poggi MM, 2003, CANCER, V98, P697, DOI 10.1002/cncr.11580; Raymont A, 2008, NEW ZEAL MED J, V121, P66; Ridao-Lopez M, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-145; Rutledge R, 1996, J AM COLL SURGEONS, V183, P31; Shao YH, 2011, PROSTATE CANCER P D, V14, P332, DOI 10.1038/pcan.2011.29; Sheikh K, 2002, UROLOGY, V59, P378, DOI 10.1016/S0090-4295(01)01588-6; Smith GL, 2009, J AM COLL SURGEONS, V209, P425, DOI 10.1016/j.jamcollsurg.2009.06.363; The Center for the Evaluative Clinical Sciences Dartmouth Medical School, 1999, DARTM ATL CARD HLTH; The Dartmouth Institute of Health Policy and Clinical Practice, 2013, DARTM ATL HEALTHC; Thompson B, 2008, ANN SURG ONCOL, V15, P443, DOI 10.1245/s10434-007-9584-4; van Steenbergen L N, 2010, Eur J Surg Oncol, V36 Suppl 1, pS36, DOI 10.1016/j.ejso.2010.06.021; Vikatmaa P, 2012, EUR J VASC ENDOVASC, V44, P11, DOI 10.1016/j.ejvs.2012.04.013; WENNBERG J, 1982, SCI AM, V246, P120, DOI 10.1038/scientificamerican0482-120; WENNBERG J, 1973, SCIENCE, V182, P1102, DOI 10.1126/science.182.4117.1102; WENNBERG JE, 1977, J MAINE MED ASSOC, V68, P275; WENNBERG JE, 1987, LANCET, V1, P1185, DOI 10.1016/s0140-6736(87)92152-0; WENNBERG JE, 1989, NEW ENGL J MED, V321, P1168, DOI 10.1056/NEJM198910263211706; WENNBERG JE, 1980, ANNU REV PUBL HEALTH, V1, P277, DOI 10.1146/annurev.pu.01.050180.001425; Wennberg JE, 2010, TRACKING MED RES QUE; Wennberg John E, 2002, Health Aff (Millwood), VSuppl Web Exclusives, pW96; Westert GP, 1999, SCAND J PUBLIC HEALT, V27, P173, DOI 10.1177/14034948990270030801; Westert GP, 2004, HEALTH PLACE, V10, P215, DOI 10.1016/j.healthplace.2003.07.002; Whelan T, 2004, JAMA-J AM MED ASSOC, V292, P435, DOI 10.1001/jama.292.4.435; Woo K, 2010, STROKE, V41, P975, DOI 10.1161/STROKEAHA.110.578856; Zhang YT, 2010, NEW ENGL J MED, V363, P1985, DOI 10.1056/NEJMp1010220; Zhang YT, 2010, NEW ENGL J MED, V363, P405, DOI 10.1056/NEJMp1004872	73	315	316	3	36	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 28	2013	382	9898					1121	1129		10.1016/S0140-6736(13)61215-5	http://dx.doi.org/10.1016/S0140-6736(13)61215-5			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	228SG	24075052	Green Accepted			2022-12-28	WOS:000325208100028
J	Dietrich, MO; Liu, ZW; Horvath, TL				Dietrich, Marcelo O.; Liu, Zhong-Wu; Horvath, Tamas L.			Mitochondrial Dynamics Controlled by Mitofusins Regulate Agrp Neuronal Activity and Diet-Induced Obesity	CELL			English	Article							NEUROPEPTIDE-Y; MELANOCORTIN SYSTEM; MAMMALIAN HOMOLOGS; ENERGY; PROTEIN; FUSION; CELL; AMPK; POMC; RESISTANCE	Mitochondria are key organelles in the maintenance of cellular energy metabolism and integrity. Here, we show that mitochondria number decrease but their size increase in orexigenic agouti-related protein (Agrp) neurons during the transition from fasted to fed to overfed state. These fusion-like dynamic changes were cell-type specific, as they occurred in the opposite direction in anorexigenic pro-opiomelanocortin (POMC) neurons. Interfering with mitochondrial fusion mechanisms in Agrp neurons by cell-selectively knocking down mitofusin 1 (Mfn1) or mitofusin 2 (Mfn2) resulted in altered mitochondria size and density in these cells. Deficiency in mitofusins impaired the electric activity of Agrp neurons during high-fat diet (HFD), an event reversed by cell-selective administration of ATP. Agrp-specific Mfn1 or Mfn2 knockout mice gained less weight when fed a HFD due to decreased fat mass. Overall, our data unmask an important role for mitochondrial dynamics governed by Mfn1 and Mfn2 in Agrp neurons in central regulation of whole-body energy metabolism.	[Dietrich, Marcelo O.; Liu, Zhong-Wu; Horvath, Tamas L.] Yale Univ, Sch Med, Comparat Med Sect, Program Integrat Cell Signaling & Neurobiol Metab, New Haven, CT 06520 USA; [Dietrich, Marcelo O.] Univ Fed Rio Grande do Sul, Dept Biochem, BR-90035 Porto Alegre, RS, Brazil	Yale University; Universidade Federal do Rio Grande do Sul	Dietrich, MO (corresponding author), Yale Univ, Sch Med, Comparat Med Sect, Program Integrat Cell Signaling & Neurobiol Metab, 333 Cedar St, New Haven, CT 06520 USA.	marcelo.dietrich@yale.edu; tamas.horvath@yale.edu	Dietrich, Marcelo/A-9928-2009	Dietrich, Marcelo/0000-0001-9781-2221	NIH [DP1 DK006850, R01AG040236, P01NS062686]; American Diabetes Association; Helmholtz Society (ICEMED); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil [401476/2012-0]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [DP1DK098058] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS062686] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG040236] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Helmholtz Society (ICEMED); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Catiele Antunes, Marcelo R. Zimmer, Antonio Giaimo, Melissa Taylor, Ester de La Fuente, Jeremy Bober, and Klara Szigeti for support in the experiments described here. This work was supported by NIH (DP1 DK006850, R01AG040236, and P01NS062686), the American Diabetes Association, the Helmholtz Society (ICEMED) and by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (401476/2012-0, Brazil).	Andrews ZB, 2008, NATURE, V454, P846, DOI 10.1038/nature07181; Aponte Y, 2011, NAT NEUROSCI, V14, P351, DOI 10.1038/nn.2739; Attwell D, 2001, J CEREBR BLOOD F MET, V21, P1133, DOI 10.1097/00004647-200110000-00001; Bach D, 2003, J BIOL CHEM, V278, P17190, DOI 10.1074/jbc.M212754200; Broberger C, 1998, P NATL ACAD SCI USA, V95, P15043, DOI 10.1073/pnas.95.25.15043; Cerveny KL, 2007, TRENDS CELL BIOL, V17, P563, DOI 10.1016/j.tcb.2007.08.006; Chen HC, 2007, CELL, V130, P548, DOI 10.1016/j.cell.2007.06.026; Chen HY, 2004, ENDOCRINOLOGY, V145, P2607, DOI 10.1210/en.2003-1596; Cipolat S, 2004, P NATL ACAD SCI USA, V101, P15927, DOI 10.1073/pnas.0407043101; Claret M, 2007, J CLIN INVEST, V117, P2325, DOI 10.1172/JCI31516; CLARK JT, 1984, ENDOCRINOLOGY, V115, P427, DOI 10.1210/endo-115-1-427; Cone RD, 2005, NAT NEUROSCI, V8, P571, DOI 10.1038/nn1455; Coppola A, 2007, CELL METAB, V5, P21, DOI 10.1016/j.cmet.2006.12.002; Diano S, 2011, NAT MED, V17, P1121, DOI 10.1038/nm.2421; Dietrich MO, 2010, J NEUROSCI, V30, P11815, DOI 10.1523/JNEUROSCI.2234-10.2010; Dietrich MO, 2009, EUR J NEUROSCI, V30, P1688, DOI 10.1111/j.1460-9568.2009.06963.x; Eura Y, 2003, J BIOCHEM, V134, P333, DOI 10.1093/jb/mvg150; Guillet V, 2011, FASEB J, V25, P1618, DOI 10.1096/fj.10-173609; Hahn TM, 1998, NAT NEUROSCI, V1, P271, DOI 10.1038/1082; Horvath TL, 2010, P NATL ACAD SCI USA, V107, P14875, DOI 10.1073/pnas.1004282107; Horvath TL, 1999, J NEUROSCI, V19, P10417; Horvath TL, 1997, BRAIN RES, V756, P283, DOI 10.1016/S0006-8993(97)00184-4; Ishihara N, 2004, J CELL SCI, V117, P6535, DOI 10.1242/jcs.01565; Jahani-Asl A, 2007, J BIOL CHEM, V282, P23788, DOI 10.1074/jbc.M703812200; Jheng HF, 2012, MOL CELL BIOL, V32, P309, DOI 10.1128/MCB.05603-11; Joly-Amado A, 2012, EMBO J, V31, P4276, DOI 10.1038/emboj.2012.250; Kohno D, 2008, BIOCHEM BIOPH RES CO, V366, P388, DOI 10.1016/j.bbrc.2007.11.166; Krashes MJ, 2011, J CLIN INVEST, V121, P1424, DOI 10.1172/JCI46229; Laughlin SB, 1998, NAT NEUROSCI, V1, P36, DOI 10.1038/236; Lee S, 2012, HUM MOL GENET, V21, P4827, DOI 10.1093/hmg/dds352; Lewis MR, 1914, SCIENCE, V39, P330, DOI 10.1126/science.39.1000.330; Liu ZW, 2011, J PHYSIOL-LONDON, V589, P4157, DOI 10.1113/jphysiol.2011.212514; Newton AJ, 2013, ENDOCRINOLOGY, V154, P172, DOI 10.1210/en.2012-1643; Ollmann MM, 1997, SCIENCE, V278, P135, DOI 10.1126/science.278.5335.135; Pham AH, 2012, HUM MOL GENET, V21, P4817, DOI 10.1093/hmg/dds311; Pich S, 2005, HUM MOL GENET, V14, P1405, DOI 10.1093/hmg/ddi149; Pinto S, 2004, SCIENCE, V304, P110, DOI 10.1126/science.1089459; POSAKONY JW, 1977, J CELL BIOL, V74, P468, DOI 10.1083/jcb.74.2.468; Reddy PH, 2011, BRAIN RES REV, V67, P103, DOI 10.1016/j.brainresrev.2010.11.004; Rodriguez-Navarro JA, 2010, NEUROBIOL DIS, V39, P423, DOI 10.1016/j.nbd.2010.05.014; Rojo M, 2002, J CELL SCI, V115, P1663; Santel A, 2003, J CELL SCI, V116, P2763, DOI 10.1242/jcs.00479; Santel A, 2001, J CELL SCI, V114, P867; Sanz E, 2009, P NATL ACAD SCI USA, V106, P13939, DOI 10.1073/pnas.0907143106; Schneeberger M, 2013, CELL, V155, P172, DOI 10.1016/j.cell.2013.09.003; Smirnova E, 1998, J CELL BIOL, V143, P351, DOI 10.1083/jcb.143.2.351; Song ZY, 2009, MOL BIOL CELL, V20, P3525, DOI 10.1091/mbc.E09-03-0252; Sternson SM, 2005, NAT NEUROSCI, V8, P1356, DOI 10.1038/nn1550; Takahashi KA, 2005, ENDOCRINOLOGY, V146, P1043, DOI 10.1210/en.2004-1397; Weibel E R, 1969, Int Rev Cytol, V26, P235, DOI 10.1016/S0074-7696(08)61637-X; WEIBEL ER, 1969, J CELL BIOL, V42, P68, DOI 10.1083/jcb.42.1.68; WEIBEL ER, 1966, J CELL BIOL, V30, P23, DOI 10.1083/jcb.30.1.23; Wicksell SD, 1925, BIOMETRIKA, V17, P84, DOI 10.1093/biomet/17.1-2.84; Wicksell SD, 1926, BIOMETRIKA, V18, P151, DOI 10.1093/biomet/18.1-2.151; Yang YL, 2011, CELL, V146, P991, DOI 10.1016/j.cell.2011.07.039; ZARJEVSKI N, 1993, ENDOCRINOLOGY, V133, P1753, DOI 10.1210/en.133.4.1753	56	209	216	2	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 26	2013	155	1					188	199		10.1016/j.cell.2013.09.004	http://dx.doi.org/10.1016/j.cell.2013.09.004			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	224UX	24074868	Bronze, Green Accepted			2022-12-28	WOS:000324916700019
J	Stenhouse, G; Walker, M; Gupta, C; Khanna, M				Stenhouse, G.; Walker, M.; Gupta, C.; Khanna, M.			Traumatic knee injury	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SOFT-TISSUE INJURIES; PATELLAR DISLOCATION; MANAGEMENT; LIGAMENT; SURGERY; TEARS; MRI		[Stenhouse, G.; Walker, M.; Gupta, C.; Khanna, M.] St Marys Hosp, Dept Radiol, Imperial NHS, London W2 1NY, England	Imperial College London	Stenhouse, G (corresponding author), St Marys Hosp, Dept Radiol, Imperial NHS, Praed St, London W2 1NY, England.	gregors45@gmail.com						Alioto R J, 1999, Am J Knee Surg, V12, P91; Casteleyn P P, 1989, Acta Orthop Belg, V55, P381; Christiansen SE, 2008, ARTHROSCOPY, V24, P881, DOI 10.1016/j.arthro.2008.03.012; Dejour H, 1994, Knee Surg Sports Traumatol Arthrosc, V2, P19, DOI 10.1007/BF01552649; Elvenes J, 2000, ARCH ORTHOP TRAUM SU, V120, P14, DOI 10.1007/PL00021235; Huang GS, 2002, RADIOLOGY, V225, P537, DOI 10.1148/radiol.2252011810; HUGHSTON JC, 1989, CLIN SPORT MED, V8, P153; JAIN AS, 1983, INJURY, V15, P178, DOI 10.1016/0020-1383(83)90009-8; KAPLAN PA, 1993, TOP MAGN RESON IMAG, V5, P228; KIRSCH MD, 1993, AM J ROENTGENOL, V161, P109, DOI 10.2214/ajr.161.1.8517287; Maenpaa H, 1997, AM J SPORT MED, V25, P213, DOI 10.1177/036354659702500213; McNally EG, 2002, SKELETAL RADIOL, V31, P570, DOI 10.1007/s00256-002-0557-1; Mori R, 1999, MAGN RESON IMAGING, V17, P1135, DOI 10.1016/S0730-725X(99)00033-8; Sallay PI, 1996, AM J SPORT MED, V24, P52, DOI 10.1177/036354659602400110; Sanders TG, 1999, RADIOLOGY, V213P, P115; Sanders TG, 2006, AM J ROENTGENOL, V187, P1332, DOI 10.2214/AJR.05.1471; Shepherd L, 2002, J ORTHOP TRAUMA, V16, P628, DOI 10.1097/00005131-200210000-00003; Sillanpaa P, 2008, MED SCI SPORT EXER, V40, P606, DOI [10.1249/MSS.001301816074017, 10.1249/MSS.0b013e318160740f]; Sillanpaa PJ, 2012, SPORTS MED ARTHROSC, V20, P128, DOI 10.1097/JSA.0b013e318256bbe5; Sillanpaa PJ, 2008, AM J SPORT MED, V36, P2301, DOI 10.1177/0363546508322894; Sperner G, 1988, Sportverletz Sportschaden, V2, P20, DOI 10.1055/s-2007-993662; STIELL IG, 1995, ANN EMERG MED, V26, P405, DOI 10.1016/S0196-0644(95)70106-0; Suarez-Almazor ME, 1999, INT J TECHNOL ASSESS, V15, P392, DOI 10.1017/S0266462399152103; Ward SR, 2007, J BONE JOINT SURG AM, V89A, P1749, DOI 10.2106/JBJS.F.00508	24	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 23	2013	347								f5303	10.1136/bmj.f5303	http://dx.doi.org/10.1136/bmj.f5303			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	227BZ	24062186				2022-12-28	WOS:000325084200001
J	Valeyre, D; Prasse, A; Nunes, H; Uzunhan, Y; Brillet, PY; Muller-Quernheim, J				Valeyre, Dominique; Prasse, Antje; Nunes, Hilario; Uzunhan, Yurdagul; Brillet, Pierre-Yves; Mueller-Quernheim, Joachim			Sarcoidosis	LANCET			English	Article							SMALL FIBER NEUROPATHY; PULMONARY SARCOIDOSIS; INFLIXIMAB THERAPY; F-18-FDG PET; DOUBLE-BLIND; CARDIAC SARCOIDOSIS; OCULAR SARCOIDOSIS; RANDOMIZED-TRIAL; FDG-PET/CT; STAGE-II	Sarcoidosis is a systemic disease of unknown cause that is characterised by the formation of immune granulomas in various organs, mainly the lungs and the lymphatic system. Studies show that sarcoidosis might be the result of an exaggerated granulomatous reaction after exposure to unidentified antigens in individuals who are genetically susceptible. Several new insights have been made, particularly with regards to the diagnosis and care of some important manifestations of sarcoidosis. The indications for endobronchial ultrasound in diagnosis and for PET in the assessment of inflammatory activity are now better specified. Recognition of unexplained persistent disabling symptoms, fatigue, small-fibre neurological impairment, cognitive failure, and changes to health state and quality of life, has improved. Mortality in patients with sarcoidosis is higher than that of the general population, mainly due to pulmonary fibrosis. Predicted advances for the future are finding the cause of sarcoidosis, and the elucidation of relevant biomarkers, reliable endpoints, and new efficient treatments, particularly in patients with refractory sarcoidosis, lung fibrosis, and those with persistent disabling symptoms.	[Valeyre, Dominique; Nunes, Hilario; Uzunhan, Yurdagul] Avicenne Univ Hosp, AP HP, Dept Pneumol, Bobigny, France; [Brillet, Pierre-Yves] Avicenne Univ Hosp, AP HP, Dept Radiol, Bobigny, France; [Valeyre, Dominique; Nunes, Hilario; Uzunhan, Yurdagul; Brillet, Pierre-Yves] Univ Paris 13, Sorbonne Paris Cite, Bobigny, France; [Prasse, Antje; Mueller-Quernheim, Joachim] Univ Hosp, Dept Pneumol, Freiburg, Germany	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Universite Paris 13; University of Freiburg	Valeyre, D (corresponding author), Hop Avicenne, Serv Pneumol, F-93009 Bobigny, France.	dominique.valeyre@avc.aphp.fr	Uzunhan, Yurdagul/AHA-1706-2022; Prasse, Antje/AAM-7521-2021; Nunes, Hilario/AAM-8127-2020; Prasse, Antje/AAY-6279-2020	Uzunhan, Yurdagul/0000-0002-1607-1407; Prasse, Antje/0000-0002-7336-7458; Nunes, Hilario/0000-0003-2896-7347; Valeyre, dominique/0000-0003-4470-1776; Brillet, Pierre-Yves/0000-0002-2411-5545	Sanofi; InterMune; Actelion; Direction de la Recherche Clinique; Chancellerie des universites de Paris	Sanofi; InterMune; Actelion; Direction de la Recherche Clinique; Chancellerie des universites de Paris	DV has received scientific advisor consultancy fees from Sanofi, InterMune, and Actelion; travel and accommodation expenses to attend the American Thoracic Society conference and European Respiratory Society congress, the Congres de Pneumologie de langue Francaise, and international meeting for orphan diseases 2011 from GlaxoSmithKline, AstraZeneca, Boehringer Ingelheim, Mundipharma, and Actelion; as well as academic grants from Direction de la Recherche Clinique and the Chancellerie des universites de Paris. DV has served as investigator or member of the steering committee for INSPIRE, CAPACITY, BUILD 1, and BUILD 3, and was an investigator in the Centocor (Jansen Biotech)funded trial evaluating golimumab versus placebo in severe sarcoidosis. The other authors declare that they have no conflicts of interest.	Baba Y, 2012, INT HEART J, V53, P287, DOI 10.1536/ihj.53.287; Bafica A, 2005, J EXP MED, V202, P1715, DOI 10.1084/jem.20051782; Baltzan M, 1999, AM J RESP CRIT CARE, V160, P192, DOI 10.1164/ajrccm.160.1.9809024; Bargagli E, 2011, RESP MED, V105, P775, DOI 10.1016/j.rmed.2010.12.010; Bargagli E, 2013, J CLIN IMMUNOL, V33, P264, DOI 10.1007/s10875-012-9754-4; Baughman RP, 2008, SARCOIDOSIS VASC DIF, V25, P76; Baughman RP, 2007, CHEST, V132, P207, DOI 10.1378/chest.06-2822; Baughman RP, 2006, AM J RESP CRIT CARE, V174, P795, DOI 10.1164/rccm.200603-402OC; Baughman RP, 2012, ARCH DERMATOL, V148, P262, DOI 10.1001/archdermatol.2011.301; Baughman RP, 2011, AM J RESP CRIT CARE, V183, P573, DOI 10.1164/rccm.201006-0865CI; Baughman RP, 2010, CHEST, V138, P1078, DOI 10.1378/chest.09-2002; Baughman RP, 2009, CHEST, V136, P526, DOI 10.1378/chest.08-1876; Baughman RP, 2005, CHEST, V128, P1062, DOI 10.1016/S0012-3692(15)50471-6; Baughman RP, 2004, SARCOIDOSIS VASC DIF, V21, P43; Baughman RP, 2000, SARCOIDOSIS VASC DIF, V17, P60; Baughman RP, 2003, LANCET, V361, P1111, DOI 10.1016/S0140-6736(03)12888-7; Berlin M, 1997, AM J RESP CRIT CARE, V156, P1601, DOI 10.1164/ajrccm.156.5.9704069; Biller H, 2006, EUR RESPIR J, V28, P1085, DOI 10.1183/09031936.00050106; Bodaghi B, 2012, PRESSE MED, V41, P349; Burke RR, 2010, SEMIN RESP CRIT CARE, V31, P474, DOI 10.1055/s-0030-1262215; Chen ES, 2008, CLIN CHEST MED, V29, P365, DOI 10.1016/j.ccm.2008.03.011; Chen ES, 2011, AM J RESP CRIT CARE, V183, P425, DOI 10.1164/rccm.201010-1570ED; Chen ES, 2010, AM J RESP CRIT CARE, V181, P360, DOI 10.1164/rccm.200905-0696OC; Cohen-Aubart F, 2010, MEDICINE, V89, P133, DOI 10.1097/MD.0b013e3181d5c6b4; Collins J, 2001, RADIOLOGY, V219, P503, DOI 10.1148/radiology.219.2.r01ma12503; Corte TJ, 2011, RESPIROLOGY, V16, P69, DOI 10.1111/j.1440-1843.2010.01872.x; Costabel U, 2010, SEMIN RESP CRIT CARE, V31, P404, DOI 10.1055/s-0030-1262207; Cremers J, 2012, EUR J GASTROEN HEPAT, V24, P17, DOI 10.1097/MEG.0b013e32834c7b71; Criado E, 2010, RADIOGRAPHICS, V30, P1567, DOI 10.1148/rg.306105512; Crouser ED, 2009, AM J RESP CRIT CARE, V179, P929, DOI 10.1164/rccm.200803-490OC; Crowley LE, 2011, AM J IND MED, V54, P175, DOI 10.1002/ajim.20924; De Vries J, 2004, BRIT J HEALTH PSYCH, V9, P279; De Vries J, 2010, SEMIN RESP CRIT CARE, V31, P485, DOI 10.1055/s-0030-1262216; Deubelbeiss U, 2010, EUR RESPIR J, V35, P1088, DOI 10.1183/09031936.00197808; Drent M, 2012, EUR RESPIR J, V40, P255, DOI 10.1183/09031936.00002512; Elfferich MD, 2010, RESPIRATION, V80, P212, DOI 10.1159/000314225; Erckens RJ, 2012, GRAEF ARCH CLIN EXP, V250, P713, DOI 10.1007/s00417-011-1844-0; Erdal BS, 2012, CHEST, V142, P1589, DOI 10.1378/chest.11-2027; Facco M, 2011, THORAX, V66, P144, DOI 10.1136/thx.2010.140319; Gibson GJ, 1996, THORAX, V51, P238, DOI 10.1136/thx.51.3.238; Gribbin J, 2006, THORAX, V61, P980, DOI 10.1136/thx.2006.062836; Grunewald J, 2010, TISSUE ANTIGENS, V76, P96, DOI 10.1111/j.1399-0039.2010.01476.x; Hamzeh NY, 2012, CHEST, V141, P154, DOI 10.1378/chest.11-0263; Handa T, 2010, SARCOIDOSIS VASC DIF, V27, P27; Herbort CP, 2009, OCUL IMMUNOL INFLAMM, V17, P160, DOI 10.1080/09273940902818861; HILLERDAL G, 1984, AM REV RESPIR DIS, V130, P29; Hofmann S, 2008, NAT GENET, V40, P1103, DOI 10.1038/ng.198; Hoitsma E, 2004, LANCET NEUROL, V3, P397, DOI 10.1016/S1474-4422(04)00805-1; Hoitsma E, 2002, LANCET, V359, P2085, DOI 10.1016/S0140-6736(02)08912-2; Hoitsma E, 2011, RESP MED, V105, P95, DOI 10.1016/j.rmed.2010.09.014; Hunninghake GW, 1999, AM J RESP CRIT CARE, V160, P736; Iannuzzi MC, 2011, JAMA-J AM MED ASSOC, V305, P391, DOI 10.1001/jama.2011.10; Ishige I, 1999, LANCET, V354, P120, DOI 10.1016/S0140-6736(98)12310-3; Judson MA, 1999, CHEST, V115, P1158, DOI 10.1378/chest.115.4.1158; Judson MA, 2003, CHEST, V123, P406, DOI 10.1378/chest.123.2.406; Judson MA, 2008, RESPIROLOGY, V13, P97, DOI 10.1111/j.1440-1843.2007.01206.x; Judson MA, 2007, SEMIN RESP CRIT CARE, V28, P83, DOI 10.1055/s-2007-970335; Judson MA, 2006, SARCOIDOSIS VASC DIF, V23, P51; Kalis C, 2005, J IMMUNOL, V174, P4295, DOI 10.4049/jimmunol.174.7.4295; Keijsers RG, 2011, SARCOIDOSIS VASC DIF, V28, P123; Keir G, 2010, SEMIN RESP CRIT CARE, V31, P409, DOI 10.1055/s-0030-1262209; KING TE, 1992, CLIN CHEST MED, V13, P607; Kollert F, 2011, RESP MED, V105, P122, DOI 10.1016/j.rmed.2010.09.007; Kouba DJ, 2003, BRIT J DERMATOL, V148, P147, DOI 10.1046/j.1365-2133.2003.05042.x; Lockstone HE, 2010, AM J RESP CRIT CARE, V181, P1367, DOI 10.1164/rccm.200912-1855OC; Lopes AJ, 2012, BRAZ J MED BIOL RES, V45, P256, DOI 10.1590/S0100-879X2012007500018; Lower EE, 2008, CHEST, V133, P1189, DOI 10.1378/chest.07-2952; Lower EE, 2012, CLIN OPHTHALMOL, V6, P1613, DOI 10.2147/OPTH.S35521; Mahevas M, 2011, MEDICINE, V90, P269, DOI 10.1097/MD.0b013e31822618b3; Mahevas M, 2009, MEDICINE, V88, P98, DOI 10.1097/MD.0b013e31819de50f; Mana Juan, 2012, Presse Med, V41, pe355, DOI 10.1016/j.lpm.2012.02.046; Marcellis RGJ, 2013, LUNG, V191, P43, DOI 10.1007/s00408-012-9432-6; McCaskill JG, 2006, AM J RESP CELL MOL, V35, P347, DOI 10.1165/rcmb.2005-0285OC; Miyara M, 2006, J EXP MED, V203, P359, DOI 10.1084/jem.20050648; Morimoto T, 2008, EUR RESPIR J, V31, P372, DOI 10.1183/09031936.00075307; Mostard RLM, 2011, RESP MED, V105, P1917, DOI 10.1016/j.rmed.2011.08.012; Mostard RLM, 2012, BMC PULM MED, V12, DOI 10.1186/1471-2466-12-57; Muller-Quernheim J, 2006, EUR RESPIR J, V27, P1190, DOI 10.1183/09031936.06.00112205; Muller-Quernheim J, 2008, CLIN CHEST MED, V29, P391, DOI 10.1016/j.ccm.2008.03.007; Muller-Quernheim J, 1999, EUR RESPIR J, V14, P1117, DOI 10.1183/09031936.99.14511179; Nardi A, 2011, EUR RESPIR J, V38, P1368, DOI 10.1183/09031936.00187410; Navani N, 2012, AM J RESP CRIT CARE, V186, P255, DOI 10.1164/rccm.201203-0393OC; NEVILLE E, 1983, Q J MED, V52, P525; Newman LS, 2004, AM J RESP CRIT CARE, V170, P1324, DOI 10.1164/rccm.200402-249OC; Nguyen T, 2006, J IMMUNOL, V176, P7354, DOI 10.4049/jimmunol.176.12.7354; Nozaki K, 2012, NEUROLOGIST, V18, P373, DOI 10.1097/NRL.0b013e3182704d04; Nunes H, 2007, SEMIN RESP CRIT CARE, V28, P102, DOI 10.1055/s-2007-970336; Nunes H, 2012, EUR RESPIR J, V40, P750, DOI 10.1183/09031936.00025212; Nunes Hilario, 2012, Presse Med, V41, pe303, DOI 10.1016/j.lpm.2012.04.003; Paramothayan NS, 2005, COCHRANE DB SYST REV, V2; Paramothayan S, 2006, COCHRANE DB SYST REV, P3; Park MK, 2009, SARCOIDOSIS VASC DIF, V26, P121; Park MA, 2008, LANCET, V372, P489, DOI 10.1016/S0140-6736(08)61199-X; Patel AS, 2013, THORAX, V68, P57, DOI 10.1136/thoraxjnl-2012-201962; Patel MR, 2009, CIRCULATION, V120, P1969, DOI 10.1161/CIRCULATIONAHA.109.851352; Perlman SE, 2011, LANCET, V378, P925, DOI 10.1016/S0140-6736(11)60967-7; Pietinalho A, 2002, CHEST, V121, P24, DOI 10.1378/chest.121.1.24; Pignatti P, 2006, AM J RESP CRIT CARE, V173, P310, DOI 10.1164/rccm.200502-244OC; Plit ML, 2013, EUR RESPIR J, V42, P1302, DOI 10.1183/09031936.00128312; Prasse A, 2008, AM J RESP CRIT CARE, V177, P330, DOI 10.1164/rccm.200705-742OC; Prasse A, 2010, AM J RESP CRIT CARE, V182, P540, DOI 10.1164/rccm.200909-1451OC; Rastogi R, 2011, AM J RESP CRIT CARE, V183, P500, DOI 10.1164/rccm.201005-0792OC; Rizzato G, 1998, SARCOIDOSIS VASC DIF, V15, P52; Rossman MD, 2003, AM J HUM GENET, V73, P720, DOI 10.1086/378097; Rossman MD, 2006, SARCOIDOSIS VASC DIF, V23, P201; Rybicki BA, 2001, AM J RESP CRIT CARE, V164, P2085, DOI 10.1164/ajrccm.164.11.2106001; Sahoo DH, 2011, EUR RESPIR J, V38, P1145, DOI 10.1183/09031936.00195010; Sato H, 2010, HUM MOL GENET, V19, P4100, DOI 10.1093/hmg/ddq325; Schuller JL, 2011, J CARDIOVASC ELECTR, V22, P1243, DOI 10.1111/j.1540-8167.2011.02099.x; Schutt AC, 2010, RESP MED, V104, P717, DOI 10.1016/j.rmed.2009.12.009; Shah L, 2007, SEMIN RESP CRIT CARE, V28, P134, DOI 10.1055/s-2007-970339; Shorr AF, 2003, CHEST, V124, P922, DOI 10.1378/chest.124.3.922; Sobic-Saranovic D, 2012, J NUCL MED, V53, P1543, DOI 10.2967/jnumed.112.104380; Sodhi M, 2009, RESP MED, V103, P268, DOI 10.1016/j.rmed.2008.08.016; Soussan M, 2013, J NUCL CARDIOL, V20, P120, DOI 10.1007/s12350-012-9653-3; Stagaki E, 2009, CHEST, V135, P468, DOI 10.1378/chest.08-1347; Sverrild A, 2008, THORAX, V63, P894, DOI 10.1136/thx.2007.094060; Swaisgood CM, 2011, AM J RESP CELL MOL, V44, P166, DOI 10.1165/rcmb.2009-0350OC; Sweiss NJ, 2010, SARCOIDOSIS VASC DIF, V27, P49; Sweiss NJ, 2010, SEMIN RESP CRIT CARE, V31, P463, DOI 10.1055/s-0030-1262214; Swigris JJ, 2011, CHEST, V140, P1261, DOI 10.1378/chest.11-0324; Swigris JJ, 2011, AM J RESP CRIT CARE, V183, P1524, DOI 10.1164/rccm.201010-1679OC; Treglia G, 2011, SARCOIDOSIS VASC DIF, V28, P87; Utz JP, 2003, CHEST, V124, P177, DOI 10.1378/chest.124.1.177; Valentonyte R, 2005, NAT GENET, V37, P357, DOI 10.1038/ng1519; Varron L, 2012, MEDICINE, V91, P137, DOI 10.1097/MD.0b013e3182569f91; Veltkamp M, 2012, TISSUE ANTIGENS, V79, P25, DOI 10.1111/j.1399-0039.2011.01808.x; Wallaert B, 2011, RESPIRATION, V82, P501, DOI 10.1159/000330050; Wasfi YS, 2006, CHEST, V129, P1234, DOI 10.1378/chest.129.5.1234; Wells AU, 2008, THORAX, V63, DOI 10.1136/thx.2008.101691; Wiken M, 2009, J CLIN IMMUNOL, V29, P78, DOI 10.1007/s10875-008-9225-0; Youssef G, 2012, J NUCL MED, V53, P241, DOI 10.2967/jnumed.111.090662; Zabel P, 1997, AM J RESP CRIT CARE, V155, P1665, DOI 10.1164/ajrccm.155.5.9154873; Zajicek JP, 1999, QJM-INT J MED, V92, P103, DOI 10.1093/qjmed/92.2.103; Zappala CJ, 2011, SARCOIDOSIS VASC DIF, V28, P130; Ziegenhagen MW, 2003, EUR RESPIR J, V21, P407, DOI 10.1183/09031936.03.00010403; Zissel G, 1996, AM J RESP CRIT CARE, V154, P713, DOI 10.1164/ajrccm.154.3.8810610; Zissel G, 2010, SEMIN RESP CRIT CARE, V31, P390, DOI 10.1055/s-0030-1262208	138	666	691	2	96	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 29	2014	383	9923					1155	1167		10.1016/S0140-6736(13)60680-7	http://dx.doi.org/10.1016/S0140-6736(13)60680-7			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE4MH	24090799				2022-12-28	WOS:000333956000035
J	Moyer, VA				Moyer, Virginia A.		US Preventive Serv Task Force	Screening for Primary Hypertension in Children and Adolescents: US Preventive Services Task Force Recommendation Statement	ANNALS OF INTERNAL MEDICINE			English	Article								Description: Update of the 2003 U.S. Preventive Services Task Force (USPSTF) recommendation on screening for high blood pressure in children and adolescents. Methods: The USPSTF reviewed the evidence on screening and diagnostic accuracy of screening tests for blood pressure in children and adolescents, the effectiveness and harms of treatment of screen-detected primary childhood hypertension, and the association of hypertension with markers of cardiovascular disease in childhood and adulthood. Population: This recommendation applies to children and adolescents who do not have symptoms of hypertension. Recommendation: The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for primary hypertension in asymptomatic children and adolescents to prevent subsequent cardiovascular disease in childhood or adulthood.	[Moyer, Virginia A.; US Preventive Serv Task Force] US Prevent Serv Task Force, Rockville, MD USA		Moyer, VA (corresponding author), US Prevent Serv Task Force, Rockville, MD USA.				Agency for Healthcare Research and Quality	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	The USPSTF is an independent, voluntary body. The U.S. Congress mandates that the Agency for Healthcare Research and Quality support the operations of the USPSTF.	American Academy of Family Physicians, 2013, REC CLIN PREV SERV H; Berg AO, 2003, AM FAM PHYSICIAN, V68, P2019; Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents, 2011, Pediatrics, V128 Suppl 5, pS213, DOI 10.1542/peds.2009-2107C; Flynn J, 2012, HYPERTENSION, V60, P1047, DOI 10.1161/HYPERTENSIONAHA.112.197525; Natl High Blood Pressure Educ Prog, 2004, PEDIATRICS, V114, P555; Pickering Thomas G, 2005, J Clin Hypertens (Greenwich), V7, P102, DOI 10.1111/j.1524-6175.2005.04377.x; Shapiro DJ, 2012, PEDIATRICS, V130, P604, DOI 10.1542/peds.2011-3888; STENN PG, 1981, CLIN INVEST MED, V4, P179; Tanski S., 2010, PERFORMING PREVENTIV; Thompson M., 2013, AHRQ PUBLICATION; Thompson M, 2013, PEDIATRICS, V131, P490, DOI 10.1542/peds.2012-3523; Viera AJ, 2010, AM FAM PHYSICIAN, V82, P1471	12	64	66	1	13	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 5	2013	159	9					613	619		10.7326/0003-4819-159-9-201311050-00725	http://dx.doi.org/10.7326/0003-4819-159-9-201311050-00725			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	249HX	24097285				2022-12-28	WOS:000326769400005
J	Venkiteswaran, G; Lewellis, SW; Wang, J; Reynolds, E; Nicholson, C; Knaut, H				Venkiteswaran, Gayatri; Lewellis, Stephen W.; Wang, John; Reynolds, Eric; Nicholson, Charles; Knaut, Holger			Generation and Dynamics of an Endogenous, Self-Generated Signaling Gradient across a Migrating Tissue	CELL			English	Article							COLLECTIVE CELL-MIGRATION; LATERAL-LINE; RECEPTOR CXCR4; CHEMOKINE; GUIDANCE; ACTIVATION; UBIQUITINATION; MORPHOGENESIS; CHEMOTAXIS; DROSOPHILA	In animals, many cells reach their destinations by migrating toward higher concentrations of an attractant. However, the nature, generation, and interpretation of attractant gradients are poorly understood. Using a GFP fusion and a signaling sensor, we analyzed the distribution of the attractant chemokine Sdf1 during migration of the zebrafish posterior lateral line primordium, a cohort of about 200 cells that migrates over a stripe of cells uniformly expressing sdf1. We find that a small fraction of the total Sdf1 pool is available to signal and induces a linear Sdf1signaling gradient across the primordium. This signaling gradient is initiated at the rear of the primordium, equilibrates across the primordium within 200 min, and operates near steady state. The rear of the primordium generates this gradient through continuous sequestration of Sdf1 protein by the alternate Sdf1-receptor Cxcr7. Modeling shows that this is a physically plausible scenario.	[Venkiteswaran, Gayatri; Lewellis, Stephen W.; Wang, John; Reynolds, Eric; Knaut, Holger] NYU, Langone Med Ctr, Skirball Inst Biomol Med, Dev Genet Program, New York, NY 10016 USA; [Reynolds, Eric] Charite, D-10117 Berlin, Germany; [Nicholson, Charles] NYU, Langone Med Ctr, Dept Neurosci & Physiol, New York, NY 10016 USA; [Knaut, Holger] NYU, Langone Med Ctr, Kimmel Ctr Stem Cell Biol, New York, NY 10016 USA	New York University; NYU Langone Medical Center; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center	Knaut, H (corresponding author), NYU, Langone Med Ctr, Skirball Inst Biomol Med, Dev Genet Program, 550 1St Ave, New York, NY 10016 USA.	holger.knaut@med.nyu.edu		Wang, John/0000-0001-5048-0952; Nicholson, Charles/0000-0002-7346-0484; Knaut, Holger/0000-0002-8399-8720	Wellcome Trust [WT 077047/Z/05/Z]; NIH [NS069839, NS28642, HD007520]; American Heart Association fellowship [12POST12060278]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007520] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024708] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028642, R01NS069839] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association fellowship(American Heart Association); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank J. Torres-Vazquez, F. Schnorrer, J. Nance, R. Lehmann, R. Cinalli, J. Hubbard, and J. Treisman for critical comments; D. Gilmour, P. Krieg, and A. J. Hudspeth for reagents; F. Fuentes for excellent fish care; K. Cadwell and G. David for cell lines; M. Stadtfeld for recombinant LIF; and A. Sfeir and M. Tahiliani for advice and reagents for tissue culture experiments. For providing the zebrafish knockout allele cxcr7b sa16, we thank E. Busch-Nentwich and D. Stemple, Sanger Institute Zebrafish Mutation Resource, sponsored by the Wellcome Trust (grant number WT 077047/Z/05/Z). This work was supported by NIH grants NS069839 (H. K.), NS28642 (C. N.), and HD007520 (S. W. L.) and by an American Heart Association fellowship 12POST12060278 (G.V.).	Affolter M, 2008, DEVELOPMENT, V135, P2055, DOI 10.1242/dev.014498; Aman A, 2010, DEV BIOL, V341, P20, DOI 10.1016/j.ydbio.2009.11.014; Sanchez-Alcaniz JA, 2011, NEURON, V69, P77, DOI 10.1016/j.neuron.2010.12.006; Boldajipour B, 2008, CELL, V132, P463, DOI 10.1016/j.cell.2007.12.034; Breau MA, 2012, DEVELOPMENT, V139, P2246, DOI 10.1242/dev.080275; Cai HQ, 2011, SEMIN CELL DEV BIOL, V22, P834, DOI 10.1016/j.semcdb.2011.07.020; Crank J., 1975, MATH DIFFUSION; CRICK F, 1970, NATURE, V225, P420, DOI 10.1038/225420a0; Crump MP, 1997, EMBO J, V16, P6996, DOI 10.1093/emboj/16.23.6996; Dambly-Chaudiere C, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-23; David NB, 2002, P NATL ACAD SCI USA, V99, P16297, DOI 10.1073/pnas.252339399; Duchesne L, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001361; Entchev EV, 2000, CELL, V103, P981, DOI 10.1016/S0092-8674(00)00200-2; FISHER PR, 1989, J CELL BIOL, V108, P973, DOI 10.1083/jcb.108.3.973; Friedl P, 2009, NAT REV MOL CELL BIO, V10, P445, DOI 10.1038/nrm2720; Ghysen A, 2007, GENE DEV, V21, P2118, DOI 10.1101/gad.1568407; Haas P, 2006, DEV CELL, V10, P673, DOI 10.1016/j.devcel.2006.02.019; Hatzikirou H, 2008, CURR TOP DEV BIOL, V81, P401, DOI 10.1016/S0070-2153(07)81014-3; KELLER EF, 1971, J THEOR BIOL, V30, P225, DOI 10.1016/0022-5193(71)90050-6; Kicheva A, 2007, SCIENCE, V315, P521, DOI 10.1126/science.1135774; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Li Q, 2004, DEV BIOL, V269, P123, DOI 10.1016/j.ydbio.2004.01.020; Marchese A, 2001, J BIOL CHEM, V276, P45509, DOI 10.1074/jbc.C100527200; Marchese A, 2003, DEV CELL, V5, P709, DOI 10.1016/S1534-5807(03)00321-6; MATO JM, 1975, P NATL ACAD SCI USA, V72, P4991, DOI 10.1073/pnas.72.12.4991; Minina S, 2007, CURR BIOL, V17, P1164, DOI 10.1016/j.cub.2007.05.073; Montell DJ, 2008, SCIENCE, V322, P1502, DOI 10.1126/science.1164073; Montell DJ, 2003, NAT REV MOL CELL BIO, V4, P13, DOI 10.1038/nrm1006; Muller P, 2013, DEVELOPMENT, V140, P1621, DOI 10.1242/dev.083519; Muller P, 2012, SCIENCE, V336, P721, DOI 10.1126/science.1221920; Muller P, 2011, DEV CELL, V21, P145, DOI 10.1016/j.devcel.2011.06.001; Nechiporuk A, 2008, SCIENCE, V320, P1774, DOI 10.1126/science.1156547; Parent CA, 1999, SCIENCE, V284, P765, DOI 10.1126/science.284.5415.765; Rajagopal S, 2010, P NATL ACAD SCI USA, V107, P628, DOI 10.1073/pnas.0912852107; Raz E, 2009, DEVELOPMENT, V136, P1223, DOI 10.1242/dev.022418; Rorth P, 2007, TRENDS CELL BIOL, V17, P575, DOI 10.1016/j.tcb.2007.09.007; Rorth P, 2011, DEV CELL, V20, P9, DOI 10.1016/j.devcel.2010.12.014; Rorth P, 2009, ANNU REV CELL DEV BI, V25, P407, DOI 10.1146/annurev.cellbio.042308.113231; Schuster K, 2010, P NATL ACAD SCI USA, V107, P19531, DOI 10.1073/pnas.1002171107; Swaney KF, 2010, ANNU REV BIOPHYS, V39, P265, DOI 10.1146/annurev.biophys.093008.131228; Teleman AA, 2000, CELL, V103, P971, DOI 10.1016/S0092-8674(00)00199-9; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Valentin G, 2007, CURR BIOL, V17, P1026, DOI 10.1016/j.cub.2007.05.020; Wang XB, 2010, NAT CELL BIOL, V12, P591, DOI 10.1038/ncb2061; Wartlick O., 2009, COLD SPRING HARB PER, V1; Weber M, 2013, SCIENCE, V339, P328, DOI 10.1126/science.1228456; Weijer CJ, 2009, J CELL SCI, V122, P3215, DOI 10.1242/jcs.036517; Yu SR, 2009, NATURE, V461, P533, DOI 10.1038/nature08391	48	131	131	0	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 24	2013	155	3					674	687		10.1016/j.cell.2013.09.046	http://dx.doi.org/10.1016/j.cell.2013.09.046			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	246WQ	24119842	Green Accepted, Bronze			2022-12-28	WOS:000326571800020
J	Fainman, Y; Porter, G				Fainman, Yeshaiahu; Porter, George			Directing Data Center Traffic	SCIENCE			English	Editorial Material									[Fainman, Yeshaiahu] Univ Calif San Diego, Dept Elect & Comp Engn, La Jolla, CA 92093 USA; [Porter, George] Univ Calif San Diego, Dept Comp Sci & Engn, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Fainman, Y (corresponding author), Univ Calif San Diego, Dept Elect & Comp Engn, 9500 Gilman Dr, La Jolla, CA 92093 USA.	fainman@eng.ucsd.edu; gmporter@cs.ucsd.edu		Porter, George/0000-0001-9753-5471				Asghari M, 2011, NAT PHOTONICS, V5, P268, DOI 10.1038/nphoton.2011.68; Farrington N, 2010, ACM SIGCOMM COMP COM, V40, P339, DOI 10.1145/1851275.1851223; Khajavikhan M, 2012, NATURE, V482, P204, DOI 10.1038/nature10840; Nezhad MP, 2010, NAT PHOTONICS, V4, P395, DOI 10.1038/NPHOTON.2010.88; Wang GH, 2010, ACM SIGCOMM COMP COM, V40, P327, DOI 10.1145/1851275.1851222	5	6	7	2	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 11	2013	342	6155					202	203		10.1126/science.1242906	http://dx.doi.org/10.1126/science.1242906			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232EV	24115429				2022-12-28	WOS:000325475200031
J	Ho, BT; Basler, M; Mekalanos, JJ				Ho, Brian T.; Basler, Marek; Mekalanos, John J.			Type 6 Secretion System-Mediated Immunity to Type 4 Secretion System-Mediated Gene Transfer	SCIENCE			English	Article							PLASMID RP4; ESCHERICHIA-COLI; POLYMYXIN-B; HOST-RANGE; TRA2 CORE; PROTEINS; IDENTIFICATION; MOBILIZATION; RESISTANCE; EFFECTOR	Gram-negative bacteria use the type VI secretion system (T6SS) to translocate toxic effector proteins into adjacent cells. The Pseudomonas aeruginosa H1-locus T6SS assembles in response to exogenous T6SS attack by other bacteria. We found that this lethal T6SS counterattack also occurs in response to the mating pair formation (Mpf) system encoded by broad-host-range IncP alpha conjugative plasmid RP4 present in adjacent donor cells. This T6SS response was eliminated by disruption of Mpf structural genes but not components required only for DNA transfer. Because T6SS activity was also strongly induced by membrane-disrupting natural product polymyxin B, we conclude that RP4 induces "donor-directed T6SS attacks" at sites corresponding to Mpf-mediated membrane perturbations in recipient P. aeruginosa cells to potentially block acquisition of parasitic foreign DNA.	[Ho, Brian T.; Basler, Marek; Mekalanos, John J.] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Mekalanos, JJ (corresponding author), Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	john_mekalanos@hms.harvard.edu	Ho, Brian/M-1976-2019; Basler, Marek/A-3559-2012	Ho, Brian/0000-0003-4979-780X; Basler, Marek/0000-0001-5414-2088	National Institute of Allergy and Infectious Diseases [AI-018045, AI-26289]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI026289, R37AI018045, R22AI018045, R01AI018045] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supporting movies and table can be found in the supplementary materials. This work was supported by National Institute of Allergy and Infectious Diseases grants AI-018045 and AI-26289 to J.J.M.	Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Basler M, 2012, SCIENCE, V337, P815, DOI 10.1126/science.1222901; Basler M, 2012, NATURE, V483, P182, DOI 10.1038/nature10846; Basler M, 2013, CELL, V152, P884, DOI 10.1016/j.cell.2013.01.042; BAYER M, 1995, J BACTERIOL, V177, P4279, DOI 10.1128/jb.177.15.4279-4288.1995; Boyer F, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-104; Christie PJ, 2000, TRENDS MICROBIOL, V8, P354, DOI 10.1016/S0966-842X(00)01792-3; Dong TG, 2013, P NATL ACAD SCI USA, V110, P2623, DOI 10.1073/pnas.1222783110; Fernandez D, 1996, J BACTERIOL, V178, P3168, DOI 10.1128/jb.178.11.3168-3176.1996; Giebelhaus LA, 1996, J BACTERIOL, V178, P6378, DOI 10.1128/jb.178.21.6378-6381.1996; HAASE J, 1995, J BACTERIOL, V177, P4779, DOI 10.1128/jb.177.16.4779-4791.1995; Hankins JV, 2012, P NATL ACAD SCI USA, V109, P8722, DOI 10.1073/pnas.1201313109; Hibbing ME, 2010, NAT REV MICROBIOL, V8, P15, DOI 10.1038/nrmicro2259; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; LANGER PJ, 1981, J BACTERIOL, V145, P1310, DOI 10.1128/JB.145.3.1310-1316.1981; Leiman PG, 2009, P NATL ACAD SCI USA, V106, P4154, DOI 10.1073/pnas.0813360106; Li ZY, 1997, J BIOL CHEM, V272, P19582, DOI 10.1074/jbc.272.31.19582; Luo ZQ, 2004, P NATL ACAD SCI USA, V101, P841, DOI 10.1073/pnas.0304916101; McPhee JB, 2003, MOL MICROBIOL, V50, P205, DOI 10.1046/j.1365-2958.2003.03673.x; MORRISON DC, 1976, IMMUNOCHEMISTRY, V13, P813, DOI 10.1016/0019-2791(76)90181-6; NAITO T, 1995, SCIENCE, V267, P897, DOI 10.1126/science.7846533; PANSEGRAU W, 1994, J MOL BIOL, V239, P623, DOI 10.1006/jmbi.1994.1404; Pukatzki S, 2006, P NATL ACAD SCI USA, V103, P1528, DOI 10.1073/pnas.0510322103; Rietsch A, 2005, P NATL ACAD SCI USA, V102, P8006, DOI 10.1073/pnas.0503005102; Schroder G, 2005, PLASMID, V54, P1, DOI 10.1016/j.plasmid.2005.02.001; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Zhong ZP, 2005, PLASMID, V54, P48, DOI 10.1016/j.plasmid.2004.11.001	29	81	83	2	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 11	2013	342	6155					250	253		10.1126/science.1243745	http://dx.doi.org/10.1126/science.1243745			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232EV	24115441	Green Accepted			2022-12-28	WOS:000325475200046
J	Babaria, P				Babaria, Palav			Threatened Hope - PEPFAR and Health in Africa	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								Mr. C. had been aged by his life circumstances. Like most of the South African clinic's patients, he was malnourished and frail but had a tenacity that had sustained him through his HIV diagnosis and his first bout of tuberculosis several years earlier. Cows, chickens, and patients lounged outside the clinic in the blistering heat of a waning South African summer. From the window, I watched them gravitate to the shade of a giant jacaranda tree. The electricity was out for the fourth time that morning, and beads of perspiration dotted our bodies as we waited. It would be hours before the x-ray machine, lights, and air conditioner returned to life. Doctor, you have another patient, the nurse announced, though I was neither a doctor nor supposed to be seeing patients. I was a fourth-year medical student posted to a rural district hospital ...	[Babaria, Palav] Univ Calif San Francisco, Dept Internal Med, San Francisco, CA 94143 USA; [Babaria, Palav] Highland Hosp, Dept Med, Oakland, CA USA	University of California System; University of California San Francisco	Babaria, P (corresponding author), Univ Calif San Francisco, Dept Internal Med, San Francisco, CA 94143 USA.								0	0	0	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 10	2013	369	15					1388	1389		10.1056/NEJMp1301649	http://dx.doi.org/10.1056/NEJMp1301649			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	231QE	24106931				2022-12-28	WOS:000325431500003
J	Colbert, JA; Jangi, S				Colbert, James A.; Jangi, Sushrut			Training Physicians to Manage Obesity - Back to the Drawing Board	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							INTERNAL-MEDICINE RESIDENTS	Just as obesity treatment should begin while patients are young and behaviors are relatively easy to change, educational programs should be developed for young physicians-in-training that will enable them to recognize, treat, and research obesity. According to the Centers for Disease Control and Prevention, nearly one third of U.S. children and about two thirds of U.S. adults are overweight or obese (see map) and therefore at increased risk for hypertension, diabetes, and musculoskeletal disease. If the trend continues unchecked, half the adults in the United States may be obese by 2030. Although a few clinics specializing in weight management have sprung up around the country, not everyone is lucky enough to be able to attend a multidisciplinary weight-management program. Thus, the front lines of the obesity epidemic often lie in a primary care doctor's office. ...	[Colbert, James A.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Jangi, Sushrut] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Colbert, James A.] Newton Wellesley Hosp, Newton, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Beth Israel Deaconess Medical Center; Newton Wellesley Hospital	Colbert, JA (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.							Block JP, 2003, PREV MED, V36, P669, DOI 10.1016/S0091-7435(03)00055-0; Blue AV, 2007, J PUBLIC HEALTH MAN, V13, P539; Martino S, 2007, MED EDUC, V41, P160, DOI 10.1111/j.1365-2929.2006.02673.x; Ruser CB, 2005, J GEN INTERN MED, V20, P1139, DOI 10.1111/j.1525-1497.2005.0263.x	4	23	23	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 10	2013	369	15					1389	1391		10.1056/NEJMp1306460	http://dx.doi.org/10.1056/NEJMp1306460			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	231QE	24106932				2022-12-28	WOS:000325431500004
J	Elmariah, SB; Lerner, EA				Elmariah, Sarina B.; Lerner, Ethan A.			The Missing Link between Itch and Inflammation in Atopic Dermatitis	CELL			English	Editorial Material							THYMIC STROMAL LYMPHOPOIETIN	Atopic dermatitis is a common skin disease with high morbidity and is associated with severe itch and chronic skin inflammation. In this issue of Cell, Wilson et al. demonstrate that epithelial cells communicate directly with cutaneous sensory neurons via a cytokine to induce itch.	[Elmariah, Sarina B.; Lerner, Ethan A.] Massachusetts Gen Hosp, Dept Dermatol, Cutaneous Biol Res Ctr, Boston, MA 02114 USA; [Elmariah, Sarina B.; Lerner, Ethan A.] Harvard Univ, Sch Med, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Elmariah, SB (corresponding author), Massachusetts Gen Hosp, Dept Dermatol, Cutaneous Biol Res Ctr, Boston, MA 02114 USA.	sbelmariah@partners.org			NIAMS NIH HHS [R01 AR057744, R01AR057744] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR057744] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Bautista DM, 2013, ANNU REV PHYSIOL, V75, P181, DOI 10.1146/annurev-physiol-030212-183811; Brandt Eric B, 2011, J Clin Cell Immunol, V2; Eichenfield LF, 2012, SEMIN CUTAN MED SURG, V31, pS3, DOI 10.1016/j.sder.2012.07.002; JANSEN CT, 1973, ARCH DERMATOL FORSCH, V246, P299, DOI 10.1007/BF00595211; Jessup HK, 2008, J IMMUNOL, V181, P4311, DOI 10.4049/jimmunol.181.6.4311; Leyva-Castillo JM, 2013, J INVEST DERMATOL, V133, P154, DOI 10.1038/jid.2012.239; Moniaga CS, 2013, AM J PATHOL, V182, P841, DOI 10.1016/j.ajpath.2012.11.039; Steinhoff M, 2003, J NEUROSCI, V23, P6176; Wilson SR, 2013, CELL, V155, P285, DOI 10.1016/j.cell.2013.08.057; Yoo J, 2005, J EXP MED, V202, P541, DOI 10.1084/jem.20041503; Ziegler SF, 2012, J ALLERGY CLIN IMMUN, V130, P845, DOI 10.1016/j.jaci.2012.07.010	11	16	18	0	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 10	2013	155	2					267	269		10.1016/j.cell.2013.09.038	http://dx.doi.org/10.1016/j.cell.2013.09.038			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	235LH	24120126	Green Accepted, Bronze			2022-12-28	WOS:000325719800002
J	Rice, CM; Kemp, K; Wilkins, A; Scolding, NJ				Rice, Claire M.; Kemp, Kevin; Wilkins, Alastair; Scolding, Neil J.			Cell therapy for multiple sclerosis: an evolving concept with implications for other neurodegenerative diseases	LANCET			English	Article							MESENCHYMAL STEM-CELLS; MARROW STROMAL CELLS; RAT SPINAL-CORD; CENTRAL-NERVOUS-SYSTEM; BONE-MARROW; REGENERATIVE MEDICINE; HEMATOPOIETIC-CELLS; IFATS COLLECTION; PURKINJE NEURONS; REMYELINATION	Multiple sclerosis is a major cause of neurological disability, and particularly occurs in young adults. It is characterised by conspicuous patches of damage throughout the brain and spinal cord, with loss of myelin and myelinating cells (oligodendrocytes), and damage to neurons and axons. Multiple sclerosis is incurable, but stem-cell therapy might off er valuable therapeutic potential. Eff orts to develop stem-cell therapies for multiple sclerosis have been conventionally built on the principle of direct implantation of cells to replace oligodendrocytes, and therefore to regenerate myelin. Recent progress in understanding of disease processes in multiple sclerosis include observations that spontaneous myelin repair is far more widespread and successful than was previously believed, that loss of axons and neurons is more closely associated with progressive disability than is myelin loss, and that damage occurs diff usely throughout the CNS in grey and white matter, not just in discrete, isolated patches or lesions. These fi ndings have introduced new and serious challenges that stem-cell therapy needs to overcome; the practical challenges to achieve cell replacement alone are diffi cult enough, but, to be useful, cell therapy for multiple sclerosis must achieve substantially more than the replacement of lost oligodendrocytes. However, parallel advances in understanding of the reparative properties of stem cells-including their distinct immunomodulatory and neuroprotective properties, interactions with resident or tissue-based stem cells, cell fusion, and neurotrophin elaboration-off er renewed hope for development of cell-based therapies. Additionally, these advances suggest avenues for translation of this approach not only for multiple sclerosis, but also for other common neurological and neurodegenerative diseases.	[Rice, Claire M.; Kemp, Kevin; Wilkins, Alastair; Scolding, Neil J.] Univ Bristol, Inst Clin Neurosci, Burden MS Stem Cell Labs, Bristol BS16 1LE, Avon, England; [Rice, Claire M.; Kemp, Kevin; Wilkins, Alastair; Scolding, Neil J.] Frenchay Hosp, BrAMS Unit, Bristol BS16 1LE, Avon, England	University of Bristol	Scolding, NJ (corresponding author), Univ Bristol, Inst Clin Neurosci, Burden MS Stem Cell Labs, Bristol BS16 1LE, Avon, England.	n.j.scolding@bristol.ac.uk	Rice, Claire M/A-1673-2011; Kemp, Kevin/B-9755-2017	Rice, Claire M/0000-0002-9851-4426; Kemp, Kevin/0000-0003-1465-1309; Scolding, Neil/0000-0001-9177-1043	National Institute for Health; Medical Research Council; Silverman Family Foundation; MRC [MR/J012580/1, MR/K004166/1] Funding Source: UKRI; Medical Research Council [MR/K004166/1, MR/J012580/1] Funding Source: researchfish; National Institute for Health Research [CL-2010-25-003] Funding Source: researchfish; Rosetrees Trust [M180] Funding Source: researchfish	National Institute for Health; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Silverman Family Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Rosetrees Trust(Rosetrees Trust)	CMR is supported by a National Institute for Health Research clinical lectureship. KK is supported by the Medical Research Council. The Burden Neurological Institute MS Stem Cell Therapy programme is supported by the Silverman Family Foundation.	Akiyama Y, 2002, GLIA, V39, P229, DOI 10.1002/glia.10102; Akiyama Y, 2002, J NEUROSCI, V22, P6623; Albert M, 2007, BRAIN PATHOL, V17, P129, DOI 10.1111/j.1750-3639.2006.00043.x; Alusi SH, 1999, J NEUROL NEUROSUR PS, V66, P131, DOI 10.1136/jnnp.66.2.131; Alves H, 2010, J CELL MOL MED, V14, P2729, DOI 10.1111/j.1582-4934.2009.00931.x; Back SA, 2005, NAT MED, V11, P966, DOI 10.1038/nm1279; Bai LH, 2009, GLIA, V57, P1192, DOI 10.1002/glia.20841; Barhum Y, 2010, J MOL NEUROSCI, V41, P129, DOI 10.1007/s12031-009-9302-8; Bennetto L, 2011, MULT SCLER J, V17, P1218, DOI 10.1177/1352458511407368; Bernardo ME, 2012, ANN NY ACAD SCI, V1266, P107, DOI 10.1111/j.1749-6632.2012.06667.x; BLAKEMORE WF, 1977, NATURE, V266, P68, DOI 10.1038/266068a0; Bonab MM, 2012, CURR STEM CELL RES T, V7, P407; Brex PA, 2002, NEW ENGL J MED, V346, P158, DOI 10.1056/NEJMoa011341; Chang A, 2008, BRAIN, V131, P2366, DOI 10.1093/brain/awn157; Chard D, 2009, CURR OPIN NEUROL, V22, P214, DOI 10.1097/WCO.0b013e32832b4c62; Charles P, 2002, BRAIN, V125, P1972, DOI 10.1093/brain/awf216; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Chen KA, 2011, MOL CELL NEUROSCI, V47, P61, DOI 10.1016/j.mcn.2011.03.003; Cogle CR, 2004, LANCET, V363, P1432, DOI 10.1016/S0140-6736(04)16102-3; Connick P, 2012, LANCET NEUROL, V11, P150, DOI 10.1016/S1474-4422(11)70305-2; Crisostomo PR, 2006, SHOCK, V26, P575, DOI 10.1097/01.shk.0000235087.45798.93; Daher SR, 2008, STEM CELLS, V26, P2664, DOI 10.1634/stemcells.2008-0927; Dahl JA, 2008, INT J DEV BIOL, V52, P1033, DOI 10.1387/ijdb.082663jd; De Feo D, 2012, CURR OPIN NEUROL, V25, P322, DOI 10.1097/WCO.0b013e328352ec45; Devine SM, 2003, BLOOD, V101, P2999, DOI 10.1182/blood-2002-06-1830; Duncan ID, 2008, J NEUROL SCI, V265, P89, DOI 10.1016/j.jns.2007.04.043; Duncan ID, 2005, J INHERIT METAB DIS, V28, P357, DOI 10.1007/s10545-005-7058-z; Evangelou N, 2005, BRAIN, V128, P29, DOI 10.1093/brain/awh323; Fancy SPJ, 2010, EXP NEUROL, V225, P18, DOI 10.1016/j.expneurol.2009.12.020; Franklin RJM, 2002, NAT REV NEUROSCI, V3, P705, DOI 10.1038/nrn917; Freedman MS, 2010, MULT SCLER J, V16, P503, DOI 10.1177/1352458509359727; Fu LJ, 2008, STEM CELLS DEV, V17, P1109, DOI 10.1089/scd.2008.0068; Fu XB, 2009, AGEING RES REV, V8, P244, DOI 10.1016/j.arr.2009.02.002; Gordon D, 2010, J NEUROPATH EXP NEUR, V69, P1087, DOI 10.1097/NEN.0b013e3181f97392; Gordon D, 2008, NEUROSCI LETT, V448, P71, DOI 10.1016/j.neulet.2008.10.040; Grigoriadis N, 2011, EXP NEUROL, V230, P78, DOI 10.1016/j.expneurol.2011.02.021; Hirst C, 2008, J NEUROL, V255, P280, DOI 10.1007/s00415-008-0743-8; Huang JK, 2011, NEUROCHEM INT, V59, P329, DOI 10.1016/j.neuint.2011.01.017; Irvine KA, 2008, BRAIN, V131, P1464, DOI 10.1093/brain/awn080; Johansson CB, 2008, NAT CELL BIOL, V10, P575, DOI 10.1038/ncb1720; Karussis D, 2010, ARCH NEUROL-CHICAGO, V67, P1187, DOI 10.1001/archneurol.2010.248; Kassis I, 2008, ARCH NEUROL-CHICAGO, V65, P753, DOI 10.1001/archneur.65.6.753; Kemp K, 2011, NEUROPATH APPL NEURO, V37, P166, DOI 10.1111/j.1365-2990.2010.01122.x; Kemp K, 2012, BRAIN, V135, P2962, DOI 10.1093/brain/aws226; Kemp K, 2010, STEM CELL REV REP, V6, P548, DOI 10.1007/s12015-010-9178-6; Kemp K, 2010, J NEUROCHEM, V114, P1569, DOI 10.1111/j.1471-4159.2009.06553.x; Korbling M, 2003, NEW ENGL J MED, V349, P570, DOI 10.1056/NEJMra022361; Kutzelnigg A, 2005, BRAIN, V128, P2705, DOI 10.1093/brain/awh641; Lalu MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047559; Lang AE, 2012, ANN NEUROL, V71, P283, DOI 10.1002/ana.22676; Lee AS, 2013, NAT MED, V19, P998, DOI 10.1038/nm.3267; Lee JP, 2007, NAT MED, V13, P439, DOI 10.1038/nm1548; Lee JK, 2012, STEM CELLS, V30, P1544, DOI 10.1002/stem.1125; Lee PH, 2012, ANN NEUROL, V72, P32, DOI 10.1002/ana.23612; Lee RH, 2009, CELL STEM CELL, V5, P54, DOI 10.1016/j.stem.2009.05.003; Lescaudron L, 2012, CURR MED CHEM, V19, P6018; Maeda Y, 2001, ANN NEUROL, V49, P776, DOI 10.1002/ana.1015; Magrassi L, 2007, J NEUROSCI, V27, P9885, DOI 10.1523/JNEUROSCI.2539-07.2007; Morikawa S, 2009, BIOCHEM BIOPH RES CO, V379, P1114, DOI 10.1016/j.bbrc.2009.01.031; Muller. R., 1949, ACTA MED SCAND  S222, V133, P1; Munoz JR, 2005, P NATL ACAD SCI USA, V102, P18171, DOI 10.1073/pnas.0508945102; Nasef A, 2009, INT J LAB HEMATOL, V31, P9, DOI 10.1111/j.1751-553X.2007.00997.x; Nygren JM, 2008, NAT CELL BIOL, V10, P584, DOI 10.1038/ncb1721; Oh JY, 2012, MOL THER, V20, P2143, DOI 10.1038/mt.2012.165; Osaka M, 2010, BRAIN RES, V1343, P226, DOI 10.1016/j.brainres.2010.05.011; Patani R, 2007, NEUROPATH APPL NEURO, V33, P277, DOI 10.1111/j.1365-2990.2007.00805.x; Paty DW, 2002, NEW ENGL J MED, V346, P199, DOI 10.1056/NEJM200201173460311; PERIER O, 1965, BRAIN, V88, P937, DOI 10.1093/brain/88.5.937; Phinney DG, 2012, J CELL BIOCHEM, V113, P2806, DOI 10.1002/jcb.24166; Picard-Riera N, 2002, P NATL ACAD SCI USA, V99, P13211, DOI 10.1073/pnas.192314199; Pisati F, 2007, CELL TRANSPLANT, V16, P41, DOI 10.3727/000000007783464443; PRINEAS JW, 1979, ANN NEUROL, V5, P22, DOI 10.1002/ana.410050105; Prockop DJ, 2012, NAT MED, V18, P653, DOI 10.1038/nm.2769; Prockop DJ, 2012, MOL THER, V20, P14, DOI 10.1038/mt.2011.211; Prockop DJ, 2010, CYTOTHERAPY, V12, P576, DOI 10.3109/14653249.2010.507330; Rice CM, 2010, CLIN PHARMACOL THER, V87, P679, DOI 10.1038/clpt.2010.44; Rice CM, 2013, J NEUROL NEUROSUR PS, V84, P1100, DOI 10.1136/jnnp-2012-304140; Rice CM, 2010, CELL ADHES MIGR, V4, P235, DOI 10.4161/cam.4.2.11404; Rice CM, 2010, BRIT J HAEMATOL, V148, P441, DOI 10.1111/j.1365-2141.2009.07986.x; Rice CM, 2004, LANCET, V364, P193, DOI 10.1016/S0140-6736(04)16633-6; Riordan NH, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-29; Sasaki H, 2009, SPINE, V34, P249, DOI 10.1097/BRS.0b013e3181913cde; Sasaki M, 2001, GLIA, V35, P26, DOI 10.1002/glia.1067; Scalfari A, 2010, BRAIN, V133, P1914, DOI 10.1093/brain/awq118; Scolding N, 1998, BRAIN, V121, P2221, DOI 10.1093/brain/121.12.2221; Scolding N, 1998, LANCET, V352, P340, DOI 10.1016/S0140-6736(05)60463-1; Shen LH, 2011, STROKE, V42, P459, DOI 10.1161/STROKEAHA.110.593863; Snethen H, 2008, REGEN MED, V3, P835, DOI 10.2217/17460751.3.6.835; Stadelmann C, 2011, BBA-MOL BASIS DIS, V1812, P275, DOI 10.1016/j.bbadis.2010.07.007; Tateno K, 2006, CURR PHARM DESIGN, V12, P557, DOI 10.2174/138161206775474332; Uccelli A, 2007, TRENDS IMMUNOL, V28, P219, DOI 10.1016/j.it.2007.03.001; Wang DX, 2012, AQUAT ECOSYST HEALTH, V15, P4, DOI 10.1080/14634988.2012.663631; Wei X, 2009, STEM CELLS, V27, P478, DOI 10.1634/stemcells.2008-0333; Wilkins A, 2003, J NEUROSCI, V23, P4967, DOI 10.1523/jneurosci.23-12-04967.2003; Wilkins A, 2009, STEM CELL RES, V3, P63, DOI 10.1016/j.scr.2009.02.006; Wolswijk G, 1998, J NEUROSCI, V18, P601; Wright KT, 2011, STEM CELLS, V29, P169, DOI 10.1002/stem.570; Yamout B, 2010, J NEUROIMMUNOL, V227, P185, DOI 10.1016/j.jneuroim.2010.07.013; Yi L, 2005, GLIA, V49, P407, DOI 10.1002/glia.20126; Zappia E, 2005, BLOOD, V106, P1755, DOI 10.1182/blood-2005-04-1496; Zhang J, 2006, J NEUROSCI RES, V84, P587, DOI 10.1002/jnr.20962	101	45	45	0	34	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 5	2013	382	9899					1204	1213		10.1016/S0140-6736(13)61810-3	http://dx.doi.org/10.1016/S0140-6736(13)61810-3			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	228SL	24095194				2022-12-28	WOS:000325209100025
J	Harley, D				Harley, Diane			Scholarly Communication: Cultural Contexts, Evolving Models	SCIENCE			English	Editorial Material								Despite predictions that emerging technologies will transform how research is conducted, disseminated, and rewarded, why do we see so little actual shift in how scholars in the most competitive and aspirant institutions actually disseminate their research? I describe research on faculty values and needs in scholarly communication that confirm a number of conservative tendencies in publishing. These tendencies, influenced by tenure and promotion requirements, as well as disciplinary cultures, have both positive and negative consequences. Rigorous research could inform development of good practices and policies in academic publishing, as well as counter rhetoric concerning the future of peer review and scholarly communication.	Univ Calif Berkeley, Ctr Studies Higher Educ, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Harley, D (corresponding author), Univ Calif Berkeley, Ctr Studies Higher Educ, Berkeley, CA 94720 USA.	dianeh@berkeley.edu						[Anonymous], 2012, REPORT OF THE WORKIN; ATKINS D.E., 2003, REVOLUTIONIZING SCIE; Bell R., 2007, THE CHANGING RESEARC; BENKLER Y, 2006, WEALTH NETWORKS; Bollen J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006022; Borowski C, 2011, J EXP MED, V208, P1337, DOI 10.1084/jem.20111061; Bourne P., 2011, FORCE11MANIFESTO IMP; Franzoni C, 2011, SCIENCE, V333, P702, DOI 10.1126/science.1197286; Greaves S., 2006, NATURE WEB DEBATE PE; Harley D., 2011, PEER REVIEW IN ACADE; Harley D., 2010, ASSESSING THE FUTURE; Henneken EA, 2007, LEARN PUBL, V20, P16, DOI 10.1087/095315107779490661; Hey T., 2004, 4 PARADIGM DATA INTE; Jensen M., 2007, CHRONICLE REVIEW THE; Maunsell J, 2010, J NEUROSCI, V30, P10599; Olds K., 2010, INSIDE HIGHER EDUCAT; Rauhvarges A., 2011, GLOBAL UNIVERSITY RA; Van Noorden R, 2010, NATURE, V465, P864, DOI 10.1038/465864a; Ware M., 2009, THE STM REPORT AN OV	19	20	20	1	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 4	2013	342	6154					80	82		10.1126/science.1243622	http://dx.doi.org/10.1126/science.1243622			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	227PP	24092736				2022-12-28	WOS:000325126100048
J	Truog, RD; Miller, FG; Halpern, SD				Truog, Robert D.; Miller, Franklin G.; Halpern, Scott D.			The Dead-Donor Rule and the Future of Organ Donation	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								The ethics of organ transplantation have been premised on the dead-donor rule: vital organs should be taken only from persons who are dead. But why shouldn't some living patients, such as those near death but on life support, be allowed to donate organs? The ethics of organ transplantation have been premised on the dead-donor rule (DDR), which states that vital organs should be taken only from persons who are dead. Yet it is not obvious why certain living patients, such as those who are near death but on life support, should not be allowed to donate their organs, if doing so would benefit others and be consistent with their own interests. This issue is not merely theoretical. In one recent case, the parents of a young girl wanted to donate her organs after an accident had left her with devastating brain damage. Plans ...	[Truog, Robert D.] Harvard Univ, Sch Med, Dept Anesthesia, Boston, MA 02115 USA; [Truog, Robert D.] Harvard Univ, Sch Med, Global Heath & Social Med, Boston, MA 02115 USA; [Truog, Robert D.] Boston Childrens Hosp, Dept Anesthesiol Perioperat & Pain Med, Boston, MA USA; [Miller, Franklin G.] NIH, Dept Bioeth, Bethesda, MD 20892 USA; [Halpern, Scott D.] Univ Penn, Dept Med Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Halpern, Scott D.] Univ Penn, Dept Med Eth & Hlth Policy, Philadelphia, PA 19104 USA; [Halpern, Scott D.] Univ Penn, FIELDS Program, Philadelphia, PA 19104 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; National Institutes of Health (NIH) - USA; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Truog, RD (corresponding author), Harvard Univ, Sch Med, Dept Anesthesia, Boston, MA 02115 USA.							BERNAT JL, 1981, ANN INTERN MED, V94, P389, DOI 10.1001/archinte.94.3.389; Miller FG, 2012, DEATH DYING ORGAN TR; Sanghavi D., 2009, NY TIMES MAGAZINE; Shewmon DA, 1998, NEUROLOGY, V51, P1538, DOI 10.1212/WNL.51.6.1538; Siminoff LA, 2004, KENNEDY INST ETHIC J, V14, P217, DOI 10.1353/ken.2004.0034	5	71	72	0	23	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 3	2013	369	14					1287	1289		10.1056/NEJMp1307220	http://dx.doi.org/10.1056/NEJMp1307220			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	227KI	24088088				2022-12-28	WOS:000325111200003
J	Jagsi, R				Jagsi, Reshma			What's in a Name?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Jagsi, Reshma] Univ Michigan, Dept Radiat Oncol, Ann Arbor, MI 48109 USA; [Jagsi, Reshma] Univ Michigan, Ctr Bioeth & Social Sci Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Jagsi, R (corresponding author), Univ Michigan, Dept Radiat Oncol, Ann Arbor, MI 48109 USA.	rjagsi@med.umich.edu		Jagsi, Reshma/0000-0001-6562-1228				Bhatnagar AK, 2007, INT J RADIAT ONCOL, V69, P1527, DOI 10.1016/j.ijrobp.2007.05.086; DIXON GD, 1985, JAMA-J AM MED ASSOC, V254, P2558, DOI 10.1001/jama.1985.03360180056022; KING LS, 1985, JAMA-J AM MED ASSOC, V254, P266, DOI 10.1001/jama.254.2.266; NATKINS LG, 1982, JAMA-J AM MED ASSOC, V247, P2415, DOI 10.1001/jama.1982.03320420059039	4	1	1	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 2	2013	310	13					1347	1348		10.1001/jama.2013.276908	http://dx.doi.org/10.1001/jama.2013.276908			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	227GB	24084918				2022-12-28	WOS:000325098100018
J	Kolle, SFT; Fischer-Nielsen, A; Mathiasen, AB; Elberg, JJ; Oliveri, RS; Glovinski, PV; Kastrup, J; Kirchhoff, M; Rasmussen, BS; Talman, MLM; Thomsen, C; Dickmeiss, E; Drzewiecki, KT				Kolle, Stig-Frederik Trojahn; Fischer-Nielsen, Anne; Mathiasen, Anders Bruun; Elberg, Jens Jorgen; Oliveri, Roberto S.; Glovinski, Peter V.; Kastrup, Jens; Kirchhoff, Maria; Rasmussen, Bo Sonnich; Talman, Maj-Lis Moller; Thomsen, Carsten; Dickmeiss, Ebbe; Drzewiecki, Krzysztof Tadeusz			Enrichment of autologous fat grafts with ex-vivo expanded adipose tissue-derived stem cells for graft survival: a randomised placebo-controlled trial	LANCET			English	Article							ASSISTED LIPOTRANSFER; STROMAL CELLS; INTERNATIONAL-SOCIETY; SUPPORTIVE USE; TRANSPLANTATION; AUGMENTATION; ANGIOGENESIS; EXPANSION; BLOOD	Background Autologous fat grafting is increasingly used in reconstructive surgery. However, resorption rates ranging from 25% to 80% have been reported. Therefore, methods to increase graft viability are needed. Here, we report the results of a triple-blind, placebo-controlled trial to compare the survival of fat grafts enriched with autologous adiposederived stem cells (ASCs) versus non-enriched fat grafts. Methods Healthy participants underwent two liposuctions taken 14 days apart: one for ASC isolation and ex-vivo expansion, and another for the preparation of fat grafts. Two purifi ed fat grafts (30 mL each) taken from the second liposuction were prepared for each participant. One graft was enriched with ASCs (20 x 106 cells per mL fat), and another graft without ASC enrichment served as a control. The fat grafts were injected subcutaneously as a bolus to the posterior part of the right and left upper arm according to the randomisation sequence. The volumes of injected fat grafts were measured by MRI immediately after injection and after 121 days before surgical removal. The primary goal was to compare the residual graft volumes of ASC-enriched grafts with those of control grafts. This study is registered at www. clinicaltrialsregister. eu, number 2010-023006-12. Findings 13 participants were enrolled, three of whom were excluded. Compared with the control grafts, the ASCenriched fat grafts had signifi cantly higher residual volumes: 23.00 (95% CI 20.57-25.43) cm 3 versus 4.66 (3.16-6.16) cm 3 for the controls, corresponding to 80.9% (76.6-85.2) versus 16.3% (11.1-21.4) of the initial volumes, respectively (p< 0.0001). The diff erence between the groups was 18.34 (95% CI 15.70-20.98) cm 3, equivalent to 64.6% (57.1-72.1; p< 0.0001). No serious adverse events were noted. Interpretation The procedure of ASC-enriched fat grafting had excellent feasibility and safety. These promising results add signifi cantly to the prospect of stem cell use in clinical settings, and indicate that ASC graft enrichment could render lipofi lling a reliable alternative to major tissue augmentation, such as breast surgery, with allogeneic material or major fl ap surgery.	[Kolle, Stig-Frederik Trojahn; Elberg, Jens Jorgen; Glovinski, Peter V.; Rasmussen, Bo Sonnich; Drzewiecki, Krzysztof Tadeusz] Copenhagen Univ Hosp, Rigshosp, Dept Plast Surg Breast Surg & Burns, Copenhagen, Denmark; [Fischer-Nielsen, Anne; Oliveri, Roberto S.; Dickmeiss, Ebbe] Copenhagen Univ Hosp, Rigshosp, Dept Clin Immunol, Blood Bank,Cell Therapy Facil, Copenhagen, Denmark; [Mathiasen, Anders Bruun; Kastrup, Jens] Copenhagen Univ Hosp, Rigshosp, Ctr Heart, Cardiol Stem Cell Lab, Copenhagen, Denmark; [Thomsen, Carsten] Copenhagen Univ Hosp, Rigshosp, Dept Radiol, Copenhagen, Denmark; [Talman, Maj-Lis Moller] Copenhagen Univ Hosp, Rigshosp, Dept Pathol, Copenhagen, Denmark; [Kirchhoff, Maria] Copenhagen Univ Hosp, Rigshosp, Dept Clin Genet, Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen	Kolle, SFT (corresponding author), Rigshosp, Copenhagen Univ Hosp, Dept Plast Surg Breast Surg & Burns 2102, Blegdamsvej 9, DK-2100 Copenhagen, Denmark.	stigfrederik@gmail.com		Vester-Glowinski, Peter Viktor/0000-0003-0686-9703; Kolle, Stig-Frederik Trojahn/0000-0003-2298-1498; Vester-Glowinski, Peter V./0000-0002-3531-7492	Danish Cancer Society; Centre of Head and Orthopaedics Rigshospitalet; Moalem Weitemeyer Bendtsen	Danish Cancer Society(Danish Cancer Society); Centre of Head and Orthopaedics Rigshospitalet; Moalem Weitemeyer Bendtsen	Danish Cancer Society, Centre of Head and Orthopaedics Rigshospitalet, and Moalem Weitemeyer Bendtsen.	Altman D.G., 1990, PRACTICAL STAT MED R, DOI DOI 10.1201/9780429258589; Barret JP, 2009, CLIN PLAST SURG, V36, P487, DOI 10.1016/j.cps.2009.02.005; Bourin P, 2013, CYTOTHERAPY, V15, P641, DOI 10.1016/j.jcyt.2013.02.006; Casiraghi F, 2013, STEM CELL REV REP, V9, P65, DOI 10.1007/s12015-011-9345-4; Chang L, 2013, ANN PLAST SURG; Coleman SR, 2001, CLIN PLAST SURG, V28, P111; Coleman SR, 2007, PLAST RECONSTR SURG, V119, P775, DOI 10.1097/01.prs.0000252001.59162.c9; Coleman SR, 2006, PLAST RECONSTR SURG, V118, p108S, DOI 10.1097/01.prs.0000234610.81672.e7; Delay E, 2009, AESTHET SURG J, V29, P360, DOI 10.1016/j.asj.2009.08.010; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Francis MP, 2010, ORGANOGENESIS, V6, P11, DOI 10.4161/org.6.1.10019; Hida N, 2008, STEM CELLS, V26, P1695, DOI 10.1634/stemcells.2007-0826; Khouri R, 2009, CLIN PLAST SURG, V36, P269, DOI 10.1016/j.cps.2008.11.009; Kolle SFT, 2013, CYTOTHERAPY, V15, P1086, DOI 10.1016/j.jcyt.2013.01.217; Leuchter I, 2010, EUR ARCH OTO-RHINO-L, V267, P977, DOI 10.1007/s00405-009-1157-7; Li J, 2013, DERMATOL SURG, V39, P449, DOI 10.1111/dsu.12058; Lu F, 2009, PLAST RECONSTR SURG, V124, P1437, DOI 10.1097/PRS.0b013e3181babbb6; Matsumoto D, 2006, TISSUE ENG, V12, P3375, DOI 10.1089/ten.2006.12.3375; Missana MC, 2007, EJSO-EUR J SURG ONC, V33, P685, DOI 10.1016/j.ejso.2006.12.002; Nishimura T, 2000, LARYNGOSCOPE, V110, P1333, DOI 10.1097/00005537-200008000-00021; Prockop DJ, 2010, CYTOTHERAPY, V12, P576, DOI 10.3109/14653249.2010.507330; Schallmoser K, 2007, TRANSFUSION, V47, P1436, DOI 10.1111/j.1537-2995.2007.01220.x; Sinna R, 2010, J PLAST RECONSTR AES, V63, P1769, DOI 10.1016/j.bjps.2009.12.002; Suga H, 2010, PLAST RECONSTR SURG, V126, P1911, DOI 10.1097/PRS.0b013e3181f4468b; Wang YY, 2013, J CRANIOFAC SURG, V24, P700, DOI 10.1097/SCS.0b013e31828b6c84; Yoshimura K, 2008, DERMATOL SURG, V34, P1178, DOI 10.1111/j.1524-4725.2008.34256.x; Yoshimura K, 2008, AESTHET PLAST SURG, V32, P48, DOI 10.1007/s00266-007-9019-4; Yoshimura K, 2010, BREAST J, V16, P169, DOI 10.1111/j.1524-4741.2009.00873.x; Yuan Y, 2013, CELL BIOL INT, V37, P547, DOI 10.1002/cbin.10068; Zhu M, 2010, ANN PLAS SURG, V64, P222, DOI 10.1097/SAP.0b013e31819ae05c	30	361	386	4	75	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 28	2013	382	9898					1113	1120		10.1016/S0140-6736(13)61410-5	http://dx.doi.org/10.1016/S0140-6736(13)61410-5			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	228SG	24075051				2022-12-28	WOS:000325208100027
J	Lai, A; Du, ZH; Gan, CL; Schuh, CA				Lai, Alan; Du, Zehui; Gan, Chee Lip; Schuh, Christopher A.			Shape Memory and Superelastic Ceramics at Small Scales	SCIENCE			English	Article							MARTENSITIC-TRANSFORMATION; ZIRCONIA; TOUGHNESS; SELECTION; BEHAVIOR; ALLOYS	Shape memory materials are a class of smart materials able to convert heat into mechanical strain (or strain into heat) by virtue of a martensitic phase transformation. Some brittle materials such as intermetallics and ceramics exhibit a martensitic transformation but fail by cracking at low strains and after only a few applied strain cycles. Here we show that such failure can be suppressed in normally brittle martensitic ceramics by providing a fine-scale structure with few crystal grains. Such oligocrystalline structures reduce internal mismatch stresses during the martensitic transformation and lead to robust shape memory ceramics that are capable of many superelastic cycles up to large strains; here we describe samples cycled as many as 50 times and samples that can withstand strains over 7%. Shape memory ceramics with these properties represent a new class of actuators or smart materials with a set of properties that include high energy output, high energy damping, and high-temperature usage.	[Lai, Alan; Schuh, Christopher A.] MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA; [Du, Zehui; Gan, Chee Lip] Nanyang Technol Univ, Temasek Labs, Singapore 639798, Singapore; [Gan, Chee Lip] Nanyang Technol Univ, Sch Mat Sci & Engn, Singapore 639798, Singapore	Massachusetts Institute of Technology (MIT); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Schuh, CA (corresponding author), MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA.	schuh@mit.edu	Gan, Chee Lip/A-2248-2011; Gan, Chee Lip/AAU-5911-2020	Gan, Chee Lip/0000-0002-8420-3168; Gan, Chee Lip/0000-0002-8420-3168; Du, Zehui/0000-0002-5511-7455; Schuh, Christopher/0000-0001-9856-2682	 [9011102294];  [9011102296]	; 	We thank A. Schwartzmann, S. Speakman, and S. Chen at MIT's Center for Materials Science and Engineering; D. Galler at MIT; and S. Amini and A. Miserez at NTU for their assistance with experiments, as well as N. Antoniou at Harvard Center for Nanoscale Systems. We acknowledge the project funding support under project agreements 9011102294 and 9011102296. MIT has applied for a patent, application number USSN 13/791,857, dated 2 July 2012; and MIT/NTU jointly applied for a provisional patent, application number USSN 61/775,446, dated 8 March 2013, related to the materials and design methods produced in this work. We acknowledge the late Prof. Ma Jan (NTU) for initiating this project collaboration.	CAI HD, 1993, SCRIPTA METALL MATER, V28, P1161, DOI 10.1016/0956-716X(93)90027-P; Chen Y, 2011, ACTA MATER, V59, P537, DOI 10.1016/j.actamat.2010.09.057; DUH JG, 1988, J MATER SCI, V23, P2786, DOI 10.1007/BF00547451; HEUER AH, 1990, J AM CERAM SOC, V73, P1084, DOI 10.1111/j.1151-2916.1990.tb05161.x; Huber JE, 1997, P ROY SOC A-MATH PHY, V453, P2185, DOI 10.1098/rspa.1997.0117; JIANG BH, 1992, MATER RES SOC SYMP P, V246, P213; Jin XJ, 2005, CURR OPIN SOLID ST M, V9, P313, DOI 10.1016/j.cossms.2006.02.012; Kelly PM, 2002, PROG MATER SCI, V47, P463, DOI 10.1016/S0079-6425(00)00005-0; KIRBY SH, 1993, J STRUCT GEOL, V15, P1223, DOI 10.1016/0191-8141(93)90165-7; KRIVEN WM, 1988, J AM CERAM SOC, V71, P1021, DOI 10.1111/j.1151-2916.1988.tb05786.x; Lagoudas DC., 2008, SHAPE MEMORY ALLOYS; LANKFORD J, 1988, J MATER SCI, V23, P4144, DOI 10.1007/BF01106850; Launey ME, 2009, ADV MATER, V21, P2103, DOI 10.1002/adma.200803322; Ma J, 2010, SCIENCE, V327, P1468, DOI 10.1126/science.1186766; Otsuka K., 1999, SHAPE MEMORY MAT; Ozdemir N, 2012, ACTA MATER, V60, P5670, DOI 10.1016/j.actamat.2012.06.035; Pelton AR, 2011, J MATER ENG PERFORM, V20, P613, DOI 10.1007/s11665-011-9864-9; REYESMOREL PE, 1988, J AM CERAM SOC, V71, P648, DOI 10.1111/j.1151-2916.1988.tb06383.x; ROBINSON AL, 1976, SCIENCE, V191, P934, DOI 10.1126/science.191.4230.934; RUHLE M, 1989, PROG MATER SCI, V33, P85, DOI 10.1016/0079-6425(89)90005-4; Runciman A, 2011, BIOMATERIALS, V32, P4987, DOI 10.1016/j.biomaterials.2011.03.057; San Juan J, 2012, ACTA MATER, V60, P4093, DOI 10.1016/j.actamat.2012.04.021; San Juan J, 2009, NAT NANOTECHNOL, V4, P415, DOI [10.1038/NNANO.2009.142, 10.1038/nnano.2009.142]; SHEU TS, 1992, J AM CERAM SOC, V75, P1108, DOI 10.1111/j.1151-2916.1992.tb05546.x; Simha NK, 1997, J MECH PHYS SOLIDS, V45, P261, DOI 10.1016/S0022-5096(96)00074-9; SWAIN MV, 1986, NATURE, V322, P234, DOI 10.1038/322234a0; TADAKI T, 1988, ANNU REV MATER SCI, V18, P25; Ueland SM, 2012, ADV FUNCT MATER, V22, P2094, DOI 10.1002/adfm.201103019; Zhang YL, 2001, MATER SCI FORUM, V394-3, P573; Zupan M, 2002, ADV ENG MATER, V4, P933, DOI 10.1002/adem.200290009	30	179	188	28	380	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 27	2013	341	6153					1505	1508		10.1126/science.1239745	http://dx.doi.org/10.1126/science.1239745			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	224NS	24072920	Green Submitted			2022-12-28	WOS:000324894600048
J	Wick, S; Decker, M; Matthes, D; Wright, R				Wick, Sue; Decker, Mark; Matthes, David; Wright, Robin			Students Propose Genetic Solutions to Societal Problems	SCIENCE			English	Editorial Material									[Wick, Sue; Decker, Mark; Matthes, David; Wright, Robin] Univ Minnesota Twin Cities, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities	Wright, R (corresponding author), Univ Minnesota Twin Cities, St Paul, MN 55108 USA.	wrightr@umn.edu						Anderson L. W., 2005, TEACHING ASSESSING R; BEICHNER RJ, 2007, RES BASED REFORM U P, V0001; Brown A. L., 2000, PEOPLE LEARN; Handelsman J, 2007, SCI TEACHING; Michaelsen L. K., 2002, TEAM BASED LEARNING; National Research Council and NetLibrary Inc., 2003, BIO 2010 TRANSF UND; Udovic D, 2002, BIOSCIENCE, V52, P272, DOI 10.1641/0006-3568(2002)052[0272:WBDTEO]2.0.CO;2	7	2	2	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 27	2013	341	6153					1467	1468		10.1126/science.1230002	http://dx.doi.org/10.1126/science.1230002			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	224NS	24072915	Bronze			2022-12-28	WOS:000324894600039
J	Oury, F; Khrimian, L; Denny, CA; Gardin, A; Chamouni, A; Goeden, N; Huang, YY; Lee, H; Srinivas, P; Gao, XB; Suyama, S; Langer, T; Mann, JJ; Horvath, TL; Bonnin, A; Karsenty, G				Oury, Franck; Khrimian, Lori; Denny, Christine A.; Gardin, Antoine; Chamouni, Alexandre; Goeden, Nick; Huang, Yung-yu; Lee, Hojoon; Srinivas, Prashanth; Gao, Xiao-Bing; Suyama, Shigetomo; Langer, Thomas; Mann, John. J.; Horvath, Tamas L.; Bonnin, Alexandre; Karsenty, Gerard			Maternal and Offspring Pools of Osteocalcin Influence Brain Development and Functions	CELL			English	Article							INHIBITS BONE-FORMATION; DEFICIENT MICE; CLEIDOCRANIAL DYSPLASIA; ENERGY-METABOLISM; SEROTONIN; MASS; HYDROXYLASE; EXPRESSION; INSULIN; ANXIETY	The powerful regulation of bone mass exerted by the brain suggests the existence of bone-derived signals modulating this regulation or other functions of the brain. We show here that the osteoblast-derived hormone osteocalcin crosses the blood-brain barrier, binds to neurons of the brainstem, midbrain, and hippocampus, enhances the synthesis of monoamine neurotransmitters, inhibits GABA synthesis, prevents anxiety and depression, and favors learning and memory independently of its metabolic functions. In addition to these postnatal functions, maternal osteocalcin crosses the placenta during pregnancy and prevents neuronal apoptosis before embryos synthesize this hormone. As a result, the severity of the neuroanatomical defects and learning and memory deficits of Osteocalcin(-/-) mice is determined by the maternal genotype, and delivering osteocalcin to pregnant Osteocalcin(-/-) mothers rescues these abnormalities in their Osteocalcin(-/-) progeny. This study reveals that the skeleton via osteocalcin influences cognition and contributes to the maternal influence on fetal brain development.	[Oury, Franck; Khrimian, Lori; Gardin, Antoine; Chamouni, Alexandre; Srinivas, Prashanth; Karsenty, Gerard] Columbia Univ, Dept Genet & Dev, New York, NY 10032 USA; [Denny, Christine A.] Columbia Univ, Dept Psychiat, New York, NY 10032 USA; [Goeden, Nick; Bonnin, Alexandre] Univ So Calif, Keck Sch Med, Zilkha Neurogenet Inst, Dept Cell & Neurobiol, Los Angeles, CA 90089 USA; [Huang, Yung-yu; Mann, John. J.] Columbia Univ, Dept Psychiat, Div Mol Imaging & Neuropathol, New York, NY 10471 USA; [Huang, Yung-yu; Mann, John. J.] New York State Psychiat Inst & Hosp, New York, NY 10471 USA; [Lee, Hojoon] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Gao, Xiao-Bing; Suyama, Shigetomo; Horvath, Tamas L.] Yale Univ, Sch Med, Comparat Med Sect, Program Integrat Cell Signaling & Neurobiol Metab, New Haven, CT 06520 USA; [Langer, Thomas] Sanofi Aventis Deutschland GmbH, R&D Biotherapeut BioInnovat, D-65926 Frankfurt, Germany	Columbia University; Columbia University; University of Southern California; Columbia University; New York State Psychiatry Institute; Columbia University; Yale University; Sanofi-Aventis	Karsenty, G (corresponding author), Columbia Univ, Dept Genet & Dev, New York, NY 10032 USA.	gk2172@columbia.edu	Langer, Thomas/AAB-7609-2020; Gao, Xiao-Bing/C-3121-2011; Denny, Christine Ann A/I-5235-2015	Gao, Xiao-Bing/0000-0002-2035-4936; Denny, Christine Ann A/0000-0002-6926-2020; OURY, FRANCK/0000-0003-0562-9900; Karsenty, Gerard/0000-0002-9253-7627; Lee, Hojoon/0000-0001-6214-629X	NIH; Sanofi Aventis; Pioneer award; Human frontier scientific program; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR045548] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [DP1DK098058] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007088] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG032959] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sanofi Aventis(Sanofi-Aventis); Pioneer award; Human frontier scientific program; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Drs. P. Ducy, C. Zuker, and R. Hen for critical reading of the manuscript or experimental advice and Drs. R. Allikmets and J. Kong for performing the electroretinogram. This work was supported by grants from the NIH (G.K.), Sanofi Aventis (G.K.), Pioneer award (T.L.H.), and Human frontier scientific program (F.O.).	Bach H, 2011, J NEUROCHEM, V118, P1067, DOI 10.1111/j.1471-4159.2011.07379.x; Banks WA, 1996, PEPTIDES, V17, P305, DOI 10.1016/0196-9781(96)00025-3; Broad KD, 2011, P NATL ACAD SCI USA, V108, P15237, DOI 10.1073/pnas.1106022108; Challis JRG, 2012, NAT REV ENDOCRINOL, V8, P629, DOI 10.1038/nrendo.2012.183; CRAWLEY JN, 1985, NEUROSCI BIOBEHAV R, V9, P37, DOI 10.1016/0149-7634(85)90030-2; Cryan JF, 2005, NEUROSCI BIOBEHAV R, V29, P571, DOI 10.1016/j.neubiorev.2005.03.009; Daubner SC, 2011, ARCH BIOCHEM BIOPHYS, V508, P1, DOI 10.1016/j.abb.2010.12.017; David DJ, 2009, NEURON, V62, P479, DOI 10.1016/j.neuron.2009.04.017; Denny CA, 2012, HIPPOCAMPUS, V22, P1188, DOI 10.1002/hipo.20964; Ducy P, 1996, NATURE, V382, P448, DOI 10.1038/382448a0; Ducy P, 2000, CELL, V100, P197, DOI 10.1016/S0092-8674(00)81558-5; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Elefteriou F, 2004, P NATL ACAD SCI USA, V101, P3258, DOI 10.1073/pnas.0308744101; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; Ferron M, 2010, CELL, V142, P296, DOI 10.1016/j.cell.2010.06.003; Gardier AM, 1996, FUND CLIN PHARMACOL, V10, P16, DOI 10.1111/j.1472-8206.1996.tb00145.x; Goeden N, 2013, NAT PROTOC, V8, P66, DOI 10.1038/nprot.2012.144; Guntur AR, 2012, ENDOCR PRACT, V18, P758, DOI 10.4158/EP12141.RA; HALES CN, 1992, DIABETOLOGIA, V35, P595, DOI 10.1007/BF00400248; Holmes A, 2000, PHYSIOL BEHAV, V71, P509, DOI 10.1016/S0031-9384(00)00373-5; Hsu CL, 2012, OSTEOPOROSIS INT, V23, P2409, DOI 10.1007/s00198-012-1992-z; Jansson T, 2007, CLIN SCI, V113, P1, DOI 10.1042/CS20060339; Karsenty G, 2012, NATURE, V481, P314, DOI 10.1038/nature10763; Kim JE, 2004, AM J PATHOL, V165, P1875, DOI 10.1016/S0002-9440(10)63240-3; Lawlor DA, 2012, NAT REV ENDOCRINOL, V8, P679, DOI 10.1038/nrendo.2012.176; Lee B, 1997, NAT GENET, V16, P307, DOI 10.1038/ng0797-307; Lee NK, 2007, CELL, V130, P456, DOI 10.1016/j.cell.2007.05.047; Lira A, 2003, BIOL PSYCHIAT, V54, P960, DOI 10.1016/S0006-3223(03)00696-6; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Mundlos S, 1997, CELL, V89, P773, DOI 10.1016/S0092-8674(00)80260-3; Nagamatsu LS, 2012, ARCH INTERN MED, V172, P666, DOI 10.1001/archinternmed.2012.379; Oury F, 2013, J CLIN INVEST, V123, P2421, DOI 10.1172/JCI65952; Oury F, 2011, CELL, V144, P796, DOI 10.1016/j.cell.2011.02.004; Oury F, 2010, GENE DEV, V24, P2330, DOI 10.1101/gad.1977210; Palmiter RD, 2008, ANN NY ACAD SCI, V1129, P35, DOI 10.1196/annals.1417.003; Pi M, 2012, ENDOCRINOLOGY, V153, P2062, DOI 10.1210/en.2011-2117; Pogoda P, 2006, J BONE MINER RES, V21, P1591, DOI 10.1359/JBMR.060709; Seibel MJ, 2002, CURR OPIN CLIN NUTR, V5, P525, DOI 10.1097/00075197-200209000-00011; SOULE AB, 1946, J BONE JOINT SURG, V28, P81; Takeda S, 2002, CELL, V111, P305, DOI 10.1016/S0092-8674(02)01049-8; Tanaka DH, 2006, DEVELOPMENT, V133, P2167, DOI 10.1242/dev.02382; Vaira S, 2012, ENDOCRINOLOGY, V153, P5622, DOI 10.1210/en.2012-1462; Van den Bergh BRH, 2005, NEUROSCI BIOBEHAV R, V29, P237, DOI 10.1016/j.neubiorev.2004.10.007; Walther DJ, 2003, SCIENCE, V299, P76, DOI 10.1126/science.1078197; Weinstock M, 2008, NEUROSCI BIOBEHAV R, V32, P1073, DOI 10.1016/j.neubiorev.2008.03.002; Yadav VK, 2009, CELL, V138, P976, DOI 10.1016/j.cell.2009.06.051	46	236	256	3	43	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 26	2013	155	1					228	241		10.1016/j.cell.2013.08.042	http://dx.doi.org/10.1016/j.cell.2013.08.042			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	224UX	24074871	Green Accepted, Bronze			2022-12-28	WOS:000324916700022
J	Black, ME				Black, Mary E.			How to get out of hospital	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												drmaryblack@gmail.com							0	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 25	2013	347								f5788	10.1136/bmj.f5788	http://dx.doi.org/10.1136/bmj.f5788			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	227CW	24068724				2022-12-28	WOS:000325087200021
J	Pennington, H; Isles, C				Pennington, Hugh; Isles, Chris			Should hospitals provide all patients with single rooms?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							INFECTION; OUTBREAK		[Pennington, Hugh] Univ Aberdeen, Aberdeen, Scotland; [Isles, Chris] Dumfries & Galloway Royal Infirm, Dept Med, Dumfries DG1 4AP, Scotland	University of Aberdeen	Pennington, H (corresponding author), Univ Aberdeen, Aberdeen, Scotland.	mmb036@abdn.ac.uk; chris.isles@nhs.net						Baussano I, 2011, EMERG INFECT DIS, V17, P488, DOI 10.3201/eid1703.100947; Commission for Healthcare Audit and Inspection, 2009, INV MIDST NHS TRUST; Department of Health, 2007, PUBL PERC PRIV DIGN; Dowdeswell B, HOSP WARD CONFIGURAT; Enstone JE, 2011, EMERG INFECT DIS, V17, P592, DOI 10.3201/eid1704.101679; Florey L, 2009, SCOT MED J, V54, P5, DOI 10.1258/rsmsmj.54.2.5; Hamel M, 2010, AM J INFECT CONTROL, V38, P173, DOI 10.1016/j.ajic.2009.08.016; Mattner F, 2006, CLIN MICROBIOL INFEC, V12, P69, DOI 10.1111/j.1469-0691.2005.01299.x; PricewaterhouseCooper, 2004, ROL HOSP DES RECR RE; Scottish Government, 2008, SINGL ROOM PROV STEE; Scottish Parliament, 2013, PET PE01482 IS SINGL; Stall N, 2012, CAN MED ASSOC J, V184, P24, DOI 10.1503/cmaj.109-4077; Teltsch DY, 2011, ARCH INTERN MED, V171, P32, DOI 10.1001/archinternmed.2010.469; U.S. Department of Health and Human Services Centers for Disease Control and Prevention, 2005, MMWR-MORBID MORTAL W, V54; Varia M, 2003, CAN MED ASSOC J, V169, P285; Welsh Health Estates, 2007, S SINGL BED WARD ACC	16	26	26	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 24	2013	347								f5695	10.1136/bmj.f5695	http://dx.doi.org/10.1136/bmj.f5695			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	227CT	24065553				2022-12-28	WOS:000325086800005
J	Benilova, I; De Strooper, B				Benilova, Iryna; De Strooper, Bart			Promiscuous Alzheimer's Amyloid: Yet Another Partner	SCIENCE			English	Editorial Material							SYNAPTIC PLASTICITY; PRION PROTEIN; DISEASE; IMPAIRMENT; PIRB; MHC		[Benilova, Iryna] VIB, Ctr Biol Dis, Louvain, Belgium; Univ Leuven KU Leuven, Ctr Human Genet, B-3000 Louvain, Belgium; Univ Leuven KU Leuven, LIND, B-3000 Louvain, Belgium; Univ Hosp, B-3000 Louvain, Belgium	Flanders Institute for Biotechnology (VIB); KU Leuven; KU Leuven	Benilova, I (corresponding author), VIB, Ctr Biol Dis, Louvain, Belgium.	bart.destrooper@cme.vib-kuleuven.be	de+Strooper, Bart/Z-1638-2019; Benilova, Iryna/H-6533-2019					[Anonymous], 2011, NAT NEUROSCI, V14, P399; Atwal JK, 2008, SCIENCE, V322, P967, DOI 10.1126/science.1161151; Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; Benilova I, 2010, EMBO MOL MED, V2, P289, DOI 10.1002/emmm.201000088; Cisse M, 2011, NATURE, V469, P47, DOI 10.1038/nature09635; Huh GS, 2000, SCIENCE, V290, P2155, DOI 10.1126/science.290.5499.2155; Kam TI, 2013, J CLIN INVEST, V123, P2791, DOI 10.1172/JCI66827; Kim T, 2013, SCIENCE, V341, P1399, DOI 10.1126/science.1242077; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Malinow R, 2012, CURR OPIN NEUROBIOL, V22, P559, DOI 10.1016/j.conb.2011.09.001; Syken J, 2006, SCIENCE, V313, P1795, DOI 10.1126/science.1128232; Takai T, 2005, IMMUNOLOGY, V115, P433, DOI 10.1111/j.1365-2567.2005.02177.x; Verdier Y, 2004, J PEPT SCI, V10, P229, DOI 10.1002/psc.573; William CM, 2012, J NEUROSCI, V32, P8004, DOI 10.1523/JNEUROSCI.5369-11.2012	14	49	51	0	72	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 20	2013	341	6152					1354	1355		10.1126/science.1244166	http://dx.doi.org/10.1126/science.1244166			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	220PK	24052299				2022-12-28	WOS:000324597200033
